[
    {
        "SNP ID": "rs2268169",
        "SNP Name": "H6PD G9321241A",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2268169",
        "Video": null,
        "Tags": "5-lactone + H2O = 6-phospho-D-gluconate,5-lactone + NAD(P)H,5-lactone 6-phosphate + NAD(P)H,6-phospho-D-glucono-1,6-phosphogluconalactonase subfamily,6-phosphogluconolactonase,6-phosphogluconolactonase activity,6-phosphogluconolactonase_DevB,adrenocorticotropin-mediated androgen excess,as well as other hexose-6-phosphates. D-glucose + NAD(P)+ = D-glucono-1,Carbohydrate metabolism,cortisol,cortison reductase deficiency,cortisone,CRD,D-glucose 6-phosphate + NAD(P)+ = D-glucono-1,endoplasmic bifunctional protein. Oxidizes glucose-6-phosphate and glucose,Endoplasmic reticulum,endoplasmic reticulum lumen,G9321241A,galactosamine-6-phosphate isomerase family,GDH/6PGL,glicose metabolism,glucosamine,glucose 1-dehydrogenase,glucose metabolic process,glucose-6-phosphate dehydrogenase,glucose-6-phosphate dehydrogenase family,glycoprotein,H6PD,Hexose-6-phosphate dehydrogenase,Hydrolase,Hyperandrogenism,N-linked (GlcNAc...),N6-succinyllysine,NAD,NADP,NADP binding,Oxidoreductase,PCOS,pentose-phosphate pathway,pentose-phosphate shunt,polystic ovary syndrome,Proton acceptor,Pyrrolidone carboxylic acid,rs2268169,Signal",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs6688832",
        "SNP Name": "H6PD G9323910A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6688832",
        "Video": null,
        "Tags": "5-lactone + H2O = 6-phospho-D-gluconate,5-lactone + NAD(P)H,5-lactone 6-phosphate + NAD(P)H,6-phospho-D-glucono-1,6-phosphogluconalactonase subfamily,6-phosphogluconolactonase,6-phosphogluconolactonase activity,6-phosphogluconolactonase_DevB,adrenocorticotropin-mediated androgen excess,as well as other hexose-6-phosphates. D-glucose + NAD(P)+ = D-glucono-1,Carbohydrate metabolism,cortisol,cortison reductase deficiency,cortisone,CRD,D-glucose 6-phosphate + NAD(P)+ = D-glucono-1,endoplasmic bifunctional protein. Oxidizes glucose-6-phosphate and glucose,Endoplasmic reticulum,endoplasmic reticulum lumen,G9323910A,galactosamine-6-phosphate isomerase family,GDH/6PGL,glicose metabolism,glucosamine,glucose 1-dehydrogenase,glucose metabolic process,glucose-6-phosphate dehydrogenase,glucose-6-phosphate dehydrogenase family,glycoprotein,H6PD,Hexose-6-phosphate dehydrogenase,hexose-6-phosphates,Hydrolase,Hyperandrogenism,N-linked (GlcNAc...),N6-succinyllysine,NAD,NADP,NADP binding,Oxidoreductase,PCOS,pentose-phosphate pathway,pentose-phosphate shunt,polystic ovary syndrome,Proton acceptor,Pyrrolidone carboxylic acid,rs6688832,Signal",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs17368528",
        "SNP Name": "H6PD P554L",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs17368528",
        "Video": null,
        "Tags": "5-lactone + H2O = 6-phospho-D-gluconate,5-lactone + NAD(P)H,5-lactone 6-phosphate + NAD(P)H,6-phospho-D-glucono-1,6-phosphogluconalactonase subfamily,6-phosphogluconolactonase,6-phosphogluconolactonase activity,6-phosphogluconolactonase_DevB,adrenocorticotropin-mediated androgen excess,as well as other hexose-6-phosphates. D-glucose + NAD(P)+ = D-glucono-1,Carbohydrate metabolism,cortisol,cortison reductase deficiency,cortisone,CRD,D-glucose 6-phosphate + NAD(P)+ = D-glucono-1,endoplasmic bifunctional protein. Oxidizes glucose-6-phosphate and glucose,Endoplasmic reticulum,endoplasmic reticulum lumen,galactosamine-6-phosphate isomerase family,GDH/6PGL,glicose metabolism,glucosamine,glucose 1-dehydrogenase,glucose metabolic process,glucose-6-phosphate dehydrogenase,glucose-6-phosphate dehydrogenase family,glycoprotein,H6PD,Hexose-6-phosphate dehydrogenase,Hydrolase,Hyperandrogenism,N-linked (GlcNAc...),N6-succinyllysine,NAD,NADP,NADP binding,Oxidoreductase,P554L,PCOS,pentose-phosphate shunt,polystic ovary syndrome,Proton acceptor,Pyrrolidone carboxylic acid,rs17368528,Signal",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs9434742",
        "SNP Name": "H6PD Y673Y",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs9434742",
        "Video": null,
        "Tags": "5-lactone + H2O = 6-phospho-D-gluconate,5-lactone + NAD(P)H,5-lactone 6-phosphate + NAD(P)H,6-phospho-D-glucono-1,6-phosphogluconalactonase subfamily,6-phosphogluconolactonase,6-phosphogluconolactonase activity,6-phosphogluconolactonase_DevB,adrenocorticotropin-mediated androgen excess,as well as other hexose-6-phosphates. D-glucose + NAD(P)+ = D-glucono-1,Carbohydrate metabolism,cortisol,cortison reductase deficiency,cortisone,CRD,D-glucose 6-phosphate + NAD(P)+ = D-glucono-1,endoplasmic bifunctional protein. Oxidizes glucose-6-phosphate and glucose,Endoplasmic reticulum,endoplasmic reticulum lumen,galactosamine-6-phosphate isomerase family,GDH/6PGL,glicose metabolism,glucosamine,glucose 1-dehydrogenase,glucose metabolic process,glucose-6-phosphate dehydrogenase,glucose-6-phosphate dehydrogenase family,glycoprotein,H6PD,Hexose-6-phosphate dehydrogenase,Hydrolase,Hyperandrogenism,N-linked (GlcNAc...),N6-succinyllysine,NAD,NADP,NADP binding,Oxidoreductase,PCOS,pentose-phosphate pathway,pentose-phosphate shunt,polystic ovary syndrome,Proton acceptor,Pyrrolidone carboxylic acid,rs9434742,Signal,Y673Y",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs516243",
        "SNP Name": "CASZ1 A10750432G",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs4846048",
        "SNP Name": "MTHFR C24909T",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4846048",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,amino acids,anencephaly,arsenic,Arsenic Methyltransferase,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,bladder cancer,blood circulation,blood pressure,cancer,cancerous,carcinogen,Catalyzes the conversion of 5,cellular amino acid metabolic process,children,cleft lip,cleft palate,cobalamin,cognitive function,colon cancer and acute leukemia,colorectal cancer,Complete proteome,conotruncal heart defects,cyanocobalamin,cysteine,cytosol,death of neural tissue of the brain,defect,developmental delay,Disease mutation,environmental risk factors,FAD,flavin adenine dinucleotide binding,Flavoprotein,folate,Folate-sensitive neural tube defects,folic acid,folic acid metabolic process,FS-NTD,Gastric Cancer,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,heart,heart disease,hepatic steatosis,high blood pressure,high blood pressure during pregnancy,high BP,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,hypertension,Ischemic stroke,ISCHSTR,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,loss of motor and sensory and/or cognitive function,MB12,mental disorder,mental retardation,methionine,methionine biosynthetic process,methylcobalamin,Methylene-tetrahydrofolate Reductase,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,miscarriage,modified amino acid binding,MTHFR,MTHFRD,myelomeningocele,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,natural menopause,Neural Tube Defect,neurodegenerative,neuron projection,NTDs,open spina bifida,Oxidoreductase,perinatal death,Polymorphism,preeclampsia,pregnancy,psychiatric disorders,psychiatric disturbances,Reference proteome,response to drug,response to folic acid,response to hypoxia,response to interleukin-1,response to vitamin B2,S-Adenosyl-Homocysteine,S-Adenosyl-Methionine,S-adenosylmethionine metabolic process,SAMe,severe mental retardation,small molecule metabolic process,spina bifida,stroke,tetrabioptrein,Tetrahydrobiopterin,tetrahydrofolate,tetrahydrofolate interconversion,THB,vascular occlusion,vitamin,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs4846048",
        "SNP Name": "MTHFR C24909T",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4846048",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,amino acids,anencephaly,arsenic,Arsenic Methyltransferase,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,bladder cancer,blood circulation,blood pressure,cancer,cancerous,carcinogen,Catalyzes the conversion of 5,cellular amino acid metabolic process,children,cleft lip,cleft palate,cobalamin,cognitive function,colon cancer and acute leukemia,colorectal cancer,Complete proteome,conotruncal heart defects,cyanocobalamin,cysteine,cytosol,death of neural tissue of the brain,defect,developmental delay,Disease mutation,environmental risk factors,FAD,flavin adenine dinucleotide binding,Flavoprotein,folate,Folate-sensitive neural tube defects,folic acid,folic acid metabolic process,FS-NTD,Gastric Cancer,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,heart,heart disease,hepatic steatosis,high blood pressure,high blood pressure during pregnancy,high BP,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,hypertension,Ischemic stroke,ISCHSTR,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,loss of motor and sensory and/or cognitive function,MB12,mental disorder,mental retardation,methionine,methionine biosynthetic process,methylcobalamin,Methylene-tetrahydrofolate Reductase,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,miscarriage,modified amino acid binding,MTHFR,MTHFRD,myelomeningocele,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,natural menopause,Neural Tube Defect,neurodegenerative,neuron projection,NTDs,open spina bifida,Oxidoreductase,perinatal death,Polymorphism,preeclampsia,pregnancy,psychiatric disorders,psychiatric disturbances,Reference proteome,response to drug,response to folic acid,response to hypoxia,response to interleukin-1,response to vitamin B2,S-Adenosyl-Homocysteine,S-Adenosyl-Methionine,S-adenosylmethionine metabolic process,SAMe,severe mental retardation,small molecule metabolic process,spina bifida,stroke,tetrabioptrein,Tetrahydrobiopterin,tetrahydrofolate,tetrahydrofolate interconversion,THB,vascular occlusion,vitamin,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2274976",
        "SNP Name": "MTHFR G1793A (R594Q)",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2274976",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Abdominal Aortic Aneurysm,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,amino acids,anencephaly,aneurysm,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,blood circulation,blood pressure,cancer,cancerous,carcinogen,Catalyzes the conversion of 5,cellular amino acid metabolic process,children,cleft lip,cleft palate,cobalamin,cognitive function,colon cancer and acute leukemia,colorectal cancer,Complete proteome,conotruncal heart defects,cyanocobalamin,cycling temperature capillary electrophoresis,cysteine,cytosol,death of neural tissue of the brain,defect,developmental delay,Disease mutation,distal colorectal adenoma,environmental risk factors,FAD,flavin adenine dinucleotide binding,Flavoprotein,folate,Folate-sensitive neural tube defects,folic acid,folic acid metabolic process,FS-NTD,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,head and neck cancer,head and neck carcinoma,heart,heart disease,high blood pressure,high blood pressure during pregnancy,high BP,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,hypertension,Ischemic stroke,ISCHSTR,Kawasaki disease,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,Leber,Leber's,Leber\u2019s hereditary optic neuropathy,loss of motor and sensory and/or cognitive function,maternal folate intake and birth size,MB12,mental disorder,mental retardation,methionine,methionine biosynthetic process,methylcobalamin,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,miscarriage,modified amino acid binding,MTHFR,MTHFRD,myelomeningocele,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,Neural Tube Defect,neurodegenerative,neuron projection,neuropathy,NTDs,open spina bifida,optic neuropathy,Oxidoreductase,perinatal death,Polymorphism,preeclampsia,pregnancy,primary angle closure glaucoma,Prostate Cancer,psychiatric disorders,psychiatric disturbances,rectal tumor,Reference proteome,response to drug,response to folic acid,response to hypoxia,response to interleukin-1,response to methotrexate in rheumatoid arthritis,response to vitamin B2,S-Adenosyl-Homocysteine,S-Adenosyl-Methionine,S-adenosylmethionine metabolic process,SAMe,severe mental retardation,small molecule metabolic process,spina bifida,stroke,tetrabioptrein,Tetrahydrobiopterin,tetrahydrofolate,tetrahydrofolate interconversion,THB,vascular occlusion,vitamin,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2274976",
        "SNP Name": "MTHFR G1793A (R594Q)",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2274976",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Abdominal Aortic Aneurysm,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,amino acids,anencephaly,aneurysm,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,blood circulation,blood pressure,cancer,cancerous,carcinogen,Catalyzes the conversion of 5,cellular amino acid metabolic process,children,cleft lip,cleft palate,cobalamin,cognitive function,colon cancer and acute leukemia,colorectal cancer,Complete proteome,conotruncal heart defects,cyanocobalamin,cycling temperature capillary electrophoresis,cysteine,cytosol,death of neural tissue of the brain,defect,developmental delay,Disease mutation,distal colorectal adenoma,environmental risk factors,FAD,flavin adenine dinucleotide binding,Flavoprotein,folate,Folate-sensitive neural tube defects,folic acid,folic acid metabolic process,FS-NTD,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,head and neck cancer,head and neck carcinoma,heart,heart disease,high blood pressure,high blood pressure during pregnancy,high BP,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,hypertension,Ischemic stroke,ISCHSTR,Kawasaki disease,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,Leber,Leber's,Leber\u2019s hereditary optic neuropathy,loss of motor and sensory and/or cognitive function,maternal folate intake and birth size,MB12,mental disorder,mental retardation,methionine,methionine biosynthetic process,methylcobalamin,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,miscarriage,modified amino acid binding,MTHFR,MTHFRD,myelomeningocele,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,Neural Tube Defect,neurodegenerative,neuron projection,neuropathy,NTDs,open spina bifida,optic neuropathy,Oxidoreductase,perinatal death,Polymorphism,preeclampsia,pregnancy,primary angle closure glaucoma,Prostate Cancer,psychiatric disorders,psychiatric disturbances,rectal tumor,Reference proteome,response to drug,response to folic acid,response to hypoxia,response to interleukin-1,response to methotrexate in rheumatoid arthritis,response to vitamin B2,S-Adenosyl-Homocysteine,S-Adenosyl-Methionine,S-adenosylmethionine metabolic process,SAMe,severe mental retardation,small molecule metabolic process,spina bifida,stroke,tetrabioptrein,Tetrahydrobiopterin,tetrahydrofolate,tetrahydrofolate interconversion,THB,vascular occlusion,vitamin,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1476413",
        "SNP Name": "MTHFR G18861A",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1476413",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,amino acids,anencephaly,arsenic,Arsenic Methyltransferase,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,blood circulation,blood pressure,cancer,cancerous,carcinogen,Catalyzes the conversion of 5,cellular amino acid metabolic process,children,cleft lip,cleft palate,cobalamin,cognitive function,colon cancer and acute leukemia,Colorectal Cancer,Complete proteome,conotruncal heart defects,CVD,cyanocobalamin,cysteine,cytosol,death of neural tissue of the brain,defect,developmental delay,Disease mutation,environmental risk factors,FAD,flavin adenine dinucleotide binding,Flavoprotein,folate,Folate-sensitive neural tube defects,folic acid,folic acid metabolic process,FS-NTD,Gastric Cancer,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,heart,heart defect,heart disease,high blood pressure,high blood pressure during pregnancy,high BP,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,hypertension,Ischemic stroke,ISCHSTR,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,loss of motor and sensory and/or cognitive function,MB12,mental disorder,mental retardation,methionine,methionine biosynthetic process,methylcobalamin,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,miscarriage,modified amino acid binding,MTHFR,MTHFRD,myelomeningocele,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,Neural Tube Defect,neurodegenerative,neuron projection,NTDs,open spina bifida,Oxidoreductase,perinatal death,Polymorphism,preeclampsia,pregnancy,psychiatric disorders,psychiatric disturbances,Reference proteome,Renal Cell Cancer,response to drug,response to folic acid,response to hypoxia,response to interleukin-1,response to vitamin B2,S-Adenosyl-Homocysteine,S-Adenosyl-Methionine,S-adenosylmethionine metabolic process,SAMe,severe mental retardation,small molecule metabolic process,spina bifida,stroke,tetrabioptrein,Tetrahydrobiopterin,tetrahydrofolate,tetrahydrofolate interconversion,THB,vascular occlusion,vitamin,vitamin A,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs1476413",
        "SNP Name": "MTHFR G18861A",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1476413",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,amino acids,anencephaly,arsenic,Arsenic Methyltransferase,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,blood circulation,blood pressure,cancer,cancerous,carcinogen,Catalyzes the conversion of 5,cellular amino acid metabolic process,children,cleft lip,cleft palate,cobalamin,cognitive function,colon cancer and acute leukemia,Colorectal Cancer,Complete proteome,conotruncal heart defects,CVD,cyanocobalamin,cysteine,cytosol,death of neural tissue of the brain,defect,developmental delay,Disease mutation,environmental risk factors,FAD,flavin adenine dinucleotide binding,Flavoprotein,folate,Folate-sensitive neural tube defects,folic acid,folic acid metabolic process,FS-NTD,Gastric Cancer,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,heart,heart defect,heart disease,high blood pressure,high blood pressure during pregnancy,high BP,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,hypertension,Ischemic stroke,ISCHSTR,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,loss of motor and sensory and/or cognitive function,MB12,mental disorder,mental retardation,methionine,methionine biosynthetic process,methylcobalamin,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,miscarriage,modified amino acid binding,MTHFR,MTHFRD,myelomeningocele,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,Neural Tube Defect,neurodegenerative,neuron projection,NTDs,open spina bifida,Oxidoreductase,perinatal death,Polymorphism,preeclampsia,pregnancy,psychiatric disorders,psychiatric disturbances,Reference proteome,Renal Cell Cancer,response to drug,response to folic acid,response to hypoxia,response to interleukin-1,response to vitamin B2,S-Adenosyl-Homocysteine,S-Adenosyl-Methionine,S-adenosylmethionine metabolic process,SAMe,severe mental retardation,small molecule metabolic process,spina bifida,stroke,tetrabioptrein,Tetrahydrobiopterin,tetrahydrofolate,tetrahydrofolate interconversion,THB,vascular occlusion,vitamin,vitamin A,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1801131",
        "SNP Name": "MTHFR A1298C",
        "Risk Allele": "G",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1801131",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Abdominal Aortic Aneurysm,acute GVHD,AD,ADHD in Myelomeningocele,alcohol consumption,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,Alzheimer,Alzheimer\u2019s Disease,amino acids,anencephaly,aneurysm,Antipsychotics and metabolic syndrome,arsenic,Arsenic Metabolism,Arsenic Methyltransferase,Arteriole Endothelial Dependent Vasodilatation In Schizophrenia,Arteriovenous Graft Failure,arthritis,ASD,autism,Autism Spectrum Disorder,autoimmune thyroid disease,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,bladder cancer,blood circulation,blood pressure,Bone Mineral Density,breast cancer,cancer,cancerous,carcinogen,cardiovascular,Cardiovascular Disease,Cardiovascular Disease in Rheumatoid Arthritis,Catalyzes the conversion of 5,cellular amino acid metabolic process,Cerebral Palsy,cerebrospinal fluid amyloid beta,Cervical Lesions,Chemoradiotherapy,Childhood Acute Lymphoblastic Leukemia,childhood leukemia,children,Chronic Allograft Dysfunction,cleft lip,cleft palate,cobalamin,cognitive function,Colon Cancer,colon cancer and acute leukemia,Colorectal Cancer,Colorectal Neoplasia,Complete proteome,Congenital Heart Defects in Down Syndrome,Conotruncal Heart Defects,cyanocobalamin,cysteine,cytosol,death of neural tissue of the brain,defect,developmental delay,Disease mutation,Down Syndrome,environmental risk factors,Esophageal Cancer,Factor V Leiden,FAD,Fetal Growth,flavin adenine dinucleotide binding,Flavoprotein,folate,folate uptake,Folate-sensitive neural tube defects,folic acid,Folic acid and breast cancer,Folic acid and cancer risk in BRCA1 carriers,folic acid metabolic process,follicular lymphoma,FS-NTD,FVL,Gastric Cancer,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,Hashimoto,Hashimoto Thyroiditis,Hashimoto's Thyroiditis,Head and Neck Cancer,head and neck carcinoma,heart,heart disease,Hepatocellular Carcinoma,high blood pressure,high blood pressure during pregnancy,high BP,Hodgkin Lymphoma,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,Huntington,Huntington disease,hypertension,idiopathic male infertility,Infant Growth,Ischemic stroke,ISCHSTR,Kawasaki disease,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,Leber,Leber\u2019s hereditary optic neuropathy,lesion,leukemia,loss of motor and sensory and/or cognitive function,lung,lung cancer,lupus,Lupus Erythematosus,lymphoblastic leukemia,Male Infertility,MB12,mental disorder,mental retardation,metabolic syndrome,metastatic breast cancer,methionine,methionine biosynthetic process,methotrexate,methylcobalamin,Methylene-tetrahydrofolate Reductase,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,miscarriage,modified amino acid binding,mortality in non-alcoholic liver transplant,MTHFR,MTHFRD,MTX,myelomeningocele,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,Neural Tube Defect,neurodegenerative,neurodevelopmental delay,neuron projection,neuropathy,non-Hodgkin lymphoma,non-small cell lung carcinoma,Nonsyndromic Cleft Lip and Palate,NTDs,Omphalocele,open spina bifida,ovarian cancer,Oxidoreductase,perinatal death,plasma HDL levels,plasma homocysteine,Plasma Total Homocysteine,Polymorphism,preeclampsia,pregnancy,primary angle closure glaucoma,psoriasis,psychiatric disorders,psychiatric disturbances,RA,rectal cancer,Reduced Sperm Counts,Reference proteome,Renal Cell Cancer,response to drug,response to folic acid,response to hypoxia,response to",
        "Group": "Mercury (Thiomersal/Thimerosal)"
    },
    {
        "SNP ID": "rs1801131",
        "SNP Name": "MTHFR A1298C",
        "Risk Allele": "G",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1801131",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Abdominal Aortic Aneurysm,acute GVHD,AD,ADHD in Myelomeningocele,alcohol consumption,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,Alzheimer,Alzheimer\u2019s Disease,amino acids,anencephaly,aneurysm,Antipsychotics and metabolic syndrome,arsenic,Arsenic Metabolism,Arsenic Methyltransferase,Arteriole Endothelial Dependent Vasodilatation In Schizophrenia,Arteriovenous Graft Failure,arthritis,ASD,autism,Autism Spectrum Disorder,autoimmune thyroid disease,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,bladder cancer,blood circulation,blood pressure,Bone Mineral Density,breast cancer,cancer,cancerous,carcinogen,cardiovascular,Cardiovascular Disease,Cardiovascular Disease in Rheumatoid Arthritis,Catalyzes the conversion of 5,cellular amino acid metabolic process,Cerebral Palsy,cerebrospinal fluid amyloid beta,Cervical Lesions,Chemoradiotherapy,Childhood Acute Lymphoblastic Leukemia,childhood leukemia,children,Chronic Allograft Dysfunction,cleft lip,cleft palate,cobalamin,cognitive function,Colon Cancer,colon cancer and acute leukemia,Colorectal Cancer,Colorectal Neoplasia,Complete proteome,Congenital Heart Defects in Down Syndrome,Conotruncal Heart Defects,cyanocobalamin,cysteine,cytosol,death of neural tissue of the brain,defect,developmental delay,Disease mutation,Down Syndrome,environmental risk factors,Esophageal Cancer,Factor V Leiden,FAD,Fetal Growth,flavin adenine dinucleotide binding,Flavoprotein,folate,folate uptake,Folate-sensitive neural tube defects,folic acid,Folic acid and breast cancer,Folic acid and cancer risk in BRCA1 carriers,folic acid metabolic process,follicular lymphoma,FS-NTD,FVL,Gastric Cancer,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,Hashimoto,Hashimoto Thyroiditis,Hashimoto's Thyroiditis,Head and Neck Cancer,head and neck carcinoma,heart,heart disease,Hepatocellular Carcinoma,high blood pressure,high blood pressure during pregnancy,high BP,Hodgkin Lymphoma,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,Huntington,Huntington disease,hypertension,idiopathic male infertility,Infant Growth,Ischemic stroke,ISCHSTR,Kawasaki disease,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,Leber,Leber\u2019s hereditary optic neuropathy,lesion,leukemia,loss of motor and sensory and/or cognitive function,lung,lung cancer,lupus,Lupus Erythematosus,lymphoblastic leukemia,Male Infertility,MB12,mental disorder,mental retardation,metabolic syndrome,metastatic breast cancer,methionine,methionine biosynthetic process,methotrexate,methylcobalamin,Methylene-tetrahydrofolate Reductase,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,miscarriage,modified amino acid binding,mortality in non-alcoholic liver transplant,MTHFR,MTHFRD,MTX,myelomeningocele,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,Neural Tube Defect,neurodegenerative,neurodevelopmental delay,neuron projection,neuropathy,non-Hodgkin lymphoma,non-small cell lung carcinoma,Nonsyndromic Cleft Lip and Palate,NTDs,Omphalocele,open spina bifida,ovarian cancer,Oxidoreductase,perinatal death,plasma HDL levels,plasma homocysteine,Plasma Total Homocysteine,Polymorphism,preeclampsia,pregnancy,primary angle closure glaucoma,psoriasis,psychiatric disorders,psychiatric disturbances,RA,rectal cancer,Reduced Sperm Counts,Reference proteome,Renal Cell Cancer,response to drug,response to folic acid,response to hypoxia,response to",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs1801131",
        "SNP Name": "MTHFR A1298C",
        "Risk Allele": "G",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1801131",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Abdominal Aortic Aneurysm,acute GVHD,AD,ADHD in Myelomeningocele,alcohol consumption,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,Alzheimer,Alzheimer\u2019s Disease,amino acids,anencephaly,aneurysm,Antipsychotics and metabolic syndrome,arsenic,Arsenic Metabolism,Arsenic Methyltransferase,Arteriole Endothelial Dependent Vasodilatation In Schizophrenia,Arteriovenous Graft Failure,arthritis,ASD,autism,Autism Spectrum Disorder,autoimmune thyroid disease,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,bladder cancer,blood circulation,blood pressure,Bone Mineral Density,breast cancer,cancer,cancerous,carcinogen,cardiovascular,Cardiovascular Disease,Cardiovascular Disease in Rheumatoid Arthritis,Catalyzes the conversion of 5,cellular amino acid metabolic process,Cerebral Palsy,cerebrospinal fluid amyloid beta,Cervical Lesions,Chemoradiotherapy,Childhood Acute Lymphoblastic Leukemia,childhood leukemia,children,Chronic Allograft Dysfunction,cleft lip,cleft palate,cobalamin,cognitive function,Colon Cancer,colon cancer and acute leukemia,Colorectal Cancer,Colorectal Neoplasia,Complete proteome,Congenital Heart Defects in Down Syndrome,Conotruncal Heart Defects,cyanocobalamin,cysteine,cytosol,death of neural tissue of the brain,defect,developmental delay,Disease mutation,Down Syndrome,environmental risk factors,Esophageal Cancer,Factor V Leiden,FAD,Fetal Growth,flavin adenine dinucleotide binding,Flavoprotein,folate,folate uptake,Folate-sensitive neural tube defects,folic acid,Folic acid and breast cancer,Folic acid and cancer risk in BRCA1 carriers,folic acid metabolic process,follicular lymphoma,FS-NTD,FVL,Gastric Cancer,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,Hashimoto,Hashimoto Thyroiditis,Hashimoto's Thyroiditis,Head and Neck Cancer,head and neck carcinoma,heart,heart disease,Hepatocellular Carcinoma,high blood pressure,high blood pressure during pregnancy,high BP,Hodgkin Lymphoma,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,Huntington,Huntington disease,hypertension,idiopathic male infertility,Infant Growth,Ischemic stroke,ISCHSTR,Kawasaki disease,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,Leber,Leber\u2019s hereditary optic neuropathy,lesion,leukemia,loss of motor and sensory and/or cognitive function,lung,lung cancer,lupus,Lupus Erythematosus,lymphoblastic leukemia,Male Infertility,MB12,mental disorder,mental retardation,metabolic syndrome,metastatic breast cancer,methionine,methionine biosynthetic process,methotrexate,methylcobalamin,Methylene-tetrahydrofolate Reductase,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,miscarriage,modified amino acid binding,mortality in non-alcoholic liver transplant,MTHFR,MTHFRD,MTX,myelomeningocele,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,Neural Tube Defect,neurodegenerative,neurodevelopmental delay,neuron projection,neuropathy,non-Hodgkin lymphoma,non-small cell lung carcinoma,Nonsyndromic Cleft Lip and Palate,NTDs,Omphalocele,open spina bifida,ovarian cancer,Oxidoreductase,perinatal death,plasma HDL levels,plasma homocysteine,Plasma Total Homocysteine,Polymorphism,preeclampsia,pregnancy,primary angle closure glaucoma,psoriasis,psychiatric disorders,psychiatric disturbances,RA,rectal cancer,Reduced Sperm Counts,Reference proteome,Renal Cell Cancer,response to drug,response to folic acid,response to hypoxia,response to",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1801133",
        "SNP Name": "MTHFR C677T",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1801133",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Abdominal Aortic Aneurysm,acute GVHD,acute lymphoblastic leukemia,Acute Myeloid Leukemia,Acute Pancreatitis,AD,ADHD in Myelomeningocele,Adverse Events Following Smallpox Vaccination,age-related macular degeneration,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,Alzheimer,Alzheimer's disease,amino acids,Amnestic Mild Cognitive Impairment,anencephaly,aneurysm,anterior ischemic optic neuropathy,arsenic,Arsenic Metabolism,arthritis,ASD,autism,Autism Spectrum Disorder,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,bladder cancer,blood circulation,blood pressure,Bone Mineral Density,brain tumor,breast cancer,cancer,cancerous,carcinogen,Cardiovascular Disease,Catalyzes the conversion of 5,celiac,celiac disease,cellular amino acid metabolic process,Cervical Cancer and Cervical Intraepithelial Neoplasia,Cervical Lesions,chemotherapy,childhood leukemia,children,cleft lip,cleft palate,cobalamin,cocaine,Cocaine Dependency,cognitive function,colon cancer,colon cancer and acute leukemia,colorectal cancer,Colorectal Neoplasia,community-acquired pneumonia,Complete proteome,Congenital Heart Defects,Congenital Heart Defects in Down Syndrome,Congenital Heart Disease,Congenital Limb Deficiencies,conotruncal heart defects,Coronary Heart Disease,Coronary Restenosis,CVD,cyanocobalamin,cycling temperature capillary electrophoresis,cysteine,cytosol,death of neural tissue of the brain,defect,depression,developmental delay,diabetes,diabetes mellitus,Diabetic Retinopathy,Disease mutation,distal colorectal adenoma,Down Syndrome,environmental risk factors,Esophageal Cancer,esophageal squamous cell carcinoma,essential hypertension,exfoliation syndrome,FAD,fat,flavin adenine dinucleotide binding,Flavoprotein,Fluoropyrimidines,folate,Folate-sensitive neural tube defects,folic acid,folic acid metabolic process,FS-NTD,gastric cancer,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,head and neck cancer,Hearing Loss,heart,heart defect,heart disease,hepatic steatosis,hepatocellular carcinoma,high blood pressure,high blood pressure during pregnancy,high BP,Hodgkin Lymphoma,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,Hydroxymethyltransferase,hypermethylation,hypertension,interaction with COMT 158Val \u2192 Met,Ischemic stroke,ISCHSTR,juvenile idiopathic arthritis,Kawasaki disease,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,leukemia,Limb Reduction Defects,lipid,lipid modulation,longevity,loss of motor and sensory and/or cognitive function,lung,Lung Cancer,lupus,Lymphoblastic Leukemia,macular degeneration,Male Infertility,Malignant Brain Tumor,Malignant Brain Tumors in Children,malignant pleural mesothelioma,MB12,mental disorder,mental retardation,metabolic syndrome,metastatic colorectal cancer,methionine,methionine biosynthetic process,Methotrexate,methylcobalamin,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,Migraine,mild cognitive impairment,miscarriage,modified amino acid binding,MTHFR,MTHFRD,MTX,myelomeningocele,Myocardial Infarction,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,Neural Tube Defect,neurodegenerative,neuron projection,neuropsychiatric disorders,Nitrous Oxide,non-Hodgkin lymphoma,non-small cell lung carcinoma,Nonsyndromic Cleft Lip and Palate,NTDs,Obesity,open spina bifida,Oral Facial Clefts,Osteoporosis,ovarian cancer,overweight,Oxidoreductase,Pancreatic Cancer,Pancreatitis,Parki",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs1801133",
        "SNP Name": "MTHFR C677T",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1801133",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Abdominal Aortic Aneurysm,acute GVHD,acute lymphoblastic leukemia,Acute Myeloid Leukemia,Acute Pancreatitis,AD,ADHD in Myelomeningocele,Adverse Events Following Smallpox Vaccination,age-related macular degeneration,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,Alzheimer,Alzheimer's disease,amino acids,Amnestic Mild Cognitive Impairment,anencephaly,aneurysm,anterior ischemic optic neuropathy,arsenic,Arsenic Metabolism,arthritis,ASD,autism,Autism Spectrum Disorder,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,bladder cancer,blood circulation,blood pressure,Bone Mineral Density,brain tumor,breast cancer,cancer,cancerous,carcinogen,Cardiovascular Disease,Catalyzes the conversion of 5,celiac,celiac disease,cellular amino acid metabolic process,Cervical Cancer and Cervical Intraepithelial Neoplasia,Cervical Lesions,chemotherapy,childhood leukemia,children,cleft lip,cleft palate,cobalamin,cocaine,Cocaine Dependency,cognitive function,colon cancer,colon cancer and acute leukemia,colorectal cancer,Colorectal Neoplasia,community-acquired pneumonia,Complete proteome,Congenital Heart Defects,Congenital Heart Defects in Down Syndrome,Congenital Heart Disease,Congenital Limb Deficiencies,conotruncal heart defects,Coronary Heart Disease,Coronary Restenosis,CVD,cyanocobalamin,cycling temperature capillary electrophoresis,cysteine,cytosol,death of neural tissue of the brain,defect,depression,developmental delay,diabetes,diabetes mellitus,Diabetic Retinopathy,Disease mutation,distal colorectal adenoma,Down Syndrome,environmental risk factors,Esophageal Cancer,esophageal squamous cell carcinoma,essential hypertension,exfoliation syndrome,FAD,fat,flavin adenine dinucleotide binding,Flavoprotein,Fluoropyrimidines,folate,Folate-sensitive neural tube defects,folic acid,folic acid metabolic process,FS-NTD,gastric cancer,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,head and neck cancer,Hearing Loss,heart,heart defect,heart disease,hepatic steatosis,hepatocellular carcinoma,high blood pressure,high blood pressure during pregnancy,high BP,Hodgkin Lymphoma,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,Hydroxymethyltransferase,hypermethylation,hypertension,interaction with COMT 158Val \u2192 Met,Ischemic stroke,ISCHSTR,juvenile idiopathic arthritis,Kawasaki disease,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,leukemia,Limb Reduction Defects,lipid,lipid modulation,longevity,loss of motor and sensory and/or cognitive function,lung,Lung Cancer,lupus,Lymphoblastic Leukemia,macular degeneration,Male Infertility,Malignant Brain Tumor,Malignant Brain Tumors in Children,malignant pleural mesothelioma,MB12,mental disorder,mental retardation,metabolic syndrome,metastatic colorectal cancer,methionine,methionine biosynthetic process,Methotrexate,methylcobalamin,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,Migraine,mild cognitive impairment,miscarriage,modified amino acid binding,MTHFR,MTHFRD,MTX,myelomeningocele,Myocardial Infarction,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,Neural Tube Defect,neurodegenerative,neuron projection,neuropsychiatric disorders,Nitrous Oxide,non-Hodgkin lymphoma,non-small cell lung carcinoma,Nonsyndromic Cleft Lip and Palate,NTDs,Obesity,open spina bifida,Oral Facial Clefts,Osteoporosis,ovarian cancer,overweight,Oxidoreductase,Pancreatic Cancer,Pancreatitis,Parki",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs17037390",
        "SNP Name": "MTHFR C10318T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs17037390",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,amino acids,anencephaly,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,blood circulation,blood pressure,cancer,cancerous,carcinogen,cardiovascular,Catalyzes the conversion of 5,cellular amino acid metabolic process,children,cleft lip,cleft palate,cobalamin,cognitive function,colon cancer and acute leukemia,Colorectal Cancer,Complete proteome,cyanocobalamin,cysteine,cytosol,death of neural tissue of the brain,defect,developmental delay,Disease mutation,environmental risk factors,FAD,flavin adenine dinucleotide binding,Flavoprotein,folate,Folate-sensitive neural tube defects,folic acid,folic acid metabolic process,FS-NTD,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,heart,heart disease,high blood pressure,high blood pressure during pregnancy,high BP,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,hypertension,Ischemic stroke,ISCHSTR,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,loss of motor and sensory and/or cognitive function,MB12,mental disorder,mental retardation,methionine,methionine biosynthetic process,methylcobalamin,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,miscarriage,modified amino acid binding,MTHFR,MTHFRD,myelomeningocele,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,natural menopause,Neural Tube Defect,neurodegenerative,neuron projection,NTDs,open spina bifida,Oxidoreductase,perinatal death,Polymorphism,preeclampsia,pregnancy,psychiatric disorders,psychiatric disturbances,Reference proteome,response to drug,response to folic acid,response to hypoxia,response to interleukin-1,response to vitamin B2,S-Adenosyl-Homocysteine,S-Adenosyl-Methionine,S-adenosylmethionine metabolic process,SAMe,severe mental retardation,small molecule metabolic process,spina bifida,stroke,tetrabioptrein,Tetrahydrobiopterin,tetrahydrofolate,tetrahydrofolate interconversion,THB,vascular occlusion,vitamin,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs17037390",
        "SNP Name": "MTHFR C10318T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs17037390",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,amino acids,anencephaly,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,blood circulation,blood pressure,cancer,cancerous,carcinogen,cardiovascular,Catalyzes the conversion of 5,cellular amino acid metabolic process,children,cleft lip,cleft palate,cobalamin,cognitive function,colon cancer and acute leukemia,Colorectal Cancer,Complete proteome,cyanocobalamin,cysteine,cytosol,death of neural tissue of the brain,defect,developmental delay,Disease mutation,environmental risk factors,FAD,flavin adenine dinucleotide binding,Flavoprotein,folate,Folate-sensitive neural tube defects,folic acid,folic acid metabolic process,FS-NTD,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,heart,heart disease,high blood pressure,high blood pressure during pregnancy,high BP,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,hypertension,Ischemic stroke,ISCHSTR,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,loss of motor and sensory and/or cognitive function,MB12,mental disorder,mental retardation,methionine,methionine biosynthetic process,methylcobalamin,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,miscarriage,modified amino acid binding,MTHFR,MTHFRD,myelomeningocele,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,natural menopause,Neural Tube Defect,neurodegenerative,neuron projection,NTDs,open spina bifida,Oxidoreductase,perinatal death,Polymorphism,preeclampsia,pregnancy,psychiatric disorders,psychiatric disturbances,Reference proteome,response to drug,response to folic acid,response to hypoxia,response to interleukin-1,response to vitamin B2,S-Adenosyl-Homocysteine,S-Adenosyl-Methionine,S-adenosylmethionine metabolic process,SAMe,severe mental retardation,small molecule metabolic process,spina bifida,stroke,tetrabioptrein,Tetrahydrobiopterin,tetrahydrofolate,tetrahydrofolate interconversion,THB,vascular occlusion,vitamin,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs17037396",
        "SNP Name": "MTHFR C841T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs17037396",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,amino acids,anencephaly,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,blood circulation,blood pressure,cancer,cancerous,carcinogen,Catalyzes the conversion of 5,cellular amino acid metabolic process,children,cleft lip,cleft palate,cobalamin,cognitive function,colon cancer and acute leukemia,Colorectal Cancer,Complete proteome,cyanocobalamin,cysteine,cytosol,death of neural tissue of the brain,defect,developmental delay,Disease mutation,environmental risk factors,FAD,flavin adenine dinucleotide binding,Flavoprotein,folate,Folate-sensitive neural tube defects,folic acid,folic acid metabolic process,FS-NTD,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,heart,heart disease,high blood pressure,high blood pressure during pregnancy,high BP,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,hypertension,Ischemic stroke,ISCHSTR,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,loss of motor and sensory and/or cognitive function,MB12,mental disorder,mental retardation,methionine,methionine biosynthetic process,methylcobalamin,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,miscarriage,modified amino acid binding,MTHFR,MTHFRD,myelomeningocele,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,Neural Tube Defect,neurodegenerative,neuron projection,NTDs,open spina bifida,Oxidoreductase,perinatal death,Polymorphism,preeclampsia,pregnancy,pseudoexfoliation syndrome,psychiatric disorders,psychiatric disturbances,Reference proteome,response to drug,response to folic acid,response to hypoxia,response to interleukin-1,response to vitamin B2,S-Adenosyl-Homocysteine,S-Adenosyl-Methionine,S-adenosylmethionine metabolic process,SAMe,severe mental retardation,small molecule metabolic process,spina bifida,stroke,tetrabioptrein,Tetrahydrobiopterin,tetrahydrofolate,tetrahydrofolate interconversion,THB,vascular occlusion,vitamin,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs17037396",
        "SNP Name": "MTHFR C841T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs17037396",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,amino acids,anencephaly,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,blood circulation,blood pressure,cancer,cancerous,carcinogen,Catalyzes the conversion of 5,cellular amino acid metabolic process,children,cleft lip,cleft palate,cobalamin,cognitive function,colon cancer and acute leukemia,Colorectal Cancer,Complete proteome,cyanocobalamin,cysteine,cytosol,death of neural tissue of the brain,defect,developmental delay,Disease mutation,environmental risk factors,FAD,flavin adenine dinucleotide binding,Flavoprotein,folate,Folate-sensitive neural tube defects,folic acid,folic acid metabolic process,FS-NTD,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,heart,heart disease,high blood pressure,high blood pressure during pregnancy,high BP,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,hypertension,Ischemic stroke,ISCHSTR,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,loss of motor and sensory and/or cognitive function,MB12,mental disorder,mental retardation,methionine,methionine biosynthetic process,methylcobalamin,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,miscarriage,modified amino acid binding,MTHFR,MTHFRD,myelomeningocele,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,Neural Tube Defect,neurodegenerative,neuron projection,NTDs,open spina bifida,Oxidoreductase,perinatal death,Polymorphism,preeclampsia,pregnancy,pseudoexfoliation syndrome,psychiatric disorders,psychiatric disturbances,Reference proteome,response to drug,response to folic acid,response to hypoxia,response to interleukin-1,response to vitamin B2,S-Adenosyl-Homocysteine,S-Adenosyl-Methionine,S-adenosylmethionine metabolic process,SAMe,severe mental retardation,small molecule metabolic process,spina bifida,stroke,tetrabioptrein,Tetrahydrobiopterin,tetrahydrofolate,tetrahydrofolate interconversion,THB,vascular occlusion,vitamin,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs17367504",
        "SNP Name": "MTHFR A1572G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs17367504",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,amino acids,anencephaly,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,blood circulation,blood pressure,cancer,cancerous,carcinogen,cardiovascular,Catalyzes the conversion of 5,cellular amino acid metabolic process,children,cleft lip,cleft palate,cobalamin,cognitive function,colon cancer and acute leukemia,Complete proteome,coronary artery disease,cyanocobalamin,cysteine,cytosol,death of neural tissue of the brain,defect,developmental delay,Disease mutation,environmental risk factors,Essential Hypertension,FAD,flavin adenine dinucleotide binding,Flavoprotein,folate,Folate-sensitive neural tube defects,folic acid,folic acid metabolic process,FS-NTD,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,heart,heart disease,high blood pressure,high blood pressure during pregnancy,high BP,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,hypertension,Ischemic stroke,ISCHSTR,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,loss of motor and sensory and/or cognitive function,MB12,mental disorder,mental retardation,methionine,methionine biosynthetic process,methylcobalamin,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,miscarriage,modified amino acid binding,MTHFR,MTHFRD,myelomeningocele,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,Neural Tube Defect,neurodegenerative,neuron projection,NTDs,open spina bifida,Orthostatic hypotension,Oxidoreductase,perinatal death,placental abruption,Plasma Homocysteine,Polymorphism,Postural Hemodynamics,preeclampsia,pregnancy,psychiatric disorders,psychiatric disturbances,Reference proteome,response to drug,response to folic acid,response to hypoxia,response to interleukin-1,response to vitamin B2,S-Adenosyl-Homocysteine,S-Adenosyl-Methionine,S-adenosylmethionine metabolic process,SAMe,severe mental retardation,Sickle Cell,Sickle Cell Disease,small molecule metabolic process,spina bifida,stroke,tetrabioptrein,Tetrahydrobiopterin,tetrahydrofolate,tetrahydrofolate interconversion,THB,vascular occlusion,vitamin,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs17367504",
        "SNP Name": "MTHFR A1572G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs17367504",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,amino acids,anencephaly,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,blood circulation,blood pressure,cancer,cancerous,carcinogen,cardiovascular,Catalyzes the conversion of 5,cellular amino acid metabolic process,children,cleft lip,cleft palate,cobalamin,cognitive function,colon cancer and acute leukemia,Complete proteome,coronary artery disease,cyanocobalamin,cysteine,cytosol,death of neural tissue of the brain,defect,developmental delay,Disease mutation,environmental risk factors,Essential Hypertension,FAD,flavin adenine dinucleotide binding,Flavoprotein,folate,Folate-sensitive neural tube defects,folic acid,folic acid metabolic process,FS-NTD,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,heart,heart disease,high blood pressure,high blood pressure during pregnancy,high BP,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,hypertension,Ischemic stroke,ISCHSTR,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,loss of motor and sensory and/or cognitive function,MB12,mental disorder,mental retardation,methionine,methionine biosynthetic process,methylcobalamin,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,miscarriage,modified amino acid binding,MTHFR,MTHFRD,myelomeningocele,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,Neural Tube Defect,neurodegenerative,neuron projection,NTDs,open spina bifida,Orthostatic hypotension,Oxidoreductase,perinatal death,placental abruption,Plasma Homocysteine,Polymorphism,Postural Hemodynamics,preeclampsia,pregnancy,psychiatric disorders,psychiatric disturbances,Reference proteome,response to drug,response to folic acid,response to hypoxia,response to interleukin-1,response to vitamin B2,S-Adenosyl-Homocysteine,S-Adenosyl-Methionine,S-adenosylmethionine metabolic process,SAMe,severe mental retardation,Sickle Cell,Sickle Cell Disease,small molecule metabolic process,spina bifida,stroke,tetrabioptrein,Tetrahydrobiopterin,tetrahydrofolate,tetrahydrofolate interconversion,THB,vascular occlusion,vitamin,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2066470",
        "SNP Name": "MTHFR 03 P39P",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2066470",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,amino acids,anencephaly,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,blood circulation,blood pressure,cancer,cancerous,carcinogen,cardiovascular,Catalyzes the conversion of 5,cellular amino acid metabolic process,children,cleft lip,cleft palate,cobalamin,cognitive function,colon cancer and acute leukemia,Complete proteome,conotruncal heart defects,CVD,cyanocobalamin,cysteine,cytosol,death of neural tissue of the brain,defect,developmental delay,Disease mutation,environmental risk factors,FAD,flavin adenine dinucleotide binding,Flavoprotein,folate,Folate-sensitive neural tube defects,folic acid,folic acid metabolic process,FS-NTD,Gastric Cancer,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,heart,heart disease,high blood pressure,high blood pressure during pregnancy,high BP,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,hypertension,Ischemic stroke,ISCHSTR,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,loss of motor and sensory and/or cognitive function,MB12,mental disorder,mental retardation,methionine,methionine biosynthetic process,methylcobalamin,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,miscarriage,modified amino acid binding,MTHFR,MTHFRD,myelomeningocele,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,natural menopause,Neural Tube Defect,neurodegenerative,neuron projection,NTDs,open spina bifida,Oxidoreductase,perinatal death,Polymorphism,preeclampsia,pregnancy,Prostate Cancer,psychiatric disorders,psychiatric disturbances,Reference proteome,response to drug,response to folic acid,response to hypoxia,response to interleukin-1,response to vitamin B2,S-Adenosyl-Homocysteine,S-Adenosyl-Methionine,S-adenosylmethionine metabolic process,SAMe,Schizophrenia,severe mental retardation,small molecule metabolic process,spina bifida,stroke,tetrabioptrein,Tetrahydrobiopterin,tetrahydrofolate,tetrahydrofolate interconversion,THB,vascular occlusion,vitamin,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2066470",
        "SNP Name": "MTHFR 03 P39P",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2066470",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,amino acids,anencephaly,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,blood circulation,blood pressure,cancer,cancerous,carcinogen,cardiovascular,Catalyzes the conversion of 5,cellular amino acid metabolic process,children,cleft lip,cleft palate,cobalamin,cognitive function,colon cancer and acute leukemia,Complete proteome,conotruncal heart defects,CVD,cyanocobalamin,cysteine,cytosol,death of neural tissue of the brain,defect,developmental delay,Disease mutation,environmental risk factors,FAD,flavin adenine dinucleotide binding,Flavoprotein,folate,Folate-sensitive neural tube defects,folic acid,folic acid metabolic process,FS-NTD,Gastric Cancer,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,heart,heart disease,high blood pressure,high blood pressure during pregnancy,high BP,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,hypertension,Ischemic stroke,ISCHSTR,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,loss of motor and sensory and/or cognitive function,MB12,mental disorder,mental retardation,methionine,methionine biosynthetic process,methylcobalamin,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,miscarriage,modified amino acid binding,MTHFR,MTHFRD,myelomeningocele,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,natural menopause,Neural Tube Defect,neurodegenerative,neuron projection,NTDs,open spina bifida,Oxidoreductase,perinatal death,Polymorphism,preeclampsia,pregnancy,Prostate Cancer,psychiatric disorders,psychiatric disturbances,Reference proteome,response to drug,response to folic acid,response to hypoxia,response to interleukin-1,response to vitamin B2,S-Adenosyl-Homocysteine,S-Adenosyl-Methionine,S-adenosylmethionine metabolic process,SAMe,Schizophrenia,severe mental retardation,small molecule metabolic process,spina bifida,stroke,tetrabioptrein,Tetrahydrobiopterin,tetrahydrofolate,tetrahydrofolate interconversion,THB,vascular occlusion,vitamin,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs13306561",
        "SNP Name": "MTHFR A4598G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs13306561",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,amino acids,anencephaly,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,blood circulation,blood pressure,cancer,cancerous,carcinogen,cardiovascular,Catalyzes the conversion of 5,cellular amino acid metabolic process,Childhood Acute Lymphoblastic Leukemia,children,cleft lip,cleft palate,cobalamin,cognitive function,colon cancer and acute leukemia,Complete proteome,cyanocobalamin,cysteine,cytosol,death of neural tissue of the brain,defect,developmental delay,Disease mutation,environmental risk factors,FAD,flavin adenine dinucleotide binding,Flavoprotein,folate,Folate-sensitive neural tube defects,folic acid,folic acid metabolic process,FS-NTD,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,heart,heart disease,high blood pressure,high blood pressure during pregnancy,high BP,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,hypertension,Ischemic stroke,ISCHSTR,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,leukemia,loss of motor and sensory and/or cognitive function,MB12,mental disorder,mental retardation,methionine,methionine biosynthetic process,methylcobalamin,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,miscarriage,modified amino acid binding,MTHFR,MTHFRD,myelomeningocele,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,Neural Tube Defect,neurodegenerative,neuron projection,NTDs,open spina bifida,Oxidoreductase,perinatal death,Polymorphism,preeclampsia,pregnancy,psychiatric disorders,psychiatric disturbances,Reference proteome,response to drug,response to folic acid,response to hypoxia,response to interleukin-1,response to vitamin B2,S-Adenosyl-Homocysteine,S-Adenosyl-Methionine,S-adenosylmethionine metabolic process,SAMe,severe mental retardation,small molecule metabolic process,spina bifida,stroke,tetrabioptrein,Tetrahydrobiopterin,tetrahydrofolate,tetrahydrofolate interconversion,THB,vascular occlusion,vitamin,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs13306561",
        "SNP Name": "MTHFR A4598G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs13306561",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,amino acids,anencephaly,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,blood circulation,blood pressure,cancer,cancerous,carcinogen,cardiovascular,Catalyzes the conversion of 5,cellular amino acid metabolic process,Childhood Acute Lymphoblastic Leukemia,children,cleft lip,cleft palate,cobalamin,cognitive function,colon cancer and acute leukemia,Complete proteome,cyanocobalamin,cysteine,cytosol,death of neural tissue of the brain,defect,developmental delay,Disease mutation,environmental risk factors,FAD,flavin adenine dinucleotide binding,Flavoprotein,folate,Folate-sensitive neural tube defects,folic acid,folic acid metabolic process,FS-NTD,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,heart,heart disease,high blood pressure,high blood pressure during pregnancy,high BP,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,hypertension,Ischemic stroke,ISCHSTR,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,leukemia,loss of motor and sensory and/or cognitive function,MB12,mental disorder,mental retardation,methionine,methionine biosynthetic process,methylcobalamin,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,miscarriage,modified amino acid binding,MTHFR,MTHFRD,myelomeningocele,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,Neural Tube Defect,neurodegenerative,neuron projection,NTDs,open spina bifida,Oxidoreductase,perinatal death,Polymorphism,preeclampsia,pregnancy,psychiatric disorders,psychiatric disturbances,Reference proteome,response to drug,response to folic acid,response to hypoxia,response to interleukin-1,response to vitamin B2,S-Adenosyl-Homocysteine,S-Adenosyl-Methionine,S-adenosylmethionine metabolic process,SAMe,severe mental retardation,small molecule metabolic process,spina bifida,stroke,tetrabioptrein,Tetrahydrobiopterin,tetrahydrofolate,tetrahydrofolate interconversion,THB,vascular occlusion,vitamin,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs13306560",
        "SNP Name": "MTHFR C-137T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs13306560",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,amino acids,anencephaly,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,blood circulation,blood pressure,cancer,cancerous,carcinogen,Catalyzes the conversion of 5,cellular amino acid metabolic process,children,cleft lip,cleft palate,cobalamin,cognitive function,colon cancer and acute leukemia,Complete proteome,cyanocobalamin,cysteine,cytosol,death of neural tissue of the brain,defect,developmental delay,Disease mutation,environmental risk factors,FAD,flavin adenine dinucleotide binding,Flavoprotein,folate,Folate-sensitive neural tube defects,folic acid,folic acid metabolic process,FS-NTD,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,heart,heart disease,high blood pressure,high blood pressure during pregnancy,high BP,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,hypertension,Ischemic stroke,ISCHSTR,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,loss of motor and sensory and/or cognitive function,MB12,mental disorder,mental retardation,methionine,methionine biosynthetic process,methylcobalamin,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,miscarriage,modified amino acid binding,MTHFR,MTHFRD,myelomeningocele,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,Neural Tube Defect,neurodegenerative,neuron projection,NTDs,open spina bifida,Oxidoreductase,perinatal death,Pharmacogenomics,Polymorphism,preeclampsia,pregnancy,psychiatric disorders,psychiatric disturbances,Reference proteome,response to drug,response to folic acid,response to hypoxia,response to interleukin-1,response to vitamin B2,S-Adenosyl-Homocysteine,S-Adenosyl-Methionine,S-adenosylmethionine metabolic process,SAMe,severe mental retardation,small molecule metabolic process,spina bifida,stroke,tetrabioptrein,Tetrahydrobiopterin,tetrahydrofolate,tetrahydrofolate interconversion,THB,vascular occlusion,vitamin,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs13306560",
        "SNP Name": "MTHFR C-137T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs13306560",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,amino acids,anencephaly,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,blood circulation,blood pressure,cancer,cancerous,carcinogen,Catalyzes the conversion of 5,cellular amino acid metabolic process,children,cleft lip,cleft palate,cobalamin,cognitive function,colon cancer and acute leukemia,Complete proteome,cyanocobalamin,cysteine,cytosol,death of neural tissue of the brain,defect,developmental delay,Disease mutation,environmental risk factors,FAD,flavin adenine dinucleotide binding,Flavoprotein,folate,Folate-sensitive neural tube defects,folic acid,folic acid metabolic process,FS-NTD,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,heart,heart disease,high blood pressure,high blood pressure during pregnancy,high BP,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,hypertension,Ischemic stroke,ISCHSTR,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,loss of motor and sensory and/or cognitive function,MB12,mental disorder,mental retardation,methionine,methionine biosynthetic process,methylcobalamin,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,miscarriage,modified amino acid binding,MTHFR,MTHFRD,myelomeningocele,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,Neural Tube Defect,neurodegenerative,neuron projection,NTDs,open spina bifida,Oxidoreductase,perinatal death,Pharmacogenomics,Polymorphism,preeclampsia,pregnancy,psychiatric disorders,psychiatric disturbances,Reference proteome,response to drug,response to folic acid,response to hypoxia,response to interleukin-1,response to vitamin B2,S-Adenosyl-Homocysteine,S-Adenosyl-Methionine,S-adenosylmethionine metabolic process,SAMe,severe mental retardation,small molecule metabolic process,spina bifida,stroke,tetrabioptrein,Tetrahydrobiopterin,tetrahydrofolate,tetrahydrofolate interconversion,THB,vascular occlusion,vitamin,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs3737964",
        "SNP Name": "MTHFR A4117C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3737964",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,amino acids,anencephaly,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,blood circulation,blood pressure,cancer,cancerous,carcinogen,Catalyzes the conversion of 5,cellular amino acid metabolic process,children,Cisplatin-Induced Hearing Loss,cleft lip,cleft palate,cobalamin,cognitive function,colon cancer and acute leukemia,Colorectal Cancer,Complete proteome,conotruncal heart defects,cyanocobalamin,cysteine,cytosol,death of neural tissue of the brain,defect,developmental delay,Disease mutation,environmental risk factors,FAD,flavin adenine dinucleotide binding,Flavoprotein,folate,Folate-sensitive neural tube defects,folic acid,folic acid metabolic process,FS-NTD,Gastric Cancer,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,hearing,hearing loss,heart,heart disease,high blood pressure,high blood pressure during pregnancy,high BP,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,hypertension,Ischemic stroke,ISCHSTR,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,loss of motor and sensory and/or cognitive function,MB12,mental disorder,mental retardation,methionine,methionine biosynthetic process,methylcobalamin,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,miscarriage,modified amino acid binding,MTHFR,MTHFRD,myelomeningocele,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,Neural Tube Defect,neurodegenerative,neuron projection,NTDs,open spina bifida,Oxidoreductase,perinatal death,Polymorphism,preeclampsia,pregnancy,psychiatric disorders,psychiatric disturbances,Reference proteome,response to drug,response to folic acid,response to hypoxia,response to interleukin-1,response to vitamin B2,S-Adenosyl-Homocysteine,S-Adenosyl-Methionine,S-adenosylmethionine metabolic process,SAMe,severe mental retardation,small molecule metabolic process,spina bifida,stroke,tetrabioptrein,Tetrahydrobiopterin,tetrahydrofolate,tetrahydrofolate interconversion,THB,vascular occlusion,vitamin,vitamin A,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs3737964",
        "SNP Name": "MTHFR A4117C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3737964",
        "Video": "p8Nhy8N1jJ4",
        "Tags": "10-methylenetetrahydrofolate + NAD(P)H,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate,5-methyltetrahydrofolate + NAD(P)+ = 5,5-MTHF,5MTH,a co-substrate for homocysteine remethylation to methionine,Allosteric enzyme,Allosterically regulated by S-adenosylmethionine,Alternative splicing,amino acids,anencephaly,Autosomal recessive disorder with a wide range of features including homocysteinuria,B12,baby,BH4,birth defect,blood circulation,blood pressure,cancer,cancerous,carcinogen,Catalyzes the conversion of 5,cellular amino acid metabolic process,children,Cisplatin-Induced Hearing Loss,cleft lip,cleft palate,cobalamin,cognitive function,colon cancer and acute leukemia,Colorectal Cancer,Complete proteome,conotruncal heart defects,cyanocobalamin,cysteine,cytosol,death of neural tissue of the brain,defect,developmental delay,Disease mutation,environmental risk factors,FAD,flavin adenine dinucleotide binding,Flavoprotein,folate,Folate-sensitive neural tube defects,folic acid,folic acid metabolic process,FS-NTD,Gastric Cancer,genetic risk factors,Genetic variation in MTHFR influences susceptibility to occlusive vascular disease,glaucoma,hearing,hearing loss,heart,heart disease,high blood pressure,high blood pressure during pregnancy,high BP,homocysteine,homocysteine metabolic process,homocysteinemia,homocystinuria,Homodimer,hypertension,Ischemic stroke,ISCHSTR,L-Homocysteine,L-Methionine,later-onset neurodegenerative disorders,loss of motor and sensory and/or cognitive function,MB12,mental disorder,mental retardation,methionine,methionine biosynthetic process,methylcobalamin,Methylenetetrahydrofolate reductase,methylenetetrahydrofolate reductase (NAD(P)H) activity,Methylenetetrahydrofolate reductase deficiency,methylenetetrahydrofolate reductase family,methylfolate,miscarriage,modified amino acid binding,MTHFR,MTHFRD,myelomeningocele,NAD,NADP,NADP binding,NADP+,NADPH,NADPH+,Neural Tube Defect,neurodegenerative,neuron projection,NTDs,open spina bifida,Oxidoreductase,perinatal death,Polymorphism,preeclampsia,pregnancy,psychiatric disorders,psychiatric disturbances,Reference proteome,response to drug,response to folic acid,response to hypoxia,response to interleukin-1,response to vitamin B2,S-Adenosyl-Homocysteine,S-Adenosyl-Methionine,S-adenosylmethionine metabolic process,SAMe,severe mental retardation,small molecule metabolic process,spina bifida,stroke,tetrabioptrein,Tetrahydrobiopterin,tetrahydrofolate,tetrahydrofolate interconversion,THB,vascular occlusion,vitamin,vitamin A,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs9424398",
        "SNP Name": "CNR2 T24221834G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/19442614",
        "Video": null,
        "Tags": "adenylate,adenylate cyclase,allergies,allergy,amphetamine,anti-inflammatory,arteries,artery,B-cells,blood pressure,bone,bone homeostasis,bones,brain,brain development,cannabinoid,Cannabinoid receptor 2,cannabinoid receptor activity,cannabinoid signaling pathway,CB-2,CB2,CB2A,CB2B,Cell membrane,Cell membrane; Multi-pass membrane protein,Cell projection,Cell projection \u203a dendrite,chemical sensitivity,CNR,CNR2,CVD,CX5,dendrite,dopamine,drug,drug response,drugs,endocannabinoid 2-arachidonoylglycerol,extrinsic component of cytoplasmic side of plasma membrane,G-protein coupled receptor,G-protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger,GABA,GABA/glutamate,GABAergic,glutamate,hCB2,heart,Heterotrimeric G protein-coupled receptor,high BP,histamine,immune response,immune system,inflammation,inflammatory,inflammatory response,integral component of plasma membrane,lipopolysaccharide,low BP,mast cell,mast cell activation syndrome,mast cells,MCAS,MCS,Membrane,multiple chemical sensitivity,negative regulation of action potential,negative regulation of inflammatory response,negative regulation of mast cell activation,negative regulation of nitric-oxide synthase activity,negative regulation of synaptic transmission,neurons,neurotransmitters,nitric oxide,NK cells,nociceptive transmission,norepinephrine,NOS,pain,pain tolerance,Perikaryon,plasma membrane,receptor,response to amphetamine,response to lipopolysaccharide,rs9424398,sensory perception of pain,serotonin,T24221834G,Transducer",
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs9424398",
        "SNP Name": "CNR2 T24221834G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/19442614",
        "Video": null,
        "Tags": "adenylate,adenylate cyclase,allergies,allergy,amphetamine,anti-inflammatory,arteries,artery,B-cells,blood pressure,bone,bone homeostasis,bones,brain,brain development,cannabinoid,Cannabinoid receptor 2,cannabinoid receptor activity,cannabinoid signaling pathway,CB-2,CB2,CB2A,CB2B,Cell membrane,Cell membrane; Multi-pass membrane protein,Cell projection,Cell projection \u203a dendrite,chemical sensitivity,CNR,CNR2,CVD,CX5,dendrite,dopamine,drug,drug response,drugs,endocannabinoid 2-arachidonoylglycerol,extrinsic component of cytoplasmic side of plasma membrane,G-protein coupled receptor,G-protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger,GABA,GABA/glutamate,GABAergic,glutamate,hCB2,heart,Heterotrimeric G protein-coupled receptor,high BP,histamine,immune response,immune system,inflammation,inflammatory,inflammatory response,integral component of plasma membrane,lipopolysaccharide,low BP,mast cell,mast cell activation syndrome,mast cells,MCAS,MCS,Membrane,multiple chemical sensitivity,negative regulation of action potential,negative regulation of inflammatory response,negative regulation of mast cell activation,negative regulation of nitric-oxide synthase activity,negative regulation of synaptic transmission,neurons,neurotransmitters,nitric oxide,NK cells,nociceptive transmission,norepinephrine,NOS,pain,pain tolerance,Perikaryon,plasma membrane,receptor,response to amphetamine,response to lipopolysaccharide,rs9424398,sensory perception of pain,serotonin,T24221834G,Transducer",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs4646487",
        "SNP Name": "CYP4B1 R173W",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4646487",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs2297810",
        "SNP Name": "CYP4B1 M332I",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2297810",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs2297809",
        "SNP Name": "CYP4B1 R376C",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2297809",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs11591147",
        "SNP Name": "PCSK9 R46L",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "3 HCHOLA3,amino acids,apolipoprotein binding,apolipoprotein receptor binding,Apoptosis,apoptotic process,arteries,atorvastatin therapy,autosomal dominant,Ca2+,Calcium,cardio,cardiovascular,cell surface,cellular response to insulin stimulus,cellular response to starvation,cholesterol,cholesterol homeostasis,cholesterol metabolic process,Cholesterol metabolism,Chronic Kidney Disease,Chronic Renal Insufficiency,CKD,cognitive performance,colon carcinoma,coronary,Coronary Artery Calcification,coronary heart disease,CVD,cytoplasm,early endosome,endoplasmic reticulum,Endosome,ER to Golgi transport vesicle,extracellular space,extrinsic component of external side of plasma membrane,Golgi apparatus,HDL-C,heart,heart attack,heart disease,high cholesterol,HIV,Human Immunodeficiency Virus,Hydrolase,Hypercholesterolemia,hypocholesterolemia,kidney development,kidneys,late endosome,LDL-C,Lipid metabolism,lipoprotein,lipoprotein metabolic process,liver development,Low-Density Lipoprotein Cholesterol,low-density lipoprotein particle binding,low-density lipoprotein particle receptor binding,low-density lipoprotein particle receptor catabolic process,low-density lipoproteins,lysosomal transport,lysosome,myocardial infarction,NARC-1,NARC1,negative regulation of low-density lipoprotein particle clearance,negative regulation of receptor recycling,neuro-epithelioma,neurogenesis,neuron differentiation,PC9,PCSK9,perinuclear region of cytoplasm,phospholipid metabolic process,plasma membrane,poly(A) RNA binding,positive regulation of neuron apoptotic process,positive regulation of receptor internalization,premature myocardial infarction,preterm birth,Proprotein convertase 9,Proprotein convertase subtilisin/kexin type 9,Protease,protein autoprocessing,protein self-association,proteolysis,PSEC0052,regulation of low-density lipoprotein particle receptor catabolic process,regulation of neuron apoptotic process,regulation of receptor activity,renal,rough endoplasmic reticulum,Secreted,Serine protease,serine-type endopeptidase activity,sodium channel inhibitor activity,Steroid metabolism,sterol elimination,Sterol metabolism,Subtilisin/kexin-like protease PC9,triglyceride metabolic process,triglycerides,very-low-density lipoprotein particle binding,very-low-density lipoprotein particle receptor binding",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs11688",
        "SNP Name": "JUN c.750G/A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Deoxycholate"
    },
    {
        "SNP ID": "rs855315",
        "SNP Name": "PGM1 A64069612G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs855315",
        "Video": null,
        "Tags": "A64069612G,acetylation,aggregation,Alpha-D-glucose 1-phosphate,alpha-D-glucose 6-phosphate,alternative slplicing,carbohydrate metabolic process,Carbohydrate metabolism,CDG1t,coagulation disorders,Congenital disorder of glycosylation 1T (CDG1T)5,Congenital disorders,defect in glycoprotein biosynthesis,Defective PGM1,differentiation,dysmorphic features,embryonic development,galactose catabolic process,Galactose catabolism,gluconeogenesis,glucose metabolic process,Glucose metabolism,Glucose phosphomutase 1,glycogen biosynthetic process,Glycogen breakdown,glycogen catabolic process,Glycogen synthesis,glycogenolysis,glycolytic process,glycosylation defects in the nervous system development,hypotonia,immunodeficiency,Magnesium,magnesium ion binding,maintenance of cell functions,Metal-binding,multisystem disorder,N-acetylmethionine,N-glycoproteins,N6-acetyllysine,N6-succinyllysine,pentose-phosphate pathway,PGM 1,PGM1,PGM1*1+,PGM1*1-,PGM1*2+,PGM1*2-,PGM1*3+,PGM1*3-,PGM1*7+,PGM1*7-,PGM1-CDG,phosphoglucomutase,phosphoglucomutase activity,Phosphoglucomutase-1,Phosphoprotein,Phosphoserine,Phosphothreonine,polymorphism,psychomotor retardation,response to radiation,rs855315,small molecule metabolic process,solubility,synthesis of glucose,under-glycosylated serum glycoproteins",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs2269260",
        "SNP Name": "PGM1 G64085337A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2269260",
        "Video": null,
        "Tags": "acetylation,aggregation,Alpha-D-glucose 1-phosphate,alpha-D-glucose 6-phosphate,alternative slplicing,carbohydrate metabolic process,Carbohydrate metabolism,CDG1t,coagulation disorders,Congenital disorder of glycosylation 1T (CDG1T)5,Congenital disorders,defect in glycoprotein biosynthesis,Defective PGM1,differentiation,dysmorphic features,embryonic development,G64085337A,galactose catabolic process,Galactose catabolism,gluconeogenesis,glucose metabolic process,Glucose metabolism,Glucose phosphomutase 1,glycogen biosynthetic process,Glycogen breakdown,glycogen catabolic process,Glycogen synthesis,glycogenolysis,glycolytic process,glycosylation defects in the nervous system development,hypotonia,immunodeficiency,Magnesium,magnesium ion binding,maintenance of cell functions,Metal-binding,multisystem disorder,N-acetylmethionine,N-glycoproteins,N6-acetyllysine,N6-succinyllysine,pentose-phosphate pathway,PGM 1,PGM1,PGM1*1+,PGM1*1-,PGM1*2+,PGM1*2-,PGM1*3+,PGM1*3-,PGM1*7+,PGM1*7-,PGM1-CDG,phosphoglucomutase,phosphoglucomutase activity,Phosphoglucomutase-1,Phosphoprotein,Phosphoserine,Phosphothreonine,polymorphism,psychomotor retardation,response to radiation,rs2269260,small molecule metabolic process,solubility,synthesis of glucose,under-glycosylated serum glycoproteins",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs2269241",
        "SNP Name": "PGM1 T64108771C",
        "Risk Allele": "G",
        "Your Allele": "TC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2269241",
        "Video": null,
        "Tags": "acetylation,aggregation,Alpha-D-glucose 1-phosphate,alpha-D-glucose 6-phosphate,alternative slplicing,carbohydrate metabolic process,Carbohydrate metabolism,CDG1t,coagulation disorders,Congenital disorder of glycosylation 1T (CDG1T)5,Congenital disorders,defect in glycoprotein biosynthesis,Defective PGM1,differentiation,dysmorphic features,embryonic development,galactose catabolic process,Galactose catabolism,gluconeogenesis,glucose metabolic process,Glucose metabolism,Glucose phosphomutase 1,glycogen biosynthetic process,Glycogen breakdown,glycogen catabolic process,Glycogen synthesis,glycogenolysis,glycolytic process,glycosylation defects in the nervous system development,hypotonia,immunodeficiency,Magnesium,magnesium ion binding,maintenance of cell functions,Metal-binding,multisystem disorder,N-acetylmethionine,N-glycoproteins,N6-acetyllysine,N6-succinyllysine,pentose-phosphate pathway,PGM 1,PGM1,PGM1*1+,PGM1*1-,PGM1*2+,PGM1*2-,PGM1*3+,PGM1*3-,PGM1*7+,PGM1*7-,PGM1-CDG,phosphoglucomutase,phosphoglucomutase activity,Phosphoglucomutase-1,Phosphoprotein,Phosphoserine,Phosphothreonine,polymorphism,psychomotor retardation,response to radiation,rs2269241,small molecule metabolic process,solubility,synthesis of glucose,T64108771C,under-glycosylated serum glycoproteins",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs4643",
        "SNP Name": "PGM1 A64125439C",
        "Risk Allele": "C",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4643",
        "Video": null,
        "Tags": "A64125439C,acetylation,aggregation,Alpha-D-glucose 1-phosphate,alpha-D-glucose 6-phosphate,alternative slplicing,carbohydrate metabolic process,Carbohydrate metabolism,CDG1t,coagulation disorders,Congenital disorder of glycosylation 1T (CDG1T)5,Congenital disorders,defect in glycoprotein biosynthesis,Defective PGM1,differentiation,dysmorphic features,embryonic development,galactose catabolic process,Galactose catabolism,gluconeogenesis,glucose metabolic process,Glucose metabolism,Glucose phosphomutase 1,glycogen biosynthetic process,Glycogen breakdown,glycogen catabolic process,Glycogen synthesis,glycogenolysis,glycolytic process,glycosylation defects in the nervous system development,hypotonia,immunodeficiency,Magnesium,magnesium ion binding,maintenance of cell functions,Metal-binding,multisystem disorder,N-acetylmethionine,N-glycoproteins,N6-acetyllysine,N6-succinyllysine,pentose-phosphate pathway,PGM 1,PGM1,PGM1*1+,PGM1*1-,PGM1*2+,PGM1*2-,PGM1*3+,PGM1*3-,PGM1*7+,PGM1*7-,PGM1-CDG,phosphoglucomutase,phosphoglucomutase activity,Phosphoglucomutase-1,Phosphoprotein,Phosphoserine,Phosphothreonine,polymorphism,psychomotor retardation,response to radiation,rs4643,small molecule metabolic process,solubility,synthesis of glucose,under-glycosylated serum glycoproteins",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs10889869",
        "SNP Name": "CTH G6010A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10889869",
        "Video": null,
        "Tags": "-SSH,2-oxobutanoate,alternative splicing,Amino-acid biosynthesis,aminoethoxyvinylglycine,ammonia,autosomal,autosomal recessive,birth defect,blood pressure,calcium-dependent,CALM,Calmodulin-binding,carbon-sulfur lyase activity,cellular nitrog",
        "Group": "L-Cystine"
    },
    {
        "SNP ID": "rs10889869",
        "SNP Name": "CTH G6010A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10889869",
        "Video": null,
        "Tags": "-SSH,2-oxobutanoate,alternative splicing,Amino-acid biosynthesis,aminoethoxyvinylglycine,ammonia,autosomal,autosomal recessive,birth defect,blood pressure,calcium-dependent,CALM,Calmodulin-binding,carbon-sulfur lyase activity,cellular nitrog",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs10889869",
        "SNP Name": "CTH G6010A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10889869",
        "Video": null,
        "Tags": "-SSH,2-oxobutanoate,alternative splicing,Amino-acid biosynthesis,aminoethoxyvinylglycine,ammonia,autosomal,autosomal recessive,birth defect,blood pressure,calcium-dependent,CALM,Calmodulin-binding,carbon-sulfur lyase activity,cellular nitrog",
        "Group": "Trans-Sulfuration Pathway"
    },
    {
        "SNP ID": "rs681475",
        "SNP Name": "CTH T8763C",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs681475",
        "Video": null,
        "Tags": "-SSH,2-oxobutanoate,alternative splicing,Amino-acid biosynthesis,aminoethoxyvinylglycine,ammonia,autosomal,autosomal recessive,blood pressure,calcium-dependent,CALM,Calmodulin-binding,carbon-sulfur lyase activity,cellular nitrogen compound me",
        "Group": "L-Cystine"
    },
    {
        "SNP ID": "rs681475",
        "SNP Name": "CTH T8763C",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs681475",
        "Video": null,
        "Tags": "-SSH,2-oxobutanoate,alternative splicing,Amino-acid biosynthesis,aminoethoxyvinylglycine,ammonia,autosomal,autosomal recessive,blood pressure,calcium-dependent,CALM,Calmodulin-binding,carbon-sulfur lyase activity,cellular nitrogen compound me",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs681475",
        "SNP Name": "CTH T8763C",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs681475",
        "Video": null,
        "Tags": "-SSH,2-oxobutanoate,alternative splicing,Amino-acid biosynthesis,aminoethoxyvinylglycine,ammonia,autosomal,autosomal recessive,blood pressure,calcium-dependent,CALM,Calmodulin-binding,carbon-sulfur lyase activity,cellular nitrogen compound me",
        "Group": "Trans-Sulfuration Pathway"
    },
    {
        "SNP ID": "rs1145920",
        "SNP Name": "CTH A11886G",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1145920",
        "Video": null,
        "Tags": "-SSH,2-oxobutanoate,alternative splicing,Amino-acid biosynthesis,aminoethoxyvinylglycine,ammonia,autosomal,autosomal recessive,blood pressure,calcium-dependent,CALM,Calmodulin-binding,carbon-sulfur lyase activity,cellular nitrogen compound me",
        "Group": "L-Cystine"
    },
    {
        "SNP ID": "rs1145920",
        "SNP Name": "CTH A11886G",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1145920",
        "Video": null,
        "Tags": "-SSH,2-oxobutanoate,alternative splicing,Amino-acid biosynthesis,aminoethoxyvinylglycine,ammonia,autosomal,autosomal recessive,blood pressure,calcium-dependent,CALM,Calmodulin-binding,carbon-sulfur lyase activity,cellular nitrogen compound me",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs1145920",
        "SNP Name": "CTH A11886G",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1145920",
        "Video": null,
        "Tags": "-SSH,2-oxobutanoate,alternative splicing,Amino-acid biosynthesis,aminoethoxyvinylglycine,ammonia,autosomal,autosomal recessive,blood pressure,calcium-dependent,CALM,Calmodulin-binding,carbon-sulfur lyase activity,cellular nitrogen compound me",
        "Group": "Trans-Sulfuration Pathway"
    },
    {
        "SNP ID": "rs663649",
        "SNP Name": "CTH G25229T",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs663649",
        "Video": null,
        "Tags": "-SSH,2-oxobutanoate,alternative splicing,Amino-acid biosynthesis,aminoethoxyvinylglycine,ammonia,autosomal,autosomal recessive,blood pressure,calcium-dependent,CALM,Calmodulin-binding,carbon-sulfur lyase activity,cellular nitrogen compound me",
        "Group": "L-Cystine"
    },
    {
        "SNP ID": "rs663649",
        "SNP Name": "CTH G25229T",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs663649",
        "Video": null,
        "Tags": "-SSH,2-oxobutanoate,alternative splicing,Amino-acid biosynthesis,aminoethoxyvinylglycine,ammonia,autosomal,autosomal recessive,blood pressure,calcium-dependent,CALM,Calmodulin-binding,carbon-sulfur lyase activity,cellular nitrogen compound me",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs663649",
        "SNP Name": "CTH G25229T",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs663649",
        "Video": null,
        "Tags": "-SSH,2-oxobutanoate,alternative splicing,Amino-acid biosynthesis,aminoethoxyvinylglycine,ammonia,autosomal,autosomal recessive,blood pressure,calcium-dependent,CALM,Calmodulin-binding,carbon-sulfur lyase activity,cellular nitrogen compound me",
        "Group": "Trans-Sulfuration Pathway"
    },
    {
        "SNP ID": "rs1021737",
        "SNP Name": "CTH S4031I",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1021737",
        "Video": null,
        "Tags": "-SSH,2-oxobutanoate,alternative splicing,Amino-acid biosynthesis,aminoethoxyvinylglycine,ammonia,autosomal,autosomal recessive,blood pressure,calcium-dependent,CALM,Calmodulin-binding,carbon-sulfur lyase activity,cellular nitrogen compound me",
        "Group": "L-Cystine"
    },
    {
        "SNP ID": "rs1021737",
        "SNP Name": "CTH S4031I",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1021737",
        "Video": null,
        "Tags": "-SSH,2-oxobutanoate,alternative splicing,Amino-acid biosynthesis,aminoethoxyvinylglycine,ammonia,autosomal,autosomal recessive,blood pressure,calcium-dependent,CALM,Calmodulin-binding,carbon-sulfur lyase activity,cellular nitrogen compound me",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs1021737",
        "SNP Name": "CTH S4031I",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1021737",
        "Video": null,
        "Tags": "-SSH,2-oxobutanoate,alternative splicing,Amino-acid biosynthesis,aminoethoxyvinylglycine,ammonia,autosomal,autosomal recessive,blood pressure,calcium-dependent,CALM,Calmodulin-binding,carbon-sulfur lyase activity,cellular nitrogen compound me",
        "Group": "Trans-Sulfuration Pathway"
    },
    {
        "SNP ID": "rs6665776",
        "SNP Name": "PTGER3 G90650T",
        "Risk Allele": "A",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs2301022",
        "SNP Name": "GCLM A7135G",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Mercury (Thiomersal/Thimerosal)"
    },
    {
        "SNP ID": "rs291593",
        "SNP Name": "DPYD 97543752G>A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs291592",
        "SNP Name": "DPYD 97543764C>T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs1801268",
        "SNP Name": "DPYD Val995Phe",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs67376798",
        "SNP Name": "DPYD Asp949Val",
        "Risk Allele": "A",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs1399291",
        "SNP Name": "DPYD 97576922C>T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs11587873",
        "SNP Name": "DPYD 97653070C>T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs12137711",
        "SNP Name": "DPYD 97700589C>T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs1801160",
        "SNP Name": "DPYD Val732Ile",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs7548189",
        "SNP Name": "DPYD 97867713C>A",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs3918290",
        "SNP Name": "DPYD 97915614C>T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs17376848",
        "SNP Name": "DPYD 97915624A>G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs55886062",
        "SNP Name": "DPYD Ile560Asn",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs1801159",
        "SNP Name": "DPYD Ile543Val",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs1801158",
        "SNP Name": "DPYD Ser534Asn",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs1801266",
        "SNP Name": "DPYD Arg235Trp",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs1801265",
        "SNP Name": "DPYD Cys29Arg",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs12021720",
        "SNP Name": "DBT G384S",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs12021720",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs12021720",
        "SNP Name": "DBT G384S",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs12021720",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs3176860",
        "SNP Name": "VCAM1 A71159137G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs3176879",
        "SNP Name": "VCAM1 G71175745A",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs4970834",
        "SNP Name": "CELSR2 -20C7927T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "2-oxoglutarate dependent 3-hydroxylation of aspartate and asparagine,ApoB,ApoB serum levels,aspartame,Cadherin EGF LAG seven-pass G-type receptor 2,Cadherin family member 10,Calcium,calcium ion binding,cardio,cardiovascular,carotid artery disease,CDHF10,CELR2,CELSR2,central nervous system,cerebrospinal fluid secretion,cholesterol,chronic kidney disease,cilium assembly,cilium movement,CKD,CNS,Coronary Heart Disease,CVD,dendrite morphogenesis,Developmental protein,Disulfide bond,DNA-templated,dyslipidemia,EGF-like protein 2,EGFL2,Epidermal growth factor-like protein 2,FE,Flamingo homolog 3,G-protein coupled receptor,G-protein coupled receptor activity,G-protein coupled receptor signaling pathway,Glycoprotein,heart,heart disease,high-density lipoprotein,homophilic cell adhesion via plasma membrane adhesion molecules,Hydroxylation,iron,KIAA0279,LDL,LDL-cholesterol,lipids,lipoprotein,low density lipoprotein,MEGF3,Multiple EGF-like domains protein 3,Multiple epidermal growth factor-like domains protein 3,Myocardial Infarction,nerves,nervous system,neural plate anterior/posterior regionalization,neuron migration,neuropeptide signaling pathway,Receptor,regulation of cell-cell adhesion,regulation of protein localization,regulation of transcription,stroke,total cholesterol,Transducer,ventricular system development,Wnt signaling pathway",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs2239892",
        "SNP Name": "GSTM1 8869A>G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2239892",
        "Video": "EKqkkYj-jhY",
        "Tags": "1 GST C-terminal domain,1 GST N-terminal domain,3D-structure,Alternative splicing,asthma,bladder cancer,cancer,cancerous,carcinogen,cellular detoxification of nitrogen compound,Complete proteome,Conjugation,Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles,Cytoplasm,cytosol,Direct protein,E2,endogenous,environmental,environmental factors,environmental toxins,enzyme binding,estrogen,exogenous,glutamate,glutathione,glutathione binding,Glutathione conjugation,glutathione derivative biosynthetic process,glutathione metabolic process,Glutathione S-transferase Mu 1,glutathione transferase activity,GST C-terminal domain,GST class-mu 1,GST HB subunit 4,GST superfamily,GST1,GSTM1,GSTM1-1,GSTM1A,GSTM1a-1a,GSTM1B,GSTM1b-1b,GTH4,Homodimer,hydrophobic electrophiles,immunology,Liver,Mu family,nitrobenzene metabolic process,oxidative stress,Polymorphism,protein homodimerization activity,R-S-glutathione,Reactive Oxygen Species,reduced glutathione,Reference proteome,ROS,RX + glutathione = HX + R-S-glutathione,small molecule metabolic process,toxins,Transferase,xenobiotic,xenobiotic catabolic process,xenobiotic metabolic process,xenoestrogen",
        "Group": "Mercury (Thiomersal/Thimerosal)"
    },
    {
        "SNP ID": "rs2239892",
        "SNP Name": "GSTM1 8869A>G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2239892",
        "Video": "EKqkkYj-jhY",
        "Tags": "1 GST C-terminal domain,1 GST N-terminal domain,3D-structure,Alternative splicing,asthma,bladder cancer,cancer,cancerous,carcinogen,cellular detoxification of nitrogen compound,Complete proteome,Conjugation,Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles,Cytoplasm,cytosol,Direct protein,E2,endogenous,environmental,environmental factors,environmental toxins,enzyme binding,estrogen,exogenous,glutamate,glutathione,glutathione binding,Glutathione conjugation,glutathione derivative biosynthetic process,glutathione metabolic process,Glutathione S-transferase Mu 1,glutathione transferase activity,GST C-terminal domain,GST class-mu 1,GST HB subunit 4,GST superfamily,GST1,GSTM1,GSTM1-1,GSTM1A,GSTM1a-1a,GSTM1B,GSTM1b-1b,GTH4,Homodimer,hydrophobic electrophiles,immunology,Liver,Mu family,nitrobenzene metabolic process,oxidative stress,Polymorphism,protein homodimerization activity,R-S-glutathione,Reactive Oxygen Species,reduced glutathione,Reference proteome,ROS,RX + glutathione = HX + R-S-glutathione,small molecule metabolic process,toxins,Transferase,xenobiotic,xenobiotic catabolic process,xenobiotic metabolic process,xenoestrogen",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs7483",
        "SNP Name": "GSTM3 V224I",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7483",
        "Video": null,
        "Tags": "4-dinitrobenzene,advanced colorectal adenoma,aging,Alzheimer,Alzheimer's,Alzheimer's disease,amine,associate with mercury biomarker levels in Michigan dental professionals,BBB,Bladder Cancer,bladder cancer risk,Blood Brain Barrier,brain,cancer,cancerous,carcinogen,cellular detoxification of nitrogen compound,cellular energy,chemotherapy,cognitive ability,cognitive decline,cognitive performance,Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles,cytoplasm,cytosol,dentical protein binding,detox,detoxification,dietary heterocyclic amine intake,Dietary Heterocyclic Amine Intake and Risk of Prostate Cancer,digestion,drug response,E2,energy,environment interactions,environmental,environmental toxins,enzyme binding,establishment of blood-nerve barrier,estrogen,extracellular vesicular exosome,Flavopiridol,Flavopiridol Pharmacogenetics,Flavopiridol response,gastrointestnial,GI,Gi tract,glutamate,glutamine,glutathione,glutathione binding,glutathione derivative biosynthetic process,glutathione metabolic process,Glutathione Pathway,Glutathione S-transferase,Glutathione S-transferase Mu 3,glutathione transferase activity,govern uptake and detoxification of both endogenous compounds and xenobiotics at the testis and brain blood barriers,gsh,GST C-terminal domain,GST class-mu 3,GST N-terminal domain,GST superfamily,GSTM3,GSTM3-3,H. pylori,heavy metal poisoning,heavy metal toxicity,Helicobacter pylori,hGSTM3-3,Homodimer,identical protein binding,KM=0.084 mM for glutathione,KM=1.1 mM for 1-chloro-2,L-glutamine,L-glutathione,liver,lung,Lung Cancer,lung cancer risk,Lung Cancer Survival After Platinum-Based Chemotherapy,lung function,lungs,Malignant Brain Tumors,Malignant Brain Tumors in Children,mercury,mercury biomarker levels in dental professionals,mercury levels,mitochondria,Mu family,nicotine,nitrobenzene metabolic process,nucleus,oxidative stress,parasite,Pharmacogenetics,Polymorphism,Prostate Cancer,protein homodimerization activity,quercetin-gene interaction,Reactive Oxygen Species,reduced glutathione,response to estrogen,ROS,RX + glutathione = HX + R-S-glutathione,small molecule metabolic process,smoke,smoking,testicles,testis,Testis and brain,testosterone,The N-terminus is blocked,tobacco,Tobacco Smoke Exposure as Determinants of Childhood Lung Function,tobacco smoke exposures and lung function growth,tobacco smoke exposures on lung function growth,toxins,Transferase,worm,xenobiotic,xenobiotic catabolic process,Xenobiotic Detoxication,xenobiotic metabolic process,xenobiotic metabolism,xenobiotics,xenoestrogen",
        "Group": "Mercury (Thiomersal/Thimerosal)"
    },
    {
        "SNP ID": "rs7483",
        "SNP Name": "GSTM3 V224I",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7483",
        "Video": null,
        "Tags": "4-dinitrobenzene,advanced colorectal adenoma,aging,Alzheimer,Alzheimer's,Alzheimer's disease,amine,associate with mercury biomarker levels in Michigan dental professionals,BBB,Bladder Cancer,bladder cancer risk,Blood Brain Barrier,brain,cancer,cancerous,carcinogen,cellular detoxification of nitrogen compound,cellular energy,chemotherapy,cognitive ability,cognitive decline,cognitive performance,Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles,cytoplasm,cytosol,dentical protein binding,detox,detoxification,dietary heterocyclic amine intake,Dietary Heterocyclic Amine Intake and Risk of Prostate Cancer,digestion,drug response,E2,energy,environment interactions,environmental,environmental toxins,enzyme binding,establishment of blood-nerve barrier,estrogen,extracellular vesicular exosome,Flavopiridol,Flavopiridol Pharmacogenetics,Flavopiridol response,gastrointestnial,GI,Gi tract,glutamate,glutamine,glutathione,glutathione binding,glutathione derivative biosynthetic process,glutathione metabolic process,Glutathione Pathway,Glutathione S-transferase,Glutathione S-transferase Mu 3,glutathione transferase activity,govern uptake and detoxification of both endogenous compounds and xenobiotics at the testis and brain blood barriers,gsh,GST C-terminal domain,GST class-mu 3,GST N-terminal domain,GST superfamily,GSTM3,GSTM3-3,H. pylori,heavy metal poisoning,heavy metal toxicity,Helicobacter pylori,hGSTM3-3,Homodimer,identical protein binding,KM=0.084 mM for glutathione,KM=1.1 mM for 1-chloro-2,L-glutamine,L-glutathione,liver,lung,Lung Cancer,lung cancer risk,Lung Cancer Survival After Platinum-Based Chemotherapy,lung function,lungs,Malignant Brain Tumors,Malignant Brain Tumors in Children,mercury,mercury biomarker levels in dental professionals,mercury levels,mitochondria,Mu family,nicotine,nitrobenzene metabolic process,nucleus,oxidative stress,parasite,Pharmacogenetics,Polymorphism,Prostate Cancer,protein homodimerization activity,quercetin-gene interaction,Reactive Oxygen Species,reduced glutathione,response to estrogen,ROS,RX + glutathione = HX + R-S-glutathione,small molecule metabolic process,smoke,smoking,testicles,testis,Testis and brain,testosterone,The N-terminus is blocked,tobacco,Tobacco Smoke Exposure as Determinants of Childhood Lung Function,tobacco smoke exposures and lung function growth,tobacco smoke exposures on lung function growth,toxins,Transferase,worm,xenobiotic,xenobiotic catabolic process,Xenobiotic Detoxication,xenobiotic metabolic process,xenobiotic metabolism,xenobiotics,xenoestrogen",
        "Group": "Polacrilin Potassium"
    },
    {
        "SNP ID": "rs7483",
        "SNP Name": "GSTM3 V224I",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7483",
        "Video": null,
        "Tags": "4-dinitrobenzene,advanced colorectal adenoma,aging,Alzheimer,Alzheimer's,Alzheimer's disease,amine,associate with mercury biomarker levels in Michigan dental professionals,BBB,Bladder Cancer,bladder cancer risk,Blood Brain Barrier,brain,cancer,cancerous,carcinogen,cellular detoxification of nitrogen compound,cellular energy,chemotherapy,cognitive ability,cognitive decline,cognitive performance,Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles,cytoplasm,cytosol,dentical protein binding,detox,detoxification,dietary heterocyclic amine intake,Dietary Heterocyclic Amine Intake and Risk of Prostate Cancer,digestion,drug response,E2,energy,environment interactions,environmental,environmental toxins,enzyme binding,establishment of blood-nerve barrier,estrogen,extracellular vesicular exosome,Flavopiridol,Flavopiridol Pharmacogenetics,Flavopiridol response,gastrointestnial,GI,Gi tract,glutamate,glutamine,glutathione,glutathione binding,glutathione derivative biosynthetic process,glutathione metabolic process,Glutathione Pathway,Glutathione S-transferase,Glutathione S-transferase Mu 3,glutathione transferase activity,govern uptake and detoxification of both endogenous compounds and xenobiotics at the testis and brain blood barriers,gsh,GST C-terminal domain,GST class-mu 3,GST N-terminal domain,GST superfamily,GSTM3,GSTM3-3,H. pylori,heavy metal poisoning,heavy metal toxicity,Helicobacter pylori,hGSTM3-3,Homodimer,identical protein binding,KM=0.084 mM for glutathione,KM=1.1 mM for 1-chloro-2,L-glutamine,L-glutathione,liver,lung,Lung Cancer,lung cancer risk,Lung Cancer Survival After Platinum-Based Chemotherapy,lung function,lungs,Malignant Brain Tumors,Malignant Brain Tumors in Children,mercury,mercury biomarker levels in dental professionals,mercury levels,mitochondria,Mu family,nicotine,nitrobenzene metabolic process,nucleus,oxidative stress,parasite,Pharmacogenetics,Polymorphism,Prostate Cancer,protein homodimerization activity,quercetin-gene interaction,Reactive Oxygen Species,reduced glutathione,response to estrogen,ROS,RX + glutathione = HX + R-S-glutathione,small molecule metabolic process,smoke,smoking,testicles,testis,Testis and brain,testosterone,The N-terminus is blocked,tobacco,Tobacco Smoke Exposure as Determinants of Childhood Lung Function,tobacco smoke exposures and lung function growth,tobacco smoke exposures on lung function growth,toxins,Transferase,worm,xenobiotic,xenobiotic catabolic process,Xenobiotic Detoxication,xenobiotic metabolic process,xenobiotic metabolism,xenobiotics,xenoestrogen",
        "Group": "IgG"
    },
    {
        "SNP ID": "rs7483",
        "SNP Name": "GSTM3 V224I",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7483",
        "Video": null,
        "Tags": "4-dinitrobenzene,advanced colorectal adenoma,aging,Alzheimer,Alzheimer's,Alzheimer's disease,amine,associate with mercury biomarker levels in Michigan dental professionals,BBB,Bladder Cancer,bladder cancer risk,Blood Brain Barrier,brain,cancer,cancerous,carcinogen,cellular detoxification of nitrogen compound,cellular energy,chemotherapy,cognitive ability,cognitive decline,cognitive performance,Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles,cytoplasm,cytosol,dentical protein binding,detox,detoxification,dietary heterocyclic amine intake,Dietary Heterocyclic Amine Intake and Risk of Prostate Cancer,digestion,drug response,E2,energy,environment interactions,environmental,environmental toxins,enzyme binding,establishment of blood-nerve barrier,estrogen,extracellular vesicular exosome,Flavopiridol,Flavopiridol Pharmacogenetics,Flavopiridol response,gastrointestnial,GI,Gi tract,glutamate,glutamine,glutathione,glutathione binding,glutathione derivative biosynthetic process,glutathione metabolic process,Glutathione Pathway,Glutathione S-transferase,Glutathione S-transferase Mu 3,glutathione transferase activity,govern uptake and detoxification of both endogenous compounds and xenobiotics at the testis and brain blood barriers,gsh,GST C-terminal domain,GST class-mu 3,GST N-terminal domain,GST superfamily,GSTM3,GSTM3-3,H. pylori,heavy metal poisoning,heavy metal toxicity,Helicobacter pylori,hGSTM3-3,Homodimer,identical protein binding,KM=0.084 mM for glutathione,KM=1.1 mM for 1-chloro-2,L-glutamine,L-glutathione,liver,lung,Lung Cancer,lung cancer risk,Lung Cancer Survival After Platinum-Based Chemotherapy,lung function,lungs,Malignant Brain Tumors,Malignant Brain Tumors in Children,mercury,mercury biomarker levels in dental professionals,mercury levels,mitochondria,Mu family,nicotine,nitrobenzene metabolic process,nucleus,oxidative stress,parasite,Pharmacogenetics,Polymorphism,Prostate Cancer,protein homodimerization activity,quercetin-gene interaction,Reactive Oxygen Species,reduced glutathione,response to estrogen,ROS,RX + glutathione = HX + R-S-glutathione,small molecule metabolic process,smoke,smoking,testicles,testis,Testis and brain,testosterone,The N-terminus is blocked,tobacco,Tobacco Smoke Exposure as Determinants of Childhood Lung Function,tobacco smoke exposures and lung function growth,tobacco smoke exposures on lung function growth,toxins,Transferase,worm,xenobiotic,xenobiotic catabolic process,Xenobiotic Detoxication,xenobiotic metabolic process,xenobiotic metabolism,xenobiotics,xenoestrogen",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1058184",
        "SNP Name": "KCNA3 T*232G",
        "Risk Allele": "C",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dipotassium Phosphate"
    },
    {
        "SNP ID": "rs1058184",
        "SNP Name": "KCNA3 T*232G",
        "Risk Allele": "C",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dulbecco's Modified Eagle Medium"
    },
    {
        "SNP ID": "rs1058184",
        "SNP Name": "KCNA3 T*232G",
        "Risk Allele": "C",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Monopotassium Glutamate"
    },
    {
        "SNP ID": "rs1058184",
        "SNP Name": "KCNA3 T*232G",
        "Risk Allele": "C",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Monopotassium Phosphate"
    },
    {
        "SNP ID": "rs1058184",
        "SNP Name": "KCNA3 T*232G",
        "Risk Allele": "C",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Polacrilin Potassium"
    },
    {
        "SNP ID": "rs1058184",
        "SNP Name": "KCNA3 T*232G",
        "Risk Allele": "C",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Potassium Chloride"
    },
    {
        "SNP ID": "rs2814778",
        "SNP Name": "DARC 5174T>C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs2814778",
        "Video": null,
        "Tags": null,
        "Group": "IgE"
    },
    {
        "SNP ID": "rs2494262",
        "SNP Name": "FCER1A / OR10J2P variant",
        "Risk Allele": "A",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs2494262",
        "Video": null,
        "Tags": null,
        "Group": "IgE"
    },
    {
        "SNP ID": "rs2427837",
        "SNP Name": "FCER1A variant",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs2427837",
        "Video": null,
        "Tags": null,
        "Group": "IgE"
    },
    {
        "SNP ID": "rs2251746",
        "SNP Name": "FCER1A 159272060T>C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/22222815, http://www.snpedia.com/index.php/Rs2251746",
        "Video": null,
        "Tags": null,
        "Group": "IgE"
    },
    {
        "SNP ID": "rs1801274",
        "SNP Name": "FCGR2A variant",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs1801274",
        "Video": null,
        "Tags": null,
        "Group": "IgG"
    },
    {
        "SNP ID": "rs6702820",
        "SNP Name": "DDR2 A162603881G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6702820",
        "Video": null,
        "Tags": "1 protein kinase,A162603881G,ablosihes signaling in response collagen binding,abolishes collagen binding,abolishes kinase activity,abolishes phosphorylation,acitvation of the transcription factor RUNX2,active site,ADP,anterior protrusions,apical plasma membrane,ATP,ATP binding,ATP-binding,autophosphorylation,binding site,binds hydroxyproline-rich sequence motifs in fibrillar,Biological processing,biomineral tissue development,bone development,bone disease,bone lining cells,brain,cartilage,catalytic activity,causes retention in intracellular compartment,CD167 antigen-like family member B,CD167b,CD_antigen,cell adhesion,cell membrane,cell migration,cell proliferation,cell surface receptor,central humps,characteristic craniofacial appearance,chondrocyte maturation,chondrocyte proliferation,collagen binding,collagen fibril organization,collagen-activated tyrosine kinase receptor signaling pathway,cutaneous wound healing,cytoplasmic,DDR2,Discoidin domain receptor 2,Discoidin domain-containing receptor 2,Discoidin domain-containing receptor tyrosine kinase 2,disease mutation,distinctive radiological findings,Disulfide bond,Domaini,Dwarfism,endochondral bone growth,Extracellular,extracellular exosome,extracellular matrix,extracellular matrix organization,F-736,F-740,facilitiates cell migration,feet brachydactyly,fibrillar collagen,flared,flattened,focal adhesion,fragmented,Glycoprotein,glycosylated collagen,GQOGVMGFO motif,hand brachydactyly,heart,helical,hydroxyproline,in SEMD-SL,in vitro,Insulin receptor subfamily,integral component of plasma membrane,Interacts (tyrosine phosphorylated) with SHC1,Interacts with SRC,irregular metaphyses. Platyspondyly in the spine,kidney,Kinase,L-tyrosin phosphate,L-tyrosine,Ligandi,liver,lung,lung large cell carcinoma,MAP kinases,Membrane,MMP1,MMP13,MMP2,Molecular functioning,muscle,mutagenesis,mutations,N-glycosylated,narrow chest,Neurotrophic tyrosine kinase,Non-integrin membrane-ECM interactions,NTRKR3,nucleoptide binding,Nucleotide-binding,ossification,osteoarthritis patients,osteoblast differentiation,osteoblastic cells,osteocytes,Osteogenesis,pancreas,pear-shaped vertebral bodies,pectus excavatum,peptidyl-tyrosine phosphorylation,Phosphoprotein,phosphorylation,placenta,plasma membrane,positive regulation of extracellular matrix disassembly,positive regulation of fibroblast migration,positive regulation of fibroblast proliferation,positive regulation of osteoblast differentiation,positive regulation of protein kinase activity,positive regulation of sequence-specific DNA binding transcription factor activity,posterior scalloping,premature calcifications,proliferation,promotes fibrolast migration,protein,protein autophosphorylation regulation of bone mineralization,protein kinase superfamily,protein level,protein tyrosine kinase collagen receptor activity,proton acceptor,Receptor,Receptor protein-tyrosine kinase,receptor-related 3,reduces autophosphorylation,regorafenib,regulates cell differentiation,regulates remodeling,regulation of extracellular matrix disassembly,remodeling of the extracellular matrix,rs6702820,RUNX2,short long bones,short-limbed dwarfism,Signal,signal transduction,signaling pathway,single-opass type I membrane protein,skeletal,skeleton,Spondyloepimetaphyseal dysplasia short limb-hand type,SRC,stippled,striking epiphyses,subchondral bone,tibia,TKT,Transferase,Transmembrane,Transmembrane helix,transmembrane receptor protein tyrosine kinase activity,tumor cell invasion,Tyr protein kinase family,TYRO10,Tyrosine kinase,Tyrosine phosphorylated,Tyrosine phosphorylation,tyrosine residues,Tyrosine-protein kinase,up regualtion of the collagenases,up-regulated in cartilege,wide intervertebral spaces",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs10494373",
        "SNP Name": "DDR2 A162619362C",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10494373",
        "Video": null,
        "Tags": "1 protein kinase,A162619362C,ablosihes signaling in response collagen binding,abolishes collagen binding,abolishes kinase activity,abolishes phosphorylation,acitvation of the transcription factor RUNX2,active site,ADP,anterior protrusions,apical plasma membrane,ATP,ATP binding,ATP-binding,autophosphorylation,binding site,binds hydroxyproline-rich sequence motifs in fibrillar,Biological processing,biomineral tissue development,bone development,bone disease,bone lining cells,brain,cartilage,catalytic activity,causes retention in intracellular compartment,CD167 antigen-like family member B,CD167b,CD_antigen,cell adhesion,cell membrane,cell migration,cell proliferation,cell surface receptor,central humps,characteristic craniofacial appearance,chondrocyte maturation,chondrocyte proliferation,collagen binding,collagen fibril organization,collagen-activated tyrosine kinase receptor signaling pathway,cutaneous wound healing,cytoplasmic,DDR2,Discoidin domain receptor 2,Discoidin domain-containing receptor 2,Discoidin domain-containing receptor tyrosine kinase 2,disease mutation,distinctive radiological findings,Disulfide bond,Domaini,Dwarfism,endochondral bone growth,Extracellular,extracellular exosome,extracellular matrix,extracellular matrix organization,F-736,F-740,facilitiates cell migration,feet brachydactyly,fibrillar collagen,flared,flattened,focal adhesion,fragmented,Glycoprotein,glycosylated collagen,GQOGVMGFO motif,hand brachydactyly,heart,helical,hydroxyproline,in SEMD-SL,in vitro,Insulin receptor subfamily,integral component of plasma membrane,Interacts (tyrosine phosphorylated) with SHC1,Interacts with SRC,irregular metaphyses. Platyspondyly in the spine,kidney,Kinase,L-tyrosin phosphate,L-tyrosine,Ligandi,liver,lung,lung large cell carcinoma,MAP kinases,Membrane,MMP1,MMP13,MMP2,Molecular functioning,muscle,mutagenesis,mutations,N-glycosylated,narrow chest,Neurotrophic tyrosine kinase,Non-integrin membrane-ECM interactions,NTRKR3,nucleoptide binding,Nucleotide-binding,ossification,osteoarthritis patients,osteoblast differentiation,osteoblastic cells,osteocytes,Osteogenesis,pancreas,pear-shaped vertebral bodies,pectus excavatum,peptidyl-tyrosine phosphorylation,Phosphoprotein,phosphorylation,placenta,plasma membrane,positive regulation of extracellular matrix disassembly,positive regulation of fibroblast migration,positive regulation of fibroblast proliferation,positive regulation of osteoblast differentiation,positive regulation of protein kinase activity,positive regulation of sequence-specific DNA binding transcription factor activity,posterior scalloping,premature calcifications,proliferation,promotes fibrolast migration,protein,protein autophosphorylation regulation of bone mineralization,protein kinase superfamily,protein level,protein tyrosine kinase collagen receptor activity,proton acceptor,Receptor,Receptor protein-tyrosine kinase,receptor-related 3,reduces autophosphorylation,regorafenib,regulates cell differentiation,regulates remodeling,regulation of extracellular matrix disassembly,remodeling of the extracellular matrix,rs10494373,RUNX2,short long bones,short-limbed dwarfism,Signal,signal transduction,signaling pathway,single-opass type I membrane protein,skeletal,skeleton,Spondyloepimetaphyseal dysplasia short limb-hand type,SRC,stippled,striking epiphyses,subchondral bone,tibia,TKT,Transferase,Transmembrane,Transmembrane helix,transmembrane receptor protein tyrosine kinase activity,tumor cell invasion,Tyr protein kinase family,TYRO10,Tyrosine kinase,Tyrosine phosphorylated,Tyrosine phosphorylation,tyrosine residues,Tyrosine-protein kinase,up regualtion of the collagenases,up-regulated in cartilege,wide intervertebral spaces",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs10799854",
        "SNP Name": "DDR2 C162619828T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10799854",
        "Video": null,
        "Tags": "1 protein kinase,ablosihes signaling in response collagen binding,abolishes collagen binding,abolishes kinase activity,abolishes phosphorylation,acitvation of the transcription factor RUNX2,active site,ADP,anterior protrusions,apical plasma membrane,ATP,ATP binding,ATP-binding,autophosphorylation,binding site,binds hydroxyproline-rich sequence motifs in fibrillar,Biological processing,biomineral tissue development,bone development,bone disease,bone lining cells,brain,C162619828T,cartilage,catalytic activity,causes retention in intracellular compartment,CD167 antigen-like family member B,CD167b,CD_antigen,cell adhesion,cell membrane,cell migration,cell proliferation,cell surface receptor,central humps,characteristic craniofacial appearance,chondrocyte maturation,chondrocyte proliferation,collagen binding,collagen fibril organization,collagen-activated tyrosine kinase receptor signaling pathway,cutaneous wound healing,cytoplasmic,DDR2,Discoidin domain receptor 2,Discoidin domain-containing receptor 2,Discoidin domain-containing receptor tyrosine kinase 2,disease mutation,distinctive radiological findings,Disulfide bond,Domaini,Dwarfism,endochondral bone growth,Extracellular,extracellular exosome,extracellular matrix,extracellular matrix organization,F-736,F-740,facilitiates cell migration,feet brachydactyly,fibrillar collagen,flared,flattened,focal adhesion,fragmented,Glycoprotein,glycosylated collagen,GQOGVMGFO motif,hand brachydactyly,heart,helical,hydroxyproline,in SEMD-SL,in vitro,Insulin receptor subfamily,integral component of plasma membrane,Interacts (tyrosine phosphorylated) with SHC1,Interacts with SRC,irregular metaphyses. Platyspondyly in the spine,kidney,Kinase,L-tyrosin phosphate,L-tyrosine,Ligandi,liver,lung,lung large cell carcinoma,MAP kinases,Membrane,MMP1,MMP13,MMP2,Molecular functioning,muscle,mutagenesis,mutations,N-glycosylated,narrow chest,Neurotrophic tyrosine kinase,Non-integrin membrane-ECM interactions,NTRKR3,nucleoptide binding,Nucleotide-binding,ossification,osteoarthritis patients,osteoblast differentiation,osteoblastic cells,osteocytes,Osteogenesis,pancreas,pear-shaped vertebral bodies,pectus excavatum,peptidyl-tyrosine phosphorylation,Phosphoprotein,phosphorylation,placenta,plasma membrane,positive regulation of extracellular matrix disassembly,positive regulation of fibroblast migration,positive regulation of fibroblast proliferation,positive regulation of osteoblast differentiation,positive regulation of protein kinase activity,positive regulation of sequence-specific DNA binding transcription factor activity,posterior scalloping,premature calcifications,proliferation,promotes fibrolast migration,protein,protein autophosphorylation regulation of bone mineralization,protein kinase superfamily,protein level,protein tyrosine kinase collagen receptor activity,proton acceptor,Receptor,Receptor protein-tyrosine kinase,receptor-related 3,reduces autophosphorylation,regorafenib,regulates cell differentiation,regulates remodeling,regulation of extracellular matrix disassembly,remodeling of the extracellular matrix,rs10799854,RUNX2,short long bones,short-limbed dwarfism,Signal,signal transduction,signaling pathway,single-opass type I membrane protein,skeletal,skeleton,Spondyloepimetaphyseal dysplasia short limb-hand type,SRC,stippled,striking epiphyses,subchondral bone,tibia,TKT,Transferase,Transmembrane,Transmembrane helix,transmembrane receptor protein tyrosine kinase activity,tumor cell invasion,Tyr protein kinase family,TYRO10,Tyrosine kinase,Tyrosine phosphorylated,Tyrosine phosphorylation,tyrosine residues,Tyrosine-protein kinase,up regualtion of the collagenases,up-regulated in cartilege,wide intervertebral spaces",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs12044481",
        "SNP Name": "DDR2 G162635875A",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs12044481",
        "Video": null,
        "Tags": "1 protein kinase,ablosihes signaling in response collagen binding,abolishes collagen binding,abolishes kinase activity,abolishes phosphorylation,acitvation of the transcription factor RUNX2,active site,ADP,anterior protrusions,apical plasma membrane,ATP,ATP binding,ATP-binding,autophosphorylation,binding site,binds hydroxyproline-rich sequence motifs in fibrillar,Biological processing,biomineral tissue development,bone development,bone disease,bone lining cells,brain,cartilage,catalytic activity,causes retention in intracellular compartment,CD167 antigen-like family member B,CD167b,CD_antigen,cell adhesion,cell membrane,cell migration,cell proliferation,cell surface receptor,central humps,characteristic craniofacial appearance,chondrocyte maturation,chondrocyte proliferation,collagen binding,collagen fibril organization,collagen-activated tyrosine kinase receptor signaling pathway,cutaneous wound healing,cytoplasmic,DDR2,Discoidin domain receptor 2,Discoidin domain-containing receptor 2,Discoidin domain-containing receptor tyrosine kinase 2,disease mutation,distinctive radiological findings,Disulfide bond,Domaini,Dwarfism,endochondral bone growth,Extracellular,extracellular exosome,extracellular matrix,extracellular matrix organization,F-736,F-740,facilitiates cell migration,feet brachydactyly,fibrillar collagen,flared,flattened,focal adhesion,fragmented,G162635875A,Glycoprotein,glycosylated collagen,GQOGVMGFO motif,hand brachydactyly,heart,helical,hydroxyproline,in SEMD-SL,in vitro,Insulin receptor subfamily,integral component of plasma membrane,Interacts (tyrosine phosphorylated) with SHC1,Interacts with SRC,irregular metaphyses. Platyspondyly in the spine,kidney,Kinase,L-tyrosin phosphate,L-tyrosine,Ligandi,liver,lung,lung large cell carcinoma,MAP kinases,Membrane,MMP1,MMP13,MMP2,Molecular functioning,muscle,mutagenesis,mutations,N-glycosylated,narrow chest,Neurotrophic tyrosine kinase,Non-integrin membrane-ECM interactions,NTRKR3,nucleoptide binding,Nucleotide-binding,ossification,osteoarthritis patients,osteoblast differentiation,osteoblastic cells,osteocytes,Osteogenesis,pancreas,pear-shaped vertebral bodies,pectus excavatum,peptidyl-tyrosine phosphorylation,Phosphoprotein,phosphorylation,placenta,plasma membrane,positive regulation of extracellular matrix disassembly,positive regulation of fibroblast migration,positive regulation of fibroblast proliferation,positive regulation of osteoblast differentiation,positive regulation of protein kinase activity,positive regulation of sequence-specific DNA binding transcription factor activity,posterior scalloping,premature calcifications,proliferation,promotes fibrolast migration,protein,protein autophosphorylation regulation of bone mineralization,protein kinase superfamily,protein level,protein tyrosine kinase collagen receptor activity,proton acceptor,Receptor,Receptor protein-tyrosine kinase,receptor-related 3,reduces autophosphorylation,regorafenib,regulates cell differentiation,regulates remodeling,regulation of extracellular matrix disassembly,remodeling of the extracellular matrix,rs12044481,RUNX2,short long bones,short-limbed dwarfism,Signal,signal transduction,signaling pathway,single-opass type I membrane protein,skeletal,skeleton,Spondyloepimetaphyseal dysplasia short limb-hand type,SRC,stippled,striking epiphyses,subchondral bone,tibia,TKT,Transferase,Transmembrane,Transmembrane helix,transmembrane receptor protein tyrosine kinase activity,tumor cell invasion,Tyr protein kinase family,TYRO10,Tyrosine kinase,Tyrosine phosphorylated,Tyrosine phosphorylation,tyrosine residues,Tyrosine-protein kinase,up regualtion of the collagenases,up-regulated in cartilege,wide intervertebral spaces",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs7553831",
        "SNP Name": "DDR2 T162661011G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7553831",
        "Video": null,
        "Tags": "1 protein kinase,ablosihes signaling in response collagen binding,abolishes collagen binding,abolishes kinase activity,abolishes phosphorylation,acitvation of the transcription factor RUNX2,active site,ADP,anterior protrusions,apical plasma membrane,ATP,ATP binding,ATP-binding,autophosphorylation,binding site,binds hydroxyproline-rich sequence motifs in fibrillar,Biological processing,biomineral tissue development,bone development,bone disease,bone lining cells,brain,cartilage,catalytic activity,causes retention in intracellular compartment,CD167 antigen-like family member B,CD167b,CD_antigen,cell adhesion,cell membrane,cell migration,cell proliferation,cell surface receptor,central humps,characteristic craniofacial appearance,chondrocyte maturation,chondrocyte proliferation,collagen binding,collagen fibril organization,collagen-activated tyrosine kinase receptor signaling pathway,cutaneous wound healing,cytoplasmic,DDR2,Discoidin domain receptor 2,Discoidin domain-containing receptor 2,Discoidin domain-containing receptor tyrosine kinase 2,disease mutation,distinctive radiological findings,Disulfide bond,Domaini,Dwarfism,endochondral bone growth,Extracellular,extracellular exosome,extracellular matrix,extracellular matrix organization,F-736,F-740,facilitiates cell migration,feet brachydactyly,fibrillar collagen,flared,flattened,focal adhesion,fragmented,Glycoprotein,glycosylated collagen,GQOGVMGFO motif,hand brachydactyly,heart,helical,hydroxyproline,in SEMD-SL,in vitro,Insulin receptor subfamily,integral component of plasma membrane,Interacts (tyrosine phosphorylated) with SHC1,Interacts with SRC,irregular metaphyses. Platyspondyly in the spine,kidney,Kinase,L-tyrosin phosphate,L-tyrosine,Ligandi,liver,lung,lung large cell carcinoma,MAP kinases,Membrane,MMP1,MMP13,MMP2,Molecular functioning,muscle,mutagenesis,mutations,N-glycosylated,narrow chest,Neurotrophic tyrosine kinase,Non-integrin membrane-ECM interactions,NTRKR3,nucleoptide binding,Nucleotide-binding,ossification,osteoarthritis patients,osteoblast differentiation,osteoblastic cells,osteocytes,Osteogenesis,pancreas,pear-shaped vertebral bodies,pectus excavatum,peptidyl-tyrosine phosphorylation,Phosphoprotein,phosphorylation,placenta,plasma membrane,positive regulation of extracellular matrix disassembly,positive regulation of fibroblast migration,positive regulation of fibroblast proliferation,positive regulation of osteoblast differentiation,positive regulation of protein kinase activity,positive regulation of sequence-specific DNA binding transcription factor activity,posterior scalloping,premature calcifications,proliferation,promotes fibrolast migration,protein,protein autophosphorylation regulation of bone mineralization,protein kinase superfamily,protein level,protein tyrosine kinase collagen receptor activity,proton acceptor,Receptor,Receptor protein-tyrosine kinase,receptor-related 3,reduces autophosphorylation,regorafenib,regulates cell differentiation,regulates remodeling,regulation of extracellular matrix disassembly,remodeling of the extracellular matrix,rs7553831,RUNX2,short long bones,short-limbed dwarfism,Signal,signal transduction,signaling pathway,single-opass type I membrane protein,skeletal,skeleton,Spondyloepimetaphyseal dysplasia short limb-hand type,SRC,stippled,striking epiphyses,subchondral bone,T162661011G,tibia,TKT,Transferase,Transmembrane,Transmembrane helix,transmembrane receptor protein tyrosine kinase activity,tumor cell invasion,Tyr protein kinase family,TYRO10,Tyrosine kinase,Tyrosine phosphorylated,Tyrosine phosphorylation,tyrosine residues,Tyrosine-protein kinase,up regualtion of the collagenases,up-regulated in cartilege,wide intervertebral spaces",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs4559477",
        "SNP Name": "DDR2 T162681151G",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4559477",
        "Video": null,
        "Tags": "1 protein kinase,ablosihes signaling in response collagen binding,abolishes collagen binding,abolishes kinase activity,abolishes phosphorylation,acitvation of the transcription factor RUNX2,active site,ADP,anterior protrusions,apical plasma membrane,ATP,ATP binding,ATP-binding,autophosphorylation,binding site,binds hydroxyproline-rich sequence motifs in fibrillar,Biological processing,biomineral tissue development,bone development,bone disease,bone lining cells,brain,cartilage,catalytic activity,causes retention in intracellular compartment,CD167 antigen-like family member B,CD167b,CD_antigen,cell adhesion,cell membrane,cell migration,cell proliferation,cell surface receptor,central humps,characteristic craniofacial appearance,chondrocyte maturation,chondrocyte proliferation,collagen binding,collagen fibril organization,collagen-activated tyrosine kinase receptor signaling pathway,cutaneous wound healing,cytoplasmic,DDR2,Discoidin domain receptor 2,Discoidin domain-containing receptor 2,Discoidin domain-containing receptor tyrosine kinase 2,disease mutation,distinctive radiological findings,Disulfide bond,Domaini,Dwarfism,endochondral bone growth,Extracellular,extracellular exosome,extracellular matrix,extracellular matrix organization,F-736,F-740,facilitiates cell migration,feet brachydactyly,fibrillar collagen,flared,flattened,focal adhesion,fragmented,Glycoprotein,glycosylated collagen,GQOGVMGFO motif,hand brachydactyly,heart,helical,hydroxyproline,in SEMD-SL,in vitro,Insulin receptor subfamily,integral component of plasma membrane,Interacts (tyrosine phosphorylated) with SHC1,Interacts with SRC,irregular metaphyses. Platyspondyly in the spine,kidney,Kinase,L-tyrosin phosphate,L-tyrosine,Ligandi,liver,lung,lung large cell carcinoma,MAP kinases,Membrane,MMP1,MMP13,MMP2,Molecular functioning,muscle,mutagenesis,mutations,N-glycosylated,narrow chest,Neurotrophic tyrosine kinase,Non-integrin membrane-ECM interactions,NTRKR3,nucleoptide binding,Nucleotide-binding,ossification,osteoarthritis patients,osteoblast differentiation,osteoblastic cells,osteocytes,Osteogenesis,pancreas,pear-shaped vertebral bodies,pectus excavatum,peptidyl-tyrosine phosphorylation,Phosphoprotein,phosphorylation,placenta,plasma membrane,positive regulation of extracellular matrix disassembly,positive regulation of fibroblast migration,positive regulation of fibroblast proliferation,positive regulation of osteoblast differentiation,positive regulation of protein kinase activity,positive regulation of sequence-specific DNA binding transcription factor activity,posterior scalloping,premature calcifications,proliferation,promotes fibrolast migration,protein,protein autophosphorylation regulation of bone mineralization,protein kinase superfamily,protein level,protein tyrosine kinase collagen receptor activity,proton acceptor,Receptor,Receptor protein-tyrosine kinase,receptor-related 3,reduces autophosphorylation,regorafenib,regulates cell differentiation,regulates remodeling,regulation of extracellular matrix disassembly,remodeling of the extracellular matrix,rs4559477,RUNX2,short long bones,short-limbed dwarfism,Signal,signal transduction,signaling pathway,single-opass type I membrane protein,skeletal,skeleton,Spondyloepimetaphyseal dysplasia short limb-hand type,SRC,stippled,striking epiphyses,subchondral bone,T162681151G,tibia,TKT,Transferase,Transmembrane,Transmembrane helix,transmembrane receptor protein tyrosine kinase activity,tumor cell invasion,Tyr protein kinase family,TYRO10,Tyrosine kinase,Tyrosine phosphorylated,Tyrosine phosphorylation,tyrosine residues,Tyrosine-protein kinase,up regualtion of the collagenases,up-regulated in cartilege,wide intervertebral spaces",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs1780007",
        "SNP Name": "DDR2 A162748025C",
        "Risk Allele": "C",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1780007",
        "Video": null,
        "Tags": "1 protein kinase,A162748025C,ablosihes signaling in response collagen binding,abolishes collagen binding,abolishes kinase activity,abolishes phosphorylation,acitvation of the transcription factor RUNX2,active site,ADP,anterior protrusions,apical plasma membrane,ATP,ATP binding,ATP-binding,autophosphorylation,binding site,binds hydroxyproline-rich sequence motifs in fibrillar,Biological processing,biomineral tissue development,bone development,bone disease,bone lining cells,brain,cartilage,catalytic activity,causes retention in intracellular compartment,CD167 antigen-like family member B,CD167b,CD_antigen,cell adhesion,cell membrane,cell migration,cell proliferation,cell surface receptor,central humps,characteristic craniofacial appearance,chondrocyte maturation,chondrocyte proliferation,collagen binding,collagen fibril organization,collagen-activated tyrosine kinase receptor signaling pathway,cutaneous wound healing,cytoplasmic,DDR2,Discoidin domain receptor 2,Discoidin domain-containing receptor 2,Discoidin domain-containing receptor tyrosine kinase 2,disease mutation,distinctive radiological findings,Disulfide bond,Domaini,Dwarfism,endochondral bone growth,Extracellular,extracellular exosome,extracellular matrix,extracellular matrix organization,F-736,F-740,facilitiates cell migration,feet brachydactyly,fibrillar collagen,flared,flattened,focal adhesion,fragmented,Glycoprotein,glycosylated collagen,GQOGVMGFO motif,hand brachydactyly,heart,helical,hydroxyproline,in SEMD-SL,in vitro,Insulin receptor subfamily,integral component of plasma membrane,Interacts (tyrosine phosphorylated) with SHC1,Interacts with SRC,irregular metaphyses. Platyspondyly in the spine,kidney,Kinase,L-tyrosin phosphate,L-tyrosine,Ligandi,liver,lung,lung large cell carcinoma,MAP kinases,Membrane,MMP1,MMP13,MMP2,Molecular functioning,muscle,mutagenesis,mutations,N-glycosylated,narrow chest,Neurotrophic tyrosine kinase,Non-integrin membrane-ECM interactions,NTRKR3,nucleoptide binding,Nucleotide-binding,ossification,osteoarthritis patients,osteoblast differentiation,osteoblastic cells,osteocytes,Osteogenesis,pancreas,pear-shaped vertebral bodies,pectus excavatum,peptidyl-tyrosine phosphorylation,Phosphoprotein,phosphorylation,placenta,plasma membrane,positive regulation of extracellular matrix disassembly,positive regulation of fibroblast migration,positive regulation of fibroblast proliferation,positive regulation of osteoblast differentiation,positive regulation of protein kinase activity,positive regulation of sequence-specific DNA binding transcription factor activity,posterior scalloping,premature calcifications,proliferation,promotes fibrolast migration,protein,protein autophosphorylation regulation of bone mineralization,protein kinase superfamily,protein level,protein tyrosine kinase collagen receptor activity,proton acceptor,Receptor,Receptor protein-tyrosine kinase,receptor-related 3,reduces autophosphorylation,regorafenib,regulates cell differentiation,regulates remodeling,regulation of extracellular matrix disassembly,remodeling of the extracellular matrix,rs1780007,RUNX2,short long bones,short-limbed dwarfism,Signal,signal transduction,signaling pathway,single-opass type I membrane protein,skeletal,skeleton,Spondyloepimetaphyseal dysplasia short limb-hand type,SRC,stippled,striking epiphyses,subchondral bone,tibia,TKT,Transferase,Transmembrane,Transmembrane helix,transmembrane receptor protein tyrosine kinase activity,tumor cell invasion,Tyr protein kinase family,TYRO10,Tyrosine kinase,Tyrosine phosphorylated,Tyrosine phosphorylation,tyrosine residues,Tyrosine-protein kinase,up regualtion of the collagenases,up-regulated in cartilege,wide intervertebral spaces",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs6656822",
        "SNP Name": "SLC19A2 A23663G",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6656822",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs6025",
        "SNP Name": "F5 Factor V Leiden FVL",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "abdominal aortic aneurysm,activated protein C,Activated protein C cofactor,acute lung injury,AD,Alzheimer,Alzheimer\u2019s disease,anticoagulant,anticoagulant response,anticoagulants,antihypertensive treatment,Arteriovenous Fistula Failure,blood circulation,blood coagulation,blood coagulation disorder,breast cancer,Budd-Chiari syndrome,CAD,Calcium,cancer,cancerous,carcinogen,cardio,cardiovascular,cell adhesion,cerebral palsy,Cerebral sinovenous thrombosis,Coagulation,Coagulation factor V,Coagulation factor V heavy chain,Coagulation factor V light chain,Coagulopathy,coagultion pathway,Congenital factor V deficiency,Copper,copper ion binding,Coronary Artery Disease,Coronary Restenosis,CVD,deep vein thrombosis,dementia,Disulfide bond,early onset stroke,East Texas bleeding disorder,endoplasmic reticulum,essential hypertension,extracellular region,extracellular space,F5,FA5,FA5D,factor V Leiden,FVL,Glycoprotein,Golgi apparatus,heart,heart disease,hemorrhagic diathesis,hemostasis,hepatic congestion,hypertension,inflammation,Inhibited by SERPINA5,ischemic necrosis,Ischemic stroke,ISCHSTR,kidney transplant,labile factor,Lemierre's syndrome,major trauma,membrane,Metal-binding,migraine,miscarriage,myeloma,myeloproliferative syndromes,myocardial infarction,neurodegenerative disease,Non rare thrombophilia,obstruction of hepatic venous outflow,ombin III deficiency,Osteonecrosis,parahemophilia,Perinatal Arterial Ischemic Stroke,pharmacogenetics,Phosphoprotein,Phosphorylation,plasma membrane,platelet,platelet activation,platelet alpha granule lumen,platelet degranulation,Preeclampsia,Pregnancy loss recurrent 1,Proaccelerin,procoagulant activity,protein C,protein C deficiency,protein C pathway,protein C resistance,prothrombin to thrombin,prothrombinase activity,Recurrent pregnancy loss,RPRGL1,sclerosis,serine-type endopeptidase activity,sporadic amyotrophic lateral sclerosis,stroke,Sulfation,Systemic Lupus Erythematosus,THPH2,thrombophilia,Thrombophilia due to activated protein C resistance,thrombosis,Type 2 Diabetes,Venous Thromboembolism,vesicle,Zymogen",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs6025",
        "SNP Name": "F5 Factor V Leiden FVL",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "abdominal aortic aneurysm,activated protein C,Activated protein C cofactor,acute lung injury,AD,Alzheimer,Alzheimer\u2019s disease,anticoagulant,anticoagulant response,anticoagulants,antihypertensive treatment,Arteriovenous Fistula Failure,blood circulation,blood coagulation,blood coagulation disorder,breast cancer,Budd-Chiari syndrome,CAD,Calcium,cancer,cancerous,carcinogen,cardio,cardiovascular,cell adhesion,cerebral palsy,Cerebral sinovenous thrombosis,Coagulation,Coagulation factor V,Coagulation factor V heavy chain,Coagulation factor V light chain,Coagulopathy,coagultion pathway,Congenital factor V deficiency,Copper,copper ion binding,Coronary Artery Disease,Coronary Restenosis,CVD,deep vein thrombosis,dementia,Disulfide bond,early onset stroke,East Texas bleeding disorder,endoplasmic reticulum,essential hypertension,extracellular region,extracellular space,F5,FA5,FA5D,factor V Leiden,FVL,Glycoprotein,Golgi apparatus,heart,heart disease,hemorrhagic diathesis,hemostasis,hepatic congestion,hypertension,inflammation,Inhibited by SERPINA5,ischemic necrosis,Ischemic stroke,ISCHSTR,kidney transplant,labile factor,Lemierre's syndrome,major trauma,membrane,Metal-binding,migraine,miscarriage,myeloma,myeloproliferative syndromes,myocardial infarction,neurodegenerative disease,Non rare thrombophilia,obstruction of hepatic venous outflow,ombin III deficiency,Osteonecrosis,parahemophilia,Perinatal Arterial Ischemic Stroke,pharmacogenetics,Phosphoprotein,Phosphorylation,plasma membrane,platelet,platelet activation,platelet alpha granule lumen,platelet degranulation,Preeclampsia,Pregnancy loss recurrent 1,Proaccelerin,procoagulant activity,protein C,protein C deficiency,protein C pathway,protein C resistance,prothrombin to thrombin,prothrombinase activity,Recurrent pregnancy loss,RPRGL1,sclerosis,serine-type endopeptidase activity,sporadic amyotrophic lateral sclerosis,stroke,Sulfation,Systemic Lupus Erythematosus,THPH2,thrombophilia,Thrombophilia due to activated protein C resistance,thrombosis,Type 2 Diabetes,Venous Thromboembolism,vesicle,Zymogen",
        "Group": "Clotting Factors"
    },
    {
        "SNP ID": "rs2227589",
        "SNP Name": "SERPINC1 G5301A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "ANT3,antithrombin deficiency,Antithrombin III deficiency,Antithrombin-III,Ardeparin,AT-III inhibits thrombin,AT3,AT3D,ATIII,blood coagulation,blood microparticle,coagulation,congenital antithrombin deficiency,Dalteparin,Disease mutation,Disulfide bond,Enoxaparin,extracellular region,extracellular space,extracellular vesicular exosome,Fondaparinux sodium,Glycoprotein,Hemostasis,hemostatic disorder,heparin,heparin binding,Heparin-binding,hereditary thrombophilia,inflammation,intrinsic pathway,matriptase-3/TMPRSS7,Nadroparin,negative regulation of endopeptidase activity,negative regulation of inflammatory response,Phosphoprotein,plasma membrane,protease binding,Protease inhibitor,recurrent thrombosis,regulation of blood coagulation,regulation of proteolysis,response to nutrient,serine protease inhibitor,serine-type endopeptidase inhibitor activity,Serpin C1,serpin family,SERPINC1,Sulodexide,thrombin,thrombophilia,thrombosis,Tinzaparin,\u00a0lower extremity deep venous thrombosis",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs2227589",
        "SNP Name": "SERPINC1 G5301A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "ANT3,antithrombin deficiency,Antithrombin III deficiency,Antithrombin-III,Ardeparin,AT-III inhibits thrombin,AT3,AT3D,ATIII,blood coagulation,blood microparticle,coagulation,congenital antithrombin deficiency,Dalteparin,Disease mutation,Disulfide bond,Enoxaparin,extracellular region,extracellular space,extracellular vesicular exosome,Fondaparinux sodium,Glycoprotein,Hemostasis,hemostatic disorder,heparin,heparin binding,Heparin-binding,hereditary thrombophilia,inflammation,intrinsic pathway,matriptase-3/TMPRSS7,Nadroparin,negative regulation of endopeptidase activity,negative regulation of inflammatory response,Phosphoprotein,plasma membrane,protease binding,Protease inhibitor,recurrent thrombosis,regulation of blood coagulation,regulation of proteolysis,response to nutrient,serine protease inhibitor,serine-type endopeptidase inhibitor activity,Serpin C1,serpin family,SERPINC1,Sulodexide,thrombin,thrombophilia,thrombosis,Tinzaparin,\u00a0lower extremity deep venous thrombosis",
        "Group": "Clotting Factors"
    },
    {
        "SNP ID": "rs5275",
        "SNP Name": "PTGS2 A186649221G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Polysorbate 20"
    },
    {
        "SNP ID": "rs6677604",
        "SNP Name": "CFH variant",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs6677604",
        "Video": null,
        "Tags": null,
        "Group": "IgA"
    },
    {
        "SNP ID": "rs4950928",
        "SNP Name": "CHI3L1 C131G",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Gentamicin Sulfate"
    },
    {
        "SNP ID": "rs1800896",
        "SNP Name": "IL10 T206946897C",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Formaldehyde"
    },
    {
        "SNP ID": "rs6656401",
        "SNP Name": "CR1 A27577G",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,age-related cognitive decline,Alzheimer,Alzheimer's Disease,amyloid,Amyloid-Beta,antigen,Blood group antigen,brain atrophy,Brain Atrophy in Multiple Sclerosis,C3b/C4b receptor,C3BR,CD35,CD_antigen: CD35,cell surface,cerebral amyloid angiopathy,cerebral malaria,Cerebral Microbleeds,cholesterol,cholesterol metabolism,chronic inflammation,cognition,Cognitive Ageing,cognitive decline,cognitive function,complement activation,complement component C3b binding,complement component C3b receptor activity,complement component C4b binding,complement component C4b receptor activity,Complement pathway,complement receptor mediated signaling pathway,Complement receptor type 1,CR1,dementia,Disulfide bond,dopamine,episodic memory,Erythrocyte Sedimentation,erythrocytes,extracellular vesicular exosome,gallbladder,gallbladder carcinomas,glomerular podocytes,Glycoprotein,IgM Anti-Herpes Simplex Virus,immune,immune response,immune system,Immunity,infection,inflammation,innate immune response,Innate immunity,integral component of plasma membrane,Knops,Knops blood,Knops blood group system,L-Serine,late-onset Alzheimer's disease,leukocytes,lipids,lupus,malaria,malarial rosetting,McCoy,memory,MS,multiple sclerosis,negative regulation of complement activation,negative regulation of serine-type endopeptidase activity,neurodegenerative disorder,non-small cell lung cancer,parasite,Parkinson,Parkinson Disease,PD,Plasma Amyloid-Beta Levels,Plasmodium falciparum malaria,Plasmodium falciparum rosetting,positive regulation of serine-type endopeptidase activity,Pyrrolidone,Pyrrolidone carboxylic acid,RBC,RBCs,Receptor,red blood cells,regulation of complement activation,Repeat,sarcoidosis,serine,severe malaria,Signal,Single-pass type I membrane protein,Sl(a)/Vil (Kn4 or Swain-Langley; Vil or Villien),splenic follicular dendritic cells,stroke,Sushi,systemic lupus,systemic lupus erythematosus,Transmembrane,Transmembrane helix",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63750048",
        "SNP Name": "PSEN2 Ala85Val",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,AD3LP,AD4,AD5,Alzheimer,Alzheimer disease 4,Alzheimer's disease,amino acids,amyloid precursor protein catabolic process,amyloid-beta-APP 40-42 peptide,Amyloidosis,anagen,apoptosis,apoptotic signaling pathway,APP,arrhythmia,asparagine,aspartic-type endopeptidase activity,axon,beta-amyloid metabolic process,beta-amyloid precursor protein,brain morphogenesis,calcium ion transport,cardiac muscle contraction,cardio,cardiomyopathy,Cardiomyopathy dilated 1V,cardiovascular,cell cortex,cell fate specification,cell surface,centrosome,ciliary basal body,ciliary rootlet dendritic shaft,CMD1V,cognition,CTFs,CVD,cytosol,cytotoxic C-terminal fragments,dementia,dilated,Disease mutation,dorsal/ventral neural tube patterning,E5-1,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,extracellular amyloid plaques,fibrillar amyloid,forebrain development,gamma-secretase complex,Golgi apparatus,growth cone,heart,heart disease,heart failure,hematopoietic progenitor cell differentiation,Hydrolase,integral component of plasma membrane,intracellular signal transduction,isoleucine,kinetochore,L-Methionine,L-Valine,locomotion,lung alveolus development,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane protein intracellular domain proteolysis,membrane raft,memory,methionine,mitochondrial inner membrane,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of protein binding,negative regulation of protein complex assembly,negative regulation of protein phosphorylation,Neurodegeneration,neurodegenerative disorder,neurofibrillary tangles,neuromuscular junction,neuronal cell body,neurotoxic,neurotrophin TRK receptor signaling pathway,Notch receptor processing,Notch receptors,Notch signaling pathway,Notch signaling pathway apical plasma membrane,nuclear inner membrane,peptide,perinuclear region of cytoplasm,plaque,plasma membrane,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,Presenilin-2,Presenilin-2 CTF subunit,Presenilin-2 NTF subunit,progressive dementia,Protease,protein complex,protein processing,protein transport,PS-2,PS2,PSEN2,PSNL2,regulation of epidermal growth factor-activated receptor activity,regulation of synaptic plasticity,response to hypoxia,somitogenesis,STM-2,STM2,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,toxic,valine,vascular amyloid deposits,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63749851",
        "SNP Name": "PSEN2 Thr122Pro",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,AD3LP,AD4,AD5,Alzheimer,Alzheimer disease 4,Alzheimer's disease,amino acids,amyloid precursor protein catabolic process,amyloid-beta-APP 40-42 peptide,Amyloidosis,anagen,apoptosis,apoptotic signaling pathway,APP,arrhythmia,asparagine,aspartic-type endopeptidase activity,axon,beta-amyloid metabolic process,beta-amyloid precursor protein,brain morphogenesis,calcium ion transport,cardiac muscle contraction,cardio,cardiomyopathy,Cardiomyopathy dilated 1V,cardiovascular,cell cortex,cell fate specification,cell surface,centrosome,ciliary basal body,ciliary rootlet dendritic shaft,CMD1V,cognition,CTFs,CVD,cytosol,cytotoxic C-terminal fragments,dementia,dilated,Disease mutation,dorsal/ventral neural tube patterning,E5-1,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,extracellular amyloid plaques,fibrillar amyloid,forebrain development,gamma-secretase complex,Golgi apparatus,growth cone,heart,heart disease,heart failure,hematopoietic progenitor cell differentiation,Hydrolase,integral component of plasma membrane,intracellular signal transduction,isoleucine,kinetochore,L-Methionine,L-Valine,locomotion,lung alveolus development,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane protein intracellular domain proteolysis,membrane raft,memory,methionine,mitochondrial inner membrane,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of protein binding,negative regulation of protein complex assembly,negative regulation of protein phosphorylation,Neurodegeneration,neurodegenerative disorder,neurofibrillary tangles,neuromuscular junction,neuronal cell body,neurotoxic,neurotrophin TRK receptor signaling pathway,Notch receptor processing,Notch receptors,Notch signaling pathway,Notch signaling pathway apical plasma membrane,nuclear inner membrane,peptide,perinuclear region of cytoplasm,plaque,plasma membrane,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,Presenilin-2,Presenilin-2 CTF subunit,Presenilin-2 NTF subunit,progressive dementia,Protease,protein complex,protein processing,protein transport,PS-2,PS2,PSEN2,PSNL2,regulation of epidermal growth factor-activated receptor activity,regulation of synaptic plasticity,response to hypoxia,somitogenesis,STM-2,STM2,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,toxic,valine,vascular amyloid deposits,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63750215",
        "SNP Name": "PSEN2 Asn141Ile",
        "Risk Allele": "T",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,AD3LP,AD4,AD5,Alzheimer,Alzheimer disease 4,Alzheimer's disease,amino acids,amyloid precursor protein catabolic process,amyloid-beta-APP 40-42 peptide,Amyloidosis,anagen,apoptosis,apoptotic signaling pathway,APP,arrhythmia,asparagine,aspartic-type endopeptidase activity,axon,beta-amyloid metabolic process,beta-amyloid precursor protein,brain morphogenesis,calcium ion transport,cardiac muscle contraction,cardio,cardiomyopathy,Cardiomyopathy dilated 1V,cardiovascular,cell cortex,cell fate specification,cell surface,centrosome,ciliary basal body,ciliary rootlet dendritic shaft,CMD1V,cognition,CTFs,CVD,cytosol,cytotoxic C-terminal fragments,dementia,dilated,Disease mutation,dorsal/ventral neural tube patterning,E5-1,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,extracellular amyloid plaques,fibrillar amyloid,forebrain development,gamma-secretase complex,Golgi apparatus,growth cone,heart,heart disease,heart failure,hematopoietic progenitor cell differentiation,Hydrolase,integral component of plasma membrane,intracellular signal transduction,isoleucine,kinetochore,L-Methionine,L-Valine,locomotion,lung alveolus development,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane protein intracellular domain proteolysis,membrane raft,memory,methionine,mitochondrial inner membrane,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of protein binding,negative regulation of protein complex assembly,negative regulation of protein phosphorylation,Neurodegeneration,neurodegenerative disorder,neurofibrillary tangles,neuromuscular junction,neuronal cell body,neurotoxic,neurotrophin TRK receptor signaling pathway,Notch receptor processing,Notch receptors,Notch signaling pathway,Notch signaling pathway apical plasma membrane,nuclear inner membrane,peptide,perinuclear region of cytoplasm,plaque,plasma membrane,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,Presenilin-2,Presenilin-2 CTF subunit,Presenilin-2 NTF subunit,progressive dementia,Protease,protein complex,protein processing,protein transport,PS-2,PS2,PSEN2,PSNL2,regulation of epidermal growth factor-activated receptor activity,regulation of synaptic plasticity,response to hypoxia,somitogenesis,STM-2,STM2,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,toxic,valine,vascular amyloid deposits,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs28936379",
        "SNP Name": "PSEN2 Met239Val",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,AD3LP,AD4,AD5,Alzheimer,Alzheimer disease 4,Alzheimer's disease,amino acids,amyloid precursor protein catabolic process,amyloid-beta-APP 40-42 peptide,Amyloidosis,anagen,apoptosis,apoptotic signaling pathway,APP,arrhythmia,asparagine,aspartic-type endopeptidase activity,axon,beta-amyloid metabolic process,beta-amyloid precursor protein,brain morphogenesis,calcium ion transport,cardiac muscle contraction,cardio,cardiomyopathy,Cardiomyopathy dilated 1V,cardiovascular,cell cortex,cell fate specification,cell surface,centrosome,ciliary basal body,ciliary rootlet dendritic shaft,CMD1V,cognition,CTFs,CVD,cytosol,cytotoxic C-terminal fragments,dementia,dilated,Disease mutation,dorsal/ventral neural tube patterning,E5-1,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,extracellular amyloid plaques,fibrillar amyloid,forebrain development,gamma-secretase complex,Golgi apparatus,growth cone,heart,heart disease,heart failure,hematopoietic progenitor cell differentiation,Hydrolase,integral component of plasma membrane,intracellular signal transduction,isoleucine,kinetochore,L-Methionine,L-Valine,locomotion,lung alveolus development,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane protein intracellular domain proteolysis,membrane raft,memory,methionine,mitochondrial inner membrane,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of protein binding,negative regulation of protein complex assembly,negative regulation of protein phosphorylation,Neurodegeneration,neurodegenerative disorder,neurofibrillary tangles,neuromuscular junction,neuronal cell body,neurotoxic,neurotrophin TRK receptor signaling pathway,Notch receptor processing,Notch receptors,Notch signaling pathway,Notch signaling pathway apical plasma membrane,nuclear inner membrane,peptide,perinuclear region of cytoplasm,plaque,plasma membrane,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,Presenilin-2,Presenilin-2 CTF subunit,Presenilin-2 NTF subunit,progressive dementia,Protease,protein complex,protein processing,protein transport,PS-2,PS2,PSEN2,PSNL2,regulation of epidermal growth factor-activated receptor activity,regulation of synaptic plasticity,response to hypoxia,somitogenesis,STM-2,STM2,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,toxic,valine,vascular amyloid deposits,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63749884",
        "SNP Name": "PSEN2 Met239Ile",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,AD3LP,AD4,AD5,Alzheimer,Alzheimer disease 4,Alzheimer's disease,amino acids,amyloid precursor protein catabolic process,amyloid-beta-APP 40-42 peptide,Amyloidosis,anagen,apoptosis,apoptotic signaling pathway,APP,arrhythmia,asparagine,aspartic-type endopeptidase activity,axon,beta-amyloid metabolic process,beta-amyloid precursor protein,brain morphogenesis,calcium ion transport,cardiac muscle contraction,cardio,cardiomyopathy,Cardiomyopathy dilated 1V,cardiovascular,cell cortex,cell fate specification,cell surface,centrosome,ciliary basal body,ciliary rootlet dendritic shaft,CMD1V,cognition,CTFs,CVD,cytosol,cytotoxic C-terminal fragments,dementia,dilated,Disease mutation,dorsal/ventral neural tube patterning,E5-1,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,extracellular amyloid plaques,fibrillar amyloid,forebrain development,gamma-secretase complex,Golgi apparatus,growth cone,heart,heart disease,heart failure,hematopoietic progenitor cell differentiation,Hydrolase,integral component of plasma membrane,intracellular signal transduction,isoleucine,kinetochore,L-Methionine,L-Valine,locomotion,lung alveolus development,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane protein intracellular domain proteolysis,membrane raft,memory,methionine,mitochondrial inner membrane,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of protein binding,negative regulation of protein complex assembly,negative regulation of protein phosphorylation,Neurodegeneration,neurodegenerative disorder,neurofibrillary tangles,neuromuscular junction,neuronal cell body,neurotoxic,neurotrophin TRK receptor signaling pathway,Notch receptor processing,Notch receptors,Notch signaling pathway,Notch signaling pathway apical plasma membrane,nuclear inner membrane,peptide,perinuclear region of cytoplasm,plaque,plasma membrane,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,Presenilin-2,Presenilin-2 CTF subunit,Presenilin-2 NTF subunit,progressive dementia,Protease,protein complex,protein processing,protein transport,PS-2,PS2,PSEN2,PSNL2,regulation of epidermal growth factor-activated receptor activity,regulation of synaptic plasticity,response to hypoxia,somitogenesis,STM-2,STM2,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,toxic,valine,vascular amyloid deposits,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63750666",
        "SNP Name": "PSEN2 Thr429Met",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,AD3LP,AD4,AD5,Alzheimer,Alzheimer disease 4,Alzheimer's disease,amino acids,amyloid precursor protein catabolic process,amyloid-beta-APP 40-42 peptide,Amyloidosis,anagen,apoptosis,apoptotic signaling pathway,APP,arrhythmia,asparagine,aspartic-type endopeptidase activity,axon,beta-amyloid metabolic process,beta-amyloid precursor protein,brain morphogenesis,calcium ion transport,cardiac muscle contraction,cardio,cardiomyopathy,Cardiomyopathy dilated 1V,cardiovascular,cell cortex,cell fate specification,cell surface,centrosome,ciliary basal body,ciliary rootlet dendritic shaft,CMD1V,cognition,CTFs,CVD,cytosol,cytotoxic C-terminal fragments,dementia,dilated,Disease mutation,dorsal/ventral neural tube patterning,E5-1,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,extracellular amyloid plaques,fibrillar amyloid,forebrain development,gamma-secretase complex,Golgi apparatus,growth cone,heart,heart disease,heart failure,hematopoietic progenitor cell differentiation,Hydrolase,integral component of plasma membrane,intracellular signal transduction,isoleucine,kinetochore,L-Methionine,L-Valine,locomotion,lung alveolus development,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane protein intracellular domain proteolysis,membrane raft,memory,methionine,mitochondrial inner membrane,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of protein binding,negative regulation of protein complex assembly,negative regulation of protein phosphorylation,Neurodegeneration,neurodegenerative disorder,neurofibrillary tangles,neuromuscular junction,neuronal cell body,neurotoxic,neurotrophin TRK receptor signaling pathway,Notch receptor processing,Notch receptors,Notch signaling pathway,Notch signaling pathway apical plasma membrane,nuclear inner membrane,peptide,perinuclear region of cytoplasm,plaque,plasma membrane,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,Presenilin-2,Presenilin-2 CTF subunit,Presenilin-2 NTF subunit,progressive dementia,Protease,protein complex,protein processing,protein transport,PS-2,PS2,PSEN2,PSNL2,regulation of epidermal growth factor-activated receptor activity,regulation of synaptic plasticity,response to hypoxia,somitogenesis,STM-2,STM2,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,toxic,valine,vascular amyloid deposits,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63750110",
        "SNP Name": "PSEN2 Asp438Ala",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,AD3LP,AD4,AD5,Alzheimer,Alzheimer disease 4,Alzheimer's disease,amino acids,amyloid precursor protein catabolic process,amyloid-beta-APP 40-42 peptide,Amyloidosis,anagen,apoptosis,apoptotic signaling pathway,APP,arrhythmia,asparagine,aspartic-type endopeptidase activity,axon,beta-amyloid metabolic process,beta-amyloid precursor protein,brain morphogenesis,calcium ion transport,cardiac muscle contraction,cardio,cardiomyopathy,Cardiomyopathy dilated 1V,cardiovascular,cell cortex,cell fate specification,cell surface,centrosome,ciliary basal body,ciliary rootlet dendritic shaft,CMD1V,cognition,CTFs,CVD,cytosol,cytotoxic C-terminal fragments,dementia,dilated,Disease mutation,dorsal/ventral neural tube patterning,E5-1,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,extracellular amyloid plaques,fibrillar amyloid,forebrain development,gamma-secretase complex,Golgi apparatus,growth cone,heart,heart disease,heart failure,hematopoietic progenitor cell differentiation,Hydrolase,integral component of plasma membrane,intracellular signal transduction,isoleucine,kinetochore,L-Methionine,L-Valine,locomotion,lung alveolus development,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane protein intracellular domain proteolysis,membrane raft,memory,methionine,mitochondrial inner membrane,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of protein binding,negative regulation of protein complex assembly,negative regulation of protein phosphorylation,Neurodegeneration,neurodegenerative disorder,neurofibrillary tangles,neuromuscular junction,neuronal cell body,neurotoxic,neurotrophin TRK receptor signaling pathway,Notch receptor processing,Notch receptors,Notch signaling pathway,Notch signaling pathway apical plasma membrane,nuclear inner membrane,peptide,perinuclear region of cytoplasm,plaque,plasma membrane,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,Presenilin-2,Presenilin-2 CTF subunit,Presenilin-2 NTF subunit,progressive dementia,Protease,protein complex,protein processing,protein transport,PS-2,PS2,PSEN2,PSNL2,regulation of epidermal growth factor-activated receptor activity,regulation of synaptic plasticity,response to hypoxia,somitogenesis,STM-2,STM2,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,toxic,valine,vascular amyloid deposits,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs7079",
        "SNP Name": "AGT 17006C>A",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs7079",
        "SNP Name": "AGT 17006C>A",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs2478523",
        "SNP Name": "AGT 13828T>C",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs2478523",
        "SNP Name": "AGT 13828T>C",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs2478545",
        "SNP Name": "AGT 11216C>T",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs2478545",
        "SNP Name": "AGT 11216C>T",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs699",
        "SNP Name": "AGT M235T/C4072T",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs699",
        "Video": "fCsbe-HXcr4",
        "Tags": "(R)-3-amino-2-methylpropanoate,(R)-3-amino-2-methylpropionate,2-methyl-3-oxopropanoate,abdominal aortic aneurysm,ACE,Acetylation,ADMA,AGT,AGT 2,AGT2,AGXT2,Alanine--glyoxylate aminotransferase 2,alanine-glyoxylate,alpha-keto-delta,Aminotransferase,angiotensin I,angiotensin II,Angiotensinogen,Angiotensinogen polymorphism,asymmetric dimethylarginine,atherosclerosis,Atrial Fibrillation,B6,Beta-ALAAT II,beta-alanine-pyruvate,Beta-alanine-pyruvate aminotransferase,blodd pressure,blood pressure,blood pressure control,blood pressure regulation,blood sugar,BMI,body mass index,cancer,cancerous,carcinogen,cardiomyopathy,cardiovascular,Cardiovascular Drug response,cerebral,cerebral blood flow,cerebral blood flow regulation,cerebral vasoreactivity,children with sickle cell anemia,cholesterol,Chronic Allograft Dysfunction,class-III pyridoxal-phosphate-dependent aminotransferase,class-III pyridoxal-phosphate-dependent aminotransferase family,colorectal cancer,Complete proteome,Coronary artery disease,coronary heart disease and type 2 diabetes mellitus,CVD,D-AIBAT,diabetes,diabetic,dimethylarginine,DMGV,EC=2.6.1.40,End-Stage Renal Disease,essential hypertension,Gene-disease interactions,glycine,glyoxylate,HDL,heart,heart disease,heart failure,high BP,high density lipoprotein,Homotetramer,Hypertensive,hypertrophic cardiomyopathy,insulin resistance,Insulin Sensitivity,Ischemic Stroke,kidney,kidney disease,L-alanine,LDL,linkage disequilibrium,lipid,lipid related cardiovascular disease,low density lipoprotein,Migraine,mitochondria,mitochondrial,Mitochondrion,mortality in Chinese coronary atherosclerosis patients,n-3 PUFAs,nephropathy,nitric oxide synthase,nitric-oxide,nitric-oxide inhibitor,nitric-oxide synthase inhibitor,NN-dimethylguanidino,NO,NO inhibitor,NOS,NOS inhibitor,Obesity,Omega-3 fatty acids,oral glucose tolerance test,P5P,placental abruption,Plasma lipids,Pleiotropy,PLP,Polymorphism,pregnancy induced hypertension,Primary hypertension,Pyridoxal phosphate,pyridoxal phosphate binding,pyridoxal-5'-phosphate,pyruvate,pyruvate transaminase,RAS,renal cell carcinoma,renal failure,Renin angiotensin system,renin-angiotensin,renin-angiotensin-aldosterone system,risk and protection against type 2 diabetic retinopathy,Salt-Sensitive Hypertension,Schizophrenia,stroke,Transferase,Transit peptide,Treatment Resistant Hypertension,Type 2 diabetes,Type 2 diabetes mellitus,valeric acid,vasoreactivity",
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs699",
        "SNP Name": "AGT M235T/C4072T",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs699",
        "Video": "fCsbe-HXcr4",
        "Tags": "(R)-3-amino-2-methylpropanoate,(R)-3-amino-2-methylpropionate,2-methyl-3-oxopropanoate,abdominal aortic aneurysm,ACE,Acetylation,ADMA,AGT,AGT 2,AGT2,AGXT2,Alanine--glyoxylate aminotransferase 2,alanine-glyoxylate,alpha-keto-delta,Aminotransferase,angiotensin I,angiotensin II,Angiotensinogen,Angiotensinogen polymorphism,asymmetric dimethylarginine,atherosclerosis,Atrial Fibrillation,B6,Beta-ALAAT II,beta-alanine-pyruvate,Beta-alanine-pyruvate aminotransferase,blodd pressure,blood pressure,blood pressure control,blood pressure regulation,blood sugar,BMI,body mass index,cancer,cancerous,carcinogen,cardiomyopathy,cardiovascular,Cardiovascular Drug response,cerebral,cerebral blood flow,cerebral blood flow regulation,cerebral vasoreactivity,children with sickle cell anemia,cholesterol,Chronic Allograft Dysfunction,class-III pyridoxal-phosphate-dependent aminotransferase,class-III pyridoxal-phosphate-dependent aminotransferase family,colorectal cancer,Complete proteome,Coronary artery disease,coronary heart disease and type 2 diabetes mellitus,CVD,D-AIBAT,diabetes,diabetic,dimethylarginine,DMGV,EC=2.6.1.40,End-Stage Renal Disease,essential hypertension,Gene-disease interactions,glycine,glyoxylate,HDL,heart,heart disease,heart failure,high BP,high density lipoprotein,Homotetramer,Hypertensive,hypertrophic cardiomyopathy,insulin resistance,Insulin Sensitivity,Ischemic Stroke,kidney,kidney disease,L-alanine,LDL,linkage disequilibrium,lipid,lipid related cardiovascular disease,low density lipoprotein,Migraine,mitochondria,mitochondrial,Mitochondrion,mortality in Chinese coronary atherosclerosis patients,n-3 PUFAs,nephropathy,nitric oxide synthase,nitric-oxide,nitric-oxide inhibitor,nitric-oxide synthase inhibitor,NN-dimethylguanidino,NO,NO inhibitor,NOS,NOS inhibitor,Obesity,Omega-3 fatty acids,oral glucose tolerance test,P5P,placental abruption,Plasma lipids,Pleiotropy,PLP,Polymorphism,pregnancy induced hypertension,Primary hypertension,Pyridoxal phosphate,pyridoxal phosphate binding,pyridoxal-5'-phosphate,pyruvate,pyruvate transaminase,RAS,renal cell carcinoma,renal failure,Renin angiotensin system,renin-angiotensin,renin-angiotensin-aldosterone system,risk and protection against type 2 diabetic retinopathy,Salt-Sensitive Hypertension,Schizophrenia,stroke,Transferase,Transit peptide,Treatment Resistant Hypertension,Type 2 diabetes,Type 2 diabetes mellitus,valeric acid,vasoreactivity",
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs699",
        "SNP Name": "AGT M235T/C4072T",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs699",
        "Video": "fCsbe-HXcr4",
        "Tags": "(R)-3-amino-2-methylpropanoate,(R)-3-amino-2-methylpropionate,2-methyl-3-oxopropanoate,abdominal aortic aneurysm,ACE,Acetylation,ADMA,AGT,AGT 2,AGT2,AGXT2,Alanine--glyoxylate aminotransferase 2,alanine-glyoxylate,alpha-keto-delta,Aminotransferase,angiotensin I,angiotensin II,Angiotensinogen,Angiotensinogen polymorphism,asymmetric dimethylarginine,atherosclerosis,Atrial Fibrillation,B6,Beta-ALAAT II,beta-alanine-pyruvate,Beta-alanine-pyruvate aminotransferase,blodd pressure,blood pressure,blood pressure control,blood pressure regulation,blood sugar,BMI,body mass index,cancer,cancerous,carcinogen,cardiomyopathy,cardiovascular,Cardiovascular Drug response,cerebral,cerebral blood flow,cerebral blood flow regulation,cerebral vasoreactivity,children with sickle cell anemia,cholesterol,Chronic Allograft Dysfunction,class-III pyridoxal-phosphate-dependent aminotransferase,class-III pyridoxal-phosphate-dependent aminotransferase family,colorectal cancer,Complete proteome,Coronary artery disease,coronary heart disease and type 2 diabetes mellitus,CVD,D-AIBAT,diabetes,diabetic,dimethylarginine,DMGV,EC=2.6.1.40,End-Stage Renal Disease,essential hypertension,Gene-disease interactions,glycine,glyoxylate,HDL,heart,heart disease,heart failure,high BP,high density lipoprotein,Homotetramer,Hypertensive,hypertrophic cardiomyopathy,insulin resistance,Insulin Sensitivity,Ischemic Stroke,kidney,kidney disease,L-alanine,LDL,linkage disequilibrium,lipid,lipid related cardiovascular disease,low density lipoprotein,Migraine,mitochondria,mitochondrial,Mitochondrion,mortality in Chinese coronary atherosclerosis patients,n-3 PUFAs,nephropathy,nitric oxide synthase,nitric-oxide,nitric-oxide inhibitor,nitric-oxide synthase inhibitor,NN-dimethylguanidino,NO,NO inhibitor,NOS,NOS inhibitor,Obesity,Omega-3 fatty acids,oral glucose tolerance test,P5P,placental abruption,Plasma lipids,Pleiotropy,PLP,Polymorphism,pregnancy induced hypertension,Primary hypertension,Pyridoxal phosphate,pyridoxal phosphate binding,pyridoxal-5'-phosphate,pyruvate,pyruvate transaminase,RAS,renal cell carcinoma,renal failure,Renin angiotensin system,renin-angiotensin,renin-angiotensin-aldosterone system,risk and protection against type 2 diabetic retinopathy,Salt-Sensitive Hypertension,Schizophrenia,stroke,Transferase,Transit peptide,Treatment Resistant Hypertension,Type 2 diabetes,Type 2 diabetes mellitus,valeric acid,vasoreactivity",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2004776",
        "SNP Name": "AGT 6635G>A",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs2004776",
        "SNP Name": "AGT 6635G>A",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs2493134",
        "SNP Name": "AGT 5978A>G",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs2493134",
        "SNP Name": "AGT 5978A>G",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs2148582",
        "SNP Name": "AGT 5538T>C",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs2148582",
        "SNP Name": "AGT 5538T>C",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs5051",
        "SNP Name": "AGT 5465G>A",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs5051",
        "SNP Name": "AGT 5465G>A",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs11568020",
        "SNP Name": "AGT 5319G>A",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs11568020",
        "SNP Name": "AGT 5319G>A",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs823162",
        "SNP Name": "DISC1 C14853T",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs823162",
        "Video": "knXWzqwgWSk",
        "Tags": "ACTN2,adult dentate gyrus,adult neurogenesis,amplitude,ANKHD1,ATF4,ATF5,biomarker,bipolar,bipolar disorder,bizarre behavior,C-terminus,canonical Wnt signaling pathway,CCDC88A,Cell junction,cell migration,cell proliferation in forebrain,centrosome,CEP63,cerebral cortex,CHCHD6,chromosomal aberration,cis-regulation,cognitive function,Colocalize,CTNNB1 abundance,Cytoplasm,cytoplasmic foci,cytoskeleton,delusions,dementias,dendritic development,dentate gyrus,DISC1,DISC1 pathway gene,DISC1 pathway genes,EEG,EIF3S3,embryonic brain development,embryonic neurogenesis,endophenoytpes,ERP,granule cell precursors,GSK3B,GSK3B activity,hallucinations,haplotypes analysis,hippocampal development,hippocampus,IAKT-mTOR,KIAA0457,latency,learning,linear regression,loss of ego boundaries,MAP1A,memory,mental disorder,microtubule cytoskeleton organization,microtubule network formation,microtubules,mitochondria,mitochondrial calcium ion homeostasis,modulator of the AKT-mTOR signaling pathway,NDEL1,neural progenitor proliferation,neuroanatomical,neuroblast proliferation,neurocognitive,neuron migration,neuron positioning,neuron projection development,neurophysiological,neurophysiology,newborn neurons integration,P300,P300 deficits,P300 endophenotypes,P300 waveforms,PAFAH1B1,panic,parahippocampal cortice,PCNT,perinuclear region,polymorphisms,postsynaptic cell membrane,postsynaptic density,protein localization,protein ubiquitination,psychiatric disorders,psychotic bipolar disorder,psychotic disorder,purposeless behavior,RANBP9,schizoaffective disorder,schizophrenia,schizophrenia 1 protein,Schizophrenia 9,SCZD9,SPTBN4,synapse,synapse formation,synapse maturation,SYNE1,temporal cortice,TRAF3IP1,truncated DISC1 protein,tubulin alpha,ubiquitin-dependent protein catabolic process,ventrical/subventrical zone,withdrawal,Wnt signaling pathway,Wnt-mediated neural progenitor proliferation",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs7526063",
        "SNP Name": "MTR C18418T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7526063",
        "Video": null,
        "Tags": "5-methyltetrahydrofolate,5-methyltetrahydrofolate + L-homocysteine = tetrahydrofolate + L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-MTHF,AdoMet,AdoMet activation domain,alcohol,alcohol dependence,amino acids,Amino-acid biosynthesis,Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route),anencephaly,autosomal recessive,B12,B12 -binding domain binds the cofactor,B12 metabolism,B12 transport,B12-binding domain,B12-binding N-terminal domain,birth defect,brain,Catalyzes the transfer of a methyl group from methyl-cobalamin to homocysteine,cblG complementation type (HMAG),cellular nitrogen compound metabolic process,cobalamin,cobalamin binding,cobalamin deficiency,cobalamin metabolic process,Cobalt,Complete proteome,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,Down syndrome,Expressed at lower levels in lung,Expressed at the highest levels in pancreas,folate,Folate-sensitive neural tube defects (FS-NTD),folic acid,Hcy,Hcy-binding domain,Hcy-binding domain catalyzes methyl transfer from free methylcobalamin to homocysteine,heart,homocysteine,homocysteine S-methyltransferase activity,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error,inborn error of metabolism resulting from defects in the cobalamin-dependent pathway that converts homocysteine to methionine,intellectual disability,L-5-MTHF,L-homocysteine,L-homocysteine is bound via the zinc atom,L-methionine,L-methionine biosynthesis,liver and kidney,megaloblastic anemia,mental retardation,Metal-binding,methionine,Methionine biosynthesis,Methionine synthase,methionine synthase activity,methylation,methylcobalamin,Methylcobalamin (MeCBL),Methyltransferase,Modular enzyme with four functionally distinct domains,MS,MTR,myelomeningocele,nervous system development,neural tube defect,nicotine,nicotine dependence,NTDs,open spina bifida (myelomeningocele),Polymorphism,pteridine-containing compound metabolic process,pterin-binding domain,Reference proteome,remethylates the cofactor using methyltetrahydrofolate,Repeat,S-adenosyl-L-methionine,S-adenosyl-L-methionine and flavodoxin regenerates methylcobalamin,S-adenosylmethionine,SAMe,skeletal muscle and placenta,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,tetrahydrofolate,tobacco,Transferase,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,vitamin-B12 dependent methionine synthase family,water-soluble vitamin metabolic process,xenobiotic metabolic process,Zinc,zinc ion binding",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2789352",
        "SNP Name": "MTR A50417C",
        "Risk Allele": "A",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2789352",
        "Video": null,
        "Tags": "5-methyltetrahydrofolate,5-methyltetrahydrofolate + L-homocysteine = tetrahydrofolate + L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-MTHF,AdoMet,AdoMet activation domain,amino acids,Amino-acid biosynthesis,Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route),anencephaly,autosomal recessive,B12,B12 -binding domain binds the cofactor,B12 metabolism,B12 transport,B12-binding domain,B12-binding N-terminal domain,birth defect,brain,Catalyzes the transfer of a methyl group from methyl-cobalamin to homocysteine,cblG complementation type (HMAG),cellular nitrogen compound metabolic process,cobalamin,cobalamin binding,cobalamin deficiency,cobalamin metabolic process,Cobalt,Complete proteome,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,Down syndrome,Expressed at lower levels in lung,Expressed at the highest levels in pancreas,folate,Folate-sensitive neural tube defects (FS-NTD),folic acid,Hcy,Hcy-binding domain,Hcy-binding domain catalyzes methyl transfer from free methylcobalamin to homocysteine,heart,homocysteine,homocysteine S-methyltransferase activity,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error,inborn error of metabolism resulting from defects in the cobalamin-dependent pathway that converts homocysteine to methionine,intellectual disability,L-5-MTHF,L-homocysteine,L-homocysteine is bound via the zinc atom,L-methionine,L-methionine biosynthesis,liver and kidney,megaloblastic anemia,mental retardation,Metal-binding,methionine,Methionine biosynthesis,Methionine synthase,methionine synthase activity,methylation,methylcobalamin,Methylcobalamin (MeCBL),Methyltransferase,Modular enzyme with four functionally distinct domains,MS,MTR,myelomeningocele,nervous system development,neural tube defect,NTDs,open spina bifida (myelomeningocele),Polymorphism,pteridine-containing compound metabolic process,pterin-binding domain,Reference proteome,remethylates the cofactor using methyltetrahydrofolate,Repeat,S-adenosyl-L-methionine,S-adenosyl-L-methionine and flavodoxin regenerates methylcobalamin,S-adenosylmethionine,SAMe,skeletal muscle and placenta,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,tetrahydrofolate,Transferase,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,vitamin-B12 dependent methionine synthase family,water-soluble vitamin metabolic process,xenobiotic metabolic process,Zinc,zinc ion binding",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2275568",
        "SNP Name": "MTR C62048T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2275568",
        "Video": null,
        "Tags": "5-methyltetrahydrofolate,5-methyltetrahydrofolate + L-homocysteine = tetrahydrofolate + L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-MTHF,AdoMet,AdoMet activation domain,amino acids,Amino-acid biosynthesis,Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route),anencephaly,autosomal recessive,B12,B12 -binding domain binds the cofactor,B12 metabolism,B12 transport,B12-binding domain,B12-binding N-terminal domain,birth defect,brain,Catalyzes the transfer of a methyl group from methyl-cobalamin to homocysteine,cblG complementation type (HMAG),cellular nitrogen compound metabolic process,cobalamin,cobalamin binding,cobalamin deficiency,cobalamin metabolic process,Cobalt,Complete proteome,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,Down syndrome,Expressed at lower levels in lung,Expressed at the highest levels in pancreas,folate,Folate-sensitive neural tube defects (FS-NTD),folic acid,Hcy,Hcy-binding domain,Hcy-binding domain catalyzes methyl transfer from free methylcobalamin to homocysteine,heart,homocysteine,homocysteine S-methyltransferase activity,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error,inborn error of metabolism resulting from defects in the cobalamin-dependent pathway that converts homocysteine to methionine,intellectual disability,kidney,kidney aging,kidney decline with age,L-5-MTHF,L-homocysteine,L-homocysteine is bound via the zinc atom,L-methionine,L-methionine biosynthesis,liver and kidney,megaloblastic anemia,mental retardation,Metal-binding,methionine,Methionine biosynthesis,Methionine synthase,methionine synthase activity,methylation,methylcobalamin,Methylcobalamin (MeCBL),Methyltransferase,Modular enzyme with four functionally distinct domains,MS,MTR,myelomeningocele,nervous system development,neural tube defect,NTDs,open spina bifida (myelomeningocele),Polymorphism,pteridine-containing compound metabolic process,pterin-binding domain,Reference proteome,remethylates the cofactor using methyltetrahydrofolate,Repeat,S-adenosyl-L-methionine,S-adenosyl-L-methionine and flavodoxin regenerates methylcobalamin,S-adenosylmethionine,SAMe,skeletal muscle and placenta,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,tetrahydrofolate,Transferase,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,vitamin-B12 dependent methionine synthase family,water-soluble vitamin metabolic process,xenobiotic metabolic process,Zinc,zinc ion binding",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs1770449",
        "SNP Name": "MTR T84581C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1770449",
        "Video": null,
        "Tags": "5-methyltetrahydrofolate,5-methyltetrahydrofolate + L-homocysteine = tetrahydrofolate + L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-MTHF,AdoMet,AdoMet activation domain,amino acids,Amino-acid biosynthesis,Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route),anencephaly,autosomal recessive,B12,B12 -binding domain binds the cofactor,B12 metabolism,B12 transport,B12-binding domain,B12-binding N-terminal domain,birth defect,brain,Catalyzes the transfer of a methyl group from methyl-cobalamin to homocysteine,cblG complementation type (HMAG),cellular nitrogen compound metabolic process,childhood obesity,cobalamin,cobalamin binding,cobalamin deficiency,cobalamin metabolic process,Cobalt,Complete proteome,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,Down syndrome,Expressed at lower levels in lung,Expressed at the highest levels in pancreas,folate,Folate-sensitive neural tube defects (FS-NTD),folic acid,Hcy,Hcy-binding domain,Hcy-binding domain catalyzes methyl transfer from free methylcobalamin to homocysteine,heart,homocysteine,homocysteine S-methyltransferase activity,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error,inborn error of metabolism resulting from defects in the cobalamin-dependent pathway that converts homocysteine to methionine,intellectual disability,L-5-MTHF,L-homocysteine,L-homocysteine is bound via the zinc atom,L-methionine,L-methionine biosynthesis,liver and kidney,megaloblastic anemia,mental retardation,Metal-binding,methionine,Methionine biosynthesis,Methionine synthase,methionine synthase activity,methylation,methylcobalamin,Methylcobalamin (MeCBL),Methyltransferase,Modular enzyme with four functionally distinct domains,MS,MTR,myelomeningocele,nervous system development,neural tube defect,NTDs,obesity,open spina bifida (myelomeningocele),Polymorphism,pteridine-containing compound metabolic process,pterin-binding domain,Reference proteome,remethylates the cofactor using methyltetrahydrofolate,Repeat,S-adenosyl-L-methionine,S-adenosyl-L-methionine and flavodoxin regenerates methylcobalamin,S-adenosylmethionine,SAMe,skeletal muscle and placenta,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,tetrahydrofolate,Transferase,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,vitamin-B12 dependent methionine synthase family,water-soluble vitamin metabolic process,xenobiotic metabolic process,Zinc,zinc ion binding",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs10925257",
        "SNP Name": "MTR A92580G",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10925257",
        "Video": null,
        "Tags": "5-methyltetrahydrofolate,5-methyltetrahydrofolate + L-homocysteine = tetrahydrofolate + L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-MTHF,Acute Lymphoblastic Leukemia,AdoMet,AdoMet activation domain,amino acids,Amino-acid biosynthesis,Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route),anencephaly,autosomal recessive,B-vitamin deficiency,B12,B12 -binding domain binds the cofactor,B12 metabolism,B12 transport,B12-binding domain,B12-binding N-terminal domain,birth defect,brain,Catalyzes the transfer of a methyl group from methyl-cobalamin to homocysteine,cblG complementation type (HMAG),cellular nitrogen compound metabolic process,Childhood Acute Lymphoblastic Leukemia,cobalamin,cobalamin binding,cobalamin deficiency,cobalamin metabolic process,Cobalt,Complete proteome,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,Down syndrome,Expressed at lower levels in lung,Expressed at the highest levels in pancreas,folate,Folate-sensitive neural tube defects (FS-NTD),folic acid,frailty syndrome,Hcy,Hcy-binding domain,Hcy-binding domain catalyzes methyl transfer from free methylcobalamin to homocysteine,heart,homocysteine,homocysteine S-methyltransferase activity,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error,inborn error of metabolism resulting from defects in the cobalamin-dependent pathway that converts homocysteine to methionine,increased risk of frailty,intellectual disability,L-5-MTHF,L-homocysteine,L-homocysteine is bound via the zinc atom,L-methionine,L-methionine biosynthesis,Leukemia,liver and kidney,Lymphoblastic Leukemia,megaloblastic anemia,mental retardation,Metal-binding,methionine,Methionine biosynthesis,Methionine synthase,methionine synthase activity,methylation,methylcobalamin,Methylcobalamin (MeCBL),Methyltransferase,Modular enzyme with four functionally distinct domains,MS,MTR,myelomeningocele,nervous system development,neural tube defect,NTDs,open spina bifida (myelomeningocele),Polymorphism,pteridine-containing compound metabolic process,pterin-binding domain,Reference proteome,remethylates the cofactor using methyltetrahydrofolate,Repeat,S-adenosyl-L-methionine,S-adenosyl-L-methionine and flavodoxin regenerates methylcobalamin,S-adenosylmethionine,SAMe,skeletal muscle and placenta,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,tetrahydrofolate,transcobalamin,TRANSCOBALAMIN-II,Transferase,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,vitamin-B12 dependent methionine synthase family,water-soluble vitamin metabolic process,xenobiotic metabolic process,Zinc,zinc ion binding",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs1805087",
        "SNP Name": "MTR A2756G",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1805087",
        "Video": null,
        "Tags": "5-methyltetrahydrofolate,5-methyltetrahydrofolate + L-homocysteine = tetrahydrofolate + L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-MTHF,Abdominal Aortic Aneurysm,adenoma,AdoMet,AdoMet activation domain,amino acids,Amino-acid biosynthesis,Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route),anencephaly,Aneurysm,Arsenic,Arsenic Metabolism,ASD,Aspirin,autism,Autism Spectrum Disorder,autosomal recessive,B12,B12 -binding domain binds the cofactor,B12 metabolism,B12 transport,B12-binding domain,B12-binding N-terminal domain,birth defect,brain,breast cancer,cancer,cancerous,carcinogen,Catalyzes the transfer of a methyl group from methyl-cobalamin to homocysteine,cblG complementation type (HMAG),celiac,celiac disease,cellular nitrogen compound metabolic process,childhood acute lymphoblastic leukemia,childhood leukemia,cleft,cobalamin,cobalamin binding,cobalamin deficiency,cobalamin metabolic process,Cobalt,colorectal cancer,Complete proteome,Congenital Heart Disease,conotruncal heart defects,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,distal colorectal adenoma,Down syndrome,drug metabolism,Esophageal Cancer,Expressed at lower levels in lung,Expressed at the highest levels in pancreas,folate,Folate and Alcohol Intake,Folate Metabolic Pathway,folate metabolism,Folate-sensitive neural tube defects (FS-NTD),folic acid,Gastric Cancer,glaucoma,Hcy,Hcy-binding domain,Hcy-binding domain catalyzes methyl transfer from free methylcobalamin to homocysteine,heart,heart disease,homocysteine,homocysteine S-methyltransferase activity,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error,inborn error of metabolism resulting from defects in the cobalamin-dependent pathway that converts homocysteine to methionine,intellectual disability,L-5-MTHF,L-homocysteine,L-homocysteine is bound via the zinc atom,L-methionine,L-methionine biosynthesis,leukemia,liver and kidney,lung,megaloblastic anemia,mental disorder,mental retardation,Metal-binding,methionine,Methionine biosynthesis,Methionine synthase,methionine synthase activity,methylation,methylcobalamin,Methylcobalamin (MeCBL),Methyltransferase,Modular enzyme with four functionally distinct domains,MS,MTR,Myeloid Leukemia,myelomeningocele,neck carcinoma,Negative Symptom Severity in Schizophrenia,nervous system development,neural tube defect,non-Hodgkin lymphoma,non-small cell lung carcinoma,NTDs,open spina bifida (myelomeningocele),Oral Facial Clefts,ovarian cancer,Pharmacogenomics,Plasma Homocysteine,Polymorphism,prostate cancer,pseudoexfoliation syndrome,pteridine-containing compound metabolic process,pterin-binding domain,Reference proteome,remethylates the cofactor using methyltetrahydrofolate,Renal Cell Cancer,Repeat,S-adenosyl-L-methionine,S-adenosyl-L-methionine and flavodoxin regenerates methylcobalamin,S-adenosylmethionine,SAMe,Schizophrenia,skeletal muscle and placenta,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,Telomere,Telomere Length,temporomandibular disorder,tetrahydrofolate,TMJ,Transferase,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,vitamin-B12 dependent methionine synthase family,water-soluble vitamin metabolic process,xenobiotic metabolic process,Zinc,zinc ion binding",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2275565",
        "SNP Name": "MTR G95096T",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2275565",
        "Video": null,
        "Tags": "5-methyltetrahydrofolate,5-methyltetrahydrofolate + L-homocysteine = tetrahydrofolate + L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-MTHF,Acute Lymphoblastic Leukemia,AdoMet,AdoMet activation domain,amino acids,Amino-acid biosynthesis,Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route),anencephaly,autosomal recessive,B12,B12 -binding domain binds the cofactor,B12 metabolism,B12 transport,B12-binding domain,B12-binding N-terminal domain,birth defect,brain,Catalyzes the transfer of a methyl group from methyl-cobalamin to homocysteine,cblG complementation type (HMAG),cellular nitrogen compound metabolic process,Childhood Acute Lymphoblastic Leukemia,cobalamin,cobalamin binding,cobalamin deficiency,cobalamin metabolic process,Cobalt,Complete proteome,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,Down syndrome,Expressed at lower levels in lung,Expressed at the highest levels in pancreas,folate,Folate-sensitive neural tube defects (FS-NTD),folic acid,Hcy,Hcy-binding domain,Hcy-binding domain catalyzes methyl transfer from free methylcobalamin to homocysteine,heart,homocysteine,homocysteine S-methyltransferase activity,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error,inborn error of metabolism resulting from defects in the cobalamin-dependent pathway that converts homocysteine to methionine,intellectual disability,L-5-MTHF,L-homocysteine,L-homocysteine is bound via the zinc atom,L-methionine,L-methionine biosynthesis,Leukemia,liver and kidney,Lymphoblastic Leukemia,megaloblastic anemia,mental retardation,Metal-binding,methionine,Methionine biosynthesis,Methionine synthase,methionine synthase activity,methylation,methylcobalamin,Methylcobalamin (MeCBL),Methyltransferase,Modular enzyme with four functionally distinct domains,MS,MTR,myelomeningocele,nervous system development,neural tube defect,NTDs,open spina bifida (myelomeningocele),Polymorphism,pteridine-containing compound metabolic process,pterin-binding domain,Reference proteome,remethylates the cofactor using methyltetrahydrofolate,Repeat,S-adenosyl-L-methionine,S-adenosyl-L-methionine and flavodoxin regenerates methylcobalamin,S-adenosylmethionine,SAMe,skeletal muscle and placenta,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,tetrahydrofolate,Transferase,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,vitamin-B12 dependent methionine synthase family,water-soluble vitamin metabolic process,xenobiotic metabolic process,Zinc,zinc ion binding",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs3820571",
        "SNP Name": "MTR G106853T",
        "Risk Allele": "G",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3820571",
        "Video": null,
        "Tags": "5-methyltetrahydrofolate,5-methyltetrahydrofolate + L-homocysteine = tetrahydrofolate + L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-MTHF,AdoMet,AdoMet activation domain,amino acids,Amino-acid biosynthesis,Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route),anencephaly,autosomal recessive,B12,B12 -binding domain binds the cofactor,B12 metabolism,B12 transport,B12-binding domain,B12-binding N-terminal domain,birth defect,brain,Catalyzes the transfer of a methyl group from methyl-cobalamin to homocysteine,cblG complementation type (HMAG),cellular nitrogen compound metabolic process,cobalamin,cobalamin binding,cobalamin deficiency,cobalamin metabolic process,Cobalt,Complete proteome,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,Down syndrome,Expressed at lower levels in lung,Expressed at the highest levels in pancreas,folate,Folate-sensitive neural tube defects (FS-NTD),folic acid,Hcy,Hcy-binding domain,Hcy-binding domain catalyzes methyl transfer from free methylcobalamin to homocysteine,heart,homocysteine,homocysteine S-methyltransferase activity,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error,inborn error of metabolism resulting from defects in the cobalamin-dependent pathway that converts homocysteine to methionine,intellectual disability,L-5-MTHF,L-homocysteine,L-homocysteine is bound via the zinc atom,L-methionine,L-methionine biosynthesis,liver and kidney,megaloblastic anemia,mental retardation,Metal-binding,methionine,Methionine biosynthesis,Methionine synthase,methionine synthase activity,methylation,methylcobalamin,Methylcobalamin (MeCBL),Methyltransferase,Modular enzyme with four functionally distinct domains,MS,MTR,myelomeningocele,nervous system development,neural tube defect,NTDs,open spina bifida (myelomeningocele),Polymorphism,pteridine-containing compound metabolic process,pterin-binding domain,Reference proteome,remethylates the cofactor using methyltetrahydrofolate,Repeat,S-adenosyl-L-methionine,S-adenosyl-L-methionine and flavodoxin regenerates methylcobalamin,S-adenosylmethionine,SAMe,skeletal muscle and placenta,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,tetrahydrofolate,Transferase,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,vitamin-B12 dependent methionine synthase family,water-soluble vitamin metabolic process,xenobiotic metabolic process,Zinc,zinc ion binding",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2853522",
        "SNP Name": "MTR A*112C",
        "Risk Allele": "A",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2853522",
        "Video": null,
        "Tags": "5-methyltetrahydrofolate,5-methyltetrahydrofolate + L-homocysteine = tetrahydrofolate + L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-MTHF,AdoMet,AdoMet activation domain,amino acids,Amino-acid biosynthesis,Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route),anencephaly,autosomal recessive,B12,B12 -binding domain binds the cofactor,B12 metabolism,B12 transport,B12-binding domain,B12-binding N-terminal domain,birth defect,brain,Catalyzes the transfer of a methyl group from methyl-cobalamin to homocysteine,cblG complementation type (HMAG),cellular nitrogen compound metabolic process,cobalamin,cobalamin binding,cobalamin deficiency,cobalamin metabolic process,Cobalt,Complete proteome,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,Down syndrome,Expressed at lower levels in lung,Expressed at the highest levels in pancreas,folate,Folate-sensitive neural tube defects (FS-NTD),folic acid,Hcy,Hcy-binding domain,Hcy-binding domain catalyzes methyl transfer from free methylcobalamin to homocysteine,heart,homocysteine,homocysteine S-methyltransferase activity,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error,inborn error of metabolism resulting from defects in the cobalamin-dependent pathway that converts homocysteine to methionine,intellectual disability,L-5-MTHF,L-homocysteine,L-homocysteine is bound via the zinc atom,L-methionine,L-methionine biosynthesis,liver and kidney,megaloblastic anemia,mental retardation,Metal-binding,methionine,Methionine biosynthesis,Methionine synthase,methionine synthase activity,methylation,methylcobalamin,Methylcobalamin (MeCBL),Methyltransferase,Modular enzyme with four functionally distinct domains,MS,MTR,myelomeningocele,nervous system development,neural tube defect,NTDs,open spina bifida (myelomeningocele),Polymorphism,pteridine-containing compound metabolic process,pterin-binding domain,Reference proteome,remethylates the cofactor using methyltetrahydrofolate,Repeat,S-adenosyl-L-methionine,S-adenosyl-L-methionine and flavodoxin regenerates methylcobalamin,S-adenosylmethionine,SAMe,skeletal muscle and placenta,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,tetrahydrofolate,Transferase,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,vitamin-B12 dependent methionine synthase family,water-soluble vitamin metabolic process,xenobiotic metabolic process,Zinc,zinc ion binding",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs11799670",
        "SNP Name": "MTR A*153G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs11799670",
        "Video": null,
        "Tags": "5-methyltetrahydrofolate,5-methyltetrahydrofolate + L-homocysteine = tetrahydrofolate + L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-MTHF,AdoMet,AdoMet activation domain,amino acids,Amino-acid biosynthesis,Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route),anencephaly,autosomal recessive,B12,B12 -binding domain binds the cofactor,B12 metabolism,B12 transport,B12-binding domain,B12-binding N-terminal domain,birth defect,brain,Catalyzes the transfer of a methyl group from methyl-cobalamin to homocysteine,cblG complementation type (HMAG),cellular nitrogen compound metabolic process,cobalamin,cobalamin binding,cobalamin deficiency,cobalamin metabolic process,Cobalt,Complete proteome,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,Down syndrome,Expressed at lower levels in lung,Expressed at the highest levels in pancreas,folate,Folate-sensitive neural tube defects (FS-NTD),folic acid,Hcy,Hcy-binding domain,Hcy-binding domain catalyzes methyl transfer from free methylcobalamin to homocysteine,heart,homocysteine,homocysteine S-methyltransferase activity,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error,inborn error of metabolism resulting from defects in the cobalamin-dependent pathway that converts homocysteine to methionine,intellectual disability,L-5-MTHF,L-homocysteine,L-homocysteine is bound via the zinc atom,L-methionine,L-methionine biosynthesis,liver and kidney,megaloblastic anemia,mental retardation,Metal-binding,methionine,Methionine biosynthesis,Methionine synthase,methionine synthase activity,methylation,methylcobalamin,Methylcobalamin (MeCBL),Methyltransferase,Modular enzyme with four functionally distinct domains,MS,MTR,myelomeningocele,nervous system development,neural tube defect,NTDs,open spina bifida (myelomeningocele),Polymorphism,pteridine-containing compound metabolic process,pterin-binding domain,Reference proteome,remethylates the cofactor using methyltetrahydrofolate,Repeat,S-adenosyl-L-methionine,S-adenosyl-L-methionine and flavodoxin regenerates methylcobalamin,S-adenosylmethionine,SAMe,skeletal muscle and placenta,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,tetrahydrofolate,Transferase,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,vitamin-B12 dependent methionine synthase family,water-soluble vitamin metabolic process,xenobiotic metabolic process,Zinc,zinc ion binding",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2853523",
        "SNP Name": "MTR A*1254C",
        "Risk Allele": "A",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2853523",
        "Video": null,
        "Tags": "5-methyltetrahydrofolate,5-methyltetrahydrofolate + L-homocysteine = tetrahydrofolate + L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-MTHF,Abdominal Aortic Aneurysm,Acute Lymphoblastic Leukemia,AdoMet,AdoMet activation domain,amino acids,Amino-acid biosynthesis,Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route),anencephaly,aneurysm,autosomal recessive,B12,B12 -binding domain binds the cofactor,B12 metabolism,B12 transport,B12-binding domain,B12-binding N-terminal domain,birth defect,brain,cancer,cancerous,carcinogen,Catalyzes the transfer of a methyl group from methyl-cobalamin to homocysteine,cblG complementation type (HMAG),cellular nitrogen compound metabolic process,Childhood Acute Lymphoblastic Leukemia,cobalamin,cobalamin binding,cobalamin deficiency,cobalamin metabolic process,Cobalt,Complete proteome,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,Down syndrome,Expressed at lower levels in lung,Expressed at the highest levels in pancreas,folate,Folate-sensitive neural tube defects (FS-NTD),folic acid,Hcy,Hcy-binding domain,Hcy-binding domain catalyzes methyl transfer from free methylcobalamin to homocysteine,heart,homocysteine,homocysteine S-methyltransferase activity,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error,inborn error of metabolism resulting from defects in the cobalamin-dependent pathway that converts homocysteine to methionine,intellectual disability,L-5-MTHF,L-homocysteine,L-homocysteine is bound via the zinc atom,L-methionine,L-methionine biosynthesis,Leukemia,liver and kidney,Lymphoblastic Leukemia,megaloblastic anemia,mental retardation,Metal-binding,methionine,Methionine biosynthesis,Methionine synthase,methionine synthase activity,methylation,methylcobalamin,Methylcobalamin (MeCBL),Methyltransferase,Modular enzyme with four functionally distinct domains,MS,MTR,myelomeningocele,nervous system development,neural tube defect,NTDs,open spina bifida (myelomeningocele),ovarian cancer risk,Polymorphism,pteridine-containing compound metabolic process,pterin-binding domain,Reference proteome,remethylates the cofactor using methyltetrahydrofolate,Repeat,S-adenosyl-L-methionine,S-adenosyl-L-methionine and flavodoxin regenerates methylcobalamin,S-adenosylmethionine,SAMe,skeletal muscle and placenta,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,tetrahydrofolate,Transferase,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,vitamin-B12 dependent methionine synthase family,water-soluble vitamin metabolic process,xenobiotic metabolic process,Zinc,zinc ion binding",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs1050993",
        "SNP Name": "MTR A*1361G",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050993",
        "Video": null,
        "Tags": "5-methyltetrahydrofolate,5-methyltetrahydrofolate + L-homocysteine = tetrahydrofolate + L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-MTHF,AdoMet,AdoMet activation domain,amino acids,Amino-acid biosynthesis,Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route),anencephaly,autosomal recessive,B-vitamin deficiency,B12,B12 -binding domain binds the cofactor,B12 metabolism,B12 transport,B12-binding domain,B12-binding N-terminal domain,birth defect,brain,cancerous,carcinogen,Catalyzes the transfer of a methyl group from methyl-cobalamin to homocysteine,cblG complementation type (HMAG),cellular nitrogen compound metabolic process,childhood obesity,cobalamin,cobalamin binding,cobalamin deficiency,cobalamin metabolic process,Cobalt,Complete proteome,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,Down syndrome,Expressed at lower levels in lung,Expressed at the highest levels in pancreas,folate,Folate-sensitive neural tube defects (FS-NTD),folic acid,frailty syndrome,Hcy,Hcy-binding domain,Hcy-binding domain catalyzes methyl transfer from free methylcobalamin to homocysteine,heart,homocysteine,homocysteine S-methyltransferase activity,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error,inborn error of metabolism resulting from defects in the cobalamin-dependent pathway that converts homocysteine to methionine,increased risk of frailty,intellectual disability,L-5-MTHF,L-homocysteine,L-homocysteine is bound via the zinc atom,L-methionine,L-methionine biosynthesis,liver and kidney,megaloblastic anemia,mental retardation,Metal-binding,methionine,Methionine biosynthesis,Methionine synthase,methionine synthase activity,methylation,methylcobalamin,Methylcobalamin (MeCBL),Methyltransferase,Modular enzyme with four functionally distinct domains,MS,MTR,myelomeningocele,nervous system development,neural tube defect,NTDs,obesity,open spina bifida (myelomeningocele),ovarian cancer,Polymorphism,prostate cancer,pteridine-containing compound metabolic process,pterin-binding domain,Reference proteome,remethylates the cofactor using methyltetrahydrofolate,Repeat,S-adenosyl-L-methionine,S-adenosyl-L-methionine and flavodoxin regenerates methylcobalamin,S-adenosylmethionine,SAMe,skeletal muscle and placenta,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,tetrahydrofolate,transcobalamin,TRANSCOBALAMIN-II,Transferase,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,vitamin-B12 dependent methionine synthase family,water-soluble vitamin metabolic process,xenobiotic metabolic process,Zinc,zinc ion binding",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2027432",
        "SNP Name": "NLRP3 variant",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs3806265",
        "SNP Name": "NLRP3 variant",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs10754557",
        "SNP Name": "NLRP3 variant",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs1539019",
        "SNP Name": "NLRP3 variant",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs10157379",
        "SNP Name": "NLRP3 variant",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs4353135",
        "SNP Name": "NLRP3 247617036G>T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs4353135",
        "SNP Name": "NLRP3 247617036G>T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "IgA"
    },
    {
        "SNP ID": "rs4353135",
        "SNP Name": "NLRP3 247617036G>T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs4666014",
        "SNP Name": "RBKS G28019175A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4666014",
        "Video": null,
        "Tags": "2-carboxethylphosphonic acid,3-D structure,ADP,alternative splicing,ATP,ATP binding,beta-D-ribopyranose,carbohydrate kinase PfkB family,Carbohydrate metabolism,clodronate,Complete proteome,D-ribose,D-ribose 5-phosphate,D-ribose catabolic process,D-ribose degradation,etidronate,extracellular exosome,G28019175A,Kinase,N-(phosphonomethyl)glycine,N-(phosphonomethyl)iminodiacetic acid,N-(phosphonomethyl)iminodiacetic acid and clodronate,Nucleotide-binding,pentose-phosphate pathway,phosphonoacetic acid,RBKS,Reference proteome,Ribokinase,ribokinase activity,rs4666014,Transferase",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs4666020",
        "SNP Name": "RBKS G28046028A",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4666020",
        "Video": null,
        "Tags": "2-carboxethylphosphonic acid,3-D structure,ADP,alternative splicing,ATP,ATP binding,beta-D-ribopyranose,carbohydrate kinase PfkB family,Carbohydrate metabolism,clodronate,Complete proteome,D-ribose,D-ribose 5-phosphate,D-ribose catabolic process,D-ribose degradation,etidronate,extracellular exosome,G28046028A,Kinase,N-(phosphonomethyl)glycine,N-(phosphonomethyl)iminodiacetic acid,N-(phosphonomethyl)iminodiacetic acid and clodronate,Nucleotide-binding,pentose-phosphate pathway,phosphonoacetic acid,RBKS,Reference proteome,Ribokinase,ribokinase activity,rs4666020,Transferase",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs207444",
        "SNP Name": "XDH 31563797A>G",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs1884725",
        "SNP Name": "XDH 31571786A>G",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs1429376",
        "SNP Name": "XDH 31588561A>C",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs17011368",
        "SNP Name": "XDH Ile703Val",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs17323225",
        "SNP Name": "XDH Ile646Val",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs185925",
        "SNP Name": "XDH 31609993G>A",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs2073316",
        "SNP Name": "XDH 31611029G>A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs206811",
        "SNP Name": "XDH 31636915A>G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs9341266",
        "SNP Name": "CYP1B1 C1871T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs9341266",
        "Video": "Yucm1mrp0qo",
        "Tags": "acting on paired donors,Amodiaquine,and incorporation of one atom of oxygen,angiogenesis,anionic phospholipids,antiangiogenic factor THBS2,arachidonic acid,arachidonic acid metabolic process,aromatase activity,Arsenic trioxide,ARTIFICIAL ESTROGEN,beta-estradiol,Biotin,blood vessel morphogenesis,breast cancer,Caffeine,CANCER,CANCEROUS,CARCINOGEN,cardiolipin,cell adhesion,cell migration,cellular aromatic compound metabolic process,cellular response to hydrogen peroxide,cellular response to organic cyclic compound,Clozapine,collagen fibril organization,compounds,congenital,CYP,CYP P450,CYP1B1,CYPIB1,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 1B1,Dasatinib,Daunorubicin,DETOX,DETOXIFICATION,Dexamethasone,dimethyltetraphene,Docetaxel,Doxorubicin,DRUG,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,early-onset glaucoma,Endoplasmic reticulum,Endoplasmic reticulum membrane,endothelial cell migration,endothelial cell-cell adhesion,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,ENZYME,epoxygenase P450 pathway,Erlotinib,estradiol,ESTROGEN,estrogen metabolic process,Estrone,eye,FAST METABOLIZER,fat,fatty acids,Flutamide,glaucoma,HEME,heme binding,heme-thiolate monooxygenase,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,intrinsic apoptotic signaling pathway in response to oxidative stress,Iron,iron ion binding,Ketoconazole,Lansoprazole,lipids,liposomes,LIVER,LIVER ENZYME,Melatonin,Membrane,membrane lipid catabolic process,Metal-binding,Microsome,Microsome membrane,mitochondria,mitochondrion,Mitoxantrone,Monooxygenase,monooxygenase activity,NADPH,NADPH-dependent electron transport pathway,negative regulation of cell adhesion mediated by integrin,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of NF-kappaB transcription factor activity,NF-kappa-B expression,nitric oxide biosynthetic process,omega-hydroxylase P450 pathway,Omeprazole,Oxaliplatin,oxidation,oxidation-reduction process,oxidative homeostasis,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paclitaxel,Peripheral membrane protein,Peters anomaly,Phenobarbital,phosphatidic acid,phospholipids,positive regulation of angiogenesis,positive regulation of apoptotic process,positive regulation of JAK-STAT cascade,positive regulation vascular endothelial growth factor production,POSTN expression,Primaquine,Procarbazine,progesterone,Propofol,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,regulation of reactive oxygen species metabolic process,response to toxic substance,retinal,retinal blood vessel morphogenesis,retinal metabolic process,retinoid,retinol,retinol metabolic process,RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O,sex hormone,SLOW METABOLIZER,small molecule metabolic process,steroid,steroid metabolic process,sterol metabolic process,Tamoxifen,TESTOSTERONE,THBS2,Theophylline,TOXIC,TOXICITY,toxin metabolic process,trabecular,trabecular meshwork development,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,vision,visual,visual perception,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs1800440",
        "SNP Name": "CYP1B1 N453S",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs1800440",
        "Video": "Yucm1mrp0qo",
        "Tags": "17-beta-estradiol 2-hydroxylation,17-beta-estradiol 4-hydroxylation,2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),acting on paired donors,Amodiaquine,and incorporation of one atom of oxygen,angiogenesis,anionic phospholipids,antiangiogenic factor THBS2,antibiotic response,antibiotics,anticancer drug,arachidonic acid,arachidonic acid metabolic process,aromatase activity,Arsenic trioxide,ARTIFICIAL ESTROGEN,benzo(a)pyrene,beta-estradiol,Biotin,Bladder cancer,blood pressure,blood vessel morphogenesis,breast cancer,Caffeine,cancer,cancerous,capillary morphogenesis,carcinogen,carcinogenic 4-hydroxy derivative,cardio,cardiolipin,cardiovascular disease,Catalytic activity,cell adhesion,cell migration,cellular aromatic compound metabolic process,cellular energy,cellular response to hydrogen peroxide,cellular response to organic cyclic compound,central corneal leukoma,childhood acute lymphoblastic leukemia,Childhood Medulloblastoma,cigarette smoking,cigarette-smoke carcinogen metabolism,Clozapine,cofactor,collagen,collagen fibril organization,colorectal cancer,colorectal polyps,compounds,congenital,Congenital glaucoma,CVD,CYP,CYP P450,CYP1B1,CYPIB1,CYTOCHROME,Cytochrome P450,Cytochrome P450 1B1,Dasatinib,Daunorubicin,Descemet membrane,detox,DETOXIFICATION,Dexamethasone,dimethyltetraphene,Docetaxel,Doxorubicin,DRUG,drug metabolism,DRUG POISONING,drug response,DRUG TOXICITY,DRUGS,DRUX TOXICITY,E2,early-onset glaucoma,Endogenous sterols,Endometrial Cancer,Endoplasmic reticulum,Endoplasmic reticulum membrane,endothelial cell migration,endothelial cell-cell adhesion,endothelial cells migration,energy,ENVIRONMENT,environmental,environmental factors,ENZYME,Enzyme activity is increased by liposomes containing anionic phospholipids,epoxygenase P450 pathway,Erlotinib,estradiol,estrogen,estrogen dominance,estrogen metabolic process,estrogen plus progestin hormone therapy use,estrogen related cancer,Estrogen Synthesis,Estrone,eye,family 1,FAST METABOLIZER,fat,fatty acids,Flutamide,gastric cancer,Gastrointestinal Stromal Tumors,glaucoma,Glaucoma 1,Glaucoma 3,GLC3A,heart,heart disease,heme,heme binding,Heme group,heme-thiolate monooxygenase,heme-thiolate monooxygenases,hepatocellular carcinoma,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hormones,Inhibited by naringenin with an IC50 of 5 \u00b5M,intrinsic apoptotic signaling pathway in response to oxidative stress,iris and lenticular attachments to the central aspect of the posterior cornea,iron,iron ion binding,isoform CRA_a,Juvenile glaucoma,Ketoconazole,Lansoprazole,leukemia,lipids,liposomes,liver,LIVER ENZYME,Lung Cancer,Melatonin,Membrane,membrane lipid catabolic process,menopausal hot flashes,menopause,Metal-binding,Microsome,Microsome membrane,mitochondria,Mitochondrion,Mitoxantrone,Monooxygenase,monooxygenase activity,NADPH,NADPH-dependent electron transport pathway,negative regulation of cell adhesion mediated by integrin,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of NF-kappaB transcription factor activity,nerve damage,NF-kappa,NF-kappa-B expression,nitric oxide biosynthetic process,nitric oxide synthase activity,nitric oxide synthesis,NOS,omega-hydroxylase P450 pathway,Omeprazole,optic nerve damage,Oxaliplatin,oxidation,oxidation-reduction process,oxidative homeostasis,oxidative stress,oxidizes 17beta-estradiol,oxidizes a variety of structurally unrelated compounds,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paclitaxel,PAH,pancreatic cancer,perimenopausal,Peripheral membrane protein,PETAN,Peters anomaly,Phenobarbital,phosphatidic acid,phospholipid,phospholipids,PMS hot flash,polycyclic aromatic hydrocarbons,polycyclic aromatic hydrocarbons (PAH),polypeptide 1,positive regulation of angiogenesis,positive regulation of apoptotic process,positive regulation of gene expression involved in extracellular",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1800440",
        "SNP Name": "CYP1B1 N453S",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs1800440",
        "Video": "Yucm1mrp0qo",
        "Tags": "17-beta-estradiol 2-hydroxylation,17-beta-estradiol 4-hydroxylation,2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),acting on paired donors,Amodiaquine,and incorporation of one atom of oxygen,angiogenesis,anionic phospholipids,antiangiogenic factor THBS2,antibiotic response,antibiotics,anticancer drug,arachidonic acid,arachidonic acid metabolic process,aromatase activity,Arsenic trioxide,ARTIFICIAL ESTROGEN,benzo(a)pyrene,beta-estradiol,Biotin,Bladder cancer,blood pressure,blood vessel morphogenesis,breast cancer,Caffeine,cancer,cancerous,capillary morphogenesis,carcinogen,carcinogenic 4-hydroxy derivative,cardio,cardiolipin,cardiovascular disease,Catalytic activity,cell adhesion,cell migration,cellular aromatic compound metabolic process,cellular energy,cellular response to hydrogen peroxide,cellular response to organic cyclic compound,central corneal leukoma,childhood acute lymphoblastic leukemia,Childhood Medulloblastoma,cigarette smoking,cigarette-smoke carcinogen metabolism,Clozapine,cofactor,collagen,collagen fibril organization,colorectal cancer,colorectal polyps,compounds,congenital,Congenital glaucoma,CVD,CYP,CYP P450,CYP1B1,CYPIB1,CYTOCHROME,Cytochrome P450,Cytochrome P450 1B1,Dasatinib,Daunorubicin,Descemet membrane,detox,DETOXIFICATION,Dexamethasone,dimethyltetraphene,Docetaxel,Doxorubicin,DRUG,drug metabolism,DRUG POISONING,drug response,DRUG TOXICITY,DRUGS,DRUX TOXICITY,E2,early-onset glaucoma,Endogenous sterols,Endometrial Cancer,Endoplasmic reticulum,Endoplasmic reticulum membrane,endothelial cell migration,endothelial cell-cell adhesion,endothelial cells migration,energy,ENVIRONMENT,environmental,environmental factors,ENZYME,Enzyme activity is increased by liposomes containing anionic phospholipids,epoxygenase P450 pathway,Erlotinib,estradiol,estrogen,estrogen dominance,estrogen metabolic process,estrogen plus progestin hormone therapy use,estrogen related cancer,Estrogen Synthesis,Estrone,eye,family 1,FAST METABOLIZER,fat,fatty acids,Flutamide,gastric cancer,Gastrointestinal Stromal Tumors,glaucoma,Glaucoma 1,Glaucoma 3,GLC3A,heart,heart disease,heme,heme binding,Heme group,heme-thiolate monooxygenase,heme-thiolate monooxygenases,hepatocellular carcinoma,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hormones,Inhibited by naringenin with an IC50 of 5 \u00b5M,intrinsic apoptotic signaling pathway in response to oxidative stress,iris and lenticular attachments to the central aspect of the posterior cornea,iron,iron ion binding,isoform CRA_a,Juvenile glaucoma,Ketoconazole,Lansoprazole,leukemia,lipids,liposomes,liver,LIVER ENZYME,Lung Cancer,Melatonin,Membrane,membrane lipid catabolic process,menopausal hot flashes,menopause,Metal-binding,Microsome,Microsome membrane,mitochondria,Mitochondrion,Mitoxantrone,Monooxygenase,monooxygenase activity,NADPH,NADPH-dependent electron transport pathway,negative regulation of cell adhesion mediated by integrin,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of NF-kappaB transcription factor activity,nerve damage,NF-kappa,NF-kappa-B expression,nitric oxide biosynthetic process,nitric oxide synthase activity,nitric oxide synthesis,NOS,omega-hydroxylase P450 pathway,Omeprazole,optic nerve damage,Oxaliplatin,oxidation,oxidation-reduction process,oxidative homeostasis,oxidative stress,oxidizes 17beta-estradiol,oxidizes a variety of structurally unrelated compounds,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paclitaxel,PAH,pancreatic cancer,perimenopausal,Peripheral membrane protein,PETAN,Peters anomaly,Phenobarbital,phosphatidic acid,phospholipid,phospholipids,PMS hot flash,polycyclic aromatic hydrocarbons,polycyclic aromatic hydrocarbons (PAH),polypeptide 1,positive regulation of angiogenesis,positive regulation of apoptotic process,positive regulation of gene expression involved in extracellular",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs1056836",
        "SNP Name": "CYP1B1 L432V",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs1056836",
        "Video": "Yucm1mrp0qo",
        "Tags": "17-beta-estradiol 2-hydroxylation,17-beta-estradiol 4-hydroxylation,2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),acting on paired donors,advanced colorectal adenoma,alcohol,alcohol consumption and risk of Non-Hodgkin lymphoma,Amodiaquine,and incorporation of one atom of oxygen,angiogenesis,anionic phospholipids,antiangiogenic factor THBS2,antibiotic response,antibiotics,anticancer drug,arachidonic acid,arachidonic acid metabolic process,aromatase activity,Arsenic trioxide,ARTIFICIAL ESTROGEN,beta-estradiol,Biotin,birth defect,Bladder cancer,blood pressure,blood vessel morphogenesis,bone density,BP,breast cancer,Caffeine,cancer,cancerous,capillary morphogenesis,carcinogen,carcinogenic 4-hydroxy derivative,cardiolipin,Catalytic activity,cell adhesion,cell migration,cellular aromatic compound metabolic process,cellular energy,cellular response to hydrogen peroxide,cellular response to organic cyclic compound,central corneal leukoma,chronic respiratory diseases,cigarette,cigarette smoking,cigarette-smoke carcinogen metabolism,cleft lip,cleft palate,Clozapine,clubfoot,cofactor,collagen,collagen fibril organization,colorectal cancer,colorectal neoplasia,colorectal polyps,compounds,congenital,Congenital glaucoma,CYP,CYP P450,CYP1B1,CYPIB1,CYTOCHROME,Cytochrome P450,Cytochrome P450 1B1,Dasatinib,Daunorubicin,decreased telomere length,defect,Descemet membrane,detox,DETOXIFICATION,Dexamethasone,dimethyltetraphene,Docetaxel,Doxorubicin,DRUG,drug metabolism,DRUG POISONING,drug response,DRUG TOXICITY,DRUGS,DRUX TOXICITY,E2,Early Age Acute Leukemia,early-onset glaucoma,early-onset lung cancer,Endogenous sterols,Endometrial Cancer,endometrial cancer risk,Endoplasmic reticulum,Endoplasmic reticulum membrane,endothelial cell migration,endothelial cell-cell adhesion,endothelial cells migration,energy,ENVIRONMENT,environmental,environmental factors,ENZYME,Enzyme activity is increased by liposomes containing anionic phospholipids,epoxygenase P450 pathway,Erlotinib,Esophageal Cancer,estradiol,estrogen,ESTROGEN BIOSYNTHESIS,estrogen dominance,estrogen metabolic process,estrogen pathway,estrogen related cancer,Estrogen Synthesis,Estrone,exogenous chemicals,eye,family 1,FAST METABOLIZER,fat,fatty acids,Female Lung Cancer,Flavopiridol,Flavopiridol Pharmacogenetics,Flutamide,gastric cancer,Gastrointestinal Stromal Tumors,glaucoma,Glaucoma 1,Glaucoma 3,GLC3A,Hair Dye,Head and Neck Cancer,heme,heme binding,Heme group,heme-thiolate monooxygenase,heme-thiolate monooxygenases,hepatocellular carcinoma,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hormones,Hot Flashes,hot flashes in PMS,Hot Flushes,idiopathic male infertility,increased mortality in non-alcoholic liver transplant patients,Inhibited by naringenin with an IC50 of 5 \u00b5M,intrinsic apoptotic signaling pathway in response to oxidative stress,ionizing radiation exposure,iris and lenticular attachments to the central aspect of the posterior cornea,iron,iron ion binding,isoform CRA_a,Juvenile glaucoma,Ketoconazole,Lansoprazole,laryngeal cancer,leukemia,lipids,liposomes,liver,LIVER ENZYME,lung cancer,lymphoblastic leukemia,male infertility,Melatonin,Membrane,membrane lipid catabolic process,menopausal hot flashes,Metal-binding,Microsome,Microsome membrane,mitochondria,Mitochondrion,Mitoxantrone,Monooxygenase,monooxygenase activity,multiple myeloma,NADPH,NADPH-dependent electron transport pathway,negative regulation of cell adhesion mediated by integrin,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of NF-kappaB transcription factor activity,neoadjuvant paclitaxel,nerve damage,Neural Tube Defect,NF-kappa,NF-kappa-B expression,nitric oxide biosynthetic process,nitric oxide synthase activity,nitric oxide synthesis,non-Hodgkin lymphoma survival,non-small cell lung cancer,NOS,NTDs,omega-hydroxylase P450 pathway,Omeprazole,open-an",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1056836",
        "SNP Name": "CYP1B1 L432V",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs1056836",
        "Video": "Yucm1mrp0qo",
        "Tags": "17-beta-estradiol 2-hydroxylation,17-beta-estradiol 4-hydroxylation,2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),acting on paired donors,advanced colorectal adenoma,alcohol,alcohol consumption and risk of Non-Hodgkin lymphoma,Amodiaquine,and incorporation of one atom of oxygen,angiogenesis,anionic phospholipids,antiangiogenic factor THBS2,antibiotic response,antibiotics,anticancer drug,arachidonic acid,arachidonic acid metabolic process,aromatase activity,Arsenic trioxide,ARTIFICIAL ESTROGEN,beta-estradiol,Biotin,birth defect,Bladder cancer,blood pressure,blood vessel morphogenesis,bone density,BP,breast cancer,Caffeine,cancer,cancerous,capillary morphogenesis,carcinogen,carcinogenic 4-hydroxy derivative,cardiolipin,Catalytic activity,cell adhesion,cell migration,cellular aromatic compound metabolic process,cellular energy,cellular response to hydrogen peroxide,cellular response to organic cyclic compound,central corneal leukoma,chronic respiratory diseases,cigarette,cigarette smoking,cigarette-smoke carcinogen metabolism,cleft lip,cleft palate,Clozapine,clubfoot,cofactor,collagen,collagen fibril organization,colorectal cancer,colorectal neoplasia,colorectal polyps,compounds,congenital,Congenital glaucoma,CYP,CYP P450,CYP1B1,CYPIB1,CYTOCHROME,Cytochrome P450,Cytochrome P450 1B1,Dasatinib,Daunorubicin,decreased telomere length,defect,Descemet membrane,detox,DETOXIFICATION,Dexamethasone,dimethyltetraphene,Docetaxel,Doxorubicin,DRUG,drug metabolism,DRUG POISONING,drug response,DRUG TOXICITY,DRUGS,DRUX TOXICITY,E2,Early Age Acute Leukemia,early-onset glaucoma,early-onset lung cancer,Endogenous sterols,Endometrial Cancer,endometrial cancer risk,Endoplasmic reticulum,Endoplasmic reticulum membrane,endothelial cell migration,endothelial cell-cell adhesion,endothelial cells migration,energy,ENVIRONMENT,environmental,environmental factors,ENZYME,Enzyme activity is increased by liposomes containing anionic phospholipids,epoxygenase P450 pathway,Erlotinib,Esophageal Cancer,estradiol,estrogen,ESTROGEN BIOSYNTHESIS,estrogen dominance,estrogen metabolic process,estrogen pathway,estrogen related cancer,Estrogen Synthesis,Estrone,exogenous chemicals,eye,family 1,FAST METABOLIZER,fat,fatty acids,Female Lung Cancer,Flavopiridol,Flavopiridol Pharmacogenetics,Flutamide,gastric cancer,Gastrointestinal Stromal Tumors,glaucoma,Glaucoma 1,Glaucoma 3,GLC3A,Hair Dye,Head and Neck Cancer,heme,heme binding,Heme group,heme-thiolate monooxygenase,heme-thiolate monooxygenases,hepatocellular carcinoma,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hormones,Hot Flashes,hot flashes in PMS,Hot Flushes,idiopathic male infertility,increased mortality in non-alcoholic liver transplant patients,Inhibited by naringenin with an IC50 of 5 \u00b5M,intrinsic apoptotic signaling pathway in response to oxidative stress,ionizing radiation exposure,iris and lenticular attachments to the central aspect of the posterior cornea,iron,iron ion binding,isoform CRA_a,Juvenile glaucoma,Ketoconazole,Lansoprazole,laryngeal cancer,leukemia,lipids,liposomes,liver,LIVER ENZYME,lung cancer,lymphoblastic leukemia,male infertility,Melatonin,Membrane,membrane lipid catabolic process,menopausal hot flashes,Metal-binding,Microsome,Microsome membrane,mitochondria,Mitochondrion,Mitoxantrone,Monooxygenase,monooxygenase activity,multiple myeloma,NADPH,NADPH-dependent electron transport pathway,negative regulation of cell adhesion mediated by integrin,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of NF-kappaB transcription factor activity,neoadjuvant paclitaxel,nerve damage,Neural Tube Defect,NF-kappa,NF-kappa-B expression,nitric oxide biosynthetic process,nitric oxide synthase activity,nitric oxide synthesis,non-Hodgkin lymphoma survival,non-small cell lung cancer,NOS,NTDs,omega-hydroxylase P450 pathway,Omeprazole,open-an",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs9282671",
        "SNP Name": "CYP1B1 T241A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://onlinelibrary.wiley.com/doi/10.1111/j.1365-3156.2012.03011.x/full",
        "Video": "Yucm1mrp0qo",
        "Tags": "acting on paired donors,Amodiaquine,and incorporation of one atom of oxygen,angiogenesis,anionic phospholipids,antiangiogenic factor THBS2,arachidonic acid,arachidonic acid metabolic process,aromatase activity,Arsenic trioxide,ARTIFICIAL ESTROGEN,beta-estradiol,Biotin,blood vessel morphogenesis,Caffeine,CANCER,CANCEROUS,CARCINOGEN,cardiolipin,cell adhesion,cell migration,cellular aromatic compound metabolic process,cellular response to hydrogen peroxide,cellular response to organic cyclic compound,Clozapine,collagen fibril organization,compounds,congenital,CYP,CYP P450,CYP1B1,CYPIB1,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 1B1,Dasatinib,Daunorubicin,DETOX,DETOXIFICATION,Dexamethasone,dimethyltetraphene,Docetaxel,Doxorubicin,DRUG,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,early-onset glaucoma,Endoplasmic reticulum,Endoplasmic reticulum membrane,endothelial cell migration,endothelial cell-cell adhesion,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,ENZYME,epoxygenase P450 pathway,Erlotinib,estradiol,ESTROGEN,estrogen metabolic process,Estrone,eye,FAST METABOLIZER,fat,fatty acids,Flutamide,glaucoma,HEME,heme binding,heme-thiolate monooxygenase,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,intrinsic apoptotic signaling pathway in response to oxidative stress,Iron,iron ion binding,Ketoconazole,Lansoprazole,lipids,liposomes,LIVER,LIVER ENZYME,Melatonin,Membrane,membrane lipid catabolic process,Metal-binding,Microsome,Microsome membrane,mitochondria,mitochondrion,Mitoxantrone,Monooxygenase,monooxygenase activity,NADPH,NADPH-dependent electron transport pathway,negative regulation of cell adhesion mediated by integrin,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of NF-kappaB transcription factor activity,NF-kappa-B expression,nitric oxide biosynthetic process,omega-hydroxylase P450 pathway,Omeprazole,Oxaliplatin,oxidation,oxidation-reduction process,oxidative homeostasis,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paclitaxel,Peripheral membrane protein,Peters anomaly,Phenobarbital,phosphatidic acid,phospholipids,positive regulation of angiogenesis,positive regulation of apoptotic process,positive regulation of JAK-STAT cascade,positive regulation vascular endothelial growth factor production,POSTN expression,Primaquine,Procarbazine,progesterone,Propofol,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,regulation of reactive oxygen species metabolic process,response to toxic substance,retinal,retinal blood vessel morphogenesis,retinal metabolic process,retinoid,retinol,retinol metabolic process,RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O,sex hormone,SLOW METABOLIZER,small molecule metabolic process,steroid,steroid metabolic process,sterol metabolic process,Tamoxifen,TESTOSTERONE,THBS2,Theophylline,TOXIC,TOXICITY,toxin metabolic process,trabecular,trabecular meshwork development,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,vision,visual,visual perception,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs72549389",
        "SNP Name": "CYP1B1 T5795C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://ejhp.bmj.com/content/20/Suppl_1/A134.2.full.pdf+html",
        "Video": "Yucm1mrp0qo",
        "Tags": "acting on paired donors,Amodiaquine,and incorporation of one atom of oxygen,angiogenesis,anionic phospholipids,antiangiogenic factor THBS2,arachidonic acid,arachidonic acid metabolic process,aromatase activity,Arsenic trioxide,ARTIFICIAL ESTROGEN,beta-estradiol,Biotin,blood vessel morphogenesis,Caffeine,CANCER,CANCEROUS,CARCINOGEN,cardiolipin,cell adhesion,cell migration,cellular aromatic compound metabolic process,cellular response to hydrogen peroxide,cellular response to organic cyclic compound,Clozapine,collagen fibril organization,compounds,congenital,CYP,CYP P450,CYP1B1,CYPIB1,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 1B1,Dasatinib,Daunorubicin,DETOX,DETOXIFICATION,Dexamethasone,dimethyltetraphene,Docetaxel,Doxorubicin,DRUG,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,early-onset glaucoma,Endoplasmic reticulum,Endoplasmic reticulum membrane,endothelial cell migration,endothelial cell-cell adhesion,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,ENZYME,epoxygenase P450 pathway,Erlotinib,estradiol,ESTROGEN,estrogen metabolic process,Estrone,eye,FAST METABOLIZER,fat,fatty acids,Flutamide,glaucoma,HEME,heme binding,heme-thiolate monooxygenase,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,intrinsic apoptotic signaling pathway in response to oxidative stress,Iron,iron ion binding,Ketoconazole,Lansoprazole,lipids,liposomes,LIVER,LIVER ENZYME,Melatonin,Membrane,membrane lipid catabolic process,Metal-binding,Microsome,Microsome membrane,mitochondria,mitochondrion,Mitoxantrone,Monooxygenase,monooxygenase activity,NADPH,NADPH-dependent electron transport pathway,negative regulation of cell adhesion mediated by integrin,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of NF-kappaB transcription factor activity,NF-kappa-B expression,nitric oxide biosynthetic process,omega-hydroxylase P450 pathway,Omeprazole,Oxaliplatin,oxidation,oxidation-reduction process,oxidative homeostasis,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paclitaxel,Peripheral membrane protein,Peters anomaly,Phenobarbital,phosphatidic acid,phospholipids,positive regulation of angiogenesis,positive regulation of apoptotic process,positive regulation of JAK-STAT cascade,positive regulation vascular endothelial growth factor production,POSTN expression,Primaquine,Procarbazine,progesterone,Propofol,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,regulation of reactive oxygen species metabolic process,response to toxic substance,retinal,retinal blood vessel morphogenesis,retinal metabolic process,retinoid,retinol,retinol metabolic process,RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O,sex hormone,SLOW METABOLIZER,small molecule metabolic process,steroid,steroid metabolic process,sterol metabolic process,Tamoxifen,TESTOSTERONE,THBS2,Theophylline,TOXIC,TOXICITY,toxin metabolic process,trabecular,trabecular meshwork development,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,vision,visual,visual perception,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs2266917",
        "SNP Name": "ATP6V1B1 11708C>T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs2239484",
        "SNP Name": "ATP6V1B1 15411A>G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs2028900",
        "SNP Name": "MAT2A C6635T",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2028900",
        "Video": "fLK6nEloEY4",
        "Tags": "Acetylation,AdoMet synthase 2,AdoMet synthase family,amino acids,Amino-acid biosynthesis,AMS2,ATP,ATP + L-methionine + H2O = phosphate + diphosphate + S-adenosyl-L-methionine,ATP binding,ATP-binding,B12,beta subunits (MAT2B),betaine,blood pressure,catalytic alpha subunits,Catalyzes the formation of S-adenosylmethionine from methionine and ATP,cellular energy,cellular nitrogen compound metabolic process,choline,cobalt,cofactors,cytosol,energy,folate,heterotetramer,high BP,homocysteine,hypertension,L-methionine,low BP,Magnesium,MAT 2,MAT-II,MAT2A,MAT2B,MATA2,metal ion binding,Metal-binding,methionine,Methionine adenosyltransferase 2,methionine adenosyltransferase activity,methionine adenosyltransferase complex,Methionine adenosyltransferase II,methylation,minerals,mitochondria,mitochondrion,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,phosphate,Phosphoprotein,plasma S-adenosylmethionine,plasma SAM,potassium,potassium ion,S-Adenosyl Methionine,S-adenosyl-L-methionine biosynthesis,S-adenosyl-L-methionine from L-methionine,S-adenosylhomocysteine (SAH),S-adenosylmethionine,S-adenosylmethionine biosynthetic process,S-adenosylmethionine synthase isoform type-2,SAMe,small molecule metabolic process,sulfur amino acid metabolic process,The alpha' subunit is a post-translationally modified version of MAT2A,total homocysteine (Hcy),trace minerals,Transferase,vitamin B6,xenobiotic metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2028900",
        "SNP Name": "MAT2A C6635T",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2028900",
        "Video": "fLK6nEloEY4",
        "Tags": "Acetylation,AdoMet synthase 2,AdoMet synthase family,amino acids,Amino-acid biosynthesis,AMS2,ATP,ATP + L-methionine + H2O = phosphate + diphosphate + S-adenosyl-L-methionine,ATP binding,ATP-binding,B12,beta subunits (MAT2B),betaine,blood pressure,catalytic alpha subunits,Catalyzes the formation of S-adenosylmethionine from methionine and ATP,cellular energy,cellular nitrogen compound metabolic process,choline,cobalt,cofactors,cytosol,energy,folate,heterotetramer,high BP,homocysteine,hypertension,L-methionine,low BP,Magnesium,MAT 2,MAT-II,MAT2A,MAT2B,MATA2,metal ion binding,Metal-binding,methionine,Methionine adenosyltransferase 2,methionine adenosyltransferase activity,methionine adenosyltransferase complex,Methionine adenosyltransferase II,methylation,minerals,mitochondria,mitochondrion,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,phosphate,Phosphoprotein,plasma S-adenosylmethionine,plasma SAM,potassium,potassium ion,S-Adenosyl Methionine,S-adenosyl-L-methionine biosynthesis,S-adenosyl-L-methionine from L-methionine,S-adenosylhomocysteine (SAH),S-adenosylmethionine,S-adenosylmethionine biosynthetic process,S-adenosylmethionine synthase isoform type-2,SAMe,small molecule metabolic process,sulfur amino acid metabolic process,The alpha' subunit is a post-translationally modified version of MAT2A,total homocysteine (Hcy),trace minerals,Transferase,vitamin B6,xenobiotic metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2028900",
        "SNP Name": "MAT2A C6635T",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2028900",
        "Video": "fLK6nEloEY4",
        "Tags": "Acetylation,AdoMet synthase 2,AdoMet synthase family,amino acids,Amino-acid biosynthesis,AMS2,ATP,ATP + L-methionine + H2O = phosphate + diphosphate + S-adenosyl-L-methionine,ATP binding,ATP-binding,B12,beta subunits (MAT2B),betaine,blood pressure,catalytic alpha subunits,Catalyzes the formation of S-adenosylmethionine from methionine and ATP,cellular energy,cellular nitrogen compound metabolic process,choline,cobalt,cofactors,cytosol,energy,folate,heterotetramer,high BP,homocysteine,hypertension,L-methionine,low BP,Magnesium,MAT 2,MAT-II,MAT2A,MAT2B,MATA2,metal ion binding,Metal-binding,methionine,Methionine adenosyltransferase 2,methionine adenosyltransferase activity,methionine adenosyltransferase complex,Methionine adenosyltransferase II,methylation,minerals,mitochondria,mitochondrion,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,phosphate,Phosphoprotein,plasma S-adenosylmethionine,plasma SAM,potassium,potassium ion,S-Adenosyl Methionine,S-adenosyl-L-methionine biosynthesis,S-adenosyl-L-methionine from L-methionine,S-adenosylhomocysteine (SAH),S-adenosylmethionine,S-adenosylmethionine biosynthetic process,S-adenosylmethionine synthase isoform type-2,SAMe,small molecule metabolic process,sulfur amino acid metabolic process,The alpha' subunit is a post-translationally modified version of MAT2A,total homocysteine (Hcy),trace minerals,Transferase,vitamin B6,xenobiotic metabolic process",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs1143634",
        "SNP Name": "IL1B variant",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs3136558",
        "SNP Name": "IL1B variant",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs1143627",
        "SNP Name": "IL1B variant",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs16944",
        "SNP Name": "IL1B C-511T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "2-Phenoxyethanol"
    },
    {
        "SNP ID": "rs16944",
        "SNP Name": "IL1B C-511T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Alcohol"
    },
    {
        "SNP ID": "rs16944",
        "SNP Name": "IL1B C-511T",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs838102",
        "SNP Name": "STEAP3 8350G>A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs2322659",
        "SNP Name": "LCT A1639S",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Anhydrous Lactose"
    },
    {
        "SNP ID": "rs2322659",
        "SNP Name": "LCT A1639S",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Lactose"
    },
    {
        "SNP ID": "rs2228014",
        "SNP Name": "CXCL12 I138I",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Baculovirus"
    },
    {
        "SNP ID": "rs2228014",
        "SNP Name": "CXCL12 I138I",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Insect Cell"
    },
    {
        "SNP ID": "rs6430764",
        "SNP Name": "HNMT C3616T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6430764",
        "Video": "DGC-P0e0xhw",
        "Tags": "airway,Alternative splicing,amino acids response to glucocorticoid,asthma,brain development,cancer,cancerous,carcinogen,central nervous system,class I-like SAM-binding methyltransferase superfamily,Cytoplasm,DAO,diamine oxidase,drug interaction,drug metabolism,drugs,extracellular vesicular exosome,histamine degradation,Histamine N-methyltransferase,histamine N-methyltransferase activity,histamine related schizophrenia,HMT,HNMT,HNMT family,hyperosmotic response,IL1,interleukin,L-methionine,mental disorder,methionine,Methyltransferase,Monomer,N(tau)-methylation,N-methylation,neuron projection,neurotransmitters,nucleus,Polymorphism,red blood cells,Red man syndrome,respiratory gaseous exchange,response to amine,response to cocaine,response to interleukin-1,response to tumor cell,RMS,S-adenosyl-L-methionine,S-adenosyl-L-methionine + histamine = S-adenosyl-L-homocysteine + N(tau)-methylhistamine,S-adenosyl-methionine,same,schizophrenia,Transferase,vancomycin",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs17583889",
        "SNP Name": "HNMT C29232A",
        "Risk Allele": "A",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs17583889",
        "Video": "DGC-P0e0xhw",
        "Tags": "airway,Alternative splicing,amino acids response to glucocorticoid,anthracycline,anthracycline cardiotoxicity,asthma,brain development,cancer,cancerous,carcinogen,central nervous system,class I-like SAM-binding methyltransferase superfamily,CVD,Cytoplasm,DAO,diamine oxidase,doxorubicin,doxorubicin-mediated cardiotoxicity,drug interaction,drug metabolism,drug reaction,drugs,extracellular vesicular exosome,heart,histamine degradation,Histamine N-methyltransferase,histamine N-methyltransferase activity,histamine related schizophrenia,HMT,HNMT,HNMT family,hyperosmotic response,IL1,interleukin,L-methionine,mental disorder,methionine,Methyltransferase,Monomer,N(tau)-methylation,N-methylation,neuron projection,neurotransmitters,nucleus,Pharmacogenomics,Pharmacogenomics and adverse drug reactions in children,Polymorphism,red blood cells,respiratory gaseous exchange,response to amine,response to cocaine,response to interleukin-1,response to tumor cell,S-adenosyl-L-methionine,S-adenosyl-L-methionine + histamine = S-adenosyl-L-homocysteine + N(tau)-methylhistamine,S-adenosyl-methionine,same,schizophrenia,Transferase",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1990760",
        "SNP Name": "IFIH1 (HLA) variant",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs1990760",
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "IgA"
    },
    {
        "SNP ID": "rs3749034",
        "SNP Name": "GAD1 (GAD) G5276A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3749034",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,Affective Disorders,Alternative splicing,axon terminus,birth defect,Catalyzes the production of GABA,Catechol-O-methyl transferase,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cleft palate,cognitive difficulties,cognitive performance,COMT,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,Na-K-Cl cotransporter,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,NKCC1,oral cleft,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,Post-traumatic Seizures after Severe TBI,Prefrontal Cortex with Development,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,PTSD,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,Schizophrenia,seizure,serotonin,SLC12A5 (KCC2),spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,traumatic brain injury,vesicle membrane",
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs3749034",
        "SNP Name": "GAD1 (GAD) G5276A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3749034",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,Affective Disorders,Alternative splicing,axon terminus,birth defect,Catalyzes the production of GABA,Catechol-O-methyl transferase,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cleft palate,cognitive difficulties,cognitive performance,COMT,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,Na-K-Cl cotransporter,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,NKCC1,oral cleft,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,Post-traumatic Seizures after Severe TBI,Prefrontal Cortex with Development,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,PTSD,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,Schizophrenia,seizure,serotonin,SLC12A5 (KCC2),spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,traumatic brain injury,vesicle membrane",
        "Group": "L-Glutamine"
    },
    {
        "SNP ID": "rs3749034",
        "SNP Name": "GAD1 (GAD) G5276A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3749034",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,Affective Disorders,Alternative splicing,axon terminus,birth defect,Catalyzes the production of GABA,Catechol-O-methyl transferase,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cleft palate,cognitive difficulties,cognitive performance,COMT,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,Na-K-Cl cotransporter,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,NKCC1,oral cleft,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,Post-traumatic Seizures after Severe TBI,Prefrontal Cortex with Development,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,PTSD,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,Schizophrenia,seizure,serotonin,SLC12A5 (KCC2),spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,traumatic brain injury,vesicle membrane",
        "Group": "Monosodium Glutamate"
    },
    {
        "SNP ID": "rs3749034",
        "SNP Name": "GAD1 (GAD) G5276A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3749034",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,Affective Disorders,Alternative splicing,axon terminus,birth defect,Catalyzes the production of GABA,Catechol-O-methyl transferase,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cleft palate,cognitive difficulties,cognitive performance,COMT,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,Na-K-Cl cotransporter,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,NKCC1,oral cleft,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,Post-traumatic Seizures after Severe TBI,Prefrontal Cortex with Development,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,PTSD,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,Schizophrenia,seizure,serotonin,SLC12A5 (KCC2),spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,traumatic brain injury,vesicle membrane",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs3749034",
        "SNP Name": "GAD1 (GAD) G5276A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3749034",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,Affective Disorders,Alternative splicing,axon terminus,birth defect,Catalyzes the production of GABA,Catechol-O-methyl transferase,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cleft palate,cognitive difficulties,cognitive performance,COMT,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,Na-K-Cl cotransporter,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,NKCC1,oral cleft,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,Post-traumatic Seizures after Severe TBI,Prefrontal Cortex with Development,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,PTSD,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,Schizophrenia,seizure,serotonin,SLC12A5 (KCC2),spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,traumatic brain injury,vesicle membrane",
        "Group": "Neurotransmitter Pathway: Glutamate & GABA"
    },
    {
        "SNP ID": "rs3749034",
        "SNP Name": "GAD1 (GAD) G5276A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3749034",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,Affective Disorders,Alternative splicing,axon terminus,birth defect,Catalyzes the production of GABA,Catechol-O-methyl transferase,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cleft palate,cognitive difficulties,cognitive performance,COMT,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,Na-K-Cl cotransporter,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,NKCC1,oral cleft,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,Post-traumatic Seizures after Severe TBI,Prefrontal Cortex with Development,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,PTSD,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,Schizophrenia,seizure,serotonin,SLC12A5 (KCC2),spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,traumatic brain injury,vesicle membrane",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs2241165",
        "SNP Name": "GAD1 (GAD) C10180T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2241165",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,addiction,adrenal,adrenal cortex,adrenal gland,alcohol,alcohol dependence,Alternative splicing,Anterior Cingulate Cortex,axon terminus,BDNF,bipolar,bipolar disorder,Brain-derived neurotrophic factor,Catalyzes the production of GABA,Catechol-O-methyl transferase,cell cortex,Cerebral palsy,children,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,COMT,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug interaction,DSM-IV bipolar-I disorder,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,PTSD,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,serotonin,serotonin transporter genes,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs2241165",
        "SNP Name": "GAD1 (GAD) C10180T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2241165",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,addiction,adrenal,adrenal cortex,adrenal gland,alcohol,alcohol dependence,Alternative splicing,Anterior Cingulate Cortex,axon terminus,BDNF,bipolar,bipolar disorder,Brain-derived neurotrophic factor,Catalyzes the production of GABA,Catechol-O-methyl transferase,cell cortex,Cerebral palsy,children,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,COMT,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug interaction,DSM-IV bipolar-I disorder,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,PTSD,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,serotonin,serotonin transporter genes,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "L-Glutamine"
    },
    {
        "SNP ID": "rs2241165",
        "SNP Name": "GAD1 (GAD) C10180T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2241165",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,addiction,adrenal,adrenal cortex,adrenal gland,alcohol,alcohol dependence,Alternative splicing,Anterior Cingulate Cortex,axon terminus,BDNF,bipolar,bipolar disorder,Brain-derived neurotrophic factor,Catalyzes the production of GABA,Catechol-O-methyl transferase,cell cortex,Cerebral palsy,children,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,COMT,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug interaction,DSM-IV bipolar-I disorder,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,PTSD,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,serotonin,serotonin transporter genes,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "Monosodium Glutamate"
    },
    {
        "SNP ID": "rs2241165",
        "SNP Name": "GAD1 (GAD) C10180T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2241165",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,addiction,adrenal,adrenal cortex,adrenal gland,alcohol,alcohol dependence,Alternative splicing,Anterior Cingulate Cortex,axon terminus,BDNF,bipolar,bipolar disorder,Brain-derived neurotrophic factor,Catalyzes the production of GABA,Catechol-O-methyl transferase,cell cortex,Cerebral palsy,children,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,COMT,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug interaction,DSM-IV bipolar-I disorder,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,PTSD,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,serotonin,serotonin transporter genes,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2241165",
        "SNP Name": "GAD1 (GAD) C10180T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2241165",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,addiction,adrenal,adrenal cortex,adrenal gland,alcohol,alcohol dependence,Alternative splicing,Anterior Cingulate Cortex,axon terminus,BDNF,bipolar,bipolar disorder,Brain-derived neurotrophic factor,Catalyzes the production of GABA,Catechol-O-methyl transferase,cell cortex,Cerebral palsy,children,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,COMT,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug interaction,DSM-IV bipolar-I disorder,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,PTSD,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,serotonin,serotonin transporter genes,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "Neurotransmitter Pathway: Glutamate & GABA"
    },
    {
        "SNP ID": "rs2241165",
        "SNP Name": "GAD1 (GAD) C10180T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2241165",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,addiction,adrenal,adrenal cortex,adrenal gland,alcohol,alcohol dependence,Alternative splicing,Anterior Cingulate Cortex,axon terminus,BDNF,bipolar,bipolar disorder,Brain-derived neurotrophic factor,Catalyzes the production of GABA,Catechol-O-methyl transferase,cell cortex,Cerebral palsy,children,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,COMT,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug interaction,DSM-IV bipolar-I disorder,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,PTSD,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,serotonin,serotonin transporter genes,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs3828275",
        "SNP Name": "GAD1 (GAD) C14541T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3828275",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol dependence,Alternative splicing,ASD,autism,autism spectrum disorder,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,Post-traumatic Seizures after Severe TBI,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,traumatic brain injury,vesicle membrane",
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs3828275",
        "SNP Name": "GAD1 (GAD) C14541T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3828275",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol dependence,Alternative splicing,ASD,autism,autism spectrum disorder,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,Post-traumatic Seizures after Severe TBI,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,traumatic brain injury,vesicle membrane",
        "Group": "L-Glutamine"
    },
    {
        "SNP ID": "rs3828275",
        "SNP Name": "GAD1 (GAD) C14541T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3828275",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol dependence,Alternative splicing,ASD,autism,autism spectrum disorder,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,Post-traumatic Seizures after Severe TBI,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,traumatic brain injury,vesicle membrane",
        "Group": "Monosodium Glutamate"
    },
    {
        "SNP ID": "rs3828275",
        "SNP Name": "GAD1 (GAD) C14541T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3828275",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol dependence,Alternative splicing,ASD,autism,autism spectrum disorder,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,Post-traumatic Seizures after Severe TBI,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,traumatic brain injury,vesicle membrane",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs3828275",
        "SNP Name": "GAD1 (GAD) C14541T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3828275",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol dependence,Alternative splicing,ASD,autism,autism spectrum disorder,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,Post-traumatic Seizures after Severe TBI,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,traumatic brain injury,vesicle membrane",
        "Group": "Neurotransmitter Pathway: Glutamate & GABA"
    },
    {
        "SNP ID": "rs3828275",
        "SNP Name": "GAD1 (GAD) C14541T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3828275",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol dependence,Alternative splicing,ASD,autism,autism spectrum disorder,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,Post-traumatic Seizures after Severe TBI,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,traumatic brain injury,vesicle membrane",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs2241164",
        "SNP Name": "GAD1 (GAD) C18360T",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2241164",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol dependence,Alternative splicing,ASD,autism,autism spectrum disorder,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug addiction,drug interaction,epilepsy,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,heroin,Heroin addiction,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,serotonin,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs2241164",
        "SNP Name": "GAD1 (GAD) C18360T",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2241164",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol dependence,Alternative splicing,ASD,autism,autism spectrum disorder,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug addiction,drug interaction,epilepsy,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,heroin,Heroin addiction,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,serotonin,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "L-Glutamine"
    },
    {
        "SNP ID": "rs2241164",
        "SNP Name": "GAD1 (GAD) C18360T",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2241164",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol dependence,Alternative splicing,ASD,autism,autism spectrum disorder,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug addiction,drug interaction,epilepsy,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,heroin,Heroin addiction,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,serotonin,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "Monosodium Glutamate"
    },
    {
        "SNP ID": "rs2241164",
        "SNP Name": "GAD1 (GAD) C18360T",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2241164",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol dependence,Alternative splicing,ASD,autism,autism spectrum disorder,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug addiction,drug interaction,epilepsy,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,heroin,Heroin addiction,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,serotonin,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2241164",
        "SNP Name": "GAD1 (GAD) C18360T",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2241164",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol dependence,Alternative splicing,ASD,autism,autism spectrum disorder,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug addiction,drug interaction,epilepsy,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,heroin,Heroin addiction,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,serotonin,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "Neurotransmitter Pathway: Glutamate & GABA"
    },
    {
        "SNP ID": "rs2241164",
        "SNP Name": "GAD1 (GAD) C18360T",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2241164",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol dependence,Alternative splicing,ASD,autism,autism spectrum disorder,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug addiction,drug interaction,epilepsy,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,heroin,Heroin addiction,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,serotonin,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs701492",
        "SNP Name": "GAD1 (GAD) C34281T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs701492",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol consumption,alcohol dependence,Alternative splicing,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,drug,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,heroin addiction,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,opioid addiction,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs701492",
        "SNP Name": "GAD1 (GAD) C34281T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs701492",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol consumption,alcohol dependence,Alternative splicing,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,drug,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,heroin addiction,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,opioid addiction,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "L-Glutamine"
    },
    {
        "SNP ID": "rs701492",
        "SNP Name": "GAD1 (GAD) C34281T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs701492",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol consumption,alcohol dependence,Alternative splicing,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,drug,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,heroin addiction,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,opioid addiction,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "Monosodium Glutamate"
    },
    {
        "SNP ID": "rs701492",
        "SNP Name": "GAD1 (GAD) C34281T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs701492",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol consumption,alcohol dependence,Alternative splicing,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,drug,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,heroin addiction,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,opioid addiction,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs701492",
        "SNP Name": "GAD1 (GAD) C34281T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs701492",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol consumption,alcohol dependence,Alternative splicing,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,drug,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,heroin addiction,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,opioid addiction,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "Neurotransmitter Pathway: Glutamate & GABA"
    },
    {
        "SNP ID": "rs701492",
        "SNP Name": "GAD1 (GAD) C34281T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs701492",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol consumption,alcohol dependence,Alternative splicing,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,drug,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,heroin addiction,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,opioid addiction,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs3791850",
        "SNP Name": "GAD1 (GAD) G39901A",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3791850",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol dependence,Alternative splicing,Anterior Cingulate Cortex,axon terminus,Catalyzes the production of GABA,Catechol-O-methyl transferase,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,COMT,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,heroin addiction,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,serotonin,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs3791850",
        "SNP Name": "GAD1 (GAD) G39901A",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3791850",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol dependence,Alternative splicing,Anterior Cingulate Cortex,axon terminus,Catalyzes the production of GABA,Catechol-O-methyl transferase,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,COMT,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,heroin addiction,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,serotonin,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "L-Glutamine"
    },
    {
        "SNP ID": "rs3791850",
        "SNP Name": "GAD1 (GAD) G39901A",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3791850",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol dependence,Alternative splicing,Anterior Cingulate Cortex,axon terminus,Catalyzes the production of GABA,Catechol-O-methyl transferase,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,COMT,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,heroin addiction,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,serotonin,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "Monosodium Glutamate"
    },
    {
        "SNP ID": "rs3791850",
        "SNP Name": "GAD1 (GAD) G39901A",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3791850",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol dependence,Alternative splicing,Anterior Cingulate Cortex,axon terminus,Catalyzes the production of GABA,Catechol-O-methyl transferase,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,COMT,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,heroin addiction,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,serotonin,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs3791850",
        "SNP Name": "GAD1 (GAD) G39901A",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3791850",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol dependence,Alternative splicing,Anterior Cingulate Cortex,axon terminus,Catalyzes the production of GABA,Catechol-O-methyl transferase,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,COMT,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,heroin addiction,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,serotonin,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "Neurotransmitter Pathway: Glutamate & GABA"
    },
    {
        "SNP ID": "rs3791850",
        "SNP Name": "GAD1 (GAD) G39901A",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3791850",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,alcohol dependence,Alternative splicing,Anterior Cingulate Cortex,axon terminus,Catalyzes the production of GABA,Catechol-O-methyl transferase,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,COMT,Decarboxylase,Developmental delay,Disease mutation,dopamine,drug,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,heroin addiction,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,serotonin,spastic quadriplegic 1 (CPSQ1),synaptic transmission,testicles,testis,vesicle membrane",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs769395",
        "SNP Name": "GAD1 (GAD) A48604A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs769395",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,Alternative splicing,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,posttraumatic epilepsy,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,spastic quadriplegic 1 (CPSQ1),synaptic transmission,TBI,testicles,testis,traumatic brain injury,vesicle membrane",
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs769395",
        "SNP Name": "GAD1 (GAD) A48604A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs769395",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,Alternative splicing,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,posttraumatic epilepsy,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,spastic quadriplegic 1 (CPSQ1),synaptic transmission,TBI,testicles,testis,traumatic brain injury,vesicle membrane",
        "Group": "L-Glutamine"
    },
    {
        "SNP ID": "rs769395",
        "SNP Name": "GAD1 (GAD) A48604A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs769395",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,Alternative splicing,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,posttraumatic epilepsy,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,spastic quadriplegic 1 (CPSQ1),synaptic transmission,TBI,testicles,testis,traumatic brain injury,vesicle membrane",
        "Group": "Monosodium Glutamate"
    },
    {
        "SNP ID": "rs769395",
        "SNP Name": "GAD1 (GAD) A48604A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs769395",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,Alternative splicing,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,posttraumatic epilepsy,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,spastic quadriplegic 1 (CPSQ1),synaptic transmission,TBI,testicles,testis,traumatic brain injury,vesicle membrane",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs769395",
        "SNP Name": "GAD1 (GAD) A48604A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs769395",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,Alternative splicing,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,posttraumatic epilepsy,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,spastic quadriplegic 1 (CPSQ1),synaptic transmission,TBI,testicles,testis,traumatic brain injury,vesicle membrane",
        "Group": "Neurotransmitter Pathway: Glutamate & GABA"
    },
    {
        "SNP ID": "rs769395",
        "SNP Name": "GAD1 (GAD) A48604A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs769395",
        "Video": null,
        "Tags": "67 kDa glutamic acid decarboxylase,adrenal,adrenal cortex,adrenal gland,Alternative splicing,axon terminus,Catalyzes the production of GABA,cell cortex,Cerebral palsy,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cognitive difficulties,cognitive performance,Decarboxylase,Developmental delay,Disease mutation,drug interaction,epilepsy,fear,GABA production,GAD,GAD-67,GAD1,gamma-Aminobutyric acid,gamma-aminobutyric acid biosynthetic process,glutamate,glutamate binding,glutamate catabolic process,Glutamate decarboxylase 1,Glutamate decarboxylase 67 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Homodimer,intracellular,L-glutamate = 4-aminobutanoate + CO2,Lyase,mental disorder,mental retardation,mitochondria,mitochondrion,nervous system,neurodegenerative disorder,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,pancreas,pancreatic islets,panic disorder,phospate,plasma membrane,Polymorphism,posttraumatic epilepsy,presynaptic active zone,protein-pyridoxal-5-phosphate linkage,Pyridoxal phosphate,pyridoxal phosphate binding,response to drug,spastic quadriplegic 1 (CPSQ1),synaptic transmission,TBI,testicles,testis,traumatic brain injury,vesicle membrane",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs960748",
        "SNP Name": "CYBRD1 171523426G>A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs17554",
        "SNP Name": "CYBRD1 171546859G>A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs10455",
        "SNP Name": "CYBRD1 Ser208Asn",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs4667287",
        "SNP Name": "SLC40A1 190431875C>A",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs1123109",
        "SNP Name": "SLC40A1 190444392T>C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs1376877",
        "SNP Name": "ABI2 C204272090T",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "A-Tocopheryl Hydrogen Succinate"
    },
    {
        "SNP ID": "rs231775",
        "SNP Name": "CTLA4 Thr17Ala",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs231775",
        "Video": null,
        "Tags": null,
        "Group": "Celiac Disease/Gluten Intolerance"
    },
    {
        "SNP ID": "rs231775",
        "SNP Name": "CTLA4 Thr17Ala",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs231775",
        "Video": null,
        "Tags": null,
        "Group": "Thyroid"
    },
    {
        "SNP ID": "rs10932201",
        "SNP Name": "CREB1 G208426257A",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Amphotericin B"
    },
    {
        "SNP ID": "rs2254137",
        "SNP Name": "CREB1 C208444028A",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Amphotericin B"
    },
    {
        "SNP ID": "rs72551314",
        "SNP Name": "CYP27a1 G159null",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Magnesium Stearate"
    },
    {
        "SNP ID": "rs72551322",
        "SNP Name": "CYP27a1 A479G",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Magnesium Stearate"
    },
    {
        "SNP ID": "rs2767",
        "SNP Name": "CHRND A233400074G",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Benzethonium Chloride"
    },
    {
        "SNP ID": "rs10210302",
        "SNP Name": "ATG16L1 C234158839T",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs10210302",
        "Video": null,
        "Tags": null,
        "Group": "Other Immune Factors"
    },
    {
        "SNP ID": "rs887829",
        "SNP Name": "UGT1A1 C175181T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs887829",
        "Video": null,
        "Tags": "1-hydroxypyrene,1-naphthol,17alpha-ethinylestradiol,4-methylumbelliferone,A condition characterized by excessive concentration of bilirubin in the blood which may lead to jaundice,acute-phase response,Alternative splicing,and umbelliferone,Antipsychotics,Belongs to the UDP-glycosyltransferase family,BILIQTL1,bilirubin,bilirubin and mortality,bilirubin conjugation,bilirubin levels,Bilirubin-specific UDPGT isozyme 1,biphenyl catabolic process,Breast milk jaundice is a common problem in nursing infants,CALR,CANX,cellular glucuronidation,cellular response to ethanol,cellular response to glucocorticoid stimulus,Cholelithiasis,Cholelithiasis Risk in Sickle Cell Anemia,CN1,CN1 inheritance is autosomal recessive,CN2,CN2 inheritance is autosomal dominant,colon and small intestine,Complete proteome,Crigler-Najjar syndrome 1,Crigler-Najjar syndrome 2,cytochrome complex,Defects of UGT1A1 are an underlying cause of the prolonged unconjugated hyperbilirubinemia associated with breast milk,digestion,Disease mutation,drug metabolic process,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane;Single-pass membrane protein,enzyme binding,enzyme inhibitor activity,estrogen metabolic process,flavone metabolic process,flavonoid glucuronidation,From the 27 possible mRNA isoforms 9 produce functionally active polypeptides (UGT1A1 & 1A3 & 1A4 & 1A5 & 1A6 & 1A7 & 1A8 & 1A9 and 1A10) called isoforms 1 (i1),Genetic variation in UGT1A1 defines the bilirubin serum levels quantitative trait locus 1,Gilbert syndrome,GILBS,glucuronosyltransferase activity,Glycoprotein,Glycosyltransferase,GNT1,HBLRTFN,heme catabolic process,heterocycle metabolic process,HSP90B1,HSPA5,hUG-BR1,HYOU,hyperbilirubinemia,integral component of plasma membrane,Is also able to catalyze the glucuronidation of 17beta-estradiol,Isoform 1 also interacts with respective i2 isoforms of UGT1A3,Isoform 1 and isoform 2 are expressed in liver,Isoform 1 and isoform 2 are not expressed in esophagus,Isoform 1 interacts with isoform 2/i2suggesting that oligomerization is involved in negative regulation of transferase activity by isoform 2,Isoform 2 but not isoform 1 is expressed in kidney,Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1,liver development,Membrane,Microsome,mortality in sepsis,Mutations are identical to those detected in patients with Gilbert syndrome a risk factor of neonatal non-physiologic hyperbilirubinemia and a genetic factor in fasting hyperbilirubinemia,negative regulation of catalytic activity,negative regulation of cellular glucuronidation,negative regulation of steroid metabolic process,Non-Alcoholic Fatty Liver Disease,Not expressed in skin,Occurs as a consequence of reduced bilirubin transferase activity and is often detected in young adults with vague non-specific complaints,One or more components in the milk may trigger the jaundice in infants who have such mutations,organ regeneration,paranitrophenol,Part of a large chaperone multiprotein complex comprising DNAJB11,Patients have less severe hyperbilirubinemia and usually survive into adulthood without neurologic damage,Patients have severe hyperbilirubinemia and usually die of kernicterus (bilirubin accumulation in the basal ganglia and brainstem nuclei) within the first year of life,PDIA2,PDIA4,PDIA6,pharmagenetics,pharmagenomic,Phenobarbital which induces the partially deficient glucuronyl transferase can diminish the jaundice,porphyrin-containing compound metabolic process,PPIB,protects from bladder cancer,protein heterodimerization activity,protein homodimerization activity,Reference proteome,response to drug,response to lipopolysaccharide,response to nutrient,response to starvation,retinoic acid binding,retinoic acid metabolic process,scopoletin,SDF2L1,serum bilirubin,Serum Uric Acid,Signal,small molecule metabolic process,steroid binding,steroid metabolic process,The defect has been ascribed to various breast milk substances but th",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs4148323",
        "SNP Name": "UGT1A1 G211A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4148323",
        "Video": null,
        "Tags": "1-hydroxypyrene,1-naphthol,17alpha-ethinylestradiol,4-methylumbelliferone,A condition characterized by excessive concentration of bilirubin in the blood which may lead to jaundice,acute-phase response,Alternative splicing,and umbelliferone,Belongs to the UDP-glycosyltransferase family,BILIQTL1,bilirubin,bilirubin conjugation,bilirubin levels,Bilirubin-specific UDPGT isozyme 1,biphenyl catabolic process,Breast milk jaundice is a common problem in nursing infants,CALR,cancer chemotherapy,CANX,cellular glucuronidation,cellular response to ethanol,cellular response to glucocorticoid stimulus,chemotherapy,CN1,CN1 inheritance is autosomal recessive,CN2,CN2 inheritance is autosomal dominant,colon and small intestine,Complete proteome,Crigler-Najjar syndrome 1,Crigler-Najjar syndrome 2,cytochrome complex,Defects of UGT1A1 are an underlying cause of the prolonged unconjugated hyperbilirubinemia associated with breast milk,digestion,Disease mutation,drug metabolic process,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane;Single-pass membrane protein,enzyme binding,enzyme inhibitor activity,estrogen metabolic process,flavone metabolic process,flavonoid glucuronidation,From the 27 possible mRNA isoforms 9 produce functionally active polypeptides (UGT1A1 & 1A3 & 1A4 & 1A5 & 1A6 & 1A7 & 1A8 & 1A9 and 1A10) called isoforms 1 (i1),Genetic variation in UGT1A1 defines the bilirubin serum levels quantitative trait locus 1,Gilbert syndrome,GILBS,glucuronosyltransferase activity,Glycoprotein,Glycosyltransferase,GNT1,HBLRTFN,heme catabolic process,heterocycle metabolic process,HSP90B1,HSPA5,hUG-BR1,HYOU,hyperbilirubinemia,integral component of plasma membrane,Is also able to catalyze the glucuronidation of 17beta-estradiol,Isoform 1 also interacts with respective i2 isoforms of UGT1A3,Isoform 1 and isoform 2 are expressed in liver,Isoform 1 and isoform 2 are not expressed in esophagus,Isoform 1 interacts with isoform 2/i2suggesting that oligomerization is involved in negative regulation of transferase activity by isoform 2,Isoform 2 but not isoform 1 is expressed in kidney,Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1,liver development,Membrane,Microsome,mortality in sepsis,Mutations are identical to those detected in patients with Gilbert syndrome a risk factor of neonatal non-physiologic hyperbilirubinemia and a genetic factor in fasting hyperbilirubinemia,negative regulation of catalytic activity,negative regulation of cellular glucuronidation,negative regulation of steroid metabolic process,Not expressed in skin,Occurs as a consequence of reduced bilirubin transferase activity and is often detected in young adults with vague non-specific complaints,One or more components in the milk may trigger the jaundice in infants who have such mutations,organ regeneration,paranitrophenol,Part of a large chaperone multiprotein complex comprising DNAJB11,Patients have less severe hyperbilirubinemia and usually survive into adulthood without neurologic damage,Patients have severe hyperbilirubinemia and usually die of kernicterus (bilirubin accumulation in the basal ganglia and brainstem nuclei) within the first year of life,PDIA2,PDIA4,PDIA6,pharmacogenetic,Phenobarbital which induces the partially deficient glucuronyl transferase can diminish the jaundice,porphyrin-containing compound metabolic process,PPIB,protein heterodimerization activity,protein homodimerization activity,Reference proteome,response to cancer chemotherapy,response to drug,response to lipopolysaccharide,response to nutrient,response to starvation,retinoic acid binding,retinoic acid metabolic process,scopoletin,SDF2L1,serum bilirubin,Signal,small molecule metabolic process,steroid binding,steroid metabolic process,The defect has been ascribed to various breast milk substances but the component or combination of components that is responsible remains unclear,The disease is caused by mutations affecting the g",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs72551341",
        "SNP Name": "UGT1A1 L175G",
        "Risk Allele": "A",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs72551341",
        "Video": null,
        "Tags": "1-hydroxypyrene,1-naphthol,17alpha-ethinylestradiol,4-methylumbelliferone,A condition characterized by excessive concentration of bilirubin in the blood which may lead to jaundice,acute-phase response,Alternative splicing,and umbelliferone,Belongs to the UDP-glycosyltransferase family,BILIQTL1,bilirubin conjugation,Bilirubin-specific UDPGT isozyme 1,biphenyl catabolic process,Breast milk jaundice is a common problem in nursing infants,CALR,CANX,cellular glucuronidation,cellular response to ethanol,cellular response to glucocorticoid stimulus,CN1,CN1 inheritance is autosomal recessive,CN2,CN2 inheritance is autosomal dominant,colon and small intestine,Complete proteome,Crigler-Najjar syndrome 1,Crigler-Najjar syndrome 2,cytochrome complex,Defects of UGT1A1 are an underlying cause of the prolonged unconjugated hyperbilirubinemia associated with breast milk,digestion,Disease mutation,drug metabolic process,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane;Single-pass membrane protein,enzyme binding,enzyme inhibitor activity,estrogen metabolic process,flavone metabolic process,flavonoid glucuronidation,From the 27 possible mRNA isoforms 9 produce functionally active polypeptides (UGT1A1 & 1A3 & 1A4 & 1A5 & 1A6 & 1A7 & 1A8 & 1A9 and 1A10) called isoforms 1 (i1),Genetic variation in UGT1A1 defines the bilirubin serum levels quantitative trait locus 1,Gilbert syndrome,GILBS,glucuronosyltransferase activity,Glycoprotein,Glycosyltransferase,GNT1,HBLRTFN,heme catabolic process,heterocycle metabolic process,HSP90B1,HSPA5,hUG-BR1,HYOU,hyperbilirubinemia,integral component of plasma membrane,Is also able to catalyze the glucuronidation of 17beta-estradiol,Isoform 1 also interacts with respective i2 isoforms of UGT1A3,Isoform 1 and isoform 2 are expressed in liver,Isoform 1 and isoform 2 are not expressed in esophagus,Isoform 1 interacts with isoform 2/i2suggesting that oligomerization is involved in negative regulation of transferase activity by isoform 2,Isoform 2 but not isoform 1 is expressed in kidney,Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1,liver development,Membrane,Microsome,Mutations are identical to those detected in patients with Gilbert syndrome a risk factor of neonatal non-physiologic hyperbilirubinemia and a genetic factor in fasting hyperbilirubinemia,negative regulation of catalytic activity,negative regulation of cellular glucuronidation,negative regulation of steroid metabolic process,Not expressed in skin,Occurs as a consequence of reduced bilirubin transferase activity and is often detected in young adults with vague non-specific complaints,One or more components in the milk may trigger the jaundice in infants who have such mutations,organ regeneration,paranitrophenol,Part of a large chaperone multiprotein complex comprising DNAJB11,Patients have less severe hyperbilirubinemia and usually survive into adulthood without neurologic damage,Patients have severe hyperbilirubinemia and usually die of kernicterus (bilirubin accumulation in the basal ganglia and brainstem nuclei) within the first year of life,PDIA2,PDIA4,PDIA6,Phenobarbital which induces the partially deficient glucuronyl transferase can diminish the jaundice,porphyrin-containing compound metabolic process,PPIB,protein heterodimerization activity,protein homodimerization activity,Reference proteome,response to drug,response to lipopolysaccharide,response to nutrient,response to starvation,retinoic acid binding,retinoic acid metabolic process,scopoletin,SDF2L1,Signal,small molecule metabolic process,steroid binding,steroid metabolic process,The defect has been ascribed to various breast milk substances but the component or combination of components that is responsible remains unclear,The disease is caused by mutations affecting the gene represented in this entry,The disease may be caused by mutations affecting the gene represented in this entry,The gene is part of the UGT1A comple",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs6742078",
        "SNP Name": "UGT1A1 G179250T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6742078",
        "Video": null,
        "Tags": "1-hydroxypyrene,1-naphthol,17alpha-ethinylestradiol,4-methylumbelliferone,A condition characterized by excessive concentration of bilirubin in the blood which may lead to jaundice,acute-phase response,Alternative splicing,and umbelliferone,Belongs to the UDP-glycosyltransferase family,BILIQTL1,bilirubin conjugation,Bilirubin-specific UDPGT isozyme 1,biphenyl catabolic process,Breast milk jaundice is a common problem in nursing infants,CALR,cancer,cancerous,CANX,carcinogen,Cardiovascular,cellular glucuronidation,cellular response to ethanol,cellular response to glucocorticoid stimulus,Cholelithiasis,Cholelithiasis Risk in Sickle Cell Anemia,cirrhosis,CN1,CN1 inheritance is autosomal recessive,CN2,CN2 inheritance is autosomal dominant,colon and small intestine,Complete proteome,Crigler-Najjar syndrome 1,Crigler-Najjar syndrome 2,CVD,cytochrome complex,Defects of UGT1A1 are an underlying cause of the prolonged unconjugated hyperbilirubinemia associated with breast milk,digestion,Disease mutation,drug metabolic process,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane;Single-pass membrane protein,enzyme binding,enzyme inhibitor activity,estrogen metabolic process,flavone metabolic process,flavonoid glucuronidation,From the 27 possible mRNA isoforms 9 produce functionally active polypeptides (UGT1A1 & 1A3 & 1A4 & 1A5 & 1A6 & 1A7 & 1A8 & 1A9 and 1A10) called isoforms 1 (i1),Gallstones,Genetic variation in UGT1A1 defines the bilirubin serum levels quantitative trait locus 1,Gilbert syndrome,GILBS,glucuronosyltransferase activity,Glycoprotein,Glycosyltransferase,GNT1,HBLRTFN,heart,heme catabolic process,heterocycle metabolic process,HSP90B1,HSPA5,hUG-BR1,HYOU,hyperbilirubinemia,integral component of plasma membrane,Is also able to catalyze the glucuronidation of 17beta-estradiol,Isoform 1 also interacts with respective i2 isoforms of UGT1A3,Isoform 1 and isoform 2 are expressed in liver,Isoform 1 and isoform 2 are not expressed in esophagus,Isoform 1 interacts with isoform 2/i2suggesting that oligomerization is involved in negative regulation of transferase activity by isoform 2,Isoform 2 but not isoform 1 is expressed in kidney,Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1,liver cirrhosis,liver development,Membrane,Microsome,mortality in sepsis,Mutations are identical to those detected in patients with Gilbert syndrome a risk factor of neonatal non-physiologic hyperbilirubinemia and a genetic factor in fasting hyperbilirubinemia,negative regulation of catalytic activity,negative regulation of cellular glucuronidation,negative regulation of steroid metabolic process,Not expressed in skin,Occurs as a consequence of reduced bilirubin transferase activity and is often detected in young adults with vague non-specific complaints,One or more components in the milk may trigger the jaundice in infants who have such mutations,organ regeneration,paranitrophenol,Part of a large chaperone multiprotein complex comprising DNAJB11,Patients have less severe hyperbilirubinemia and usually survive into adulthood without neurologic damage,Patients have severe hyperbilirubinemia and usually die of kernicterus (bilirubin accumulation in the basal ganglia and brainstem nuclei) within the first year of life,PDIA2,PDIA4,PDIA6,Phenobarbital which induces the partially deficient glucuronyl transferase can diminish the jaundice,porphyrin-containing compound metabolic process,PPIB,Prostate Cancer,protects from bladder cancer,protein heterodimerization activity,protein homodimerization activity,Reference proteome,response to drug,response to lipopolysaccharide,response to nutrient,response to starvation,retinoic acid binding,retinoic acid metabolic process,scopoletin,SDF2L1,serum bilirubin,Signal,small molecule metabolic process,steroid binding,steroid metabolic process,The defect has been ascribed to various breast milk substances but the component or combination of compone",
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs6742078",
        "SNP Name": "UGT1A1 G179250T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6742078",
        "Video": null,
        "Tags": "1-hydroxypyrene,1-naphthol,17alpha-ethinylestradiol,4-methylumbelliferone,A condition characterized by excessive concentration of bilirubin in the blood which may lead to jaundice,acute-phase response,Alternative splicing,and umbelliferone,Belongs to the UDP-glycosyltransferase family,BILIQTL1,bilirubin conjugation,Bilirubin-specific UDPGT isozyme 1,biphenyl catabolic process,Breast milk jaundice is a common problem in nursing infants,CALR,cancer,cancerous,CANX,carcinogen,Cardiovascular,cellular glucuronidation,cellular response to ethanol,cellular response to glucocorticoid stimulus,Cholelithiasis,Cholelithiasis Risk in Sickle Cell Anemia,cirrhosis,CN1,CN1 inheritance is autosomal recessive,CN2,CN2 inheritance is autosomal dominant,colon and small intestine,Complete proteome,Crigler-Najjar syndrome 1,Crigler-Najjar syndrome 2,CVD,cytochrome complex,Defects of UGT1A1 are an underlying cause of the prolonged unconjugated hyperbilirubinemia associated with breast milk,digestion,Disease mutation,drug metabolic process,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane;Single-pass membrane protein,enzyme binding,enzyme inhibitor activity,estrogen metabolic process,flavone metabolic process,flavonoid glucuronidation,From the 27 possible mRNA isoforms 9 produce functionally active polypeptides (UGT1A1 & 1A3 & 1A4 & 1A5 & 1A6 & 1A7 & 1A8 & 1A9 and 1A10) called isoforms 1 (i1),Gallstones,Genetic variation in UGT1A1 defines the bilirubin serum levels quantitative trait locus 1,Gilbert syndrome,GILBS,glucuronosyltransferase activity,Glycoprotein,Glycosyltransferase,GNT1,HBLRTFN,heart,heme catabolic process,heterocycle metabolic process,HSP90B1,HSPA5,hUG-BR1,HYOU,hyperbilirubinemia,integral component of plasma membrane,Is also able to catalyze the glucuronidation of 17beta-estradiol,Isoform 1 also interacts with respective i2 isoforms of UGT1A3,Isoform 1 and isoform 2 are expressed in liver,Isoform 1 and isoform 2 are not expressed in esophagus,Isoform 1 interacts with isoform 2/i2suggesting that oligomerization is involved in negative regulation of transferase activity by isoform 2,Isoform 2 but not isoform 1 is expressed in kidney,Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1,liver cirrhosis,liver development,Membrane,Microsome,mortality in sepsis,Mutations are identical to those detected in patients with Gilbert syndrome a risk factor of neonatal non-physiologic hyperbilirubinemia and a genetic factor in fasting hyperbilirubinemia,negative regulation of catalytic activity,negative regulation of cellular glucuronidation,negative regulation of steroid metabolic process,Not expressed in skin,Occurs as a consequence of reduced bilirubin transferase activity and is often detected in young adults with vague non-specific complaints,One or more components in the milk may trigger the jaundice in infants who have such mutations,organ regeneration,paranitrophenol,Part of a large chaperone multiprotein complex comprising DNAJB11,Patients have less severe hyperbilirubinemia and usually survive into adulthood without neurologic damage,Patients have severe hyperbilirubinemia and usually die of kernicterus (bilirubin accumulation in the basal ganglia and brainstem nuclei) within the first year of life,PDIA2,PDIA4,PDIA6,Phenobarbital which induces the partially deficient glucuronyl transferase can diminish the jaundice,porphyrin-containing compound metabolic process,PPIB,Prostate Cancer,protects from bladder cancer,protein heterodimerization activity,protein homodimerization activity,Reference proteome,response to drug,response to lipopolysaccharide,response to nutrient,response to starvation,retinoic acid binding,retinoic acid metabolic process,scopoletin,SDF2L1,serum bilirubin,Signal,small molecule metabolic process,steroid binding,steroid metabolic process,The defect has been ascribed to various breast milk substances but the component or combination of compone",
        "Group": "Bovine Serum Albumin"
    },
    {
        "SNP ID": "rs6742078",
        "SNP Name": "UGT1A1 G179250T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6742078",
        "Video": null,
        "Tags": "1-hydroxypyrene,1-naphthol,17alpha-ethinylestradiol,4-methylumbelliferone,A condition characterized by excessive concentration of bilirubin in the blood which may lead to jaundice,acute-phase response,Alternative splicing,and umbelliferone,Belongs to the UDP-glycosyltransferase family,BILIQTL1,bilirubin conjugation,Bilirubin-specific UDPGT isozyme 1,biphenyl catabolic process,Breast milk jaundice is a common problem in nursing infants,CALR,cancer,cancerous,CANX,carcinogen,Cardiovascular,cellular glucuronidation,cellular response to ethanol,cellular response to glucocorticoid stimulus,Cholelithiasis,Cholelithiasis Risk in Sickle Cell Anemia,cirrhosis,CN1,CN1 inheritance is autosomal recessive,CN2,CN2 inheritance is autosomal dominant,colon and small intestine,Complete proteome,Crigler-Najjar syndrome 1,Crigler-Najjar syndrome 2,CVD,cytochrome complex,Defects of UGT1A1 are an underlying cause of the prolonged unconjugated hyperbilirubinemia associated with breast milk,digestion,Disease mutation,drug metabolic process,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane;Single-pass membrane protein,enzyme binding,enzyme inhibitor activity,estrogen metabolic process,flavone metabolic process,flavonoid glucuronidation,From the 27 possible mRNA isoforms 9 produce functionally active polypeptides (UGT1A1 & 1A3 & 1A4 & 1A5 & 1A6 & 1A7 & 1A8 & 1A9 and 1A10) called isoforms 1 (i1),Gallstones,Genetic variation in UGT1A1 defines the bilirubin serum levels quantitative trait locus 1,Gilbert syndrome,GILBS,glucuronosyltransferase activity,Glycoprotein,Glycosyltransferase,GNT1,HBLRTFN,heart,heme catabolic process,heterocycle metabolic process,HSP90B1,HSPA5,hUG-BR1,HYOU,hyperbilirubinemia,integral component of plasma membrane,Is also able to catalyze the glucuronidation of 17beta-estradiol,Isoform 1 also interacts with respective i2 isoforms of UGT1A3,Isoform 1 and isoform 2 are expressed in liver,Isoform 1 and isoform 2 are not expressed in esophagus,Isoform 1 interacts with isoform 2/i2suggesting that oligomerization is involved in negative regulation of transferase activity by isoform 2,Isoform 2 but not isoform 1 is expressed in kidney,Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1,liver cirrhosis,liver development,Membrane,Microsome,mortality in sepsis,Mutations are identical to those detected in patients with Gilbert syndrome a risk factor of neonatal non-physiologic hyperbilirubinemia and a genetic factor in fasting hyperbilirubinemia,negative regulation of catalytic activity,negative regulation of cellular glucuronidation,negative regulation of steroid metabolic process,Not expressed in skin,Occurs as a consequence of reduced bilirubin transferase activity and is often detected in young adults with vague non-specific complaints,One or more components in the milk may trigger the jaundice in infants who have such mutations,organ regeneration,paranitrophenol,Part of a large chaperone multiprotein complex comprising DNAJB11,Patients have less severe hyperbilirubinemia and usually survive into adulthood without neurologic damage,Patients have severe hyperbilirubinemia and usually die of kernicterus (bilirubin accumulation in the basal ganglia and brainstem nuclei) within the first year of life,PDIA2,PDIA4,PDIA6,Phenobarbital which induces the partially deficient glucuronyl transferase can diminish the jaundice,porphyrin-containing compound metabolic process,PPIB,Prostate Cancer,protects from bladder cancer,protein heterodimerization activity,protein homodimerization activity,Reference proteome,response to drug,response to lipopolysaccharide,response to nutrient,response to starvation,retinoic acid binding,retinoic acid metabolic process,scopoletin,SDF2L1,serum bilirubin,Signal,small molecule metabolic process,steroid binding,steroid metabolic process,The defect has been ascribed to various breast milk substances but the component or combination of compone",
        "Group": "Chicken Protein"
    },
    {
        "SNP ID": "rs6742078",
        "SNP Name": "UGT1A1 G179250T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6742078",
        "Video": null,
        "Tags": "1-hydroxypyrene,1-naphthol,17alpha-ethinylestradiol,4-methylumbelliferone,A condition characterized by excessive concentration of bilirubin in the blood which may lead to jaundice,acute-phase response,Alternative splicing,and umbelliferone,Belongs to the UDP-glycosyltransferase family,BILIQTL1,bilirubin conjugation,Bilirubin-specific UDPGT isozyme 1,biphenyl catabolic process,Breast milk jaundice is a common problem in nursing infants,CALR,cancer,cancerous,CANX,carcinogen,Cardiovascular,cellular glucuronidation,cellular response to ethanol,cellular response to glucocorticoid stimulus,Cholelithiasis,Cholelithiasis Risk in Sickle Cell Anemia,cirrhosis,CN1,CN1 inheritance is autosomal recessive,CN2,CN2 inheritance is autosomal dominant,colon and small intestine,Complete proteome,Crigler-Najjar syndrome 1,Crigler-Najjar syndrome 2,CVD,cytochrome complex,Defects of UGT1A1 are an underlying cause of the prolonged unconjugated hyperbilirubinemia associated with breast milk,digestion,Disease mutation,drug metabolic process,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane;Single-pass membrane protein,enzyme binding,enzyme inhibitor activity,estrogen metabolic process,flavone metabolic process,flavonoid glucuronidation,From the 27 possible mRNA isoforms 9 produce functionally active polypeptides (UGT1A1 & 1A3 & 1A4 & 1A5 & 1A6 & 1A7 & 1A8 & 1A9 and 1A10) called isoforms 1 (i1),Gallstones,Genetic variation in UGT1A1 defines the bilirubin serum levels quantitative trait locus 1,Gilbert syndrome,GILBS,glucuronosyltransferase activity,Glycoprotein,Glycosyltransferase,GNT1,HBLRTFN,heart,heme catabolic process,heterocycle metabolic process,HSP90B1,HSPA5,hUG-BR1,HYOU,hyperbilirubinemia,integral component of plasma membrane,Is also able to catalyze the glucuronidation of 17beta-estradiol,Isoform 1 also interacts with respective i2 isoforms of UGT1A3,Isoform 1 and isoform 2 are expressed in liver,Isoform 1 and isoform 2 are not expressed in esophagus,Isoform 1 interacts with isoform 2/i2suggesting that oligomerization is involved in negative regulation of transferase activity by isoform 2,Isoform 2 but not isoform 1 is expressed in kidney,Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1,liver cirrhosis,liver development,Membrane,Microsome,mortality in sepsis,Mutations are identical to those detected in patients with Gilbert syndrome a risk factor of neonatal non-physiologic hyperbilirubinemia and a genetic factor in fasting hyperbilirubinemia,negative regulation of catalytic activity,negative regulation of cellular glucuronidation,negative regulation of steroid metabolic process,Not expressed in skin,Occurs as a consequence of reduced bilirubin transferase activity and is often detected in young adults with vague non-specific complaints,One or more components in the milk may trigger the jaundice in infants who have such mutations,organ regeneration,paranitrophenol,Part of a large chaperone multiprotein complex comprising DNAJB11,Patients have less severe hyperbilirubinemia and usually survive into adulthood without neurologic damage,Patients have severe hyperbilirubinemia and usually die of kernicterus (bilirubin accumulation in the basal ganglia and brainstem nuclei) within the first year of life,PDIA2,PDIA4,PDIA6,Phenobarbital which induces the partially deficient glucuronyl transferase can diminish the jaundice,porphyrin-containing compound metabolic process,PPIB,Prostate Cancer,protects from bladder cancer,protein heterodimerization activity,protein homodimerization activity,Reference proteome,response to drug,response to lipopolysaccharide,response to nutrient,response to starvation,retinoic acid binding,retinoic acid metabolic process,scopoletin,SDF2L1,serum bilirubin,Signal,small molecule metabolic process,steroid binding,steroid metabolic process,The defect has been ascribed to various breast milk substances but the component or combination of compone",
        "Group": "Human Serum Albumin"
    },
    {
        "SNP ID": "rs6742078",
        "SNP Name": "UGT1A1 G179250T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6742078",
        "Video": null,
        "Tags": "1-hydroxypyrene,1-naphthol,17alpha-ethinylestradiol,4-methylumbelliferone,A condition characterized by excessive concentration of bilirubin in the blood which may lead to jaundice,acute-phase response,Alternative splicing,and umbelliferone,Belongs to the UDP-glycosyltransferase family,BILIQTL1,bilirubin conjugation,Bilirubin-specific UDPGT isozyme 1,biphenyl catabolic process,Breast milk jaundice is a common problem in nursing infants,CALR,cancer,cancerous,CANX,carcinogen,Cardiovascular,cellular glucuronidation,cellular response to ethanol,cellular response to glucocorticoid stimulus,Cholelithiasis,Cholelithiasis Risk in Sickle Cell Anemia,cirrhosis,CN1,CN1 inheritance is autosomal recessive,CN2,CN2 inheritance is autosomal dominant,colon and small intestine,Complete proteome,Crigler-Najjar syndrome 1,Crigler-Najjar syndrome 2,CVD,cytochrome complex,Defects of UGT1A1 are an underlying cause of the prolonged unconjugated hyperbilirubinemia associated with breast milk,digestion,Disease mutation,drug metabolic process,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane;Single-pass membrane protein,enzyme binding,enzyme inhibitor activity,estrogen metabolic process,flavone metabolic process,flavonoid glucuronidation,From the 27 possible mRNA isoforms 9 produce functionally active polypeptides (UGT1A1 & 1A3 & 1A4 & 1A5 & 1A6 & 1A7 & 1A8 & 1A9 and 1A10) called isoforms 1 (i1),Gallstones,Genetic variation in UGT1A1 defines the bilirubin serum levels quantitative trait locus 1,Gilbert syndrome,GILBS,glucuronosyltransferase activity,Glycoprotein,Glycosyltransferase,GNT1,HBLRTFN,heart,heme catabolic process,heterocycle metabolic process,HSP90B1,HSPA5,hUG-BR1,HYOU,hyperbilirubinemia,integral component of plasma membrane,Is also able to catalyze the glucuronidation of 17beta-estradiol,Isoform 1 also interacts with respective i2 isoforms of UGT1A3,Isoform 1 and isoform 2 are expressed in liver,Isoform 1 and isoform 2 are not expressed in esophagus,Isoform 1 interacts with isoform 2/i2suggesting that oligomerization is involved in negative regulation of transferase activity by isoform 2,Isoform 2 but not isoform 1 is expressed in kidney,Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1,liver cirrhosis,liver development,Membrane,Microsome,mortality in sepsis,Mutations are identical to those detected in patients with Gilbert syndrome a risk factor of neonatal non-physiologic hyperbilirubinemia and a genetic factor in fasting hyperbilirubinemia,negative regulation of catalytic activity,negative regulation of cellular glucuronidation,negative regulation of steroid metabolic process,Not expressed in skin,Occurs as a consequence of reduced bilirubin transferase activity and is often detected in young adults with vague non-specific complaints,One or more components in the milk may trigger the jaundice in infants who have such mutations,organ regeneration,paranitrophenol,Part of a large chaperone multiprotein complex comprising DNAJB11,Patients have less severe hyperbilirubinemia and usually survive into adulthood without neurologic damage,Patients have severe hyperbilirubinemia and usually die of kernicterus (bilirubin accumulation in the basal ganglia and brainstem nuclei) within the first year of life,PDIA2,PDIA4,PDIA6,Phenobarbital which induces the partially deficient glucuronyl transferase can diminish the jaundice,porphyrin-containing compound metabolic process,PPIB,Prostate Cancer,protects from bladder cancer,protein heterodimerization activity,protein homodimerization activity,Reference proteome,response to drug,response to lipopolysaccharide,response to nutrient,response to starvation,retinoic acid binding,retinoic acid metabolic process,scopoletin,SDF2L1,serum bilirubin,Signal,small molecule metabolic process,steroid binding,steroid metabolic process,The defect has been ascribed to various breast milk substances but the component or combination of compone",
        "Group": "Ovalbumin"
    },
    {
        "SNP ID": "rs6742078",
        "SNP Name": "UGT1A1 G179250T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6742078",
        "Video": null,
        "Tags": "1-hydroxypyrene,1-naphthol,17alpha-ethinylestradiol,4-methylumbelliferone,A condition characterized by excessive concentration of bilirubin in the blood which may lead to jaundice,acute-phase response,Alternative splicing,and umbelliferone,Belongs to the UDP-glycosyltransferase family,BILIQTL1,bilirubin conjugation,Bilirubin-specific UDPGT isozyme 1,biphenyl catabolic process,Breast milk jaundice is a common problem in nursing infants,CALR,cancer,cancerous,CANX,carcinogen,Cardiovascular,cellular glucuronidation,cellular response to ethanol,cellular response to glucocorticoid stimulus,Cholelithiasis,Cholelithiasis Risk in Sickle Cell Anemia,cirrhosis,CN1,CN1 inheritance is autosomal recessive,CN2,CN2 inheritance is autosomal dominant,colon and small intestine,Complete proteome,Crigler-Najjar syndrome 1,Crigler-Najjar syndrome 2,CVD,cytochrome complex,Defects of UGT1A1 are an underlying cause of the prolonged unconjugated hyperbilirubinemia associated with breast milk,digestion,Disease mutation,drug metabolic process,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane;Single-pass membrane protein,enzyme binding,enzyme inhibitor activity,estrogen metabolic process,flavone metabolic process,flavonoid glucuronidation,From the 27 possible mRNA isoforms 9 produce functionally active polypeptides (UGT1A1 & 1A3 & 1A4 & 1A5 & 1A6 & 1A7 & 1A8 & 1A9 and 1A10) called isoforms 1 (i1),Gallstones,Genetic variation in UGT1A1 defines the bilirubin serum levels quantitative trait locus 1,Gilbert syndrome,GILBS,glucuronosyltransferase activity,Glycoprotein,Glycosyltransferase,GNT1,HBLRTFN,heart,heme catabolic process,heterocycle metabolic process,HSP90B1,HSPA5,hUG-BR1,HYOU,hyperbilirubinemia,integral component of plasma membrane,Is also able to catalyze the glucuronidation of 17beta-estradiol,Isoform 1 also interacts with respective i2 isoforms of UGT1A3,Isoform 1 and isoform 2 are expressed in liver,Isoform 1 and isoform 2 are not expressed in esophagus,Isoform 1 interacts with isoform 2/i2suggesting that oligomerization is involved in negative regulation of transferase activity by isoform 2,Isoform 2 but not isoform 1 is expressed in kidney,Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1,liver cirrhosis,liver development,Membrane,Microsome,mortality in sepsis,Mutations are identical to those detected in patients with Gilbert syndrome a risk factor of neonatal non-physiologic hyperbilirubinemia and a genetic factor in fasting hyperbilirubinemia,negative regulation of catalytic activity,negative regulation of cellular glucuronidation,negative regulation of steroid metabolic process,Not expressed in skin,Occurs as a consequence of reduced bilirubin transferase activity and is often detected in young adults with vague non-specific complaints,One or more components in the milk may trigger the jaundice in infants who have such mutations,organ regeneration,paranitrophenol,Part of a large chaperone multiprotein complex comprising DNAJB11,Patients have less severe hyperbilirubinemia and usually survive into adulthood without neurologic damage,Patients have severe hyperbilirubinemia and usually die of kernicterus (bilirubin accumulation in the basal ganglia and brainstem nuclei) within the first year of life,PDIA2,PDIA4,PDIA6,Phenobarbital which induces the partially deficient glucuronyl transferase can diminish the jaundice,porphyrin-containing compound metabolic process,PPIB,Prostate Cancer,protects from bladder cancer,protein heterodimerization activity,protein homodimerization activity,Reference proteome,response to drug,response to lipopolysaccharide,response to nutrient,response to starvation,retinoic acid binding,retinoic acid metabolic process,scopoletin,SDF2L1,serum bilirubin,Signal,small molecule metabolic process,steroid binding,steroid metabolic process,The defect has been ascribed to various breast milk substances but the component or combination of compone",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs4148325",
        "SNP Name": "UGT1A1 C179920T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4148325",
        "Video": null,
        "Tags": "1-hydroxypyrene,1-naphthol,17alpha-ethinylestradiol,4-methylumbelliferone,A condition characterized by excessive concentration of bilirubin in the blood which may lead to jaundice,acute-phase response,Alternative splicing,and umbelliferone,Belongs to the UDP-glycosyltransferase family,BILIQTL1,Bilirubin,bilirubin conjugation,Bilirubin Levels,Bilirubin-specific UDPGT isozyme 1,biphenyl catabolic process,Breast milk jaundice is a common problem in nursing infants,CALR,cancer,cancerous,CANX,carcinogen,Cardiovascular,cellular glucuronidation,cellular response to ethanol,cellular response to glucocorticoid stimulus,Cholelithiasis,Cholelithiasis Risk in Sickle Cell Anemia,CN1,CN1 inheritance is autosomal recessive,CN2,CN2 inheritance is autosomal dominant,colon and small intestine,Complete proteome,Crigler-Najjar syndrome 1,Crigler-Najjar syndrome 2,CVD,cytochrome complex,Defects of UGT1A1 are an underlying cause of the prolonged unconjugated hyperbilirubinemia associated with breast milk,digestion,Disease mutation,drug metabolic process,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane;Single-pass membrane protein,enzyme binding,enzyme inhibitor activity,estrogen metabolic process,flavone metabolic process,flavonoid glucuronidation,From the 27 possible mRNA isoforms 9 produce functionally active polypeptides (UGT1A1 & 1A3 & 1A4 & 1A5 & 1A6 & 1A7 & 1A8 & 1A9 and 1A10) called isoforms 1 (i1),Genetic variation in UGT1A1 defines the bilirubin serum levels quantitative trait locus 1,Gilbert syndrome,GILBS,glucuronosyltransferase activity,Glycoprotein,Glycosyltransferase,GNT1,HBLRTFN,heart,heme catabolic process,heterocycle metabolic process,heterocyclic amines,HSP90B1,HSPA5,hUG-BR1,HYOU,hyperbilirubinemia,integral component of plasma membrane,Is also able to catalyze the glucuronidation of 17beta-estradiol,Isoform 1 also interacts with respective i2 isoforms of UGT1A3,Isoform 1 and isoform 2 are expressed in liver,Isoform 1 and isoform 2 are not expressed in esophagus,Isoform 1 interacts with isoform 2/i2suggesting that oligomerization is involved in negative regulation of transferase activity by isoform 2,Isoform 2 but not isoform 1 is expressed in kidney,Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1,liver development,Membrane,Microsome,Mutations are identical to those detected in patients with Gilbert syndrome a risk factor of neonatal non-physiologic hyperbilirubinemia and a genetic factor in fasting hyperbilirubinemia,negative regulation of catalytic activity,negative regulation of cellular glucuronidation,negative regulation of steroid metabolic process,Not expressed in skin,Occurs as a consequence of reduced bilirubin transferase activity and is often detected in young adults with vague non-specific complaints,One or more components in the milk may trigger the jaundice in infants who have such mutations,organ regeneration,paranitrophenol,Part of a large chaperone multiprotein complex comprising DNAJB11,Patients have less severe hyperbilirubinemia and usually survive into adulthood without neurologic damage,Patients have severe hyperbilirubinemia and usually die of kernicterus (bilirubin accumulation in the basal ganglia and brainstem nuclei) within the first year of life,PDIA2,PDIA4,PDIA6,Phenobarbital which induces the partially deficient glucuronyl transferase can diminish the jaundice,porphyrin-containing compound metabolic process,PPIB,Prostate Cancer,protein heterodimerization activity,protein homodimerization activity,Reference proteome,response to drug,response to lipopolysaccharide,response to nutrient,response to starvation,retinoic acid binding,retinoic acid metabolic process,scopoletin,SDF2L1,serum bilirubin,Signal,small molecule metabolic process,steroid binding,steroid metabolic process,The defect has been ascribed to various breast milk substances but the component or combination of components that is responsible remains unclear",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs62625011",
        "SNP Name": "UGT1A1 G182349A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs62625011",
        "Video": null,
        "Tags": "1-hydroxypyrene,1-naphthol,17alpha-ethinylestradiol,4-methylumbelliferone,A condition characterized by excessive concentration of bilirubin in the blood which may lead to jaundice,acute-phase response,Alternative splicing,and umbelliferone,Belongs to the UDP-glycosyltransferase family,BILIQTL1,bilirubin conjugation,Bilirubin-specific UDPGT isozyme 1,biphenyl catabolic process,Breast milk jaundice is a common problem in nursing infants,CALR,CANX,cellular glucuronidation,cellular response to ethanol,cellular response to glucocorticoid stimulus,CN1,CN1 inheritance is autosomal recessive,CN2,CN2 inheritance is autosomal dominant,colon and small intestine,Complete proteome,Crigler-Najjar syndrome 1,Crigler-Najjar syndrome 2,cytochrome complex,Defects of UGT1A1 are an underlying cause of the prolonged unconjugated hyperbilirubinemia associated with breast milk,digestion,Disease mutation,drug metabolic process,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane;Single-pass membrane protein,enzyme binding,enzyme inhibitor activity,estrogen metabolic process,flavone metabolic process,flavonoid glucuronidation,From the 27 possible mRNA isoforms 9 produce functionally active polypeptides (UGT1A1 & 1A3 & 1A4 & 1A5 & 1A6 & 1A7 & 1A8 & 1A9 and 1A10) called isoforms 1 (i1),Genetic variation in UGT1A1 defines the bilirubin serum levels quantitative trait locus 1,Gilbert syndrome,GILBS,glucuronosyltransferase activity,Glycoprotein,Glycosyltransferase,GNT1,HBLRTFN,heme catabolic process,heterocycle metabolic process,HSP90B1,HSPA5,hUG-BR1,HYOU,hyperbilirubinemia,integral component of plasma membrane,Is also able to catalyze the glucuronidation of 17beta-estradiol,Isoform 1 also interacts with respective i2 isoforms of UGT1A3,Isoform 1 and isoform 2 are expressed in liver,Isoform 1 and isoform 2 are not expressed in esophagus,Isoform 1 interacts with isoform 2/i2suggesting that oligomerization is involved in negative regulation of transferase activity by isoform 2,Isoform 2 but not isoform 1 is expressed in kidney,Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1,liver development,Membrane,Microsome,Mutations are identical to those detected in patients with Gilbert syndrome a risk factor of neonatal non-physiologic hyperbilirubinemia and a genetic factor in fasting hyperbilirubinemia,negative regulation of catalytic activity,negative regulation of cellular glucuronidation,negative regulation of steroid metabolic process,Not expressed in skin,Occurs as a consequence of reduced bilirubin transferase activity and is often detected in young adults with vague non-specific complaints,One or more components in the milk may trigger the jaundice in infants who have such mutations,organ regeneration,paranitrophenol,Part of a large chaperone multiprotein complex comprising DNAJB11,Patients have less severe hyperbilirubinemia and usually survive into adulthood without neurologic damage,Patients have severe hyperbilirubinemia and usually die of kernicterus (bilirubin accumulation in the basal ganglia and brainstem nuclei) within the first year of life,PDIA2,PDIA4,PDIA6,Phenobarbital which induces the partially deficient glucuronyl transferase can diminish the jaundice,porphyrin-containing compound metabolic process,PPIB,protein heterodimerization activity,protein homodimerization activity,Reference proteome,response to drug,response to lipopolysaccharide,response to nutrient,response to starvation,retinoic acid binding,retinoic acid metabolic process,scopoletin,SDF2L1,Signal,small molecule metabolic process,steroid binding,steroid metabolic process,The defect has been ascribed to various breast milk substances but the component or combination of components that is responsible remains unclear,The disease is caused by mutations affecting the gene represented in this entry,The disease may be caused by mutations affecting the gene represented in this entry,The gene is part of the UGT1A comple",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs72551348",
        "SNP Name": "UGT1A1 G328A",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs72551348",
        "Video": null,
        "Tags": "1-hydroxypyrene,1-naphthol,17alpha-ethinylestradiol,4-methylumbelliferone,A condition characterized by excessive concentration of bilirubin in the blood which may lead to jaundice,acute-phase response,Alternative splicing,and umbelliferone,Belongs to the UDP-glycosyltransferase family,BILIQTL1,bilirubin conjugation,Bilirubin-specific UDPGT isozyme 1,biphenyl catabolic process,Breast milk jaundice is a common problem in nursing infants,CALR,CANX,cellular glucuronidation,cellular response to ethanol,cellular response to glucocorticoid stimulus,CN1,CN1 inheritance is autosomal recessive,CN2,CN2 inheritance is autosomal dominant,colon and small intestine,Complete proteome,Crigler-Najjar syndrome 1,Crigler-Najjar syndrome 2,cytochrome complex,Defects of UGT1A1 are an underlying cause of the prolonged unconjugated hyperbilirubinemia associated with breast milk,digestion,Disease mutation,drug metabolic process,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane;Single-pass membrane protein,enzyme binding,enzyme inhibitor activity,estrogen metabolic process,flavone metabolic process,flavonoid glucuronidation,From the 27 possible mRNA isoforms 9 produce functionally active polypeptides (UGT1A1 & 1A3 & 1A4 & 1A5 & 1A6 & 1A7 & 1A8 & 1A9 and 1A10) called isoforms 1 (i1),Genetic variation in UGT1A1 defines the bilirubin serum levels quantitative trait locus 1,Gilbert syndrome,GILBS,glucuronosyltransferase activity,Glycoprotein,Glycosyltransferase,GNT1,HBLRTFN,heme catabolic process,heterocycle metabolic process,HSP90B1,HSPA5,hUG-BR1,HYOU,hyperbilirubinemia,integral component of plasma membrane,Is also able to catalyze the glucuronidation of 17beta-estradiol,Isoform 1 also interacts with respective i2 isoforms of UGT1A3,Isoform 1 and isoform 2 are expressed in liver,Isoform 1 and isoform 2 are not expressed in esophagus,Isoform 1 interacts with isoform 2/i2suggesting that oligomerization is involved in negative regulation of transferase activity by isoform 2,Isoform 2 but not isoform 1 is expressed in kidney,Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1,liver development,Membrane,Microsome,Mutations are identical to those detected in patients with Gilbert syndrome a risk factor of neonatal non-physiologic hyperbilirubinemia and a genetic factor in fasting hyperbilirubinemia,negative regulation of catalytic activity,negative regulation of cellular glucuronidation,negative regulation of steroid metabolic process,Not expressed in skin,Occurs as a consequence of reduced bilirubin transferase activity and is often detected in young adults with vague non-specific complaints,One or more components in the milk may trigger the jaundice in infants who have such mutations,organ regeneration,paranitrophenol,Part of a large chaperone multiprotein complex comprising DNAJB11,Patients have less severe hyperbilirubinemia and usually survive into adulthood without neurologic damage,Patients have severe hyperbilirubinemia and usually die of kernicterus (bilirubin accumulation in the basal ganglia and brainstem nuclei) within the first year of life,PDIA2,PDIA4,PDIA6,Phenobarbital which induces the partially deficient glucuronyl transferase can diminish the jaundice,porphyrin-containing compound metabolic process,PPIB,protein heterodimerization activity,protein homodimerization activity,Reference proteome,response to drug,response to lipopolysaccharide,response to nutrient,response to starvation,retinoic acid binding,retinoic acid metabolic process,scopoletin,SDF2L1,Signal,small molecule metabolic process,steroid binding,steroid metabolic process,The defect has been ascribed to various breast milk substances but the component or combination of components that is responsible remains unclear,The disease is caused by mutations affecting the gene represented in this entry,The disease may be caused by mutations affecting the gene represented in this entry,The gene is part of the UGT1A comple",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs72551351",
        "SNP Name": "UGT1A1 G354A",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs72551351",
        "Video": null,
        "Tags": "1-hydroxypyrene,1-naphthol,17alpha-ethinylestradiol,4-methylumbelliferone,A condition characterized by excessive concentration of bilirubin in the blood which may lead to jaundice,acute-phase response,Alternative splicing,and umbelliferone,Belongs to the UDP-glycosyltransferase family,BILIQTL1,bilirubin conjugation,Bilirubin-specific UDPGT isozyme 1,biphenyl catabolic process,Breast milk jaundice is a common problem in nursing infants,CALR,CANX,cellular glucuronidation,cellular response to ethanol,cellular response to glucocorticoid stimulus,CN1,CN1 inheritance is autosomal recessive,CN2,CN2 inheritance is autosomal dominant,colon and small intestine,Complete proteome,Crigler-Najjar syndrome 1,Crigler-Najjar syndrome 2,cytochrome complex,Defects of UGT1A1 are an underlying cause of the prolonged unconjugated hyperbilirubinemia associated with breast milk,digestion,Disease mutation,drug metabolic process,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane;Single-pass membrane protein,enzyme binding,enzyme inhibitor activity,estrogen metabolic process,flavone metabolic process,flavonoid glucuronidation,From the 27 possible mRNA isoforms 9 produce functionally active polypeptides (UGT1A1 & 1A3 & 1A4 & 1A5 & 1A6 & 1A7 & 1A8 & 1A9 and 1A10) called isoforms 1 (i1),Genetic variation in UGT1A1 defines the bilirubin serum levels quantitative trait locus 1,Gilbert syndrome,GILBS,glucuronosyltransferase activity,Glycoprotein,Glycosyltransferase,GNT1,HBLRTFN,heme catabolic process,heterocycle metabolic process,HSP90B1,HSPA5,hUG-BR1,HYOU,hyperbilirubinemia,integral component of plasma membrane,Is also able to catalyze the glucuronidation of 17beta-estradiol,Isoform 1 also interacts with respective i2 isoforms of UGT1A3,Isoform 1 and isoform 2 are expressed in liver,Isoform 1 and isoform 2 are not expressed in esophagus,Isoform 1 interacts with isoform 2/i2suggesting that oligomerization is involved in negative regulation of transferase activity by isoform 2,Isoform 2 but not isoform 1 is expressed in kidney,Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1,liver development,Membrane,Microsome,Mutations are identical to those detected in patients with Gilbert syndrome a risk factor of neonatal non-physiologic hyperbilirubinemia and a genetic factor in fasting hyperbilirubinemia,negative regulation of catalytic activity,negative regulation of cellular glucuronidation,negative regulation of steroid metabolic process,Not expressed in skin,Occurs as a consequence of reduced bilirubin transferase activity and is often detected in young adults with vague non-specific complaints,One or more components in the milk may trigger the jaundice in infants who have such mutations,organ regeneration,paranitrophenol,Part of a large chaperone multiprotein complex comprising DNAJB11,Patients have less severe hyperbilirubinemia and usually survive into adulthood without neurologic damage,Patients have severe hyperbilirubinemia and usually die of kernicterus (bilirubin accumulation in the basal ganglia and brainstem nuclei) within the first year of life,PDIA2,PDIA4,PDIA6,Phenobarbital which induces the partially deficient glucuronyl transferase can diminish the jaundice,porphyrin-containing compound metabolic process,PPIB,protein heterodimerization activity,protein homodimerization activity,Reference proteome,response to drug,response to lipopolysaccharide,response to nutrient,response to starvation,retinoic acid binding,retinoic acid metabolic process,scopoletin,SDF2L1,Signal,small molecule metabolic process,steroid binding,steroid metabolic process,The defect has been ascribed to various breast milk substances but the component or combination of components that is responsible remains unclear,The disease is caused by mutations affecting the gene represented in this entry,The disease may be caused by mutations affecting the gene represented in this entry,The gene is part of the UGT1A comple",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs6717546",
        "SNP Name": "UGT1A1 A188730G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6717546",
        "Video": null,
        "Tags": "1-hydroxypyrene,1-naphthol,17alpha-ethinylestradiol,4-methylumbelliferone,A condition characterized by excessive concentration of bilirubin in the blood which may lead to jaundice,acute-phase response,advanced colorectal adenoma,Alternative splicing,and umbelliferone,Belongs to the UDP-glycosyltransferase family,BILIQTL1,bilirubin conjugation,Bilirubin-specific UDPGT isozyme 1,biphenyl catabolic process,Breast milk jaundice is a common problem in nursing infants,CALR,cancer,cancerous,CANX,carcinogen,cellular glucuronidation,cellular response to ethanol,cellular response to glucocorticoid stimulus,CN1,CN1 inheritance is autosomal recessive,CN2,CN2 inheritance is autosomal dominant,colon and small intestine,colorectal adenoma,Complete proteome,Crigler-Najjar syndrome 1,Crigler-Najjar syndrome 2,cytochrome complex,Defects of UGT1A1 are an underlying cause of the prolonged unconjugated hyperbilirubinemia associated with breast milk,digestion,Disease mutation,drug metabolic process,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane;Single-pass membrane protein,enzyme binding,enzyme inhibitor activity,estrogen metabolic process,flavone metabolic process,flavonoid glucuronidation,From the 27 possible mRNA isoforms 9 produce functionally active polypeptides (UGT1A1 & 1A3 & 1A4 & 1A5 & 1A6 & 1A7 & 1A8 & 1A9 and 1A10) called isoforms 1 (i1),Genetic variation in UGT1A1 defines the bilirubin serum levels quantitative trait locus 1,Gilbert syndrome,GILBS,glucuronosyltransferase activity,Glycoprotein,Glycosyltransferase,GNT1,HBLRTFN,heme catabolic process,heterocycle metabolic process,HSP90B1,HSPA5,hUG-BR1,HYOU,hyperbilirubinemia,integral component of plasma membrane,Is also able to catalyze the glucuronidation of 17beta-estradiol,Isoform 1 also interacts with respective i2 isoforms of UGT1A3,Isoform 1 and isoform 2 are expressed in liver,Isoform 1 and isoform 2 are not expressed in esophagus,Isoform 1 interacts with isoform 2/i2suggesting that oligomerization is involved in negative regulation of transferase activity by isoform 2,Isoform 2 but not isoform 1 is expressed in kidney,Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1,liver development,Membrane,Microsome,Mutations are identical to those detected in patients with Gilbert syndrome a risk factor of neonatal non-physiologic hyperbilirubinemia and a genetic factor in fasting hyperbilirubinemia,negative regulation of catalytic activity,negative regulation of cellular glucuronidation,negative regulation of steroid metabolic process,Not expressed in skin,Occurs as a consequence of reduced bilirubin transferase activity and is often detected in young adults with vague non-specific complaints,One or more components in the milk may trigger the jaundice in infants who have such mutations,organ regeneration,paranitrophenol,Part of a large chaperone multiprotein complex comprising DNAJB11,Patients have less severe hyperbilirubinemia and usually survive into adulthood without neurologic damage,Patients have severe hyperbilirubinemia and usually die of kernicterus (bilirubin accumulation in the basal ganglia and brainstem nuclei) within the first year of life,PDIA2,PDIA4,PDIA6,Phenobarbital which induces the partially deficient glucuronyl transferase can diminish the jaundice,porphyrin-containing compound metabolic process,PPIB,Prostate Cancer,protein heterodimerization activity,protein homodimerization activity,Reference proteome,response to drug,response to lipopolysaccharide,response to nutrient,response to starvation,retinoic acid binding,retinoic acid metabolic process,scopoletin,SDF2L1,Signal,small molecule metabolic process,steroid binding,steroid metabolic process,The defect has been ascribed to various breast milk substances but the component or combination of components that is responsible remains unclear,The disease is caused by mutations affecting the gene represented in this entry,The disease may be cause",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs34116584",
        "SNP Name": "AGXT P11R",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs34116584",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs34116584",
        "SNP Name": "AGXT P11R",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs34116584",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs4426527",
        "SNP Name": "AGXT I340M",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4426527",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs4426527",
        "SNP Name": "AGXT I340M",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4426527",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs237875",
        "SNP Name": "CTSL1 A8782406G",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Benzethonium Chloride"
    },
    {
        "SNP ID": "rs901865",
        "SNP Name": "HRH1 T-17C",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs901865",
        "Video": "sd6UujGt7b8",
        "Tags": "adrenal medulla,agonist-induced receptor downregulation,catecholamine,Cell membrane,cellular response to histamine,central nervous system,cognition,cytoplasmic loops,Disulfide bond,downregulation,drug reaction,drugs,eosinophil chemotaxis,G-protein coupled receptor,G-protein coupled receptor activity,G-protein coupled receptor signaling pathway,Glycoprotein,H1R,HH1R,histamine,Histamine H1 receptor,histamine induced schizophrenia,histamine receptor activity,histamine receptors,HRH1,immune system,inflammation,inflammatory response,inositol,inositol phosphate-mediated signaling,integral component of plasma membrane,learning,Lipoprotein,Membrane,memory,mental disorder,Multi-pass membrane protein,muscle,muscle tone,neurotransmission,neurotransmitters,Palmitate,phosphate,phospholipase C-activating G-protein coupled receptor signaling pathway,Phosphoprotein,Phosphorylation,plasma membrane,Polymorphism,positive regulation of inositol trisphosphate biosynthetic process,positive regulation of vasoconstriction,Receptor,Red man syndrome,regulation of synaptic plasticity,regulation of vascular permeability,schizophrenia,terminal venules,Transducer,Transmembrane,Transmembrane helix,vancomycin,visual learning",
        "Group": "Protamine Sulphate"
    },
    {
        "SNP ID": "rs901865",
        "SNP Name": "HRH1 T-17C",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs901865",
        "Video": "sd6UujGt7b8",
        "Tags": "adrenal medulla,agonist-induced receptor downregulation,catecholamine,Cell membrane,cellular response to histamine,central nervous system,cognition,cytoplasmic loops,Disulfide bond,downregulation,drug reaction,drugs,eosinophil chemotaxis,G-protein coupled receptor,G-protein coupled receptor activity,G-protein coupled receptor signaling pathway,Glycoprotein,H1R,HH1R,histamine,Histamine H1 receptor,histamine induced schizophrenia,histamine receptor activity,histamine receptors,HRH1,immune system,inflammation,inflammatory response,inositol,inositol phosphate-mediated signaling,integral component of plasma membrane,learning,Lipoprotein,Membrane,memory,mental disorder,Multi-pass membrane protein,muscle,muscle tone,neurotransmission,neurotransmitters,Palmitate,phosphate,phospholipase C-activating G-protein coupled receptor signaling pathway,Phosphoprotein,Phosphorylation,plasma membrane,Polymorphism,positive regulation of inositol trisphosphate biosynthetic process,positive regulation of vasoconstriction,Receptor,Red man syndrome,regulation of synaptic plasticity,regulation of vascular permeability,schizophrenia,terminal venules,Transducer,Transmembrane,Transmembrane helix,vancomycin,visual learning",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs346070",
        "SNP Name": "HRH1 T*1687C",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs346070",
        "Video": "sd6UujGt7b8",
        "Tags": "adrenal medulla,agonist-induced receptor downregulation,antipsychotic medication,Antipsychotics,benzo,benzodiazepin,BMI,catecholamine,Cell membrane,cellular response to histamine,central nervous system,cognition,cytoplasmic loops,Disulfide bond,downregulation,drug metabolism,drug reaction,eosinophil chemotaxis,G-protein coupled receptor,G-protein coupled receptor activity,G-protein coupled receptor signaling pathway,GABA,Glycoprotein,H1R,HbA1c,HH1R,histamine,Histamine H1 receptor,histamine induced schizophrenia,histamine receptor activity,histamine receptors,HRH1,Hyperglycemia,immune system,inflammation,inflammatory response,inositol,inositol phosphate-mediated signaling,integral component of plasma membrane,learning,Lipoprotein,Membrane,memory,mental disorder,Multi-pass membrane protein,Muscarine,muscarinic acetylcholine receptor M3 (CHRM3),muscarinic M3 receptors,muscle,muscle tone,neurotransmission,neurotransmitters,Palmitate,Pharmacogenetics,phosphate,phospholipase C-activating G-protein coupled receptor signaling pathway,Phosphoprotein,Phosphorylation,plasma membrane,Polymorphism,positive regulation of inositol trisphosphate biosynthetic process,positive regulation of vasoconstriction,Receptor,regulation of synaptic plasticity,regulation of vascular permeability,schizophrenia,Schizophrenia research,SSRI,terminal venules,Transducer,Transmembrane,Transmembrane helix,visual learning,Weight gain",
        "Group": "Protamine Sulphate"
    },
    {
        "SNP ID": "rs346070",
        "SNP Name": "HRH1 T*1687C",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs346070",
        "Video": "sd6UujGt7b8",
        "Tags": "adrenal medulla,agonist-induced receptor downregulation,antipsychotic medication,Antipsychotics,benzo,benzodiazepin,BMI,catecholamine,Cell membrane,cellular response to histamine,central nervous system,cognition,cytoplasmic loops,Disulfide bond,downregulation,drug metabolism,drug reaction,eosinophil chemotaxis,G-protein coupled receptor,G-protein coupled receptor activity,G-protein coupled receptor signaling pathway,GABA,Glycoprotein,H1R,HbA1c,HH1R,histamine,Histamine H1 receptor,histamine induced schizophrenia,histamine receptor activity,histamine receptors,HRH1,Hyperglycemia,immune system,inflammation,inflammatory response,inositol,inositol phosphate-mediated signaling,integral component of plasma membrane,learning,Lipoprotein,Membrane,memory,mental disorder,Multi-pass membrane protein,Muscarine,muscarinic acetylcholine receptor M3 (CHRM3),muscarinic M3 receptors,muscle,muscle tone,neurotransmission,neurotransmitters,Palmitate,Pharmacogenetics,phosphate,phospholipase C-activating G-protein coupled receptor signaling pathway,Phosphoprotein,Phosphorylation,plasma membrane,Polymorphism,positive regulation of inositol trisphosphate biosynthetic process,positive regulation of vasoconstriction,Receptor,regulation of synaptic plasticity,regulation of vascular permeability,schizophrenia,Schizophrenia research,SSRI,terminal venules,Transducer,Transmembrane,Transmembrane helix,visual learning,Weight gain",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs3729931",
        "SNP Name": "RAF1 G12626516A",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Deoxycholate"
    },
    {
        "SNP ID": "rs72555366",
        "SNP Name": "GLB1 A178C",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Lactose"
    },
    {
        "SNP ID": "rs72555360",
        "SNP Name": "GLB1 A171C",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Lactose"
    },
    {
        "SNP ID": "rs72555392",
        "SNP Name": "GLB1 A59H",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Anhydrous Lactose"
    },
    {
        "SNP ID": "rs72555392",
        "SNP Name": "GLB1 A59H",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Lactose"
    },
    {
        "SNP ID": "rs72555358",
        "SNP Name": "GLB1 C145T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Anhydrous Lactose"
    },
    {
        "SNP ID": "rs72555358",
        "SNP Name": "GLB1 C145T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Lactose"
    },
    {
        "SNP ID": "rs6441961",
        "SNP Name": "3p21 near CCR3 1184A>G variant",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Celiac Disease/Gluten Intolerance"
    },
    {
        "SNP ID": "rs11130362",
        "SNP Name": "TKT C53265766T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=rs11130362",
        "Video": null,
        "Tags": "1 protein kinase,ablosihes signaling in response collagen binding,abolishes collagen binding,abolishes kinase activity,abolishes phosphorylation,acitvation of the transcription factor RUNX2,active site,ADP,anterior protrusions,apical plasma membrane,ATP,ATP binding,ATP-binding,autophosphorylation,binding site,binds hydroxyproline-rich sequence motifs in fibrillar,Biological processing,biomineral tissue development,bone development,bone disease,bone lining cells,brain,C53265766T,cartilage,catalytic activity,causes retention in intracellular compartment,CD167 antigen-like family member B,CD167b,CD_antigen,cell adhesion,cell membrane,cell migration,cell proliferation,cell surface receptor,central humps,characteristic craniofacial appearance,chondrocyte maturation,chondrocyte proliferation,collagen binding,collagen fibril organization,collagen-activated tyrosine kinase receptor signaling pathway,cutaneous wound healing,cytoplasmic,DDR2,Discoidin domain receptor 2,Discoidin domain-containing receptor 2,Discoidin domain-containing receptor tyrosine kinase 2,disease mutation,distinctive radiological findings,Disulfide bond,Domaini,Dwarfism,endochondral bone growth,Extracellular,extracellular exosome,extracellular matrix,extracellular matrix organization,F-736,F-740,facilitiates cell migration,feet brachydactyly,fibrillar collagen,flared,flattened,focal adhesion,fragmented,Glycoprotein,glycosylated collagen,GQOGVMGFO motif,hand brachydactyly,heart,helical,hydroxyproline,in SEMD-SL,in vitro,Insulin receptor subfamily,integral component of plasma membrane,Interacts (tyrosine phosphorylated) with SHC1,Interacts with SRC,irregular metaphyses. Platyspondyly in the spine,kidney,Kinase,L-tyrosin phosphate,L-tyrosine,Ligandi,liver,lung,lung large cell carcinoma,MAP kinases,Membrane,MMP1,MMP13,MMP2,Molecular functioning,muscle,mutagenesis,mutations,N-glycosylated,narrow chest,Neurotrophic tyrosine kinase,Non-integrin membrane-ECM interactions,NTRKR3,nucleoptide binding,Nucleotide-binding,ossification,osteoarthritis patients,osteoblast differentiation,osteoblastic cells,osteocytes,Osteogenesis,pancreas,pear-shaped vertebral bodies,pectus excavatum,pentose-phosphate pathway,peptidyl-tyrosine phosphorylation,Phosphoprotein,phosphorylation,placenta,plasma membrane,positive regulation of extracellular matrix disassembly,positive regulation of fibroblast migration,positive regulation of fibroblast proliferation,positive regulation of osteoblast differentiation,positive regulation of protein kinase activity,positive regulation of sequence-specific DNA binding transcription factor activity,posterior scalloping,premature calcifications,proliferation,promotes fibrolast migration,protein,protein autophosphorylation regulation of bone mineralization,protein kinase superfamily,protein level,protein tyrosine kinase collagen receptor activity,proton acceptor,Receptor,Receptor protein-tyrosine kinase,receptor-related 3,reduces autophosphorylation,regorafenib,regulates cell differentiation,regulates remodeling,regulation of extracellular matrix disassembly,remodeling of the extracellular matrix,rs11130362,RUNX2,short long bones,short-limbed dwarfism,Signal,signal transduction,signaling pathway,single-opass type I membrane protein,skeletal,skeleton,Spondyloepimetaphyseal dysplasia short limb-hand type,SRC,stippled,striking epiphyses,subchondral bone,tibia,TKT,Transferase,Transmembrane,Transmembrane helix,transmembrane receptor protein tyrosine kinase activity,tumor cell invasion,Tyr protein kinase family,TYRO10,Tyrosine kinase,Tyrosine phosphorylated,Tyrosine phosphorylation,tyrosine residues,Tyrosine-protein kinase,up regualtion of the collagenases,up-regulated in cartilege,wide intervertebral spaces",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs11130362",
        "SNP Name": "TKT C53265766T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=rs11130362",
        "Video": null,
        "Tags": "1 protein kinase,ablosihes signaling in response collagen binding,abolishes collagen binding,abolishes kinase activity,abolishes phosphorylation,acitvation of the transcription factor RUNX2,active site,ADP,anterior protrusions,apical plasma membrane,ATP,ATP binding,ATP-binding,autophosphorylation,binding site,binds hydroxyproline-rich sequence motifs in fibrillar,Biological processing,biomineral tissue development,bone development,bone disease,bone lining cells,brain,C53265766T,cartilage,catalytic activity,causes retention in intracellular compartment,CD167 antigen-like family member B,CD167b,CD_antigen,cell adhesion,cell membrane,cell migration,cell proliferation,cell surface receptor,central humps,characteristic craniofacial appearance,chondrocyte maturation,chondrocyte proliferation,collagen binding,collagen fibril organization,collagen-activated tyrosine kinase receptor signaling pathway,cutaneous wound healing,cytoplasmic,DDR2,Discoidin domain receptor 2,Discoidin domain-containing receptor 2,Discoidin domain-containing receptor tyrosine kinase 2,disease mutation,distinctive radiological findings,Disulfide bond,Domaini,Dwarfism,endochondral bone growth,Extracellular,extracellular exosome,extracellular matrix,extracellular matrix organization,F-736,F-740,facilitiates cell migration,feet brachydactyly,fibrillar collagen,flared,flattened,focal adhesion,fragmented,Glycoprotein,glycosylated collagen,GQOGVMGFO motif,hand brachydactyly,heart,helical,hydroxyproline,in SEMD-SL,in vitro,Insulin receptor subfamily,integral component of plasma membrane,Interacts (tyrosine phosphorylated) with SHC1,Interacts with SRC,irregular metaphyses. Platyspondyly in the spine,kidney,Kinase,L-tyrosin phosphate,L-tyrosine,Ligandi,liver,lung,lung large cell carcinoma,MAP kinases,Membrane,MMP1,MMP13,MMP2,Molecular functioning,muscle,mutagenesis,mutations,N-glycosylated,narrow chest,Neurotrophic tyrosine kinase,Non-integrin membrane-ECM interactions,NTRKR3,nucleoptide binding,Nucleotide-binding,ossification,osteoarthritis patients,osteoblast differentiation,osteoblastic cells,osteocytes,Osteogenesis,pancreas,pear-shaped vertebral bodies,pectus excavatum,pentose-phosphate pathway,peptidyl-tyrosine phosphorylation,Phosphoprotein,phosphorylation,placenta,plasma membrane,positive regulation of extracellular matrix disassembly,positive regulation of fibroblast migration,positive regulation of fibroblast proliferation,positive regulation of osteoblast differentiation,positive regulation of protein kinase activity,positive regulation of sequence-specific DNA binding transcription factor activity,posterior scalloping,premature calcifications,proliferation,promotes fibrolast migration,protein,protein autophosphorylation regulation of bone mineralization,protein kinase superfamily,protein level,protein tyrosine kinase collagen receptor activity,proton acceptor,Receptor,Receptor protein-tyrosine kinase,receptor-related 3,reduces autophosphorylation,regorafenib,regulates cell differentiation,regulates remodeling,regulation of extracellular matrix disassembly,remodeling of the extracellular matrix,rs11130362,RUNX2,short long bones,short-limbed dwarfism,Signal,signal transduction,signaling pathway,single-opass type I membrane protein,skeletal,skeleton,Spondyloepimetaphyseal dysplasia short limb-hand type,SRC,stippled,striking epiphyses,subchondral bone,tibia,TKT,Transferase,Transmembrane,Transmembrane helix,transmembrane receptor protein tyrosine kinase activity,tumor cell invasion,Tyr protein kinase family,TYRO10,Tyrosine kinase,Tyrosine phosphorylated,Tyrosine phosphorylation,tyrosine residues,Tyrosine-protein kinase,up regualtion of the collagenases,up-regulated in cartilege,wide intervertebral spaces",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs4687717",
        "SNP Name": "TKT T53282188C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4687717",
        "Video": null,
        "Tags": "1 protein kinase,ablosihes signaling in response collagen binding,abolishes collagen binding,abolishes kinase activity,abolishes phosphorylation,acitvation of the transcription factor RUNX2,active site,ADP,anterior protrusions,apical plasma membrane,ATP,ATP binding,ATP-binding,autophosphorylation,binding site,binds hydroxyproline-rich sequence motifs in fibrillar,Biological processing,biomineral tissue development,bone development,bone disease,bone lining cells,brain,cartilage,catalytic activity,causes retention in intracellular compartment,CD167 antigen-like family member B,CD167b,CD_antigen,cell adhesion,cell membrane,cell migration,cell proliferation,cell surface receptor,central humps,characteristic craniofacial appearance,chondrocyte maturation,chondrocyte proliferation,collagen binding,collagen fibril organization,collagen-activated tyrosine kinase receptor signaling pathway,cutaneous wound healing,cytoplasmic,DDR2,Discoidin domain receptor 2,Discoidin domain-containing receptor 2,Discoidin domain-containing receptor tyrosine kinase 2,disease mutation,distinctive radiological findings,Disulfide bond,Domaini,Dwarfism,endochondral bone growth,Extracellular,extracellular exosome,extracellular matrix,extracellular matrix organization,F-736,F-740,facilitiates cell migration,feet brachydactyly,fibrillar collagen,flared,flattened,focal adhesion,fragmented,Glycoprotein,glycosylated collagen,GQOGVMGFO motif,hand brachydactyly,heart,helical,hydroxyproline,in SEMD-SL,in vitro,Insulin receptor subfamily,integral component of plasma membrane,Interacts (tyrosine phosphorylated) with SHC1,Interacts with SRC,irregular metaphyses. Platyspondyly in the spine,kidney,Kinase,L-tyrosin phosphate,L-tyrosine,Ligandi,liver,lung,lung large cell carcinoma,MAP kinases,Membrane,MMP1,MMP13,MMP2,Molecular functioning,muscle,mutagenesis,mutations,N-glycosylated,narrow chest,Neurotrophic tyrosine kinase,Non-integrin membrane-ECM interactions,NTRKR3,nucleoptide binding,Nucleotide-binding,ossification,osteoarthritis patients,osteoblast differentiation,osteoblastic cells,osteocytes,Osteogenesis,pancreas,pear-shaped vertebral bodies,pectus excavatum,pentose-phosphate pathway,peptidyl-tyrosine phosphorylation,Phosphoprotein,phosphorylation,placenta,plasma membrane,positive regulation of extracellular matrix disassembly,positive regulation of fibroblast migration,positive regulation of fibroblast proliferation,positive regulation of osteoblast differentiation,positive regulation of protein kinase activity,positive regulation of sequence-specific DNA binding transcription factor activity,posterior scalloping,premature calcifications,proliferation,promotes fibrolast migration,protein,protein autophosphorylation regulation of bone mineralization,protein kinase superfamily,protein level,protein tyrosine kinase collagen receptor activity,proton acceptor,Receptor,Receptor protein-tyrosine kinase,receptor-related 3,reduces autophosphorylation,regorafenib,regulates cell differentiation,regulates remodeling,regulation of extracellular matrix disassembly,remodeling of the extracellular matrix,rs4687717,RUNX2,short long bones,short-limbed dwarfism,Signal,signal transduction,signaling pathway,single-opass type I membrane protein,skeletal,skeleton,Spondyloepimetaphyseal dysplasia short limb-hand type,SRC,stippled,striking epiphyses,subchondral bone,T53282188C,tibia,TKT,Transferase,Transmembrane,Transmembrane helix,transmembrane receptor protein tyrosine kinase activity,tumor cell invasion,Tyr protein kinase family,TYRO10,Tyrosine kinase,Tyrosine phosphorylated,Tyrosine phosphorylation,tyrosine residues,Tyrosine-protein kinase,up regualtion of the collagenases,up-regulated in cartilege,wide intervertebral spaces",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs4687717",
        "SNP Name": "TKT T53282188C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4687717",
        "Video": null,
        "Tags": "1 protein kinase,ablosihes signaling in response collagen binding,abolishes collagen binding,abolishes kinase activity,abolishes phosphorylation,acitvation of the transcription factor RUNX2,active site,ADP,anterior protrusions,apical plasma membrane,ATP,ATP binding,ATP-binding,autophosphorylation,binding site,binds hydroxyproline-rich sequence motifs in fibrillar,Biological processing,biomineral tissue development,bone development,bone disease,bone lining cells,brain,cartilage,catalytic activity,causes retention in intracellular compartment,CD167 antigen-like family member B,CD167b,CD_antigen,cell adhesion,cell membrane,cell migration,cell proliferation,cell surface receptor,central humps,characteristic craniofacial appearance,chondrocyte maturation,chondrocyte proliferation,collagen binding,collagen fibril organization,collagen-activated tyrosine kinase receptor signaling pathway,cutaneous wound healing,cytoplasmic,DDR2,Discoidin domain receptor 2,Discoidin domain-containing receptor 2,Discoidin domain-containing receptor tyrosine kinase 2,disease mutation,distinctive radiological findings,Disulfide bond,Domaini,Dwarfism,endochondral bone growth,Extracellular,extracellular exosome,extracellular matrix,extracellular matrix organization,F-736,F-740,facilitiates cell migration,feet brachydactyly,fibrillar collagen,flared,flattened,focal adhesion,fragmented,Glycoprotein,glycosylated collagen,GQOGVMGFO motif,hand brachydactyly,heart,helical,hydroxyproline,in SEMD-SL,in vitro,Insulin receptor subfamily,integral component of plasma membrane,Interacts (tyrosine phosphorylated) with SHC1,Interacts with SRC,irregular metaphyses. Platyspondyly in the spine,kidney,Kinase,L-tyrosin phosphate,L-tyrosine,Ligandi,liver,lung,lung large cell carcinoma,MAP kinases,Membrane,MMP1,MMP13,MMP2,Molecular functioning,muscle,mutagenesis,mutations,N-glycosylated,narrow chest,Neurotrophic tyrosine kinase,Non-integrin membrane-ECM interactions,NTRKR3,nucleoptide binding,Nucleotide-binding,ossification,osteoarthritis patients,osteoblast differentiation,osteoblastic cells,osteocytes,Osteogenesis,pancreas,pear-shaped vertebral bodies,pectus excavatum,pentose-phosphate pathway,peptidyl-tyrosine phosphorylation,Phosphoprotein,phosphorylation,placenta,plasma membrane,positive regulation of extracellular matrix disassembly,positive regulation of fibroblast migration,positive regulation of fibroblast proliferation,positive regulation of osteoblast differentiation,positive regulation of protein kinase activity,positive regulation of sequence-specific DNA binding transcription factor activity,posterior scalloping,premature calcifications,proliferation,promotes fibrolast migration,protein,protein autophosphorylation regulation of bone mineralization,protein kinase superfamily,protein level,protein tyrosine kinase collagen receptor activity,proton acceptor,Receptor,Receptor protein-tyrosine kinase,receptor-related 3,reduces autophosphorylation,regorafenib,regulates cell differentiation,regulates remodeling,regulation of extracellular matrix disassembly,remodeling of the extracellular matrix,rs4687717,RUNX2,short long bones,short-limbed dwarfism,Signal,signal transduction,signaling pathway,single-opass type I membrane protein,skeletal,skeleton,Spondyloepimetaphyseal dysplasia short limb-hand type,SRC,stippled,striking epiphyses,subchondral bone,T53282188C,tibia,TKT,Transferase,Transmembrane,Transmembrane helix,transmembrane receptor protein tyrosine kinase activity,tumor cell invasion,Tyr protein kinase family,TYRO10,Tyrosine kinase,Tyrosine phosphorylated,Tyrosine phosphorylation,tyrosine residues,Tyrosine-protein kinase,up regualtion of the collagenases,up-regulated in cartilege,wide intervertebral spaces",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs4687718",
        "SNP Name": "TKT A53282303G",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4687718",
        "Video": null,
        "Tags": "1 protein kinase,A53282303G,ablosihes signaling in response collagen binding,abolishes collagen binding,abolishes kinase activity,abolishes phosphorylation,acitvation of the transcription factor RUNX2,active site,ADP,anterior protrusions,apical plasma membrane,ATP,ATP binding,ATP-binding,autophosphorylation,binding site,binds hydroxyproline-rich sequence motifs in fibrillar,Biological processing,biomineral tissue development,bone development,bone disease,bone lining cells,brain,cartilage,catalytic activity,causes retention in intracellular compartment,CD167 antigen-like family member B,CD167b,CD_antigen,cell adhesion,cell membrane,cell migration,cell proliferation,cell surface receptor,central humps,characteristic craniofacial appearance,chondrocyte maturation,chondrocyte proliferation,collagen binding,collagen fibril organization,collagen-activated tyrosine kinase receptor signaling pathway,cutaneous wound healing,cytoplasmic,DDR2,Discoidin domain receptor 2,Discoidin domain-containing receptor 2,Discoidin domain-containing receptor tyrosine kinase 2,disease mutation,distinctive radiological findings,Disulfide bond,Domaini,Dwarfism,endochondral bone growth,Extracellular,extracellular exosome,extracellular matrix,extracellular matrix organization,F-736,F-740,facilitiates cell migration,feet brachydactyly,fibrillar collagen,flared,flattened,focal adhesion,fragmented,Glycoprotein,glycosylated collagen,GQOGVMGFO motif,hand brachydactyly,heart,helical,hydroxyproline,in SEMD-SL,in vitro,Insulin receptor subfamily,integral component of plasma membrane,Interacts (tyrosine phosphorylated) with SHC1,Interacts with SRC,irregular metaphyses. Platyspondyly in the spine,kidney,Kinase,L-tyrosin phosphate,L-tyrosine,Ligandi,liver,lung,lung large cell carcinoma,MAP kinases,Membrane,MMP1,MMP13,MMP2,Molecular functioning,muscle,mutagenesis,mutations,N-glycosylated,narrow chest,Neurotrophic tyrosine kinase,Non-integrin membrane-ECM interactions,NTRKR3,nucleoptide binding,Nucleotide-binding,ossification,osteoarthritis patients,osteoblast differentiation,osteoblastic cells,osteocytes,Osteogenesis,pancreas,pear-shaped vertebral bodies,pectus excavatum,pentose-phosphate pathway,peptidyl-tyrosine phosphorylation,Phosphoprotein,phosphorylation,placenta,plasma membrane,positive regulation of extracellular matrix disassembly,positive regulation of fibroblast migration,positive regulation of fibroblast proliferation,positive regulation of osteoblast differentiation,positive regulation of protein kinase activity,positive regulation of sequence-specific DNA binding transcription factor activity,posterior scalloping,premature calcifications,proliferation,promotes fibrolast migration,protein,protein autophosphorylation regulation of bone mineralization,protein kinase superfamily,protein level,protein tyrosine kinase collagen receptor activity,proton acceptor,Receptor,Receptor protein-tyrosine kinase,receptor-related 3,reduces autophosphorylation,regorafenib,regulates cell differentiation,regulates remodeling,regulation of extracellular matrix disassembly,remodeling of the extracellular matrix,rs4687718,RUNX2,short long bones,short-limbed dwarfism,Signal,signal transduction,signaling pathway,single-opass type I membrane protein,skeletal,skeleton,Spondyloepimetaphyseal dysplasia short limb-hand type,SRC,stippled,striking epiphyses,subchondral bone,tibia,TKT,Transferase,Transmembrane,Transmembrane helix,transmembrane receptor protein tyrosine kinase activity,tumor cell invasion,Tyr protein kinase family,TYRO10,Tyrosine kinase,Tyrosine phosphorylated,Tyrosine phosphorylation,tyrosine residues,Tyrosine-protein kinase,up regualtion of the collagenases,up-regulated in cartilege,wide intervertebral spaces",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs4687718",
        "SNP Name": "TKT A53282303G",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4687718",
        "Video": null,
        "Tags": "1 protein kinase,A53282303G,ablosihes signaling in response collagen binding,abolishes collagen binding,abolishes kinase activity,abolishes phosphorylation,acitvation of the transcription factor RUNX2,active site,ADP,anterior protrusions,apical plasma membrane,ATP,ATP binding,ATP-binding,autophosphorylation,binding site,binds hydroxyproline-rich sequence motifs in fibrillar,Biological processing,biomineral tissue development,bone development,bone disease,bone lining cells,brain,cartilage,catalytic activity,causes retention in intracellular compartment,CD167 antigen-like family member B,CD167b,CD_antigen,cell adhesion,cell membrane,cell migration,cell proliferation,cell surface receptor,central humps,characteristic craniofacial appearance,chondrocyte maturation,chondrocyte proliferation,collagen binding,collagen fibril organization,collagen-activated tyrosine kinase receptor signaling pathway,cutaneous wound healing,cytoplasmic,DDR2,Discoidin domain receptor 2,Discoidin domain-containing receptor 2,Discoidin domain-containing receptor tyrosine kinase 2,disease mutation,distinctive radiological findings,Disulfide bond,Domaini,Dwarfism,endochondral bone growth,Extracellular,extracellular exosome,extracellular matrix,extracellular matrix organization,F-736,F-740,facilitiates cell migration,feet brachydactyly,fibrillar collagen,flared,flattened,focal adhesion,fragmented,Glycoprotein,glycosylated collagen,GQOGVMGFO motif,hand brachydactyly,heart,helical,hydroxyproline,in SEMD-SL,in vitro,Insulin receptor subfamily,integral component of plasma membrane,Interacts (tyrosine phosphorylated) with SHC1,Interacts with SRC,irregular metaphyses. Platyspondyly in the spine,kidney,Kinase,L-tyrosin phosphate,L-tyrosine,Ligandi,liver,lung,lung large cell carcinoma,MAP kinases,Membrane,MMP1,MMP13,MMP2,Molecular functioning,muscle,mutagenesis,mutations,N-glycosylated,narrow chest,Neurotrophic tyrosine kinase,Non-integrin membrane-ECM interactions,NTRKR3,nucleoptide binding,Nucleotide-binding,ossification,osteoarthritis patients,osteoblast differentiation,osteoblastic cells,osteocytes,Osteogenesis,pancreas,pear-shaped vertebral bodies,pectus excavatum,pentose-phosphate pathway,peptidyl-tyrosine phosphorylation,Phosphoprotein,phosphorylation,placenta,plasma membrane,positive regulation of extracellular matrix disassembly,positive regulation of fibroblast migration,positive regulation of fibroblast proliferation,positive regulation of osteoblast differentiation,positive regulation of protein kinase activity,positive regulation of sequence-specific DNA binding transcription factor activity,posterior scalloping,premature calcifications,proliferation,promotes fibrolast migration,protein,protein autophosphorylation regulation of bone mineralization,protein kinase superfamily,protein level,protein tyrosine kinase collagen receptor activity,proton acceptor,Receptor,Receptor protein-tyrosine kinase,receptor-related 3,reduces autophosphorylation,regorafenib,regulates cell differentiation,regulates remodeling,regulation of extracellular matrix disassembly,remodeling of the extracellular matrix,rs4687718,RUNX2,short long bones,short-limbed dwarfism,Signal,signal transduction,signaling pathway,single-opass type I membrane protein,skeletal,skeleton,Spondyloepimetaphyseal dysplasia short limb-hand type,SRC,stippled,striking epiphyses,subchondral bone,tibia,TKT,Transferase,Transmembrane,Transmembrane helix,transmembrane receptor protein tyrosine kinase activity,tumor cell invasion,Tyr protein kinase family,TYRO10,Tyrosine kinase,Tyrosine phosphorylated,Tyrosine phosphorylation,tyrosine residues,Tyrosine-protein kinase,up regualtion of the collagenases,up-regulated in cartilege,wide intervertebral spaces",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs9828046",
        "SNP Name": "DRD3 C44637T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs9828046",
        "Video": null,
        "Tags": "3D-structure,acid secretion,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,Alternative splicing,apical part of cell,arachidonic acid secretion,autosomal dominant,basal conditions,behavioral response to cocaine,belongs to the G-protein coupled receptor 1 family,Brain,Cell membrane,cell projection,cell proliferation,cellular calcium ion homeostasis,circadian regulation of gene expression,CLIC6,co-localize,Complete proteome,cytoplasm,D(3) dopamine receptor,dispersal,Disulfide bond,dopamine binding,Dopamine D3 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity coupled via Gi/Go,Dopamine receptor,dopaminergic,DRD3,drug binding,emotions,endocytic vesicle,ETM1,facial muscles,fatigue,functional disability,G proteins,G-protein coupled,G-protein coupled receptor,G-protein coupled receptor internalization,gastric emptying,Glycoprotein,GRK4,GRK4-alpha,GRK4-gamma,Head,hereditary essential 1,hunger,incapacitation,integral component of plasma membrane,jaw,learning,learning or memory,legs,lipid rafts,locomotory behavior,membrane,membrane-bound,mental disorder,movement disorder,Multi-pass membrane protein,musculoskeletal movement,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of dopamine receptor signaling pathway,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of sodium:hydrogen antiporter activity,negative regulation of transcription from RNA polymerase II promoter,PALM,perinuclear area,Phosphorylation,plasma membrane,Polymorphism,positive regulation of cell proliferation,positive regulation of cytokinesis,positive regulation of dopamine receptor signaling pathway,positive regulation of mitosis,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,postural tremor of the arms,prepulse inhibition,rapid internalization,Receptor,receptor sialing pathway,Receptor stimulation,receptors,Reference proteome,regulation of blood volume by renin-angiotensin,regulation of cAMP metabolic process,regulation of circadian sleep/wake cycle,regulation of dopamine uptake involved in synaptic transmission,regulation of lipid metabolic process,regulation of locomotion involved in locomotory behavior,regulation of multicellular organism growth,renal proximal tubule cells,response to amphetamine,response to cocaine,response to drug,response to histamine,response to morphine,schizophrenia,sequestration,sleep regulation of dopamine secretion,social behavior,spinal reflex action,synaptic transmission,temperature extremes,Transducer,transmembrane,Transmembrane helix,Tremor,trunk,visual learning,voice",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs9828046",
        "SNP Name": "DRD3 C44637T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs9828046",
        "Video": null,
        "Tags": "3D-structure,acid secretion,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,Alternative splicing,apical part of cell,arachidonic acid secretion,autosomal dominant,basal conditions,behavioral response to cocaine,belongs to the G-protein coupled receptor 1 family,Brain,Cell membrane,cell projection,cell proliferation,cellular calcium ion homeostasis,circadian regulation of gene expression,CLIC6,co-localize,Complete proteome,cytoplasm,D(3) dopamine receptor,dispersal,Disulfide bond,dopamine binding,Dopamine D3 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity coupled via Gi/Go,Dopamine receptor,dopaminergic,DRD3,drug binding,emotions,endocytic vesicle,ETM1,facial muscles,fatigue,functional disability,G proteins,G-protein coupled,G-protein coupled receptor,G-protein coupled receptor internalization,gastric emptying,Glycoprotein,GRK4,GRK4-alpha,GRK4-gamma,Head,hereditary essential 1,hunger,incapacitation,integral component of plasma membrane,jaw,learning,learning or memory,legs,lipid rafts,locomotory behavior,membrane,membrane-bound,mental disorder,movement disorder,Multi-pass membrane protein,musculoskeletal movement,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of dopamine receptor signaling pathway,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of sodium:hydrogen antiporter activity,negative regulation of transcription from RNA polymerase II promoter,PALM,perinuclear area,Phosphorylation,plasma membrane,Polymorphism,positive regulation of cell proliferation,positive regulation of cytokinesis,positive regulation of dopamine receptor signaling pathway,positive regulation of mitosis,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,postural tremor of the arms,prepulse inhibition,rapid internalization,Receptor,receptor sialing pathway,Receptor stimulation,receptors,Reference proteome,regulation of blood volume by renin-angiotensin,regulation of cAMP metabolic process,regulation of circadian sleep/wake cycle,regulation of dopamine uptake involved in synaptic transmission,regulation of lipid metabolic process,regulation of locomotion involved in locomotory behavior,regulation of multicellular organism growth,renal proximal tubule cells,response to amphetamine,response to cocaine,response to drug,response to histamine,response to morphine,schizophrenia,sequestration,sleep regulation of dopamine secretion,social behavior,spinal reflex action,synaptic transmission,temperature extremes,Transducer,transmembrane,Transmembrane helix,Tremor,trunk,visual learning,voice",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs9288993",
        "SNP Name": "DRD3 T43727C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs9288993",
        "Video": null,
        "Tags": "3D-structure,acid secretion,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,Alternative splicing,apical part of cell,arachidonic acid secretion,autosomal dominant,basal conditions,behavioral response to cocaine,belongs to the G-protein coupled receptor 1 family,Brain,Cell membrane,cell projection,cell proliferation,cellular calcium ion homeostasis,circadian regulation of gene expression,CLIC6,co-localize,Complete proteome,cytoplasm,D(3) dopamine receptor,dispersal,Disulfide bond,dopamine binding,Dopamine D3 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity coupled via Gi/Go,Dopamine receptor,dopaminergic,DRD3,drug binding,emotions,endocytic vesicle,ETM1,facial muscles,fatigue,functional disability,G proteins,G-protein coupled,G-protein coupled receptor,G-protein coupled receptor internalization,gastric emptying,Glycoprotein,GRK4,GRK4-alpha,GRK4-gamma,Head,hereditary essential 1,hunger,incapacitation,integral component of plasma membrane,jaw,learning,learning or memory,legs,lipid rafts,locomotory behavior,membrane,membrane-bound,mental disorder,movement disorder,Multi-pass membrane protein,musculoskeletal movement,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of dopamine receptor signaling pathway,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of sodium:hydrogen antiporter activity,negative regulation of transcription from RNA polymerase II promoter,PALM,perinuclear area,Phosphorylation,plasma membrane,Polymorphism,positive regulation of cell proliferation,positive regulation of cytokinesis,positive regulation of dopamine receptor signaling pathway,positive regulation of mitosis,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,postural tremor of the arms,prepulse inhibition,rapid internalization,Receptor,receptor sialing pathway,Receptor stimulation,receptors,Reference proteome,regulation of blood volume by renin-angiotensin,regulation of cAMP metabolic process,regulation of circadian sleep/wake cycle,regulation of dopamine uptake involved in synaptic transmission,regulation of lipid metabolic process,regulation of locomotion involved in locomotory behavior,regulation of multicellular organism growth,renal proximal tubule cells,response to amphetamine,response to cocaine,response to drug,response to histamine,response to morphine,schizophrenia,sequestration,sleep regulation of dopamine secretion,social behavior,spinal reflex action,synaptic transmission,temperature extremes,Transducer,transmembrane,Transmembrane helix,Tremor,trunk,visual learning,voice",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs9288993",
        "SNP Name": "DRD3 T43727C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs9288993",
        "Video": null,
        "Tags": "3D-structure,acid secretion,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,Alternative splicing,apical part of cell,arachidonic acid secretion,autosomal dominant,basal conditions,behavioral response to cocaine,belongs to the G-protein coupled receptor 1 family,Brain,Cell membrane,cell projection,cell proliferation,cellular calcium ion homeostasis,circadian regulation of gene expression,CLIC6,co-localize,Complete proteome,cytoplasm,D(3) dopamine receptor,dispersal,Disulfide bond,dopamine binding,Dopamine D3 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity coupled via Gi/Go,Dopamine receptor,dopaminergic,DRD3,drug binding,emotions,endocytic vesicle,ETM1,facial muscles,fatigue,functional disability,G proteins,G-protein coupled,G-protein coupled receptor,G-protein coupled receptor internalization,gastric emptying,Glycoprotein,GRK4,GRK4-alpha,GRK4-gamma,Head,hereditary essential 1,hunger,incapacitation,integral component of plasma membrane,jaw,learning,learning or memory,legs,lipid rafts,locomotory behavior,membrane,membrane-bound,mental disorder,movement disorder,Multi-pass membrane protein,musculoskeletal movement,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of dopamine receptor signaling pathway,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of sodium:hydrogen antiporter activity,negative regulation of transcription from RNA polymerase II promoter,PALM,perinuclear area,Phosphorylation,plasma membrane,Polymorphism,positive regulation of cell proliferation,positive regulation of cytokinesis,positive regulation of dopamine receptor signaling pathway,positive regulation of mitosis,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,postural tremor of the arms,prepulse inhibition,rapid internalization,Receptor,receptor sialing pathway,Receptor stimulation,receptors,Reference proteome,regulation of blood volume by renin-angiotensin,regulation of cAMP metabolic process,regulation of circadian sleep/wake cycle,regulation of dopamine uptake involved in synaptic transmission,regulation of lipid metabolic process,regulation of locomotion involved in locomotory behavior,regulation of multicellular organism growth,renal proximal tubule cells,response to amphetamine,response to cocaine,response to drug,response to histamine,response to morphine,schizophrenia,sequestration,sleep regulation of dopamine secretion,social behavior,spinal reflex action,synaptic transmission,temperature extremes,Transducer,transmembrane,Transmembrane helix,Tremor,trunk,visual learning,voice",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs963468",
        "SNP Name": "DRD3 C40013T",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs963468",
        "Video": null,
        "Tags": "3D-structure,acid secretion,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,Alternative splicing,apical part of cell,arachidonic acid secretion,autosomal dominant,basal conditions,behavioral response to cocaine,belongs to the G-protein coupled receptor 1 family,Brain,Cell membrane,cell projection,cell proliferation,cellular calcium ion homeostasis,circadian regulation of gene expression,CLIC6,co-localize,Complete proteome,cytoplasm,D(3) dopamine receptor,depression,dispersal,Disulfide bond,dopamine binding,Dopamine D3 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity coupled via Gi/Go,Dopamine receptor,dopaminergic,DRD3,drug binding,emotions,endocytic vesicle,ETM1,facial muscles,fatigue,functional disability,G proteins,G-protein coupled,G-protein coupled receptor,G-protein coupled receptor internalization,gastric emptying,Glycoprotein,GRK4,GRK4-alpha,GRK4-gamma,Head,hereditary essential 1,hunger,incapacitation,integral component of plasma membrane,jaw,learning,learning or memory,legs,lipid rafts,locomotory behavior,membrane,membrane-bound,mental disorder,movement disorder,Multi-pass membrane protein,musculoskeletal movement,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of dopamine receptor signaling pathway,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of sodium:hydrogen antiporter activity,negative regulation of transcription from RNA polymerase II promoter,PALM,perinuclear area,Phosphorylation,plasma membrane,Polymorphism,positive regulation of cell proliferation,positive regulation of cytokinesis,positive regulation of dopamine receptor signaling pathway,positive regulation of mitosis,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,postural tremor of the arms,prepulse inhibition,rapid internalization,Receptor,receptor sialing pathway,Receptor stimulation,receptors,Reference proteome,regulation of blood volume by renin-angiotensin,regulation of cAMP metabolic process,regulation of circadian sleep/wake cycle,regulation of dopamine uptake involved in synaptic transmission,regulation of lipid metabolic process,regulation of locomotion involved in locomotory behavior,regulation of multicellular organism growth,renal proximal tubule cells,response to amphetamine,response to cocaine,response to drug,response to histamine,response to morphine,schizophrenia,sequestration,sleep regulation of dopamine secretion,social behavior,spinal reflex action,synaptic transmission,temperature extremes,Transducer,transmembrane,Transmembrane helix,Tremor,trunk,visual learning,voice",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs963468",
        "SNP Name": "DRD3 C40013T",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs963468",
        "Video": null,
        "Tags": "3D-structure,acid secretion,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,Alternative splicing,apical part of cell,arachidonic acid secretion,autosomal dominant,basal conditions,behavioral response to cocaine,belongs to the G-protein coupled receptor 1 family,Brain,Cell membrane,cell projection,cell proliferation,cellular calcium ion homeostasis,circadian regulation of gene expression,CLIC6,co-localize,Complete proteome,cytoplasm,D(3) dopamine receptor,depression,dispersal,Disulfide bond,dopamine binding,Dopamine D3 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity coupled via Gi/Go,Dopamine receptor,dopaminergic,DRD3,drug binding,emotions,endocytic vesicle,ETM1,facial muscles,fatigue,functional disability,G proteins,G-protein coupled,G-protein coupled receptor,G-protein coupled receptor internalization,gastric emptying,Glycoprotein,GRK4,GRK4-alpha,GRK4-gamma,Head,hereditary essential 1,hunger,incapacitation,integral component of plasma membrane,jaw,learning,learning or memory,legs,lipid rafts,locomotory behavior,membrane,membrane-bound,mental disorder,movement disorder,Multi-pass membrane protein,musculoskeletal movement,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of dopamine receptor signaling pathway,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of sodium:hydrogen antiporter activity,negative regulation of transcription from RNA polymerase II promoter,PALM,perinuclear area,Phosphorylation,plasma membrane,Polymorphism,positive regulation of cell proliferation,positive regulation of cytokinesis,positive regulation of dopamine receptor signaling pathway,positive regulation of mitosis,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,postural tremor of the arms,prepulse inhibition,rapid internalization,Receptor,receptor sialing pathway,Receptor stimulation,receptors,Reference proteome,regulation of blood volume by renin-angiotensin,regulation of cAMP metabolic process,regulation of circadian sleep/wake cycle,regulation of dopamine uptake involved in synaptic transmission,regulation of lipid metabolic process,regulation of locomotion involved in locomotory behavior,regulation of multicellular organism growth,renal proximal tubule cells,response to amphetamine,response to cocaine,response to drug,response to histamine,response to morphine,schizophrenia,sequestration,sleep regulation of dopamine secretion,social behavior,spinal reflex action,synaptic transmission,temperature extremes,Transducer,transmembrane,Transmembrane helix,Tremor,trunk,visual learning,voice",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs3773678",
        "SNP Name": "DRD3 T32822C",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3773678",
        "Video": null,
        "Tags": "3D-structure,acid secretion,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,Alternative splicing,apical part of cell,arachidonic acid secretion,autosomal dominant,basal conditions,behavioral response to cocaine,belongs to the G-protein coupled receptor 1 family,Brain,Cell membrane,cell projection,cell proliferation,cellular calcium ion homeostasis,circadian regulation of gene expression,CLIC6,co-localize,cocaine dependence,Complete proteome,Continuous Performance Task,cytoplasm,D(3) dopamine receptor,depression,dispersal,Disulfide bond,dopamine binding,Dopamine D3 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity coupled via Gi/Go,Dopamine receptor,dopaminergic,DRD3,drug binding,emotions,endocytic vesicle,ETM1,facial muscles,fatigue,functional disability,G proteins,G-protein coupled,G-protein coupled receptor,G-protein coupled receptor internalization,gastric emptying,Glycoprotein,GRK4,GRK4-alpha,GRK4-gamma,Head,hereditary essential 1,hunger,incapacitation,integral component of plasma membrane,jaw,learning,learning or memory,legs,lipid rafts,locomotory behavior,membrane,membrane-bound,movement disorder,Multi-pass membrane protein,musculoskeletal movement,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of dopamine receptor signaling pathway,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of sodium:hydrogen antiporter activity,negative regulation of transcription from RNA polymerase II promoter,PALM,perinuclear area,Phosphorylation,plasma membrane,Polymorphism,positive regulation of cell proliferation,positive regulation of cytokinesis,positive regulation of dopamine receptor signaling pathway,positive regulation of mitosis,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,postural tremor of the arms,prepulse inhibition,rapid internalization,Receptor,receptor sialing pathway,Receptor stimulation,receptors,Reference proteome,regulation of blood volume by renin-angiotensin,regulation of cAMP metabolic process,regulation of circadian sleep/wake cycle,regulation of dopamine uptake involved in synaptic transmission,regulation of lipid metabolic process,regulation of locomotion involved in locomotory behavior,regulation of multicellular organism growth,renal proximal tubule cells,response to amphetamine,response to cocaine,response to drug,response to histamine,response to morphine,sequestration,sleep regulation of dopamine secretion,social behavior,spinal reflex action,synaptic transmission,temperature extremes,Transducer,transmembrane,Transmembrane helix,Tremor,trunk,visual learning,voice",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs3773678",
        "SNP Name": "DRD3 T32822C",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3773678",
        "Video": null,
        "Tags": "3D-structure,acid secretion,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,Alternative splicing,apical part of cell,arachidonic acid secretion,autosomal dominant,basal conditions,behavioral response to cocaine,belongs to the G-protein coupled receptor 1 family,Brain,Cell membrane,cell projection,cell proliferation,cellular calcium ion homeostasis,circadian regulation of gene expression,CLIC6,co-localize,cocaine dependence,Complete proteome,Continuous Performance Task,cytoplasm,D(3) dopamine receptor,depression,dispersal,Disulfide bond,dopamine binding,Dopamine D3 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity coupled via Gi/Go,Dopamine receptor,dopaminergic,DRD3,drug binding,emotions,endocytic vesicle,ETM1,facial muscles,fatigue,functional disability,G proteins,G-protein coupled,G-protein coupled receptor,G-protein coupled receptor internalization,gastric emptying,Glycoprotein,GRK4,GRK4-alpha,GRK4-gamma,Head,hereditary essential 1,hunger,incapacitation,integral component of plasma membrane,jaw,learning,learning or memory,legs,lipid rafts,locomotory behavior,membrane,membrane-bound,movement disorder,Multi-pass membrane protein,musculoskeletal movement,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of dopamine receptor signaling pathway,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of sodium:hydrogen antiporter activity,negative regulation of transcription from RNA polymerase II promoter,PALM,perinuclear area,Phosphorylation,plasma membrane,Polymorphism,positive regulation of cell proliferation,positive regulation of cytokinesis,positive regulation of dopamine receptor signaling pathway,positive regulation of mitosis,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,postural tremor of the arms,prepulse inhibition,rapid internalization,Receptor,receptor sialing pathway,Receptor stimulation,receptors,Reference proteome,regulation of blood volume by renin-angiotensin,regulation of cAMP metabolic process,regulation of circadian sleep/wake cycle,regulation of dopamine uptake involved in synaptic transmission,regulation of lipid metabolic process,regulation of locomotion involved in locomotory behavior,regulation of multicellular organism growth,renal proximal tubule cells,response to amphetamine,response to cocaine,response to drug,response to histamine,response to morphine,sequestration,sleep regulation of dopamine secretion,social behavior,spinal reflex action,synaptic transmission,temperature extremes,Transducer,transmembrane,Transmembrane helix,Tremor,trunk,visual learning,voice",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs167771",
        "SNP Name": "DRD3 C26625T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs167771",
        "Video": null,
        "Tags": "3D-structure,acid secretion,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,Alternative splicing,antipsychotic-induced side effects,apical part of cell,arachidonic acid secretion,ASD,autism,Autism Spectrum Disorder,autosomal dominant,basal conditions,behavioral response to cocaine,belongs to the G-protein coupled receptor 1 family,Brain,Cell membrane,cell projection,cell proliferation,cellular calcium ion homeostasis,circadian regulation of gene expression,CLIC6,co-localize,Complete proteome,Continuous Performance Task,CPT,cytoplasm,D(3) dopamine receptor,depression,dispersal,Disulfide bond,dopamine binding,Dopamine D3 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity coupled via Gi/Go,Dopamine receptor,dopaminergic,DRD3,drug binding,emotions,endocytic vesicle,ETM1,facial muscles,fatigue,functional disability,G proteins,G-protein coupled,G-protein coupled receptor,G-protein coupled receptor internalization,gastric emptying,Glycoprotein,GRK4,GRK4-alpha,GRK4-gamma,Head,hereditary essential 1,hunger,incapacitation,integral component of plasma membrane,jaw,learning,learning or memory,legs,lipid rafts,locomotory behavior,Major Depressive Disorder,membrane,membrane-bound,mental disorder,movement disorder,Multi-pass membrane protein,musculoskeletal movement,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of dopamine receptor signaling pathway,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of sodium:hydrogen antiporter activity,negative regulation of transcription from RNA polymerase II promoter,PALM,perinuclear area,Phosphorylation,plasma membrane,Polymorphism,positive regulation of cell proliferation,positive regulation of cytokinesis,positive regulation of dopamine receptor signaling pathway,positive regulation of mitosis,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,postural tremor of the arms,prepulse inhibition,rapid internalization,Receptor,receptor sialing pathway,Receptor stimulation,receptors,Reference proteome,regulation of blood volume by renin-angiotensin,regulation of cAMP metabolic process,regulation of circadian sleep/wake cycle,regulation of dopamine uptake involved in synaptic transmission,regulation of lipid metabolic process,regulation of locomotion involved in locomotory behavior,regulation of multicellular organism growth,renal proximal tubule cells,response to amphetamine,response to cocaine,response to drug,response to histamine,response to morphine,schizophrenia,sequestration,sleep regulation of dopamine secretion,social behavior,spinal reflex action,synaptic transmission,temperature extremes,Transducer,transmembrane,Transmembrane helix,Tremor,trunk,visual learning,voice",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs167771",
        "SNP Name": "DRD3 C26625T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs167771",
        "Video": null,
        "Tags": "3D-structure,acid secretion,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,Alternative splicing,antipsychotic-induced side effects,apical part of cell,arachidonic acid secretion,ASD,autism,Autism Spectrum Disorder,autosomal dominant,basal conditions,behavioral response to cocaine,belongs to the G-protein coupled receptor 1 family,Brain,Cell membrane,cell projection,cell proliferation,cellular calcium ion homeostasis,circadian regulation of gene expression,CLIC6,co-localize,Complete proteome,Continuous Performance Task,CPT,cytoplasm,D(3) dopamine receptor,depression,dispersal,Disulfide bond,dopamine binding,Dopamine D3 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity coupled via Gi/Go,Dopamine receptor,dopaminergic,DRD3,drug binding,emotions,endocytic vesicle,ETM1,facial muscles,fatigue,functional disability,G proteins,G-protein coupled,G-protein coupled receptor,G-protein coupled receptor internalization,gastric emptying,Glycoprotein,GRK4,GRK4-alpha,GRK4-gamma,Head,hereditary essential 1,hunger,incapacitation,integral component of plasma membrane,jaw,learning,learning or memory,legs,lipid rafts,locomotory behavior,Major Depressive Disorder,membrane,membrane-bound,mental disorder,movement disorder,Multi-pass membrane protein,musculoskeletal movement,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of dopamine receptor signaling pathway,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of sodium:hydrogen antiporter activity,negative regulation of transcription from RNA polymerase II promoter,PALM,perinuclear area,Phosphorylation,plasma membrane,Polymorphism,positive regulation of cell proliferation,positive regulation of cytokinesis,positive regulation of dopamine receptor signaling pathway,positive regulation of mitosis,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,postural tremor of the arms,prepulse inhibition,rapid internalization,Receptor,receptor sialing pathway,Receptor stimulation,receptors,Reference proteome,regulation of blood volume by renin-angiotensin,regulation of cAMP metabolic process,regulation of circadian sleep/wake cycle,regulation of dopamine uptake involved in synaptic transmission,regulation of lipid metabolic process,regulation of locomotion involved in locomotory behavior,regulation of multicellular organism growth,renal proximal tubule cells,response to amphetamine,response to cocaine,response to drug,response to histamine,response to morphine,schizophrenia,sequestration,sleep regulation of dopamine secretion,social behavior,spinal reflex action,synaptic transmission,temperature extremes,Transducer,transmembrane,Transmembrane helix,Tremor,trunk,visual learning,voice",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs324029",
        "SNP Name": "DRD3 T21277C",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs324029",
        "Video": null,
        "Tags": "3D-structure,acid secretion,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,Alternative splicing,apical part of cell,arachidonic acid secretion,autosomal dominant,basal conditions,behavioral response to cocaine,belongs to the G-protein coupled receptor 1 family,Brain,Cell membrane,cell projection,cell proliferation,cellular calcium ion homeostasis,circadian regulation of gene expression,CLIC6,co-localize,Complete proteome,Continuous Performance Task,craving for alcohol,cytoplasm,D(3) dopamine receptor,depression,dispersal,Disulfide bond,dopamine binding,Dopamine D3 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity coupled via Gi/Go,Dopamine receptor,dopaminergic,DRD3,drug binding,emotions,endocytic vesicle,ETM1,facial muscles,fatigue,functional disability,G proteins,G-protein coupled,G-protein coupled receptor,G-protein coupled receptor internalization,gastric emptying,Glycoprotein,GRK4,GRK4-alpha,GRK4-gamma,Head,hereditary essential 1,hunger,incapacitation,integral component of plasma membrane,jaw,learning,learning or memory,legs,lipid rafts,locomotory behavior,Major Depressive Disorder,membrane,membrane-bound,movement disorder,Multi-pass membrane protein,musculoskeletal movement,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of dopamine receptor signaling pathway,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of sodium:hydrogen antiporter activity,negative regulation of transcription from RNA polymerase II promoter,PALM,perinuclear area,Phosphorylation,plasma membrane,Polymorphism,positive regulation of cell proliferation,positive regulation of cytokinesis,positive regulation of dopamine receptor signaling pathway,positive regulation of mitosis,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,postural tremor of the arms,prepulse inhibition,rapid internalization,Receptor,receptor sialing pathway,Receptor stimulation,receptors,Reference proteome,regulation of blood volume by renin-angiotensin,regulation of cAMP metabolic process,regulation of circadian sleep/wake cycle,regulation of dopamine uptake involved in synaptic transmission,regulation of lipid metabolic process,regulation of locomotion involved in locomotory behavior,regulation of multicellular organism growth,renal proximal tubule cells,response to amphetamine,response to cocaine,response to drug,response to histamine,response to morphine,sequestration,sleep regulation of dopamine secretion,social behavior,spinal reflex action,synaptic transmission,temperature extremes,Transducer,transmembrane,Transmembrane helix,Tremor,trunk,visual learning,voice",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs324029",
        "SNP Name": "DRD3 T21277C",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs324029",
        "Video": null,
        "Tags": "3D-structure,acid secretion,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,Alternative splicing,apical part of cell,arachidonic acid secretion,autosomal dominant,basal conditions,behavioral response to cocaine,belongs to the G-protein coupled receptor 1 family,Brain,Cell membrane,cell projection,cell proliferation,cellular calcium ion homeostasis,circadian regulation of gene expression,CLIC6,co-localize,Complete proteome,Continuous Performance Task,craving for alcohol,cytoplasm,D(3) dopamine receptor,depression,dispersal,Disulfide bond,dopamine binding,Dopamine D3 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity coupled via Gi/Go,Dopamine receptor,dopaminergic,DRD3,drug binding,emotions,endocytic vesicle,ETM1,facial muscles,fatigue,functional disability,G proteins,G-protein coupled,G-protein coupled receptor,G-protein coupled receptor internalization,gastric emptying,Glycoprotein,GRK4,GRK4-alpha,GRK4-gamma,Head,hereditary essential 1,hunger,incapacitation,integral component of plasma membrane,jaw,learning,learning or memory,legs,lipid rafts,locomotory behavior,Major Depressive Disorder,membrane,membrane-bound,movement disorder,Multi-pass membrane protein,musculoskeletal movement,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of dopamine receptor signaling pathway,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of sodium:hydrogen antiporter activity,negative regulation of transcription from RNA polymerase II promoter,PALM,perinuclear area,Phosphorylation,plasma membrane,Polymorphism,positive regulation of cell proliferation,positive regulation of cytokinesis,positive regulation of dopamine receptor signaling pathway,positive regulation of mitosis,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,postural tremor of the arms,prepulse inhibition,rapid internalization,Receptor,receptor sialing pathway,Receptor stimulation,receptors,Reference proteome,regulation of blood volume by renin-angiotensin,regulation of cAMP metabolic process,regulation of circadian sleep/wake cycle,regulation of dopamine uptake involved in synaptic transmission,regulation of lipid metabolic process,regulation of locomotion involved in locomotory behavior,regulation of multicellular organism growth,renal proximal tubule cells,response to amphetamine,response to cocaine,response to drug,response to histamine,response to morphine,sequestration,sleep regulation of dopamine secretion,social behavior,spinal reflex action,synaptic transmission,temperature extremes,Transducer,transmembrane,Transmembrane helix,Tremor,trunk,visual learning,voice",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1486009",
        "SNP Name": "DRD3 T14368C",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1486009",
        "Video": null,
        "Tags": "3D-structure,acid secretion,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,ADHD,Alternative splicing,apical part of cell,arachidonic acid secretion,autosomal dominant,basal conditions,behavioral response to cocaine,belongs to the G-protein coupled receptor 1 family,Brain,Cell membrane,cell projection,cell proliferation,cellular calcium ion homeostasis,circadian regulation of gene expression,CLIC6,co-localize,Complete proteome,Continuous Performance Task,CPT,cytoplasm,D(3) dopamine receptor,depression,dispersal,Disulfide bond,dopamine binding,Dopamine D3 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity coupled via Gi/Go,Dopamine receptor,dopaminergic,DRD3,drug binding,emotions,endocytic vesicle,ETM1,facial muscles,fatigue,functional disability,G proteins,G-protein coupled,G-protein coupled receptor,G-protein coupled receptor internalization,gastric emptying,Glycoprotein,GRK4,GRK4-alpha,GRK4-gamma,Head,hereditary essential 1,hunger,incapacitation,integral component of plasma membrane,jaw,learning,learning or memory,legs,lipid rafts,locomotory behavior,membrane,membrane-bound,movement disorder,Multi-pass membrane protein,musculoskeletal movement,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of dopamine receptor signaling pathway,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of sodium:hydrogen antiporter activity,negative regulation of transcription from RNA polymerase II promoter,PALM,perinuclear area,Phosphorylation,plasma membrane,Polymorphism,positive regulation of cell proliferation,positive regulation of cytokinesis,positive regulation of dopamine receptor signaling pathway,positive regulation of mitosis,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,postural tremor of the arms,prepulse inhibition,rapid internalization,Receptor,receptor sialing pathway,Receptor stimulation,receptors,Reference proteome,regulation of blood volume by renin-angiotensin,regulation of cAMP metabolic process,regulation of circadian sleep/wake cycle,regulation of dopamine uptake involved in synaptic transmission,regulation of lipid metabolic process,regulation of locomotion involved in locomotory behavior,regulation of multicellular organism growth,renal proximal tubule cells,response to amphetamine,response to cocaine,response to drug,response to histamine,response to morphine,sequestration,sleep regulation of dopamine secretion,social behavior,spinal reflex action,synaptic transmission,temperature extremes,Transducer,transmembrane,Transmembrane helix,Tremor,trunk,visual learning,voice",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1486009",
        "SNP Name": "DRD3 T14368C",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1486009",
        "Video": null,
        "Tags": "3D-structure,acid secretion,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,ADHD,Alternative splicing,apical part of cell,arachidonic acid secretion,autosomal dominant,basal conditions,behavioral response to cocaine,belongs to the G-protein coupled receptor 1 family,Brain,Cell membrane,cell projection,cell proliferation,cellular calcium ion homeostasis,circadian regulation of gene expression,CLIC6,co-localize,Complete proteome,Continuous Performance Task,CPT,cytoplasm,D(3) dopamine receptor,depression,dispersal,Disulfide bond,dopamine binding,Dopamine D3 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity coupled via Gi/Go,Dopamine receptor,dopaminergic,DRD3,drug binding,emotions,endocytic vesicle,ETM1,facial muscles,fatigue,functional disability,G proteins,G-protein coupled,G-protein coupled receptor,G-protein coupled receptor internalization,gastric emptying,Glycoprotein,GRK4,GRK4-alpha,GRK4-gamma,Head,hereditary essential 1,hunger,incapacitation,integral component of plasma membrane,jaw,learning,learning or memory,legs,lipid rafts,locomotory behavior,membrane,membrane-bound,movement disorder,Multi-pass membrane protein,musculoskeletal movement,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of dopamine receptor signaling pathway,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of sodium:hydrogen antiporter activity,negative regulation of transcription from RNA polymerase II promoter,PALM,perinuclear area,Phosphorylation,plasma membrane,Polymorphism,positive regulation of cell proliferation,positive regulation of cytokinesis,positive regulation of dopamine receptor signaling pathway,positive regulation of mitosis,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,postural tremor of the arms,prepulse inhibition,rapid internalization,Receptor,receptor sialing pathway,Receptor stimulation,receptors,Reference proteome,regulation of blood volume by renin-angiotensin,regulation of cAMP metabolic process,regulation of circadian sleep/wake cycle,regulation of dopamine uptake involved in synaptic transmission,regulation of lipid metabolic process,regulation of locomotion involved in locomotory behavior,regulation of multicellular organism growth,renal proximal tubule cells,response to amphetamine,response to cocaine,response to drug,response to histamine,response to morphine,sequestration,sleep regulation of dopamine secretion,social behavior,spinal reflex action,synaptic transmission,temperature extremes,Transducer,transmembrane,Transmembrane helix,Tremor,trunk,visual learning,voice",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs6280",
        "SNP Name": "DRD3 G25A",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6280",
        "Video": null,
        "Tags": "3D-structure,acid secretion,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,ADHD,alcohol dependence,Alternative splicing,antipsychotic-induced side effects,Antipsychotics,apical part of cell,arachidonic acid secretion,ASD,autism,Autism Spectrum Disorder,autosomal dominant,basal conditions,behavioral response to cocaine,belongs to the G-protein coupled receptor 1 family,Brain,Cell membrane,cell projection,cell proliferation,cellular calcium ion homeostasis,circadian regulation of gene expression,CLIC6,co-localize,cocaine dependence,cognitive impairment,Complete proteome,Continuous Performance Task,CPT,cytoplasm,D(3) dopamine receptor,depression,dispersal,Disulfide bond,dopamine binding,Dopamine D3 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity coupled via Gi/Go,Dopamine receptor,dopaminergic,DRD3,Drug Addiction,drug binding,emotions,endocytic vesicle,essential tremor,ETM1,facial muscles,fatigue,functional disability,G proteins,G-protein coupled,G-protein coupled receptor,G-protein coupled receptor internalization,gastric emptying,Glycoprotein,GRK4,GRK4-alpha,GRK4-gamma,Head,hereditary essential 1,hunger,incapacitation,integral component of plasma membrane,jaw,L-Dopa,learning,learning or memory,legs,lipid rafts,locomotory behavior,major depressive disorder,membrane,membrane-bound,mental disorder,Methamphetamine-Associated Psychosis,motor learning,movement,movement disorder,Multi-pass membrane protein,multiple sclerosis,musculoskeletal movement,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of dopamine receptor signaling pathway,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of sodium:hydrogen antiporter activity,negative regulation of transcription from RNA polymerase II promoter,Nicotine Dependence,PALM,Parkinson,Parkinson\u2019s Disease,PD,perinuclear area,Pharmacogenetics,Phosphorylation,plasma membrane,polycystic ovary syndrome,Polymorphism,positive regulation of cell proliferation,positive regulation of cytokinesis,positive regulation of dopamine receptor signaling pathway,positive regulation of mitosis,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,postural tremor of the arms,prepulse inhibition,Psychosis,rapid internalization,Receptor,receptor sialing pathway,Receptor stimulation,receptors,Reference proteome,regulation of blood volume by renin-angiotensin,regulation of cAMP metabolic process,regulation of circadian sleep/wake cycle,regulation of dopamine uptake involved in synaptic transmission,regulation of lipid metabolic process,regulation of locomotion involved in locomotory behavior,regulation of multicellular organism growth,renal proximal tubule cells,response to amphetamine,response to cocaine,response to drug,response to histamine,response to morphine,Reward,schizophrenia,sequestration,sleep regulation of dopamine secretion,smoking cessation,social behavior,spinal reflex action,substance addiction,synaptic transmission,Tardive Dyskinesia,temperature extremes,Transducer,transmembrane,Transmembrane helix,Tremor,trunk,visual learning,voice",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs6280",
        "SNP Name": "DRD3 G25A",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6280",
        "Video": null,
        "Tags": "3D-structure,acid secretion,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,ADHD,alcohol dependence,Alternative splicing,antipsychotic-induced side effects,Antipsychotics,apical part of cell,arachidonic acid secretion,ASD,autism,Autism Spectrum Disorder,autosomal dominant,basal conditions,behavioral response to cocaine,belongs to the G-protein coupled receptor 1 family,Brain,Cell membrane,cell projection,cell proliferation,cellular calcium ion homeostasis,circadian regulation of gene expression,CLIC6,co-localize,cocaine dependence,cognitive impairment,Complete proteome,Continuous Performance Task,CPT,cytoplasm,D(3) dopamine receptor,depression,dispersal,Disulfide bond,dopamine binding,Dopamine D3 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity coupled via Gi/Go,Dopamine receptor,dopaminergic,DRD3,Drug Addiction,drug binding,emotions,endocytic vesicle,essential tremor,ETM1,facial muscles,fatigue,functional disability,G proteins,G-protein coupled,G-protein coupled receptor,G-protein coupled receptor internalization,gastric emptying,Glycoprotein,GRK4,GRK4-alpha,GRK4-gamma,Head,hereditary essential 1,hunger,incapacitation,integral component of plasma membrane,jaw,L-Dopa,learning,learning or memory,legs,lipid rafts,locomotory behavior,major depressive disorder,membrane,membrane-bound,mental disorder,Methamphetamine-Associated Psychosis,motor learning,movement,movement disorder,Multi-pass membrane protein,multiple sclerosis,musculoskeletal movement,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of dopamine receptor signaling pathway,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of sodium:hydrogen antiporter activity,negative regulation of transcription from RNA polymerase II promoter,Nicotine Dependence,PALM,Parkinson,Parkinson\u2019s Disease,PD,perinuclear area,Pharmacogenetics,Phosphorylation,plasma membrane,polycystic ovary syndrome,Polymorphism,positive regulation of cell proliferation,positive regulation of cytokinesis,positive regulation of dopamine receptor signaling pathway,positive regulation of mitosis,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,postural tremor of the arms,prepulse inhibition,Psychosis,rapid internalization,Receptor,receptor sialing pathway,Receptor stimulation,receptors,Reference proteome,regulation of blood volume by renin-angiotensin,regulation of cAMP metabolic process,regulation of circadian sleep/wake cycle,regulation of dopamine uptake involved in synaptic transmission,regulation of lipid metabolic process,regulation of locomotion involved in locomotory behavior,regulation of multicellular organism growth,renal proximal tubule cells,response to amphetamine,response to cocaine,response to drug,response to histamine,response to morphine,Reward,schizophrenia,sequestration,sleep regulation of dopamine secretion,smoking cessation,social behavior,spinal reflex action,substance addiction,synaptic transmission,Tardive Dyskinesia,temperature extremes,Transducer,transmembrane,Transmembrane helix,Tremor,trunk,visual learning,voice",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs9825563",
        "SNP Name": "DRD3 T2680C",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs9825563",
        "Video": null,
        "Tags": "3D-structure,acid secretion,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,Alternative splicing,apical part of cell,arachidonic acid secretion,autosomal dominant,basal conditions,behavioral response to cocaine,belongs to the G-protein coupled receptor 1 family,Brain,Cell membrane,cell projection,cell proliferation,cellular calcium ion homeostasis,circadian regulation of gene expression,CLIC6,co-localize,cocaine dependence,Complete proteome,Continuous Performance Task,CPT,cytoplasm,D(3) dopamine receptor,depression,dispersal,Disulfide bond,dopamine binding,Dopamine D3 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity coupled via Gi/Go,Dopamine receptor,dopaminergic,DRD3,drug binding,emotions,endocytic vesicle,ETM1,facial muscles,fatigue,functional disability,G proteins,G-protein coupled,G-protein coupled receptor,G-protein coupled receptor internalization,gastric emptying,Glycoprotein,GRK4,GRK4-alpha,GRK4-gamma,Head,hereditary essential 1,hunger,incapacitation,integral component of plasma membrane,jaw,learning,learning or memory,legs,lipid rafts,locomotory behavior,Major Depressive Disorder,membrane,membrane-bound,movement disorder,Multi-pass membrane protein,musculoskeletal movement,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of dopamine receptor signaling pathway,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of sodium:hydrogen antiporter activity,negative regulation of transcription from RNA polymerase II promoter,PALM,perinuclear area,Phosphorylation,plasma membrane,Polymorphism,positive regulation of cell proliferation,positive regulation of cytokinesis,positive regulation of dopamine receptor signaling pathway,positive regulation of mitosis,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,postural tremor of the arms,prepulse inhibition,rapid internalization,Receptor,receptor sialing pathway,Receptor stimulation,receptors,Reference proteome,regulation of blood volume by renin-angiotensin,regulation of cAMP metabolic process,regulation of circadian sleep/wake cycle,regulation of dopamine uptake involved in synaptic transmission,regulation of lipid metabolic process,regulation of locomotion involved in locomotory behavior,regulation of multicellular organism growth,renal proximal tubule cells,response to amphetamine,response to cocaine,response to drug,response to histamine,response to morphine,sequestration,sleep regulation of dopamine secretion,social behavior,spinal reflex action,synaptic transmission,temperature extremes,Transducer,transmembrane,Transmembrane helix,Tremor,trunk,visual learning,voice",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs9825563",
        "SNP Name": "DRD3 T2680C",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs9825563",
        "Video": null,
        "Tags": "3D-structure,acid secretion,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,Alternative splicing,apical part of cell,arachidonic acid secretion,autosomal dominant,basal conditions,behavioral response to cocaine,belongs to the G-protein coupled receptor 1 family,Brain,Cell membrane,cell projection,cell proliferation,cellular calcium ion homeostasis,circadian regulation of gene expression,CLIC6,co-localize,cocaine dependence,Complete proteome,Continuous Performance Task,CPT,cytoplasm,D(3) dopamine receptor,depression,dispersal,Disulfide bond,dopamine binding,Dopamine D3 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity coupled via Gi/Go,Dopamine receptor,dopaminergic,DRD3,drug binding,emotions,endocytic vesicle,ETM1,facial muscles,fatigue,functional disability,G proteins,G-protein coupled,G-protein coupled receptor,G-protein coupled receptor internalization,gastric emptying,Glycoprotein,GRK4,GRK4-alpha,GRK4-gamma,Head,hereditary essential 1,hunger,incapacitation,integral component of plasma membrane,jaw,learning,learning or memory,legs,lipid rafts,locomotory behavior,Major Depressive Disorder,membrane,membrane-bound,movement disorder,Multi-pass membrane protein,musculoskeletal movement,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of dopamine receptor signaling pathway,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of sodium:hydrogen antiporter activity,negative regulation of transcription from RNA polymerase II promoter,PALM,perinuclear area,Phosphorylation,plasma membrane,Polymorphism,positive regulation of cell proliferation,positive regulation of cytokinesis,positive regulation of dopamine receptor signaling pathway,positive regulation of mitosis,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,postural tremor of the arms,prepulse inhibition,rapid internalization,Receptor,receptor sialing pathway,Receptor stimulation,receptors,Reference proteome,regulation of blood volume by renin-angiotensin,regulation of cAMP metabolic process,regulation of circadian sleep/wake cycle,regulation of dopamine uptake involved in synaptic transmission,regulation of lipid metabolic process,regulation of locomotion involved in locomotory behavior,regulation of multicellular organism growth,renal proximal tubule cells,response to amphetamine,response to cocaine,response to drug,response to histamine,response to morphine,sequestration,sleep regulation of dopamine secretion,social behavior,spinal reflex action,synaptic transmission,temperature extremes,Transducer,transmembrane,Transmembrane helix,Tremor,trunk,visual learning,voice",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1394016",
        "SNP Name": "DRD3 G20405035A",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1394016",
        "Video": null,
        "Tags": "3D-structure,acid secretion,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,ADHD,Alternative splicing,apical part of cell,arachidonic acid secretion,autosomal dominant,basal conditions,behavioral response to cocaine,belongs to the G-protein coupled receptor 1 family,Brain,Cell membrane,cell projection,cell proliferation,cellular calcium ion homeostasis,circadian regulation of gene expression,CLIC6,co-localize,Complete proteome,cytoplasm,D(3) dopamine receptor,dispersal,Disulfide bond,dopamine binding,Dopamine D3 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity coupled via Gi/Go,Dopamine receptor,dopaminergic,DRD3,drug binding,emotions,endocytic vesicle,ETM1,facial muscles,fatigue,functional disability,G proteins,G-protein coupled,G-protein coupled receptor,G-protein coupled receptor internalization,gastric emptying,Glycoprotein,GRK4,GRK4-alpha,GRK4-gamma,Head,hereditary essential 1,hunger,incapacitation,integral component of plasma membrane,jaw,learning,learning or memory,legs,lipid rafts,locomotory behavior,membrane,membrane-bound,movement disorder,Multi-pass membrane protein,musculoskeletal movement,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of dopamine receptor signaling pathway,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of sodium:hydrogen antiporter activity,negative regulation of transcription from RNA polymerase II promoter,PALM,perinuclear area,Phosphorylation,plasma membrane,Polymorphism,positive regulation of cell proliferation,positive regulation of cytokinesis,positive regulation of dopamine receptor signaling pathway,positive regulation of mitosis,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,postural tremor of the arms,prepulse inhibition,rapid internalization,Receptor,receptor sialing pathway,Receptor stimulation,receptors,Reference proteome,regulation of blood volume by renin-angiotensin,regulation of cAMP metabolic process,regulation of circadian sleep/wake cycle,regulation of dopamine uptake involved in synaptic transmission,regulation of lipid metabolic process,regulation of locomotion involved in locomotory behavior,regulation of multicellular organism growth,renal proximal tubule cells,response to amphetamine,response to cocaine,response to drug,response to histamine,response to morphine,sequestration,sleep regulation of dopamine secretion,social behavior,spinal reflex action,synaptic transmission,temperature extremes,Transducer,transmembrane,Transmembrane helix,Tremor,trunk,visual learning,voice",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1394016",
        "SNP Name": "DRD3 G20405035A",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1394016",
        "Video": null,
        "Tags": "3D-structure,acid secretion,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,ADHD,Alternative splicing,apical part of cell,arachidonic acid secretion,autosomal dominant,basal conditions,behavioral response to cocaine,belongs to the G-protein coupled receptor 1 family,Brain,Cell membrane,cell projection,cell proliferation,cellular calcium ion homeostasis,circadian regulation of gene expression,CLIC6,co-localize,Complete proteome,cytoplasm,D(3) dopamine receptor,dispersal,Disulfide bond,dopamine binding,Dopamine D3 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity coupled via Gi/Go,Dopamine receptor,dopaminergic,DRD3,drug binding,emotions,endocytic vesicle,ETM1,facial muscles,fatigue,functional disability,G proteins,G-protein coupled,G-protein coupled receptor,G-protein coupled receptor internalization,gastric emptying,Glycoprotein,GRK4,GRK4-alpha,GRK4-gamma,Head,hereditary essential 1,hunger,incapacitation,integral component of plasma membrane,jaw,learning,learning or memory,legs,lipid rafts,locomotory behavior,membrane,membrane-bound,movement disorder,Multi-pass membrane protein,musculoskeletal movement,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of dopamine receptor signaling pathway,negative regulation of oligodendrocyte differentiation,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of sodium:hydrogen antiporter activity,negative regulation of transcription from RNA polymerase II promoter,PALM,perinuclear area,Phosphorylation,plasma membrane,Polymorphism,positive regulation of cell proliferation,positive regulation of cytokinesis,positive regulation of dopamine receptor signaling pathway,positive regulation of mitosis,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,postural tremor of the arms,prepulse inhibition,rapid internalization,Receptor,receptor sialing pathway,Receptor stimulation,receptors,Reference proteome,regulation of blood volume by renin-angiotensin,regulation of cAMP metabolic process,regulation of circadian sleep/wake cycle,regulation of dopamine uptake involved in synaptic transmission,regulation of lipid metabolic process,regulation of locomotion involved in locomotory behavior,regulation of multicellular organism growth,renal proximal tubule cells,response to amphetamine,response to cocaine,response to drug,response to histamine,response to morphine,sequestration,sleep regulation of dopamine secretion,social behavior,spinal reflex action,synaptic transmission,temperature extremes,Transducer,transmembrane,Transmembrane helix,Tremor,trunk,visual learning,voice",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1523127",
        "SNP Name": "NR1I2 C6709A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Activator,antibiotics,aspirin,cancer,cancerous,carcinogen,ciclosporin,colorectal cancer,colupulone,DNA-binding,DNA-templated,drug binding,drug export,drug metabolism,drugs,estrogen,exogenous drug catabolic process,gene expression,guggulipid,HIV,hyperforin,inflammation,inflammatory bowel disease,intracellular receptor signaling pathway,isoflavones,ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity,liver,Metal-binding,negative regulation of transcription,nonsteroidal anti-inflammatory drugs,NR1I2,NSAIDs,Nuclear receptor subfamily 1 group I member 2,nucleoplasm,Nucleus,Orphan nuclear receptor PAR1,Orphan nuclear receptor PXR,pharmacogenomics,plant metabolites,positive regulation of transcription,positive regulation of transcription from RNA polymerase II promoter,Pregnane X receptor,pregnenolone,progesterone,PXR,Receptor,rifampicin,RNA polymerase II regulatory region sequence-specific DNA binding,RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription,signal transduction,Steroid and xenobiotic receptor,steroid hormone receptor activity,steroid metabolic process,steroids,SXR,Transcription,transcription coactivator activity,transcription initiation from RNA polymerase II promoter,Transcription regulation,xenobiotic,xenobiotic metabolic process,xenobiotic transport,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs1523127",
        "SNP Name": "NR1I2 C6709A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Activator,antibiotics,aspirin,cancer,cancerous,carcinogen,ciclosporin,colorectal cancer,colupulone,DNA-binding,DNA-templated,drug binding,drug export,drug metabolism,drugs,estrogen,exogenous drug catabolic process,gene expression,guggulipid,HIV,hyperforin,inflammation,inflammatory bowel disease,intracellular receptor signaling pathway,isoflavones,ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity,liver,Metal-binding,negative regulation of transcription,nonsteroidal anti-inflammatory drugs,NR1I2,NSAIDs,Nuclear receptor subfamily 1 group I member 2,nucleoplasm,Nucleus,Orphan nuclear receptor PAR1,Orphan nuclear receptor PXR,pharmacogenomics,plant metabolites,positive regulation of transcription,positive regulation of transcription from RNA polymerase II promoter,Pregnane X receptor,pregnenolone,progesterone,PXR,Receptor,rifampicin,RNA polymerase II regulatory region sequence-specific DNA binding,RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription,signal transduction,Steroid and xenobiotic receptor,steroid hormone receptor activity,steroid metabolic process,steroids,SXR,Transcription,transcription coactivator activity,transcription initiation from RNA polymerase II promoter,Transcription regulation,xenobiotic,xenobiotic metabolic process,xenobiotic transport,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Clotting Factors"
    },
    {
        "SNP ID": "rs1129055",
        "SNP Name": "CD86 A228T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs4428180",
        "SNP Name": "TF 6398A>G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs12493168",
        "SNP Name": "TF 6612A>G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs8177190",
        "SNP Name": "TF 7720C>T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs1799852",
        "SNP Name": "TF Leu247Leu",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs1799852",
        "SNP Name": "TF Leu247Leu",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Bovine Serum Albumin"
    },
    {
        "SNP ID": "rs1799852",
        "SNP Name": "TF Leu247Leu",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Chicken Protein"
    },
    {
        "SNP ID": "rs1799852",
        "SNP Name": "TF Leu247Leu",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Human Serum Albumin"
    },
    {
        "SNP ID": "rs1799852",
        "SNP Name": "TF Leu247Leu",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Ovalbumin"
    },
    {
        "SNP ID": "rs1799899",
        "SNP Name": "TF Gly277Ser",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs3811647",
        "SNP Name": "TF A24053G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Mercury (Thiomersal/Thimerosal)"
    },
    {
        "SNP ID": "rs3811647",
        "SNP Name": "TF 24053G>A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs1358024",
        "SNP Name": "TF 24212C>T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs1049296",
        "SNP Name": "TF C34378T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": "AD,Alzheimer,Alzheimer's disease,anemia,anion,Antiretroviral,Antiretroviral Therapy,apical plasma membrane,ATRAF,Atransferrinemia,basal part of cell,basal plasma membrane,Beta-1 metal-binding globulin,bicarbonate,blood coagulation,blood microparticle,cell surface,cellular iron ion homeostasis,cerebrospinal fluid amyloid beta,Cerebrospinal Fluid Biomarkers,coagulation,coated pit,cytoplasmic membrane-bounded vesicle,degradation,dementia,diabetes,Disulfide bond,dopamine,early endosome,endocytic vesicle,endosome membrane,extracellular region,extracellular space,extracellular vesicular exosome,Fe,Fe3+,ferric iron binding,glioma,Glycoprotein,Haemochromatosis,heme,hemoglobin levels,Hereditary Haemochromatosis,HFE,hypochromic,hypochromic anemia,Ion transport,IQ,iron,iron dyshomeostasis,iron metabolism,iron overload,Iron transport,Iron uptake,late endosome,lead,Metal-binding,Methylation,microcytic,microcytic hypochromic anemia,mild cognitive impairment,neurodegenerative disease,Neuropathic Pain,oxidative stress,Parkinson,Parkinson's diseases,PD,perinuclear region of cytoplasm,platelet,platelet activation,platelet degranulation,recycling endosome,reticuloendothelial system,retina homeostasis,ROS,secretory granule lumen,Serotransferrin,serum ferritin,Siderophilin,TF,Transferrin,transferrin glycosylation,transferrin transport,transmembrane transport,Transport,tremor,TRFE,type 2 diabetes,vesicle",
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs1049296",
        "SNP Name": "TF C34378T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": "AD,Alzheimer,Alzheimer's disease,anemia,anion,Antiretroviral,Antiretroviral Therapy,apical plasma membrane,ATRAF,Atransferrinemia,basal part of cell,basal plasma membrane,Beta-1 metal-binding globulin,bicarbonate,blood coagulation,blood microparticle,cell surface,cellular iron ion homeostasis,cerebrospinal fluid amyloid beta,Cerebrospinal Fluid Biomarkers,coagulation,coated pit,cytoplasmic membrane-bounded vesicle,degradation,dementia,diabetes,Disulfide bond,dopamine,early endosome,endocytic vesicle,endosome membrane,extracellular region,extracellular space,extracellular vesicular exosome,Fe,Fe3+,ferric iron binding,glioma,Glycoprotein,Haemochromatosis,heme,hemoglobin levels,Hereditary Haemochromatosis,HFE,hypochromic,hypochromic anemia,Ion transport,IQ,iron,iron dyshomeostasis,iron metabolism,iron overload,Iron transport,Iron uptake,late endosome,lead,Metal-binding,Methylation,microcytic,microcytic hypochromic anemia,mild cognitive impairment,neurodegenerative disease,Neuropathic Pain,oxidative stress,Parkinson,Parkinson's diseases,PD,perinuclear region of cytoplasm,platelet,platelet activation,platelet degranulation,recycling endosome,reticuloendothelial system,retina homeostasis,ROS,secretory granule lumen,Serotransferrin,serum ferritin,Siderophilin,TF,Transferrin,transferrin glycosylation,transferrin transport,transmembrane transport,Transport,tremor,TRFE,type 2 diabetes,vesicle",
        "Group": "Bovine Serum Albumin"
    },
    {
        "SNP ID": "rs1049296",
        "SNP Name": "TF C34378T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": "AD,Alzheimer,Alzheimer's disease,anemia,anion,Antiretroviral,Antiretroviral Therapy,apical plasma membrane,ATRAF,Atransferrinemia,basal part of cell,basal plasma membrane,Beta-1 metal-binding globulin,bicarbonate,blood coagulation,blood microparticle,cell surface,cellular iron ion homeostasis,cerebrospinal fluid amyloid beta,Cerebrospinal Fluid Biomarkers,coagulation,coated pit,cytoplasmic membrane-bounded vesicle,degradation,dementia,diabetes,Disulfide bond,dopamine,early endosome,endocytic vesicle,endosome membrane,extracellular region,extracellular space,extracellular vesicular exosome,Fe,Fe3+,ferric iron binding,glioma,Glycoprotein,Haemochromatosis,heme,hemoglobin levels,Hereditary Haemochromatosis,HFE,hypochromic,hypochromic anemia,Ion transport,IQ,iron,iron dyshomeostasis,iron metabolism,iron overload,Iron transport,Iron uptake,late endosome,lead,Metal-binding,Methylation,microcytic,microcytic hypochromic anemia,mild cognitive impairment,neurodegenerative disease,Neuropathic Pain,oxidative stress,Parkinson,Parkinson's diseases,PD,perinuclear region of cytoplasm,platelet,platelet activation,platelet degranulation,recycling endosome,reticuloendothelial system,retina homeostasis,ROS,secretory granule lumen,Serotransferrin,serum ferritin,Siderophilin,TF,Transferrin,transferrin glycosylation,transferrin transport,transmembrane transport,Transport,tremor,TRFE,type 2 diabetes,vesicle",
        "Group": "Chicken Protein"
    },
    {
        "SNP ID": "rs1049296",
        "SNP Name": "TF C34378T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": "AD,Alzheimer,Alzheimer's disease,anemia,anion,Antiretroviral,Antiretroviral Therapy,apical plasma membrane,ATRAF,Atransferrinemia,basal part of cell,basal plasma membrane,Beta-1 metal-binding globulin,bicarbonate,blood coagulation,blood microparticle,cell surface,cellular iron ion homeostasis,cerebrospinal fluid amyloid beta,Cerebrospinal Fluid Biomarkers,coagulation,coated pit,cytoplasmic membrane-bounded vesicle,degradation,dementia,diabetes,Disulfide bond,dopamine,early endosome,endocytic vesicle,endosome membrane,extracellular region,extracellular space,extracellular vesicular exosome,Fe,Fe3+,ferric iron binding,glioma,Glycoprotein,Haemochromatosis,heme,hemoglobin levels,Hereditary Haemochromatosis,HFE,hypochromic,hypochromic anemia,Ion transport,IQ,iron,iron dyshomeostasis,iron metabolism,iron overload,Iron transport,Iron uptake,late endosome,lead,Metal-binding,Methylation,microcytic,microcytic hypochromic anemia,mild cognitive impairment,neurodegenerative disease,Neuropathic Pain,oxidative stress,Parkinson,Parkinson's diseases,PD,perinuclear region of cytoplasm,platelet,platelet activation,platelet degranulation,recycling endosome,reticuloendothelial system,retina homeostasis,ROS,secretory granule lumen,Serotransferrin,serum ferritin,Siderophilin,TF,Transferrin,transferrin glycosylation,transferrin transport,transmembrane transport,Transport,tremor,TRFE,type 2 diabetes,vesicle",
        "Group": "Human Serum Albumin"
    },
    {
        "SNP ID": "rs1049296",
        "SNP Name": "TF C34378T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": "AD,Alzheimer,Alzheimer's disease,anemia,anion,Antiretroviral,Antiretroviral Therapy,apical plasma membrane,ATRAF,Atransferrinemia,basal part of cell,basal plasma membrane,Beta-1 metal-binding globulin,bicarbonate,blood coagulation,blood microparticle,cell surface,cellular iron ion homeostasis,cerebrospinal fluid amyloid beta,Cerebrospinal Fluid Biomarkers,coagulation,coated pit,cytoplasmic membrane-bounded vesicle,degradation,dementia,diabetes,Disulfide bond,dopamine,early endosome,endocytic vesicle,endosome membrane,extracellular region,extracellular space,extracellular vesicular exosome,Fe,Fe3+,ferric iron binding,glioma,Glycoprotein,Haemochromatosis,heme,hemoglobin levels,Hereditary Haemochromatosis,HFE,hypochromic,hypochromic anemia,Ion transport,IQ,iron,iron dyshomeostasis,iron metabolism,iron overload,Iron transport,Iron uptake,late endosome,lead,Metal-binding,Methylation,microcytic,microcytic hypochromic anemia,mild cognitive impairment,neurodegenerative disease,Neuropathic Pain,oxidative stress,Parkinson,Parkinson's diseases,PD,perinuclear region of cytoplasm,platelet,platelet activation,platelet degranulation,recycling endosome,reticuloendothelial system,retina homeostasis,ROS,secretory granule lumen,Serotransferrin,serum ferritin,Siderophilin,TF,Transferrin,transferrin glycosylation,transferrin transport,transmembrane transport,Transport,tremor,TRFE,type 2 diabetes,vesicle",
        "Group": "Ovalbumin"
    },
    {
        "SNP ID": "rs1049296",
        "SNP Name": "TF C34378T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,Alzheimer,Alzheimer's disease,anemia,anion,Antiretroviral,Antiretroviral Therapy,apical plasma membrane,ATRAF,Atransferrinemia,basal part of cell,basal plasma membrane,Beta-1 metal-binding globulin,bicarbonate,blood coagulation,blood microparticle,cell surface,cellular iron ion homeostasis,cerebrospinal fluid amyloid beta,Cerebrospinal Fluid Biomarkers,coagulation,coated pit,cytoplasmic membrane-bounded vesicle,degradation,dementia,diabetes,Disulfide bond,dopamine,early endosome,endocytic vesicle,endosome membrane,extracellular region,extracellular space,extracellular vesicular exosome,Fe,Fe3+,ferric iron binding,glioma,Glycoprotein,Haemochromatosis,heme,hemoglobin levels,Hereditary Haemochromatosis,HFE,hypochromic,hypochromic anemia,Ion transport,IQ,iron,iron dyshomeostasis,iron metabolism,iron overload,Iron transport,Iron uptake,late endosome,lead,Metal-binding,Methylation,microcytic,microcytic hypochromic anemia,mild cognitive impairment,neurodegenerative disease,Neuropathic Pain,oxidative stress,Parkinson,Parkinson's diseases,PD,perinuclear region of cytoplasm,platelet,platelet activation,platelet degranulation,recycling endosome,reticuloendothelial system,retina homeostasis,ROS,secretory granule lumen,Serotransferrin,serum ferritin,Siderophilin,TF,Transferrin,transferrin glycosylation,transferrin transport,transmembrane transport,Transport,tremor,TRFE,type 2 diabetes,vesicle",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs1049296",
        "SNP Name": "TF Pro589Ser",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs13072552",
        "SNP Name": "CP 148913126G>T",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs9851967",
        "SNP Name": "LPP 220966C>T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Celiac Disease/Gluten Intolerance"
    },
    {
        "SNP ID": "rs406271",
        "SNP Name": "TFRC 195776976T>C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs3817672",
        "SNP Name": "TFRC Gly142Ser",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs4961",
        "SNP Name": "ADD1 G460W",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4961",
        "Video": "4uCU2ZrwDu0",
        "Tags": "ACE,Acetylation,actin,actin cytoskeleton organization,actin filament,actin filament bundle assembly,Actin-binding,ADD1,ADDA,Adducin,Adducin subfamily,adverse cardiovascular outcomes,aldolase class II,Alpha-adducin,Alternative splicing,angiogenesis,apoptosis,apoptotic process,blood pressure,breast cancer,calmodulin,Calmodulin-binding,cancerous,carcinogen,cardiovascular,Cell membrane,cerebral palsy,congestive heart failure,Cytoplasm,cytoskeleton,cytosol,decline of renal function in human IgA nephropathy,dendritic spine,endocytosis,essential hypertension,heart,heart attack,heart disease,heart failure,hemoglobin,hemorrhage,high blood pressure,high BP,high LDL levels,hypertension,hypertensive,inherited cerebral palsy,intracerebral,Ischemic Stroke,kidney failure,lateral sclerosis,LDL,magnesium,Membrane,Membrane-cytoskeleton-associated protein,MI,Migraine,myocardial infarction,Pharmacogenetics,Phosphoprotein,podocyte proteins,Polymorphism,potassium,proteinuria,Recurrent Venous Thromboembolism,renal,renal failure,Renal Function Decline,renal sodium handling in primary hypertension,retinoic acid,RNA,RNA binding,RVT,Salt-Sensitive Hypertension,Salt-Sensitivity of Blood Pressure,sclerosis,sodium,sodium imbalance,spectrin-actin,spectrin-actin network,sporadic amyotrophic lateral sclerosis,stroke,weak heart,\u00a0 cytoskeleton,\u00a0Erythrocyte adducin,\u00a0\u00a0aldolase class II family,\u03b1ADDUCIN",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs734312",
        "SNP Name": "WFS1 A611H",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs2855262",
        "SNP Name": "SOD3 489 C>T",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2855262",
        "Video": "ozi0K5pNHKw",
        "Tags": "2 superoxide + 2 H+ = O2 + H2O2,Acute Lung Injury and Mortality,aggressive prostate cancer,anchored to heparan sulfate proteoglycans in the tissue interstitium and 1% is located in the vasculature in equilibrium between the plasma and the endothelium,Antioxidant,Binds 1 copper ion per subunit,Binds 1 zinc ion per subunit,Catalytic activity,cellular energy,cofactor,copper,copper ion binding,cu,Cu-Zn superoxide dismutase family,cytoplasm,Disulfide bond,energy,extracellular matrix,extracellular region,extracellular space,Extracellular superoxide dismutase [Cu-Zn],extracellular vesicular exosome,Glc,GlcNAc,glycation,Glycoprotein,Golgi lumen,heart,heparin binding,Heparin-binding,lungs,Major SOD isoenzyme in extracellular fluids such as plasma and lymph and synovial fluid,Metal binding,Metal-binding,minerals,N-Acetylglucosamine,Not glycated,nucleus,O2,oxidate stress,oxidation,oxidative damage,Oxidoreductase,oxygen,prostate cancer,Protect the extracellular space from toxic effect of reactive oxygen intermediates by converting superoxide radicals into hydrogen peroxide and oxygen,protein binding,proteoglycans,reactive oxygen species,removal of superoxide radicals,response to copper ion,response to hypoxia,ROS,SOD3,sulfate,superoxide dismutase activity,trans-Golgi network,zinc,zinc ion binding,zn",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs4624663",
        "SNP Name": "TLR1 T38797876C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Mercury (Thiomersal/Thimerosal)"
    },
    {
        "SNP ID": "rs5743618",
        "SNP Name": "TLR1 S602I",
        "Risk Allele": "C",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Mercury (Thiomersal/Thimerosal)"
    },
    {
        "SNP ID": "rs2066786",
        "SNP Name": "RFC1 P848P",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2066786",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs6844176",
        "SNP Name": "RFC1 T39366590C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6844176",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs6851075",
        "SNP Name": "RFC1 T39367654C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6851075",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs2259073",
        "SNP Name": "LIAS A19410C",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2259073",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs2259073",
        "SNP Name": "LIAS A19410C",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2259073",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs2231164",
        "SNP Name": "ABCG2 89015857C>T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs1481012",
        "SNP Name": "ABCG2 89039082A>G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs2231142",
        "SNP Name": "ABCG2 Gln141Lys",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs72552713",
        "SNP Name": "ABCG2 Gln126Ter",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs4148155",
        "SNP Name": "ABCG2 89060909T>C",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs4148155",
        "SNP Name": "ABCG2 89054667A>G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs2622604",
        "SNP Name": "ABCG2 89078924T>C",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs3816873",
        "SNP Name": "MTTP I28T",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Polysorbate 20"
    },
    {
        "SNP ID": "rs1377210",
        "SNP Name": "AGXT2L1 S127P",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1377210",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs1377210",
        "SNP Name": "AGXT2L1 S127P",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1377210",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs4444903",
        "SNP Name": "EGF A110834110G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Taurodeoxycholate"
    },
    {
        "SNP ID": "rs4444903",
        "SNP Name": "EGF A110834110G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Urea"
    },
    {
        "SNP ID": "rs2237051",
        "SNP Name": "EGF M708I",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Urea"
    },
    {
        "SNP ID": "rs2069762",
        "SNP Name": "IL2 T4671G",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Formaldehyde"
    },
    {
        "SNP ID": "rs6822844",
        "SNP Name": "4q27 Region 123509421G>T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs6822844",
        "Video": null,
        "Tags": null,
        "Group": "Celiac Disease/Gluten Intolerance"
    },
    {
        "SNP ID": "rs6822844",
        "SNP Name": "4q27 Region 123509421G>T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs6822844",
        "Video": null,
        "Tags": null,
        "Group": "Other Immune Factors"
    },
    {
        "SNP ID": "rs1449683",
        "SNP Name": "FGF2 S52S",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs1449683",
        "SNP Name": "FGF2 S52S",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Gelatin"
    },
    {
        "SNP ID": "rs1048201",
        "SNP Name": "FGF2/NUDT6 A209G",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs1048201",
        "SNP Name": "FGF2/NUDT6 A209G",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Gelatin"
    },
    {
        "SNP ID": "rs1490453",
        "SNP Name": "NR3C2 G149321346A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs3804100",
        "SNP Name": "TLR2 S450S",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Mercury (Thiomersal/Thimerosal)"
    },
    {
        "SNP ID": "rs13146272",
        "SNP Name": "CYP4V2 Q259K",
        "Risk Allele": "C",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "21-hydroxydocosahexaenoate,CYP P450,CYP4V2,Cytochrome P450 4V2,deep venous thrombosis,DHA,docosahexaenoate,Docosahexaenoic acid omega-hydroxylase CYP4V2,drug response,drugs,fat,fat metabolism,fatty acid metabolism,fatty acid omega-oxidation,heme,heme binding,HIV,HIV-1,Iron,laurate,lauric acid,lipid metabolism,lipids,liver,lupus,MCF,medium-chain saturated fatty acids,Metal-binding,Monooxygenase,monooxygenase activity,myristate,myristic acid,N-hydroxy-N'-(4-n-butyl-2-methylphenyl formamidine),NADP,NADPH,NADPH-dependent pathway,omega-3,Omega-hydroxylase,Oxidoreductase,oxidoreductase activity,P450,palmitate,polyunsaturated,response to stimulus,Sensory transduction,steroid,steroid metabolism,systemic lupus Erythematosus,tamoxifen,Tamoxifen-Induced Venothromboembolic,Thromboembolism,thrombosis,venothromboembolic,Vision,visual perception",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs13146272",
        "SNP Name": "CYP4V2 Q259K",
        "Risk Allele": "C",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "21-hydroxydocosahexaenoate,CYP P450,CYP4V2,Cytochrome P450 4V2,deep venous thrombosis,DHA,docosahexaenoate,Docosahexaenoic acid omega-hydroxylase CYP4V2,drug response,drugs,fat,fat metabolism,fatty acid metabolism,fatty acid omega-oxidation,heme,heme binding,HIV,HIV-1,Iron,laurate,lauric acid,lipid metabolism,lipids,liver,lupus,MCF,medium-chain saturated fatty acids,Metal-binding,Monooxygenase,monooxygenase activity,myristate,myristic acid,N-hydroxy-N'-(4-n-butyl-2-methylphenyl formamidine),NADP,NADPH,NADPH-dependent pathway,omega-3,Omega-hydroxylase,Oxidoreductase,oxidoreductase activity,P450,palmitate,polyunsaturated,response to stimulus,Sensory transduction,steroid,steroid metabolism,systemic lupus Erythematosus,tamoxifen,Tamoxifen-Induced Venothromboembolic,Thromboembolism,thrombosis,venothromboembolic,Vision,visual perception",
        "Group": "Clotting Factors"
    },
    {
        "SNP ID": "rs2036914",
        "SNP Name": "F11 T10364C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "blood coagulation,CAD,cardio,cardiovascular,clotting disorders,coagulation,Coagulation factor XI,Coagulation factor XIa heavy chain,Coagulation factor XIa light chain,Congenital factor XI deficiency,Coronary Artery Disease,Disulfide bond,extracellular region,extracellular space,extracellular vesicular exosome,F11,FA11,FA11D,Factor XI deficiency,FXI,Glycoprotein,heart,heart disease,Hemostasis,heparin binding,Heparin-binding,Hydrolase,Inhibited by SERPINA5,intrinsic pathway,Ischemic stroke,liver,megakaryocytes,membrane,menorrhagia,plasma membrane,Plasma thromboplastin antecedent,plasminogen activation,platelets,positive regulation of fibrinolysis,Protease,PTA,Serine protease,serine-type aminopeptidase activity,serine-type endopeptidase activity,venous thromboembolism,Venous Thrombosis",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs2036914",
        "SNP Name": "F11 T10364C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "blood coagulation,CAD,cardio,cardiovascular,clotting disorders,coagulation,Coagulation factor XI,Coagulation factor XIa heavy chain,Coagulation factor XIa light chain,Congenital factor XI deficiency,Coronary Artery Disease,Disulfide bond,extracellular region,extracellular space,extracellular vesicular exosome,F11,FA11,FA11D,Factor XI deficiency,FXI,Glycoprotein,heart,heart disease,Hemostasis,heparin binding,Heparin-binding,Hydrolase,Inhibited by SERPINA5,intrinsic pathway,Ischemic stroke,liver,megakaryocytes,membrane,menorrhagia,plasma membrane,Plasma thromboplastin antecedent,plasminogen activation,platelets,positive regulation of fibrinolysis,Protease,PTA,Serine protease,serine-type aminopeptidase activity,serine-type endopeptidase activity,venous thromboembolism,Venous Thrombosis",
        "Group": "Clotting Factors"
    },
    {
        "SNP ID": "rs2289252",
        "SNP Name": "F11 C25264T",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "blood coagulation,CAD,cardio,cardiovascular,clotting disorders,coagulation,Coagulation factor XI,Coagulation factor XIa heavy chain,Coagulation factor XIa light chain,Congenital factor XI deficiency,Coronary Artery Disease,CVD,Disulfide bond,extracellular region,extracellular space,extracellular vesicular exosome,F11,FA11,FA11D,Factor XI deficiency,FXI,Glycoprotein,heart,heart disease,Hemostasis,heparin binding,Heparin-binding,Hydrolase,Inhibited by SERPINA5,intrinsic pathway,ischemic stroke,liver,lupus,megakaryocytes,membrane,menorrhagia,Partial Thromboplastin Time,plasma membrane,Plasma thromboplastin antecedent,plasminogen activation,platelets,positive regulation of fibrinolysis,Protease,Prothrombin Time,PTA,Serine protease,serine-type aminopeptidase activity,serine-type endopeptidase activity,Systemic Lupus Erythematosus,Venous Thromboembolism,venous thrombosis",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs2289252",
        "SNP Name": "F11 C25264T",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "blood coagulation,CAD,cardio,cardiovascular,clotting disorders,coagulation,Coagulation factor XI,Coagulation factor XIa heavy chain,Coagulation factor XIa light chain,Congenital factor XI deficiency,Coronary Artery Disease,CVD,Disulfide bond,extracellular region,extracellular space,extracellular vesicular exosome,F11,FA11,FA11D,Factor XI deficiency,FXI,Glycoprotein,heart,heart disease,Hemostasis,heparin binding,Heparin-binding,Hydrolase,Inhibited by SERPINA5,intrinsic pathway,ischemic stroke,liver,lupus,megakaryocytes,membrane,menorrhagia,Partial Thromboplastin Time,plasma membrane,Plasma thromboplastin antecedent,plasminogen activation,platelets,positive regulation of fibrinolysis,Protease,Prothrombin Time,PTA,Serine protease,serine-type aminopeptidase activity,serine-type endopeptidase activity,Systemic Lupus Erythematosus,Venous Thromboembolism,venous thrombosis",
        "Group": "Clotting Factors"
    },
    {
        "SNP ID": "rs27072",
        "SNP Name": "SLC6A3 G56022A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs27072",
        "Video": null,
        "Tags": "adenohypophysis development,ADHD,aggressive behavior,aging,alcohol dependence,Amine transporter,axon,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,bipolar,Bipolar Disorder,bradykinesia,cell death,Cell membrane,Cell membrane; Multi-pass membrane protein,Complete proteome,Continuous Performance Task,cytoplasm,DA transporter,DAT,Disease mutation,Disulfide bond,dopamine,dopamine binding,dopamine biosynthetic process,dopamine catabolic process,dopamine transmembrane transporter activity,dopamine transport,dopamine:sodium symporter activity,dopaminergic,drug,drug binding,drug metabolism,drug response,dystonia,esponse to iron ion,Financial and Psychological Risk Attitudes,global developmental delay,Glycoprotein,Highly expressed in substantia nigra,Homooligomer; disulfide-linked,integral component of membrane,integral component of plasma membrane,Interacts (via N-terminus) with SYNGR3 (via N-terminus),Interacts with PRKCABP and TGFB1I1,Interacts with SLC18A2,Interacts with TOR1A (ATP-bound); TOR1A regulates SLC6A3 subcellular location,lactation,locomotory behavior,Membrane,mental disorder,monoamine transmembrane transporter activity,monoamine transport,Neurodegeneration,neurodegenerative disorder,Neurodevelopmental Phenotypes following Cardiac Surgery in Infancy,neuronal cell body,neurotransmitter biosynthetic process,Neurotransmitter transport,neurotransmitters,Parkinson,Parkinsonism,Parkinsonism-dystonia infantile (PKDYS),Parkinson\u2019s disease,plasma membrane,Polymorphism,positive regulation of multicellular organism growth,Posttraumatic Stress Disorder,prepulse inhibition,protein binding,PTSD,pyramidal tract signs,Reference proteome,regulation of dopamine metabolic process,response to cAMP,response to cocaine,response to drug,response to ethanol,response to nicotine,Reward Deficiency Syndrome (RDS),risk of lethal cocaine abuse,schizophrenia,seizure,sensitivity to nicotine in nonsmokers,sensory perception of smell,SLC6A3,SLC6A3 subfamily,Sodium-dependent dopamine transporter,Solute carrier family 6 member 3,Symport,synaptic transmission,Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport,withdrawal seizures in patients with alcohol dependence",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs27072",
        "SNP Name": "SLC6A3 G56022A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs27072",
        "Video": null,
        "Tags": "adenohypophysis development,ADHD,aggressive behavior,aging,alcohol dependence,Amine transporter,axon,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,bipolar,Bipolar Disorder,bradykinesia,cell death,Cell membrane,Cell membrane; Multi-pass membrane protein,Complete proteome,Continuous Performance Task,cytoplasm,DA transporter,DAT,Disease mutation,Disulfide bond,dopamine,dopamine binding,dopamine biosynthetic process,dopamine catabolic process,dopamine transmembrane transporter activity,dopamine transport,dopamine:sodium symporter activity,dopaminergic,drug,drug binding,drug metabolism,drug response,dystonia,esponse to iron ion,Financial and Psychological Risk Attitudes,global developmental delay,Glycoprotein,Highly expressed in substantia nigra,Homooligomer; disulfide-linked,integral component of membrane,integral component of plasma membrane,Interacts (via N-terminus) with SYNGR3 (via N-terminus),Interacts with PRKCABP and TGFB1I1,Interacts with SLC18A2,Interacts with TOR1A (ATP-bound); TOR1A regulates SLC6A3 subcellular location,lactation,locomotory behavior,Membrane,mental disorder,monoamine transmembrane transporter activity,monoamine transport,Neurodegeneration,neurodegenerative disorder,Neurodevelopmental Phenotypes following Cardiac Surgery in Infancy,neuronal cell body,neurotransmitter biosynthetic process,Neurotransmitter transport,neurotransmitters,Parkinson,Parkinsonism,Parkinsonism-dystonia infantile (PKDYS),Parkinson\u2019s disease,plasma membrane,Polymorphism,positive regulation of multicellular organism growth,Posttraumatic Stress Disorder,prepulse inhibition,protein binding,PTSD,pyramidal tract signs,Reference proteome,regulation of dopamine metabolic process,response to cAMP,response to cocaine,response to drug,response to ethanol,response to nicotine,Reward Deficiency Syndrome (RDS),risk of lethal cocaine abuse,schizophrenia,seizure,sensitivity to nicotine in nonsmokers,sensory perception of smell,SLC6A3,SLC6A3 subfamily,Sodium-dependent dopamine transporter,Solute carrier family 6 member 3,Symport,synaptic transmission,Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport,withdrawal seizures in patients with alcohol dependence",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs40184",
        "SNP Name": "SLC6A3 G55467A",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs40184",
        "Video": null,
        "Tags": "acute post-surgical pain,adenohypophysis development,ADHD,aging,Amine transporter,Amino acids,axon,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,Biogenic amines,bipolar,bipolar disorder,bradykinesia,cell death,Cell membrane,Cell membrane; Multi-pass membrane protein,children\u2019s telomere length,cocaine,Complete proteome,Continuous Performance Task,cytoplasm,DA transporter,DAT,depression,Disease mutation,Disulfide bond,dopamine,dopamine binding,dopamine biosynthetic process,dopamine catabolic process,dopamine transmembrane transporter activity,dopamine transport,dopamine:sodium symporter activity,dopaminergic,drug,drug binding,drug metabolism,drug response,dystonia,Early Trauma and Depression,Environment Interactions,environmental,Epigenetics,esponse to iron ion,Financial and Psychological Risk Attitudes,genetic sensitivity,global developmental delay,Glycoprotein,Highly expressed in substantia nigra,Homooligomer; disulfide-linked,integral component of membrane,integral component of plasma membrane,Interacts (via N-terminus) with SYNGR3 (via N-terminus),Interacts with PRKCABP and TGFB1I1,Interacts with SLC18A2,Interacts with TOR1A (ATP-bound); TOR1A regulates SLC6A3 subcellular location,lactation,locomotory behavior,Membrane,mental disorder,migraine,monoamine transmembrane transporter activity,monoamine transport,Neurodegeneration,neurodegenerative disorder,neuronal cell body,neurotransmitter biosynthetic process,Neurotransmitter transport,neurotransmitters,Nicotine Receptor (CHRNA4),Parkinson,Parkinsonism,Parkinsonism-dystonia infantile (PKDYS),Parkinson\u2019s disease,plasma membrane,Polymorphism,positive regulation of multicellular organism growth,prepulse inhibition,protein binding,pyramidal tract signs,Reference proteome,regulation of dopamine metabolic process,response to cAMP,response to cocaine,response to drug,response to ethanol,response to nicotine,schizophrenia,sensory perception of smell,SLC6A3,SLC6A3 subfamily,Social disadvantage,Sodium-dependent dopamine transporter,Solute carrier family 6 member 3,Symport,synaptic transmission,telomere,Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs40184",
        "SNP Name": "SLC6A3 G55467A",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs40184",
        "Video": null,
        "Tags": "acute post-surgical pain,adenohypophysis development,ADHD,aging,Amine transporter,Amino acids,axon,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,Biogenic amines,bipolar,bipolar disorder,bradykinesia,cell death,Cell membrane,Cell membrane; Multi-pass membrane protein,children\u2019s telomere length,cocaine,Complete proteome,Continuous Performance Task,cytoplasm,DA transporter,DAT,depression,Disease mutation,Disulfide bond,dopamine,dopamine binding,dopamine biosynthetic process,dopamine catabolic process,dopamine transmembrane transporter activity,dopamine transport,dopamine:sodium symporter activity,dopaminergic,drug,drug binding,drug metabolism,drug response,dystonia,Early Trauma and Depression,Environment Interactions,environmental,Epigenetics,esponse to iron ion,Financial and Psychological Risk Attitudes,genetic sensitivity,global developmental delay,Glycoprotein,Highly expressed in substantia nigra,Homooligomer; disulfide-linked,integral component of membrane,integral component of plasma membrane,Interacts (via N-terminus) with SYNGR3 (via N-terminus),Interacts with PRKCABP and TGFB1I1,Interacts with SLC18A2,Interacts with TOR1A (ATP-bound); TOR1A regulates SLC6A3 subcellular location,lactation,locomotory behavior,Membrane,mental disorder,migraine,monoamine transmembrane transporter activity,monoamine transport,Neurodegeneration,neurodegenerative disorder,neuronal cell body,neurotransmitter biosynthetic process,Neurotransmitter transport,neurotransmitters,Nicotine Receptor (CHRNA4),Parkinson,Parkinsonism,Parkinsonism-dystonia infantile (PKDYS),Parkinson\u2019s disease,plasma membrane,Polymorphism,positive regulation of multicellular organism growth,prepulse inhibition,protein binding,pyramidal tract signs,Reference proteome,regulation of dopamine metabolic process,response to cAMP,response to cocaine,response to drug,response to ethanol,response to nicotine,schizophrenia,sensory perception of smell,SLC6A3,SLC6A3 subfamily,Social disadvantage,Sodium-dependent dopamine transporter,Solute carrier family 6 member 3,Symport,synaptic transmission,telomere,Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs6347",
        "SNP Name": "SLC6A3 A39132G",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6347",
        "Video": null,
        "Tags": "adenohypophysis development,ADHD,aging,alcohol dependence,Amine transporter,axon,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,bipolar,bipolar disorder,bradykinesia,cancer,cancerous,carcinogen,cell death,Cell membrane,Cell membrane; Multi-pass membrane protein,Colorectal cancer,Complete proteome,Continuous Performance Task,cytoplasm,DA transporter,DAT,Disease mutation,Disulfide bond,dopamine,dopamine binding,dopamine biosynthetic process,dopamine catabolic process,dopamine transmembrane transporter activity,dopamine transport,dopamine:sodium symporter activity,dopaminergic,drug,drug binding,drug metabolism,drug response,dystonia,esponse to iron ion,Financial and Psychological Risk Attitudes,global developmental delay,Glycoprotein,Highly expressed in substantia nigra,Homooligomer; disulfide-linked,integral component of membrane,integral component of plasma membrane,Interacts (via N-terminus) with SYNGR3 (via N-terminus),Interacts with PRKCABP and TGFB1I1,Interacts with SLC18A2,Interacts with TOR1A (ATP-bound); TOR1A regulates SLC6A3 subcellular location,lactation,lethal cocaine abuse,locomotory behavior,Lung cancer,Membrane,mental disorder,monoamine transmembrane transporter activity,monoamine transport,Neurodegeneration,neurodegenerative disorder,neuronal cell body,neurotransmitter biosynthetic process,Neurotransmitter transport,neurotransmitters,Nicotine Receptor (CHRNA4),Ovarian Cancer,Parkinson,Parkinsonism,Parkinsonism-dystonia infantile (PKDYS),Parkinson\u2019s disease,pharmacogenetics,plasma membrane,Polymorphism,positive regulation of multicellular organism growth,prepulse inhibition,Prostate cancer,protein binding,pyramidal tract signs,Reference proteome,regulation of dopamine metabolic process,response to cAMP,response to cocaine,response to drug,response to ethanol,response to nicotine,schizophrenia,sensory perception of smell,SLC6A3,SLC6A3 subfamily,Sodium-dependent dopamine transporter,Solute carrier family 6 member 3,substance addiction,Symport,synaptic transmission,Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs6347",
        "SNP Name": "SLC6A3 A39132G",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6347",
        "Video": null,
        "Tags": "adenohypophysis development,ADHD,aging,alcohol dependence,Amine transporter,axon,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,bipolar,bipolar disorder,bradykinesia,cancer,cancerous,carcinogen,cell death,Cell membrane,Cell membrane; Multi-pass membrane protein,Colorectal cancer,Complete proteome,Continuous Performance Task,cytoplasm,DA transporter,DAT,Disease mutation,Disulfide bond,dopamine,dopamine binding,dopamine biosynthetic process,dopamine catabolic process,dopamine transmembrane transporter activity,dopamine transport,dopamine:sodium symporter activity,dopaminergic,drug,drug binding,drug metabolism,drug response,dystonia,esponse to iron ion,Financial and Psychological Risk Attitudes,global developmental delay,Glycoprotein,Highly expressed in substantia nigra,Homooligomer; disulfide-linked,integral component of membrane,integral component of plasma membrane,Interacts (via N-terminus) with SYNGR3 (via N-terminus),Interacts with PRKCABP and TGFB1I1,Interacts with SLC18A2,Interacts with TOR1A (ATP-bound); TOR1A regulates SLC6A3 subcellular location,lactation,lethal cocaine abuse,locomotory behavior,Lung cancer,Membrane,mental disorder,monoamine transmembrane transporter activity,monoamine transport,Neurodegeneration,neurodegenerative disorder,neuronal cell body,neurotransmitter biosynthetic process,Neurotransmitter transport,neurotransmitters,Nicotine Receptor (CHRNA4),Ovarian Cancer,Parkinson,Parkinsonism,Parkinsonism-dystonia infantile (PKDYS),Parkinson\u2019s disease,pharmacogenetics,plasma membrane,Polymorphism,positive regulation of multicellular organism growth,prepulse inhibition,Prostate cancer,protein binding,pyramidal tract signs,Reference proteome,regulation of dopamine metabolic process,response to cAMP,response to cocaine,response to drug,response to ethanol,response to nicotine,schizophrenia,sensory perception of smell,SLC6A3,SLC6A3 subfamily,Sodium-dependent dopamine transporter,Solute carrier family 6 member 3,substance addiction,Symport,synaptic transmission,Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs27048",
        "SNP Name": "SLC6A3 G37899A",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs27048",
        "Video": null,
        "Tags": "adenohypophysis development,ADHD,aging,alcohol dependence,Amine transporter,axon,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,bipolar disorder,bradykinesia,cell death,Cell membrane,Cell membrane; Multi-pass membrane protein,Childhood ADHD,cocaine abuse,Complete proteome,Continuous Performance Task,cytoplasm,DA transporter,DAT,Disease mutation,Disulfide bond,dopamine,dopamine binding,dopamine biosynthetic process,dopamine catabolic process,dopamine transmembrane transporter activity,dopamine transport,dopamine:sodium symporter activity,dopaminergic,drug,drug binding,drug metabolism,drug response,dystonia,esponse to iron ion,global developmental delay,Glycoprotein,Highly expressed in substantia nigra,Homooligomer; disulfide-linked,integral component of membrane,integral component of plasma membrane,Interacts (via N-terminus) with SYNGR3 (via N-terminus),Interacts with PRKCABP and TGFB1I1,Interacts with SLC18A2,Interacts with TOR1A (ATP-bound); TOR1A regulates SLC6A3 subcellular location,lactation,locomotory behavior,Membrane,mental disorder,monoamine transmembrane transporter activity,monoamine transport,Neurodegeneration,neurodegenerative disorder,neuronal cell body,neurotransmitter biosynthetic process,Neurotransmitter transport,neurotransmitters,Parkinson,Parkinsonism,Parkinsonism-dystonia infantile (PKDYS),Parkinson\u2019s disease,plasma membrane,Polymorphism,positive regulation of multicellular organism growth,prepulse inhibition,protein binding,pyramidal tract signs,Reference proteome,regulation of dopamine metabolic process,response to cAMP,response to cocaine,response to drug,response to ethanol,response to nicotine,schizophrenia,sensory perception of smell,SLC6A3,SLC6A3 subfamily,Sodium-dependent dopamine transporter,Solute carrier family 6 member 3,substance addiction,Symport,synaptic transmission,Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs27048",
        "SNP Name": "SLC6A3 `",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs27048",
        "Video": null,
        "Tags": "adenohypophysis development,ADHD,aging,alcohol dependence,Amine transporter,axon,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,bipolar disorder,bradykinesia,cell death,Cell membrane,Cell membrane; Multi-pass membrane protein,Childhood ADHD,cocaine abuse,Complete proteome,Continuous Performance Task,cytoplasm,DA transporter,DAT,Disease mutation,Disulfide bond,dopamine,dopamine binding,dopamine biosynthetic process,dopamine catabolic process,dopamine transmembrane transporter activity,dopamine transport,dopamine:sodium symporter activity,dopaminergic,drug,drug binding,drug metabolism,drug response,dystonia,esponse to iron ion,global developmental delay,Glycoprotein,Highly expressed in substantia nigra,Homooligomer; disulfide-linked,integral component of membrane,integral component of plasma membrane,Interacts (via N-terminus) with SYNGR3 (via N-terminus),Interacts with PRKCABP and TGFB1I1,Interacts with SLC18A2,Interacts with TOR1A (ATP-bound); TOR1A regulates SLC6A3 subcellular location,lactation,locomotory behavior,Membrane,mental disorder,monoamine transmembrane transporter activity,monoamine transport,Neurodegeneration,neurodegenerative disorder,neuronal cell body,neurotransmitter biosynthetic process,Neurotransmitter transport,neurotransmitters,Parkinson,Parkinsonism,Parkinsonism-dystonia infantile (PKDYS),Parkinson\u2019s disease,plasma membrane,Polymorphism,positive regulation of multicellular organism growth,prepulse inhibition,protein binding,pyramidal tract signs,Reference proteome,regulation of dopamine metabolic process,response to cAMP,response to cocaine,response to drug,response to ethanol,response to nicotine,schizophrenia,sensory perception of smell,SLC6A3,SLC6A3 subfamily,Sodium-dependent dopamine transporter,Solute carrier family 6 member 3,substance addiction,Symport,synaptic transmission,Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs464049",
        "SNP Name": "SLC6A3 T26639C",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs464049",
        "Video": null,
        "Tags": "adenohypophysis development,ADHD,aging,Amine transporter,axon,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,bipolar,bipolar disorder,bradykinesia,cell death,Cell membrane,Cell membrane; Multi-pass membrane protein,Cigarette Smoking Behaviors,Complete proteome,Continuous Performance Task,cytoplasm,DA transporter,DAT,Disease mutation,Disulfide bond,dopamine,dopamine binding,dopamine biosynthetic process,dopamine catabolic process,dopamine transmembrane transporter activity,dopamine transport,dopamine:sodium symporter activity,dopaminergic,drug,drug binding,drug metabolism,drug response,dystonia,esponse to iron ion,Financial and Psychological Risk Attitudes,global developmental delay,Glycoprotein,Highly expressed in substantia nigra,Homooligomer; disulfide-linked,integral component of membrane,integral component of plasma membrane,Interacts (via N-terminus) with SYNGR3 (via N-terminus),Interacts with PRKCABP and TGFB1I1,Interacts with SLC18A2,Interacts with TOR1A (ATP-bound); TOR1A regulates SLC6A3 subcellular location,lactation,locomotory behavior,Membrane,mental disorder,monoamine transmembrane transporter activity,monoamine transport,Neurodegeneration,neurodegenerative disorder,neuronal cell body,neurotransmitter biosynthetic process,Neurotransmitter transport,neurotransmitters,Nicotine Receptor (CHRNA4),Parkinson,Parkinsonism,Parkinsonism-dystonia infantile (PKDYS),Parkinson\u2019s disease,plasma membrane,Polymorphism,positive regulation of multicellular organism growth,prepulse inhibition,protein binding,pyramidal tract signs,Reference proteome,regulation of dopamine metabolic process,response to cAMP,response to cocaine,response to drug,response to ethanol,response to nicotine,schizophrenia,sensory perception of smell,SLC6A3,SLC6A3 subfamily,smoking,Sodium-dependent dopamine transporter,Solute carrier family 6 member 3,Symport,synaptic transmission,Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport,tuberculosis",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs464049",
        "SNP Name": "SLC6A3 T26639C",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs464049",
        "Video": null,
        "Tags": "adenohypophysis development,ADHD,aging,Amine transporter,axon,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,bipolar,bipolar disorder,bradykinesia,cell death,Cell membrane,Cell membrane; Multi-pass membrane protein,Cigarette Smoking Behaviors,Complete proteome,Continuous Performance Task,cytoplasm,DA transporter,DAT,Disease mutation,Disulfide bond,dopamine,dopamine binding,dopamine biosynthetic process,dopamine catabolic process,dopamine transmembrane transporter activity,dopamine transport,dopamine:sodium symporter activity,dopaminergic,drug,drug binding,drug metabolism,drug response,dystonia,esponse to iron ion,Financial and Psychological Risk Attitudes,global developmental delay,Glycoprotein,Highly expressed in substantia nigra,Homooligomer; disulfide-linked,integral component of membrane,integral component of plasma membrane,Interacts (via N-terminus) with SYNGR3 (via N-terminus),Interacts with PRKCABP and TGFB1I1,Interacts with SLC18A2,Interacts with TOR1A (ATP-bound); TOR1A regulates SLC6A3 subcellular location,lactation,locomotory behavior,Membrane,mental disorder,monoamine transmembrane transporter activity,monoamine transport,Neurodegeneration,neurodegenerative disorder,neuronal cell body,neurotransmitter biosynthetic process,Neurotransmitter transport,neurotransmitters,Nicotine Receptor (CHRNA4),Parkinson,Parkinsonism,Parkinsonism-dystonia infantile (PKDYS),Parkinson\u2019s disease,plasma membrane,Polymorphism,positive regulation of multicellular organism growth,prepulse inhibition,protein binding,pyramidal tract signs,Reference proteome,regulation of dopamine metabolic process,response to cAMP,response to cocaine,response to drug,response to ethanol,response to nicotine,schizophrenia,sensory perception of smell,SLC6A3,SLC6A3 subfamily,smoking,Sodium-dependent dopamine transporter,Solute carrier family 6 member 3,Symport,synaptic transmission,Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport,tuberculosis",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs460000",
        "SNP Name": "SLC6A3 C17719T",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs460000",
        "Video": null,
        "Tags": "adenohypophysis development,ADHD,aging,Amine transporter,axon,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,bradykinesia,cell death,Cell membrane,Cell membrane; Multi-pass membrane protein,Complete proteome,Continuous Performance Task,cytoplasm,DA transporter,DAT,Disease mutation,Disulfide bond,dopamine,dopamine binding,dopamine biosynthetic process,dopamine catabolic process,dopamine transmembrane transporter activity,dopamine transport,dopamine:sodium symporter activity,dopaminergic,drug,drug binding,drug metabolism,drug response,dystonia,esponse to iron ion,global developmental delay,Glycoprotein,Highly expressed in substantia nigra,Homooligomer; disulfide-linked,impulsive behaviour,impulsivity,integral component of membrane,integral component of plasma membrane,Interacts (via N-terminus) with SYNGR3 (via N-terminus),Interacts with PRKCABP and TGFB1I1,Interacts with SLC18A2,Interacts with TOR1A (ATP-bound); TOR1A regulates SLC6A3 subcellular location,lactation,locomotory behavior,Membrane,mental disorder,monoamine transmembrane transporter activity,monoamine transport,Neurodegeneration,neurodegenerative disorder,neuronal cell body,neurotransmitter biosynthetic process,Neurotransmitter transport,neurotransmitters,Parkinson,Parkinsonism,Parkinsonism-dystonia infantile (PKDYS),Parkinson\u2019s disease,plasma membrane,Polymorphism,positive regulation of multicellular organism growth,prepulse inhibition,protein binding,pyramidal tract signs,Reference proteome,regulation of dopamine metabolic process,response to cAMP,response to cocaine,response to drug,response to ethanol,response to nicotine,schizophrenia,sensory perception of smell,SLC6A3,SLC6A3 subfamily,Sodium-dependent dopamine transporter,Solute carrier family 6 member 3,Stimulant Drugs,stimulants,Symport,synaptic transmission,Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs460000",
        "SNP Name": "SLC6A3 C17719T",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs460000",
        "Video": null,
        "Tags": "adenohypophysis development,ADHD,aging,Amine transporter,axon,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,bradykinesia,cell death,Cell membrane,Cell membrane; Multi-pass membrane protein,Complete proteome,Continuous Performance Task,cytoplasm,DA transporter,DAT,Disease mutation,Disulfide bond,dopamine,dopamine binding,dopamine biosynthetic process,dopamine catabolic process,dopamine transmembrane transporter activity,dopamine transport,dopamine:sodium symporter activity,dopaminergic,drug,drug binding,drug metabolism,drug response,dystonia,esponse to iron ion,global developmental delay,Glycoprotein,Highly expressed in substantia nigra,Homooligomer; disulfide-linked,impulsive behaviour,impulsivity,integral component of membrane,integral component of plasma membrane,Interacts (via N-terminus) with SYNGR3 (via N-terminus),Interacts with PRKCABP and TGFB1I1,Interacts with SLC18A2,Interacts with TOR1A (ATP-bound); TOR1A regulates SLC6A3 subcellular location,lactation,locomotory behavior,Membrane,mental disorder,monoamine transmembrane transporter activity,monoamine transport,Neurodegeneration,neurodegenerative disorder,neuronal cell body,neurotransmitter biosynthetic process,Neurotransmitter transport,neurotransmitters,Parkinson,Parkinsonism,Parkinsonism-dystonia infantile (PKDYS),Parkinson\u2019s disease,plasma membrane,Polymorphism,positive regulation of multicellular organism growth,prepulse inhibition,protein binding,pyramidal tract signs,Reference proteome,regulation of dopamine metabolic process,response to cAMP,response to cocaine,response to drug,response to ethanol,response to nicotine,schizophrenia,sensory perception of smell,SLC6A3,SLC6A3 subfamily,Sodium-dependent dopamine transporter,Solute carrier family 6 member 3,Stimulant Drugs,stimulants,Symport,synaptic transmission,Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs403636",
        "SNP Name": "SLC6A3 T12190G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs403636",
        "Video": null,
        "Tags": "acute post-surgical pain,adenohypophysis development,ADHD,aging,Amine transporter,axon,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,bradykinesia,cell death,Cell membrane,Cell membrane; Multi-pass membrane protein,Complete proteome,Continuous Performance Task,cytoplasm,DA transporter,DAT,Disease mutation,Disulfide bond,dopamine,dopamine binding,dopamine biosynthetic process,dopamine catabolic process,dopamine transmembrane transporter activity,dopamine transport,dopamine:sodium symporter activity,dopaminergic,drug,drug binding,drug metabolism,drug response,dystonia,esponse to iron ion,global developmental delay,Glycoprotein,Highly expressed in substantia nigra,Homooligomer; disulfide-linked,integral component of membrane,integral component of plasma membrane,Interacts (via N-terminus) with SYNGR3 (via N-terminus),Interacts with PRKCABP and TGFB1I1,Interacts with SLC18A2,Interacts with TOR1A (ATP-bound); TOR1A regulates SLC6A3 subcellular location,lactation,locomotory behavior,Membrane,mental disorder,monoamine transmembrane transporter activity,monoamine transport,Neurodegeneration,neurodegenerative disorder,neuronal cell body,neurotransmitter biosynthetic process,Neurotransmitter transport,neurotransmitters,Parkinson,Parkinsonism,Parkinsonism-dystonia infantile (PKDYS),Parkinson\u2019s disease,plasma membrane,Polymorphism,positive regulation of multicellular organism growth,prepulse inhibition,protein binding,pyramidal tract signs,Reference proteome,regulation of dopamine metabolic process,response to cAMP,response to cocaine,response to drug,response to ethanol,response to nicotine,schizophrenia,sensory perception of smell,SLC6A3,SLC6A3 subfamily,Sodium-dependent dopamine transporter,Solute carrier family 6 member 3,suicidal tendencies,Symport,synaptic transmission,Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport,tuberculosis",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs403636",
        "SNP Name": "SLC6A3 T12190G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs403636",
        "Video": null,
        "Tags": "acute post-surgical pain,adenohypophysis development,ADHD,aging,Amine transporter,axon,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,bradykinesia,cell death,Cell membrane,Cell membrane; Multi-pass membrane protein,Complete proteome,Continuous Performance Task,cytoplasm,DA transporter,DAT,Disease mutation,Disulfide bond,dopamine,dopamine binding,dopamine biosynthetic process,dopamine catabolic process,dopamine transmembrane transporter activity,dopamine transport,dopamine:sodium symporter activity,dopaminergic,drug,drug binding,drug metabolism,drug response,dystonia,esponse to iron ion,global developmental delay,Glycoprotein,Highly expressed in substantia nigra,Homooligomer; disulfide-linked,integral component of membrane,integral component of plasma membrane,Interacts (via N-terminus) with SYNGR3 (via N-terminus),Interacts with PRKCABP and TGFB1I1,Interacts with SLC18A2,Interacts with TOR1A (ATP-bound); TOR1A regulates SLC6A3 subcellular location,lactation,locomotory behavior,Membrane,mental disorder,monoamine transmembrane transporter activity,monoamine transport,Neurodegeneration,neurodegenerative disorder,neuronal cell body,neurotransmitter biosynthetic process,Neurotransmitter transport,neurotransmitters,Parkinson,Parkinsonism,Parkinsonism-dystonia infantile (PKDYS),Parkinson\u2019s disease,plasma membrane,Polymorphism,positive regulation of multicellular organism growth,prepulse inhibition,protein binding,pyramidal tract signs,Reference proteome,regulation of dopamine metabolic process,response to cAMP,response to cocaine,response to drug,response to ethanol,response to nicotine,schizophrenia,sensory perception of smell,SLC6A3,SLC6A3 subfamily,Sodium-dependent dopamine transporter,Solute carrier family 6 member 3,suicidal tendencies,Symport,synaptic transmission,Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport,tuberculosis",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2617605",
        "SNP Name": "SLC6A3 A8023G",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2617605",
        "Video": null,
        "Tags": "adenohypophysis development,ADHD,aging,Amine transporter,axon,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,bradykinesia,cell death,Cell membrane,Cell membrane; Multi-pass membrane protein,Complete proteome,Continuous Performance Task,cytoplasm,DA transporter,DAT,Disease mutation,Disulfide bond,dopamine,dopamine binding,dopamine biosynthetic process,dopamine catabolic process,dopamine transmembrane transporter activity,dopamine transport,dopamine:sodium symporter activity,dopaminergic,drug,drug binding,drug metabolism,drug response,dystonia,esponse to iron ion,global developmental delay,Glycoprotein,Highly expressed in substantia nigra,Homooligomer; disulfide-linked,integral component of membrane,integral component of plasma membrane,Interacts (via N-terminus) with SYNGR3 (via N-terminus),Interacts with PRKCABP and TGFB1I1,Interacts with SLC18A2,Interacts with TOR1A (ATP-bound); TOR1A regulates SLC6A3 subcellular location,lactation,locomotory behavior,Membrane,mental disorder,monoamine transmembrane transporter activity,monoamine transport,Neurodegeneration,neurodegenerative disorder,neuronal cell body,neurotransmitter biosynthetic process,Neurotransmitter transport,neurotransmitters,Parkinson,Parkinsonism,Parkinsonism-dystonia infantile (PKDYS),Parkinson\u2019s disease,plasma membrane,Polymorphism,positive regulation of multicellular organism growth,prepulse inhibition,protein binding,pyramidal tract signs,Reference proteome,regulation of dopamine metabolic process,response to cAMP,response to cocaine,response to drug,response to ethanol,response to nicotine,sensory perception of smell,SLC6A3,SLC6A3 subfamily,Sodium-dependent dopamine transporter,Solute carrier family 6 member 3,Symport,synaptic transmission,Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2617605",
        "SNP Name": "SLC6A3 A8023G",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2617605",
        "Video": null,
        "Tags": "adenohypophysis development,ADHD,aging,Amine transporter,axon,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,bradykinesia,cell death,Cell membrane,Cell membrane; Multi-pass membrane protein,Complete proteome,Continuous Performance Task,cytoplasm,DA transporter,DAT,Disease mutation,Disulfide bond,dopamine,dopamine binding,dopamine biosynthetic process,dopamine catabolic process,dopamine transmembrane transporter activity,dopamine transport,dopamine:sodium symporter activity,dopaminergic,drug,drug binding,drug metabolism,drug response,dystonia,esponse to iron ion,global developmental delay,Glycoprotein,Highly expressed in substantia nigra,Homooligomer; disulfide-linked,integral component of membrane,integral component of plasma membrane,Interacts (via N-terminus) with SYNGR3 (via N-terminus),Interacts with PRKCABP and TGFB1I1,Interacts with SLC18A2,Interacts with TOR1A (ATP-bound); TOR1A regulates SLC6A3 subcellular location,lactation,locomotory behavior,Membrane,mental disorder,monoamine transmembrane transporter activity,monoamine transport,Neurodegeneration,neurodegenerative disorder,neuronal cell body,neurotransmitter biosynthetic process,Neurotransmitter transport,neurotransmitters,Parkinson,Parkinsonism,Parkinsonism-dystonia infantile (PKDYS),Parkinson\u2019s disease,plasma membrane,Polymorphism,positive regulation of multicellular organism growth,prepulse inhibition,protein binding,pyramidal tract signs,Reference proteome,regulation of dopamine metabolic process,response to cAMP,response to cocaine,response to drug,response to ethanol,response to nicotine,sensory perception of smell,SLC6A3,SLC6A3 subfamily,Sodium-dependent dopamine transporter,Solute carrier family 6 member 3,Symport,synaptic transmission,Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs6350",
        "SNP Name": "SLC6A3 C7345T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6350",
        "Video": null,
        "Tags": "acute post-surgical pain,adenohypophysis development,aging,alcohol dependence,Amine transporter,axon,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,bradykinesia,cancer,cancerous,carcinogen,cell death,Cell membrane,Cell membrane; Multi-pass membrane protein,Colorectal cancer,Complete proteome,Continuous Performance Task,cytoplasm,DA transporter,DAT,Disease mutation,Disulfide bond,dopamine,dopamine binding,dopamine biosynthetic process,dopamine catabolic process,dopamine transmembrane transporter activity,dopamine transport,dopamine:sodium symporter activity,dopaminergic,drug,drug binding,drug metabolism,drug response,dystonia,esponse to iron ion,Financial and Psychological Risk Attitudes,global developmental delay,Glycoprotein,Highly expressed in substantia nigra,Homooligomer; disulfide-linked,integral component of membrane,integral component of plasma membrane,Interacts (via N-terminus) with SYNGR3 (via N-terminus),Interacts with PRKCABP and TGFB1I1,Interacts with SLC18A2,Interacts with TOR1A (ATP-bound); TOR1A regulates SLC6A3 subcellular location,lactation,locomotory behavior,Lung cancer,Membrane,monoamine transmembrane transporter activity,monoamine transport,Neurodegeneration,neurodegenerative disorder,neuronal cell body,neurotransmitter biosynthetic process,Neurotransmitter transport,neurotransmitters,nicotine dependence,Nicotine Receptor (CHRNA4),Ovarian Cancer,Parkinson,Parkinsonism,Parkinsonism-dystonia infantile (PKDYS),Parkinson\u2019s disease,plasma membrane,Polymorphism,positive regulation of multicellular organism growth,prepulse inhibition,Prostate cancer,protein binding,pyramidal tract signs,Reference proteome,regulation of dopamine metabolic process,response to cAMP,response to cocaine,response to drug,response to ethanol,response to nicotine,sensory perception of smell,SLC6A3,SLC6A3 subfamily,smoking,Sodium-dependent dopamine transporter,Solute carrier family 6 member 3,Symport,synaptic transmission,Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs6350",
        "SNP Name": "SLC6A3 C7345T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6350",
        "Video": null,
        "Tags": "acute post-surgical pain,adenohypophysis development,aging,alcohol dependence,Amine transporter,axon,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,bradykinesia,cancer,cancerous,carcinogen,cell death,Cell membrane,Cell membrane; Multi-pass membrane protein,Colorectal cancer,Complete proteome,Continuous Performance Task,cytoplasm,DA transporter,DAT,Disease mutation,Disulfide bond,dopamine,dopamine binding,dopamine biosynthetic process,dopamine catabolic process,dopamine transmembrane transporter activity,dopamine transport,dopamine:sodium symporter activity,dopaminergic,drug,drug binding,drug metabolism,drug response,dystonia,esponse to iron ion,Financial and Psychological Risk Attitudes,global developmental delay,Glycoprotein,Highly expressed in substantia nigra,Homooligomer; disulfide-linked,integral component of membrane,integral component of plasma membrane,Interacts (via N-terminus) with SYNGR3 (via N-terminus),Interacts with PRKCABP and TGFB1I1,Interacts with SLC18A2,Interacts with TOR1A (ATP-bound); TOR1A regulates SLC6A3 subcellular location,lactation,locomotory behavior,Lung cancer,Membrane,monoamine transmembrane transporter activity,monoamine transport,Neurodegeneration,neurodegenerative disorder,neuronal cell body,neurotransmitter biosynthetic process,Neurotransmitter transport,neurotransmitters,nicotine dependence,Nicotine Receptor (CHRNA4),Ovarian Cancer,Parkinson,Parkinsonism,Parkinsonism-dystonia infantile (PKDYS),Parkinson\u2019s disease,plasma membrane,Polymorphism,positive regulation of multicellular organism growth,prepulse inhibition,Prostate cancer,protein binding,pyramidal tract signs,Reference proteome,regulation of dopamine metabolic process,response to cAMP,response to cocaine,response to drug,response to ethanol,response to nicotine,sensory perception of smell,SLC6A3,SLC6A3 subfamily,smoking,Sodium-dependent dopamine transporter,Solute carrier family 6 member 3,Symport,synaptic transmission,Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1801394",
        "SNP Name": "MTRR A66G",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1801394",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,Abdominal Aortic Aneurysm,acting on paired donors,Alternative splicing,Alzheimer\u2019s Disease,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autism,autosomal recessive,B12,biomarkers of prostate cancer aggressiveness,birth defect,cardiovascular,Cardiovascular Disease,cblE complementation type,celiac disease,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,CHD,Childhood Acute Lymphoblastic Leukemia,chromosomal non-disjunction,cleft palate,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,congenital heart defects,Congenital Heart Defects Among Individuals With Down Syndrome,Congenital Heart Disease,conotruncal heart defects,converts homocysteine to methionine,CVD,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate and Alcohol Intake and Colon Cancer Risk,folate and drug metabolism,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,Folic Acid and Methylation,folic acid metabolic process,Found in all tissues tested,Gastric Cancer,head and neck carcinoma,heart,heart defect,High Intake of Folate from Food Sources Is Associated with Reduced Risk of Esophageal Cancer,HMAE,homocysteine,Homocysteine Concentrations,Homocysteine Concentrations in Systemic Lupus Erythematosus,homocysteine metabolism in celiac disease,Homocystinuria,Homocystinuria-megaloblastic anemia,hypermethylation in colorectal cancer,hypomethioninemia,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,Increased Mortality among Women with Breast Cancer,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,leukocyte telomere length,lung cancer,lupus,megaloblastic anemia,meningioma,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,Methionine Synthase Reductase and the Risk of Colorectal Cancer,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,Negative Symptom Severity in Schizophrenia,Neural Tube Defects,non-small cell lung carcinoma,Nonsyndromic Limb Reduction Defects,nucleus,Nutritional Risk Factors for Lung Cancer,Obesity,open spina bifida (myelomeningocele),Oral Facial Clefts,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Pancreatic Cancer,Phosphoprotein,Plasma Homocysteine,Plasma Total Homocysteine Levels: Impact of Population-wide Folate Fortification,Polymorphism,RBC folate,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,S-adenosylmethionine,SAMe,serum folate levels,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,telomere,temporomandibular disorder,TMJ,transgenerational epigenetic inheritance,Trial of Aspirin Use and Folic Acid Supplementation,Unexplained Reduced Sperm Counts,utilization of methylgroups from the folate cycle,vitamin B12,vitamin B12 and transcobalamin in prostate cancer,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metab",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs1801394",
        "SNP Name": "MTRR A66G",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1801394",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,Abdominal Aortic Aneurysm,acting on paired donors,Alternative splicing,Alzheimer\u2019s Disease,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autism,autosomal recessive,B12,biomarkers of prostate cancer aggressiveness,birth defect,cardiovascular,Cardiovascular Disease,cblE complementation type,celiac disease,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,CHD,Childhood Acute Lymphoblastic Leukemia,chromosomal non-disjunction,cleft palate,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,congenital heart defects,Congenital Heart Defects Among Individuals With Down Syndrome,Congenital Heart Disease,conotruncal heart defects,converts homocysteine to methionine,CVD,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate and Alcohol Intake and Colon Cancer Risk,folate and drug metabolism,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,Folic Acid and Methylation,folic acid metabolic process,Found in all tissues tested,Gastric Cancer,head and neck carcinoma,heart,heart defect,High Intake of Folate from Food Sources Is Associated with Reduced Risk of Esophageal Cancer,HMAE,homocysteine,Homocysteine Concentrations,Homocysteine Concentrations in Systemic Lupus Erythematosus,homocysteine metabolism in celiac disease,Homocystinuria,Homocystinuria-megaloblastic anemia,hypermethylation in colorectal cancer,hypomethioninemia,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,Increased Mortality among Women with Breast Cancer,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,leukocyte telomere length,lung cancer,lupus,megaloblastic anemia,meningioma,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,Methionine Synthase Reductase and the Risk of Colorectal Cancer,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,Negative Symptom Severity in Schizophrenia,Neural Tube Defects,non-small cell lung carcinoma,Nonsyndromic Limb Reduction Defects,nucleus,Nutritional Risk Factors for Lung Cancer,Obesity,open spina bifida (myelomeningocele),Oral Facial Clefts,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Pancreatic Cancer,Phosphoprotein,Plasma Homocysteine,Plasma Total Homocysteine Levels: Impact of Population-wide Folate Fortification,Polymorphism,RBC folate,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,S-adenosylmethionine,SAMe,serum folate levels,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,telomere,temporomandibular disorder,TMJ,transgenerational epigenetic inheritance,Trial of Aspirin Use and Folic Acid Supplementation,Unexplained Reduced Sperm Counts,utilization of methylgroups from the folate cycle,vitamin B12,vitamin B12 and transcobalamin in prostate cancer,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metab",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs3776467",
        "SNP Name": "MTRR G12099A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3776467",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,acting on paired donors,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autosomal recessive,B12,birth defect,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,chromosomal non-disjunction,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,converts homocysteine to methionine,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,folic acid metabolic process,Found in all tissues tested,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypermethylation,hypermethylation in the lung epithelium of smokers,hypomethioninemia,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,nicotine,nucleus,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Phosphoprotein,Polymorphism,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,S-adenosylmethionine,SAMe,small molecule metabolic process,smoking,spina bifida,sulfur amino acid metabolic process,tobacco,transgenerational epigenetic inheritance,utilization of methylgroups from the folate cycle,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs3776467",
        "SNP Name": "MTRR G12099A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3776467",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,acting on paired donors,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autosomal recessive,B12,birth defect,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,chromosomal non-disjunction,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,converts homocysteine to methionine,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,folic acid metabolic process,Found in all tissues tested,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypermethylation,hypermethylation in the lung epithelium of smokers,hypomethioninemia,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,nicotine,nucleus,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Phosphoprotein,Polymorphism,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,S-adenosylmethionine,SAMe,small molecule metabolic process,smoking,spina bifida,sulfur amino acid metabolic process,tobacco,transgenerational epigenetic inheritance,utilization of methylgroups from the folate cycle,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs1532268",
        "SNP Name": "MTRR C524T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1532268",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,Abdominal Aortic Aneurysm,acting on paired donors,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autosomal recessive,B12,birth defect,cardiovascular,Cardiovascular Disease,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,Childhood Acute Lymphoblastic Leukemia,chromosomal non-disjunction,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,congenital heart disease,converts homocysteine to methionine,CVD,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate and vitamin B12 in idiopathic male infertility,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,Folic Acid and Methylation,folic acid metabolic process,Found in all tissues tested,gastric cancer,glaucoma,head and neck carcinoma,heart,heart defect,heart defects,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,infertility,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,leukocyte telomere length,male infertility,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,neural tube defects,NTDs,nucleus,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Phosphoprotein,Polymorphism,Prostate Cancer Risk,pseudoexfoliation syndrome,pseudoexfoliation syndrome and glaucoma,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,S-adenosylmethionine,SAMe,small molecule metabolic process,spina bifida,spina bifida and conotruncal heart defects,sulfur amino acid metabolic process,Telomere Length,transgenerational epigenetic inheritance,Unexplained Reduced Sperm Counts,utilization of methylgroups from the folate cycle,Ventricular Septal Defect,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs1532268",
        "SNP Name": "MTRR C524T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1532268",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,Abdominal Aortic Aneurysm,acting on paired donors,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autosomal recessive,B12,birth defect,cardiovascular,Cardiovascular Disease,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,Childhood Acute Lymphoblastic Leukemia,chromosomal non-disjunction,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,congenital heart disease,converts homocysteine to methionine,CVD,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate and vitamin B12 in idiopathic male infertility,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,Folic Acid and Methylation,folic acid metabolic process,Found in all tissues tested,gastric cancer,glaucoma,head and neck carcinoma,heart,heart defect,heart defects,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,infertility,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,leukocyte telomere length,male infertility,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,neural tube defects,NTDs,nucleus,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Phosphoprotein,Polymorphism,Prostate Cancer Risk,pseudoexfoliation syndrome,pseudoexfoliation syndrome and glaucoma,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,S-adenosylmethionine,SAMe,small molecule metabolic process,spina bifida,spina bifida and conotruncal heart defects,sulfur amino acid metabolic process,Telomere Length,transgenerational epigenetic inheritance,Unexplained Reduced Sperm Counts,utilization of methylgroups from the folate cycle,Ventricular Septal Defect,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs7703033",
        "SNP Name": "MTRR G15734A",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7703033",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,acting on paired donors,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autosomal recessive,B12,birth defect,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,chromosomal non-disjunction,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,converts homocysteine to methionine,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,folic acid metabolic process,Found in all tissues tested,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,nucleus,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Phosphoprotein,plasma B12,plasma B6,plasma homocysteine,Polymorphism,pyridoxamine,pyridoxine,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,S-adenosylmethionine,SAMe,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,transgenerational epigenetic inheritance,utilization of methylgroups from the folate cycle,vitamin B12,vitamin B6,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs7703033",
        "SNP Name": "MTRR G15734A",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7703033",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,acting on paired donors,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autosomal recessive,B12,birth defect,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,chromosomal non-disjunction,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,converts homocysteine to methionine,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,folic acid metabolic process,Found in all tissues tested,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,nucleus,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Phosphoprotein,plasma B12,plasma B6,plasma homocysteine,Polymorphism,pyridoxamine,pyridoxine,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,S-adenosylmethionine,SAMe,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,transgenerational epigenetic inheritance,utilization of methylgroups from the folate cycle,vitamin B12,vitamin B6,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs162031",
        "SNP Name": "MTRR T16071C",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs162031",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,acting on paired donors,Acute Lymphoblastic Leukemia,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autosomal recessive,B12,birth defect,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,Childhood Acute Lymphoblastic Leukemia,chromosomal non-disjunction,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,converts homocysteine to methionine,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,folic acid metabolic process,Found in all tissues tested,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,Leukemia,Lymphoblastic Leukemia,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,nucleus,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Phosphoprotein,Polymorphism,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,S-adenosylmethionine,SAMe,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,transgenerational epigenetic inheritance,utilization of methylgroups from the folate cycle,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs162031",
        "SNP Name": "MTRR T16071C",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs162031",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,acting on paired donors,Acute Lymphoblastic Leukemia,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autosomal recessive,B12,birth defect,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,Childhood Acute Lymphoblastic Leukemia,chromosomal non-disjunction,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,converts homocysteine to methionine,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,folic acid metabolic process,Found in all tissues tested,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,Leukemia,Lymphoblastic Leukemia,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,nucleus,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Phosphoprotein,Polymorphism,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,S-adenosylmethionine,SAMe,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,transgenerational epigenetic inheritance,utilization of methylgroups from the folate cycle,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs162036",
        "SNP Name": "MTRR K350A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs162036",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,acting on paired donors,Acute Lymphoblastic Leukemia,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autosomal recessive,B12,birth defect,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,Childhood Acute Lymphoblastic Leukemia,chromosomal non-disjunction,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,Congenital Heart Defects Among Individuals With Down Syndrome,converts homocysteine to methionine,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,Folic Acid and Methylation,folic acid metabolic process,Found in all tissues tested,Gastric Cancer,glaucoma,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,Leukemia,leukocyte telomere length,Lymphoblastic Leukemia,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,Neural Tube Defects,NTDs,nucleus,obesity,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Phosphoprotein,Polymorphism,Prostate Cancer Risk,pseudoexfoliation syndrome,pseudoexfoliation syndrome and glaucoma,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,S-adenosylmethionine,SAMe,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,telomere,transgenerational epigenetic inheritance,utilization of methylgroups from the folate cycle,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs162036",
        "SNP Name": "MTRR K350A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs162036",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,acting on paired donors,Acute Lymphoblastic Leukemia,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autosomal recessive,B12,birth defect,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,Childhood Acute Lymphoblastic Leukemia,chromosomal non-disjunction,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,Congenital Heart Defects Among Individuals With Down Syndrome,converts homocysteine to methionine,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,Folic Acid and Methylation,folic acid metabolic process,Found in all tissues tested,Gastric Cancer,glaucoma,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,Leukemia,leukocyte telomere length,Lymphoblastic Leukemia,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,Neural Tube Defects,NTDs,nucleus,obesity,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Phosphoprotein,Polymorphism,Prostate Cancer Risk,pseudoexfoliation syndrome,pseudoexfoliation syndrome and glaucoma,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,S-adenosylmethionine,SAMe,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,telomere,transgenerational epigenetic inheritance,utilization of methylgroups from the folate cycle,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs2287779",
        "SNP Name": "MTRR G1155A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2287779",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,Abdominal Aortic Aneurysm,acting on paired donors,Acute Lymphoblastic Leukemia,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,aneurysm,ATP,autosomal recessive,B12,birth defect,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,Childhood Acute Lymphoblastic Leukemia,chromosomal non-disjunction,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,conotruncal heart defects,converts homocysteine to methionine,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,folic acid metabolic process,Found in all tissues tested,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,Leukemia,Lymphoblastic Leukemia,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,nucleus,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Phosphoprotein,Polymorphism,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,S-adenosylmethionine,SAMe,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,transgenerational epigenetic inheritance,utilization of methylgroups from the folate cycle,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2287779",
        "SNP Name": "MTRR G1155A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2287779",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,Abdominal Aortic Aneurysm,acting on paired donors,Acute Lymphoblastic Leukemia,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,aneurysm,ATP,autosomal recessive,B12,birth defect,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,Childhood Acute Lymphoblastic Leukemia,chromosomal non-disjunction,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,conotruncal heart defects,converts homocysteine to methionine,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,folic acid metabolic process,Found in all tissues tested,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,Leukemia,Lymphoblastic Leukemia,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,nucleus,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Phosphoprotein,Polymorphism,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,S-adenosylmethionine,SAMe,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,transgenerational epigenetic inheritance,utilization of methylgroups from the folate cycle,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs2287780",
        "SNP Name": "MTRR R415T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2287780",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,acting on paired donors,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autosomal recessive,B12,birth defect,Blood leukocyte,cancer,cancerous,carcinogen,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,chromosomal non-disjunction,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Colorectal Cancer,Complete proteome,converts homocysteine to methionine,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,folic acid metabolic process,Found in all tissues tested,gastric cancer,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,hypomethylation,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,leukocyte,leukocyte telomere length,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,nucleus,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Phosphoprotein,Polymorphism,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,S-adenosylmethionine,SAMe,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,telomere,transgenerational epigenetic inheritance,utilization of methylgroups from the folate cycle,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2287780",
        "SNP Name": "MTRR R415T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2287780",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,acting on paired donors,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autosomal recessive,B12,birth defect,Blood leukocyte,cancer,cancerous,carcinogen,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,chromosomal non-disjunction,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Colorectal Cancer,Complete proteome,converts homocysteine to methionine,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,folic acid metabolic process,Found in all tissues tested,gastric cancer,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,hypomethylation,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,leukocyte,leukocyte telomere length,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,nucleus,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Phosphoprotein,Polymorphism,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,S-adenosylmethionine,SAMe,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,telomere,transgenerational epigenetic inheritance,utilization of methylgroups from the folate cycle,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs162049",
        "SNP Name": "MTRR G28905A",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs162049",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,acting on paired donors,alcohol metabolic pathway,alcohol metabolism,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autosomal recessive,B12,birth defect,breast cancer,cancer,cancerous,carcinogen,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,chromosomal non-disjunction,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,converts homocysteine to methionine,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,folate metabolism,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,folic acid metabolic process,Found in all tissues tested,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,nucleus,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Pancreatic Cancer,Phosphoprotein,Polymorphism,postmenopausal endogenous sex hormones,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,S-adenosylmethionine,SAMe,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,transgenerational epigenetic inheritance,utilization of methylgroups from the folate cycle,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs162049",
        "SNP Name": "MTRR G28905A",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs162049",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,acting on paired donors,alcohol metabolic pathway,alcohol metabolism,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autosomal recessive,B12,birth defect,breast cancer,cancer,cancerous,carcinogen,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,chromosomal non-disjunction,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,converts homocysteine to methionine,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,folate metabolism,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,folic acid metabolic process,Found in all tissues tested,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,nucleus,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Pancreatic Cancer,Phosphoprotein,Polymorphism,postmenopausal endogenous sex hormones,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,S-adenosylmethionine,SAMe,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,transgenerational epigenetic inheritance,utilization of methylgroups from the folate cycle,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs3776455",
        "SNP Name": "MTRR C32295T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3776455",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,acting on paired donors,Acute Lymphoblastic Leukemia,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autosomal recessive,B12,birth defect,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,Childhood Acute Lymphoblastic Leukemia,chromosomal non-disjunction,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,conotruncal heart defects,converts homocysteine to methionine,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,folic acid metabolic process,Found in all tissues tested,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,Leukemia,Lymphoblastic Leukemia,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,nucleus,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Phosphoprotein,Polymorphism,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,S-adenosylmethionine,SAMe,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,transgenerational epigenetic inheritance,utilization of methylgroups from the folate cycle,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs3776455",
        "SNP Name": "MTRR C32295T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3776455",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,acting on paired donors,Acute Lymphoblastic Leukemia,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autosomal recessive,B12,birth defect,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,Childhood Acute Lymphoblastic Leukemia,chromosomal non-disjunction,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,conotruncal heart defects,converts homocysteine to methionine,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,folic acid metabolic process,Found in all tissues tested,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,Leukemia,Lymphoblastic Leukemia,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,nucleus,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Phosphoprotein,Polymorphism,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,S-adenosylmethionine,SAMe,small molecule metabolic process,spina bifida,sulfur amino acid metabolic process,transgenerational epigenetic inheritance,utilization of methylgroups from the folate cycle,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs10380",
        "SNP Name": "MTRR H595Y",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10380",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,acting on paired donors,Acute Lymphoblastic Leukemia,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autosomal recessive,B12,birth defect,cancer,cancerous,carcinogen,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,Childhood Acute Lymphoblastic Leukemia,chromosomal non-disjunction,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,conotruncal heart defects,converts homocysteine to methionine,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,folic acid metabolic process,Found in all tissues tested,Gastric Cancer,heart,heart defect,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,Leukemia,leukocyte telomere length,Lymphoblastic Leukemia,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,nucleus,Obesity,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Pancreatic Cancer,Phosphoprotein,Polymorphism,Prostate Cancer Risk,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,S-adenosylmethionine,SAMe,small molecule metabolic process,spina bifida,spina bifida and conotruncal heart defects,sulfur amino acid metabolic process,Telomere Length,transgenerational epigenetic inheritance,utilization of methylgroups from the folate cycle,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs10380",
        "SNP Name": "MTRR H595Y",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10380",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,acting on paired donors,Acute Lymphoblastic Leukemia,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autosomal recessive,B12,birth defect,cancer,cancerous,carcinogen,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,Childhood Acute Lymphoblastic Leukemia,chromosomal non-disjunction,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,conotruncal heart defects,converts homocysteine to methionine,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,folic acid metabolic process,Found in all tissues tested,Gastric Cancer,heart,heart defect,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,Leukemia,leukocyte telomere length,Lymphoblastic Leukemia,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,nucleus,Obesity,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Pancreatic Cancer,Phosphoprotein,Polymorphism,Prostate Cancer Risk,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,S-adenosylmethionine,SAMe,small molecule metabolic process,spina bifida,spina bifida and conotruncal heart defects,sulfur amino acid metabolic process,Telomere Length,transgenerational epigenetic inheritance,utilization of methylgroups from the folate cycle,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs1802059",
        "SNP Name": "MTRR -11 A664A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1802059",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,acting on paired donors,Acute Calcineurin Inhibitor-Related Nephrotoxicity,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autosomal recessive,B12,birth defect,Blood leukocyte,calcineurin inhibitor,Calcineurin inhibitor (CNI)-related acute nephrotoxicity,cancer,cancerous,carcinogen,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,chromosomal non-disjunction,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,converts homocysteine to methionine,cyanocobalamin,cyclosporine,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,Early Calcineurin Inhibitor-Related Nephrotoxicity,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,folic acid metabolic process,Found in all tissues tested,gastric cancer,heart,heart defect,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,hypomethylation,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,leukocyte,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,Nephrotoxicity,nucleus,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,pharmacogenetics,Phosphoprotein,Polymorphism,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,Results from a Kidney Transplant Consortium,S-adenosylmethionine,SAMe,small molecule metabolic process,spina bifida,spina bifida and conotruncal heart defects,sulfur amino acid metabolic process,tacrolimus,transgenerational epigenetic inheritance,utilization of methylgroups from the folate cycle,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs1802059",
        "SNP Name": "MTRR -11 A664A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1802059",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,acting on paired donors,Acute Calcineurin Inhibitor-Related Nephrotoxicity,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autosomal recessive,B12,birth defect,Blood leukocyte,calcineurin inhibitor,Calcineurin inhibitor (CNI)-related acute nephrotoxicity,cancer,cancerous,carcinogen,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,chromosomal non-disjunction,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,converts homocysteine to methionine,cyanocobalamin,cyclosporine,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,Early Calcineurin Inhibitor-Related Nephrotoxicity,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,folic acid metabolic process,Found in all tissues tested,gastric cancer,heart,heart defect,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,hypomethylation,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,leukocyte,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,Nephrotoxicity,nucleus,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,pharmacogenetics,Phosphoprotein,Polymorphism,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,Results from a Kidney Transplant Consortium,S-adenosylmethionine,SAMe,small molecule metabolic process,spina bifida,spina bifida and conotruncal heart defects,sulfur amino acid metabolic process,tacrolimus,transgenerational epigenetic inheritance,utilization of methylgroups from the folate cycle,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs9332",
        "SNP Name": "MTRR G*541A",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs9332",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,acting on paired donors,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autosomal recessive,B12,birth defect,cancer,cancerous,carcinogen,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,chromosomal non-disjunction,Clear Cell Renal Cell Carcinoma,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,converts homocysteine to methionine,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,folic acid metabolic process,Found in all tissues tested,gastric cancer risk,heart defect,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,nucleus,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Phosphoprotein,Polymorphism,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,renal cancer,S-adenosylmethionine,SAMe,small molecule metabolic process,spina bifida,spina bifida and conotruncal heart defects,sulfur amino acid metabolic process,transgenerational epigenetic inheritance,utilization of methylgroups from the folate cycle,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs9332",
        "SNP Name": "MTRR G*541A",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs9332",
        "Video": null,
        "Tags": "2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine,5-methyltetrahydrofolate-homocysteine methyltransferase,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,5-MTHF,acting on paired donors,Alternative splicing,amino acids,Amino-acid biosynthesis,anencephaly,ATP,autosomal recessive,B12,birth defect,cancer,cancerous,carcinogen,cblE complementation type,cell extracts show normal methionine synthase activity in the presence of a reducing agent,Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells,cellular energy,cellular methylation,cellular nitrogen compound metabolic process,chromosomal non-disjunction,Clear Cell Renal Cell Carcinoma,cobalamin,cobalamin deficiency,cobalamin metabolic process,cobalamin-dependent pathway,Complete proteome,converts homocysteine to methionine,cyanocobalamin,Cytoplasm,cytosol,defect,delayed psychomotor development,Disease mutation,DNA methylation,Down syndrome,energy,epigenetic inheritance,FAD,FAD-binding FR-type domain,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,folate,Folate pathway,Folate-sensitive neural tube defects (FS-NTD),folic acid,folic acid metabolic process,Found in all tissues tested,gastric cancer risk,heart defect,HMAE,homocysteine,Homocystinuria,Homocystinuria-megaloblastic anemia,hypomethioninemia,inborn error of metabolism,incorporation of one atom of oxygen,incorporation or reduction of molecular oxygen,intermediate filament cytoskeleton,iron ion binding,L-5-MTHF,L-homocysteine,L-methionine,megaloblastic anemia,mental retardation,methionine,Methionine biosynthesis,methionine biosynthetic process,methionine metabolic process,Methionine synthase,Methionine synthase reductase,methylation,methylcobalamin,mitochondria,mitochondrion,MTRR,myelomeningocele,NAD(P)H as one donor,NADH,NADP,NADP binding,NADPH,nucleus,open spina bifida (myelomeningocele),oxidation-reduction process,Oxidoreductase,oxidoreductase activity,Phosphoprotein,Polymorphism,Reference proteome,regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase,renal cancer,S-adenosylmethionine,SAMe,small molecule metabolic process,spina bifida,spina bifida and conotruncal heart defects,sulfur amino acid metabolic process,transgenerational epigenetic inheritance,utilization of methylgroups from the folate cycle,vitamin B12,vitamin deficiency,vitamin metabolic process,Vitamin-B12 dependent methionine synthase,water-soluble vitamin metabolic process,xenobiotic metabolic process,[methionine synthase] reductase activity",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs16899974",
        "SNP Name": "AGXT2 V498L",
        "Risk Allele": "A",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs16899974",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs16899974",
        "SNP Name": "AGXT2 V498L",
        "Risk Allele": "A",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs16899974",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs7717823",
        "SNP Name": "AGXT2 C35000795T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7717823",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs7717823",
        "SNP Name": "AGXT2 C35000795T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7717823",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs344156",
        "SNP Name": "AGXT2 A35035579G",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs344156",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs344156",
        "SNP Name": "AGXT2 A35035579G",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs344156",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs37369",
        "SNP Name": "AGXT2 V140I",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs37369",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs37369",
        "SNP Name": "AGXT2 V140I",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs37369",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs28305",
        "SNP Name": "AGXT2 C35044298G",
        "Risk Allele": "C",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs28305",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs28305",
        "SNP Name": "AGXT2 C35044298G",
        "Risk Allele": "C",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs28305",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs40200",
        "SNP Name": "AGXT2 A35045745G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs40200",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs40200",
        "SNP Name": "AGXT2 A35045745G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs40200",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs6897932",
        "SNP Name": "IL7 T23148959C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs7579",
        "SNP Name": "SEPP1 3",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Mercury (Thiomersal/Thimerosal)"
    },
    {
        "SNP ID": "rs479405",
        "SNP Name": "DMGDH G67591T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs479405",
        "Video": "parGjUuHAcI",
        "Tags": "alternative splicing,aminomethyltransferase activity,catabolism of choline,catalize,catalyzing,choline,chronic muscle fatigue,cleft,Complete proteome,creatine,creatine kinase,creatine\u00a0kinase,cytoplasm,defect,deficiency,demethylation,dimethylglycine,Dimethylglycine dehydrogenase,dimethylglycine dehydrogenase deficiency,DMG,DMGDH,DMGDHD,fish odor,fishlike body odor,flavin adenine dinucleotide,folate,glycine catabolic process,kinase,lip,ME2GLYDH,mitochondrial,mitochondrial matrix,monomer,multiple transcript variants,muscle fatigue,N,N-dimethylglycine,oral facial clefts,oxidative,oxidoreductase activity,palate,protein,Reference proteome,sarcosine,serum creatine kinase,Vitamin,Vitamin-A",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs479405",
        "SNP Name": "DMGDH G67591T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs479405",
        "Video": "parGjUuHAcI",
        "Tags": "alternative splicing,aminomethyltransferase activity,catabolism of choline,catalize,catalyzing,choline,chronic muscle fatigue,cleft,Complete proteome,creatine,creatine kinase,creatine\u00a0kinase,cytoplasm,defect,deficiency,demethylation,dimethylglycine,Dimethylglycine dehydrogenase,dimethylglycine dehydrogenase deficiency,DMG,DMGDH,DMGDHD,fish odor,fishlike body odor,flavin adenine dinucleotide,folate,glycine catabolic process,kinase,lip,ME2GLYDH,mitochondrial,mitochondrial matrix,monomer,multiple transcript variants,muscle fatigue,N,N-dimethylglycine,oral facial clefts,oxidative,oxidoreductase activity,palate,protein,Reference proteome,sarcosine,serum creatine kinase,Vitamin,Vitamin-A",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs479405",
        "SNP Name": "DMGDH G67591T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs479405",
        "Video": "parGjUuHAcI",
        "Tags": "alternative splicing,aminomethyltransferase activity,catabolism of choline,catalize,catalyzing,choline,chronic muscle fatigue,cleft,Complete proteome,creatine,creatine kinase,creatine\u00a0kinase,cytoplasm,defect,deficiency,demethylation,dimethylglycine,Dimethylglycine dehydrogenase,dimethylglycine dehydrogenase deficiency,DMG,DMGDH,DMGDHD,fish odor,fishlike body odor,flavin adenine dinucleotide,folate,glycine catabolic process,kinase,lip,ME2GLYDH,mitochondrial,mitochondrial matrix,monomer,multiple transcript variants,muscle fatigue,N,N-dimethylglycine,oral facial clefts,oxidative,oxidoreductase activity,palate,protein,Reference proteome,sarcosine,serum creatine kinase,Vitamin,Vitamin-A",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs479405",
        "SNP Name": "DMGDH G67591T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs479405",
        "Video": "parGjUuHAcI",
        "Tags": "alternative splicing,aminomethyltransferase activity,catabolism of choline,catalize,catalyzing,choline,chronic muscle fatigue,cleft,Complete proteome,creatine,creatine kinase,creatine\u00a0kinase,cytoplasm,defect,deficiency,demethylation,dimethylglycine,Dimethylglycine dehydrogenase,dimethylglycine dehydrogenase deficiency,DMG,DMGDH,DMGDHD,fish odor,fishlike body odor,flavin adenine dinucleotide,folate,glycine catabolic process,kinase,lip,ME2GLYDH,mitochondrial,mitochondrial matrix,monomer,multiple transcript variants,muscle fatigue,N,N-dimethylglycine,oral facial clefts,oxidative,oxidoreductase activity,palate,protein,Reference proteome,sarcosine,serum creatine kinase,Vitamin,Vitamin-A",
        "Group": "Other Immune Factors"
    },
    {
        "SNP ID": "rs2253262",
        "SNP Name": "DMGDH T372G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2253262",
        "Video": "parGjUuHAcI",
        "Tags": "alternative splicing,aminomethyltransferase activity,birth defect,catabolism of choline,catalize,catalyzing,choline,chronic muscle fatigue,cleft,Complete proteome,conotruncal heart defects,creatine,creatine kinase,creatine\u00a0kinase,cytoplasm,defect,deficiency,demethylation,dimethylglycine,Dimethylglycine dehydrogenase,dimethylglycine dehydrogenase deficiency,DMG,DMGDH,DMGDHD,fish odor,fishlike body odor,flavin adenine dinucleotide,folate,glycine catabolic process,heart defect,kinase,lip,ME2GLYDH,mitochondrial,mitochondrial matrix,monomer,multiple transcript variants,muscle fatigue,N,N-dimethylglycine,oral facial clefts,oxidative,oxidoreductase activity,palate,protein,Reference proteome,sarcosine,serum creatine kinase,spina bifida,Vitamin,Vitamin-A",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2253262",
        "SNP Name": "DMGDH T372G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2253262",
        "Video": "parGjUuHAcI",
        "Tags": "alternative splicing,aminomethyltransferase activity,birth defect,catabolism of choline,catalize,catalyzing,choline,chronic muscle fatigue,cleft,Complete proteome,conotruncal heart defects,creatine,creatine kinase,creatine\u00a0kinase,cytoplasm,defect,deficiency,demethylation,dimethylglycine,Dimethylglycine dehydrogenase,dimethylglycine dehydrogenase deficiency,DMG,DMGDH,DMGDHD,fish odor,fishlike body odor,flavin adenine dinucleotide,folate,glycine catabolic process,heart defect,kinase,lip,ME2GLYDH,mitochondrial,mitochondrial matrix,monomer,multiple transcript variants,muscle fatigue,N,N-dimethylglycine,oral facial clefts,oxidative,oxidoreductase activity,palate,protein,Reference proteome,sarcosine,serum creatine kinase,spina bifida,Vitamin,Vitamin-A",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2253262",
        "SNP Name": "DMGDH T372G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2253262",
        "Video": "parGjUuHAcI",
        "Tags": "alternative splicing,aminomethyltransferase activity,birth defect,catabolism of choline,catalize,catalyzing,choline,chronic muscle fatigue,cleft,Complete proteome,conotruncal heart defects,creatine,creatine kinase,creatine\u00a0kinase,cytoplasm,defect,deficiency,demethylation,dimethylglycine,Dimethylglycine dehydrogenase,dimethylglycine dehydrogenase deficiency,DMG,DMGDH,DMGDHD,fish odor,fishlike body odor,flavin adenine dinucleotide,folate,glycine catabolic process,heart defect,kinase,lip,ME2GLYDH,mitochondrial,mitochondrial matrix,monomer,multiple transcript variants,muscle fatigue,N,N-dimethylglycine,oral facial clefts,oxidative,oxidoreductase activity,palate,protein,Reference proteome,sarcosine,serum creatine kinase,spina bifida,Vitamin,Vitamin-A",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs2253262",
        "SNP Name": "DMGDH T372G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2253262",
        "Video": "parGjUuHAcI",
        "Tags": "alternative splicing,aminomethyltransferase activity,birth defect,catabolism of choline,catalize,catalyzing,choline,chronic muscle fatigue,cleft,Complete proteome,conotruncal heart defects,creatine,creatine kinase,creatine\u00a0kinase,cytoplasm,defect,deficiency,demethylation,dimethylglycine,Dimethylglycine dehydrogenase,dimethylglycine dehydrogenase deficiency,DMG,DMGDH,DMGDHD,fish odor,fishlike body odor,flavin adenine dinucleotide,folate,glycine catabolic process,heart defect,kinase,lip,ME2GLYDH,mitochondrial,mitochondrial matrix,monomer,multiple transcript variants,muscle fatigue,N,N-dimethylglycine,oral facial clefts,oxidative,oxidoreductase activity,palate,protein,Reference proteome,sarcosine,serum creatine kinase,spina bifida,Vitamin,Vitamin-A",
        "Group": "Other Immune Factors"
    },
    {
        "SNP ID": "rs16876512",
        "SNP Name": "BHMT C-448T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs16876512",
        "Video": null,
        "Tags": "2 L-methionine,Amino-acid biosynthesis,Betaine,Betaine--homocysteine S-methyltransferase 2,BHMT,BhmT route,BHMT2,birth defect,brain,cytoplasm,de novo pathway,defect,diabetes,glycine,Glycine Metabolism,heart,homocysteien,homocysteine,homocysteine metabolism,Homotetramer,Insulin Sensitivity,kidney,L-homocysteine,L-methionine biosynthesis,L-methionine biosynthesis via de novo pathway,L-methionine from L-homocysteine,liver,Metal-binding,methionine,methionine biosynthetic process,methyl donor,Methyltransferase,neural tube defect,NTDs,Phosphoprotein,PRNP,S-methyl-L-methionine,S-methylmethionine,S-methylmethionine--homocysteine S-methyltransferase,SAMe,skeletal muscle,SMM,SMM-hcy methyltransferase,Spina Bifida,transferase,Type 2 Diabetes,zinc,zinc ion binding",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs16876512",
        "SNP Name": "BHMT C-448T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs16876512",
        "Video": null,
        "Tags": "2 L-methionine,Amino-acid biosynthesis,Betaine,Betaine--homocysteine S-methyltransferase 2,BHMT,BhmT route,BHMT2,birth defect,brain,cytoplasm,de novo pathway,defect,diabetes,glycine,Glycine Metabolism,heart,homocysteien,homocysteine,homocysteine metabolism,Homotetramer,Insulin Sensitivity,kidney,L-homocysteine,L-methionine biosynthesis,L-methionine biosynthesis via de novo pathway,L-methionine from L-homocysteine,liver,Metal-binding,methionine,methionine biosynthetic process,methyl donor,Methyltransferase,neural tube defect,NTDs,Phosphoprotein,PRNP,S-methyl-L-methionine,S-methylmethionine,S-methylmethionine--homocysteine S-methyltransferase,SAMe,skeletal muscle,SMM,SMM-hcy methyltransferase,Spina Bifida,transferase,Type 2 Diabetes,zinc,zinc ion binding",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs6875201",
        "SNP Name": "BHMT A7961G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6875201",
        "Video": null,
        "Tags": "2 L-methionine,Amino-acid biosynthesis,Betaine,Betaine--homocysteine S-methyltransferase 2,BHMT,BhmT route,BHMT2,brain,cytoplasm,de novo pathway,diabetes,glycine,Glycine Metabolism,heart,homocysteien,homocysteine,homocysteine metabolism,Homotetramer,Insulin Sensitivity,kidney,L-homocysteine,L-methionine biosynthesis,L-methionine biosynthesis via de novo pathway,L-methionine from L-homocysteine,liver,Metal-binding,methionine,methionine biosynthetic process,methyl donor,Methyltransferase,Phosphoprotein,PRNP,S-methyl-L-methionine,S-methylmethionine,S-methylmethionine--homocysteine S-methyltransferase,SAMe,skeletal muscle,SMM,SMM-hcy methyltransferase,transferase,Type 2 Diabetes,zinc,zinc ion binding",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs6875201",
        "SNP Name": "BHMT A7961G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6875201",
        "Video": null,
        "Tags": "2 L-methionine,Amino-acid biosynthesis,Betaine,Betaine--homocysteine S-methyltransferase 2,BHMT,BhmT route,BHMT2,brain,cytoplasm,de novo pathway,diabetes,glycine,Glycine Metabolism,heart,homocysteien,homocysteine,homocysteine metabolism,Homotetramer,Insulin Sensitivity,kidney,L-homocysteine,L-methionine biosynthesis,L-methionine biosynthesis via de novo pathway,L-methionine from L-homocysteine,liver,Metal-binding,methionine,methionine biosynthetic process,methyl donor,Methyltransferase,Phosphoprotein,PRNP,S-methyl-L-methionine,S-methylmethionine,S-methylmethionine--homocysteine S-methyltransferase,SAMe,skeletal muscle,SMM,SMM-hcy methyltransferase,transferase,Type 2 Diabetes,zinc,zinc ion binding",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs567754",
        "SNP Name": "BHMT-02 C13813T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs567754",
        "Video": null,
        "Tags": "2 L-methionine,Abdominal Aortic Aneurysm,Amino-acid biosynthesis,aneurysm,aortic aneurysm,atherothrombosis,betaine,Betaine--homocysteine S-methyltransferase 2,BHMT,BhmT route,BHMT2,birth defect,brain,cleft lip,cleft palate,conotruncal heart defects,conotuncal heart defect,cytoplasm,de novo pathway,defect,heart,heart defect,heart defects,homocysteien,homocysteine,homocysteine metabolism,Homotetramer,Hyperhomocysteinemia,kidney,L-homocysteine,L-methionine biosynthesis,L-methionine biosynthesis via de novo pathway,L-methionine from L-homocysteine,liver,Metal-binding,methionine,methionine biosynthetic process,methyl donor,Methyltransferase,oral facial cleft,Oral facial clefts,Phosphoprotein,placental abruption,PRNP,S-methyl-L-methionine,S-methylmethionine,S-methylmethionine homocysteine S-methyltransferase,SAMe,skeletal muscle,SMM,SMM-hcy methyltransferase,spina bifida,transferase,zinc,zinc ion binding",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs567754",
        "SNP Name": "BHMT-02 C13813T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs567754",
        "Video": null,
        "Tags": "2 L-methionine,Abdominal Aortic Aneurysm,Amino-acid biosynthesis,aneurysm,aortic aneurysm,atherothrombosis,betaine,Betaine--homocysteine S-methyltransferase 2,BHMT,BhmT route,BHMT2,birth defect,brain,cleft lip,cleft palate,conotruncal heart defects,conotuncal heart defect,cytoplasm,de novo pathway,defect,heart,heart defect,heart defects,homocysteien,homocysteine,homocysteine metabolism,Homotetramer,Hyperhomocysteinemia,kidney,L-homocysteine,L-methionine biosynthesis,L-methionine biosynthesis via de novo pathway,L-methionine from L-homocysteine,liver,Metal-binding,methionine,methionine biosynthetic process,methyl donor,Methyltransferase,oral facial cleft,Oral facial clefts,Phosphoprotein,placental abruption,PRNP,S-methyl-L-methionine,S-methylmethionine,S-methylmethionine homocysteine S-methyltransferase,SAMe,skeletal muscle,SMM,SMM-hcy methyltransferase,spina bifida,transferase,zinc,zinc ion binding",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs3733890",
        "SNP Name": "BHMT R239Q",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3733890",
        "Video": null,
        "Tags": "2 L-methionine,Abdominal Aortic Aneurysm,Amino-acid biosynthesis,aneurysm,aortic aneurysm,ASD,asperger's,aspergers,autism,autism spectrum disorder,B12,betaine,Betaine--homocysteine S-methyltransferase 2,BHMT,BhmT route,BHMT2,birth defect,brain,breast cancer,breast cancer mortality,cancer,cancerous,carcinogen,cholesterol,choline metabolism,cleft,cleft lip,cleft palate,cobalamin,Conotruncal Heart Defects,cytoplasm,de novo pathway,defect,Fatty Liver and Hepatocellular Carcinomas,folate,folic acid,heart,heart defect,heart defects,histone,histone methylation,homocysteien,homocysteine,homocysteine metabolism,Homotetramer,kidney,L-homocysteine,L-methionine biosynthesis,L-methionine biosynthesis via de novo pathway,L-methionine from L-homocysteine,liver,Metal-binding,methionine,methionine biosynthetic process,methyl donor,Methyltransferase,neural tube defect,neural tube defects,Neurological Complications Following West Nile Virus Infection,Nonsyndromic Limb Reduction Defects,NTD,NTDs,Obesity,Omphalocele,oral cleft palate,oral facial cleft,Oral Facial Clefts,Phosphoprotein,Plasma Homocysteine,PRNP,rbc folate,red blood cell folate,requirement for choline,S-methyl-L-methionine,S-methylmethionine,S-methylmethionine--homocysteine S-methyltransferase,SAMe,shorter telomeres,skeletal muscle,SMM,SMM-hcy methyltransferase,spina bifida,telomere,Telomere Length,telomeres,temporomandibular disorder,TMJ,transferase,Vitamin B12,zinc,zinc ion binding",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs3733890",
        "SNP Name": "BHMT R239Q",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3733890",
        "Video": null,
        "Tags": "2 L-methionine,Abdominal Aortic Aneurysm,Amino-acid biosynthesis,aneurysm,aortic aneurysm,ASD,asperger's,aspergers,autism,autism spectrum disorder,B12,betaine,Betaine--homocysteine S-methyltransferase 2,BHMT,BhmT route,BHMT2,birth defect,brain,breast cancer,breast cancer mortality,cancer,cancerous,carcinogen,cholesterol,choline metabolism,cleft,cleft lip,cleft palate,cobalamin,Conotruncal Heart Defects,cytoplasm,de novo pathway,defect,Fatty Liver and Hepatocellular Carcinomas,folate,folic acid,heart,heart defect,heart defects,histone,histone methylation,homocysteien,homocysteine,homocysteine metabolism,Homotetramer,kidney,L-homocysteine,L-methionine biosynthesis,L-methionine biosynthesis via de novo pathway,L-methionine from L-homocysteine,liver,Metal-binding,methionine,methionine biosynthetic process,methyl donor,Methyltransferase,neural tube defect,neural tube defects,Neurological Complications Following West Nile Virus Infection,Nonsyndromic Limb Reduction Defects,NTD,NTDs,Obesity,Omphalocele,oral cleft palate,oral facial cleft,Oral Facial Clefts,Phosphoprotein,Plasma Homocysteine,PRNP,rbc folate,red blood cell folate,requirement for choline,S-methyl-L-methionine,S-methylmethionine,S-methylmethionine--homocysteine S-methyltransferase,SAMe,shorter telomeres,skeletal muscle,SMM,SMM-hcy methyltransferase,spina bifida,telomere,Telomere Length,telomeres,temporomandibular disorder,TMJ,transferase,Vitamin B12,zinc,zinc ion binding",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs617219",
        "SNP Name": "BHMT-04 A26991C",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs617219",
        "Video": null,
        "Tags": "2 L-methionine,Amino-acid biosynthesis,aneurysm,aortic aneurysm,atherothrombosis,betaine,Betaine--homocysteine S-methyltransferase 2,BHMT,BhmT route,BHMT2,birth defect,brain,cleft lip,cleft palate,conotruncal heart defects,conotuncal heart defect,cytoplasm,de novo pathway,defect,heart,heart defect,heart defects,homocysteien,homocysteine,homocysteine metabolism,Homotetramer,Hyperhomocysteinemia,kidney,L-homocysteine,L-methionine biosynthesis,L-methionine biosynthesis via de novo pathway,L-methionine from L-homocysteine,liver,Metal-binding,methionine,methionine biosynthetic process,methyl donor,Methyltransferase,oral facial cleft,Phosphoprotein,placental abruption,PRNP,S-methyl-L-methionine,S-methylmethionine,S-methylmethionine homocysteine S-methyltransferase,SAMe,skeletal muscle,SMM,SMM-hcy methyltransferase,spina bifida,transferase,zinc,zinc ion binding",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs617219",
        "SNP Name": "BHMT-04 A26991C",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs617219",
        "Video": null,
        "Tags": "2 L-methionine,Amino-acid biosynthesis,aneurysm,aortic aneurysm,atherothrombosis,betaine,Betaine--homocysteine S-methyltransferase 2,BHMT,BhmT route,BHMT2,birth defect,brain,cleft lip,cleft palate,conotruncal heart defects,conotuncal heart defect,cytoplasm,de novo pathway,defect,heart,heart defect,heart defects,homocysteien,homocysteine,homocysteine metabolism,Homotetramer,Hyperhomocysteinemia,kidney,L-homocysteine,L-methionine biosynthesis,L-methionine biosynthesis via de novo pathway,L-methionine from L-homocysteine,liver,Metal-binding,methionine,methionine biosynthetic process,methyl donor,Methyltransferase,oral facial cleft,Phosphoprotein,placental abruption,PRNP,S-methyl-L-methionine,S-methylmethionine,S-methylmethionine homocysteine S-methyltransferase,SAMe,skeletal muscle,SMM,SMM-hcy methyltransferase,spina bifida,transferase,zinc,zinc ion binding",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs1650697",
        "SNP Name": "DHFR/MSH T-473A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1650697",
        "Video": "jMnNHKP62eQ",
        "Tags": "5,6,7,8-dihydrofolate,8-tetrahydrofolate,adult brains,adult tissues,birth defect,Breast Cancer,cancerous,carcinogen,catalyze,cerebral tetrahydrobiopterin deficiency,childhood absence epilepsy,Cofactor biosynthesis,complete proteome,Conotruncal Heart Defects,cytosol,de novo glycine,defect,DHFR,DHFRD,DHFRL1,dihydrofolate,Dihydrofolate reductase,dihydrofolate reductase activity,dihydrofolate reductase deficiency,dihydrofolate reductase domain,dihydrofolate reductase family,Disease,Disease mutation,DNA precursor synthesis,drug binding,fetal brains,fetal tissues,folate,folate metabolism,folic acid metabolic process,G1/S transition of mitotic cell cycle,generalized\u00a0 seizures in infancy,glycine,glycine biosynthetic process,heart defect,inborn error of metabolism,learning difficulties,megaloblastic anemia,methotrexate,methotrexate resistance,mitotic cell cycle,mRNA,mRNA binding,mutations,NADP,NADP binding,NADPH,neurologic symptoms,nitric oxide metabolic process,novo mitochondrial thymidylate biosynthesis pathway,nucleoplasm,nucleotide biosynthetic process,one-carbon metabolic process,Oxidoreductase,pancytopenia,purine synthesis,Radiation Sensitivity,reference proteome,regulation of nitric-oxide synthase activity,regulation of transcription involved in G1/S transition of mitotic cell cycle,response to methotrexate,RNA-binding,rs1650697,severe cerebral folate deficiency,severe developmental delay,small molecule metabolic process,spina bifida,T-473A,tetrahydrofolate biosynthesis,tetrahydrofolate biosynthetic process,tetrahydrofolate metabolic process,vitamin metabolic process,water-soluble vitamin metabolic process,whole blood",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1650697",
        "SNP Name": "DHFR/MSH T-473A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1650697",
        "Video": "jMnNHKP62eQ",
        "Tags": "5,6,7,8-dihydrofolate,8-tetrahydrofolate,adult brains,adult tissues,birth defect,Breast Cancer,cancerous,carcinogen,catalyze,cerebral tetrahydrobiopterin deficiency,childhood absence epilepsy,Cofactor biosynthesis,complete proteome,Conotruncal Heart Defects,cytosol,de novo glycine,defect,DHFR,DHFRD,DHFRL1,dihydrofolate,Dihydrofolate reductase,dihydrofolate reductase activity,dihydrofolate reductase deficiency,dihydrofolate reductase domain,dihydrofolate reductase family,Disease,Disease mutation,DNA precursor synthesis,drug binding,fetal brains,fetal tissues,folate,folate metabolism,folic acid metabolic process,G1/S transition of mitotic cell cycle,generalized\u00a0 seizures in infancy,glycine,glycine biosynthetic process,heart defect,inborn error of metabolism,learning difficulties,megaloblastic anemia,methotrexate,methotrexate resistance,mitotic cell cycle,mRNA,mRNA binding,mutations,NADP,NADP binding,NADPH,neurologic symptoms,nitric oxide metabolic process,novo mitochondrial thymidylate biosynthesis pathway,nucleoplasm,nucleotide biosynthetic process,one-carbon metabolic process,Oxidoreductase,pancytopenia,purine synthesis,Radiation Sensitivity,reference proteome,regulation of nitric-oxide synthase activity,regulation of transcription involved in G1/S transition of mitotic cell cycle,response to methotrexate,RNA-binding,rs1650697,severe cerebral folate deficiency,severe developmental delay,small molecule metabolic process,spina bifida,T-473A,tetrahydrofolate biosynthesis,tetrahydrofolate biosynthetic process,tetrahydrofolate metabolic process,vitamin metabolic process,water-soluble vitamin metabolic process,whole blood",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs1650697",
        "SNP Name": "DHFR/MSH T-473A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1650697",
        "Video": "jMnNHKP62eQ",
        "Tags": "5,6,7,8-dihydrofolate,8-tetrahydrofolate,adult brains,adult tissues,birth defect,Breast Cancer,cancerous,carcinogen,catalyze,cerebral tetrahydrobiopterin deficiency,childhood absence epilepsy,Cofactor biosynthesis,complete proteome,Conotruncal Heart Defects,cytosol,de novo glycine,defect,DHFR,DHFRD,DHFRL1,dihydrofolate,Dihydrofolate reductase,dihydrofolate reductase activity,dihydrofolate reductase deficiency,dihydrofolate reductase domain,dihydrofolate reductase family,Disease,Disease mutation,DNA precursor synthesis,drug binding,fetal brains,fetal tissues,folate,folate metabolism,folic acid metabolic process,G1/S transition of mitotic cell cycle,generalized\u00a0 seizures in infancy,glycine,glycine biosynthetic process,heart defect,inborn error of metabolism,learning difficulties,megaloblastic anemia,methotrexate,methotrexate resistance,mitotic cell cycle,mRNA,mRNA binding,mutations,NADP,NADP binding,NADPH,neurologic symptoms,nitric oxide metabolic process,novo mitochondrial thymidylate biosynthesis pathway,nucleoplasm,nucleotide biosynthetic process,one-carbon metabolic process,Oxidoreductase,pancytopenia,purine synthesis,Radiation Sensitivity,reference proteome,regulation of nitric-oxide synthase activity,regulation of transcription involved in G1/S transition of mitotic cell cycle,response to methotrexate,RNA-binding,rs1650697,severe cerebral folate deficiency,severe developmental delay,small molecule metabolic process,spina bifida,T-473A,tetrahydrofolate biosynthesis,tetrahydrofolate biosynthetic process,tetrahydrofolate metabolic process,vitamin metabolic process,water-soluble vitamin metabolic process,whole blood",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1650697",
        "SNP Name": "DHFR/MSH T-473A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1650697",
        "Video": "jMnNHKP62eQ",
        "Tags": "5,6,7,8-dihydrofolate,8-tetrahydrofolate,adult brains,adult tissues,birth defect,Breast Cancer,cancerous,carcinogen,catalyze,cerebral tetrahydrobiopterin deficiency,childhood absence epilepsy,Cofactor biosynthesis,complete proteome,Conotruncal Heart Defects,cytosol,de novo glycine,defect,DHFR,DHFRD,DHFRL1,dihydrofolate,Dihydrofolate reductase,dihydrofolate reductase activity,dihydrofolate reductase deficiency,dihydrofolate reductase domain,dihydrofolate reductase family,Disease,Disease mutation,DNA precursor synthesis,drug binding,fetal brains,fetal tissues,folate,folate metabolism,folic acid metabolic process,G1/S transition of mitotic cell cycle,generalized\u00a0 seizures in infancy,glycine,glycine biosynthetic process,heart defect,inborn error of metabolism,learning difficulties,megaloblastic anemia,methotrexate,methotrexate resistance,mitotic cell cycle,mRNA,mRNA binding,mutations,NADP,NADP binding,NADPH,neurologic symptoms,nitric oxide metabolic process,novo mitochondrial thymidylate biosynthesis pathway,nucleoplasm,nucleotide biosynthetic process,one-carbon metabolic process,Oxidoreductase,pancytopenia,purine synthesis,Radiation Sensitivity,reference proteome,regulation of nitric-oxide synthase activity,regulation of transcription involved in G1/S transition of mitotic cell cycle,response to methotrexate,RNA-binding,rs1650697,severe cerebral folate deficiency,severe developmental delay,small molecule metabolic process,spina bifida,T-473A,tetrahydrofolate biosynthesis,tetrahydrofolate biosynthetic process,tetrahydrofolate metabolic process,vitamin metabolic process,water-soluble vitamin metabolic process,whole blood",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs2069812",
        "SNP Name": "IL5 A131879916G",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs2069812",
        "Video": null,
        "Tags": null,
        "Group": "Other Immune Factors"
    },
    {
        "SNP ID": "rs2040704",
        "SNP Name": "RAD50 85562A>G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs2040704",
        "Video": null,
        "Tags": null,
        "Group": "IgE"
    },
    {
        "SNP ID": "rs20541",
        "SNP Name": "IL-13 variant",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs20541",
        "Video": null,
        "Tags": null,
        "Group": "Other Immune Factors"
    },
    {
        "SNP ID": "rs2243250",
        "SNP Name": "IL4 C-589",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum"
    },
    {
        "SNP ID": "rs2243250",
        "SNP Name": "IL4 C-589",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Hydroxide"
    },
    {
        "SNP ID": "rs2243250",
        "SNP Name": "IL4 C-589",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Hydroxyphosphate Sulfate"
    },
    {
        "SNP ID": "rs2243250",
        "SNP Name": "IL4 C-589",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Phosphate"
    },
    {
        "SNP ID": "rs2243250",
        "SNP Name": "IL4 C-589",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Potassium Sulfate"
    },
    {
        "SNP ID": "rs2243250",
        "SNP Name": "IL4 C-589",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Salts"
    },
    {
        "SNP ID": "rs2243250",
        "SNP Name": "IL4 C-589",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Sulfate"
    },
    {
        "SNP ID": "rs2243250",
        "SNP Name": "IL4 C-589",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs2243250",
        "SNP Name": "IL4 C-589",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs2243250",
        "SNP Name": "IL4 C-589",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Mercury (Thiomersal/Thimerosal)"
    },
    {
        "SNP ID": "rs2070874",
        "SNP Name": "IL4 C-33T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum"
    },
    {
        "SNP ID": "rs2070874",
        "SNP Name": "IL4 C-33T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Hydroxide"
    },
    {
        "SNP ID": "rs2070874",
        "SNP Name": "IL4 C-33T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Hydroxyphosphate Sulfate"
    },
    {
        "SNP ID": "rs2070874",
        "SNP Name": "IL4 C-33T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Phosphate"
    },
    {
        "SNP ID": "rs2070874",
        "SNP Name": "IL4 C-33T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Potassium Sulfate"
    },
    {
        "SNP ID": "rs2070874",
        "SNP Name": "IL4 C-33T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Salts"
    },
    {
        "SNP ID": "rs2070874",
        "SNP Name": "IL4 C-33T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Sulfate"
    },
    {
        "SNP ID": "rs2070874",
        "SNP Name": "IL4 C-33T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs2070874",
        "SNP Name": "IL4 C-33T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs2070874",
        "SNP Name": "IL4 C-33T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Mercury (Thiomersal/Thimerosal)"
    },
    {
        "SNP ID": "rs17286676",
        "SNP Name": "SLC4A9 G139749028A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Borate"
    },
    {
        "SNP ID": "rs258751",
        "SNP Name": "NR3C1 A593A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Acetone"
    },
    {
        "SNP ID": "rs258751",
        "SNP Name": "NR3C1 C3843271A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Acetone"
    },
    {
        "SNP ID": "rs8177412",
        "SNP Name": "GPX3 129T>C",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs8177412",
        "Video": "I1oq4HXLJBw",
        "Tags": "2 glutathione,2 glutathione + H2O2 = glutathione disulfide + 2 H2O,3D-structure,catalyze,catalyzing the reduction of hydrogen peroxide,CD,cell protection,Chron,Complete proteome,Crohn\u2019s Disease,detox,digestive,Direct protein sequencing,Extracellular glutathione peroxidase,extracellular region,extracellular space,extracellular vesicular exosome,GCLC,glutamate,glutamate cysteine ligase catalytic subunit,glutamine,glutathione,glutathione disulfide,Glutathione peroxidase 3,glutathione peroxidase activity,glutathione peroxidase family,GPx-3,GPx-P,GPX3,GPXP,GSHPx-3,GSHPx-P,H2O2,Homotetramer,hydrogen peroxide,hydrogen peroxide catabolic process,lipid,lipid peroxides,lutathione peroxidase family,N-terminus,organic hydroperoxide,oxidative damage,oxidative stress,oxides,Oxidoreductase,Peroxidase,Plasma glutathione peroxidase,Polymorphism,Protects cells and enzymes from oxidative damage,protein homotetramerization,reactive oxygen species,Reference proteome,renal,renal disease,renal disease in type 1 diabetes mellitus,response to lipid hydroperoxide,ROS,Secreted,Secreted in plasma,Selenium,selenium binding,selenocysteine,Selenoprotein,Signal,sulfamethoxazole,sulfamethoxazole-induced hypersensitivity,sulfamethoxazole-induced hypersensitivity in HIV/AIDS,transcription factor binding",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs4869089",
        "SNP Name": "MAT2B A7755681G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4869089",
        "Video": "2MjP12uSbHw",
        "Tags": "Alternative splicing,amino acids,Amino-acid biosynthesis,ATP,beta subunits (MAT2B),betaine,catalytic alpha subunits (MAT2A),cell proliferation,cellular energy,cellular nitrogen compound metabolic process,choline,cytosol,DNA synthesis,dTDP-4-dehydrorhamnose reductase activity,dTDP-4-dehydrorhamnose reductase family,energy,enzyme binding,extracellular polysaccharide biosynthetic process,folate,Heterotetramer,homocysteine,intracellular,L-methionine,MAT II beta,MAT2A,MAT2B,MAT2B subfamily,methionine,Methionine adenosyltransferase 2 subunit beta,methionine adenosyltransferase complex,Methionine adenosyltransferase II beta,methionine adenosyltransferase regulator activity,methylation,mitochondria,mitochondrion,Non-catalytic regulatory subunit of S-adenosylmethionine synthetase 2 (MAT2A),nucleus,one-carbon metabolic process,One-carbon metabolism,plasma S-adenosylmethionine,plasma SAM,Polymorphism,Regulates the activity of S-adenosylmethionine synthetase 2,regulation of catalytic activity,S-Adenosyl Methionine,S-adenosyl-L-methionine biosynthesis,S-adenosyl-L-methionine from L-methionine,S-adenosylhomocysteine (SAH),S-adenosylmethionine,S-adenosylmethionine biosynthetic process,S-adenosylmethionine inhibition,S-adenosylmethionine synthetase 2,SAMe catalyzes the formation of S-adenosylmethionine from methionine and ATP,small molecule metabolic process,sulfur amino acid metabolic process,total homocysteine (Hcy),vitamin B12,vitamin B6,Widely expressed,xenobiotic metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs4869089",
        "SNP Name": "MAT2B A7755681G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4869089",
        "Video": "2MjP12uSbHw",
        "Tags": "Alternative splicing,amino acids,Amino-acid biosynthesis,ATP,beta subunits (MAT2B),betaine,catalytic alpha subunits (MAT2A),cell proliferation,cellular energy,cellular nitrogen compound metabolic process,choline,cytosol,DNA synthesis,dTDP-4-dehydrorhamnose reductase activity,dTDP-4-dehydrorhamnose reductase family,energy,enzyme binding,extracellular polysaccharide biosynthetic process,folate,Heterotetramer,homocysteine,intracellular,L-methionine,MAT II beta,MAT2A,MAT2B,MAT2B subfamily,methionine,Methionine adenosyltransferase 2 subunit beta,methionine adenosyltransferase complex,Methionine adenosyltransferase II beta,methionine adenosyltransferase regulator activity,methylation,mitochondria,mitochondrion,Non-catalytic regulatory subunit of S-adenosylmethionine synthetase 2 (MAT2A),nucleus,one-carbon metabolic process,One-carbon metabolism,plasma S-adenosylmethionine,plasma SAM,Polymorphism,Regulates the activity of S-adenosylmethionine synthetase 2,regulation of catalytic activity,S-Adenosyl Methionine,S-adenosyl-L-methionine biosynthesis,S-adenosyl-L-methionine from L-methionine,S-adenosylhomocysteine (SAH),S-adenosylmethionine,S-adenosylmethionine biosynthetic process,S-adenosylmethionine inhibition,S-adenosylmethionine synthetase 2,SAMe catalyzes the formation of S-adenosylmethionine from methionine and ATP,small molecule metabolic process,sulfur amino acid metabolic process,total homocysteine (Hcy),vitamin B12,vitamin B6,Widely expressed,xenobiotic metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs4869089",
        "SNP Name": "MAT2B A7755681G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4869089",
        "Video": "2MjP12uSbHw",
        "Tags": "Alternative splicing,amino acids,Amino-acid biosynthesis,ATP,beta subunits (MAT2B),betaine,catalytic alpha subunits (MAT2A),cell proliferation,cellular energy,cellular nitrogen compound metabolic process,choline,cytosol,DNA synthesis,dTDP-4-dehydrorhamnose reductase activity,dTDP-4-dehydrorhamnose reductase family,energy,enzyme binding,extracellular polysaccharide biosynthetic process,folate,Heterotetramer,homocysteine,intracellular,L-methionine,MAT II beta,MAT2A,MAT2B,MAT2B subfamily,methionine,Methionine adenosyltransferase 2 subunit beta,methionine adenosyltransferase complex,Methionine adenosyltransferase II beta,methionine adenosyltransferase regulator activity,methylation,mitochondria,mitochondrion,Non-catalytic regulatory subunit of S-adenosylmethionine synthetase 2 (MAT2A),nucleus,one-carbon metabolic process,One-carbon metabolism,plasma S-adenosylmethionine,plasma SAM,Polymorphism,Regulates the activity of S-adenosylmethionine synthetase 2,regulation of catalytic activity,S-Adenosyl Methionine,S-adenosyl-L-methionine biosynthesis,S-adenosyl-L-methionine from L-methionine,S-adenosylhomocysteine (SAH),S-adenosylmethionine,S-adenosylmethionine biosynthetic process,S-adenosylmethionine inhibition,S-adenosylmethionine synthetase 2,SAMe catalyzes the formation of S-adenosylmethionine from methionine and ATP,small molecule metabolic process,sulfur amino acid metabolic process,total homocysteine (Hcy),vitamin B12,vitamin B6,Widely expressed,xenobiotic metabolic process",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs322351",
        "SNP Name": "DUSP1 G*892A",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "2-Phenoxyethanol"
    },
    {
        "SNP ID": "rs322351",
        "SNP Name": "DUSP1 G*892A",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Alcohol"
    },
    {
        "SNP ID": "rs322351",
        "SNP Name": "DUSP1 G*892A",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs251937",
        "SNP Name": "DRD1 A9244G",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs251937",
        "Video": null,
        "Tags": "activation of adenylate cyclase activity,adenylyl cyclase,behavior,biosynthesis,Cell membrane,cyclase-activating dopamine receptor signaling pathway,cyclase-activating G-protein coupled receptor signaling pathway,D(1A) dopamine receptor,Disulfide bond,DNAJC14,dopamine,Dopamine D1 receptor,dopamine receptor,DRD1,DRD1IP,Endoplasmic reticulum,G-protein coupled receptor,G-protein coupled receptor signaling pathway,GABAergic interneuron migration,glutamatergic,Glycoprotein,interaction,Lipoprotein,long term synaptic depression,Membrane,Palmitate,perception,Polymorphism,psychology,Receptor,sensitization,striatum development,Transducer,Transmembrane,Transmembrane helix,\u00a0adenylate,\u00a0adult walking behavior,\u00a0astrocyte,\u00a0astrocyte development,\u00a0behavioral fear response,\u00a0behavioral response to cocaine,\u00a0blood pressure,\u00a0blood sugar,\u00a0calcium,\u00a0calcium ion,\u00a0cAMP,\u00a0catecholamine,\u00a0cellular response to catecholamine stimulus,\u00a0cerebral cortex,\u00a0cocaine,\u00a0conditioned taste aversion,\u00a0cyclase,\u00a0dentate gyrus development,\u00a0depression,\u00a0dopamine binding,\u00a0dopamine metabolic process,\u00a0dopamine neurotransmitter receptor activity,\u00a0dopamine transport,\u00a0dopaminergic,\u00a0drug,\u00a0electrolyte,\u00a0endoplasmic reticulum membrane,\u00a0fear,\u00a0G-protein,\u00a0GABA,\u00a0glucose,\u00a0glucose import,\u00a0grooming,\u00a0habituation,\u00a0integral component of plasma membrane,\u00a0learning,\u00a0long-term synaptic potentiation,\u00a0magnesium,\u00a0mao,\u00a0maoa,\u00a0maternal behavior,\u00a0mating behavior,\u00a0memory,\u00a0migraine,\u00a0migraine aura,\u00a0motor,\u00a0neorological disorder,\u00a0neuronal action potential,\u00a0nucleus,\u00a0operant conditioning,\u00a0paranoia,\u00a0paranoid schizophrenia,\u00a0peristalsis,\u00a0phospholipase C-activating dopamine receptor signaling pathway,\u00a0plasma membrane,\u00a0positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,\u00a0positive regulation of cAMP biosynthetic process,\u00a0positive regulation of cell migration,\u00a0positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,\u00a0positive regulation of potassium ion transport,\u00a0positive regulation of release of sequestered calcium ion into cytosol,\u00a0positive regulation of synaptic transmission,\u00a0potassium,\u00a0potassium ion,\u00a0prepulse inhibition,\u00a0protein,\u00a0protein import into nucleus,\u00a0regulation of dopamine metabolic process,\u00a0regulation of dopamine uptake involved in synaptic transmission,\u00a0response to amphetamine,\u00a0response to drug,\u00a0schizophrenia,\u00a0serotonin,\u00a0sexual behavior,\u00a0sodium,\u00a0synapse assembly,\u00a0synaptic transmission,\u00a0taste,\u00a0temperature homeostasis,\u00a0transmission of nerve impulse,\u00a0vasodilation,\u00a0visual learning",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs251937",
        "SNP Name": "DRD1 A9244G",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs251937",
        "Video": null,
        "Tags": "activation of adenylate cyclase activity,adenylyl cyclase,behavior,biosynthesis,Cell membrane,cyclase-activating dopamine receptor signaling pathway,cyclase-activating G-protein coupled receptor signaling pathway,D(1A) dopamine receptor,Disulfide bond,DNAJC14,dopamine,Dopamine D1 receptor,dopamine receptor,DRD1,DRD1IP,Endoplasmic reticulum,G-protein coupled receptor,G-protein coupled receptor signaling pathway,GABAergic interneuron migration,glutamatergic,Glycoprotein,interaction,Lipoprotein,long term synaptic depression,Membrane,Palmitate,perception,Polymorphism,psychology,Receptor,sensitization,striatum development,Transducer,Transmembrane,Transmembrane helix,\u00a0adenylate,\u00a0adult walking behavior,\u00a0astrocyte,\u00a0astrocyte development,\u00a0behavioral fear response,\u00a0behavioral response to cocaine,\u00a0blood pressure,\u00a0blood sugar,\u00a0calcium,\u00a0calcium ion,\u00a0cAMP,\u00a0catecholamine,\u00a0cellular response to catecholamine stimulus,\u00a0cerebral cortex,\u00a0cocaine,\u00a0conditioned taste aversion,\u00a0cyclase,\u00a0dentate gyrus development,\u00a0depression,\u00a0dopamine binding,\u00a0dopamine metabolic process,\u00a0dopamine neurotransmitter receptor activity,\u00a0dopamine transport,\u00a0dopaminergic,\u00a0drug,\u00a0electrolyte,\u00a0endoplasmic reticulum membrane,\u00a0fear,\u00a0G-protein,\u00a0GABA,\u00a0glucose,\u00a0glucose import,\u00a0grooming,\u00a0habituation,\u00a0integral component of plasma membrane,\u00a0learning,\u00a0long-term synaptic potentiation,\u00a0magnesium,\u00a0mao,\u00a0maoa,\u00a0maternal behavior,\u00a0mating behavior,\u00a0memory,\u00a0migraine,\u00a0migraine aura,\u00a0motor,\u00a0neorological disorder,\u00a0neuronal action potential,\u00a0nucleus,\u00a0operant conditioning,\u00a0paranoia,\u00a0paranoid schizophrenia,\u00a0peristalsis,\u00a0phospholipase C-activating dopamine receptor signaling pathway,\u00a0plasma membrane,\u00a0positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,\u00a0positive regulation of cAMP biosynthetic process,\u00a0positive regulation of cell migration,\u00a0positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,\u00a0positive regulation of potassium ion transport,\u00a0positive regulation of release of sequestered calcium ion into cytosol,\u00a0positive regulation of synaptic transmission,\u00a0potassium,\u00a0potassium ion,\u00a0prepulse inhibition,\u00a0protein,\u00a0protein import into nucleus,\u00a0regulation of dopamine metabolic process,\u00a0regulation of dopamine uptake involved in synaptic transmission,\u00a0response to amphetamine,\u00a0response to drug,\u00a0schizophrenia,\u00a0serotonin,\u00a0sexual behavior,\u00a0sodium,\u00a0synapse assembly,\u00a0synaptic transmission,\u00a0taste,\u00a0temperature homeostasis,\u00a0transmission of nerve impulse,\u00a0vasodilation,\u00a0visual learning",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs686",
        "SNP Name": "DRD1 C7464T",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=Rs5326",
        "Video": null,
        "Tags": "activation of adenylate cyclase activity,addiction,adenylate,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-activating G-protein coupled receptor signaling pathway,adenylyl cyclase,ADHD,adult walking behavior,alcohol,alcohol metabolism,ASD,astrocyte,astrocyte development,autism,autism spectrum disorder,behavioral fear response,behavioral response to cocaine,biosynthesis,blood pressure,blood sugar,calcium,calcium ion,cAMP,cancer,catecholamine,Cell membrane,cellular response to catecholamine stimulus,cerebral cortex GABAergic interneuron migration,cocaine,cognitive,conditioned taste aversion,cyclase,D(1A) dopamine receptor,dentate gyrus development,depression,Disulfide bond,DNAJC14,dopamine,dopamine binding,Dopamine D1 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,dopamine receptor,dopamine transport,dopaminergic,DRD1,DRD1IP,drug,electrolyte,Endoplasmic reticulum,endoplasmic reticulum membrane,ethanol,fear,Fish-Swarm Logic Regression,G-protein,G-protein coupled receptor,G-protein coupled receptor signaling pathway,GABA,glucose,glucose import,glutamatergic,Glycoprotein,grooming behavior,habituation,heroin,impulsivity,integral component of plasma membrane,interaction,learning,Leukemia,leukemic,Lipoprotein,long term synaptic depression,long-term synaptic potentiation,magnesium,maternal behavior,mating behavior,Membrane,memory,motor,neuronal action potential,neuroplasticity,nucleus,operant conditioning,opioid,opioid dependence,Palmitate,peristalsis,phospholipase C-activating dopamine receptor signaling pathway,plasma membrane,Polymorphism,positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,positive regulation of cAMP biosynthetic process,positive regulation of cell migration,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of potassium ion transport,positive regulation of release of sequestered calcium ion into cytosol,positive regulation of synaptic transmission,potassium,potassium ion,prepulse inhibition,protein,protein import into nucleus,psychology,Receptor,regulation of dopamine metabolic process,regulation of dopamine uptake involved in synaptic transmission,response to amphetamine,response to drug,sensitization,serotonin,sexual behavior,sodium,striatum development,synapse assembly,synaptic transmission,T cell,taste perception,temperature homeostasis,Transducer,Transmembrane,Transmembrane helix,transmission of nerve impulse,vasodilation,visual learning",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs686",
        "SNP Name": "DRD1 C7464T",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=Rs5326",
        "Video": null,
        "Tags": "activation of adenylate cyclase activity,addiction,adenylate,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-activating G-protein coupled receptor signaling pathway,adenylyl cyclase,ADHD,adult walking behavior,alcohol,alcohol metabolism,ASD,astrocyte,astrocyte development,autism,autism spectrum disorder,behavioral fear response,behavioral response to cocaine,biosynthesis,blood pressure,blood sugar,calcium,calcium ion,cAMP,cancer,catecholamine,Cell membrane,cellular response to catecholamine stimulus,cerebral cortex GABAergic interneuron migration,cocaine,cognitive,conditioned taste aversion,cyclase,D(1A) dopamine receptor,dentate gyrus development,depression,Disulfide bond,DNAJC14,dopamine,dopamine binding,Dopamine D1 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,dopamine receptor,dopamine transport,dopaminergic,DRD1,DRD1IP,drug,electrolyte,Endoplasmic reticulum,endoplasmic reticulum membrane,ethanol,fear,Fish-Swarm Logic Regression,G-protein,G-protein coupled receptor,G-protein coupled receptor signaling pathway,GABA,glucose,glucose import,glutamatergic,Glycoprotein,grooming behavior,habituation,heroin,impulsivity,integral component of plasma membrane,interaction,learning,Leukemia,leukemic,Lipoprotein,long term synaptic depression,long-term synaptic potentiation,magnesium,maternal behavior,mating behavior,Membrane,memory,motor,neuronal action potential,neuroplasticity,nucleus,operant conditioning,opioid,opioid dependence,Palmitate,peristalsis,phospholipase C-activating dopamine receptor signaling pathway,plasma membrane,Polymorphism,positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,positive regulation of cAMP biosynthetic process,positive regulation of cell migration,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of potassium ion transport,positive regulation of release of sequestered calcium ion into cytosol,positive regulation of synaptic transmission,potassium,potassium ion,prepulse inhibition,protein,protein import into nucleus,psychology,Receptor,regulation of dopamine metabolic process,regulation of dopamine uptake involved in synaptic transmission,response to amphetamine,response to drug,sensitization,serotonin,sexual behavior,sodium,striatum development,synapse assembly,synaptic transmission,T cell,taste perception,temperature homeostasis,Transducer,Transmembrane,Transmembrane helix,transmission of nerve impulse,vasodilation,visual learning",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs4532",
        "SNP Name": "DRD1 G6014A",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4532",
        "Video": null,
        "Tags": "activation of adenylate cyclase activity,addiction,adenylyl cyclase,ADHD,alcohol,alcohol dependence,alcohol metabolism,ASD,autism,autism spectrum disorder,biosynthesis,Cancer,CCKAR,Cell membrane,Cholecystokinin,Cholecystokinin A Receptor,chronic renal insufficiency,Continuous Performance Task,CPT,D(1A) dopamine receptor,Disulfide bond,DNAJC14,dopamine,Dopamine D1 receptor,dopamine receptor,DRD1,DRD1IP,Endoplasmic reticulum,ethanol,G-protein coupled receptor,glutamate,glutamatergic,Glycoprotein,infant,interaction,L-Dopa,Leukemia,Leukemic,Lipoprotein,Membrane,Methamphetamine,Methamphetamine-Associated Psychosis,nicotine,opiate,opiate abuse,Palmitate,paranoia,paranoid schizophrenia,Polymorphism,positive regulation of synaptic transmission,psychology,psychosis,Receptor,renal traits,schizophrenia,sensitization,signaling pathway,smoking,T cell,Transducer,Transmembrane,Transmembrane helix,\u00a0adenylate,\u00a0adenylate cyclase-activating dopamine receptor signaling pathway,\u00a0adenylate cyclase-activating G-protein coupled receptor signaling pathway,\u00a0adult walking behavior,\u00a0astrocyte,\u00a0astrocyte development,\u00a0behavioral fear response,\u00a0behavioral response to cocaine,\u00a0blood pressure,\u00a0blood sugar,\u00a0calcium,\u00a0calcium ion,\u00a0cAMP,\u00a0catecholamine,\u00a0cellular response to catecholamine stimulus,\u00a0cerebral cortex GABAergic interneuron migration,\u00a0cocaine,\u00a0conditioned taste aversion,\u00a0cyclase,\u00a0dentate gyrus development,\u00a0depression,\u00a0dopamine binding,\u00a0dopamine metabolic process,\u00a0dopamine neurotransmitter receptor activity,\u00a0dopamine transport,\u00a0dopaminergic,\u00a0drug,\u00a0electrolyte,\u00a0endoplasmic reticulum membrane,\u00a0fear,\u00a0G-protein,\u00a0GABA,\u00a0glucose,\u00a0glucose import,\u00a0grooming behavior,\u00a0habituation,\u00a0integral component of plasma membrane,\u00a0learning,\u00a0long term synaptic depression,\u00a0long-term synaptic potentiation,\u00a0magnesium,\u00a0maternal behavior,\u00a0mating behavior,\u00a0memory,\u00a0motor,\u00a0neuronal action potential,\u00a0nucleus,\u00a0operant conditioning,\u00a0peristalsis,\u00a0phospholipase C-activating dopamine receptor signaling pathway,\u00a0plasma membrane,\u00a0positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,\u00a0positive regulation of cAMP biosynthetic process,\u00a0positive regulation of cell migration,\u00a0positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,\u00a0positive regulation of potassium ion transport,\u00a0positive regulation of release of sequestered calcium ion into cytosol,\u00a0potassium,\u00a0potassium ion,\u00a0prepulse inhibition,\u00a0protein,\u00a0protein import into nucleus,\u00a0regulation of dopamine metabolic process,\u00a0regulation of dopamine uptake involved in synaptic transmission,\u00a0response to amphetamine,\u00a0response to drug,\u00a0sexual behavior,\u00a0sodium,\u00a0striatum development,\u00a0synapse assembly,\u00a0synaptic transmission,\u00a0taste perception,\u00a0temperature homeostasis,\u00a0transmission of nerve impulse,\u00a0vasodilation,\u00a0visual learning",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs4532",
        "SNP Name": "DRD1 G6014A",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4532",
        "Video": null,
        "Tags": "activation of adenylate cyclase activity,addiction,adenylyl cyclase,ADHD,alcohol,alcohol dependence,alcohol metabolism,ASD,autism,autism spectrum disorder,biosynthesis,Cancer,CCKAR,Cell membrane,Cholecystokinin,Cholecystokinin A Receptor,chronic renal insufficiency,Continuous Performance Task,CPT,D(1A) dopamine receptor,Disulfide bond,DNAJC14,dopamine,Dopamine D1 receptor,dopamine receptor,DRD1,DRD1IP,Endoplasmic reticulum,ethanol,G-protein coupled receptor,glutamate,glutamatergic,Glycoprotein,infant,interaction,L-Dopa,Leukemia,Leukemic,Lipoprotein,Membrane,Methamphetamine,Methamphetamine-Associated Psychosis,nicotine,opiate,opiate abuse,Palmitate,paranoia,paranoid schizophrenia,Polymorphism,positive regulation of synaptic transmission,psychology,psychosis,Receptor,renal traits,schizophrenia,sensitization,signaling pathway,smoking,T cell,Transducer,Transmembrane,Transmembrane helix,\u00a0adenylate,\u00a0adenylate cyclase-activating dopamine receptor signaling pathway,\u00a0adenylate cyclase-activating G-protein coupled receptor signaling pathway,\u00a0adult walking behavior,\u00a0astrocyte,\u00a0astrocyte development,\u00a0behavioral fear response,\u00a0behavioral response to cocaine,\u00a0blood pressure,\u00a0blood sugar,\u00a0calcium,\u00a0calcium ion,\u00a0cAMP,\u00a0catecholamine,\u00a0cellular response to catecholamine stimulus,\u00a0cerebral cortex GABAergic interneuron migration,\u00a0cocaine,\u00a0conditioned taste aversion,\u00a0cyclase,\u00a0dentate gyrus development,\u00a0depression,\u00a0dopamine binding,\u00a0dopamine metabolic process,\u00a0dopamine neurotransmitter receptor activity,\u00a0dopamine transport,\u00a0dopaminergic,\u00a0drug,\u00a0electrolyte,\u00a0endoplasmic reticulum membrane,\u00a0fear,\u00a0G-protein,\u00a0GABA,\u00a0glucose,\u00a0glucose import,\u00a0grooming behavior,\u00a0habituation,\u00a0integral component of plasma membrane,\u00a0learning,\u00a0long term synaptic depression,\u00a0long-term synaptic potentiation,\u00a0magnesium,\u00a0maternal behavior,\u00a0mating behavior,\u00a0memory,\u00a0motor,\u00a0neuronal action potential,\u00a0nucleus,\u00a0operant conditioning,\u00a0peristalsis,\u00a0phospholipase C-activating dopamine receptor signaling pathway,\u00a0plasma membrane,\u00a0positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,\u00a0positive regulation of cAMP biosynthetic process,\u00a0positive regulation of cell migration,\u00a0positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,\u00a0positive regulation of potassium ion transport,\u00a0positive regulation of release of sequestered calcium ion into cytosol,\u00a0potassium,\u00a0potassium ion,\u00a0prepulse inhibition,\u00a0protein,\u00a0protein import into nucleus,\u00a0regulation of dopamine metabolic process,\u00a0regulation of dopamine uptake involved in synaptic transmission,\u00a0response to amphetamine,\u00a0response to drug,\u00a0sexual behavior,\u00a0sodium,\u00a0striatum development,\u00a0synapse assembly,\u00a0synaptic transmission,\u00a0taste perception,\u00a0temperature homeostasis,\u00a0transmission of nerve impulse,\u00a0vasodilation,\u00a0visual learning",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs5326",
        "SNP Name": "DRD1 G5968A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=Rs5326",
        "Video": null,
        "Tags": "activation of adenylate cyclase activity,addiction,adenylate,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-activating G-protein coupled receptor signaling pathway,adenylyl cyclase,adult walking behavior,antipsychotics-induced tardive dyskinesia,arterial stiffness,Arterial Stiffness in Diabetic Subjects,astrocyte,astrocyte development,behavioral fear response,behavioral response to cocaine,biosynthesis,blood pressure,blood sugar,calcium,calcium ion,cAMP,catecholamine,Cell membrane,cellular response to catecholamine stimulus,cerebral cortex GABAergic interneuron migration,cocaine,conditioned taste aversion,Continous Performance Task,CPT,cyclase,D(1A) dopamine receptor,dentate gyrus development,depression,diabetes,diabetic,Disulfide bond,DNAJC14,dopamine,dopamine binding,Dopamine D1 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,dopamine receptor,dopamine transport,dopaminergic,DRD1,DRD1IP,drug,drug addiction,drug response,electrolyte,Endoplasmic reticulum,endoplasmic reticulum membrane,fear,G-protein,G-protein coupled receptor,G-protein coupled receptor signaling pathway,GABA,glucose,glucose import,glutamatergic,Glycoprotein,grooming behavior,habituation,heroin,hyperactivity,integral component of plasma membrane,interaction,learning,Lipoprotein,long term synaptic depression,long-term synaptic potentiation,magnesium,maternal behavior,mating behavior,Membrane,memory,mental disorder,methylphenidate,methylphenidate response,methylphenidate response in children with autism spectrum disorder,monoamine neurotransmission,motor,neuronal action potential,nucleus,operant conditioning,Opioid Dependence,Palmitate,peristalsis,phospholipase C-activating dopamine receptor signaling pathway,plasma membrane,Polymorphism,positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,positive regulation of cAMP biosynthetic process,positive regulation of cell migration,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of potassium ion transport,positive regulation of release of sequestered calcium ion into cytosol,positive regulation of synaptic transmission,potassium,potassium ion,prepulse inhibition,protein,protein import into nucleus,psychology,Receptor,regulation of dopamine metabolic process,regulation of dopamine uptake involved in synaptic transmission,response to amphetamine,response to drug,Salt-Sensitive Hypertension,schizophrenia,sensitization,sexual behavior,sodium,striatum development,substance addiction,synapse assembly,synaptic transmission,taste perception,temperature homeostasis,Transducer,Transmembrane,Transmembrane helix,transmission of nerve impulse,vasodilation,visual learning",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs5326",
        "SNP Name": "DRD1 G5968A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=Rs5326",
        "Video": null,
        "Tags": "activation of adenylate cyclase activity,addiction,adenylate,adenylate cyclase-activating dopamine receptor signaling pathway,adenylate cyclase-activating G-protein coupled receptor signaling pathway,adenylyl cyclase,adult walking behavior,antipsychotics-induced tardive dyskinesia,arterial stiffness,Arterial Stiffness in Diabetic Subjects,astrocyte,astrocyte development,behavioral fear response,behavioral response to cocaine,biosynthesis,blood pressure,blood sugar,calcium,calcium ion,cAMP,catecholamine,Cell membrane,cellular response to catecholamine stimulus,cerebral cortex GABAergic interneuron migration,cocaine,conditioned taste aversion,Continous Performance Task,CPT,cyclase,D(1A) dopamine receptor,dentate gyrus development,depression,diabetes,diabetic,Disulfide bond,DNAJC14,dopamine,dopamine binding,Dopamine D1 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,dopamine receptor,dopamine transport,dopaminergic,DRD1,DRD1IP,drug,drug addiction,drug response,electrolyte,Endoplasmic reticulum,endoplasmic reticulum membrane,fear,G-protein,G-protein coupled receptor,G-protein coupled receptor signaling pathway,GABA,glucose,glucose import,glutamatergic,Glycoprotein,grooming behavior,habituation,heroin,hyperactivity,integral component of plasma membrane,interaction,learning,Lipoprotein,long term synaptic depression,long-term synaptic potentiation,magnesium,maternal behavior,mating behavior,Membrane,memory,mental disorder,methylphenidate,methylphenidate response,methylphenidate response in children with autism spectrum disorder,monoamine neurotransmission,motor,neuronal action potential,nucleus,operant conditioning,Opioid Dependence,Palmitate,peristalsis,phospholipase C-activating dopamine receptor signaling pathway,plasma membrane,Polymorphism,positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,positive regulation of cAMP biosynthetic process,positive regulation of cell migration,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of potassium ion transport,positive regulation of release of sequestered calcium ion into cytosol,positive regulation of synaptic transmission,potassium,potassium ion,prepulse inhibition,protein,protein import into nucleus,psychology,Receptor,regulation of dopamine metabolic process,regulation of dopamine uptake involved in synaptic transmission,response to amphetamine,response to drug,Salt-Sensitive Hypertension,schizophrenia,sensitization,sexual behavior,sodium,striatum development,substance addiction,synapse assembly,synaptic transmission,taste perception,temperature homeostasis,Transducer,Transmembrane,Transmembrane helix,transmission of nerve impulse,vasodilation,visual learning",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs265981",
        "SNP Name": "DRD1 T5262C",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs265981",
        "Video": null,
        "Tags": "activation of adenylate cyclase activity,addiction,adenylyl cyclase,ADHD,ASD,Attention-Deficit/Hyperactivity Disorder,autism,autism spectrum disorder,biosynthesis,Cancer,Cell membrane,D(1A) dopamine receptor,Disulfide bond,DNAJC14,dopamine,Dopamine D1 receptor,dopamine receptor,DRD1,DRD1IP,Endoplasmic reticulum,exercise,Fish-Swarm Logic Regression,G-protein coupled receptor,G-protein coupled receptor signaling pathway,glutamatergic,Glycoprotein,interaction,Leukemia,Leukemic,Lipoprotein,Membrane,Palmitate,Polymorphism,psychology,Receptor,T Cell,Transducer,Transmembrane,Transmembrane helix,\u00a0adenylate,\u00a0adenylate cyclase-activating dopamine receptor signaling pathway,\u00a0adenylate cyclase-activating G-protein coupled receptor signaling pathway,\u00a0adult walking behavior,\u00a0astrocyte,\u00a0astrocyte development,\u00a0behavioral fear response,\u00a0behavioral response to cocaine,\u00a0blood pressure,\u00a0blood sugar,\u00a0calcium,\u00a0calcium ion,\u00a0cAMP,\u00a0catecholamine,\u00a0cellular response to catecholamine stimulus,\u00a0cerebral cortex GABAergic interneuron migration,\u00a0cocaine,\u00a0conditioned taste aversion,\u00a0cyclase,\u00a0dentate gyrus development,\u00a0depression,\u00a0dopamine binding,\u00a0dopamine metabolic process,\u00a0dopamine neurotransmitter receptor activity,\u00a0dopamine transport,\u00a0dopaminergic,\u00a0drug,\u00a0electrolyte,\u00a0endoplasmic reticulum membrane,\u00a0fear,\u00a0G-protein,\u00a0GABA,\u00a0glucose,\u00a0glucose import,\u00a0grooming behavior,\u00a0habituation,\u00a0integral component of plasma membrane,\u00a0learning,\u00a0long term synaptic depression,\u00a0long-term synaptic potentiation,\u00a0magnesium,\u00a0maternal behavior,\u00a0mating behavior,\u00a0memory,\u00a0motor,\u00a0neuronal action potential,\u00a0nucleus,\u00a0operant conditioning,\u00a0peristalsis,\u00a0phospholipase C-activating dopamine receptor signaling pathway,\u00a0plasma membrane,\u00a0positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,\u00a0positive regulation of cAMP biosynthetic process,\u00a0positive regulation of cell migration,\u00a0positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,\u00a0positive regulation of potassium ion transport,\u00a0positive regulation of release of sequestered calcium ion into cytosol,\u00a0positive regulation of synaptic transmission,\u00a0potassium,\u00a0potassium ion,\u00a0prepulse inhibition,\u00a0protein,\u00a0protein import into nucleus,\u00a0regulation of dopamine metabolic process,\u00a0regulation of dopamine uptake involved in synaptic transmission,\u00a0response to amphetamine,\u00a0response to drug,\u00a0sexual behavior,\u00a0sodium,\u00a0striatum development,\u00a0synapse assembly,\u00a0synaptic transmission,\u00a0taste perception,\u00a0temperature homeostasis,\u00a0transmission of nerve impulse,\u00a0vasodilation,\u00a0visual learning,\u00a0\u00a0sensitization",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs265981",
        "SNP Name": "DRD1 T5262C",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs265981",
        "Video": null,
        "Tags": "activation of adenylate cyclase activity,addiction,adenylyl cyclase,ADHD,ASD,Attention-Deficit/Hyperactivity Disorder,autism,autism spectrum disorder,biosynthesis,Cancer,Cell membrane,D(1A) dopamine receptor,Disulfide bond,DNAJC14,dopamine,Dopamine D1 receptor,dopamine receptor,DRD1,DRD1IP,Endoplasmic reticulum,exercise,Fish-Swarm Logic Regression,G-protein coupled receptor,G-protein coupled receptor signaling pathway,glutamatergic,Glycoprotein,interaction,Leukemia,Leukemic,Lipoprotein,Membrane,Palmitate,Polymorphism,psychology,Receptor,T Cell,Transducer,Transmembrane,Transmembrane helix,\u00a0adenylate,\u00a0adenylate cyclase-activating dopamine receptor signaling pathway,\u00a0adenylate cyclase-activating G-protein coupled receptor signaling pathway,\u00a0adult walking behavior,\u00a0astrocyte,\u00a0astrocyte development,\u00a0behavioral fear response,\u00a0behavioral response to cocaine,\u00a0blood pressure,\u00a0blood sugar,\u00a0calcium,\u00a0calcium ion,\u00a0cAMP,\u00a0catecholamine,\u00a0cellular response to catecholamine stimulus,\u00a0cerebral cortex GABAergic interneuron migration,\u00a0cocaine,\u00a0conditioned taste aversion,\u00a0cyclase,\u00a0dentate gyrus development,\u00a0depression,\u00a0dopamine binding,\u00a0dopamine metabolic process,\u00a0dopamine neurotransmitter receptor activity,\u00a0dopamine transport,\u00a0dopaminergic,\u00a0drug,\u00a0electrolyte,\u00a0endoplasmic reticulum membrane,\u00a0fear,\u00a0G-protein,\u00a0GABA,\u00a0glucose,\u00a0glucose import,\u00a0grooming behavior,\u00a0habituation,\u00a0integral component of plasma membrane,\u00a0learning,\u00a0long term synaptic depression,\u00a0long-term synaptic potentiation,\u00a0magnesium,\u00a0maternal behavior,\u00a0mating behavior,\u00a0memory,\u00a0motor,\u00a0neuronal action potential,\u00a0nucleus,\u00a0operant conditioning,\u00a0peristalsis,\u00a0phospholipase C-activating dopamine receptor signaling pathway,\u00a0plasma membrane,\u00a0positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,\u00a0positive regulation of cAMP biosynthetic process,\u00a0positive regulation of cell migration,\u00a0positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,\u00a0positive regulation of potassium ion transport,\u00a0positive regulation of release of sequestered calcium ion into cytosol,\u00a0positive regulation of synaptic transmission,\u00a0potassium,\u00a0potassium ion,\u00a0prepulse inhibition,\u00a0protein,\u00a0protein import into nucleus,\u00a0regulation of dopamine metabolic process,\u00a0regulation of dopamine uptake involved in synaptic transmission,\u00a0response to amphetamine,\u00a0response to drug,\u00a0sexual behavior,\u00a0sodium,\u00a0striatum development,\u00a0synapse assembly,\u00a0synaptic transmission,\u00a0taste perception,\u00a0temperature homeostasis,\u00a0transmission of nerve impulse,\u00a0vasodilation,\u00a0visual learning,\u00a0\u00a0sensitization",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2067474",
        "SNP Name": "HRH2 G175109219A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Protamine Sulphate"
    },
    {
        "SNP ID": "rs1800689",
        "SNP Name": "HRH2 V181V",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Protamine Sulphate"
    },
    {
        "SNP ID": "rs1801020",
        "SNP Name": "F12 T5046C",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "angioedema,angiotensin,antihypertensive treatment,Beta-factor XIIa part 1,Beta-factor XIIa part 2,blood coagulation,bradykinin,cardio,cardiovascular,Cardiovascular Disease,CHD,coagulation,Coagulation factor XII,Coagulation factor XIIa heavy chain,Coagulation factor XIIa light chain,Congenital factor XII deficiency,COOH,COOH-terminal light chain,CRM-positive group,CVD,EGF-like domain,extracellular region,extracellular space,extracellular vesicular exosome,F12,FA12,FA12D,Factor XII,Factor XII activation,Factor XII deficiency,fibrinolysis,HAE3,HAF,Hageman factor,heart,heart disease,Hemostasis,hereditary angioedema,Hereditary angioedema 3,Hereditary angioedema type,Hydrolase,innate immune response,intrinsic pathway,Kringle,misfolded protein binding,negative F12 antigen detection,Non rare thrombophilia,Partial Thromboplastin Time,Peptidase families,peptidase S1 family,plasma kallikrein-kinin cascade,plasma membrane,positive F12 antigen detection,positive regulation of blood coagulation,positive regulation of fibrinolysis,positive regulation of plasminogen activation,Prekallikrein,Protease,protein autoprocessing,protein C,protein C resistance,protein processing,Repeat,response to misfolded protein,Serine protease,serine-type aminopeptidase activity,serine-type endopeptidase activity,serum glycoprotein,Signal,trypsin,zymogen activation",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs1801020",
        "SNP Name": "F12 T5046C",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "angioedema,angiotensin,antihypertensive treatment,Beta-factor XIIa part 1,Beta-factor XIIa part 2,blood coagulation,bradykinin,cardio,cardiovascular,Cardiovascular Disease,CHD,coagulation,Coagulation factor XII,Coagulation factor XIIa heavy chain,Coagulation factor XIIa light chain,Congenital factor XII deficiency,COOH,COOH-terminal light chain,CRM-positive group,CVD,EGF-like domain,extracellular region,extracellular space,extracellular vesicular exosome,F12,FA12,FA12D,Factor XII,Factor XII activation,Factor XII deficiency,fibrinolysis,HAE3,HAF,Hageman factor,heart,heart disease,Hemostasis,hereditary angioedema,Hereditary angioedema 3,Hereditary angioedema type,Hydrolase,innate immune response,intrinsic pathway,Kringle,misfolded protein binding,negative F12 antigen detection,Non rare thrombophilia,Partial Thromboplastin Time,Peptidase families,peptidase S1 family,plasma kallikrein-kinin cascade,plasma membrane,positive F12 antigen detection,positive regulation of blood coagulation,positive regulation of fibrinolysis,positive regulation of plasminogen activation,Prekallikrein,Protease,protein autoprocessing,protein C,protein C resistance,protein processing,Repeat,response to misfolded protein,Serine protease,serine-type aminopeptidase activity,serine-type endopeptidase activity,serum glycoprotein,Signal,trypsin,zymogen activation",
        "Group": "Clotting Factors"
    },
    {
        "SNP ID": "rs2731672",
        "SNP Name": "KNG I598T GP IIIa HPA-1",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Activated Partial Thromboplastin Time,activated protein C resistance,Alpha-2-thiol proteinase inhibitor,Atherosclerosis,BDK,blood coagulation,blood microparticle,Bradykinin,CAD,cardio,cardiovascular,coagulation,Coronary Artery Disease,CVD,cysteine-type endopeptidase inhibitor activity,decrease in blood glucose level,Disulfide bond,diuresis,extracellular region,extracellular space,extracellular vesicular exosome,fibrinolysis,Fitzgerald factor,Glycoprotein,heart,heart disease,hemorrhagic,Hemostasis,heparin binding,High molecular weight kininogen,High molecular weight kininogen deficiency,high-molecular-weight kininogen deficiency,HMW-kininogen,HMWK,HMWK deficiency,Hydroxylation,hypotension,Ile-Ser-Bradykinin,inflammation,inflammatory response,intrinsic pathway,Kallidin I,Kallidin II,Kininogen-1,Kininogen-1 heavy chain,Kininogen-1 light chain,Kininogens,KNG,KNG1,LMW-kininogen,Low molecular weight growth-promoting factor,Lysyl-bradykinin,natriuresis,negative regulation of blood coagulation,negative regulation of cell adhesion,negative regulation of endopeptidase activity,negative regulation of proteolysis,Phosphoprotein,plasma membrane,platelet activation,platelet alpha granule lumen,platelet degranulation,positive regulation of apoptotic process,positive regulation of cytosolic calcium ion concentration,positive regulation of renal sodium excretion,positive regulation of urine volume,prekallikrein,prostaglandins,Protease inhibitor,protein C,Pyrrolidone carboxylic acid,receptor binding,smooth muscle contraction,T-kinin,Thiol protease inhibitor,thiol proteases,thromboplastin,vascular permeability,Vasoactive,vasodilation,Vasodilator,Williams-Fitzgerald-Flaujeac factor,zinc ion binding",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs2731672",
        "SNP Name": "KNG I598T GP IIIa HPA-1",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Activated Partial Thromboplastin Time,activated protein C resistance,Alpha-2-thiol proteinase inhibitor,Atherosclerosis,BDK,blood coagulation,blood microparticle,Bradykinin,CAD,cardio,cardiovascular,coagulation,Coronary Artery Disease,CVD,cysteine-type endopeptidase inhibitor activity,decrease in blood glucose level,Disulfide bond,diuresis,extracellular region,extracellular space,extracellular vesicular exosome,fibrinolysis,Fitzgerald factor,Glycoprotein,heart,heart disease,hemorrhagic,Hemostasis,heparin binding,High molecular weight kininogen,High molecular weight kininogen deficiency,high-molecular-weight kininogen deficiency,HMW-kininogen,HMWK,HMWK deficiency,Hydroxylation,hypotension,Ile-Ser-Bradykinin,inflammation,inflammatory response,intrinsic pathway,Kallidin I,Kallidin II,Kininogen-1,Kininogen-1 heavy chain,Kininogen-1 light chain,Kininogens,KNG,KNG1,LMW-kininogen,Low molecular weight growth-promoting factor,Lysyl-bradykinin,natriuresis,negative regulation of blood coagulation,negative regulation of cell adhesion,negative regulation of endopeptidase activity,negative regulation of proteolysis,Phosphoprotein,plasma membrane,platelet activation,platelet alpha granule lumen,platelet degranulation,positive regulation of apoptotic process,positive regulation of cytosolic calcium ion concentration,positive regulation of renal sodium excretion,positive regulation of urine volume,prekallikrein,prostaglandins,Protease inhibitor,protein C,Pyrrolidone carboxylic acid,receptor binding,smooth muscle contraction,T-kinin,Thiol protease inhibitor,thiol proteases,thromboplastin,vascular permeability,Vasoactive,vasodilation,Vasodilator,Williams-Fitzgerald-Flaujeac factor,zinc ion binding",
        "Group": "Clotting Factors"
    },
    {
        "SNP ID": "rs7768030",
        "SNP Name": "PHACTR1 12822973A>C",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs9369640",
        "SNP Name": "PHACTR1 12901441C>A",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs9349379",
        "SNP Name": "PHACTR1 12903957A>G",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs4715166",
        "SNP Name": "PHACTR1 13216058A>G",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs202072",
        "SNP Name": "PHACTR1 13268211A>G",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs2619522",
        "SNP Name": "DTNBP1 T14623G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2619522",
        "Video": "KKuAu-RY3VU",
        "Tags": "actin cytoskeleton reorganization,Albinism,Alternative initiation,Alternative splicing,anterograde axon cargo transport,anterograde synaptic vesicle transport,Antimanic Agents in Patients with Bipolar I Disorder,AP-3 complex,AP-3 protein complex and membrane protein cargos,axon,axons,biogenesis,biogenesis of lysosome-related organelles complex 1 (BLOC-1),Biogenesis of lysosome-related organelles complex 1 subunit 8,bleeding disorder,bleeding due to platelet storage pool deficiency,BLOC-1 complex,BLOC-1 complex associates with BLOC-2 complex in early endosome-associated tubules,BLOC-2 complex,BLOC-2 complex in endosomes,BLOC1S1,BLOC1S2,BLOC1S3,BLOC1S4,BLOC1S5,BLOC1S6,blood coagulation,CA1-3,CA3,cell,Cell junction,Cell membrane,cerebral cortex,cognitive decline,cognitive impairment,Coiled coil,Complete proteome,Cytoplasm,cytoplasmic,Cytoplasmic side,Cytoplasmic vesicle,Cytoplasmic vesicle membrane,cytosol,Defects in DTNBP1 are associated with susceptibility to schizophrenia,dendrites,dendritic spine,detected at the membrane of pigmented melanosomes in cultured melanoma cells,Detected in brain,Detection at tubulovesicular elements in the vicinity of the Golgi apparatus and of melanosomes,DGh,diverse cytoplasmic organelles,dopamine,DRD2,DTNA bind,DTNB bind,DTNBP1,DTNBP1/BLOC1S7,Dysbindin,Dysbindin-1,Dystrobrevin-binding protein 1,Endoplasmic reticulum,endoplasmic reticulum membrane,Endosome,Endosome membrane,gene regulation,glutamate,glutamatergic release,glutamatergic transmisssion,glutamine,glutathione,granule cells in the dense cell layer of the DG (DGg),granules,growth cone,Hermansky-Pudlak syndrome,Hermansky-Pudlak syndrome 7 (HPS7),Hermansky-Pudlak syndrome 7 protein,hippocampal frontal (HF),HPS,IL3,intelligence,interaction AP3B2,interaction AP3M1,interaction DTNBP1,interaction phosphorylates,interaction TRIM32,interaction XPO1,interaction XRCC5,interaction XRCC6,Interacts (via its coiled coil domain) with KXD1,interacts with BLOC1S5,interacts with BLOC1S6,Interacts with CMYA5,interacts with PI4K2,interacts with RNF151,interacts with SNAPIN/BLOC1S8,interleukin 3,Isoform 1 Cytoplasm,Isoform 3 only weakly phosphorylated by PRKDC in vitro,Isoforms 1 and 2 highly phosphorylated by PRKDC in vitro,lungs,lysosomal storage defects,lysosome,lysosome-related organelles (LRO),MAPK8 phosphorylation,Maximal levels in CA2,Melanosome membrane,melanosome organization,melanosomes,membrane,membrane organization,memory tasks,mental disorder,modulating PI3-kinase-Akt signaling,nerve terminals,NES,neurite extension,neurite outgrowth,neurites,neuron cell bodies,neuron projection,neuron projection development,neuron projection morphogenesis,neuronal transmission,neurons,neuropil,neurotransmitter,neurotransmitter release,nucleus,oculocutaneous albinism,Peripheral membrane protein,Phosphoprotein,platelet dense granule organization,platelet dense granules and lysosomes,polymorph cells in the hilus of the DG (DGh),Polymorphism,positive regulation of gene expression,positive regulation of neurotransmitter secretion,post-Golgi vesicle-mediated transport,postsynaptic cell membrane,postsynaptic density,postsynaptic membrane,prefrontal cortical activity,premature death,protein kinase,pulmonary fibrosis,pyramidal cells,Reference proteome,regulates the expression of SYN1,regulating the expression of SNAP25 and SYN1,regulation of cell surface exposure of DRD2,regulation of dopamine receptor signaling pathway,regulation of dopamine secretion,sarcolemma,sarcoplasm,schizophrenia,Sensory transduction,SNAPIN/BLOC1S8,SNARE proteins,SSRI,subiculum,superior temporal gyrus (pSTG),SYN1,synapse,synaptic vesicle membrane,synaptic vesicle trafficking,transport of TYRP1 independent of AP-3 function,Ubiquitinated by TRIM32,Ubiquitination leads to DTNBP1 degradation,Ubl conjugation,XPO1-dependent manner",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs179943",
        "SNP Name": "ATXN1 C368404T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "ADCA,ADCA I,adenine,adult locomotory behavior,Alzheimer,Alzheimer's disease,ANP32A,ataxia,ataxin,ataxin 1,Ataxin-1,ATX1,ATXN1,ATXN1L,autosomal dominant cerebellar ataxias type I,brain,brain cells,brain damage,CAG,CBF1 corepressor,cell death,central nervous system,cerebellar disorders,cerebellum,Chromatin-binding factor,CNS,coordination,cytoplasm,cytosine,dementia,DNA binding,DNA-binding,DNA-templated,Glycyl,guanine,HEY promoter,highly polymorphic,identical protein binding,incoordination,intracellular membrane-bounded organelle,L-Lysine,Late-Onset Alzheimer\u2019s Disease,lysine,NCOR2,negative regulation of insulin-like growth factor receptor signaling pathway,negative regulation of phosphorylation,negative regulation of transcription,Neurodegeneration,neurodegenerative disorder,Notch signaling,nuclear export,nuclear inclusion body,nuclear matrix,nucleoplasm,nucleus,ophthalmoplegia,optic atrophy,peripheral neuropathy,Phosphoprotein,Phosphorylation,poly(G) binding,poly(U) RNA binding,polyglutamine,poor coordination,positive regulation of transcription from RNA polymerase II promoter,PQBP1,protein C-terminus binding,protein self-association,Purkinje,Purkinje cells,RBPJ-binding,RBPJ-mediated repression,regulation of excitatory postsynaptic membrane potential,Repressor,RNA metabolism,RNA processing,RNA-binding,SCA1,spinal,spinal cord,spinal damage,Spinocerebellar ataxia,Spinocerebellar ataxia 1,Spinocerebellar ataxia type 1 protein,Sumoylation Isopeptide bond,transcription,Transcription regulation,trinucleotide repeat,Ubl conjugation,UBQLN4,USP7,visual learning,ZNF804A",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs1341239",
        "SNP Name": "PRL T3879G",
        "Risk Allele": "T",
        "Your Allele": "AC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Plasdone C"
    },
    {
        "SNP ID": "rs2794719",
        "SNP Name": "HFE 6382T>G",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/snp/?term=rs2794719",
        "Video": null,
        "Tags": "abdominal pain,angiogenesis,antigen binding,antigen processing and presentation,antigen processing and presentation of peptide antigen via MHC class I,apical part of cell,arthritis,associated with susceptibility to porphyria cutanea tarda,basal part of cell,Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin,biosynthesis of heme,blindness,blood clot,blood pressure,cardiomyopathy,cardiovascular,cellular iron ion homeostasis,cellular response to iron ion starvation,cirrhosis,clot,clotting,coproporphyrin,cutanea tarda,CVD,cytoplasmic vesicle,diabetes,diabetes mellitus,diabetic,diabetic retinopathy,early endosome,end-stage renal disease,female pregnancy,heart,hemachromatosis,heme,hemochromatosis,Hemochromatosis 1 (HFE1),hepatomas,Hereditary hemochromatosis protein,HFE,high BP,High fecal levels of protoporphyrin and coproporphyrin,HLA-H,HLAH,hormone biosynthetic process,hyperpigmentation,hypertension,hypertrichosis,hypogonadism,hypogonadotropic hypogonadism,immune response,Immunity,increased serum transferrin,increased urine uroporphyrins and iron overload,integral component of plasma membrane,Ion transport,iron,iron ion import into cell,iron overload,Iron transport,ischemia,liver,liver cirrhosis,male hormone,Membrane,MHC class I protein complex,MHC I,multicellular organismal iron ion homeostasis,neuromuscular disturbances,peptide antigen binding,perinuclear region of cytoplasm,pigment,plasma membrane,porphyria,porphyrins,positive regulation of T cell mediated cytotoxicity,protein binding,protein complex assembly,protoporphyrin,receptor binding,recycling endosome,red blood cells,renal disease,sex hormone,skin,tachycardia,testosterone,Transport,Variegate porphyria,vascular permeability",
        "Group": "Ascorbic Acid"
    },
    {
        "SNP ID": "rs2794719",
        "SNP Name": "HFE 6382T>G",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/snp/?term=rs2794719",
        "Video": null,
        "Tags": "abdominal pain,angiogenesis,antigen binding,antigen processing and presentation,antigen processing and presentation of peptide antigen via MHC class I,apical part of cell,arthritis,associated with susceptibility to porphyria cutanea tarda,basal part of cell,Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin,biosynthesis of heme,blindness,blood clot,blood pressure,cardiomyopathy,cardiovascular,cellular iron ion homeostasis,cellular response to iron ion starvation,cirrhosis,clot,clotting,coproporphyrin,cutanea tarda,CVD,cytoplasmic vesicle,diabetes,diabetes mellitus,diabetic,diabetic retinopathy,early endosome,end-stage renal disease,female pregnancy,heart,hemachromatosis,heme,hemochromatosis,Hemochromatosis 1 (HFE1),hepatomas,Hereditary hemochromatosis protein,HFE,high BP,High fecal levels of protoporphyrin and coproporphyrin,HLA-H,HLAH,hormone biosynthetic process,hyperpigmentation,hypertension,hypertrichosis,hypogonadism,hypogonadotropic hypogonadism,immune response,Immunity,increased serum transferrin,increased urine uroporphyrins and iron overload,integral component of plasma membrane,Ion transport,iron,iron ion import into cell,iron overload,Iron transport,ischemia,liver,liver cirrhosis,male hormone,Membrane,MHC class I protein complex,MHC I,multicellular organismal iron ion homeostasis,neuromuscular disturbances,peptide antigen binding,perinuclear region of cytoplasm,pigment,plasma membrane,porphyria,porphyrins,positive regulation of T cell mediated cytotoxicity,protein binding,protein complex assembly,protoporphyrin,receptor binding,recycling endosome,red blood cells,renal disease,sex hormone,skin,tachycardia,testosterone,Transport,Variegate porphyria,vascular permeability",
        "Group": "Sodium Pyruvate"
    },
    {
        "SNP ID": "rs2794719",
        "SNP Name": "HFE 6382T>G",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/snp/?term=rs2794719",
        "Video": null,
        "Tags": "abdominal pain,angiogenesis,antigen binding,antigen processing and presentation,antigen processing and presentation of peptide antigen via MHC class I,apical part of cell,arthritis,associated with susceptibility to porphyria cutanea tarda,basal part of cell,Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin,biosynthesis of heme,blindness,blood clot,blood pressure,cardiomyopathy,cardiovascular,cellular iron ion homeostasis,cellular response to iron ion starvation,cirrhosis,clot,clotting,coproporphyrin,cutanea tarda,CVD,cytoplasmic vesicle,diabetes,diabetes mellitus,diabetic,diabetic retinopathy,early endosome,end-stage renal disease,female pregnancy,heart,hemachromatosis,heme,hemochromatosis,Hemochromatosis 1 (HFE1),hepatomas,Hereditary hemochromatosis protein,HFE,high BP,High fecal levels of protoporphyrin and coproporphyrin,HLA-H,HLAH,hormone biosynthetic process,hyperpigmentation,hypertension,hypertrichosis,hypogonadism,hypogonadotropic hypogonadism,immune response,Immunity,increased serum transferrin,increased urine uroporphyrins and iron overload,integral component of plasma membrane,Ion transport,iron,iron ion import into cell,iron overload,Iron transport,ischemia,liver,liver cirrhosis,male hormone,Membrane,MHC class I protein complex,MHC I,multicellular organismal iron ion homeostasis,neuromuscular disturbances,peptide antigen binding,perinuclear region of cytoplasm,pigment,plasma membrane,porphyria,porphyrins,positive regulation of T cell mediated cytotoxicity,protein binding,protein complex assembly,protoporphyrin,receptor binding,recycling endosome,red blood cells,renal disease,sex hormone,skin,tachycardia,testosterone,Transport,Variegate porphyria,vascular permeability",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs9366637",
        "SNP Name": "HFE 6590C>T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs9366637",
        "Video": null,
        "Tags": "abdominal pain,angiogenesis,antigen binding,antigen processing and presentation,antigen processing and presentation of peptide antigen via MHC class I,apical part of cell,arthritis,associated with susceptibility to porphyria cutanea tarda,basal part of cell,Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin,biosynthesis of heme,blindness,blood clot,blood pressure,cardiomyopathy,cardiovascular,cellular iron ion homeostasis,cellular response to iron ion starvation,Childhood Acute Lymphoblastic Leukemia,cirrhosis,clot,clotting,coproporphyrin,cutanea tarda,CVD,cytoplasmic vesicle,diabetes,diabetes mellitus,diabetic,diabetic retinopathy,early endosome,end-stage renal disease,female pregnancy,heart,hemachromatosis,heme,hemochromatosis,Hemochromatosis 1 (HFE1),hepatomas,Hereditary hemochromatosis protein,HFE,high BP,High fecal levels of protoporphyrin and coproporphyrin,HLA-H,HLAH,hormone biosynthetic process,hyperpigmentation,hypertension,hypertrichosis,hypogonadism,hypogonadotropic hypogonadism,immune response,Immunity,increased serum transferrin,increased urine uroporphyrins and iron overload,integral component of plasma membrane,Ion transport,iron,iron ion import into cell,iron overload,Iron transport,ischemia,Leukemia,liver,liver cirrhosis,male hormone,Membrane,MHC class I protein complex,MHC I,multicellular organismal iron ion homeostasis,neuromuscular disturbances,peptide antigen binding,perinuclear region of cytoplasm,pigment,plasma membrane,porphyria,porphyrins,positive regulation of T cell mediated cytotoxicity,protein binding,protein complex assembly,protoporphyrin,receptor binding,recycling endosome,red blood cells,renal disease,sex hormone,skin,tachycardia,testosterone,Transport,Variegate porphyria,vascular permeability",
        "Group": "Ascorbic Acid"
    },
    {
        "SNP ID": "rs9366637",
        "SNP Name": "HFE 6590C>T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs9366637",
        "Video": null,
        "Tags": "abdominal pain,angiogenesis,antigen binding,antigen processing and presentation,antigen processing and presentation of peptide antigen via MHC class I,apical part of cell,arthritis,associated with susceptibility to porphyria cutanea tarda,basal part of cell,Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin,biosynthesis of heme,blindness,blood clot,blood pressure,cardiomyopathy,cardiovascular,cellular iron ion homeostasis,cellular response to iron ion starvation,Childhood Acute Lymphoblastic Leukemia,cirrhosis,clot,clotting,coproporphyrin,cutanea tarda,CVD,cytoplasmic vesicle,diabetes,diabetes mellitus,diabetic,diabetic retinopathy,early endosome,end-stage renal disease,female pregnancy,heart,hemachromatosis,heme,hemochromatosis,Hemochromatosis 1 (HFE1),hepatomas,Hereditary hemochromatosis protein,HFE,high BP,High fecal levels of protoporphyrin and coproporphyrin,HLA-H,HLAH,hormone biosynthetic process,hyperpigmentation,hypertension,hypertrichosis,hypogonadism,hypogonadotropic hypogonadism,immune response,Immunity,increased serum transferrin,increased urine uroporphyrins and iron overload,integral component of plasma membrane,Ion transport,iron,iron ion import into cell,iron overload,Iron transport,ischemia,Leukemia,liver,liver cirrhosis,male hormone,Membrane,MHC class I protein complex,MHC I,multicellular organismal iron ion homeostasis,neuromuscular disturbances,peptide antigen binding,perinuclear region of cytoplasm,pigment,plasma membrane,porphyria,porphyrins,positive regulation of T cell mediated cytotoxicity,protein binding,protein complex assembly,protoporphyrin,receptor binding,recycling endosome,red blood cells,renal disease,sex hormone,skin,tachycardia,testosterone,Transport,Variegate porphyria,vascular permeability",
        "Group": "Sodium Pyruvate"
    },
    {
        "SNP ID": "rs9366637",
        "SNP Name": "HFE 6590C>T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs9366637",
        "Video": null,
        "Tags": "abdominal pain,angiogenesis,antigen binding,antigen processing and presentation,antigen processing and presentation of peptide antigen via MHC class I,apical part of cell,arthritis,associated with susceptibility to porphyria cutanea tarda,basal part of cell,Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin,biosynthesis of heme,blindness,blood clot,blood pressure,cardiomyopathy,cardiovascular,cellular iron ion homeostasis,cellular response to iron ion starvation,Childhood Acute Lymphoblastic Leukemia,cirrhosis,clot,clotting,coproporphyrin,cutanea tarda,CVD,cytoplasmic vesicle,diabetes,diabetes mellitus,diabetic,diabetic retinopathy,early endosome,end-stage renal disease,female pregnancy,heart,hemachromatosis,heme,hemochromatosis,Hemochromatosis 1 (HFE1),hepatomas,Hereditary hemochromatosis protein,HFE,high BP,High fecal levels of protoporphyrin and coproporphyrin,HLA-H,HLAH,hormone biosynthetic process,hyperpigmentation,hypertension,hypertrichosis,hypogonadism,hypogonadotropic hypogonadism,immune response,Immunity,increased serum transferrin,increased urine uroporphyrins and iron overload,integral component of plasma membrane,Ion transport,iron,iron ion import into cell,iron overload,Iron transport,ischemia,Leukemia,liver,liver cirrhosis,male hormone,Membrane,MHC class I protein complex,MHC I,multicellular organismal iron ion homeostasis,neuromuscular disturbances,peptide antigen binding,perinuclear region of cytoplasm,pigment,plasma membrane,porphyria,porphyrins,positive regulation of T cell mediated cytotoxicity,protein binding,protein complex assembly,protoporphyrin,receptor binding,recycling endosome,red blood cells,renal disease,sex hormone,skin,tachycardia,testosterone,Transport,Variegate porphyria,vascular permeability",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1799945",
        "SNP Name": "HFE H63D",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1799945",
        "Video": null,
        "Tags": "abdominal pain,Acute Lymphoblastic Leukemia,AD,Air Pollution,ALS,Altered Cardiac Repolarization,Alzheimer,Alzheimer's disease,Amyotrophic Lateral Sclerosis,anemia,angiogenesis,antigen binding,antigen processing and presentation,antigen processing and presentation of peptide antigen via MHC class I,apical part of cell,arthritis,associated with susceptibility to porphyria cutanea tarda,basal part of cell,Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin,biosynthesis of heme,blindness,blood clot,blood manganese levels,blood pressure,blood sugar,brain sturcture,breast and colorectal cancer,breast cancer,cancer,Cancer and Nutrition,cancerous,carcinogen,carcinoma,cardio,Cardiometabolic,cardiomyopathy,cardiorespiratory,cardiovascular,cardiovascular disease,Cell Cycle Regulation,Cellular Adhesion,cellular iron ion homeostasis,cellular response to iron ion starvation,Childhood Acute Lymphoblastic Leukemia,chondrocalcinosis,chronic hepatitis C,Chronic Kidney Disease,circulating LDL levels,cirrhosis,CKD,clot,clotting,cognition,cognitive,cognitive impairment,colorectal cancer,coproporphyrin,cutanea tarda,CVD,cytoplasmic vesicle,dementia,diabetes,diabetes mellitus,diabetic,diabetic nephropathy,diabetic retinopathy,dopamine,dyshomeostasis,early endosome,Elevated Transferrin Saturation in Patients With Diabetes,end-stage renal disease,environmental,Fe,female pregnancy,female reproductive disorders,fertility,gastric cancer,glioma,Glucose Intolerance,Glucose Intolerance in Premenopausal Women,Glycemic,GPH,Haematopoietic Cell Transplantation,heart,heart attack,heart disease,Heart Failure,heavy metals,hemachromatosis,heme,hemochromatosis,Hemochromatosis 1,Hemochromatosis 1 (HFE1),hemoglobin levels,hep C,hepatitis,hepatitis C,hepatocellular carcinoma,hepatomas,Hereditary Hemochromatosis,Hereditary hemochromatosis protein,HFE,HFE1,high BP,High fecal levels of protoporphyrin and coproporphyrin,high ferritin,high iron,HLA,HLA-H,HLAH,Homocysteine,hormone biosynthetic process,hyperandrogenism,hyperpigmentation,hypertension,hypertrichosis,hypogonadism,hypogonadotropic hypogonadism,Ig-like C1-type (immunoglobulin-like) domain,immune response,immune system,Immunity,immunoglobin,increased serum transferrin,increased urine uroporphyrins and iron overload,inflammation,Influence of Diet,insulin resistance,integral component of plasma membrane,Ion transport,IQ,IQ  score,iron,Iron Deficiency,iron deficiency anaemia,Iron deficiency and cognitive functions,iron excess,iron in nonalcoholic fatty liver disease,iron ion import into cell,iron metabolism,Iron Metabolism Genes,iron overload,Iron transport,iron-loaded transferrin,ischemia,kidneys,Lead,leukemia,lipids,liver,liver cirrhosis,liver disease,liver disorders,liver disorders and chronic hepatitis C,longevity,Lower serum hepcidin,Lymphoblastic Leukemia,male hormone,manganese levels,Membrane,menstruation,MHC class I family,MHC class I protein complex,MHC I,Microvascular complications of diabetes 7,mild cognitive impairment,multicellular organismal iron ion homeostasis,MVCD7,Myocardial Infarction,neurodegenerative,neurodegenerative disease,neuromuscular disturbances,nonalcoholic fatty liver disease,Nonglycemic Pathways,Obesity,organ failure,Orthostatic hypotension,osteoarthritis,oxidative phosphorylation,Oxidative Stress,oxygen,oxygen transport,parenchymal iron,Parkinson,Parkinson Disease,Parkinson's disease,PD,peptide antigen binding,perinuclear region of cytoplasm,peripheral iron dyshomeostasis,pigment,plasma membrane,Pollution and Air Temperature among Myocardial Infarction Survivors,porphyria,porphyria cutanea tarda,Porphyrias,porphyrins,positive regulation of T cell mediated cytotoxicity,postoperative complications after bariatric surgery,Postural Hemodynamics,pregnancy,protein binding,protein complex assembly,protoporphyrin,RBC,receptor binding,recycling endoso",
        "Group": "Ascorbic Acid"
    },
    {
        "SNP ID": "rs1799945",
        "SNP Name": "HFE H63D",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1799945",
        "Video": null,
        "Tags": "abdominal pain,Acute Lymphoblastic Leukemia,AD,Air Pollution,ALS,Altered Cardiac Repolarization,Alzheimer,Alzheimer's disease,Amyotrophic Lateral Sclerosis,anemia,angiogenesis,antigen binding,antigen processing and presentation,antigen processing and presentation of peptide antigen via MHC class I,apical part of cell,arthritis,associated with susceptibility to porphyria cutanea tarda,basal part of cell,Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin,biosynthesis of heme,blindness,blood clot,blood manganese levels,blood pressure,blood sugar,brain sturcture,breast and colorectal cancer,breast cancer,cancer,Cancer and Nutrition,cancerous,carcinogen,carcinoma,cardio,Cardiometabolic,cardiomyopathy,cardiorespiratory,cardiovascular,cardiovascular disease,Cell Cycle Regulation,Cellular Adhesion,cellular iron ion homeostasis,cellular response to iron ion starvation,Childhood Acute Lymphoblastic Leukemia,chondrocalcinosis,chronic hepatitis C,Chronic Kidney Disease,circulating LDL levels,cirrhosis,CKD,clot,clotting,cognition,cognitive,cognitive impairment,colorectal cancer,coproporphyrin,cutanea tarda,CVD,cytoplasmic vesicle,dementia,diabetes,diabetes mellitus,diabetic,diabetic nephropathy,diabetic retinopathy,dopamine,dyshomeostasis,early endosome,Elevated Transferrin Saturation in Patients With Diabetes,end-stage renal disease,environmental,Fe,female pregnancy,female reproductive disorders,fertility,gastric cancer,glioma,Glucose Intolerance,Glucose Intolerance in Premenopausal Women,Glycemic,GPH,Haematopoietic Cell Transplantation,heart,heart attack,heart disease,Heart Failure,heavy metals,hemachromatosis,heme,hemochromatosis,Hemochromatosis 1,Hemochromatosis 1 (HFE1),hemoglobin levels,hep C,hepatitis,hepatitis C,hepatocellular carcinoma,hepatomas,Hereditary Hemochromatosis,Hereditary hemochromatosis protein,HFE,HFE1,high BP,High fecal levels of protoporphyrin and coproporphyrin,high ferritin,high iron,HLA,HLA-H,HLAH,Homocysteine,hormone biosynthetic process,hyperandrogenism,hyperpigmentation,hypertension,hypertrichosis,hypogonadism,hypogonadotropic hypogonadism,Ig-like C1-type (immunoglobulin-like) domain,immune response,immune system,Immunity,immunoglobin,increased serum transferrin,increased urine uroporphyrins and iron overload,inflammation,Influence of Diet,insulin resistance,integral component of plasma membrane,Ion transport,IQ,IQ  score,iron,Iron Deficiency,iron deficiency anaemia,Iron deficiency and cognitive functions,iron excess,iron in nonalcoholic fatty liver disease,iron ion import into cell,iron metabolism,Iron Metabolism Genes,iron overload,Iron transport,iron-loaded transferrin,ischemia,kidneys,Lead,leukemia,lipids,liver,liver cirrhosis,liver disease,liver disorders,liver disorders and chronic hepatitis C,longevity,Lower serum hepcidin,Lymphoblastic Leukemia,male hormone,manganese levels,Membrane,menstruation,MHC class I family,MHC class I protein complex,MHC I,Microvascular complications of diabetes 7,mild cognitive impairment,multicellular organismal iron ion homeostasis,MVCD7,Myocardial Infarction,neurodegenerative,neurodegenerative disease,neuromuscular disturbances,nonalcoholic fatty liver disease,Nonglycemic Pathways,Obesity,organ failure,Orthostatic hypotension,osteoarthritis,oxidative phosphorylation,Oxidative Stress,oxygen,oxygen transport,parenchymal iron,Parkinson,Parkinson Disease,Parkinson's disease,PD,peptide antigen binding,perinuclear region of cytoplasm,peripheral iron dyshomeostasis,pigment,plasma membrane,Pollution and Air Temperature among Myocardial Infarction Survivors,porphyria,porphyria cutanea tarda,Porphyrias,porphyrins,positive regulation of T cell mediated cytotoxicity,postoperative complications after bariatric surgery,Postural Hemodynamics,pregnancy,protein binding,protein complex assembly,protoporphyrin,RBC,receptor binding,recycling endoso",
        "Group": "Sodium Pyruvate"
    },
    {
        "SNP ID": "rs1799945",
        "SNP Name": "HFE H63D",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1799945",
        "Video": null,
        "Tags": "abdominal pain,Acute Lymphoblastic Leukemia,AD,Air Pollution,ALS,Altered Cardiac Repolarization,Alzheimer,Alzheimer's disease,Amyotrophic Lateral Sclerosis,anemia,angiogenesis,antigen binding,antigen processing and presentation,antigen processing and presentation of peptide antigen via MHC class I,apical part of cell,arthritis,associated with susceptibility to porphyria cutanea tarda,basal part of cell,Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin,biosynthesis of heme,blindness,blood clot,blood manganese levels,blood pressure,blood sugar,brain sturcture,breast and colorectal cancer,breast cancer,cancer,Cancer and Nutrition,cancerous,carcinogen,carcinoma,cardio,Cardiometabolic,cardiomyopathy,cardiorespiratory,cardiovascular,cardiovascular disease,Cell Cycle Regulation,Cellular Adhesion,cellular iron ion homeostasis,cellular response to iron ion starvation,Childhood Acute Lymphoblastic Leukemia,chondrocalcinosis,chronic hepatitis C,Chronic Kidney Disease,circulating LDL levels,cirrhosis,CKD,clot,clotting,cognition,cognitive,cognitive impairment,colorectal cancer,coproporphyrin,cutanea tarda,CVD,cytoplasmic vesicle,dementia,diabetes,diabetes mellitus,diabetic,diabetic nephropathy,diabetic retinopathy,dopamine,dyshomeostasis,early endosome,Elevated Transferrin Saturation in Patients With Diabetes,end-stage renal disease,environmental,Fe,female pregnancy,female reproductive disorders,fertility,gastric cancer,glioma,Glucose Intolerance,Glucose Intolerance in Premenopausal Women,Glycemic,GPH,Haematopoietic Cell Transplantation,heart,heart attack,heart disease,Heart Failure,heavy metals,hemachromatosis,heme,hemochromatosis,Hemochromatosis 1,Hemochromatosis 1 (HFE1),hemoglobin levels,hep C,hepatitis,hepatitis C,hepatocellular carcinoma,hepatomas,Hereditary Hemochromatosis,Hereditary hemochromatosis protein,HFE,HFE1,high BP,High fecal levels of protoporphyrin and coproporphyrin,high ferritin,high iron,HLA,HLA-H,HLAH,Homocysteine,hormone biosynthetic process,hyperandrogenism,hyperpigmentation,hypertension,hypertrichosis,hypogonadism,hypogonadotropic hypogonadism,Ig-like C1-type (immunoglobulin-like) domain,immune response,immune system,Immunity,immunoglobin,increased serum transferrin,increased urine uroporphyrins and iron overload,inflammation,Influence of Diet,insulin resistance,integral component of plasma membrane,Ion transport,IQ,IQ  score,iron,Iron Deficiency,iron deficiency anaemia,Iron deficiency and cognitive functions,iron excess,iron in nonalcoholic fatty liver disease,iron ion import into cell,iron metabolism,Iron Metabolism Genes,iron overload,Iron transport,iron-loaded transferrin,ischemia,kidneys,Lead,leukemia,lipids,liver,liver cirrhosis,liver disease,liver disorders,liver disorders and chronic hepatitis C,longevity,Lower serum hepcidin,Lymphoblastic Leukemia,male hormone,manganese levels,Membrane,menstruation,MHC class I family,MHC class I protein complex,MHC I,Microvascular complications of diabetes 7,mild cognitive impairment,multicellular organismal iron ion homeostasis,MVCD7,Myocardial Infarction,neurodegenerative,neurodegenerative disease,neuromuscular disturbances,nonalcoholic fatty liver disease,Nonglycemic Pathways,Obesity,organ failure,Orthostatic hypotension,osteoarthritis,oxidative phosphorylation,Oxidative Stress,oxygen,oxygen transport,parenchymal iron,Parkinson,Parkinson Disease,Parkinson's disease,PD,peptide antigen binding,perinuclear region of cytoplasm,peripheral iron dyshomeostasis,pigment,plasma membrane,Pollution and Air Temperature among Myocardial Infarction Survivors,porphyria,porphyria cutanea tarda,Porphyrias,porphyrins,positive regulation of T cell mediated cytotoxicity,postoperative complications after bariatric surgery,Postural Hemodynamics,pregnancy,protein binding,protein complex assembly,protoporphyrin,RBC,receptor binding,recycling endoso",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs1799945",
        "SNP Name": "HFE H63D",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1799945",
        "Video": null,
        "Tags": "abdominal pain,Acute Lymphoblastic Leukemia,AD,Air Pollution,ALS,Altered Cardiac Repolarization,Alzheimer,Alzheimer's disease,Amyotrophic Lateral Sclerosis,anemia,angiogenesis,antigen binding,antigen processing and presentation,antigen processing and presentation of peptide antigen via MHC class I,apical part of cell,arthritis,associated with susceptibility to porphyria cutanea tarda,basal part of cell,Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin,biosynthesis of heme,blindness,blood clot,blood manganese levels,blood pressure,blood sugar,brain sturcture,breast and colorectal cancer,breast cancer,cancer,Cancer and Nutrition,cancerous,carcinogen,carcinoma,cardio,Cardiometabolic,cardiomyopathy,cardiorespiratory,cardiovascular,cardiovascular disease,Cell Cycle Regulation,Cellular Adhesion,cellular iron ion homeostasis,cellular response to iron ion starvation,Childhood Acute Lymphoblastic Leukemia,chondrocalcinosis,chronic hepatitis C,Chronic Kidney Disease,circulating LDL levels,cirrhosis,CKD,clot,clotting,cognition,cognitive,cognitive impairment,colorectal cancer,coproporphyrin,cutanea tarda,CVD,cytoplasmic vesicle,dementia,diabetes,diabetes mellitus,diabetic,diabetic nephropathy,diabetic retinopathy,dopamine,dyshomeostasis,early endosome,Elevated Transferrin Saturation in Patients With Diabetes,end-stage renal disease,environmental,Fe,female pregnancy,female reproductive disorders,fertility,gastric cancer,glioma,Glucose Intolerance,Glucose Intolerance in Premenopausal Women,Glycemic,GPH,Haematopoietic Cell Transplantation,heart,heart attack,heart disease,Heart Failure,heavy metals,hemachromatosis,heme,hemochromatosis,Hemochromatosis 1,Hemochromatosis 1 (HFE1),hemoglobin levels,hep C,hepatitis,hepatitis C,hepatocellular carcinoma,hepatomas,Hereditary Hemochromatosis,Hereditary hemochromatosis protein,HFE,HFE1,high BP,High fecal levels of protoporphyrin and coproporphyrin,high ferritin,high iron,HLA,HLA-H,HLAH,Homocysteine,hormone biosynthetic process,hyperandrogenism,hyperpigmentation,hypertension,hypertrichosis,hypogonadism,hypogonadotropic hypogonadism,Ig-like C1-type (immunoglobulin-like) domain,immune response,immune system,Immunity,immunoglobin,increased serum transferrin,increased urine uroporphyrins and iron overload,inflammation,Influence of Diet,insulin resistance,integral component of plasma membrane,Ion transport,IQ,IQ  score,iron,Iron Deficiency,iron deficiency anaemia,Iron deficiency and cognitive functions,iron excess,iron in nonalcoholic fatty liver disease,iron ion import into cell,iron metabolism,Iron Metabolism Genes,iron overload,Iron transport,iron-loaded transferrin,ischemia,kidneys,Lead,leukemia,lipids,liver,liver cirrhosis,liver disease,liver disorders,liver disorders and chronic hepatitis C,longevity,Lower serum hepcidin,Lymphoblastic Leukemia,male hormone,manganese levels,Membrane,menstruation,MHC class I family,MHC class I protein complex,MHC I,Microvascular complications of diabetes 7,mild cognitive impairment,multicellular organismal iron ion homeostasis,MVCD7,Myocardial Infarction,neurodegenerative,neurodegenerative disease,neuromuscular disturbances,nonalcoholic fatty liver disease,Nonglycemic Pathways,Obesity,organ failure,Orthostatic hypotension,osteoarthritis,oxidative phosphorylation,Oxidative Stress,oxygen,oxygen transport,parenchymal iron,Parkinson,Parkinson Disease,Parkinson's disease,PD,peptide antigen binding,perinuclear region of cytoplasm,peripheral iron dyshomeostasis,pigment,plasma membrane,Pollution and Air Temperature among Myocardial Infarction Survivors,porphyria,porphyria cutanea tarda,Porphyrias,porphyrins,positive regulation of T cell mediated cytotoxicity,postoperative complications after bariatric surgery,Postural Hemodynamics,pregnancy,protein binding,protein complex assembly,protoporphyrin,RBC,receptor binding,recycling endoso",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1799945",
        "SNP Name": "HFE H63D",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs1800730",
        "SNP Name": "HFE 193A>T",
        "Risk Allele": "T",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1800730",
        "Video": null,
        "Tags": "abdominal pain,angiogenesis,antigen binding,antigen processing and presentation,antigen processing and presentation of peptide antigen via MHC class I,apical part of cell,arthritis,associated with susceptibility to porphyria cutanea tarda,basal part of cell,Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin,biosynthesis of heme,blindness,blood clot,blood pressure,cardiomyopathy,cardiovascular,cellular iron ion homeostasis,cellular response to iron ion starvation,cirrhosis,clot,clotting,coproporphyrin,cutanea tarda,CVD,cytoplasmic vesicle,diabetes,diabetes mellitus,diabetic,diabetic retinopathy,early endosome,end-stage renal disease,female pregnancy,heart,hemachromatosis,heme,hemochromatosis,Hemochromatosis 1 (HFE1),hepatomas,Hereditary Hemochromatosis,Hereditary hemochromatosis protein,HFE,high BP,High fecal levels of protoporphyrin and coproporphyrin,HLA-H,HLAH,hormone biosynthetic process,hyperpigmentation,hypertension,hypertrichosis,hypogonadism,hypogonadotropic hypogonadism,immune response,Immunity,increased serum transferrin,increased urine uroporphyrins and iron overload,integral component of plasma membrane,Ion transport,iron,iron ion import into cell,iron overload,Iron transport,ischemia,liver,liver cirrhosis,male hormone,Membrane,MHC class I protein complex,MHC I,multicellular organismal iron ion homeostasis,neuromuscular disturbances,peptide antigen binding,perinuclear region of cytoplasm,pigment,plasma membrane,porphyria,porphyrins,positive regulation of T cell mediated cytotoxicity,protein binding,protein complex assembly,protoporphyrin,receptor binding,recycling endosome,red blood cells,renal disease,sex hormone,skin,tachycardia,testosterone,Transport,Variegate porphyria,vascular permeability",
        "Group": "Ascorbic Acid"
    },
    {
        "SNP ID": "rs1800730",
        "SNP Name": "HFE 193A>T",
        "Risk Allele": "T",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1800730",
        "Video": null,
        "Tags": "abdominal pain,angiogenesis,antigen binding,antigen processing and presentation,antigen processing and presentation of peptide antigen via MHC class I,apical part of cell,arthritis,associated with susceptibility to porphyria cutanea tarda,basal part of cell,Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin,biosynthesis of heme,blindness,blood clot,blood pressure,cardiomyopathy,cardiovascular,cellular iron ion homeostasis,cellular response to iron ion starvation,cirrhosis,clot,clotting,coproporphyrin,cutanea tarda,CVD,cytoplasmic vesicle,diabetes,diabetes mellitus,diabetic,diabetic retinopathy,early endosome,end-stage renal disease,female pregnancy,heart,hemachromatosis,heme,hemochromatosis,Hemochromatosis 1 (HFE1),hepatomas,Hereditary Hemochromatosis,Hereditary hemochromatosis protein,HFE,high BP,High fecal levels of protoporphyrin and coproporphyrin,HLA-H,HLAH,hormone biosynthetic process,hyperpigmentation,hypertension,hypertrichosis,hypogonadism,hypogonadotropic hypogonadism,immune response,Immunity,increased serum transferrin,increased urine uroporphyrins and iron overload,integral component of plasma membrane,Ion transport,iron,iron ion import into cell,iron overload,Iron transport,ischemia,liver,liver cirrhosis,male hormone,Membrane,MHC class I protein complex,MHC I,multicellular organismal iron ion homeostasis,neuromuscular disturbances,peptide antigen binding,perinuclear region of cytoplasm,pigment,plasma membrane,porphyria,porphyrins,positive regulation of T cell mediated cytotoxicity,protein binding,protein complex assembly,protoporphyrin,receptor binding,recycling endosome,red blood cells,renal disease,sex hormone,skin,tachycardia,testosterone,Transport,Variegate porphyria,vascular permeability",
        "Group": "Sodium Pyruvate"
    },
    {
        "SNP ID": "rs1800730",
        "SNP Name": "HFE 193A>T",
        "Risk Allele": "T",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1800730",
        "Video": null,
        "Tags": "abdominal pain,angiogenesis,antigen binding,antigen processing and presentation,antigen processing and presentation of peptide antigen via MHC class I,apical part of cell,arthritis,associated with susceptibility to porphyria cutanea tarda,basal part of cell,Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin,biosynthesis of heme,blindness,blood clot,blood pressure,cardiomyopathy,cardiovascular,cellular iron ion homeostasis,cellular response to iron ion starvation,cirrhosis,clot,clotting,coproporphyrin,cutanea tarda,CVD,cytoplasmic vesicle,diabetes,diabetes mellitus,diabetic,diabetic retinopathy,early endosome,end-stage renal disease,female pregnancy,heart,hemachromatosis,heme,hemochromatosis,Hemochromatosis 1 (HFE1),hepatomas,Hereditary Hemochromatosis,Hereditary hemochromatosis protein,HFE,high BP,High fecal levels of protoporphyrin and coproporphyrin,HLA-H,HLAH,hormone biosynthetic process,hyperpigmentation,hypertension,hypertrichosis,hypogonadism,hypogonadotropic hypogonadism,immune response,Immunity,increased serum transferrin,increased urine uroporphyrins and iron overload,integral component of plasma membrane,Ion transport,iron,iron ion import into cell,iron overload,Iron transport,ischemia,liver,liver cirrhosis,male hormone,Membrane,MHC class I protein complex,MHC I,multicellular organismal iron ion homeostasis,neuromuscular disturbances,peptide antigen binding,perinuclear region of cytoplasm,pigment,plasma membrane,porphyria,porphyrins,positive regulation of T cell mediated cytotoxicity,protein binding,protein complex assembly,protoporphyrin,receptor binding,recycling endosome,red blood cells,renal disease,sex hormone,skin,tachycardia,testosterone,Transport,Variegate porphyria,vascular permeability",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs2071303",
        "SNP Name": "HFE 8828T>C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2071303",
        "Video": null,
        "Tags": "abdominal pain,angiogenesis,antigen binding,antigen processing and presentation,antigen processing and presentation of peptide antigen via MHC class I,apical part of cell,arthritis,associated with susceptibility to porphyria cutanea tarda,basal part of cell,Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin,biosynthesis of heme,blindness,blood clot,blood pressure,cardiomyopathy,cardiovascular,cellular iron ion homeostasis,cellular response to iron ion starvation,cirrhosis,clot,clotting,coproporphyrin,cutanea tarda,CVD,cytoplasmic vesicle,diabetes,diabetes mellitus,diabetic,diabetic retinopathy,early endosome,end-stage renal disease,female pregnancy,heart,hemachromatosis,heme,hemochromatosis,Hemochromatosis 1 (HFE1),hepatomas,Hereditary hemochromatosis protein,HFE,high BP,High fecal levels of protoporphyrin and coproporphyrin,HLA-H,HLAH,hormone biosynthetic process,hyperpigmentation,hypertension,hypertrichosis,hypogonadism,hypogonadotropic hypogonadism,immune response,Immunity,increased serum transferrin,increased urine uroporphyrins and iron overload,integral component of plasma membrane,Ion transport,iron,iron intake interactions and the risk of type 2 diabetes,iron ion import into cell,iron overload,Iron transport,ischemia,liver,liver cirrhosis,male hormone,Membrane,MHC class I protein complex,MHC I,multicellular organismal iron ion homeostasis,neuromuscular disturbances,peptide antigen binding,perinuclear region of cytoplasm,pigment,plasma membrane,porphyria,porphyrins,positive regulation of T cell mediated cytotoxicity,protein binding,protein complex assembly,protoporphyrin,receptor binding,recycling endosome,red blood cells,renal disease,sex hormone,skin,tachycardia,testosterone,Transport,Type 2 Diabetes,Variegate porphyria,vascular permeability",
        "Group": "Ascorbic Acid"
    },
    {
        "SNP ID": "rs2071303",
        "SNP Name": "HFE 8828T>C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2071303",
        "Video": null,
        "Tags": "abdominal pain,angiogenesis,antigen binding,antigen processing and presentation,antigen processing and presentation of peptide antigen via MHC class I,apical part of cell,arthritis,associated with susceptibility to porphyria cutanea tarda,basal part of cell,Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin,biosynthesis of heme,blindness,blood clot,blood pressure,cardiomyopathy,cardiovascular,cellular iron ion homeostasis,cellular response to iron ion starvation,cirrhosis,clot,clotting,coproporphyrin,cutanea tarda,CVD,cytoplasmic vesicle,diabetes,diabetes mellitus,diabetic,diabetic retinopathy,early endosome,end-stage renal disease,female pregnancy,heart,hemachromatosis,heme,hemochromatosis,Hemochromatosis 1 (HFE1),hepatomas,Hereditary hemochromatosis protein,HFE,high BP,High fecal levels of protoporphyrin and coproporphyrin,HLA-H,HLAH,hormone biosynthetic process,hyperpigmentation,hypertension,hypertrichosis,hypogonadism,hypogonadotropic hypogonadism,immune response,Immunity,increased serum transferrin,increased urine uroporphyrins and iron overload,integral component of plasma membrane,Ion transport,iron,iron intake interactions and the risk of type 2 diabetes,iron ion import into cell,iron overload,Iron transport,ischemia,liver,liver cirrhosis,male hormone,Membrane,MHC class I protein complex,MHC I,multicellular organismal iron ion homeostasis,neuromuscular disturbances,peptide antigen binding,perinuclear region of cytoplasm,pigment,plasma membrane,porphyria,porphyrins,positive regulation of T cell mediated cytotoxicity,protein binding,protein complex assembly,protoporphyrin,receptor binding,recycling endosome,red blood cells,renal disease,sex hormone,skin,tachycardia,testosterone,Transport,Type 2 Diabetes,Variegate porphyria,vascular permeability",
        "Group": "Sodium Pyruvate"
    },
    {
        "SNP ID": "rs2071303",
        "SNP Name": "HFE 8828T>C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2071303",
        "Video": null,
        "Tags": "abdominal pain,angiogenesis,antigen binding,antigen processing and presentation,antigen processing and presentation of peptide antigen via MHC class I,apical part of cell,arthritis,associated with susceptibility to porphyria cutanea tarda,basal part of cell,Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin,biosynthesis of heme,blindness,blood clot,blood pressure,cardiomyopathy,cardiovascular,cellular iron ion homeostasis,cellular response to iron ion starvation,cirrhosis,clot,clotting,coproporphyrin,cutanea tarda,CVD,cytoplasmic vesicle,diabetes,diabetes mellitus,diabetic,diabetic retinopathy,early endosome,end-stage renal disease,female pregnancy,heart,hemachromatosis,heme,hemochromatosis,Hemochromatosis 1 (HFE1),hepatomas,Hereditary hemochromatosis protein,HFE,high BP,High fecal levels of protoporphyrin and coproporphyrin,HLA-H,HLAH,hormone biosynthetic process,hyperpigmentation,hypertension,hypertrichosis,hypogonadism,hypogonadotropic hypogonadism,immune response,Immunity,increased serum transferrin,increased urine uroporphyrins and iron overload,integral component of plasma membrane,Ion transport,iron,iron intake interactions and the risk of type 2 diabetes,iron ion import into cell,iron overload,Iron transport,ischemia,liver,liver cirrhosis,male hormone,Membrane,MHC class I protein complex,MHC I,multicellular organismal iron ion homeostasis,neuromuscular disturbances,peptide antigen binding,perinuclear region of cytoplasm,pigment,plasma membrane,porphyria,porphyrins,positive regulation of T cell mediated cytotoxicity,protein binding,protein complex assembly,protoporphyrin,receptor binding,recycling endosome,red blood cells,renal disease,sex hormone,skin,tachycardia,testosterone,Transport,Type 2 Diabetes,Variegate porphyria,vascular permeability",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1800562",
        "SNP Name": "HFE C282Y",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1800562",
        "Video": null,
        "Tags": "abdominal pain,Acute Lymphoblastic Leukemia,AD,Air Pollution,ALS,Altered Cardiac Repolarization,Alzheimer,Alzheimer's disease,Amyotrophic Lateral Sclerosis,anemia,angiogenesis,antigen binding,antigen processing and presentation,antigen processing and presentation of peptide antigen via MHC class I,apical part of cell,arthritis,associated with susceptibility to porphyria cutanea tarda,basal part of cell,Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin,biosynthesis of heme,blindness,blood clot,blood pressure,blood sugar,brain sturcture,breast and colorectal cancer,cancer,Cancer and Nutrition,cancerous,carcinogen,carcinoma,cardio,Cardiometabolic,cardiomyopathy,cardiorespiratory,cardiovascular,cardiovascular disease,Cell Cycle Regulation,Cellular Adhesion,cellular iron ion homeostasis,cellular response to iron ion starvation,Childhood Acute Lymphoblastic Leukemia,cholesterol,chondrocalcinosis,chronic hepatitis C,Chronic Kidney Disease,circulating LDL levels,cirrhosis,CKD,clot,clotting,cognition,cognitive impairment,colorectal cancer,coproporphyrin,cutanea tarda,CVD,cytoplasmic vesicle,dementia,diabetes,diabetes mellitus,diabetic,diabetic nephropathy,diabetic retinopathy,dopamine,dyshomeostasis,early endosome,Elevated Transferrin Saturation in Patients With Diabetes,end-stage renal disease,environmental,Fe,female pregnancy,female reproductive disorders,fertility,gastric cancer,glioma,Glucose Intolerance,Glucose Intolerance in Premenopausal Women,Glycemic,heart,heart attack,heart disease,heavy metals,hemachromatosis,heme,hemochromatosis,Hemochromatosis 1,Hemochromatosis 1 (HFE1),hemoglobin levels,hep C,hepatitis,hepatitis C,hepatocellular carcinoma,hepatomas,Hereditary Hemochromatosis,Hereditary hemochromatosis protein,HFE,HFE1,high BP,High fecal levels of protoporphyrin and coproporphyrin,high ferritin,high iron,HLA,HLA-H,HLAH,Homocysteine,hormone biosynthetic process,hyperandrogenism,hyperpigmentation,hypertension,hypertrichosis,hypogonadism,hypogonadotropic hypogonadism,Ig-like C1-type (immunoglobulin-like) domain,immune response,immune system,Immunity,immunoglobin,increased serum transferrin,increased urine uroporphyrins and iron overload,inflammation,Influence of Diet,insulin resistance,integral component of plasma membrane,Ion transport,IQ  score,iron,iron deficiency,iron deficiency anaemia,Iron deficiency and cognitive functions,iron excess,iron in nonalcoholic fatty liver disease,iron ion import into cell,iron metabolism,Iron Metabolism Genes,iron overload,Iron transport,iron-loaded transferrin,ischemia,kidney disease,kidneys,LDL,Lead,leukemia,lipids,liver,liver cirrhosis,liver disease,liver disorders,liver disorders and chronic hepatitis C,longevity,Lower serum hepcidin,Lymphoblastic Leukemia,male hormone,manganese levels,Membrane,menstruation,MHC class I family,MHC class I protein complex,MHC I,Microvascular complications of diabetes 7,mild cognitive impairment,multicellular organismal iron ion homeostasis,MVCD7,Myocardial Infarction,neurodegenerative,neurodegenerative disease,neuromuscular disturbances,nonalcoholic fatty liver disease,Nonglycemic Pathways,Obesity,organ failure,Orthostatic hypotension,osteoarthritis,ovarian,oxidative phosphorylation,Oxidative Stress,oxygen,oxygen transport,parenchymal iron,Parkinson,Parkinson Disease,Parkinson's disease,PD,peptide antigen binding,perinuclear region of cytoplasm,peripheral iron dyshomeostasis,pigment,plasma membrane,Pollution and Air Temperature among Myocardial Infarction Survivors,polycystic ovary syndrome,porphyria,porphyria cutanea tarda,Porphyrias,porphyrins,positive regulation of T cell mediated cytotoxicity,postoperative complications after bariatric surgery,Postural Hemodynamics,protein binding,protein complex assembly,protoporphyrin,RBC,receptor binding,recycling endosome,red blood cell,red blood cell traits,red blood",
        "Group": "Ascorbic Acid"
    },
    {
        "SNP ID": "rs1800562",
        "SNP Name": "HFE C282Y",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1800562",
        "Video": null,
        "Tags": "abdominal pain,Acute Lymphoblastic Leukemia,AD,Air Pollution,ALS,Altered Cardiac Repolarization,Alzheimer,Alzheimer's disease,Amyotrophic Lateral Sclerosis,anemia,angiogenesis,antigen binding,antigen processing and presentation,antigen processing and presentation of peptide antigen via MHC class I,apical part of cell,arthritis,associated with susceptibility to porphyria cutanea tarda,basal part of cell,Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin,biosynthesis of heme,blindness,blood clot,blood pressure,blood sugar,brain sturcture,breast and colorectal cancer,cancer,Cancer and Nutrition,cancerous,carcinogen,carcinoma,cardio,Cardiometabolic,cardiomyopathy,cardiorespiratory,cardiovascular,cardiovascular disease,Cell Cycle Regulation,Cellular Adhesion,cellular iron ion homeostasis,cellular response to iron ion starvation,Childhood Acute Lymphoblastic Leukemia,cholesterol,chondrocalcinosis,chronic hepatitis C,Chronic Kidney Disease,circulating LDL levels,cirrhosis,CKD,clot,clotting,cognition,cognitive impairment,colorectal cancer,coproporphyrin,cutanea tarda,CVD,cytoplasmic vesicle,dementia,diabetes,diabetes mellitus,diabetic,diabetic nephropathy,diabetic retinopathy,dopamine,dyshomeostasis,early endosome,Elevated Transferrin Saturation in Patients With Diabetes,end-stage renal disease,environmental,Fe,female pregnancy,female reproductive disorders,fertility,gastric cancer,glioma,Glucose Intolerance,Glucose Intolerance in Premenopausal Women,Glycemic,heart,heart attack,heart disease,heavy metals,hemachromatosis,heme,hemochromatosis,Hemochromatosis 1,Hemochromatosis 1 (HFE1),hemoglobin levels,hep C,hepatitis,hepatitis C,hepatocellular carcinoma,hepatomas,Hereditary Hemochromatosis,Hereditary hemochromatosis protein,HFE,HFE1,high BP,High fecal levels of protoporphyrin and coproporphyrin,high ferritin,high iron,HLA,HLA-H,HLAH,Homocysteine,hormone biosynthetic process,hyperandrogenism,hyperpigmentation,hypertension,hypertrichosis,hypogonadism,hypogonadotropic hypogonadism,Ig-like C1-type (immunoglobulin-like) domain,immune response,immune system,Immunity,immunoglobin,increased serum transferrin,increased urine uroporphyrins and iron overload,inflammation,Influence of Diet,insulin resistance,integral component of plasma membrane,Ion transport,IQ  score,iron,iron deficiency,iron deficiency anaemia,Iron deficiency and cognitive functions,iron excess,iron in nonalcoholic fatty liver disease,iron ion import into cell,iron metabolism,Iron Metabolism Genes,iron overload,Iron transport,iron-loaded transferrin,ischemia,kidney disease,kidneys,LDL,Lead,leukemia,lipids,liver,liver cirrhosis,liver disease,liver disorders,liver disorders and chronic hepatitis C,longevity,Lower serum hepcidin,Lymphoblastic Leukemia,male hormone,manganese levels,Membrane,menstruation,MHC class I family,MHC class I protein complex,MHC I,Microvascular complications of diabetes 7,mild cognitive impairment,multicellular organismal iron ion homeostasis,MVCD7,Myocardial Infarction,neurodegenerative,neurodegenerative disease,neuromuscular disturbances,nonalcoholic fatty liver disease,Nonglycemic Pathways,Obesity,organ failure,Orthostatic hypotension,osteoarthritis,ovarian,oxidative phosphorylation,Oxidative Stress,oxygen,oxygen transport,parenchymal iron,Parkinson,Parkinson Disease,Parkinson's disease,PD,peptide antigen binding,perinuclear region of cytoplasm,peripheral iron dyshomeostasis,pigment,plasma membrane,Pollution and Air Temperature among Myocardial Infarction Survivors,polycystic ovary syndrome,porphyria,porphyria cutanea tarda,Porphyrias,porphyrins,positive regulation of T cell mediated cytotoxicity,postoperative complications after bariatric surgery,Postural Hemodynamics,protein binding,protein complex assembly,protoporphyrin,RBC,receptor binding,recycling endosome,red blood cell,red blood cell traits,red blood",
        "Group": "Sodium Pyruvate"
    },
    {
        "SNP ID": "rs1800562",
        "SNP Name": "HFE C282Y",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1800562",
        "Video": null,
        "Tags": "abdominal pain,Acute Lymphoblastic Leukemia,AD,Air Pollution,ALS,Altered Cardiac Repolarization,Alzheimer,Alzheimer's disease,Amyotrophic Lateral Sclerosis,anemia,angiogenesis,antigen binding,antigen processing and presentation,antigen processing and presentation of peptide antigen via MHC class I,apical part of cell,arthritis,associated with susceptibility to porphyria cutanea tarda,basal part of cell,Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin,biosynthesis of heme,blindness,blood clot,blood pressure,blood sugar,brain sturcture,breast and colorectal cancer,cancer,Cancer and Nutrition,cancerous,carcinogen,carcinoma,cardio,Cardiometabolic,cardiomyopathy,cardiorespiratory,cardiovascular,cardiovascular disease,Cell Cycle Regulation,Cellular Adhesion,cellular iron ion homeostasis,cellular response to iron ion starvation,Childhood Acute Lymphoblastic Leukemia,cholesterol,chondrocalcinosis,chronic hepatitis C,Chronic Kidney Disease,circulating LDL levels,cirrhosis,CKD,clot,clotting,cognition,cognitive impairment,colorectal cancer,coproporphyrin,cutanea tarda,CVD,cytoplasmic vesicle,dementia,diabetes,diabetes mellitus,diabetic,diabetic nephropathy,diabetic retinopathy,dopamine,dyshomeostasis,early endosome,Elevated Transferrin Saturation in Patients With Diabetes,end-stage renal disease,environmental,Fe,female pregnancy,female reproductive disorders,fertility,gastric cancer,glioma,Glucose Intolerance,Glucose Intolerance in Premenopausal Women,Glycemic,heart,heart attack,heart disease,heavy metals,hemachromatosis,heme,hemochromatosis,Hemochromatosis 1,Hemochromatosis 1 (HFE1),hemoglobin levels,hep C,hepatitis,hepatitis C,hepatocellular carcinoma,hepatomas,Hereditary Hemochromatosis,Hereditary hemochromatosis protein,HFE,HFE1,high BP,High fecal levels of protoporphyrin and coproporphyrin,high ferritin,high iron,HLA,HLA-H,HLAH,Homocysteine,hormone biosynthetic process,hyperandrogenism,hyperpigmentation,hypertension,hypertrichosis,hypogonadism,hypogonadotropic hypogonadism,Ig-like C1-type (immunoglobulin-like) domain,immune response,immune system,Immunity,immunoglobin,increased serum transferrin,increased urine uroporphyrins and iron overload,inflammation,Influence of Diet,insulin resistance,integral component of plasma membrane,Ion transport,IQ  score,iron,iron deficiency,iron deficiency anaemia,Iron deficiency and cognitive functions,iron excess,iron in nonalcoholic fatty liver disease,iron ion import into cell,iron metabolism,Iron Metabolism Genes,iron overload,Iron transport,iron-loaded transferrin,ischemia,kidney disease,kidneys,LDL,Lead,leukemia,lipids,liver,liver cirrhosis,liver disease,liver disorders,liver disorders and chronic hepatitis C,longevity,Lower serum hepcidin,Lymphoblastic Leukemia,male hormone,manganese levels,Membrane,menstruation,MHC class I family,MHC class I protein complex,MHC I,Microvascular complications of diabetes 7,mild cognitive impairment,multicellular organismal iron ion homeostasis,MVCD7,Myocardial Infarction,neurodegenerative,neurodegenerative disease,neuromuscular disturbances,nonalcoholic fatty liver disease,Nonglycemic Pathways,Obesity,organ failure,Orthostatic hypotension,osteoarthritis,ovarian,oxidative phosphorylation,Oxidative Stress,oxygen,oxygen transport,parenchymal iron,Parkinson,Parkinson Disease,Parkinson's disease,PD,peptide antigen binding,perinuclear region of cytoplasm,peripheral iron dyshomeostasis,pigment,plasma membrane,Pollution and Air Temperature among Myocardial Infarction Survivors,polycystic ovary syndrome,porphyria,porphyria cutanea tarda,Porphyrias,porphyrins,positive regulation of T cell mediated cytotoxicity,postoperative complications after bariatric surgery,Postural Hemodynamics,protein binding,protein complex assembly,protoporphyrin,RBC,receptor binding,recycling endosome,red blood cell,red blood cell traits,red blood",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs1800562",
        "SNP Name": "HFE C282Y",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1800562",
        "Video": null,
        "Tags": "abdominal pain,Acute Lymphoblastic Leukemia,AD,Air Pollution,ALS,Altered Cardiac Repolarization,Alzheimer,Alzheimer's disease,Amyotrophic Lateral Sclerosis,anemia,angiogenesis,antigen binding,antigen processing and presentation,antigen processing and presentation of peptide antigen via MHC class I,apical part of cell,arthritis,associated with susceptibility to porphyria cutanea tarda,basal part of cell,Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin,biosynthesis of heme,blindness,blood clot,blood pressure,blood sugar,brain sturcture,breast and colorectal cancer,cancer,Cancer and Nutrition,cancerous,carcinogen,carcinoma,cardio,Cardiometabolic,cardiomyopathy,cardiorespiratory,cardiovascular,cardiovascular disease,Cell Cycle Regulation,Cellular Adhesion,cellular iron ion homeostasis,cellular response to iron ion starvation,Childhood Acute Lymphoblastic Leukemia,cholesterol,chondrocalcinosis,chronic hepatitis C,Chronic Kidney Disease,circulating LDL levels,cirrhosis,CKD,clot,clotting,cognition,cognitive impairment,colorectal cancer,coproporphyrin,cutanea tarda,CVD,cytoplasmic vesicle,dementia,diabetes,diabetes mellitus,diabetic,diabetic nephropathy,diabetic retinopathy,dopamine,dyshomeostasis,early endosome,Elevated Transferrin Saturation in Patients With Diabetes,end-stage renal disease,environmental,Fe,female pregnancy,female reproductive disorders,fertility,gastric cancer,glioma,Glucose Intolerance,Glucose Intolerance in Premenopausal Women,Glycemic,heart,heart attack,heart disease,heavy metals,hemachromatosis,heme,hemochromatosis,Hemochromatosis 1,Hemochromatosis 1 (HFE1),hemoglobin levels,hep C,hepatitis,hepatitis C,hepatocellular carcinoma,hepatomas,Hereditary Hemochromatosis,Hereditary hemochromatosis protein,HFE,HFE1,high BP,High fecal levels of protoporphyrin and coproporphyrin,high ferritin,high iron,HLA,HLA-H,HLAH,Homocysteine,hormone biosynthetic process,hyperandrogenism,hyperpigmentation,hypertension,hypertrichosis,hypogonadism,hypogonadotropic hypogonadism,Ig-like C1-type (immunoglobulin-like) domain,immune response,immune system,Immunity,immunoglobin,increased serum transferrin,increased urine uroporphyrins and iron overload,inflammation,Influence of Diet,insulin resistance,integral component of plasma membrane,Ion transport,IQ  score,iron,iron deficiency,iron deficiency anaemia,Iron deficiency and cognitive functions,iron excess,iron in nonalcoholic fatty liver disease,iron ion import into cell,iron metabolism,Iron Metabolism Genes,iron overload,Iron transport,iron-loaded transferrin,ischemia,kidney disease,kidneys,LDL,Lead,leukemia,lipids,liver,liver cirrhosis,liver disease,liver disorders,liver disorders and chronic hepatitis C,longevity,Lower serum hepcidin,Lymphoblastic Leukemia,male hormone,manganese levels,Membrane,menstruation,MHC class I family,MHC class I protein complex,MHC I,Microvascular complications of diabetes 7,mild cognitive impairment,multicellular organismal iron ion homeostasis,MVCD7,Myocardial Infarction,neurodegenerative,neurodegenerative disease,neuromuscular disturbances,nonalcoholic fatty liver disease,Nonglycemic Pathways,Obesity,organ failure,Orthostatic hypotension,osteoarthritis,ovarian,oxidative phosphorylation,Oxidative Stress,oxygen,oxygen transport,parenchymal iron,Parkinson,Parkinson Disease,Parkinson's disease,PD,peptide antigen binding,perinuclear region of cytoplasm,peripheral iron dyshomeostasis,pigment,plasma membrane,Pollution and Air Temperature among Myocardial Infarction Survivors,polycystic ovary syndrome,porphyria,porphyria cutanea tarda,Porphyrias,porphyrins,positive regulation of T cell mediated cytotoxicity,postoperative complications after bariatric surgery,Postural Hemodynamics,protein binding,protein complex assembly,protoporphyrin,RBC,receptor binding,recycling endosome,red blood cell,red blood cell traits,red blood",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1800562",
        "SNP Name": "HFE C282Y",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs2844846",
        "SNP Name": "HLA-F-AS1, MICE 4945T>A",
        "Risk Allele": "T",
        "Your Allele": "TA",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs1632933",
        "SNP Name": "HLA-G 8178C>T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs3823339",
        "SNP Name": "HLA-A 7727C>G",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs1061235",
        "SNP Name": "HLA-A 8057A>T",
        "Risk Allele": "T",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs3893538",
        "SNP Name": "HLA-W 915T>C",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs2517701",
        "SNP Name": "HLA-W 2462A>T",
        "Risk Allele": "T",
        "Your Allele": "TA",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs1265159",
        "SNP Name": "POU5F1 G31140047A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phenol Red"
    },
    {
        "SNP ID": "rs2001181",
        "SNP Name": "HLA-C 7911A>G",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs1058026",
        "SNP Name": "HLA-B 8305T>G",
        "Risk Allele": "C",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs3819299",
        "SNP Name": "HLA-B His363Pro",
        "Risk Allele": "G",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs2523608",
        "SNP Name": "HLA-B 7431C>T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs3094228",
        "SNP Name": "HLA-X 441A>G",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs2071594",
        "SNP Name": "ATP6V1G2-DDX39B,ATP6V1G2 3093G>C",
        "Risk Allele": "C",
        "Your Allele": "CG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs1800629",
        "SNP Name": "TNF -308 variant",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs1800629",
        "Video": null,
        "Tags": null,
        "Group": "Other Immune Factors"
    },
    {
        "SNP ID": "rs361525",
        "SNP Name": "TNF -238 variant",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs361525",
        "Video": null,
        "Tags": null,
        "Group": "Other Immune Factors"
    },
    {
        "SNP ID": "rs3135394",
        "SNP Name": "HLA-DRA 5055G>A",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs9268645",
        "SNP Name": "HLA-DRA 5085C>G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs3129878",
        "SNP Name": "HLA-DRA 5293C>A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs3129881",
        "SNP Name": "HLA-DRA 6041T>C",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs3129882",
        "SNP Name": "HLA-DRA 6087A>G",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs3129883",
        "SNP Name": "HLA-DRA 6694C>T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs9268658",
        "SNP Name": "HLA-DRA 7273G>A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs3135391",
        "SNP Name": "HLA-DRA 7544G>A",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs8084",
        "SNP Name": "HLA-DRA 7592A>C",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs2239804",
        "SNP Name": "HLA-DRA 8080T>C",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs7192",
        "SNP Name": "HLA-DRA Leu242Val",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs3129888",
        "SNP Name": "HLA-DRA 8283A>G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs2239803",
        "SNP Name": "HLA-DRA 8390C>T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs2239802",
        "SNP Name": "HLA-DRA 8403G>C",
        "Risk Allele": "C",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs3177928",
        "SNP Name": "HLA-DRA 8958G>A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs1041885",
        "SNP Name": "HLA-DRA 9332A>T",
        "Risk Allele": "A",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs9268831",
        "SNP Name": "HLA-DRB9 7239C>T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs660895",
        "SNP Name": "HLA-DRB1 variant",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs660895",
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs660895",
        "SNP Name": "HLA-DRB1 variant",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs660895",
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "Other Immune Factors"
    },
    {
        "SNP ID": "rs9271366",
        "SNP Name": "HLA variant",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs9271366",
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs9271366",
        "SNP Name": "HLA variant",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs9271366",
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "IgA"
    },
    {
        "SNP ID": "rs2187668",
        "SNP Name": "HLA-DQA1 variant",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "Celiac Disease/Gluten Intolerance"
    },
    {
        "SNP ID": "rs2858331",
        "SNP Name": "HLA 4126892A>G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs2858331",
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "Celiac Disease/Gluten Intolerance"
    },
    {
        "SNP ID": "rs2858331",
        "SNP Name": "HLA 4126892A>G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs2858331",
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs9276431",
        "SNP Name": "HLA-DQA2 4158042T>C",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs2239800",
        "SNP Name": "HLA-DQA2 4159063A>G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs7453920",
        "SNP Name": "HLA-DQB2 4175809A>G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs2051549",
        "SNP Name": "HLA-DQB2 4175883G>A",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs1573649",
        "SNP Name": "HLA-DQB2 Met1Thr",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs11244",
        "SNP Name": "HLA-DOB 9102C>T",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs2856997",
        "SNP Name": "HLA-DOB 8050G>T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs2071473",
        "SNP Name": "HLA-DOB 7221G>A",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs7383287",
        "SNP Name": "HLA-DOB 6740T>C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs2621326",
        "SNP Name": "HLA-DOB 5930C>T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs2071554",
        "SNP Name": "HLA-DOB Arg18Gln",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs2071469",
        "SNP Name": "HLA-DOB 5043G>A",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs241448",
        "SNP Name": "TAP2 T14863C",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "ABC transporter superfamily,ABCB family,ABCB3,AD,Adaptive immunity,adenovirus,adenovirus E3-19K,alternative splicing,Alzheimer,Alzheimer's disease,antigen,Antigen peptide transporter 2,antigen processing and presentation of endogenous peptide antigen via MHC class I,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I,antigen processing and presentation of peptide antigen via MHC class I,antigens,APT2,ATP,ATP binding,ATP-binding,ATP-binding cassette sub-family B member 3,autoimmune disease,Bare lymphocyte syndrome 1,Bare lymphocyte syndrome type 1,BLS1,cellular energy,chronic,cytomegalovirus,cytoplasm,cytosol to ER transportintracellular transport of viral protein in host cell,deficiency,dementia,diabetes,diabetes mellitus,E3-19K,endoplasmic reticulum,endoplasmic reticulum membrane,energy,glycoprotein,herpes,herpes simplex virus,herpes simplex virus ICP47,HLA,HLA class I deficiency,Host-virus interaction,ICP47,immune system,Immunity,immunodeficiency,Inhibited by herpes,Inhibited by human adenovirus E3-19K glycoprotein,Inhibited by human cytomegalovirus US6 glycoprotein,Inhibited by virus,insulin,integral component of endoplasmic reticulum membrane,integral component of membrane,lymphocyte,membrane,MHC class I molecules,MHC class I/TAP,MHC class Ib protein binding,MHC peptide exporter,mitochondria,mitochondrial,mitochondrion,neurodegenerative disorder,Non-Hodgkin Lymphoma,Nucleotide-binding,peptide antigen transport,peptide antigen-transporting ATPase activity,peptide binding,Peptide supply factor 2,Peptide transport,Peptide transporter involved in antigen processing 2,Peptide transporter PSF2,positive regulation of antigen processing and presentation of peptide antigen via MHC class I,Protein transport,PSF-2,PSF2,RING11,spondylitis,TAP complex,TAP-dependent,TAP-dependent antigen processing and presentation of exogenous peptide antigen via MHC class I,TAP-dependent antigen processing and presentation of exogenous protein antigen via MHC class Ib,TAP1 binding,TAP2,tapasin,tapasin binding,tapasin inhibitor,Transmembrane,Transmembrane helix,transmembrane transport,Transport,transport of antigens,transporter activity,type 1 diabetes,US6,virus,Y1",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs9357155",
        "SNP Name": "PSMB8 / TAP1 / TAP2 variant",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs9357155",
        "Video": null,
        "Tags": null,
        "Group": "IgA"
    },
    {
        "SNP ID": "rs23544",
        "SNP Name": "HLA-DMB 4348055C>T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs151719",
        "SNP Name": "HLA-DMB 4348318T>C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs3128935",
        "SNP Name": "HLA-DOA 9986A>G",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs1044429",
        "SNP Name": "HLA-DOA 9748G>A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs376892",
        "SNP Name": "HLA-DOA 9503C>T",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs416622",
        "SNP Name": "HLA-DOA 9109A>G",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs9276977",
        "SNP Name": "HLA-DOA 8549C>T",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs2581",
        "SNP Name": "HLA-DOA 7989C>A",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs399604",
        "SNP Name": "HLA-DOA 7376A>G",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs2284191",
        "SNP Name": "HLA-DOA 5736C>T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs86567",
        "SNP Name": "HLA-DOA 5631C>A",
        "Risk Allele": "G",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs3077",
        "SNP Name": "HLA-DPA1 20534T>C",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs2301226",
        "SNP Name": "HLA-DPA1 18960C>T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs9277535",
        "SNP Name": "HLA-DPB1 16159A>G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Mold,Mould,Biotoxin,Biotoxins,Mold toxicity,Cytokine,TGF,B-1,MMP-9,Clot formation,Arterial blockage,Gladin,Cardiolipins,Blood clotting,Protein C3a,Protein C4a,C3a,C4a,Low oxygen,Capillaries,VEGF,Fatigue,CFS,Muscle cramps,Shortness of breath,Fat cell,Leptin,Leptin receptor,Obesity,Exercise non-responsive,VIP,AVP,MSH,MSH hormone,Chronic pain,Suppressed endorphin production,Malabsorption in the gut,Diarrhea,Leaky gut,Gluten,Whey,Amylose,Hypothalamus,Pituitary,Frequent urination,ADH (Anti-diuretic hormone),Static electricity shock,Sex hormone production low,Sleep disturbance,Production of melatonin,Non-REM sleep,Illness prolonged,Cortisol elevated,Cortisol low,ACTH,Resistant staph bacteria,Mucous membrane,High cytokine levels,Low MSH levels,Nerve cell,Impairment of nerve cell function.",
        "Group": "HLA"
    },
    {
        "SNP ID": "rs3025039",
        "SNP Name": "VEGFA C936T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs3025039",
        "SNP Name": "VEGFA C936T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Gelatin"
    },
    {
        "SNP ID": "rs10434",
        "SNP Name": "VEGFA A*913G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs10434",
        "SNP Name": "VEGFA A*913G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Gelatin"
    },
    {
        "SNP ID": "rs6931421",
        "SNP Name": "BCKDHB T68795G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6931421",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs6931421",
        "SNP Name": "BCKDHB T68795G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6931421",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs10455370",
        "SNP Name": "BCKDHB C229524T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10455370",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs10455370",
        "SNP Name": "BCKDHB C229524T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10455370",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs806368",
        "SNP Name": "CNR1 T88850100C",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs806368",
        "Video": null,
        "Tags": "adenylate cyclase,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,aging,allergies,allergy,anandamide,anti-inflammatory,arteries,artery,axon,axonal fasciculation,binding,blood pressure,blood sugar,BP,brain,brain cell,brain cells,brain development,CANN6,cannabinoid,Cannabinoid receptor 1,cannabinoid receptor activity,cannabinoid signaling pathway,cardiovascular,CB-R,CB1,central nervous system,chemical sensitivity,cigarette,cigarette smoking,CNR,CNR1,CNS,cocaine,CVD,diabetes,dopamine,drug,drug binding,drug response,drugs,ED,erectile dysfunction,ethanol,fat,fatty acids,feeding,feeding behavior,G-protein coupled receptor 1 family,G-protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger,GABA,GABA/glutamate,GABAergic,glucose,glucose homeostasis,glutamate,glutamatergic,Glycoprotein,growth cone,heart,heart disease,high BP,histamine,hyperglycemia,hypoglycemia,immune system,impotence,inflammation,inflammatory,insulin,integral component of plasma membrane,intracellular membrane-bounded organelle,L-type Ca2+,ligand binding,lipid,lipids,Lipoprotein,liver,low BP,marijuana,mast cell,mast cell activation syndrome,mast cells,maternal process involved in female pregnancy,MCAS,MCS,membrane raft,memory,morphine,multiple chemical sensitivity,negative regulation of action potential,negative regulation of blood pressure,negative regulation of dopamine secretion,negative regulation of fatty acid beta-oxidation,negative regulation of mast cell activation,negative regulation of nitric-oxide synthase activity,neurons,neurotransmitter,neurotransmitters,nicotine,nitric oxide,norepinephrine,NOS,nucleotide,nutrient,nutrition,Omega 3,Omega 6,Omega 9,oxidation,oxidative stress,pain perception,pain toleranceG-protein coupled receptor,Palmitate,Palmitoylation,pancreas,Phosphoprotein,plasma membrane,positive regulation of acute inflammatory response to antigenic stimulus,positive regulation of apoptotic process,positive regulation of blood pressure,positive regulation of fever generation,positive regulation of neuron projection development,pregnancy,receptor,regulation of feeding behavior,regulation of insulin secretion,regulation of penile erection,regulation of synaptic transmission,response to cocaine,response to drug,response to ethanol,response to lipopolysaccharide,response to morphine,response to nicotine,response to nutrient,ROS,rs806368,sensory perception of pain,serotonin,smoking,spermatogenesis,T88850100C,Transducer,Type 1 diabetes,Type 2 diabetes",
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs806368",
        "SNP Name": "CNR1 T88850100C",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs806368",
        "Video": null,
        "Tags": "adenylate cyclase,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,aging,allergies,allergy,anandamide,anti-inflammatory,arteries,artery,axon,axonal fasciculation,binding,blood pressure,blood sugar,BP,brain,brain cell,brain cells,brain development,CANN6,cannabinoid,Cannabinoid receptor 1,cannabinoid receptor activity,cannabinoid signaling pathway,cardiovascular,CB-R,CB1,central nervous system,chemical sensitivity,cigarette,cigarette smoking,CNR,CNR1,CNS,cocaine,CVD,diabetes,dopamine,drug,drug binding,drug response,drugs,ED,erectile dysfunction,ethanol,fat,fatty acids,feeding,feeding behavior,G-protein coupled receptor 1 family,G-protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger,GABA,GABA/glutamate,GABAergic,glucose,glucose homeostasis,glutamate,glutamatergic,Glycoprotein,growth cone,heart,heart disease,high BP,histamine,hyperglycemia,hypoglycemia,immune system,impotence,inflammation,inflammatory,insulin,integral component of plasma membrane,intracellular membrane-bounded organelle,L-type Ca2+,ligand binding,lipid,lipids,Lipoprotein,liver,low BP,marijuana,mast cell,mast cell activation syndrome,mast cells,maternal process involved in female pregnancy,MCAS,MCS,membrane raft,memory,morphine,multiple chemical sensitivity,negative regulation of action potential,negative regulation of blood pressure,negative regulation of dopamine secretion,negative regulation of fatty acid beta-oxidation,negative regulation of mast cell activation,negative regulation of nitric-oxide synthase activity,neurons,neurotransmitter,neurotransmitters,nicotine,nitric oxide,norepinephrine,NOS,nucleotide,nutrient,nutrition,Omega 3,Omega 6,Omega 9,oxidation,oxidative stress,pain perception,pain toleranceG-protein coupled receptor,Palmitate,Palmitoylation,pancreas,Phosphoprotein,plasma membrane,positive regulation of acute inflammatory response to antigenic stimulus,positive regulation of apoptotic process,positive regulation of blood pressure,positive regulation of fever generation,positive regulation of neuron projection development,pregnancy,receptor,regulation of feeding behavior,regulation of insulin secretion,regulation of penile erection,regulation of synaptic transmission,response to cocaine,response to drug,response to ethanol,response to lipopolysaccharide,response to morphine,response to nicotine,response to nutrient,ROS,rs806368,sensory perception of pain,serotonin,smoking,spermatogenesis,T88850100C,Transducer,Type 1 diabetes,Type 2 diabetes",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs4707436",
        "SNP Name": "CNR1 G88851751A",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4707436",
        "Video": null,
        "Tags": "adenylate cyclase,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,ADHD,aging,allergies,allergy,anandamide,anhedonia,anti-inflammatory,antipsychotic-induced weight gain,arteries,artery,axon,axonal fasciculation,binding,blood pressure,blood sugar,BP,brain,brain cell,brain cells,brain development,CANN6,cannabinoid,Cannabinoid receptor 1,cannabinoid receptor activity,cannabinoid signaling pathway,cannabis,cannabis dependence,cardiometabolic,cardiovascular,CB-R,CB1,central nervous system,chemical sensitivity,childhood physical abuse,cigarette,cigarette smoking,CNR,CNR1,CNS,cocaine,CVD,depression,diabetes,dopamine,drug,drug addiction,drug binding,drug dependence,drug response,drugs,ED,erectile dysfunction,ethanol,fat,fatty acids,feeding,feeding behavior,G-protein coupled receptor 1 family,G-protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger,G88851751A,GABA,GABA/glutamate,GABAergic,glucose,glucose homeostasis,glutamate,glutamatergic,Glycoprotein,growth cone,heart,heart disease,high BP,histamine,hyperglycemia,hypoglycemia,immune system,impotence,inflammation,inflammatory,insulin,integral component of plasma membrane,intracellular membrane-bounded organelle,L-type Ca2+,ligand binding,lipid,lipids,Lipoprotein,liver,low BP,marijuana,mast cell,mast cell activation syndrome,mast cells,maternal process involved in female pregnancy,MCAS,MCS,membrane raft,memory,morphine,multiple chemical sensitivity,negative regulation of action potential,negative regulation of blood pressure,negative regulation of dopamine secretion,negative regulation of fatty acid beta-oxidation,negative regulation of mast cell activation,negative regulation of nitric-oxide synthase activity,neurons,neurotransmitter,neurotransmitters,nicotine,nitric oxide,norepinephrine,NOS,nucleotide,nutrient,nutrition,Omega 3,Omega 6,Omega 9,oxidation,oxidative stress,pain perception,pain toleranceG-protein coupled receptor,Palmitate,Palmitoylation,pancreas,Phosphoprotein,plasma membrane,positive regulation of acute inflammatory response to antigenic stimulus,positive regulation of apoptotic process,positive regulation of blood pressure,positive regulation of fever generation,positive regulation of neuron projection development,Post-Traumatic Stress Disorder,pregnancy,PTSD,receptor,regulation of feeding behavior,regulation of insulin secretion,regulation of penile erection,regulation of synaptic transmission,response to cocaine,response to drug,response to ethanol,response to lipopolysaccharide,response to morphine,response to nicotine,response to nutrient,ROS,rs4707436,sensory perception of pain,serotonin,smoking,spermatogenesis,Transducer,Type 1 diabetes,Type 2 diabetes",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs1049353",
        "SNP Name": "CNR1 T453T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1049353",
        "Video": null,
        "Tags": "addiction,adenylate cyclase,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,ADHD,aging,alcohol,Alcohol Dependence,allergies,allergy,Amygdala,anandamide,anhedonia,anorexia,anorexia nervosa,anti-inflammatory,Antipsychotic-Induced Weight Gain,apoptosis,arteries,artery,ASD,autism,Autism Spectrum Disorder,axon,axonal fasciculation,binding,blood pressure,blood sugar,bone pain,BP,brain,brain cell,brain cells,brain development,cancer,cancer cachexia,Cancer-Induced Bone Pain,cancerous,CANN6,cannabinoid,Cannabinoid receptor 1,cannabinoid receptor activity,cannabinoid signaling pathway,cannabis,Cannabis Dependence,carcinogen,cardiometabolic,cardiovascular,CB-R,CB1,central nervous system,chemical sensitivity,childhood abuse,childhood physical abuse,cholesterol,cigarette,cigarette smoking,CNR,CNR1,CNS,cocaine,Crohn's Disease,CVD,cyst,depression,diabetes,digestion,digestive,dopamine,drug,drug addiction,drug binding,drug dependence,drug response,drugs,ED,erectile dysfunction,ethanol,fat,fatty acids,fatty liver,fatty liver disease,feeding,feeding behavior,G-protein coupled receptor 1 family,G-protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger,GABA,GABA/glutamate,GABAergic,glucose,glucose homeostasis,glutamate,glutamatergic,Glycoprotein,growth cone,HDL Cholesterol,heart,heart disease,high BP,Hippocampus,histamine,hyperglycemia,hypoglycemia,immune system,impotence,inflammation,inflammatory,insulin,integral component of plasma membrane,intracellular membrane-bounded organelle,L-type Ca2+,ligand binding,lipid,lipid homeostasis,lipids,Lipoprotein,liver,liver disease,low BP,major depression,marijuana,mast cell,mast cell activation syndrome,mast cells,maternal process involved in female pregnancy,MCAS,MCS,membrane raft,memory,morphine,multiple chemical sensitivity,negative regulation of action potential,negative regulation of blood pressure,negative regulation of dopamine secretion,negative regulation of fatty acid beta-oxidation,negative regulation of mast cell activation,negative regulation of nitric-oxide synthase activity,neurons,neurotransmitter,neurotransmitters,nicotine,Nicotine Dependence,nitric oxide,Nonalcoholic Fatty Liver Disease,norepinephrine,NOS,nucleotide,nutrient,nutrition,obesity,Omega 3,Omega 6,Omega 9,ovaries,ovary,oxidation,oxidative stress,pain,pain perception,pain toleranceG-protein coupled receptor,Palmitate,Palmitoylation,pancreas,PCOS,Phosphoprotein,physical abuse,plasma membrane,Polycystic Ovary Syndrome,positive regulation of acute inflammatory response to antigenic stimulus,positive regulation of apoptotic process,positive regulation of blood pressure,positive regulation of fever generation,positive regulation of neuron projection development,Post-Traumatic Stress Disorder,pregnancy,premenstrual dysphoric disorders,Psychosis,PTSD,receptor,regulation of feeding behavior,regulation of insulin secretion,regulation of penile erection,regulation of synaptic transmission,response to cocaine,response to drug,response to ethanol,response to lipopolysaccharide,response to morphine,response to nicotine,response to nutrient,ROS,rs1049353,schizophrenia,sensory perception of pain,serotonin,smoking,spermatogenesis,stimulant addiction,synaptic plasticity,T-cell,T453T,Transducer,tumor,Type 1 diabetes,Type 2 diabetes",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs806369",
        "SNP Name": "CNR1 T88856178C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs806369",
        "Video": null,
        "Tags": "adenylate cyclase,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,aging,allergies,allergy,anandamide,anti-inflammatory,arteries,artery,axon,axonal fasciculation,binding,blood pressure,blood sugar,BP,brain,brain cell,brain cells,brain development,CANN6,cannabinoid,Cannabinoid receptor 1,cannabinoid receptor activity,cannabinoid signaling pathway,cardiovascular,CB-R,CB1,central nervous system,chemical sensitivity,cigarette,cigarette smoking,CNR,CNR1,CNS,cocaine,CVD,diabetes,dopamine,drug,drug binding,drug response,drugs,ED,erectile dysfunction,ethanol,fat,fatty acids,feeding,feeding behavior,G-protein coupled receptor 1 family,G-protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger,GABA,GABA/glutamate,GABAergic,glucose,glucose homeostasis,glutamate,glutamatergic,Glycoprotein,growth cone,heart,heart disease,high BP,histamine,hyperglycemia,hypoglycemia,immune system,impotence,inflammation,inflammatory,insulin,integral component of plasma membrane,intracellular membrane-bounded organelle,L-type Ca2+,ligand binding,lipid,lipids,Lipoprotein,liver,low BP,marijuana,mast cell,mast cell activation syndrome,mast cells,maternal process involved in female pregnancy,MCAS,MCS,membrane raft,memory,morphine,multiple chemical sensitivity,negative regulation of action potential,negative regulation of blood pressure,negative regulation of dopamine secretion,negative regulation of fatty acid beta-oxidation,negative regulation of mast cell activation,negative regulation of nitric-oxide synthase activity,neurons,neurotransmitter,neurotransmitters,nicotine,nitric oxide,norepinephrine,NOS,nucleotide,nutrient,nutrition,Omega 3,Omega 6,Omega 9,oxidation,oxidative stress,pain perception,pain toleranceG-protein coupled receptor,Palmitate,Palmitoylation,pancreas,Phosphoprotein,plasma membrane,positive regulation of acute inflammatory response to antigenic stimulus,positive regulation of apoptotic process,positive regulation of blood pressure,positive regulation of fever generation,positive regulation of neuron projection development,pregnancy,receptor,regulation of feeding behavior,regulation of insulin secretion,regulation of penile erection,regulation of synaptic transmission,response to cocaine,response to drug,response to ethanol,response to lipopolysaccharide,response to morphine,response to nicotine,response to nutrient,ROS,rs806369,sensory perception of pain,serotonin,smoking,spermatogenesis,T88856178C,Transducer,Type 1 diabetes,Type 2 diabetes",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs806374",
        "SNP Name": "CNR1 T88857320C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs806374",
        "Video": null,
        "Tags": "adenylate cyclase,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,aging,allergies,allergy,anandamide,anti-inflammatory,arteries,artery,axon,axonal fasciculation,binding,blood pressure,blood sugar,BP,brain,brain cell,brain cells,brain development,CANN6,cannabinoid,Cannabinoid receptor 1,cannabinoid receptor activity,cannabinoid signaling pathway,cardiovascular,CB-R,CB1,central nervous system,chemical sensitivity,cigarette,cigarette smoking,CNR,CNR1,CNS,cocaine,CVD,diabetes,dopamine,drug,drug binding,drug response,drugs,ED,erectile dysfunction,ethanol,fat,fatty acids,feeding,feeding behavior,G-protein coupled receptor 1 family,G-protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger,GABA,GABA/glutamate,GABAergic,glucose,glucose homeostasis,glutamate,glutamatergic,Glycoprotein,growth cone,heart,heart disease,high BP,histamine,hyperglycemia,hypoglycemia,immune system,impotence,inflammation,inflammatory,insulin,integral component of plasma membrane,intracellular membrane-bounded organelle,L-type Ca2+,ligand binding,lipid,lipids,Lipoprotein,liver,low BP,marijuana,mast cell,mast cell activation syndrome,mast cells,maternal process involved in female pregnancy,MCAS,MCS,membrane raft,memory,morphine,multiple chemical sensitivity,negative regulation of action potential,negative regulation of blood pressure,negative regulation of dopamine secretion,negative regulation of fatty acid beta-oxidation,negative regulation of mast cell activation,negative regulation of nitric-oxide synthase activity,neurons,neurotransmitter,neurotransmitters,nicotine,nitric oxide,norepinephrine,NOS,nucleotide,nutrient,nutrition,Omega 3,Omega 6,Omega 9,oxidation,oxidative stress,pain perception,pain toleranceG-protein coupled receptor,Palmitate,Palmitoylation,pancreas,Phosphoprotein,plasma membrane,positive regulation of acute inflammatory response to antigenic stimulus,positive regulation of apoptotic process,positive regulation of blood pressure,positive regulation of fever generation,positive regulation of neuron projection development,pregnancy,receptor,regulation of feeding behavior,regulation of insulin secretion,regulation of penile erection,regulation of synaptic transmission,response to cocaine,response to drug,response to ethanol,response to lipopolysaccharide,response to morphine,response to nicotine,response to nutrient,ROS,rs806374,sensory perception of pain,serotonin,smoking,spermatogenesis,T88857320C,Transducer,Type 1 diabetes,Type 2 diabetes",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs806376",
        "SNP Name": "CNR1 T88858648C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs806376",
        "Video": null,
        "Tags": "adenylate cyclase,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,aging,allergies,allergy,anandamide,anti-inflammatory,arteries,artery,axon,axonal fasciculation,binding,blood pressure,blood sugar,BP,brain,brain cell,brain cells,brain development,CANN6,cannabinoid,Cannabinoid receptor 1,cannabinoid receptor activity,cannabinoid signaling pathway,cardiovascular,CB-R,CB1,central nervous system,chemical sensitivity,cigarette,cigarette smoking,CNR,CNR1,CNS,cocaine,CVD,diabetes,dopamine,drug,drug binding,drug response,drugs,ED,erectile dysfunction,ethanol,fat,fatty acids,feeding,feeding behavior,G-protein coupled receptor 1 family,G-protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger,GABA,GABA/glutamate,GABAergic,glucose,glucose homeostasis,glutamate,glutamatergic,Glycoprotein,growth cone,heart,heart disease,high BP,histamine,hyperglycemia,hypoglycemia,immune system,impotence,inflammation,inflammatory,insulin,integral component of plasma membrane,intracellular membrane-bounded organelle,L-type Ca2+,ligand binding,lipid,lipids,Lipoprotein,liver,low BP,marijuana,mast cell,mast cell activation syndrome,mast cells,maternal process involved in female pregnancy,MCAS,MCS,membrane raft,memory,morphine,multiple chemical sensitivity,negative regulation of action potential,negative regulation of blood pressure,negative regulation of dopamine secretion,negative regulation of fatty acid beta-oxidation,negative regulation of mast cell activation,negative regulation of nitric-oxide synthase activity,neurons,neurotransmitter,neurotransmitters,nicotine,nitric oxide,norepinephrine,NOS,nucleotide,nutrient,nutrition,Omega 3,Omega 6,Omega 9,oxidation,oxidative stress,pain perception,pain toleranceG-protein coupled receptor,Palmitate,Palmitoylation,pancreas,Phosphoprotein,plasma membrane,positive regulation of acute inflammatory response to antigenic stimulus,positive regulation of apoptotic process,positive regulation of blood pressure,positive regulation of fever generation,positive regulation of neuron projection development,pregnancy,receptor,regulation of feeding behavior,regulation of insulin secretion,regulation of penile erection,regulation of synaptic transmission,response to cocaine,response to drug,response to ethanol,response to lipopolysaccharide,response to morphine,response to nicotine,response to nutrient,ROS,rs806376,sensory perception of pain,serotonin,smoking,spermatogenesis,T88858648C,Transducer,Type 1 diabetes,Type 2 diabetes",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs806377",
        "SNP Name": "CNR1 T88858723C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs806377",
        "Video": null,
        "Tags": "adenylate cyclase,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,aging,allergies,allergy,anandamide,anti-inflammatory,arteries,artery,axon,axonal fasciculation,binding,blood pressure,blood sugar,BP,brain,brain cell,brain cells,brain development,CANN6,cannabinoid,Cannabinoid receptor 1,cannabinoid receptor activity,cannabinoid signaling pathway,cardiovascular,CB-R,CB1,central nervous system,chemical sensitivity,cigarette,cigarette smoking,CNR,CNR1,CNS,cocaine,CVD,diabetes,dopamine,drug,drug binding,drug response,drugs,ED,erectile dysfunction,ethanol,fat,fatty acids,feeding,feeding behavior,G-protein coupled receptor 1 family,G-protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger,GABA,GABA/glutamate,GABAergic,glucose,glucose homeostasis,glutamate,glutamatergic,Glycoprotein,growth cone,heart,heart disease,high BP,histamine,hyperglycemia,hypoglycemia,immune system,impotence,inflammation,inflammatory,insulin,integral component of plasma membrane,intracellular membrane-bounded organelle,L-type Ca2+,ligand binding,lipid,lipids,Lipoprotein,liver,low BP,marijuana,mast cell,mast cell activation syndrome,mast cells,maternal process involved in female pregnancy,MCAS,MCS,membrane raft,memory,morphine,multiple chemical sensitivity,negative regulation of action potential,negative regulation of blood pressure,negative regulation of dopamine secretion,negative regulation of fatty acid beta-oxidation,negative regulation of mast cell activation,negative regulation of nitric-oxide synthase activity,neurons,neurotransmitter,neurotransmitters,nicotine,nitric oxide,norepinephrine,NOS,nucleotide,nutrient,nutrition,Omega 3,Omega 6,Omega 9,oxidation,oxidative stress,pain perception,pain toleranceG-protein coupled receptor,Palmitate,Palmitoylation,pancreas,Phosphoprotein,plasma membrane,positive regulation of acute inflammatory response to antigenic stimulus,positive regulation of apoptotic process,positive regulation of blood pressure,positive regulation of fever generation,positive regulation of neuron projection development,pregnancy,receptor,regulation of feeding behavior,regulation of insulin secretion,regulation of penile erection,regulation of synaptic transmission,response to cocaine,response to drug,response to ethanol,response to lipopolysaccharide,response to morphine,response to nicotine,response to nutrient,ROS,rs806377,sensory perception of pain,serotonin,smoking,spermatogenesis,T88858723C,Transducer,Type 1 diabetes,Type 2 diabetes",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs806378",
        "SNP Name": "CNR1 C88859551T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs806378",
        "Video": null,
        "Tags": "adenylate cyclase,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,aging,allergies,allergy,anandamide,anti-inflammatory,arteries,artery,axon,axonal fasciculation,binding,blood pressure,blood sugar,BP,brain,brain cell,brain cells,brain development,C88859551T,CANN6,cannabinoid,Cannabinoid receptor 1,cannabinoid receptor activity,cannabinoid signaling pathway,cardiovascular,CB-R,CB1,central nervous system,chemical sensitivity,cigarette,cigarette smoking,CNR,CNR1,CNS,cocaine,CVD,diabetes,dopamine,drug,drug binding,drug response,drugs,ED,erectile dysfunction,ethanol,fat,fatty acids,feeding,feeding behavior,G-protein coupled receptor 1 family,G-protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger,GABA,GABA/glutamate,GABAergic,glucose,glucose homeostasis,glutamate,glutamatergic,Glycoprotein,growth cone,heart,heart disease,high BP,histamine,hyperglycemia,hypoglycemia,immune system,impotence,inflammation,inflammatory,insulin,integral component of plasma membrane,intracellular membrane-bounded organelle,L-type Ca2+,ligand binding,lipid,lipids,Lipoprotein,liver,low BP,marijuana,mast cell,mast cell activation syndrome,mast cells,maternal process involved in female pregnancy,MCAS,MCS,membrane raft,memory,morphine,multiple chemical sensitivity,negative regulation of action potential,negative regulation of blood pressure,negative regulation of dopamine secretion,negative regulation of fatty acid beta-oxidation,negative regulation of mast cell activation,negative regulation of nitric-oxide synthase activity,neurons,neurotransmitter,neurotransmitters,nicotine,nitric oxide,norepinephrine,NOS,nucleotide,nutrient,nutrition,Omega 3,Omega 6,Omega 9,oxidation,oxidative stress,pain perception,pain toleranceG-protein coupled receptor,Palmitate,Palmitoylation,pancreas,Phosphoprotein,plasma membrane,positive regulation of acute inflammatory response to antigenic stimulus,positive regulation of apoptotic process,positive regulation of blood pressure,positive regulation of fever generation,positive regulation of neuron projection development,pregnancy,receptor,regulation of feeding behavior,regulation of insulin secretion,regulation of penile erection,regulation of synaptic transmission,response to cocaine,response to drug,response to ethanol,response to lipopolysaccharide,response to morphine,response to nicotine,response to nutrient,ROS,rs806378,sensory perception of pain,serotonin,smoking,spermatogenesis,Transducer,Type 1 diabetes,Type 2 diabetes",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs6928813",
        "SNP Name": "CNR1 A88861698G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6928813",
        "Video": null,
        "Tags": "A88861698G,adenylate cyclase,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,aging,allergies,allergy,anandamide,anti-inflammatory,arteries,artery,axon,axonal fasciculation,binding,blood pressure,blood sugar,BP,brain,brain cell,brain cells,brain development,CANN6,cannabinoid,Cannabinoid receptor 1,cannabinoid receptor activity,cannabinoid signaling pathway,cardiovascular,CB-R,CB1,central nervous system,chemical sensitivity,cigarette,cigarette smoking,CNR,CNR1,CNS,cocaine,CVD,diabetes,dopamine,drug,drug binding,drug response,drugs,ED,erectile dysfunction,ethanol,fat,fatty acids,feeding,feeding behavior,G-protein coupled receptor 1 family,G-protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger,GABA,GABA/glutamate,GABAergic,glucose,glucose homeostasis,glutamate,glutamatergic,Glycoprotein,growth cone,heart,heart disease,high BP,histamine,hyperglycemia,hypoglycemia,immune system,impotence,inflammation,inflammatory,insulin,integral component of plasma membrane,intracellular membrane-bounded organelle,L-type Ca2+,ligand binding,lipid,lipids,Lipoprotein,liver,low BP,marijuana,mast cell,mast cell activation syndrome,mast cells,maternal process involved in female pregnancy,MCAS,MCS,membrane raft,memory,morphine,multiple chemical sensitivity,negative regulation of action potential,negative regulation of blood pressure,negative regulation of dopamine secretion,negative regulation of fatty acid beta-oxidation,negative regulation of mast cell activation,negative regulation of nitric-oxide synthase activity,neurons,neurotransmitter,neurotransmitters,nicotine,nitric oxide,norepinephrine,NOS,nucleotide,nutrient,nutrition,Omega 3,Omega 6,Omega 9,oxidation,oxidative stress,pain perception,pain toleranceG-protein coupled receptor,Palmitate,Palmitoylation,pancreas,Phosphoprotein,plasma membrane,positive regulation of acute inflammatory response to antigenic stimulus,positive regulation of apoptotic process,positive regulation of blood pressure,positive regulation of fever generation,positive regulation of neuron projection development,pregnancy,receptor,regulation of feeding behavior,regulation of insulin secretion,regulation of penile erection,regulation of synaptic transmission,response to cocaine,response to drug,response to ethanol,response to lipopolysaccharide,response to morphine,response to nicotine,response to nutrient,ROS,rs6928813,sensory perception of pain,serotonin,smoking,spermatogenesis,Transducer,Type 1 diabetes,Type 2 diabetes",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs806381",
        "SNP Name": "CNR1 A88865901G",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs806381",
        "Video": null,
        "Tags": "A88865901G,adenylate cyclase,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,aging,allergies,allergy,anandamide,anti-inflammatory,arteries,artery,axon,axonal fasciculation,binding,blood pressure,blood sugar,BP,brain,brain cell,brain cells,brain development,CANN6,cannabinoid,Cannabinoid receptor 1,cannabinoid receptor activity,cannabinoid signaling pathway,cardiovascular,CB-R,CB1,central nervous system,chemical sensitivity,cigarette,cigarette smoking,CNR,CNR1,CNS,cocaine,CVD,diabetes,dopamine,drug,drug binding,drug response,drugs,ED,erectile dysfunction,ethanol,fat,fatty acids,feeding,feeding behavior,G-protein coupled receptor 1 family,G-protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger,GABA,GABA/glutamate,GABAergic,glucose,glucose homeostasis,glutamate,glutamatergic,Glycoprotein,growth cone,heart,heart disease,high BP,histamine,hyperglycemia,hypoglycemia,immune system,impotence,inflammation,inflammatory,insulin,integral component of plasma membrane,intracellular membrane-bounded organelle,L-type Ca2+,ligand binding,lipid,lipids,Lipoprotein,liver,low BP,marijuana,mast cell,mast cell activation syndrome,mast cells,maternal process involved in female pregnancy,MCAS,MCS,membrane raft,memory,morphine,multiple chemical sensitivity,negative regulation of action potential,negative regulation of blood pressure,negative regulation of dopamine secretion,negative regulation of fatty acid beta-oxidation,negative regulation of mast cell activation,negative regulation of nitric-oxide synthase activity,neurons,neurotransmitter,neurotransmitters,nicotine,nitric oxide,norepinephrine,NOS,nucleotide,nutrient,nutrition,Omega 3,Omega 6,Omega 9,oxidation,oxidative stress,pain perception,pain toleranceG-protein coupled receptor,Palmitate,Palmitoylation,pancreas,Phosphoprotein,plasma membrane,positive regulation of acute inflammatory response to antigenic stimulus,positive regulation of apoptotic process,positive regulation of blood pressure,positive regulation of fever generation,positive regulation of neuron projection development,pregnancy,receptor,regulation of feeding behavior,regulation of insulin secretion,regulation of penile erection,regulation of synaptic transmission,response to cocaine,response to drug,response to ethanol,response to lipopolysaccharide,response to morphine,response to nicotine,response to nutrient,ROS,rs806381,sensory perception of pain,serotonin,smoking,spermatogenesis,Transducer,Type 1 diabetes,Type 2 diabetes",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs12205430",
        "SNP Name": "CNR1 T88867925C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs12205430",
        "Video": null,
        "Tags": "adenylate cyclase,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,aging,allergies,allergy,anandamide,anti-inflammatory,arteries,artery,axon,axonal fasciculation,binding,blood pressure,blood sugar,BP,brain,brain cell,brain cells,brain development,CANN6,cannabinoid,Cannabinoid receptor 1,cannabinoid receptor activity,cannabinoid signaling pathway,cardiovascular,CB-R,CB1,central nervous system,chemical sensitivity,cholesterol,cigarette,cigarette smoking,CNR,CNR1,CNS,cocaine,CVD,diabetes,dopamine,drug,drug binding,drug response,drugs,ED,erectile dysfunction,ethanol,fat,fatty acids,feeding,feeding behavior,G-protein coupled receptor 1 family,G-protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger,GABA,GABA/glutamate,GABAergic,glucose,glucose homeostasis,glutamate,glutamatergic,Glycoprotein,growth cone,HDL cholesterol,heart,heart disease,high BP,histamine,hyperglycemia,hypoglycemia,immune system,impotence,inflammation,inflammatory,insulin,integral component of plasma membrane,intracellular membrane-bounded organelle,L-type Ca2+,ligand binding,lipid,lipids,Lipoprotein,liver,low BP,marijuana,mast cell,mast cell activation syndrome,mast cells,maternal process involved in female pregnancy,MCAS,MCS,membrane raft,memory,morphine,multiple chemical sensitivity,negative regulation of action potential,negative regulation of blood pressure,negative regulation of dopamine secretion,negative regulation of fatty acid beta-oxidation,negative regulation of mast cell activation,negative regulation of nitric-oxide synthase activity,neurons,neurotransmitter,neurotransmitters,nicotine,nitric oxide,norepinephrine,NOS,nucleotide,nutrient,nutrition,Omega 3,Omega 6,Omega 9,oxidation,oxidative stress,pain perception,pain toleranceG-protein coupled receptor,Palmitate,Palmitoylation,pancreas,Phosphoprotein,plasma membrane,positive regulation of acute inflammatory response to antigenic stimulus,positive regulation of apoptotic process,positive regulation of blood pressure,positive regulation of fever generation,positive regulation of neuron projection development,pregnancy,receptor,regulation of feeding behavior,regulation of insulin secretion,regulation of penile erection,regulation of synaptic transmission,response to cocaine,response to drug,response to ethanol,response to lipopolysaccharide,response to morphine,response to nicotine,response to nutrient,ROS,rs12205430,sensory perception of pain,serotonin,smoking,spermatogenesis,T88867925C,Transducer,Type 1 diabetes,Type 2 diabetes",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs6454673",
        "SNP Name": "CNR1 G88871049A",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6454673",
        "Video": null,
        "Tags": "adenylate cyclase,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,aging,allergies,allergy,anandamide,anti-inflammatory,arteries,artery,axon,axonal fasciculation,binding,blood pressure,blood sugar,BP,brain,brain cell,brain cells,brain development,CANN6,cannabinoid,Cannabinoid receptor 1,cannabinoid receptor activity,cannabinoid signaling pathway,cardiovascular,CB-R,CB1,central nervous system,chemical sensitivity,cigarette,cigarette smoking,CNR,CNR1,CNS,cocaine,CVD,diabetes,dopamine,drug,drug binding,drug response,drugs,ED,erectile dysfunction,ethanol,fat,fatty acids,feeding,feeding behavior,G-protein coupled receptor 1 family,G-protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger,G88871049A,GABA,GABA/glutamate,GABAergic,glucose,glucose homeostasis,glutamate,glutamatergic,Glycoprotein,growth cone,heart,heart disease,high BP,histamine,hyperglycemia,hypoglycemia,immune system,impotence,inflammation,inflammatory,insulin,integral component of plasma membrane,intracellular membrane-bounded organelle,L-type Ca2+,ligand binding,lipid,lipids,Lipoprotein,liver,low BP,marijuana,mast cell,mast cell activation syndrome,mast cells,maternal process involved in female pregnancy,MCAS,MCS,membrane raft,memory,morphine,multiple chemical sensitivity,negative regulation of action potential,negative regulation of blood pressure,negative regulation of dopamine secretion,negative regulation of fatty acid beta-oxidation,negative regulation of mast cell activation,negative regulation of nitric-oxide synthase activity,neurons,neurotransmitter,neurotransmitters,nicotine,nitric oxide,norepinephrine,NOS,nucleotide,nutrient,nutrition,Omega 3,Omega 6,Omega 9,oxidation,oxidative stress,pain perception,pain toleranceG-protein coupled receptor,Palmitate,Palmitoylation,pancreas,Phosphoprotein,plasma membrane,positive regulation of acute inflammatory response to antigenic stimulus,positive regulation of apoptotic process,positive regulation of blood pressure,positive regulation of fever generation,positive regulation of neuron projection development,pregnancy,receptor,regulation of feeding behavior,regulation of insulin secretion,regulation of penile erection,regulation of synaptic transmission,response to cocaine,response to drug,response to ethanol,response to lipopolysaccharide,response to morphine,response to nicotine,response to nutrient,ROS,rs6454673,sensory perception of pain,serotonin,smoking,spermatogenesis,Transducer,Type 1 diabetes,Type 2 diabetes",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs6454674",
        "SNP Name": "CNR1 T88872930G",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6454674",
        "Video": null,
        "Tags": "adenylate cyclase,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,aging,allergies,allergy,anandamide,anti-inflammatory,arteries,artery,axon,axonal fasciculation,binding,blood pressure,blood sugar,BP,brain,brain cell,brain cells,brain development,CANN6,cannabinoid,Cannabinoid receptor 1,cannabinoid receptor activity,cannabinoid signaling pathway,cardiovascular,CB-R,CB1,central nervous system,chemical sensitivity,cigarette,cigarette smoking,CNR,CNR1,CNS,cocaine,CVD,diabetes,dopamine,drug,drug binding,drug response,drugs,ED,erectile dysfunction,ethanol,fat,fatty acids,feeding,feeding behavior,G-protein coupled receptor 1 family,G-protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger,GABA,GABA/glutamate,GABAergic,glucose,glucose homeostasis,glutamate,glutamatergic,Glycoprotein,growth cone,heart,heart disease,high BP,histamine,hyperglycemia,hypoglycemia,immune system,impotence,inflammation,inflammatory,insulin,integral component of plasma membrane,intracellular membrane-bounded organelle,L-type Ca2+,ligand binding,lipid,lipids,Lipoprotein,liver,low BP,marijuana,mast cell,mast cell activation syndrome,mast cells,maternal process involved in female pregnancy,MCAS,MCS,membrane raft,memory,morphine,multiple chemical sensitivity,negative regulation of action potential,negative regulation of blood pressure,negative regulation of dopamine secretion,negative regulation of fatty acid beta-oxidation,negative regulation of mast cell activation,negative regulation of nitric-oxide synthase activity,neurons,neurotransmitter,neurotransmitters,nicotine,nitric oxide,norepinephrine,NOS,nucleotide,nutrient,nutrition,Omega 3,Omega 6,Omega 9,oxidation,oxidative stress,pain perception,pain toleranceG-protein coupled receptor,Palmitate,Palmitoylation,pancreas,Phosphoprotein,plasma membrane,positive regulation of acute inflammatory response to antigenic stimulus,positive regulation of apoptotic process,positive regulation of blood pressure,positive regulation of fever generation,positive regulation of neuron projection development,pregnancy,receptor,regulation of feeding behavior,regulation of insulin secretion,regulation of penile erection,regulation of synaptic transmission,response to cocaine,response to drug,response to ethanol,response to lipopolysaccharide,response to morphine,response to nicotine,response to nutrient,ROS,rs6454674,sensory perception of pain,serotonin,smoking,spermatogenesis,T88872930G,Transducer,Type 1 diabetes,Type 2 diabetes",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs2057149",
        "SNP Name": "DDO C110717493T",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2057149",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs2057149",
        "SNP Name": "DDO C110717493T",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2057149",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs11914",
        "SNP Name": "IFNGR1 S359S",
        "Risk Allele": "C",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Magnesium Stearate"
    },
    {
        "SNP ID": "rs3799488",
        "SNP Name": "IFNGR1 A25788G",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Magnesium Stearate"
    },
    {
        "SNP ID": "rs1327474",
        "SNP Name": "IFNGR1 -611G>A",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Magnesium Stearate"
    },
    {
        "SNP ID": "rs11754661",
        "SNP Name": "MTHFD1L G25264A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs11754661",
        "Video": null,
        "Tags": "Acetylation,acetylator,AD,Alternative splicing,Alzheimer,Alzheimer's disease,ATP,ATP + formate + tetrahydrofolate = ADP + phosphate + 10-formyltetrahydrofolate,ATP binding,ATP-binding,brain,C-terminal section,cancer,cancer therapy,cancer upregulation,cancerous,carcinogen,cellular energy,colon adenocarcinoma,colon cancer,Complete proteome,cyclohydrolase,dementia,Direct protein sequencing,energy,fast acetylator,folate,folic acid,folic acid-containing compound biosynthetic process,folic acid-containing compound metabolic process,formate metabolic process,formate--tetrahydrofolate ligase family,formate-tetrahydrofolate ligase activity,formyl-THF synthetase C-terminal,Formyltetrahydrofolate synthetase,FTHFSDC1,G25264A,highest expression found in placenta,Homodimer,Late-Onset Alzheimer Disease,Ligase,liver,Low expression is found in liver and skeletal muscle,May provide the missing metabolic reaction required to link the mitochondria and the cytoplasm in the mammalian model of one-carbon folate metabolism in embryonic an transformed cells complementing thus the enzymatic activities of MTHFD2,mitochondria,mitochondrial,mitochondrion,Monofunctional C1-tetrahydrofolate synthase,monoglutamate,MTHFD1L,N-terminal inactive methylene-THF dehydrogenase,N-terminal section,neurodegenerative disease,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,One-carbon metabolism; tetrahydrofolate interconversion,oxidation,oxidation-reduction process,oxidative stress,phosphate,Polymorphism,progression of colorectal cancer,protein homodimerization activity,Reference proteome,ROS,rs11754661,skeletal muscle,slow acetylator,tetrahydrofolate,tetrahydrofolate dehydrogenase/cyclohydrolase family,tetrahydrofolate interconversion,tetrahydrofolate metabolic process,thymus,thymus and brain,Transit peptide,Up-regulated in colon adenocarcinoma",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs11754661",
        "SNP Name": "MTHFD1L G25264A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs11754661",
        "Video": null,
        "Tags": "Acetylation,acetylator,AD,Alternative splicing,Alzheimer,Alzheimer's disease,ATP,ATP + formate + tetrahydrofolate = ADP + phosphate + 10-formyltetrahydrofolate,ATP binding,ATP-binding,brain,C-terminal section,cancer,cancer therapy,cancer upregulation,cancerous,carcinogen,cellular energy,colon adenocarcinoma,colon cancer,Complete proteome,cyclohydrolase,dementia,Direct protein sequencing,energy,fast acetylator,folate,folic acid,folic acid-containing compound biosynthetic process,folic acid-containing compound metabolic process,formate metabolic process,formate--tetrahydrofolate ligase family,formate-tetrahydrofolate ligase activity,formyl-THF synthetase C-terminal,Formyltetrahydrofolate synthetase,FTHFSDC1,G25264A,highest expression found in placenta,Homodimer,Late-Onset Alzheimer Disease,Ligase,liver,Low expression is found in liver and skeletal muscle,May provide the missing metabolic reaction required to link the mitochondria and the cytoplasm in the mammalian model of one-carbon folate metabolism in embryonic an transformed cells complementing thus the enzymatic activities of MTHFD2,mitochondria,mitochondrial,mitochondrion,Monofunctional C1-tetrahydrofolate synthase,monoglutamate,MTHFD1L,N-terminal inactive methylene-THF dehydrogenase,N-terminal section,neurodegenerative disease,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,One-carbon metabolism; tetrahydrofolate interconversion,oxidation,oxidation-reduction process,oxidative stress,phosphate,Polymorphism,progression of colorectal cancer,protein homodimerization activity,Reference proteome,ROS,rs11754661,skeletal muscle,slow acetylator,tetrahydrofolate,tetrahydrofolate dehydrogenase/cyclohydrolase family,tetrahydrofolate interconversion,tetrahydrofolate metabolic process,thymus,thymus and brain,Transit peptide,Up-regulated in colon adenocarcinoma",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs11754661",
        "SNP Name": "MTHFD1L G25264A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs11754661",
        "Video": null,
        "Tags": "Acetylation,acetylator,AD,Alternative splicing,Alzheimer,Alzheimer's disease,ATP,ATP + formate + tetrahydrofolate = ADP + phosphate + 10-formyltetrahydrofolate,ATP binding,ATP-binding,brain,C-terminal section,cancer,cancer therapy,cancer upregulation,cancerous,carcinogen,cellular energy,colon adenocarcinoma,colon cancer,Complete proteome,cyclohydrolase,dementia,Direct protein sequencing,energy,fast acetylator,folate,folic acid,folic acid-containing compound biosynthetic process,folic acid-containing compound metabolic process,formate metabolic process,formate--tetrahydrofolate ligase family,formate-tetrahydrofolate ligase activity,formyl-THF synthetase C-terminal,Formyltetrahydrofolate synthetase,FTHFSDC1,G25264A,highest expression found in placenta,Homodimer,Late-Onset Alzheimer Disease,Ligase,liver,Low expression is found in liver and skeletal muscle,May provide the missing metabolic reaction required to link the mitochondria and the cytoplasm in the mammalian model of one-carbon folate metabolism in embryonic an transformed cells complementing thus the enzymatic activities of MTHFD2,mitochondria,mitochondrial,mitochondrion,Monofunctional C1-tetrahydrofolate synthase,monoglutamate,MTHFD1L,N-terminal inactive methylene-THF dehydrogenase,N-terminal section,neurodegenerative disease,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,One-carbon metabolism; tetrahydrofolate interconversion,oxidation,oxidation-reduction process,oxidative stress,phosphate,Polymorphism,progression of colorectal cancer,protein homodimerization activity,Reference proteome,ROS,rs11754661,skeletal muscle,slow acetylator,tetrahydrofolate,tetrahydrofolate dehydrogenase/cyclohydrolase family,tetrahydrofolate interconversion,tetrahydrofolate metabolic process,thymus,thymus and brain,Transit peptide,Up-regulated in colon adenocarcinoma",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs11754661",
        "SNP Name": "MTHFD1L G25264A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs11754661",
        "Video": null,
        "Tags": "Acetylation,acetylator,AD,Alternative splicing,Alzheimer,Alzheimer's disease,ATP,ATP + formate + tetrahydrofolate = ADP + phosphate + 10-formyltetrahydrofolate,ATP binding,ATP-binding,brain,C-terminal section,cancer,cancer therapy,cancer upregulation,cancerous,carcinogen,cellular energy,colon adenocarcinoma,colon cancer,Complete proteome,cyclohydrolase,dementia,Direct protein sequencing,energy,fast acetylator,folate,folic acid,folic acid-containing compound biosynthetic process,folic acid-containing compound metabolic process,formate metabolic process,formate--tetrahydrofolate ligase family,formate-tetrahydrofolate ligase activity,formyl-THF synthetase C-terminal,Formyltetrahydrofolate synthetase,FTHFSDC1,G25264A,highest expression found in placenta,Homodimer,Late-Onset Alzheimer Disease,Ligase,liver,Low expression is found in liver and skeletal muscle,May provide the missing metabolic reaction required to link the mitochondria and the cytoplasm in the mammalian model of one-carbon folate metabolism in embryonic an transformed cells complementing thus the enzymatic activities of MTHFD2,mitochondria,mitochondrial,mitochondrion,Monofunctional C1-tetrahydrofolate synthase,monoglutamate,MTHFD1L,N-terminal inactive methylene-THF dehydrogenase,N-terminal section,neurodegenerative disease,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,One-carbon metabolism; tetrahydrofolate interconversion,oxidation,oxidation-reduction process,oxidative stress,phosphate,Polymorphism,progression of colorectal cancer,protein homodimerization activity,Reference proteome,ROS,rs11754661,skeletal muscle,slow acetylator,tetrahydrofolate,tetrahydrofolate dehydrogenase/cyclohydrolase family,tetrahydrofolate interconversion,tetrahydrofolate metabolic process,thymus,thymus and brain,Transit peptide,Up-regulated in colon adenocarcinoma",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs11754661",
        "SNP Name": "MTHFD1L G25264A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs11754661",
        "Video": null,
        "Tags": "Acetylation,acetylator,AD,Alternative splicing,Alzheimer,Alzheimer's disease,ATP,ATP + formate + tetrahydrofolate = ADP + phosphate + 10-formyltetrahydrofolate,ATP binding,ATP-binding,brain,C-terminal section,cancer,cancer therapy,cancer upregulation,cancerous,carcinogen,cellular energy,colon adenocarcinoma,colon cancer,Complete proteome,cyclohydrolase,dementia,Direct protein sequencing,energy,fast acetylator,folate,folic acid,folic acid-containing compound biosynthetic process,folic acid-containing compound metabolic process,formate metabolic process,formate--tetrahydrofolate ligase family,formate-tetrahydrofolate ligase activity,formyl-THF synthetase C-terminal,Formyltetrahydrofolate synthetase,FTHFSDC1,G25264A,highest expression found in placenta,Homodimer,Late-Onset Alzheimer Disease,Ligase,liver,Low expression is found in liver and skeletal muscle,May provide the missing metabolic reaction required to link the mitochondria and the cytoplasm in the mammalian model of one-carbon folate metabolism in embryonic an transformed cells complementing thus the enzymatic activities of MTHFD2,mitochondria,mitochondrial,mitochondrion,Monofunctional C1-tetrahydrofolate synthase,monoglutamate,MTHFD1L,N-terminal inactive methylene-THF dehydrogenase,N-terminal section,neurodegenerative disease,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,One-carbon metabolism; tetrahydrofolate interconversion,oxidation,oxidation-reduction process,oxidative stress,phosphate,Polymorphism,progression of colorectal cancer,protein homodimerization activity,Reference proteome,ROS,rs11754661,skeletal muscle,slow acetylator,tetrahydrofolate,tetrahydrofolate dehydrogenase/cyclohydrolase family,tetrahydrofolate interconversion,tetrahydrofolate metabolic process,thymus,thymus and brain,Transit peptide,Up-regulated in colon adenocarcinoma",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs17349743",
        "SNP Name": "MTHFD1L T31397C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs17349743",
        "Video": null,
        "Tags": "Acetylation,Alternative splicing,Alzheimer,Alzheimer's disease,ATP,ATP + formate + tetrahydrofolate = ADP + phosphate + 10-formyltetrahydrofolate,ATP binding,ATP-binding,brain,C-terminal section,cancer,cancer therapy,cancer upregulation,cancerous,carcinogen,cellular energy,colon adenocarcinoma,colon cancer,Complete proteome,cyclohydrolase,Direct protein sequencing,energy,folic acid-containing compound biosynthetic process,folic acid-containing compound metabolic process,formate metabolic process,formate--tetrahydrofolate ligase family,formate-tetrahydrofolate ligase activity,formyl-THF synthetase C-terminal,Formyltetrahydrofolate synthetase,FTHFSDC1,highest expression found in placenta,Homodimer,Ligase,liver,Low expression is found in liver and skeletal muscle,May provide the missing metabolic reaction required to link the mitochondria and the cytoplasm in the mammalian model of one-carbon folate metabolism in embryonic an transformed cells complementing thus the enzymatic activities of MTHFD2,methionine to homocysteine,mitochondria,mitochondrial,mitochondrion,Monofunctional C1-tetrahydrofolate synthase,MTHFD1L,N-terminal inactive methylene-THF dehydrogenase,N-terminal section,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,One-carbon metabolism; tetrahydrofolate interconversion,oxidation-reduction process,phosphate,Polymorphism,progression of colorectal cancer,protein homodimerization activity,Reference proteome,rs17349743,skeletal muscle,T31397C,tetrahydrofolate dehydrogenase/cyclohydrolase family,tetrahydrofolate interconversion,tetrahydrofolate metabolic process,thymus,thymus and brain,Transit peptide,Up-regulated in colon adenocarcinoma",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs17349743",
        "SNP Name": "MTHFD1L T31397C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs17349743",
        "Video": null,
        "Tags": "Acetylation,Alternative splicing,Alzheimer,Alzheimer's disease,ATP,ATP + formate + tetrahydrofolate = ADP + phosphate + 10-formyltetrahydrofolate,ATP binding,ATP-binding,brain,C-terminal section,cancer,cancer therapy,cancer upregulation,cancerous,carcinogen,cellular energy,colon adenocarcinoma,colon cancer,Complete proteome,cyclohydrolase,Direct protein sequencing,energy,folic acid-containing compound biosynthetic process,folic acid-containing compound metabolic process,formate metabolic process,formate--tetrahydrofolate ligase family,formate-tetrahydrofolate ligase activity,formyl-THF synthetase C-terminal,Formyltetrahydrofolate synthetase,FTHFSDC1,highest expression found in placenta,Homodimer,Ligase,liver,Low expression is found in liver and skeletal muscle,May provide the missing metabolic reaction required to link the mitochondria and the cytoplasm in the mammalian model of one-carbon folate metabolism in embryonic an transformed cells complementing thus the enzymatic activities of MTHFD2,methionine to homocysteine,mitochondria,mitochondrial,mitochondrion,Monofunctional C1-tetrahydrofolate synthase,MTHFD1L,N-terminal inactive methylene-THF dehydrogenase,N-terminal section,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,One-carbon metabolism; tetrahydrofolate interconversion,oxidation-reduction process,phosphate,Polymorphism,progression of colorectal cancer,protein homodimerization activity,Reference proteome,rs17349743,skeletal muscle,T31397C,tetrahydrofolate dehydrogenase/cyclohydrolase family,tetrahydrofolate interconversion,tetrahydrofolate metabolic process,thymus,thymus and brain,Transit peptide,Up-regulated in colon adenocarcinoma",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs17349743",
        "SNP Name": "MTHFD1L T31397C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs17349743",
        "Video": null,
        "Tags": "Acetylation,Alternative splicing,Alzheimer,Alzheimer's disease,ATP,ATP + formate + tetrahydrofolate = ADP + phosphate + 10-formyltetrahydrofolate,ATP binding,ATP-binding,brain,C-terminal section,cancer,cancer therapy,cancer upregulation,cancerous,carcinogen,cellular energy,colon adenocarcinoma,colon cancer,Complete proteome,cyclohydrolase,Direct protein sequencing,energy,folic acid-containing compound biosynthetic process,folic acid-containing compound metabolic process,formate metabolic process,formate--tetrahydrofolate ligase family,formate-tetrahydrofolate ligase activity,formyl-THF synthetase C-terminal,Formyltetrahydrofolate synthetase,FTHFSDC1,highest expression found in placenta,Homodimer,Ligase,liver,Low expression is found in liver and skeletal muscle,May provide the missing metabolic reaction required to link the mitochondria and the cytoplasm in the mammalian model of one-carbon folate metabolism in embryonic an transformed cells complementing thus the enzymatic activities of MTHFD2,methionine to homocysteine,mitochondria,mitochondrial,mitochondrion,Monofunctional C1-tetrahydrofolate synthase,MTHFD1L,N-terminal inactive methylene-THF dehydrogenase,N-terminal section,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,One-carbon metabolism; tetrahydrofolate interconversion,oxidation-reduction process,phosphate,Polymorphism,progression of colorectal cancer,protein homodimerization activity,Reference proteome,rs17349743,skeletal muscle,T31397C,tetrahydrofolate dehydrogenase/cyclohydrolase family,tetrahydrofolate interconversion,tetrahydrofolate metabolic process,thymus,thymus and brain,Transit peptide,Up-regulated in colon adenocarcinoma",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs17349743",
        "SNP Name": "MTHFD1L T31397C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs17349743",
        "Video": null,
        "Tags": "Acetylation,Alternative splicing,Alzheimer,Alzheimer's disease,ATP,ATP + formate + tetrahydrofolate = ADP + phosphate + 10-formyltetrahydrofolate,ATP binding,ATP-binding,brain,C-terminal section,cancer,cancer therapy,cancer upregulation,cancerous,carcinogen,cellular energy,colon adenocarcinoma,colon cancer,Complete proteome,cyclohydrolase,Direct protein sequencing,energy,folic acid-containing compound biosynthetic process,folic acid-containing compound metabolic process,formate metabolic process,formate--tetrahydrofolate ligase family,formate-tetrahydrofolate ligase activity,formyl-THF synthetase C-terminal,Formyltetrahydrofolate synthetase,FTHFSDC1,highest expression found in placenta,Homodimer,Ligase,liver,Low expression is found in liver and skeletal muscle,May provide the missing metabolic reaction required to link the mitochondria and the cytoplasm in the mammalian model of one-carbon folate metabolism in embryonic an transformed cells complementing thus the enzymatic activities of MTHFD2,methionine to homocysteine,mitochondria,mitochondrial,mitochondrion,Monofunctional C1-tetrahydrofolate synthase,MTHFD1L,N-terminal inactive methylene-THF dehydrogenase,N-terminal section,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,One-carbon metabolism; tetrahydrofolate interconversion,oxidation-reduction process,phosphate,Polymorphism,progression of colorectal cancer,protein homodimerization activity,Reference proteome,rs17349743,skeletal muscle,T31397C,tetrahydrofolate dehydrogenase/cyclohydrolase family,tetrahydrofolate interconversion,tetrahydrofolate metabolic process,thymus,thymus and brain,Transit peptide,Up-regulated in colon adenocarcinoma",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs803422",
        "SNP Name": "MTHFD1L A33780G",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs803422",
        "Video": null,
        "Tags": "A33780G,Acetylation,Alternative splicing,Alzheimer's disease,ATP,ATP + formate + tetrahydrofolate = ADP + phosphate + 10-formyltetrahydrofolate,ATP binding,ATP-binding,birth defect,brain,C-terminal section,cancer,cancer therapy,cancer upregulation,cancerous,carcinogen,cellular energy,colon adenocarcinoma,colon cancer,Complete proteome,cyclohydrolase,defect,Direct protein sequencing,energy,folate,folic acid-containing compound biosynthetic process,folic acid-containing compound metabolic process,formate metabolic process,formate--tetrahydrofolate ligase family,formate-tetrahydrofolate ligase activity,formyl-THF synthetase C-terminal,Formyltetrahydrofolate synthetase,FTHFSDC1,highest expression found in placenta,Homodimer,Late-Onset Alzheimer Disease,Ligase,liver,Low expression is found in liver and skeletal muscle,May provide the missing metabolic reaction required to link the mitochondria and the cytoplasm in the mammalian model of one-carbon folate metabolism in embryonic an transformed cells complementing thus the enzymatic activities of MTHFD2,mitochondria,mitochondrial,mitochondrion,Monofunctional C1-tetrahydrofolate synthase,MTHFD1L,N-terminal inactive methylene-THF dehydrogenase,N-terminal section,neural tube defect,NTDs,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,One-carbon metabolism; tetrahydrofolate interconversion,oxidation-reduction process,phosphate,Polymorphism,progression of colorectal cancer,protein homodimerization activity,Reference proteome,rs803422,skeletal muscle,tetrahydrofolate dehydrogenase/cyclohydrolase family,tetrahydrofolate interconversion,tetrahydrofolate metabolic process,thymus,thymus and brain,Transit peptide,Up-regulated in colon adenocarcinoma",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs803422",
        "SNP Name": "MTHFD1L A33780G",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs803422",
        "Video": null,
        "Tags": "A33780G,Acetylation,Alternative splicing,Alzheimer's disease,ATP,ATP + formate + tetrahydrofolate = ADP + phosphate + 10-formyltetrahydrofolate,ATP binding,ATP-binding,birth defect,brain,C-terminal section,cancer,cancer therapy,cancer upregulation,cancerous,carcinogen,cellular energy,colon adenocarcinoma,colon cancer,Complete proteome,cyclohydrolase,defect,Direct protein sequencing,energy,folate,folic acid-containing compound biosynthetic process,folic acid-containing compound metabolic process,formate metabolic process,formate--tetrahydrofolate ligase family,formate-tetrahydrofolate ligase activity,formyl-THF synthetase C-terminal,Formyltetrahydrofolate synthetase,FTHFSDC1,highest expression found in placenta,Homodimer,Late-Onset Alzheimer Disease,Ligase,liver,Low expression is found in liver and skeletal muscle,May provide the missing metabolic reaction required to link the mitochondria and the cytoplasm in the mammalian model of one-carbon folate metabolism in embryonic an transformed cells complementing thus the enzymatic activities of MTHFD2,mitochondria,mitochondrial,mitochondrion,Monofunctional C1-tetrahydrofolate synthase,MTHFD1L,N-terminal inactive methylene-THF dehydrogenase,N-terminal section,neural tube defect,NTDs,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,One-carbon metabolism; tetrahydrofolate interconversion,oxidation-reduction process,phosphate,Polymorphism,progression of colorectal cancer,protein homodimerization activity,Reference proteome,rs803422,skeletal muscle,tetrahydrofolate dehydrogenase/cyclohydrolase family,tetrahydrofolate interconversion,tetrahydrofolate metabolic process,thymus,thymus and brain,Transit peptide,Up-regulated in colon adenocarcinoma",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs803422",
        "SNP Name": "MTHFD1L A33780G",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs803422",
        "Video": null,
        "Tags": "A33780G,Acetylation,Alternative splicing,Alzheimer's disease,ATP,ATP + formate + tetrahydrofolate = ADP + phosphate + 10-formyltetrahydrofolate,ATP binding,ATP-binding,birth defect,brain,C-terminal section,cancer,cancer therapy,cancer upregulation,cancerous,carcinogen,cellular energy,colon adenocarcinoma,colon cancer,Complete proteome,cyclohydrolase,defect,Direct protein sequencing,energy,folate,folic acid-containing compound biosynthetic process,folic acid-containing compound metabolic process,formate metabolic process,formate--tetrahydrofolate ligase family,formate-tetrahydrofolate ligase activity,formyl-THF synthetase C-terminal,Formyltetrahydrofolate synthetase,FTHFSDC1,highest expression found in placenta,Homodimer,Late-Onset Alzheimer Disease,Ligase,liver,Low expression is found in liver and skeletal muscle,May provide the missing metabolic reaction required to link the mitochondria and the cytoplasm in the mammalian model of one-carbon folate metabolism in embryonic an transformed cells complementing thus the enzymatic activities of MTHFD2,mitochondria,mitochondrial,mitochondrion,Monofunctional C1-tetrahydrofolate synthase,MTHFD1L,N-terminal inactive methylene-THF dehydrogenase,N-terminal section,neural tube defect,NTDs,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,One-carbon metabolism; tetrahydrofolate interconversion,oxidation-reduction process,phosphate,Polymorphism,progression of colorectal cancer,protein homodimerization activity,Reference proteome,rs803422,skeletal muscle,tetrahydrofolate dehydrogenase/cyclohydrolase family,tetrahydrofolate interconversion,tetrahydrofolate metabolic process,thymus,thymus and brain,Transit peptide,Up-regulated in colon adenocarcinoma",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs803422",
        "SNP Name": "MTHFD1L A33780G",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs803422",
        "Video": null,
        "Tags": "A33780G,Acetylation,Alternative splicing,Alzheimer's disease,ATP,ATP + formate + tetrahydrofolate = ADP + phosphate + 10-formyltetrahydrofolate,ATP binding,ATP-binding,birth defect,brain,C-terminal section,cancer,cancer therapy,cancer upregulation,cancerous,carcinogen,cellular energy,colon adenocarcinoma,colon cancer,Complete proteome,cyclohydrolase,defect,Direct protein sequencing,energy,folate,folic acid-containing compound biosynthetic process,folic acid-containing compound metabolic process,formate metabolic process,formate--tetrahydrofolate ligase family,formate-tetrahydrofolate ligase activity,formyl-THF synthetase C-terminal,Formyltetrahydrofolate synthetase,FTHFSDC1,highest expression found in placenta,Homodimer,Late-Onset Alzheimer Disease,Ligase,liver,Low expression is found in liver and skeletal muscle,May provide the missing metabolic reaction required to link the mitochondria and the cytoplasm in the mammalian model of one-carbon folate metabolism in embryonic an transformed cells complementing thus the enzymatic activities of MTHFD2,mitochondria,mitochondrial,mitochondrion,Monofunctional C1-tetrahydrofolate synthase,MTHFD1L,N-terminal inactive methylene-THF dehydrogenase,N-terminal section,neural tube defect,NTDs,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,One-carbon metabolism; tetrahydrofolate interconversion,oxidation-reduction process,phosphate,Polymorphism,progression of colorectal cancer,protein homodimerization activity,Reference proteome,rs803422,skeletal muscle,tetrahydrofolate dehydrogenase/cyclohydrolase family,tetrahydrofolate interconversion,tetrahydrofolate metabolic process,thymus,thymus and brain,Transit peptide,Up-regulated in colon adenocarcinoma",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs2881766",
        "SNP Name": "ESR1 T152119119G",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Nonylphenol Ethoxylate"
    },
    {
        "SNP ID": "rs2758331",
        "SNP Name": "SOD2 406+816G>T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2758331",
        "Video": null,
        "Tags": "2 superoxide + 2 H+ = O2 + H2O2,acetyl,Acetylation,Acetylation at Lys-122 decreases enzymatic activity,age-dependent response to reactive oxygen species,aggressive prostate cancer,angiogenesis,antioxidant,Binds 1 manganese ion per subunit,blood pressure,Catalytic activity,cellular response to ethanol,cigarette smoking,cofactor,Destroys superoxide anion radicals which are normally produced within the cells and which are toxic to biological systems,detection of oxygen,detox,diabetes,diabetes mellitus,diabetic nephropathy leading to end-stage renal disease,diabetic retinopathy,DNA binding,drug response,drugs,energy,Enhanced dityrosine formation on peroxynitrite treatment,erythrophore differentiation,exercise,extracellular vesicular exosome,fat,free radicals,glutamate,glutathione,glutathione metabolic process,heart,heart development,hemopoiesis,hydrogen peroxide,hydrogen peroxide biosynthetic process,identical protein binding,intrinsic apoptotic signaling pathway in response to DNA damage,intrinsic apoptotic signaling pathway in response to oxidative stress,iron,iron ion homeostasis,iron/manganese superoxide dismutase family,ischemia,L-Lysine,L-Tyrosine,liver,liver development,locomotory behavior,long term prostate cancer risk,Longevity,lung cancer,lysine,Manganese,manganese ion binding,metal-binding,Microvascular complications of diabetes 6,mitochondrial,mitochondrial inner membrane,mitochondrial matrix,mitochondrial nucleoid,mitochondrion,Mitochondrion matrix,N6-acetyllysine,N6-succinyllysine,negative regulation of cell proliferation,negative regulation of fat cell differentiation,negative regulation of fibroblast proliferation,negative regulation of intrinsic apoptotic signaling pathway in response to oxidative stress,negative regulation of neuron apoptotic process,neuron development,NIHL,Nitrated tyrosine,Nitrated under oxidative stress,Noise Induced Hearing Loss,non-Hodgkin lymphoma,oxidation,oxidative stress,Oxidoreductase,oxygen binding,oxygen homeostasis,positive regulation of nitric oxide biosynthetic process,post-embryonic development,prostate cancer,protein homotetramerization,reactive oxygen species,regulation of blood pressure,regulation of catalytic activity,regulation of mitochondrial membrane potential,regulation of transcription from RNA polymerase II promoter,release of cytochrome c from mitochondria,removal of superoxide radicals,renal,renal disease,respiratory electron transport chain,response to activity,response to axon injury,response to cadmium ion,response to drug,response to electrical stimulus,response to gamma radiation,response to hydrogen peroxide,response to hyperoxia,response to hypoxia,response to L-ascorbic acid,response to lipopolysaccharide,response to manganese ion,response to selenium ion,response to silicon dioxide,response to superoxide,response to zinc ion,ROS,serium selenium,smoking,smoking and lung cancer,SOD2,superoxide anion generation,superoxide dismutase activity,Superoxide dismutase [Mn],superoxide metabolic process,tyrosine,vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure,vegetable and fruit intake and risk of non-Hodgkin lymphoma,zinc",
        "Group": "Sodium Pyruvate"
    },
    {
        "SNP ID": "rs2758331",
        "SNP Name": "SOD2 406+816G>T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2758331",
        "Video": null,
        "Tags": "2 superoxide + 2 H+ = O2 + H2O2,acetyl,Acetylation,Acetylation at Lys-122 decreases enzymatic activity,age-dependent response to reactive oxygen species,aggressive prostate cancer,angiogenesis,antioxidant,Binds 1 manganese ion per subunit,blood pressure,Catalytic activity,cellular response to ethanol,cigarette smoking,cofactor,Destroys superoxide anion radicals which are normally produced within the cells and which are toxic to biological systems,detection of oxygen,detox,diabetes,diabetes mellitus,diabetic nephropathy leading to end-stage renal disease,diabetic retinopathy,DNA binding,drug response,drugs,energy,Enhanced dityrosine formation on peroxynitrite treatment,erythrophore differentiation,exercise,extracellular vesicular exosome,fat,free radicals,glutamate,glutathione,glutathione metabolic process,heart,heart development,hemopoiesis,hydrogen peroxide,hydrogen peroxide biosynthetic process,identical protein binding,intrinsic apoptotic signaling pathway in response to DNA damage,intrinsic apoptotic signaling pathway in response to oxidative stress,iron,iron ion homeostasis,iron/manganese superoxide dismutase family,ischemia,L-Lysine,L-Tyrosine,liver,liver development,locomotory behavior,long term prostate cancer risk,Longevity,lung cancer,lysine,Manganese,manganese ion binding,metal-binding,Microvascular complications of diabetes 6,mitochondrial,mitochondrial inner membrane,mitochondrial matrix,mitochondrial nucleoid,mitochondrion,Mitochondrion matrix,N6-acetyllysine,N6-succinyllysine,negative regulation of cell proliferation,negative regulation of fat cell differentiation,negative regulation of fibroblast proliferation,negative regulation of intrinsic apoptotic signaling pathway in response to oxidative stress,negative regulation of neuron apoptotic process,neuron development,NIHL,Nitrated tyrosine,Nitrated under oxidative stress,Noise Induced Hearing Loss,non-Hodgkin lymphoma,oxidation,oxidative stress,Oxidoreductase,oxygen binding,oxygen homeostasis,positive regulation of nitric oxide biosynthetic process,post-embryonic development,prostate cancer,protein homotetramerization,reactive oxygen species,regulation of blood pressure,regulation of catalytic activity,regulation of mitochondrial membrane potential,regulation of transcription from RNA polymerase II promoter,release of cytochrome c from mitochondria,removal of superoxide radicals,renal,renal disease,respiratory electron transport chain,response to activity,response to axon injury,response to cadmium ion,response to drug,response to electrical stimulus,response to gamma radiation,response to hydrogen peroxide,response to hyperoxia,response to hypoxia,response to L-ascorbic acid,response to lipopolysaccharide,response to manganese ion,response to selenium ion,response to silicon dioxide,response to superoxide,response to zinc ion,ROS,serium selenium,smoking,smoking and lung cancer,SOD2,superoxide anion generation,superoxide dismutase activity,Superoxide dismutase [Mn],superoxide metabolic process,tyrosine,vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure,vegetable and fruit intake and risk of non-Hodgkin lymphoma,zinc",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs4880",
        "SNP Name": "SOD2 V16A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4880",
        "Video": null,
        "Tags": "2 superoxide + 2 H+ = O2 + H2O2,acetyl,Acetylation,Acetylation at Lys-122 decreases enzymatic activity,Acute Toxicity among Head and Neck Cancer Patients,adult brain tumors,age-dependent response to reactive oxygen species,age-related macular degeneration,aggressive prostate cancer,aging and longevity,alcohol,AMD,angiogenesis,antioxidant,antipsychotic treatment response and side effects,Antipsychotic-Induced Movement Disorders,antipsychotic-induced side effects,Asbestosis,Asthma,Binds 1 manganese ion per subunit,bladder cancer,blood pressure,brain tumor,Breast Cancer,breast conserving radiotherapy,Bronchopulmonary Dysplasia,cancer,cardio,cardiovascular,Cardiovascular Disease,Catalytic activity,cellular response to ethanol,cofactor,CVD,Cyclophosphamide,depression,Destroys superoxide anion radicals which are normally produced within the cells and which are toxic to biological systems,detection of oxygen,detox,diabetes,diabetes mellitus,diabetic nephropathy leading to end-stage renal disease,diabetic retinopathy,Diabetic Retinopathy in Type 1 Diabetes,Diisocyanate-Induced Asthma,DNA binding,drug response,drugs,energy,Enhanced dityrosine formation on peroxynitrite treatment,erythrophore differentiation,exercise,extracellular vesicular exosome,fat,free radicals,gastric cancer,glaucoma,glutamate,glutathione,glutathione metabolic process,Gray Matter Volume Shrinkage in Alcoholics,Healthy Aging and Longevity,heart,heart development,heart disease,hemopoiesis,hydrogen peroxide,hydrogen peroxide biosynthetic process,identical protein binding,intrinsic apoptotic signaling pathway in response to DNA damage,intrinsic apoptotic signaling pathway in response to oxidative stress,iron,iron ion homeostasis,iron/manganese superoxide dismutase family,ischemia,Kidney Complications in Subjects with Type 1 Diabetes,Kidney disease,kidneys,L-Lysine,L-Tyrosine,liver,liver development,locomotory behavior,lung cancer,lungs,lysine,Manganese,manganese ion binding,MCS,mental disorder,metabolic abnormalities in patients with schizophrenia,metal-binding,Methamphetamine-Associated Psychosis,Microvascular complications of diabetes 6,mitochondrial,mitochondrial inner membrane,mitochondrial matrix,mitochondrial nucleoid,mitochondrion,Mitochondrion matrix,Multiple Chemical Sensitivity,N6-acetyllysine,N6-succinyllysine,negative regulation of cell proliferation,negative regulation of fat cell differentiation,negative regulation of fibroblast proliferation,negative regulation of intrinsic apoptotic signaling pathway in response to oxidative stress,negative regulation of neuron apoptotic process,neuron development,NIHL,Nitrated tyrosine,Nitrated under oxidative stress,Noise Induced Hearing Loss,non-Hodgkin lymphoma,normal tension glaucoma,obesity,oral squamous cell carcinoma,oxidation,oxidative stress,Oxidoreductase,oxygen binding,oxygen homeostasis,pancreatic cancer,Parkinson,Parkinson's Disease,PD,pharmacogenetics,Plasma Advanced Oxidation Protein Products (AOPP),polypoidal choroidal vasculopathy,positive regulation of nitric oxide biosynthetic process,post-embryonic development,postmenopausal breast cancer,premenopausal women,progressive supranuclear palsy,prostate cancer,protein homotetramerization,reactive oxygen species,recurrent depressive disorders,regulation of blood pressure,regulation of catalytic activity,regulation of mitochondrial membrane potential,regulation of transcription from RNA polymerase II promoter,release of cytochrome c from mitochondria,removal of superoxide radicals,renal,renal disease,respiratory electron transport chain,response to activity,response to axon injury,response to cadmium ion,response to drug,response to electrical stimulus,response to gamma radiation,response to hydrogen peroxide,response to hyperoxia,response to hypoxia,response to L-ascorbic acid,response to lipopolysaccharide,response to manganese ion,response to selenium ion,response to silicon dioxide,respon",
        "Group": "Sodium Pyruvate"
    },
    {
        "SNP ID": "rs4880",
        "SNP Name": "SOD2 V16A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4880",
        "Video": null,
        "Tags": "2 superoxide + 2 H+ = O2 + H2O2,acetyl,Acetylation,Acetylation at Lys-122 decreases enzymatic activity,Acute Toxicity among Head and Neck Cancer Patients,adult brain tumors,age-dependent response to reactive oxygen species,age-related macular degeneration,aggressive prostate cancer,aging and longevity,alcohol,AMD,angiogenesis,antioxidant,antipsychotic treatment response and side effects,Antipsychotic-Induced Movement Disorders,antipsychotic-induced side effects,Asbestosis,Asthma,Binds 1 manganese ion per subunit,bladder cancer,blood pressure,brain tumor,Breast Cancer,breast conserving radiotherapy,Bronchopulmonary Dysplasia,cancer,cardio,cardiovascular,Cardiovascular Disease,Catalytic activity,cellular response to ethanol,cofactor,CVD,Cyclophosphamide,depression,Destroys superoxide anion radicals which are normally produced within the cells and which are toxic to biological systems,detection of oxygen,detox,diabetes,diabetes mellitus,diabetic nephropathy leading to end-stage renal disease,diabetic retinopathy,Diabetic Retinopathy in Type 1 Diabetes,Diisocyanate-Induced Asthma,DNA binding,drug response,drugs,energy,Enhanced dityrosine formation on peroxynitrite treatment,erythrophore differentiation,exercise,extracellular vesicular exosome,fat,free radicals,gastric cancer,glaucoma,glutamate,glutathione,glutathione metabolic process,Gray Matter Volume Shrinkage in Alcoholics,Healthy Aging and Longevity,heart,heart development,heart disease,hemopoiesis,hydrogen peroxide,hydrogen peroxide biosynthetic process,identical protein binding,intrinsic apoptotic signaling pathway in response to DNA damage,intrinsic apoptotic signaling pathway in response to oxidative stress,iron,iron ion homeostasis,iron/manganese superoxide dismutase family,ischemia,Kidney Complications in Subjects with Type 1 Diabetes,Kidney disease,kidneys,L-Lysine,L-Tyrosine,liver,liver development,locomotory behavior,lung cancer,lungs,lysine,Manganese,manganese ion binding,MCS,mental disorder,metabolic abnormalities in patients with schizophrenia,metal-binding,Methamphetamine-Associated Psychosis,Microvascular complications of diabetes 6,mitochondrial,mitochondrial inner membrane,mitochondrial matrix,mitochondrial nucleoid,mitochondrion,Mitochondrion matrix,Multiple Chemical Sensitivity,N6-acetyllysine,N6-succinyllysine,negative regulation of cell proliferation,negative regulation of fat cell differentiation,negative regulation of fibroblast proliferation,negative regulation of intrinsic apoptotic signaling pathway in response to oxidative stress,negative regulation of neuron apoptotic process,neuron development,NIHL,Nitrated tyrosine,Nitrated under oxidative stress,Noise Induced Hearing Loss,non-Hodgkin lymphoma,normal tension glaucoma,obesity,oral squamous cell carcinoma,oxidation,oxidative stress,Oxidoreductase,oxygen binding,oxygen homeostasis,pancreatic cancer,Parkinson,Parkinson's Disease,PD,pharmacogenetics,Plasma Advanced Oxidation Protein Products (AOPP),polypoidal choroidal vasculopathy,positive regulation of nitric oxide biosynthetic process,post-embryonic development,postmenopausal breast cancer,premenopausal women,progressive supranuclear palsy,prostate cancer,protein homotetramerization,reactive oxygen species,recurrent depressive disorders,regulation of blood pressure,regulation of catalytic activity,regulation of mitochondrial membrane potential,regulation of transcription from RNA polymerase II promoter,release of cytochrome c from mitochondria,removal of superoxide radicals,renal,renal disease,respiratory electron transport chain,response to activity,response to axon injury,response to cadmium ion,response to drug,response to electrical stimulus,response to gamma radiation,response to hydrogen peroxide,response to hyperoxia,response to hypoxia,response to L-ascorbic acid,response to lipopolysaccharide,response to manganese ion,response to selenium ion,response to silicon dioxide,respon",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs8089",
        "SNP Name": "THBS2 A169617726C",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Calcium Chloride"
    },
    {
        "SNP ID": "rs2069827",
        "SNP Name": "IL6 variant",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs1800797",
        "SNP Name": "IL6 variant",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs2069837",
        "SNP Name": "IL6 A6262G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": "acute inflammatory response,Acute phase,acute-phase response,AD,aging,Alzheimer,Alzheimer's disease,amino acids,antibiotic,antibiotic response,apnea,arteriovenous,arteriovenous malformations of the brain,arthritis,B-cell stimulatory factor 2,B-cells,blood sugar,BMD,bone mineral density,bone remodeling,bones,branching involved in salivary gland morphogenesis,breakdown of fats,BSF-2,C-reactive protein,caffeine,caffeine response,cancer,cancerous,carcinogen,cardio,Cardiovascular,CDF,cell growth,cell redox homeostasis,cellular response to hydrogen peroxide,cellular response to lipopolysaccharide,central nervous system,Cerebral arteriovenous malformation,cerebral palsy,cerebral palsy in children,chronic hepatitis B virus,circadian,circadyan,Classic Kaposi sarcoma,CNS,cold intolerance,collagen,CTL differentiation factor,CVD,cyrcadian,Cytokine,cytokine activity,cytokine-mediated signaling pathway,defense response to Gram-negative bacterium,defense response to Gram-positive bacterium,defense response to protozoan,defense response to virus,dementia,diabetes,diabetes mellitus,Diabetes mellitus type 2,DNA-templated,drug,drug response,drugs,endocrine pancreas development,epithelial cell proliferation involved in salivary gland morphogenesis,external side of plasma membrane,extracellular region,extracellular space,fat,fat metabolism,fats,Gastric Ulcer,glucagon secretion,gluconeogenesis,Growth factor,growth factor activity,heart,heart disease,heat intolerance,hematopoietic progenitor cells,hep B,hep C,hepatic immune response,hepatitis,hepatitis B,hepatitis B virus,Hepatitis C Virus,hepatocytes,hepatosplenomegaly,HIV,humoral immune response,Hybridoma growth factor,IFN-beta-2,IFNB2,Ig-secreting cells,IL-6,IL6,immune system,impaired renal function,infection,inflammation,Inflammatory bowel disease 1,inflammatory response,insulin,insulin resistance,Interferon beta-2,interleukin,Interleukin-6,interleukin-6 receptor binding,interleukin-6 receptor complex,interleukin-6-mediated signaling pathway,Kaposi,Kaposi sarcoma,lipid storage,lymphocyte,monocyte,monocyte chemotaxis,muscle cell cellular homeostasis,myalgia,myeloma,myokine,negative regulation of apoptotic process,negative regulation of cell proliferation,negative regulation of chemokine biosynthetic process,negative regulation of collagen biosynthetic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,negative regulation of cytokine secretion,negative regulation of fat cell differentiation,negative regulation of gluconeogenesis,negative regulation of hormone secretion,negative regulation of lipid storage,negative regulation of muscle organ development,negative regulation of neuron death,negative regulation of protein kinase activity,neurodegenerative disease,neuron projection development,neutrophil apoptotic process,neutrophil mediated immunity,nitric oxide,non-REM sleep,Obstructive Sleep Apnea,Osteoporosis,osteoporotic fracture,palsy,pancreas,pancreatic,pancreatic development,plasmacytoma growth,platelet activation,positive regulation of acute inflammatory response,positive regulation of apoptotic process,positive regulation of B cell activation,positive regulation of cell proliferation,positive regulation of chemokine production,positive regulation of DNA replication,positive regulation of epithelial cell proliferation,positive regulation of ERK1 and ERK2 cascade,positive regulation of immunoglobulin secretion,positive regulation of interleukin-6 production,positive regulation of JAK-STAT cascade,positive regulation of leukocyte chemotaxis,positive regulation of MAPK cascade,positive regulation of neuron differentiation,positive regulation of nitric oxide biosynthetic process,positive regulation of osteoblast differentiation,positive regulation of peptidyl-serine phosphorylation,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of protein import int",
        "Group": "Mercury (Thiomersal/Thimerosal)"
    },
    {
        "SNP ID": "rs2069837",
        "SNP Name": "IL6 A6262G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "acute inflammatory response,Acute phase,acute-phase response,AD,aging,Alzheimer,Alzheimer's disease,amino acids,antibiotic,antibiotic response,apnea,arteriovenous,arteriovenous malformations of the brain,arthritis,B-cell stimulatory factor 2,B-cells,blood sugar,BMD,bone mineral density,bone remodeling,bones,branching involved in salivary gland morphogenesis,breakdown of fats,BSF-2,C-reactive protein,caffeine,caffeine response,cancer,cancerous,carcinogen,cardio,Cardiovascular,CDF,cell growth,cell redox homeostasis,cellular response to hydrogen peroxide,cellular response to lipopolysaccharide,central nervous system,Cerebral arteriovenous malformation,cerebral palsy,cerebral palsy in children,chronic hepatitis B virus,circadian,circadyan,Classic Kaposi sarcoma,CNS,cold intolerance,collagen,CTL differentiation factor,CVD,cyrcadian,Cytokine,cytokine activity,cytokine-mediated signaling pathway,defense response to Gram-negative bacterium,defense response to Gram-positive bacterium,defense response to protozoan,defense response to virus,dementia,diabetes,diabetes mellitus,Diabetes mellitus type 2,DNA-templated,drug,drug response,drugs,endocrine pancreas development,epithelial cell proliferation involved in salivary gland morphogenesis,external side of plasma membrane,extracellular region,extracellular space,fat,fat metabolism,fats,Gastric Ulcer,glucagon secretion,gluconeogenesis,Growth factor,growth factor activity,heart,heart disease,heat intolerance,hematopoietic progenitor cells,hep B,hep C,hepatic immune response,hepatitis,hepatitis B,hepatitis B virus,Hepatitis C Virus,hepatocytes,hepatosplenomegaly,HIV,humoral immune response,Hybridoma growth factor,IFN-beta-2,IFNB2,Ig-secreting cells,IL-6,IL6,immune system,impaired renal function,infection,inflammation,Inflammatory bowel disease 1,inflammatory response,insulin,insulin resistance,Interferon beta-2,interleukin,Interleukin-6,interleukin-6 receptor binding,interleukin-6 receptor complex,interleukin-6-mediated signaling pathway,Kaposi,Kaposi sarcoma,lipid storage,lymphocyte,monocyte,monocyte chemotaxis,muscle cell cellular homeostasis,myalgia,myeloma,myokine,negative regulation of apoptotic process,negative regulation of cell proliferation,negative regulation of chemokine biosynthetic process,negative regulation of collagen biosynthetic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,negative regulation of cytokine secretion,negative regulation of fat cell differentiation,negative regulation of gluconeogenesis,negative regulation of hormone secretion,negative regulation of lipid storage,negative regulation of muscle organ development,negative regulation of neuron death,negative regulation of protein kinase activity,neurodegenerative disease,neuron projection development,neutrophil apoptotic process,neutrophil mediated immunity,nitric oxide,non-REM sleep,Obstructive Sleep Apnea,Osteoporosis,osteoporotic fracture,palsy,pancreas,pancreatic,pancreatic development,plasmacytoma growth,platelet activation,positive regulation of acute inflammatory response,positive regulation of apoptotic process,positive regulation of B cell activation,positive regulation of cell proliferation,positive regulation of chemokine production,positive regulation of DNA replication,positive regulation of epithelial cell proliferation,positive regulation of ERK1 and ERK2 cascade,positive regulation of immunoglobulin secretion,positive regulation of interleukin-6 production,positive regulation of JAK-STAT cascade,positive regulation of leukocyte chemotaxis,positive regulation of MAPK cascade,positive regulation of neuron differentiation,positive regulation of nitric oxide biosynthetic process,positive regulation of osteoblast differentiation,positive regulation of peptidyl-serine phosphorylation,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of protein import int",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs2066992",
        "SNP Name": "IL6 variant",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs1554606",
        "SNP Name": "IL6 T22768707G",
        "Risk Allele": "G",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Mercury (Thiomersal/Thimerosal)"
    },
    {
        "SNP ID": "rs2069849",
        "SNP Name": "IL6 variant",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs730497",
        "SNP Name": "GCK G44223721A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs1799884",
        "SNP Name": "GCK G4955A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs2167364",
        "SNP Name": "DDC T155196C",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2167364",
        "Video": null,
        "Tags": "4-dihydroxyphenylalanine,5-hydroxy-L-tryptophan,5-hydroxytryptamine,AADC,AADCD,Acetylation,alternative splicing,amino acid binding,Aromatic L-amino-acid decarboxylase deficiency,Aromatic-L-amino-acid decarboxylase,aromatic-L-amino-acid decarboxylase activity,autosomal recessive,axon,cancer,cancerous,carcinogen,catalytic activity,catalyze,Catecholamine biosynthesis,catecholamine biosynthetic process,catecholamine deficiency,cellular amino acid metabolic process,cellular nitrogen compound metabolic process,cellular response to alkaloid,cellular response to drug,cellular response to growth factor stimulus,childhood acute lymphoblastic leukemia,circadian rhythm,CO2,Cofactor,Complete proteome,cytosol,DDC,Decarboxylase,decarboxylation,developmental delay,Disease,Disease mutation,DOPA decarboxylase,dopamine,dopamine biosynthesis,dopamine biosynthetic process,early infancy onset,exosome,extracellular vesicular,gastrointestinal disturbances,Glutathione,GSTs,II decarboxylase family,inborn error,indolalkylamine biosynthetic process,inheritance,intermittent hypothermia,isoquinoline alkaloid metabolic process,L-3,L-5-hydroxytryptophan,L-dopa,L-tryptophan,L-tyrosine,lethargy,Leukemia,Lyase,MTHFR,multicellular organismal aging,mutations,neuronal cell body,neurotransmitter,neurotransmitter metabolism,phytoalexin metabolic process,polymorphism,poor feeding,psychomotor delay,ptosis,Pyridoxal phosphate,pyridoxal phosphate binding,Reference proteome,response to pyrethroid,serotonin,serotonin biosynthetic process,small molecule metabolic process,synaptic vesicle,synaptic vesicle amine transport,tryptamine",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1451375",
        "SNP Name": "DDC G15443T",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1451375",
        "Video": null,
        "Tags": "4-dihydroxyphenylalanine,5-hydroxy-L-tryptophan,5-hydroxytryptamine,AADC,AADCD,Acetylation,alternative splicing,amino acid binding,Aromatic L-amino-acid decarboxylase deficiency,Aromatic-L-amino-acid decarboxylase,aromatic-L-amino-acid decarboxylase activity,autoimmune,Autoimmune Disease,autosomal recessive,axon,cancer,cancerous,carcinogen,catalytic activity,catalyze,Catecholamine biosynthesis,catecholamine biosynthetic process,catecholamine deficiency,cellular amino acid metabolic process,cellular nitrogen compound metabolic process,cellular response to alkaloid,cellular response to drug,cellular response to growth factor stimulus,circadian rhythm,CO2,Cofactor,Complete proteome,cytosol,DDC,Decarboxylase,decarboxylation,developmental delay,Disease,Disease mutation,DOPA decarboxylase,dopamine,dopamine biosynthesis,dopamine biosynthetic process,early infancy onset,exosome,extracellular vesicular,gastrointestinal disturbances,II decarboxylase family,inborn error,indolalkylamine biosynthetic process,inheritance,intermittent hypothermia,isoquinoline alkaloid metabolic process,L-3,L-5-hydroxytryptophan,L-dopa,L-tryptophan,L-tyrosine,lethargy,Lyase,Malaria,multicellular organismal aging,mutations,neuronal cell body,neurotransmitter,neurotransmitter metabolism,phytoalexin metabolic process,polymorphism,poor feeding,psychomotor delay,ptosis,Pyridoxal phosphate,pyridoxal phosphate binding,Reference proteome,response to pyrethroid,serotonin,serotonin biosynthetic process,small molecule metabolic process,synaptic vesicle,synaptic vesicle amine transport,tryptamine",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs10230120",
        "SNP Name": "COBL A577A",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Microcrystalline Cellulose"
    },
    {
        "SNP ID": "rs2293347",
        "SNP Name": "EGFR D994D",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Polysorbate 20"
    },
    {
        "SNP ID": "rs2293347",
        "SNP Name": "EGFR D994D",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Deoxycholate"
    },
    {
        "SNP ID": "rs3812316",
        "SNP Name": "MLXIPL or MLX G24H",
        "Risk Allele": "C",
        "Your Allele": "GC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs6951030",
        "SNP Name": "STX1A T73133241G,",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Deoxycholate"
    },
    {
        "SNP ID": "rs4717865",
        "SNP Name": "ELN 16773G>A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs2071307",
        "SNP Name": "ELN Gly422Ser",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs2856728",
        "SNP Name": "ELN 33356C>T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs2528795",
        "SNP Name": "ELN 36068T>C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs41511151",
        "SNP Name": "ELN Gly711Asp",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs6942458",
        "SNP Name": "CACNA2D1 T295518C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Magnesium Sulfate"
    },
    {
        "SNP ID": "rs929351",
        "SNP Name": "CACNA2D1 A220139C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Magnesium Sulfate"
    },
    {
        "SNP ID": "rs662",
        "SNP Name": "PON1 Q192R",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs662",
        "Video": "p3JYJFHpMcg",
        "Tags": "A-esterase 1,Abdominal Aortic Aneurysm,Acute Myocardial Infarction,AD,adult brain tumors,Age-Related Macular Degeneration,ALS,Alzheimer,Alzheimer's disease,Amyotrophic lateral sclerosis,Aneurysm,angiogenesis,Anti-coagulation,Anti-platelet,Anti-platelet Therapy,Aortic Aneurysm,aromatic compound catabolic process,Aromatic esterase 1,aryl dialkyl phosphate + H2O = dialkyl phosphate + an aryl alcohol,aryldialkylphosphatase activity,Arylesterase,arylesterase activity,ASD,associated with HDL (at protein level),associated with stroke protection in pediatric patients with sickle cell anemia,Atherosclerosis,atherothrombotic,Atorvastatin-Lactone Hydrolysis,autism,Autism Spectrum Disorder,Ayurgenomics,Binds 2 calcium ions per subunit,birth defect,blood microparticle,brain astrocytoma,brain tumor,breast cancer,CAD,calcific valvular aortic stenosis,calcium,Calcium 1; catalytic,calcium ion binding,cancer,Capable of hydrolyzing a broad spectrum of organophosphate substrates and lactones and a number of aromatic carboxylic acid esters,carbonyl oxygen,carboxylic acid catabolic process,cardio,cardiovascular,Cardiovascular Disease,Cardiovascular Disease and Type 2 Diabetes,Cardiovascular Pharmacogenomics,Carotid Intima-Media Thickness,Catalytic activity,Cerebral Hemorrhage,chemicals,childhood leukemia,cholesterol,Cholinesterase Activity in Farmworkers Exposed to Organophosphorus Pesticides,Clopidogrel,Clopidogrel Response,coagulation,Coronary Artery Disease,CVD,defect,dephosphorylation,detoxification,developmental neurotoxicity matters,diabetes,diabetes mellitus,diabetic nephropathy leading to end-stage renal disease,diabetic retinopathy,Dietary cholesterol increases paraoxonase 1 enzyme activity,Disulfide bond,Environmental toxicants and autism spectrum disorders,exogenous chemicals with risk of multiple myeloma,extracellular region,extracellular space,extracellular vesicular exosome,Familial Breast Cancer,fat,Future Coronary Artery Disease,glaucoma,glioma,Glycoprotein,Glycosylated,HDL,HDL cholesterol levels,heart,Hemorrhage,Heterooligomer,high-density lipoprotein particle,Histone Methylation,Homodimer,Hydrolase,Hydrolyzes the toxic metabolites of a variety of organophosphorus insecticides,intracellular membrane-bounded organelle,ischemia,ischemic stroke,Ischemic Stroke and Cerebral Hemorrhage,K-45,lactones,lacunar stroke,leukemia,lipid,lipid related cardiovascular disease,lipoprotein,lymphoma,Lymphotoxin-alpha,Lymphotoxin-alpha in Non-hypertensive Patients,Macular Degeneration,Mediates an enzymatic protection of low density lipoproteins against oxidative modification and the consequent series of events leading to atheroma formation,M\u00e9ni\u00e8re's Disease,meningioma,Metabolic Disorders,metabolic syndrome,Metal-binding,Microvascular complications of diabetes 5,multiple myeloma,MVCD5,myeloma,Myocardial Infarction,N-Acetylglucosamine,N-acyl-L-homoserine lactone + H2O = an N-acyl-L-homoserine,neurodegenerative disease,nonfatal myocardial infarction,obesity,Omega 3,Omega-3 fatty acids,Oral Facial Clefts,organophosphate,organophosphate catabolic process,Ovarian Epithelial Carcinoma,overweight,oxidate stress,oxidation,Oxidative Stress,Oxidative Stress in Obesity,palsy,paraoxonase activity,paraoxonase family,Parkinson,Parkinson's disease,PCOS,PD,pesticide,Pharmacogenomics,Pharmacogenomics of Anti-platelet and Anti-coagulation Therapy,phenyl acetate + H2O = a phenol + acetate,phosphate,phosphate-binding protein (HPBP),phosphatidylcholine metabolic process,phospholipid binding,Plasma,platelet,Platelet Reactivity,Platelet Reactivity and Cardiac Adverse Events in Patients Undergoing Percutaneous Coronary Intervention,polycystic ovary syndrome,PON,PON1,positive regulation of binding,positive regulation of cholesterol efflux,positive regulation of transporter activity,primary open angle glaucoma,progressive supranuclear palsy,protein homodimerization activity,Proton acceptor,reactive oxygen s",
        "Group": "Mercury (Thiomersal/Thimerosal)"
    },
    {
        "SNP ID": "rs662",
        "SNP Name": "PON1 Q192R",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs662",
        "Video": "p3JYJFHpMcg",
        "Tags": "A-esterase 1,Abdominal Aortic Aneurysm,Acute Myocardial Infarction,AD,adult brain tumors,Age-Related Macular Degeneration,ALS,Alzheimer,Alzheimer's disease,Amyotrophic lateral sclerosis,Aneurysm,angiogenesis,Anti-coagulation,Anti-platelet,Anti-platelet Therapy,Aortic Aneurysm,aromatic compound catabolic process,Aromatic esterase 1,aryl dialkyl phosphate + H2O = dialkyl phosphate + an aryl alcohol,aryldialkylphosphatase activity,Arylesterase,arylesterase activity,ASD,associated with HDL (at protein level),associated with stroke protection in pediatric patients with sickle cell anemia,Atherosclerosis,atherothrombotic,Atorvastatin-Lactone Hydrolysis,autism,Autism Spectrum Disorder,Ayurgenomics,Binds 2 calcium ions per subunit,birth defect,blood microparticle,brain astrocytoma,brain tumor,breast cancer,CAD,calcific valvular aortic stenosis,calcium,Calcium 1; catalytic,calcium ion binding,cancer,Capable of hydrolyzing a broad spectrum of organophosphate substrates and lactones and a number of aromatic carboxylic acid esters,carbonyl oxygen,carboxylic acid catabolic process,cardio,cardiovascular,Cardiovascular Disease,Cardiovascular Disease and Type 2 Diabetes,Cardiovascular Pharmacogenomics,Carotid Intima-Media Thickness,Catalytic activity,Cerebral Hemorrhage,chemicals,childhood leukemia,cholesterol,Cholinesterase Activity in Farmworkers Exposed to Organophosphorus Pesticides,Clopidogrel,Clopidogrel Response,coagulation,Coronary Artery Disease,CVD,defect,dephosphorylation,detoxification,developmental neurotoxicity matters,diabetes,diabetes mellitus,diabetic nephropathy leading to end-stage renal disease,diabetic retinopathy,Dietary cholesterol increases paraoxonase 1 enzyme activity,Disulfide bond,Environmental toxicants and autism spectrum disorders,exogenous chemicals with risk of multiple myeloma,extracellular region,extracellular space,extracellular vesicular exosome,Familial Breast Cancer,fat,Future Coronary Artery Disease,glaucoma,glioma,Glycoprotein,Glycosylated,HDL,HDL cholesterol levels,heart,Hemorrhage,Heterooligomer,high-density lipoprotein particle,Histone Methylation,Homodimer,Hydrolase,Hydrolyzes the toxic metabolites of a variety of organophosphorus insecticides,intracellular membrane-bounded organelle,ischemia,ischemic stroke,Ischemic Stroke and Cerebral Hemorrhage,K-45,lactones,lacunar stroke,leukemia,lipid,lipid related cardiovascular disease,lipoprotein,lymphoma,Lymphotoxin-alpha,Lymphotoxin-alpha in Non-hypertensive Patients,Macular Degeneration,Mediates an enzymatic protection of low density lipoproteins against oxidative modification and the consequent series of events leading to atheroma formation,M\u00e9ni\u00e8re's Disease,meningioma,Metabolic Disorders,metabolic syndrome,Metal-binding,Microvascular complications of diabetes 5,multiple myeloma,MVCD5,myeloma,Myocardial Infarction,N-Acetylglucosamine,N-acyl-L-homoserine lactone + H2O = an N-acyl-L-homoserine,neurodegenerative disease,nonfatal myocardial infarction,obesity,Omega 3,Omega-3 fatty acids,Oral Facial Clefts,organophosphate,organophosphate catabolic process,Ovarian Epithelial Carcinoma,overweight,oxidate stress,oxidation,Oxidative Stress,Oxidative Stress in Obesity,palsy,paraoxonase activity,paraoxonase family,Parkinson,Parkinson's disease,PCOS,PD,pesticide,Pharmacogenomics,Pharmacogenomics of Anti-platelet and Anti-coagulation Therapy,phenyl acetate + H2O = a phenol + acetate,phosphate,phosphate-binding protein (HPBP),phosphatidylcholine metabolic process,phospholipid binding,Plasma,platelet,Platelet Reactivity,Platelet Reactivity and Cardiac Adverse Events in Patients Undergoing Percutaneous Coronary Intervention,polycystic ovary syndrome,PON,PON1,positive regulation of binding,positive regulation of cholesterol efflux,positive regulation of transporter activity,primary open angle glaucoma,progressive supranuclear palsy,protein homodimerization activity,Proton acceptor,reactive oxygen s",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs10264272",
        "SNP Name": "CYP3A5*6 G624A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs10264272",
        "Video": null,
        "Tags": "Acids,ado-trastuzumab emtansine,Alfentanil,alkaloid catabolic process,Alprazolam,alternative splicing,Amiodarone,Amitriptyline,Amlodipine,AmprenavirApixaban,Aprepitant,Argatroban,Aripiprazole,aromatase activity,Artemether,ARTIFICIAL ESTROGEN,Astemizole,Atorvastatin,Axitinib,Azelastine,Beclomethasone,blood pressure,Boceprevir,BP,Brentuximab vedotin,Buprenorphine,Buspirone,Cabazitaxel,Caffeine,calcineurin inhibitors,CANCER,CANCEROUS,Carbamazepine,CARCINOGEN,Chloramphenicol,Chloroquine,Chlorphenamine,cholesterol,Cilostazol,Cimetidine,Ciprofloxacin,Cisapride,Clarithromycin,Clonidine,Clopidogrel,Cocaine,Codeine,COMPOUNDS,Crizotinib,CyclophosphamideCyclosporine,cyclosporine,cyclosporine levels,CYP,CYP P450,CYP3A5,CYPIIIA5,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A5,Cytochrome P450 HLp2,Cytochrome P450-PCN3,cytochromes,Dapsone,Dasatinib,Daunorubicin,Delavirdine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diltiazem,Disulfiram,Docetaxel,Dolutegravir,Domperidone,DRUG,drug catabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,electron,elevated blood pressure,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Eplerenone,Erlotinib,Erythromycin,Estradiol,ESTROGEN,Estrone,Ethosuximide,Etoposide,FAST METABOLIZER,fat,FATTY ACIDS,FelodipineFentanyl,Finasteride,Fluconazole,Fluoxetine,Flutamide,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Gefitinib,Gestodene,Granisetron,Halofantrine,Haloperidol,heme,heme binding,heme-thiolate monooxygenases,high BP,HORMONAL BALANCE,HORMONAL IMBALANCE,HORMONE,Hydrocortisone,hypertension,Ifosfamide,Iloperidone,Imatinib,Indinavir,intracellular membrane-bounded organelle,Irinotecan,iron,iron ion binding,Itraconazole,Ketoconazole,Lapatinib,Lercanidipine,Levomethadyl Acetate,Lidocaine,liver microsomes,Losartan,Lovastatin,Membrane,Metal-binding,Methadone,Microsome,Microsome membrane,microsomes,Midazolam,Mifepristone,Modafinil,Monooxygenase,monooxygenase activity,Mycophenolate mofetil,NADPH,NADPH-dependent electron transport pathway,Nateglinide,Nefazodone,Nelfinavir,Nevirapine,Nicardipine,Nifedipine,Nimodipine,Nisoldipine,Nitrendipine,Norethindrone,Norfloxacin,Nortriptyline,nucleotide,Ondansetron,Oxazepam,Oxcarbazepine,OXIDATION,oxidative demethylation,Oxidoreductase,oxidoreductase activity,Oxybutynin,Oxycodone,oxygen binding,P450,Paclitaxel,Paliperidone,Pentamidine,Perampanel,Peripheral membrane protein,pharmacogenomics,Phenelzine,Phenobarbital,Phenytoin,Pimozide,Ponatinib,Pravastatin,Praziquantel,Progesterone,Propranolol,protein,Quetiapine,Quinacrine,Quinine,Ranitidine,RAPID METABOLISM,RAPID METABOLIZER,Reserpine,RETINOID,RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O,Rifampicin,Rifapentine,Risperidone,Ritonavir,Rivaroxaban,Rosuvastatin,Salmeterol,Saquinavir,Saxagliptin,Sildenafil,Simvastatin,Sirolimus,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,STEROID,steroid metabolic process,Sulfasalazine,Sunitinib,synthesis,Tacrolimus,Tacrolimus dose selection,tacrolimus levels,Tamoxifen,Telithromycin,Temsirolimus,Teniposide,TESTOSTERONE,Thalidomide,TOXIC,TOXICITY,transcript,Trazodone,Tretinoin,Triazolam,Troleandomycin,TUMOR,TUMOR GROWTH,Udenafil,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Vardenafil,Verapamil,Vincristine,Voriconazole,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN,Zalcitabine,Zaleplon,Ziprasidone,Zolpidem",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs10264272",
        "SNP Name": "CYP3A5*6 G624A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs10264272",
        "Video": null,
        "Tags": "Acids,ado-trastuzumab emtansine,Alfentanil,alkaloid catabolic process,Alprazolam,alternative splicing,Amiodarone,Amitriptyline,Amlodipine,AmprenavirApixaban,Aprepitant,Argatroban,Aripiprazole,aromatase activity,Artemether,ARTIFICIAL ESTROGEN,Astemizole,Atorvastatin,Axitinib,Azelastine,Beclomethasone,blood pressure,Boceprevir,BP,Brentuximab vedotin,Buprenorphine,Buspirone,Cabazitaxel,Caffeine,calcineurin inhibitors,CANCER,CANCEROUS,Carbamazepine,CARCINOGEN,Chloramphenicol,Chloroquine,Chlorphenamine,cholesterol,Cilostazol,Cimetidine,Ciprofloxacin,Cisapride,Clarithromycin,Clonidine,Clopidogrel,Cocaine,Codeine,COMPOUNDS,Crizotinib,CyclophosphamideCyclosporine,cyclosporine,cyclosporine levels,CYP,CYP P450,CYP3A5,CYPIIIA5,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A5,Cytochrome P450 HLp2,Cytochrome P450-PCN3,cytochromes,Dapsone,Dasatinib,Daunorubicin,Delavirdine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diltiazem,Disulfiram,Docetaxel,Dolutegravir,Domperidone,DRUG,drug catabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,electron,elevated blood pressure,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Eplerenone,Erlotinib,Erythromycin,Estradiol,ESTROGEN,Estrone,Ethosuximide,Etoposide,FAST METABOLIZER,fat,FATTY ACIDS,FelodipineFentanyl,Finasteride,Fluconazole,Fluoxetine,Flutamide,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Gefitinib,Gestodene,Granisetron,Halofantrine,Haloperidol,heme,heme binding,heme-thiolate monooxygenases,high BP,HORMONAL BALANCE,HORMONAL IMBALANCE,HORMONE,Hydrocortisone,hypertension,Ifosfamide,Iloperidone,Imatinib,Indinavir,intracellular membrane-bounded organelle,Irinotecan,iron,iron ion binding,Itraconazole,Ketoconazole,Lapatinib,Lercanidipine,Levomethadyl Acetate,Lidocaine,liver microsomes,Losartan,Lovastatin,Membrane,Metal-binding,Methadone,Microsome,Microsome membrane,microsomes,Midazolam,Mifepristone,Modafinil,Monooxygenase,monooxygenase activity,Mycophenolate mofetil,NADPH,NADPH-dependent electron transport pathway,Nateglinide,Nefazodone,Nelfinavir,Nevirapine,Nicardipine,Nifedipine,Nimodipine,Nisoldipine,Nitrendipine,Norethindrone,Norfloxacin,Nortriptyline,nucleotide,Ondansetron,Oxazepam,Oxcarbazepine,OXIDATION,oxidative demethylation,Oxidoreductase,oxidoreductase activity,Oxybutynin,Oxycodone,oxygen binding,P450,Paclitaxel,Paliperidone,Pentamidine,Perampanel,Peripheral membrane protein,pharmacogenomics,Phenelzine,Phenobarbital,Phenytoin,Pimozide,Ponatinib,Pravastatin,Praziquantel,Progesterone,Propranolol,protein,Quetiapine,Quinacrine,Quinine,Ranitidine,RAPID METABOLISM,RAPID METABOLIZER,Reserpine,RETINOID,RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O,Rifampicin,Rifapentine,Risperidone,Ritonavir,Rivaroxaban,Rosuvastatin,Salmeterol,Saquinavir,Saxagliptin,Sildenafil,Simvastatin,Sirolimus,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,STEROID,steroid metabolic process,Sulfasalazine,Sunitinib,synthesis,Tacrolimus,Tacrolimus dose selection,tacrolimus levels,Tamoxifen,Telithromycin,Temsirolimus,Teniposide,TESTOSTERONE,Thalidomide,TOXIC,TOXICITY,transcript,Trazodone,Tretinoin,Triazolam,Troleandomycin,TUMOR,TUMOR GROWTH,Udenafil,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Vardenafil,Verapamil,Vincristine,Voriconazole,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN,Zalcitabine,Zaleplon,Ziprasidone,Zolpidem",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs776746",
        "SNP Name": "CYP3A5*3 G237A",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs776746",
        "Video": null,
        "Tags": "acetaminophen,acetaminophen-induced acute liver failure,Acids,acute leukemia,acute rejection in kidney transplantation,adjuvant chemotherapy-induced neutropenia,ado-trastuzumab emtansine,advanced renal-cell carcinoma,AIDS,Alfentanil,alkaloid catabolic process,allogeneic hematopoietic stem cell transplantation,Alprazolam,alternative splicing,Amiodarone,Amitriptyline,Amlodipine,AmprenavirApixaban,anti-tuberculosis drug-induced hepatotoxicity,Aprepitant,Argatroban,Aripiprazole,aromatase activity,Artemether,ARTIFICIAL ESTROGEN,Astemizole,atherothrombotic,atherothrombotic events in stroke patients,Atorvastatin,Axitinib,Azelastine,Beclomethasone,blood pressure,Boceprevir,BP,breast cancer,Brentuximab vedotin,Buprenorphine,Buspirone,Cabazitaxel,Caffeine,calcineurin inhibitor nephrotoxicity,calcineurin inhibitors,calcineurin inhibitors in allogeneic hematopoietic SCT recipients,calcineurin-inhibitor,calcineurin-inhibitor toxicity in heart transplant,CANCER,CANCEROUS,Carbamazepine,CARCINOGEN,carcinoma,cerebral infarctions,chemotherapy,chemotherapy-induced neutropenia,Chloramphenicol,Chloroquine,Chlorphenamine,cholesterol,chronic myeloid leukemia,chronic obstructive pulmonary disease,Cilostazol,Cimetidine,Ciprofloxacin,Cisapride,Clarithromycin,Clonidine,Clopidogrel,Cocaine,Codeine,colorectal cancer,COMPOUNDS,COPD,Crizotinib,CyclophosphamideCyclosporine,cyclosporine,cyclosporine blood levels,cyclosporine metabolism,CYP,CYP P450,CYP3A5,CYPIIIA5,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A5,Cytochrome P450 HLp2,Cytochrome P450-PCN3,cytochromes,Dapsone,Dasatinib,Daunorubicin,Delavirdine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diltiazem,Disulfiram,Docetaxel,Dolutegravir,Domperidone,DRUG,drug catabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Early Age Acute Leukemia,electron,elevated blood pressure,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Eplerenone,Erlotinib,Erythromycin,Estradiol,ESTROGEN,Estrone,Ethosuximide,Etoposide,FAST METABOLIZER,fat,FATTY ACIDS,FelodipineFentanyl,Finasteride,Fluconazole,Fluoxetine,Flutamide,Fluticasone Propionate,Fluvastatin,Fluvoxamine,FOLFIRI chemotherapy,Gefitinib,Gestodene,Granisetron,Halofantrine,Haloperidol,heart transplant,heme,heme binding,heme-thiolate monooxygenases,hepatotoxicity,high BP,HIV,HIV-1,HORMONAL BALANCE,HORMONAL IMBALANCE,HORMONE,human proximal tubule cells,Hydrocortisone,hypertension,hypertension in pregnancy,Ifosfamide,Iloperidone,Imatinib,immunosuppressants,Indinavir,intracellular membrane-bounded organelle,Irinotecan,iron,iron ion binding,ischemic stroke,Itraconazole,Ketoconazole,kidney transplant,Lapatinib,Lercanidipine,leukemia,Levomethadyl Acetate,Lidocaine,lipid-lowering response to atorvastatin,lipids,liver failure,liver microsomes,liver transplant,Losartan,Lovastatin,lung,lung function,Membrane,Metal-binding,metastatic colorectal cancer,Methadone,Microsome,Microsome membrane,microsomes,Midazolam,Mifepristone,Modafinil,Monooxygenase,monooxygenase activity,Mycophenolate mofetil,NADPH,NADPH-dependent electron transport pathway,Nateglinide,Nefazodone,Nelfinavir,neutropenia,Nevirapine,Nicardipine,Nifedipine,Nimodipine,Nisoldipine,Nitrendipine,Norethindrone,Norfloxacin,Nortriptyline,nucleotide,Ondansetron,Oxazepam,Oxcarbazepine,OXIDATION,oxidative demethylation,Oxidoreductase,oxidoreductase activity,Oxybutynin,Oxycodone,oxygen binding,P450,Paclitaxel,paediatric tuberculosis,Paliperidone,Pentamidine,Perampanel,Peripheral membrane protein,Pharmacogenetics,pharmacogenomic,pharmacogenomics,pharmacokinetics,Phenelzine,Phenobarbital,Phenytoin,Pimozide,Ponatinib,Pravastatin,Praziquantel,Progesterone,Propranolol,prostate cancer,protein,proximal tubule cells,Quetiapine,Quinacrine,Quinine,Ranitidine,RAPID",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs776746",
        "SNP Name": "CYP3A5*3 G237A",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs776746",
        "Video": null,
        "Tags": "acetaminophen,acetaminophen-induced acute liver failure,Acids,acute leukemia,acute rejection in kidney transplantation,adjuvant chemotherapy-induced neutropenia,ado-trastuzumab emtansine,advanced renal-cell carcinoma,AIDS,Alfentanil,alkaloid catabolic process,allogeneic hematopoietic stem cell transplantation,Alprazolam,alternative splicing,Amiodarone,Amitriptyline,Amlodipine,AmprenavirApixaban,anti-tuberculosis drug-induced hepatotoxicity,Aprepitant,Argatroban,Aripiprazole,aromatase activity,Artemether,ARTIFICIAL ESTROGEN,Astemizole,atherothrombotic,atherothrombotic events in stroke patients,Atorvastatin,Axitinib,Azelastine,Beclomethasone,blood pressure,Boceprevir,BP,breast cancer,Brentuximab vedotin,Buprenorphine,Buspirone,Cabazitaxel,Caffeine,calcineurin inhibitor nephrotoxicity,calcineurin inhibitors,calcineurin inhibitors in allogeneic hematopoietic SCT recipients,calcineurin-inhibitor,calcineurin-inhibitor toxicity in heart transplant,CANCER,CANCEROUS,Carbamazepine,CARCINOGEN,carcinoma,cerebral infarctions,chemotherapy,chemotherapy-induced neutropenia,Chloramphenicol,Chloroquine,Chlorphenamine,cholesterol,chronic myeloid leukemia,chronic obstructive pulmonary disease,Cilostazol,Cimetidine,Ciprofloxacin,Cisapride,Clarithromycin,Clonidine,Clopidogrel,Cocaine,Codeine,colorectal cancer,COMPOUNDS,COPD,Crizotinib,CyclophosphamideCyclosporine,cyclosporine,cyclosporine blood levels,cyclosporine metabolism,CYP,CYP P450,CYP3A5,CYPIIIA5,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A5,Cytochrome P450 HLp2,Cytochrome P450-PCN3,cytochromes,Dapsone,Dasatinib,Daunorubicin,Delavirdine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diltiazem,Disulfiram,Docetaxel,Dolutegravir,Domperidone,DRUG,drug catabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Early Age Acute Leukemia,electron,elevated blood pressure,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Eplerenone,Erlotinib,Erythromycin,Estradiol,ESTROGEN,Estrone,Ethosuximide,Etoposide,FAST METABOLIZER,fat,FATTY ACIDS,FelodipineFentanyl,Finasteride,Fluconazole,Fluoxetine,Flutamide,Fluticasone Propionate,Fluvastatin,Fluvoxamine,FOLFIRI chemotherapy,Gefitinib,Gestodene,Granisetron,Halofantrine,Haloperidol,heart transplant,heme,heme binding,heme-thiolate monooxygenases,hepatotoxicity,high BP,HIV,HIV-1,HORMONAL BALANCE,HORMONAL IMBALANCE,HORMONE,human proximal tubule cells,Hydrocortisone,hypertension,hypertension in pregnancy,Ifosfamide,Iloperidone,Imatinib,immunosuppressants,Indinavir,intracellular membrane-bounded organelle,Irinotecan,iron,iron ion binding,ischemic stroke,Itraconazole,Ketoconazole,kidney transplant,Lapatinib,Lercanidipine,leukemia,Levomethadyl Acetate,Lidocaine,lipid-lowering response to atorvastatin,lipids,liver failure,liver microsomes,liver transplant,Losartan,Lovastatin,lung,lung function,Membrane,Metal-binding,metastatic colorectal cancer,Methadone,Microsome,Microsome membrane,microsomes,Midazolam,Mifepristone,Modafinil,Monooxygenase,monooxygenase activity,Mycophenolate mofetil,NADPH,NADPH-dependent electron transport pathway,Nateglinide,Nefazodone,Nelfinavir,neutropenia,Nevirapine,Nicardipine,Nifedipine,Nimodipine,Nisoldipine,Nitrendipine,Norethindrone,Norfloxacin,Nortriptyline,nucleotide,Ondansetron,Oxazepam,Oxcarbazepine,OXIDATION,oxidative demethylation,Oxidoreductase,oxidoreductase activity,Oxybutynin,Oxycodone,oxygen binding,P450,Paclitaxel,paediatric tuberculosis,Paliperidone,Pentamidine,Perampanel,Peripheral membrane protein,Pharmacogenetics,pharmacogenomic,pharmacogenomics,pharmacokinetics,Phenelzine,Phenobarbital,Phenytoin,Pimozide,Ponatinib,Pravastatin,Praziquantel,Progesterone,Propranolol,prostate cancer,protein,proximal tubule cells,Quetiapine,Quinacrine,Quinine,Ranitidine,RAPID",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs1041988",
        "SNP Name": "CYP3A4 C1431T",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": "91ugq1mPu-k",
        "Tags": null,
        "Group": "FD&C Yellow #6 Aluminum Lake Dye"
    },
    {
        "SNP ID": "rs4646440",
        "SNP Name": "CYP3A4 C608T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs4646440",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizide,Glyburide,Granisetron,Griseofulvin,Guanethidine",
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs4646440",
        "SNP Name": "CYP3A4 C608T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs4646440",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizide,Glyburide,Granisetron,Griseofulvin,Guanethidine",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs2242480",
        "SNP Name": "CYP3A4*_20239G>A G12A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs2242480",
        "Video": "91ugq1mPu-k",
        "Tags": "25-hydroxyvitamin D,Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,CAD,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,coronary heart disease,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,drug side effects,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,Fatal methadone toxicity,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Gal",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs4646437",
        "SNP Name": "CYP3A4 C202T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs4646437",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,drug side effects,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,finasteride and prostate cancer,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizide",
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs4646437",
        "SNP Name": "CYP3A4 C202T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs4646437",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,drug side effects,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,finasteride and prostate cancer,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizide",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs2246709",
        "SNP Name": "CYP3A4 T258C",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs2246709",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,chemotherapy,Chenodeoxycholic acid,childhood acute lymphoblastic leukemia,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizi",
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs2246709",
        "SNP Name": "CYP3A4 T258C",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs2246709",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,chemotherapy,Chenodeoxycholic acid,childhood acute lymphoblastic leukemia,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizi",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs55785340",
        "SNP Name": "CYP3A4*2 S222P",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://cancerres.aacrjournals.org/content/72/8_Supplement/1883.short",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizide,Glyburide,Granisetron,Griseofulvin,Guanethidine",
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs55785340",
        "SNP Name": "CYP3A4*2 S222P",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://cancerres.aacrjournals.org/content/72/8_Supplement/1883.short",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizide,Glyburide,Granisetron,Griseofulvin,Guanethidine",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs55901263",
        "SNP Name": "CYP3A4*5 P218R",
        "Risk Allele": "C",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://cancerres.aacrjournals.org/content/72/8_Supplement/1883.short",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizide,Glyburide,Granisetron,Griseofulvin,Guanethidine",
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs55901263",
        "SNP Name": "CYP3A4*5 P218R",
        "Risk Allele": "C",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://cancerres.aacrjournals.org/content/72/8_Supplement/1883.short",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizide,Glyburide,Granisetron,Griseofulvin,Guanethidine",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs12721627",
        "SNP Name": "CYP3A4*16 T185S",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2807960/",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizide,Glyburide,Granisetron,Griseofulvin,Guanethidine",
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs12721627",
        "SNP Name": "CYP3A4*16 T185S",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2807960/",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizide,Glyburide,Granisetron,Griseofulvin,Guanethidine",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs35599367",
        "SNP Name": "CYP3A4 C191T",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs35599367",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,AIDS,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,chemotherapy,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,cholesterol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,fat,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizide,Glyburide,G",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs55951658",
        "SNP Name": "CYP3A4*4 I118V",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://cancerres.aacrjournals.org/content/72/8_Supplement/1883.short",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizide,Glyburide,Granisetron,Griseofulvin,Guanethidine",
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs55951658",
        "SNP Name": "CYP3A4*4 I118V",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://cancerres.aacrjournals.org/content/72/8_Supplement/1883.short",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizide,Glyburide,Granisetron,Griseofulvin,Guanethidine",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs3091339",
        "SNP Name": "CYP3A4*_11460A>G(K96E) K96E",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs3091339",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizide,Glyburide,Granisetron,Griseofulvin,Guanethidine",
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs3091339",
        "SNP Name": "CYP3A4*_11460A>G(K96E) K96E",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs3091339",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizide,Glyburide,Granisetron,Griseofulvin,Guanethidine",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs56324128",
        "SNP Name": "CYP3A4*7 G56D",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://eurheartj.oxfordjournals.org/content/early/2015/04/22/eurheartj.ehv116.abstract",
        "Video": "91ugq1mPu-k",
        "Tags": "Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors with incorporation or reduction of molecular oxygen,Adinazolam,ado-trastuzumab emtansine,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,androgen metabolic process,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benzphetamine,Benzyl alcohol,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,Boceprevir,Bortezomib,Bosentan,Bosutinib,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desvenlafaxine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Disopyramide,Disulfiram,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,Econazole,Efavirenz,Eletriptan,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,Epinastine,Epinephrine,Eplerenone,Ergocalciferol,Ergoloid mesylate,Ergonovine,Ergotamine,Erlotinib,Erythromycin,Escitalopram,Esomeprazole,Estazolam,Estradiol,Estradiol valerate/Dienogest,Estramustine,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Ethinyl Estradiol,Ethosuximide,Ethylmorphine,Etonogestrel,Etoposide,Etoricoxib,Etravirine,Everolimus,Exemestane,exogenous drug catabolic process,Ezetimibe,Famciclovir,FAST METABOLIZER,FATTY ACIDS,Felbamate,Felodipine,Fenofibrate,Fentanyl,Fesoterodine,Finasteride,Fingolimod,Flucloxacillin,Fluconazole,Flunisolide,Flunitrazepam,Fluorometholone,Fluoxetine,Flurazepam,Flutamide,Fluticasone furoate,Fluticasone Propionate,Fluvastatin,Fluvoxamine,Fosamprenavir,Fosphenytoin,Fulvestrant,Galantamine,Gefitinib,Gemfibrozil,Glipizide,Glyburide,Granisetron,Griseofulvin,Guanethidine",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs2740574",
        "SNP Name": "CYP3A4*1B A392G",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs2740574",
        "Video": "91ugq1mPu-k",
        "Tags": "1,8-cineole + NADP+ + H2O,8-cineole + NADPH + O2 = 2-exo-hydroxy-1,8-cineole 2-exo-monooxygenase,Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors,acting on paired donors with incorporation or reduction of molecular oxygen,Acute Leukemia,Adinazolam,ado-trastuzumab emtansine,AIDS Clinical Trials,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,Aliskiren,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,and incorporation of one atom of oxygen,androgen metabolic process,antibiotic response,antibiotics,Antineoplastic Drugs,Antineoplastic Drugs metabolism,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benazepril,Benzphetamine,Benzyl alcohol,Bepridil,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,blood pressure,Boceprevir,Bortezomib,Bosentan,Bosutinib,breast and ovarian cancer,breast cancer,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,calcineurin inhibitors,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,cancer,cancerous,Carbamazepine,carbamazepine major metabolism,Carbinoxamine,carcinogen,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,chemotherapy,chemotherapy response,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpheniramine,Chlorpromazine,Chlorzoxazone,Cholecalciferol,cholesterol,chronic migraine,chronic myeloid leukemia patients receiving imatinib therapy,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,Clofibrate,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,colorectal cancer,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,cyclophosphamide metabolism pathway,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cyproterone,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desogestrel,Desvenlafaxine,detox,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,diabetes,Diabetes Mellitus,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Disopyramide,Disulfiram,DNA repair,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,Drospirenone,DRUG,drug catabolic process,drug metabolic process,drug metabolism,DRUG POISONING,drug response,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,E2,Early Age Acute Leukemia,Early Hypertensive Renal Disease,Econazole,Efavirenz,Eletriptan,elevated blood pressure,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,environmental,environmental factors,Enzalutamide,enzyme binding,epilepsy,Epinastine,Epi",
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs2740574",
        "SNP Name": "CYP3A4*1B A392G",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs2740574",
        "Video": "91ugq1mPu-k",
        "Tags": "1,8-cineole + NADP+ + H2O,8-cineole + NADPH + O2 = 2-exo-hydroxy-1,8-cineole 2-exo-monooxygenase,Abiraterone,Acenocoumarol,Acetaminophen,Acetazolamide,acting on paired donors,acting on paired donors with incorporation or reduction of molecular oxygen,Acute Leukemia,Adinazolam,ado-trastuzumab emtansine,AIDS Clinical Trials,Albendazole,Albendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O,Albendazole monooxygenase,albendazole monooxygenase activity,Albendazole sulfoxidase,Alclometasone,Aldesleukin,Alfentanil,Alfuzosin,Alimemazine,Aliskiren,alkaloid catabolic process,Allylestrenol,Almotriptan,Alogliptin,Alosetron,Alprazolam,Ambroxol,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Amprenavir,Anastrozole,and incorporation of one atom of oxygen,androgen metabolic process,antibiotic response,antibiotics,Antineoplastic Drugs,Antineoplastic Drugs metabolism,Antipyrine,Apixaban,Aprepitant,Argatroban,Aripiprazole,Arsenic trioxide,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atazanavir,Atomoxetine,Atorvastatin,Avanafil,Axitinib,Azatadine,Azelastine,Azithromycin,Bedaquiline,Benazepril,Benzphetamine,Benzyl alcohol,Bepridil,Betamethasone,Bexarotene,Bezafibrate,Bicalutamide,Bifonazole,Bisoprolol,blood pressure,Boceprevir,Bortezomib,Bosentan,Bosutinib,breast and ovarian cancer,breast cancer,Brentuximab vedotin,Brinzolamide,Bromazepam,Bromocriptine,Brompheniramine,Budesonide,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Busulfan,Cabazitaxel,Cabergoline,Cabozantinib,caffeine,caffeine 8-oxidation,caffeine metabolism,caffeine oxidase activity,calcineurin inhibitors,Calcitriol,calcitriol biosynthetic process from calciol,Canagliflozin,cancer,cancerous,Carbamazepine,carbamazepine major metabolism,Carbinoxamine,carcinogen,Carvedilol,Caspofungin,Cefradine,Celecoxib,Cephalexin,Cevimeline,chemotherapy,chemotherapy response,Chenodeoxycholic acid,Chloramphenicol,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorphenesin,Chlorpheniramine,Chlorpromazine,Chlorzoxazone,Cholecalciferol,cholesterol,chronic migraine,chronic myeloid leukemia patients receiving imatinib therapy,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,cineole,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clemastine,Clevidipine,Clindamycin,Clobazam,Clofazimine,Clofibrate,ClofibrateClomifene,Clomipramine,Clonazepam,Clonidine,Clopidogrel,Clorazepate,Clotiazepam,Clotrimazole,Clozapine,Cocaine,Codeine,coffee,Colchicine,colorectal cancer,COMPOUNDS,Conivaptan,Conjugated Estrogens,Cortisone acetate,Crizotinib,Cyclobenzaprine,Cyclophosphamide,cyclophosphamide metabolism pathway,Cyclosporine,CYP,CYP P450,CYP3A4,CYPIIIA3,CYPIIIA4,Cyproterone,Cytarabine,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 3A3,Cytochrome P450 3A4,Cytochrome P450 HLp,Cytochrome P450 NF-25,Cytochrome P450-PCN1,cytoplasm,Dabrafenib,Dalfopristin,Danazol,Dantrolene,Dapagliflozin,Dapsone,Darifenacin,Darunavir,Dasatinib,Daunorubicin,Deferasirox,Delavirdine,Desipramine,Desogestrel,Desvenlafaxine,detox,DETOXIFICATION,Dexamethasone,Dextromethorphan,Dextropropoxyphene,diabetes,Diabetes Mellitus,Diazepam,Diclofenac,Dicloxacillin,Diethylstilbestrol,Digitoxin,Digoxin,Dihydrocodeine,Dihydroergotamine,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Disopyramide,Disulfiram,DNA repair,Docetaxel,Dofetilide,Dolasetron,Dolutegravir,Domperidone,Donepezil,Dorzolamide,Doxepin,Doxorubicin,Doxycycline,Dronabinol,Dronedarone,Drospirenone,DRUG,drug catabolic process,drug metabolic process,drug metabolism,DRUG POISONING,drug response,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Dutasteride,E2,Early Age Acute Leukemia,Early Hypertensive Renal Disease,Econazole,Efavirenz,Eletriptan,elevated blood pressure,Enalapril,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,environmental,environmental factors,Enzalutamide,enzyme binding,epilepsy,Epinastine,Epi",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs7636",
        "SNP Name": "ACHE P477P",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dulbecco's Modified Eagle Medium"
    },
    {
        "SNP ID": "rs7636",
        "SNP Name": "ACHE P477P",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Monosodium Phosphate"
    },
    {
        "SNP ID": "rs7636",
        "SNP Name": "ACHE P477P",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phosphate-Buffered Saline"
    },
    {
        "SNP ID": "rs7636",
        "SNP Name": "ACHE P477P",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Chloride"
    },
    {
        "SNP ID": "rs2227692",
        "SNP Name": "SERPINE1 C38812087T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dulbecco's Modified Eagle Medium"
    },
    {
        "SNP ID": "rs2227692",
        "SNP Name": "SERPINE1 C38812087T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Monosodium Phosphate"
    },
    {
        "SNP ID": "rs2227692",
        "SNP Name": "SERPINE1 C38812087T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phosphate-Buffered Saline"
    },
    {
        "SNP ID": "rs2227692",
        "SNP Name": "SERPINE1 C38812087T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Chloride"
    },
    {
        "SNP ID": "rs7242",
        "SNP Name": "SERPINE1 T16067G",
        "Risk Allele": "G",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dulbecco's Modified Eagle Medium"
    },
    {
        "SNP ID": "rs7242",
        "SNP Name": "SERPINE1 T16067G",
        "Risk Allele": "G",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Monosodium Phosphate"
    },
    {
        "SNP ID": "rs7242",
        "SNP Name": "SERPINE1 T16067G",
        "Risk Allele": "G",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phosphate-Buffered Saline"
    },
    {
        "SNP ID": "rs7242",
        "SNP Name": "SERPINE1 T16067G",
        "Risk Allele": "G",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Chloride"
    },
    {
        "SNP ID": "rs10263341",
        "SNP Name": "DLD T19214C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10263341",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs10263341",
        "SNP Name": "DLD T19214C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10263341",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs121909011",
        "SNP Name": "CTFR R334W",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Deoxycholate"
    },
    {
        "SNP ID": "rs113993959",
        "SNP Name": "CFTR G542X",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Deoxycholate"
    },
    {
        "SNP ID": "rs121909005",
        "SNP Name": "CTFR G1647T",
        "Risk Allele": "G",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Deoxycholate"
    },
    {
        "SNP ID": "rs121908760",
        "SNP Name": "CFTR C2125T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Deoxycholate"
    },
    {
        "SNP ID": "rs121908810",
        "SNP Name": "CTFR C2290T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Deoxycholate"
    },
    {
        "SNP ID": "rs121908797",
        "SNP Name": "CTFR C2988G",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Deoxycholate"
    },
    {
        "SNP ID": "rs2167270",
        "SNP Name": "LEP G127881349A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs4728142",
        "SNP Name": "IRF5 variant",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs4728142",
        "Video": null,
        "Tags": null,
        "Group": "IgA"
    },
    {
        "SNP ID": "rs969356",
        "SNP Name": "TPK1 C364824T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs969356",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs1049748",
        "SNP Name": "ABP1 P574P",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/21488903",
        "Video": "dCnRGmH0hxQ",
        "Tags": "3-diamine oxidase activity,ABP1,allergic,allergy,amiloride,Amiloride-binding protein 1,Amiloride-sensitive amine oxidase,Amine oxidase copper domain-containing protein 1,Amniota,AOC1,apoptosis,asthma,avalox,Calcium,calcium ion binding,calcium ions,Catarrhini,cation channel activity,cell proliferation,childhood,Chordata,cipro,copper,copper containing,copper dependent,copper ion,copper ion binding,copper-containing,copper/topaquinone oxidase family,DAO,DAO1,Diamine oxidase,diamine oxidase activity,Dipnotetrapodomorpha,Disulfide bond,disulfide-linked,drug binding,dusykfude,Euarchontoglires,Eukaryota,Euteleostomi,Eutheria,female reproductive function,fluoroquinolone,fluoroquinolones,Glycoprotein,heparin binding,Histaminase,Histamine,histamine oxidase activity,Hominidae,Homo,Homodimer,Hypersensitivity Response to Non-Steroidal Anti-Inflammatory Drugs,immune responses,KAO,kidney,Kidney  amine oxidase,Kidney amine oxidase,levequin,Mammalia,metal binding,methylputrescine oxidase activity,osteonecrosis,Oxidoreductase,P574P,Placenta,Placental DAO,Polymorphism,primary amine oxidase activity,Primates,propane-1,protein complex binding,protein homodimerization activity,putrescine,quinone binding,receptor activity,Red Man Syndrome,reproduction,RMS,rs1049748,sodium channel activity,spermidine,spermine,Tetrapoda,tissue differentiation,topaquinone,topaquinone oxidase,TPQ,tumor formation,zinc ion binding,zoledronic acid-related osteonecrosis,\u00a0 Craniata,\u00a0 Hominoidea,\u00a0 Opisthokonta \u203a  Metazoa,\u00a0 Sarcopterygii,\u00a0 tyrosyl,\u00a0 Vertebrata",
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs1049748",
        "SNP Name": "ABP1 P574P",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/21488903",
        "Video": "dCnRGmH0hxQ",
        "Tags": "3-diamine oxidase activity,ABP1,allergic,allergy,amiloride,Amiloride-binding protein 1,Amiloride-sensitive amine oxidase,Amine oxidase copper domain-containing protein 1,Amniota,AOC1,apoptosis,asthma,avalox,Calcium,calcium ion binding,calcium ions,Catarrhini,cation channel activity,cell proliferation,childhood,Chordata,cipro,copper,copper containing,copper dependent,copper ion,copper ion binding,copper-containing,copper/topaquinone oxidase family,DAO,DAO1,Diamine oxidase,diamine oxidase activity,Dipnotetrapodomorpha,Disulfide bond,disulfide-linked,drug binding,dusykfude,Euarchontoglires,Eukaryota,Euteleostomi,Eutheria,female reproductive function,fluoroquinolone,fluoroquinolones,Glycoprotein,heparin binding,Histaminase,Histamine,histamine oxidase activity,Hominidae,Homo,Homodimer,Hypersensitivity Response to Non-Steroidal Anti-Inflammatory Drugs,immune responses,KAO,kidney,Kidney  amine oxidase,Kidney amine oxidase,levequin,Mammalia,metal binding,methylputrescine oxidase activity,osteonecrosis,Oxidoreductase,P574P,Placenta,Placental DAO,Polymorphism,primary amine oxidase activity,Primates,propane-1,protein complex binding,protein homodimerization activity,putrescine,quinone binding,receptor activity,Red Man Syndrome,reproduction,RMS,rs1049748,sodium channel activity,spermidine,spermine,Tetrapoda,tissue differentiation,topaquinone,topaquinone oxidase,TPQ,tumor formation,zinc ion binding,zoledronic acid-related osteonecrosis,\u00a0 Craniata,\u00a0 Hominoidea,\u00a0 Opisthokonta \u203a  Metazoa,\u00a0 Sarcopterygii,\u00a0 tyrosyl,\u00a0 Vertebrata",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs1049748",
        "SNP Name": "ABP1 P574P",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/21488903",
        "Video": "dCnRGmH0hxQ",
        "Tags": "3-diamine oxidase activity,ABP1,allergic,allergy,amiloride,Amiloride-binding protein 1,Amiloride-sensitive amine oxidase,Amine oxidase copper domain-containing protein 1,Amniota,AOC1,apoptosis,asthma,avalox,Calcium,calcium ion binding,calcium ions,Catarrhini,cation channel activity,cell proliferation,childhood,Chordata,cipro,copper,copper containing,copper dependent,copper ion,copper ion binding,copper-containing,copper/topaquinone oxidase family,DAO,DAO1,Diamine oxidase,diamine oxidase activity,Dipnotetrapodomorpha,Disulfide bond,disulfide-linked,drug binding,dusykfude,Euarchontoglires,Eukaryota,Euteleostomi,Eutheria,female reproductive function,fluoroquinolone,fluoroquinolones,Glycoprotein,heparin binding,Histaminase,Histamine,histamine oxidase activity,Hominidae,Homo,Homodimer,Hypersensitivity Response to Non-Steroidal Anti-Inflammatory Drugs,immune responses,KAO,kidney,Kidney  amine oxidase,Kidney amine oxidase,levequin,Mammalia,metal binding,methylputrescine oxidase activity,osteonecrosis,Oxidoreductase,P574P,Placenta,Placental DAO,Polymorphism,primary amine oxidase activity,Primates,propane-1,protein complex binding,protein homodimerization activity,putrescine,quinone binding,receptor activity,Red Man Syndrome,reproduction,RMS,rs1049748,sodium channel activity,spermidine,spermine,Tetrapoda,tissue differentiation,topaquinone,topaquinone oxidase,TPQ,tumor formation,zinc ion binding,zoledronic acid-related osteonecrosis,\u00a0 Craniata,\u00a0 Hominoidea,\u00a0 Opisthokonta \u203a  Metazoa,\u00a0 Sarcopterygii,\u00a0 tyrosyl,\u00a0 Vertebrata",
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs1800779",
        "SNP Name": "NOS3 G6797A",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1800779",
        "Video": null,
        "Tags": "2 L-arginine + 3 NADPH + 4 O2 = 2 L-citrulline + 2 nitric oxide + 3 NADP+ + 4 H2O,actin monomer binding,air pollution and Obesity,Alternative splicing,angiogenesis,arginine,arginine binding,arginine catabolic process,BH4,Binds 1 FAD,Binds 1 FMN,birth defect,blood coagulation,blood pressure,blood vessel remodeling,cadmium ion binding,calcium,calmodulin,Calmodulin-binding,cardiovascular,Cardiovascular Disease,caveola,Cell membrane,Cerebral Palsy,cGMP-mediated signal transduction pathway,chronic obstructive pulmonary disease,cNOS,Complete proteome,Constitutive NOS,Contains 1 FAD-binding FR-type domain,Contains 1 flavodoxin-like domain,CVD,Cytoplasm,Cytoplasm \u203a cytoskeleton,Cytoskeleton,cytosol,defect,Direct protein sequencing,drug reaction,EC-NOS,endocytic vesicle membrane,endothelial,endothelial cell migration,Endothelial NOS,eNOS,FAD,fat,ferritin,flavin adenine dinucleotide binding,Flavoprotein,FMN,FMN binding,Gene-Environment Interaction Effects on the Development of Immune Responses in the 1st Year of Life,glaucoma,Golgi apparatus,Golgi membrane,heart,heart defect,heart disease,heme,heme binding,Heme group,high BP,high-tension Primary Open Angle Glaucoma,Homodimer,hypertension,hypoxic-ischemic encephalopathy,In absence of Ca2+-calmodulin AMPK also phosphorylates Thr-495 resulting in inhibition of activity By similarity,in utero embryonic development,inflammation,Inhibited by NOSIP and NOSTRIN,interaction with host,Interactions with Sex and Postmenopausal Hormone Use,Interacts with NOSIP and NOSTRIN,Iron,iron ion binding,ischemic stroke,Isoform eNOS13C:Lacks eNOS activity dominant-negative form that may down-regulate eNOS activity by forming heterodimers with isoform 1,kidney,L-arginine,lipid,lipopolysaccharide-mediated signaling pathway,Lipoprotein,liver,lung development,Lymphotoxin-alpha,Membrane,Membrane \u203a caveola,Metal-binding,Methamphetamine-Induced Psychosis,Migraine and Stroke,mitochondrion organization,Myristate,NAD,NADP,NADP binding,NADPH,NADPH-hemoprotein reductase activity,negative regulation of blood pressure,negative regulation of calcium ion transport,negative regulation of cell proliferation,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of hydrolase activity,negative regulation of muscle hyperplasia,negative regulation of platelet activation,negative regulation of potassium ion transport,nitric oxide biosynthetic process,nitric oxide mediated signal transduction,nitric oxide metabolic process,Nitric oxide synthase,nitric-oxide synthase activity,NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets,NOS family,NOS type III,NOS3,NOSIII,nosip,nostrin,nucleus,Open-Angle Glaucoma,ovulation from ovarian follicle,Oxidoreductase,Palmitate,phagosome maturation,Pharmacogenetics,phosphate,Phosphoprotein,Phosphorylation by AMPK at Ser-1177 in the presence of Ca2+-calmodulin (CaM) activates activity,Phosphorylation of Ser-114 by CDK5 reduces activity,placenta,placental function,plasma membrane,Platelets,PMS,Polymorphism,positive regulation of angiogenesis,positive regulation of guanylate cyclase activity,positive regulation of vasodilation,pregnancy,Produces nitric oxide (NO),Recovery from Aneurysmal Subarachnoid Hemorrhage,Recurrent Venous Thromboembolism,Reference proteome,regulation of blood pressure,regulation of blood vessel size,regulation of nitric-oxide synthase activity,regulation of sodium ion transport,regulation of systemic arterial blood pressure by endothelin,regulation of the force of heart contraction by chemical signal,response to fluid shear stress,response to heat,sclerosis,small molecule metabolic process,smooth muscle hyperplasia,Specifically associates with actin cytoskeleton in the G2 phase of the cell cycle; which is favored by interaction with NOSIP and results in a reduced en",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs1800779",
        "SNP Name": "NOS3 G6797A",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1800779",
        "Video": null,
        "Tags": "2 L-arginine + 3 NADPH + 4 O2 = 2 L-citrulline + 2 nitric oxide + 3 NADP+ + 4 H2O,actin monomer binding,air pollution and Obesity,Alternative splicing,angiogenesis,arginine,arginine binding,arginine catabolic process,BH4,Binds 1 FAD,Binds 1 FMN,birth defect,blood coagulation,blood pressure,blood vessel remodeling,cadmium ion binding,calcium,calmodulin,Calmodulin-binding,cardiovascular,Cardiovascular Disease,caveola,Cell membrane,Cerebral Palsy,cGMP-mediated signal transduction pathway,chronic obstructive pulmonary disease,cNOS,Complete proteome,Constitutive NOS,Contains 1 FAD-binding FR-type domain,Contains 1 flavodoxin-like domain,CVD,Cytoplasm,Cytoplasm \u203a cytoskeleton,Cytoskeleton,cytosol,defect,Direct protein sequencing,drug reaction,EC-NOS,endocytic vesicle membrane,endothelial,endothelial cell migration,Endothelial NOS,eNOS,FAD,fat,ferritin,flavin adenine dinucleotide binding,Flavoprotein,FMN,FMN binding,Gene-Environment Interaction Effects on the Development of Immune Responses in the 1st Year of Life,glaucoma,Golgi apparatus,Golgi membrane,heart,heart defect,heart disease,heme,heme binding,Heme group,high BP,high-tension Primary Open Angle Glaucoma,Homodimer,hypertension,hypoxic-ischemic encephalopathy,In absence of Ca2+-calmodulin AMPK also phosphorylates Thr-495 resulting in inhibition of activity By similarity,in utero embryonic development,inflammation,Inhibited by NOSIP and NOSTRIN,interaction with host,Interactions with Sex and Postmenopausal Hormone Use,Interacts with NOSIP and NOSTRIN,Iron,iron ion binding,ischemic stroke,Isoform eNOS13C:Lacks eNOS activity dominant-negative form that may down-regulate eNOS activity by forming heterodimers with isoform 1,kidney,L-arginine,lipid,lipopolysaccharide-mediated signaling pathway,Lipoprotein,liver,lung development,Lymphotoxin-alpha,Membrane,Membrane \u203a caveola,Metal-binding,Methamphetamine-Induced Psychosis,Migraine and Stroke,mitochondrion organization,Myristate,NAD,NADP,NADP binding,NADPH,NADPH-hemoprotein reductase activity,negative regulation of blood pressure,negative regulation of calcium ion transport,negative regulation of cell proliferation,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of hydrolase activity,negative regulation of muscle hyperplasia,negative regulation of platelet activation,negative regulation of potassium ion transport,nitric oxide biosynthetic process,nitric oxide mediated signal transduction,nitric oxide metabolic process,Nitric oxide synthase,nitric-oxide synthase activity,NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets,NOS family,NOS type III,NOS3,NOSIII,nosip,nostrin,nucleus,Open-Angle Glaucoma,ovulation from ovarian follicle,Oxidoreductase,Palmitate,phagosome maturation,Pharmacogenetics,phosphate,Phosphoprotein,Phosphorylation by AMPK at Ser-1177 in the presence of Ca2+-calmodulin (CaM) activates activity,Phosphorylation of Ser-114 by CDK5 reduces activity,placenta,placental function,plasma membrane,Platelets,PMS,Polymorphism,positive regulation of angiogenesis,positive regulation of guanylate cyclase activity,positive regulation of vasodilation,pregnancy,Produces nitric oxide (NO),Recovery from Aneurysmal Subarachnoid Hemorrhage,Recurrent Venous Thromboembolism,Reference proteome,regulation of blood pressure,regulation of blood vessel size,regulation of nitric-oxide synthase activity,regulation of sodium ion transport,regulation of systemic arterial blood pressure by endothelin,regulation of the force of heart contraction by chemical signal,response to fluid shear stress,response to heat,sclerosis,small molecule metabolic process,smooth muscle hyperplasia,Specifically associates with actin cytoskeleton in the G2 phase of the cell cycle; which is favored by interaction with NOSIP and results in a reduced en",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs1800779",
        "SNP Name": "NOS3 G6797A",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1800779",
        "Video": null,
        "Tags": "2 L-arginine + 3 NADPH + 4 O2 = 2 L-citrulline + 2 nitric oxide + 3 NADP+ + 4 H2O,actin monomer binding,air pollution and Obesity,Alternative splicing,angiogenesis,arginine,arginine binding,arginine catabolic process,BH4,Binds 1 FAD,Binds 1 FMN,birth defect,blood coagulation,blood pressure,blood vessel remodeling,cadmium ion binding,calcium,calmodulin,Calmodulin-binding,cardiovascular,Cardiovascular Disease,caveola,Cell membrane,Cerebral Palsy,cGMP-mediated signal transduction pathway,chronic obstructive pulmonary disease,cNOS,Complete proteome,Constitutive NOS,Contains 1 FAD-binding FR-type domain,Contains 1 flavodoxin-like domain,CVD,Cytoplasm,Cytoplasm \u203a cytoskeleton,Cytoskeleton,cytosol,defect,Direct protein sequencing,drug reaction,EC-NOS,endocytic vesicle membrane,endothelial,endothelial cell migration,Endothelial NOS,eNOS,FAD,fat,ferritin,flavin adenine dinucleotide binding,Flavoprotein,FMN,FMN binding,Gene-Environment Interaction Effects on the Development of Immune Responses in the 1st Year of Life,glaucoma,Golgi apparatus,Golgi membrane,heart,heart defect,heart disease,heme,heme binding,Heme group,high BP,high-tension Primary Open Angle Glaucoma,Homodimer,hypertension,hypoxic-ischemic encephalopathy,In absence of Ca2+-calmodulin AMPK also phosphorylates Thr-495 resulting in inhibition of activity By similarity,in utero embryonic development,inflammation,Inhibited by NOSIP and NOSTRIN,interaction with host,Interactions with Sex and Postmenopausal Hormone Use,Interacts with NOSIP and NOSTRIN,Iron,iron ion binding,ischemic stroke,Isoform eNOS13C:Lacks eNOS activity dominant-negative form that may down-regulate eNOS activity by forming heterodimers with isoform 1,kidney,L-arginine,lipid,lipopolysaccharide-mediated signaling pathway,Lipoprotein,liver,lung development,Lymphotoxin-alpha,Membrane,Membrane \u203a caveola,Metal-binding,Methamphetamine-Induced Psychosis,Migraine and Stroke,mitochondrion organization,Myristate,NAD,NADP,NADP binding,NADPH,NADPH-hemoprotein reductase activity,negative regulation of blood pressure,negative regulation of calcium ion transport,negative regulation of cell proliferation,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of hydrolase activity,negative regulation of muscle hyperplasia,negative regulation of platelet activation,negative regulation of potassium ion transport,nitric oxide biosynthetic process,nitric oxide mediated signal transduction,nitric oxide metabolic process,Nitric oxide synthase,nitric-oxide synthase activity,NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets,NOS family,NOS type III,NOS3,NOSIII,nosip,nostrin,nucleus,Open-Angle Glaucoma,ovulation from ovarian follicle,Oxidoreductase,Palmitate,phagosome maturation,Pharmacogenetics,phosphate,Phosphoprotein,Phosphorylation by AMPK at Ser-1177 in the presence of Ca2+-calmodulin (CaM) activates activity,Phosphorylation of Ser-114 by CDK5 reduces activity,placenta,placental function,plasma membrane,Platelets,PMS,Polymorphism,positive regulation of angiogenesis,positive regulation of guanylate cyclase activity,positive regulation of vasodilation,pregnancy,Produces nitric oxide (NO),Recovery from Aneurysmal Subarachnoid Hemorrhage,Recurrent Venous Thromboembolism,Reference proteome,regulation of blood pressure,regulation of blood vessel size,regulation of nitric-oxide synthase activity,regulation of sodium ion transport,regulation of systemic arterial blood pressure by endothelin,regulation of the force of heart contraction by chemical signal,response to fluid shear stress,response to heat,sclerosis,small molecule metabolic process,smooth muscle hyperplasia,Specifically associates with actin cytoskeleton in the G2 phase of the cell cycle; which is favored by interaction with NOSIP and results in a reduced en",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2070744",
        "SNP Name": "NOS3 T786C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2070744",
        "Video": null,
        "Tags": "2 L-arginine + 3 NADPH + 4 O2 = 2 L-citrulline + 2 nitric oxide + 3 NADP+ + 4 H2O,actin monomer binding,Age Onset of Menarche in Sickle Cell Disease,albuminuria,Alternative splicing,angiogenesis,Angiogenesis and Endothelial Dysfunction in Preeclampsia,angiogenesis pathway,Ankle-Brachial Index,ankylosing spondylitis,arginine,arginine binding,arginine catabolic process,associated with albumin to creatinine,athlete status,Atrial Fibrillation,BH4,bicuspid aortic valve and ascending aorta complications,Binds 1 FAD,Binds 1 FMN,blood coagulation,blood pressure,blood vessel remodeling,Bone Density,cadmium ion binding,calcium,calmodulin,Calmodulin-binding,cancer,cancerous,carcinogen,cardiovascular,Cardiovascular Disease in Patients with Hypertension,caveola,Cell membrane,Cerebral vasospasm,cGMP-mediated signal transduction pathway,cNOS,Complete proteome,Constitutive NOS,Contains 1 FAD-binding FR-type domain,Contains 1 flavodoxin-like domain,Coronary Artery Disease,Coronary Restenosis,CVD,Cytoplasm,Cytoplasm \u203a cytoskeleton,Cytoskeleton,cytosol,diabetes,diabetic nephropathy,Dilated Cardiomyopathy,Direct protein sequencing,drug response,early-onset colorectal cancer,EC-NOS,end-stage renal disease,endocytic vesicle membrane,endothelial,endothelial cell migration,Endothelial Function to Migraine and Stroke,Endothelial NOS,eNOS,Esophageal Adenocarcinoma,essential hypertension,Exercise,FAD,fasting blood lipids,fat,ferritin,Fitness,flavin adenine dinucleotide binding,Flavoprotein,FMN,FMN binding,gentamicin-induced vestibular dysfunction,Golgi apparatus,Golgi membrane,growth factor pathway,heart,heart failure,heme,heme binding,Heme group,hemorrhage,high BP,Homodimer,Hypertension,hypoxic-ischemic encephalopathy,idiopathic pulmonary arterial hypertension,idiopathic recurrent miscarriage,In absence of Ca2+-calmodulin AMPK also phosphorylates Thr-495 resulting in inhibition of activity By similarity,in utero embryonic development,inflammation,Inhibited by NOSIP and NOSTRIN,interaction with host,Interactions with Sex and Postmenopausal Hormone Use,Interacts with NOSIP and NOSTRIN,IRM,Iron,iron ion binding,Isoform eNOS13C:Lacks eNOS activity dominant-negative form that may down-regulate eNOS activity by forming heterodimers with isoform 1,kidney,L-arginine,Left Ventricular Hypertrophy,leisure-time physical activity on serum triglyceride levels,lipid,lipopolysaccharide-mediated signaling pathway,Lipoprotein,liver,lung development,Membrane,Membrane \u203a caveola,metabolic syndrome,metabolic syndrome and endothelial function in schizophrenia,Metal-binding,Methamphetamine-Induced Psychosis,migraine,miscarriage,mitochondrion organization,Myristate,NAD,NADP,NADP binding,NADPH,NADPH-hemoprotein reductase activity,negative regulation of blood pressure,negative regulation of calcium ion transport,negative regulation of cell proliferation,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of hydrolase activity,negative regulation of muscle hyperplasia,negative regulation of platelet activation,negative regulation of potassium ion transport,nitric oxide biosynthetic process,nitric oxide mediated signal transduction,nitric oxide metabolic process,Nitric oxide synthase,nitric-oxide synthase activity,NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets,NOS family,NOS type III,NOS3,NOSIII,nosip,nostrin,nucleus,Open-Angle Glaucoma: Interactions with Hypertension and Alcohol and Cigarette Smoking,ovulation from ovarian follicle,Oxidoreductase,Palmitate,Performance,phagosome maturation,pharmacogenetics,phosphate,Phosphoprotein,Phosphorylation by AMPK at Ser-1177 in the presence of Ca2+-calmodulin (CaM) activates activity,Phosphorylation of Ser-114 by CDK5 reduces activity,placenta,plasma membrane,Platelets,PMS,Polymorphism,positive regulation",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2070744",
        "SNP Name": "NOS3 T786C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2070744",
        "Video": null,
        "Tags": "2 L-arginine + 3 NADPH + 4 O2 = 2 L-citrulline + 2 nitric oxide + 3 NADP+ + 4 H2O,actin monomer binding,Age Onset of Menarche in Sickle Cell Disease,albuminuria,Alternative splicing,angiogenesis,Angiogenesis and Endothelial Dysfunction in Preeclampsia,angiogenesis pathway,Ankle-Brachial Index,ankylosing spondylitis,arginine,arginine binding,arginine catabolic process,associated with albumin to creatinine,athlete status,Atrial Fibrillation,BH4,bicuspid aortic valve and ascending aorta complications,Binds 1 FAD,Binds 1 FMN,blood coagulation,blood pressure,blood vessel remodeling,Bone Density,cadmium ion binding,calcium,calmodulin,Calmodulin-binding,cancer,cancerous,carcinogen,cardiovascular,Cardiovascular Disease in Patients with Hypertension,caveola,Cell membrane,Cerebral vasospasm,cGMP-mediated signal transduction pathway,cNOS,Complete proteome,Constitutive NOS,Contains 1 FAD-binding FR-type domain,Contains 1 flavodoxin-like domain,Coronary Artery Disease,Coronary Restenosis,CVD,Cytoplasm,Cytoplasm \u203a cytoskeleton,Cytoskeleton,cytosol,diabetes,diabetic nephropathy,Dilated Cardiomyopathy,Direct protein sequencing,drug response,early-onset colorectal cancer,EC-NOS,end-stage renal disease,endocytic vesicle membrane,endothelial,endothelial cell migration,Endothelial Function to Migraine and Stroke,Endothelial NOS,eNOS,Esophageal Adenocarcinoma,essential hypertension,Exercise,FAD,fasting blood lipids,fat,ferritin,Fitness,flavin adenine dinucleotide binding,Flavoprotein,FMN,FMN binding,gentamicin-induced vestibular dysfunction,Golgi apparatus,Golgi membrane,growth factor pathway,heart,heart failure,heme,heme binding,Heme group,hemorrhage,high BP,Homodimer,Hypertension,hypoxic-ischemic encephalopathy,idiopathic pulmonary arterial hypertension,idiopathic recurrent miscarriage,In absence of Ca2+-calmodulin AMPK also phosphorylates Thr-495 resulting in inhibition of activity By similarity,in utero embryonic development,inflammation,Inhibited by NOSIP and NOSTRIN,interaction with host,Interactions with Sex and Postmenopausal Hormone Use,Interacts with NOSIP and NOSTRIN,IRM,Iron,iron ion binding,Isoform eNOS13C:Lacks eNOS activity dominant-negative form that may down-regulate eNOS activity by forming heterodimers with isoform 1,kidney,L-arginine,Left Ventricular Hypertrophy,leisure-time physical activity on serum triglyceride levels,lipid,lipopolysaccharide-mediated signaling pathway,Lipoprotein,liver,lung development,Membrane,Membrane \u203a caveola,metabolic syndrome,metabolic syndrome and endothelial function in schizophrenia,Metal-binding,Methamphetamine-Induced Psychosis,migraine,miscarriage,mitochondrion organization,Myristate,NAD,NADP,NADP binding,NADPH,NADPH-hemoprotein reductase activity,negative regulation of blood pressure,negative regulation of calcium ion transport,negative regulation of cell proliferation,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of hydrolase activity,negative regulation of muscle hyperplasia,negative regulation of platelet activation,negative regulation of potassium ion transport,nitric oxide biosynthetic process,nitric oxide mediated signal transduction,nitric oxide metabolic process,Nitric oxide synthase,nitric-oxide synthase activity,NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets,NOS family,NOS type III,NOS3,NOSIII,nosip,nostrin,nucleus,Open-Angle Glaucoma: Interactions with Hypertension and Alcohol and Cigarette Smoking,ovulation from ovarian follicle,Oxidoreductase,Palmitate,Performance,phagosome maturation,pharmacogenetics,phosphate,Phosphoprotein,Phosphorylation by AMPK at Ser-1177 in the presence of Ca2+-calmodulin (CaM) activates activity,Phosphorylation of Ser-114 by CDK5 reduces activity,placenta,plasma membrane,Platelets,PMS,Polymorphism,positive regulation",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs2070744",
        "SNP Name": "NOS3 T786C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2070744",
        "Video": null,
        "Tags": "2 L-arginine + 3 NADPH + 4 O2 = 2 L-citrulline + 2 nitric oxide + 3 NADP+ + 4 H2O,actin monomer binding,Age Onset of Menarche in Sickle Cell Disease,albuminuria,Alternative splicing,angiogenesis,Angiogenesis and Endothelial Dysfunction in Preeclampsia,angiogenesis pathway,Ankle-Brachial Index,ankylosing spondylitis,arginine,arginine binding,arginine catabolic process,associated with albumin to creatinine,athlete status,Atrial Fibrillation,BH4,bicuspid aortic valve and ascending aorta complications,Binds 1 FAD,Binds 1 FMN,blood coagulation,blood pressure,blood vessel remodeling,Bone Density,cadmium ion binding,calcium,calmodulin,Calmodulin-binding,cancer,cancerous,carcinogen,cardiovascular,Cardiovascular Disease in Patients with Hypertension,caveola,Cell membrane,Cerebral vasospasm,cGMP-mediated signal transduction pathway,cNOS,Complete proteome,Constitutive NOS,Contains 1 FAD-binding FR-type domain,Contains 1 flavodoxin-like domain,Coronary Artery Disease,Coronary Restenosis,CVD,Cytoplasm,Cytoplasm \u203a cytoskeleton,Cytoskeleton,cytosol,diabetes,diabetic nephropathy,Dilated Cardiomyopathy,Direct protein sequencing,drug response,early-onset colorectal cancer,EC-NOS,end-stage renal disease,endocytic vesicle membrane,endothelial,endothelial cell migration,Endothelial Function to Migraine and Stroke,Endothelial NOS,eNOS,Esophageal Adenocarcinoma,essential hypertension,Exercise,FAD,fasting blood lipids,fat,ferritin,Fitness,flavin adenine dinucleotide binding,Flavoprotein,FMN,FMN binding,gentamicin-induced vestibular dysfunction,Golgi apparatus,Golgi membrane,growth factor pathway,heart,heart failure,heme,heme binding,Heme group,hemorrhage,high BP,Homodimer,Hypertension,hypoxic-ischemic encephalopathy,idiopathic pulmonary arterial hypertension,idiopathic recurrent miscarriage,In absence of Ca2+-calmodulin AMPK also phosphorylates Thr-495 resulting in inhibition of activity By similarity,in utero embryonic development,inflammation,Inhibited by NOSIP and NOSTRIN,interaction with host,Interactions with Sex and Postmenopausal Hormone Use,Interacts with NOSIP and NOSTRIN,IRM,Iron,iron ion binding,Isoform eNOS13C:Lacks eNOS activity dominant-negative form that may down-regulate eNOS activity by forming heterodimers with isoform 1,kidney,L-arginine,Left Ventricular Hypertrophy,leisure-time physical activity on serum triglyceride levels,lipid,lipopolysaccharide-mediated signaling pathway,Lipoprotein,liver,lung development,Membrane,Membrane \u203a caveola,metabolic syndrome,metabolic syndrome and endothelial function in schizophrenia,Metal-binding,Methamphetamine-Induced Psychosis,migraine,miscarriage,mitochondrion organization,Myristate,NAD,NADP,NADP binding,NADPH,NADPH-hemoprotein reductase activity,negative regulation of blood pressure,negative regulation of calcium ion transport,negative regulation of cell proliferation,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of hydrolase activity,negative regulation of muscle hyperplasia,negative regulation of platelet activation,negative regulation of potassium ion transport,nitric oxide biosynthetic process,nitric oxide mediated signal transduction,nitric oxide metabolic process,Nitric oxide synthase,nitric-oxide synthase activity,NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets,NOS family,NOS type III,NOS3,NOSIII,nosip,nostrin,nucleus,Open-Angle Glaucoma: Interactions with Hypertension and Alcohol and Cigarette Smoking,ovulation from ovarian follicle,Oxidoreductase,Palmitate,Performance,phagosome maturation,pharmacogenetics,phosphate,Phosphoprotein,Phosphorylation by AMPK at Ser-1177 in the presence of Ca2+-calmodulin (CaM) activates activity,Phosphorylation of Ser-114 by CDK5 reduces activity,placenta,plasma membrane,Platelets,PMS,Polymorphism,positive regulation",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs3918226",
        "SNP Name": "NOS3 variant",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs2853792",
        "SNP Name": "NOS3 variant",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs3918227",
        "SNP Name": "NOS3 variant",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs2853796",
        "SNP Name": "NOS3 variant",
        "Risk Allele": "G",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs743507",
        "SNP Name": "NOS3 variant",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs7830",
        "SNP Name": "NOS3 G10T",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7830",
        "Video": null,
        "Tags": "2 L-arginine + 3 NADPH + 4 O2 = 2 L-citrulline + 2 nitric oxide + 3 NADP+ + 4 H2O,actin monomer binding,Alternative splicing,angiogenesis,ankle-brachial index,arginine,arginine binding,arginine catabolic process,Asthma,BH4,Binds 1 FAD,Binds 1 FMN,blood coagulation,Blood Pressure Response,Blood Pressure Response to Potassium Supplementation is Associated with Genetic Variation,blood vessel remodeling,cadmium ion binding,calcium,calmodulin,Calmodulin-binding,cardiovascular,caveola,Cell membrane,cGMP-mediated signal transduction pathway,cNOS,Complete proteome,Constitutive NOS,Contains 1 FAD-binding FR-type domain,Contains 1 flavodoxin-like domain,CVD,Cytoplasm,Cytoplasm \u203a cytoskeleton,Cytoskeleton,cytosol,Direct protein sequencing,EC-NOS,end-stage renal disease,endocytic vesicle membrane,endothelial,endothelial cell migration,Endothelial NOS,eNOS,FAD,fat,ferritin,flavin adenine dinucleotide binding,Flavoprotein,FMN,FMN binding,Golgi apparatus,Golgi membrane,heart,heme,heme binding,Heme group,Homodimer,hypertensive adults,In absence of Ca2+-calmodulin AMPK also phosphorylates Thr-495 resulting in inhibition of activity By similarity,in utero embryonic development,Inhibited by NOSIP and NOSTRIN,interaction with host,Interactions with Hypertension and Alcohol and Cigarette Smoking,Interactions with Sex and Postmenopausal Hormone Use,Interacts with NOSIP and NOSTRIN,Iron,iron ion binding,Isoform eNOS13C:Lacks eNOS activity dominant-negative form that may down-regulate eNOS activity by forming heterodimers with isoform 1,kidney,L-arginine,lipid,lipopolysaccharide-mediated signaling pathway,Lipoprotein,liver,lung development,Membrane,Membrane \u203a caveola,Metal-binding,Methamphetamine-Induced Psychosis,mitochondrion organization,Myocardial Infarction,Myristate,NAD,NADP,NADP binding,NADPH,NADPH-hemoprotein reductase activity,negative regulation of blood pressure,negative regulation of calcium ion transport,negative regulation of cell proliferation,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of hydrolase activity,negative regulation of muscle hyperplasia,negative regulation of platelet activation,negative regulation of potassium ion transport,nitric oxide biosynthetic process,nitric oxide mediated signal transduction,nitric oxide metabolic process,Nitric oxide synthase,nitric-oxide synthase activity,NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets,NOS family,NOS type III,NOS3,NOSIII,nosip,nostrin,nucleus,Open-Angle Glaucoma,ovulation from ovarian follicle,Oxidoreductase,Palmitate,peripheral arterial disease,phagosome maturation,phosphate,Phosphoprotein,Phosphorylation by AMPK at Ser-1177 in the presence of Ca2+-calmodulin (CaM) activates activity,Phosphorylation of Ser-114 by CDK5 reduces activity,placenta,plasma membrane,Platelets,Polymorphism,positive regulation of angiogenesis,positive regulation of guanylate cyclase activity,positive regulation of vasodilation,Primary Open-Angle Glaucoma,Produces nitric oxide (NO),Reference proteome,regulation of blood pressure,regulation of blood vessel size,regulation of nitric-oxide synthase activity,regulation of sodium ion transport,regulation of systemic arterial blood pressure by endothelin,regulation of the force of heart contraction by chemical signal,response to fluid shear stress,response to heat,small molecule metabolic process,smooth muscle hyperplasia,Specifically associates with actin cytoskeleton in the G2 phase of the cell cycle; which is favored by interaction with NOSIP and results in a reduced enzymatic activity,stabilize the dimeric form of the enzyme,Stimulated by calcium/calmodulin,Tetrahydrobiopterin (BH4),tetrahydrobiopterin binding,THP,Variation in NOS3 seem to be associated with susceptibility to coronary spasm,vascular smooth muscle relaxation,Zinc",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs7830",
        "SNP Name": "NOS3 G10T",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7830",
        "Video": null,
        "Tags": "2 L-arginine + 3 NADPH + 4 O2 = 2 L-citrulline + 2 nitric oxide + 3 NADP+ + 4 H2O,actin monomer binding,Alternative splicing,angiogenesis,ankle-brachial index,arginine,arginine binding,arginine catabolic process,Asthma,BH4,Binds 1 FAD,Binds 1 FMN,blood coagulation,Blood Pressure Response,Blood Pressure Response to Potassium Supplementation is Associated with Genetic Variation,blood vessel remodeling,cadmium ion binding,calcium,calmodulin,Calmodulin-binding,cardiovascular,caveola,Cell membrane,cGMP-mediated signal transduction pathway,cNOS,Complete proteome,Constitutive NOS,Contains 1 FAD-binding FR-type domain,Contains 1 flavodoxin-like domain,CVD,Cytoplasm,Cytoplasm \u203a cytoskeleton,Cytoskeleton,cytosol,Direct protein sequencing,EC-NOS,end-stage renal disease,endocytic vesicle membrane,endothelial,endothelial cell migration,Endothelial NOS,eNOS,FAD,fat,ferritin,flavin adenine dinucleotide binding,Flavoprotein,FMN,FMN binding,Golgi apparatus,Golgi membrane,heart,heme,heme binding,Heme group,Homodimer,hypertensive adults,In absence of Ca2+-calmodulin AMPK also phosphorylates Thr-495 resulting in inhibition of activity By similarity,in utero embryonic development,Inhibited by NOSIP and NOSTRIN,interaction with host,Interactions with Hypertension and Alcohol and Cigarette Smoking,Interactions with Sex and Postmenopausal Hormone Use,Interacts with NOSIP and NOSTRIN,Iron,iron ion binding,Isoform eNOS13C:Lacks eNOS activity dominant-negative form that may down-regulate eNOS activity by forming heterodimers with isoform 1,kidney,L-arginine,lipid,lipopolysaccharide-mediated signaling pathway,Lipoprotein,liver,lung development,Membrane,Membrane \u203a caveola,Metal-binding,Methamphetamine-Induced Psychosis,mitochondrion organization,Myocardial Infarction,Myristate,NAD,NADP,NADP binding,NADPH,NADPH-hemoprotein reductase activity,negative regulation of blood pressure,negative regulation of calcium ion transport,negative regulation of cell proliferation,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of hydrolase activity,negative regulation of muscle hyperplasia,negative regulation of platelet activation,negative regulation of potassium ion transport,nitric oxide biosynthetic process,nitric oxide mediated signal transduction,nitric oxide metabolic process,Nitric oxide synthase,nitric-oxide synthase activity,NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets,NOS family,NOS type III,NOS3,NOSIII,nosip,nostrin,nucleus,Open-Angle Glaucoma,ovulation from ovarian follicle,Oxidoreductase,Palmitate,peripheral arterial disease,phagosome maturation,phosphate,Phosphoprotein,Phosphorylation by AMPK at Ser-1177 in the presence of Ca2+-calmodulin (CaM) activates activity,Phosphorylation of Ser-114 by CDK5 reduces activity,placenta,plasma membrane,Platelets,Polymorphism,positive regulation of angiogenesis,positive regulation of guanylate cyclase activity,positive regulation of vasodilation,Primary Open-Angle Glaucoma,Produces nitric oxide (NO),Reference proteome,regulation of blood pressure,regulation of blood vessel size,regulation of nitric-oxide synthase activity,regulation of sodium ion transport,regulation of systemic arterial blood pressure by endothelin,regulation of the force of heart contraction by chemical signal,response to fluid shear stress,response to heat,small molecule metabolic process,smooth muscle hyperplasia,Specifically associates with actin cytoskeleton in the G2 phase of the cell cycle; which is favored by interaction with NOSIP and results in a reduced enzymatic activity,stabilize the dimeric form of the enzyme,Stimulated by calcium/calmodulin,Tetrahydrobiopterin (BH4),tetrahydrobiopterin binding,THP,Variation in NOS3 seem to be associated with susceptibility to coronary spasm,vascular smooth muscle relaxation,Zinc",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs7830",
        "SNP Name": "NOS3 G10T",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7830",
        "Video": null,
        "Tags": "2 L-arginine + 3 NADPH + 4 O2 = 2 L-citrulline + 2 nitric oxide + 3 NADP+ + 4 H2O,actin monomer binding,Alternative splicing,angiogenesis,ankle-brachial index,arginine,arginine binding,arginine catabolic process,Asthma,BH4,Binds 1 FAD,Binds 1 FMN,blood coagulation,Blood Pressure Response,Blood Pressure Response to Potassium Supplementation is Associated with Genetic Variation,blood vessel remodeling,cadmium ion binding,calcium,calmodulin,Calmodulin-binding,cardiovascular,caveola,Cell membrane,cGMP-mediated signal transduction pathway,cNOS,Complete proteome,Constitutive NOS,Contains 1 FAD-binding FR-type domain,Contains 1 flavodoxin-like domain,CVD,Cytoplasm,Cytoplasm \u203a cytoskeleton,Cytoskeleton,cytosol,Direct protein sequencing,EC-NOS,end-stage renal disease,endocytic vesicle membrane,endothelial,endothelial cell migration,Endothelial NOS,eNOS,FAD,fat,ferritin,flavin adenine dinucleotide binding,Flavoprotein,FMN,FMN binding,Golgi apparatus,Golgi membrane,heart,heme,heme binding,Heme group,Homodimer,hypertensive adults,In absence of Ca2+-calmodulin AMPK also phosphorylates Thr-495 resulting in inhibition of activity By similarity,in utero embryonic development,Inhibited by NOSIP and NOSTRIN,interaction with host,Interactions with Hypertension and Alcohol and Cigarette Smoking,Interactions with Sex and Postmenopausal Hormone Use,Interacts with NOSIP and NOSTRIN,Iron,iron ion binding,Isoform eNOS13C:Lacks eNOS activity dominant-negative form that may down-regulate eNOS activity by forming heterodimers with isoform 1,kidney,L-arginine,lipid,lipopolysaccharide-mediated signaling pathway,Lipoprotein,liver,lung development,Membrane,Membrane \u203a caveola,Metal-binding,Methamphetamine-Induced Psychosis,mitochondrion organization,Myocardial Infarction,Myristate,NAD,NADP,NADP binding,NADPH,NADPH-hemoprotein reductase activity,negative regulation of blood pressure,negative regulation of calcium ion transport,negative regulation of cell proliferation,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of hydrolase activity,negative regulation of muscle hyperplasia,negative regulation of platelet activation,negative regulation of potassium ion transport,nitric oxide biosynthetic process,nitric oxide mediated signal transduction,nitric oxide metabolic process,Nitric oxide synthase,nitric-oxide synthase activity,NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets,NOS family,NOS type III,NOS3,NOSIII,nosip,nostrin,nucleus,Open-Angle Glaucoma,ovulation from ovarian follicle,Oxidoreductase,Palmitate,peripheral arterial disease,phagosome maturation,phosphate,Phosphoprotein,Phosphorylation by AMPK at Ser-1177 in the presence of Ca2+-calmodulin (CaM) activates activity,Phosphorylation of Ser-114 by CDK5 reduces activity,placenta,plasma membrane,Platelets,Polymorphism,positive regulation of angiogenesis,positive regulation of guanylate cyclase activity,positive regulation of vasodilation,Primary Open-Angle Glaucoma,Produces nitric oxide (NO),Reference proteome,regulation of blood pressure,regulation of blood vessel size,regulation of nitric-oxide synthase activity,regulation of sodium ion transport,regulation of systemic arterial blood pressure by endothelin,regulation of the force of heart contraction by chemical signal,response to fluid shear stress,response to heat,small molecule metabolic process,smooth muscle hyperplasia,Specifically associates with actin cytoskeleton in the G2 phase of the cell cycle; which is favored by interaction with NOSIP and results in a reduced enzymatic activity,stabilize the dimeric form of the enzyme,Stimulated by calcium/calmodulin,Tetrahydrobiopterin (BH4),tetrahydrobiopterin binding,THP,Variation in NOS3 seem to be associated with susceptibility to coronary spasm,vascular smooth muscle relaxation,Zinc",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs4986782",
        "SNP Name": "NAT1 R187Q",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4986782",
        "Video": "BFH6KRZS81Q",
        "Tags": "AAC1,Acetyl-CoA + an arylamine = CoA + an N-acetylarylamine,Acetyl-L-methionine,acetylation,Acetylmethionine,activate and deactivate arylamine and hydrazine drugs and carcinogens,Acyltransferase,amine,amine toxicity,aromatic amine tumor,Arylamide acetylase 1,arylamine,Arylamine N-acetyltransferase 1,arylamine N-acetyltransferase activity,arylamine N-acetyltransferase family,Belongs to the arylamine N-acetyltransferase family,birth defect,Bladder Cancer,cancer,cancerous,Candidate risk factor for susceptibility to neural tube defects,carcinogen,Catalyzes the N- or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens,cigarette smoking,cigarette smoking and risk of colorectal polyps,colon cancer,colorectal adenoma,colorectal polyps,Complete proteome,cytoplasm,cytosol,defect,detox,detoxification of a plethora of hydrazine and arylamine drugs,drug detoxification,drug interaction,drug toxicity,drugs,E2,estrogen,fast acetylator,heterocyclic amine,hydrazine,liver,lung,lung cancer,lymphoma,methionine,MNAT,Monomorphic arylamine N-acetyltransferase,N-acetylation polymorphism is determined by a low or high NAT activity in liver and has been implicated in the action and toxicity of amine-containing drugs,N-acetylmethionine,N-acetyltransferase type 1,NAT-1,NAT1,NAT1 was historically considered to be monomorphic in nature but reports of allelic variations at the NAT1 locus suggest that it is a polymorphically expressed enzyme,neural tube defect,Neural Tube Defects,non-Hodgkin lymphoma,non-Hodgkin lymphoma survival,NTDs,palsy,Participates in the detoxification of a plethora of hydrazine and arylamine drugs,Polymorphism,polyp,progressive supranuclear palsy,Reference proteome,Renal Cell Cancer,sex hormones,Slow acetylation associated with lung cancer,Slow acetylation genotypes have been associated with significant lung cancer risk,slow acetylator,small molecule metabolic process,smoking,sulfur,sulfur-containing compounds,sulphur,The NAT1*10 allele has been associated with increased risk of colon and urinary bladder cancers and with higher levels of N-acetyltransferase activity and DNA adducts in aromatic amine tumor target organs such as colon and urinary bladder,toxicity of amine-containing drugs,Transferase,urinary bladder cancer,Xenobiotic,xenobiotic metabolic process,Xenobiotic metabolism,xenoestrogen",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1805158",
        "SNP Name": "NAT2 R64W",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1805158",
        "Video": "jzenBdH-efs",
        "Tags": "AAC2,Acetyl-CoA + an arylamine = CoA + an N-acetylarylamine,Acyltransferase,Arylamide acetylase 2,arylamine,arylamine detoxification,arylamine N-acetyltransferase activity,arymaline toxicity,Belongs to the arylamine N-acetyltransferase family,bladder cancer,cancer,cancer chemotherapy,cancerous,carcinogen,Catalyzes the N- or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens,chemotherapy,Complete proteome,Cytoplasm,cytosol,detox,detoxification,Direct protein sequencing,drug metabolism,drug toxicity,hydrazine,hydrazine detoxification,N-acetyltransferase type 2,NAT-2,NAT2,Participates in the detoxification of a plethora of hydrazine and arylamine drugs,plethora,plethora detoxification,PNAT,Polymorphic arylamine N-acetyltransferase,Polymorphism,Polymorphisms in NAT2 are the cause of slow and fast acetylation phenotypes and influence drug therapy response and susceptibility to chemical toxicity or carcinogenicity,Reference proteome,Slow acetylator,small molecule metabolic process,Transferase,xenobiotic metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1801279",
        "SNP Name": "NAT2 G191A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1801279",
        "Video": "jzenBdH-efs",
        "Tags": "AAC1,Acetyl-CoA + an arylamine = CoA + an N-acetylarylamine,acetylation,acetylator,activate and deactivate arylamine and hydrazine drugs and carcinogens,Acyltransferase,amine,amine toxicity,aromatic amine tumor,Arylamide acetylase 2,arylamine,Arylamine N-acetyltransferase 2,arylamine N-acetyltransferase activity,arylamine N-acetyltransferase family,birth defect,bladder cancer,cancer,cancer chemotherapy,cancerous,carcinogen,Carcinogen-metabolizing Enzymes,Catalyzes the N- or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens,chemotherapy,cigarette smoking,colon cancer,Colorectal Cancer,colorectal polyps,cytoplasm,defect,detox,detoxification of a plethora of hydrazine and arylamine drugs,drug detoxification,drug toxicity,drugs,E2,estrogen,fast acetylator,heterocyclic amine,hydrazine,liver,lung cancer,N-acetyltransferase type 2,NAT-2,NAT2,neural tube defect,NTDs,palsy,PNAT,Polymorphic arylamine N-acetyltransferase,progressive supranuclear palsy,prostate\u00a0cancer,response to cancer chemotherapy,response to chemotherapy,sex hormones,Slow acetylation associated with lung cancer,slow acetylator,small molecule metabolic process,smoking,sulfamethoxazole-induced hypersensitivity,toxicity of amine-containing drugs,Transferase,urinary bladder cancer,Very Slow Acetylation,xenobiotic metabolic process,xenoestrogen",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1041983",
        "SNP Name": "NAT2 C282T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1041983",
        "Video": "jzenBdH-efs",
        "Tags": "AAC1,Acetyl-CoA + an arylamine = CoA + an N-acetylarylamine,acetylation,acetylator,activate and deactivate arylamine and hydrazine drugs and carcinogens,Acyltransferase,Advanced Colorectal Adenoma,adverse events with co-trimoxazole in systemic lupus erythematosus patients,amine,amine toxicity,Anti-TB Drug Induced Liver Injury,aromatic amine tumor,Arylamide acetylase 2,arylamine,Arylamine N-acetyltransferase 2,arylamine N-acetyltransferase activity,arylamine N-acetyltransferase family,birth defect,Bladder Cancer,Breast Cancer,cancer,cancer chemotherapy,cancerous,carcinogen,Catalyzes the N- or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens,chemotherapy,colon cancer,colorectal polyps,cytoplasm,defect,detox,detoxification,detoxification of a plethora of hydrazine and arylamine drugs,drug detoxification,drug reaction,drug toxicity,drugs,E2,Esophageal Squamous Cell Carcinoma,estrogen,fast acetylator,heterocyclic amine,hydrazine,liver,liver injury,lung cancer,lupus,lymphoma,mental disorder,N-acetyltransferase type 2,NAT-2,NAT2,neural tube defect,non-Hodgkin lymphoma,NTDs,obese children,obesity,Pharmacogenetics,PNAT,Polymorphic arylamine N-acetyltransferase,Prenatal Smoking and Birth Weight,Renal Cell Cancer,Schizophrenia,sex hormones,Slow acetylation associated with lung cancer,slow acetylator,small molecule metabolic process,toxicity of amine-containing drugs,Transferase,urinary bladder cancer,Very Slow Acetylation,xenobiotic metabolic process,xenoestrogen",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1801280",
        "SNP Name": "NAT2 I114T",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1801280",
        "Video": "jzenBdH-efs",
        "Tags": "AAC2,Acetyl-CoA + an arylamine = CoA + an N-acetylarylamine,acetylation,Acyltransferase,adenomatous polyposis,Advanced Colorectal Adenoma,adverse events with co-trimoxazole in patients with systemic lupus erythematosus,amine toxicity,Arylamide acetylase 2,arylamine,arylamine detoxification,arylamine N-acetyltransferase activity,arymaline toxicity,Belongs to the arylamine N-acetyltransferase family,bladder cancer,cancer,cancer chemotherapy,cancerous,carcinogen,Catalyzes the N- or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens,chemotherapy,clubfoot,colon cancer,colorectal adenoma,Colorectal Cancer,Complete proteome,Cytoplasm,cytosol,detox,detoxification,Direct protein sequencing,drug metabolism,drug toxicity,epithelial ovarian cancer,Esophageal Cancer,Esophageal Squamous Cell Carcinoma,fish,fish intake and prostate\u00a0cancer,fish oil,heterocyclic amine exposure,hydrazine,hydrazine detoxification,infertility,Low Dose Aspirin-Associated Small Bowel Bleeding,lung cancer,lymphoma,Male Infertility,MCS,Meat intake and colorectal polyp risk,Multiple Chemical Sensitivity,N-acetyltransferase type 2,NAT-2,NAT2,non-Hodgkin lymphoma,non-Hodgkin lymphoma survival,palsy,pancreatic cancer,Parkinson,Parkinson\u2019s disease,Participates in the detoxification of a plethora of hydrazine and arylamine drugs,PD,plethora,plethora detoxification,PNAT,Polymorphic arylamine N-acetyltransferase,Polymorphism,Polymorphisms in NAT2 are the cause of slow and fast acetylation phenotypes and influence drug therapy response and susceptibility to chemical toxicity or carcinogenicity,prediabetes,progressive supranuclear palsy,Prostate Cancer,prostate\u00a0cancer,rapid acetylator,Reference proteome,Renal Cell Cancer,Slow acetylator,small molecule metabolic process,sulfamethoxazole-induced hypersensitivity,Transferase,Very Slow Acetylation,xenobiotic metabolic process,xenobiotic metabolism",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1799929",
        "SNP Name": "NAT2 C481T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1799929",
        "Video": "jzenBdH-efs",
        "Tags": "AAC1,Acetyl-CoA + an arylamine = CoA + an N-acetylarylamine,acetylation,acetylator,activate and deactivate arylamine and hydrazine drugs and carcinogens,Acyltransferase,Advanced Colorectal Adenoma,amine,amine toxicity,Anti-TB Drug Induced Liver Injury,aromatic amine tumor,Arylamide acetylase 2,arylamine,Arylamine N-acetyltransferase 2,arylamine N-acetyltransferase activity,arylamine N-acetyltransferase family,birth defect,bladder cancer,Breast Cancer,cancer,cancer chemotherapy,cancerous,carcinogen,Catalyzes the N- or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens,chemotherapy,cigarette smoking,cleft lip,cleft palate,clubfoot,colon cancer,colorectal adenoma,COLORECTAL CANCER,colorectal polyp risk,colorectal polyps,cytoplasm,defect,detox,detoxification of a plethora of hydrazine and arylamine drugs,drug detoxification,drug toxicity,drugs,E2,early onset lung cancer,epithelial ovarian cancer,Esophageal Cancer,estrogen,estrogen receptors,fast acetylator,Head and Neck Cancers,heterocyclic amine,hydrazine,liver,liver injury,lung cancer,lungs,lymphoma,N-acetyltransferase type 2,NAT-2,NAT2,neural tube defect,non-Hodgkin lymphoma,NTDs,ovarian cancer,pancreatic cancer,Parkinson,Parkinson\u2019s disease,PD,Personal Hair Dye Use and Risk of Non-Hodgkin Lymphoma,Pharmacogenomics,PNAT,Polymorphic arylamine N-acetyltransferase,Prostate Cancer,sex hormones,skin fluorescence,Slow acetylation associated with lung cancer,slow acetylator,small molecule metabolic process,smoking,smoking and cancer,Tobacco Smoking,toxicity of amine-containing drugs,Transferase,urinary bladder cancer,Very Slow Acetylation,xenobiotic metabolic process,xenoestrogen",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1799930",
        "SNP Name": "NAT2 R197Q",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1799930",
        "Video": "jzenBdH-efs",
        "Tags": "AAC2,Acetyl-CoA + an arylamine = CoA + an N-acetylarylamine,acetylation,Acyltransferase,Advanced Colorectal Adenoma,adverse events with co-trimoxazole,adverse events with co-trimoxazole in patients with systemic lupus erythematosus,amine exposure,amine toxicity,Arylamide acetylase 2,arylamine,arylamine detoxification,arylamine N-acetyltransferase activity,arymaline toxicity,Belongs to the arylamine N-acetyltransferase family,Breast Cancer,cancer,cancer chemotherapy,cancerous,carcinogen,Catalyzes the N- or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens,cell carcinoma,chemotherapy,cigarette smoking and pancreatic cancer,colon cancer,colorectal adenoma,colorectal polyps,Complete proteome,Cytoplasm,cytosol,detox,detoxification,Direct protein sequencing,drug metabolism,drug toxicity,Esophageal Cancer,Esophageal Squamous Cell Carcinoma,fish,fish intake and prostate\u00a0cancer,fish oil,hydrazine,hydrazine detoxification,Infertility,lung,lung cancer,lymphoma,Male Infertility,MCS,mental illness,Multiple Chemical Sensitivity,N-acetyltransferase type 2,NAT-2,NAT2,Neural Tube Defects,non-Hodgkin lymphoma,non-Hodgkin lymphoma survival,NTDs,pancreatic cancer,Parkinson,Parkinson\u2019s disease,Participates in the detoxification of a plethora of hydrazine and arylamine drugs,PD,plethora,plethora detoxification,PNAT,Polymorphic arylamine N-acetyltransferase,Polymorphism,Polymorphisms in NAT2 are the cause of slow and fast acetylation phenotypes and influence drug therapy response and susceptibility to chemical toxicity or carcinogenicity,polyp,Prostate Cancer,rapid acetylator,Red meat intake and colorectal cancer risk,Reference proteome,Renal Cell Cancer,Slow acetylator,small molecule metabolic process,Squamous Cell Carcinoma,sulfamethoxazole-induced hypersensitivity,Transferase,Very Slow Acetylation,xenobiotic metabolic process,Xenobiotic metabolism",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1208",
        "SNP Name": "NAT2 K268R",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1208",
        "Video": "jzenBdH-efs",
        "Tags": "AAC2,Acetyl-CoA + an arylamine = CoA + an N-acetylarylamine,acetylation,Acyltransferase,adenomatous polyposis,Advanced Colorectal Adenoma,Alcohol,arthritis,Arylamide acetylase 2,arylamine,arylamine detoxification,arylamine N-acetyltransferase activity,arymaline toxicity,Belongs to the arylamine N-acetyltransferase family,bladder cancer,Breast Cancer,Caffeine,cancer,cancer chemotherapy,cancerous,carcinogen,Catalyzes the N- or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens,chemotherapy,Colorectal Adenoma,colorectal cancer,colorectal polyps,Complete proteome,Cytoplasm,cytosol,detox,detoxification,Direct protein sequencing,drug metabolism,drug toxicity,hydrazine,hydrazine detoxification,lymphoma,mental illness,N-acetyltransferase type 2,NAT-2,NAT2,non-Hodgkin lymphoma survival,obese,pancreatic cancer,Participates in the detoxification of a plethora of hydrazine and arylamine drugs,plethora,plethora detoxification,PNAT,Polymorphic arylamine N-acetyltransferase,Polymorphism,Polymorphisms in NAT2 are the cause of slow and fast acetylation phenotypes and influence drug therapy response and susceptibility to chemical toxicity or carcinogenicity,polyp,Prostate Cancer,RA,rapid acetylator,Reference proteome,Rheumatoid Arthritis,Slow acetylator,small molecule metabolic process,Smoking,Transferase,xenobiotic metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1799931",
        "SNP Name": "NAT2 G286E",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1799931",
        "Video": "jzenBdH-efs",
        "Tags": "AAC2,Acetyl-CoA + an arylamine = CoA + an N-acetylarylamine,acetylation,Acyltransferase,adenomatous polyposis,Advanced Colorectal Adenoma,adverse events with co-trimoxazole in patients with systemic lupus erythematosus,amine toxicity,Arylamide acetylase 2,arylamine,arylamine detoxification,arylamine N-acetyltransferase activity,arymaline toxicity,Belongs to the arylamine N-acetyltransferase family,bladder cancer,cancer,cancer chemotherapy,cancerous,carcinogen,Catalyzes the N- or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens,chemotherapy,clubfoot,colon cancer,colorectal adenoma,Colorectal Cancer,Complete proteome,Cytoplasm,cytosol,detox,detoxification,Direct protein sequencing,drug metabolism,drug toxicity,epithelial ovarian cancer,Esophageal Cancer,Esophageal Squamous Cell Carcinoma,fish,fish intake and prostate\u00a0cancer,fish oil,heterocyclic amine exposure,hydrazine,hydrazine detoxification,infertility,Low Dose Aspirin-Associated Small Bowel Bleeding,lung cancer,lymphoma,Male Infertility,MCS,Meat intake and colorectal polyp risk,Multiple Chemical Sensitivity,N-acetyltransferase type 2,NAT-2,NAT2,non-Hodgkin lymphoma,non-Hodgkin lymphoma survival,palsy,pancreatic cancer,Parkinson,Parkinson\u2019s disease,Participates in the detoxification of a plethora of hydrazine and arylamine drugs,PD,plethora,plethora detoxification,PNAT,Polymorphic arylamine N-acetyltransferase,Polymorphism,Polymorphisms in NAT2 are the cause of slow and fast acetylation phenotypes and influence drug therapy response and susceptibility to chemical toxicity or carcinogenicity,prediabetes,progressive supranuclear palsy,Prostate Cancer,prostate\u00a0cancer,rapid acetylator,Reference proteome,Renal Cell Cancer,Slow acetylator,small molecule metabolic process,sulfamethoxazole-induced hypersensitivity,Transferase,Very Slow Acetylation,xenobiotic metabolic process,xenobiotic metabolism",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs11136000",
        "SNP Name": "CLU A58V",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "40,AAG4,AD,age-related cognitive decline,Aging-associated gene 4 protein,Alzheimer,Alzheimer's disease,Alzheimer's-related senile plaques,amyloid plaque,Anti-Herpes Simplex,apical dendrite,Apo-J,APOJ,ApoJalpha,ApoJbeta,Apolipoprotein J,Apoptosis,ATP,autoimmune,blood coagulation,blood microparticle,brain atrophy,cardio,Cardiovascular,cell morphogenesis,cellular energy,central nervous system myelin maintenance,Cerebrospinal Fluid Biomarkers,chaperone-mediated protein complex assembly,chaperone-mediated protein folding,cholesterol,Cholesterol Metabolism,classical pathway,CLI,clotting,CLU,Clusterin,Clusterin alpha chain,Clusterin beta chain,coagulation,cognition,Cognitive Decline,cognitive function,cognitive impairment,complement activation,Complement cytolysis inhibitor,Complement cytolysis inhibitor a chain,Complement cytolysis inhibitor b chain,Complement pathway,Complement-associated protein SP-40,cortical gray matter thickness,CVD,cytoplasm,dementia,Detected in blood plasma and cerebrospinal fluid and milk and seminal plasma and colon mucosa,dopamine,endoplasmic reticulum,energy,enterovirus,enterovirus 71,entorhinal cortex volume,episodic memory,EV71,extracellular matrix,extracellular region,extracellular space,extracellular vesicular exosome,fat,fatty acid distribution,heart,heart disease,herpes,IgM Anti-Herpes Simplex,immune response,immune system,Immunity,innate immune response,Innate immunity,intrinsic apoptotic signaling pathway,Ku70-binding protein 1,KUB1,late-onset Alzheimer's disease,late-onset Alzheimer\u2019s disease,lipid,lipid metabolic process,lipids,lipoprotein,membrane,microglial cell activation,microglial cell proliferation,Microtubule-Associated Protein Tau,misfolded protein binding,mitochondria,mitochondrial,Multiple Sclerosis,NA1/NA2,negative regulation of beta-amyloid formation,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,negative regulation of protein homooligomerization,neurodegenerative disorder,neurofibrillary tangle,nitric oxide,NO,nucleus,Parkinson,Parkinson Disease,Parkinson's disease,PD,perinuclear region of cytoplasm,Plasma Amyloid-Beta Levels,platelet activation,platelet alpha granule lumen,platelet degranulation,positive regulation of apoptotic process,positive regulation of beta-amyloid formation,positive regulation of intrinsic apoptotic signaling pathway,positive regulation of neurofibrillary tangle assembly,positive regulation of neuron death,positive regulation of NF-kappaB transcription factor activity,positive regulation of nitric oxide biosynthetic process,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,positive regulation of tau-protein kinase activity,positive regulation of tumor necrosis factor production,protein import,protein stabilization,pseudoexfoliation syndrome,regulation of beta-amyloid clearance,regulation of neuron death,regulation of neuronal signal transduction,release of cytochrome c from mitochondria,response to misfolded protein,response to virus,reverse cholesterol transport,senile,senile plaques,spherical high-density lipoprotein particle,Testosterone-repressed prostate message 2,TRPM-2,ubiquitin protein ligase binding,Up-regulated in response to enterovirus 71 (EV71) infection,Ventricular Expansion,virus",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs2551715",
        "SNP Name": "GSR A43851G",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2551715",
        "Video": "5qhtoaQgBj8",
        "Tags": "2 glutathione,3D-structure,Acetylation,Alternative initiation,Alternative splicing,Antioxidant,asthma,cell redox homeostasis,class-I pyridine nucleotide-disulfide oxidoreductase family,Complete proteome,Cytoplasm,Cytoplasmic: Cytoplasm,cytosol,Direct protein sequencing,Disulfide bond,disulfide-linked,electron carrier activity,extracellular vesicular exosome,FAD,flavin adenine dinucleotide binding,Flavoprotein,GLUR,glutathione,glutathione disulfide,glutathione metabolic process,Glutathione reductase,glutathione-disulfide reductase activity,GR,GRase,GRD1,GSR,Homodimer,lupus,mitochondrial,mitochondrial matrix,Mitochondrial: Mitochondrion,Mitochondrion,NADP,NADP binding,NADPH,nucleobase-containing small molecule interconversion,nucleobase-containing small molecule metabolic process,oxidoreductase,Polymorphism,polypeptide chain,Redox-active center,redox-active disulfide bond,Reference proteome,SLE,small molecule metabolic process,sulfamethoxazole,sulfamethoxazole-induced hypersensitivity,systemic lupus erythematosus,Transit peptide",
        "Group": "Polacrilin Potassium"
    },
    {
        "SNP ID": "rs2551715",
        "SNP Name": "GSR A43851G",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2551715",
        "Video": "5qhtoaQgBj8",
        "Tags": "2 glutathione,3D-structure,Acetylation,Alternative initiation,Alternative splicing,Antioxidant,asthma,cell redox homeostasis,class-I pyridine nucleotide-disulfide oxidoreductase family,Complete proteome,Cytoplasm,Cytoplasmic: Cytoplasm,cytosol,Direct protein sequencing,Disulfide bond,disulfide-linked,electron carrier activity,extracellular vesicular exosome,FAD,flavin adenine dinucleotide binding,Flavoprotein,GLUR,glutathione,glutathione disulfide,glutathione metabolic process,Glutathione reductase,glutathione-disulfide reductase activity,GR,GRase,GRD1,GSR,Homodimer,lupus,mitochondrial,mitochondrial matrix,Mitochondrial: Mitochondrion,Mitochondrion,NADP,NADP binding,NADPH,nucleobase-containing small molecule interconversion,nucleobase-containing small molecule metabolic process,oxidoreductase,Polymorphism,polypeptide chain,Redox-active center,redox-active disulfide bond,Reference proteome,SLE,small molecule metabolic process,sulfamethoxazole,sulfamethoxazole-induced hypersensitivity,systemic lupus erythematosus,Transit peptide",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs6994992",
        "SNP Name": "NRG1 C3314T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6994992",
        "Video": "PoMzEhWoceM",
        "Tags": "acethylcholine,Acetylcholine receptor-inducing activity,ACh,activation of transmembrane receptor protein tyrosine kinase activity,Alternative splicing,apical plasma membrane,ARIA,axon,bipolar,bipolar disorder,BPD,breast cancer,Breast cancer cell differentiation factor p45,cancer,cancerous,carcinogen,carcinoma,cardiac,cardiac conduction system development,cardiac muscle cell differentiation,cardiac muscle cell myoblast differentiation,cardiovascular,cell communication,Cell membrane,cell migration,cell morphogenesis,cell proliferation,cellular protein complex disassembly,choline,chromosomal aberration involving NRG1 produces gamma-heregulin,Chromosomal rearrangement,Complete proteome,Concomitantly recruits ERBB1 and ERBB2 coreceptors,Contains 1 EGF-like domain,Contains 1 Ig-like C2-type (immunoglobulin-like) domain,creativity,cytokine activity,cytoplasm,cytoplasmic domain interacts with the LIM domain region of LIMK1,cytoplasmic domain may be involved in the regulation of trafficking and proteolytic processing,Detectable at early embryonic ages,detected in adult heart and placenta and lung and liver and kidney and pancreas,Direct ligand for ERBB3 and ERBB4 tyrosine kinase receptors,Direct protein sequencing,Disulfide bond,DNA-templated,dopamine,EGF-like domain,embryo development,endocardial cell differentiation,epidermal growth factor receptor signaling pathway,ERBB receptor binding,ERBB signaling pathway,ErbB-3 class receptor binding,Expression is maintained only in both adult motor neurons and dorsal root ganglion neurons,Extensive glycosylation precedes the proteolytic cleavage,extracellular region,extracellular space,Fc-epsilon receptor signaling pathway,fibroblast growth factor receptor signaling pathway,Gamma-heregulin is a soluble activating ligand for the ERBB2-ERBB3 receptor complex and acts as an autocrine growth factor in a specific breast cancer cell line (MDA-MB-175),glial cell fate commitment,Glial growth factor,Glycoprotein,Growth factor,growth factor activity,heart,Heregulin,HRG,Immunoglobulin domain,implication in the development of the myocardium such as trabeculation of the developing heart,innate immune response,integral component of plasma membrane,intellectual,Interacts with ERBB3 and ERBB4,Isoform 10 is expressed in nervous system: spinal cord motor neurons and dorsal root ganglion neurons and brain,Isoform 10 is highly expressed in developing spinal motor neurons and in developing cranial nerve nuclei,Isoform 10 may play a role in motor and sensory neuron development,Isoform 10: Membrane; Single-pass type I membrane protein,Isoform 3 is the predominant form in mesenchymal cells and in non-neuronal organs,isoform 6 is the major neuronal form,Isoform 8 is expressed in spinal cord and brain,Isoform 8: Nucleus,Isoform 9 is the major form in skeletal muscle cells; in the nervous system it is expressed in spinal cord and brain,Isoform 9: Secreted,Isoform alphais expressed in breast,kidney,L-Tyrosine,ligand-stimulated tyrosine phosphorylation and activation of the ERBB receptors isoforms perform diverse functions such as inducing growth and differentiation of epithelial and glial and neuronal and skeletal muscle cells; inducing expression of acetylcho,locomotory behavior,lung,mammary gland development,MAPK cascade,Membrane,membrane-bound isoform,membrane-bound isoform: Cell membrane; Single-pass type I membrane protein,mental disorder,myocardium,N- and O-glycosylated,negative regulation of cardiac muscle cell apoptotic process,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,negative regulation of protein catabolic process,negative regulation of secretion,negative regulation of transcription,nervous system development,Neu differentiation factor,neural crest cell development,neuregulin family,Neuregulin-1,neuromuscular junction,neuron fate commitment,neurotransmitter receptor metabolic process,neurotrophin TRK receptor signaling pathway,not detected in adult heart",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs7820268",
        "SNP Name": "IDO1 C6202T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7820268",
        "Video": "YSV7z-H-I9g",
        "Tags": "3-dioxygenase,3-dioxygenase 1,3-dioxygenase activity,3-dioxygenase family,amino acids,Amino-acid degradation,autoimmune,blood cells,Catalytic efficiency for L-tryptophan is 150 times higher than for D-tryptophan,cellular nitrogen compound metabolic process,Chronic Hepatitis C,Constant Immunosuppression,cytokine production involved in inflammatory response,cytosol,D-1MT (1-methyl-D-tryptophan),D-tryptophan,Dioxygenase,electron carrier activity,female pregnancy,ferritin,heavy metals,heme,heme binding,hemoglobin,hepatitis C,IDO,IDO-1,IDO1,IFN-\u03b1,IFN-\u03b1-induced depression,IFNG/IFN-gamma,IL-10,IL-12,IL10,IL12,immune system,immunity,INDO,Indoleamine 2,Indoleamine-pyrrole 2,INF,Interferon (IFN)-\u03b1,interferon-alpha,interleukin,interleukin-10,interleukin-12,iron,kynurenic acid biosynthetic process,kynurenine pathway,L-1MT (1-methyl-L-tryptophan),L-kynurenine from L-tryptophan,L-Tryptophan,L-tryptophan + O2 = N-formyl-L-kynurenine,L-tryptophan degradation via kynurenine pathway,liver,Mesenchymal Stem Cell Therapy for Autoimmune Diseases,metal ion binding,Metal-binding,methylthiohydantoin-DL-tryptophan,minerals,multicellular organismal response to stress,N-formyl-D-kynurenine D-tryptophan + O2 = N-formyl-D-kynurenine,N-formyl-L-kynurenine,negative regulation of activated T cell proliferation,negative regulation of interleukin-10 production,negative regulation of T cell apoptotic process,neuroendocrine,neurotransmission,neurotransmitters,Oxidoreductase,oxygen,Polymorphism,positive regulation of apoptotic process,positive regulation of chronic inflammatory response,positive regulation of interleukin-12 production,positive regulation of T cell tolerance induction,positive regulation of type 2 immune response,pregnancy,pyroluria,pyrrol,pyrrole,pyrrole disorder,red blood cell,response to lipopolysaccharide,small molecule metabolic process,smooth muscle contractile fiber,stereocilium bundle,swimming behavior,T cells,trace minerals,tryptohan,tryptophan 2,tryptophan catabolic process,tryptophan catabolic process to kynurenine,white blood cell",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2020921",
        "SNP Name": "PLAT/COX2 A164T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs11545078",
        "SNP Name": "GGH C17847T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs11545078",
        "Video": "ZCYSAhJYURs",
        "Tags": "5-MTHF,antifolates,bioavailability,cancer,cancerous,carcinogen,cellular folate,Childhood Acute Lymphoblastic Leukemia,colorectal cancer,colorectal cancer risk,Conjugase,CVD,cytosol,Diabetic Retinopathy in Persons with Type 2 Diabetes,drug interaction,drug metabolism,enzyme,exopeptidase activity,extracellular space,extracellular vesicular exosome,folate,folic acid,folinic acid,folylpolyglutamate synthase,Gamma-Glu-X carboxypeptidase,Gamma-glutamyl hydrolase,gamma-glutamyl hydrolase domain,gamma-glutamyl-peptidase activity,GGH,GH,glutahione,glutamate,glutamine,glutamine metabolic process,Glycoprotein,heart,homocysteine,Homodimer,Hydrolase,Hydrolysis of a gamma-glutamyl bond,Hydrolyzes the polyglutamate sidechains of pteroylpolyglutamates,L-5-MTHF,L-glutamine,leukemia,leukocyte telomere length,Lysosome,Melanosome,methotrexate,methotrexate (MTX) drug,methotrexate pathway,methotrexate polyglutamate (MTXPG),methotrexate toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis,methylenetetrahydrofolate reductase,MTHFR,mutation,omega peptidase activity,peptidase C26 family,plasma homocysteine levels,polyglutamate,Polymorphism,Progressively removes gamma-glutamyl residues from pteroylpoly-gamma-glutamate to yield pteroyl-alpha-glutamate (folic acid) and free glutamate,proteolysis,pteroyl-alpha-glutamate,pteroylpoly-gamma-glutamate,pteroylpolyglutamates,response to drug,response to insulin,response to zinc ion,secreted,Signal,\u03b3-glutamyl hydrolase",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs3780127",
        "SNP Name": "GGH C15472T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3780127",
        "Video": "ZCYSAhJYURs",
        "Tags": "5-MTHF,antifolates,bioavailability,cancer,cancerous,carcinogen,Childhood Acute Lymphoblastic Leukemia (ALL),Conjugase,CVD,cytosol,drug interaction,drug metabolism,enzyme,exopeptidase activity,extracellular space,extracellular vesicular exosome,folate,folic acid,folinic acid,Gamma-Glu-X carboxypeptidase,Gamma-glutamyl hydrolase,gamma-glutamyl hydrolase domain,gamma-glutamyl-peptidase activity,GGH,GH,glutahione,glutamate,glutamine,glutamine metabolic process,Glycoprotein,heart,homocysteine,Homodimer,Hydrolase,Hydrolysis of a gamma-glutamyl bond,Hydrolyzes the polyglutamate sidechains of pteroylpolyglutamates,L-5-MTHF,L-glutamine,leukemia,Lysosome,Melanosome,methotrexate\r\npolyglutamate (MTXPG),methotrexate,methotrexate (MTX) drug,methylenetetrahydrofolate reductase,MTHFR,mutation,omega peptidase activity,peptidase C26 family,polyglutamate,Polymorphism,Progressively removes gamma-glutamyl residues from pteroylpoly-gamma-glutamate to yield pteroyl-alpha-glutamate (folic acid) and free glutamate,proteolysis,pteroyl-alpha-glutamate,pteroylpoly-gamma-glutamate,pteroylpolyglutamates,response to drug,response to insulin,response to zinc ion,secreted,Signal,\u03b3-glutamyl hydrolase",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs4617146",
        "SNP Name": "GGH G13894A",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4617146",
        "Video": "ZCYSAhJYURs",
        "Tags": "5-MTHF,antifolates,bioavailability,cancer,cancerous,carcinogen,colorectal cancer risk,colorectal cancer riskplasma homocysteine levels,Conjugase,CVD,cytosol,drug interaction,drug metabolism,enzyme,exopeptidase activity,extracellular space,extracellular vesicular exosome,folate,folic acid,folinic acid,folylpolyglutamate synthase,Gamma-Glu-X carboxypeptidase,Gamma-glutamyl hydrolase,gamma-glutamyl hydrolase domain,gamma-glutamyl-peptidase activity,GGH,GH,glutahione,glutamate,glutamine,glutamine metabolic process,Glycoprotein,heart,homocysteine,Homodimer,Hydrolase,Hydrolysis of a gamma-glutamyl bond,Hydrolyzes the polyglutamate sidechains of pteroylpolyglutamates,intracellular folate,L-5-MTHF,L-glutamine,Lysosome,Melanosome,methotrexate,methotrexate (MTX) drug,methotrexate polyglutamate (MTXPG),methylenetetrahydrofolate reductase,Modifiers of Radiotherapy and Chemotherapy on Survival in Pancreatic Cancer,MTHFR,mutation,omega peptidase activity,peptidase C26 family,plasma homocysteine,polyglutamate,Polymorphism,Progressively removes gamma-glutamyl residues from pteroylpoly-gamma-glutamate to yield pteroyl-alpha-glutamate (folic acid) and free glutamate,proteolysis,pteroyl-alpha-glutamate,pteroylpoly-gamma-glutamate,pteroylpolyglutamates,response to drug,response to insulin,response to zinc ion,secreted,Signal,\u03b3-glutamyl hydrolase",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs3780126",
        "SNP Name": "GGH C6699T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3780126",
        "Video": "ZCYSAhJYURs",
        "Tags": "5-MTHF,antifolates,bioavailability,cancer,cancerous,carcinogen,colorectal cancer risk,Conjugase,CVD,cytosol,drug interaction,drug metabolism,enzyme,exopeptidase activity,extracellular space,extracellular vesicular exosome,folate,folic acid,folinic acid,folylpolyglutamate synthase,Gamma-Glu-X carboxypeptidase,Gamma-glutamyl hydrolase,gamma-glutamyl hydrolase domain,gamma-glutamyl-peptidase activity,GGH,GH,glutahione,glutamate,glutamine,glutamine metabolic process,Glycoprotein,heart,homocysteine,Homodimer,Hydrolase,Hydrolysis of a gamma-glutamyl bond,Hydrolyzes the polyglutamate sidechains of pteroylpolyglutamates,L-5-MTHF,L-glutamine,lung,lung cancer,Lysosome,Melanosome,mesothelioma,methotrexate,methotrexate (MTX) drug,methotrexate polyglutamate (MTXPG),methylenetetrahydrofolate reductase,MTHFR,non\u2013small-cell lung cancer,omega peptidase activity,pemetrexed and bevacizumab \r\nresponse,pemetrexed and bevacizumab response,peptidase C26 family,plasma homocysteine levels,polyglutamate,Polymorphism,Progressively removes gamma-glutamyl residues from pteroylpoly-gamma-glutamate to yield pteroyl-alpha-glutamate (folic acid) and free glutamate,proteolysis,pteroyl-alpha-glutamate,pteroylpoly-gamma-glutamate,pteroylpolyglutamates,response to drug,response to insulin,response to zinc ion,secreted,Signal,Trial of Pemetrexed Plus Bevacizumab for Second-Line Therapy of Patients With Advanced Non\u2013Small-Cell Lung Cancer,\u03b3-glutamyl hydrolase",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs10974944",
        "SNP Name": "JAK2 C5070831G",
        "Risk Allele": "G",
        "Your Allele": "CG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Baculovirus"
    },
    {
        "SNP ID": "rs10974944",
        "SNP Name": "JAK2 C5070831G",
        "Risk Allele": "G",
        "Your Allele": "CG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Insect Cell"
    },
    {
        "SNP ID": "rs7848919",
        "SNP Name": "GLDC C118216T",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7848919",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs7848919",
        "SNP Name": "GLDC C118216T",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7848919",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs11789777",
        "SNP Name": "GLDC A55715G",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs11789777",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs11789777",
        "SNP Name": "GLDC A55715G",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs11789777",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs1051922",
        "SNP Name": "IFNB1 Y51Y",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Disodium Phosphate"
    },
    {
        "SNP ID": "rs12342831",
        "SNP Name": "B4GALT1 A47485G",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Anhydrous Lactose"
    },
    {
        "SNP ID": "rs12342831",
        "SNP Name": "B4GALT1 A47485G",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Lactose"
    },
    {
        "SNP ID": "rs10813960",
        "SNP Name": "B4GALT1 C33170362T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Anhydrous Lactose"
    },
    {
        "SNP ID": "rs10813960",
        "SNP Name": "B4GALT1 C33170362T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Lactose"
    },
    {
        "SNP ID": "rs706118",
        "SNP Name": "BAG1 A13581C",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs706118",
        "SNP Name": "BAG1 A13581C",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Gelatin"
    },
    {
        "SNP ID": "rs7019241",
        "SNP Name": "GOLM1 C17857992T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,adult giant-cell hepatitis,Alzheimer,Alzheimer\u2019s disease,C9orf155,Coiled coil,dementia,extracellular space,extracellular vesicular exosome,GCH,Glycoprotein,Golgi apparatus,Golgi membrane protein 1,Golgi membrane protein GP73,Golgi phosphoprotein 2,GOLM1,GOLPH2,HCV,hep C,hepaptitis,hepatitis,Hepatitis C,integral component of plasma membrane,late-onset Alzheimer\u2019s disease,neurodegenerative disorder,Phosphoprotein,PSEC0242,Signal-anchor,Transmembrane,Transmembrane helix,UNQ686/PRO1326,Up-regulated in response to viral infection,Upregulated by Hepatitis C Virus,virus",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs10868366",
        "SNP Name": "GOLM1 G88700060T",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,adult giant-cell hepatitis,Alzheimer,Alzheimer\u2019s disease,C9orf155,Coiled coil,dementia,extracellular space,extracellular vesicular exosome,GCH,Glycoprotein,Golgi apparatus,Golgi membrane protein 1,Golgi membrane protein GP73,Golgi phosphoprotein 2,GOLM1,GOLPH2,HCV,hep C,hepaptitis,hepatitis,Hepatitis C,integral component of plasma membrane,late-onset Alzheimer\u2019s disease,neurodegenerative disorder,Phosphoprotein,PSEC0242,Signal-anchor,Transmembrane,Transmembrane helix,UNQ686/PRO1326,Up-regulated in response to viral infection,Upregulated by Hepatitis C Virus,virus",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs1769259",
        "SNP Name": "FBP1 R218K",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Hydroxyphosphate Sulfate"
    },
    {
        "SNP ID": "rs1769259",
        "SNP Name": "FBP1 R218K",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Phosphate"
    },
    {
        "SNP ID": "rs1769259",
        "SNP Name": "FBP1 R218K",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "D-Fructose"
    },
    {
        "SNP ID": "rs1769259",
        "SNP Name": "FBP1 R218K",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dipotassium Phosphate"
    },
    {
        "SNP ID": "rs1769259",
        "SNP Name": "FBP1 R218K",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Disodium Phosphate"
    },
    {
        "SNP ID": "rs1769259",
        "SNP Name": "FBP1 R218K",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Monopotassium Phosphate"
    },
    {
        "SNP ID": "rs1769259",
        "SNP Name": "FBP1 R218K",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Monosodium Phosphate"
    },
    {
        "SNP ID": "rs1769259",
        "SNP Name": "FBP1 R218K",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phosphate-Buffered Saline"
    },
    {
        "SNP ID": "rs4129219",
        "SNP Name": "FBP1 T97390288C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4129219",
        "Video": null,
        "Tags": "6-bisphosphate,6-bisphosphate 1-phosphatase activity,active R-state,adiposity,allosteric inhibitor,AMP,AMP binding,appetite-stimulating neuropeptides,bound substrate,carbohydrate biosynthesis,carbohydrate metabolic process,carbohydrate metabolism,cellular response to drug,cellular response to magnesium ion,circulating satiety hormones,competitive inhibitor,complex allosteric regulation,D-fructose 1,D-fructose 6-phosphate,dephosphorylation,divalent cations,FBP1,feedback mechanism,fructose 1,Fructose 2,fructose 6-phosphate,fructose 6-phosphate metabolic process,fructose metabolic process,gluconeogenesis,glucose metabolic process,glycerol,hydrolase,identical protein binding,inactive T-state,insulin secretion,liver,Magnesium,metal ion binding,Metal-binding,modulate,monosaccharide binding,negative regulation of cell growth,negative regulation of glycolytic process,negative regulation of Ras protein signal transduction,nutrient excess,pancreatic beta-cells,pentose-phosphate pathway,phosphate,protein homotetramerization,protein in liver,recombinant enzyme,regulating glucose sensing,regulation of gluconeogenesis,regulator of appetite,rs4129219,schizophrenia,small molecule metabolic process,substrate,synergistic effects,T97390288C,weight gain",
        "Group": "Aluminum Hydroxyphosphate Sulfate"
    },
    {
        "SNP ID": "rs4129219",
        "SNP Name": "FBP1 T97390288C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4129219",
        "Video": null,
        "Tags": "6-bisphosphate,6-bisphosphate 1-phosphatase activity,active R-state,adiposity,allosteric inhibitor,AMP,AMP binding,appetite-stimulating neuropeptides,bound substrate,carbohydrate biosynthesis,carbohydrate metabolic process,carbohydrate metabolism,cellular response to drug,cellular response to magnesium ion,circulating satiety hormones,competitive inhibitor,complex allosteric regulation,D-fructose 1,D-fructose 6-phosphate,dephosphorylation,divalent cations,FBP1,feedback mechanism,fructose 1,Fructose 2,fructose 6-phosphate,fructose 6-phosphate metabolic process,fructose metabolic process,gluconeogenesis,glucose metabolic process,glycerol,hydrolase,identical protein binding,inactive T-state,insulin secretion,liver,Magnesium,metal ion binding,Metal-binding,modulate,monosaccharide binding,negative regulation of cell growth,negative regulation of glycolytic process,negative regulation of Ras protein signal transduction,nutrient excess,pancreatic beta-cells,pentose-phosphate pathway,phosphate,protein homotetramerization,protein in liver,recombinant enzyme,regulating glucose sensing,regulation of gluconeogenesis,regulator of appetite,rs4129219,schizophrenia,small molecule metabolic process,substrate,synergistic effects,T97390288C,weight gain",
        "Group": "Aluminum Phosphate"
    },
    {
        "SNP ID": "rs4129219",
        "SNP Name": "FBP1 T97390288C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4129219",
        "Video": null,
        "Tags": "6-bisphosphate,6-bisphosphate 1-phosphatase activity,active R-state,adiposity,allosteric inhibitor,AMP,AMP binding,appetite-stimulating neuropeptides,bound substrate,carbohydrate biosynthesis,carbohydrate metabolic process,carbohydrate metabolism,cellular response to drug,cellular response to magnesium ion,circulating satiety hormones,competitive inhibitor,complex allosteric regulation,D-fructose 1,D-fructose 6-phosphate,dephosphorylation,divalent cations,FBP1,feedback mechanism,fructose 1,Fructose 2,fructose 6-phosphate,fructose 6-phosphate metabolic process,fructose metabolic process,gluconeogenesis,glucose metabolic process,glycerol,hydrolase,identical protein binding,inactive T-state,insulin secretion,liver,Magnesium,metal ion binding,Metal-binding,modulate,monosaccharide binding,negative regulation of cell growth,negative regulation of glycolytic process,negative regulation of Ras protein signal transduction,nutrient excess,pancreatic beta-cells,pentose-phosphate pathway,phosphate,protein homotetramerization,protein in liver,recombinant enzyme,regulating glucose sensing,regulation of gluconeogenesis,regulator of appetite,rs4129219,schizophrenia,small molecule metabolic process,substrate,synergistic effects,T97390288C,weight gain",
        "Group": "Dipotassium Phosphate"
    },
    {
        "SNP ID": "rs4129219",
        "SNP Name": "FBP1 T97390288C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4129219",
        "Video": null,
        "Tags": "6-bisphosphate,6-bisphosphate 1-phosphatase activity,active R-state,adiposity,allosteric inhibitor,AMP,AMP binding,appetite-stimulating neuropeptides,bound substrate,carbohydrate biosynthesis,carbohydrate metabolic process,carbohydrate metabolism,cellular response to drug,cellular response to magnesium ion,circulating satiety hormones,competitive inhibitor,complex allosteric regulation,D-fructose 1,D-fructose 6-phosphate,dephosphorylation,divalent cations,FBP1,feedback mechanism,fructose 1,Fructose 2,fructose 6-phosphate,fructose 6-phosphate metabolic process,fructose metabolic process,gluconeogenesis,glucose metabolic process,glycerol,hydrolase,identical protein binding,inactive T-state,insulin secretion,liver,Magnesium,metal ion binding,Metal-binding,modulate,monosaccharide binding,negative regulation of cell growth,negative regulation of glycolytic process,negative regulation of Ras protein signal transduction,nutrient excess,pancreatic beta-cells,pentose-phosphate pathway,phosphate,protein homotetramerization,protein in liver,recombinant enzyme,regulating glucose sensing,regulation of gluconeogenesis,regulator of appetite,rs4129219,schizophrenia,small molecule metabolic process,substrate,synergistic effects,T97390288C,weight gain",
        "Group": "Disodium Phosphate"
    },
    {
        "SNP ID": "rs4129219",
        "SNP Name": "FBP1 T97390288C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4129219",
        "Video": null,
        "Tags": "6-bisphosphate,6-bisphosphate 1-phosphatase activity,active R-state,adiposity,allosteric inhibitor,AMP,AMP binding,appetite-stimulating neuropeptides,bound substrate,carbohydrate biosynthesis,carbohydrate metabolic process,carbohydrate metabolism,cellular response to drug,cellular response to magnesium ion,circulating satiety hormones,competitive inhibitor,complex allosteric regulation,D-fructose 1,D-fructose 6-phosphate,dephosphorylation,divalent cations,FBP1,feedback mechanism,fructose 1,Fructose 2,fructose 6-phosphate,fructose 6-phosphate metabolic process,fructose metabolic process,gluconeogenesis,glucose metabolic process,glycerol,hydrolase,identical protein binding,inactive T-state,insulin secretion,liver,Magnesium,metal ion binding,Metal-binding,modulate,monosaccharide binding,negative regulation of cell growth,negative regulation of glycolytic process,negative regulation of Ras protein signal transduction,nutrient excess,pancreatic beta-cells,pentose-phosphate pathway,phosphate,protein homotetramerization,protein in liver,recombinant enzyme,regulating glucose sensing,regulation of gluconeogenesis,regulator of appetite,rs4129219,schizophrenia,small molecule metabolic process,substrate,synergistic effects,T97390288C,weight gain",
        "Group": "Monopotassium Phosphate"
    },
    {
        "SNP ID": "rs4129219",
        "SNP Name": "FBP1 T97390288C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4129219",
        "Video": null,
        "Tags": "6-bisphosphate,6-bisphosphate 1-phosphatase activity,active R-state,adiposity,allosteric inhibitor,AMP,AMP binding,appetite-stimulating neuropeptides,bound substrate,carbohydrate biosynthesis,carbohydrate metabolic process,carbohydrate metabolism,cellular response to drug,cellular response to magnesium ion,circulating satiety hormones,competitive inhibitor,complex allosteric regulation,D-fructose 1,D-fructose 6-phosphate,dephosphorylation,divalent cations,FBP1,feedback mechanism,fructose 1,Fructose 2,fructose 6-phosphate,fructose 6-phosphate metabolic process,fructose metabolic process,gluconeogenesis,glucose metabolic process,glycerol,hydrolase,identical protein binding,inactive T-state,insulin secretion,liver,Magnesium,metal ion binding,Metal-binding,modulate,monosaccharide binding,negative regulation of cell growth,negative regulation of glycolytic process,negative regulation of Ras protein signal transduction,nutrient excess,pancreatic beta-cells,pentose-phosphate pathway,phosphate,protein homotetramerization,protein in liver,recombinant enzyme,regulating glucose sensing,regulation of gluconeogenesis,regulator of appetite,rs4129219,schizophrenia,small molecule metabolic process,substrate,synergistic effects,T97390288C,weight gain",
        "Group": "Monosodium Phosphate"
    },
    {
        "SNP ID": "rs4129219",
        "SNP Name": "FBP1 T97390288C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4129219",
        "Video": null,
        "Tags": "6-bisphosphate,6-bisphosphate 1-phosphatase activity,active R-state,adiposity,allosteric inhibitor,AMP,AMP binding,appetite-stimulating neuropeptides,bound substrate,carbohydrate biosynthesis,carbohydrate metabolic process,carbohydrate metabolism,cellular response to drug,cellular response to magnesium ion,circulating satiety hormones,competitive inhibitor,complex allosteric regulation,D-fructose 1,D-fructose 6-phosphate,dephosphorylation,divalent cations,FBP1,feedback mechanism,fructose 1,Fructose 2,fructose 6-phosphate,fructose 6-phosphate metabolic process,fructose metabolic process,gluconeogenesis,glucose metabolic process,glycerol,hydrolase,identical protein binding,inactive T-state,insulin secretion,liver,Magnesium,metal ion binding,Metal-binding,modulate,monosaccharide binding,negative regulation of cell growth,negative regulation of glycolytic process,negative regulation of Ras protein signal transduction,nutrient excess,pancreatic beta-cells,pentose-phosphate pathway,phosphate,protein homotetramerization,protein in liver,recombinant enzyme,regulating glucose sensing,regulation of gluconeogenesis,regulator of appetite,rs4129219,schizophrenia,small molecule metabolic process,substrate,synergistic effects,T97390288C,weight gain",
        "Group": "Phosphate-Buffered Saline"
    },
    {
        "SNP ID": "rs4129219",
        "SNP Name": "FBP1 T97390288C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4129219",
        "Video": null,
        "Tags": "6-bisphosphate,6-bisphosphate 1-phosphatase activity,active R-state,adiposity,allosteric inhibitor,AMP,AMP binding,appetite-stimulating neuropeptides,bound substrate,carbohydrate biosynthesis,carbohydrate metabolic process,carbohydrate metabolism,cellular response to drug,cellular response to magnesium ion,circulating satiety hormones,competitive inhibitor,complex allosteric regulation,D-fructose 1,D-fructose 6-phosphate,dephosphorylation,divalent cations,FBP1,feedback mechanism,fructose 1,Fructose 2,fructose 6-phosphate,fructose 6-phosphate metabolic process,fructose metabolic process,gluconeogenesis,glucose metabolic process,glycerol,hydrolase,identical protein binding,inactive T-state,insulin secretion,liver,Magnesium,metal ion binding,Metal-binding,modulate,monosaccharide binding,negative regulation of cell growth,negative regulation of glycolytic process,negative regulation of Ras protein signal transduction,nutrient excess,pancreatic beta-cells,pentose-phosphate pathway,phosphate,protein homotetramerization,protein in liver,recombinant enzyme,regulating glucose sensing,regulation of gluconeogenesis,regulator of appetite,rs4129219,schizophrenia,small molecule metabolic process,substrate,synergistic effects,T97390288C,weight gain",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs357564",
        "SNP Name": "PTCH1 P1164L",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dulbecco's Modified Eagle Medium"
    },
    {
        "SNP ID": "rs357564",
        "SNP Name": "PTCH1 P1164L",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Monosodium Phosphate"
    },
    {
        "SNP ID": "rs357564",
        "SNP Name": "PTCH1 P1164L",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phosphate-Buffered Saline"
    },
    {
        "SNP ID": "rs357564",
        "SNP Name": "PTCH1 P1164L",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Chloride"
    },
    {
        "SNP ID": "rs2236405",
        "SNP Name": "PTCH1 T1044S",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dulbecco's Modified Eagle Medium"
    },
    {
        "SNP ID": "rs2236405",
        "SNP Name": "PTCH1 T1044S",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Monosodium Phosphate"
    },
    {
        "SNP ID": "rs2236405",
        "SNP Name": "PTCH1 T1044S",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phosphate-Buffered Saline"
    },
    {
        "SNP ID": "rs2236405",
        "SNP Name": "PTCH1 T1044S",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Chloride"
    },
    {
        "SNP ID": "rs10984009",
        "SNP Name": "FOXE1 8124G>A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "UNAVAILABLE",
        "Video": null,
        "Tags": null,
        "Group": "Thyroid"
    },
    {
        "SNP ID": "rs1800546",
        "SNP Name": "ALDOB A150P",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "D-Fructose"
    },
    {
        "SNP ID": "rs4986790",
        "SNP Name": "TLR4 D299G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Acetaminophen Use and Asthma,acids,activation of MAPK activity,AD,Age-related macular degeneration,Aggressive Prostate Cancer,Alzheimer,amyloid,amyloid-beta,amyloid-beta 42,Ankylosing Spondylitis,ARMD10,Arteriovenous Fistula Failure,Arthritis,asthma,Asymptomatic Bacteriuria,Atherosclerosis,B cell,B cell proliferation involved in immune response,B-cell,Bacterial Meningitis,Bacterial Vaginosis,Baluchi Malaria,bicuspid aortic valve,breast cancer,breast tumorigenesis,Bronchopulmonary Dysplasia,campylobacteriosis,cancer,cancerous,carcinogen,cardio,Cardiovascular,CD284,CD36,cellular response to lipopolysaccharide,cellular response to lipoteichoic acid,cellular response to mechanical stimulus,Cervical Cytokine,Chlamydia trachomatis,cholesterol,chron,chronic liver disease,Chronic Obstructive Pulmonary Disease,Chronic Periaortitis,Chrons,cirrhosis,Colon Cancer,colorectal cancer,Colorectal Carcinogenesis,congenital toxoplasmosis,COPD,Crohn's Disease,Crohn\u2019s disease,CVD,cytoplasm,defense response to bacterium,defense response to Gram-negative bacterium,dementia,dependent toll-like receptor signaling pathway,detection of fungus,detection of lipopolysaccharide,Diabetic Foot Ulcers,diabetic retinopathy,diabetic retinopathy in type 2 diabetes,Dilated Cardiomyopathy,drug-resistant Plasmodium falciparum parasites,Early-Onset Preeclampsia,eczema,endometrial cancer,endosome membrane,epithelium,external side of plasma membrane,fatty acids,Fatty Liver,Foot Ulcers,free fatty acids,gastric cancer,Gastric Carcinogenesis,gastric malignancy,Geographic Atrophy,haemochromatosis,Haemophilus influenzae,head and neck squamous cell carcinomas,Hearing Loss,heart,heart disease,Helicobacter pylori,Helicobacter pylori-induced gastric precancerous,HELLP,HELLP syndrome,Hep C,Hepatic Cirrhosis,hepatic fibrogenesis,Hepatic Stellate Cell,hepatitis,hepatitis B,Hepatitis C Virus,HIV,hToll,I-kappaB kinase/NF-kappaB signaling,I-kappaB phosphorylation,IBS,IL-10,IL-12,IL-17,IL-6,IL-8,IL10,IL12,IL17,IL6,IL8,immune response,Immunity,Immunometabolism,inflammation,Inflammatory response,innate immune response,Innate immunity,integral component of plasma membrane,interferon-gamma production,interlekin 17,interleukin,interleukin 10,interleukin 12,interleukin 6,interleukin 8,intestinal epithelial structure maintenance,Invasive Aspergillosis,irate bowel disease,irritable bowel disease,ischemia,Ischemic Stroke,isoforms,juvenile idiopathic arthritis,Kaposi Sarcoma Herpesvirus,kappa,L-leucine,Late-Onset Alzheimer's Disease,Lbp,LDL,Legionnaires\u2019 Disease,leucine,life-threatening sepsis,lipid,lipopolysaccharide,lipopolysaccharide binding,lipopolysaccharide receptor activity,lipopolysaccharide receptor complex,Lipopolysaccharide-Binding Protein,lipopolysaccharide-mediated signaling pathway,lipoprotein,liver,liver fat,liver injury,longevity,low-density lipoprotein,LPS,LRR (leucine-rich) repeats,LRRCT domain,macrophage activation,macrophages,macular,Macular degeneration,malaria,Malaria-Resistance,Malignant Melanoma,mediate,Melioidosis,Meningococcal Meningitis,monocyte,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,negative regulation of ERK1 and ERK2 cascade,negative regulation of interferon-gamma production,negative regulation of interleukin-17 production,negative regulation of interleukin-23 production,negative regulation of interleukin-6 production,negative regulation of osteoclast differentiation,negative regulation of tumor necrosis factor production,neurodegenerative disease,NF-kappa-B,NF-kappa-B-dependent,nitric oxide,nitric oxide production involved in inflammatory response,NO,Non-Fatal Myocardial Infarction,non-Hodgkin lymphoma,non-small cell lung cancer,Noncardia Gastric Cancer,obesity,ovarian cancers,oxLDL,Paediatric cholestatic liver disease,pathogen,Pelvic Inflammatory Disease,Periaortitis,perinuclear region of cy",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs3761847",
        "SNP Name": "TRAF1 variant",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs3761847",
        "Video": null,
        "Tags": null,
        "Group": "IgA"
    },
    {
        "SNP ID": "rs10306114",
        "SNP Name": "PTGS1/COX-1 A-287G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "2-Phenoxyethanol"
    },
    {
        "SNP ID": "rs10306114",
        "SNP Name": "PTGS1/COX-1 A-287G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Alcohol"
    },
    {
        "SNP ID": "rs10306114",
        "SNP Name": "PTGS1/COX-1 A-287G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Polysorbate 20"
    },
    {
        "SNP ID": "rs10306114",
        "SNP Name": "PTGS1/COX-1 A-287G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs3842787",
        "SNP Name": "PTGS1/COX-1 P17L",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "2-Phenoxyethanol"
    },
    {
        "SNP ID": "rs3842787",
        "SNP Name": "PTGS1/COX-1 P17L",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Alcohol"
    },
    {
        "SNP ID": "rs3842787",
        "SNP Name": "PTGS1/COX-1 P17L",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Polysorbate 20"
    },
    {
        "SNP ID": "rs3842787",
        "SNP Name": "PTGS1/COX-1 P17L",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs12009",
        "SNP Name": "HSPA5 (GRP78) C11364T",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs12009",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs1611114",
        "SNP Name": "DBH C3719T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1611114",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Copper,copper type II ascorbate-dependent monooxygenase family,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,Dopamine,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,Metal-binding,Monooxygenase,mutations,nerve growth factor,noradrenaline,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,sensation,sensation seeking,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1611114",
        "SNP Name": "DBH C3719T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1611114",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Copper,copper type II ascorbate-dependent monooxygenase family,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,Dopamine,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,Metal-binding,Monooxygenase,mutations,nerve growth factor,noradrenaline,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,sensation,sensation seeking,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1611115",
        "SNP Name": "DBH variant",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1611115",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,AD,addiction,addictive behavior,ADHD,adrenal medulla,Ala-318,Alzheimer,Alzheimer's disease,anxiety,ascorbate,ASD,Autism,Autism Spectrum Disorder,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,cocaine,Cocaine Abuse,cocaine addiction,Complete proteome,COMT,Copper,copper type II ascorbate-dependent monooxygenase family,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,Dopamine,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,IFN-\u03b2,IFN-\u03b2 treatment response in Irish multiple sclerosis patients,impulsivity,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,mental disorder,Metal-binding,Migraine,Monooxygenase,mutations,nerve growth factor,noradrenaline,ODD,Oxidoreductase,Parkinson,Parkinson\u2019s disease,PD,Pharmacogenetics,Polymorphism,positive regulation of vasoconstriction,Post-traumatic Stress Disorder,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,PTSD,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,schizophrenia,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,smoking behavior,soluble dopamine beta-hydroxylase,stimulant drug response,stimulants,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,trauma,Trauma-Related Disorders,visual learning,Vitamin C",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1611115",
        "SNP Name": "DBH variant",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1611115",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,AD,addiction,addictive behavior,ADHD,adrenal medulla,Ala-318,Alzheimer,Alzheimer's disease,anxiety,ascorbate,ASD,Autism,Autism Spectrum Disorder,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,cocaine,Cocaine Abuse,cocaine addiction,Complete proteome,COMT,Copper,copper type II ascorbate-dependent monooxygenase family,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,Dopamine,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,IFN-\u03b2,IFN-\u03b2 treatment response in Irish multiple sclerosis patients,impulsivity,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,mental disorder,Metal-binding,Migraine,Monooxygenase,mutations,nerve growth factor,noradrenaline,ODD,Oxidoreductase,Parkinson,Parkinson\u2019s disease,PD,Pharmacogenetics,Polymorphism,positive regulation of vasoconstriction,Post-traumatic Stress Disorder,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,PTSD,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,schizophrenia,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,smoking behavior,soluble dopamine beta-hydroxylase,stimulant drug response,stimulants,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,trauma,Trauma-Related Disorders,visual learning,Vitamin C",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs3025382",
        "SNP Name": "DBH G5837A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3025382",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,addiction,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,choline,cholinergic,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Copper,copper type II ascorbate-dependent monooxygenase family,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,dependence,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,dopamine,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,GABA,glucocorticoids,glucose homeostasis,glutamate,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,Metal-binding,Monooxygenase,mutations,nerve growth factor,Nicotine,nicotine dependence,nicotinic,noradrenaline,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,smoking,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs3025382",
        "SNP Name": "DBH G5837A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3025382",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,addiction,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,choline,cholinergic,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Copper,copper type II ascorbate-dependent monooxygenase family,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,dependence,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,dopamine,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,GABA,glucocorticoids,glucose homeostasis,glutamate,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,Metal-binding,Monooxygenase,mutations,nerve growth factor,Nicotine,nicotine dependence,nicotinic,noradrenaline,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,smoking,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2007153",
        "SNP Name": "DBH T7335C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2007153",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,mental disorder,Metal-binding,Monooxygenase,mutations,nerve growth factor,noradrenaline,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,schizophrenia,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs2007153",
        "SNP Name": "DBH T7335C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2007153",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,mental disorder,Metal-binding,Monooxygenase,mutations,nerve growth factor,noradrenaline,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,schizophrenia,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1108580",
        "SNP Name": "DBH A486G",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1108580",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,Decision Making,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,Fetal Growth,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,Metal-binding,Monooxygenase,mutations,nerve growth factor,Neurotransmitters,noradrenaline,ODD,Oxidoreductase,Parkinson,Parkinson's disease,PD,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Psychotic Depression,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1108580",
        "SNP Name": "DBH A486G",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1108580",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,Decision Making,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,Fetal Growth,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,Metal-binding,Monooxygenase,mutations,nerve growth factor,Neurotransmitters,noradrenaline,ODD,Oxidoreductase,Parkinson,Parkinson's disease,PD,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Psychotic Depression,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1108581",
        "SNP Name": "DBH A8757G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1108581",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,ASD,Autism,Autism Spectrum Disorder,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,dopamine,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,Metal-binding,Monooxygenase,mutations,nerve growth factor,noradrenaline,norepinephrine,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small  molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1108581",
        "SNP Name": "DBH A8757G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1108581",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,ASD,Autism,Autism Spectrum Disorder,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,dopamine,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,Metal-binding,Monooxygenase,mutations,nerve growth factor,noradrenaline,norepinephrine,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small  molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2873804",
        "SNP Name": "DBH T9160C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2873804",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,Metal-binding,Monooxygenase,mutations,nerve growth factor,noradrenaline,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs2873804",
        "SNP Name": "DBH T9160C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2873804",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,Metal-binding,Monooxygenase,mutations,nerve growth factor,noradrenaline,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs5320",
        "SNP Name": "DBH G631A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5320",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,AD,adrenal medulla,Ala-318,Alzheimer,Alzheimer's disease,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,Metal-binding,Monooxygenase,mutations,nerve growth factor,noradrenaline,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs5320",
        "SNP Name": "DBH G631A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5320",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,AD,adrenal medulla,Ala-318,Alzheimer,Alzheimer's disease,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,Metal-binding,Monooxygenase,mutations,nerve growth factor,noradrenaline,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1611123",
        "SNP Name": "DBH C12599T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1611123",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,Dopamine,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,Highly Sensitive Personality,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,Metal-binding,Monooxygenase,mutations,nerve growth factor,noradrenaline,ODD,Oxidoreductase,personality,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1611123",
        "SNP Name": "DBH C12599T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1611123",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,Dopamine,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,Highly Sensitive Personality,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,Metal-binding,Monooxygenase,mutations,nerve growth factor,noradrenaline,ODD,Oxidoreductase,personality,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs4531",
        "SNP Name": "DBH G952T",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4531",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Copper,copper type II ascorbate-dependent monooxygenase family,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,dopamine,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,Fetal Growth,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,mental disorder,Metal-binding,Monooxygenase,mutations,nerve growth factor,nicotine dependence,noradrenaline,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic \r\nsignaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,Schizophrenia,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,serotonin,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs4531",
        "SNP Name": "DBH G952T",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4531",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Copper,copper type II ascorbate-dependent monooxygenase family,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,dopamine,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,Fetal Growth,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,mental disorder,Metal-binding,Monooxygenase,mutations,nerve growth factor,nicotine dependence,noradrenaline,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic \r\nsignaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,Schizophrenia,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,serotonin,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1541332",
        "SNP Name": "DBH G15032A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1541332",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,D2,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,dopamine,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,Metal-binding,Monooxygenase,mutations,nerve growth factor,noradrenaline,norepinephrine,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1541332",
        "SNP Name": "DBH G15032A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1541332",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,D2,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,dopamine,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,Metal-binding,Monooxygenase,mutations,nerve growth factor,noradrenaline,norepinephrine,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2519154",
        "SNP Name": "DBH T15791C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2519154",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,Autism,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,D2,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,Dopamine,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,Metal-binding,Monooxygenase,mutations,nerve growth factor,NET,noradrenaline,Norepinephrine,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs2519154",
        "SNP Name": "DBH T15791C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2519154",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,Autism,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,D2,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,Dopamine,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,Metal-binding,Monooxygenase,mutations,nerve growth factor,NET,noradrenaline,Norepinephrine,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2283123",
        "SNP Name": "DBH C18813T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2283123",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,mental disorder,Metal-binding,Monooxygenase,mutations,nerve growth factor,noradrenaline,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,schizophrenia,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs2283123",
        "SNP Name": "DBH C18813T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2283123",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,mental disorder,Metal-binding,Monooxygenase,mutations,nerve growth factor,noradrenaline,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,schizophrenia,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs77905",
        "SNP Name": "DBH A1410G",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs77905",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Cigarette Smoking Behavior,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,D2,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,Dopamine,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,mental disorder,Metal-binding,Monooxygenase,mutations,nerve growth factor,NET,nicotine addiction,noradrenaline,Norepinephrine,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,schizophrenia,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,smoking,smoking behavior,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs77905",
        "SNP Name": "DBH A1410G",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs77905",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Cigarette Smoking Behavior,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,D2,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,Dopamine,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,mental disorder,Metal-binding,Monooxygenase,mutations,nerve growth factor,NET,nicotine addiction,noradrenaline,Norepinephrine,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,schizophrenia,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,smoking,smoking behavior,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2097628",
        "SNP Name": "DBH T2145C",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2097628",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,Autism,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,D2,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,Dopamine,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,Metal-binding,Monooxygenase,mutations,nerve growth factor,NET,noradrenaline,Norepinephrine,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs2097628",
        "SNP Name": "DBH T2145C",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2097628",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,Autism,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,D2,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,Dopamine,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,Metal-binding,Monooxygenase,mutations,nerve growth factor,NET,noradrenaline,Norepinephrine,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs129882",
        "SNP Name": "DBH C27185T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs129882",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,dopamine,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,Metal-binding,Monooxygenase,mutations,nerve growth factor,noradrenaline,norepinephrine,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs129882",
        "SNP Name": "DBH C27185T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs129882",
        "Video": null,
        "Tags": "(R)-noradrenaline,(R)-noradrenaline biosynthesis,3,4-dihydroxyphenethylamine,acetylcholine,ADHD,adrenal medulla,Ala-318,anxiety,ascorbate,blood vessel remodeling,catalytic activity copper ion binding,catecholamine biosynthesis,catecholamine biosynthetic process,CD,cellular nitrogen compound metabolic process,chromaffin granule lumen,chromaffin granule membrane,Complete proteome,COMT,Continuous Performance Task,Copper,copper type II ascorbate-dependent monooxygenase family,CPT,cytokine production,cytoplasm,Cytoplasmic vesicle,cytoplasmic vesticle,DBH,DBH deficiency,DBH-A,DBH-B,DDC,dehydroascorbate,depression,Direct protein sequencing,Disease mutation,Disulfide bond,disulfide-linked dimers,dopamine,Dopamine beta-hydroxylase,Dopamine beta-hydroxylase deficiency,Dopamine beta-monooxygenase,dopamine beta-monooxygenase activity,dopamine catabolic process,DRD2,DRD4,extracellular region,fear response,glucocorticoids,glucose homeostasis,Glycoprotein,homoiothermy,integral component of membrane,L-ascorbic acid binding,learning dopamine,leukocyte mediated immunity,leukocyte migration,locomotory behavior,maternal behavior,Membrane,memory,Metal-binding,Monooxygenase,mutations,nerve growth factor,noradrenaline,norepinephrine,ODD,Oxidoreductase,Polymorphism,positive regulation of vasoconstriction,PQQ,process behavioral response to ethanol,profound deficits in autonomic function,profund deficits in cardiovascular function,Reference proteome,regulation of cell proliferation,regulation of extrinsic apoptotic signaling pathway,repinephrine biosynthetic process,reserpine,response to amphetamine,response to pain,secretory granule lumen,secretory vesicle,secretory vesicle lumen,secretory vesicle membrane,Ser-318,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,soluble dopamine beta-hydroxylase,subtle deficitis in central nervous system dysfunction,superior cervical ganglia,synaptic transmission,Trans-synaptic stimulation,Transmembrane,Transmembrane helix,transport vesicle membrane,visual learning,Vitamin C",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1244422",
        "SNP Name": "ATP5c1 variant",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs3740015",
        "SNP Name": "DHTKD1 Y272D",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3740015",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs3740015",
        "SNP Name": "DHTKD1 Y272D",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3740015",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs2236418",
        "SNP Name": "GAD2 (GAD) A26505496G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2236418",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs8190612",
        "SNP Name": "GAD2 (GAD) C26512375T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs8190612",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs8190646",
        "SNP Name": "GAD2 (GAD) A26520507G",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs8190646",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs1330581",
        "SNP Name": "GAD2 (GAD) A26528835G",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1330581",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs1805398",
        "SNP Name": "GAD2 (GAD) G26474809T",
        "Risk Allele": "G",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1805398",
        "Video": null,
        "Tags": "65 kDa glutamic acid decarboxylase,addiction,alcohol dependence,anchored component of membrane,axon,B6,Catalyzes the production of GABA,cell junction,Cell membrane,cholesterol,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cytoplasm,cytoplasmic side,cytoplasmic vesicle,cytosol,decarboxylase,drug,fat,fat transport,GABA,GAD-65,GAD2,GAD65,gamma-Aminobutyric acid,glutamate,glutamate binding,Glutamate decarboxylase 2,Glutamate decarboxylase 65 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Golgi apparatus,golgi apparatus membrane,Golgi membrane,group II decarboxylase family,Homodimer,L-glutamate,L-glutamate = 4-aminobutanoate + CO2,l-glutamine,lipid-anchor,Lipoprotein,lyase,membrane,neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,p5p,Palmitate,Palmitoylated,perinuclear region of cytoplasm,peripheral membrane protein,phospate,Phosphoprotein,Phosphorylated,plasma membrane,Polymorphism,presynaptic cell membrane,presynaptic clustering,presynaptic membrane,Pyridoxal phosphate,pyridoxal phosphate binding,pyridoxamine,pyridoxine,pyridoxol,response to drug,synapse,synaptic transmission,synaptic vesicle membrane,vitamin B6",
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs1805398",
        "SNP Name": "GAD2 (GAD) G26474809T",
        "Risk Allele": "G",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1805398",
        "Video": null,
        "Tags": "65 kDa glutamic acid decarboxylase,addiction,alcohol dependence,anchored component of membrane,axon,B6,Catalyzes the production of GABA,cell junction,Cell membrane,cholesterol,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cytoplasm,cytoplasmic side,cytoplasmic vesicle,cytosol,decarboxylase,drug,fat,fat transport,GABA,GAD-65,GAD2,GAD65,gamma-Aminobutyric acid,glutamate,glutamate binding,Glutamate decarboxylase 2,Glutamate decarboxylase 65 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Golgi apparatus,golgi apparatus membrane,Golgi membrane,group II decarboxylase family,Homodimer,L-glutamate,L-glutamate = 4-aminobutanoate + CO2,l-glutamine,lipid-anchor,Lipoprotein,lyase,membrane,neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,p5p,Palmitate,Palmitoylated,perinuclear region of cytoplasm,peripheral membrane protein,phospate,Phosphoprotein,Phosphorylated,plasma membrane,Polymorphism,presynaptic cell membrane,presynaptic clustering,presynaptic membrane,Pyridoxal phosphate,pyridoxal phosphate binding,pyridoxamine,pyridoxine,pyridoxol,response to drug,synapse,synaptic transmission,synaptic vesicle membrane,vitamin B6",
        "Group": "L-Glutamine"
    },
    {
        "SNP ID": "rs1805398",
        "SNP Name": "GAD2 (GAD) G26474809T",
        "Risk Allele": "G",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1805398",
        "Video": null,
        "Tags": "65 kDa glutamic acid decarboxylase,addiction,alcohol dependence,anchored component of membrane,axon,B6,Catalyzes the production of GABA,cell junction,Cell membrane,cholesterol,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cytoplasm,cytoplasmic side,cytoplasmic vesicle,cytosol,decarboxylase,drug,fat,fat transport,GABA,GAD-65,GAD2,GAD65,gamma-Aminobutyric acid,glutamate,glutamate binding,Glutamate decarboxylase 2,Glutamate decarboxylase 65 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Golgi apparatus,golgi apparatus membrane,Golgi membrane,group II decarboxylase family,Homodimer,L-glutamate,L-glutamate = 4-aminobutanoate + CO2,l-glutamine,lipid-anchor,Lipoprotein,lyase,membrane,neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,p5p,Palmitate,Palmitoylated,perinuclear region of cytoplasm,peripheral membrane protein,phospate,Phosphoprotein,Phosphorylated,plasma membrane,Polymorphism,presynaptic cell membrane,presynaptic clustering,presynaptic membrane,Pyridoxal phosphate,pyridoxal phosphate binding,pyridoxamine,pyridoxine,pyridoxol,response to drug,synapse,synaptic transmission,synaptic vesicle membrane,vitamin B6",
        "Group": "Monosodium Glutamate"
    },
    {
        "SNP ID": "rs1805398",
        "SNP Name": "GAD2 (GAD) G26474809T",
        "Risk Allele": "G",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1805398",
        "Video": null,
        "Tags": "65 kDa glutamic acid decarboxylase,addiction,alcohol dependence,anchored component of membrane,axon,B6,Catalyzes the production of GABA,cell junction,Cell membrane,cholesterol,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cytoplasm,cytoplasmic side,cytoplasmic vesicle,cytosol,decarboxylase,drug,fat,fat transport,GABA,GAD-65,GAD2,GAD65,gamma-Aminobutyric acid,glutamate,glutamate binding,Glutamate decarboxylase 2,Glutamate decarboxylase 65 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Golgi apparatus,golgi apparatus membrane,Golgi membrane,group II decarboxylase family,Homodimer,L-glutamate,L-glutamate = 4-aminobutanoate + CO2,l-glutamine,lipid-anchor,Lipoprotein,lyase,membrane,neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,p5p,Palmitate,Palmitoylated,perinuclear region of cytoplasm,peripheral membrane protein,phospate,Phosphoprotein,Phosphorylated,plasma membrane,Polymorphism,presynaptic cell membrane,presynaptic clustering,presynaptic membrane,Pyridoxal phosphate,pyridoxal phosphate binding,pyridoxamine,pyridoxine,pyridoxol,response to drug,synapse,synaptic transmission,synaptic vesicle membrane,vitamin B6",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1805398",
        "SNP Name": "GAD2 (GAD) G26474809T",
        "Risk Allele": "G",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1805398",
        "Video": null,
        "Tags": "65 kDa glutamic acid decarboxylase,addiction,alcohol dependence,anchored component of membrane,axon,B6,Catalyzes the production of GABA,cell junction,Cell membrane,cholesterol,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cytoplasm,cytoplasmic side,cytoplasmic vesicle,cytosol,decarboxylase,drug,fat,fat transport,GABA,GAD-65,GAD2,GAD65,gamma-Aminobutyric acid,glutamate,glutamate binding,Glutamate decarboxylase 2,Glutamate decarboxylase 65 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Golgi apparatus,golgi apparatus membrane,Golgi membrane,group II decarboxylase family,Homodimer,L-glutamate,L-glutamate = 4-aminobutanoate + CO2,l-glutamine,lipid-anchor,Lipoprotein,lyase,membrane,neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,p5p,Palmitate,Palmitoylated,perinuclear region of cytoplasm,peripheral membrane protein,phospate,Phosphoprotein,Phosphorylated,plasma membrane,Polymorphism,presynaptic cell membrane,presynaptic clustering,presynaptic membrane,Pyridoxal phosphate,pyridoxal phosphate binding,pyridoxamine,pyridoxine,pyridoxol,response to drug,synapse,synaptic transmission,synaptic vesicle membrane,vitamin B6",
        "Group": "Neurotransmitter Pathway: Glutamate & GABA"
    },
    {
        "SNP ID": "rs1805398",
        "SNP Name": "GAD2 (GAD) G26474809T",
        "Risk Allele": "G",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1805398",
        "Video": null,
        "Tags": "65 kDa glutamic acid decarboxylase,addiction,alcohol dependence,anchored component of membrane,axon,B6,Catalyzes the production of GABA,cell junction,Cell membrane,cholesterol,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,cytoplasm,cytoplasmic side,cytoplasmic vesicle,cytosol,decarboxylase,drug,fat,fat transport,GABA,GAD-65,GAD2,GAD65,gamma-Aminobutyric acid,glutamate,glutamate binding,Glutamate decarboxylase 2,Glutamate decarboxylase 65 kDa isoform,glutamate decarboxylase activity,glutamate decarboxylation to succinate,glutamine,glutathione,Golgi apparatus,golgi apparatus membrane,Golgi membrane,group II decarboxylase family,Homodimer,L-glutamate,L-glutamate = 4-aminobutanoate + CO2,l-glutamine,lipid-anchor,Lipoprotein,lyase,membrane,neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,p5p,Palmitate,Palmitoylated,perinuclear region of cytoplasm,peripheral membrane protein,phospate,Phosphoprotein,Phosphorylated,plasma membrane,Polymorphism,presynaptic cell membrane,presynaptic clustering,presynaptic membrane,Pyridoxal phosphate,pyridoxal phosphate binding,pyridoxamine,pyridoxine,pyridoxol,response to drug,synapse,synaptic transmission,synaptic vesicle membrane,vitamin B6",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs1880676",
        "SNP Name": "CHAT Asp7Asn",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Acetyl-CoA + choline = CoA + O-acetylcholine,Acyltransferase,AD,adult walking behavior,Alzheimer,Alzheimer's disease,Amnestic Mild Cognitive Impairment,apnea,ATP,bulbar paralysis,carnitine,carnitine/choline acetyltransferase family,cellular energy,CHAT,CHOACTase,choline,Choline acetylase,Choline O-acetyltransferase,choline O-acetyltransferase activity,CMSEA,CoA,cognition,cognitive function,cognitive impairment,Congenital myasthenic syndrome,dementia,dendrite development,drugs,energy,episodic apnea,establishment of synaptic specificity at neuromuscular junction,glycerophospholipid biosynthetic process,L-Carnitine,Late-Onset Alzheimer Disease,mitochondria,mitochondrion,muscle,muscle organ development,muscle weakness,Myasthenic syndrome,neurodegenerative disorder,neuromuscular synaptic transmission,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,nicotine,nicotine dependence,paralize,paralysis,phosphatidylcholine,phosphatidylcholine biosynthetic process,phospholipid metabolic process,Prospective Smoking Cessation,rhythmic behavior,rhythmic excitation,small molecule metabolic process,synaptic transmission,Transferase,weakness",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs3810950",
        "SNP Name": "CHAT A120T",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Acetyl-CoA + choline = CoA + O-acetylcholine,Acyltransferase,AD,adult walking behavior,Alzheimer,Alzheimer's disease,Amnestic Mild Cognitive Impairment,apnea,ATP,bulbar paralysis,carnitine,carnitine/choline acetyltransferase family,cellular energy,CHAT,CHOACTase,choline,Choline acetylase,Choline O-acetyltransferase,choline O-acetyltransferase activity,CMSEA,CoA,cognition,cognitive function,cognitive impairment,Congenital myasthenic syndrome,dementia,dendrite development,drugs,energy,episodic apnea,establishment of synaptic specificity at neuromuscular junction,glycerophospholipid biosynthetic process,L-Carnitine,mitochondria,mitochondrion,muscle,muscle organ development,muscle weakness,Myasthenic syndrome,neurodegenerative disorder,neuromuscular synaptic transmission,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitter secretion,nicotine,nicotine dependence,paralize,paralysis,phosphatidylcholine,phosphatidylcholine biosynthetic process,phospholipid metabolic process,Prospective Smoking Cessation,rhythmic behavior,rhythmic excitation,small molecule metabolic process,synaptic transmission,Transferase,weakness",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs1800450",
        "SNP Name": "MBL2 G54A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "D-Mannose"
    },
    {
        "SNP ID": "rs11599164",
        "SNP Name": "ANK3 C666301A",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs11599164",
        "Video": null,
        "Tags": "A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period,A homozygous deletion in ANK3 predicted to result in frameshift and premature truncation,AD,Alternative splicing,Alzheimer,Alzheimer Disease,an ADHD-like phenotype and behavioral problems in a consanguineous family,ANK repeat,ANK-3,ANK3,Ankyrin-3,Ankyrin-G,autosomal recessive 37,axon guidance,axon initial segment,axonogenesis,basolateral plasma membrane,bridging,bruxism,cadherin binding,Cell junction,Cell membrane,Cell membrane \u203a sarcolemma. Cell junction \u203a synapse \u203a postsynaptic cell membrane,Cell projection,cell surface,Complete proteome,costamere,Cytoplasm,Cytoplasm \u203a cytoskeleton. Cell projection \u203a axon,cytoskeletal anchoring at plasma membrane,cytoskeletal protein binding,Cytoskeleton,dendrite,Directly interacts with DMD and betaDAG1,endoplasmic reticulum,establishment of protein localization,Expressed in brain,Genetic variations in ANK3 may be associated with autism spectrum disorders susceptibility,Golgi apparatus,Golgi to plasma membrane protein transport,grinding of the teeth,has been shown to be the cause of moderate intellectual disability,hyperactivity,hypotonia,In skeletal muscle localized at costameres and neuromuscular junctions,In skeletal muscle required for costamere localization of DMD and betaDAG1,Interacts (via N-terminal ANK repeats) with SCHIP1 isoform 5 (via C-terminus); this interaction is required for the localization at axon initial segments (AISs) and nodes of Ranvier (NRs),Interacts with RHBG. Interacts with PLEC and FLNC,intercalated disc,ion channel binding,Isoform 5: Cytoplasm \u203a cytoskeleton. Golgi apparatus,Isoform 5:May be part of a Golgi-specific membrane cytoskeleton in association with beta-spectrin,Isopeptide bond,it is also required for DMD and betaDAG1 retention at costameres,lateral plasma membrane,Lysosome,maintenance of protein location in plasma membrane,May be a constituent of a neurofascin/NRCAM/ankyrin G complex,May participate in the maintenance/targeting of ion channels and cell adhesion molecules at the nodes of Ranvier and axonal initial segments,Membrane,membrane assembly,Membrane-cytoskeleton linker,Mental retardation,mitotic cytokinesis,MRT37,MRT37 patients manifest delayed global development with speech delay,muscles and other tissues,neuromuscular junction,neuromuscular junction development,neuronal action potential,neurons,node of Ranvier,paranode region of axon,Phosphoprotein,plasma membrane,plasma membrane organization,Polymorphism,positive regulation of cell communication by electrical coupling,positive regulation of gene expression,positive regulation of homotypic cell-cell adhesion,positive regulation of membrane depolarization during cardiac muscle cell action potential,positive regulation of membrane potential,positive regulation of protein targeting to membrane,positive regulation of sodium ion transmembrane transporter activity,positive regulation of sodium ion transport,Postsynaptic cell membrane,postsynaptic membrane,protein binding,protein localization to plasma membrane,protein targeting to plasma membrane,Reference proteome,regulation of potassium ion transport,Repeat,sarcolemma,sarcoplasmic reticulum,Severe behavioral abnormalities include aggression,signal transduction,sleep disorder,spasticity,spectrin binding,spectrin-associated cytoskeleton,structural constituent of cytoskeleton,Synapse,T-tubule,The disease is caused by mutations affecting the gene represented in this entry,The tandem configuration of the two ZU5 and the UPA domains forms a structural supramodule termed ZZU,this interaction does not interfere with binding between DMD and betaDAG1,Ubl conjugation,Up-regulated during muscle cell differentiation,Z disc,ZU5-1 mediates interaction with beta-spectrin and the ZU5-1/UPA interface is required for ankyrin's function other than binding to",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs11599164",
        "SNP Name": "ANK3 C666301A",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs11599164",
        "Video": null,
        "Tags": "A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period,A homozygous deletion in ANK3 predicted to result in frameshift and premature truncation,AD,Alternative splicing,Alzheimer,Alzheimer Disease,an ADHD-like phenotype and behavioral problems in a consanguineous family,ANK repeat,ANK-3,ANK3,Ankyrin-3,Ankyrin-G,autosomal recessive 37,axon guidance,axon initial segment,axonogenesis,basolateral plasma membrane,bridging,bruxism,cadherin binding,Cell junction,Cell membrane,Cell membrane \u203a sarcolemma. Cell junction \u203a synapse \u203a postsynaptic cell membrane,Cell projection,cell surface,Complete proteome,costamere,Cytoplasm,Cytoplasm \u203a cytoskeleton. Cell projection \u203a axon,cytoskeletal anchoring at plasma membrane,cytoskeletal protein binding,Cytoskeleton,dendrite,Directly interacts with DMD and betaDAG1,endoplasmic reticulum,establishment of protein localization,Expressed in brain,Genetic variations in ANK3 may be associated with autism spectrum disorders susceptibility,Golgi apparatus,Golgi to plasma membrane protein transport,grinding of the teeth,has been shown to be the cause of moderate intellectual disability,hyperactivity,hypotonia,In skeletal muscle localized at costameres and neuromuscular junctions,In skeletal muscle required for costamere localization of DMD and betaDAG1,Interacts (via N-terminal ANK repeats) with SCHIP1 isoform 5 (via C-terminus); this interaction is required for the localization at axon initial segments (AISs) and nodes of Ranvier (NRs),Interacts with RHBG. Interacts with PLEC and FLNC,intercalated disc,ion channel binding,Isoform 5: Cytoplasm \u203a cytoskeleton. Golgi apparatus,Isoform 5:May be part of a Golgi-specific membrane cytoskeleton in association with beta-spectrin,Isopeptide bond,it is also required for DMD and betaDAG1 retention at costameres,lateral plasma membrane,Lysosome,maintenance of protein location in plasma membrane,May be a constituent of a neurofascin/NRCAM/ankyrin G complex,May participate in the maintenance/targeting of ion channels and cell adhesion molecules at the nodes of Ranvier and axonal initial segments,Membrane,membrane assembly,Membrane-cytoskeleton linker,Mental retardation,mitotic cytokinesis,MRT37,MRT37 patients manifest delayed global development with speech delay,muscles and other tissues,neuromuscular junction,neuromuscular junction development,neuronal action potential,neurons,node of Ranvier,paranode region of axon,Phosphoprotein,plasma membrane,plasma membrane organization,Polymorphism,positive regulation of cell communication by electrical coupling,positive regulation of gene expression,positive regulation of homotypic cell-cell adhesion,positive regulation of membrane depolarization during cardiac muscle cell action potential,positive regulation of membrane potential,positive regulation of protein targeting to membrane,positive regulation of sodium ion transmembrane transporter activity,positive regulation of sodium ion transport,Postsynaptic cell membrane,postsynaptic membrane,protein binding,protein localization to plasma membrane,protein targeting to plasma membrane,Reference proteome,regulation of potassium ion transport,Repeat,sarcolemma,sarcoplasmic reticulum,Severe behavioral abnormalities include aggression,signal transduction,sleep disorder,spasticity,spectrin binding,spectrin-associated cytoskeleton,structural constituent of cytoskeleton,Synapse,T-tubule,The disease is caused by mutations affecting the gene represented in this entry,The tandem configuration of the two ZU5 and the UPA domains forms a structural supramodule termed ZZU,this interaction does not interfere with binding between DMD and betaDAG1,Ubl conjugation,Up-regulated during muscle cell differentiation,Z disc,ZU5-1 mediates interaction with beta-spectrin and the ZU5-1/UPA interface is required for ankyrin's function other than binding to",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs9804190",
        "SNP Name": "ANK3 G658454A",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs9804190",
        "Video": null,
        "Tags": "A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period,A homozygous deletion in ANK3 predicted to result in frameshift and premature truncation,Alternative splicing,an ADHD-like phenotype and behavioral problems in a consanguineous family,ANK repeat,ANK-3,ANK3,Ankyrin-3,Ankyrin-G,autosomal recessive 37,axon guidance,axon initial segment,axonogenesis,basolateral plasma membrane,bipolar,bipolar disorder,bridging,bruxism,cadherin binding,Cell junction,Cell membrane,Cell membrane \u203a sarcolemma. Cell junction \u203a synapse \u203a postsynaptic cell membrane,Cell projection,cell surface,Complete proteome,cortical thickness,costamere,Cytoplasm,Cytoplasm \u203a cytoskeleton. Cell projection \u203a axon,cytoskeletal anchoring at plasma membrane,cytoskeletal protein binding,Cytoskeleton,dendrite,Directly interacts with DMD and betaDAG1,endoplasmic reticulum,establishment of protein localization,Expressed in brain,Genetic variations in ANK3 may be associated with autism spectrum disorders susceptibility,Golgi apparatus,Golgi to plasma membrane protein transport,grinding of the teeth,has been shown to be the cause of moderate intellectual disability,hyperactivity,hypotonia,In skeletal muscle localized at costameres and neuromuscular junctions,In skeletal muscle required for costamere localization of DMD and betaDAG1,Interacts (via N-terminal ANK repeats) with SCHIP1 isoform 5 (via C-terminus); this interaction is required for the localization at axon initial segments (AISs) and nodes of Ranvier (NRs),Interacts with RHBG. Interacts with PLEC and FLNC,intercalated disc,ion channel binding,Isoform 5: Cytoplasm \u203a cytoskeleton. Golgi apparatus,Isoform 5:May be part of a Golgi-specific membrane cytoskeleton in association with beta-spectrin,Isopeptide bond,it is also required for DMD and betaDAG1 retention at costameres,lateral plasma membrane,Lysosome,maintenance of protein location in plasma membrane,May be a constituent of a neurofascin/NRCAM/ankyrin G complex,May participate in the maintenance/targeting of ion channels and cell adhesion molecules at the nodes of Ranvier and axonal initial segments,Membrane,membrane assembly,Membrane-cytoskeleton linker,mental disorder,Mental retardation,mitotic cytokinesis,MRT37,MRT37 patients manifest delayed global development with speech delay,muscles and other tissues,neuromuscular junction,neuromuscular junction development,neuronal action potential,neurons,node of Ranvier,paranode region of axon,Phosphoprotein,plasma membrane,plasma membrane organization,Polymorphism,positive regulation of cell communication by electrical coupling,positive regulation of gene expression,positive regulation of homotypic cell-cell adhesion,positive regulation of membrane depolarization during cardiac muscle cell action potential,positive regulation of membrane potential,positive regulation of protein targeting to membrane,positive regulation of sodium ion transmembrane transporter activity,positive regulation of sodium ion transport,Postsynaptic cell membrane,postsynaptic membrane,protein binding,protein localization to plasma membrane,protein targeting to plasma membrane,psychiatric,Reference proteome,regulation of potassium ion transport,Repeat,sarcolemma,sarcoplasmic reticulum,Schizophrenia,Severe behavioral abnormalities include aggression,signal transduction,sleep disorder,spasticity,spectrin binding,spectrin-associated cytoskeleton,structural constituent of cytoskeleton,Synapse,T-tubule,The disease is caused by mutations affecting the gene represented in this entry,The tandem configuration of the two ZU5 and the UPA domains forms a structural supramodule termed ZZU,this interaction does not interfere with binding between DMD and betaDAG1,Ubl conjugation,Up-regulated during muscle cell differentiation,Z disc,ZU5-1 mediates interaction with beta-spectrin and the ZU5-1/UPA interface",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs9804190",
        "SNP Name": "ANK3 G658454A",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs9804190",
        "Video": null,
        "Tags": "A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period,A homozygous deletion in ANK3 predicted to result in frameshift and premature truncation,Alternative splicing,an ADHD-like phenotype and behavioral problems in a consanguineous family,ANK repeat,ANK-3,ANK3,Ankyrin-3,Ankyrin-G,autosomal recessive 37,axon guidance,axon initial segment,axonogenesis,basolateral plasma membrane,bipolar,bipolar disorder,bridging,bruxism,cadherin binding,Cell junction,Cell membrane,Cell membrane \u203a sarcolemma. Cell junction \u203a synapse \u203a postsynaptic cell membrane,Cell projection,cell surface,Complete proteome,cortical thickness,costamere,Cytoplasm,Cytoplasm \u203a cytoskeleton. Cell projection \u203a axon,cytoskeletal anchoring at plasma membrane,cytoskeletal protein binding,Cytoskeleton,dendrite,Directly interacts with DMD and betaDAG1,endoplasmic reticulum,establishment of protein localization,Expressed in brain,Genetic variations in ANK3 may be associated with autism spectrum disorders susceptibility,Golgi apparatus,Golgi to plasma membrane protein transport,grinding of the teeth,has been shown to be the cause of moderate intellectual disability,hyperactivity,hypotonia,In skeletal muscle localized at costameres and neuromuscular junctions,In skeletal muscle required for costamere localization of DMD and betaDAG1,Interacts (via N-terminal ANK repeats) with SCHIP1 isoform 5 (via C-terminus); this interaction is required for the localization at axon initial segments (AISs) and nodes of Ranvier (NRs),Interacts with RHBG. Interacts with PLEC and FLNC,intercalated disc,ion channel binding,Isoform 5: Cytoplasm \u203a cytoskeleton. Golgi apparatus,Isoform 5:May be part of a Golgi-specific membrane cytoskeleton in association with beta-spectrin,Isopeptide bond,it is also required for DMD and betaDAG1 retention at costameres,lateral plasma membrane,Lysosome,maintenance of protein location in plasma membrane,May be a constituent of a neurofascin/NRCAM/ankyrin G complex,May participate in the maintenance/targeting of ion channels and cell adhesion molecules at the nodes of Ranvier and axonal initial segments,Membrane,membrane assembly,Membrane-cytoskeleton linker,mental disorder,Mental retardation,mitotic cytokinesis,MRT37,MRT37 patients manifest delayed global development with speech delay,muscles and other tissues,neuromuscular junction,neuromuscular junction development,neuronal action potential,neurons,node of Ranvier,paranode region of axon,Phosphoprotein,plasma membrane,plasma membrane organization,Polymorphism,positive regulation of cell communication by electrical coupling,positive regulation of gene expression,positive regulation of homotypic cell-cell adhesion,positive regulation of membrane depolarization during cardiac muscle cell action potential,positive regulation of membrane potential,positive regulation of protein targeting to membrane,positive regulation of sodium ion transmembrane transporter activity,positive regulation of sodium ion transport,Postsynaptic cell membrane,postsynaptic membrane,protein binding,protein localization to plasma membrane,protein targeting to plasma membrane,psychiatric,Reference proteome,regulation of potassium ion transport,Repeat,sarcolemma,sarcoplasmic reticulum,Schizophrenia,Severe behavioral abnormalities include aggression,signal transduction,sleep disorder,spasticity,spectrin binding,spectrin-associated cytoskeleton,structural constituent of cytoskeleton,Synapse,T-tubule,The disease is caused by mutations affecting the gene represented in this entry,The tandem configuration of the two ZU5 and the UPA domains forms a structural supramodule termed ZZU,this interaction does not interfere with binding between DMD and betaDAG1,Ubl conjugation,Up-regulated during muscle cell differentiation,Z disc,ZU5-1 mediates interaction with beta-spectrin and the ZU5-1/UPA interface",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs10761482",
        "SNP Name": "ANK3 T62085337C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10761482",
        "Video": null,
        "Tags": "A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period,A homozygous deletion in ANK3 predicted to result in frameshift and premature truncation,Alternative splicing,an ADHD-like phenotype and behavioral problems in a consanguineous family,ANK repeat,ANK-3,ANK3,Ankyrin-3,Ankyrin-G,autosomal recessive 37,axon guidance,axon initial segment,axonogenesis,basolateral plasma membrane,bipolar,bipolar disorder,bridging,bruxism,cadherin binding,Cell junction,Cell membrane,Cell membrane \u203a sarcolemma. Cell junction \u203a synapse \u203a postsynaptic cell membrane,Cell projection,cell surface,cognition,cognitive performance,Complete proteome,cortical thickness,costamere,Cytoplasm,Cytoplasm \u203a cytoskeleton. Cell projection \u203a axon,cytoskeletal anchoring at plasma membrane,cytoskeletal protein binding,Cytoskeleton,dendrite,Directly interacts with DMD and betaDAG1,endoplasmic reticulum,establishment of protein localization,Expressed in brain,Genetic variations in ANK3 may be associated with autism spectrum disorders susceptibility,Golgi apparatus,Golgi to plasma membrane protein transport,grinding of the teeth,has been shown to be the cause of moderate intellectual disability,hyperactivity,hypotonia,In skeletal muscle localized at costameres and neuromuscular junctions,In skeletal muscle required for costamere localization of DMD and betaDAG1,Interacts (via N-terminal ANK repeats) with SCHIP1 isoform 5 (via C-terminus); this interaction is required for the localization at axon initial segments (AISs) and nodes of Ranvier (NRs),Interacts with RHBG. Interacts with PLEC and FLNC,intercalated disc,ion channel binding,Isoform 5: Cytoplasm \u203a cytoskeleton. Golgi apparatus,Isoform 5:May be part of a Golgi-specific membrane cytoskeleton in association with beta-spectrin,Isopeptide bond,it is also required for DMD and betaDAG1 retention at costameres,lateral plasma membrane,Lysosome,maintenance of protein location in plasma membrane,May be a constituent of a neurofascin/NRCAM/ankyrin G complex,May participate in the maintenance/targeting of ion channels and cell adhesion molecules at the nodes of Ranvier and axonal initial segments,Membrane,membrane assembly,Membrane-cytoskeleton linker,mental disorder,Mental retardation,mitotic cytokinesis,MRT37,MRT37 patients manifest delayed global development with speech delay,muscles and other tissues,neuromuscular junction,neuromuscular junction development,neuronal action potential,neurons,node of Ranvier,paranode region of axon,Phosphoprotein,plasma membrane,plasma membrane organization,Polymorphism,positive regulation of cell communication by electrical coupling,positive regulation of gene expression,positive regulation of homotypic cell-cell adhesion,positive regulation of membrane depolarization during cardiac muscle cell action potential,positive regulation of membrane potential,positive regulation of protein targeting to membrane,positive regulation of sodium ion transmembrane transporter activity,positive regulation of sodium ion transport,Postsynaptic cell membrane,postsynaptic membrane,protein binding,protein localization to plasma membrane,protein targeting to plasma membrane,psychosis,Reference proteome,regulation of potassium ion transport,Repeat,sarcolemma,sarcoplasmic reticulum,schizophrenia,Severe behavioral abnormalities include aggression,signal transduction,sleep disorder,spasticity,spectrin binding,spectrin-associated cytoskeleton,structural constituent of cytoskeleton,Synapse,T-tubule,The disease is caused by mutations affecting the gene represented in this entry,The tandem configuration of the two ZU5 and the UPA domains forms a structural supramodule termed ZZU,this interaction does not interfere with binding between DMD and betaDAG1,Ubl conjugation,Up-regulated during muscle cell differentiation,Z disc,ZU5-1 mediates interaction with beta-spec",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs10761482",
        "SNP Name": "ANK3 T62085337C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10761482",
        "Video": null,
        "Tags": "A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period,A homozygous deletion in ANK3 predicted to result in frameshift and premature truncation,Alternative splicing,an ADHD-like phenotype and behavioral problems in a consanguineous family,ANK repeat,ANK-3,ANK3,Ankyrin-3,Ankyrin-G,autosomal recessive 37,axon guidance,axon initial segment,axonogenesis,basolateral plasma membrane,bipolar,bipolar disorder,bridging,bruxism,cadherin binding,Cell junction,Cell membrane,Cell membrane \u203a sarcolemma. Cell junction \u203a synapse \u203a postsynaptic cell membrane,Cell projection,cell surface,cognition,cognitive performance,Complete proteome,cortical thickness,costamere,Cytoplasm,Cytoplasm \u203a cytoskeleton. Cell projection \u203a axon,cytoskeletal anchoring at plasma membrane,cytoskeletal protein binding,Cytoskeleton,dendrite,Directly interacts with DMD and betaDAG1,endoplasmic reticulum,establishment of protein localization,Expressed in brain,Genetic variations in ANK3 may be associated with autism spectrum disorders susceptibility,Golgi apparatus,Golgi to plasma membrane protein transport,grinding of the teeth,has been shown to be the cause of moderate intellectual disability,hyperactivity,hypotonia,In skeletal muscle localized at costameres and neuromuscular junctions,In skeletal muscle required for costamere localization of DMD and betaDAG1,Interacts (via N-terminal ANK repeats) with SCHIP1 isoform 5 (via C-terminus); this interaction is required for the localization at axon initial segments (AISs) and nodes of Ranvier (NRs),Interacts with RHBG. Interacts with PLEC and FLNC,intercalated disc,ion channel binding,Isoform 5: Cytoplasm \u203a cytoskeleton. Golgi apparatus,Isoform 5:May be part of a Golgi-specific membrane cytoskeleton in association with beta-spectrin,Isopeptide bond,it is also required for DMD and betaDAG1 retention at costameres,lateral plasma membrane,Lysosome,maintenance of protein location in plasma membrane,May be a constituent of a neurofascin/NRCAM/ankyrin G complex,May participate in the maintenance/targeting of ion channels and cell adhesion molecules at the nodes of Ranvier and axonal initial segments,Membrane,membrane assembly,Membrane-cytoskeleton linker,mental disorder,Mental retardation,mitotic cytokinesis,MRT37,MRT37 patients manifest delayed global development with speech delay,muscles and other tissues,neuromuscular junction,neuromuscular junction development,neuronal action potential,neurons,node of Ranvier,paranode region of axon,Phosphoprotein,plasma membrane,plasma membrane organization,Polymorphism,positive regulation of cell communication by electrical coupling,positive regulation of gene expression,positive regulation of homotypic cell-cell adhesion,positive regulation of membrane depolarization during cardiac muscle cell action potential,positive regulation of membrane potential,positive regulation of protein targeting to membrane,positive regulation of sodium ion transmembrane transporter activity,positive regulation of sodium ion transport,Postsynaptic cell membrane,postsynaptic membrane,protein binding,protein localization to plasma membrane,protein targeting to plasma membrane,psychosis,Reference proteome,regulation of potassium ion transport,Repeat,sarcolemma,sarcoplasmic reticulum,schizophrenia,Severe behavioral abnormalities include aggression,signal transduction,sleep disorder,spasticity,spectrin binding,spectrin-associated cytoskeleton,structural constituent of cytoskeleton,Synapse,T-tubule,The disease is caused by mutations affecting the gene represented in this entry,The tandem configuration of the two ZU5 and the UPA domains forms a structural supramodule termed ZZU,this interaction does not interfere with binding between DMD and betaDAG1,Ubl conjugation,Up-regulated during muscle cell differentiation,Z disc,ZU5-1 mediates interaction with beta-spec",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs10994336",
        "SNP Name": "ANK3 G318473A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10994336",
        "Video": null,
        "Tags": "A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period,A homozygous deletion in ANK3 predicted to result in frameshift and premature truncation,AD,Agitation,Alternative splicing,Alzheimer,Alzheimer\u2019s disease,an ADHD-like phenotype and behavioral problems in a consanguineous family,ANK repeat,ANK-3,ANK3,Ankyrin-3,Ankyrin-G,autosomal recessive 37,axon guidance,axon initial segment,axonogenesis,basolateral plasma membrane,bipolar,bipolar disorder,bridging,bruxism,cadherin binding,Cell junction,Cell membrane,Cell membrane \u203a sarcolemma. Cell junction \u203a synapse \u203a postsynaptic cell membrane,Cell projection,cell surface,cognition,cognitive performance,Complete proteome,cortical thickness,costamere,Cytoplasm,Cytoplasm \u203a cytoskeleton. Cell projection \u203a axon,cytoskeletal anchoring at plasma membrane,cytoskeletal protein binding,Cytoskeleton,dendrite,Depression,Directly interacts with DMD and betaDAG1,endoplasmic reticulum,establishment of protein localization,Expressed in brain,Genetic variations in ANK3 may be associated with autism spectrum disorders susceptibility,glutamate,glutamate receptor,Golgi apparatus,Golgi to plasma membrane protein transport,grinding of the teeth,has been shown to be the cause of moderate intellectual disability,hyperactivity,hypotonia,In skeletal muscle localized at costameres and neuromuscular junctions,In skeletal muscle required for costamere localization of DMD and betaDAG1,Interacts (via N-terminal ANK repeats) with SCHIP1 isoform 5 (via C-terminus); this interaction is required for the localization at axon initial segments (AISs) and nodes of Ranvier (NRs),Interacts with RHBG. Interacts with PLEC and FLNC,intercalated disc,ion channel binding,Isoform 5: Cytoplasm \u203a cytoskeleton. Golgi apparatus,Isoform 5:May be part of a Golgi-specific membrane cytoskeleton in association with beta-spectrin,Isopeptide bond,it is also required for DMD and betaDAG1 retention at costameres,lateral plasma membrane,Lysosome,maintenance of protein location in plasma membrane,Major Depressive Disorder,major psychoses,May be a constituent of a neurofascin/NRCAM/ankyrin G complex,May participate in the maintenance/targeting of ion channels and cell adhesion molecules at the nodes of Ranvier and axonal initial segments,Membrane,membrane assembly,Membrane-cytoskeleton linker,mental disorder,Mental retardation,mitotic cytokinesis,mood,mood disorder,MRT37,MRT37 patients manifest delayed global development with speech delay,muscles and other tissues,neurodegenerative,neuromuscular junction,neuromuscular junction development,neuronal action potential,neurons,Neuropsychiatric Disorders,node of Ranvier,panic,panic attack,paranode region of axon,Phosphoprotein,plasma membrane,plasma membrane organization,Polymorphism,positive regulation of cell communication by electrical coupling,positive regulation of gene expression,positive regulation of homotypic cell-cell adhesion,positive regulation of membrane depolarization during cardiac muscle cell action potential,positive regulation of membrane potential,positive regulation of protein targeting to membrane,positive regulation of sodium ion transmembrane transporter activity,positive regulation of sodium ion transport,Postsynaptic cell membrane,postsynaptic membrane,protein binding,protein localization to plasma membrane,protein targeting to plasma membrane,psychosis,Reference proteome,regulation of potassium ion transport,Repeat,sarcolemma,sarcoplasmic reticulum,schizophrenia,Severe behavioral abnormalities include aggression,signal transduction,sleep disorder,spasticity,spectrin binding,spectrin-associated cytoskeleton,structural constituent of cytoskeleton,Synapse,T-tubule,The disease is caused by mutations affecting the gene represented in this entry,The tandem configuration of the two ZU5 and the UPA domains forms a",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs10994336",
        "SNP Name": "ANK3 G318473A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10994336",
        "Video": null,
        "Tags": "A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period,A homozygous deletion in ANK3 predicted to result in frameshift and premature truncation,AD,Agitation,Alternative splicing,Alzheimer,Alzheimer\u2019s disease,an ADHD-like phenotype and behavioral problems in a consanguineous family,ANK repeat,ANK-3,ANK3,Ankyrin-3,Ankyrin-G,autosomal recessive 37,axon guidance,axon initial segment,axonogenesis,basolateral plasma membrane,bipolar,bipolar disorder,bridging,bruxism,cadherin binding,Cell junction,Cell membrane,Cell membrane \u203a sarcolemma. Cell junction \u203a synapse \u203a postsynaptic cell membrane,Cell projection,cell surface,cognition,cognitive performance,Complete proteome,cortical thickness,costamere,Cytoplasm,Cytoplasm \u203a cytoskeleton. Cell projection \u203a axon,cytoskeletal anchoring at plasma membrane,cytoskeletal protein binding,Cytoskeleton,dendrite,Depression,Directly interacts with DMD and betaDAG1,endoplasmic reticulum,establishment of protein localization,Expressed in brain,Genetic variations in ANK3 may be associated with autism spectrum disorders susceptibility,glutamate,glutamate receptor,Golgi apparatus,Golgi to plasma membrane protein transport,grinding of the teeth,has been shown to be the cause of moderate intellectual disability,hyperactivity,hypotonia,In skeletal muscle localized at costameres and neuromuscular junctions,In skeletal muscle required for costamere localization of DMD and betaDAG1,Interacts (via N-terminal ANK repeats) with SCHIP1 isoform 5 (via C-terminus); this interaction is required for the localization at axon initial segments (AISs) and nodes of Ranvier (NRs),Interacts with RHBG. Interacts with PLEC and FLNC,intercalated disc,ion channel binding,Isoform 5: Cytoplasm \u203a cytoskeleton. Golgi apparatus,Isoform 5:May be part of a Golgi-specific membrane cytoskeleton in association with beta-spectrin,Isopeptide bond,it is also required for DMD and betaDAG1 retention at costameres,lateral plasma membrane,Lysosome,maintenance of protein location in plasma membrane,Major Depressive Disorder,major psychoses,May be a constituent of a neurofascin/NRCAM/ankyrin G complex,May participate in the maintenance/targeting of ion channels and cell adhesion molecules at the nodes of Ranvier and axonal initial segments,Membrane,membrane assembly,Membrane-cytoskeleton linker,mental disorder,Mental retardation,mitotic cytokinesis,mood,mood disorder,MRT37,MRT37 patients manifest delayed global development with speech delay,muscles and other tissues,neurodegenerative,neuromuscular junction,neuromuscular junction development,neuronal action potential,neurons,Neuropsychiatric Disorders,node of Ranvier,panic,panic attack,paranode region of axon,Phosphoprotein,plasma membrane,plasma membrane organization,Polymorphism,positive regulation of cell communication by electrical coupling,positive regulation of gene expression,positive regulation of homotypic cell-cell adhesion,positive regulation of membrane depolarization during cardiac muscle cell action potential,positive regulation of membrane potential,positive regulation of protein targeting to membrane,positive regulation of sodium ion transmembrane transporter activity,positive regulation of sodium ion transport,Postsynaptic cell membrane,postsynaptic membrane,protein binding,protein localization to plasma membrane,protein targeting to plasma membrane,psychosis,Reference proteome,regulation of potassium ion transport,Repeat,sarcolemma,sarcoplasmic reticulum,schizophrenia,Severe behavioral abnormalities include aggression,signal transduction,sleep disorder,spasticity,spectrin binding,spectrin-associated cytoskeleton,structural constituent of cytoskeleton,Synapse,T-tubule,The disease is caused by mutations affecting the gene represented in this entry,The tandem configuration of the two ZU5 and the UPA domains forms a",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs10994397",
        "SNP Name": "ANK3 G219161A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10994397",
        "Video": null,
        "Tags": "A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period,A homozygous deletion in ANK3 predicted to result in frameshift and premature truncation,Alternative splicing,an ADHD-like phenotype and behavioral problems in a consanguineous family,ANK repeat,ANK-3,ANK3,Ankyrin-3,Ankyrin-G,autosomal recessive 37,axon guidance,axon initial segment,axonogenesis,basolateral plasma membrane,bipolar,Bipolar Disorder,bridging,bruxism,cadherin binding,Cell junction,Cell membrane,Cell membrane \u203a sarcolemma. Cell junction \u203a synapse \u203a postsynaptic cell membrane,Cell projection,cell surface,Complete proteome,costamere,Cytoplasm,Cytoplasm \u203a cytoskeleton. Cell projection \u203a axon,cytoskeletal anchoring at plasma membrane,cytoskeletal protein binding,Cytoskeleton,dendrite,Directly interacts with DMD and betaDAG1,endoplasmic reticulum,establishment of protein localization,Expressed in brain,Genetic variations in ANK3 may be associated with autism spectrum disorders susceptibility,Golgi apparatus,Golgi to plasma membrane protein transport,grinding of the teeth,has been shown to be the cause of moderate intellectual disability,hyperactivity,hypotonia,In skeletal muscle localized at costameres and neuromuscular junctions,In skeletal muscle required for costamere localization of DMD and betaDAG1,Interacts (via N-terminal ANK repeats) with SCHIP1 isoform 5 (via C-terminus); this interaction is required for the localization at axon initial segments (AISs) and nodes of Ranvier (NRs),Interacts with RHBG. Interacts with PLEC and FLNC,intercalated disc,ion channel binding,Isoform 5: Cytoplasm \u203a cytoskeleton. Golgi apparatus,Isoform 5:May be part of a Golgi-specific membrane cytoskeleton in association with beta-spectrin,Isopeptide bond,it is also required for DMD and betaDAG1 retention at costameres,lateral plasma membrane,Lysosome,maintenance of protein location in plasma membrane,May be a constituent of a neurofascin/NRCAM/ankyrin G complex,May participate in the maintenance/targeting of ion channels and cell adhesion molecules at the nodes of Ranvier and axonal initial segments,Membrane,membrane assembly,Membrane-cytoskeleton linker,Mental retardation,mitotic cytokinesis,MRT37,MRT37 patients manifest delayed global development with speech delay,muscles and other tissues,neuromuscular junction,neuromuscular junction development,neuronal action potential,neurons,node of Ranvier,paranode region of axon,Phosphoprotein,plasma membrane,plasma membrane organization,Polymorphism,positive regulation of cell communication by electrical coupling,positive regulation of gene expression,positive regulation of homotypic cell-cell adhesion,positive regulation of membrane depolarization during cardiac muscle cell action potential,positive regulation of membrane potential,positive regulation of protein targeting to membrane,positive regulation of sodium ion transmembrane transporter activity,positive regulation of sodium ion transport,Postsynaptic cell membrane,postsynaptic membrane,protein binding,protein localization to plasma membrane,protein targeting to plasma membrane,Reference proteome,regulation of potassium ion transport,Repeat,sarcolemma,sarcoplasmic reticulum,Severe behavioral abnormalities include aggression,signal transduction,sleep disorder,spasticity,spectrin binding,spectrin-associated cytoskeleton,structural constituent of cytoskeleton,Synapse,T-tubule,The disease is caused by mutations affecting the gene represented in this entry,The tandem configuration of the two ZU5 and the UPA domains forms a structural supramodule termed ZZU,this interaction does not interfere with binding between DMD and betaDAG1,Ubl conjugation,Up-regulated during muscle cell differentiation,Z disc,ZU5-1 mediates interaction with beta-spectrin and the ZU5-1/UPA interface is required for ankyrin's function other than binding to spectri",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs10994397",
        "SNP Name": "ANK3 G219161A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10994397",
        "Video": null,
        "Tags": "A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period,A homozygous deletion in ANK3 predicted to result in frameshift and premature truncation,Alternative splicing,an ADHD-like phenotype and behavioral problems in a consanguineous family,ANK repeat,ANK-3,ANK3,Ankyrin-3,Ankyrin-G,autosomal recessive 37,axon guidance,axon initial segment,axonogenesis,basolateral plasma membrane,bipolar,Bipolar Disorder,bridging,bruxism,cadherin binding,Cell junction,Cell membrane,Cell membrane \u203a sarcolemma. Cell junction \u203a synapse \u203a postsynaptic cell membrane,Cell projection,cell surface,Complete proteome,costamere,Cytoplasm,Cytoplasm \u203a cytoskeleton. Cell projection \u203a axon,cytoskeletal anchoring at plasma membrane,cytoskeletal protein binding,Cytoskeleton,dendrite,Directly interacts with DMD and betaDAG1,endoplasmic reticulum,establishment of protein localization,Expressed in brain,Genetic variations in ANK3 may be associated with autism spectrum disorders susceptibility,Golgi apparatus,Golgi to plasma membrane protein transport,grinding of the teeth,has been shown to be the cause of moderate intellectual disability,hyperactivity,hypotonia,In skeletal muscle localized at costameres and neuromuscular junctions,In skeletal muscle required for costamere localization of DMD and betaDAG1,Interacts (via N-terminal ANK repeats) with SCHIP1 isoform 5 (via C-terminus); this interaction is required for the localization at axon initial segments (AISs) and nodes of Ranvier (NRs),Interacts with RHBG. Interacts with PLEC and FLNC,intercalated disc,ion channel binding,Isoform 5: Cytoplasm \u203a cytoskeleton. Golgi apparatus,Isoform 5:May be part of a Golgi-specific membrane cytoskeleton in association with beta-spectrin,Isopeptide bond,it is also required for DMD and betaDAG1 retention at costameres,lateral plasma membrane,Lysosome,maintenance of protein location in plasma membrane,May be a constituent of a neurofascin/NRCAM/ankyrin G complex,May participate in the maintenance/targeting of ion channels and cell adhesion molecules at the nodes of Ranvier and axonal initial segments,Membrane,membrane assembly,Membrane-cytoskeleton linker,Mental retardation,mitotic cytokinesis,MRT37,MRT37 patients manifest delayed global development with speech delay,muscles and other tissues,neuromuscular junction,neuromuscular junction development,neuronal action potential,neurons,node of Ranvier,paranode region of axon,Phosphoprotein,plasma membrane,plasma membrane organization,Polymorphism,positive regulation of cell communication by electrical coupling,positive regulation of gene expression,positive regulation of homotypic cell-cell adhesion,positive regulation of membrane depolarization during cardiac muscle cell action potential,positive regulation of membrane potential,positive regulation of protein targeting to membrane,positive regulation of sodium ion transmembrane transporter activity,positive regulation of sodium ion transport,Postsynaptic cell membrane,postsynaptic membrane,protein binding,protein localization to plasma membrane,protein targeting to plasma membrane,Reference proteome,regulation of potassium ion transport,Repeat,sarcolemma,sarcoplasmic reticulum,Severe behavioral abnormalities include aggression,signal transduction,sleep disorder,spasticity,spectrin binding,spectrin-associated cytoskeleton,structural constituent of cytoskeleton,Synapse,T-tubule,The disease is caused by mutations affecting the gene represented in this entry,The tandem configuration of the two ZU5 and the UPA domains forms a structural supramodule termed ZZU,this interaction does not interfere with binding between DMD and betaDAG1,Ubl conjugation,Up-regulated during muscle cell differentiation,Z disc,ZU5-1 mediates interaction with beta-spectrin and the ZU5-1/UPA interface is required for ankyrin's function other than binding to spectri",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1538311",
        "SNP Name": "ADK G509567T",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1538311",
        "Video": "VZ4zys3rYz4",
        "Tags": "Acetylation,AD,adenosine,Adenosine 5'-phosphotransferase,Adenosine kinase,adenosine kinase activity,adenosine kinase deficiency,adenosine metabolic process,ADK,ADP,AK,Alzheimer's,Alzheimer's disease,AMP,AMP biosynthesis,AMP salvage,ATP,ATP to adenosine,ATP-binding,biochemical anomalies,carbohydrate kinase,cardiac,cardiac muscle hypertrophy,cardiovascular,cellular energy,circadian,circadian cycle,circadian rhythm,CVD,Cytoplasm,cytosol,developmental delay,dysmorphic,elevated S-adenosylhomocysteine,elevated S-adenosylmethionine,elevated SAH,elevated SAMe,energy,gamma-phosphate,heart,heart disease,hypermethioninemia,kidney,Kinase,liver,LOAD,magnesium,magnesium ions,metal ion binding,Metal-binding,mitochondria,mitochondrial,mitochondrion,Monomer,muscle,Nucleotide-binding,Nucleus,pancreas,PfkB,PfkB family,phosphate,Phosphoprotein,phosphotransferase,placenta,purine metabolism,purine nucleobase,purine ribonucleoside,purine ribonucleoside salvage,Purine salvage,respiratory,ribonucleoside monophosphate,RNA,S-adenosylhomocysteine,S-adenosylmethionine,SAH,SAMe,seizure,seizures,T cell,T cell proliferation,Transferase,type B pancreatic cell proliferation",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1985908",
        "SNP Name": "MAT1A T*1297C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1985908",
        "Video": "mhldH-wrYfY",
        "Tags": "adenosyl,adenosyltransferase,adiposity,AdoMet,AdoMet synthase 1,AdoMet synthase family,adult metabolic disorder,amino acids,Amino-acid biosynthesis,AMS1,ATP,ATP + L-methionine + H2O = phosphate + diphosphate + S-adenosyl-L-methionine,ATP binding,ATP-binding,B12,blood pressure,cardiovascular disease,Catalyzes the formation of S-adenosylmethionine from methionine and ATP,cellular amino acid metabolic process,cellular energy,cellular nitrogen compound metabolic process,central nervous system,childhood obesity,chronic metabolic disorders,cobalt,cofactors,CVD,cytosol,diabetes,Disease mutation,Disulfide bond,energy,Expressed in liver,fat,fatty acids,heart,high BP,homocysteine,homocysteine metabolism,homodimer,homodimer (MAT-III),homotetramer,Homotetramer (MAT-I),Hyperhomocysteinemia,hypermethioninemia,hypertension,inborn error of metabolism resulting in isolated hypermethioninemia,L-methionine,leptin,lipid,liver,low BP,Magnesium,MAT 1,MAT-I/III,MAT1A,MATA1,MATD,metal ion binding,Metal-binding,methionine,Methionine adenosyltransferase 1,methionine adenosyltransferase activity,Methionine adenosyltransferase deficiency,Methionine adenosyltransferase I/III,methionine deficiency,methylation,minerals,mitochondria,mitochondrion,nervous system,neurological disorder,neurotransmitters,Nucleotide-binding,obesity,one-carbon metabolic process,One-carbon metabolism,phosphate,plasma leptin,Polymorphism,potassium,potassium ion,protein,S-Adenosyl Methionine,S-adenosyl-L-methionine biosynthesis,S-adenosyl-L-methionine from L-methionine,S-adenosylmethionine,S-adenosylmethionine biosynthetic process,S-adenosylmethionine synthase isoform type-1,S-nitrosylation,S-nitrosylation of Cys-120,SAMe,small molecule metabolic process,sulfur amino acid metabolic process,Telomere,Telomere Length,trace minerals,Transferase,transmethylation,xenobiotic metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1985908",
        "SNP Name": "MAT1A T*1297C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1985908",
        "Video": "mhldH-wrYfY",
        "Tags": "adenosyl,adenosyltransferase,adiposity,AdoMet,AdoMet synthase 1,AdoMet synthase family,adult metabolic disorder,amino acids,Amino-acid biosynthesis,AMS1,ATP,ATP + L-methionine + H2O = phosphate + diphosphate + S-adenosyl-L-methionine,ATP binding,ATP-binding,B12,blood pressure,cardiovascular disease,Catalyzes the formation of S-adenosylmethionine from methionine and ATP,cellular amino acid metabolic process,cellular energy,cellular nitrogen compound metabolic process,central nervous system,childhood obesity,chronic metabolic disorders,cobalt,cofactors,CVD,cytosol,diabetes,Disease mutation,Disulfide bond,energy,Expressed in liver,fat,fatty acids,heart,high BP,homocysteine,homocysteine metabolism,homodimer,homodimer (MAT-III),homotetramer,Homotetramer (MAT-I),Hyperhomocysteinemia,hypermethioninemia,hypertension,inborn error of metabolism resulting in isolated hypermethioninemia,L-methionine,leptin,lipid,liver,low BP,Magnesium,MAT 1,MAT-I/III,MAT1A,MATA1,MATD,metal ion binding,Metal-binding,methionine,Methionine adenosyltransferase 1,methionine adenosyltransferase activity,Methionine adenosyltransferase deficiency,Methionine adenosyltransferase I/III,methionine deficiency,methylation,minerals,mitochondria,mitochondrion,nervous system,neurological disorder,neurotransmitters,Nucleotide-binding,obesity,one-carbon metabolic process,One-carbon metabolism,phosphate,plasma leptin,Polymorphism,potassium,potassium ion,protein,S-Adenosyl Methionine,S-adenosyl-L-methionine biosynthesis,S-adenosyl-L-methionine from L-methionine,S-adenosylmethionine,S-adenosylmethionine biosynthetic process,S-adenosylmethionine synthase isoform type-1,S-nitrosylation,S-nitrosylation of Cys-120,SAMe,small molecule metabolic process,sulfur amino acid metabolic process,Telomere,Telomere Length,trace minerals,Transferase,transmethylation,xenobiotic metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs1985908",
        "SNP Name": "MAT1A T*1297C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1985908",
        "Video": "mhldH-wrYfY",
        "Tags": "adenosyl,adenosyltransferase,adiposity,AdoMet,AdoMet synthase 1,AdoMet synthase family,adult metabolic disorder,amino acids,Amino-acid biosynthesis,AMS1,ATP,ATP + L-methionine + H2O = phosphate + diphosphate + S-adenosyl-L-methionine,ATP binding,ATP-binding,B12,blood pressure,cardiovascular disease,Catalyzes the formation of S-adenosylmethionine from methionine and ATP,cellular amino acid metabolic process,cellular energy,cellular nitrogen compound metabolic process,central nervous system,childhood obesity,chronic metabolic disorders,cobalt,cofactors,CVD,cytosol,diabetes,Disease mutation,Disulfide bond,energy,Expressed in liver,fat,fatty acids,heart,high BP,homocysteine,homocysteine metabolism,homodimer,homodimer (MAT-III),homotetramer,Homotetramer (MAT-I),Hyperhomocysteinemia,hypermethioninemia,hypertension,inborn error of metabolism resulting in isolated hypermethioninemia,L-methionine,leptin,lipid,liver,low BP,Magnesium,MAT 1,MAT-I/III,MAT1A,MATA1,MATD,metal ion binding,Metal-binding,methionine,Methionine adenosyltransferase 1,methionine adenosyltransferase activity,Methionine adenosyltransferase deficiency,Methionine adenosyltransferase I/III,methionine deficiency,methylation,minerals,mitochondria,mitochondrion,nervous system,neurological disorder,neurotransmitters,Nucleotide-binding,obesity,one-carbon metabolic process,One-carbon metabolism,phosphate,plasma leptin,Polymorphism,potassium,potassium ion,protein,S-Adenosyl Methionine,S-adenosyl-L-methionine biosynthesis,S-adenosyl-L-methionine from L-methionine,S-adenosylmethionine,S-adenosylmethionine biosynthetic process,S-adenosylmethionine synthase isoform type-1,S-nitrosylation,S-nitrosylation of Cys-120,SAMe,small molecule metabolic process,sulfur amino acid metabolic process,Telomere,Telomere Length,trace minerals,Transferase,transmethylation,xenobiotic metabolic process",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs2993763",
        "SNP Name": "MAT1A C1131T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2993763",
        "Video": "mhldH-wrYfY",
        "Tags": "adenosyl,adenosyltransferase,AdoMet,AdoMet synthase 1,AdoMet synthase family,adult metabolic disorder,amino acids,Amino-acid biosynthesis,AMS1,ATP,ATP + L-methionine + H2O = phosphate + diphosphate + S-adenosyl-L-methionine,ATP binding,ATP-binding,B12,betaine,blood pressure,cardiovascular disease,Catalyzes the formation of S-adenosylmethionine from methionine and ATP,cellular amino acid metabolic process,cellular energy,cellular nitrogen compound metabolic process,central nervous system,choline,chronic metabolic disorders,cobalt,cofactors,CVD,cytosol,diabetes,Disease mutation,Disulfide bond,energy,Expressed in liver,fat,fatty acids,folate,heart,high BP,homocysteine,homocysteine metabolism,homodimer,homodimer (MAT-III),homotetramer,Homotetramer (MAT-I),hypermethioninemia,hypertension,inborn error of metabolism resulting in isolated hypermethioninemia,L-methionine,lipid,liver,low BP,Magnesium,MAT 1,MAT-I/III,MAT1A,MATA1,MATD,metal ion binding,Metal-binding,methionine,Methionine adenosyltransferase 1,methionine adenosyltransferase activity,Methionine adenosyltransferase deficiency,Methionine adenosyltransferase I/III,methionine deficiency,methylation,minerals,mitochondria,mitochondrion,nervous system,neurological disorder,neurotransmitters,Nucleotide-binding,obesity,one-carbon metabolic process,One-carbon metabolism,phosphate,plasma S-adenosylmethionine,plasma SAM,Polymorphism,potassium,potassium ion,protein,S-Adenosyl Methionine,S-adenosyl-L-methionine biosynthesis,S-adenosyl-L-methionine from L-methionine,S-adenosylhomocysteine (SAH),S-adenosylmethionine,S-adenosylmethionine biosynthetic process,S-adenosylmethionine synthase isoform type-1,S-nitrosylation,S-nitrosylation of Cys-120,SAMe,small molecule metabolic process,sulfur amino acid metabolic process,total homocysteine (Hcy),trace minerals,Transferase,transmethylation,vitamin B12,vitamin B6,xenobiotic metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2993763",
        "SNP Name": "MAT1A C1131T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2993763",
        "Video": "mhldH-wrYfY",
        "Tags": "adenosyl,adenosyltransferase,AdoMet,AdoMet synthase 1,AdoMet synthase family,adult metabolic disorder,amino acids,Amino-acid biosynthesis,AMS1,ATP,ATP + L-methionine + H2O = phosphate + diphosphate + S-adenosyl-L-methionine,ATP binding,ATP-binding,B12,betaine,blood pressure,cardiovascular disease,Catalyzes the formation of S-adenosylmethionine from methionine and ATP,cellular amino acid metabolic process,cellular energy,cellular nitrogen compound metabolic process,central nervous system,choline,chronic metabolic disorders,cobalt,cofactors,CVD,cytosol,diabetes,Disease mutation,Disulfide bond,energy,Expressed in liver,fat,fatty acids,folate,heart,high BP,homocysteine,homocysteine metabolism,homodimer,homodimer (MAT-III),homotetramer,Homotetramer (MAT-I),hypermethioninemia,hypertension,inborn error of metabolism resulting in isolated hypermethioninemia,L-methionine,lipid,liver,low BP,Magnesium,MAT 1,MAT-I/III,MAT1A,MATA1,MATD,metal ion binding,Metal-binding,methionine,Methionine adenosyltransferase 1,methionine adenosyltransferase activity,Methionine adenosyltransferase deficiency,Methionine adenosyltransferase I/III,methionine deficiency,methylation,minerals,mitochondria,mitochondrion,nervous system,neurological disorder,neurotransmitters,Nucleotide-binding,obesity,one-carbon metabolic process,One-carbon metabolism,phosphate,plasma S-adenosylmethionine,plasma SAM,Polymorphism,potassium,potassium ion,protein,S-Adenosyl Methionine,S-adenosyl-L-methionine biosynthesis,S-adenosyl-L-methionine from L-methionine,S-adenosylhomocysteine (SAH),S-adenosylmethionine,S-adenosylmethionine biosynthetic process,S-adenosylmethionine synthase isoform type-1,S-nitrosylation,S-nitrosylation of Cys-120,SAMe,small molecule metabolic process,sulfur amino acid metabolic process,total homocysteine (Hcy),trace minerals,Transferase,transmethylation,vitamin B12,vitamin B6,xenobiotic metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2993763",
        "SNP Name": "MAT1A C1131T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2993763",
        "Video": "mhldH-wrYfY",
        "Tags": "adenosyl,adenosyltransferase,AdoMet,AdoMet synthase 1,AdoMet synthase family,adult metabolic disorder,amino acids,Amino-acid biosynthesis,AMS1,ATP,ATP + L-methionine + H2O = phosphate + diphosphate + S-adenosyl-L-methionine,ATP binding,ATP-binding,B12,betaine,blood pressure,cardiovascular disease,Catalyzes the formation of S-adenosylmethionine from methionine and ATP,cellular amino acid metabolic process,cellular energy,cellular nitrogen compound metabolic process,central nervous system,choline,chronic metabolic disorders,cobalt,cofactors,CVD,cytosol,diabetes,Disease mutation,Disulfide bond,energy,Expressed in liver,fat,fatty acids,folate,heart,high BP,homocysteine,homocysteine metabolism,homodimer,homodimer (MAT-III),homotetramer,Homotetramer (MAT-I),hypermethioninemia,hypertension,inborn error of metabolism resulting in isolated hypermethioninemia,L-methionine,lipid,liver,low BP,Magnesium,MAT 1,MAT-I/III,MAT1A,MATA1,MATD,metal ion binding,Metal-binding,methionine,Methionine adenosyltransferase 1,methionine adenosyltransferase activity,Methionine adenosyltransferase deficiency,Methionine adenosyltransferase I/III,methionine deficiency,methylation,minerals,mitochondria,mitochondrion,nervous system,neurological disorder,neurotransmitters,Nucleotide-binding,obesity,one-carbon metabolic process,One-carbon metabolism,phosphate,plasma S-adenosylmethionine,plasma SAM,Polymorphism,potassium,potassium ion,protein,S-Adenosyl Methionine,S-adenosyl-L-methionine biosynthesis,S-adenosyl-L-methionine from L-methionine,S-adenosylhomocysteine (SAH),S-adenosylmethionine,S-adenosylmethionine biosynthetic process,S-adenosylmethionine synthase isoform type-1,S-nitrosylation,S-nitrosylation of Cys-120,SAMe,small molecule metabolic process,sulfur amino acid metabolic process,total homocysteine (Hcy),trace minerals,Transferase,transmethylation,vitamin B12,vitamin B6,xenobiotic metabolic process",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs72558181",
        "SNP Name": "MAT1A G19502A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://snpedia.com/index.php/Rs72558181",
        "Video": "mhldH-wrYfY",
        "Tags": "adenosyl,adenosyltransferase,AdoMet,AdoMet synthase 1,AdoMet synthase family,amino acids,Amino-acid biosynthesis,AMS1,ATP,ATP + L-methionine + H2O = phosphate + diphosphate + S-adenosyl-L-methionine,ATP binding,ATP-binding,autosomal dominant,B12,blood pressure,Catalyzes the formation of S-adenosylmethionine from methionine and ATP,cellular amino acid metabolic process,cellular energy,cellular nitrogen compound metabolic process,central nervous system,cobalt,cofactors,cytosol,Disease mutation,Disulfide bond,energy,Expressed in liver,fat,fatty acids,high BP,homocysteine,homodimer,homodimer (MAT-III),homotetramer,Homotetramer (MAT-I),hypermethioninemia,hypertension,inborn error of metabolism resulting in isolated hypermethioninemia,L-methionine,lipid,liver,low BP,Magnesium,MAT 1,MAT-I/III,MAT1A,MATA1,MATD,metal ion binding,Metal-binding,methionine,Methionine adenosyltransferase 1,methionine adenosyltransferase activity,Methionine adenosyltransferase deficiency,Methionine adenosyltransferase I/III,methionine deficiency,methylation,minerals,mitochondria,mitochondrion,nervous system,neurological disorder,neurotransmitters,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,phosphate,Polymorphism,potassium,potassium ion,protein,S-Adenosyl Methionine,S-adenosyl-L-methionine biosynthesis,S-adenosyl-L-methionine from L-methionine,S-adenosylmethionine,S-adenosylmethionine biosynthetic process,S-adenosylmethionine synthase isoform type-1,S-nitrosylation,S-nitrosylation of Cys-120,SAMe,small molecule metabolic process,sulfur amino acid metabolic process,trace minerals,Transferase,transmethylation,xenobiotic metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs72558181",
        "SNP Name": "MAT1A G19502A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://snpedia.com/index.php/Rs72558181",
        "Video": "mhldH-wrYfY",
        "Tags": "adenosyl,adenosyltransferase,AdoMet,AdoMet synthase 1,AdoMet synthase family,amino acids,Amino-acid biosynthesis,AMS1,ATP,ATP + L-methionine + H2O = phosphate + diphosphate + S-adenosyl-L-methionine,ATP binding,ATP-binding,autosomal dominant,B12,blood pressure,Catalyzes the formation of S-adenosylmethionine from methionine and ATP,cellular amino acid metabolic process,cellular energy,cellular nitrogen compound metabolic process,central nervous system,cobalt,cofactors,cytosol,Disease mutation,Disulfide bond,energy,Expressed in liver,fat,fatty acids,high BP,homocysteine,homodimer,homodimer (MAT-III),homotetramer,Homotetramer (MAT-I),hypermethioninemia,hypertension,inborn error of metabolism resulting in isolated hypermethioninemia,L-methionine,lipid,liver,low BP,Magnesium,MAT 1,MAT-I/III,MAT1A,MATA1,MATD,metal ion binding,Metal-binding,methionine,Methionine adenosyltransferase 1,methionine adenosyltransferase activity,Methionine adenosyltransferase deficiency,Methionine adenosyltransferase I/III,methionine deficiency,methylation,minerals,mitochondria,mitochondrion,nervous system,neurological disorder,neurotransmitters,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,phosphate,Polymorphism,potassium,potassium ion,protein,S-Adenosyl Methionine,S-adenosyl-L-methionine biosynthesis,S-adenosyl-L-methionine from L-methionine,S-adenosylmethionine,S-adenosylmethionine biosynthetic process,S-adenosylmethionine synthase isoform type-1,S-nitrosylation,S-nitrosylation of Cys-120,SAMe,small molecule metabolic process,sulfur amino acid metabolic process,trace minerals,Transferase,transmethylation,xenobiotic metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs72558181",
        "SNP Name": "MAT1A G19502A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://snpedia.com/index.php/Rs72558181",
        "Video": "mhldH-wrYfY",
        "Tags": "adenosyl,adenosyltransferase,AdoMet,AdoMet synthase 1,AdoMet synthase family,amino acids,Amino-acid biosynthesis,AMS1,ATP,ATP + L-methionine + H2O = phosphate + diphosphate + S-adenosyl-L-methionine,ATP binding,ATP-binding,autosomal dominant,B12,blood pressure,Catalyzes the formation of S-adenosylmethionine from methionine and ATP,cellular amino acid metabolic process,cellular energy,cellular nitrogen compound metabolic process,central nervous system,cobalt,cofactors,cytosol,Disease mutation,Disulfide bond,energy,Expressed in liver,fat,fatty acids,high BP,homocysteine,homodimer,homodimer (MAT-III),homotetramer,Homotetramer (MAT-I),hypermethioninemia,hypertension,inborn error of metabolism resulting in isolated hypermethioninemia,L-methionine,lipid,liver,low BP,Magnesium,MAT 1,MAT-I/III,MAT1A,MATA1,MATD,metal ion binding,Metal-binding,methionine,Methionine adenosyltransferase 1,methionine adenosyltransferase activity,Methionine adenosyltransferase deficiency,Methionine adenosyltransferase I/III,methionine deficiency,methylation,minerals,mitochondria,mitochondrion,nervous system,neurological disorder,neurotransmitters,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,phosphate,Polymorphism,potassium,potassium ion,protein,S-Adenosyl Methionine,S-adenosyl-L-methionine biosynthesis,S-adenosyl-L-methionine from L-methionine,S-adenosylmethionine,S-adenosylmethionine biosynthetic process,S-adenosylmethionine synthase isoform type-1,S-nitrosylation,S-nitrosylation of Cys-120,SAMe,small molecule metabolic process,sulfur amino acid metabolic process,trace minerals,Transferase,transmethylation,xenobiotic metabolic process",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs4934028",
        "SNP Name": "MAT1A C15656T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4934028",
        "Video": "mhldH-wrYfY",
        "Tags": "adenosyl,adenosyltransferase,AdoMet,AdoMet synthase 1,AdoMet synthase family,adult metabolic disorder,amino acids,Amino-acid biosynthesis,AMS1,ATP,ATP + L-methionine + H2O = phosphate + diphosphate + S-adenosyl-L-methionine,ATP binding,ATP-binding,B12,betaine,blood pressure,cardiovascular disease,Catalyzes the formation of S-adenosylmethionine from methionine and ATP,cellular amino acid metabolic process,cellular energy,cellular nitrogen compound metabolic process,central nervous system,choline,chronic metabolic disorders,cobalt,cofactors,CVD,cytosol,diabetes,Disease mutation,Disulfide bond,energy,Expressed in liver,fat,fatty acids,folate,heart,high BP,homocysteine,homocysteine metabolism,homodimer,homodimer (MAT-III),homotetramer,Homotetramer (MAT-I),hypermethioninemia,hypertension,inborn error of metabolism resulting in isolated hypermethioninemia,L-methionine,lipid,liver,low BP,Magnesium,MAT 1,MAT-I/III,MAT1A,MATA1,MATD,metal ion binding,Metal-binding,methionine,Methionine adenosyltransferase 1,methionine adenosyltransferase activity,Methionine adenosyltransferase deficiency,Methionine adenosyltransferase I/III,methionine deficiency,methylation,minerals,mitochondria,mitochondrion,nervous system,neurological disorder,neurotransmitters,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,phosphate,plasma S-adenosylmethionine,plasma SAM,Polymorphism,potassium,potassium ion,protein,S-Adenosyl Methionine,S-adenosyl-L-methionine biosynthesis,S-adenosyl-L-methionine from L-methionine,S-adenosylhomocysteine (SAH),S-adenosylmethionine,S-adenosylmethionine biosynthetic process,S-adenosylmethionine synthase isoform type-1,S-nitrosylation,S-nitrosylation of Cys-120,SAMe,small molecule metabolic process,sulfur amino acid metabolic process,total homocysteine (Hcy),trace minerals,Transferase,transmethylation,vitamin B12,vitamin B6,xenobiotic metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs4934028",
        "SNP Name": "MAT1A C15656T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4934028",
        "Video": "mhldH-wrYfY",
        "Tags": "adenosyl,adenosyltransferase,AdoMet,AdoMet synthase 1,AdoMet synthase family,adult metabolic disorder,amino acids,Amino-acid biosynthesis,AMS1,ATP,ATP + L-methionine + H2O = phosphate + diphosphate + S-adenosyl-L-methionine,ATP binding,ATP-binding,B12,betaine,blood pressure,cardiovascular disease,Catalyzes the formation of S-adenosylmethionine from methionine and ATP,cellular amino acid metabolic process,cellular energy,cellular nitrogen compound metabolic process,central nervous system,choline,chronic metabolic disorders,cobalt,cofactors,CVD,cytosol,diabetes,Disease mutation,Disulfide bond,energy,Expressed in liver,fat,fatty acids,folate,heart,high BP,homocysteine,homocysteine metabolism,homodimer,homodimer (MAT-III),homotetramer,Homotetramer (MAT-I),hypermethioninemia,hypertension,inborn error of metabolism resulting in isolated hypermethioninemia,L-methionine,lipid,liver,low BP,Magnesium,MAT 1,MAT-I/III,MAT1A,MATA1,MATD,metal ion binding,Metal-binding,methionine,Methionine adenosyltransferase 1,methionine adenosyltransferase activity,Methionine adenosyltransferase deficiency,Methionine adenosyltransferase I/III,methionine deficiency,methylation,minerals,mitochondria,mitochondrion,nervous system,neurological disorder,neurotransmitters,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,phosphate,plasma S-adenosylmethionine,plasma SAM,Polymorphism,potassium,potassium ion,protein,S-Adenosyl Methionine,S-adenosyl-L-methionine biosynthesis,S-adenosyl-L-methionine from L-methionine,S-adenosylhomocysteine (SAH),S-adenosylmethionine,S-adenosylmethionine biosynthetic process,S-adenosylmethionine synthase isoform type-1,S-nitrosylation,S-nitrosylation of Cys-120,SAMe,small molecule metabolic process,sulfur amino acid metabolic process,total homocysteine (Hcy),trace minerals,Transferase,transmethylation,vitamin B12,vitamin B6,xenobiotic metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs4934028",
        "SNP Name": "MAT1A C15656T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4934028",
        "Video": "mhldH-wrYfY",
        "Tags": "adenosyl,adenosyltransferase,AdoMet,AdoMet synthase 1,AdoMet synthase family,adult metabolic disorder,amino acids,Amino-acid biosynthesis,AMS1,ATP,ATP + L-methionine + H2O = phosphate + diphosphate + S-adenosyl-L-methionine,ATP binding,ATP-binding,B12,betaine,blood pressure,cardiovascular disease,Catalyzes the formation of S-adenosylmethionine from methionine and ATP,cellular amino acid metabolic process,cellular energy,cellular nitrogen compound metabolic process,central nervous system,choline,chronic metabolic disorders,cobalt,cofactors,CVD,cytosol,diabetes,Disease mutation,Disulfide bond,energy,Expressed in liver,fat,fatty acids,folate,heart,high BP,homocysteine,homocysteine metabolism,homodimer,homodimer (MAT-III),homotetramer,Homotetramer (MAT-I),hypermethioninemia,hypertension,inborn error of metabolism resulting in isolated hypermethioninemia,L-methionine,lipid,liver,low BP,Magnesium,MAT 1,MAT-I/III,MAT1A,MATA1,MATD,metal ion binding,Metal-binding,methionine,Methionine adenosyltransferase 1,methionine adenosyltransferase activity,Methionine adenosyltransferase deficiency,Methionine adenosyltransferase I/III,methionine deficiency,methylation,minerals,mitochondria,mitochondrion,nervous system,neurological disorder,neurotransmitters,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,phosphate,plasma S-adenosylmethionine,plasma SAM,Polymorphism,potassium,potassium ion,protein,S-Adenosyl Methionine,S-adenosyl-L-methionine biosynthesis,S-adenosyl-L-methionine from L-methionine,S-adenosylhomocysteine (SAH),S-adenosylmethionine,S-adenosylmethionine biosynthetic process,S-adenosylmethionine synthase isoform type-1,S-nitrosylation,S-nitrosylation of Cys-120,SAMe,small molecule metabolic process,sulfur amino acid metabolic process,total homocysteine (Hcy),trace minerals,Transferase,transmethylation,vitamin B12,vitamin B6,xenobiotic metabolic process",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs12248560",
        "SNP Name": "CYP2C19*17 C806T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs12248560",
        "Video": "xnUGxjQ3iyI",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,Acenocoumarol,Acetylsalicylic acid,acting on paired donors,Adinazolam,Almotriptan,Aminoglutethimide,Aminophenazone,Amiodarone,Amitriptyline,amitriptyline adverse reaction,amitriptyline resistance,Amitriptyline toxicity,Amoxicillin,Amprenavir,and incorporation of one atom of oxygen,Anti-coagulation therapy,Anti-platelet Therapy,antibiotic response,antibiotics,anticonvulsant,anticonvulsant metabolism,antidepressant,antidepressant response,Antidepressant toxicity,antiepileptics,antiplatelet,antiplatelet treatment with clopidogrel,antipsychotics,antipsychotics toxicity,Antipyrine,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,ARTIFICIAL ESTROGEN,atherothrombotic,Atomoxetine,Atorvastatin,Axitinib,Azelastine,barbiturates,Benzatropine,Bicalutamide,Bifonazole,Bortezomib,breast cancer,Bromazepam,Brompheniramine,Bupivacaine,Buprenorphine,cancer,cancerous,Carbamazepine,Carbinoxamine,carcinogen,Cardiac Adverse Events,cardio,cardiovascular,cardiovascular disease,cardiovascular therapeutics,Carisoprodol,cessation of leflunomide,chimera,Chloramphenicol,Chlorpropamide,Chlorzoxazone,Cholecalciferol,cholesterol,Cilostazol,Cimetidine,Cisapride,Citalopram,Clarithromycin,Clevidipine,Clobazam,Clomipramine,clomipramine adverse reaction,clomipramine resistance,Clomipramine toxicity,Clopidogrel,clopidogrel resistance,clopidogrel responsiveness,Clopidogrel Therapy,Clotiazepam,Clotrimazole,Clozapine,COMPOUNDS,CVD,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C19,CYPIIC17,CYPIIC19,CYTOCHROME,Cytochrome P450,Cytochrome P450 2C19,Cytochrome P450 family 2 subfamily C polypeptide 19,Cytochrome P450-11A,Cytochrome P450-254C,cytoplasm,Dapsone,Delavirdine,Desipramine,Desloratadine,detox,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,diazepam,Diclofenac,dihydroxyeicosatrienoic acids,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Dopamine,Doxazosin,Doxepin,Dronabinol,DRUG,drug metabolic process,drug metabolism,DRUG POISONING,drug response,DRUG TOXICITY,drugs,DRUX TOXICITY,E2,Efavirenz,Eletriptan,endometriosis,endoplasmic,endoplasmic reticulum,Endoplasmic reticulum membrane,Enfuvirtide,ENVIRONMENT,environmental,environmental factors,Enzalutamide,enzyme binding,epoxygenase P450 pathway,Escitalopram,Esomeprazole,Estradiol,estrogen,estrogen dominance,estrogen related cancer,Ethanol,Ethotoin,Etoricoxib,Etravirine,exogenous drug catabolic process,extensive metabolizers,Famotidine,FAST METABOLIZER,FATTY ACIDS,Felbamate,Finasteride,Fluconazole,Flunitrazepam,Fluoxetine,Flutamide,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,Gefitinib,Gemfibrozil,Gliclazide,Glucosamine,Glyburide,Guanfacine,Haloperidol,heart,heart disease,heme,heme binding,Heme group,heme-thiolate monooxygenases,heterocycle metabolic process,Hexobarbital,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydroxyeicosatetraenoic acids,Ibuprofen,Ifosfamide,Imatinib,Imipramine,imipramine adverse reaction,imipramine resistance,Imipramine toxicity,Indinavir,Indomethacin,intracellular membrane-bounded organelle,iron,iron ion binding,Isoniazid,Ketobemidone,Ketoconazole,Lansoprazole,Lapatinib,leflunomide,Levomilnacipran,liver,Lopinavir,Loratadine,Lorcaserin,Losartan,Lovastatin,LULICONAZOLE,Lumiracoxib,MACITENTAN,Melatonin,Memantine,Membrane,mephenytoin,Mephenytoin 4-hydroxylase,Meprobamate,metabolic syndrome,Metal-binding,Methadone,Methazolamide,Methimazole,Methsuximide,Methylphenobarbital",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs4986894",
        "SNP Name": "CYP2C19 T98C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs4986894",
        "Video": "xnUGxjQ3iyI",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,4-tert-octylphenol,Acenocoumarol,Acetylsalicylic acid,acting on paired donors,Adinazolam,Almotriptan,Aminoglutethimide,Aminophenazone,Amiodarone,Amitriptyline,Amoxicillin,Amprenavir,and incorporation of one atom of oxygen,anticonvulsant,anticonvulsant metabolism,Antidepressant,antidepressant response,Antidepressant toxicity,antipsychotics,antipsychotics toxicity,Antipyrine,antituberculosis drug,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,ARTIFICIAL ESTROGEN,Atomoxetine,Atorvastatin,Axitinib,Azelastine,barbiturates,Benzatropine,Bicalutamide,Bifonazole,Bortezomib,Bromazepam,Brompheniramine,Bupivacaine,Buprenorphine,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carisoprodol,chimera,Chloramphenicol,Chlorpropamide,Cholecalciferol,cholesterol,Cilostazol,Cimetidine,Cisapride,citalopram,Clarithromycin,Clevidipine,Clobazam,Clomipramine,clopidogrel,clopidogrel resistance,Clotiazepam,Clotrimazole,Clozapine,COMPOUNDS,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C19,CYPIIC17,CYPIIC19,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2C19,Cytochrome P450-11A,Cytochrome P450-254C,cytoplasm,Dapsone,Delavirdine,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,diazepam,Diclofenac,dihydroxyeicosatrienoic acids,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Dopamine,Doxazosin,Doxepin,Dronabinol,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Eletriptan,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enfuvirtide,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,epoxygenase P450 pathway,Escitalopram,Esomeprazole,Estradiol,ESTROGEN,Ethanol,Ethotoin,Etoricoxib,Etravirine,exogenous drug catabolic process,extensive metabolizers,Famotidine,FAST METABOLIZER,FATTY ACIDS,Felbamate,Fluconazole,Flunitrazepam,Fluoxetine,Flutamide,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,Gefitinib,Gemfibrozil,Gliclazide,Glucosamine,Glyburide,Guanfacine,Haloperidol,heme,heme binding,heterocycle metabolic process,Hexobarbital,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydroxyeicosatetraenoic acids,Ibuprofen,idiopathic male infertility,Ifosfamide,Imatinib,imipramine,Indinavir,Indomethacin,infertility,intracellular membrane-bounded organelle,iron,iron ion binding,Isoniazid,Ketobemidone,Ketoconazole,Lansoprazole,Lapatinib,Levomilnacipran,liver injury,Lopinavir,Loratadine,Lorcaserin,Losartan,Lovastatin,LULICONAZOLE,Lumiracoxib,MACITENTAN,male infertility,Melatonin,Memantine,Membrane,Mephenytoin 4-hydroxylase,Meprobamate,Metal-binding,Methadone,Methazolamide,Methimazole,Methsuximide,MethylphenobarbitalMetoprolol,Miconazole,Microsome,Microsome membrane,Moclobemide,Modafinil,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,NADP,NADPH,Nelfinavir,Nicardipine,Nicotine,Nilutamide,Nilvadipine,Norethindrone,Nortriptyline,NSAID,NSAID metabolism,NSAIDs,Olanzapine,omega-hydroxylase P450 pathway,omeprazole,Ospemifene,Oxcarbazepine,Oxiconazole,OXIDATION,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Pantoprazole,Pegvisomant,Pentamidine,Pentobarbital,Peripheral membrane protein,Perphenazine,Pethidine,Phenelzine,Phenobarbital,Phensuximide,Phenytoin,Pimozide,Pioglitazone,Pipotiazine,Podofilox,poor metabolizers,Prasugrel,Praziquantel,Prednisone,Primidone,Pr",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs28399504",
        "SNP Name": "CYP2C19*4 A5001G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs28399504",
        "Video": "xnUGxjQ3iyI",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,Acenocoumarol,Acetylsalicylic acid,acting on paired donors,Adinazolam,Almotriptan,Aminoglutethimide,Aminophenazone,Amiodarone,Amitriptyline,Amoxicillin,Amprenavir,and incorporation of one atom of oxygen,anticonvulsant,anticonvulsant metabolism,Antidepressant,Antidepressant toxicity,antipsychotics,antipsychotics toxicity,Antipyrine,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,ARTIFICIAL ESTROGEN,Atomoxetine,Atorvastatin,Axitinib,Azelastine,barbiturates,Benzatropine,Bicalutamide,Bifonazole,Bortezomib,Bromazepam,Brompheniramine,Bupivacaine,Buprenorphine,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carisoprodol,chimera,Chloramphenicol,Chlorpropamide,Cholecalciferol,cholesterol,Cilostazol,Cimetidine,Cisapride,citalopram,Clarithromycin,Clevidipine,Clobazam,Clomipramine,clopidogrel,clopidogrel resistance,Clotiazepam,Clotrimazole,Clozapine,COMPOUNDS,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C19,CYPIIC17,CYPIIC19,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2C19,Cytochrome P450-11A,Cytochrome P450-254C,cytoplasm,Dapsone,Delavirdine,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,diazepam,Diclofenac,dihydroxyeicosatrienoic acids,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Dopamine,Doxazosin,Doxepin,Dronabinol,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Eletriptan,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enfuvirtide,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,epoxygenase P450 pathway,Escitalopram,Esomeprazole,Estradiol,ESTROGEN,Ethanol,Ethotoin,Etoricoxib,Etravirine,exogenous drug catabolic process,extensive metabolizers,Famotidine,FAST METABOLIZER,FATTY ACIDS,Felbamate,Fluconazole,Flunitrazepam,Fluoxetine,Flutamide,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,Gefitinib,Gemfibrozil,Gliclazide,Glucosamine,Glyburide,Guanfacine,Haloperidol,heme,heme binding,heterocycle metabolic process,Hexobarbital,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydroxyeicosatetraenoic acids,Ibuprofen,Ifosfamide,Imatinib,imipramine,Indinavir,Indomethacin,intracellular membrane-bounded organelle,iron,iron ion binding,Isoniazid,Ketobemidone,Ketoconazole,Lansoprazole,Lapatinib,Levomilnacipran,Lopinavir,Loratadine,Lorcaserin,Losartan,Lovastatin,LULICONAZOLE,Lumiracoxib,MACITENTAN,Melatonin,Memantine,Membrane,Mephenytoin 4-hydroxylase,Meprobamate,Metal-binding,Methadone,Methazolamide,Methimazole,Methsuximide,MethylphenobarbitalMetoprolol,Miconazole,Microsome,Microsome membrane,Moclobemide,Modafinil,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,NADP,NADPH,Nelfinavir,Nicardipine,Nicotine,Nilutamide,Nilvadipine,Norethindrone,Nortriptyline,NSAID,NSAID metabolism,NSAIDs,Olanzapine,omega-hydroxylase P450 pathway,omeprazole,Ospemifene,Oxcarbazepine,Oxiconazole,OXIDATION,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Pantoprazole,Pegvisomant,Pentamidine,Pentobarbital,Peripheral membrane protein,Perphenazine,Pethidine,Phenelzine,Phenobarbital,Phensuximide,Phenytoin,Pimozide,Pioglitazone,Pipotiazine,Podofilox,poor metabolizers,Prasugrel,Praziquantel,Prednisone,Primidone,Probenecid,Progesterone,proguanil,Promazine,Propofol,propranolol,protein,Quazepam,Quetiapine,Quinine,Rabeprazole,Ramelteon,Ranitidin",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs17878459",
        "SNP Name": "CYP2C19*2B G276A",
        "Risk Allele": "C",
        "Your Allele": "CG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://annonc.oxfordjournals.org/content/25/1/90.full",
        "Video": "xnUGxjQ3iyI",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,Acenocoumarol,Acetylsalicylic acid,acting on paired donors,Adinazolam,Almotriptan,Aminoglutethimide,Aminophenazone,Amiodarone,Amitriptyline,Amoxicillin,Amprenavir,and incorporation of one atom of oxygen,anticonvulsant,anticonvulsant metabolism,Antidepressant,Antidepressant toxicity,antipsychotics,antipsychotics toxicity,Antipyrine,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,ARTIFICIAL ESTROGEN,Atomoxetine,Atorvastatin,Axitinib,Azelastine,barbiturates,Benzatropine,Bicalutamide,Bifonazole,Bortezomib,Bromazepam,Brompheniramine,Bupivacaine,Buprenorphine,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carisoprodol,chimera,Chloramphenicol,Chlorpropamide,Cholecalciferol,cholesterol,Cilostazol,Cimetidine,Cisapride,citalopram,Clarithromycin,Clevidipine,Clobazam,Clomipramine,clopidogrel,clopidogrel resistance,Clotiazepam,Clotrimazole,Clozapine,COMPOUNDS,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C19,CYPIIC17,CYPIIC19,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2C19,Cytochrome P450-11A,Cytochrome P450-254C,cytoplasm,Dapsone,Delavirdine,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,diazepam,Diclofenac,dihydroxyeicosatrienoic acids,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Dopamine,Doxazosin,Doxepin,Dronabinol,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Eletriptan,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enfuvirtide,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,epoxygenase P450 pathway,Escitalopram,Esomeprazole,Estradiol,ESTROGEN,Ethanol,Ethotoin,Etoricoxib,Etravirine,exogenous drug catabolic process,extensive metabolizers,Famotidine,FAST METABOLIZER,FATTY ACIDS,Felbamate,Fluconazole,Flunitrazepam,Fluoxetine,Flutamide,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,Gefitinib,Gemfibrozil,Gliclazide,Glucosamine,Glyburide,Guanfacine,Haloperidol,heme,heme binding,heterocycle metabolic process,Hexobarbital,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydroxyeicosatetraenoic acids,Ibuprofen,Ifosfamide,Imatinib,imipramine,Indinavir,Indomethacin,intracellular membrane-bounded organelle,iron,iron ion binding,Isoniazid,Ketobemidone,Ketoconazole,Lansoprazole,Lapatinib,Levomilnacipran,Lopinavir,Loratadine,Lorcaserin,Losartan,Lovastatin,LULICONAZOLE,Lumiracoxib,MACITENTAN,Melatonin,Memantine,Membrane,Mephenytoin 4-hydroxylase,Meprobamate,Metal-binding,Methadone,Methazolamide,Methimazole,Methsuximide,MethylphenobarbitalMetoprolol,Miconazole,Microsome,Microsome membrane,Moclobemide,Modafinil,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,NADP,NADPH,Nelfinavir,Nicardipine,Nicotine,Nilutamide,Nilvadipine,Norethindrone,Nortriptyline,NSAID,NSAID metabolism,NSAIDs,Olanzapine,omega-hydroxylase P450 pathway,omeprazole,Ospemifene,Oxcarbazepine,Oxiconazole,OXIDATION,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Pantoprazole,Pegvisomant,Pentamidine,Pentobarbital,Peripheral membrane protein,Perphenazine,Pethidine,Phenelzine,Phenobarbital,Phensuximide,Phenytoin,Pimozide,Pioglitazone,Pipotiazine,Podofilox,poor metabolizers,Prasugrel,Praziquantel,Prednisone,Primidone,Probenecid,Progesterone,proguanil,Promazine,Propofol,propranolol,protein,Quazepam,Quetiapine,Quinine,Rabeprazole,Ramelteon,Ranitidin",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs41291556",
        "SNP Name": "CYP2C19*8 T358C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349992/",
        "Video": "xnUGxjQ3iyI",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,Acenocoumarol,Acetylsalicylic acid,acting on paired donors,Adinazolam,Almotriptan,Aminoglutethimide,Aminophenazone,Amiodarone,Amitriptyline,Amoxicillin,Amprenavir,and incorporation of one atom of oxygen,anticonvulsant,anticonvulsant metabolism,Antidepressant,Antidepressant toxicity,antipsychotics,antipsychotics toxicity,Antipyrine,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,ARTIFICIAL ESTROGEN,Atomoxetine,Atorvastatin,Axitinib,Azelastine,barbiturates,Benzatropine,Bicalutamide,Bifonazole,Bortezomib,Bromazepam,Brompheniramine,Bupivacaine,Buprenorphine,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carisoprodol,chimera,Chloramphenicol,Chlorpropamide,Cholecalciferol,cholesterol,Cilostazol,Cimetidine,Cisapride,citalopram,Clarithromycin,Clevidipine,Clobazam,Clomipramine,clopidogrel,clopidogrel resistance,Clotiazepam,Clotrimazole,Clozapine,COMPOUNDS,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C19,CYPIIC17,CYPIIC19,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2C19,Cytochrome P450-11A,Cytochrome P450-254C,cytoplasm,Dapsone,Delavirdine,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,diazepam,Diclofenac,dihydroxyeicosatrienoic acids,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Dopamine,Doxazosin,Doxepin,Dronabinol,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Eletriptan,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enfuvirtide,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,epoxygenase P450 pathway,Escitalopram,Esomeprazole,Estradiol,ESTROGEN,Ethanol,Ethotoin,Etoricoxib,Etravirine,exogenous drug catabolic process,extensive metabolizers,Famotidine,FAST METABOLIZER,FATTY ACIDS,Felbamate,Fluconazole,Flunitrazepam,Fluoxetine,Flutamide,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,Gefitinib,Gemfibrozil,Gliclazide,Glucosamine,Glyburide,Guanfacine,Haloperidol,heme,heme binding,heterocycle metabolic process,Hexobarbital,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydroxyeicosatetraenoic acids,Ibuprofen,Ifosfamide,Imatinib,imipramine,Indinavir,Indomethacin,intracellular membrane-bounded organelle,iron,iron ion binding,Isoniazid,Ketobemidone,Ketoconazole,Lansoprazole,Lapatinib,Levomilnacipran,Lopinavir,Loratadine,Lorcaserin,Losartan,Lovastatin,LULICONAZOLE,Lumiracoxib,MACITENTAN,Melatonin,Memantine,Membrane,Mephenytoin 4-hydroxylase,Meprobamate,Metal-binding,Methadone,Methazolamide,Methimazole,Methsuximide,MethylphenobarbitalMetoprolol,Miconazole,Microsome,Microsome membrane,Moclobemide,Modafinil,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,NADP,NADPH,Nelfinavir,Nicardipine,Nicotine,Nilutamide,Nilvadipine,Norethindrone,Nortriptyline,NSAID,NSAID metabolism,NSAIDs,Olanzapine,omega-hydroxylase P450 pathway,omeprazole,Ospemifene,Oxcarbazepine,Oxiconazole,OXIDATION,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Pantoprazole,Pegvisomant,Pentamidine,Pentobarbital,Peripheral membrane protein,Perphenazine,Pethidine,Phenelzine,Phenobarbital,Phensuximide,Phenytoin,Pimozide,Pioglitazone,Pipotiazine,Podofilox,poor metabolizers,Prasugrel,Praziquantel,Prednisone,Primidone,Probenecid,Progesterone,proguanil,Promazine,Propofol,propranolol,protein,Quazepam,Quetiapine,Quinine,Rabeprazole,Ramelteon,Ranitidin",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs72552267",
        "SNP Name": "CYP2C19*6 G395A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349992/",
        "Video": "xnUGxjQ3iyI",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,Acenocoumarol,Acetylsalicylic acid,acting on paired donors,Adinazolam,Almotriptan,Aminoglutethimide,Aminophenazone,Amiodarone,Amitriptyline,Amoxicillin,Amprenavir,and incorporation of one atom of oxygen,anticonvulsant,anticonvulsant metabolism,Antidepressant,Antidepressant toxicity,antipsychotics,antipsychotics toxicity,Antipyrine,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,ARTIFICIAL ESTROGEN,Atomoxetine,Atorvastatin,Axitinib,Azelastine,barbiturates,Benzatropine,Bicalutamide,Bifonazole,Bortezomib,Bromazepam,Brompheniramine,Bupivacaine,Buprenorphine,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carisoprodol,chimera,Chloramphenicol,Chlorpropamide,Cholecalciferol,cholesterol,Cilostazol,Cimetidine,Cisapride,citalopram,Clarithromycin,Clevidipine,Clobazam,Clomipramine,clopidogrel,clopidogrel resistance,Clotiazepam,Clotrimazole,Clozapine,COMPOUNDS,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C19,CYPIIC17,CYPIIC19,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2C19,Cytochrome P450-11A,Cytochrome P450-254C,cytoplasm,Dapsone,Delavirdine,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,diazepam,Diclofenac,dihydroxyeicosatrienoic acids,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Dopamine,Doxazosin,Doxepin,Dronabinol,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Eletriptan,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enfuvirtide,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,epoxygenase P450 pathway,Escitalopram,Esomeprazole,Estradiol,ESTROGEN,Ethanol,Ethotoin,Etoricoxib,Etravirine,exogenous drug catabolic process,extensive metabolizers,Famotidine,FAST METABOLIZER,FATTY ACIDS,Felbamate,Fluconazole,Flunitrazepam,Fluoxetine,Flutamide,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,Gefitinib,Gemfibrozil,Gliclazide,Glucosamine,Glyburide,Guanfacine,Haloperidol,heme,heme binding,heterocycle metabolic process,Hexobarbital,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydroxyeicosatetraenoic acids,Ibuprofen,Ifosfamide,Imatinib,imipramine,Indinavir,Indomethacin,intracellular membrane-bounded organelle,iron,iron ion binding,Isoniazid,Ketobemidone,Ketoconazole,Lansoprazole,Lapatinib,Levomilnacipran,Lopinavir,Loratadine,Lorcaserin,Losartan,Lovastatin,LULICONAZOLE,Lumiracoxib,MACITENTAN,Melatonin,Memantine,Membrane,Mephenytoin 4-hydroxylase,Meprobamate,Metal-binding,Methadone,Methazolamide,Methimazole,Methsuximide,MethylphenobarbitalMetoprolol,Miconazole,Microsome,Microsome membrane,Moclobemide,Modafinil,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,NADP,NADPH,Nelfinavir,Nicardipine,Nicotine,Nilutamide,Nilvadipine,Norethindrone,Nortriptyline,NSAID,NSAID metabolism,NSAIDs,Olanzapine,omega-hydroxylase P450 pathway,omeprazole,Ospemifene,Oxcarbazepine,Oxiconazole,OXIDATION,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Pantoprazole,Pegvisomant,Pentamidine,Pentobarbital,Peripheral membrane protein,Perphenazine,Pethidine,Phenelzine,Phenobarbital,Phensuximide,Phenytoin,Pimozide,Pioglitazone,Pipotiazine,Podofilox,poor metabolizers,Prasugrel,Praziquantel,Prednisone,Primidone,Probenecid,Progesterone,proguanil,Promazine,Propofol,propranolol,protein,Quazepam,Quetiapine,Quinine,Rabeprazole,Ramelteon,Ranitidin",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs4986893",
        "SNP Name": "CYP2C19*3 G636A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs4986893",
        "Video": "xnUGxjQ3iyI",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,Acenocoumarol,Acetylsalicylic acid,acting on paired donors,Adinazolam,Almotriptan,Aminoglutethimide,Aminophenazone,Amiodarone,Amitriptyline,Amoxicillin,Amprenavir,and incorporation of one atom of oxygen,anticonvulsant,anticonvulsant metabolism,Antidepressant,Antidepressant toxicity,antipsychotics,antipsychotics toxicity,Antipyrine,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,ARTIFICIAL ESTROGEN,Atomoxetine,Atorvastatin,Axitinib,Azelastine,barbiturates,Benzatropine,Bicalutamide,Bifonazole,Bortezomib,Bromazepam,Brompheniramine,Bupivacaine,Buprenorphine,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cardiac side effects of methadone,Carisoprodol,chimera,Chloramphenicol,Chlorpropamide,Cholecalciferol,cholesterol,Cilostazol,Cimetidine,Cisapride,citalopram,Clarithromycin,Clevidipine,Clobazam,Clomipramine,clopidogrel,clopidogrel resistance,clopidogrel response,clopidogrel responsiveness,Clotiazepam,Clotrimazole,Clozapine,COMPOUNDS,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C19,CYPIIC17,CYPIIC19,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2C19,Cytochrome P450-11A,Cytochrome P450-254C,cytoplasm,Dapsone,Delavirdine,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,diazepam,Diclofenac,dihydroxyeicosatrienoic acids,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Dopamine,Doxazosin,Doxepin,Dronabinol,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Eletriptan,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enfuvirtide,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,epoxygenase P450 pathway,Escitalopram,Esomeprazole,Estradiol,ESTROGEN,Ethanol,Ethotoin,Etoricoxib,Etravirine,exogenous drug catabolic process,extensive metabolizers,Famotidine,FAST METABOLIZER,FATTY ACIDS,Felbamate,Fluconazole,Flunitrazepam,Fluoxetine,Flutamide,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,Gefitinib,Gemfibrozil,Gliclazide,Glucosamine,Glyburide,Guanfacine,Haloperidol,heme,heme binding,heterocycle metabolic process,Hexobarbital,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydroxyeicosatetraenoic acids,Ibuprofen,Ifosfamide,Imatinib,imipramine,Indinavir,Indomethacin,intracellular membrane-bounded organelle,iron,iron ion binding,Isoniazid,Ketobemidone,Ketoconazole,Lansoprazole,Lapatinib,Levomilnacipran,Lopinavir,Loratadine,Lorcaserin,Losartan,Lovastatin,LULICONAZOLE,Lumiracoxib,MACITENTAN,Melatonin,Memantine,Membrane,Mephenytoin 4-hydroxylase,Meprobamate,Metal-binding,Methadone,Methazolamide,Methimazole,Methsuximide,MethylphenobarbitalMetoprolol,Miconazole,Microsome,Microsome membrane,Moclobemide,Modafinil,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,NADP,NADPH,Nelfinavir,Nicardipine,Nicotine,Nilutamide,Nilvadipine,Norethindrone,Nortriptyline,NSAID,NSAID metabolism,NSAIDs,Olanzapine,omega-hydroxylase P450 pathway,omeprazole,Ospemifene,Oxcarbazepine,Oxiconazole,OXIDATION,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,paediatric tuberculosis,Pantoprazole,Pegvisomant,Pentamidine,Pentobarbital,Peripheral membrane protein,Perphenazine,Pethidine,Phenelzine,Phenobarbital,Phensuximide,Phenytoin,Pimozide,Pioglitazone,Pipotiazine,platelet reactivity,Podofilox,poor metabolizers,Prasugrel,Praziquantel,Prednisone,Primidone,Probenecid,P",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs4244285",
        "SNP Name": "CYP2C19*2 G681A",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs4244285",
        "Video": "xnUGxjQ3iyI",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,Acenocoumarol,Acetylsalicylic acid,acting on paired donors,Adinazolam,AIDS,Almotriptan,Aminoglutethimide,Aminophenazone,Amiodarone,Amitriptyline,Amoxicillin,Amprenavir,and incorporation of one atom of oxygen,anticonvulsant,anticonvulsant metabolism,Antidepressant,Antidepressant toxicity,antipsychotics,antipsychotics toxicity,Antipyrine,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,arthritis,ARTIFICIAL ESTROGEN,Aspirin,atazanavir,Atomoxetine,Atorvastatin,Axitinib,Azelastine,barbiturates,Benzatropine,Bicalutamide,Bifonazole,blood pressure,Bortezomib,BP,breast cancer treatment outcomes,Bromazepam,Brompheniramine,Bupivacaine,Buprenorphine,CAD,calcineurin inhibitors,calcium-channel blockers,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carisoprodol,cessation of leflunomide,chimera,Chloramphenicol,Chlorpropamide,Cholecalciferol,cholesterol,Cilostazol,Cimetidine,Cisapride,citalopram,Clarithromycin,Clevidipine,Clobazam,Clomipramine,clopidogrel,clopidogrel resistance,clopidogrel response,clopidogrel responsiveness,clopidogrel therapy,Clotiazepam,Clotrimazole,Clozapine,COMPOUNDS,coronary heart disease,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C19,CYPIIC17,CYPIIC19,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2C19,Cytochrome P450-11A,Cytochrome P450-254C,cytoplasm,Dapsone,Delavirdine,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,diazepam,Diclofenac,dihydroxyeicosatrienoic acids,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Dopamine,Doxazosin,Doxepin,Dronabinol,DRUG,drug interaction,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Eletriptan,endometriosis,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enfuvirtide,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,epoxygenase P450 pathway,Escitalopram,Esomeprazole,Estradiol,ESTROGEN,Ethanol,Ethotoin,Etoricoxib,Etravirine,exogenous drug catabolic process,extensive metabolizers,Famotidine,FAST METABOLIZER,FATTY ACIDS,Felbamate,Fluconazole,Flunitrazepam,Fluoxetine,Flutamide,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,Gefitinib,Gemfibrozil,Gliclazide,Glucosamine,Glyburide,Guanfacine,Haloperidol,heart,heart disease,heme,heme binding,heterocycle metabolic process,Hexobarbital,HIV,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydroxyeicosatetraenoic acids,Ibuprofen,Ifosfamide,Imatinib,imipramine,Indinavir,Indomethacin,intracellular membrane-bounded organelle,iron,iron ion binding,Isoniazid,Ketobemidone,Ketoconazole,Lansoprazole,Lapatinib,leflunomide,Levomilnacipran,Lopinavir,Loratadine,Lorcaserin,Losartan,Lovastatin,LULICONAZOLE,Lumiracoxib,MACITENTAN,Melatonin,Memantine,Membrane,Mephenytoin 4-hydroxylase,Meprobamate,metabolic enzymes,metabolic syndrome,Metal-binding,Methadone,methadone cardiac side effects,Methazolamide,Methimazole,Methsuximide,MethylphenobarbitalMetoprolol,Miconazole,Microsome,Microsome membrane,Moclobemide,Modafinil,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,multiple myeloma,NADP,NADPH,Nelfinavir,Nicardipine,Nicotine,Nilutamide,Nilvadipine,Norethindrone,Nortriptyline,NSAID,NSAID metabolism,NSAIDs,Olanzapine,omega-hydroxylase P450 pathway,omeprazole,Ospemifene,Oxcarbazepine,Oxiconazole,OXIDATION,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen bindi",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs72558186",
        "SNP Name": "CYP2C19*7 T24294A",
        "Risk Allele": "A",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349992/",
        "Video": "xnUGxjQ3iyI",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,Acenocoumarol,Acetylsalicylic acid,acting on paired donors,Adinazolam,Almotriptan,Aminoglutethimide,Aminophenazone,Amiodarone,Amitriptyline,Amoxicillin,Amprenavir,and incorporation of one atom of oxygen,anticonvulsant,anticonvulsant metabolism,Antidepressant,Antidepressant toxicity,antipsychotics,antipsychotics toxicity,Antipyrine,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,ARTIFICIAL ESTROGEN,Atomoxetine,Atorvastatin,Axitinib,Azelastine,barbiturates,Benzatropine,Bicalutamide,Bifonazole,Bortezomib,Bromazepam,Brompheniramine,Bupivacaine,Buprenorphine,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carisoprodol,chimera,Chloramphenicol,Chlorpropamide,Cholecalciferol,cholesterol,Cilostazol,Cimetidine,Cisapride,citalopram,Clarithromycin,Clevidipine,Clobazam,Clomipramine,clopidogrel,clopidogrel resistance,Clotiazepam,Clotrimazole,Clozapine,COMPOUNDS,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C19,CYPIIC17,CYPIIC19,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2C19,Cytochrome P450-11A,Cytochrome P450-254C,cytoplasm,Dapsone,Delavirdine,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,diazepam,Diclofenac,dihydroxyeicosatrienoic acids,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Dopamine,Doxazosin,Doxepin,Dronabinol,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Eletriptan,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enfuvirtide,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,epoxygenase P450 pathway,Escitalopram,Esomeprazole,Estradiol,ESTROGEN,Ethanol,Ethotoin,Etoricoxib,Etravirine,exogenous drug catabolic process,extensive metabolizers,Famotidine,FAST METABOLIZER,FATTY ACIDS,Felbamate,Fluconazole,Flunitrazepam,Fluoxetine,Flutamide,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,Gefitinib,Gemfibrozil,Gliclazide,Glucosamine,Glyburide,Guanfacine,Haloperidol,heme,heme binding,heterocycle metabolic process,Hexobarbital,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydroxyeicosatetraenoic acids,Ibuprofen,Ifosfamide,Imatinib,imipramine,Indinavir,Indomethacin,intracellular membrane-bounded organelle,iron,iron ion binding,Isoniazid,Ketobemidone,Ketoconazole,Lansoprazole,Lapatinib,Levomilnacipran,Lopinavir,Loratadine,Lorcaserin,Losartan,Lovastatin,LULICONAZOLE,Lumiracoxib,MACITENTAN,Melatonin,Memantine,Membrane,Mephenytoin 4-hydroxylase,Meprobamate,Metal-binding,Methadone,Methazolamide,Methimazole,Methsuximide,MethylphenobarbitalMetoprolol,Miconazole,Microsome,Microsome membrane,Moclobemide,Modafinil,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,NADP,NADPH,Nelfinavir,Nicardipine,Nicotine,Nilutamide,Nilvadipine,Norethindrone,Nortriptyline,NSAID,NSAID metabolism,NSAIDs,Olanzapine,omega-hydroxylase P450 pathway,omeprazole,Ospemifene,Oxcarbazepine,Oxiconazole,OXIDATION,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Pantoprazole,Pegvisomant,Pentamidine,Pentobarbital,Peripheral membrane protein,Perphenazine,Pethidine,Phenelzine,Phenobarbital,Phensuximide,Phenytoin,Pimozide,Pioglitazone,Pipotiazine,Podofilox,poor metabolizers,Prasugrel,Praziquantel,Prednisone,Primidone,Probenecid,Progesterone,proguanil,Promazine,Propofol,propranolol,protein,Quazepam,Quetiapine,Quinine,Rabeprazole,Ramelteon,Ranitidin",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs12767583",
        "SNP Name": "CYP2C19 C5709T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs12767583",
        "Video": "xnUGxjQ3iyI",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,Acenocoumarol,Acetylsalicylic acid,acting on paired donors,Adinazolam,Almotriptan,Aminoglutethimide,Aminophenazone,Amiodarone,Amitriptyline,Amoxicillin,Amprenavir,and incorporation of one atom of oxygen,anticonvulsant,anticonvulsant metabolism,Antidepressant,antidepressant metabolism,antidepressant side effects,Antidepressant toxicity,antipsychotics,antipsychotics toxicity,Antipyrine,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,ARTIFICIAL ESTROGEN,Atomoxetine,Atorvastatin,Axitinib,Azelastine,barbiturates,Benzatropine,Bicalutamide,Bifonazole,Bortezomib,Bromazepam,Brompheniramine,Bupivacaine,Buprenorphine,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carisoprodol,chimera,Chloramphenicol,Chlorpropamide,Cholecalciferol,cholesterol,Cilostazol,Cimetidine,Cisapride,citalopram,Clarithromycin,Clevidipine,Clobazam,Clomipramine,clopidogrel,clopidogrel resistance,Clotiazepam,Clotrimazole,Clozapine,COMPOUNDS,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C19,CYPIIC17,CYPIIC19,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2C19,Cytochrome P450-11A,Cytochrome P450-254C,cytoplasm,Dapsone,Delavirdine,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,diazepam,Diclofenac,dihydroxyeicosatrienoic acids,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Dopamine,Doxazosin,Doxepin,Dronabinol,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Eletriptan,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enfuvirtide,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,epoxygenase P450 pathway,Escitalopram,Esomeprazole,Estradiol,ESTROGEN,Ethanol,Ethotoin,Etoricoxib,Etravirine,exogenous drug catabolic process,extensive metabolizers,Famotidine,FAST METABOLIZER,FATTY ACIDS,Felbamate,Fluconazole,Flunitrazepam,Fluoxetine,Flutamide,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,Gefitinib,Gemfibrozil,Gliclazide,Glucosamine,Glyburide,Guanfacine,Haloperidol,heme,heme binding,heterocycle metabolic process,Hexobarbital,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydroxyeicosatetraenoic acids,Ibuprofen,Ifosfamide,Imatinib,imipramine,Indinavir,Indomethacin,intracellular membrane-bounded organelle,iron,iron ion binding,Isoniazid,Ketobemidone,Ketoconazole,Lansoprazole,Lapatinib,Levomilnacipran,Lopinavir,Loratadine,Lorcaserin,Losartan,Lovastatin,LULICONAZOLE,Lumiracoxib,MACITENTAN,Melatonin,Memantine,Membrane,Mephenytoin 4-hydroxylase,Meprobamate,Metal-binding,Methadone,Methazolamide,Methimazole,Methsuximide,MethylphenobarbitalMetoprolol,Miconazole,Microsome,Microsome membrane,Moclobemide,Modafinil,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,NADP,NADPH,Nelfinavir,Nicardipine,Nicotine,Nilutamide,Nilvadipine,Norethindrone,Nortriptyline,NSAID,NSAID metabolism,NSAIDs,Olanzapine,omega-hydroxylase P450 pathway,omeprazole,Ospemifene,Oxcarbazepine,Oxiconazole,OXIDATION,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Pantoprazole,Pegvisomant,Pentamidine,Pentobarbital,Peripheral membrane protein,Perphenazine,Pethidine,Phenelzine,Phenobarbital,Phensuximide,Phenytoin,Pimozide,Pioglitazone,Pipotiazine,Podofilox,poor metabolizers,Prasugrel,Praziquantel,Prednisone,Primidone,Probenecid,Progesterone,proguanil,Promazine,Propofol,propranolol,protein,Quazepam",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs4917623",
        "SNP Name": "CYP2C19 T106C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs4917623",
        "Video": "xnUGxjQ3iyI",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,Acenocoumarol,Acetylsalicylic acid,acting on paired donors,Adinazolam,Almotriptan,Aminoglutethimide,Aminophenazone,Amiodarone,Amitriptyline,Amoxicillin,Amprenavir,and incorporation of one atom of oxygen,anticonvulsant,anticonvulsant metabolism,Antidepressant,Antidepressant toxicity,antipsychotics,antipsychotics toxicity,Antipyrine,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,ARTIFICIAL ESTROGEN,Atomoxetine,Atorvastatin,Axitinib,Azelastine,barbiturates,Benzatropine,Bicalutamide,Bifonazole,Bortezomib,breast cancer,Bromazepam,Brompheniramine,Bupivacaine,Buprenorphine,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carisoprodol,chimera,Chloramphenicol,Chlorpropamide,Cholecalciferol,cholesterol,Cilostazol,Cimetidine,Cisapride,citalopram,Clarithromycin,Clevidipine,Clobazam,Clomipramine,clopidogrel,clopidogrel resistance,Clotiazepam,Clotrimazole,Clozapine,COMPOUNDS,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C19,CYPIIC17,CYPIIC19,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2C19,Cytochrome P450-11A,Cytochrome P450-254C,cytoplasm,Dapsone,Delavirdine,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,diazepam,Diclofenac,dihydroxyeicosatrienoic acids,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Dopamine,Doxazosin,Doxepin,Dronabinol,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Eletriptan,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enfuvirtide,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,epoxygenase P450 pathway,Escitalopram,Esomeprazole,Estradiol,ESTROGEN,estrogen metabolism,Ethanol,Ethotoin,Etoricoxib,Etravirine,exogenous drug catabolic process,extensive metabolizers,Famotidine,FAST METABOLIZER,FATTY ACIDS,Felbamate,Fluconazole,Flunitrazepam,Fluoxetine,Flutamide,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,Gefitinib,Gemfibrozil,Gliclazide,Glucosamine,Glyburide,Guanfacine,Haloperidol,heme,heme binding,heterocycle metabolic process,Hexobarbital,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydroxyeicosatetraenoic acids,Ibuprofen,Ifosfamide,Imatinib,imipramine,Indinavir,Indomethacin,intracellular membrane-bounded organelle,iron,iron ion binding,Isoniazid,Ketobemidone,Ketoconazole,Lansoprazole,Lapatinib,Levomilnacipran,Lopinavir,Loratadine,Lorcaserin,Losartan,Lovastatin,LULICONAZOLE,Lumiracoxib,MACITENTAN,Melatonin,Memantine,Membrane,Mephenytoin 4-hydroxylase,Meprobamate,Metal-binding,Methadone,Methazolamide,Methimazole,Methsuximide,MethylphenobarbitalMetoprolol,Miconazole,Microsome,Microsome membrane,Moclobemide,Modafinil,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,NADP,NADPH,Nelfinavir,Nicardipine,Nicotine,Nilutamide,Nilvadipine,Norethindrone,Nortriptyline,NSAID,NSAID metabolism,NSAIDs,Olanzapine,omega-hydroxylase P450 pathway,omeprazole,Ospemifene,Oxcarbazepine,Oxiconazole,OXIDATION,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Pantoprazole,Pegvisomant,Pentamidine,Pentobarbital,Peripheral membrane protein,Perphenazine,Pethidine,Phenelzine,Phenobarbital,Phensuximide,Phenytoin,Pimozide,Pioglitazone,Pipotiazine,Podofilox,poor metabolizers,Prasugrel,Praziquantel,Prednisone,Primidone,Probenecid,Progesterone,proguanil,Promazine,Propofol,propranolol,protein,Quazepam,Quetiapine,Quinin",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs56337013",
        "SNP Name": "CYP2C19*5 C1297T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs56337013",
        "Video": "xnUGxjQ3iyI",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,Acenocoumarol,Acetylsalicylic acid,acting on paired donors,Adinazolam,Almotriptan,Aminoglutethimide,Aminophenazone,Amiodarone,Amitriptyline,Amoxicillin,Amprenavir,and incorporation of one atom of oxygen,anticonvulsant,anticonvulsant metabolism,Antidepressant,Antidepressant toxicity,antipsychotics,antipsychotics toxicity,Antipyrine,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,ARTIFICIAL ESTROGEN,Atomoxetine,Atorvastatin,Axitinib,Azelastine,barbiturates,Benzatropine,Bicalutamide,Bifonazole,Bortezomib,Bromazepam,Brompheniramine,Bupivacaine,Buprenorphine,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,Carisoprodol,chimera,Chloramphenicol,Chlorpropamide,Cholecalciferol,cholesterol,Cilostazol,Cimetidine,Cisapride,citalopram,Clarithromycin,Clevidipine,Clobazam,Clomipramine,clopidogrel,clopidogrel resistance,Clotiazepam,Clotrimazole,Clozapine,COMPOUNDS,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C19,CYPIIC17,CYPIIC19,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2C19,Cytochrome P450-11A,Cytochrome P450-254C,cytoplasm,Dapsone,Delavirdine,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,diazepam,Diclofenac,dihydroxyeicosatrienoic acids,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Dopamine,Doxazosin,Doxepin,Dronabinol,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Eletriptan,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enfuvirtide,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme binding,epoxygenase P450 pathway,Escitalopram,Esomeprazole,Estradiol,ESTROGEN,Ethanol,Ethotoin,Etoricoxib,Etravirine,exogenous drug catabolic process,extensive metabolizers,Famotidine,FAST METABOLIZER,FATTY ACIDS,Felbamate,Fluconazole,Flunitrazepam,Fluoxetine,Flutamide,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,Gefitinib,Gemfibrozil,Gliclazide,Glucosamine,Glyburide,Guanfacine,Haloperidol,heme,heme binding,heterocycle metabolic process,Hexobarbital,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydroxyeicosatetraenoic acids,Ibuprofen,Ifosfamide,Imatinib,imipramine,Indinavir,Indomethacin,intracellular membrane-bounded organelle,iron,iron ion binding,Isoniazid,Ketobemidone,Ketoconazole,Lansoprazole,Lapatinib,Levomilnacipran,Lopinavir,Loratadine,Lorcaserin,Losartan,Lovastatin,LULICONAZOLE,Lumiracoxib,MACITENTAN,Melatonin,Memantine,Membrane,Mephenytoin 4-hydroxylase,Meprobamate,Metal-binding,Methadone,Methazolamide,Methimazole,Methsuximide,MethylphenobarbitalMetoprolol,Miconazole,Microsome,Microsome membrane,Moclobemide,Modafinil,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,NADP,NADPH,Nelfinavir,Nicardipine,Nicotine,Nilutamide,Nilvadipine,Norethindrone,Nortriptyline,NSAID,NSAID metabolism,NSAIDs,Olanzapine,omega-hydroxylase P450 pathway,omeprazole,Ospemifene,Oxcarbazepine,Oxiconazole,OXIDATION,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Pantoprazole,Pegvisomant,Pentamidine,Pentobarbital,Peripheral membrane protein,Perphenazine,Pethidine,Phenelzine,Phenobarbital,Phensuximide,Phenytoin,Pimozide,Pioglitazone,Pipotiazine,Podofilox,poor metabolizers,Prasugrel,Praziquantel,Prednisone,Primidone,Probenecid,Progesterone,proguanil,Promazine,Propofol,propranolol,protein,Quazepam,Quetiapine,Quinine,Rabeprazole,Ramelteon,Ranitidin",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs4918758",
        "SNP Name": "CYP2C9 T1188C",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs4918758",
        "Video": "Rulupr4HrA4",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,Acenocoumarol,Acetaminophen,Acetylsalicylic acid,acids,acting on paired donors,Agomelatine,Alosetron,Alprazolam,amino acid,Aminophenazone,Amiodarone,Amitriptyline,Amlodipine,Amodiaquine,Amprenavir,Anastrozole,and incorporation of one atom of oxygen,Antipyrine,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,ARTIFICIAL ESTROGEN,Atazanavir,Atorvastatin,Atovaquone,Azelastine,Bexarotene,Bicalutamide,Bortezomib,Bosentan,Brompheniramine,Buprenorphine,Bupropion,Cabozantinib,Caffeine,caffeine oxidase activity,CANCER,CANCEROUS,Candesartan,Capecitabine,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Celecoxib,cellular amide metabolic process,Chloramphenicol,Chlorpropamide,Cholecalciferol,cholesterol,Cimetidine,Cinnarizine,Cisapride,Cisplatin,Clevidipine,Clopidogrel,Clotrimazole,Clozapine,Cocaine,Colchicine,COMPOUNDS,coumarin resistance,Cyclizine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C9,CYPIIC9,CYTOCHROME,Cytochrome P-450MP,CYTOCHROME P450,Cytochrome P450 2C9,Cytochrome P450 MP-4,Cytochrome P450 MP-8,Cytochrome P450 PB-1,cytoplasm,Dapagliflozin,Dapsone,Delavirdine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Diclofenamide,Dicoumarol,Diethylstilbestrol,dihydroxyeicosatrienoic acids,Diltiazem,Diphenhydramine,Disulfiram,Dolasetron,Donepezil,Dopamine,Dorzolamide,Doxepin,Dronabinol,DRUG,drug binding,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,electron,Eletriptan,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Epinephrine,Epoprostenol,epoxygenase P450 pathway,Eprosartan,Estradiol,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Etodolac,Etoricoxib,Etravirine,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felodipine,Fenofibrate,Flecainide,Fluconazole,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Flurbiprofen,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,Gefitinib,Gemfibrozil,Ginkgo biloba,Gliclazide,Glimepiride,Glipizide,Glyburide,Guanfacine,Haloperidol,Halothane,heme,heme binding,Hexobarbital,Histamine Phosphate,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Human Serum Albumin,Hydromorphone,Ibuprofen,Idarubicin,idiopathic male infertility,Ifosfamide,Imatinib,Indinavir,Indomethacin,infertility,intracellular membrane-bounded organelle,Irbesartan,iron,iron ion binding,Isoniazid,Ketamine,Ketobemidone,Ketoconazole,Ketoprofen,L-Lysine,Lansoprazole,Leflunomide,Lidocaine,Lopinavir,Loratadine,Lornoxicam,Losartan,Lovastatin,Lumiracoxib,lysine,male infertility,Medroxyprogesterone Acetate,Mefenamic acid,Melatonin,Meloxicam,Membrane,Mestranol,Metal-binding,Methadone,Methazolamide,Methimazole,Methoxyflurane,Metronidazole,Miconazole,Microsome,Microsome membrane,Mirtazapine,Moclobemide,Modafinil,monocarboxylic acid metabolic process,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,Montelukast,N6-acetyllysine,NADP,NADPH,NADPH-dependent electron transport pathway,Naproxen,Nateglinide,Nelfinavir,Nevirapine,Nicardipine,Niclosamide,Nicotine,Nifedipine,Nilotinib,Nilutamide,Nilvadipine,Nortriptyline,NSAID,NSAID metabolism,NSAIDs,Olanzapine,omega-hydroxylase P450 pathway,Omeprazole,Ondansetron,Ospemifene,Oxaprozin,OXIDATION,oxidation-reduction proces",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs72558187",
        "SNP Name": "CYP2C9*13 269T>C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://onlinelibrary.wiley.com/doi/10.1111/j.1742-7843.2011.00751.x/full",
        "Video": "Rulupr4HrA4",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,Acenocoumarol,Acetaminophen,Acetylsalicylic acid,acids,acting on paired donors,Agomelatine,Alosetron,Alprazolam,amino acid,Aminophenazone,Amiodarone,Amitriptyline,Amlodipine,Amodiaquine,Amprenavir,Anastrozole,and incorporation of one atom of oxygen,Antipyrine,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,ARTIFICIAL ESTROGEN,Atazanavir,Atorvastatin,Atovaquone,Azelastine,Bexarotene,Bicalutamide,Bortezomib,Bosentan,Brompheniramine,Buprenorphine,Bupropion,Cabozantinib,Caffeine,caffeine oxidase activity,CANCER,CANCEROUS,Candesartan,Capecitabine,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Celecoxib,cellular amide metabolic process,Chloramphenicol,Chlorpropamide,Cholecalciferol,cholesterol,Cimetidine,Cinnarizine,Cisapride,Cisplatin,Clevidipine,Clopidogrel,Clotrimazole,Clozapine,Cocaine,Colchicine,COMPOUNDS,coumarin resistance,Cyclizine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C9,CYPIIC9,CYTOCHROME,Cytochrome P-450MP,CYTOCHROME P450,Cytochrome P450 2C9,Cytochrome P450 MP-4,Cytochrome P450 MP-8,Cytochrome P450 PB-1,cytoplasm,Dapagliflozin,Dapsone,Delavirdine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Diclofenamide,Dicoumarol,Diethylstilbestrol,dihydroxyeicosatrienoic acids,Diltiazem,Diphenhydramine,Disulfiram,Dolasetron,Donepezil,Dopamine,Dorzolamide,Doxepin,Dronabinol,DRUG,drug binding,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,electron,Eletriptan,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Epinephrine,Epoprostenol,epoxygenase P450 pathway,Eprosartan,Estradiol,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Etodolac,Etoricoxib,Etravirine,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felodipine,Fenofibrate,Flecainide,Fluconazole,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Flurbiprofen,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,Gefitinib,Gemfibrozil,Ginkgo biloba,Gliclazide,Glimepiride,Glipizide,Glyburide,Guanfacine,Haloperidol,Halothane,heme,heme binding,Hexobarbital,Histamine Phosphate,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Human Serum Albumin,Hydromorphone,Ibuprofen,Idarubicin,Ifosfamide,Imatinib,Indinavir,Indomethacin,intracellular membrane-bounded organelle,Irbesartan,iron,iron ion binding,Isoniazid,Ketamine,Ketobemidone,Ketoconazole,Ketoprofen,L-Lysine,Lansoprazole,Leflunomide,Lidocaine,Lopinavir,Loratadine,Lornoxicam,Losartan,Lovastatin,Lumiracoxib,lysine,Medroxyprogesterone Acetate,Mefenamic acid,Melatonin,Meloxicam,Membrane,Mestranol,Metal-binding,Methadone,Methazolamide,Methimazole,Methoxyflurane,Metronidazole,Miconazole,Microsome,Microsome membrane,Mirtazapine,Moclobemide,Modafinil,monocarboxylic acid metabolic process,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,Montelukast,N6-acetyllysine,NADP,NADPH,NADPH-dependent electron transport pathway,Naproxen,Nateglinide,Nelfinavir,Nevirapine,Nicardipine,Niclosamide,Nicotine,Nifedipine,Nilotinib,Nilutamide,Nilvadipine,Nortriptyline,NSAID,NSAID metabolism,NSAIDs,Olanzapine,omega-hydroxylase P450 pathway,Omeprazole,Ondansetron,Ospemifene,Oxaprozin,OXIDATION,oxidation-reduction process,oxidative demethylation,Oxidoreductase,oxidoreductase a",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs1799853",
        "SNP Name": "CYP2C9*2 430C>T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs1799853",
        "Video": "Rulupr4HrA4",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,Acenocoumarol,acenocoumarol dosage,Acenocoumarol toxicity,Acetaminophen,Acetylsalicylic acid,acids,acting on paired donors,Advanced Colorectal Adenoma,Agomelatine,alcohol,alcohol consumption and risk of Non-Hodgkin lymphoma,Alosetron,Alprazolam,amino acid,Aminophenazone,Amiodarone,Amitriptyline,Amlodipine,Amodiaquine,Amprenavir,Anastrozole,and incorporation of one atom of oxygen,anti-coagulant,anti-coagulant response,anti-coagulant response among factor V Leiden,Anti-Diabetes Drugs,Anti-platelet and Anti-coagulation Therapy,antibiotic response,antibiotics,Anticoagulation,Antihemophilic Factor,Antineoplastic Drugs,Antipyrine,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,ARTIFICIAL ESTROGEN,aspirin,aspirin intolerance,Atazanavir,atherothrombotic events,Atorvastatin,Atovaquone,Azelastine,Bexarotene,Bicalutamide,Bortezomib,Bosentan,breast cancer,Brompheniramine,Buprenorphine,Bupropion,Cabozantinib,Caffeine,caffeine oxidase activity,cancer,cancerous,Candesartan,Capecitabine,Carbamazepine,carbamazepine hypersensitivity,Carbinoxamine,carcinogen,cardiovascular disease,cardiovascular therapeutics,Carprofen,Carvedilol,Celecoxib,Celecoxib pathways,cellular amide metabolic process,cerebral infarctions,chemotherapy,Chloramphenicol,Chlorpropamide,Cholecalciferol,cholesterol,Chronic Pain,Cimetidine,Cinnarizine,Cisapride,Cisplatin,Clevidipine,Clomipramine,Clopidogrel,Clotrimazole,Clozapine,Cocaine,Colchicine,Colorectal Adenoma,Colorectal Cancer,COMPOUNDS,Coronary Artery Disease,coumarin resistance,CVD,Cyclizine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C9,CYPIIC9,CYTOCHROME,Cytochrome P-450MP,CYTOCHROME P450,Cytochrome P450 2C9,Cytochrome P450 MP-4,Cytochrome P450 MP-8,Cytochrome P450 PB-1,cytoplasm,Dapagliflozin,Dapsone,Delavirdine,Desloratadine,Desogestrel,detox,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,Dextropropoxyphene,diabetes,Diazepam,diclofenac,Diclofenamide,Dicoumarol,Diethylstilbestrol,dihydroxyeicosatrienoic acids,Diltiazem,Diphenhydramine,Disulfiram,Dolasetron,Donepezil,Dopamine,Dorzolamide,Doxepin,Dronabinol,DRUG,drug binding,drug catabolic process,drug catabolic process Source,drug metabolic process,drug metabolic process Source,drug metabolism,DRUG POISONING,drug response,DRUG TOXICITY,drugs,DRUX TOXICITY,E2,Efavirenz,Electromagnetic Hypersensitive,electron,Eletriptan,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,environmental,environmental factors,Environmental Sensitivity-Related Illnesses,Enzalutamide,enzyme,Epinephrine,Epoprostenol,epoxygenase P450 pathway,Eprosartan,Esomeprazole,Estradiol,estrogen,estrogen dominance,estrogen related cancer,Estrone,Estropipate,Eszopiclone,Ethanol,Etodolac,Etoricoxib,Etravirine,exogenous drug catabolic process,factor V Leiden,FAST METABOLIZER,fatty acids,Felodipine,Fenofibrate,Flecainide,Fluconazole,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Flurbiprofen,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,FVL,gallbladder cancer,Gefitinib,Gemfibrozil,Ginkgo biloba,Glibenclamide,Gliclazide,Glimepiride,Glipizide,Glyburide,Guanfacine,Haloperidol,Halothane,heart,heart attack,heart disease,heart failure therapy,heme,heme binding,Heme group,heme-thiolate monooxygenases,Hexobarbital,Higher Acenocoumarol Requirements,Histamine Phosphate,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Human Serum Albumin,Hydromorphone,Ibuprofen,Ibup",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs4086116",
        "SNP Name": "CYP2C9 C334T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs4086116",
        "Video": "Rulupr4HrA4",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,Acenocoumarol,acenocoumarol maintance dosage,Acetaminophen,Acetylsalicylic acid,acids,acting on paired donors,Agomelatine,Alosetron,Alprazolam,amino acid,Aminophenazone,Amiodarone,Amitriptyline,Amlodipine,Amodiaquine,Amprenavir,Anastrozole,and incorporation of one atom of oxygen,Antipyrine,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,ARTIFICIAL ESTROGEN,Atazanavir,Atorvastatin,Atovaquone,Azelastine,Bexarotene,Bicalutamide,Bortezomib,Bosentan,Brompheniramine,Buprenorphine,Bupropion,Cabozantinib,CAD,Caffeine,caffeine oxidase activity,CANCER,CANCEROUS,Candesartan,Capecitabine,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Celecoxib,cellular amide metabolic process,Chloramphenicol,Chlorpropamide,Cholecalciferol,cholesterol,Cimetidine,Cinnarizine,Cisapride,Cisplatin,Clevidipine,Clopidogrel,Clotrimazole,Clozapine,Cocaine,Colchicine,COMPOUNDS,coronary artery disease,coumarin resistance,Cyclizine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C9,CYPIIC9,CYTOCHROME,Cytochrome P-450MP,CYTOCHROME P450,Cytochrome P450 2C9,Cytochrome P450 MP-4,Cytochrome P450 MP-8,Cytochrome P450 PB-1,cytoplasm,Dapagliflozin,Dapsone,Delavirdine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Diclofenamide,Dicoumarol,Diethylstilbestrol,dihydroxyeicosatrienoic acids,Diltiazem,Diphenhydramine,Disulfiram,Dolasetron,Donepezil,Dopamine,Dorzolamide,Doxepin,Dronabinol,DRUG,drug binding,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,electron,Eletriptan,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Epinephrine,Epoprostenol,epoxygenase P450 pathway,Eprosartan,Estradiol,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Etodolac,Etoricoxib,Etravirine,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felodipine,Fenofibrate,Flecainide,Fluconazole,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Flurbiprofen,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,Gefitinib,Gemfibrozil,Ginkgo biloba,Gliclazide,Glimepiride,Glipizide,Glyburide,Guanfacine,Haloperidol,Halothane,heart,heart disease,heme,heme binding,Hexobarbital,Histamine Phosphate,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Human Serum Albumin,Hydromorphone,Ibuprofen,Idarubicin,Ifosfamide,Imatinib,Indinavir,Indomethacin,intracellular membrane-bounded organelle,Irbesartan,iron,iron ion binding,Isoniazid,Ketamine,Ketobemidone,Ketoconazole,Ketoprofen,L-Lysine,Lansoprazole,Leflunomide,Lidocaine,Lopinavir,Loratadine,Lornoxicam,Losartan,Lovastatin,Lumiracoxib,lysine,Medroxyprogesterone Acetate,Mefenamic acid,Melatonin,Meloxicam,Membrane,Mestranol,Metal-binding,Methadone,Methazolamide,Methimazole,Methoxyflurane,Metronidazole,Miconazole,Microsome,Microsome membrane,Mirtazapine,Moclobemide,Modafinil,monocarboxylic acid metabolic process,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,Montelukast,N6-acetyllysine,NADP,NADPH,NADPH-dependent electron transport pathway,Naproxen,Nateglinide,Nelfinavir,Nevirapine,Nicardipine,Niclosamide,Nicotine,Nifedipine,Nilotinib,Nilutamide,Nilvadipine,Nortriptyline,NSAID,NSAID metabolism,NSAIDs,Olanzapine,omega-hydroxylase P450 pathway,Omeprazole,Ondansetron,Ospemifene,Oxaprozin,OXIDATION,ox",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs2256871",
        "SNP Name": "CYP2C9*9 752A>G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2010.03709.x/full",
        "Video": "Rulupr4HrA4",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,Acenocoumarol,Acetaminophen,Acetylsalicylic acid,acids,acting on paired donors,Agomelatine,Alosetron,Alprazolam,amino acid,Aminophenazone,Amiodarone,Amitriptyline,Amlodipine,Amodiaquine,Amprenavir,Anastrozole,and incorporation of one atom of oxygen,Antipyrine,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,ARTIFICIAL ESTROGEN,Atazanavir,Atorvastatin,Atovaquone,Azelastine,Bexarotene,Bicalutamide,Bortezomib,Bosentan,Brompheniramine,Buprenorphine,Bupropion,Cabozantinib,Caffeine,caffeine oxidase activity,CANCER,CANCEROUS,Candesartan,Capecitabine,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Celecoxib,cellular amide metabolic process,Chloramphenicol,Chlorpropamide,Cholecalciferol,cholesterol,Cimetidine,Cinnarizine,Cisapride,Cisplatin,Clevidipine,Clopidogrel,Clotrimazole,Clozapine,Cocaine,Colchicine,COMPOUNDS,coumarin resistance,Cyclizine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C9,CYPIIC9,CYTOCHROME,Cytochrome P-450MP,CYTOCHROME P450,Cytochrome P450 2C9,Cytochrome P450 MP-4,Cytochrome P450 MP-8,Cytochrome P450 PB-1,cytoplasm,Dapagliflozin,Dapsone,Delavirdine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Diclofenamide,Dicoumarol,Diethylstilbestrol,dihydroxyeicosatrienoic acids,Diltiazem,Diphenhydramine,Disulfiram,Dolasetron,Donepezil,Dopamine,Dorzolamide,Doxepin,Dronabinol,DRUG,drug binding,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,electron,Eletriptan,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Epinephrine,Epoprostenol,epoxygenase P450 pathway,Eprosartan,Estradiol,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Etodolac,Etoricoxib,Etravirine,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felodipine,Fenofibrate,Flecainide,Fluconazole,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Flurbiprofen,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,Gefitinib,Gemfibrozil,Ginkgo biloba,Gliclazide,Glimepiride,Glipizide,Glyburide,Guanfacine,Haloperidol,Halothane,heme,heme binding,Hexobarbital,Histamine Phosphate,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Human Serum Albumin,Hydromorphone,Ibuprofen,Idarubicin,Ifosfamide,Imatinib,Indinavir,Indomethacin,intracellular membrane-bounded organelle,Irbesartan,iron,iron ion binding,Isoniazid,Ketamine,Ketobemidone,Ketoconazole,Ketoprofen,L-Lysine,Lansoprazole,Leflunomide,Lidocaine,Lopinavir,Loratadine,Lornoxicam,Losartan,Lovastatin,Lumiracoxib,lysine,Medroxyprogesterone Acetate,Mefenamic acid,Melatonin,Meloxicam,Membrane,Mestranol,Metal-binding,Methadone,Methazolamide,Methimazole,Methoxyflurane,Metronidazole,Miconazole,Microsome,Microsome membrane,Mirtazapine,Moclobemide,Modafinil,monocarboxylic acid metabolic process,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,Montelukast,N6-acetyllysine,NADP,NADPH,NADPH-dependent electron transport pathway,Naproxen,Nateglinide,Nelfinavir,Nevirapine,Nicardipine,Niclosamide,Nicotine,Nifedipine,Nilotinib,Nilutamide,Nilvadipine,Nortriptyline,NSAID,NSAID metabolism,NSAIDs,Olanzapine,omega-hydroxylase P450 pathway,Omeprazole,Ondansetron,Ospemifene,Oxaprozin,OXIDATION,oxidation-reduction process,oxidative demethylation,Oxidoreductase,oxidoreductase a",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs4917639",
        "SNP Name": "CYP2C9 A6326C",
        "Risk Allele": "C",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs4917639",
        "Video": "Rulupr4HrA4",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,Acenocoumarol,Acetaminophen,Acetylsalicylic acid,acids,acting on paired donors,Agomelatine,Alosetron,Alprazolam,amino acid,Aminophenazone,Amiodarone,Amitriptyline,Amlodipine,Amodiaquine,Amprenavir,Anastrozole,and incorporation of one atom of oxygen,Antipyrine,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,ARTIFICIAL ESTROGEN,Atazanavir,Atorvastatin,Atovaquone,Azelastine,Bexarotene,Bicalutamide,Bortezomib,Bosentan,Brompheniramine,Buprenorphine,Bupropion,Cabozantinib,CAD,Caffeine,caffeine oxidase activity,CANCER,CANCEROUS,Candesartan,Capecitabine,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Celecoxib,cellular amide metabolic process,Chloramphenicol,Chlorpropamide,Cholecalciferol,cholesterol,Cimetidine,Cinnarizine,Cisapride,Cisplatin,Clevidipine,Clopidogrel,Clotrimazole,Clozapine,Cocaine,Colchicine,COMPOUNDS,coronary artery disease,coumarin resistance,Cyclizine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C9,CYPIIC9,CYTOCHROME,Cytochrome P-450MP,CYTOCHROME P450,Cytochrome P450 2C9,Cytochrome P450 MP-4,Cytochrome P450 MP-8,Cytochrome P450 PB-1,cytoplasm,Dapagliflozin,Dapsone,Delavirdine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Diclofenamide,Dicoumarol,Diethylstilbestrol,dihydroxyeicosatrienoic acids,Diltiazem,Diphenhydramine,Disulfiram,Dolasetron,Donepezil,Dopamine,Dorzolamide,Doxepin,Dronabinol,DRUG,drug binding,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,electron,Eletriptan,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Epinephrine,Epoprostenol,epoxygenase P450 pathway,Eprosartan,Estradiol,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Etodolac,Etoricoxib,Etravirine,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felodipine,Fenofibrate,Flecainide,Fluconazole,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Flurbiprofen,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,Gefitinib,Gemfibrozil,Ginkgo biloba,Gliclazide,Glimepiride,Glipizide,Glyburide,Guanfacine,Haloperidol,Halothane,heart,heart disease,heme,heme binding,Hexobarbital,Histamine Phosphate,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Human Serum Albumin,Hydromorphone,Ibuprofen,Idarubicin,Ifosfamide,Imatinib,Indinavir,Indomethacin,intracellular membrane-bounded organelle,Irbesartan,iron,iron ion binding,Isoniazid,Ketamine,Ketobemidone,Ketoconazole,Ketoprofen,L-Lysine,Lansoprazole,Leflunomide,Lidocaine,Lopinavir,Loratadine,Lornoxicam,Losartan,Lovastatin,Lumiracoxib,lysine,Medroxyprogesterone Acetate,Mefenamic acid,Melatonin,Meloxicam,Membrane,Mestranol,Metal-binding,Methadone,Methazolamide,Methimazole,Methoxyflurane,Metronidazole,Miconazole,Microsome,Microsome membrane,Mirtazapine,Moclobemide,Modafinil,monocarboxylic acid metabolic process,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,Montelukast,N6-acetyllysine,NADP,NADPH,NADPH-dependent electron transport pathway,Naproxen,Nateglinide,Nelfinavir,Nevirapine,Nicardipine,Niclosamide,Nicotine,Nifedipine,Nilotinib,Nilutamide,Nilvadipine,Nortriptyline,NSAID,NSAID metabolism,NSAIDs,Olanzapine,omega-hydroxylase P450 pathway,Omeprazole,Ondansetron,Ospemifene,Oxaprozin,OXIDATION,oxidation-reduction process,oxida",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs10509680",
        "SNP Name": "CYP2C9 G2337T",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs10509680",
        "Video": "Rulupr4HrA4",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,Acenocoumarol,Acetaminophen,Acetylsalicylic acid,acids,acting on paired donors,Agomelatine,Alosetron,Alprazolam,amino acid,Aminophenazone,Amiodarone,Amitriptyline,Amlodipine,Amodiaquine,Amprenavir,Anastrozole,and incorporation of one atom of oxygen,Antipyrine,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,ARTIFICIAL ESTROGEN,Atazanavir,Atorvastatin,Atovaquone,Azelastine,Bexarotene,Bicalutamide,Bortezomib,Bosentan,Brompheniramine,Buprenorphine,Bupropion,Cabozantinib,Caffeine,caffeine oxidase activity,CANCER,CANCEROUS,Candesartan,Capecitabine,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Celecoxib,cellular amide metabolic process,Chloramphenicol,Chlorpropamide,Cholecalciferol,cholesterol,Cimetidine,Cinnarizine,Cisapride,Cisplatin,Clevidipine,Clopidogrel,Clotrimazole,Clozapine,Cocaine,Colchicine,COMPOUNDS,coumarin resistance,Cyclizine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C9,CYPIIC9,CYTOCHROME,Cytochrome P-450MP,CYTOCHROME P450,Cytochrome P450 2C9,Cytochrome P450 MP-4,Cytochrome P450 MP-8,Cytochrome P450 PB-1,cytoplasm,Dapagliflozin,Dapsone,Delavirdine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Diclofenamide,Dicoumarol,Diethylstilbestrol,dihydroxyeicosatrienoic acids,Diltiazem,Diphenhydramine,Disulfiram,Dolasetron,Donepezil,Dopamine,Dorzolamide,Doxepin,Dronabinol,DRUG,drug binding,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,electron,Eletriptan,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Epinephrine,Epoprostenol,epoxygenase P450 pathway,Eprosartan,Estradiol,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Etodolac,Etoricoxib,Etravirine,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felodipine,Fenofibrate,Flecainide,Fluconazole,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Flurbiprofen,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,Gefitinib,Gemfibrozil,Ginkgo biloba,Gliclazide,Glimepiride,Glipizide,Glyburide,Guanfacine,Haloperidol,Halothane,heme,heme binding,Hexobarbital,Histamine Phosphate,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Human Serum Albumin,Hydromorphone,Ibuprofen,Idarubicin,Ifosfamide,Imatinib,Indinavir,Indomethacin,intracellular membrane-bounded organelle,Irbesartan,iron,iron ion binding,Isoniazid,Ketamine,Ketobemidone,Ketoconazole,Ketoprofen,L-Lysine,Lansoprazole,Leflunomide,Lidocaine,Lopinavir,Loratadine,Lornoxicam,Losartan,Lovastatin,Lumiracoxib,lysine,Medroxyprogesterone Acetate,Mefenamic acid,Melatonin,Meloxicam,Membrane,Mestranol,Metal-binding,Methadone,Methazolamide,Methimazole,Methoxyflurane,Metronidazole,Miconazole,Microsome,Microsome membrane,Mirtazapine,Moclobemide,Modafinil,monocarboxylic acid metabolic process,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,Montelukast,N6-acetyllysine,NADP,NADPH,NADPH-dependent electron transport pathway,Naproxen,Nateglinide,Nelfinavir,Nevirapine,Nicardipine,Niclosamide,Nicotine,Nifedipine,Nilotinib,Nilutamide,Nilvadipine,Nortriptyline,NSAID,NSAID metabolism,NSAIDs,Olanzapine,omega-hydroxylase P450 pathway,Omeprazole,Ondansetron,Ospemifene,Oxaprozin,OXIDATION,oxidation-reduction process,oxidative demethylation,Oxidoreductase,oxidoreductase a",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs28371685",
        "SNP Name": "CYP2C9*11 1003C>T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs28371685",
        "Video": "Rulupr4HrA4",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,Acenocoumarol,Acetaminophen,Acetylsalicylic acid,acids,acting on paired donors,Agomelatine,Alosetron,Alprazolam,amino acid,Aminophenazone,Amiodarone,Amitriptyline,Amlodipine,Amodiaquine,Amprenavir,Anastrozole,and incorporation of one atom of oxygen,Antipyrine,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,ARTIFICIAL ESTROGEN,aspirin,aspirin intolerance,Atazanavir,Atorvastatin,Atovaquone,Azelastine,Bexarotene,Bicalutamide,Bortezomib,Bosentan,Brompheniramine,Buprenorphine,Bupropion,Cabozantinib,Caffeine,caffeine oxidase activity,CANCER,CANCEROUS,Candesartan,Capecitabine,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Celecoxib,cellular amide metabolic process,Chloramphenicol,Chlorpropamide,Cholecalciferol,cholesterol,Cimetidine,Cinnarizine,Cisapride,Cisplatin,Clevidipine,Clopidogrel,Clotrimazole,Clozapine,Cocaine,Colchicine,COMPOUNDS,coumarin resistance,Cyclizine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C9,CYPIIC9,CYTOCHROME,Cytochrome P-450MP,CYTOCHROME P450,Cytochrome P450 2C9,Cytochrome P450 MP-4,Cytochrome P450 MP-8,Cytochrome P450 PB-1,cytoplasm,Dapagliflozin,Dapsone,Delavirdine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Diclofenamide,Dicoumarol,Diethylstilbestrol,dihydroxyeicosatrienoic acids,Diltiazem,Diphenhydramine,Disulfiram,Dolasetron,Donepezil,Dopamine,Dorzolamide,Doxepin,Dronabinol,DRUG,drug binding,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,electron,Eletriptan,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Epinephrine,Epoprostenol,epoxygenase P450 pathway,Eprosartan,Estradiol,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Etodolac,Etoricoxib,Etravirine,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felodipine,Fenofibrate,Flecainide,Fluconazole,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Flurbiprofen,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,Gefitinib,Gemfibrozil,Ginkgo biloba,Gliclazide,Glimepiride,Glipizide,Glyburide,Guanfacine,Haloperidol,Halothane,heme,heme binding,Hexobarbital,Histamine Phosphate,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Human Serum Albumin,Hydromorphone,Ibuprofen,Idarubicin,Ifosfamide,Imatinib,Indinavir,Indomethacin,intracellular membrane-bounded organelle,Irbesartan,iron,iron ion binding,Isoniazid,Ketamine,Ketobemidone,Ketoconazole,Ketoprofen,L-Lysine,Lansoprazole,Leflunomide,Lidocaine,Lopinavir,Loratadine,Lornoxicam,Losartan,Lovastatin,Lumiracoxib,lysine,Medroxyprogesterone Acetate,Mefenamic acid,Melatonin,Meloxicam,Membrane,Mestranol,Metal-binding,Methadone,Methazolamide,Methimazole,Methoxyflurane,Metronidazole,Miconazole,Microsome,Microsome membrane,Mirtazapine,Moclobemide,Modafinil,monocarboxylic acid metabolic process,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,Montelukast,N6-acetyllysine,NADP,NADPH,NADPH-dependent electron transport pathway,Naproxen,Nateglinide,Nelfinavir,Nevirapine,Nicardipine,Niclosamide,Nicotine,Nifedipine,Nilotinib,Nilutamide,Nilvadipine,Nortriptyline,NSAID,NSAID metabolism,NSAIDs,Olanzapine,omega-hydroxylase P450 pathway,Omeprazole,Ondansetron,Ospemifene,Oxaprozin,OXIDATION,oxidation-reduction process,oxidative demethylation,Ox",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs1057910",
        "SNP Name": "CYP2C9*3 1075A>C",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs1057910",
        "Video": "Rulupr4HrA4",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,5-fluorouracil,Acenocoumarol,acenocoumarol maintenance dose,Acenocoumarol toxicity,Acetaminophen,Acetylsalicylic acid,acids,acting on paired donors,Advanced Colorectal Adenoma,Agomelatine,alcohol,alcohol consumption and risk of Non-Hodgkin lymphoma,Alosetron,Alprazolam,amino acid,Aminophenazone,Amiodarone,Amitriptyline,Amlodipine,Amodiaquine,Amprenavir,Anastrozole,and incorporation of one atom of oxygen,anti-coagulant,anti-coagulant response,anti-coagulant response among factor V Leiden,Anti-Diabetes Drugs,Anti-platelet and Anti-coagulation Therapy,antibiotic response,antibiotics,Anticoagulation,Antihemophilic Factor,Antineoplastic Drugs,Antipyrine,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,ARTIFICIAL ESTROGEN,aspirin,aspirin intolerance,Atazanavir,atherothrombotic events,Atorvastatin,Atovaquone,Azelastine,Bexarotene,Bicalutamide,Bortezomib,Bosentan,breast cancer,Brompheniramine,Buprenorphine,Bupropion,Cabozantinib,CAD,Caffeine,caffeine oxidase activity,cancer,cancerous,Candesartan,Capecitabine,Carbamazepine,carbamazepine hypersensitivity,Carbinoxamine,carcinogen,cardiovascular disease,cardiovascular therapeutics,Carprofen,Carvedilol,Celecoxib,Celecoxib pathways,cellular amide metabolic process,cerebral infarctions,chemotherapy,Chloramphenicol,Chlorpropamide,Cholecalciferol,cholesterol,Chronic Pain,Cimetidine,Cinnarizine,Cisapride,Cisplatin,Clevidipine,Clomipramine,Clopidogrel,Clotrimazole,Clozapine,Cocaine,Colchicine,Colorectal Adenoma,Colorectal Cancer,COMPOUNDS,Coronary Artery Disease,coumarin resistance,CVD,Cyclizine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C9,CYPIIC9,CYTOCHROME,Cytochrome P-450MP,CYTOCHROME P450,Cytochrome P450 2C9,Cytochrome P450 MP-4,Cytochrome P450 MP-8,Cytochrome P450 PB-1,cytoplasm,Dapagliflozin,Dapsone,Delavirdine,Desloratadine,Desogestrel,detox,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,Dextropropoxyphene,diabetes,Diazepam,diclofenac,Diclofenamide,Dicoumarol,Diethylstilbestrol,dihydroxyeicosatrienoic acids,Diltiazem,Diphenhydramine,Disulfiram,docetaxel,Dolasetron,Donepezil,Dopamine,Dorzolamide,Doxepin,Dronabinol,DRUG,drug binding,drug catabolic process,drug catabolic process Source,drug metabolic process,drug metabolic process Source,drug metabolism,DRUG POISONING,drug response,DRUG TOXICITY,drugs,DRUX TOXICITY,E2,Efavirenz,Electromagnetic Hypersensitive,electron,Eletriptan,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,environmental,environmental factors,Environmental Sensitivity-Related Illnesses,Enzalutamide,enzyme,Epinephrine,epirubicin,Epoprostenol,epoxygenase P450 pathway,Eprosartan,Esomeprazole,Estradiol,estrogen,estrogen dominance,estrogen related cancer,Estrone,Estropipate,Eszopiclone,Ethanol,Etodolac,Etoricoxib,Etravirine,exogenous drug catabolic process,factor V Leiden,FAST METABOLIZER,fatty acids,Felodipine,Fenofibrate,Flecainide,Fluconazole,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Flurbiprofen,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,FVL,gallbladder cancer,gastrointestinal bleeding,Gefitinib,Gemfibrozil,Ginkgo biloba,Glibenclamide,Gliclazide,Glimepiride,Glipizide,Glyburide,Guanfacine,Haloperidol,Halothane,heart,heart attack,heart disease,heart failure therapy,heme,heme binding,Heme group,heme-thiolate monooxygenases,Hexobarbital,Higher Acenocoumarol Requirements,Histamine Phosphate,HORMONAL BALANCE,Hormonal carcinogenesis",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs1934967",
        "SNP Name": "CYP2C9 T2674C",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs1934967",
        "Video": "Rulupr4HrA4",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,Acenocoumarol,Acetaminophen,Acetylsalicylic acid,acids,acting on paired donors,Agomelatine,Alosetron,Alprazolam,amino acid,Aminophenazone,Amiodarone,Amitriptyline,Amlodipine,Amodiaquine,Amprenavir,Anastrozole,and incorporation of one atom of oxygen,Antipyrine,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,ARTIFICIAL ESTROGEN,Atazanavir,Atorvastatin,Atovaquone,Azelastine,Bexarotene,Bicalutamide,Bortezomib,Bosentan,Brompheniramine,Buprenorphine,Bupropion,Cabozantinib,CAD,Caffeine,caffeine oxidase activity,CANCER,CANCEROUS,Candesartan,Capecitabine,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Celecoxib,cellular amide metabolic process,Chloramphenicol,Chlorpropamide,Cholecalciferol,cholesterol,Cimetidine,Cinnarizine,Cisapride,Cisplatin,Clevidipine,Clopidogrel,Clotrimazole,Clozapine,Cocaine,Colchicine,COMPOUNDS,coronary artery disease,coumarin resistance,Cyclizine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C9,CYPIIC9,CYTOCHROME,Cytochrome P-450MP,CYTOCHROME P450,Cytochrome P450 2C9,Cytochrome P450 MP-4,Cytochrome P450 MP-8,Cytochrome P450 PB-1,cytoplasm,Dapagliflozin,Dapsone,Delavirdine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Diclofenamide,Dicoumarol,Diethylstilbestrol,dihydroxyeicosatrienoic acids,Diltiazem,Diphenhydramine,Disulfiram,Dolasetron,Donepezil,Dopamine,Dorzolamide,Doxepin,Dronabinol,DRUG,drug binding,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,electron,Eletriptan,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Epinephrine,Epoprostenol,epoxygenase P450 pathway,Eprosartan,Estradiol,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Etodolac,Etoricoxib,Etravirine,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felodipine,Fenofibrate,Flecainide,Fluconazole,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Flurbiprofen,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,Gefitinib,Gemfibrozil,Ginkgo biloba,Gliclazide,Glimepiride,Glipizide,Glyburide,Guanfacine,Haloperidol,Halothane,heart,heart disease,heme,heme binding,Hexobarbital,Histamine Phosphate,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Human Serum Albumin,Hydromorphone,Ibuprofen,Idarubicin,Ifosfamide,Imatinib,Indinavir,Indomethacin,intracellular membrane-bounded organelle,Irbesartan,iron,iron ion binding,Isoniazid,Ketamine,Ketobemidone,Ketoconazole,Ketoprofen,L-Lysine,Lansoprazole,Leflunomide,Lidocaine,Lopinavir,Loratadine,Lornoxicam,Losartan,Lovastatin,Lumiracoxib,lysine,Medroxyprogesterone Acetate,Mefenamic acid,Melatonin,Meloxicam,Membrane,Mestranol,Metal-binding,Methadone,Methazolamide,Methimazole,Methoxyflurane,Metronidazole,Miconazole,Microsome,Microsome membrane,Mirtazapine,Moclobemide,Modafinil,monocarboxylic acid metabolic process,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,Montelukast,N6-acetyllysine,NADP,NADPH,NADPH-dependent electron transport pathway,Naproxen,Nateglinide,Nelfinavir,Nevirapine,Nicardipine,Niclosamide,Nicotine,Nifedipine,Nilotinib,Nilutamide,Nilvadipine,Nortriptyline,NSAID,NSAID metabolism,NSAIDs,Olanzapine,omega-hydroxylase P450 pathway,Omeprazole,Ondansetron,Ospemifene,Oxaprozin,OXIDATION,oxidation-reduction process,oxida",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs1057911",
        "SNP Name": "CYP2C9 50298A>T",
        "Risk Allele": "T",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs1057911",
        "Video": "Rulupr4HrA4",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,Acenocoumarol,Acetaminophen,Acetylsalicylic acid,acids,acting on paired donors,Agomelatine,Alosetron,Alprazolam,amino acid,Aminophenazone,Amiodarone,Amitriptyline,Amlodipine,Amodiaquine,Amprenavir,Anastrozole,and incorporation of one atom of oxygen,Antipyrine,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,ARTIFICIAL ESTROGEN,Atazanavir,Atorvastatin,Atovaquone,Azelastine,Bexarotene,Bicalutamide,Bortezomib,Bosentan,Brompheniramine,Buprenorphine,Bupropion,Cabozantinib,Caffeine,caffeine oxidase activity,CANCER,CANCEROUS,Candesartan,Capecitabine,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Celecoxib,cellular amide metabolic process,Chloramphenicol,Chlorpropamide,Cholecalciferol,cholesterol,Cimetidine,Cinnarizine,Cisapride,Cisplatin,Clevidipine,Clopidogrel,Clotrimazole,Clozapine,Cocaine,Colchicine,colorectal carcinoma,COMPOUNDS,coumarin resistance,Cyclizine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C9,CYPIIC9,CYTOCHROME,Cytochrome P-450MP,CYTOCHROME P450,Cytochrome P450 2C9,Cytochrome P450 MP-4,Cytochrome P450 MP-8,Cytochrome P450 PB-1,cytoplasm,Dapagliflozin,Dapsone,Delavirdine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Diclofenamide,Dicoumarol,Diethylstilbestrol,dihydroxyeicosatrienoic acids,Diltiazem,Diphenhydramine,Disulfiram,Dolasetron,Donepezil,Dopamine,Dorzolamide,Doxepin,Dronabinol,DRUG,drug binding,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,electron,Eletriptan,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Epinephrine,Epoprostenol,epoxygenase P450 pathway,Eprosartan,Estradiol,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Etodolac,Etoricoxib,Etravirine,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felodipine,Fenofibrate,Flecainide,Fluconazole,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Flurbiprofen,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,Gefitinib,Gemfibrozil,Ginkgo biloba,Gliclazide,Glimepiride,Glipizide,Glyburide,Guanfacine,Haloperidol,Halothane,heme,heme binding,Hexobarbital,Histamine Phosphate,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Human Serum Albumin,Hydromorphone,Ibuprofen,Idarubicin,Ifosfamide,Imatinib,Indinavir,Indomethacin,intracellular membrane-bounded organelle,Irbesartan,iron,iron ion binding,Isoniazid,Ketamine,Ketobemidone,Ketoconazole,Ketoprofen,L-Lysine,Lansoprazole,Leflunomide,Lidocaine,Lopinavir,Loratadine,Lornoxicam,Losartan,Lovastatin,Lumiracoxib,lysine,Medroxyprogesterone Acetate,Mefenamic acid,Melatonin,Meloxicam,Membrane,Mestranol,Metal-binding,Methadone,Methazolamide,Methimazole,Methoxyflurane,Metronidazole,Miconazole,Microsome,Microsome membrane,Mirtazapine,Moclobemide,Modafinil,monocarboxylic acid metabolic process,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,Montelukast,N6-acetyllysine,NADP,NADPH,NADPH-dependent electron transport pathway,Naproxen,Nateglinide,Nelfinavir,Nevirapine,Nicardipine,Niclosamide,Nicotine,Nifedipine,Nilotinib,Nilutamide,Nilvadipine,Nortriptyline,NSAID,NSAID metabolism,NSAIDs,Olanzapine,omega-hydroxylase P450 pathway,Omeprazole,Ondansetron,Ospemifene,Oxaprozin,OXIDATION,oxidation-reduction process,oxidative demethylation,Oxidoreduc",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs9332239",
        "SNP Name": "CYP2C9*12 1465C>T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs9332239",
        "Video": "Rulupr4HrA4",
        "Tags": "(R)-limonene 6-monooxygenase,(R)-limonene 6-monooxygenase activity,(S)-limonene 6-monooxygenase,(S)-limonene 6-monooxygenase activity,(S)-limonene 7-monooxygenase,(S)-limonene 7-monooxygenase activity,+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O,--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O,Acenocoumarol,Acetaminophen,Acetylsalicylic acid,acids,acting on paired donors,Agomelatine,Alosetron,Alprazolam,amino acid,Aminophenazone,Amiodarone,Amitriptyline,Amlodipine,Amodiaquine,Amprenavir,Anastrozole,and incorporation of one atom of oxygen,Antipyrine,Apixaban,Aprepitant,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Artemether,ARTIFICIAL ESTROGEN,Atazanavir,Atorvastatin,Atovaquone,Azelastine,Bexarotene,Bicalutamide,Bortezomib,Bosentan,Brompheniramine,Buprenorphine,Bupropion,Cabozantinib,Caffeine,caffeine oxidase activity,CANCER,CANCEROUS,Candesartan,Capecitabine,Carbamazepine,Carbinoxamine,CARCINOGEN,Carvedilol,Celecoxib,cellular amide metabolic process,Chloramphenicol,Chlorpropamide,Cholecalciferol,cholesterol,Cimetidine,Cinnarizine,Cisapride,Cisplatin,Clevidipine,Clopidogrel,Clotrimazole,Clozapine,Cocaine,Colchicine,COMPOUNDS,coumarin resistance,Cyclizine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2C9,CYPIIC9,CYTOCHROME,Cytochrome P-450MP,CYTOCHROME P450,Cytochrome P450 2C9,Cytochrome P450 MP-4,Cytochrome P450 MP-8,Cytochrome P450 PB-1,cytoplasm,Dapagliflozin,Dapsone,Delavirdine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dextromethorphan,Dextropropoxyphene,Diazepam,Diclofenac,Diclofenamide,Dicoumarol,Diethylstilbestrol,dihydroxyeicosatrienoic acids,Diltiazem,Diphenhydramine,Disulfiram,Dolasetron,Donepezil,Dopamine,Dorzolamide,Doxepin,Dronabinol,DRUG,drug binding,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,electron,Eletriptan,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Epinephrine,Epoprostenol,epoxygenase P450 pathway,Eprosartan,Estradiol,ESTROGEN,Estrone,Estropipate,Eszopiclone,Ethanol,Etodolac,Etoricoxib,Etravirine,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felodipine,Fenofibrate,Flecainide,Fluconazole,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Flurbiprofen,Fluvastatin,Fluvoxamine,Formoterol,Fosphenytoin,Gefitinib,Gemfibrozil,Ginkgo biloba,Gliclazide,Glimepiride,Glipizide,Glyburide,Guanfacine,Haloperidol,Halothane,heme,heme binding,Hexobarbital,Histamine Phosphate,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Human Serum Albumin,Hydromorphone,Ibuprofen,Idarubicin,Ifosfamide,Imatinib,Indinavir,Indomethacin,intracellular membrane-bounded organelle,Irbesartan,iron,iron ion binding,Isoniazid,Ketamine,Ketobemidone,Ketoconazole,Ketoprofen,L-Lysine,Lansoprazole,Leflunomide,Lidocaine,Lopinavir,Loratadine,Lornoxicam,Losartan,Lovastatin,Lumiracoxib,lysine,Medroxyprogesterone Acetate,Mefenamic acid,Melatonin,Meloxicam,Membrane,Mestranol,Metal-binding,Methadone,Methazolamide,Methimazole,Methoxyflurane,Metronidazole,Miconazole,Microsome,Microsome membrane,Mirtazapine,Moclobemide,Modafinil,monocarboxylic acid metabolic process,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,Montelukast,N6-acetyllysine,NADP,NADPH,NADPH-dependent electron transport pathway,Naproxen,Nateglinide,Nelfinavir,Nevirapine,Nicardipine,Niclosamide,Nicotine,Nifedipine,Nilotinib,Nilutamide,Nilvadipine,Nortriptyline,NSAID,NSAID metabolism,NSAIDs,Olanzapine,omega-hydroxylase P450 pathway,Omeprazole,Ondansetron,Ospemifene,Oxaprozin,OXIDATION,oxidation-reduction process,oxidative demethylation,Oxidoreductase,oxidoreductase a",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs2297644",
        "SNP Name": "HOGA1 T20638C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2297644",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs2297644",
        "SNP Name": "HOGA1 T20638C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2297644",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs717620",
        "SNP Name": "ABCC2/MRP2 C118T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Mercury (Thiomersal/Thimerosal)"
    },
    {
        "SNP ID": "rs2273697",
        "SNP Name": "ABCC2/MRP2 V417I",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Mercury (Thiomersal/Thimerosal)"
    },
    {
        "SNP ID": "rs2273697",
        "SNP Name": "ABCC2/MRP2 V417I",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phenol Red"
    },
    {
        "SNP ID": "rs17222723",
        "SNP Name": "ABCC2 V956G",
        "Risk Allele": "A",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phenol Red"
    },
    {
        "SNP ID": "rs3813867",
        "SNP Name": "CYP2E1_-1295G>C G1295C",
        "Risk Allele": "C",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs3813867",
        "Video": "7th_nXzQc2Y",
        "Tags": "4-nitrophenol + NADPH + O2 = 4-nitrocatechol + NADP+ + H2O,4-nitrophenol 2-hydroxylase,Acetaminophen,acute methanol poisoning,acute methanol poisoning outcome,alcohol,alcohol metabolising,alcohol metabolism,alcoholic liver disease,Aldesleukin,Almotriptan,Alosetron,Aminophylline,Amitriptyline,Antipyrine,arachidonic acid epoxygenase activity,ARTIFICIAL ESTROGEN,Azelastine,benzene,benzene exposure,benzene poisoning,Benzyl alcohol,Bifonazole,bioactivates,blood pressure,Bromazepam,Brompheniramine,Bupropion,Caffeine,CANCER,CANCEROUS,Carbinoxamine,CARCINOGEN,carcinogen vinyl chloride,Carvedilol,cervical dysplasia,Childhood acute leukemia,Chlorpromazine,Chlorzoxazone,chronic benzene poisoning,Cimetidine,Citalopram,Clevidipine,Clofibrate,Clomifene,Clonazepam,Clotrimazole,Clozapine,Colchicine,colorectal cancer,COMPOUNDS,CYP,CYP P450,CYP2E1,CYPIIE1,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2E1,Cytochrome P450-J,cytoplasm,Dacarbazine,Dalfampridine,Dapsone,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dexmedetomidine,Dextromethorphan,Diazepam,Diclofenac,Diethylstilbestrol,Disulfiram,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,dysplasia,Econazole,elevated blood pressure,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enflurane,Enfuvirtide,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,enzyme binding,epoxygenase P450 pathway,essential hypertension,ESTROGEN,Estrone,Ethanol,Ethanolamine Oleate,Ethosuximide,Etoposide,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felbamate,Fingolimod,Flunitrazepam,Fluphenazine,Flurazepam,Fluvoxamine,Folate,Folic Acid,Fomepizole,Glucosamine,Golgi membrane,Halothane,head and neck cancer,head cancer,heme,heme binding,hepatoxic,heterocycle metabolic process,Hexobarbital,high altitude polycythemia,high BP,HORMONAL BALANCE,HORMONAL CARCINOGENESIS,HORMONAL IMBALANCE,HORMONE,hypertension,Iloperidone,Imipramine,intracellular membrane-bounded organelle,intrinsic component of endoplasmic reticulum membrane,iron,iron ion binding,ischemic stroke,Isoflurane,Isoniazid,Isosorbide Dinitrate,Itraconazole,leukemia,lung cancer,Membrane,Menadione,Meprobamate,Metal-binding,methanol,methanol poisoning,Methazolamide,MethimazoleMethotrimeprazine,Methoxyflurane,Metyrapone,Mexiletine,Miconazole,Microsome,Microsome membrane,Midazolam,mitochondria,mitochondrial,mitochondrion,Mitoxantrone,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,N-terminally processed,NADP,NADPH,neck cancer,Nicardipine,Nicotine,Nifedipine,Nilvadipine,Nitrazepam,Nortriptyline,Ondansetron,oral cancer,Orphenadrine,Oxaliplatin,OXIDATION,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,ozone,ozone response,P450,Paramethadione,Peripheral membrane protein,Phenelzine,Phenobarbital,Pilocarpine,Pimozide,polycythemia,precarcinogens,Proguanil,Propofol,Quinidine,Quinine,RAPID METABOLISM,RAPID METABOLIZER,reactive metabolites,response to ethanol,response to organonitrogen compound,response to ozone,RETINOID,Rifampicin,risperidone,risperidone response,Ritonavir,Rufinamide,S-Adenosylmethionine,schizophrenia,schizophrenia susceptibility,Selegiline,Sevoflurane,Sildenafil,SLOW METABOLIZER,small molecule metabolic process,solvents,STEROID,steroid hydroxylase activity,steroid metabolic process,Streptozocin,stroke,Sulfadiazine,Sulfanilamide,Tamoxifen,TESTOSTERONE,Thalidomide,Theobromine,Theophylline,Thiopental,Thioridazine,Ticlopidine,Tioconazole,TOXIC,TOXICITY,Trabectedin,Tranylcypromine,triglyceride,triglyceride metabolic process,Trimethadione,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Ursodeoxycholic acid,vinyl chloride,XENO,XENOBIOTIC,xenobiotic metabolic process,xenobiotic to hepatotoxic,XENOESTROGEN,Zafirlukast,Zopiclone",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs2031920",
        "SNP Name": "CYP2E1_-1055C>T G1055T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs2031920",
        "Video": "7th_nXzQc2Y",
        "Tags": "4-nitrophenol + NADPH + O2 = 4-nitrocatechol + NADP+ + H2O,4-nitrophenol 2-hydroxylase,Acetaminophen,acute methanol poisoning outcome,alcohol,alcohol metabolising,alcohol metabolism,alcoholic liver disease,Aldesleukin,Almotriptan,Alosetron,Aminophylline,Amitriptyline,anti-tuberculosis drug-induced hepatitis,Antipyrine,antituberculosis drug hepatotoxicity,arachidonic acid epoxygenase activity,ARTIFICIAL ESTROGEN,Azelastine,benzene,benzene exposure,benzene metabolism,Benzyl alcohol,Bifonazole,bioactivates,bladder cancer,blood pressure,Bromazepam,Brompheniramine,Bupropion,Caffeine,CANCER,CANCEROUS,Carbinoxamine,CARCINOGEN,Carvedilol,Childhood acute leukemia,Chlorpromazine,Chlorzoxazone,Cimetidine,Citalopram,Clevidipine,Clofibrate,Clomifene,Clonazepam,Clotrimazole,Clozapine,Colchicine,colorectal cancer,COMPOUNDS,CYP,CYP P450,CYP2E1,CYPIIE1,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2E1,Cytochrome P450-J,cytoplasm,Dacarbazine,Dalfampridine,Dapsone,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dexmedetomidine,Dextromethorphan,Diazepam,Diclofenac,Diethylstilbestrol,Disulfiram,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Econazole,elevated blood pressure,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enflurane,Enfuvirtide,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,enzyme binding,epoxygenase P450 pathway,essential hypertension,ESTROGEN,Estrone,Ethanol,Ethanolamine Oleate,Ethosuximide,Etoposide,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felbamate,Fingolimod,Flunitrazepam,Fluphenazine,Flurazepam,Fluvoxamine,Folate,Folic Acid,Fomepizole,Glucosamine,Golgi membrane,Halothane,heme,heme binding,hepatitis,hepatoxic,heterocycle metabolic process,Hexobarbital,high BP,HORMONAL BALANCE,HORMONAL CARCINOGENESIS,HORMONAL IMBALANCE,HORMONE,hypertension,Iloperidone,Imipramine,intracellular membrane-bounded organelle,intrinsic component of endoplasmic reticulum membrane,iron,iron ion binding,Isoflurane,Isoniazid,Isosorbide Dinitrate,Itraconazole,leukemia,lung cancer,Membrane,Menadione,Meprobamate,Metal-binding,methanol,Methazolamide,MethimazoleMethotrimeprazine,Methoxyflurane,Metyrapone,Mexiletine,Miconazole,Microsome,Microsome membrane,Midazolam,mitochondria,mitochondrial,mitochondrion,Mitoxantrone,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,N-terminally processed,NADP,NADPH,Nasopharyngeal Carcinoma,Nicardipine,Nicotine,Nifedipine,Nilvadipine,Nitrazepam,Nortriptyline,Ondansetron,oral cancer,Orphenadrine,Oxaliplatin,OXIDATION,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,ozone,ozone response,P450,Paramethadione,Peripheral membrane protein,Phenelzine,Phenobarbital,Pilocarpine,Pimozide,precarcinogens,Proguanil,Propofol,Quinidine,Quinine,RAPID METABOLISM,RAPID METABOLIZER,reactive metabolites,response to ethanol,response to organonitrogen compound,response to ozone,RETINOID,Rifampicin,Ritonavir,Rufinamide,S-Adenosylmethionine,schizophrenia,schizophrenia susceptibility,Selegiline,Sevoflurane,Sildenafil,SLOW METABOLIZER,small molecule metabolic process,solvents,STEROID,steroid hydroxylase activity,steroid metabolic process,Streptozocin,Sulfadiazine,Sulfanilamide,Tamoxifen,TESTOSTERONE,Thalidomide,Theobromine,Theophylline,Thiopental,Thioridazine,Ticlopidine,Tioconazole,TOXIC,TOXICITY,Trabectedin,Tranylcypromine,triglyceride,triglyceride metabolic process,Trimethadione,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Ursodeoxycholic acid,XENO,XENOBIOTIC,xenobiotic metabolic process,xenobiotic to hepatotoxic,XENOESTROGEN,Zafirlukast,Zopiclone",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs2070672",
        "SNP Name": "CYP2E1*7_-352A>G A352G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs2070672",
        "Video": "7th_nXzQc2Y",
        "Tags": "4-nitrophenol + NADPH + O2 = 4-nitrocatechol + NADP+ + H2O,4-nitrophenol 2-hydroxylase,Acetaminophen,Aldesleukin,Almotriptan,Alosetron,Aminophylline,Amitriptyline,anti-tuberculosis drug-induced hepatitis,Antipyrine,arachidonic acid epoxygenase activity,ARTIFICIAL ESTROGEN,Azelastine,Benzyl alcohol,Bifonazole,bioactivates,Bromazepam,Brompheniramine,Bupropion,Caffeine,CANCER,CANCEROUS,Carbinoxamine,CARCINOGEN,Carvedilol,Chlorpromazine,Chlorzoxazone,Cimetidine,Citalopram,Clevidipine,Clofibrate,Clomifene,Clonazepam,Clotrimazole,Clozapine,Colchicine,COMPOUNDS,CYP,CYP P450,CYP2E1,CYPIIE1,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2E1,Cytochrome P450-J,cytoplasm,Dacarbazine,Dalfampridine,Dapsone,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dexmedetomidine,Dextromethorphan,Diazepam,Diclofenac,Diethylstilbestrol,Disulfiram,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Econazole,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enflurane,Enfuvirtide,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,enzyme binding,epoxygenase P450 pathway,ESTROGEN,Estrone,Ethanol,Ethanolamine Oleate,Ethosuximide,Etoposide,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felbamate,Fingolimod,Flunitrazepam,Fluphenazine,Flurazepam,Fluvoxamine,Folate,Folic Acid,Fomepizole,Glucosamine,Golgi membrane,Halothane,heme,heme binding,hepatitis,hepatoxic,heterocycle metabolic process,Hexobarbital,HORMONAL BALANCE,HORMONAL CARCINOGENESIS,HORMONAL IMBALANCE,HORMONE,Iloperidone,Imipramine,intracellular membrane-bounded organelle,intrinsic component of endoplasmic reticulum membrane,iron,iron ion binding,Isoflurane,Isoniazid,Isosorbide Dinitrate,Itraconazole,Membrane,Menadione,Meprobamate,Metal-binding,Methazolamide,MethimazoleMethotrimeprazine,Methoxyflurane,Metyrapone,Mexiletine,Miconazole,Microsome,Microsome membrane,Midazolam,mitochondria,mitochondrial,mitochondrion,Mitoxantrone,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,N-terminally processed,NADP,NADPH,Nicardipine,Nicotine,Nifedipine,Nilvadipine,Nitrazepam,Nortriptyline,Ondansetron,Orphenadrine,Oxaliplatin,OXIDATION,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,ozone,ozone response,P450,Paramethadione,Peripheral membrane protein,Phenelzine,Phenobarbital,Pilocarpine,Pimozide,precarcinogens,Proguanil,Propofol,Quinidine,Quinine,RAPID METABOLISM,RAPID METABOLIZER,reactive metabolites,response to ethanol,response to organonitrogen compound,response to ozone,RETINOID,Rifampicin,Ritonavir,Rufinamide,S-Adenosylmethionine,Selegiline,Sevoflurane,Sildenafil,SLOW METABOLIZER,small molecule metabolic process,solvents,STEROID,steroid hydroxylase activity,steroid metabolic process,Streptozocin,Sulfadiazine,Sulfanilamide,Tamoxifen,TESTOSTERONE,Thalidomide,Theobromine,Theophylline,Thiopental,Thioridazine,Ticlopidine,Tioconazole,TOXIC,TOXICITY,Trabectedin,Tranylcypromine,triglyceride,triglyceride metabolic process,Trimethadione,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Ursodeoxycholic acid,XENO,XENOBIOTIC,xenobiotic metabolic process,xenobiotic to hepatotoxic,XENOESTROGEN,Zafirlukast,Zopiclone",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs6413420",
        "SNP Name": "CYP2E1*7_-71G>T G71T",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs6413420",
        "Video": "7th_nXzQc2Y",
        "Tags": "4-nitrophenol + NADPH + O2 = 4-nitrocatechol + NADP+ + H2O,4-nitrophenol 2-hydroxylase,Acetaminophen,Aldesleukin,Almotriptan,Alosetron,Aminophylline,Amitriptyline,Antipyrine,arachidonic acid epoxygenase activity,ARTIFICIAL ESTROGEN,Azelastine,Benzyl alcohol,Bifonazole,bioactivates,Bromazepam,Brompheniramine,Bupropion,Caffeine,CANCER,CANCEROUS,Carbinoxamine,CARCINOGEN,Carvedilol,Chlorpromazine,Chlorzoxazone,Cimetidine,Citalopram,Clevidipine,Clofibrate,Clomifene,Clonazepam,Clotrimazole,Clozapine,Colchicine,COMPOUNDS,CYP,CYP P450,CYP2E1,CYPIIE1,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2E1,Cytochrome P450-J,cytoplasm,Dacarbazine,Dalfampridine,Dapsone,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dexmedetomidine,Dextromethorphan,Diazepam,Diclofenac,Diethylstilbestrol,Disulfiram,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Econazole,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enflurane,Enfuvirtide,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,enzyme binding,epoxygenase P450 pathway,ESTROGEN,Estrone,Ethanol,Ethanolamine Oleate,Ethosuximide,Etoposide,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felbamate,Fingolimod,Flunitrazepam,Fluphenazine,Flurazepam,Fluvoxamine,Folate,Folic Acid,Fomepizole,Glucosamine,Golgi membrane,Halothane,heme,heme binding,hepatoxic,heterocycle metabolic process,Hexobarbital,HORMONAL BALANCE,HORMONAL CARCINOGENESIS,HORMONAL IMBALANCE,HORMONE,Iloperidone,Imipramine,intracellular membrane-bounded organelle,intrinsic component of endoplasmic reticulum membrane,iron,iron ion binding,Isoflurane,Isoniazid,Isosorbide Dinitrate,Itraconazole,Membrane,Menadione,Meprobamate,Metal-binding,Methazolamide,MethimazoleMethotrimeprazine,Methoxyflurane,Metyrapone,Mexiletine,Miconazole,Microsome,Microsome membrane,Midazolam,mitochondria,mitochondrial,mitochondrion,Mitoxantrone,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,N-terminally processed,NADP,NADPH,Nicardipine,Nicotine,Nifedipine,Nilvadipine,Nitrazepam,Nortriptyline,Ondansetron,Orphenadrine,Oxaliplatin,OXIDATION,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,ozone,ozone response,P450,Paramethadione,Peripheral membrane protein,Phenelzine,Phenobarbital,Pilocarpine,Pimozide,precarcinogens,Proguanil,Propofol,Quinidine,Quinine,RAPID METABOLISM,RAPID METABOLIZER,reactive metabolites,response to ethanol,response to organonitrogen compound,response to ozone,RETINOID,Rifampicin,Ritonavir,Rufinamide,S-Adenosylmethionine,Selegiline,Sevoflurane,Sildenafil,SLOW METABOLIZER,small molecule metabolic process,solvents,STEROID,steroid hydroxylase activity,steroid metabolic process,Streptozocin,Sulfadiazine,Sulfanilamide,Tamoxifen,TESTOSTERONE,Thalidomide,Theobromine,Theophylline,Thiopental,Thioridazine,Ticlopidine,Tioconazole,TOXIC,TOXICITY,Trabectedin,Tranylcypromine,triglyceride,triglyceride metabolic process,Trimethadione,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Ursodeoxycholic acid,XENO,XENOBIOTIC,xenobiotic metabolic process,xenobiotic to hepatotoxic,XENOESTROGEN,Zafirlukast,Zopiclone",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs72559710",
        "SNP Name": "CYP2E1*2 R76H",
        "Risk Allele": "C",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs72559710",
        "Video": "7th_nXzQc2Y",
        "Tags": "4-nitrophenol + NADPH + O2 = 4-nitrocatechol + NADP+ + H2O,4-nitrophenol 2-hydroxylase,Acetaminophen,alcohol metabolising,alcohol metabolism,Aldesleukin,Almotriptan,Alosetron,Aminophylline,Amitriptyline,Antipyrine,arachidonic acid epoxygenase activity,ARTIFICIAL ESTROGEN,Azelastine,Benzyl alcohol,Bifonazole,bioactivates,Bromazepam,Brompheniramine,Bupropion,Caffeine,CANCER,CANCEROUS,Carbinoxamine,CARCINOGEN,Carvedilol,Chlorpromazine,Chlorzoxazone,Cimetidine,Citalopram,Clevidipine,Clofibrate,Clomifene,Clonazepam,Clotrimazole,Clozapine,Colchicine,COMPOUNDS,CYP,CYP P450,CYP2E1,CYPIIE1,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2E1,Cytochrome P450-J,cytoplasm,Dacarbazine,Dalfampridine,Dapsone,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dexmedetomidine,Dextromethorphan,Diazepam,Diclofenac,Diethylstilbestrol,Disulfiram,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Econazole,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enflurane,Enfuvirtide,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,enzyme binding,epoxygenase P450 pathway,ESTROGEN,Estrone,Ethanol,Ethanolamine Oleate,Ethosuximide,Etoposide,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felbamate,Fingolimod,Flunitrazepam,Fluphenazine,Flurazepam,Fluvoxamine,Folate,Folic Acid,Fomepizole,Glucosamine,Golgi membrane,Halothane,heme,heme binding,hepatoxic,heterocycle metabolic process,Hexobarbital,HORMONAL BALANCE,HORMONAL CARCINOGENESIS,HORMONAL IMBALANCE,HORMONE,Iloperidone,Imipramine,intracellular membrane-bounded organelle,intrinsic component of endoplasmic reticulum membrane,iron,iron ion binding,Isoflurane,Isoniazid,Isosorbide Dinitrate,Itraconazole,Membrane,Menadione,Meprobamate,Metal-binding,Methazolamide,MethimazoleMethotrimeprazine,Methoxyflurane,Metyrapone,Mexiletine,Miconazole,Microsome,Microsome membrane,Midazolam,mitochondria,mitochondrial,mitochondrion,Mitoxantrone,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,N-terminally processed,NADP,NADPH,Nicardipine,Nicotine,Nifedipine,Nilvadipine,Nitrazepam,Nortriptyline,Ondansetron,Orphenadrine,Oxaliplatin,OXIDATION,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,ozone,ozone response,P450,Paramethadione,Peripheral membrane protein,Phenelzine,Phenobarbital,Pilocarpine,Pimozide,precarcinogens,Proguanil,Propofol,Quinidine,Quinine,RAPID METABOLISM,RAPID METABOLIZER,reactive metabolites,response to ethanol,response to organonitrogen compound,response to ozone,RETINOID,Rifampicin,Ritonavir,Rufinamide,S-Adenosylmethionine,Selegiline,Sevoflurane,Sildenafil,SLOW METABOLIZER,small molecule metabolic process,solvents,STEROID,steroid hydroxylase activity,steroid metabolic process,Streptozocin,Sulfadiazine,Sulfanilamide,Tamoxifen,TESTOSTERONE,Thalidomide,Theobromine,Theophylline,Thiopental,Thioridazine,Ticlopidine,Tioconazole,TOXIC,TOXICITY,Trabectedin,Tranylcypromine,triglyceride,triglyceride metabolic process,Trimethadione,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Ursodeoxycholic acid,XENO,XENOBIOTIC,xenobiotic metabolic process,xenobiotic to hepatotoxic,XENOESTROGEN,Zafirlukast,Zopiclone",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs8192772",
        "SNP Name": "CYP2E1 T8845C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs8192772",
        "Video": "7th_nXzQc2Y",
        "Tags": "4-nitrophenol + NADPH + O2 = 4-nitrocatechol + NADP+ + H2O,4-nitrophenol 2-hydroxylase,Acetaminophen,Aldesleukin,Almotriptan,Alosetron,Aminophylline,Amitriptyline,Antipyrine,arachidonic acid epoxygenase activity,ARTIFICIAL ESTROGEN,autoimmune,Azelastine,Benzyl alcohol,Bifonazole,bioactivates,Bromazepam,Brompheniramine,Bupropion,Caffeine,CANCER,CANCEROUS,Carbinoxamine,CARCINOGEN,Carvedilol,Chlorpromazine,Chlorzoxazone,Cimetidine,Citalopram,Clevidipine,Clofibrate,Clomifene,Clonazepam,Clotrimazole,Clozapine,Colchicine,COMPOUNDS,CYP,CYP P450,CYP2E1,CYPIIE1,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2E1,Cytochrome P450-J,cytoplasm,Dacarbazine,Dalfampridine,Dapsone,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dexmedetomidine,Dextromethorphan,Diazepam,Diclofenac,Diethylstilbestrol,Disulfiram,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Econazole,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enflurane,Enfuvirtide,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,enzyme binding,epoxygenase P450 pathway,ESTROGEN,Estrone,Ethanol,Ethanolamine Oleate,Ethosuximide,Etoposide,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felbamate,Fingolimod,Flunitrazepam,Fluphenazine,Flurazepam,Fluvoxamine,Folate,Folic Acid,Fomepizole,Glucosamine,Golgi membrane,Halothane,head and neck cancer,head cancer,heme,heme binding,hepatoxic,heterocycle metabolic process,Hexobarbital,HORMONAL BALANCE,HORMONAL CARCINOGENESIS,HORMONAL IMBALANCE,HORMONE,Iloperidone,Imipramine,intracellular membrane-bounded organelle,intrinsic component of endoplasmic reticulum membrane,iron,iron ion binding,Isoflurane,Isoniazid,Isosorbide Dinitrate,Itraconazole,lupus,Membrane,Menadione,Meprobamate,Metal-binding,Methazolamide,MethimazoleMethotrimeprazine,Methoxyflurane,Metyrapone,Mexiletine,Miconazole,Microsome,Microsome membrane,Midazolam,mitochondria,mitochondrial,mitochondrion,Mitoxantrone,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,N-terminally processed,NADP,NADPH,neck cancer,Nicardipine,Nicotine,Nifedipine,Nilvadipine,Nitrazepam,Nortriptyline,Ondansetron,Orphenadrine,Oxaliplatin,OXIDATION,oxidation-reduction process,oxidative stress,Oxidoreductase,oxidoreductase activity,oxygen binding,ozone,ozone response,P450,Paramethadione,Peripheral membrane protein,Phenelzine,Phenobarbital,Pilocarpine,Pimozide,precarcinogens,Proguanil,Propofol,Quinidine,Quinine,RAPID METABOLISM,RAPID METABOLIZER,reactive metabolites,response to ethanol,response to organonitrogen compound,response to ozone,RETINOID,Rifampicin,Ritonavir,ROS,Rufinamide,S-Adenosylmethionine,Selegiline,Sevoflurane,Sildenafil,SLOW METABOLIZER,small molecule metabolic process,solvents,STEROID,steroid hydroxylase activity,steroid metabolic process,Streptozocin,Sulfadiazine,Sulfanilamide,systemic lupus erythematosus,Tamoxifen,TESTOSTERONE,Thalidomide,Theobromine,Theophylline,Thiopental,Thioridazine,Ticlopidine,Tioconazole,TOXIC,TOXICITY,Trabectedin,Tranylcypromine,triglyceride,triglyceride metabolic process,Trimethadione,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Ursodeoxycholic acid,XENO,XENOBIOTIC,xenobiotic metabolic process,xenobiotic to hepatotoxic,XENOESTROGEN,Zafirlukast,Zopiclone",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs6413419",
        "SNP Name": "CYP2E1*4 A4768G",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs6413419",
        "Video": "7th_nXzQc2Y",
        "Tags": "4-nitrophenol + NADPH + O2 = 4-nitrocatechol + NADP+ + H2O,4-nitrophenol 2-hydroxylase,acetaldehyde-metabolising,Acetaminophen,Acrylamide,acting on paired donors,acting on paired donors with incorporation or reduction of molecular oxygen NAD(P)H as one donor and incorporation of one atom of oxygen,alcohol dependence,alcohol metabolising,alcohol metabolism,Aldesleukin,Almotriptan,Alosetron,Aminophylline,Amitriptyline,and incorporation of one atom of oxygen,antibiotic response,antibiotics,Antipyrine,anxiety,arachidonic acid epoxygenase activity,ARTIFICIAL ESTROGEN,Azelastine,Benzyl alcohol,Bifonazole,bioactivates,bioactivates many xenobiotic substrates hepatotoxic or carcinogenic forms,breast cancer,Bromazepam,Brompheniramine,Bupropion,Caffeine,cancer,cancerous,Carbinoxamine,carcinogen,Carvedilol,Chlorpromazine,Chlorzoxazone,Cimetidine,Cinnarizine,Citalopram,Clevidipine,Clofibrate,Clomifene,Clonazepam,Clotrimazole,Clozapine,Colchicine,COMPOUNDS,CYP,CYP P450,CYP2E1,CYPIIE1,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2E1,Cytochrome P450-J,cytoplasm,Dacarbazine,Dalfampridine,Dapsone,Desipramine,detox,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dexmedetomidine,Dextromethorphan,Diazepam,Diclofenac,Diethylstilbestrol,Disulfiram,DRUG,drug metabolic process,drug metabolism,DRUG POISONING,drug response,DRUG TOXICITY,drugs,DRUX TOXICITY,E2,Econazole,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enflurane,Enfuvirtide,ENVIRONMENT,environmental,environmental factors,enzyme binding,epoxygenase P450 pathway,estrogen,estrogen dominance,estrogen related cancer,Estrone,Eszopiclone,Ethanol,Ethanolamine Oleate,Ethosuximide,Etoposide,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felbamate,Fingolimod,Flunitrazepam,Fluphenazine,Flurazepam,Fluvoxamine,Folate,Folic Acid,Fomepizole,Glucosamine,glutamate,Glutathione,Golgi membrane,Halothane,heme,heme binding,Heme group,hepatoxic,heterocycle metabolic process,Hexobarbital,HORMONAL BALANCE,HORMONAL CARCINOGENESIS,HORMONAL IMBALANCE,HORMONE,Iloperidone,Imipramine,Inactivates a number of drugs and xenobiotics,intracellular membrane-bounded organelle,intrinsic component of endoplasmic reticulum membrane,Iron,iron ion binding,Isoflurane,Isoniazid,Isosorbide Dinitrate,Itraconazole,Membrane,Menadione,Mephenytoin,Meprobamate,Metal-binding,Methazolamide,MethimazoleMethotrimeprazine,Methoxyflurane,Metyrapone,Mexiletine,Miconazole,Microsome,Microsome membrane,Midazolam,mitochondria,mitochondrial,mitochondrion,Mitoxantrone,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,N-terminally processed,NADP,NADPH,Nicardipine,Nicotine,Nifedipine,Nilvadipine,Nitrazepam,Nitrofurantoin,Nortriptyline,Ondansetron,Orphenadrine,Oxaliplatin,OXIDATION,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxidoreductase activity acting on paired donors with incorporation or reduction of molecular oxygen reduced flavin or flavoprotein as one donor and incorporation of one atom of oxygen,oxygen binding,ozone,ozone response,P450,Paramethadione,Peripheral membrane protein,Phenelzine,Phenobarbital,Pilocarpine,Pimozide,precarcinogen metabolism,precarcinogens,Proguanil,Propofol,Quinidine,Quinine,RAPID METABOLISM,RAPID METABOLIZER,reactive metabolites,reduced flavin or flavoprotein as one donor,response to drug,response to ethanol,response to organonitrogen compound,response to ozone,RETINOID,Rifampicin,Ritonavir,Rufinamide,S-Adenosylmethionine,Selegiline,Sevoflurane,sex hormones,Sildenafil,SLOW METABOLIZER,small molecule metabolic process,solvent metabolism,solvents,STEROID,steroid hydroxylase activity,steroid metabolic process,Streptozocin,Sulfadiazine,Sulfanilamide,Tamoxifen,TESTOSTERONE,Thalidomide,Theobromine,Theophylline,Thiopental,Thioridazine,Ticlopidine,Tioconazole,Tolbutamide,TOXIC,TOXICITY,Trabectedin,Tranylcypromine,triglyceride",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs3758653",
        "SNP Name": "DRD4 T4095C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3758653",
        "Video": null,
        "Tags": "4.4,6 amino acids,activation of MAPK activity,addiction susceptibility,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,ADHD,ADORA2A,adult locomotory behavior,agonist-induced downstream signaling,alcohol,alcohol metabolism,Antipsychotic-Induced Movement Disorders,arachidonic acid secretion,BCR(KLHL12) E3 ubiquitin ligase complex,behavioral fear response,behavioral response to cocaine,behavioral response to ethanol,cell cortex,Cell membrane,cellular calcium ion homeostasis,circadian rhythm,CLIC6,cognitive impulsivity,Complete proteome,complex behavior,Continuous Performance Task,coupled via Gi/Go,D(2C) dopamine receptor,D(4) dopamine receptor,D4.7,D42,degradation,dendritic spine,depression,Disulfide bond,dopamine binding,Dopamine D4 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopamine receptor signaling pathway,DRD2 heterodimers,DRD4,DRD4 protein,DRD4-binding profiles,drug binding,emotion,Erroneous gene model prediction,fear response,Female Sexual Dysfunction,G protein interaction,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,Glycoprotein,GPRASP1,homo- and heterooligomers with DRD2,homodimers,identical protein binding,impulsivity,integral component of plasma membrane,KLHL12,Membrane,mental disorder,mesolimbic system of the brain,methylphenidate on hyperactivity,Movement Disorders,Multi-pass membrane protein,negative regulation of adenylate cyclase activity,negative regulation of cAMP biosynthetic process,negative regulation of protein secretion,negative regulation of voltage-gated calcium channel activity,neuronal cell body,neuronal signaling,olfactory learning,paminergic,photoperiodism,plasma membrane,polymorphic,polymorphic repeat sequence,Polymorphism,polyubiquitinated,polyubiquitination,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of excitatory postsynaptic membrane potential,positive regulation of kinase activity,positive regulation of penile erection,positive regulation of sodium:hydrogen antiporter activity,potassium channel regulator activity,Receptor Transducer,Reference proteome,regulation of calcium-mediated signaling,regulation of dopamine metabolic process,regulation of inhibitory postsynaptic membrane potential,regulation of neurotransmitter secretion,Repeat,response to amphetamine,response to histamine,response to steroid hormone,retina development in camera-type eye,Schizophrenia,sequence AAL58637.1,SH3 domain binding,short-term memory,social behavior,synaptic transmission,terminal bouton,third cytoplasmic loop,transmembrane,Transmembrane helix,Ubl conjugation,vesicle membrane",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs3758653",
        "SNP Name": "DRD4 T4095C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3758653",
        "Video": null,
        "Tags": "4.4,6 amino acids,activation of MAPK activity,addiction susceptibility,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,ADHD,ADORA2A,adult locomotory behavior,agonist-induced downstream signaling,alcohol,alcohol metabolism,Antipsychotic-Induced Movement Disorders,arachidonic acid secretion,BCR(KLHL12) E3 ubiquitin ligase complex,behavioral fear response,behavioral response to cocaine,behavioral response to ethanol,cell cortex,Cell membrane,cellular calcium ion homeostasis,circadian rhythm,CLIC6,cognitive impulsivity,Complete proteome,complex behavior,Continuous Performance Task,coupled via Gi/Go,D(2C) dopamine receptor,D(4) dopamine receptor,D4.7,D42,degradation,dendritic spine,depression,Disulfide bond,dopamine binding,Dopamine D4 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopamine receptor signaling pathway,DRD2 heterodimers,DRD4,DRD4 protein,DRD4-binding profiles,drug binding,emotion,Erroneous gene model prediction,fear response,Female Sexual Dysfunction,G protein interaction,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,Glycoprotein,GPRASP1,homo- and heterooligomers with DRD2,homodimers,identical protein binding,impulsivity,integral component of plasma membrane,KLHL12,Membrane,mental disorder,mesolimbic system of the brain,methylphenidate on hyperactivity,Movement Disorders,Multi-pass membrane protein,negative regulation of adenylate cyclase activity,negative regulation of cAMP biosynthetic process,negative regulation of protein secretion,negative regulation of voltage-gated calcium channel activity,neuronal cell body,neuronal signaling,olfactory learning,paminergic,photoperiodism,plasma membrane,polymorphic,polymorphic repeat sequence,Polymorphism,polyubiquitinated,polyubiquitination,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of excitatory postsynaptic membrane potential,positive regulation of kinase activity,positive regulation of penile erection,positive regulation of sodium:hydrogen antiporter activity,potassium channel regulator activity,Receptor Transducer,Reference proteome,regulation of calcium-mediated signaling,regulation of dopamine metabolic process,regulation of inhibitory postsynaptic membrane potential,regulation of neurotransmitter secretion,Repeat,response to amphetamine,response to histamine,response to steroid hormone,retina development in camera-type eye,Schizophrenia,sequence AAL58637.1,SH3 domain binding,short-term memory,social behavior,synaptic transmission,terminal bouton,third cytoplasmic loop,transmembrane,Transmembrane helix,Ubl conjugation,vesicle membrane",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs752306",
        "SNP Name": "DRD4 C5318T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs752306",
        "Video": null,
        "Tags": "4.4,6 amino acids,activation of MAPK activity,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,ADORA2A,adult locomotory behavior,agonist-induced downstream signaling,alcohol,alcohol metabolism,arachidonic acid secretion,BCR(KLHL12) E3 ubiquitin ligase complex,behavioral fear response,behavioral response to cocaine,behavioral response to ethanol,cell cortex,Cell membrane,cellular calcium ion homeostasis,circadian rhythm,CLIC6,Complete proteome,complex behavior,coupled via Gi/Go,D(2C) dopamine receptor,D(4) dopamine receptor,D4.7,D42,degradation,dendritic spine,Disulfide bond,dopamine binding,Dopamine D4 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopamine receptor signaling pathway,DRD2 heterodimers,DRD4,DRD4 protein,DRD4-binding profiles,drug binding,emotion,Erroneous gene model prediction,fear response,G protein interaction,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,Glycoprotein,GPRASP1,homo- and heterooligomers with DRD2,homodimers,identical protein binding,integral component of plasma membrane,KLHL12,Membrane,mental disorder,mesolimbic system of the brain,methylphenidate on hyperactivity,Multi-pass membrane protein,negative regulation of adenylate cyclase activity,negative regulation of cAMP biosynthetic process,negative regulation of protein secretion,negative regulation of voltage-gated calcium channel activity,neuronal cell body,neuronal signaling,olfactory learning,paminergic,photoperiodism,plasma membrane,polymorphic,polymorphic repeat sequence,Polymorphism,polyubiquitinated,polyubiquitination,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of excitatory postsynaptic membrane potential,positive regulation of kinase activity,positive regulation of penile erection,positive regulation of sodium:hydrogen antiporter activity,potassium channel regulator activity,Receptor Transducer,Reference proteome,regulation of calcium-mediated signaling,regulation of dopamine metabolic process,regulation of inhibitory postsynaptic membrane potential,regulation of neurotransmitter secretion,Repeat,response to amphetamine,response to histamine,response to steroid hormone,retina development in camera-type eye,Schizophrenia,sequence AAL58637.1,SH3 domain binding,short-term memory,social behavior,synaptic transmission,terminal bouton,third cytoplasmic loop,transmembrane,Transmembrane helix,Ubl conjugation,vesicle membrane",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs752306",
        "SNP Name": "DRD4 C5318T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs752306",
        "Video": null,
        "Tags": "4.4,6 amino acids,activation of MAPK activity,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,ADORA2A,adult locomotory behavior,agonist-induced downstream signaling,alcohol,alcohol metabolism,arachidonic acid secretion,BCR(KLHL12) E3 ubiquitin ligase complex,behavioral fear response,behavioral response to cocaine,behavioral response to ethanol,cell cortex,Cell membrane,cellular calcium ion homeostasis,circadian rhythm,CLIC6,Complete proteome,complex behavior,coupled via Gi/Go,D(2C) dopamine receptor,D(4) dopamine receptor,D4.7,D42,degradation,dendritic spine,Disulfide bond,dopamine binding,Dopamine D4 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopamine receptor signaling pathway,DRD2 heterodimers,DRD4,DRD4 protein,DRD4-binding profiles,drug binding,emotion,Erroneous gene model prediction,fear response,G protein interaction,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,Glycoprotein,GPRASP1,homo- and heterooligomers with DRD2,homodimers,identical protein binding,integral component of plasma membrane,KLHL12,Membrane,mental disorder,mesolimbic system of the brain,methylphenidate on hyperactivity,Multi-pass membrane protein,negative regulation of adenylate cyclase activity,negative regulation of cAMP biosynthetic process,negative regulation of protein secretion,negative regulation of voltage-gated calcium channel activity,neuronal cell body,neuronal signaling,olfactory learning,paminergic,photoperiodism,plasma membrane,polymorphic,polymorphic repeat sequence,Polymorphism,polyubiquitinated,polyubiquitination,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of excitatory postsynaptic membrane potential,positive regulation of kinase activity,positive regulation of penile erection,positive regulation of sodium:hydrogen antiporter activity,potassium channel regulator activity,Receptor Transducer,Reference proteome,regulation of calcium-mediated signaling,regulation of dopamine metabolic process,regulation of inhibitory postsynaptic membrane potential,regulation of neurotransmitter secretion,Repeat,response to amphetamine,response to histamine,response to steroid hormone,retina development in camera-type eye,Schizophrenia,sequence AAL58637.1,SH3 domain binding,short-term memory,social behavior,synaptic transmission,terminal bouton,third cytoplasmic loop,transmembrane,Transmembrane helix,Ubl conjugation,vesicle membrane",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs11246226",
        "SNP Name": "DRD4 C8887A",
        "Risk Allele": "A",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs11246226",
        "Video": null,
        "Tags": "4.4,6 amino acids,activation of MAPK activity,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,ADORA2A,adult locomotory behavior,agonist-induced downstream signaling,alcohol,alcohol metabolism,arachidonic acid secretion,BCR(KLHL12) E3 ubiquitin ligase complex,behavioral fear response,behavioral response to cocaine,behavioral response to ethanol,cell cortex,Cell membrane,cellular calcium ion homeostasis,circadian rhythm,CLIC6,Complete proteome,complex behavior,Continuous Performance Task,coupled via Gi/Go,D(2C) dopamine receptor,D(4) dopamine receptor,D4.7,D42,degradation,dendritic spine,depression,Disulfide bond,dopamine binding,Dopamine D4 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopamine receptor signaling pathway,DRD2 heterodimers,DRD4,DRD4 protein,DRD4-binding profiles,drug binding,emotion,Erroneous gene model prediction,fear response,Female Sexual Dysfunction,G protein interaction,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,Glycoprotein,GPRASP1,homo- and heterooligomers with DRD2,homodimers,identical protein binding,integral component of plasma membrane,KLHL12,Membrane,mental disorder,mesolimbic system of the brain,methylphenidate on hyperactivity,Multi-pass membrane protein,negative regulation of adenylate cyclase activity,negative regulation of cAMP biosynthetic process,negative regulation of protein secretion,negative regulation of voltage-gated calcium channel activity,neuronal cell body,neuronal signaling,olfactory learning,paminergic,photoperiodism,plasma membrane,polymorphic,polymorphic repeat sequence,Polymorphism,polyubiquitinated,polyubiquitination,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of excitatory postsynaptic membrane potential,positive regulation of kinase activity,positive regulation of penile erection,positive regulation of sodium:hydrogen antiporter activity,potassium channel regulator activity,Receptor Transducer,Reference proteome,regulation of calcium-mediated signaling,regulation of dopamine metabolic process,regulation of inhibitory postsynaptic membrane potential,regulation of neurotransmitter secretion,Repeat,response to amphetamine,response to histamine,response to steroid hormone,retina development in camera-type eye,Schizophrenia,sequence AAL58637.1,SH3 domain binding,short-term memory,social behavior,synaptic transmission,terminal bouton,third cytoplasmic loop,transmembrane,Transmembrane helix,Ubl conjugation,vesicle membrane",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs11246226",
        "SNP Name": "DRD4 C8887A",
        "Risk Allele": "A",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs11246226",
        "Video": null,
        "Tags": "4.4,6 amino acids,activation of MAPK activity,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,ADORA2A,adult locomotory behavior,agonist-induced downstream signaling,alcohol,alcohol metabolism,arachidonic acid secretion,BCR(KLHL12) E3 ubiquitin ligase complex,behavioral fear response,behavioral response to cocaine,behavioral response to ethanol,cell cortex,Cell membrane,cellular calcium ion homeostasis,circadian rhythm,CLIC6,Complete proteome,complex behavior,Continuous Performance Task,coupled via Gi/Go,D(2C) dopamine receptor,D(4) dopamine receptor,D4.7,D42,degradation,dendritic spine,depression,Disulfide bond,dopamine binding,Dopamine D4 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopamine receptor signaling pathway,DRD2 heterodimers,DRD4,DRD4 protein,DRD4-binding profiles,drug binding,emotion,Erroneous gene model prediction,fear response,Female Sexual Dysfunction,G protein interaction,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,Glycoprotein,GPRASP1,homo- and heterooligomers with DRD2,homodimers,identical protein binding,integral component of plasma membrane,KLHL12,Membrane,mental disorder,mesolimbic system of the brain,methylphenidate on hyperactivity,Multi-pass membrane protein,negative regulation of adenylate cyclase activity,negative regulation of cAMP biosynthetic process,negative regulation of protein secretion,negative regulation of voltage-gated calcium channel activity,neuronal cell body,neuronal signaling,olfactory learning,paminergic,photoperiodism,plasma membrane,polymorphic,polymorphic repeat sequence,Polymorphism,polyubiquitinated,polyubiquitination,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of excitatory postsynaptic membrane potential,positive regulation of kinase activity,positive regulation of penile erection,positive regulation of sodium:hydrogen antiporter activity,potassium channel regulator activity,Receptor Transducer,Reference proteome,regulation of calcium-mediated signaling,regulation of dopamine metabolic process,regulation of inhibitory postsynaptic membrane potential,regulation of neurotransmitter secretion,Repeat,response to amphetamine,response to histamine,response to steroid hormone,retina development in camera-type eye,Schizophrenia,sequence AAL58637.1,SH3 domain binding,short-term memory,social behavior,synaptic transmission,terminal bouton,third cytoplasmic loop,transmembrane,Transmembrane helix,Ubl conjugation,vesicle membrane",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs11246300",
        "SNP Name": "TALDO1 C749776T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs11246300",
        "Video": null,
        "Tags": "Acetylation,Aldolase,beta-D-fructose 6 phosphate,bleeding tendancy,C749776T,carbodjydrate metabolic process,Carbohydtate degradtion,congenital heart disease,cutis laxa,cytoplasm,cytosol,D-erythrose 4-phosphate,D-fructose 6-phosphate,D-glyceraldehyde 3-phosphate,D-ribose 5 phosphate,D-xyluclose 5 phosphate (non-oxidative stage),disease mutation,dysmorphic features,early-onset multisystem disease,energy reverse metabolic process,extracellular exosome,fructose 6-phosphate metabolic process,growth retardation,hepatosplenomegaly,hexose monophosphate shunt,human proteome,inborn errors,Insulin,metabolites,monosaccharide binding,mutations,N6-acetyllysine,non-oxidative branch,nucleus,pancytopenia,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,Phosphoserine,rs11246300,Schiff base,Sedoheptulose 7-phosphate,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,small molecule metabolic process,synthesis,TALDO1,telangiectases of the skin,Transaldolase,Transaldolase (TALDO1),Transaldolase deficiency,transaldolase family,Transferasem Pentose shunt,type 1 subfamily,xylulose biosyntheric process,Xylulose-5-phosphate",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs2856111",
        "SNP Name": "MUC2 T1075747C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Taurodeoxycholate"
    },
    {
        "SNP ID": "rs10902088",
        "SNP Name": "MUC2 C1087972T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Taurodeoxycholate"
    },
    {
        "SNP ID": "rs17571",
        "SNP Name": "CTSD A58V",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Acid protease,AD,ADHD,Alzheimer,Alzheimer's disease,antigen processing and presentation of exogenous peptide antigen via MHC class II,apoptosis,aspartic protease,aspartic-type endopeptidase activity,Aspartyl protease,autofluorescent liposomal material,autophagic vacuole assembly,breast cancer,cancer,cancerous,carcinogen,Cathepsin D,Cathepsin D heavy chain,Cathepsin D light chain,cell death,cerebral atrophy,cognition,collagen,collagen catabolic process,Creutzfeldt-Jakob disease,CTSD,dementia,extracellular matrix disassembly,extracellular matrix organization,extracellular region,extracellular space,extracellular vesicular exosome,guanidinoacetate N-methyltransferase,Hydrolase,intelligence,intracellular protein breakdown,IQ,lysosomal,lysosomal lumen,lysosomal storage diseases,Lysosome,melanosome,mitochondrion,N- and O-glycosylated,Neurodegeneration,neurodegenerative disorder,neuronal ceroid lipofuscinosis,oxidative stress,pepsin A,peptidase A1 family,Protease,protein,ROS,Secreted,seizure,seizures,visual loss",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs2070762",
        "SNP Name": "TH T1090C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2070762",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,autism,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,blood pressure,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,CFS,Chronic Fatigue Syndrome,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,diabetes,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,essential hypertension,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,Financial and Psychological Risk Attitudes,glycoside metabolic process,heart,heart development,heart morphogenesis,high BP,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,locomotory behavior,Mainly expressed in the brain and adrenal glands,mating behavior,melanosome membrane,memory,mental disorder,Metal-binding,migraine,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,Schizophrenia,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,TYH,type I diabetes,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,visual perception",
        "Group": "Aminoglycoside Antibiotic"
    },
    {
        "SNP ID": "rs2070762",
        "SNP Name": "TH T1090C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2070762",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,autism,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,blood pressure,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,CFS,Chronic Fatigue Syndrome,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,diabetes,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,essential hypertension,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,Financial and Psychological Risk Attitudes,glycoside metabolic process,heart,heart development,heart morphogenesis,high BP,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,locomotory behavior,Mainly expressed in the brain and adrenal glands,mating behavior,melanosome membrane,memory,mental disorder,Metal-binding,migraine,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,Schizophrenia,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,TYH,type I diabetes,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,visual perception",
        "Group": "L-Tyrosine"
    },
    {
        "SNP ID": "rs2070762",
        "SNP Name": "TH T1090C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2070762",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,autism,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,blood pressure,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,CFS,Chronic Fatigue Syndrome,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,diabetes,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,essential hypertension,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,Financial and Psychological Risk Attitudes,glycoside metabolic process,heart,heart development,heart morphogenesis,high BP,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,locomotory behavior,Mainly expressed in the brain and adrenal glands,mating behavior,melanosome membrane,memory,mental disorder,Metal-binding,migraine,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,Schizophrenia,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,TYH,type I diabetes,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,visual perception",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs2070762",
        "SNP Name": "TH T1090C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2070762",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,autism,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,blood pressure,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,CFS,Chronic Fatigue Syndrome,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,diabetes,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,essential hypertension,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,Financial and Psychological Risk Attitudes,glycoside metabolic process,heart,heart development,heart morphogenesis,high BP,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,locomotory behavior,Mainly expressed in the brain and adrenal glands,mating behavior,melanosome membrane,memory,mental disorder,Metal-binding,migraine,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,Schizophrenia,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,TYH,type I diabetes,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,visual perception",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs28934580",
        "SNP Name": "TH G1010A//R337H",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/clinvar/RCV000013121/",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,glycoside metabolic process,heart,heart development,heart morphogenesis,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,locomotory behavior,Mainly expressed in the brain and adrenal glands,mating behavior,melanosome membrane,memory,Metal-binding,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,Segawa syndrome,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,TYH,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,visual perception",
        "Group": "Aminoglycoside Antibiotic"
    },
    {
        "SNP ID": "rs28934580",
        "SNP Name": "TH G1010A//R337H",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/clinvar/RCV000013121/",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,glycoside metabolic process,heart,heart development,heart morphogenesis,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,locomotory behavior,Mainly expressed in the brain and adrenal glands,mating behavior,melanosome membrane,memory,Metal-binding,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,Segawa syndrome,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,TYH,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,visual perception",
        "Group": "L-Tyrosine"
    },
    {
        "SNP ID": "rs28934580",
        "SNP Name": "TH G1010A//R337H",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/clinvar/RCV000013121/",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,glycoside metabolic process,heart,heart development,heart morphogenesis,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,locomotory behavior,Mainly expressed in the brain and adrenal glands,mating behavior,melanosome membrane,memory,Metal-binding,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,Segawa syndrome,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,TYH,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,visual perception",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs28934580",
        "SNP Name": "TH G1010A//R337H",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/clinvar/RCV000013121/",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,glycoside metabolic process,heart,heart development,heart morphogenesis,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,locomotory behavior,Mainly expressed in the brain and adrenal glands,mating behavior,melanosome membrane,memory,Metal-binding,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,Segawa syndrome,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,TYH,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,visual perception",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs28934581",
        "SNP Name": "TH A733C",
        "Risk Allele": "G",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://omim.org/entry/191290",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,glycoside metabolic process,heart,heart development,heart morphogenesis,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,locomotory behavior,Mainly expressed in the brain and adrenal glands,mating behavior,melanosome membrane,memory,Metal-binding,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,TYH,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,visual perception",
        "Group": "Aminoglycoside Antibiotic"
    },
    {
        "SNP ID": "rs28934581",
        "SNP Name": "TH A733C",
        "Risk Allele": "G",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://omim.org/entry/191290",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,glycoside metabolic process,heart,heart development,heart morphogenesis,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,locomotory behavior,Mainly expressed in the brain and adrenal glands,mating behavior,melanosome membrane,memory,Metal-binding,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,TYH,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,visual perception",
        "Group": "L-Tyrosine"
    },
    {
        "SNP ID": "rs28934581",
        "SNP Name": "TH A733C",
        "Risk Allele": "G",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://omim.org/entry/191290",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,glycoside metabolic process,heart,heart development,heart morphogenesis,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,locomotory behavior,Mainly expressed in the brain and adrenal glands,mating behavior,melanosome membrane,memory,Metal-binding,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,TYH,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,visual perception",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs28934581",
        "SNP Name": "TH A733C",
        "Risk Allele": "G",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://omim.org/entry/191290",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,glycoside metabolic process,heart,heart development,heart morphogenesis,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,locomotory behavior,Mainly expressed in the brain and adrenal glands,mating behavior,melanosome membrane,memory,Metal-binding,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,TYH,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,visual perception",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs7483056",
        "SNP Name": "TH T7517C",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7483056",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,drug induced liver injury,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,Flucloxacillin,glycoside metabolic process,heart,heart development,heart morphogenesis,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,liver injury,locomotory behavior,Mainly expressed in the brain and adrenal glands,Maternal Circulating Glucose Concentrations in Pregnancy,mating behavior,melanosome membrane,memory,Metal-binding,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,TYH,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,UC,Ulcerative Colitis and Flucloxacillin-induced liver injury,visual perception",
        "Group": "L-Tyrosine"
    },
    {
        "SNP ID": "rs7483056",
        "SNP Name": "TH T7517C",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7483056",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,drug induced liver injury,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,Flucloxacillin,glycoside metabolic process,heart,heart development,heart morphogenesis,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,liver injury,locomotory behavior,Mainly expressed in the brain and adrenal glands,Maternal Circulating Glucose Concentrations in Pregnancy,mating behavior,melanosome membrane,memory,Metal-binding,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,TYH,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,UC,Ulcerative Colitis and Flucloxacillin-induced liver injury,visual perception",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs7483056",
        "SNP Name": "TH T7517C",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7483056",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,drug induced liver injury,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,Flucloxacillin,glycoside metabolic process,heart,heart development,heart morphogenesis,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,liver injury,locomotory behavior,Mainly expressed in the brain and adrenal glands,Maternal Circulating Glucose Concentrations in Pregnancy,mating behavior,melanosome membrane,memory,Metal-binding,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,TYH,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,UC,Ulcerative Colitis and Flucloxacillin-induced liver injury,visual perception",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs6356",
        "SNP Name": "TH V112M",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6356",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alcohol Dependence,alcohol metabolising genes,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,Bipolar Disorder,blood pressure,cardiovascular risk,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,diabetes,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,Dopaminergic pathway,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,glycoside metabolic process,heart,heart development,heart morphogenesis,high BP,hypertenstion,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,locomotory behavior,Mainly expressed in the brain and adrenal glands,Maternal Circulating Glucose Concentrations in Pregnancy,mating behavior,melanosome membrane,memory,mental disorders,Metal-binding,migraine,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,Nicotine dependence,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,Parkinson's disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,personality traits,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,schizophrenia,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),suicidal behavior,synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,the protective role of a functional tyrosine hydroxylase polymorphism in nicotine dependence,TYH,Type 1 Diabetes,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,visual perception",
        "Group": "Aminoglycoside Antibiotic"
    },
    {
        "SNP ID": "rs6356",
        "SNP Name": "TH V112M",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6356",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alcohol Dependence,alcohol metabolising genes,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,Bipolar Disorder,blood pressure,cardiovascular risk,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,diabetes,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,Dopaminergic pathway,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,glycoside metabolic process,heart,heart development,heart morphogenesis,high BP,hypertenstion,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,locomotory behavior,Mainly expressed in the brain and adrenal glands,Maternal Circulating Glucose Concentrations in Pregnancy,mating behavior,melanosome membrane,memory,mental disorders,Metal-binding,migraine,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,Nicotine dependence,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,Parkinson's disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,personality traits,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,schizophrenia,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),suicidal behavior,synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,the protective role of a functional tyrosine hydroxylase polymorphism in nicotine dependence,TYH,Type 1 Diabetes,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,visual perception",
        "Group": "L-Tyrosine"
    },
    {
        "SNP ID": "rs6356",
        "SNP Name": "TH V112M",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6356",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alcohol Dependence,alcohol metabolising genes,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,Bipolar Disorder,blood pressure,cardiovascular risk,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,diabetes,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,Dopaminergic pathway,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,glycoside metabolic process,heart,heart development,heart morphogenesis,high BP,hypertenstion,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,locomotory behavior,Mainly expressed in the brain and adrenal glands,Maternal Circulating Glucose Concentrations in Pregnancy,mating behavior,melanosome membrane,memory,mental disorders,Metal-binding,migraine,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,Nicotine dependence,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,Parkinson's disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,personality traits,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,schizophrenia,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),suicidal behavior,synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,the protective role of a functional tyrosine hydroxylase polymorphism in nicotine dependence,TYH,Type 1 Diabetes,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,visual perception",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs6356",
        "SNP Name": "TH V112M",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6356",
        "Video": null,
        "Tags": "A form of DOPA-responsive dystonia presenting in infancy or early childhood,Alcohol Dependence,alcohol metabolising genes,Alternative splicing,amino acid binding,amino acids,anatomical structure morphogenesis,aromatic amino acid family metabolic process,ATP,Belongs to the biopterin-dependent aromatic amino acid hydroxylase family,BH4,BH4 binding,Bipolar Disorder,blood pressure,cardiovascular risk,catecholamine,Catecholamine biosynthesis,catecholamine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,cellular response to drug,cellular response to glucose stimulus,cellular response to growth factor stimulus,cellular response to manganese ion,cellular response to nicotine,cerebral cortex development,circadian sleep/wake cycle,Complete proteome,cytoplasm,cytoplasmic side of plasma membrane,cytoplasmic vesicle,cytosol,dendrite,diabetes,Disease mutation,DOPA,dopamine,dopamine binding,dopamine biosynthesis,dopamine biosynthetic process,dopamine biosynthetic process from tyrosine,dopamine from L-tyrosine: step 1/2,dopaminergic,Dopaminergic pathway,drug response,dystonia,eating behavior,embryonic camera-type eye morphogenesis,energy,epinephrine biosynthetic process,eye photoreceptor cell development,fatty acid metabolic process,Fe2+ ion,ferric iron binding,ferrous iron binding,glycoside metabolic process,heart,heart development,heart morphogenesis,high BP,hypertenstion,involuntary movement,involuntary muscle contractions often leading to abnormal postures,Iron,iron ion binding,isoquinoline alkaloid metabolic process,L-DOPA,L-tyrosine,L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin,learning,locomotory behavior,Mainly expressed in the brain and adrenal glands,Maternal Circulating Glucose Concentrations in Pregnancy,mating behavior,melanosome membrane,memory,mental disorders,Metal-binding,migraine,mitochondria,mitochondrion,Monooxygenase,multicellular organismal aging,nervous system,neuron projection,Neurotransmitter biosynthesis,neurotransmitter biosynthetic process,neurotransmitters,Nicotine dependence,norepinephrine biosynthetic process,nucleus,organ morphogenesis,Oxidoreductase,oxygen binding,parkinson,Parkinson disease,Parkinson's disease,parkinsonian symptoms in infancy,Parkinsonism,parkinson\u2019s disease,PD,perikaryon,personality traits,Phosphoprotein,Phosphorylation leads to an increase in the catalytic activity,phthalate metabolic process,phytoalexin metabolic process,pigmentation,Plays an important role in the physiology of adrenergic neurons,Polymorphism,protein binding,Reference proteome,regulation of heart contraction,response to activity,response to amphetamine,response to corticosterone,response to electrical stimulus,response to estradiol,response to ethanol,response to ether,response to herbicide,response to hypoxia,response to light stimulus,response to lipopolysaccharide,response to nutrient levels,response to peptide hormone,response to pyrethroid,response to salt stress,response to water deprivation,response to zinc ion,schizophrenia,Segawa syndrome autosomal recessive (ARSEGS),sensory perception of sound,small molecule metabolic process,smooth endoplasmic reticulum,social behavior,sphingolipid metabolic process,sudden infant death syndrome (SIDS),suicidal behavior,synaptic transmission,synaptic vesicle,synaptic vesicle amine transport,terminal bouton,terpene metabolic process,tetrahydrobiopterin,tetrahydrobiopterin binding,TH,THB,the protective role of a functional tyrosine hydroxylase polymorphism in nicotine dependence,TYH,Type 1 Diabetes,tyrosine,Tyrosine 3-hydroxylase,Tyrosine 3-monooxygenase,tyrosine 3-monooxygenase activity,visual perception",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs5215",
        "SNP Name": "KCNJ11 V250I",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs5219",
        "SNP Name": "KCNJ11 L23G",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs4638289",
        "SNP Name": "SAA1 A18285774T",
        "Risk Allele": "A",
        "Your Allele": "AT",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs4638289",
        "SNP Name": "SAA1 A18285774T",
        "Risk Allele": "A",
        "Your Allele": "AT",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Bovine Serum Albumin"
    },
    {
        "SNP ID": "rs4638289",
        "SNP Name": "SAA1 A18285774T",
        "Risk Allele": "A",
        "Your Allele": "AT",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Human Serum Albumin"
    },
    {
        "SNP ID": "rs7124442",
        "SNP Name": "BDNF C27677041T",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Amphotericin B"
    },
    {
        "SNP ID": "rs11030104",
        "SNP Name": "BDNF T64089C",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Abrineurin,AD,ADHD,Alzheimer,Alzheimer's disease,Antidepressant Treatment Response,Antidepressants,Antipsychotic Treatment Resistance,apnea,attention deficit/hyperactivity disorder,axon extension,axon guidance,axon target recognition,BDNF,behavioral fear response,bipolar,bipolar disorder,Brain-derived neurotrophic factor,bulimia,bulimia nervosa 2,BULN2,CCHS,cellular energy,central nervous system,chronic inflammatory response,circadian rhythm,Cleavage on pair of basic residues,CNS,cognitive function,Congenital central hypoventilation syndrome,cytoplasm,dementia,dendrite development,dendrite extension,depression,Disulfide bond,dopamine,drug resistance,energy,extracellular region,feeding behavior,gaba,GABA/glutamate,GABAergic,gamma-aminobutyric acid signaling pathway,glutamate,glutamate secretion,Glycoprotein,growth factor activity,inflammation,inflammatory,inner ear development,learning,learning or memory,long-term depression,long-term potentiation,LTD,LTP,major depression,mechanoreceptor differentiation,memory,mitochondial,mitochondria,mitochondrial electron transport,NADH to ubiquinone,negative regulation of neuroblast proliferation,negative regulation of neuron apoptotic process,negative regulation of striated muscle tissue development,negative regulation of synaptic transmission,nerve development,nervous system development,neurodegenerative disorder,neuron recognition,Neurotrophic Factor Gene,Ondine,Ondine syndrome,Ondine's curse,Parkinson,Parkinson's Disease,PD,perinuclear region of cytoplasm,positive regulation of long-term neuronal synaptic plasticity,positive regulation of neuron differentiation,positive regulation of peptidyl-serine phosphorylation,positive regulation of synapse assembly,Processing Speed,regulation of excitatory postsynaptic membrane potential,regulation of retinal cell programmed cell death,regulation of short-term neuronal synaptic plasticity,response to anesthetic,response to fluoxetine,response to hormone,response to hyperoxia,response to hypoxia,response to vitamin A,schizoaffective disorder,schizophrenia,sleep apnea,synaptic transmission,synaptic vesicle,taste bud development,ureteric bud development,WAGR syndrome",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs962369",
        "SNP Name": "BDNF A14186C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs962369",
        "SNP Name": "BDNF A14186C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Gelatin"
    },
    {
        "SNP ID": "rs480575",
        "SNP Name": "CAT A12175G",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs480575",
        "Video": "BSmdOO5jCjY",
        "Tags": "age-related macular degeneration,air pollution,AMD,amino acid,amino acid transport,amino acids,Amino-acid transport,amygdala,arginine,ATRC2,ATRC3,blood pressure,brain,breast cancer,cancer,cancerous,carcinogen,CAT,CAT-2,CAT-3,CAT2,CAT3,CAT53,Cationic amino acid transporter,Cationic amino acid transporter 3,Cationic amino acid transporter y+,CVD,FB19,fetal spleen,Glycoprotein,heart,high BP,hippocampus,homocysteine,hydrogen peroxide,hypertension,kidney,liver,Low affinity cationic amino acid transporter 2,lysine,macrophages,macular degeneration,mammary gland,Membrane,Multi-pass membrane protein,N-glycosylated,obesity,ornithine,ovary,pancreas,Phosphoprotein,placenta,PNUTS,PPP1R10,prostate,Protein FB19,ROS,salivary gland,Serine/threonine-protein phosphatase 1 regulatory subunit 10,skeletal muscle,SLC7A2,SLC7A3,Solute carrier family 7 member 2,Solute carrier family 7 member 3,testis,thymus,transmembrane,transport,uterus",
        "Group": "Non-Viral Proteins"
    },
    {
        "SNP ID": "rs480575",
        "SNP Name": "CAT A12175G",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs480575",
        "Video": "BSmdOO5jCjY",
        "Tags": "age-related macular degeneration,air pollution,AMD,amino acid,amino acid transport,amino acids,Amino-acid transport,amygdala,arginine,ATRC2,ATRC3,blood pressure,brain,breast cancer,cancer,cancerous,carcinogen,CAT,CAT-2,CAT-3,CAT2,CAT3,CAT53,Cationic amino acid transporter,Cationic amino acid transporter 3,Cationic amino acid transporter y+,CVD,FB19,fetal spleen,Glycoprotein,heart,high BP,hippocampus,homocysteine,hydrogen peroxide,hypertension,kidney,liver,Low affinity cationic amino acid transporter 2,lysine,macrophages,macular degeneration,mammary gland,Membrane,Multi-pass membrane protein,N-glycosylated,obesity,ornithine,ovary,pancreas,Phosphoprotein,placenta,PNUTS,PPP1R10,prostate,Protein FB19,ROS,salivary gland,Serine/threonine-protein phosphatase 1 regulatory subunit 10,skeletal muscle,SLC7A2,SLC7A3,Solute carrier family 7 member 2,Solute carrier family 7 member 3,testis,thymus,transmembrane,transport,uterus",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs480575",
        "SNP Name": "CAT A12175G",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs480575",
        "Video": "BSmdOO5jCjY",
        "Tags": "age-related macular degeneration,air pollution,AMD,amino acid,amino acid transport,amino acids,Amino-acid transport,amygdala,arginine,ATRC2,ATRC3,blood pressure,brain,breast cancer,cancer,cancerous,carcinogen,CAT,CAT-2,CAT-3,CAT2,CAT3,CAT53,Cationic amino acid transporter,Cationic amino acid transporter 3,Cationic amino acid transporter y+,CVD,FB19,fetal spleen,Glycoprotein,heart,high BP,hippocampus,homocysteine,hydrogen peroxide,hypertension,kidney,liver,Low affinity cationic amino acid transporter 2,lysine,macrophages,macular degeneration,mammary gland,Membrane,Multi-pass membrane protein,N-glycosylated,obesity,ornithine,ovary,pancreas,Phosphoprotein,placenta,PNUTS,PPP1R10,prostate,Protein FB19,ROS,salivary gland,Serine/threonine-protein phosphatase 1 regulatory subunit 10,skeletal muscle,SLC7A2,SLC7A3,Solute carrier family 7 member 2,Solute carrier family 7 member 3,testis,thymus,transmembrane,transport,uterus",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs2300181",
        "SNP Name": "CAT C21068T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2300181",
        "Video": "BSmdOO5jCjY",
        "Tags": "air pollution,amino acid,amino acid transport,amino acids,Amino-acid transport,amygdala,arginine,asthma,ATRC2,ATRC3,brain,cardiorespiratory health,CAT,CAT-2,CAT-3,CAT2,CAT3,CAT53,Cationic amino acid transporter,Cationic amino acid transporter 3,Cationic amino acid transporter y+,CVD,diabetes,FB19,fetal spleen,Glycoprotein,heart,heart disease,heart health,hippocampus,homocysteine,kidney,liver,Low affinity cationic amino acid transporter 2,lysine,macrophages,mammary gland,Membrane,Multi-pass membrane protein,N-glycosylated,obesity,ornithine,ovary,oxidative damage,oxidative stress,pancreas,Phosphoprotein,placenta,PNUTS,PPP1R10,prostate,Protein FB19,ROS,salivary gland,Second Primary Tumors/Recurrence in Head and Neck Cancer Patients,Serine/threonine-protein phosphatase 1 regulatory subunit 10,skeletal muscle,SLC7A2,SLC7A3,Solute carrier family 7 member 2,Solute carrier family 7 member 3,testis,thymus,transmembrane,transport,tumor recurrence,uterus",
        "Group": "Non-Viral Proteins"
    },
    {
        "SNP ID": "rs2300181",
        "SNP Name": "CAT C21068T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2300181",
        "Video": "BSmdOO5jCjY",
        "Tags": "air pollution,amino acid,amino acid transport,amino acids,Amino-acid transport,amygdala,arginine,asthma,ATRC2,ATRC3,brain,cardiorespiratory health,CAT,CAT-2,CAT-3,CAT2,CAT3,CAT53,Cationic amino acid transporter,Cationic amino acid transporter 3,Cationic amino acid transporter y+,CVD,diabetes,FB19,fetal spleen,Glycoprotein,heart,heart disease,heart health,hippocampus,homocysteine,kidney,liver,Low affinity cationic amino acid transporter 2,lysine,macrophages,mammary gland,Membrane,Multi-pass membrane protein,N-glycosylated,obesity,ornithine,ovary,oxidative damage,oxidative stress,pancreas,Phosphoprotein,placenta,PNUTS,PPP1R10,prostate,Protein FB19,ROS,salivary gland,Second Primary Tumors/Recurrence in Head and Neck Cancer Patients,Serine/threonine-protein phosphatase 1 regulatory subunit 10,skeletal muscle,SLC7A2,SLC7A3,Solute carrier family 7 member 2,Solute carrier family 7 member 3,testis,thymus,transmembrane,transport,tumor recurrence,uterus",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2300181",
        "SNP Name": "CAT C21068T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2300181",
        "Video": "BSmdOO5jCjY",
        "Tags": "air pollution,amino acid,amino acid transport,amino acids,Amino-acid transport,amygdala,arginine,asthma,ATRC2,ATRC3,brain,cardiorespiratory health,CAT,CAT-2,CAT-3,CAT2,CAT3,CAT53,Cationic amino acid transporter,Cationic amino acid transporter 3,Cationic amino acid transporter y+,CVD,diabetes,FB19,fetal spleen,Glycoprotein,heart,heart disease,heart health,hippocampus,homocysteine,kidney,liver,Low affinity cationic amino acid transporter 2,lysine,macrophages,mammary gland,Membrane,Multi-pass membrane protein,N-glycosylated,obesity,ornithine,ovary,oxidative damage,oxidative stress,pancreas,Phosphoprotein,placenta,PNUTS,PPP1R10,prostate,Protein FB19,ROS,salivary gland,Second Primary Tumors/Recurrence in Head and Neck Cancer Patients,Serine/threonine-protein phosphatase 1 regulatory subunit 10,skeletal muscle,SLC7A2,SLC7A3,Solute carrier family 7 member 2,Solute carrier family 7 member 3,testis,thymus,transmembrane,transport,tumor recurrence,uterus",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs497582",
        "SNP Name": "PDHX V271V",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs497582",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs497582",
        "SNP Name": "PDHX V271V",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs497582",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs5896",
        "SNP Name": "F2\u00a0\u00a0 C494T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Activation peptide fragment 1,Activation peptide fragment 2,Acute phase,acute-phase response,arg,blood clot,blood coagulation,blood homeostasis,blood microparticle,breast cancer,calcium,calcium ion binding,cardio,cardiovascular,cardiovascular disease,Cell surface interactions at the vascular wall,cell surface receptor signaling pathway,cellular protein metabolic process,clot,coagulation,Coagulation factor II,Congenital factor II deficiency,coumadin,CVD,cytosolic calcium ion homeostasis,Disease mutation,drug metabolism,drug response,drugs,endoplasmic reticulum lumen,extracellular region,extracellular space,extracellular vesicular exosome,F2,FA2D,factor 2,factor II,Factor II deficiency,fibrin,fibrinogen,fibrinolysis,Gamma-carboxylation of protein precursors,Golgi lumen,growth factor activity,heart,heart disease,Hemostasis,Hydrolase,IGF,IGFBPs,inflammation,Inhibited by SERPINA5,Insulin-like Growth Factor Binding Proteins,intrinsic pathway,Ischemic stroke,Ischemic strokes,ISCHSTR,kidney stone,Kidney Stone Disease,kidneys,leukocyte migration,lys,miscarriage,mucocutaneous bleeding,multicellular organismal development,negative regulation of astrocyte differentiation,negative regulation of fibrinolysis,negative regulation of platelet activation,negative regulation of proteolysis,PARs,Peptide ligand-binding receptors,peptidyl-glutamic acid carboxylation,pharmacogenetic,plasma membrane,platelet,platelet activation,Platelet Aggregation,positive regulation of blood coagulation,positive regulation of cell growth,positive regulation of cell proliferation,positive regulation of collagen biosynthetic process,positive regulation of phosphatidylinositol 3-kinase signaling,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,positive regulation of protein phosphorylation,positive regulation of reactive oxygen species metabolic process,positive regulation of release of sequestered calcium ion into cytosol,post-translational protein modification,Pregnancy loss recurrent 2 (RPRGL2),Protease,protein C,proteolysis,Prothrombin,receptor binding,Recurrent pregnancy loss,regulation of blood coagulation,regulation of cell shape,Regulation of Insulin-like Growth Factor,response to wounding,Serine protease,serine-type endopeptidase activity,spontaneous abortion,therapeutic dose of warfarin,THPH1,THRB,Thrombin,Thrombin heavy chain,Thrombin light chain,Thrombin signalling through proteinase activated receptors,thrombomodulin,Thrombophilia,Thrombophilia due to thrombin defect,thrombospondin receptor activity,Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus,vascular occlusion,venous thrombosis,warfarin,warfarin dose,wound healing",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs1799963",
        "SNP Name": "F2 (Prothrombin 20210A) variant",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs1799963",
        "Video": null,
        "Tags": null,
        "Group": "Clotting Factors"
    },
    {
        "SNP ID": "rs8373",
        "SNP Name": "CNTF/ZFP91 S207G",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs8373",
        "SNP Name": "CNTF/ZFP91 S207G",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Gelatin"
    },
    {
        "SNP ID": "rs1800169",
        "SNP Name": "CNTF/ZFP91 1845-6G>A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs1800169",
        "SNP Name": "CNTF/ZFP91 1845-6G>A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Gelatin"
    },
    {
        "SNP ID": "rs557564",
        "SNP Name": "TCN1 C59629305T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum"
    },
    {
        "SNP ID": "rs557564",
        "SNP Name": "TCN1 C59629305T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Hydroxide"
    },
    {
        "SNP ID": "rs557564",
        "SNP Name": "TCN1 C59629305T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Hydroxyphosphate Sulfate"
    },
    {
        "SNP ID": "rs557564",
        "SNP Name": "TCN1 C59629305T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Phosphate"
    },
    {
        "SNP ID": "rs557564",
        "SNP Name": "TCN1 C59629305T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Potassium Sulfate"
    },
    {
        "SNP ID": "rs557564",
        "SNP Name": "TCN1 C59629305T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Salts"
    },
    {
        "SNP ID": "rs557564",
        "SNP Name": "TCN1 C59629305T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Sulfate"
    },
    {
        "SNP ID": "rs526934",
        "SNP Name": "TCN1 G4939288A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs526934",
        "Video": null,
        "Tags": "B12,B12 binding,Belongs to the eukaryotic cobalamin transport proteins family,Binds vitamin B12 with femtomolar affinity and protects it from the acidic environment of the stomach,Cardioembolic Stroke,cardiovascular,cobalamin binding,cobalamin metabolic process,cobalamin transport,Cobalt,cobalt ion transport,Cobalt transport,Complete proteome,Congenital Heart Disease,Contains about 30% carbohydrates,cyanocobalamin,Disulfide bond,DLBCL,extracellular region,Follicular Lymphoma,Glycoprotein,Haptocorrin,HC,heart,heart disease,Ion transport,Large B-Cell Lymphoma,lower plasma B12 levels,Major constituent of secondary granules in neutrophils,MB12,methylcobalamin,non-Hodgkin lymphoma,plasma B12,Polymorphism,Produced by the salivary glands of the oral cavity in response to ingestion of food,prostate cancer,Protein R,reduced transport of transcobalamin,Reference proteome,Secreted,Signal,small molecule metabolic process,stroke,TC I,TC-1,TC1,TCI,TCN1,Transcobalamin,Transcobalamin I,Transcobalamin-1,Transport,vitamin B12,vitamin B12 binding,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Aluminum"
    },
    {
        "SNP ID": "rs526934",
        "SNP Name": "TCN1 G4939288A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs526934",
        "Video": null,
        "Tags": "B12,B12 binding,Belongs to the eukaryotic cobalamin transport proteins family,Binds vitamin B12 with femtomolar affinity and protects it from the acidic environment of the stomach,Cardioembolic Stroke,cardiovascular,cobalamin binding,cobalamin metabolic process,cobalamin transport,Cobalt,cobalt ion transport,Cobalt transport,Complete proteome,Congenital Heart Disease,Contains about 30% carbohydrates,cyanocobalamin,Disulfide bond,DLBCL,extracellular region,Follicular Lymphoma,Glycoprotein,Haptocorrin,HC,heart,heart disease,Ion transport,Large B-Cell Lymphoma,lower plasma B12 levels,Major constituent of secondary granules in neutrophils,MB12,methylcobalamin,non-Hodgkin lymphoma,plasma B12,Polymorphism,Produced by the salivary glands of the oral cavity in response to ingestion of food,prostate cancer,Protein R,reduced transport of transcobalamin,Reference proteome,Secreted,Signal,small molecule metabolic process,stroke,TC I,TC-1,TC1,TCI,TCN1,Transcobalamin,Transcobalamin I,Transcobalamin-1,Transport,vitamin B12,vitamin B12 binding,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Aluminum Hydroxide"
    },
    {
        "SNP ID": "rs526934",
        "SNP Name": "TCN1 G4939288A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs526934",
        "Video": null,
        "Tags": "B12,B12 binding,Belongs to the eukaryotic cobalamin transport proteins family,Binds vitamin B12 with femtomolar affinity and protects it from the acidic environment of the stomach,Cardioembolic Stroke,cardiovascular,cobalamin binding,cobalamin metabolic process,cobalamin transport,Cobalt,cobalt ion transport,Cobalt transport,Complete proteome,Congenital Heart Disease,Contains about 30% carbohydrates,cyanocobalamin,Disulfide bond,DLBCL,extracellular region,Follicular Lymphoma,Glycoprotein,Haptocorrin,HC,heart,heart disease,Ion transport,Large B-Cell Lymphoma,lower plasma B12 levels,Major constituent of secondary granules in neutrophils,MB12,methylcobalamin,non-Hodgkin lymphoma,plasma B12,Polymorphism,Produced by the salivary glands of the oral cavity in response to ingestion of food,prostate cancer,Protein R,reduced transport of transcobalamin,Reference proteome,Secreted,Signal,small molecule metabolic process,stroke,TC I,TC-1,TC1,TCI,TCN1,Transcobalamin,Transcobalamin I,Transcobalamin-1,Transport,vitamin B12,vitamin B12 binding,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Aluminum Hydroxyphosphate Sulfate"
    },
    {
        "SNP ID": "rs526934",
        "SNP Name": "TCN1 G4939288A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs526934",
        "Video": null,
        "Tags": "B12,B12 binding,Belongs to the eukaryotic cobalamin transport proteins family,Binds vitamin B12 with femtomolar affinity and protects it from the acidic environment of the stomach,Cardioembolic Stroke,cardiovascular,cobalamin binding,cobalamin metabolic process,cobalamin transport,Cobalt,cobalt ion transport,Cobalt transport,Complete proteome,Congenital Heart Disease,Contains about 30% carbohydrates,cyanocobalamin,Disulfide bond,DLBCL,extracellular region,Follicular Lymphoma,Glycoprotein,Haptocorrin,HC,heart,heart disease,Ion transport,Large B-Cell Lymphoma,lower plasma B12 levels,Major constituent of secondary granules in neutrophils,MB12,methylcobalamin,non-Hodgkin lymphoma,plasma B12,Polymorphism,Produced by the salivary glands of the oral cavity in response to ingestion of food,prostate cancer,Protein R,reduced transport of transcobalamin,Reference proteome,Secreted,Signal,small molecule metabolic process,stroke,TC I,TC-1,TC1,TCI,TCN1,Transcobalamin,Transcobalamin I,Transcobalamin-1,Transport,vitamin B12,vitamin B12 binding,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Aluminum Phosphate"
    },
    {
        "SNP ID": "rs526934",
        "SNP Name": "TCN1 G4939288A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs526934",
        "Video": null,
        "Tags": "B12,B12 binding,Belongs to the eukaryotic cobalamin transport proteins family,Binds vitamin B12 with femtomolar affinity and protects it from the acidic environment of the stomach,Cardioembolic Stroke,cardiovascular,cobalamin binding,cobalamin metabolic process,cobalamin transport,Cobalt,cobalt ion transport,Cobalt transport,Complete proteome,Congenital Heart Disease,Contains about 30% carbohydrates,cyanocobalamin,Disulfide bond,DLBCL,extracellular region,Follicular Lymphoma,Glycoprotein,Haptocorrin,HC,heart,heart disease,Ion transport,Large B-Cell Lymphoma,lower plasma B12 levels,Major constituent of secondary granules in neutrophils,MB12,methylcobalamin,non-Hodgkin lymphoma,plasma B12,Polymorphism,Produced by the salivary glands of the oral cavity in response to ingestion of food,prostate cancer,Protein R,reduced transport of transcobalamin,Reference proteome,Secreted,Signal,small molecule metabolic process,stroke,TC I,TC-1,TC1,TCI,TCN1,Transcobalamin,Transcobalamin I,Transcobalamin-1,Transport,vitamin B12,vitamin B12 binding,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Aluminum Potassium Sulfate"
    },
    {
        "SNP ID": "rs526934",
        "SNP Name": "TCN1 G4939288A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs526934",
        "Video": null,
        "Tags": "B12,B12 binding,Belongs to the eukaryotic cobalamin transport proteins family,Binds vitamin B12 with femtomolar affinity and protects it from the acidic environment of the stomach,Cardioembolic Stroke,cardiovascular,cobalamin binding,cobalamin metabolic process,cobalamin transport,Cobalt,cobalt ion transport,Cobalt transport,Complete proteome,Congenital Heart Disease,Contains about 30% carbohydrates,cyanocobalamin,Disulfide bond,DLBCL,extracellular region,Follicular Lymphoma,Glycoprotein,Haptocorrin,HC,heart,heart disease,Ion transport,Large B-Cell Lymphoma,lower plasma B12 levels,Major constituent of secondary granules in neutrophils,MB12,methylcobalamin,non-Hodgkin lymphoma,plasma B12,Polymorphism,Produced by the salivary glands of the oral cavity in response to ingestion of food,prostate cancer,Protein R,reduced transport of transcobalamin,Reference proteome,Secreted,Signal,small molecule metabolic process,stroke,TC I,TC-1,TC1,TCI,TCN1,Transcobalamin,Transcobalamin I,Transcobalamin-1,Transport,vitamin B12,vitamin B12 binding,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Aluminum Sulfate"
    },
    {
        "SNP ID": "rs526934",
        "SNP Name": "TCN1 G4939288A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs526934",
        "Video": null,
        "Tags": "B12,B12 binding,Belongs to the eukaryotic cobalamin transport proteins family,Binds vitamin B12 with femtomolar affinity and protects it from the acidic environment of the stomach,Cardioembolic Stroke,cardiovascular,cobalamin binding,cobalamin metabolic process,cobalamin transport,Cobalt,cobalt ion transport,Cobalt transport,Complete proteome,Congenital Heart Disease,Contains about 30% carbohydrates,cyanocobalamin,Disulfide bond,DLBCL,extracellular region,Follicular Lymphoma,Glycoprotein,Haptocorrin,HC,heart,heart disease,Ion transport,Large B-Cell Lymphoma,lower plasma B12 levels,Major constituent of secondary granules in neutrophils,MB12,methylcobalamin,non-Hodgkin lymphoma,plasma B12,Polymorphism,Produced by the salivary glands of the oral cavity in response to ingestion of food,prostate cancer,Protein R,reduced transport of transcobalamin,Reference proteome,Secreted,Signal,small molecule metabolic process,stroke,TC I,TC-1,TC1,TCI,TCN1,Transcobalamin,Transcobalamin I,Transcobalamin-1,Transport,vitamin B12,vitamin B12 binding,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs11231865",
        "SNP Name": "PYGM P410P",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum"
    },
    {
        "SNP ID": "rs11231865",
        "SNP Name": "PYGM P410P",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Hydroxide"
    },
    {
        "SNP ID": "rs11231865",
        "SNP Name": "PYGM P410P",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Hydroxyphosphate Sulfate"
    },
    {
        "SNP ID": "rs11231865",
        "SNP Name": "PYGM P410P",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Phosphate"
    },
    {
        "SNP ID": "rs11231865",
        "SNP Name": "PYGM P410P",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Potassium Sulfate"
    },
    {
        "SNP ID": "rs11231865",
        "SNP Name": "PYGM P410P",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Salts"
    },
    {
        "SNP ID": "rs11231865",
        "SNP Name": "PYGM P410P",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Sulfate"
    },
    {
        "SNP ID": "rs1695",
        "SNP Name": "GSTP1 I105V",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1695",
        "Video": "1Lq5UFRZ_zE",
        "Tags": "5-fluorouracil/leucovorin/oxaliplatin,Acetylation,acute lymphoblastic leukemia,Acute Toxicity among Head and Neck Cancer Patients,advanced colorectal adenoma,Air Pollution,Air Pollution and Incident Childhood Asthma: The Traffic and Asthma,Altered Risk of Oesophageal Squamous Cell Carcinoma,amino acids,anaplastic glioma,antioxidant,Antioxidant Genes,Antioxidant Pathway,apoptosis,arginine,arsenic,arsenic-induced urothelial carcinoma,arsenic-related bladder cancer,ARVCF,ASD,Aspirin,Asthma,atopic asthma,autism,Autism Spectrum Disorder,azathioprine,benzo(a)pyrene and fetal growth,birth defect,bladder cancer,Blood Pressure,Breast Cancer,Breast Cancer Risk,cancer,cancerous,carcinogen,cardiovascular death among hemodialyses patients,catechol estrogen metabolism,Catechol Estrogen Metabolism Pathway (CEMP),CDK5,cell death,cellular energy,cellular response to lipopolysaccharide,central nervous system development,chemo,chemotherapy,chemotherapy metabolizing enzymes,childhood acute lymphoblastic leukemia,childhood allergy,Childhood Brain Tumors,Chronic Obstructive Pulmonary Disease,cigarette smoking,cigarette smoking and pancreatic cancer,cleft lip,cleft palate,Colon Cancer Receiving Oxaliplatin,Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy,Colorectal Cancer,common myeloid progenitor cell proliferation,Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles,COPD,cruciferous vegetables,Cyclophosphamide Chemotherapy,cyclophosphamide metabolism pathway,cystic fibrosis,cystic fibrosis severity,cytoplasm,cytosol,defect,detox,Diisocyanate-Induced Asthma,dinitrosyl-iron complex binding,docetaxel,docetaxel-induced peripheral neuropathy (DIPN),drug metabolism,drug reaction,drug side effects,drugs,E2,energy,environmental,environmental factors,erythema,esophageal squamous cell carcinoma,estrogen,estrogen plus progestin hormone therapy use and risk of postmenopausal breast cancer,extracellular space,extracellular vesicular exosome,FAEES3,gastric cancer,gentamicin-induced vestibular dysfunction,Glucocorticoid resistance,glutamate,glutamine,glutathione,glutathione derivative biosynthetic process,glutathione metabolic process,Glutathione Pathways,Glutathione S-transferase P,Glutathione S-Transferase P1 Haplotypes,glutathione transferase activity,GMO,GSH metabolic pathway,GST C-terminal domain,GST class-pi,GST N-terminal domain,GST superfamily,GST3,GSTP1,GSTP1-1,Head and Neck Cancer,heavy metals,Heavy Smoking on the Risk of Rheumatoid Arthritis,hemodialyses,high BP,Homodimer,hypertension,IL-10,IL10,IL6,inflammation,inflammatory cytokines,interleukin,interleukin-10,interleukin-6 (IL-6),intracellular,iron,JUN kinase binding,kinase regulator activity,L-arginine,L-glutathione,L-glutatime,L-peptide,late subcutaneous fibrosis,leukemia,liver,low BP,Low Dose Aspirin-Associated Small Bowel Bleeding,lung,lung cancer,lungs,lymphoma,macular degeneration,Medulloblastoma,M\u00e9ni\u00e8re's Disease,mercury,mercury biomarker levels in dentists,methylmercury or n-3 polyunsaturated long chain fatty acids and risk of myocardial infarction,mitochondria,mitochondrial,mitochondrion,mortality in breast cancer survivors,Myocardial Infarction,N-terminal amino acids,N6-acetyllysine,N6-succinyllysine,negative regulation of acute inflammatory response,negative regulation of apoptotic process,negative regulation of biosynthetic process,negative regulation of ERK1 and ERK2 cascade,negative regulation of extrinsic apoptotic signaling pathway,negative regulation of fibroblast proliferation,negative regulation of I-kappaB kinase/NF-kappaB signaling,negative regulation of interleukin-1 beta production,negative regulation of JUN kinase activity,negative regulation of leukocyte proliferation,negative regulation of MAP kinase activity,negative regulation of MAPK cascade,negative regulation of monocyte chemotactic protein-1 production,negative regulation of nitr",
        "Group": "Mercury (Thiomersal/Thimerosal)"
    },
    {
        "SNP ID": "rs1695",
        "SNP Name": "GSTP1 I105V",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1695",
        "Video": "1Lq5UFRZ_zE",
        "Tags": "5-fluorouracil/leucovorin/oxaliplatin,Acetylation,acute lymphoblastic leukemia,Acute Toxicity among Head and Neck Cancer Patients,advanced colorectal adenoma,Air Pollution,Air Pollution and Incident Childhood Asthma: The Traffic and Asthma,Altered Risk of Oesophageal Squamous Cell Carcinoma,amino acids,anaplastic glioma,antioxidant,Antioxidant Genes,Antioxidant Pathway,apoptosis,arginine,arsenic,arsenic-induced urothelial carcinoma,arsenic-related bladder cancer,ARVCF,ASD,Aspirin,Asthma,atopic asthma,autism,Autism Spectrum Disorder,azathioprine,benzo(a)pyrene and fetal growth,birth defect,bladder cancer,Blood Pressure,Breast Cancer,Breast Cancer Risk,cancer,cancerous,carcinogen,cardiovascular death among hemodialyses patients,catechol estrogen metabolism,Catechol Estrogen Metabolism Pathway (CEMP),CDK5,cell death,cellular energy,cellular response to lipopolysaccharide,central nervous system development,chemo,chemotherapy,chemotherapy metabolizing enzymes,childhood acute lymphoblastic leukemia,childhood allergy,Childhood Brain Tumors,Chronic Obstructive Pulmonary Disease,cigarette smoking,cigarette smoking and pancreatic cancer,cleft lip,cleft palate,Colon Cancer Receiving Oxaliplatin,Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy,Colorectal Cancer,common myeloid progenitor cell proliferation,Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles,COPD,cruciferous vegetables,Cyclophosphamide Chemotherapy,cyclophosphamide metabolism pathway,cystic fibrosis,cystic fibrosis severity,cytoplasm,cytosol,defect,detox,Diisocyanate-Induced Asthma,dinitrosyl-iron complex binding,docetaxel,docetaxel-induced peripheral neuropathy (DIPN),drug metabolism,drug reaction,drug side effects,drugs,E2,energy,environmental,environmental factors,erythema,esophageal squamous cell carcinoma,estrogen,estrogen plus progestin hormone therapy use and risk of postmenopausal breast cancer,extracellular space,extracellular vesicular exosome,FAEES3,gastric cancer,gentamicin-induced vestibular dysfunction,Glucocorticoid resistance,glutamate,glutamine,glutathione,glutathione derivative biosynthetic process,glutathione metabolic process,Glutathione Pathways,Glutathione S-transferase P,Glutathione S-Transferase P1 Haplotypes,glutathione transferase activity,GMO,GSH metabolic pathway,GST C-terminal domain,GST class-pi,GST N-terminal domain,GST superfamily,GST3,GSTP1,GSTP1-1,Head and Neck Cancer,heavy metals,Heavy Smoking on the Risk of Rheumatoid Arthritis,hemodialyses,high BP,Homodimer,hypertension,IL-10,IL10,IL6,inflammation,inflammatory cytokines,interleukin,interleukin-10,interleukin-6 (IL-6),intracellular,iron,JUN kinase binding,kinase regulator activity,L-arginine,L-glutathione,L-glutatime,L-peptide,late subcutaneous fibrosis,leukemia,liver,low BP,Low Dose Aspirin-Associated Small Bowel Bleeding,lung,lung cancer,lungs,lymphoma,macular degeneration,Medulloblastoma,M\u00e9ni\u00e8re's Disease,mercury,mercury biomarker levels in dentists,methylmercury or n-3 polyunsaturated long chain fatty acids and risk of myocardial infarction,mitochondria,mitochondrial,mitochondrion,mortality in breast cancer survivors,Myocardial Infarction,N-terminal amino acids,N6-acetyllysine,N6-succinyllysine,negative regulation of acute inflammatory response,negative regulation of apoptotic process,negative regulation of biosynthetic process,negative regulation of ERK1 and ERK2 cascade,negative regulation of extrinsic apoptotic signaling pathway,negative regulation of fibroblast proliferation,negative regulation of I-kappaB kinase/NF-kappaB signaling,negative regulation of interleukin-1 beta production,negative regulation of JUN kinase activity,negative regulation of leukocyte proliferation,negative regulation of MAP kinase activity,negative regulation of MAPK cascade,negative regulation of monocyte chemotactic protein-1 production,negative regulation of nitr",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1138272",
        "SNP Name": "GSTP1 A114V",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1138272",
        "Video": "1Lq5UFRZ_zE",
        "Tags": "5-fluorouracil/leucovorin/oxaliplatin,Acetylation,advanced lung cancer treated with platinum-based chemotherapy,Advanced Nasopharyngeal Carcinoma,air pollution,Air Pollution and Incident Childhood Asthma,alcohol consumption and risk of Non-Hodgkin lymphoma,allergic rhinitis,allergies,allergy,amino acids,anaplastic glioma,antioxidant,Antioxidant enzyme,apoptosis,arginine,Ashkenazi Jewish health,ashtma,Associations between Air Pollution and Incident Childhood Asthma: The Traffic,birth defects,brain tumor,Breast Cancer,cancer,cancerous,carcinogen,cardiovascular,cardiovascular disease,CDK5,cell death,cellular energy,cellular response to lipopolysaccharide,central nervous system development,Chemotherapy,childhood acute lymphoblastic leukemia,Childhood Brain Tumors,Chronic Obstructive Pulmonary Disease,cigarette smoking and pancreatic cancer,cleft lip,cleft palate,colorectal cancer,colorectal cancer in Lynch syndrome,common myeloid progenitor cell proliferation,Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles,COPD,CVD,cytoplasm,cytosol,defect,detox,dinitrosyl-iron complex binding,drug,drug metabolism,drug response,E2,energy,environmental,environmental factors,Esophageal Cancer,estrogen,Exposure to Polycyclic Aromatic Hydrocarbons Among Never Smokers in Golestan Province an Area of High Incidence of Esophageal Cancer,extracellular space,extracellular vesicular exosome,FAEES3,FOLFOX4,gentamicin,gentamicin-induced vestibular dysfunction,glutamate,glutamine,glutathione,glutathione derivative biosynthetic process,glutathione metabolic process,Glutathione S-transferase P,glutathione transferase activity,GMO,GST C-terminal domain,GST class-pi,GST N-terminal domain,GST superfamily,GST3,GSTP1,GSTP1-1,heart,heart attack,Homodimer,inhibition by heavy metals,intracellular,iron,JUN kinase binding,kinase regulator activity,L-arginine,L-glutathione,L-glutatime,L-peptide,leukemia,liver,lung,lung cancer,lung cnacer,lymphoblastic leukemia,Lynch syndrome,macular degeneration,macular telangiectasia,Medulloblastoma,mercury,mercury biomarker levels in dentists,mercury biomarker levels in Michigan dental professionals,mercury poisoning,mercury toxicity,methylmercury or n-3 polyunsaturated long chain fatty acids and risk of myocardial infarction,mitochondria,mitochondrial,mitochondrion,myocardial infarction,N-terminal amino acids,N6-acetyllysine,N6-succinyllysine,negative regulation of acute inflammatory response,negative regulation of apoptotic process,negative regulation of biosynthetic process,negative regulation of ERK1 and ERK2 cascade,negative regulation of extrinsic apoptotic signaling pathway,negative regulation of fibroblast proliferation,negative regulation of I-kappaB kinase/NF-kappaB signaling,negative regulation of interleukin-1 beta production,negative regulation of JUN kinase activity,negative regulation of leukocyte proliferation,negative regulation of MAP kinase activity,negative regulation of MAPK cascade,negative regulation of monocyte chemotactic protein-1 production,negative regulation of nitric-oxide synthase biosynthetic process,negative regulation of protein kinase activity,negative regulation of stress-activated MAPK cascade,negative regulation of tumor necrosis factor production,negative regulation of tumor necrosis factor-mediated signaling pathway,neurodegeneration,neurotoxicity,nicotine,nitric oxide binding,nitric oxide storage,nitric oxide synthase,Non-Hodgkin lymphoma,non-Hodgkin lymphoma survival,NOS,nucleus,oesophageal cancer,Orofacial cleft,oxidative balance-related exposures with incident,oxidative stress genes,P25,p25/p35,p35,PAH,pancreatic cancer,papillary thyroid cancer,Parental Smoking and Risk of Childhood Brain Tumors,Parental Smoking and Risk of Childhood Brain Tumors by Functional Polymorphisms in Polycyclic Aromatic Hydrocarbon Metabolism,peptide,Personal Hair Dye Use and Risk of Non-Hodgkin Lymph",
        "Group": "Mercury (Thiomersal/Thimerosal)"
    },
    {
        "SNP ID": "rs1138272",
        "SNP Name": "GSTP1 A114V",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1138272",
        "Video": "1Lq5UFRZ_zE",
        "Tags": "5-fluorouracil/leucovorin/oxaliplatin,Acetylation,advanced lung cancer treated with platinum-based chemotherapy,Advanced Nasopharyngeal Carcinoma,air pollution,Air Pollution and Incident Childhood Asthma,alcohol consumption and risk of Non-Hodgkin lymphoma,allergic rhinitis,allergies,allergy,amino acids,anaplastic glioma,antioxidant,Antioxidant enzyme,apoptosis,arginine,Ashkenazi Jewish health,ashtma,Associations between Air Pollution and Incident Childhood Asthma: The Traffic,birth defects,brain tumor,Breast Cancer,cancer,cancerous,carcinogen,cardiovascular,cardiovascular disease,CDK5,cell death,cellular energy,cellular response to lipopolysaccharide,central nervous system development,Chemotherapy,childhood acute lymphoblastic leukemia,Childhood Brain Tumors,Chronic Obstructive Pulmonary Disease,cigarette smoking and pancreatic cancer,cleft lip,cleft palate,colorectal cancer,colorectal cancer in Lynch syndrome,common myeloid progenitor cell proliferation,Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles,COPD,CVD,cytoplasm,cytosol,defect,detox,dinitrosyl-iron complex binding,drug,drug metabolism,drug response,E2,energy,environmental,environmental factors,Esophageal Cancer,estrogen,Exposure to Polycyclic Aromatic Hydrocarbons Among Never Smokers in Golestan Province an Area of High Incidence of Esophageal Cancer,extracellular space,extracellular vesicular exosome,FAEES3,FOLFOX4,gentamicin,gentamicin-induced vestibular dysfunction,glutamate,glutamine,glutathione,glutathione derivative biosynthetic process,glutathione metabolic process,Glutathione S-transferase P,glutathione transferase activity,GMO,GST C-terminal domain,GST class-pi,GST N-terminal domain,GST superfamily,GST3,GSTP1,GSTP1-1,heart,heart attack,Homodimer,inhibition by heavy metals,intracellular,iron,JUN kinase binding,kinase regulator activity,L-arginine,L-glutathione,L-glutatime,L-peptide,leukemia,liver,lung,lung cancer,lung cnacer,lymphoblastic leukemia,Lynch syndrome,macular degeneration,macular telangiectasia,Medulloblastoma,mercury,mercury biomarker levels in dentists,mercury biomarker levels in Michigan dental professionals,mercury poisoning,mercury toxicity,methylmercury or n-3 polyunsaturated long chain fatty acids and risk of myocardial infarction,mitochondria,mitochondrial,mitochondrion,myocardial infarction,N-terminal amino acids,N6-acetyllysine,N6-succinyllysine,negative regulation of acute inflammatory response,negative regulation of apoptotic process,negative regulation of biosynthetic process,negative regulation of ERK1 and ERK2 cascade,negative regulation of extrinsic apoptotic signaling pathway,negative regulation of fibroblast proliferation,negative regulation of I-kappaB kinase/NF-kappaB signaling,negative regulation of interleukin-1 beta production,negative regulation of JUN kinase activity,negative regulation of leukocyte proliferation,negative regulation of MAP kinase activity,negative regulation of MAPK cascade,negative regulation of monocyte chemotactic protein-1 production,negative regulation of nitric-oxide synthase biosynthetic process,negative regulation of protein kinase activity,negative regulation of stress-activated MAPK cascade,negative regulation of tumor necrosis factor production,negative regulation of tumor necrosis factor-mediated signaling pathway,neurodegeneration,neurotoxicity,nicotine,nitric oxide binding,nitric oxide storage,nitric oxide synthase,Non-Hodgkin lymphoma,non-Hodgkin lymphoma survival,NOS,nucleus,oesophageal cancer,Orofacial cleft,oxidative balance-related exposures with incident,oxidative stress genes,P25,p25/p35,p35,PAH,pancreatic cancer,papillary thyroid cancer,Parental Smoking and Risk of Childhood Brain Tumors,Parental Smoking and Risk of Childhood Brain Tumors by Functional Polymorphisms in Polycyclic Aromatic Hydrocarbon Metabolism,peptide,Personal Hair Dye Use and Risk of Non-Hodgkin Lymph",
        "Group": "Polacrilin Potassium"
    },
    {
        "SNP ID": "rs1138272",
        "SNP Name": "GSTP1 A114V",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1138272",
        "Video": "1Lq5UFRZ_zE",
        "Tags": "5-fluorouracil/leucovorin/oxaliplatin,Acetylation,advanced lung cancer treated with platinum-based chemotherapy,Advanced Nasopharyngeal Carcinoma,air pollution,Air Pollution and Incident Childhood Asthma,alcohol consumption and risk of Non-Hodgkin lymphoma,allergic rhinitis,allergies,allergy,amino acids,anaplastic glioma,antioxidant,Antioxidant enzyme,apoptosis,arginine,Ashkenazi Jewish health,ashtma,Associations between Air Pollution and Incident Childhood Asthma: The Traffic,birth defects,brain tumor,Breast Cancer,cancer,cancerous,carcinogen,cardiovascular,cardiovascular disease,CDK5,cell death,cellular energy,cellular response to lipopolysaccharide,central nervous system development,Chemotherapy,childhood acute lymphoblastic leukemia,Childhood Brain Tumors,Chronic Obstructive Pulmonary Disease,cigarette smoking and pancreatic cancer,cleft lip,cleft palate,colorectal cancer,colorectal cancer in Lynch syndrome,common myeloid progenitor cell proliferation,Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles,COPD,CVD,cytoplasm,cytosol,defect,detox,dinitrosyl-iron complex binding,drug,drug metabolism,drug response,E2,energy,environmental,environmental factors,Esophageal Cancer,estrogen,Exposure to Polycyclic Aromatic Hydrocarbons Among Never Smokers in Golestan Province an Area of High Incidence of Esophageal Cancer,extracellular space,extracellular vesicular exosome,FAEES3,FOLFOX4,gentamicin,gentamicin-induced vestibular dysfunction,glutamate,glutamine,glutathione,glutathione derivative biosynthetic process,glutathione metabolic process,Glutathione S-transferase P,glutathione transferase activity,GMO,GST C-terminal domain,GST class-pi,GST N-terminal domain,GST superfamily,GST3,GSTP1,GSTP1-1,heart,heart attack,Homodimer,inhibition by heavy metals,intracellular,iron,JUN kinase binding,kinase regulator activity,L-arginine,L-glutathione,L-glutatime,L-peptide,leukemia,liver,lung,lung cancer,lung cnacer,lymphoblastic leukemia,Lynch syndrome,macular degeneration,macular telangiectasia,Medulloblastoma,mercury,mercury biomarker levels in dentists,mercury biomarker levels in Michigan dental professionals,mercury poisoning,mercury toxicity,methylmercury or n-3 polyunsaturated long chain fatty acids and risk of myocardial infarction,mitochondria,mitochondrial,mitochondrion,myocardial infarction,N-terminal amino acids,N6-acetyllysine,N6-succinyllysine,negative regulation of acute inflammatory response,negative regulation of apoptotic process,negative regulation of biosynthetic process,negative regulation of ERK1 and ERK2 cascade,negative regulation of extrinsic apoptotic signaling pathway,negative regulation of fibroblast proliferation,negative regulation of I-kappaB kinase/NF-kappaB signaling,negative regulation of interleukin-1 beta production,negative regulation of JUN kinase activity,negative regulation of leukocyte proliferation,negative regulation of MAP kinase activity,negative regulation of MAPK cascade,negative regulation of monocyte chemotactic protein-1 production,negative regulation of nitric-oxide synthase biosynthetic process,negative regulation of protein kinase activity,negative regulation of stress-activated MAPK cascade,negative regulation of tumor necrosis factor production,negative regulation of tumor necrosis factor-mediated signaling pathway,neurodegeneration,neurotoxicity,nicotine,nitric oxide binding,nitric oxide storage,nitric oxide synthase,Non-Hodgkin lymphoma,non-Hodgkin lymphoma survival,NOS,nucleus,oesophageal cancer,Orofacial cleft,oxidative balance-related exposures with incident,oxidative stress genes,P25,p25/p35,p35,PAH,pancreatic cancer,papillary thyroid cancer,Parental Smoking and Risk of Childhood Brain Tumors,Parental Smoking and Risk of Childhood Brain Tumors by Functional Polymorphisms in Polycyclic Aromatic Hydrocarbon Metabolism,peptide,Personal Hair Dye Use and Risk of Non-Hodgkin Lymph",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs4147776",
        "SNP Name": "NDUFS8 variant",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs2075626",
        "SNP Name": "NDUFS8 variant",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs7925545",
        "SNP Name": "FOLR3 A3771G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7925545",
        "Video": null,
        "Tags": "5-methyltetrahydrofolate,5-MTHF,Alternative splicing,binds to folate and reduced folic acid derivatives and mediates delivery of 5-methyltetrahydrofolate to the interior of cells,birth defects,bone marrow,cancer,carcinogen,Complete proteome,Disulfide bond,extracellular region,extrinsic component of membrane,folate,folate binding,Folate receptor 3,folate receptor family,Folate receptor gamma,folate transport genes,folate-binding,folic acid,folic acid binding,folic acid supplementation,folic acid transport,folinic acid,FOLR1,FOLR2,FOLR3,FR-gamma,Glycoprotein,immune system,L-5-MTHF,Meningomyelocele (MM),natural killer cell,neural tube,neural tube defect,NTDs,ovarian carcinoma,receptor,reduced folate carrier (SLC19A1),Reference proteome,Secreted,signal,Spleen,supplement,T cell,thymus,uterine carcinoma",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs7925545",
        "SNP Name": "FOLR3 A3771G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7925545",
        "Video": null,
        "Tags": "5-methyltetrahydrofolate,5-MTHF,Alternative splicing,binds to folate and reduced folic acid derivatives and mediates delivery of 5-methyltetrahydrofolate to the interior of cells,birth defects,bone marrow,cancer,carcinogen,Complete proteome,Disulfide bond,extracellular region,extrinsic component of membrane,folate,folate binding,Folate receptor 3,folate receptor family,Folate receptor gamma,folate transport genes,folate-binding,folic acid,folic acid binding,folic acid supplementation,folic acid transport,folinic acid,FOLR1,FOLR2,FOLR3,FR-gamma,Glycoprotein,immune system,L-5-MTHF,Meningomyelocele (MM),natural killer cell,neural tube,neural tube defect,NTDs,ovarian carcinoma,receptor,reduced folate carrier (SLC19A1),Reference proteome,Secreted,signal,Spleen,supplement,T cell,thymus,uterine carcinoma",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs7926875",
        "SNP Name": "FOLR3 C7672A",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7926875",
        "Video": null,
        "Tags": "5-methyltetrahydrofolate,5-MTHF,Alternative splicing,binds to folate and reduced folic acid derivatives and mediates delivery of 5-methyltetrahydrofolate to the interior of cells,birth defects,bone marrow,cancer,carcinogen,Complete proteome,Disulfide bond,extracellular region,extrinsic component of membrane,folate,folate binding,Folate receptor 3,folate receptor family,Folate receptor gamma,folate transport genes,folate-binding,folic acid,folic acid binding,folic acid supplementation,folic acid transport,folinic acid,FOLR1,FOLR2,FOLR3,FR-gamma,Glycoprotein,immune system,L-5-MTHF,Meningomyelocele (MM),natural killer cell,neural tube,neural tube defect,NTDs,ovarian carcinoma,receptor,reduced folate carrier (SLC19A1),Reference proteome,Secreted,signal,Spleen,supplement,T cell,thymus,uterine carcinoma",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs7926875",
        "SNP Name": "FOLR3 C7672A",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7926875",
        "Video": null,
        "Tags": "5-methyltetrahydrofolate,5-MTHF,Alternative splicing,binds to folate and reduced folic acid derivatives and mediates delivery of 5-methyltetrahydrofolate to the interior of cells,birth defects,bone marrow,cancer,carcinogen,Complete proteome,Disulfide bond,extracellular region,extrinsic component of membrane,folate,folate binding,Folate receptor 3,folate receptor family,Folate receptor gamma,folate transport genes,folate-binding,folic acid,folic acid binding,folic acid supplementation,folic acid transport,folinic acid,FOLR1,FOLR2,FOLR3,FR-gamma,Glycoprotein,immune system,L-5-MTHF,Meningomyelocele (MM),natural killer cell,neural tube,neural tube defect,NTDs,ovarian carcinoma,receptor,reduced folate carrier (SLC19A1),Reference proteome,Secreted,signal,Spleen,supplement,T cell,thymus,uterine carcinoma",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2071010",
        "SNP Name": "FOLR1 G-20A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2071010",
        "Video": null,
        "Tags": "5-methyltetrahydrofolate,acidic pH,Adult folate-binding protein,alternative splicing,Apical cell membrane,apical plasma membrane,ASD,autism,Autism Spectrum Disorder,birth defect,brain-specific folate deficiency,brush border membrane,cancer,cancerous,carcinogen,cell,cell death,Cell membrane,cell proliferation,cerebellum,cerebral folate transport deficiency,clathrin-coated vesicle,colorectal cancer,conotruncal heart defects,Cytoplasmic vesicle,defect,deficiency,Disulfide bond,embryonic,embryonic development,endocytosis,Endosome,epilepsy,epithelial,FBP,folate,folate analogs,Folate receptor,Folate receptor 1,folate receptor adult,Folate receptor alpha,folate receptor family,folate uptake,Folate-binding,folic acid analogs,folic acid binding,folic acid metabolic process,folic acid transport,folic acid transporter activity,FOLR,FOLR1,FR-alpha,gene,gene product,Glycoprotein,GPI-anchor,heart,heart defect,KB cells FBP,kidney,leukodystrophy,linkage,Lipid-anchor,Lipoprotein,lung,malignant tissues,Meningomyelocele,metalloprotease,movement disturbances,mutations,NCFTD,Neurodegeneration,neurodegenerative disorder,neutral pH,Ovarian tumor-associated antigen MOv18,pH,placenta epithelium,plasma membrane,Polymorphism,proliferation,protein,proteolysis,proteome,Receptor,receptor activity,receptor endocytosis triggers,receptor-mediated endocytosis,reduced folic acid derivatives,regression,severe developmental regression,soluble,splicing,thymus epithelium,transcript,transcription,xtracellular vesicular exosome",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2071010",
        "SNP Name": "FOLR1 G-20A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2071010",
        "Video": null,
        "Tags": "5-methyltetrahydrofolate,acidic pH,Adult folate-binding protein,alternative splicing,Apical cell membrane,apical plasma membrane,ASD,autism,Autism Spectrum Disorder,birth defect,brain-specific folate deficiency,brush border membrane,cancer,cancerous,carcinogen,cell,cell death,Cell membrane,cell proliferation,cerebellum,cerebral folate transport deficiency,clathrin-coated vesicle,colorectal cancer,conotruncal heart defects,Cytoplasmic vesicle,defect,deficiency,Disulfide bond,embryonic,embryonic development,endocytosis,Endosome,epilepsy,epithelial,FBP,folate,folate analogs,Folate receptor,Folate receptor 1,folate receptor adult,Folate receptor alpha,folate receptor family,folate uptake,Folate-binding,folic acid analogs,folic acid binding,folic acid metabolic process,folic acid transport,folic acid transporter activity,FOLR,FOLR1,FR-alpha,gene,gene product,Glycoprotein,GPI-anchor,heart,heart defect,KB cells FBP,kidney,leukodystrophy,linkage,Lipid-anchor,Lipoprotein,lung,malignant tissues,Meningomyelocele,metalloprotease,movement disturbances,mutations,NCFTD,Neurodegeneration,neurodegenerative disorder,neutral pH,Ovarian tumor-associated antigen MOv18,pH,placenta epithelium,plasma membrane,Polymorphism,proliferation,protein,proteolysis,proteome,Receptor,receptor activity,receptor endocytosis triggers,receptor-mediated endocytosis,reduced folic acid derivatives,regression,severe developmental regression,soluble,splicing,thymus epithelium,transcript,transcription,xtracellular vesicular exosome",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs651933",
        "SNP Name": "FOLR2 G-1316A",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs651933",
        "Video": null,
        "Tags": "anchored component of external side of plasma membrane,birth defects,carcinogen,defect,folate deficiency,folate gene,folate transport genes,folic acid supplementation,FOLR1,FOLR2,FOLR2 retinoic acid upregulation,FOLR3,Meningomyelocele,Meningomyelocele (MM),neural tube,neural tube defect,neutral pH,NTDs,Reduced Folate Carrier (SLC19A1),SLC19A1,supplement,\u00a05-methyltetrahydrofolate,\u00a05-MTHF,\u00a0acidic pH,\u00a0cancer,\u00a0cancerous,\u00a0Cell membrane,\u00a0Disulfide bond,\u00a0Expressed in placenta and hematopoietic cells,\u00a0Expression is increased in malignant tissues,\u00a0extracellular region,\u00a0fetal/placental,\u00a0folate,\u00a0Folate receptor 2Folate receptor,\u00a0Folate receptor beta,\u00a0folate receptor family,\u00a0Folate-binding,\u00a0folic acid,\u00a0folic acid binding,\u00a0folic acid transport,\u00a0folic acid transporter activity,\u00a0folinic acid,\u00a0FR-beta,\u00a0Glycoprotein,\u00a0GPI-anchor,\u00a0L-5-MTHF,\u00a0Lipid-anchor,\u00a0Lipoprotein,\u00a0membrane,\u00a0N-glycosylated,\u00a0Placental folate-binding protein,\u00a0Polymorphism,\u00a0Receptor,\u00a0Secreted,\u00a0Signal,\u00a0Transport,\u00a0tumor",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs651933",
        "SNP Name": "FOLR2 G-1316A",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs651933",
        "Video": null,
        "Tags": "anchored component of external side of plasma membrane,birth defects,carcinogen,defect,folate deficiency,folate gene,folate transport genes,folic acid supplementation,FOLR1,FOLR2,FOLR2 retinoic acid upregulation,FOLR3,Meningomyelocele,Meningomyelocele (MM),neural tube,neural tube defect,neutral pH,NTDs,Reduced Folate Carrier (SLC19A1),SLC19A1,supplement,\u00a05-methyltetrahydrofolate,\u00a05-MTHF,\u00a0acidic pH,\u00a0cancer,\u00a0cancerous,\u00a0Cell membrane,\u00a0Disulfide bond,\u00a0Expressed in placenta and hematopoietic cells,\u00a0Expression is increased in malignant tissues,\u00a0extracellular region,\u00a0fetal/placental,\u00a0folate,\u00a0Folate receptor 2Folate receptor,\u00a0Folate receptor beta,\u00a0folate receptor family,\u00a0Folate-binding,\u00a0folic acid,\u00a0folic acid binding,\u00a0folic acid transport,\u00a0folic acid transporter activity,\u00a0folinic acid,\u00a0FR-beta,\u00a0Glycoprotein,\u00a0GPI-anchor,\u00a0L-5-MTHF,\u00a0Lipid-anchor,\u00a0Lipoprotein,\u00a0membrane,\u00a0N-glycosylated,\u00a0Placental folate-binding protein,\u00a0Polymorphism,\u00a0Receptor,\u00a0Secreted,\u00a0Signal,\u00a0Transport,\u00a0tumor",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs10793294",
        "SNP Name": "GAB2 G137466T",
        "Risk Allele": "A",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "4,4-bisphosphate binding,5-trisphosphate binding,AD,allergic response,Alzheimer,Alzheimer\u2019s disease,antigen,B-cell,cell matrix,cell migration,cytokine,dementia,Fc-epsilon receptor signaling pathway,GAB2,GRB2,GRB2-associated binder 2,GRB2-associated-binding protein 2,Growth factor receptor bound protein 2-associated protein 2,growth factor receptors,hormone,IL-6,IL6,immune system,immunodeficiency,innate immune response,integrin-mediated signaling pathway,interleukin,KIAA0571,L-Tyrosine,late-onset Alzheimer's disease,Late-Onset Alzheimer\u2019s Disease,mast cell,mast cell activation,mast cells,mastocytosis,neurodegenerative disorder,osteoclast differentiation,phosphatidylinositol-3,phosphatidylinositol-mediated signaling,Phosphorylated,Phosphothreonine,Phosphotyrosine,PI-3 kinase,PI-3-kinase,positive regulation of cell proliferation,positive regulation of mast cell degranulation,pp100,SHC1,T-cell,thrombopoietin receptor,TNFRSF11A/RANK,TPOR,transmembrane receptor protein tyrosine kinase adaptor activity,transmembrane receptor protein tyrosine kinase signaling pathway,tyrosine",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs2373115",
        "SNP Name": "GAB2 G42719T",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "4,4-bisphosphate binding,5-trisphosphate binding,AD,allergic response,Alzheimer,Alzheimer\u2019s disease,antigen,B-cell,cell matrix,cell migration,cytokine,dementia,Fc-epsilon receptor signaling pathway,GAB2,glucose,glucose metabolism,GRB2,GRB2-associated binder 2,GRB2-associated-binding protein 2,Growth factor receptor bound protein 2-associated protein 2,growth factor receptors,higher glucose metabolism,hormone,IL-6,IL6,immune system,immunodeficiency,innate immune response,integrin-mediated signaling pathway,interleukin,KIAA0571,L-Tyrosine,late-onset Alzheimer's disease,Late-Onset Alzheimer\u2019s Disease,mast cell,mast cell activation,mast cells,mastocytosis,neurodegenerative disorder,osteoclast differentiation,phosphatidylinositol-3,phosphatidylinositol-mediated signaling,Phosphorylated,Phosphothreonine,Phosphotyrosine,PI-3 kinase,PI-3-kinase,positive regulation of cell proliferation,positive regulation of mast cell degranulation,pp100,SHC1,T-cell,thrombopoietin receptor,TNFRSF11A/RANK,TPOR,transmembrane receptor protein tyrosine kinase adaptor activity,transmembrane receptor protein tyrosine kinase signaling pathway,tyrosine",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs28940881",
        "SNP Name": "TYR A5083G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "L-Tyrosine"
    },
    {
        "SNP ID": "rs28940879",
        "SNP Name": "TYR (MeFV) V726A variant",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs28940879",
        "Video": null,
        "Tags": null,
        "Group": "Other Immune Factors"
    },
    {
        "SNP ID": "rs1393350",
        "SNP Name": "TYR G105007A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "L-Tyrosine"
    },
    {
        "SNP ID": "rs3741049",
        "SNP Name": "ACAT1 G22670A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.mcponline.org/content/12/6/1589.short",
        "Video": "xK0C8Jd99BU",
        "Tags": "2 acetyl-CoA = CoA,2-methyl-3-hydroxybutyric acid,2-methylacetoacetic acid,2-methylacetoacetyl coenzyme A,3-ketothiolase deficiency,ACAT1,acetoacetyl coenzyme A,acetoacetyl-CoA,Acetoacetyl-CoA thiolase,acetyl coenzyme A,Acetyl-CoA acetyltransferase,acetyl-CoA C-acetyltransferase activity,Acetylation,Acyltransferase,adeno b12,adenosyl b12,adenosyl cobalamin,adenosyl cobalamine,adipose tissue development,b12,b12 deficiency,brain development,branched-chain amino acid catabolic process,butanone,c diff,cancer,cellular ketone body metabolic process,cellular lipid metabolic process,cellular nitrogen compound metabolic process,cholesterol,cholesterol metabolism,coenzyme A,Disease mutation,extracellular vesicular exosome,Homotetramer,increased  butanone,isoleucine catabolism,ketoacidotic attacks,ketogenic,ketone body biosynthetic process,ketone body catabolic process,ketone body metabolism,ketone metabolism,Ketones,liver development,MAT,metal ion binding,Metal-binding,metanephric proximal convoluted tubule development,mitochondrial,mitochondrial inner membrane,mitochondrial matrix,Mitochondrion,Polymorphism,potassium,potassium activation,potassium ions,prostate,protein homooligomerization,response to hormone,response to organic cyclic compound,response to starvation,small molecule metabolic process,T2,thiolase,thiolase family,Transferase,Transit peptide,triglylglycine,unconsciousness",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1946518",
        "SNP Name": "IL8 A4383C",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "2-Phenoxyethanol"
    },
    {
        "SNP ID": "rs1946518",
        "SNP Name": "IL8 A4383C",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Alcohol"
    },
    {
        "SNP ID": "rs1946518",
        "SNP Name": "IL8 A4383C",
        "Risk Allele": "G",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs1800497",
        "SNP Name": "ANKK1 E713K",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1800497",
        "Video": null,
        "Tags": "addiction,addictive behavior,adenoma,ADHD,adiposity,ADP,advanced adenoma,Alcohol,alcohol addiction,alcohol dependence,alcoholism,alters reversal learning and associated neural activity,ANK repeat,ANK repeats,ANKK1,Ankyrin repeat and protein kinase domain-containing protein 1,antipsychotic drug treatment response,Antipsychotic-Induced Movement Disorders,antipsychotic-induced side effects,antipsychotics,Antipsychotics: Therapeutic Efficacy and Side Effects Prediction,anxiety,ASD,asperger's,aspergers,ATP,ATP-binding,Attention-deficit-hyperactivity-disorder,Attention-Deficit/Hyperactivity Disorder,autism,autism spectrum,autism spectrum disorder,autism spectrum disorders,bipolar disorder,blood lead,borderline personality,brain injury outcome,brain response to a primary food reward,caffeine induced anxiety,caffeine metabolism,Caffeine-Induced Anxiety,cannabis dependence,children\u2019s telomere length,chronic renal insufficiency,cocaine,cocaine addiction,cognition,Cognitive Effects of Nicotine,Cognitive Outcome Shortly After Traumatic Brain Injury,comorbid alcohol use and depressive disorders,Comorbid Antisocial Personality Disorder (ASPD),Complete proteome,COMT,copper,creative potential,creativity,daily tobacco smoking,DAT1,decision making,Delayed Reward Discounting,depression,depressive and anxious symptoms in childhood,disequilibrium,divergent thinking,dopamine,dopamine receptor,dopamine receptor levels,dopaminergic,DRD2,DRD4,drug,Drug Dependence,drugs,energy,Fatigue,fear conditioning,hemoglobin,Hemoglobin and Lead Exposure and Intelligence Quotient,heroin,heroin addiction,heroin dependence,Huntington\u2019s disease,IBS,Impulsivity,inflammation,intelligence quotient,Iron-deficiency anemia,Irritable Bowel Syndrome,Kinase,L dopa,L-dopa,Major Depressive Disorder,mental disorder,mental illness,metabolic syndrome,metabolic syndrome genes in primary open angle glaucoma,Methamphetamine-Associated Psychosis,modulates motivation to smoke,Motor Learning and Its Modulation by L-Dopa,neural reward sensitivity,neurocognitive development,neuropsychiatric,neuropsychiatric disorder,neuropsychiatric disorders,nicotine addiction,nicotine dependence,Novelty Seeking and Harm Avoidance,Nucleotide-binding,obesity,opiates,opiod,opioid addiction,Parkinson,Parkinson's,Parkinson's disease,Parkinsons disease,Pharmacogenetics,phosphoprotein,PKK2,Polymorphism,prediction of depression,Prenatal Nicotine Exposure,protein kinase domain,Protein kinase PKK2,protein kinase superfamily,protein serine/threonine kinase activity,psychiatric,psychiatric disorder,psychiatric disorders,reactivity reward,Reference proteome,Reward Sensitivity Deficit in Smokers,Schizophrenia,sensitivity to nicotine in nonsmokers,Serine/threonine-protein kinase,serotonin,SGK288,SgK288 X-kinase,smoking genetics,Social disadvantage,striatal glucose metabolism,substance abuse,Sugen kinase 288,Tardive Dyskinesia in schizophrenia,TBI,TKL Ser/Thr protein kinase family,Transferase,traumatic brain injury,type-2 diabetes,Ventral Striatum Reactivity,Visual Working Memory,Wilson Disease,Working memory",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1800497",
        "SNP Name": "ANKK1 E713K",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1800497",
        "Video": null,
        "Tags": "addiction,addictive behavior,adenoma,ADHD,adiposity,ADP,advanced adenoma,Alcohol,alcohol addiction,alcohol dependence,alcoholism,alters reversal learning and associated neural activity,ANK repeat,ANK repeats,ANKK1,Ankyrin repeat and protein kinase domain-containing protein 1,antipsychotic drug treatment response,Antipsychotic-Induced Movement Disorders,antipsychotic-induced side effects,antipsychotics,Antipsychotics: Therapeutic Efficacy and Side Effects Prediction,anxiety,ASD,asperger's,aspergers,ATP,ATP-binding,Attention-deficit-hyperactivity-disorder,Attention-Deficit/Hyperactivity Disorder,autism,autism spectrum,autism spectrum disorder,autism spectrum disorders,bipolar disorder,blood lead,borderline personality,brain injury outcome,brain response to a primary food reward,caffeine induced anxiety,caffeine metabolism,Caffeine-Induced Anxiety,cannabis dependence,children\u2019s telomere length,chronic renal insufficiency,cocaine,cocaine addiction,cognition,Cognitive Effects of Nicotine,Cognitive Outcome Shortly After Traumatic Brain Injury,comorbid alcohol use and depressive disorders,Comorbid Antisocial Personality Disorder (ASPD),Complete proteome,COMT,copper,creative potential,creativity,daily tobacco smoking,DAT1,decision making,Delayed Reward Discounting,depression,depressive and anxious symptoms in childhood,disequilibrium,divergent thinking,dopamine,dopamine receptor,dopamine receptor levels,dopaminergic,DRD2,DRD4,drug,Drug Dependence,drugs,energy,Fatigue,fear conditioning,hemoglobin,Hemoglobin and Lead Exposure and Intelligence Quotient,heroin,heroin addiction,heroin dependence,Huntington\u2019s disease,IBS,Impulsivity,inflammation,intelligence quotient,Iron-deficiency anemia,Irritable Bowel Syndrome,Kinase,L dopa,L-dopa,Major Depressive Disorder,mental disorder,mental illness,metabolic syndrome,metabolic syndrome genes in primary open angle glaucoma,Methamphetamine-Associated Psychosis,modulates motivation to smoke,Motor Learning and Its Modulation by L-Dopa,neural reward sensitivity,neurocognitive development,neuropsychiatric,neuropsychiatric disorder,neuropsychiatric disorders,nicotine addiction,nicotine dependence,Novelty Seeking and Harm Avoidance,Nucleotide-binding,obesity,opiates,opiod,opioid addiction,Parkinson,Parkinson's,Parkinson's disease,Parkinsons disease,Pharmacogenetics,phosphoprotein,PKK2,Polymorphism,prediction of depression,Prenatal Nicotine Exposure,protein kinase domain,Protein kinase PKK2,protein kinase superfamily,protein serine/threonine kinase activity,psychiatric,psychiatric disorder,psychiatric disorders,reactivity reward,Reference proteome,Reward Sensitivity Deficit in Smokers,Schizophrenia,sensitivity to nicotine in nonsmokers,Serine/threonine-protein kinase,serotonin,SGK288,SgK288 X-kinase,smoking genetics,Social disadvantage,striatal glucose metabolism,substance abuse,Sugen kinase 288,Tardive Dyskinesia in schizophrenia,TBI,TKL Ser/Thr protein kinase family,Transferase,traumatic brain injury,type-2 diabetes,Ventral Striatum Reactivity,Visual Working Memory,Wilson Disease,Working memory",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs10891549",
        "SNP Name": "DRD2 A72555G",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10891549",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,addictionnsmembrane,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol metabolism,alcoholism,Alternative splicing,ANKK1,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Complete proteome,coupled via Gi/Go drug binding,D (2) dopamine receptor,dendrite,dendritic spine,dependence,Disease mutation,Disulfide bond,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart rate,regulation of locomotion involved in locomotory behavior,regulation of long-term neuronal synaptic plasticity,regulation of phosphoprotein phosphatase activity,regulation of potassium ion transport,regulation of sodium ion tra",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs10891549",
        "SNP Name": "DRD2 A72555G",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10891549",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,addictionnsmembrane,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol metabolism,alcoholism,Alternative splicing,ANKK1,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Complete proteome,coupled via Gi/Go drug binding,D (2) dopamine receptor,dendrite,dendritic spine,dependence,Disease mutation,Disulfide bond,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart rate,regulation of locomotion involved in locomotory behavior,regulation of long-term neuronal synaptic plasticity,regulation of phosphoprotein phosphatase activity,regulation of potassium ion transport,regulation of sodium ion tra",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2242592",
        "SNP Name": "DRD2 C71572T",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2242592",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,Continuous Performance Task,coupled via Gi/Go drug binding,D (2) dopamine receptor,dendrite,dendritic spine,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,migraine,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart rate,regulation of loc",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs2242592",
        "SNP Name": "DRD2 C71572T",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2242592",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,Continuous Performance Task,coupled via Gi/Go drug binding,D (2) dopamine receptor,dendrite,dendritic spine,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,migraine,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart rate,regulation of loc",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs6275",
        "SNP Name": "DRD2 T852C",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6275",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,Alcohol Use,alcoholism,Alternative splicing,antipsychotic treatment response,Antipsychotic-Induced Movement Disorders,anxiety,arachidonic acid secretion,ARRB2,ASD,associative learning,auditory behavior,autism,autism spectrum disorders,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Caffeine-Induced Anxiety,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,coupled via Gi/Go drug binding,D (2) dopamine receptor,dendrite,dendritic spine,depression,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,mental disorder,migraine,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,Opioid Dependence,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteom",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs6275",
        "SNP Name": "DRD2 T852C",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6275",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,Alcohol Use,alcoholism,Alternative splicing,antipsychotic treatment response,Antipsychotic-Induced Movement Disorders,anxiety,arachidonic acid secretion,ARRB2,ASD,associative learning,auditory behavior,autism,autism spectrum disorders,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Caffeine-Induced Anxiety,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,coupled via Gi/Go drug binding,D (2) dopamine receptor,dendrite,dendritic spine,depression,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,mental disorder,migraine,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,Opioid Dependence,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteom",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1076560",
        "SNP Name": "DRD2 G67314T",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=Rs5326",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,ADHD,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,alters reversal learning,arachidonic acid secretion,ARRB2,ASD,associative learning,attentional processing,auditory behavior,autism spectrum disorders,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,coupled via Gi/Go drug binding,D (2) dopamine receptor,dendrite,dendritic spine,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,drug dependence,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,independent signaling,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,lethal cocaine abuse,locomotory behavior,long-term memory,methadone dose,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,olanzapine response,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,pharmacogenetics,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychiatric Disorders,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in syna",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1076560",
        "SNP Name": "DRD2 G67314T",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=Rs5326",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,ADHD,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,alters reversal learning,arachidonic acid secretion,ARRB2,ASD,associative learning,attentional processing,auditory behavior,autism spectrum disorders,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,coupled via Gi/Go drug binding,D (2) dopamine receptor,dendrite,dendritic spine,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,drug dependence,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,independent signaling,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,lethal cocaine abuse,locomotory behavior,long-term memory,methadone dose,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,olanzapine response,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,pharmacogenetics,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychiatric Disorders,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in syna",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2734838",
        "SNP Name": "DRD2 T64501C",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2734838",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,addiction susceptibility,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,coupled via Gi/Go drug binding,D (2) dopamine receptor,dendrite,dendritic spine,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart rate,regulation of locomotion invol",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs2734838",
        "SNP Name": "DRD2 T64501C",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2734838",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,addiction susceptibility,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,coupled via Gi/Go drug binding,D (2) dopamine receptor,dendrite,dendritic spine,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart rate,regulation of locomotion invol",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1079597",
        "SNP Name": "DRD2 G54716A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1079597",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol metabolism,alcoholism,Alternative splicing,anxiety,arachidonic acid secretion,ARRB2,ASD,associative learning,auditory behavior,autism,autism spectrum disorders,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,borderline personality,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Caffeine-Induced Anxiety,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Complete proteome,coupled via Gi/Go drug binding,D (2) dopamine receptor,dendrite,dendritic spine,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,drug dependence,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,Heroin Dependence,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,orbitofrontal cortex development,Parkinson,Parkinson\u2019s disease,paternal history of alcholism,pattern of body involvement,PD,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,Post-Traumatic Stress Disorder,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,PTSD,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart rate,regulation of locomotion involved in locomotory b",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1079597",
        "SNP Name": "DRD2 G54716A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1079597",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol metabolism,alcoholism,Alternative splicing,anxiety,arachidonic acid secretion,ARRB2,ASD,associative learning,auditory behavior,autism,autism spectrum disorders,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,borderline personality,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Caffeine-Induced Anxiety,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Complete proteome,coupled via Gi/Go drug binding,D (2) dopamine receptor,dendrite,dendritic spine,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,drug dependence,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,Heroin Dependence,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,orbitofrontal cortex development,Parkinson,Parkinson\u2019s disease,paternal history of alcholism,pattern of body involvement,PD,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,Post-Traumatic Stress Disorder,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,PTSD,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart rate,regulation of locomotion involved in locomotory b",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1079596",
        "SNP Name": "DRD2 G54383A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1079596",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol metabolism,alcoholism,Alternative splicing,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Complete proteome,Continuous Performance Task,coupled via Gi/Go drug binding,D (2) dopamine receptor,d-Amphetamine,dendrite,dendritic spine,Disease mutation,Disulfide bond,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart rate,regulation of locomotion involved in locomotory behavior,regulation of long-term neuronal synaptic plasticity,regulation of phosphoprotein phosphatase activity,regulation of po",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1079596",
        "SNP Name": "DRD2 G54383A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1079596",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol metabolism,alcoholism,Alternative splicing,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Complete proteome,Continuous Performance Task,coupled via Gi/Go drug binding,D (2) dopamine receptor,d-Amphetamine,dendrite,dendritic spine,Disease mutation,Disulfide bond,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart rate,regulation of locomotion involved in locomotory behavior,regulation of long-term neuronal synaptic plasticity,regulation of phosphoprotein phosphatase activity,regulation of po",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2471857",
        "SNP Name": "DRD2 G52663A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/gquery/?term=rs2471857",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,Continuous Performance Task,coupled via Gi/Go drug binding,CPT,D (2) dopamine receptor,dendrite,dendritic spine,depression,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,mental disorder,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs2471857",
        "SNP Name": "DRD2 G52663A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/gquery/?term=rs2471857",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,Continuous Performance Task,coupled via Gi/Go drug binding,CPT,D (2) dopamine receptor,dendrite,dendritic spine,depression,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,mental disorder,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs4620755",
        "SNP Name": "DRD2 C41383T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4620755",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,Continuous Performance Task,coupled via Gi/Go drug binding,CPT,D (2) dopamine receptor,dendrite,dendritic spine,depression,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,mental disorder,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs4620755",
        "SNP Name": "DRD2 C41383T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4620755",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,Continuous Performance Task,coupled via Gi/Go drug binding,CPT,D (2) dopamine receptor,dendrite,dendritic spine,depression,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,mental disorder,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs7125415",
        "SNP Name": "DRD2 G40321A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7125415",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,Continuous Performance Task,coupled via Gi/Go drug binding,CPT,D (2) dopamine receptor,dendrite,dendritic spine,depression,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart rate,regulation",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs7125415",
        "SNP Name": "DRD2 G40321A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7125415",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,Continuous Performance Task,coupled via Gi/Go drug binding,CPT,D (2) dopamine receptor,dendrite,dendritic spine,depression,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart rate,regulation",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs4648318",
        "SNP Name": "DRD2 A37613G",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4648318",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,acute post-surgical pain,addiction susceptibility,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,Continuous Performance Task,coupled via Gi/Go drug binding,CPT,D (2) dopamine receptor,dendrite,dendritic spine,depression,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Drug Addiction,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake inv",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs4648318",
        "SNP Name": "DRD2 A37613G",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4648318",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,acute post-surgical pain,addiction susceptibility,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,Continuous Performance Task,coupled via Gi/Go drug binding,CPT,D (2) dopamine receptor,dendrite,dendritic spine,depression,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Drug Addiction,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake inv",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs17529477",
        "SNP Name": "DRD2 C33935T",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs17529477",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,coupled via Gi/Go drug binding,D (2) dopamine receptor,dendrite,dendritic spine,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart rate,regulation of locomotion involved in locomotory behavior",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs17529477",
        "SNP Name": "DRD2 C33935T",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs17529477",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,coupled via Gi/Go drug binding,D (2) dopamine receptor,dendrite,dendritic spine,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart rate,regulation of locomotion involved in locomotory behavior",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs4245146",
        "SNP Name": "DRD2 A33029G",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=rs4245146",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,anxiety,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,coupled via Gi/Go drug binding,D (2) dopamine receptor,dendrite,dendritic spine,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart rate,regulation of locomotion involved in",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs4245146",
        "SNP Name": "DRD2 A33029G",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=rs4245146",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,anxiety,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,coupled via Gi/Go drug binding,D (2) dopamine receptor,dendrite,dendritic spine,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart rate,regulation of locomotion involved in",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs7131056",
        "SNP Name": "DRD2 T21228G",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7131056",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Cognitive Outcome Shortly After Traumatic Brain Injury,Complete proteome,Continuous Performance Task,coupled via Gi/Go drug binding,CPT,D (2) dopamine receptor,dendrite,dendritic spine,depression,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,Highly Sensitive Personality,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,mental disorder,migraine,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,personality,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs7131056",
        "SNP Name": "DRD2 T21228G",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7131056",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Cognitive Outcome Shortly After Traumatic Brain Injury,Complete proteome,Continuous Performance Task,coupled via Gi/Go drug binding,CPT,D (2) dopamine receptor,dendrite,dendritic spine,depression,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,Highly Sensitive Personality,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,mental disorder,migraine,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,personality,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs4648317",
        "SNP Name": "DRD2 C19470T",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4648317",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,coupled via Gi/Go drug binding,creative potential,creativity,D (2) dopamine receptor,dendrite,dendritic spine,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,mental disorder,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart rate,regulat",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs4648317",
        "SNP Name": "DRD2 C19470T",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4648317",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,coupled via Gi/Go drug binding,creative potential,creativity,D (2) dopamine receptor,dendrite,dendritic spine,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,mental disorder,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart rate,regulat",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1799978",
        "SNP Name": "DRD2 A4651G",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1799978",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Caffeine-Induced Anxiety,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,coupled via Gi/Go drug binding,D (2) dopamine receptor,dendrite,dendritic spine,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,mental disorder,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart rate,regulation of",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1799978",
        "SNP Name": "DRD2 A4651G",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1799978",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Caffeine-Induced Anxiety,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,coupled via Gi/Go drug binding,D (2) dopamine receptor,dendrite,dendritic spine,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,mental disorder,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart rate,regulation of",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs12364283",
        "SNP Name": "DRD2 T4047C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs12364283",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,ADHD,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,Continuous Performance Task,coupled via Gi/Go drug binding,CPT,D (2) dopamine receptor,dendrite,dendritic spine,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,mental disorder,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart rate",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs12364283",
        "SNP Name": "DRD2 T4047C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs12364283",
        "Video": null,
        "Tags": "3D-structure,a 11,abnormal postures,activation of protein kinase activity,adenohypophysis development,adenylate cyclase-inhibiting dopamine receptor signaling pathway,adenylyl cyclase,ADHD,adrenergic receptor activity,adult walking behavior,age of onset,alcohol,alcohol dependence,alcohol metabolism,alcoholism,Alternative splicing,antipsychotic treatment response,arachidonic acid secretion,ARRB2,associative learning,auditory behavior,autosomal dominant,axon,axon terminus,axonogenesis,behavioral response to cocaine,behavioral response to ethanol,borderline,BPD,branching morphogenesis of a nerve,CADPS,CADPS2,Cell membrane,cellular calcium ion homeostasis,cerebral cortex GABAergic interneuron migration,circadian regulation of gene expression,CLIC6,Cocaine Abuse,Complete proteome,Continuous Performance Task,coupled via Gi/Go drug binding,CPT,D (2) dopamine receptor,dendrite,dendritic spine,Disease mutation,Disulfide bond,dopamine,dopamine binding,Dopamine D2 receptor,dopamine metabolic process,dopamine neurotransmitter receptor activity,Dopamine receptor,dopaminergic,downstream signaling,DRD2,DRD4,Dystonia,dystonic movements,dystonic postures alleviated by alcohol,DYT11,emotion,endocytic vesicle,feeding behavior,G proteins,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor internalization,GABAergic,Genetic variations,glutamatergic,Glycoprotein,GNAI1,GNAI2,GPRASP1,grandpaternal history of alcoholism,grooming behavior,homo- and heterooligomers with DRD4,HTR2A,identical protein binding,Impulsivity,integral component of plasma membrane,intracellular pool,intracellular signal transduction,involuntary lightning jerks,lateral plasma membrane,locomotory behavior,long-term memory,mental disorder,Multi-pass membrane protein,myoclonic dystonia,negative regulation of adenylate cyclase activity,negative regulation of blood pressure,negative regulation of cell migration,negative regulation of cell proliferation,negative regulation of circadian sleep/wake cycle,negative regulation of cytosolic calcium ion concentration,negative regulation of dopamine receptor signaling pathway,negative regulation of dopamine secretion,negative regulation of insulin secretion,negative regulation of protein kinase B signaling,negative regulation of protein secretion,negative regulation of synaptic transmission,negative regulation of voltage-gated calcium channel activity,neurological system process involved in regulation of systemic arterial blood pressure,neuron-neuron synaptic transmission,neuronal activity during working memory,openness to experience,opioid addiction,orbitofrontal cortex development,paternal history of alcholism,pattern of body involvement,perikaryon,peristalsis,phosphatidylinositol metabolic process,phospholipase C-activating dopamine receptor signaling pathway,pigmentation,plasma membrane,Polymorphism,positive regulation of cytokinesis,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of dopamine uptake involved in synaptic transmission,positive regulation of ERK1 and ERK2 cascade,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of growth hormone secretion,positive regulation of long-term synaptic potentiation,positive regulation of multicellular organism growth,positive regulation of neuroblast proliferation,positive regulation of receptor internalization,positive regulation of renal sodium excretion,positive regulation of transcription from RNA polymerase II promoter,positive regulation of urine volume,postsynaptic density,potassium channel regulator activity,PPP1R9B,prepulse inhibition,presence of myoclonus,protein localization,Psychological Risk Attitudes,Receptor,Reference proteome,regulation of cAMP metabolic process,regulation of dopamine uptake involved in synaptic transmission,regulation of heart rate",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1792113",
        "SNP Name": "SORL1 A146986G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,ADP-ribosylation factor binding,Alzheimer,Alzheimer's disease,amyloid beta,amyloidogenic peptide formation,Amyloidosis,apoptosis,APP,beta-amyloid binding,C11orf32,caspase,cell death,cell migration,cell proliferation,cholesterol,cholesterol metabolic process,Cholesterol metabolism,choline,dementia,Disease mutation,early endosome,Endocytosis,endoplasmic reticulum,endosome,extracellular space,extracellular vesicular exosome,fat,Golgi apparatus,Golgi cisterna,growth factor,integral component of plasma membrane,LDL,LDLR relative with 11 ligand-binding repeats,Lipid metabolism,lipid transport,lipoprotein,low-density lipoprotein particle,low-density lipoprotein particle binding,Low-density lipoprotein receptor relative with 11 ligand-binding repeats,LR11,membrane,mosaic,multivesicular body,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,negative regulation of beta-amyloid formation,negative regulation of MAP kinase activity,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,negative regulation of neurofibrillary tangle assembly,negative regulation of neurogenesis,negative regulation of neuron death,negative regulation of protein binding,negative regulation of protein oligomerization,negative regulation of tau-protein kinase activity,Neurodegeneration,neurodegenerative disease,neurodegenerative disorder,neurofibrillary tangles,neuronal cell body,nuclear envelope lumen,nuclear envelope lumen trans-Golgi network,peptide,PLAUR,positive regulation of choline O-acetyltransferase activity,positive regulation of early endosome to recycling endosome transport,positive regulation of endocytic recycling,positive regulation of ER to Golgi vesicle-mediated transport,positive regulation of protein catabolic process,positive regulation of protein exit from endoplasmic reticulum,positive regulation of protein localization to early endosome,post-Golgi vesicle-mediated transport,protein maturation,protein retention in Golgi apparatus,protein targeting,protein targeting to Golgi,protein targeting to lysosome,RAP,receptor-associated protein,receptor-mediated endocytosis,recycling endosome,regulation of smooth muscle cell migration,signal transduction,SORL1,SorLA,SorLA-1,Sortilin-related receptor,Steroid metabolism,Sterol metabolism,trans-Golgi network,transmembrane,transmembrane signaling receptor activity,Transport,vascular",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs1006737",
        "SNP Name": "CACNA1C G115699A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1006737",
        "Video": null,
        "Tags": "A heart disease characterized by the association of Brugada syndrome with shortened QT intervals,adult walking behavior,alpha-1 polypeptide,alpha-2,alpha-actinin binding,Alternative splicing,and by omega-agatoxin-IIIA (omega-Aga-IIIA),ASD,autism,Autism Spectrum Disorder,axon guidance,Belongs to the calcium channel alpha-1 subunit (TC 1.A.1.11) family,benzothiazepines,beta and delta subunits in a 1:1:1:1 ratio,Binding of calmodulin or CABP1 at the same regulatory sites results in an opposit effects on the channel function,Binding of intracellular calcium through the EF-hand motif inhibits the opening of the channel,bipolar,bipolar disorder,BRGDA3,Brugada syndrome,Brugada syndrome 3,Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram,CACH2,CACN2,CACNA1C,CACNA1C subfamily,CACNL1A1,Calcium,Calcium channel,Calcium channels containing the alpha-1C subunit play an important role in excitation-contraction coupling in the heart,calcium ion import,calcium ion transport into cytosol,calcium ion-dependent exocytosis,Calcium transport,calcium-mediated signaling using extracellular calcium source,calmodulin binding,cardiac muscle,caveolar macromolecular signaling complex,CCHL1A1,cell communication by electrical coupling involved in cardiac conduction,cell division and cell death,Cell membrane,cell motility,cognitive abnormalities,cognitive vulnerability,Complete proteome,congenital heart disease,consisting of alpha-1,cytoplasm,dendritic shaft,depression,Disease mutation,Disorder characterized by multiorgan dysfunction including lethal arrhythmias,Disulfide bond,Each of the four internal repeats contains five hydrophobic transmembrane segments (S1,ECG,energy reserve metabolic process,Expressed in brain and heart and jejunum and ovary and pancreatic beta-cells and vascular smooth muscle,gene expression,glucose homeostasis,Glycoprotein,growth hormone secretion,high voltage-gated calcium channel activity,hormone or neurotransmitter release,immune deficiency,including muscle contraction,insomnia,insulin secretion,integral component of membrane,interaction between RRAD and CACNB2 regulates its trafficking to the cell membrane,Interacts (via C-terminal CDB motif) with CABP5; in a calcium-dependent manner,Interacts (via the N-terminus and the C-terminal C and IQ motifs) with CABP1,Interacts with CACNA2D4,Interacts with CIB1; the interaction increases upon cardiomyocytes hypertrophy,intermittent hypoglycemia,Ion channel,Ion transport,isoform 1,It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs the individual will faint and may die in a few minutes if the heart is not reset,L type,Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group,major depression,major depressive disorder,major psychoses,Membrane,membrane depolarization during action potential,Membrane; Multi-pass membrane protein,mental disorder,mental illness,metal ion binding,Metal-binding,mood disorder,neuronal cell body,Neuropsychiatry,Overall expression is reduced in atherosclerotic vascular smooth muscle,phenylalkylamines,Phosphoprotein,Phosphorylation by PKA activates the channel,plasma membrane,Polymorphism,positive regulation of cytosolic calcium ion concentration,postsynaptic density,protein binding,psychiatric disease,Reference proteome,regulation of blood pressure,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,regulation of insulin secretion,regulation of organ growth,regulation of vasoconstriction,Repeat,S2,S3,S4 segments probably represent the voltage-sensor and are characterized by a series of positively charged amino acids at every third position,S5,S6) and one positively charged transmembrane segment (S4),schizophrenia,small molecule metabolic process,smooth muscle contraction involved in micturition,synapt",
        "Group": "Magnesium Sulfate"
    },
    {
        "SNP ID": "rs1006737",
        "SNP Name": "CACNA1C G115699A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1006737",
        "Video": null,
        "Tags": "A heart disease characterized by the association of Brugada syndrome with shortened QT intervals,adult walking behavior,alpha-1 polypeptide,alpha-2,alpha-actinin binding,Alternative splicing,and by omega-agatoxin-IIIA (omega-Aga-IIIA),ASD,autism,Autism Spectrum Disorder,axon guidance,Belongs to the calcium channel alpha-1 subunit (TC 1.A.1.11) family,benzothiazepines,beta and delta subunits in a 1:1:1:1 ratio,Binding of calmodulin or CABP1 at the same regulatory sites results in an opposit effects on the channel function,Binding of intracellular calcium through the EF-hand motif inhibits the opening of the channel,bipolar,bipolar disorder,BRGDA3,Brugada syndrome,Brugada syndrome 3,Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram,CACH2,CACN2,CACNA1C,CACNA1C subfamily,CACNL1A1,Calcium,Calcium channel,Calcium channels containing the alpha-1C subunit play an important role in excitation-contraction coupling in the heart,calcium ion import,calcium ion transport into cytosol,calcium ion-dependent exocytosis,Calcium transport,calcium-mediated signaling using extracellular calcium source,calmodulin binding,cardiac muscle,caveolar macromolecular signaling complex,CCHL1A1,cell communication by electrical coupling involved in cardiac conduction,cell division and cell death,Cell membrane,cell motility,cognitive abnormalities,cognitive vulnerability,Complete proteome,congenital heart disease,consisting of alpha-1,cytoplasm,dendritic shaft,depression,Disease mutation,Disorder characterized by multiorgan dysfunction including lethal arrhythmias,Disulfide bond,Each of the four internal repeats contains five hydrophobic transmembrane segments (S1,ECG,energy reserve metabolic process,Expressed in brain and heart and jejunum and ovary and pancreatic beta-cells and vascular smooth muscle,gene expression,glucose homeostasis,Glycoprotein,growth hormone secretion,high voltage-gated calcium channel activity,hormone or neurotransmitter release,immune deficiency,including muscle contraction,insomnia,insulin secretion,integral component of membrane,interaction between RRAD and CACNB2 regulates its trafficking to the cell membrane,Interacts (via C-terminal CDB motif) with CABP5; in a calcium-dependent manner,Interacts (via the N-terminus and the C-terminal C and IQ motifs) with CABP1,Interacts with CACNA2D4,Interacts with CIB1; the interaction increases upon cardiomyocytes hypertrophy,intermittent hypoglycemia,Ion channel,Ion transport,isoform 1,It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs the individual will faint and may die in a few minutes if the heart is not reset,L type,Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group,major depression,major depressive disorder,major psychoses,Membrane,membrane depolarization during action potential,Membrane; Multi-pass membrane protein,mental disorder,mental illness,metal ion binding,Metal-binding,mood disorder,neuronal cell body,Neuropsychiatry,Overall expression is reduced in atherosclerotic vascular smooth muscle,phenylalkylamines,Phosphoprotein,Phosphorylation by PKA activates the channel,plasma membrane,Polymorphism,positive regulation of cytosolic calcium ion concentration,postsynaptic density,protein binding,psychiatric disease,Reference proteome,regulation of blood pressure,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,regulation of insulin secretion,regulation of organ growth,regulation of vasoconstriction,Repeat,S2,S3,S4 segments probably represent the voltage-sensor and are characterized by a series of positively charged amino acids at every third position,S5,S6) and one positively charged transmembrane segment (S4),schizophrenia,small molecule metabolic process,smooth muscle contraction involved in micturition,synapt",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1006737",
        "SNP Name": "CACNA1C G115699A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1006737",
        "Video": null,
        "Tags": "A heart disease characterized by the association of Brugada syndrome with shortened QT intervals,adult walking behavior,alpha-1 polypeptide,alpha-2,alpha-actinin binding,Alternative splicing,and by omega-agatoxin-IIIA (omega-Aga-IIIA),ASD,autism,Autism Spectrum Disorder,axon guidance,Belongs to the calcium channel alpha-1 subunit (TC 1.A.1.11) family,benzothiazepines,beta and delta subunits in a 1:1:1:1 ratio,Binding of calmodulin or CABP1 at the same regulatory sites results in an opposit effects on the channel function,Binding of intracellular calcium through the EF-hand motif inhibits the opening of the channel,bipolar,bipolar disorder,BRGDA3,Brugada syndrome,Brugada syndrome 3,Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram,CACH2,CACN2,CACNA1C,CACNA1C subfamily,CACNL1A1,Calcium,Calcium channel,Calcium channels containing the alpha-1C subunit play an important role in excitation-contraction coupling in the heart,calcium ion import,calcium ion transport into cytosol,calcium ion-dependent exocytosis,Calcium transport,calcium-mediated signaling using extracellular calcium source,calmodulin binding,cardiac muscle,caveolar macromolecular signaling complex,CCHL1A1,cell communication by electrical coupling involved in cardiac conduction,cell division and cell death,Cell membrane,cell motility,cognitive abnormalities,cognitive vulnerability,Complete proteome,congenital heart disease,consisting of alpha-1,cytoplasm,dendritic shaft,depression,Disease mutation,Disorder characterized by multiorgan dysfunction including lethal arrhythmias,Disulfide bond,Each of the four internal repeats contains five hydrophobic transmembrane segments (S1,ECG,energy reserve metabolic process,Expressed in brain and heart and jejunum and ovary and pancreatic beta-cells and vascular smooth muscle,gene expression,glucose homeostasis,Glycoprotein,growth hormone secretion,high voltage-gated calcium channel activity,hormone or neurotransmitter release,immune deficiency,including muscle contraction,insomnia,insulin secretion,integral component of membrane,interaction between RRAD and CACNB2 regulates its trafficking to the cell membrane,Interacts (via C-terminal CDB motif) with CABP5; in a calcium-dependent manner,Interacts (via the N-terminus and the C-terminal C and IQ motifs) with CABP1,Interacts with CACNA2D4,Interacts with CIB1; the interaction increases upon cardiomyocytes hypertrophy,intermittent hypoglycemia,Ion channel,Ion transport,isoform 1,It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs the individual will faint and may die in a few minutes if the heart is not reset,L type,Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group,major depression,major depressive disorder,major psychoses,Membrane,membrane depolarization during action potential,Membrane; Multi-pass membrane protein,mental disorder,mental illness,metal ion binding,Metal-binding,mood disorder,neuronal cell body,Neuropsychiatry,Overall expression is reduced in atherosclerotic vascular smooth muscle,phenylalkylamines,Phosphoprotein,Phosphorylation by PKA activates the channel,plasma membrane,Polymorphism,positive regulation of cytosolic calcium ion concentration,postsynaptic density,protein binding,psychiatric disease,Reference proteome,regulation of blood pressure,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,regulation of insulin secretion,regulation of organ growth,regulation of vasoconstriction,Repeat,S2,S3,S4 segments probably represent the voltage-sensor and are characterized by a series of positively charged amino acids at every third position,S5,S6) and one positively charged transmembrane segment (S4),schizophrenia,small molecule metabolic process,smooth muscle contraction involved in micturition,synapt",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2159100",
        "SNP Name": "CACNA1C C271442T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2159100",
        "Video": null,
        "Tags": "A heart disease characterized by the association of Brugada syndrome with shortened QT intervals,adult walking behavior,alpha-1 polypeptide,alpha-2,alpha-actinin binding,Alternative splicing,and by omega-agatoxin-IIIA (omega-Aga-IIIA),ASD,autism,Autism Spectrum Disorder,axon guidance,Belongs to the calcium channel alpha-1 subunit (TC 1.A.1.11) family,benzothiazepines,beta and delta subunits in a 1:1:1:1 ratio,Binding of calmodulin or CABP1 at the same regulatory sites results in an opposit effects on the channel function,Binding of intracellular calcium through the EF-hand motif inhibits the opening of the channel,bipolar,bipolar disorder,BRGDA3,Brugada syndrome,Brugada syndrome 3,Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram,CACH2,CACN2,CACNA1C,CACNA1C subfamily,CACNL1A1,Calcium,Calcium channel,Calcium channels containing the alpha-1C subunit play an important role in excitation-contraction coupling in the heart,calcium ion import,calcium ion transport into cytosol,calcium ion-dependent exocytosis,Calcium transport,calcium-mediated signaling using extracellular calcium source,calmodulin binding,cardiac muscle,caveolar macromolecular signaling complex,CCHL1A1,cell communication by electrical coupling involved in cardiac conduction,cell division and cell death,Cell membrane,cell motility,cognitive abnormalities,Complete proteome,congenital heart disease,consisting of alpha-1,cytoplasm,dendritic shaft,Disease mutation,Disorder characterized by multiorgan dysfunction including lethal arrhythmias,Disulfide bond,Each of the four internal repeats contains five hydrophobic transmembrane segments (S1,ECG,energy reserve metabolic process,Expressed in brain and heart and jejunum and ovary and pancreatic beta-cells and vascular smooth muscle,gene expression,glucose homeostasis,Glycoprotein,growth hormone secretion,high voltage-gated calcium channel activity,hormone or neurotransmitter release,immune deficiency,including muscle contraction,insulin secretion,integral component of membrane,interaction between RRAD and CACNB2 regulates its trafficking to the cell membrane,Interacts (via C-terminal CDB motif) with CABP5; in a calcium-dependent manner,Interacts (via the N-terminus and the C-terminal C and IQ motifs) with CABP1,Interacts with CACNA2D4,Interacts with CIB1; the interaction increases upon cardiomyocytes hypertrophy,intermittent hypoglycemia,Ion channel,Ion transport,isoform 1,It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs the individual will faint and may die in a few minutes if the heart is not reset,L type,Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group,Membrane,membrane depolarization during action potential,Membrane; Multi-pass membrane protein,mental illness,metal ion binding,Metal-binding,neuronal cell body,Overall expression is reduced in atherosclerotic vascular smooth muscle,phenylalkylamines,Phosphoprotein,Phosphorylation by PKA activates the channel,plasma membrane,Polymorphism,positive regulation of cytosolic calcium ion concentration,postsynaptic density,protein binding,Reference proteome,regulation of blood pressure,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,regulation of insulin secretion,regulation of organ growth,regulation of vasoconstriction,Repeat,S2,S3,S4 segments probably represent the voltage-sensor and are characterized by a series of positively charged amino acids at every third position,S5,S6) and one positively charged transmembrane segment (S4),small molecule metabolic process,smooth muscle contraction involved in micturition,synaptic transmission,The auxiliary subunits beta and alpha-2/delta linked by a disulfide bridge regulate the channel activity,The binding to the cytoplasmic N-terminal domain is calcium independent",
        "Group": "Magnesium Sulfate"
    },
    {
        "SNP ID": "rs2159100",
        "SNP Name": "CACNA1C C271442T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2159100",
        "Video": null,
        "Tags": "A heart disease characterized by the association of Brugada syndrome with shortened QT intervals,adult walking behavior,alpha-1 polypeptide,alpha-2,alpha-actinin binding,Alternative splicing,and by omega-agatoxin-IIIA (omega-Aga-IIIA),ASD,autism,Autism Spectrum Disorder,axon guidance,Belongs to the calcium channel alpha-1 subunit (TC 1.A.1.11) family,benzothiazepines,beta and delta subunits in a 1:1:1:1 ratio,Binding of calmodulin or CABP1 at the same regulatory sites results in an opposit effects on the channel function,Binding of intracellular calcium through the EF-hand motif inhibits the opening of the channel,bipolar,bipolar disorder,BRGDA3,Brugada syndrome,Brugada syndrome 3,Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram,CACH2,CACN2,CACNA1C,CACNA1C subfamily,CACNL1A1,Calcium,Calcium channel,Calcium channels containing the alpha-1C subunit play an important role in excitation-contraction coupling in the heart,calcium ion import,calcium ion transport into cytosol,calcium ion-dependent exocytosis,Calcium transport,calcium-mediated signaling using extracellular calcium source,calmodulin binding,cardiac muscle,caveolar macromolecular signaling complex,CCHL1A1,cell communication by electrical coupling involved in cardiac conduction,cell division and cell death,Cell membrane,cell motility,cognitive abnormalities,Complete proteome,congenital heart disease,consisting of alpha-1,cytoplasm,dendritic shaft,Disease mutation,Disorder characterized by multiorgan dysfunction including lethal arrhythmias,Disulfide bond,Each of the four internal repeats contains five hydrophobic transmembrane segments (S1,ECG,energy reserve metabolic process,Expressed in brain and heart and jejunum and ovary and pancreatic beta-cells and vascular smooth muscle,gene expression,glucose homeostasis,Glycoprotein,growth hormone secretion,high voltage-gated calcium channel activity,hormone or neurotransmitter release,immune deficiency,including muscle contraction,insulin secretion,integral component of membrane,interaction between RRAD and CACNB2 regulates its trafficking to the cell membrane,Interacts (via C-terminal CDB motif) with CABP5; in a calcium-dependent manner,Interacts (via the N-terminus and the C-terminal C and IQ motifs) with CABP1,Interacts with CACNA2D4,Interacts with CIB1; the interaction increases upon cardiomyocytes hypertrophy,intermittent hypoglycemia,Ion channel,Ion transport,isoform 1,It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs the individual will faint and may die in a few minutes if the heart is not reset,L type,Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group,Membrane,membrane depolarization during action potential,Membrane; Multi-pass membrane protein,mental illness,metal ion binding,Metal-binding,neuronal cell body,Overall expression is reduced in atherosclerotic vascular smooth muscle,phenylalkylamines,Phosphoprotein,Phosphorylation by PKA activates the channel,plasma membrane,Polymorphism,positive regulation of cytosolic calcium ion concentration,postsynaptic density,protein binding,Reference proteome,regulation of blood pressure,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,regulation of insulin secretion,regulation of organ growth,regulation of vasoconstriction,Repeat,S2,S3,S4 segments probably represent the voltage-sensor and are characterized by a series of positively charged amino acids at every third position,S5,S6) and one positively charged transmembrane segment (S4),small molecule metabolic process,smooth muscle contraction involved in micturition,synaptic transmission,The auxiliary subunits beta and alpha-2/delta linked by a disulfide bridge regulate the channel activity,The binding to the cytoplasmic N-terminal domain is calcium independent",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs2159100",
        "SNP Name": "CACNA1C C271442T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2159100",
        "Video": null,
        "Tags": "A heart disease characterized by the association of Brugada syndrome with shortened QT intervals,adult walking behavior,alpha-1 polypeptide,alpha-2,alpha-actinin binding,Alternative splicing,and by omega-agatoxin-IIIA (omega-Aga-IIIA),ASD,autism,Autism Spectrum Disorder,axon guidance,Belongs to the calcium channel alpha-1 subunit (TC 1.A.1.11) family,benzothiazepines,beta and delta subunits in a 1:1:1:1 ratio,Binding of calmodulin or CABP1 at the same regulatory sites results in an opposit effects on the channel function,Binding of intracellular calcium through the EF-hand motif inhibits the opening of the channel,bipolar,bipolar disorder,BRGDA3,Brugada syndrome,Brugada syndrome 3,Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram,CACH2,CACN2,CACNA1C,CACNA1C subfamily,CACNL1A1,Calcium,Calcium channel,Calcium channels containing the alpha-1C subunit play an important role in excitation-contraction coupling in the heart,calcium ion import,calcium ion transport into cytosol,calcium ion-dependent exocytosis,Calcium transport,calcium-mediated signaling using extracellular calcium source,calmodulin binding,cardiac muscle,caveolar macromolecular signaling complex,CCHL1A1,cell communication by electrical coupling involved in cardiac conduction,cell division and cell death,Cell membrane,cell motility,cognitive abnormalities,Complete proteome,congenital heart disease,consisting of alpha-1,cytoplasm,dendritic shaft,Disease mutation,Disorder characterized by multiorgan dysfunction including lethal arrhythmias,Disulfide bond,Each of the four internal repeats contains five hydrophobic transmembrane segments (S1,ECG,energy reserve metabolic process,Expressed in brain and heart and jejunum and ovary and pancreatic beta-cells and vascular smooth muscle,gene expression,glucose homeostasis,Glycoprotein,growth hormone secretion,high voltage-gated calcium channel activity,hormone or neurotransmitter release,immune deficiency,including muscle contraction,insulin secretion,integral component of membrane,interaction between RRAD and CACNB2 regulates its trafficking to the cell membrane,Interacts (via C-terminal CDB motif) with CABP5; in a calcium-dependent manner,Interacts (via the N-terminus and the C-terminal C and IQ motifs) with CABP1,Interacts with CACNA2D4,Interacts with CIB1; the interaction increases upon cardiomyocytes hypertrophy,intermittent hypoglycemia,Ion channel,Ion transport,isoform 1,It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs the individual will faint and may die in a few minutes if the heart is not reset,L type,Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group,Membrane,membrane depolarization during action potential,Membrane; Multi-pass membrane protein,mental illness,metal ion binding,Metal-binding,neuronal cell body,Overall expression is reduced in atherosclerotic vascular smooth muscle,phenylalkylamines,Phosphoprotein,Phosphorylation by PKA activates the channel,plasma membrane,Polymorphism,positive regulation of cytosolic calcium ion concentration,postsynaptic density,protein binding,Reference proteome,regulation of blood pressure,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,regulation of insulin secretion,regulation of organ growth,regulation of vasoconstriction,Repeat,S2,S3,S4 segments probably represent the voltage-sensor and are characterized by a series of positively charged amino acids at every third position,S5,S6) and one positively charged transmembrane segment (S4),small molecule metabolic process,smooth muscle contraction involved in micturition,synaptic transmission,The auxiliary subunits beta and alpha-2/delta linked by a disulfide bridge regulate the channel activity,The binding to the cytoplasmic N-terminal domain is calcium independent",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs216013",
        "SNP Name": "CACNA1C A2729632G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs216013",
        "Video": null,
        "Tags": "A heart disease characterized by the association of Brugada syndrome with shortened QT intervals,adult walking behavior,alpha-1 polypeptide,alpha-2,alpha-actinin binding,Alternative splicing,and by omega-agatoxin-IIIA (omega-Aga-IIIA),anticoagulant,ASD,autism,Autism Spectrum Disorder,axon guidance,Belongs to the calcium channel alpha-1 subunit (TC 1.A.1.11) family,benzothiazepines,beta and delta subunits in a 1:1:1:1 ratio,Binding of calmodulin or CABP1 at the same regulatory sites results in an opposit effects on the channel function,Binding of intracellular calcium through the EF-hand motif inhibits the opening of the channel,BRGDA3,Brugada syndrome,Brugada syndrome 3,Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram,CACH2,CACN2,CACNA1C,CACNA1C subfamily,CACNL1A1,Calcium,Calcium channel,Calcium channels containing the alpha-1C subunit play an important role in excitation-contraction coupling in the heart,calcium ion import,calcium ion transport into cytosol,calcium ion-dependent exocytosis,Calcium transport,calcium-mediated signaling using extracellular calcium source,calmodulin binding,cardiac muscle,caveolar macromolecular signaling complex,CCHL1A1,cell communication by electrical coupling involved in cardiac conduction,cell division and cell death,Cell membrane,cell motility,cognitive abnormalities,Complete proteome,congenital heart disease,consisting of alpha-1,cytoplasm,dendritic shaft,Disease mutation,Disorder characterized by multiorgan dysfunction including lethal arrhythmias,Disulfide bond,Each of the four internal repeats contains five hydrophobic transmembrane segments (S1,ECG,energy reserve metabolic process,Expressed in brain and heart and jejunum and ovary and pancreatic beta-cells and vascular smooth muscle,gene expression,glucose homeostasis,Glycoprotein,growth hormone secretion,high voltage-gated calcium channel activity,hormone or neurotransmitter release,immune deficiency,including muscle contraction,insulin secretion,integral component of membrane,interaction between RRAD and CACNB2 regulates its trafficking to the cell membrane,Interacts (via C-terminal CDB motif) with CABP5; in a calcium-dependent manner,Interacts (via the N-terminus and the C-terminal C and IQ motifs) with CABP1,Interacts with CACNA2D4,Interacts with CIB1; the interaction increases upon cardiomyocytes hypertrophy,intermittent hypoglycemia,Ion channel,Ion transport,isoform 1,It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs the individual will faint and may die in a few minutes if the heart is not reset,L type,Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group,Membrane,membrane depolarization during action potential,Membrane; Multi-pass membrane protein,metal ion binding,Metal-binding,neuronal cell body,Overall expression is reduced in atherosclerotic vascular smooth muscle,phenylalkylamines,Phosphoprotein,Phosphorylation by PKA activates the channel,plasma membrane,Polymorphism,positive regulation of cytosolic calcium ion concentration,postsynaptic density,protein binding,Reference proteome,regulation of blood pressure,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,regulation of insulin secretion,regulation of organ growth,regulation of vasoconstriction,Repeat,S2,S3,S4 segments probably represent the voltage-sensor and are characterized by a series of positively charged amino acids at every third position,S5,S6) and one positively charged transmembrane segment (S4),small molecule metabolic process,smooth muscle contraction involved in micturition,synaptic transmission,The auxiliary subunits beta and alpha-2/delta linked by a disulfide bridge regulate the channel activity,The binding to the cytoplasmic N-terminal domain is calcium independent but is essential for the ch",
        "Group": "Magnesium Sulfate"
    },
    {
        "SNP ID": "rs216013",
        "SNP Name": "CACNA1C A2729632G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs216013",
        "Video": null,
        "Tags": "A heart disease characterized by the association of Brugada syndrome with shortened QT intervals,adult walking behavior,alpha-1 polypeptide,alpha-2,alpha-actinin binding,Alternative splicing,and by omega-agatoxin-IIIA (omega-Aga-IIIA),anticoagulant,ASD,autism,Autism Spectrum Disorder,axon guidance,Belongs to the calcium channel alpha-1 subunit (TC 1.A.1.11) family,benzothiazepines,beta and delta subunits in a 1:1:1:1 ratio,Binding of calmodulin or CABP1 at the same regulatory sites results in an opposit effects on the channel function,Binding of intracellular calcium through the EF-hand motif inhibits the opening of the channel,BRGDA3,Brugada syndrome,Brugada syndrome 3,Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram,CACH2,CACN2,CACNA1C,CACNA1C subfamily,CACNL1A1,Calcium,Calcium channel,Calcium channels containing the alpha-1C subunit play an important role in excitation-contraction coupling in the heart,calcium ion import,calcium ion transport into cytosol,calcium ion-dependent exocytosis,Calcium transport,calcium-mediated signaling using extracellular calcium source,calmodulin binding,cardiac muscle,caveolar macromolecular signaling complex,CCHL1A1,cell communication by electrical coupling involved in cardiac conduction,cell division and cell death,Cell membrane,cell motility,cognitive abnormalities,Complete proteome,congenital heart disease,consisting of alpha-1,cytoplasm,dendritic shaft,Disease mutation,Disorder characterized by multiorgan dysfunction including lethal arrhythmias,Disulfide bond,Each of the four internal repeats contains five hydrophobic transmembrane segments (S1,ECG,energy reserve metabolic process,Expressed in brain and heart and jejunum and ovary and pancreatic beta-cells and vascular smooth muscle,gene expression,glucose homeostasis,Glycoprotein,growth hormone secretion,high voltage-gated calcium channel activity,hormone or neurotransmitter release,immune deficiency,including muscle contraction,insulin secretion,integral component of membrane,interaction between RRAD and CACNB2 regulates its trafficking to the cell membrane,Interacts (via C-terminal CDB motif) with CABP5; in a calcium-dependent manner,Interacts (via the N-terminus and the C-terminal C and IQ motifs) with CABP1,Interacts with CACNA2D4,Interacts with CIB1; the interaction increases upon cardiomyocytes hypertrophy,intermittent hypoglycemia,Ion channel,Ion transport,isoform 1,It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs the individual will faint and may die in a few minutes if the heart is not reset,L type,Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group,Membrane,membrane depolarization during action potential,Membrane; Multi-pass membrane protein,metal ion binding,Metal-binding,neuronal cell body,Overall expression is reduced in atherosclerotic vascular smooth muscle,phenylalkylamines,Phosphoprotein,Phosphorylation by PKA activates the channel,plasma membrane,Polymorphism,positive regulation of cytosolic calcium ion concentration,postsynaptic density,protein binding,Reference proteome,regulation of blood pressure,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,regulation of insulin secretion,regulation of organ growth,regulation of vasoconstriction,Repeat,S2,S3,S4 segments probably represent the voltage-sensor and are characterized by a series of positively charged amino acids at every third position,S5,S6) and one positively charged transmembrane segment (S4),small molecule metabolic process,smooth muscle contraction involved in micturition,synaptic transmission,The auxiliary subunits beta and alpha-2/delta linked by a disulfide bridge regulate the channel activity,The binding to the cytoplasmic N-terminal domain is calcium independent but is essential for the ch",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs216013",
        "SNP Name": "CACNA1C A2729632G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs216013",
        "Video": null,
        "Tags": "A heart disease characterized by the association of Brugada syndrome with shortened QT intervals,adult walking behavior,alpha-1 polypeptide,alpha-2,alpha-actinin binding,Alternative splicing,and by omega-agatoxin-IIIA (omega-Aga-IIIA),anticoagulant,ASD,autism,Autism Spectrum Disorder,axon guidance,Belongs to the calcium channel alpha-1 subunit (TC 1.A.1.11) family,benzothiazepines,beta and delta subunits in a 1:1:1:1 ratio,Binding of calmodulin or CABP1 at the same regulatory sites results in an opposit effects on the channel function,Binding of intracellular calcium through the EF-hand motif inhibits the opening of the channel,BRGDA3,Brugada syndrome,Brugada syndrome 3,Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram,CACH2,CACN2,CACNA1C,CACNA1C subfamily,CACNL1A1,Calcium,Calcium channel,Calcium channels containing the alpha-1C subunit play an important role in excitation-contraction coupling in the heart,calcium ion import,calcium ion transport into cytosol,calcium ion-dependent exocytosis,Calcium transport,calcium-mediated signaling using extracellular calcium source,calmodulin binding,cardiac muscle,caveolar macromolecular signaling complex,CCHL1A1,cell communication by electrical coupling involved in cardiac conduction,cell division and cell death,Cell membrane,cell motility,cognitive abnormalities,Complete proteome,congenital heart disease,consisting of alpha-1,cytoplasm,dendritic shaft,Disease mutation,Disorder characterized by multiorgan dysfunction including lethal arrhythmias,Disulfide bond,Each of the four internal repeats contains five hydrophobic transmembrane segments (S1,ECG,energy reserve metabolic process,Expressed in brain and heart and jejunum and ovary and pancreatic beta-cells and vascular smooth muscle,gene expression,glucose homeostasis,Glycoprotein,growth hormone secretion,high voltage-gated calcium channel activity,hormone or neurotransmitter release,immune deficiency,including muscle contraction,insulin secretion,integral component of membrane,interaction between RRAD and CACNB2 regulates its trafficking to the cell membrane,Interacts (via C-terminal CDB motif) with CABP5; in a calcium-dependent manner,Interacts (via the N-terminus and the C-terminal C and IQ motifs) with CABP1,Interacts with CACNA2D4,Interacts with CIB1; the interaction increases upon cardiomyocytes hypertrophy,intermittent hypoglycemia,Ion channel,Ion transport,isoform 1,It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs the individual will faint and may die in a few minutes if the heart is not reset,L type,Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group,Membrane,membrane depolarization during action potential,Membrane; Multi-pass membrane protein,metal ion binding,Metal-binding,neuronal cell body,Overall expression is reduced in atherosclerotic vascular smooth muscle,phenylalkylamines,Phosphoprotein,Phosphorylation by PKA activates the channel,plasma membrane,Polymorphism,positive regulation of cytosolic calcium ion concentration,postsynaptic density,protein binding,Reference proteome,regulation of blood pressure,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,regulation of insulin secretion,regulation of organ growth,regulation of vasoconstriction,Repeat,S2,S3,S4 segments probably represent the voltage-sensor and are characterized by a series of positively charged amino acids at every third position,S5,S6) and one positively charged transmembrane segment (S4),small molecule metabolic process,smooth muscle contraction involved in micturition,synaptic transmission,The auxiliary subunits beta and alpha-2/delta linked by a disulfide bridge regulate the channel activity,The binding to the cytoplasmic N-terminal domain is calcium independent but is essential for the ch",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2302729",
        "SNP Name": "CACNA1C T709021C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2302729",
        "Video": null,
        "Tags": "A heart disease characterized by the association of Brugada syndrome with shortened QT intervals,adult walking behavior,alpha-1 polypeptide,alpha-2,alpha-actinin binding,Alternative splicing,and by omega-agatoxin-IIIA (omega-Aga-IIIA),ASD,autism,Autism Spectrum Disorder,axon guidance,Belongs to the calcium channel alpha-1 subunit (TC 1.A.1.11) family,benzothiazepines,beta and delta subunits in a 1:1:1:1 ratio,Binding of calmodulin or CABP1 at the same regulatory sites results in an opposit effects on the channel function,Binding of intracellular calcium through the EF-hand motif inhibits the opening of the channel,BRGDA3,Brugada syndrome,Brugada syndrome 3,Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram,CACH2,CACN2,CACNA1C,CACNA1C subfamily,CACNL1A1,Calcium,Calcium channel,Calcium channels containing the alpha-1C subunit play an important role in excitation-contraction coupling in the heart,calcium ion import,calcium ion transport into cytosol,calcium ion-dependent exocytosis,Calcium transport,calcium-mediated signaling using extracellular calcium source,calmodulin binding,cardiac muscle,caveolar macromolecular signaling complex,CCHL1A1,cell communication by electrical coupling involved in cardiac conduction,cell division and cell death,Cell membrane,cell motility,cognitive abnormalities,Complete proteome,congenital heart disease,consisting of alpha-1,cytoplasm,dendritic shaft,Disease mutation,Disorder characterized by multiorgan dysfunction including lethal arrhythmias,Disulfide bond,Each of the four internal repeats contains five hydrophobic transmembrane segments (S1,ECG,energy reserve metabolic process,Expressed in brain and heart and jejunum and ovary and pancreatic beta-cells and vascular smooth muscle,gene expression,glucose homeostasis,Glycoprotein,growth hormone secretion,high voltage-gated calcium channel activity,hormone or neurotransmitter release,immune deficiency,including muscle contraction,insomnia,insulin secretion,integral component of membrane,interaction between RRAD and CACNB2 regulates its trafficking to the cell membrane,Interacts (via C-terminal CDB motif) with CABP5; in a calcium-dependent manner,Interacts (via the N-terminus and the C-terminal C and IQ motifs) with CABP1,Interacts with CACNA2D4,Interacts with CIB1; the interaction increases upon cardiomyocytes hypertrophy,intermittent hypoglycemia,Ion channel,Ion transport,isoform 1,It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs the individual will faint and may die in a few minutes if the heart is not reset,L type,Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group,Membrane,membrane depolarization during action potential,Membrane; Multi-pass membrane protein,metal ion binding,Metal-binding,neuronal cell body,Overall expression is reduced in atherosclerotic vascular smooth muscle,phenylalkylamines,Phosphoprotein,Phosphorylation by PKA activates the channel,plasma membrane,Polymorphism,positive regulation of cytosolic calcium ion concentration,postsynaptic density,protein binding,Reference proteome,regulation of blood pressure,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,regulation of insulin secretion,regulation of organ growth,regulation of vasoconstriction,Repeat,S2,S3,S4 segments probably represent the voltage-sensor and are characterized by a series of positively charged amino acids at every third position,S5,S6) and one positively charged transmembrane segment (S4),small molecule metabolic process,smooth muscle contraction involved in micturition,synaptic transmission,The auxiliary subunits beta and alpha-2/delta linked by a disulfide bridge regulate the channel activity,The binding to the cytoplasmic N-terminal domain is calcium independent but is essential for the channel",
        "Group": "Magnesium Sulfate"
    },
    {
        "SNP ID": "rs2302729",
        "SNP Name": "CACNA1C T709021C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2302729",
        "Video": null,
        "Tags": "A heart disease characterized by the association of Brugada syndrome with shortened QT intervals,adult walking behavior,alpha-1 polypeptide,alpha-2,alpha-actinin binding,Alternative splicing,and by omega-agatoxin-IIIA (omega-Aga-IIIA),ASD,autism,Autism Spectrum Disorder,axon guidance,Belongs to the calcium channel alpha-1 subunit (TC 1.A.1.11) family,benzothiazepines,beta and delta subunits in a 1:1:1:1 ratio,Binding of calmodulin or CABP1 at the same regulatory sites results in an opposit effects on the channel function,Binding of intracellular calcium through the EF-hand motif inhibits the opening of the channel,BRGDA3,Brugada syndrome,Brugada syndrome 3,Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram,CACH2,CACN2,CACNA1C,CACNA1C subfamily,CACNL1A1,Calcium,Calcium channel,Calcium channels containing the alpha-1C subunit play an important role in excitation-contraction coupling in the heart,calcium ion import,calcium ion transport into cytosol,calcium ion-dependent exocytosis,Calcium transport,calcium-mediated signaling using extracellular calcium source,calmodulin binding,cardiac muscle,caveolar macromolecular signaling complex,CCHL1A1,cell communication by electrical coupling involved in cardiac conduction,cell division and cell death,Cell membrane,cell motility,cognitive abnormalities,Complete proteome,congenital heart disease,consisting of alpha-1,cytoplasm,dendritic shaft,Disease mutation,Disorder characterized by multiorgan dysfunction including lethal arrhythmias,Disulfide bond,Each of the four internal repeats contains five hydrophobic transmembrane segments (S1,ECG,energy reserve metabolic process,Expressed in brain and heart and jejunum and ovary and pancreatic beta-cells and vascular smooth muscle,gene expression,glucose homeostasis,Glycoprotein,growth hormone secretion,high voltage-gated calcium channel activity,hormone or neurotransmitter release,immune deficiency,including muscle contraction,insomnia,insulin secretion,integral component of membrane,interaction between RRAD and CACNB2 regulates its trafficking to the cell membrane,Interacts (via C-terminal CDB motif) with CABP5; in a calcium-dependent manner,Interacts (via the N-terminus and the C-terminal C and IQ motifs) with CABP1,Interacts with CACNA2D4,Interacts with CIB1; the interaction increases upon cardiomyocytes hypertrophy,intermittent hypoglycemia,Ion channel,Ion transport,isoform 1,It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs the individual will faint and may die in a few minutes if the heart is not reset,L type,Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group,Membrane,membrane depolarization during action potential,Membrane; Multi-pass membrane protein,metal ion binding,Metal-binding,neuronal cell body,Overall expression is reduced in atherosclerotic vascular smooth muscle,phenylalkylamines,Phosphoprotein,Phosphorylation by PKA activates the channel,plasma membrane,Polymorphism,positive regulation of cytosolic calcium ion concentration,postsynaptic density,protein binding,Reference proteome,regulation of blood pressure,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,regulation of insulin secretion,regulation of organ growth,regulation of vasoconstriction,Repeat,S2,S3,S4 segments probably represent the voltage-sensor and are characterized by a series of positively charged amino acids at every third position,S5,S6) and one positively charged transmembrane segment (S4),small molecule metabolic process,smooth muscle contraction involved in micturition,synaptic transmission,The auxiliary subunits beta and alpha-2/delta linked by a disulfide bridge regulate the channel activity,The binding to the cytoplasmic N-terminal domain is calcium independent but is essential for the channel",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs2302729",
        "SNP Name": "CACNA1C T709021C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2302729",
        "Video": null,
        "Tags": "A heart disease characterized by the association of Brugada syndrome with shortened QT intervals,adult walking behavior,alpha-1 polypeptide,alpha-2,alpha-actinin binding,Alternative splicing,and by omega-agatoxin-IIIA (omega-Aga-IIIA),ASD,autism,Autism Spectrum Disorder,axon guidance,Belongs to the calcium channel alpha-1 subunit (TC 1.A.1.11) family,benzothiazepines,beta and delta subunits in a 1:1:1:1 ratio,Binding of calmodulin or CABP1 at the same regulatory sites results in an opposit effects on the channel function,Binding of intracellular calcium through the EF-hand motif inhibits the opening of the channel,BRGDA3,Brugada syndrome,Brugada syndrome 3,Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram,CACH2,CACN2,CACNA1C,CACNA1C subfamily,CACNL1A1,Calcium,Calcium channel,Calcium channels containing the alpha-1C subunit play an important role in excitation-contraction coupling in the heart,calcium ion import,calcium ion transport into cytosol,calcium ion-dependent exocytosis,Calcium transport,calcium-mediated signaling using extracellular calcium source,calmodulin binding,cardiac muscle,caveolar macromolecular signaling complex,CCHL1A1,cell communication by electrical coupling involved in cardiac conduction,cell division and cell death,Cell membrane,cell motility,cognitive abnormalities,Complete proteome,congenital heart disease,consisting of alpha-1,cytoplasm,dendritic shaft,Disease mutation,Disorder characterized by multiorgan dysfunction including lethal arrhythmias,Disulfide bond,Each of the four internal repeats contains five hydrophobic transmembrane segments (S1,ECG,energy reserve metabolic process,Expressed in brain and heart and jejunum and ovary and pancreatic beta-cells and vascular smooth muscle,gene expression,glucose homeostasis,Glycoprotein,growth hormone secretion,high voltage-gated calcium channel activity,hormone or neurotransmitter release,immune deficiency,including muscle contraction,insomnia,insulin secretion,integral component of membrane,interaction between RRAD and CACNB2 regulates its trafficking to the cell membrane,Interacts (via C-terminal CDB motif) with CABP5; in a calcium-dependent manner,Interacts (via the N-terminus and the C-terminal C and IQ motifs) with CABP1,Interacts with CACNA2D4,Interacts with CIB1; the interaction increases upon cardiomyocytes hypertrophy,intermittent hypoglycemia,Ion channel,Ion transport,isoform 1,It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs the individual will faint and may die in a few minutes if the heart is not reset,L type,Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group,Membrane,membrane depolarization during action potential,Membrane; Multi-pass membrane protein,metal ion binding,Metal-binding,neuronal cell body,Overall expression is reduced in atherosclerotic vascular smooth muscle,phenylalkylamines,Phosphoprotein,Phosphorylation by PKA activates the channel,plasma membrane,Polymorphism,positive regulation of cytosolic calcium ion concentration,postsynaptic density,protein binding,Reference proteome,regulation of blood pressure,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,regulation of insulin secretion,regulation of organ growth,regulation of vasoconstriction,Repeat,S2,S3,S4 segments probably represent the voltage-sensor and are characterized by a series of positively charged amino acids at every third position,S5,S6) and one positively charged transmembrane segment (S4),small molecule metabolic process,smooth muscle contraction involved in micturition,synaptic transmission,The auxiliary subunits beta and alpha-2/delta linked by a disulfide bridge regulate the channel activity,The binding to the cytoplasmic N-terminal domain is calcium independent but is essential for the channel",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs28933382",
        "SNP Name": "KCNA1 P244H",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dipotassium Phosphate"
    },
    {
        "SNP ID": "rs28933382",
        "SNP Name": "KCNA1 P244H",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dulbecco's Modified Eagle Medium"
    },
    {
        "SNP ID": "rs28933382",
        "SNP Name": "KCNA1 P244H",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Monopotassium Glutamate"
    },
    {
        "SNP ID": "rs28933382",
        "SNP Name": "KCNA1 P244H",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Monopotassium Phosphate"
    },
    {
        "SNP ID": "rs28933382",
        "SNP Name": "KCNA1 P244H",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Polacrilin Potassium"
    },
    {
        "SNP ID": "rs28933382",
        "SNP Name": "KCNA1 P244H",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Potassium Chloride"
    },
    {
        "SNP ID": "rs669",
        "SNP Name": "A2M Ile1000Val",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "A-beta,A2M,acute phase protein,AD,Alpha-2-M,Alpha-2-macroglobulin,Alpha-2-macroglobulin deficiency,Alzheimer,Alzheimer's disease,bait region,beta-amyloid deposits,blood clot,blood coagulation,blood microparticle,blood pressure,calcium-dependent protein binding,cleavage site,clot,clotting,coagulation,collagenase,cytosol,degradation of A-beta,Disulfide bond,disulfide-linked,enzyme binding,enzyme thioester bond,essential hypertension,extracellular matrix disassembly,extracellular matrix organization,extracellular region,extracellular vesicular exosome,GlcNAc,Gln-Lys,Glycoprotein,growth factor binding,high BP,Homotetramer,hypertension,IL-8,IL8,inhibit proteinases,interleukin,interleukin-1 binding,interleukin-8 binding,intrinsic pathway,Isoglutamyl lysine isopeptide,Isopeptide bond,lectin pathway,macroglobulin,negative regulation of complement activation,negative regulation of endopeptidase activity,neurodegenerative disorder,obesity,peptide,peptide stretch,platelet activation,platelet alpha granule lumen,platelet degranulation,protease binding,Protease inhibitor,protease inhibitor I39 (alpha-2-macroglobulin),proteinase trap,receptor binding,regulation of small GTPase mediated signal transduction,secreted,Secreted in plasma,serine,Serine protease inhibitor,serine-type endopeptidase inhibitor activity,small GTPase mediated signal transduction,stem cell,stem cell differentiation,thioester,Thioester bond,thrombin,TNF,trypsin,tumor necrosis factor binding",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs12316150",
        "SNP Name": "OLR1 T17500A",
        "Risk Allele": "T",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "activated platelets,AD,adhesion molecule,advanced glycation end,AGE,Alzheimer,Alzheimer's disease,apoptosis,atherosclerosis,blood circulation,blood coagulation,C-type lectin domain family 8 member A,carbohydrate binding,cardiovascular,Cell adhesion,cell death,CLEC8A,coagulation,CVD,dementia,Disulfide bond,endotoxin-induced inflammation,extracellular vesicular exosome,Glycoprotein,Gram-negative and Gram-positive bacteria,heart,heart attack,hLOX-1,Immunity,inflammation,inflammatory response,integral component of plasma membrane,intracellular membrane-bounded organelle,LDL,Lectin,Lectin-like oxidized LDL receptor 1,Lectin-type oxidized LDL receptor 1,leukocyte,leukocyte cell-cell adhesion,leukocyte migration,leukocyte-adhesion molecule,lipoprotein,lipoprotein metabolic process,low density lipoprotein,low-density lipoprotein receptor activity,LOX-1,LOX1,membrane,monocyte,myocardial,myocardial infarction,neurodegenerative disorder,nitric oxide,NO,nucleus,OLR1,Ox-LDL receptor 1,Oxidized low-density lipoprotein receptor 1,oxygen,Palmitate,plasma membrane,platelet,platelets,proteolysis,receptor complex,response to hydrogen peroxide,T cells,T-cells,vascular,vascular endothelial cells",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs2160525",
        "SNP Name": "LRP6 T154522C",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "ADCAD2,Alzheimer,Alzheimer's disease,anterior/posterior pattern specification,apolipoprotein,apolipoprotein binding,arteries,artery,atherosclerosis,autosomal dominant 2,axis elongation involved in somitogenesis,beta-catenin,bone formation,bone morphogenesis,bone remodeling,branching involved in mammary gland duct morphogenesis,CAD,cancer,cancerous,canonical Wnt signaling pathway,canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development,canonical Wnt signaling pathway involved in neural crest cell differentiation,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,canonical Wnt signaling pathway involved in regulation of cell proliferation,carcinogen,cardiovascular,cell migration involved in gastrulation,cell surface,cellular response to cholesterol,cerebellum morphogenesis,cerebral cortex cell migration,cerebral cortex development,convergent extension,coreceptor activity involved in Wnt signaling pathway,Coronary artery disease,cytoplasmic vesicle,dementia,DNA-templated,dopamine,dopaminergic,dopaminergic neuron differentiation,DVL1 polymers,early endosome,embryonic camera-type eye morphogenesis,embryonic digit morphogenesis,embryonic forelimb morphogenesis,embryonic hindlimb morphogenesis,embryonic limb morphogenesis,embryonic pattern specification,embryonic retina morphogenesis in camera-type eye,endoplasmic reticulum,external genitalia morphogenesis,face morphogenesis,folate,folic acid,forebrain radial glial cell differentiation,formation of radial glial scaffolds,frizzled binding,gastrulation with mouth forming second,heart,heart disease,heart looping,identical protein binding,infarction,integral component of membrane,kinase inhibitor activity,LDL,lipoprotein,low-density lipoprotein receptor activity,Low-density lipoprotein receptor-related protein 6,LRP-6,LRP6,mammary placode formation,methylfolate,midbrain development,midbrain-hindbrain boundary development,myocardial,myocardial infarction,negative regulation of epithelial cell proliferation,negative regulation of fat cell differentiation,negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis,negative regulation of planar cell polarity pathway involved in neural tube closure,negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis,negative regulation of planar cell polarity pathway involved in pericardium morphogenesis,negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis,negative regulation of protein kinase activity,negative regulation of protein phosphorylation,negative regulation of protein serine/threonine kinase activity,negative regulation of smooth muscle cell apoptotic process,neural crest cell differentiation,neural crest formation,neural tube closure,neurodegenerative disorder,neuronal cell body,odontogenesis of dentin-containing tooth,palate development,pericardium morphogenesis,phosphorylation,plasma membrane,positive regulation of apoptotic process,positive regulation of bone resorption,positive regulation of canonical Wnt signaling pathway,positive regulation of cell cycle,positive regulation of cytosolic calcium ion concentration,positive regulation of mesenchymal cell proliferation,positive regulation of ossification,positive regulation of sequence-specific DNA binding transcription factor activity,positive regulation of transcription,positive regulation of transcription from RNA polymerase II promoter,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,post-anal tail morphogenesis,primitive streak formation,protein homodimerization activity,receptor binding,receptor complex,receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol tran",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs1012672",
        "SNP Name": "LRP6 Cys1270",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,ADCAD2,Alzheimer,Alzheimer's disease,anterior/posterior pattern specification,apolipoprotein,apolipoprotein binding,arteries,artery,atherosclerosis,autosomal dominant 2,axis elongation involved in somitogenesis,beta-catenin,bone formation,bone morphogenesis,bone remodeling,branching involved in mammary gland duct morphogenesis,CAD,cancer,cancerous,canonical Wnt signaling pathway,canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development,canonical Wnt signaling pathway involved in neural crest cell differentiation,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,canonical Wnt signaling pathway involved in regulation of cell proliferation,carcinogen,cardiovascular,cell migration involved in gastrulation,cell surface,cellular response to cholesterol,cerebellum morphogenesis,cerebral cortex cell migration,cerebral cortex development,convergent extension,coreceptor activity involved in Wnt signaling pathway,Coronary artery disease,CVD,cytoplasmic vesicle,dementia,DNA-templated,dopamine,dopaminergic,dopaminergic neuron differentiation,DVL1 polymers,early endosome,embryonic camera-type eye morphogenesis,embryonic digit morphogenesis,embryonic forelimb morphogenesis,embryonic hindlimb morphogenesis,embryonic limb morphogenesis,embryonic pattern specification,embryonic retina morphogenesis in camera-type eye,endoplasmic reticulum,external genitalia morphogenesis,face morphogenesis,folate,folic acid,forebrain radial glial cell differentiation,formation of radial glial scaffolds,frizzled binding,gastrulation with mouth forming second,heart,heart disease,heart looping,identical protein binding,infarction,integral component of membrane,kinase inhibitor activity,Late-Onset Alzheimer Disease,LDL,lipoprotein,Low-Density Lipoprotein,low-density lipoprotein receptor activity,Low-density lipoprotein receptor-related protein 6,LRP-6,LRP6,mammary placode formation,methylfolate,midbrain development,midbrain-hindbrain boundary development,myocardial,myocardial infarction,negative regulation of epithelial cell proliferation,negative regulation of fat cell differentiation,negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis,negative regulation of planar cell polarity pathway involved in neural tube closure,negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis,negative regulation of planar cell polarity pathway involved in pericardium morphogenesis,negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis,negative regulation of protein kinase activity,negative regulation of protein phosphorylation,negative regulation of protein serine/threonine kinase activity,negative regulation of smooth muscle cell apoptotic process,neural crest cell differentiation,neural crest formation,neural tube closure,neurodegenerative disease,neurodegenerative disorder,neuronal cell body,odontogenesis of dentin-containing tooth,palate development,pericardium morphogenesis,phosphorylation,plasma membrane,positive regulation of apoptotic process,positive regulation of bone resorption,positive regulation of canonical Wnt signaling pathway,positive regulation of cell cycle,positive regulation of cytosolic calcium ion concentration,positive regulation of mesenchymal cell proliferation,positive regulation of ossification,positive regulation of sequence-specific DNA binding transcription factor activity,positive regulation of transcription,positive regulation of transcription from RNA polymerase II promoter,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,post-anal tail morphogenesis,primitive streak formation,protein homodimerization activity,receptor binding,receptor complex,rec",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs2302685",
        "SNP Name": "LRP6 V1062I",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,ADCAD2,Alzheimer,Alzheimer's disease,anterior/posterior pattern specification,apolipoprotein,apolipoprotein binding,arteries,artery,atherosclerosis,autosomal dominant 2,axis elongation involved in somitogenesis,beta-catenin,bone formation,bone morphogenesis,bone remodeling,branching involved in mammary gland duct morphogenesis,CAD,cancer,cancerous,canonical Wnt signaling pathway,canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development,canonical Wnt signaling pathway involved in neural crest cell differentiation,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,canonical Wnt signaling pathway involved in regulation of cell proliferation,carcinogen,cardio,cardiovascular,CD,cell migration involved in gastrulation,cell surface,cellular response to cholesterol,cerebellum morphogenesis,cerebral cortex cell migration,cerebral cortex development,chron,chrons,Cognitive Impairment,coloboma,convergent extension,coreceptor activity involved in Wnt signaling pathway,Coronary artery disease,Crohn's Disease,CVD,cytoplasmic vesicle,dementia,Diabetic Nephropathy,DNA-templated,dopamine,dopaminergic,dopaminergic neuron differentiation,DVL1 polymers,early endosome,embryonic camera-type eye morphogenesis,embryonic digit morphogenesis,embryonic forelimb morphogenesis,embryonic hindlimb morphogenesis,embryonic limb morphogenesis,embryonic pattern specification,embryonic retina morphogenesis in camera-type eye,endoplasmic reticulum,external genitalia morphogenesis,face morphogenesis,folate,folic acid,forebrain radial glial cell differentiation,formation of radial glial scaffolds,frizzled binding,gastrulation with mouth forming second,heart,heart attack,heart disease,heart looping,identical protein binding,infarction,integral component of membrane,kinase inhibitor activity,late-onset Alzheimer's disease,LDL,LDL-C,lipoprotein,low-density lipoprotein receptor activity,Low-density lipoprotein receptor-related protein 6,LRP-6,LRP6,mammary placode formation,methylfolate,microphthalmia,midbrain development,midbrain-hindbrain boundary development,myocardial,myocardial infarction,negative regulation of epithelial cell proliferation,negative regulation of fat cell differentiation,negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis,negative regulation of planar cell polarity pathway involved in neural tube closure,negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis,negative regulation of planar cell polarity pathway involved in pericardium morphogenesis,negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis,negative regulation of protein kinase activity,negative regulation of protein phosphorylation,negative regulation of protein serine/threonine kinase activity,negative regulation of smooth muscle cell apoptotic process,neural crest cell differentiation,neural crest formation,neural tube closure,neurodegenerative disease,neurodegenerative disorder,neuronal cell body,odontogenesis of dentin-containing tooth,Osteoporosis,palate development,pericardium morphogenesis,phosphorylation,plasma membrane,positive regulation of apoptotic process,positive regulation of bone resorption,positive regulation of canonical Wnt signaling pathway,positive regulation of cell cycle,positive regulation of cytosolic calcium ion concentration,positive regulation of mesenchymal cell proliferation,positive regulation of ossification,positive regulation of sequence-specific DNA binding transcription factor activity,positive regulation of transcription,positive regulation of transcription from RNA polymerase II promoter,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,post-a",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs3847987",
        "SNP Name": "VDR C48238068A",
        "Risk Allele": "A",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3847987",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,C48238068A,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs3847987,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs731236",
        "SNP Name": "VDR TAQ",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs731236",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs731236,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,TAQ,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "D-Mannose"
    },
    {
        "SNP ID": "rs731236",
        "SNP Name": "VDR TAQ",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs731236",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs731236,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,TAQ,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs1544410",
        "SNP Name": "VDR VDR:BsmI",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1544410",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,25-Hydroxyvitamin D,Acute Kidney Injury,acute lymphoblastic leukemia,adiposity phenotypes,adolescent idiopathic scoliosis,age-related macular degeneration,Alternative splicing,asthma,autoantibodies,autoimmune,Autoimmune Disease Type 1 Diabetes,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,Bone Mineral Density,breast cancer,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cancer,cancer protection,cancerous,carcinogen,cardiovascular disease,cell morphogenesis,cellular calcium ion homeostasis,chronic obstructive pulmonary disease,chronic periodontitis,cirrhosis,colon adenoma,colorectal adenoma,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,congestive heart failure,Contains 1 nuclear receptor DNA-binding domain,COPD,Coronary Heart Disease,cutaneous melanoma,CVD,D3,decidualization,depression,diabetes,Disease mutation,DNA binding,DNA-binding,DNA-templated,drug reaction,drug response,endometrial cancer risk,estrogen,fatigue,femoral neck stress fractures,gene expression,genetic predisposition to disease,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,glioma,Head and Neck Squamous Cell Carcinoma,heart,heart disease,Hepatitis,Hepatitis C,hepatocellular carcinoma,Heterodimer with RXRA after vitamin D3 binding,high blood pressure,high BP,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypertension,hypocalcemia,immune regulator,immune response,immune system,immunization,immunogenetics,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,ischemic stroke,islet autoimmunity,lactation,leukemia,Leukocyte Telomere Length,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,liver,liver disease,longitudinal cognitive change,macular degeneration,mammary gland branching involved in pregnancy,Melanoma,metabolic pathway,Metal-binding,migraine,mineral metabolism,modulates soy intake and 25-hydroxyvitamin D supplementation benefits in cardiovascular disease,mortality,Most patients have total alopecia in addition to rickets,multiple sclerosis,Myopia,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,Nervous System Autoantibodies,non-Hodgkin lymphoma,Non-small Cell Lung Cancer,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Osteoporosis,Osteoporotic Fracture,Ovarian Cancer,Pancreas Cancer,pancreatic cancer,Parkinson,Parkinson's disease,PCOS,PD,pharmacogenomics,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,postmenopausal breast cancer,Primary Biliary Cirrhosis,prostate cancer,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,Renal Cancer,Response to Interferon/Ribavirin Therapy in Chroni",
        "Group": "D-Mannose"
    },
    {
        "SNP ID": "rs1544410",
        "SNP Name": "VDR VDR:BsmI",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1544410",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,25-Hydroxyvitamin D,Acute Kidney Injury,acute lymphoblastic leukemia,adiposity phenotypes,adolescent idiopathic scoliosis,age-related macular degeneration,Alternative splicing,asthma,autoantibodies,autoimmune,Autoimmune Disease Type 1 Diabetes,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,Bone Mineral Density,breast cancer,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cancer,cancer protection,cancerous,carcinogen,cardiovascular disease,cell morphogenesis,cellular calcium ion homeostasis,chronic obstructive pulmonary disease,chronic periodontitis,cirrhosis,colon adenoma,colorectal adenoma,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,congestive heart failure,Contains 1 nuclear receptor DNA-binding domain,COPD,Coronary Heart Disease,cutaneous melanoma,CVD,D3,decidualization,depression,diabetes,Disease mutation,DNA binding,DNA-binding,DNA-templated,drug reaction,drug response,endometrial cancer risk,estrogen,fatigue,femoral neck stress fractures,gene expression,genetic predisposition to disease,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,glioma,Head and Neck Squamous Cell Carcinoma,heart,heart disease,Hepatitis,Hepatitis C,hepatocellular carcinoma,Heterodimer with RXRA after vitamin D3 binding,high blood pressure,high BP,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypertension,hypocalcemia,immune regulator,immune response,immune system,immunization,immunogenetics,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,ischemic stroke,islet autoimmunity,lactation,leukemia,Leukocyte Telomere Length,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,liver,liver disease,longitudinal cognitive change,macular degeneration,mammary gland branching involved in pregnancy,Melanoma,metabolic pathway,Metal-binding,migraine,mineral metabolism,modulates soy intake and 25-hydroxyvitamin D supplementation benefits in cardiovascular disease,mortality,Most patients have total alopecia in addition to rickets,multiple sclerosis,Myopia,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,Nervous System Autoantibodies,non-Hodgkin lymphoma,Non-small Cell Lung Cancer,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Osteoporosis,Osteoporotic Fracture,Ovarian Cancer,Pancreas Cancer,pancreatic cancer,Parkinson,Parkinson's disease,PCOS,PD,pharmacogenomics,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,postmenopausal breast cancer,Primary Biliary Cirrhosis,prostate cancer,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,Renal Cancer,Response to Interferon/Ribavirin Therapy in Chroni",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs1544410",
        "SNP Name": "VDR VDR:BsmI",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1544410",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,25-Hydroxyvitamin D,Acute Kidney Injury,acute lymphoblastic leukemia,adiposity phenotypes,adolescent idiopathic scoliosis,age-related macular degeneration,Alternative splicing,asthma,autoantibodies,autoimmune,Autoimmune Disease Type 1 Diabetes,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,Bone Mineral Density,breast cancer,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cancer,cancer protection,cancerous,carcinogen,cardiovascular disease,cell morphogenesis,cellular calcium ion homeostasis,chronic obstructive pulmonary disease,chronic periodontitis,cirrhosis,colon adenoma,colorectal adenoma,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,congestive heart failure,Contains 1 nuclear receptor DNA-binding domain,COPD,Coronary Heart Disease,cutaneous melanoma,CVD,D3,decidualization,depression,diabetes,Disease mutation,DNA binding,DNA-binding,DNA-templated,drug reaction,drug response,endometrial cancer risk,estrogen,fatigue,femoral neck stress fractures,gene expression,genetic predisposition to disease,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,glioma,Head and Neck Squamous Cell Carcinoma,heart,heart disease,Hepatitis,Hepatitis C,hepatocellular carcinoma,Heterodimer with RXRA after vitamin D3 binding,high blood pressure,high BP,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypertension,hypocalcemia,immune regulator,immune response,immune system,immunization,immunogenetics,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,ischemic stroke,islet autoimmunity,lactation,leukemia,Leukocyte Telomere Length,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,liver,liver disease,longitudinal cognitive change,macular degeneration,mammary gland branching involved in pregnancy,Melanoma,metabolic pathway,Metal-binding,migraine,mineral metabolism,modulates soy intake and 25-hydroxyvitamin D supplementation benefits in cardiovascular disease,mortality,Most patients have total alopecia in addition to rickets,multiple sclerosis,Myopia,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,Nervous System Autoantibodies,non-Hodgkin lymphoma,Non-small Cell Lung Cancer,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Osteoporosis,Osteoporotic Fracture,Ovarian Cancer,Pancreas Cancer,pancreatic cancer,Parkinson,Parkinson's disease,PCOS,PD,pharmacogenomics,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,postmenopausal breast cancer,Primary Biliary Cirrhosis,prostate cancer,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,Renal Cancer,Response to Interferon/Ribavirin Therapy in Chroni",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs7967152",
        "SNP Name": "VDR A48244184C",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7967152",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,A48244184C,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs7967152,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs2248098",
        "SNP Name": "VDR T50459C",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2248098",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs2248098,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,T50459C,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs2239182",
        "SNP Name": "VDR T48255411C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2239182",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs2239182,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,T48255411C,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs2107301",
        "SNP Name": "VDR C48245T",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2107301",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,C48245T,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs2107301,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs2239181",
        "SNP Name": "VDR T47866G",
        "Risk Allele": "C",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2239181",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs2239181,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,T47866G,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs1540339",
        "SNP Name": "VDR G46489A",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1540339",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,G46489A Vitamin D3 receptor,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs1540339,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs12721370",
        "SNP Name": "VDR G41742T",
        "Risk Allele": "A",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs12721370",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,G41742T,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs12721370,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs886441",
        "SNP Name": "VDR G48262964A",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs886441",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,G48262964A,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs886441,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs2189480",
        "SNP Name": "VDR C39987A",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2189480",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,C39987A,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs2189480,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs2239186",
        "SNP Name": "VDR T34405C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2239186",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs2239186,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,T34405C,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs11168275",
        "SNP Name": "VDR T48272275C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs11168275",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs11168275,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,T48272275C,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs2254210",
        "SNP Name": "VDR G48273714A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2254210",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,G48273714A,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs2254210,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs2238136",
        "SNP Name": "VDR C48277713T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2238136",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,C48277713T,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs2238136,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs2853564",
        "SNP Name": "VDR G48278487A",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2853564",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,G48278487A,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs2853564,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs11168287",
        "SNP Name": "VDR G48285414A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs11168287",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,G48285414A,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs11168287,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs4328262",
        "SNP Name": "VDR C18167A",
        "Risk Allele": "G",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4328262",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,C18167A,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs4328262,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs4334089",
        "SNP Name": "VDR G48286015A",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4334089",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,G48286015A,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs4334089,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs4237855",
        "SNP Name": "VDR G48287203A",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4237855",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,G48287203A,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs4237855,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs3890733",
        "SNP Name": "VDR G14442A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3890733",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,G14442A,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs3890733,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs10875695",
        "SNP Name": "VDR C48293037A",
        "Risk Allele": "A",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10875695",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,C48293037A,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs10875695,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs11168293",
        "SNP Name": "VDR G48293716T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs11168293",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,G48293716T,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs11168293,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs7136534",
        "SNP Name": "VDR G9189A",
        "Risk Allele": "G",
        "Your Allele": "TC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7136534",
        "Video": null,
        "Tags": "1,25-dihydroxyvitamin D3 receptor,Alternative splicing,Belongs to the nuclear hormone receptor family,bile acid,bile acid signaling pathway,calcitriol binding,calcitriol receptor activity,calcium,calcium ion transport,cell morphogenesis,cellular calcium ion homeostasis,Complete proteome,Composed of three domains: a modulating N-terminal domain a DNA-binding domain and a C-terminal ligand-binding domain,Contains 1 nuclear receptor DNA-binding domain,D3,decidualization,Disease mutation,DNA binding,DNA-binding,DNA-templated,G9189A,gene expression,Genetic variations in VDR may determine Mycobacterium tuberculosis susceptibility,Heterodimer with RXRA after vitamin D3 binding,Homodimer in the absence of bound vitamin D3,hormone,hyperparathyroidism,hypocalcemia,immune response,immune system,Interacts (in a ligand-dependent manner) with BAZ1B/WSTF,Interacts with IRX4 and the interaction doesn't affect its transactivation activity,Interacts with MED1 and NCOA1 and NCOA2 and NCOA3 and NCOA6 coactivators leading to a strong increase of transcription of target genes,Interacts with SMAD3,Interacts with SNW1,intestinal absorption,lactation,lithocholic acid,lithocholic acid binding,lithocholic acid receptor activity,mammary gland branching involved in pregnancy,metabolic pathway,Metal-binding,mineral metabolism,Most patients have total alopecia in addition to rickets,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,NR1 subfamily,Nuclear hormone receptor,Nuclear receptor subfamily 1 group I member 1,nucleoplasm,Nucleus,organ morphogenesis,Plays a central role in calcium homeostasis,Polymorphism,positive regulation of apoptotic process involved in mammary gland involution,positive regulation of gene expression,positive regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vitamin D 24-hydroxylase activity,protein binding,Receptor,Recruited to promoters via its interaction with the WINAC complex subunit BAZ1B/WSTF which mediates the interaction with acetylated histones an essential step for VDR-promoter association,Reference proteome,Regulates transcription of hormone sensitive genes via its association with the WINAC complex a chromatin-remodeling complex,regulation of calcidiol 1-monooxygenase activity,retinoid X receptor binding,rickets,Rickets vitamin D-dependent 2A (VDDR2A),rs7136534,sequence-specific DNA binding,sex hormone,signal transduction,skeletal system development,steroid,steroid hormone receptor activity,thyroid,thyroid hormone receptor,Transcription,Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes,transcription initiation from RNA polymerase II promoter,Transcription regulation,VDR,vitamin D metabolism,vitamin D receptor,vitamin D receptor signaling pathway,Vitamin D3 receptor,Zinc,zinc ion binding,Zinc-finger",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs149411",
        "SNP Name": "SLC11A2 51380232A>G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs2272306",
        "SNP Name": "CSAD C25411T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "NO STUDIES ON PUBMED",
        "Video": null,
        "Tags": "acetyltransferase,cancer,cancerous,carboxy-lyase activity,carboxylic acid metabolic process,carcinogen,choline,CSAD,CSAD protein,cysteine,cysteine sulfinic acid decarboxylase,homocysteine,L-glutamic acid decarboxylase,Lyase,neurotransmitter,neurotransmitter-synthesizing enzymes,neurotransmitters,prostate,prostate cancer,Pyridoxal phosphate,pyridoxal phosphate binding,tyrosine hydroxylase",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2272306",
        "SNP Name": "CSAD C25411T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "NO STUDIES ON PUBMED",
        "Video": null,
        "Tags": "acetyltransferase,cancer,cancerous,carboxy-lyase activity,carboxylic acid metabolic process,carcinogen,choline,CSAD,CSAD protein,cysteine,cysteine sulfinic acid decarboxylase,homocysteine,L-glutamic acid decarboxylase,Lyase,neurotransmitter,neurotransmitter-synthesizing enzymes,neurotransmitters,prostate,prostate cancer,Pyridoxal phosphate,pyridoxal phosphate binding,tyrosine hydroxylase",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2272306",
        "SNP Name": "CSAD C25411T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "NO STUDIES ON PUBMED",
        "Video": null,
        "Tags": "acetyltransferase,cancer,cancerous,carboxy-lyase activity,carboxylic acid metabolic process,carcinogen,choline,CSAD,CSAD protein,cysteine,cysteine sulfinic acid decarboxylase,homocysteine,L-glutamic acid decarboxylase,Lyase,neurotransmitter,neurotransmitter-synthesizing enzymes,neurotransmitters,prostate,prostate cancer,Pyridoxal phosphate,pyridoxal phosphate binding,tyrosine hydroxylase",
        "Group": "Trans-Sulfuration Pathway"
    },
    {
        "SNP ID": "rs10506328",
        "SNP Name": "NFE2 A54687232C",
        "Risk Allele": "A",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Gentamicin Sulfate"
    },
    {
        "SNP ID": "rs10506328",
        "SNP Name": "NFE2 A54687232C",
        "Risk Allele": "A",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Kanamycin"
    },
    {
        "SNP ID": "rs10506328",
        "SNP Name": "NFE2 A54687232C",
        "Risk Allele": "A",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Neomycin (Neomycin Sulfate)"
    },
    {
        "SNP ID": "rs10876550",
        "SNP Name": "NFE2 G16855614A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Gentamicin Sulfate"
    },
    {
        "SNP ID": "rs10876550",
        "SNP Name": "NFE2 G16855614A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Kanamycin"
    },
    {
        "SNP ID": "rs10876550",
        "SNP Name": "NFE2 G16855614A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Neomycin (Neomycin Sulfate)"
    },
    {
        "SNP ID": "rs2638315",
        "SNP Name": "GLS2 G56865056C",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Yeast Protein"
    },
    {
        "SNP ID": "rs2657879",
        "SNP Name": "GLS2 L581P",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Yeast Protein"
    },
    {
        "SNP ID": "rs6214",
        "SNP Name": "IGF1 G85810A",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "2-Phenoxyethanol"
    },
    {
        "SNP ID": "rs6214",
        "SNP Name": "IGF1 G85810A",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Alcohol"
    },
    {
        "SNP ID": "rs6214",
        "SNP Name": "IGF1 G85810A",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs35767",
        "SNP Name": "IGF1 A102875569G",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Mercury (Thiomersal/Thimerosal)"
    },
    {
        "SNP ID": "rs1801153",
        "SNP Name": "PAH G*187A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1801153",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,ASD,autism,autism spectrum disorder,autosomal recessive,Autosomal recessive inborn error of phenylalanine metabolism,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,G*187A,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs1801153,schizophrenia,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "Phenol USP"
    },
    {
        "SNP ID": "rs1801153",
        "SNP Name": "PAH G*187A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1801153",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,ASD,autism,autism spectrum disorder,autosomal recessive,Autosomal recessive inborn error of phenylalanine metabolism,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,G*187A,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs1801153,schizophrenia,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1801153",
        "SNP Name": "PAH G*187A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1801153",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,ASD,autism,autism spectrum disorder,autosomal recessive,Autosomal recessive inborn error of phenylalanine metabolism,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,G*187A,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs1801153,schizophrenia,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs5030861",
        "SNP Name": "PAH IVS12+1G>A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/7557973",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,anorexia,Anorexia Nervosa,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),BH4 load test,BH4-response,biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eating disorder,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,IVS12+1G>A,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,PKU Autosomal recessive inborn error of phenylalanine metabolism,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs5030861,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs5030861",
        "SNP Name": "PAH IVS12+1G>A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/7557973",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,anorexia,Anorexia Nervosa,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),BH4 load test,BH4-response,biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eating disorder,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,IVS12+1G>A,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,PKU Autosomal recessive inborn error of phenylalanine metabolism,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs5030861,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs5030858",
        "SNP Name": "PAH R408W",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=rs5030858",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,C1222T,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,cleft lip,cleft palate,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,non-syndromic cleft lip with or without cleft palate,NSCL/P,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs5030858,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine,\u00a0Autosomal recessive inborn error of phenylalanine metabolism",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs5030858",
        "SNP Name": "PAH R408W",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=rs5030858",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,C1222T,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,cleft lip,cleft palate,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,non-syndromic cleft lip with or without cleft palate,NSCL/P,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs5030858,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine,\u00a0Autosomal recessive inborn error of phenylalanine metabolism",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs5030857",
        "SNP Name": "PAH A403V",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/21820508",
        "Video": null,
        "Tags": "A403V,ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,anorexia,Anorexia Nervosa,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eating disorder,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Europe,european,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,PKU Autosomal recessive inborn error of phenylalanine metabolism,Poland,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs5030857,skin color,Slovene,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs5030857",
        "SNP Name": "PAH A403V",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/21820508",
        "Video": null,
        "Tags": "A403V,ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,anorexia,Anorexia Nervosa,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eating disorder,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Europe,european,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,PKU Autosomal recessive inborn error of phenylalanine metabolism,Poland,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs5030857,skin color,Slovene,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2245360",
        "SNP Name": "PAH C81837T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2245360",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,C81837T,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental disorder,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs2245360,schizophrenia,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine,\u00a0Autosomal recessive inborn error of phenylalanine metabolism",
        "Group": "Phenol USP"
    },
    {
        "SNP ID": "rs2245360",
        "SNP Name": "PAH C81837T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2245360",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,C81837T,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental disorder,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs2245360,schizophrenia,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine,\u00a0Autosomal recessive inborn error of phenylalanine metabolism",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs2245360",
        "SNP Name": "PAH C81837T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2245360",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,C81837T,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental disorder,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs2245360,schizophrenia,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine,\u00a0Autosomal recessive inborn error of phenylalanine metabolism",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs5030855",
        "SNP Name": "PAH IVS10-11G>A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/7557973",
        "Video": null,
        "Tags": "acceptor splice,ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,anorexia,Anorexia Nervosa,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eating disorder,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Europe,european,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,IVS10-11G>A,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,Latvia,latvian,melanin,melanin deficiency,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Novosibirsk region,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,PKU Autosomal recessive inborn error of phenylalanine metabolism,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs5030855,Russia,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs5030855",
        "SNP Name": "PAH IVS10-11G>A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/7557973",
        "Video": null,
        "Tags": "acceptor splice,ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,anorexia,Anorexia Nervosa,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eating disorder,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Europe,european,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,IVS10-11G>A,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,Latvia,latvian,melanin,melanin deficiency,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Novosibirsk region,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,PKU Autosomal recessive inborn error of phenylalanine metabolism,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs5030855,Russia,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs5030853",
        "SNP Name": "PAH A300S",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.pahdb.mcgill.ca/?Topic=About&Section=CuratorsPage&Page=0",
        "Video": null,
        "Tags": "A300S,ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,anorexia,Anorexia Nervosa,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,Canada,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eating disorder,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,PKU Autosomal recessive inborn error of phenylalanine metabolism,Polymorphism,psychosis,psychotic,Quebec,rashes,Reference proteome,rs5030853,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs5030853",
        "SNP Name": "PAH A300S",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.pahdb.mcgill.ca/?Topic=About&Section=CuratorsPage&Page=0",
        "Video": null,
        "Tags": "A300S,ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,anorexia,Anorexia Nervosa,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,Canada,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eating disorder,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,PKU Autosomal recessive inborn error of phenylalanine metabolism,Polymorphism,psychosis,psychotic,Quebec,rashes,Reference proteome,rs5030853,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs5030852",
        "SNP Name": "PAH IVS7+1G>A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/7557973",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,anorexia,Anorexia Nervosa,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),BH4 load test,BH4-response,biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eating disorder,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,IVS7+1G>A,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,PKU Autosomal recessive inborn error of phenylalanine metabolism,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs5030852,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs5030852",
        "SNP Name": "PAH IVS7+1G>A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/7557973",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,anorexia,Anorexia Nervosa,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),BH4 load test,BH4-response,biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eating disorder,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,IVS7+1G>A,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,PKU Autosomal recessive inborn error of phenylalanine metabolism,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs5030852,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs5030849",
        "SNP Name": "PAH G782A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5030849",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,G782A,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,PKU\u00a0Autosomal recessive inborn error of phenylalanine metabolism,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs5030849,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "Phenol USP"
    },
    {
        "SNP ID": "rs5030849",
        "SNP Name": "PAH G782A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5030849",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,G782A,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,PKU\u00a0Autosomal recessive inborn error of phenylalanine metabolism,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs5030849,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs5030849",
        "SNP Name": "PAH G782A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5030849",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,G782A,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,PKU\u00a0Autosomal recessive inborn error of phenylalanine metabolism,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs5030849,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1042503",
        "SNP Name": "PAH G735A",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1042503",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,G735A,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental disorder,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs1042503,schizophrenia,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine,\u00a0Autosomal recessive inborn error of phenylalanine metabolism",
        "Group": "Phenol USP"
    },
    {
        "SNP ID": "rs1042503",
        "SNP Name": "PAH G735A",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1042503",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,G735A,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental disorder,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs1042503,schizophrenia,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine,\u00a0Autosomal recessive inborn error of phenylalanine metabolism",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1042503",
        "SNP Name": "PAH G735A",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1042503",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,G735A,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental disorder,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs1042503,schizophrenia,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine,\u00a0Autosomal recessive inborn error of phenylalanine metabolism",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs3817446",
        "SNP Name": "PAH A55562G",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3817446",
        "Video": null,
        "Tags": "A55562G,ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,cognition,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,memory,memory performance,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs3817446,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine,\u00a0Autosomal recessive inborn error of phenylalanine metabolism",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs3817446",
        "SNP Name": "PAH A55562G",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3817446",
        "Video": null,
        "Tags": "A55562G,ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,cognition,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,memory,memory performance,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs3817446,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine,\u00a0Autosomal recessive inborn error of phenylalanine metabolism",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2037639",
        "SNP Name": "PAH C45031T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2037639",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,C45031T,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,cognition,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,memory,memory performance,mental disorder,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs2037639,schizophrenia,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine,\u00a0Autosomal recessive inborn error of phenylalanine metabolism",
        "Group": "Phenol USP"
    },
    {
        "SNP ID": "rs2037639",
        "SNP Name": "PAH C45031T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2037639",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,C45031T,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,cognition,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,memory,memory performance,mental disorder,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs2037639,schizophrenia,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine,\u00a0Autosomal recessive inborn error of phenylalanine metabolism",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs2037639",
        "SNP Name": "PAH C45031T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2037639",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,C45031T,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,cognition,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,memory,memory performance,mental disorder,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs2037639,schizophrenia,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine,\u00a0Autosomal recessive inborn error of phenylalanine metabolism",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1722392",
        "SNP Name": "PAH G37636A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1722392",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,autosomal recessive,Autosomal recessive inborn error of phenylalanine metabolism,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,G37636A,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental disorder,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs1722392,schizophrenia,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "Phenol USP"
    },
    {
        "SNP ID": "rs1722392",
        "SNP Name": "PAH G37636A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1722392",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,autosomal recessive,Autosomal recessive inborn error of phenylalanine metabolism,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,G37636A,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental disorder,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs1722392,schizophrenia,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1722392",
        "SNP Name": "PAH G37636A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1722392",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,autosomal recessive,Autosomal recessive inborn error of phenylalanine metabolism,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,G37636A,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental disorder,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs1722392,schizophrenia,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs10860936",
        "SNP Name": "PAH A33429G",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10860936",
        "Video": null,
        "Tags": "A33429G,ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,cognition,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,memory,memory performance,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs10860936,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine,\u00a0Autosomal recessive inborn error of phenylalanine metabolism",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs10860936",
        "SNP Name": "PAH A33429G",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10860936",
        "Video": null,
        "Tags": "A33429G,ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,cognition,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,memory,memory performance,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs10860936,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine,\u00a0Autosomal recessive inborn error of phenylalanine metabolism",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs10778209",
        "SNP Name": "PAH T32409C",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10778209",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,anorexia,Anorexia Nervosa,arginine,autosomal recessive,Autosomal recessive inborn error of phenylalanine metabolism,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eating disorder,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental disorder,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs10778209,schizophrenia,skin color,small molecule metabolic process,T32409C,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "Phenol USP"
    },
    {
        "SNP ID": "rs10778209",
        "SNP Name": "PAH T32409C",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10778209",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,anorexia,Anorexia Nervosa,arginine,autosomal recessive,Autosomal recessive inborn error of phenylalanine metabolism,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eating disorder,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental disorder,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs10778209,schizophrenia,skin color,small molecule metabolic process,T32409C,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs10778209",
        "SNP Name": "PAH T32409C",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10778209",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,anorexia,Anorexia Nervosa,arginine,autosomal recessive,Autosomal recessive inborn error of phenylalanine metabolism,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eating disorder,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental disorder,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs10778209,schizophrenia,skin color,small molecule metabolic process,T32409C,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs62507347",
        "SNP Name": "PAH A27743C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://snpedia.com/index.php/Rs62507347",
        "Video": null,
        "Tags": "A27743C,ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,autosomal recessive,Autosomal recessive inborn error of phenylalanine metabolism,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,non-pku Hyperphenylalaninemia,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs62507347,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs62507347",
        "SNP Name": "PAH A27743C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://snpedia.com/index.php/Rs62507347",
        "Video": null,
        "Tags": "A27743C,ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,autosomal recessive,Autosomal recessive inborn error of phenylalanine metabolism,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,non-pku Hyperphenylalaninemia,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs62507347,skin color,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1522307",
        "SNP Name": "PAH T17864C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1522307",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,ASD,autism,autism spectrum disorder,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs1522307,skin color,small molecule metabolic process,T17864C,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine,\u00a0Autosomal recessive inborn error of phenylalanine metabolism",
        "Group": "Phenol USP"
    },
    {
        "SNP ID": "rs1522307",
        "SNP Name": "PAH T17864C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1522307",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,ASD,autism,autism spectrum disorder,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs1522307,skin color,small molecule metabolic process,T17864C,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine,\u00a0Autosomal recessive inborn error of phenylalanine metabolism",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1522307",
        "SNP Name": "PAH T17864C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1522307",
        "Video": null,
        "Tags": "ACT domain,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,arginine,ASD,autism,autism spectrum disorder,autosomal recessive,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eczema,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,melanin,melanin deficiency,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,Polymorphism,psychosis,psychotic,rashes,Reference proteome,rs1522307,skin color,small molecule metabolic process,T17864C,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine,\u00a0Autosomal recessive inborn error of phenylalanine metabolism",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs5030841",
        "SNP Name": "PAH L48S",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/10720436",
        "Video": null,
        "Tags": "ACT domain,ADD,ADHD,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,anorexia,Anorexia Nervosa,arginine,attention deficit,attention-deficit,autosomal recessive,behavior,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),BH4 load test,biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,concentration,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eating disorder,eczema,emotion,emotional,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,focus,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hunger,hunger pain,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,L48S,melanin,melanin deficiency,memory,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,mood,mood changes,mood disturbance,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neophobia,neuro-pyschometric,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,phenylalanine tolerance,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,PKU Autosomal recessive inborn error of phenylalanine metabolism,Polymorphism,psychiatric,psychological,psychosis,psychotic,rashes,Reference proteome,rs5030841,Sapropterin,Sapropterin dihydrochloride,satiety,skin color,slow responder,small molecule metabolic process,social,social behavior,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs5030841",
        "SNP Name": "PAH L48S",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/10720436",
        "Video": null,
        "Tags": "ACT domain,ADD,ADHD,Allosteric enzyme,amino acid binding,amino acid toxic build up,amino acids,Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine,anorexia,Anorexia Nervosa,arginine,attention deficit,attention-deficit,autosomal recessive,behavior,BH4,BH4 as cofactor (preincubated with BH4),BH4 as cofactor (preincubated with L-Phe),BH4 load test,biopterin-dependent aromatic amino acid hydroxylase family,birth defect,body odor,brain,brain damage,catecholamine biosynthetic process,cellular amino acid biosynthetic process,cellular nitrogen compound metabolic process,Complete proteome,concentration,cytosol,defect,diet,Direct protein sequencing,Disease mutation,dopamine,due to severe phenylalanine hydroxylase deficiency. It is characterized by blood concentrations of phenylalanine persistently above 1200 mumol (normal concentration 100 mumol) which usually causes mental retardation (unless low phenylalanine diet is intro,eating disorder,eczema,emotion,emotional,energy,energy production,enzyme activity of the variant protein is indistinguishable from that of the wild-type form,epilepsy,Fe2+ ion,focus,Glu-274 variant occurs on approximately 4% of African-American PAH alleles,hair color,Homodimer and homotetramer,hunger,hunger pain,hyperactivity,hyperphenylalaninemia,Hyperphenylalaninemia (HPA),Iron,iron ion binding,L-arginine,L-Phe with BH4 as cofactor,L-Phenylalanine,L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin,L-phenylalanine catabolic process,L-Tyrosine,L48S,melanin,melanin deficiency,memory,mental retardation,Metal-binding,Mild form of phenylalanine hydroxylase deficiency characterized by phenylalanine levels persistently below 600 mumol which allows normal intellectual and behavioral development without treatment,Mildest form of phenylalanine hydroxylase deficiency,Monooxygenase,mood,mood changes,mood disturbance,N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an \"inhibitory\" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule,neophobia,neuro-pyschometric,neurotransmitter biosynthetic process,neurotransmitters,Non-phenylketonuria hyperphenylalaninemia,Non-PKU HPA,Non-PKU HPA is usually caused by the combined effect of a mild hyperphenylalaninemia mutation and a severe one,Oxidoreductase,PAH,Phe-4-monooxygenase,Phenylalanine,phenylalanine 4-monooxygenase activity,Phenylalanine catabolism,phenylalanine hydroxylase,phenylalanine tolerance,Phenylalanine-4-hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylation at Ser-16 increases basal activity and facilitates activation by the substrate phenylalanine,pigmentation,PKU,PKU Autosomal recessive inborn error of phenylalanine metabolism,Polymorphism,psychiatric,psychological,psychosis,psychotic,rashes,Reference proteome,rs5030841,Sapropterin,Sapropterin dihydrochloride,satiety,skin color,slow responder,small molecule metabolic process,social,social behavior,tetrahydrobiopterin,Tetrahydrobiopterin Pathway,Tyrosine",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2070586",
        "SNP Name": "DAO G8864A",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2070586",
        "Video": "wUDYy96aums",
        "Tags": "aromatic,cellular nitrogen compound metabolic process,cofactor binding,cytosol,D-alanine,D-alanine catabolic process,D-amino acids,D-amino-acid oxidase,D-amino-acid oxidase activity,D-DOPA,D-phenylalanine,D-proline,D-serine,D-serine catabolic process,D-serine metabolic process,D-tyrosine,DAAO,DAMOX,DAMOX/DASOX family,DAO,DAOA,dopamine biosynthetic process,dopamine synthesis,FAD,FAD binding,flavin adenine dinucleotide,flavoprotein,G109277720A,glutamate,Glutamate neurotransmission,glyoxylate metabolic process,Homodimer,L-amino acids,leucine metabolic process,mental disorder,neuromodulator D-serine,NMDA receptor,OXDA,Oxidoreductase,peroxisomal,peroxisomal matrix,peroxisomal membrane,Peroxisome,polar,proline catabolic process,protein dimerization activity,proteome,receptor binding,rs2070586,schizophrenia,small hydrophobic side chains,small molecule metabolic process",
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs2070586",
        "SNP Name": "DAO G8864A",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2070586",
        "Video": "wUDYy96aums",
        "Tags": "aromatic,cellular nitrogen compound metabolic process,cofactor binding,cytosol,D-alanine,D-alanine catabolic process,D-amino acids,D-amino-acid oxidase,D-amino-acid oxidase activity,D-DOPA,D-phenylalanine,D-proline,D-serine,D-serine catabolic process,D-serine metabolic process,D-tyrosine,DAAO,DAMOX,DAMOX/DASOX family,DAO,DAOA,dopamine biosynthetic process,dopamine synthesis,FAD,FAD binding,flavin adenine dinucleotide,flavoprotein,G109277720A,glutamate,Glutamate neurotransmission,glyoxylate metabolic process,Homodimer,L-amino acids,leucine metabolic process,mental disorder,neuromodulator D-serine,NMDA receptor,OXDA,Oxidoreductase,peroxisomal,peroxisomal matrix,peroxisomal membrane,Peroxisome,polar,proline catabolic process,protein dimerization activity,proteome,receptor binding,rs2070586,schizophrenia,small hydrophobic side chains,small molecule metabolic process",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs2070586",
        "SNP Name": "DAO G8864A",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2070586",
        "Video": "wUDYy96aums",
        "Tags": "aromatic,cellular nitrogen compound metabolic process,cofactor binding,cytosol,D-alanine,D-alanine catabolic process,D-amino acids,D-amino-acid oxidase,D-amino-acid oxidase activity,D-DOPA,D-phenylalanine,D-proline,D-serine,D-serine catabolic process,D-serine metabolic process,D-tyrosine,DAAO,DAMOX,DAMOX/DASOX family,DAO,DAOA,dopamine biosynthetic process,dopamine synthesis,FAD,FAD binding,flavin adenine dinucleotide,flavoprotein,G109277720A,glutamate,Glutamate neurotransmission,glyoxylate metabolic process,Homodimer,L-amino acids,leucine metabolic process,mental disorder,neuromodulator D-serine,NMDA receptor,OXDA,Oxidoreductase,peroxisomal,peroxisomal matrix,peroxisomal membrane,Peroxisome,polar,proline catabolic process,protein dimerization activity,proteome,receptor binding,rs2070586,schizophrenia,small hydrophobic side chains,small molecule metabolic process",
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs2070586",
        "SNP Name": "DAO G8864A",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2070586",
        "Video": "wUDYy96aums",
        "Tags": "aromatic,cellular nitrogen compound metabolic process,cofactor binding,cytosol,D-alanine,D-alanine catabolic process,D-amino acids,D-amino-acid oxidase,D-amino-acid oxidase activity,D-DOPA,D-phenylalanine,D-proline,D-serine,D-serine catabolic process,D-serine metabolic process,D-tyrosine,DAAO,DAMOX,DAMOX/DASOX family,DAO,DAOA,dopamine biosynthetic process,dopamine synthesis,FAD,FAD binding,flavin adenine dinucleotide,flavoprotein,G109277720A,glutamate,Glutamate neurotransmission,glyoxylate metabolic process,Homodimer,L-amino acids,leucine metabolic process,mental disorder,neuromodulator D-serine,NMDA receptor,OXDA,Oxidoreductase,peroxisomal,peroxisomal matrix,peroxisomal membrane,Peroxisome,polar,proline catabolic process,protein dimerization activity,proteome,receptor binding,rs2070586,schizophrenia,small hydrophobic side chains,small molecule metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2070587",
        "SNP Name": "DAO T887G",
        "Risk Allele": "G",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2070587",
        "Video": "wUDYy96aums",
        "Tags": "aromatic,cellular nitrogen compound metabolic process,cofactor binding,cytosol,D-alanine,D-alanine catabolic process,D-amino acids,D-amino-acid oxidase,D-amino-acid oxidase activity,D-DOPA,D-phenylalanine,D-proline,D-serine,D-serine catabolic process,D-serine metabolic process,D-tyrosine,DAAO,DAMOX,DAMOX/DASOX family,DAO,dopamine biosynthetic process,dopamine synthesis,FAD,FAD binding,flavin adenine dinucleotide,flavoprotein,glyoxylate metabolic process,Homodimer,L-amino acids,leucine metabolic process,mental disorder,neuromodulator D-serine,NMDA,NMDA receptor,OXDA,Oxidoreductase,peroxisomal,peroxisomal matrix,peroxisomal membrane,Peroxisome,polar,proline catabolic process,protein dimerization activity,proteome,receptor binding,rs2070587,schizophrenia,small hydrophobic side chains,small molecule metabolic process,T109277743G",
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs2070587",
        "SNP Name": "DAO T887G",
        "Risk Allele": "G",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2070587",
        "Video": "wUDYy96aums",
        "Tags": "aromatic,cellular nitrogen compound metabolic process,cofactor binding,cytosol,D-alanine,D-alanine catabolic process,D-amino acids,D-amino-acid oxidase,D-amino-acid oxidase activity,D-DOPA,D-phenylalanine,D-proline,D-serine,D-serine catabolic process,D-serine metabolic process,D-tyrosine,DAAO,DAMOX,DAMOX/DASOX family,DAO,dopamine biosynthetic process,dopamine synthesis,FAD,FAD binding,flavin adenine dinucleotide,flavoprotein,glyoxylate metabolic process,Homodimer,L-amino acids,leucine metabolic process,mental disorder,neuromodulator D-serine,NMDA,NMDA receptor,OXDA,Oxidoreductase,peroxisomal,peroxisomal matrix,peroxisomal membrane,Peroxisome,polar,proline catabolic process,protein dimerization activity,proteome,receptor binding,rs2070587,schizophrenia,small hydrophobic side chains,small molecule metabolic process,T109277743G",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs2070587",
        "SNP Name": "DAO T887G",
        "Risk Allele": "G",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2070587",
        "Video": "wUDYy96aums",
        "Tags": "aromatic,cellular nitrogen compound metabolic process,cofactor binding,cytosol,D-alanine,D-alanine catabolic process,D-amino acids,D-amino-acid oxidase,D-amino-acid oxidase activity,D-DOPA,D-phenylalanine,D-proline,D-serine,D-serine catabolic process,D-serine metabolic process,D-tyrosine,DAAO,DAMOX,DAMOX/DASOX family,DAO,dopamine biosynthetic process,dopamine synthesis,FAD,FAD binding,flavin adenine dinucleotide,flavoprotein,glyoxylate metabolic process,Homodimer,L-amino acids,leucine metabolic process,mental disorder,neuromodulator D-serine,NMDA,NMDA receptor,OXDA,Oxidoreductase,peroxisomal,peroxisomal matrix,peroxisomal membrane,Peroxisome,polar,proline catabolic process,protein dimerization activity,proteome,receptor binding,rs2070587,schizophrenia,small hydrophobic side chains,small molecule metabolic process,T109277743G",
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs2070587",
        "SNP Name": "DAO T887G",
        "Risk Allele": "G",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2070587",
        "Video": "wUDYy96aums",
        "Tags": "aromatic,cellular nitrogen compound metabolic process,cofactor binding,cytosol,D-alanine,D-alanine catabolic process,D-amino acids,D-amino-acid oxidase,D-amino-acid oxidase activity,D-DOPA,D-phenylalanine,D-proline,D-serine,D-serine catabolic process,D-serine metabolic process,D-tyrosine,DAAO,DAMOX,DAMOX/DASOX family,DAO,dopamine biosynthetic process,dopamine synthesis,FAD,FAD binding,flavin adenine dinucleotide,flavoprotein,glyoxylate metabolic process,Homodimer,L-amino acids,leucine metabolic process,mental disorder,neuromodulator D-serine,NMDA,NMDA receptor,OXDA,Oxidoreductase,peroxisomal,peroxisomal matrix,peroxisomal membrane,Peroxisome,polar,proline catabolic process,protein dimerization activity,proteome,receptor binding,rs2070587,schizophrenia,small hydrophobic side chains,small molecule metabolic process,T109277743G",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2111902",
        "SNP Name": "DAO T9891G",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2111902",
        "Video": "wUDYy96aums",
        "Tags": "aromatic,bipolar DAO,cellular nitrogen compound metabolic process,cofactor binding,cytosol,D-alanine,D-alanine catabolic process,D-amino acids,D-amino-acid oxidase,D-amino-acid oxidase activity,D-DOPA,D-phenylalanine,D-proline,D-serine,D-serine catabolic process,D-serine metabolic process,D-tyrosine,DAAO,DAMOX,DAMOX/DASOX family,DAO,dopamine biosynthetic process,dopamine synthesis,FAD,FAD binding,flavin adenine dinucleotide,flavoprotein,glyoxylate metabolic process,Homodimer,L-amino acids,leucine metabolic process,mental disorder,neuromodulator D-serine,NMDA receptor,OXDA,Oxidoreductase,peroxisomal,peroxisomal matrix,peroxisomal membrane,Peroxisome,polar,proline catabolic process,protein dimerization activity,proteome,Psychiatric Disease,receptor binding,rs2111902,schizophrenia,small hydrophobic side chains,small molecule metabolic process,T109278747G,Working Memory",
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs2111902",
        "SNP Name": "DAO T9891G",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2111902",
        "Video": "wUDYy96aums",
        "Tags": "aromatic,bipolar DAO,cellular nitrogen compound metabolic process,cofactor binding,cytosol,D-alanine,D-alanine catabolic process,D-amino acids,D-amino-acid oxidase,D-amino-acid oxidase activity,D-DOPA,D-phenylalanine,D-proline,D-serine,D-serine catabolic process,D-serine metabolic process,D-tyrosine,DAAO,DAMOX,DAMOX/DASOX family,DAO,dopamine biosynthetic process,dopamine synthesis,FAD,FAD binding,flavin adenine dinucleotide,flavoprotein,glyoxylate metabolic process,Homodimer,L-amino acids,leucine metabolic process,mental disorder,neuromodulator D-serine,NMDA receptor,OXDA,Oxidoreductase,peroxisomal,peroxisomal matrix,peroxisomal membrane,Peroxisome,polar,proline catabolic process,protein dimerization activity,proteome,Psychiatric Disease,receptor binding,rs2111902,schizophrenia,small hydrophobic side chains,small molecule metabolic process,T109278747G,Working Memory",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs2111902",
        "SNP Name": "DAO T9891G",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2111902",
        "Video": "wUDYy96aums",
        "Tags": "aromatic,bipolar DAO,cellular nitrogen compound metabolic process,cofactor binding,cytosol,D-alanine,D-alanine catabolic process,D-amino acids,D-amino-acid oxidase,D-amino-acid oxidase activity,D-DOPA,D-phenylalanine,D-proline,D-serine,D-serine catabolic process,D-serine metabolic process,D-tyrosine,DAAO,DAMOX,DAMOX/DASOX family,DAO,dopamine biosynthetic process,dopamine synthesis,FAD,FAD binding,flavin adenine dinucleotide,flavoprotein,glyoxylate metabolic process,Homodimer,L-amino acids,leucine metabolic process,mental disorder,neuromodulator D-serine,NMDA receptor,OXDA,Oxidoreductase,peroxisomal,peroxisomal matrix,peroxisomal membrane,Peroxisome,polar,proline catabolic process,protein dimerization activity,proteome,Psychiatric Disease,receptor binding,rs2111902,schizophrenia,small hydrophobic side chains,small molecule metabolic process,T109278747G,Working Memory",
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs2111902",
        "SNP Name": "DAO T9891G",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2111902",
        "Video": "wUDYy96aums",
        "Tags": "aromatic,bipolar DAO,cellular nitrogen compound metabolic process,cofactor binding,cytosol,D-alanine,D-alanine catabolic process,D-amino acids,D-amino-acid oxidase,D-amino-acid oxidase activity,D-DOPA,D-phenylalanine,D-proline,D-serine,D-serine catabolic process,D-serine metabolic process,D-tyrosine,DAAO,DAMOX,DAMOX/DASOX family,DAO,dopamine biosynthetic process,dopamine synthesis,FAD,FAD binding,flavin adenine dinucleotide,flavoprotein,glyoxylate metabolic process,Homodimer,L-amino acids,leucine metabolic process,mental disorder,neuromodulator D-serine,NMDA receptor,OXDA,Oxidoreductase,peroxisomal,peroxisomal matrix,peroxisomal membrane,Peroxisome,polar,proline catabolic process,protein dimerization activity,proteome,Psychiatric Disease,receptor binding,rs2111902,schizophrenia,small hydrophobic side chains,small molecule metabolic process,T109278747G,Working Memory",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs3918347",
        "SNP Name": "DAO A24464G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3918347",
        "Video": "wUDYy96aums",
        "Tags": "A109293320G,aromatic,Ashkenazi,Bipolar,Bipolar Disorder,cellular nitrogen compound metabolic process,cofactor binding,cytosol,D-alanine,D-alanine catabolic process,D-amino acids,D-amino-acid oxidase,D-amino-acid oxidase activity,D-DOPA,D-phenylalanine,D-proline,D-serine,D-serine catabolic process,D-serine metabolic process,D-tyrosine,DAAO,DAMOX,DAMOX/DASOX family,DAO,dopamine biosynthetic process,dopamine synthesis,FAD,FAD binding,flavin adenine dinucleotide,flavoprotein,glyoxylate metabolic process,Homodimer,Jewish,L-amino acids,leucine metabolic process,mental disorder,neuromodulator D-serine,NMDA receptor,OXDA,Oxidoreductase,peroxisomal,peroxisomal matrix,peroxisomal membrane,Peroxisome,polar,proline catabolic process,protein dimerization activity,proteome,receptor binding,rs3918347,Schizophrenia,small hydrophobic side chains,small molecule metabolic process",
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs3918347",
        "SNP Name": "DAO A24464G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3918347",
        "Video": "wUDYy96aums",
        "Tags": "A109293320G,aromatic,Ashkenazi,Bipolar,Bipolar Disorder,cellular nitrogen compound metabolic process,cofactor binding,cytosol,D-alanine,D-alanine catabolic process,D-amino acids,D-amino-acid oxidase,D-amino-acid oxidase activity,D-DOPA,D-phenylalanine,D-proline,D-serine,D-serine catabolic process,D-serine metabolic process,D-tyrosine,DAAO,DAMOX,DAMOX/DASOX family,DAO,dopamine biosynthetic process,dopamine synthesis,FAD,FAD binding,flavin adenine dinucleotide,flavoprotein,glyoxylate metabolic process,Homodimer,Jewish,L-amino acids,leucine metabolic process,mental disorder,neuromodulator D-serine,NMDA receptor,OXDA,Oxidoreductase,peroxisomal,peroxisomal matrix,peroxisomal membrane,Peroxisome,polar,proline catabolic process,protein dimerization activity,proteome,receptor binding,rs3918347,Schizophrenia,small hydrophobic side chains,small molecule metabolic process",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs3918347",
        "SNP Name": "DAO A24464G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3918347",
        "Video": "wUDYy96aums",
        "Tags": "A109293320G,aromatic,Ashkenazi,Bipolar,Bipolar Disorder,cellular nitrogen compound metabolic process,cofactor binding,cytosol,D-alanine,D-alanine catabolic process,D-amino acids,D-amino-acid oxidase,D-amino-acid oxidase activity,D-DOPA,D-phenylalanine,D-proline,D-serine,D-serine catabolic process,D-serine metabolic process,D-tyrosine,DAAO,DAMOX,DAMOX/DASOX family,DAO,dopamine biosynthetic process,dopamine synthesis,FAD,FAD binding,flavin adenine dinucleotide,flavoprotein,glyoxylate metabolic process,Homodimer,Jewish,L-amino acids,leucine metabolic process,mental disorder,neuromodulator D-serine,NMDA receptor,OXDA,Oxidoreductase,peroxisomal,peroxisomal matrix,peroxisomal membrane,Peroxisome,polar,proline catabolic process,protein dimerization activity,proteome,receptor binding,rs3918347,Schizophrenia,small hydrophobic side chains,small molecule metabolic process",
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs3918347",
        "SNP Name": "DAO A24464G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3918347",
        "Video": "wUDYy96aums",
        "Tags": "A109293320G,aromatic,Ashkenazi,Bipolar,Bipolar Disorder,cellular nitrogen compound metabolic process,cofactor binding,cytosol,D-alanine,D-alanine catabolic process,D-amino acids,D-amino-acid oxidase,D-amino-acid oxidase activity,D-DOPA,D-phenylalanine,D-proline,D-serine,D-serine catabolic process,D-serine metabolic process,D-tyrosine,DAAO,DAMOX,DAMOX/DASOX family,DAO,dopamine biosynthetic process,dopamine synthesis,FAD,FAD binding,flavin adenine dinucleotide,flavoprotein,glyoxylate metabolic process,Homodimer,Jewish,L-amino acids,leucine metabolic process,mental disorder,neuromodulator D-serine,NMDA receptor,OXDA,Oxidoreductase,peroxisomal,peroxisomal matrix,peroxisomal membrane,Peroxisome,polar,proline catabolic process,protein dimerization activity,proteome,receptor binding,rs3918347,Schizophrenia,small hydrophobic side chains,small molecule metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs7134594",
        "SNP Name": "MMAB G16110A",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7134594",
        "Video": null,
        "Tags": "Acetylation,adenosylcobalamin (AdoCbl),adenosylcobalamin biosynthesis,ATP,ATP + cob(I)yrinic acid a,ATP + cobinamide = triphosphate + adenosylcobinamide,ATP binding,ATP-binding,B12,B12 deficiency,breast cancer,c-diamide,c-diamide = triphosphate + adenosylcob(III)yrinic acid a,c-diamide adenosyltransferase,c-diamide adenosyltransferase activity,calcified plaque,cancer,cancerous,carcinogen,cholesterol,Cob(I)alamin adenosyltransferase,Cob(I)alamin adenosyltransferase family,Cob(I)yrinic acid a,cobalamin,cobalamin biosynthetic process,cobalamin deficiency,cobalamin metabolic process,cobalamin metabolism,cobalamin to AdoCbl conversion,Cofactor biosynthesis,Cofactor biosynthesis; adenosylcobalamin biosynthesis; adenosylcobalamin from cob(II)yrinate a,coronary artery calcified plaque and mortality,coronary artery disease,cyanocobalamin,diabetes,Disease mutation,energy,enzyme,Expressed in liver and skeletal muscle,fat,fats (lipids),HDL cholesterol,helps break down certain proteins,Homotrimer,lipid,liver,methylcobalamin,methylmalonate,methylmalonic acidemia,Methylmalonic aciduria type B protein,Methylmalonic aciduria type cblB,methylmalonyl CoA mutase,mitochondria,mitochondrial,mitochondrial matrix,mitochondrion,MMAB,mortality,muscle,Nucleotide-binding,plaque,Plasma High-Density Lipoprotein,Polymorphism,prostate cancer,Relationship with Breast and Prostate Cancer Risk,skeletal muscle,small molecule metabolic process,Transferase,Transit peptide,type 2 diabetes,vitamin B12,vitamin deficiency,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs4767939",
        "SNP Name": "ALDH2 A7550G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4767939",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,H2O,head and neck cancer,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,oxidative stress,Oxidoreductase,ROS,SCC,scchn,xenobiotic",
        "Group": "Glutaraldehyde"
    },
    {
        "SNP ID": "rs4767939",
        "SNP Name": "ALDH2 A7550G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4767939",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,H2O,head and neck cancer,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,oxidative stress,Oxidoreductase,ROS,SCC,scchn,xenobiotic",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs4767939",
        "SNP Name": "ALDH2 A7550G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4767939",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,H2O,head and neck cancer,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,oxidative stress,Oxidoreductase,ROS,SCC,scchn,xenobiotic",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs4767939",
        "SNP Name": "ALDH2 A7550G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4767939",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,H2O,head and neck cancer,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,oxidative stress,Oxidoreductase,ROS,SCC,scchn,xenobiotic",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs4767939",
        "SNP Name": "ALDH2 A7550G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4767939",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,H2O,head and neck cancer,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,oxidative stress,Oxidoreductase,ROS,SCC,scchn,xenobiotic",
        "Group": "Yeast/Alcohol Metabolism"
    },
    {
        "SNP ID": "rs2238151",
        "SNP Name": "ALDH2 T12488C",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2238151",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,H2O,head and neck cancer,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,oxidative stress,Oxidoreductase,ROS,SCC,scchn,xenobiotic",
        "Group": "Formaldehyde"
    },
    {
        "SNP ID": "rs2238151",
        "SNP Name": "ALDH2 T12488C",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2238151",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,H2O,head and neck cancer,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,oxidative stress,Oxidoreductase,ROS,SCC,scchn,xenobiotic",
        "Group": "Glutaraldehyde"
    },
    {
        "SNP ID": "rs2238151",
        "SNP Name": "ALDH2 T12488C",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2238151",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,H2O,head and neck cancer,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,oxidative stress,Oxidoreductase,ROS,SCC,scchn,xenobiotic",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs2238151",
        "SNP Name": "ALDH2 T12488C",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2238151",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,H2O,head and neck cancer,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,oxidative stress,Oxidoreductase,ROS,SCC,scchn,xenobiotic",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs2238151",
        "SNP Name": "ALDH2 T12488C",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2238151",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,H2O,head and neck cancer,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,oxidative stress,Oxidoreductase,ROS,SCC,scchn,xenobiotic",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2238151",
        "SNP Name": "ALDH2 T12488C",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2238151",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,H2O,head and neck cancer,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,oxidative stress,Oxidoreductase,ROS,SCC,scchn,xenobiotic",
        "Group": "Yeast/Alcohol Metabolism"
    },
    {
        "SNP ID": "rs4648328",
        "SNP Name": "ALDH2 C23443T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4648328",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,H2O,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidoreductase,SCC,scchn,xenobiotic",
        "Group": "Glutaraldehyde"
    },
    {
        "SNP ID": "rs4648328",
        "SNP Name": "ALDH2 C23443T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4648328",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,H2O,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidoreductase,SCC,scchn,xenobiotic",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs4648328",
        "SNP Name": "ALDH2 C23443T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4648328",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,H2O,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidoreductase,SCC,scchn,xenobiotic",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs4648328",
        "SNP Name": "ALDH2 C23443T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4648328",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,H2O,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidoreductase,SCC,scchn,xenobiotic",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs4648328",
        "SNP Name": "ALDH2 C23443T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4648328",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,H2O,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidoreductase,SCC,scchn,xenobiotic",
        "Group": "Yeast/Alcohol Metabolism"
    },
    {
        "SNP ID": "rs968529",
        "SNP Name": "ALDH2 T35023C",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs968529",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,gastric cancer,H2O,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidoreductase,SCC,scchn,xenobiotic",
        "Group": "Formaldehyde"
    },
    {
        "SNP ID": "rs968529",
        "SNP Name": "ALDH2 T35023C",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs968529",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,gastric cancer,H2O,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidoreductase,SCC,scchn,xenobiotic",
        "Group": "Glutaraldehyde"
    },
    {
        "SNP ID": "rs968529",
        "SNP Name": "ALDH2 T35023C",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs968529",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,gastric cancer,H2O,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidoreductase,SCC,scchn,xenobiotic",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs968529",
        "SNP Name": "ALDH2 T35023C",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs968529",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,gastric cancer,H2O,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidoreductase,SCC,scchn,xenobiotic",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs968529",
        "SNP Name": "ALDH2 T35023C",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs968529",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,gastric cancer,H2O,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidoreductase,SCC,scchn,xenobiotic",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs968529",
        "SNP Name": "ALDH2 T35023C",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs968529",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,gastric cancer,H2O,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidoreductase,SCC,scchn,xenobiotic",
        "Group": "Yeast/Alcohol Metabolism"
    },
    {
        "SNP ID": "rs4646778",
        "SNP Name": "ALDH2 C36438A",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4646778",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,H2O,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidoreductase,SCC,scchn,xenobiotic",
        "Group": "Glutaraldehyde"
    },
    {
        "SNP ID": "rs4646778",
        "SNP Name": "ALDH2 C36438A",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4646778",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,H2O,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidoreductase,SCC,scchn,xenobiotic",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs4646778",
        "SNP Name": "ALDH2 C36438A",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4646778",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,H2O,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidoreductase,SCC,scchn,xenobiotic",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs4646778",
        "SNP Name": "ALDH2 C36438A",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4646778",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,H2O,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidoreductase,SCC,scchn,xenobiotic",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs4646778",
        "SNP Name": "ALDH2 C36438A",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4646778",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,H2O,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidoreductase,SCC,scchn,xenobiotic",
        "Group": "Yeast/Alcohol Metabolism"
    },
    {
        "SNP ID": "rs671",
        "SNP Name": "ALDH2 G1369A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs671",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,Addictive Disorders,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,Alcohol-Induced Medical Diseases,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,Benign Prostate Hyperplasia,blood pressure,Breast and Prostate Cancer,breast cancer,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cardiovascular disease,cellular energy,Colorectal Cancer Risk,coronary artery disease,CVD,cytosolic,diabetes,diabetes mellitus,diabetic retinopathy,EC=1.2.1.3,electron,energy,esophageal cancer,esophageal squamous cell dysplasia,ethanol,ethanol degradation,ethanol oxidation,gastric adenocarcinoma,gastric cancer,Genetic and environmental factors,H2O,HDL cholesterol levels,high BP,Homotetramer,hypertension,intoxication,joint,Lipid Levels,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,Multiple Chemical Sensitivity,NAD,NADH,NADP,neurotransmitter,niacin,oesophageal squamous cell carcinoma,OSCC,Oxidoreductase,primary hepatocellular carcinoma,prostate cancer,SCC,scchn,smoking,Substance Dependence,Type 2 Diabetes,type 2 diabetes mellitus,xenobiotic",
        "Group": "2-Phenoxyethanol"
    },
    {
        "SNP ID": "rs671",
        "SNP Name": "ALDH2 G1369A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs671",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,Addictive Disorders,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,Alcohol-Induced Medical Diseases,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,Benign Prostate Hyperplasia,blood pressure,Breast and Prostate Cancer,breast cancer,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cardiovascular disease,cellular energy,Colorectal Cancer Risk,coronary artery disease,CVD,cytosolic,diabetes,diabetes mellitus,diabetic retinopathy,EC=1.2.1.3,electron,energy,esophageal cancer,esophageal squamous cell dysplasia,ethanol,ethanol degradation,ethanol oxidation,gastric adenocarcinoma,gastric cancer,Genetic and environmental factors,H2O,HDL cholesterol levels,high BP,Homotetramer,hypertension,intoxication,joint,Lipid Levels,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,Multiple Chemical Sensitivity,NAD,NADH,NADP,neurotransmitter,niacin,oesophageal squamous cell carcinoma,OSCC,Oxidoreductase,primary hepatocellular carcinoma,prostate cancer,SCC,scchn,smoking,Substance Dependence,Type 2 Diabetes,type 2 diabetes mellitus,xenobiotic",
        "Group": "Alcohol"
    },
    {
        "SNP ID": "rs671",
        "SNP Name": "ALDH2 G1369A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs671",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,Addictive Disorders,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,Alcohol-Induced Medical Diseases,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,Benign Prostate Hyperplasia,blood pressure,Breast and Prostate Cancer,breast cancer,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cardiovascular disease,cellular energy,Colorectal Cancer Risk,coronary artery disease,CVD,cytosolic,diabetes,diabetes mellitus,diabetic retinopathy,EC=1.2.1.3,electron,energy,esophageal cancer,esophageal squamous cell dysplasia,ethanol,ethanol degradation,ethanol oxidation,gastric adenocarcinoma,gastric cancer,Genetic and environmental factors,H2O,HDL cholesterol levels,high BP,Homotetramer,hypertension,intoxication,joint,Lipid Levels,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,Multiple Chemical Sensitivity,NAD,NADH,NADP,neurotransmitter,niacin,oesophageal squamous cell carcinoma,OSCC,Oxidoreductase,primary\r\nhepatocellular carcinoma,prostate cancer,SCC,scchn,smoking,Substance Dependence,Type 2 Diabetes,type 2 diabetes mellitus,xenobiotic",
        "Group": "Formaldehyde"
    },
    {
        "SNP ID": "rs671",
        "SNP Name": "ALDH2 G1369A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs671",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,Addictive Disorders,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,Alcohol-Induced Medical Diseases,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,Benign Prostate Hyperplasia,blood pressure,Breast and Prostate Cancer,breast cancer,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cardiovascular disease,cellular energy,Colorectal Cancer Risk,coronary artery disease,CVD,cytosolic,diabetes,diabetes mellitus,diabetic retinopathy,EC=1.2.1.3,electron,energy,esophageal cancer,esophageal squamous cell dysplasia,ethanol,ethanol degradation,ethanol oxidation,gastric adenocarcinoma,gastric cancer,Genetic and environmental factors,H2O,HDL cholesterol levels,high BP,Homotetramer,hypertension,intoxication,joint,Lipid Levels,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,Multiple Chemical Sensitivity,NAD,NADH,NADP,neurotransmitter,niacin,oesophageal squamous cell carcinoma,OSCC,Oxidoreductase,primary\r\nhepatocellular carcinoma,prostate cancer,SCC,scchn,smoking,Substance Dependence,Type 2 Diabetes,type 2 diabetes mellitus,xenobiotic",
        "Group": "Glutaraldehyde"
    },
    {
        "SNP ID": "rs671",
        "SNP Name": "ALDH2 G1369A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs671",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,Addictive Disorders,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,Alcohol-Induced Medical Diseases,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,Benign Prostate Hyperplasia,blood pressure,Breast and Prostate Cancer,breast cancer,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cardiovascular disease,cellular energy,Colorectal Cancer Risk,coronary artery disease,CVD,cytosolic,diabetes,diabetes mellitus,diabetic retinopathy,EC=1.2.1.3,electron,energy,esophageal cancer,esophageal squamous cell dysplasia,ethanol,ethanol degradation,ethanol oxidation,gastric adenocarcinoma,gastric cancer,Genetic and environmental factors,H2O,HDL cholesterol levels,high BP,Homotetramer,hypertension,intoxication,joint,Lipid Levels,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,Multiple Chemical Sensitivity,NAD,NADH,NADP,neurotransmitter,niacin,oesophageal squamous cell carcinoma,OSCC,Oxidoreductase,primary\r\nhepatocellular carcinoma,prostate cancer,SCC,scchn,smoking,Substance Dependence,Type 2 Diabetes,type 2 diabetes mellitus,xenobiotic",
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs671",
        "SNP Name": "ALDH2 G1369A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs671",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,Addictive Disorders,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,Alcohol-Induced Medical Diseases,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,Benign Prostate Hyperplasia,blood pressure,Breast and Prostate Cancer,breast cancer,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cardiovascular disease,cellular energy,Colorectal Cancer Risk,coronary artery disease,CVD,cytosolic,diabetes,diabetes mellitus,diabetic retinopathy,EC=1.2.1.3,electron,energy,esophageal cancer,esophageal squamous cell dysplasia,ethanol,ethanol degradation,ethanol oxidation,gastric adenocarcinoma,gastric cancer,Genetic and environmental factors,H2O,HDL cholesterol levels,high BP,Homotetramer,hypertension,intoxication,joint,Lipid Levels,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,Multiple Chemical Sensitivity,NAD,NADH,NADP,neurotransmitter,niacin,oesophageal squamous cell carcinoma,OSCC,Oxidoreductase,primary hepatocellular carcinoma,prostate cancer,SCC,scchn,smoking,Substance Dependence,Type 2 Diabetes,type 2 diabetes mellitus,xenobiotic",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs671",
        "SNP Name": "ALDH2 G1369A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs671",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,Addictive Disorders,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,Alcohol-Induced Medical Diseases,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,Benign Prostate Hyperplasia,blood pressure,Breast and Prostate Cancer,breast cancer,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cardiovascular disease,cellular energy,Colorectal Cancer Risk,coronary artery disease,CVD,cytosolic,diabetes,diabetes mellitus,diabetic retinopathy,EC=1.2.1.3,electron,energy,esophageal cancer,esophageal squamous cell dysplasia,ethanol,ethanol degradation,ethanol oxidation,gastric adenocarcinoma,gastric cancer,Genetic and environmental factors,H2O,HDL cholesterol levels,high BP,Homotetramer,hypertension,intoxication,joint,Lipid Levels,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,Multiple Chemical Sensitivity,NAD,NADH,NADP,neurotransmitter,niacin,oesophageal squamous cell carcinoma,OSCC,Oxidoreductase,primary\r\nhepatocellular carcinoma,prostate cancer,SCC,scchn,smoking,Substance Dependence,Type 2 Diabetes,type 2 diabetes mellitus,xenobiotic",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs671",
        "SNP Name": "ALDH2 G1369A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs671",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,Addictive Disorders,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,Alcohol-Induced Medical Diseases,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,Benign Prostate Hyperplasia,blood pressure,Breast and Prostate Cancer,breast cancer,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cardiovascular disease,cellular energy,Colorectal Cancer Risk,coronary artery disease,CVD,cytosolic,diabetes,diabetes mellitus,diabetic retinopathy,EC=1.2.1.3,electron,energy,esophageal cancer,esophageal squamous cell dysplasia,ethanol,ethanol degradation,ethanol oxidation,gastric adenocarcinoma,gastric cancer,Genetic and environmental factors,H2O,HDL cholesterol levels,high BP,Homotetramer,hypertension,intoxication,joint,Lipid Levels,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,Multiple Chemical Sensitivity,NAD,NADH,NADP,neurotransmitter,niacin,oesophageal squamous cell carcinoma,OSCC,Oxidoreductase,primary\r\nhepatocellular carcinoma,prostate cancer,SCC,scchn,smoking,Substance Dependence,Type 2 Diabetes,type 2 diabetes mellitus,xenobiotic",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs671",
        "SNP Name": "ALDH2 G1369A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs671",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,Addictive Disorders,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,Alcohol-Induced Medical Diseases,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,Benign Prostate Hyperplasia,blood pressure,Breast and Prostate Cancer,breast cancer,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cardiovascular disease,cellular energy,Colorectal Cancer Risk,coronary artery disease,CVD,cytosolic,diabetes,diabetes mellitus,diabetic retinopathy,EC=1.2.1.3,electron,energy,esophageal cancer,esophageal squamous cell dysplasia,ethanol,ethanol degradation,ethanol oxidation,gastric adenocarcinoma,gastric cancer,Genetic and environmental factors,H2O,HDL cholesterol levels,high BP,Homotetramer,hypertension,intoxication,joint,Lipid Levels,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,Multiple Chemical Sensitivity,NAD,NADH,NADP,neurotransmitter,niacin,oesophageal squamous cell carcinoma,OSCC,Oxidoreductase,primary\r\nhepatocellular carcinoma,prostate cancer,SCC,scchn,smoking,Substance Dependence,Type 2 Diabetes,type 2 diabetes mellitus,xenobiotic",
        "Group": "Yeast/Alcohol Metabolism"
    },
    {
        "SNP ID": "rs16941667",
        "SNP Name": "ALDH2 C45068T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs16941667",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,Gastric Cancer,H2O,head and neck cancer,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidative Stress,Oxidoreductase,ROS,SCC,scchn,xenobiotic",
        "Group": "Formaldehyde"
    },
    {
        "SNP ID": "rs16941667",
        "SNP Name": "ALDH2 C45068T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs16941667",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,Gastric Cancer,H2O,head and neck cancer,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidative Stress,Oxidoreductase,ROS,SCC,scchn,xenobiotic",
        "Group": "Glutaraldehyde"
    },
    {
        "SNP ID": "rs16941667",
        "SNP Name": "ALDH2 C45068T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs16941667",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,Gastric Cancer,H2O,head and neck cancer,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidative Stress,Oxidoreductase,ROS,SCC,scchn,xenobiotic",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs16941667",
        "SNP Name": "ALDH2 C45068T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs16941667",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,Gastric Cancer,H2O,head and neck cancer,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidative Stress,Oxidoreductase,ROS,SCC,scchn,xenobiotic",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs16941667",
        "SNP Name": "ALDH2 C45068T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs16941667",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,Gastric Cancer,H2O,head and neck cancer,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidative Stress,Oxidoreductase,ROS,SCC,scchn,xenobiotic",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs16941667",
        "SNP Name": "ALDH2 C45068T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs16941667",
        "Video": null,
        "Tags": "acetate,Acetylation,acute alcohol intoxication,acute hangover,alcohol,alcohol consumption,alcohol dependence,Alcohol metabolism,alcohol sensitivity,alcoholism,Aldehyde dehydrogenase,aldehyde dehydrogenase family,ALDH class 2,ALDH-E2,ALDH2,ALDH2*2,ALDHI,ALDM,An aldehyde,cancer,cancerous,carbohydrate,carbohydrate metabolism,carboxylate,carcinogen,cellular energy,cytosolic,EC=1.2.1.3,electron,energy,ethanol,ethanol degradation,ethanol oxidation,Gastric Cancer,H2O,head and neck cancer,Homotetramer,intoxication,joint,mitochondria,mitochondrial,mitochondrion,Mitochondrion matrix,NAD,NADH,NADP,neurotransmitter,niacin,Oxidative Stress,Oxidoreductase,ROS,SCC,scchn,xenobiotic",
        "Group": "Yeast/Alcohol Metabolism"
    },
    {
        "SNP ID": "rs2293054",
        "SNP Name": "NOS1 T2202C",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2293054",
        "Video": null,
        "Tags": "2 L-arginine + 3 NADPH + 4 O2 = 2 L-citrulline + 2 nitric oxide + 3 NADP+ + 4 H2O,Alternative splicing,and kidney and at low levels in the brain but not in the heart and adrenal gland,antioxidant,Antioxidant Pathway,arginine,arginine binding,arginine catabolic process,ATP,Binds 1 FAD,Binds 1 FMN,blood coagulation,bNOS,brain,brain and peripheral nervous system,cadmium ion binding,calcium,calmodulin,Calmodulin-binding,CAPON,Cell membrane,Cell projection,Cell projection \u203a dendritic spine,cellular energy,cellular response to growth factor stimulus,cognitive ability and cognitive ageing,Complete proteome,cytoplasm,cytoplasmic,cytoskeleton,cytosol,dendritic spine,DLG4,dopamine,DZ (DHR) domain,energy,environmental factors in Parkinson\u2019s disease,exogenous drug catabolic process,FAD,FAD-binding FR-type domain,fast-twitch muscle,ferritin,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,Forms a ternary complex with CAPON and RASD1,Forms a ternary complex with CAPON and SYN1,glutathione,heme,heme binding,Heme group,Homodimer,In neurons enriched in dendritic spines,In skeletal muscle it is localized beneath the sarcolemma of fast-twitch muscle fiber by associating with the dystrophin glycoprotein complex,Inhibited by n-Nos-inhibiting protein (PIN),Inhibited by NOSIP,interaction possibly being prevented by the association between NOS1 and CAPON,interaction with host,Interacts (via N-terminal domain) with DLG4,Interacts with HTR4,Interacts with NOSIP; which may impair its synaptic location,Interacts with SLC6A4,Interacts with VAC14,Interacts with ZDHHC23,ion channel binding,Iron,iron ion binding,Isoform 1 is ubiquitously expressed: detected in skeletal muscle and brain also in testis and lung and kidney and at low levels in heart and adrenal gland and retina,Isoform 3 is expressed only in testis,Isoform 4 is detected in testis and skeletal muscle and lung,L-arginine,lymphoma,mediated by STUB1/CHIP in the presence of Hsp70 and Hsp40,mediates cysteine S-nitrosylation,mediates cysteine S-nitrosylation of cytoplasmic target proteins such SRR,mediates interaction with VAC14,Membrane,mental disorder,Metal-binding,mitochondria,mitochondrion,multicellular organismal response to stress,muscle,myoblast fusion,N-NOS,NAD,NADP,NADP binding,NADPH,NADPH-hemoprotein reductase activity,NC-NOS,negative regulation of blood pressure,negative regulation of calcium ion transport into cytosol,negative regulation of hydrolase activity,negative regulation of potassium ion transport,negative regulation of serotonin uptake,Neuronal NOS,neurotransmitter biosynthetic process,neurotransmitters,nitric oxide biosynthetic process,nitric oxide mediated signal transduction,Nitric oxide synthase,nitric-oxide synthase activity,nitrosylase activity,nNOS,NO,non-Hodgkin lymphoma,NOS,NOS family,NOS type I,NOS1,Not detected in the platelets,oxidative\r\nstress pathway,oxidative stress,Oxidoreductase,oxidoreductase activity,Parkinson,Parkinson's disease,Peptidyl-cysteine S-nitrosylase NOS1,peptidyl-cysteine S-nitrosylation,perinuclear region of cytoplasm,Peripheral membrane protein,phagosome maturation,photoreceptor inner segment,Polymorphism,positive regulation of guanylate cyclase activity,positive regulation of histone acetylation,positive regulation of sodium ion transmembrane transport,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vasodilation,potassium,Produces nitric oxide (NO),protein complex,RASD1,Reference proteome,regulation of cardiac muscle contraction,response to heat,response to hypoxia,responsible for targeting nNos to synaptic membranes in muscles,ROS,sarcolemma,sarcoplasmic reticulum,scaffold protein binding,schizophrenia,serotonin,sodium channel regulator activity,SRR,Stimulated by calcium/calmodulin,striated muscle contraction,synapse,Tetrahydrobiopterin (BH4),tetrahydrobiopterin binding,THB,The PDZ domain in the N-termin",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2293054",
        "SNP Name": "NOS1 T2202C",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2293054",
        "Video": null,
        "Tags": "2 L-arginine + 3 NADPH + 4 O2 = 2 L-citrulline + 2 nitric oxide + 3 NADP+ + 4 H2O,Alternative splicing,and kidney and at low levels in the brain but not in the heart and adrenal gland,antioxidant,Antioxidant Pathway,arginine,arginine binding,arginine catabolic process,ATP,Binds 1 FAD,Binds 1 FMN,blood coagulation,bNOS,brain,brain and peripheral nervous system,cadmium ion binding,calcium,calmodulin,Calmodulin-binding,CAPON,Cell membrane,Cell projection,Cell projection \u203a dendritic spine,cellular energy,cellular response to growth factor stimulus,cognitive ability and cognitive ageing,Complete proteome,cytoplasm,cytoplasmic,cytoskeleton,cytosol,dendritic spine,DLG4,dopamine,DZ (DHR) domain,energy,environmental factors in Parkinson\u2019s disease,exogenous drug catabolic process,FAD,FAD-binding FR-type domain,fast-twitch muscle,ferritin,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,Forms a ternary complex with CAPON and RASD1,Forms a ternary complex with CAPON and SYN1,glutathione,heme,heme binding,Heme group,Homodimer,In neurons enriched in dendritic spines,In skeletal muscle it is localized beneath the sarcolemma of fast-twitch muscle fiber by associating with the dystrophin glycoprotein complex,Inhibited by n-Nos-inhibiting protein (PIN),Inhibited by NOSIP,interaction possibly being prevented by the association between NOS1 and CAPON,interaction with host,Interacts (via N-terminal domain) with DLG4,Interacts with HTR4,Interacts with NOSIP; which may impair its synaptic location,Interacts with SLC6A4,Interacts with VAC14,Interacts with ZDHHC23,ion channel binding,Iron,iron ion binding,Isoform 1 is ubiquitously expressed: detected in skeletal muscle and brain also in testis and lung and kidney and at low levels in heart and adrenal gland and retina,Isoform 3 is expressed only in testis,Isoform 4 is detected in testis and skeletal muscle and lung,L-arginine,lymphoma,mediated by STUB1/CHIP in the presence of Hsp70 and Hsp40,mediates cysteine S-nitrosylation,mediates cysteine S-nitrosylation of cytoplasmic target proteins such SRR,mediates interaction with VAC14,Membrane,mental disorder,Metal-binding,mitochondria,mitochondrion,multicellular organismal response to stress,muscle,myoblast fusion,N-NOS,NAD,NADP,NADP binding,NADPH,NADPH-hemoprotein reductase activity,NC-NOS,negative regulation of blood pressure,negative regulation of calcium ion transport into cytosol,negative regulation of hydrolase activity,negative regulation of potassium ion transport,negative regulation of serotonin uptake,Neuronal NOS,neurotransmitter biosynthetic process,neurotransmitters,nitric oxide biosynthetic process,nitric oxide mediated signal transduction,Nitric oxide synthase,nitric-oxide synthase activity,nitrosylase activity,nNOS,NO,non-Hodgkin lymphoma,NOS,NOS family,NOS type I,NOS1,Not detected in the platelets,oxidative\r\nstress pathway,oxidative stress,Oxidoreductase,oxidoreductase activity,Parkinson,Parkinson's disease,Peptidyl-cysteine S-nitrosylase NOS1,peptidyl-cysteine S-nitrosylation,perinuclear region of cytoplasm,Peripheral membrane protein,phagosome maturation,photoreceptor inner segment,Polymorphism,positive regulation of guanylate cyclase activity,positive regulation of histone acetylation,positive regulation of sodium ion transmembrane transport,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vasodilation,potassium,Produces nitric oxide (NO),protein complex,RASD1,Reference proteome,regulation of cardiac muscle contraction,response to heat,response to hypoxia,responsible for targeting nNos to synaptic membranes in muscles,ROS,sarcolemma,sarcoplasmic reticulum,scaffold protein binding,schizophrenia,serotonin,sodium channel regulator activity,SRR,Stimulated by calcium/calmodulin,striated muscle contraction,synapse,Tetrahydrobiopterin (BH4),tetrahydrobiopterin binding,THB,The PDZ domain in the N-termin",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs2293054",
        "SNP Name": "NOS1 T2202C",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2293054",
        "Video": null,
        "Tags": "2 L-arginine + 3 NADPH + 4 O2 = 2 L-citrulline + 2 nitric oxide + 3 NADP+ + 4 H2O,Alternative splicing,and kidney and at low levels in the brain but not in the heart and adrenal gland,antioxidant,Antioxidant Pathway,arginine,arginine binding,arginine catabolic process,ATP,Binds 1 FAD,Binds 1 FMN,blood coagulation,bNOS,brain,brain and peripheral nervous system,cadmium ion binding,calcium,calmodulin,Calmodulin-binding,CAPON,Cell membrane,Cell projection,Cell projection \u203a dendritic spine,cellular energy,cellular response to growth factor stimulus,cognitive ability and cognitive ageing,Complete proteome,cytoplasm,cytoplasmic,cytoskeleton,cytosol,dendritic spine,DLG4,dopamine,DZ (DHR) domain,energy,environmental factors in Parkinson\u2019s disease,exogenous drug catabolic process,FAD,FAD-binding FR-type domain,fast-twitch muscle,ferritin,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,Forms a ternary complex with CAPON and RASD1,Forms a ternary complex with CAPON and SYN1,glutathione,heme,heme binding,Heme group,Homodimer,In neurons enriched in dendritic spines,In skeletal muscle it is localized beneath the sarcolemma of fast-twitch muscle fiber by associating with the dystrophin glycoprotein complex,Inhibited by n-Nos-inhibiting protein (PIN),Inhibited by NOSIP,interaction possibly being prevented by the association between NOS1 and CAPON,interaction with host,Interacts (via N-terminal domain) with DLG4,Interacts with HTR4,Interacts with NOSIP; which may impair its synaptic location,Interacts with SLC6A4,Interacts with VAC14,Interacts with ZDHHC23,ion channel binding,Iron,iron ion binding,Isoform 1 is ubiquitously expressed: detected in skeletal muscle and brain also in testis and lung and kidney and at low levels in heart and adrenal gland and retina,Isoform 3 is expressed only in testis,Isoform 4 is detected in testis and skeletal muscle and lung,L-arginine,lymphoma,mediated by STUB1/CHIP in the presence of Hsp70 and Hsp40,mediates cysteine S-nitrosylation,mediates cysteine S-nitrosylation of cytoplasmic target proteins such SRR,mediates interaction with VAC14,Membrane,mental disorder,Metal-binding,mitochondria,mitochondrion,multicellular organismal response to stress,muscle,myoblast fusion,N-NOS,NAD,NADP,NADP binding,NADPH,NADPH-hemoprotein reductase activity,NC-NOS,negative regulation of blood pressure,negative regulation of calcium ion transport into cytosol,negative regulation of hydrolase activity,negative regulation of potassium ion transport,negative regulation of serotonin uptake,Neuronal NOS,neurotransmitter biosynthetic process,neurotransmitters,nitric oxide biosynthetic process,nitric oxide mediated signal transduction,Nitric oxide synthase,nitric-oxide synthase activity,nitrosylase activity,nNOS,NO,non-Hodgkin lymphoma,NOS,NOS family,NOS type I,NOS1,Not detected in the platelets,oxidative\r\nstress pathway,oxidative stress,Oxidoreductase,oxidoreductase activity,Parkinson,Parkinson's disease,Peptidyl-cysteine S-nitrosylase NOS1,peptidyl-cysteine S-nitrosylation,perinuclear region of cytoplasm,Peripheral membrane protein,phagosome maturation,photoreceptor inner segment,Polymorphism,positive regulation of guanylate cyclase activity,positive regulation of histone acetylation,positive regulation of sodium ion transmembrane transport,positive regulation of transcription from RNA polymerase II promoter,positive regulation of vasodilation,potassium,Produces nitric oxide (NO),protein complex,RASD1,Reference proteome,regulation of cardiac muscle contraction,response to heat,response to hypoxia,responsible for targeting nNos to synaptic membranes in muscles,ROS,sarcolemma,sarcoplasmic reticulum,scaffold protein binding,schizophrenia,serotonin,sodium channel regulator activity,SRR,Stimulated by calcium/calmodulin,striated muscle contraction,synapse,Tetrahydrobiopterin (BH4),tetrahydrobiopterin binding,THB,The PDZ domain in the N-termin",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs25644",
        "SNP Name": "P2RX4 S42G",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Octylphenol Ethoxylate (Triton X-100)"
    },
    {
        "SNP ID": "rs7320729",
        "SNP Name": "ATP8A2 (ATP) T7044148C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7320729",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs6491066",
        "SNP Name": "ATP8A2 (ATP) F561F",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6491066",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs3117849",
        "SNP Name": "ATP8A2 (ATP) G7279179A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3117849",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs3783139",
        "SNP Name": "ATP8A2 (ATP) T7520642C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3783139",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs912514",
        "SNP Name": "ATP8A2 (ATP) C7524369T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs912514",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs975508",
        "SNP Name": "ATP8A2 (ATP) A7545586G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs975508",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs1360485",
        "SNP Name": "HMGB1 variant",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs1412125",
        "SNP Name": "HMGB1 variant",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs4145277",
        "SNP Name": "HMGB1 variant",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs7997012",
        "SNP Name": "HTR2A T64185C",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7997012",
        "Video": "dEhGR7dBzh0",
        "Tags": "1-(2,1-(4-iodo-2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI),5-dimethoxyphenyl)propan-2-amine binding,5-HT-2,5-HT-2A,5-hydroxytryptamine,5-hydroxytryptamine receptor 2A,activation of phospholipase C activity,aging,alcohol,Alcohol dependence,Also functions as a receptor for various drugs and psychoactive substances,alternative signaling pathways,Alternative splicing,anorexia,Anorexia nervosa,antidepressant,anxiety,APBA1,apiptosis,arterial vasoconstriction,artery smooth muscle contraction,axo-dendritic synapses,axon,behavior,behavioral response to cocaine,Beta-arrestin family,bipolar,bipolar disorder,blood pressure,Ca2+ ions,calcium,calming effect,CASK,catechol-O-methyltransferase,catecholamine,caveola,cell body fiber,cell death,Cell membrane,Cell projection,cellular calcium ion homeostasis,citalopram response,Citalopram Treatment in Major Depressive Disorder,cocaine,cognition,Complete proteome,COMT,cytoplasmic membrane-bounded vesicle,Cytoplasmic vesicle,cytosol,dendrite,dendritic shaft,depression,Detected in blood platelets,Detected in brain cortex,detection of mechanical stimulus involved in sensory perception of pain,detection of temperature stimulus involved in sensory perception of pain,Disulfide bond,DLG1,DLG1 and DLG4,DLG4,dopamine,DRD2,drug binding,drug metabolism,drug reaction,drug response,drugs,duloxetine,eating disorder,G-protein coupled receptor,G-protein coupled receptor 1 family,glutamatergic,Glycoprotein,GRIK4,GRM2,guanine nucleotide-binding proteins (G proteins),high BP,HTR2,HTR2A,hypertension,INADL,integral component of plasma membrane,intestinal smooth muscle contraction,intestines,intracellular,Ligand binding,low BP,lsd,lysergic acid diethylamide (LSD),MAGI2,major depression,major depressive disorder (MDD),MDD,Membrane,memory,mental disorder,mescaline,monoamine,mood,mood and anxiety disorders,MPDZ,MPP3,Multi-pass membrane protein,negative regulation of potassium ion transport,negative regulation of synaptic transmission,neural activity,neuronal cell body,neurotransmitters,obsessive-compulsive disorder,OCD,Outcome of Antidepressant Treatment,Pain Catastrophizing,panic disorder,PDZ domain-binding motif is involved in the interaction with INADL,perception,pharmacogenetics,pharmacogenetics in bipolar disorder,phobia,phosphate,phosphatidylinositol 3-kinase,phosphatidylinositol 3-kinase signaling,phosphatidylinositol-calcium,phospholipase C,phospholipase C-activating serotonin receptor signaling pathway,plasma membrane,Polymorphism,positive regulation of cell proliferation,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAP kinase activity,positive regulation of phosphatidylinositol biosynthetic process,positive regulation of vasoconstriction,postsynaptic thickening,PRDX6,Predicting Remission to Antidepressant Treatment,psilocybin,psychoactive substances,psychology,Receptor,Reference proteome,regulation of behavior,regulation of dopamine secretion,regulation of hormone secretion,release of sequestered calcium ion into cytosol,response to drug,responses to anxiogenic situations,Role of Serotonin in Hot Flashes After Breast Cancer Using Acute Tryptophan Depletion,Role of Serotonin on Neuropsychological Function After Breast Cancer Using Acute Tryptophan Depletion,Schizophrenia,serotonin,serotonin binding,serotonin degradation,serotonin metabolism,Serotonin receptor 2A,serotonin receptor activity,serotonin receptor signaling pathway,SLC6A4,sleep,SSRI,synaptic transmission,temperature homeostasis,Transducer,Transmembrane,Transmembrane helix,tryptophan,urinary bladder smooth muscle contraction",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2248663",
        "SNP Name": "RNF219 T79207588C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,Alzheimer,Alzheimer's disease,C13orf7,Coiled coil,dementia,Metal-binding,neurodegenerative disorder,RING finger protein 219,RN219,RNF219,zinc,zinc ion binding,Zinc-finger,Zn",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs6046",
        "SNP Name": "F7 A353G Arg329Gln",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "blood coagulation,blood pressure regulation,CAD,calcium,calcium ion binding,cardio,cardiovascular,cellular protein metabolic process,Cerebral Hemorrhage,circadian rhythm,coagulation,Coagulation factor VII,coagulation pathway,Coronary Artery Disease,coronary heart disease,coumadin,CVD,drug metabolism,drugs,endoplasmic reticulum lumen,epistaxis,Eptacog alfa,estrogen,extracellular region,extracellular space,extrinsic pathway,F7,FA7,FA7D,Factor VII,Factor VII deficiency,Factor VII heavy chain,Factor VII light chain,Gamma-carboxylation,glycoprotein binding,Golgi lumen,growth hormone,heart,heart disease,hemorrhagic disease,Hemostasis,HGH,Hydrolase,hypertension,inflammation,Ischemic stroke,Lemierre's syndrome,Lymphotoxin-alpha,menorrhagia,migraine,minor proteolysis,organ regeneration,peptidyl-glutamic acid carboxylation,plasma membrane,positive regulation of blood coagulation,positive regulation of cell migration,positive regulation of leukocyte chemotaxis,positive regulation of platelet-derived growth factor receptor signaling pathway,positive regulation of positive chemotaxis,positive regulation of protein kinase B signaling,post-translational protein modification,Proconvertin,Protease,proteolysis,response to estrogen,response to growth hormone,response to vitamin K,sclerosis,Serine protease,serine-type endopeptidase activity,serine-type peptidase activity,Serum prothrombin conversion accelerator,SPCA,sporadic amyotrophic lateral sclerosis,stroke,thrombin,thromboembolism,thrombosis,Venous Thromboembolism,vesicle,virus,vit K,vitamin K,warfarin,warfarin dose,West Nile Virus,West Nile Virus Infection",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs6046",
        "SNP Name": "F7 A353G Arg329Gln",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "blood coagulation,blood pressure regulation,CAD,calcium,calcium ion binding,cardio,cardiovascular,cellular protein metabolic process,Cerebral Hemorrhage,circadian rhythm,coagulation,Coagulation factor VII,coagulation pathway,Coronary Artery Disease,coronary heart disease,coumadin,CVD,drug metabolism,drugs,endoplasmic reticulum lumen,epistaxis,Eptacog alfa,estrogen,extracellular region,extracellular space,extrinsic pathway,F7,FA7,FA7D,Factor VII,Factor VII deficiency,Factor VII heavy chain,Factor VII light chain,Gamma-carboxylation,glycoprotein binding,Golgi lumen,growth hormone,heart,heart disease,hemorrhagic disease,Hemostasis,HGH,Hydrolase,hypertension,inflammation,Ischemic stroke,Lemierre's syndrome,Lymphotoxin-alpha,menorrhagia,migraine,minor proteolysis,organ regeneration,peptidyl-glutamic acid carboxylation,plasma membrane,positive regulation of blood coagulation,positive regulation of cell migration,positive regulation of leukocyte chemotaxis,positive regulation of platelet-derived growth factor receptor signaling pathway,positive regulation of positive chemotaxis,positive regulation of protein kinase B signaling,post-translational protein modification,Proconvertin,Protease,proteolysis,response to estrogen,response to growth hormone,response to vitamin K,sclerosis,Serine protease,serine-type endopeptidase activity,serine-type peptidase activity,Serum prothrombin conversion accelerator,SPCA,sporadic amyotrophic lateral sclerosis,stroke,thrombin,thromboembolism,thrombosis,Venous Thromboembolism,vesicle,virus,vit K,vitamin K,warfarin,warfarin dose,West Nile Virus,West Nile Virus Infection",
        "Group": "Clotting Factors"
    },
    {
        "SNP ID": "rs3211719",
        "SNP Name": "F10 113777509 A5397C",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Activated factor Xa heavy chain,Antihemophilic Factor,Apixaban,blood clotting,blood coagulation,breast cancer,calcium,calcium ion binding,cancer,cancerous,carcinogen,cardio,cardiovascular,cellular protein metabolic process,coagulation,Coagulation Factor IX,Coagulation factor VIIa,Coagulation factor X,coronary heart disease,CVD,EGF-like domain,endoplasmic reticulum lumen,Enoxaparin,enzymatic carboxylation,extracellular region,extrinsic pathway,F10,FA10,FA10D,factor Va,Factor X deficiency,Factor X heavy chain,Factor X light chain,Fondaparinux sodium,Gamma-carboxylation,Golgi lumen,heart,heart disease,hemarthrosis,hematuria,hemorrhage,hemorrhagic disease,Hemostasis,Heparin,Hydrolase,inflammation,inhibited by SERPINA5 and SERPINA10,intrinsic component of external side of plasma membrane,intrinsic pathway,Menadione,menorrhagia,nasal and mucosal hemorrhage,peptidase S1 family,peptidyl-glutamic acid carboxylation,phospholipid,phospholipid binding,plasma membrane,positive regulation of cell migration,positive regulation of protein kinase B signaling,post-translational protein modification,Protease,proteolysis,prothrombin to thrombin,Repeat,Rivaroxaban,Serine protease,serine-type endopeptidase activity,Signal,Stuart factor,Stuart-Prower factor,vit K,vitamin K,vitamin K-dependent,vitamin K-dependent glycoprotein",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs3211719",
        "SNP Name": "F10 113777509 A5397C",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Activated factor Xa heavy chain,Antihemophilic Factor,Apixaban,blood clotting,blood coagulation,breast cancer,calcium,calcium ion binding,cancer,cancerous,carcinogen,cardio,cardiovascular,cellular protein metabolic process,coagulation,Coagulation Factor IX,Coagulation factor VIIa,Coagulation factor X,coronary heart disease,CVD,EGF-like domain,endoplasmic reticulum lumen,Enoxaparin,enzymatic carboxylation,extracellular region,extrinsic pathway,F10,FA10,FA10D,factor Va,Factor X deficiency,Factor X heavy chain,Factor X light chain,Fondaparinux sodium,Gamma-carboxylation,Golgi lumen,heart,heart disease,hemarthrosis,hematuria,hemorrhage,hemorrhagic disease,Hemostasis,Heparin,Hydrolase,inflammation,inhibited by SERPINA5 and SERPINA10,intrinsic component of external side of plasma membrane,intrinsic pathway,Menadione,menorrhagia,nasal and mucosal hemorrhage,peptidase S1 family,peptidyl-glutamic acid carboxylation,phospholipid,phospholipid binding,plasma membrane,positive regulation of cell migration,positive regulation of protein kinase B signaling,post-translational protein modification,Protease,proteolysis,prothrombin to thrombin,Repeat,Rivaroxaban,Serine protease,serine-type endopeptidase activity,Signal,Stuart factor,Stuart-Prower factor,vit K,vitamin K,vitamin K-dependent,vitamin K-dependent glycoprotein",
        "Group": "Clotting Factors"
    },
    {
        "SNP ID": "rs1049564",
        "SNP Name": "PNP Gly51Ser",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs10483639",
        "SNP Name": "GCH1 G55306457C",
        "Risk Allele": "C",
        "Your Allele": "CG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10483639",
        "Video": null,
        "Tags": "2,3-trihydroxypropyl)-dihydropteridine triphosphate,7,8-bromo-cGMP,8-dihydroneopterin 3'-triphosphate biosynthetic process,8-dihydroneopterin triphosphate,8-dihydroneopterin triphosphate biosynthesis,abnormal movements,AHSA1,Alternative splicing,amino acids,associated with lowers levels of Tetrahydrobioptrein,atherothrombotic cardiovascular disease,bacterial lipopolysaccharides (LPS) and phenylalanine,BH4,BH4 deficiency,birth defect,birth defects,blood pressure,BP,calcium ion binding,cAMP,cancer,cancerous,carcinogen,catalytic activity,CFS,chemotherapy-induced symptoms,chronic fatigue syndrome,coenzyme binding,Cofactor biosynthesis,convulsions,Coronary Artery Disease,Coronary Artery Disease (CAD),Cytokine-induced GCH1 up-regulation,Cytoplasm,cytoplasmic vesicle,cytosol,defect,deficiency,dibutyryl-cAMP,difficulty swallowing,Disease mutation,dopa-responsive dystonia,dopamine,dopamine and serotonin,dopamine biosynthetic process,dopamine synthesis,drowsiness,dystonia,DYT5,endothelial nitric oxide synthase activity,enzyme,exercise,exercise induced fatigue,fatigue,GCH,GCH1,GCH1 heterodecamers,GCHFR/GFRP,GTP + H2O = formate + 2-amino-4-hydroxy-6-(erythro-1,GTP binding,GTP catabolic process,GTP cyclohydrolase 1,GTP cyclohydrolase 1 deficiency (GCH1D),GTP cyclohydrolase I,GTP cyclohydrolase I activity,GTP-binding,GTP-CH-I,GTPCH1,GTPCH1 deficiency,heart,high BP,human aorta endothelial cells (HAECs),HUVEC cells,hydrogen peroxide,Hydrolase,hyperphenylalaninemia,hypersalivation,hypertension,hyperthermia,IFNG/IFN-gamma,IL,IL1B/interleukin-1 beta,iloprost,interleukin,irritability,JAK2/STAT,keratinocytes,L-Dopa,labor analgesia,low BP,lungs,magnesium,malignant,malignant hyperphenylalaninemia,ME,melanocytes,metabolic process,Metal-binding,MG,mild dystonia type 5,mutation,myalgic encephalomyelitis,negative regulation of blood pressure,neural tube defect,neural tube defects,neuromuscular process controlling posture,NF-kappa-B,nitric oxide (NO),nitric oxide bioavailability,nitric oxide biosynthetic process,nitric oxide metabolic process,nitric oxide synthase,nitric oxide synthesis,NOS,NTDs,nuclear membrane,Nucleotide-binding,Nucleus,oscillatory shear stress,pain,pain perception,pain persistence,pain sensitivity,pain tolerance,Parkinson,Parkinsonism,Parkinson\u2019s disease,persistent widespread pain,phenol,phenylalanine,phenylalanine hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylated by casein kinase II at Ser-81,phosphorylation at Ser-81 results in increased enzyme activity,plasma biopterin,Polymorphism,positive regulation of nitric-oxide synthase activity,postural and motor disturbances,protein complex,protein heterooligomerization,protein homodimerization activity,protein homooligomerization,psychomotor retardation,pteridine-containing compound biosynthetic process,regulation of blood pressure,regulation of lung blood pressure,regulation of nitric-oxide synthase activity,response to interferon-gamma,response to lipopolysaccharide,response to pain,response to tumor necrosis factor,SER-81,serotonin,small molecule metabolic process,sporadic primary dystonia,tetrahydrobiopterin,Tetrahydrobiopterin biosynthesis,tetrahydrobiopterin biosynthetic process,tetrahydrobiopterin deficiency,tetrahydrofolate biosynthetic process,TNF,tonicity disorders,Toroid-shaped homodecamer,tremors,tumor,tyrosine,umbilical vein endothelial cells (HUVECs),Up-regulation of GCH1 expression stimulates production of tetrahydrobiopterin,vascular superoxide production,vasodilation,zinc,zinc ion binding",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs10483639",
        "SNP Name": "GCH1 G55306457C",
        "Risk Allele": "C",
        "Your Allele": "CG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10483639",
        "Video": null,
        "Tags": "2,3-trihydroxypropyl)-dihydropteridine triphosphate,7,8-bromo-cGMP,8-dihydroneopterin 3'-triphosphate biosynthetic process,8-dihydroneopterin triphosphate,8-dihydroneopterin triphosphate biosynthesis,abnormal movements,AHSA1,Alternative splicing,amino acids,associated with lowers levels of Tetrahydrobioptrein,atherothrombotic cardiovascular disease,bacterial lipopolysaccharides (LPS) and phenylalanine,BH4,BH4 deficiency,birth defect,birth defects,blood pressure,BP,calcium ion binding,cAMP,cancer,cancerous,carcinogen,catalytic activity,CFS,chemotherapy-induced symptoms,chronic fatigue syndrome,coenzyme binding,Cofactor biosynthesis,convulsions,Coronary Artery Disease,Coronary Artery Disease (CAD),Cytokine-induced GCH1 up-regulation,Cytoplasm,cytoplasmic vesicle,cytosol,defect,deficiency,dibutyryl-cAMP,difficulty swallowing,Disease mutation,dopa-responsive dystonia,dopamine,dopamine and serotonin,dopamine biosynthetic process,dopamine synthesis,drowsiness,dystonia,DYT5,endothelial nitric oxide synthase activity,enzyme,exercise,exercise induced fatigue,fatigue,GCH,GCH1,GCH1 heterodecamers,GCHFR/GFRP,GTP + H2O = formate + 2-amino-4-hydroxy-6-(erythro-1,GTP binding,GTP catabolic process,GTP cyclohydrolase 1,GTP cyclohydrolase 1 deficiency (GCH1D),GTP cyclohydrolase I,GTP cyclohydrolase I activity,GTP-binding,GTP-CH-I,GTPCH1,GTPCH1 deficiency,heart,high BP,human aorta endothelial cells (HAECs),HUVEC cells,hydrogen peroxide,Hydrolase,hyperphenylalaninemia,hypersalivation,hypertension,hyperthermia,IFNG/IFN-gamma,IL,IL1B/interleukin-1 beta,iloprost,interleukin,irritability,JAK2/STAT,keratinocytes,L-Dopa,labor analgesia,low BP,lungs,magnesium,malignant,malignant hyperphenylalaninemia,ME,melanocytes,metabolic process,Metal-binding,MG,mild dystonia type 5,mutation,myalgic encephalomyelitis,negative regulation of blood pressure,neural tube defect,neural tube defects,neuromuscular process controlling posture,NF-kappa-B,nitric oxide (NO),nitric oxide bioavailability,nitric oxide biosynthetic process,nitric oxide metabolic process,nitric oxide synthase,nitric oxide synthesis,NOS,NTDs,nuclear membrane,Nucleotide-binding,Nucleus,oscillatory shear stress,pain,pain perception,pain persistence,pain sensitivity,pain tolerance,Parkinson,Parkinsonism,Parkinson\u2019s disease,persistent widespread pain,phenol,phenylalanine,phenylalanine hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylated by casein kinase II at Ser-81,phosphorylation at Ser-81 results in increased enzyme activity,plasma biopterin,Polymorphism,positive regulation of nitric-oxide synthase activity,postural and motor disturbances,protein complex,protein heterooligomerization,protein homodimerization activity,protein homooligomerization,psychomotor retardation,pteridine-containing compound biosynthetic process,regulation of blood pressure,regulation of lung blood pressure,regulation of nitric-oxide synthase activity,response to interferon-gamma,response to lipopolysaccharide,response to pain,response to tumor necrosis factor,SER-81,serotonin,small molecule metabolic process,sporadic primary dystonia,tetrahydrobiopterin,Tetrahydrobiopterin biosynthesis,tetrahydrobiopterin biosynthetic process,tetrahydrobiopterin deficiency,tetrahydrofolate biosynthetic process,TNF,tonicity disorders,Toroid-shaped homodecamer,tremors,tumor,tyrosine,umbilical vein endothelial cells (HUVECs),Up-regulation of GCH1 expression stimulates production of tetrahydrobiopterin,vascular superoxide production,vasodilation,zinc,zinc ion binding",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2878168",
        "SNP Name": "GCH1 C53758T",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2878168",
        "Video": null,
        "Tags": "2,3-trihydroxypropyl)-dihydropteridine triphosphate,7,8-bromo-cGMP,8-dihydroneopterin 3'-triphosphate biosynthetic process,8-dihydroneopterin triphosphate,8-dihydroneopterin triphosphate biosynthesis,abnormal movements,AHSA1,Alternative splicing,amino acids,bacterial lipopolysaccharides (LPS) and phenylalanine,BH4,BH4 deficiency,blood pressure,BP,calcium ion binding,cAMP,cancer,cancerous,carcinogen,catalytic activity,CFS,chronic fatigue syndrome,coenzyme binding,Cofactor biosynthesis,convulsions,Coronary Artery Disease (CAD),Cytokine-induced GCH1 up-regulation,Cytoplasm,cytoplasmic vesicle,cytosol,defect,deficiency,dibutyryl-cAMP,difficulty swallowing,Disease mutation,dopa-responsive dystonia,dopamine,dopamine and serotonin,dopamine biosynthetic process,dopamine synthesis,drowsiness,dystonia,DYT5,endothelial nitric oxide synthase activity,enzyme,exercise,exercise induced fatigue,fatigue,GCH,GCH1,GCH1 heterodecamers,GCHFR/GFRP,GTP + H2O = formate + 2-amino-4-hydroxy-6-(erythro-1,GTP binding,GTP catabolic process,GTP cyclohydrolase 1,GTP cyclohydrolase 1 deficiency (GCH1D),GTP cyclohydrolase I,GTP cyclohydrolase I activity,GTP-binding,GTP-CH-I,GTPCH1,GTPCH1 deficiency,high BP,human aorta endothelial cells (HAECs),HUVEC cells,hydrogen peroxide,Hydrolase,hyperphenylalaninemia,hypersalivation,hypertension,hyperthermia,IFNG/IFN-gamma,IL,IL1B/interleukin-1 beta,iloprost,interleukin,irritability,JAK2/STAT,keratinocytes,L-Dopa,low BP,lungs,magnesium,malignant,malignant hyperphenylalaninemia,ME,melanocytes,metabolic process,Metal-binding,MG,mild dystonia type 5,mutation,myalgic encephalomyelitis,negative regulation of blood pressure,neuromuscular process controlling posture,NF-kappa-B,nitric oxide (NO),nitric oxide bioavailability,nitric oxide biosynthetic process,nitric oxide metabolic process,nitric oxide synthase,nitric oxide synthesis,NOS,nuclear membrane,Nucleotide-binding,Nucleus,oscillatory shear stress,pain,pain perception,pain persistence,pain sensitivity,pain tolerance,Parkinson,Parkinsonism,Parkinson\u2019s disease,phenol,phenylalanine,phenylalanine hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylated by casein kinase II at Ser-81,phosphorylation at Ser-81 results in increased enzyme activity,plasma BH4,plasma biopterin,Polymorphism,positive regulation of nitric-oxide synthase activity,postural and motor disturbances,protein complex,protein heterooligomerization,protein homodimerization activity,protein homooligomerization,psychomotor retardation,pteridine-containing compound biosynthetic process,regulation of blood pressure,regulation of lung blood pressure,regulation of nitric-oxide synthase activity,response to interferon-gamma,response to lipopolysaccharide,response to pain,response to tumor necrosis factor,SER-81,serotonin,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin biosynthesis,tetrahydrobiopterin biosynthetic process,tetrahydrobiopterin deficiency,tetrahydrofolate biosynthetic process,TNF,tonicity disorders,Toroid-shaped homodecamer,tremors,tumor,tyrosine,umbilical vein endothelial cells (HUVECs),Up-regulation of GCH1 expression stimulates production of tetrahydrobiopterin,vascular superoxide production,vasodilation,zinc,zinc ion binding",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs2878168",
        "SNP Name": "GCH1 C53758T",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2878168",
        "Video": null,
        "Tags": "2,3-trihydroxypropyl)-dihydropteridine triphosphate,7,8-bromo-cGMP,8-dihydroneopterin 3'-triphosphate biosynthetic process,8-dihydroneopterin triphosphate,8-dihydroneopterin triphosphate biosynthesis,abnormal movements,AHSA1,Alternative splicing,amino acids,bacterial lipopolysaccharides (LPS) and phenylalanine,BH4,BH4 deficiency,blood pressure,BP,calcium ion binding,cAMP,cancer,cancerous,carcinogen,catalytic activity,CFS,chronic fatigue syndrome,coenzyme binding,Cofactor biosynthesis,convulsions,Coronary Artery Disease (CAD),Cytokine-induced GCH1 up-regulation,Cytoplasm,cytoplasmic vesicle,cytosol,defect,deficiency,dibutyryl-cAMP,difficulty swallowing,Disease mutation,dopa-responsive dystonia,dopamine,dopamine and serotonin,dopamine biosynthetic process,dopamine synthesis,drowsiness,dystonia,DYT5,endothelial nitric oxide synthase activity,enzyme,exercise,exercise induced fatigue,fatigue,GCH,GCH1,GCH1 heterodecamers,GCHFR/GFRP,GTP + H2O = formate + 2-amino-4-hydroxy-6-(erythro-1,GTP binding,GTP catabolic process,GTP cyclohydrolase 1,GTP cyclohydrolase 1 deficiency (GCH1D),GTP cyclohydrolase I,GTP cyclohydrolase I activity,GTP-binding,GTP-CH-I,GTPCH1,GTPCH1 deficiency,high BP,human aorta endothelial cells (HAECs),HUVEC cells,hydrogen peroxide,Hydrolase,hyperphenylalaninemia,hypersalivation,hypertension,hyperthermia,IFNG/IFN-gamma,IL,IL1B/interleukin-1 beta,iloprost,interleukin,irritability,JAK2/STAT,keratinocytes,L-Dopa,low BP,lungs,magnesium,malignant,malignant hyperphenylalaninemia,ME,melanocytes,metabolic process,Metal-binding,MG,mild dystonia type 5,mutation,myalgic encephalomyelitis,negative regulation of blood pressure,neuromuscular process controlling posture,NF-kappa-B,nitric oxide (NO),nitric oxide bioavailability,nitric oxide biosynthetic process,nitric oxide metabolic process,nitric oxide synthase,nitric oxide synthesis,NOS,nuclear membrane,Nucleotide-binding,Nucleus,oscillatory shear stress,pain,pain perception,pain persistence,pain sensitivity,pain tolerance,Parkinson,Parkinsonism,Parkinson\u2019s disease,phenol,phenylalanine,phenylalanine hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylated by casein kinase II at Ser-81,phosphorylation at Ser-81 results in increased enzyme activity,plasma BH4,plasma biopterin,Polymorphism,positive regulation of nitric-oxide synthase activity,postural and motor disturbances,protein complex,protein heterooligomerization,protein homodimerization activity,protein homooligomerization,psychomotor retardation,pteridine-containing compound biosynthetic process,regulation of blood pressure,regulation of lung blood pressure,regulation of nitric-oxide synthase activity,response to interferon-gamma,response to lipopolysaccharide,response to pain,response to tumor necrosis factor,SER-81,serotonin,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin biosynthesis,tetrahydrobiopterin biosynthetic process,tetrahydrobiopterin deficiency,tetrahydrofolate biosynthetic process,TNF,tonicity disorders,Toroid-shaped homodecamer,tremors,tumor,tyrosine,umbilical vein endothelial cells (HUVECs),Up-regulation of GCH1 expression stimulates production of tetrahydrobiopterin,vascular superoxide production,vasodilation,zinc,zinc ion binding",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs3783637",
        "SNP Name": "GCH1 G26425A",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3783637",
        "Video": null,
        "Tags": "2,3-trihydroxypropyl)-dihydropteridine triphosphate,7,8-bromo-cGMP,8-dihydroneopterin 3'-triphosphate biosynthetic process,8-dihydroneopterin triphosphate,8-dihydroneopterin triphosphate biosynthesis,abnormal movements,AHSA1,Alternative splicing,amino acids,bacterial lipopolysaccharides (LPS) and phenylalanine,BH4,BH4 deficiency,blood pressure,BP,calcium ion binding,cAMP,cancer,cancerous,carcinogen,catalytic activity,CFS,childhood obesity,chronic fatigue syndrome,coenzyme binding,Cofactor biosynthesis,convulsions,Coronary Artery Disease (CAD),Cytokine-induced GCH1 up-regulation,Cytoplasm,cytoplasmic vesicle,cytosol,defect,deficiency,dibutyryl-cAMP,difficulty swallowing,Disease mutation,dopa-responsive dystonia,dopamine,dopamine and serotonin,dopamine biosynthetic process,dopamine synthesis,drowsiness,dystonia,DYT5,endothelial nitric oxide synthase activity,enzyme,exercise,exercise induced fatigue,fat,fatigue,GCH,GCH1,GCH1 heterodecamers,GCHFR/GFRP,GTP + H2O = formate + 2-amino-4-hydroxy-6-(erythro-1,GTP binding,GTP catabolic process,GTP cyclohydrolase 1,GTP cyclohydrolase 1 deficiency (GCH1D),GTP cyclohydrolase I,GTP cyclohydrolase I activity,GTP-binding,GTP-CH-I,GTPCH1,GTPCH1 deficiency,high BP,human aorta endothelial cells (HAECs),HUVEC cells,hydrogen peroxide,Hydrolase,hyperphenylalaninemia,hypersalivation,hypertension,hyperthermia,IFNG/IFN-gamma,IL,IL1B/interleukin-1 beta,iloprost,interleukin,irritability,JAK2/STAT,keratinocytes,L-Dopa,low BP,lungs,magnesium,malignant,malignant hyperphenylalaninemia,ME,melanocytes,metabolic process,Metal-binding,MG,mild dystonia type 5,mutation,myalgic encephalomyelitis,negative regulation of blood pressure,neuromuscular process controlling posture,NF-kappa-B,nitric oxide (NO),nitric oxide bioavailability,nitric oxide biosynthetic process,nitric oxide metabolic process,nitric oxide synthase,nitric oxide synthesis,NOS,nuclear membrane,Nucleotide-binding,Nucleus,obesity,oscillatory shear stress,pain,pain perception,pain persistence,pain sensitivity,pain tolerance,Parkinson,Parkinsonism,Parkinson\u2019s disease,phenol,phenylalanine,phenylalanine hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylated by casein kinase II at Ser-81,phosphorylation at Ser-81 results in increased enzyme activity,plasma BH4,plasma biopterin,Polymorphism,positive regulation of nitric-oxide synthase activity,postural and motor disturbances,protein complex,protein heterooligomerization,protein homodimerization activity,protein homooligomerization,psychomotor retardation,pteridine-containing compound biosynthetic process,regulation of blood pressure,regulation of lung blood pressure,regulation of nitric-oxide synthase activity,response to interferon-gamma,response to lipopolysaccharide,response to pain,response to tumor necrosis factor,SER-81,serotonin,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin biosynthesis,tetrahydrobiopterin biosynthetic process,tetrahydrobiopterin deficiency,tetrahydrofolate biosynthetic process,TNF,tonicity disorders,Toroid-shaped homodecamer,tremors,tumor,tyrosine,umbilical vein endothelial cells (HUVECs),Up-regulation of GCH1 expression stimulates production of tetrahydrobiopterin,vascular superoxide production,vasodilation,zinc,zinc ion binding",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs3783637",
        "SNP Name": "GCH1 G26425A",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3783637",
        "Video": null,
        "Tags": "2,3-trihydroxypropyl)-dihydropteridine triphosphate,7,8-bromo-cGMP,8-dihydroneopterin 3'-triphosphate biosynthetic process,8-dihydroneopterin triphosphate,8-dihydroneopterin triphosphate biosynthesis,abnormal movements,AHSA1,Alternative splicing,amino acids,bacterial lipopolysaccharides (LPS) and phenylalanine,BH4,BH4 deficiency,blood pressure,BP,calcium ion binding,cAMP,cancer,cancerous,carcinogen,catalytic activity,CFS,childhood obesity,chronic fatigue syndrome,coenzyme binding,Cofactor biosynthesis,convulsions,Coronary Artery Disease (CAD),Cytokine-induced GCH1 up-regulation,Cytoplasm,cytoplasmic vesicle,cytosol,defect,deficiency,dibutyryl-cAMP,difficulty swallowing,Disease mutation,dopa-responsive dystonia,dopamine,dopamine and serotonin,dopamine biosynthetic process,dopamine synthesis,drowsiness,dystonia,DYT5,endothelial nitric oxide synthase activity,enzyme,exercise,exercise induced fatigue,fat,fatigue,GCH,GCH1,GCH1 heterodecamers,GCHFR/GFRP,GTP + H2O = formate + 2-amino-4-hydroxy-6-(erythro-1,GTP binding,GTP catabolic process,GTP cyclohydrolase 1,GTP cyclohydrolase 1 deficiency (GCH1D),GTP cyclohydrolase I,GTP cyclohydrolase I activity,GTP-binding,GTP-CH-I,GTPCH1,GTPCH1 deficiency,high BP,human aorta endothelial cells (HAECs),HUVEC cells,hydrogen peroxide,Hydrolase,hyperphenylalaninemia,hypersalivation,hypertension,hyperthermia,IFNG/IFN-gamma,IL,IL1B/interleukin-1 beta,iloprost,interleukin,irritability,JAK2/STAT,keratinocytes,L-Dopa,low BP,lungs,magnesium,malignant,malignant hyperphenylalaninemia,ME,melanocytes,metabolic process,Metal-binding,MG,mild dystonia type 5,mutation,myalgic encephalomyelitis,negative regulation of blood pressure,neuromuscular process controlling posture,NF-kappa-B,nitric oxide (NO),nitric oxide bioavailability,nitric oxide biosynthetic process,nitric oxide metabolic process,nitric oxide synthase,nitric oxide synthesis,NOS,nuclear membrane,Nucleotide-binding,Nucleus,obesity,oscillatory shear stress,pain,pain perception,pain persistence,pain sensitivity,pain tolerance,Parkinson,Parkinsonism,Parkinson\u2019s disease,phenol,phenylalanine,phenylalanine hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylated by casein kinase II at Ser-81,phosphorylation at Ser-81 results in increased enzyme activity,plasma BH4,plasma biopterin,Polymorphism,positive regulation of nitric-oxide synthase activity,postural and motor disturbances,protein complex,protein heterooligomerization,protein homodimerization activity,protein homooligomerization,psychomotor retardation,pteridine-containing compound biosynthetic process,regulation of blood pressure,regulation of lung blood pressure,regulation of nitric-oxide synthase activity,response to interferon-gamma,response to lipopolysaccharide,response to pain,response to tumor necrosis factor,SER-81,serotonin,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin biosynthesis,tetrahydrobiopterin biosynthetic process,tetrahydrobiopterin deficiency,tetrahydrofolate biosynthetic process,TNF,tonicity disorders,Toroid-shaped homodecamer,tremors,tumor,tyrosine,umbilical vein endothelial cells (HUVECs),Up-regulation of GCH1 expression stimulates production of tetrahydrobiopterin,vascular superoxide production,vasodilation,zinc,zinc ion binding",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs8004018",
        "SNP Name": "GCH1 T23847C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs8004018",
        "Video": null,
        "Tags": "2,3-trihydroxypropyl)-dihydropteridine triphosphate,7,8-bromo-cGMP,8-dihydroneopterin 3'-triphosphate biosynthetic process,8-dihydroneopterin triphosphate,8-dihydroneopterin triphosphate biosynthesis,abnormal movements,AHSA1,Alternative splicing,amino acids,bacterial lipopolysaccharides (LPS) and phenylalanine,BH4,BH4 deficiency,blood pressure,BP,calcium ion binding,cAMP,cancer,cancerous,carcinogen,catalytic activity,CFS,chronic fatigue syndrome,coenzyme binding,Cofactor biosynthesis,convulsions,Coronary Artery Disease (CAD),Cytokine-induced GCH1 up-regulation,Cytoplasm,cytoplasmic vesicle,cytosol,defect,deficiency,dibutyryl-cAMP,difficulty swallowing,Disease mutation,dopa-responsive dystonia,dopamine,dopamine and serotonin,dopamine biosynthetic process,dopamine synthesis,drowsiness,dystonia,DYT5,endothelial nitric oxide synthase activity,enzyme,exercise,exercise induced fatigue,fatigue,GCH,GCH1,GCH1 heterodecamers,GCHFR/GFRP,GTP + H2O = formate + 2-amino-4-hydroxy-6-(erythro-1,GTP binding,GTP catabolic process,GTP cyclohydrolase 1,GTP cyclohydrolase 1 deficiency (GCH1D),GTP cyclohydrolase I,GTP cyclohydrolase I activity,GTP-binding,GTP-CH-I,GTPCH1,GTPCH1 deficiency,high BP,human aorta endothelial cells (HAECs),HUVEC cells,hydrogen peroxide,Hydrolase,hyperphenylalaninemia,hypersalivation,hypertension,hyperthermia,IFNG/IFN-gamma,IL,IL1B/interleukin-1 beta,iloprost,interleukin,irritability,JAK2/STAT,keratinocytes,L-Dopa,low BP,lungs,magnesium,malignant,malignant hyperphenylalaninemia,ME,melanocytes,metabolic process,Metal-binding,MG,mild dystonia type 5,mutation,myalgic encephalomyelitis,negative regulation of blood pressure,neuromuscular process controlling posture,NF-kappa-B,nitric oxide (NO),nitric oxide bioavailability,nitric oxide biosynthetic process,nitric oxide metabolic process,nitric oxide synthase,nitric oxide synthesis,NOS,nuclear membrane,Nucleotide-binding,Nucleus,oscillatory shear stress,pain,pain perception,pain persistence,pain sensitivity,pain tolerance,Parkinson,Parkinsonism,Parkinson\u2019s disease,phenol,phenylalanine,phenylalanine hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylated by casein kinase II at Ser-81,phosphorylation at Ser-81 results in increased enzyme activity,plasma BH4,plasma biopterin,Polymorphism,positive regulation of nitric-oxide synthase activity,postural and motor disturbances,protein complex,protein heterooligomerization,protein homodimerization activity,protein homooligomerization,psychomotor retardation,pteridine-containing compound biosynthetic process,regulation of blood pressure,regulation of lung blood pressure,regulation of nitric-oxide synthase activity,response to interferon-gamma,response to lipopolysaccharide,response to pain,response to tumor necrosis factor,SER-81,serotonin,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin biosynthesis,tetrahydrobiopterin biosynthetic process,tetrahydrobiopterin deficiency,tetrahydrofolate biosynthetic process,TNF,tonicity disorders,Toroid-shaped homodecamer,tremors,tumor,tyrosine,umbilical vein endothelial cells (HUVECs),Up-regulation of GCH1 expression stimulates production of tetrahydrobiopterin,vascular superoxide production,vasodilation,zinc,zinc ion binding",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs8004018",
        "SNP Name": "GCH1 T23847C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs8004018",
        "Video": null,
        "Tags": "2,3-trihydroxypropyl)-dihydropteridine triphosphate,7,8-bromo-cGMP,8-dihydroneopterin 3'-triphosphate biosynthetic process,8-dihydroneopterin triphosphate,8-dihydroneopterin triphosphate biosynthesis,abnormal movements,AHSA1,Alternative splicing,amino acids,bacterial lipopolysaccharides (LPS) and phenylalanine,BH4,BH4 deficiency,blood pressure,BP,calcium ion binding,cAMP,cancer,cancerous,carcinogen,catalytic activity,CFS,chronic fatigue syndrome,coenzyme binding,Cofactor biosynthesis,convulsions,Coronary Artery Disease (CAD),Cytokine-induced GCH1 up-regulation,Cytoplasm,cytoplasmic vesicle,cytosol,defect,deficiency,dibutyryl-cAMP,difficulty swallowing,Disease mutation,dopa-responsive dystonia,dopamine,dopamine and serotonin,dopamine biosynthetic process,dopamine synthesis,drowsiness,dystonia,DYT5,endothelial nitric oxide synthase activity,enzyme,exercise,exercise induced fatigue,fatigue,GCH,GCH1,GCH1 heterodecamers,GCHFR/GFRP,GTP + H2O = formate + 2-amino-4-hydroxy-6-(erythro-1,GTP binding,GTP catabolic process,GTP cyclohydrolase 1,GTP cyclohydrolase 1 deficiency (GCH1D),GTP cyclohydrolase I,GTP cyclohydrolase I activity,GTP-binding,GTP-CH-I,GTPCH1,GTPCH1 deficiency,high BP,human aorta endothelial cells (HAECs),HUVEC cells,hydrogen peroxide,Hydrolase,hyperphenylalaninemia,hypersalivation,hypertension,hyperthermia,IFNG/IFN-gamma,IL,IL1B/interleukin-1 beta,iloprost,interleukin,irritability,JAK2/STAT,keratinocytes,L-Dopa,low BP,lungs,magnesium,malignant,malignant hyperphenylalaninemia,ME,melanocytes,metabolic process,Metal-binding,MG,mild dystonia type 5,mutation,myalgic encephalomyelitis,negative regulation of blood pressure,neuromuscular process controlling posture,NF-kappa-B,nitric oxide (NO),nitric oxide bioavailability,nitric oxide biosynthetic process,nitric oxide metabolic process,nitric oxide synthase,nitric oxide synthesis,NOS,nuclear membrane,Nucleotide-binding,Nucleus,oscillatory shear stress,pain,pain perception,pain persistence,pain sensitivity,pain tolerance,Parkinson,Parkinsonism,Parkinson\u2019s disease,phenol,phenylalanine,phenylalanine hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylated by casein kinase II at Ser-81,phosphorylation at Ser-81 results in increased enzyme activity,plasma BH4,plasma biopterin,Polymorphism,positive regulation of nitric-oxide synthase activity,postural and motor disturbances,protein complex,protein heterooligomerization,protein homodimerization activity,protein homooligomerization,psychomotor retardation,pteridine-containing compound biosynthetic process,regulation of blood pressure,regulation of lung blood pressure,regulation of nitric-oxide synthase activity,response to interferon-gamma,response to lipopolysaccharide,response to pain,response to tumor necrosis factor,SER-81,serotonin,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin biosynthesis,tetrahydrobiopterin biosynthetic process,tetrahydrobiopterin deficiency,tetrahydrofolate biosynthetic process,TNF,tonicity disorders,Toroid-shaped homodecamer,tremors,tumor,tyrosine,umbilical vein endothelial cells (HUVECs),Up-regulation of GCH1 expression stimulates production of tetrahydrobiopterin,vascular superoxide production,vasodilation,zinc,zinc ion binding",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs3783641",
        "SNP Name": "GCH1 A14404T",
        "Risk Allele": "A",
        "Your Allele": "AT",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3783641",
        "Video": null,
        "Tags": "2,3-trihydroxypropyl)-dihydropteridine triphosphate,7,8-bromo-cGMP,8-dihydroneopterin 3'-triphosphate biosynthetic process,8-dihydroneopterin triphosphate,8-dihydroneopterin triphosphate biosynthesis,abnormal movements,AHSA1,Alternative splicing,amino acids,ASD,associated with lower levels of \u00a0Tetrahydrobiopterin,autism,Autism Spectrum Disorder,bacterial lipopolysaccharides (LPS) and phenylalanine,BH4,BH4 deficiency,bioavailability,birth defect,blood pressure,BP,calcium ion binding,cAMP,cancer,cancerous,capsaicin pain,carcinogen,catalytic activity,CFS,chemotherapy-induced symptoms,chronic fatigue syndrome,coenzyme binding,Cofactor biosynthesis,convulsions,coronary artery disease,Coronary Artery Disease (CAD),CVD,Cytokine-induced GCH1 up-regulation,Cytoplasm,cytoplasmic vesicle,cytosol,defect,deficiency,dibutyryl-cAMP,difficulty swallowing,Disease mutation,dopa-responsive dystonia,dopamine,dopamine and serotonin,dopamine biosynthetic process,dopamine synthesis,drowsiness,dystonia,DYT5,endothelial function,endothelial nitric oxide synthase activity,enzyme,exercise,exercise induced fatigue,fatigue,fibromyalgia,fibromyalgia syndrome,GCH,GCH1,GCH1 heterodecamers,GCHFR/GFRP,GTP + H2O = formate + 2-amino-4-hydroxy-6-(erythro-1,GTP binding,GTP catabolic process,GTP cyclohydrolase 1,GTP cyclohydrolase 1 deficiency (GCH1D),GTP cyclohydrolase I,GTP cyclohydrolase I activity,GTP-binding,GTP-CH-I,GTPCH1,GTPCH1 deficiency,heart,high BP,human aorta endothelial cells (HAECs),HUVEC cells,hydrogen peroxide,Hydrolase,hyperphenylalaninemia,hypersalivation,hypertension,hyperthermia,IFNG/IFN-gamma,IL,IL1B/interleukin-1 beta,iloprost,interleukin,irritability,JAK2/STAT,keratinocytes,L-Dopa,low BP,lungs,magnesium,malignant,malignant hyperphenylalaninemia,ME,melanocytes,metabolic process,Metal-binding,MG,mild dystonia type 5,mutation,myalgic encephalomyelitis,negative regulation of blood pressure,neural tube defects,neuromuscular process controlling posture,NF-kappa-B,nitric oxide (NO),nitric oxide bioavailability,nitric oxide biosynthetic process,nitric oxide metabolic process,nitric oxide synthase,nitric oxide synthesis,NOS,NTDs,nuclear membrane,Nucleotide-binding,Nucleus,oscillatory shear stress,pain,pain perception,pain persistence,pain sensitivity,pain tolerance,Parkinson,Parkinsonism,Parkinson\u2019s disease,phenol,phenylalanine,phenylalanine hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylated by casein kinase II at Ser-81,phosphorylation at Ser-81 results in increased enzyme activity,plasma BH4,plasma biopterin,Polymorphism,positive regulation of nitric-oxide synthase activity,postoperative pain intensity,postural and motor disturbances,protein complex,protein heterooligomerization,protein homodimerization activity,protein homooligomerization,psychomotor retardation,pteridine-containing compound biosynthetic process,regulation of blood pressure,regulation of lung blood pressure,regulation of nitric-oxide synthase activity,response to interferon-gamma,response to lipopolysaccharide,response to pain,response to tumor necrosis factor,SER-81,serotonin,severity of pain in chronic pancreatitis,Sickle Cell Disease,small molecule metabolic process,SSRI response,tetrahydrobiopterin,Tetrahydrobiopterin biosynthesis,tetrahydrobiopterin biosynthetic process,tetrahydrobiopterin deficiency,tetrahydrofolate biosynthetic process,THB,TNF,tonicity disorders,Toroid-shaped homodecamer,tremors,tumor,tyrosine,umbilical vein endothelial cells (HUVECs),Up-regulation of GCH1 expression stimulates production of tetrahydrobiopterin,vascular superoxide production,vasodilation,zinc,zinc ion binding",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs3783641",
        "SNP Name": "GCH1 A14404T",
        "Risk Allele": "A",
        "Your Allele": "AT",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3783641",
        "Video": null,
        "Tags": "2,3-trihydroxypropyl)-dihydropteridine triphosphate,7,8-bromo-cGMP,8-dihydroneopterin 3'-triphosphate biosynthetic process,8-dihydroneopterin triphosphate,8-dihydroneopterin triphosphate biosynthesis,abnormal movements,AHSA1,Alternative splicing,amino acids,ASD,associated with lower levels of \u00a0Tetrahydrobiopterin,autism,Autism Spectrum Disorder,bacterial lipopolysaccharides (LPS) and phenylalanine,BH4,BH4 deficiency,bioavailability,birth defect,blood pressure,BP,calcium ion binding,cAMP,cancer,cancerous,capsaicin pain,carcinogen,catalytic activity,CFS,chemotherapy-induced symptoms,chronic fatigue syndrome,coenzyme binding,Cofactor biosynthesis,convulsions,coronary artery disease,Coronary Artery Disease (CAD),CVD,Cytokine-induced GCH1 up-regulation,Cytoplasm,cytoplasmic vesicle,cytosol,defect,deficiency,dibutyryl-cAMP,difficulty swallowing,Disease mutation,dopa-responsive dystonia,dopamine,dopamine and serotonin,dopamine biosynthetic process,dopamine synthesis,drowsiness,dystonia,DYT5,endothelial function,endothelial nitric oxide synthase activity,enzyme,exercise,exercise induced fatigue,fatigue,fibromyalgia,fibromyalgia syndrome,GCH,GCH1,GCH1 heterodecamers,GCHFR/GFRP,GTP + H2O = formate + 2-amino-4-hydroxy-6-(erythro-1,GTP binding,GTP catabolic process,GTP cyclohydrolase 1,GTP cyclohydrolase 1 deficiency (GCH1D),GTP cyclohydrolase I,GTP cyclohydrolase I activity,GTP-binding,GTP-CH-I,GTPCH1,GTPCH1 deficiency,heart,high BP,human aorta endothelial cells (HAECs),HUVEC cells,hydrogen peroxide,Hydrolase,hyperphenylalaninemia,hypersalivation,hypertension,hyperthermia,IFNG/IFN-gamma,IL,IL1B/interleukin-1 beta,iloprost,interleukin,irritability,JAK2/STAT,keratinocytes,L-Dopa,low BP,lungs,magnesium,malignant,malignant hyperphenylalaninemia,ME,melanocytes,metabolic process,Metal-binding,MG,mild dystonia type 5,mutation,myalgic encephalomyelitis,negative regulation of blood pressure,neural tube defects,neuromuscular process controlling posture,NF-kappa-B,nitric oxide (NO),nitric oxide bioavailability,nitric oxide biosynthetic process,nitric oxide metabolic process,nitric oxide synthase,nitric oxide synthesis,NOS,NTDs,nuclear membrane,Nucleotide-binding,Nucleus,oscillatory shear stress,pain,pain perception,pain persistence,pain sensitivity,pain tolerance,Parkinson,Parkinsonism,Parkinson\u2019s disease,phenol,phenylalanine,phenylalanine hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylated by casein kinase II at Ser-81,phosphorylation at Ser-81 results in increased enzyme activity,plasma BH4,plasma biopterin,Polymorphism,positive regulation of nitric-oxide synthase activity,postoperative pain intensity,postural and motor disturbances,protein complex,protein heterooligomerization,protein homodimerization activity,protein homooligomerization,psychomotor retardation,pteridine-containing compound biosynthetic process,regulation of blood pressure,regulation of lung blood pressure,regulation of nitric-oxide synthase activity,response to interferon-gamma,response to lipopolysaccharide,response to pain,response to tumor necrosis factor,SER-81,serotonin,severity of pain in chronic pancreatitis,Sickle Cell Disease,small molecule metabolic process,SSRI response,tetrahydrobiopterin,Tetrahydrobiopterin biosynthesis,tetrahydrobiopterin biosynthetic process,tetrahydrobiopterin deficiency,tetrahydrofolate biosynthetic process,THB,TNF,tonicity disorders,Toroid-shaped homodecamer,tremors,tumor,tyrosine,umbilical vein endothelial cells (HUVECs),Up-regulation of GCH1 expression stimulates production of tetrahydrobiopterin,vascular superoxide production,vasodilation,zinc,zinc ion binding",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs3783642",
        "SNP Name": "GCH1 A14340G",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3783642",
        "Video": null,
        "Tags": "2,3-trihydroxypropyl)-dihydropteridine triphosphate,7,8-bromo-cGMP,8-dihydroneopterin 3'-triphosphate biosynthetic process,8-dihydroneopterin triphosphate,8-dihydroneopterin triphosphate biosynthesis,abnormal movements,AHSA1,Alternative splicing,amino acids,bacterial lipopolysaccharides (LPS) and phenylalanine,BH4,BH4 deficiency,blood pressure,BP,calcium ion binding,cAMP,cancer,cancerous,carcinogen,catalytic activity,CFS,chronic fatigue syndrome,coenzyme binding,Cofactor biosynthesis,convulsions,Coronary Artery Disease (CAD),Cytokine-induced GCH1 up-regulation,Cytoplasm,cytoplasmic vesicle,cytosol,defect,deficiency,dibutyryl-cAMP,difficulty swallowing,Disease mutation,dopa-responsive dystonia,dopamine,dopamine and serotonin,dopamine biosynthetic process,dopamine synthesis,drowsiness,dystonia,DYT5,endothelial nitric oxide synthase activity,enzyme,exercise,exercise induced fatigue,fatigue,GCH,GCH1,GCH1 heterodecamers,GCHFR/GFRP,GTP + H2O = formate + 2-amino-4-hydroxy-6-(erythro-1,GTP binding,GTP catabolic process,GTP cyclohydrolase 1,GTP cyclohydrolase 1 deficiency (GCH1D),GTP cyclohydrolase I,GTP cyclohydrolase I activity,GTP-binding,GTP-CH-I,GTPCH1,GTPCH1 deficiency,high BP,human aorta endothelial cells (HAECs),HUVEC cells,hydrogen peroxide,Hydrolase,hyperphenylalaninemia,hypersalivation,hypertension,hyperthermia,IFNG/IFN-gamma,IL,IL1B/interleukin-1 beta,iloprost,interleukin,irritability,JAK2/STAT,keratinocytes,L-Dopa,low BP,lungs,magnesium,malignant,malignant hyperphenylalaninemia,ME,melanocytes,metabolic process,Metal-binding,MG,mild dystonia type 5,mutation,myalgic encephalomyelitis,negative regulation of blood pressure,neuromuscular process controlling posture,NF-kappa-B,nitric oxide (NO),nitric oxide bioavailability,nitric oxide biosynthetic process,nitric oxide metabolic process,nitric oxide synthase,nitric oxide synthesis,NOS,nuclear membrane,Nucleotide-binding,Nucleus,oscillatory shear stress,pain,pain perception,pain persistence,pain sensitivity,pain tolerance,Parkinson,Parkinsonism,Parkinson\u2019s disease,phenol,phenylalanine,phenylalanine hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylated by casein kinase II at Ser-81,phosphorylation at Ser-81 results in increased enzyme activity,plasma BH4,plasma biopterin,Polymorphism,positive regulation of nitric-oxide synthase activity,postural and motor disturbances,protein complex,protein heterooligomerization,protein homodimerization activity,protein homooligomerization,psychomotor retardation,pteridine-containing compound biosynthetic process,regulation of blood pressure,regulation of lung blood pressure,regulation of nitric-oxide synthase activity,response to interferon-gamma,response to lipopolysaccharide,response to pain,response to tumor necrosis factor,SER-81,serotonin,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin biosynthesis,tetrahydrobiopterin biosynthetic process,tetrahydrobiopterin deficiency,tetrahydrofolate biosynthetic process,TNF,tonicity disorders,Toroid-shaped homodecamer,tremors,tumor,tyrosine,umbilical vein endothelial cells (HUVECs),Up-regulation of GCH1 expression stimulates production of tetrahydrobiopterin,vascular superoxide production,vasodilation,zinc,zinc ion binding",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs3783642",
        "SNP Name": "GCH1 A14340G",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3783642",
        "Video": null,
        "Tags": "2,3-trihydroxypropyl)-dihydropteridine triphosphate,7,8-bromo-cGMP,8-dihydroneopterin 3'-triphosphate biosynthetic process,8-dihydroneopterin triphosphate,8-dihydroneopterin triphosphate biosynthesis,abnormal movements,AHSA1,Alternative splicing,amino acids,bacterial lipopolysaccharides (LPS) and phenylalanine,BH4,BH4 deficiency,blood pressure,BP,calcium ion binding,cAMP,cancer,cancerous,carcinogen,catalytic activity,CFS,chronic fatigue syndrome,coenzyme binding,Cofactor biosynthesis,convulsions,Coronary Artery Disease (CAD),Cytokine-induced GCH1 up-regulation,Cytoplasm,cytoplasmic vesicle,cytosol,defect,deficiency,dibutyryl-cAMP,difficulty swallowing,Disease mutation,dopa-responsive dystonia,dopamine,dopamine and serotonin,dopamine biosynthetic process,dopamine synthesis,drowsiness,dystonia,DYT5,endothelial nitric oxide synthase activity,enzyme,exercise,exercise induced fatigue,fatigue,GCH,GCH1,GCH1 heterodecamers,GCHFR/GFRP,GTP + H2O = formate + 2-amino-4-hydroxy-6-(erythro-1,GTP binding,GTP catabolic process,GTP cyclohydrolase 1,GTP cyclohydrolase 1 deficiency (GCH1D),GTP cyclohydrolase I,GTP cyclohydrolase I activity,GTP-binding,GTP-CH-I,GTPCH1,GTPCH1 deficiency,high BP,human aorta endothelial cells (HAECs),HUVEC cells,hydrogen peroxide,Hydrolase,hyperphenylalaninemia,hypersalivation,hypertension,hyperthermia,IFNG/IFN-gamma,IL,IL1B/interleukin-1 beta,iloprost,interleukin,irritability,JAK2/STAT,keratinocytes,L-Dopa,low BP,lungs,magnesium,malignant,malignant hyperphenylalaninemia,ME,melanocytes,metabolic process,Metal-binding,MG,mild dystonia type 5,mutation,myalgic encephalomyelitis,negative regulation of blood pressure,neuromuscular process controlling posture,NF-kappa-B,nitric oxide (NO),nitric oxide bioavailability,nitric oxide biosynthetic process,nitric oxide metabolic process,nitric oxide synthase,nitric oxide synthesis,NOS,nuclear membrane,Nucleotide-binding,Nucleus,oscillatory shear stress,pain,pain perception,pain persistence,pain sensitivity,pain tolerance,Parkinson,Parkinsonism,Parkinson\u2019s disease,phenol,phenylalanine,phenylalanine hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylated by casein kinase II at Ser-81,phosphorylation at Ser-81 results in increased enzyme activity,plasma BH4,plasma biopterin,Polymorphism,positive regulation of nitric-oxide synthase activity,postural and motor disturbances,protein complex,protein heterooligomerization,protein homodimerization activity,protein homooligomerization,psychomotor retardation,pteridine-containing compound biosynthetic process,regulation of blood pressure,regulation of lung blood pressure,regulation of nitric-oxide synthase activity,response to interferon-gamma,response to lipopolysaccharide,response to pain,response to tumor necrosis factor,SER-81,serotonin,small molecule metabolic process,tetrahydrobiopterin,Tetrahydrobiopterin biosynthesis,tetrahydrobiopterin biosynthetic process,tetrahydrobiopterin deficiency,tetrahydrofolate biosynthetic process,TNF,tonicity disorders,Toroid-shaped homodecamer,tremors,tumor,tyrosine,umbilical vein endothelial cells (HUVECs),Up-regulation of GCH1 expression stimulates production of tetrahydrobiopterin,vascular superoxide production,vasodilation,zinc,zinc ion binding",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs8007267",
        "SNP Name": "GCH1 C36378991T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs8007267",
        "Video": null,
        "Tags": "2,3-trihydroxypropyl)-dihydropteridine triphosphate,7,8-bromo-cGMP,8-dihydroneopterin 3'-triphosphate biosynthetic process,8-dihydroneopterin triphosphate,8-dihydroneopterin triphosphate biosynthesis,abnormal movements,AHSA1,Alternative splicing,amino acids,bacterial lipopolysaccharides (LPS) and phenylalanine,BH4,BH4 deficiency,birth defect,blood pressure,BP,calcium ion binding,cAMP,cancer,cancerous,capsaicin pain,carcinogen,catalytic activity,CFS,chemotherapy-induced symptoms,chronic fatigue syndrome,coenzyme binding,Cofactor biosynthesis,convulsions,Coronary Artery Disease (CAD),Cytokine-induced GCH1 up-regulation,Cytoplasm,cytoplasmic vesicle,cytosol,defect,deficiency,dibutyryl-cAMP,difficulty swallowing,Disease mutation,dopa-responsive dystonia,dopamine,dopamine and serotonin,dopamine biosynthetic process,dopamine synthesis,drowsiness,dystonia,DYT5,endothelial nitric oxide synthase activity,enzyme,exercise,exercise induced fatigue,fatigue,GCH,GCH1,GCH1 heterodecamers,GCHFR/GFRP,GTP + H2O = formate + 2-amino-4-hydroxy-6-(erythro-1,GTP binding,GTP catabolic process,GTP cyclohydrolase 1,GTP cyclohydrolase 1 deficiency (GCH1D),GTP cyclohydrolase I,GTP cyclohydrolase I activity,GTP-binding,GTP-CH-I,GTPCH1,GTPCH1 deficiency,high BP,human aorta endothelial cells (HAECs),HUVEC cells,hydrogen peroxide,Hydrolase,hyperphenylalaninemia,hypersalivation,hypertension,hyperthermia,IFNG/IFN-gamma,IL,IL1B/interleukin-1 beta,iloprost,interleukin,irritability,JAK2/STAT,keratinocytes,L-Dopa,low BP,lungs,magnesium,malignant,malignant hyperphenylalaninemia,ME,melanocytes,metabolic process,Metal-binding,MG,mild dystonia type 5,mutation,myalgic encephalomyelitis,negative regulation of blood pressure,neural tube defects,neuromuscular process controlling posture,NF-kappa-B,nitric oxide (NO),nitric oxide bioavailability,nitric oxide biosynthetic process,nitric oxide metabolic process,nitric oxide synthase,nitric oxide synthesis,NOS,NTDs,nuclear membrane,Nucleotide-binding,Nucleus,oscillatory shear stress,pain,pain perception,pain persistence,pain sensitivity,pain tolerance,Parkinson,Parkinsonism,Parkinson\u2019s disease,persistent widespread pain,phenol,phenylalanine,phenylalanine hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylated by casein kinase II at Ser-81,phosphorylation at Ser-81 results in increased enzyme activity,Polymorphism,positive regulation of nitric-oxide synthase activity,postoperative pain intensity,postural and motor disturbances,protein complex,protein heterooligomerization,protein homodimerization activity,protein homooligomerization,psychomotor retardation,pteridine-containing compound biosynthetic process,regulation of blood pressure,regulation of lung blood pressure,regulation of nitric-oxide synthase activity,response to interferon-gamma,response to lipopolysaccharide,response to pain,response to tumor necrosis factor,SER-81,serotonin,severity of pain,small molecule metabolic process,SSRI response,susceptibility to pain crises and altered endothelial function in adults with sickle cell anemia,tetrahydrobiopterin,Tetrahydrobiopterin biosynthesis,tetrahydrobiopterin biosynthetic process,tetrahydrobiopterin deficiency,tetrahydrofolate biosynthetic process,TNF,tonicity disorders,Toroid-shaped homodecamer,tremors,tumor,tyrosine,umbilical vein endothelial cells (HUVECs),Up-regulation of GCH1 expression stimulates production of tetrahydrobiopterin,vascular superoxide production,vasodilation,zinc,zinc ion binding",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs8007267",
        "SNP Name": "GCH1 C36378991T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs8007267",
        "Video": null,
        "Tags": "2,3-trihydroxypropyl)-dihydropteridine triphosphate,7,8-bromo-cGMP,8-dihydroneopterin 3'-triphosphate biosynthetic process,8-dihydroneopterin triphosphate,8-dihydroneopterin triphosphate biosynthesis,abnormal movements,AHSA1,Alternative splicing,amino acids,bacterial lipopolysaccharides (LPS) and phenylalanine,BH4,BH4 deficiency,birth defect,blood pressure,BP,calcium ion binding,cAMP,cancer,cancerous,capsaicin pain,carcinogen,catalytic activity,CFS,chemotherapy-induced symptoms,chronic fatigue syndrome,coenzyme binding,Cofactor biosynthesis,convulsions,Coronary Artery Disease (CAD),Cytokine-induced GCH1 up-regulation,Cytoplasm,cytoplasmic vesicle,cytosol,defect,deficiency,dibutyryl-cAMP,difficulty swallowing,Disease mutation,dopa-responsive dystonia,dopamine,dopamine and serotonin,dopamine biosynthetic process,dopamine synthesis,drowsiness,dystonia,DYT5,endothelial nitric oxide synthase activity,enzyme,exercise,exercise induced fatigue,fatigue,GCH,GCH1,GCH1 heterodecamers,GCHFR/GFRP,GTP + H2O = formate + 2-amino-4-hydroxy-6-(erythro-1,GTP binding,GTP catabolic process,GTP cyclohydrolase 1,GTP cyclohydrolase 1 deficiency (GCH1D),GTP cyclohydrolase I,GTP cyclohydrolase I activity,GTP-binding,GTP-CH-I,GTPCH1,GTPCH1 deficiency,high BP,human aorta endothelial cells (HAECs),HUVEC cells,hydrogen peroxide,Hydrolase,hyperphenylalaninemia,hypersalivation,hypertension,hyperthermia,IFNG/IFN-gamma,IL,IL1B/interleukin-1 beta,iloprost,interleukin,irritability,JAK2/STAT,keratinocytes,L-Dopa,low BP,lungs,magnesium,malignant,malignant hyperphenylalaninemia,ME,melanocytes,metabolic process,Metal-binding,MG,mild dystonia type 5,mutation,myalgic encephalomyelitis,negative regulation of blood pressure,neural tube defects,neuromuscular process controlling posture,NF-kappa-B,nitric oxide (NO),nitric oxide bioavailability,nitric oxide biosynthetic process,nitric oxide metabolic process,nitric oxide synthase,nitric oxide synthesis,NOS,NTDs,nuclear membrane,Nucleotide-binding,Nucleus,oscillatory shear stress,pain,pain perception,pain persistence,pain sensitivity,pain tolerance,Parkinson,Parkinsonism,Parkinson\u2019s disease,persistent widespread pain,phenol,phenylalanine,phenylalanine hydroxylase,Phenylketonuria,phosphate,Phosphoprotein,Phosphorylated by casein kinase II at Ser-81,phosphorylation at Ser-81 results in increased enzyme activity,Polymorphism,positive regulation of nitric-oxide synthase activity,postoperative pain intensity,postural and motor disturbances,protein complex,protein heterooligomerization,protein homodimerization activity,protein homooligomerization,psychomotor retardation,pteridine-containing compound biosynthetic process,regulation of blood pressure,regulation of lung blood pressure,regulation of nitric-oxide synthase activity,response to interferon-gamma,response to lipopolysaccharide,response to pain,response to tumor necrosis factor,SER-81,serotonin,severity of pain,small molecule metabolic process,SSRI response,susceptibility to pain crises and altered endothelial function in adults with sickle cell anemia,tetrahydrobiopterin,Tetrahydrobiopterin biosynthesis,tetrahydrobiopterin biosynthetic process,tetrahydrobiopterin deficiency,tetrahydrofolate biosynthetic process,TNF,tonicity disorders,Toroid-shaped homodecamer,tremors,tumor,tyrosine,umbilical vein endothelial cells (HUVECs),Up-regulation of GCH1 expression stimulates production of tetrahydrobiopterin,vascular superoxide production,vasodilation,zinc,zinc ion binding",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2236225",
        "SNP Name": "MTHFD1 R635Q",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2236225",
        "Video": null,
        "Tags": "10-formyltetrahydrofolate synthetase,10-methenyltetrahydrofolate + H2O = 10-formyltetrahydrofolate,10-methenyltetrahydrofolate + NADPH,10-methenyltetrahydrofolate cyclohydrolase,10-methylenetetrahydrofolate + NADP+ = 5,10-methylenetetrahydrofolate dehydrogenase,5,5-MTHF,Acetylation,adenocarcinoma,adenoma,Amino-acid biosynthesis,anencephaly,ATP,ATP + formate + tetrahydrofolate = ADP + phosphate + 10-formyltetrahydrofolate,ATP binding,ATP-binding,birth defect,C-1-tetrahydrofolate synthase,C1-THF synthase,cancer,canerous,carcinogen,celiac disease,cellular energy,Childhood Acute Lymphoblastic Leukemia,choline metabolism when folate intake is restricted,colon,Colorectal cancer,Complete proteomeDirect protein sequencing,Conotruncal Heart Defects,consists of two major domains: an N-terminal part containing the methylene-THF dehydrogenase and cyclohydrolase activities and a larger C-terminal part containing formyl-THF synthetase activity,CRC,cyclohydrolase family,Cytoplasm,cytoplasmic,cytosol,digestive,Disease mutation,Down syndrome,drug metabolism,energy,extracellular vesicular exosome,folate,folate and drug metabolism,Folate-sensitive neural tube defects,folic acid,folic acid-containing compound biosynthetic process,formate-tetrahydrofolate ligase activity,Formyltetrahydrofolate synthetase,G1958A,gi tract,glaucoma,heart,heart defect,Histidine biosynthesis,histidine biosynthetic process,homocysteine,homocysteine metabolism in celiac disease,Homodimer,Hydrolase,In the C-terminal section; belongs to the formate--tetrahydrofolate ligase family,In the N-terminal section; belongs to the tetrahydrofolate dehydrogenase/cyclohydrolase family,increased risk of tetralogy of Fallot,intestine,invasive adenocarcinoma,L-5-MTHF,lesion,Ligase,malignant,mental retardation,Methenyltetrahydrofolate cyclohydrolase,methenyltetrahydrofolate cyclohydrolase activity,Methionine biosynthesis,methionine biosynthetic process,Methylenetetrahydrofolate,Methylenetetrahydrofolate dehydrogenase,methylenetetrahydrofolate dehydrogenase (NADP+) activity,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,mitochondria,mitochondrion,MTHFC,MTHFD1,Multifunctional enzyme,myelomeningocele,N-terminally processed,NADP,NADPH,neural tube defect,neural tube defects,Neural Tube Defects and Folic Acid,NTDs,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,One-carbon metabolism; tetrahydrofolate interconversion,Oxidoreductase,Plasma choline metabolites associate with metabolic stress among young overweight men,Polymorphism,polyp,premalignant lesion,pseudoexfoliation syndrome,Purine biosynthesis,purine nucleotide biosynthetic process,rectal tumor mutations,rectum,Reference proteome folic acid metabolic process,rs2236225,S-adenosyl methionine,SAMe,small molecule metabolic process,spina bifida,temporomandibular disorder,tetrahydrofolate dehydrogenase family,tetrahydrofolate interconversion,tetrahydrofolate ligase family,TMJ,Ubiquitous,UC,ulcerative colitis,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2236225",
        "SNP Name": "MTHFD1 R635Q",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2236225",
        "Video": null,
        "Tags": "10-formyltetrahydrofolate synthetase,10-methenyltetrahydrofolate + H2O = 10-formyltetrahydrofolate,10-methenyltetrahydrofolate + NADPH,10-methenyltetrahydrofolate cyclohydrolase,10-methylenetetrahydrofolate + NADP+ = 5,10-methylenetetrahydrofolate dehydrogenase,5,5-MTHF,Acetylation,adenocarcinoma,adenoma,Amino-acid biosynthesis,anencephaly,ATP,ATP + formate + tetrahydrofolate = ADP + phosphate + 10-formyltetrahydrofolate,ATP binding,ATP-binding,birth defect,C-1-tetrahydrofolate synthase,C1-THF synthase,cancer,canerous,carcinogen,celiac disease,cellular energy,Childhood Acute Lymphoblastic Leukemia,choline metabolism when folate intake is restricted,colon,Colorectal cancer,Complete proteomeDirect protein sequencing,Conotruncal Heart Defects,consists of two major domains: an N-terminal part containing the methylene-THF dehydrogenase and cyclohydrolase activities and a larger C-terminal part containing formyl-THF synthetase activity,CRC,cyclohydrolase family,Cytoplasm,cytoplasmic,cytosol,digestive,Disease mutation,Down syndrome,drug metabolism,energy,extracellular vesicular exosome,folate,folate and drug metabolism,Folate-sensitive neural tube defects,folic acid,folic acid-containing compound biosynthetic process,formate-tetrahydrofolate ligase activity,Formyltetrahydrofolate synthetase,G1958A,gi tract,glaucoma,heart,heart defect,Histidine biosynthesis,histidine biosynthetic process,homocysteine,homocysteine metabolism in celiac disease,Homodimer,Hydrolase,In the C-terminal section; belongs to the formate--tetrahydrofolate ligase family,In the N-terminal section; belongs to the tetrahydrofolate dehydrogenase/cyclohydrolase family,increased risk of tetralogy of Fallot,intestine,invasive adenocarcinoma,L-5-MTHF,lesion,Ligase,malignant,mental retardation,Methenyltetrahydrofolate cyclohydrolase,methenyltetrahydrofolate cyclohydrolase activity,Methionine biosynthesis,methionine biosynthetic process,Methylenetetrahydrofolate,Methylenetetrahydrofolate dehydrogenase,methylenetetrahydrofolate dehydrogenase (NADP+) activity,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,mitochondria,mitochondrion,MTHFC,MTHFD1,Multifunctional enzyme,myelomeningocele,N-terminally processed,NADP,NADPH,neural tube defect,neural tube defects,Neural Tube Defects and Folic Acid,NTDs,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,One-carbon metabolism; tetrahydrofolate interconversion,Oxidoreductase,Plasma choline metabolites associate with metabolic stress among young overweight men,Polymorphism,polyp,premalignant lesion,pseudoexfoliation syndrome,Purine biosynthesis,purine nucleotide biosynthetic process,rectal tumor mutations,rectum,Reference proteome folic acid metabolic process,rs2236225,S-adenosyl methionine,SAMe,small molecule metabolic process,spina bifida,temporomandibular disorder,tetrahydrofolate dehydrogenase family,tetrahydrofolate interconversion,tetrahydrofolate ligase family,TMJ,Ubiquitous,UC,ulcerative colitis,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2236225",
        "SNP Name": "MTHFD1 R635Q",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2236225",
        "Video": null,
        "Tags": "10-formyltetrahydrofolate synthetase,10-methenyltetrahydrofolate + H2O = 10-formyltetrahydrofolate,10-methenyltetrahydrofolate + NADPH,10-methenyltetrahydrofolate cyclohydrolase,10-methylenetetrahydrofolate + NADP+ = 5,10-methylenetetrahydrofolate dehydrogenase,5,5-MTHF,Acetylation,adenocarcinoma,adenoma,Amino-acid biosynthesis,anencephaly,ATP,ATP + formate + tetrahydrofolate = ADP + phosphate + 10-formyltetrahydrofolate,ATP binding,ATP-binding,birth defect,C-1-tetrahydrofolate synthase,C1-THF synthase,cancer,canerous,carcinogen,celiac disease,cellular energy,Childhood Acute Lymphoblastic Leukemia,choline metabolism when folate intake is restricted,colon,Colorectal cancer,Complete proteomeDirect protein sequencing,Conotruncal Heart Defects,consists of two major domains: an N-terminal part containing the methylene-THF dehydrogenase and cyclohydrolase activities and a larger C-terminal part containing formyl-THF synthetase activity,CRC,cyclohydrolase family,Cytoplasm,cytoplasmic,cytosol,digestive,Disease mutation,Down syndrome,drug metabolism,energy,extracellular vesicular exosome,folate,folate and drug metabolism,Folate-sensitive neural tube defects,folic acid,folic acid-containing compound biosynthetic process,formate-tetrahydrofolate ligase activity,Formyltetrahydrofolate synthetase,G1958A,gi tract,glaucoma,heart,heart defect,Histidine biosynthesis,histidine biosynthetic process,homocysteine,homocysteine metabolism in celiac disease,Homodimer,Hydrolase,In the C-terminal section; belongs to the formate--tetrahydrofolate ligase family,In the N-terminal section; belongs to the tetrahydrofolate dehydrogenase/cyclohydrolase family,increased risk of tetralogy of Fallot,intestine,invasive adenocarcinoma,L-5-MTHF,lesion,Ligase,malignant,mental retardation,Methenyltetrahydrofolate cyclohydrolase,methenyltetrahydrofolate cyclohydrolase activity,Methionine biosynthesis,methionine biosynthetic process,Methylenetetrahydrofolate,Methylenetetrahydrofolate dehydrogenase,methylenetetrahydrofolate dehydrogenase (NADP+) activity,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,mitochondria,mitochondrion,MTHFC,MTHFD1,Multifunctional enzyme,myelomeningocele,N-terminally processed,NADP,NADPH,neural tube defect,neural tube defects,Neural Tube Defects and Folic Acid,NTDs,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,One-carbon metabolism; tetrahydrofolate interconversion,Oxidoreductase,Plasma choline metabolites associate with metabolic stress among young overweight men,Polymorphism,polyp,premalignant lesion,pseudoexfoliation syndrome,Purine biosynthesis,purine nucleotide biosynthetic process,rectal tumor mutations,rectum,Reference proteome folic acid metabolic process,rs2236225,S-adenosyl methionine,SAMe,small molecule metabolic process,spina bifida,temporomandibular disorder,tetrahydrofolate dehydrogenase family,tetrahydrofolate interconversion,tetrahydrofolate ligase family,TMJ,Ubiquitous,UC,ulcerative colitis,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs2236225",
        "SNP Name": "MTHFD1 R635Q",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2236225",
        "Video": null,
        "Tags": "10-formyltetrahydrofolate synthetase,10-methenyltetrahydrofolate + H2O = 10-formyltetrahydrofolate,10-methenyltetrahydrofolate + NADPH,10-methenyltetrahydrofolate cyclohydrolase,10-methylenetetrahydrofolate + NADP+ = 5,10-methylenetetrahydrofolate dehydrogenase,5,5-MTHF,Acetylation,adenocarcinoma,adenoma,Amino-acid biosynthesis,anencephaly,ATP,ATP + formate + tetrahydrofolate = ADP + phosphate + 10-formyltetrahydrofolate,ATP binding,ATP-binding,birth defect,C-1-tetrahydrofolate synthase,C1-THF synthase,cancer,canerous,carcinogen,celiac disease,cellular energy,Childhood Acute Lymphoblastic Leukemia,choline metabolism when folate intake is restricted,colon,Colorectal cancer,Complete proteomeDirect protein sequencing,Conotruncal Heart Defects,consists of two major domains: an N-terminal part containing the methylene-THF dehydrogenase and cyclohydrolase activities and a larger C-terminal part containing formyl-THF synthetase activity,CRC,cyclohydrolase family,Cytoplasm,cytoplasmic,cytosol,digestive,Disease mutation,Down syndrome,drug metabolism,energy,extracellular vesicular exosome,folate,folate and drug metabolism,Folate-sensitive neural tube defects,folic acid,folic acid-containing compound biosynthetic process,formate-tetrahydrofolate ligase activity,Formyltetrahydrofolate synthetase,G1958A,gi tract,glaucoma,heart,heart defect,Histidine biosynthesis,histidine biosynthetic process,homocysteine,homocysteine metabolism in celiac disease,Homodimer,Hydrolase,In the C-terminal section; belongs to the formate--tetrahydrofolate ligase family,In the N-terminal section; belongs to the tetrahydrofolate dehydrogenase/cyclohydrolase family,increased risk of tetralogy of Fallot,intestine,invasive adenocarcinoma,L-5-MTHF,lesion,Ligase,malignant,mental retardation,Methenyltetrahydrofolate cyclohydrolase,methenyltetrahydrofolate cyclohydrolase activity,Methionine biosynthesis,methionine biosynthetic process,Methylenetetrahydrofolate,Methylenetetrahydrofolate dehydrogenase,methylenetetrahydrofolate dehydrogenase (NADP+) activity,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,mitochondria,mitochondrion,MTHFC,MTHFD1,Multifunctional enzyme,myelomeningocele,N-terminally processed,NADP,NADPH,neural tube defect,neural tube defects,Neural Tube Defects and Folic Acid,NTDs,Nucleotide-binding,one-carbon metabolic process,One-carbon metabolism,One-carbon metabolism; tetrahydrofolate interconversion,Oxidoreductase,Plasma choline metabolites associate with metabolic stress among young overweight men,Polymorphism,polyp,premalignant lesion,pseudoexfoliation syndrome,Purine biosynthesis,purine nucleotide biosynthetic process,rectal tumor mutations,rectum,Reference proteome folic acid metabolic process,rs2236225,S-adenosyl methionine,SAMe,small molecule metabolic process,spina bifida,temporomandibular disorder,tetrahydrofolate dehydrogenase family,tetrahydrofolate interconversion,tetrahydrofolate ligase family,TMJ,Ubiquitous,UC,ulcerative colitis,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs8020095",
        "SNP Name": "GPHN 484734G>A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs63749824",
        "SNP Name": "PSEN1 Ala75Val",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "3,Acne inversa familial,ACNINV3,activation of MAPKK activity,AD,AD3,Alzheimer,Alzheimer's disease,amyloid,anagen,aphasia,apical plasma membrane,apoptosis,APP,aspartic-type endopeptidase activity,autophagic vacuole assembly,axon,beta-amyloid formation,beta-amyloid metabolic process,beta-amyloid precursor protein,beta-catenin,beta-catenin binding,blood vessel development,brain morphogenesis,cadherin binding,Cajal-Retzius cell differentiation,calcium channel activity,calcium influx,calcium ion transmembrane transport,canonical Wnt signaling pathway,cardio,Cardiomyopathy,cardiovascular,Cell adhesion,cell cortex,cell fate specification,cell surface,cellular response to DNA damage stimulus,centrosome,cerebral cortex cell migration,choline,choline transport,ciliary rootlet,CMD1U,CVD,cytoplasmic vesicle,dementia,dendritic shaft,dilated 1U,dorsal/ventral neural tube patterning,draining sinuses,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,epithelial cell proliferation,extracellular matrix disassembly,extracellular matrix organization,familial dilated cardiomyopathy,frontotemporal,Frontotemporal dementia,frontotemporal lobar degeneration,FTD,gamma-secretase complex,glutamatergic,Golgi apparatus,growth cone,hair,hair follicles,heart,heart disease,heart looping,hematopoietic progenitor cell differentiation,Hidradenitis suppurativa,Hydrolase,immune system,inflammation,integral component of membrane,integral component of plasma membrane,intracellular signal transduction,kinetochore,L-Glutamate,L-glutamate transport,L-Glutamine,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane raft,memory,mitochondria,mitochondrial inner membrane,mitochondrial transport,mitochondrion,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of apoptotic signaling pathway,negative regulation of axonogenesis,negative regulation of epidermal growth factor-activated receptor activity,negative regulation of neuron apoptotic process,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,negative regulation of transcription from RNA polymerase II promoter,negative regulation of ubiquitin-protein transferase activity,neurodegenerative disorder,neuromuscular junction,neuron apoptotic process,neuron development,neuron migration,neuronal cell body,nodules,Notch,Notch receptor processing,Notch signaling pathway,nuclear membrane,nuclear outer membrane,oxidative stress,Parkinson,Parkinson's disease,parkinsonian,PD,PDZ domain binding,perinuclear region of cytoplasm,Phosphoprotein,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of MAP kinase activity,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of receptor recycling,post-embryonic development,Presenilin-1,Presenilin-1 CTF subunit,Presenilin-1 CTF12,Presenilin-1 NTF subunit,Progressive non-fluent aphasia,Protease,protein glycosylation,protein processing,Protein S182,protein transport,PS-1,PS1,PS1-CTF12,PSEN1,PSN1,PSNL1,regulation of phosphorylation,regulation of protein binding,regulation of resting membrane potential,regulation of synaptic plasticity,regulation of synaptic transmission,response to oxidative stress,ROS,rough endoplasmic reticulum,scars,Semantic dementia,single organismal cell-cell adhesion,sinus,skeletal system morphogenesis,skin,skin morphogenesis,smooth endoplasmic reticulum,smooth endoplasmic reticulum calcium ion homeostasis,somitogenesis,synaptic vesicle targeting,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63750599",
        "SNP Name": "PSEN1 Leu81Pro",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "3,Acne inversa familial,ACNINV3,activation of MAPKK activity,AD,AD3,Alzheimer,Alzheimer's disease,amyloid,anagen,aphasia,apical plasma membrane,apoptosis,APP,aspartic-type endopeptidase activity,autophagic vacuole assembly,axon,beta-amyloid formation,beta-amyloid metabolic process,beta-amyloid precursor protein,beta-catenin,beta-catenin binding,blood vessel development,brain morphogenesis,cadherin binding,Cajal-Retzius cell differentiation,calcium channel activity,calcium influx,calcium ion transmembrane transport,canonical Wnt signaling pathway,cardio,Cardiomyopathy,cardiovascular,Cell adhesion,cell cortex,cell fate specification,cell surface,cellular response to DNA damage stimulus,centrosome,cerebral cortex cell migration,choline,choline transport,ciliary rootlet,CMD1U,CVD,cytoplasmic vesicle,dementia,dendritic shaft,dilated 1U,dorsal/ventral neural tube patterning,draining sinuses,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,epithelial cell proliferation,extracellular matrix disassembly,extracellular matrix organization,familial dilated cardiomyopathy,frontotemporal,Frontotemporal dementia,frontotemporal lobar degeneration,FTD,gamma-secretase complex,glutamatergic,Golgi apparatus,growth cone,hair,hair follicles,heart,heart disease,heart looping,hematopoietic progenitor cell differentiation,Hidradenitis suppurativa,Hydrolase,immune system,inflammation,integral component of membrane,integral component of plasma membrane,intracellular signal transduction,kinetochore,L-Glutamate,L-glutamate transport,L-Glutamine,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane raft,memory,mitochondria,mitochondrial inner membrane,mitochondrial transport,mitochondrion,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of apoptotic signaling pathway,negative regulation of axonogenesis,negative regulation of epidermal growth factor-activated receptor activity,negative regulation of neuron apoptotic process,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,negative regulation of transcription from RNA polymerase II promoter,negative regulation of ubiquitin-protein transferase activity,neurodegenerative disorder,neuromuscular junction,neuron apoptotic process,neuron development,neuron migration,neuronal cell body,nodules,Notch,Notch receptor processing,Notch signaling pathway,nuclear membrane,nuclear outer membrane,oxidative stress,Parkinson,Parkinson's disease,parkinsonian,PD,PDZ domain binding,perinuclear region of cytoplasm,Phosphoprotein,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of MAP kinase activity,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of receptor recycling,post-embryonic development,Presenilin-1,Presenilin-1 CTF subunit,Presenilin-1 CTF12,Presenilin-1 NTF subunit,Progressive non-fluent aphasia,Protease,protein glycosylation,protein processing,Protein S182,protein transport,PS-1,PS1,PS1-CTF12,PSEN1,PSN1,PSNL1,regulation of phosphorylation,regulation of protein binding,regulation of resting membrane potential,regulation of synaptic plasticity,regulation of synaptic transmission,response to oxidative stress,ROS,rough endoplasmic reticulum,scars,Semantic dementia,single organismal cell-cell adhesion,sinus,skeletal system morphogenesis,skin,skin morphogenesis,smooth endoplasmic reticulum,smooth endoplasmic reticulum calcium ion homeostasis,somitogenesis,synaptic vesicle targeting,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63750815",
        "SNP Name": "PSEN1 Val85Leu",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "3,Acne inversa familial,ACNINV3,activation of MAPKK activity,AD,AD3,Alzheimer,Alzheimer's disease,amyloid,anagen,aphasia,apical plasma membrane,apoptosis,APP,aspartic-type endopeptidase activity,autophagic vacuole assembly,axon,beta-amyloid formation,beta-amyloid metabolic process,beta-amyloid precursor protein,beta-catenin,beta-catenin binding,blood vessel development,brain morphogenesis,cadherin binding,Cajal-Retzius cell differentiation,calcium channel activity,calcium influx,calcium ion transmembrane transport,canonical Wnt signaling pathway,cardio,Cardiomyopathy,cardiovascular,Cell adhesion,cell cortex,cell fate specification,cell surface,cellular response to DNA damage stimulus,centrosome,cerebral cortex cell migration,choline,choline transport,ciliary rootlet,CMD1U,CVD,cytoplasmic vesicle,dementia,dendritic shaft,dilated 1U,dorsal/ventral neural tube patterning,draining sinuses,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,epithelial cell proliferation,extracellular matrix disassembly,extracellular matrix organization,familial dilated cardiomyopathy,frontotemporal,Frontotemporal dementia,frontotemporal lobar degeneration,FTD,gamma-secretase complex,glutamatergic,Golgi apparatus,growth cone,hair,hair follicles,heart,heart disease,heart looping,hematopoietic progenitor cell differentiation,Hidradenitis suppurativa,Hydrolase,immune system,inflammation,integral component of membrane,integral component of plasma membrane,intracellular signal transduction,kinetochore,L-Glutamate,L-glutamate transport,L-Glutamine,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane raft,memory,mitochondria,mitochondrial inner membrane,mitochondrial transport,mitochondrion,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of apoptotic signaling pathway,negative regulation of axonogenesis,negative regulation of epidermal growth factor-activated receptor activity,negative regulation of neuron apoptotic process,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,negative regulation of transcription from RNA polymerase II promoter,negative regulation of ubiquitin-protein transferase activity,neurodegenerative disorder,neuromuscular junction,neuron apoptotic process,neuron development,neuron migration,neuronal cell body,nodules,Notch,Notch receptor processing,Notch signaling pathway,nuclear membrane,nuclear outer membrane,oxidative stress,Parkinson,Parkinson's disease,parkinsonian,PD,PDZ domain binding,perinuclear region of cytoplasm,Phosphoprotein,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of MAP kinase activity,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of receptor recycling,post-embryonic development,Presenilin-1,Presenilin-1 CTF subunit,Presenilin-1 CTF12,Presenilin-1 NTF subunit,Progressive non-fluent aphasia,Protease,protein glycosylation,protein processing,Protein S182,protein transport,PS-1,PS1,PS1-CTF12,PSEN1,PSN1,PSNL1,regulation of phosphorylation,regulation of protein binding,regulation of resting membrane potential,regulation of synaptic plasticity,regulation of synaptic transmission,response to oxidative stress,ROS,rough endoplasmic reticulum,scars,Semantic dementia,single organismal cell-cell adhesion,sinus,skeletal system morphogenesis,skin,skin morphogenesis,smooth endoplasmic reticulum,smooth endoplasmic reticulum calcium ion homeostasis,somitogenesis,synaptic vesicle targeting,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63751037",
        "SNP Name": "PSEN1 Met135Val",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "3,Acne inversa familial,ACNINV3,activation of MAPKK activity,AD,AD3,Alzheimer,Alzheimer's disease,amyloid,anagen,aphasia,apical plasma membrane,apoptosis,APP,aspartic-type endopeptidase activity,autophagic vacuole assembly,axon,beta-amyloid formation,beta-amyloid metabolic process,beta-amyloid precursor protein,beta-catenin,beta-catenin binding,blood vessel development,brain morphogenesis,cadherin binding,Cajal-Retzius cell differentiation,calcium channel activity,calcium influx,calcium ion transmembrane transport,canonical Wnt signaling pathway,cardio,Cardiomyopathy,cardiovascular,Cell adhesion,cell cortex,cell fate specification,cell surface,cellular response to DNA damage stimulus,centrosome,cerebral cortex cell migration,choline,choline transport,ciliary rootlet,CMD1U,CVD,cytoplasmic vesicle,dementia,dendritic shaft,dilated 1U,dorsal/ventral neural tube patterning,draining sinuses,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,epithelial cell proliferation,extracellular matrix disassembly,extracellular matrix organization,familial dilated cardiomyopathy,frontotemporal,Frontotemporal dementia,frontotemporal lobar degeneration,FTD,gamma-secretase complex,glutamatergic,Golgi apparatus,growth cone,hair,hair follicles,heart,heart disease,heart looping,hematopoietic progenitor cell differentiation,Hidradenitis suppurativa,Hydrolase,immune system,inflammation,integral component of membrane,integral component of plasma membrane,intracellular signal transduction,kinetochore,L-Glutamate,L-glutamate transport,L-Glutamine,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane raft,memory,mitochondria,mitochondrial inner membrane,mitochondrial transport,mitochondrion,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of apoptotic signaling pathway,negative regulation of axonogenesis,negative regulation of epidermal growth factor-activated receptor activity,negative regulation of neuron apoptotic process,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,negative regulation of transcription from RNA polymerase II promoter,negative regulation of ubiquitin-protein transferase activity,neurodegenerative disorder,neuromuscular junction,neuron apoptotic process,neuron development,neuron migration,neuronal cell body,nodules,Notch,Notch receptor processing,Notch signaling pathway,nuclear membrane,nuclear outer membrane,oxidative stress,Parkinson,Parkinson's disease,parkinsonian,PD,PDZ domain binding,perinuclear region of cytoplasm,Phosphoprotein,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of MAP kinase activity,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of receptor recycling,post-embryonic development,Presenilin-1,Presenilin-1 CTF subunit,Presenilin-1 CTF12,Presenilin-1 NTF subunit,Progressive non-fluent aphasia,Protease,protein glycosylation,protein processing,Protein S182,protein transport,PS-1,PS1,PS1-CTF12,PSEN1,PSN1,PSNL1,regulation of phosphorylation,regulation of protein binding,regulation of resting membrane potential,regulation of synaptic plasticity,regulation of synaptic transmission,response to oxidative stress,ROS,rough endoplasmic reticulum,scars,Semantic dementia,single organismal cell-cell adhesion,sinus,skeletal system morphogenesis,skin,skin morphogenesis,smooth endoplasmic reticulum,smooth endoplasmic reticulum calcium ion homeostasis,somitogenesis,synaptic vesicle targeting,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63749885",
        "SNP Name": "PSEN2 His159Tyr",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,AD3LP,AD4,AD5,Alzheimer,Alzheimer disease 4,Alzheimer's disease,amino acids,amyloid precursor protein catabolic process,amyloid-beta-APP 40-42 peptide,Amyloidosis,anagen,apoptosis,apoptotic signaling pathway,APP,arrhythmia,asparagine,aspartic-type endopeptidase activity,axon,beta-amyloid metabolic process,beta-amyloid precursor protein,brain morphogenesis,calcium ion transport,cardiac muscle contraction,cardio,cardiomyopathy,Cardiomyopathy dilated 1V,cardiovascular,cell cortex,cell fate specification,cell surface,centrosome,ciliary basal body,ciliary rootlet dendritic shaft,CMD1V,cognition,CTFs,CVD,cytosol,cytotoxic C-terminal fragments,dementia,dilated,Disease mutation,dorsal/ventral neural tube patterning,E5-1,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,extracellular amyloid plaques,fibrillar amyloid,forebrain development,gamma-secretase complex,Golgi apparatus,growth cone,heart,heart disease,heart failure,hematopoietic progenitor cell differentiation,Hydrolase,integral component of plasma membrane,intracellular signal transduction,isoleucine,kinetochore,L-Methionine,L-Valine,locomotion,lung alveolus development,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane protein intracellular domain proteolysis,membrane raft,memory,methionine,mitochondrial inner membrane,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of protein binding,negative regulation of protein complex assembly,negative regulation of protein phosphorylation,Neurodegeneration,neurodegenerative disorder,neurofibrillary tangles,neuromuscular junction,neuronal cell body,neurotoxic,neurotrophin TRK receptor signaling pathway,Notch receptor processing,Notch receptors,Notch signaling pathway,Notch signaling pathway apical plasma membrane,nuclear inner membrane,peptide,perinuclear region of cytoplasm,plaque,plasma membrane,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,Presenilin-2,Presenilin-2 CTF subunit,Presenilin-2 NTF subunit,progressive dementia,Protease,protein complex,protein processing,protein transport,PS-2,PS2,PSEN2,PSNL2,regulation of epidermal growth factor-activated receptor activity,regulation of synaptic plasticity,response to hypoxia,somitogenesis,STM-2,STM2,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,toxic,valine,vascular amyloid deposits,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63750590",
        "SNP Name": "PSEN1 His159Arg",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "3,Acne inversa familial,ACNINV3,activation of MAPKK activity,AD,AD3,Alzheimer,Alzheimer's disease,amyloid,anagen,aphasia,apical plasma membrane,apoptosis,APP,aspartic-type endopeptidase activity,autophagic vacuole assembly,axon,beta-amyloid formation,beta-amyloid metabolic process,beta-amyloid precursor protein,beta-catenin,beta-catenin binding,blood vessel development,brain morphogenesis,cadherin binding,Cajal-Retzius cell differentiation,calcium channel activity,calcium influx,calcium ion transmembrane transport,canonical Wnt signaling pathway,cardio,Cardiomyopathy,cardiovascular,Cell adhesion,cell cortex,cell fate specification,cell surface,cellular response to DNA damage stimulus,centrosome,cerebral cortex cell migration,choline,choline transport,ciliary rootlet,CMD1U,CVD,cytoplasmic vesicle,dementia,dendritic shaft,dilated 1U,dorsal/ventral neural tube patterning,draining sinuses,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,epithelial cell proliferation,extracellular matrix disassembly,extracellular matrix organization,familial dilated cardiomyopathy,frontotemporal,Frontotemporal dementia,frontotemporal lobar degeneration,FTD,gamma-secretase complex,glutamatergic,Golgi apparatus,growth cone,hair,hair follicles,heart,heart disease,heart looping,hematopoietic progenitor cell differentiation,Hidradenitis suppurativa,Hydrolase,immune system,inflammation,integral component of membrane,integral component of plasma membrane,intracellular signal transduction,kinetochore,L-Glutamate,L-glutamate transport,L-Glutamine,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane raft,memory,mitochondria,mitochondrial inner membrane,mitochondrial transport,mitochondrion,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of apoptotic signaling pathway,negative regulation of axonogenesis,negative regulation of epidermal growth factor-activated receptor activity,negative regulation of neuron apoptotic process,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,negative regulation of transcription from RNA polymerase II promoter,negative regulation of ubiquitin-protein transferase activity,neurodegenerative disorder,neuromuscular junction,neuron apoptotic process,neuron development,neuron migration,neuronal cell body,nodules,Notch,Notch receptor processing,Notch signaling pathway,nuclear membrane,nuclear outer membrane,oxidative stress,Parkinson,Parkinson's disease,parkinsonian,PD,PDZ domain binding,perinuclear region of cytoplasm,Phosphoprotein,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of MAP kinase activity,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of receptor recycling,post-embryonic development,Presenilin-1,Presenilin-1 CTF subunit,Presenilin-1 CTF12,Presenilin-1 NTF subunit,Progressive non-fluent aphasia,Protease,protein glycosylation,protein processing,Protein S182,protein transport,PS-1,PS1,PS1-CTF12,PSEN1,PSN1,PSNL1,regulation of phosphorylation,regulation of protein binding,regulation of resting membrane potential,regulation of synaptic plasticity,regulation of synaptic transmission,response to oxidative stress,ROS,rough endoplasmic reticulum,scars,Semantic dementia,single organismal cell-cell adhesion,sinus,skeletal system morphogenesis,skin,skin morphogenesis,smooth endoplasmic reticulum,smooth endoplasmic reticulum calcium ion homeostasis,somitogenesis,synaptic vesicle targeting,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63750577",
        "SNP Name": "PSEN1 Ser166Phe",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "3,Acne inversa familial,ACNINV3,activation of MAPKK activity,AD,AD3,Alzheimer,Alzheimer's disease,amyloid,anagen,aphasia,apical plasma membrane,apoptosis,APP,aspartic-type endopeptidase activity,autophagic vacuole assembly,axon,beta-amyloid formation,beta-amyloid metabolic process,beta-amyloid precursor protein,beta-catenin,beta-catenin binding,blood vessel development,brain morphogenesis,cadherin binding,Cajal-Retzius cell differentiation,calcium channel activity,calcium influx,calcium ion transmembrane transport,canonical Wnt signaling pathway,cardio,Cardiomyopathy,cardiovascular,Cell adhesion,cell cortex,cell fate specification,cell surface,cellular response to DNA damage stimulus,centrosome,cerebral cortex cell migration,choline,choline transport,ciliary rootlet,CMD1U,CVD,cytoplasmic vesicle,dementia,dendritic shaft,dilated 1U,dorsal/ventral neural tube patterning,draining sinuses,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,epithelial cell proliferation,extracellular matrix disassembly,extracellular matrix organization,familial dilated cardiomyopathy,frontotemporal,Frontotemporal dementia,frontotemporal lobar degeneration,FTD,gamma-secretase complex,glutamatergic,Golgi apparatus,growth cone,hair,hair follicles,heart,heart disease,heart looping,hematopoietic progenitor cell differentiation,Hidradenitis suppurativa,Hydrolase,immune system,inflammation,integral component of membrane,integral component of plasma membrane,intracellular signal transduction,kinetochore,L-Glutamate,L-glutamate transport,L-Glutamine,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane raft,memory,mitochondria,mitochondrial inner membrane,mitochondrial transport,mitochondrion,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of apoptotic signaling pathway,negative regulation of axonogenesis,negative regulation of epidermal growth factor-activated receptor activity,negative regulation of neuron apoptotic process,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,negative regulation of transcription from RNA polymerase II promoter,negative regulation of ubiquitin-protein transferase activity,neurodegenerative disorder,neuromuscular junction,neuron apoptotic process,neuron development,neuron migration,neuronal cell body,nodules,Notch,Notch receptor processing,Notch signaling pathway,nuclear membrane,nuclear outer membrane,oxidative stress,Parkinson,Parkinson's disease,parkinsonian,PD,PDZ domain binding,perinuclear region of cytoplasm,Phosphoprotein,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of MAP kinase activity,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of receptor recycling,post-embryonic development,Presenilin-1,Presenilin-1 CTF subunit,Presenilin-1 CTF12,Presenilin-1 NTF subunit,Progressive non-fluent aphasia,Protease,protein glycosylation,protein processing,Protein S182,protein transport,PS-1,PS1,PS1-CTF12,PSEN1,PSN1,PSNL1,regulation of phosphorylation,regulation of protein binding,regulation of resting membrane potential,regulation of synaptic plasticity,regulation of synaptic transmission,response to oxidative stress,ROS,rough endoplasmic reticulum,scars,Semantic dementia,single organismal cell-cell adhesion,sinus,skeletal system morphogenesis,skin,skin morphogenesis,smooth endoplasmic reticulum,smooth endoplasmic reticulum calcium ion homeostasis,somitogenesis,synaptic vesicle targeting,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63751144",
        "SNP Name": "PSEN1 Leu170Met",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "3,Acne inversa familial,ACNINV3,activation of MAPKK activity,AD,AD3,Alzheimer,Alzheimer's disease,amyloid,anagen,aphasia,apical plasma membrane,apoptosis,APP,aspartic-type endopeptidase activity,autophagic vacuole assembly,axon,beta-amyloid formation,beta-amyloid metabolic process,beta-amyloid precursor protein,beta-catenin,beta-catenin binding,blood vessel development,brain morphogenesis,cadherin binding,Cajal-Retzius cell differentiation,calcium channel activity,calcium influx,calcium ion transmembrane transport,canonical Wnt signaling pathway,cardio,Cardiomyopathy,cardiovascular,Cell adhesion,cell cortex,cell fate specification,cell surface,cellular response to DNA damage stimulus,centrosome,cerebral cortex cell migration,choline,choline transport,ciliary rootlet,CMD1U,CVD,cytoplasmic vesicle,dementia,dendritic shaft,dilated 1U,dorsal/ventral neural tube patterning,draining sinuses,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,epithelial cell proliferation,extracellular matrix disassembly,extracellular matrix organization,familial dilated cardiomyopathy,frontotemporal,Frontotemporal dementia,frontotemporal lobar degeneration,FTD,gamma-secretase complex,glutamatergic,Golgi apparatus,growth cone,hair,hair follicles,heart,heart disease,heart looping,hematopoietic progenitor cell differentiation,Hidradenitis suppurativa,Hydrolase,immune system,inflammation,integral component of membrane,integral component of plasma membrane,intracellular signal transduction,kinetochore,L-Glutamate,L-glutamate transport,L-Glutamine,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane raft,memory,mitochondria,mitochondrial inner membrane,mitochondrial transport,mitochondrion,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of apoptotic signaling pathway,negative regulation of axonogenesis,negative regulation of epidermal growth factor-activated receptor activity,negative regulation of neuron apoptotic process,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,negative regulation of transcription from RNA polymerase II promoter,negative regulation of ubiquitin-protein transferase activity,neurodegenerative disorder,neuromuscular junction,neuron apoptotic process,neuron development,neuron migration,neuronal cell body,nodules,Notch,Notch receptor processing,Notch signaling pathway,nuclear membrane,nuclear outer membrane,oxidative stress,Parkinson,Parkinson's disease,parkinsonian,PD,PDZ domain binding,perinuclear region of cytoplasm,Phosphoprotein,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of MAP kinase activity,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of receptor recycling,post-embryonic development,Presenilin-1,Presenilin-1 CTF subunit,Presenilin-1 CTF12,Presenilin-1 NTF subunit,Progressive non-fluent aphasia,Protease,protein glycosylation,protein processing,Protein S182,protein transport,PS-1,PS1,PS1-CTF12,PSEN1,PSN1,PSNL1,regulation of phosphorylation,regulation of protein binding,regulation of resting membrane potential,regulation of synaptic plasticity,regulation of synaptic transmission,response to oxidative stress,ROS,rough endoplasmic reticulum,scars,Semantic dementia,single organismal cell-cell adhesion,sinus,skeletal system morphogenesis,skin,skin morphogenesis,smooth endoplasmic reticulum,smooth endoplasmic reticulum calcium ion homeostasis,somitogenesis,synaptic vesicle targeting,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63751068",
        "SNP Name": "PSEN1 Gly179Val",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "3,Acne inversa familial,ACNINV3,activation of MAPKK activity,AD,AD3,Alzheimer,Alzheimer's disease,amyloid,anagen,aphasia,apical plasma membrane,apoptosis,APP,aspartic-type endopeptidase activity,autophagic vacuole assembly,axon,beta-amyloid formation,beta-amyloid metabolic process,beta-amyloid precursor protein,beta-catenin,beta-catenin binding,blood vessel development,brain morphogenesis,cadherin binding,Cajal-Retzius cell differentiation,calcium channel activity,calcium influx,calcium ion transmembrane transport,canonical Wnt signaling pathway,cardio,Cardiomyopathy,cardiovascular,Cell adhesion,cell cortex,cell fate specification,cell surface,cellular response to DNA damage stimulus,centrosome,cerebral cortex cell migration,choline,choline transport,ciliary rootlet,CMD1U,CVD,cytoplasmic vesicle,dementia,dendritic shaft,dilated 1U,dorsal/ventral neural tube patterning,draining sinuses,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,epithelial cell proliferation,extracellular matrix disassembly,extracellular matrix organization,familial dilated cardiomyopathy,frontotemporal,Frontotemporal dementia,frontotemporal lobar degeneration,FTD,gamma-secretase complex,glutamatergic,Golgi apparatus,growth cone,hair,hair follicles,heart,heart disease,heart looping,hematopoietic progenitor cell differentiation,Hidradenitis suppurativa,Hydrolase,immune system,inflammation,integral component of membrane,integral component of plasma membrane,intracellular signal transduction,kinetochore,L-Glutamate,L-glutamate transport,L-Glutamine,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane raft,memory,mitochondria,mitochondrial inner membrane,mitochondrial transport,mitochondrion,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of apoptotic signaling pathway,negative regulation of axonogenesis,negative regulation of epidermal growth factor-activated receptor activity,negative regulation of neuron apoptotic process,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,negative regulation of transcription from RNA polymerase II promoter,negative regulation of ubiquitin-protein transferase activity,neurodegenerative disorder,neuromuscular junction,neuron apoptotic process,neuron development,neuron migration,neuronal cell body,nodules,Notch,Notch receptor processing,Notch signaling pathway,nuclear membrane,nuclear outer membrane,oxidative stress,Parkinson,Parkinson's disease,parkinsonian,PD,PDZ domain binding,perinuclear region of cytoplasm,Phosphoprotein,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of MAP kinase activity,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of receptor recycling,post-embryonic development,Presenilin-1,Presenilin-1 CTF subunit,Presenilin-1 CTF12,Presenilin-1 NTF subunit,Progressive non-fluent aphasia,Protease,protein glycosylation,protein processing,Protein S182,protein transport,PS-1,PS1,PS1-CTF12,PSEN1,PSN1,PSNL1,regulation of phosphorylation,regulation of protein binding,regulation of resting membrane potential,regulation of synaptic plasticity,regulation of synaptic transmission,response to oxidative stress,ROS,rough endoplasmic reticulum,scars,Semantic dementia,single organismal cell-cell adhesion,sinus,skeletal system morphogenesis,skin,skin morphogenesis,smooth endoplasmic reticulum,smooth endoplasmic reticulum calcium ion homeostasis,somitogenesis,synaptic vesicle targeting,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63750526",
        "SNP Name": "PSEN1 Ala242Glu",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "3,Acne inversa familial,ACNINV3,activation of MAPKK activity,AD,AD3,Alzheimer,Alzheimer's disease,amyloid,anagen,aphasia,apical plasma membrane,apoptosis,APP,aspartic-type endopeptidase activity,autophagic vacuole assembly,axon,beta-amyloid formation,beta-amyloid metabolic process,beta-amyloid precursor protein,beta-catenin,beta-catenin binding,blood vessel development,brain morphogenesis,cadherin binding,Cajal-Retzius cell differentiation,calcium channel activity,calcium influx,calcium ion transmembrane transport,canonical Wnt signaling pathway,cardio,Cardiomyopathy,cardiovascular,Cell adhesion,cell cortex,cell fate specification,cell surface,cellular response to DNA damage stimulus,centrosome,cerebral cortex cell migration,choline,choline transport,ciliary rootlet,CMD1U,CVD,cytoplasmic vesicle,dementia,dendritic shaft,dilated 1U,dorsal/ventral neural tube patterning,draining sinuses,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,epithelial cell proliferation,extracellular matrix disassembly,extracellular matrix organization,familial dilated cardiomyopathy,frontotemporal,Frontotemporal dementia,frontotemporal lobar degeneration,FTD,gamma-secretase complex,glutamatergic,Golgi apparatus,growth cone,hair,hair follicles,heart,heart disease,heart looping,hematopoietic progenitor cell differentiation,Hidradenitis suppurativa,Hydrolase,immune system,inflammation,integral component of membrane,integral component of plasma membrane,intracellular signal transduction,kinetochore,L-Glutamate,L-glutamate transport,L-Glutamine,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane raft,memory,mitochondria,mitochondrial inner membrane,mitochondrial transport,mitochondrion,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of apoptotic signaling pathway,negative regulation of axonogenesis,negative regulation of epidermal growth factor-activated receptor activity,negative regulation of neuron apoptotic process,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,negative regulation of transcription from RNA polymerase II promoter,negative regulation of ubiquitin-protein transferase activity,neurodegenerative disorder,neuromuscular junction,neuron apoptotic process,neuron development,neuron migration,neuronal cell body,nodules,Notch,Notch receptor processing,Notch signaling pathway,nuclear membrane,nuclear outer membrane,oxidative stress,Parkinson,Parkinson's disease,parkinsonian,PD,PDZ domain binding,perinuclear region of cytoplasm,Phosphoprotein,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of MAP kinase activity,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of receptor recycling,post-embryonic development,Presenilin-1,Presenilin-1 CTF subunit,Presenilin-1 CTF12,Presenilin-1 NTF subunit,Progressive non-fluent aphasia,Protease,protein glycosylation,protein processing,Protein S182,protein transport,PS-1,PS1,PS1-CTF12,PSEN1,PSN1,PSNL1,regulation of phosphorylation,regulation of protein binding,regulation of resting membrane potential,regulation of synaptic plasticity,regulation of synaptic transmission,response to oxidative stress,ROS,rough endoplasmic reticulum,scars,Semantic dementia,single organismal cell-cell adhesion,sinus,skeletal system morphogenesis,skin,skin morphogenesis,smooth endoplasmic reticulum,smooth endoplasmic reticulum calcium ion homeostasis,somitogenesis,synaptic vesicle targeting,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63751163",
        "SNP Name": "PSEN1 Leu246Ser",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "3,Acne inversa familial,ACNINV3,activation of MAPKK activity,AD,AD3,Alzheimer,Alzheimer's disease,amyloid,anagen,aphasia,apical plasma membrane,apoptosis,APP,aspartic-type endopeptidase activity,autophagic vacuole assembly,axon,beta-amyloid formation,beta-amyloid metabolic process,beta-amyloid precursor protein,beta-catenin,beta-catenin binding,blood vessel development,brain morphogenesis,cadherin binding,Cajal-Retzius cell differentiation,calcium channel activity,calcium influx,calcium ion transmembrane transport,canonical Wnt signaling pathway,cardio,Cardiomyopathy,cardiovascular,Cell adhesion,cell cortex,cell fate specification,cell surface,cellular response to DNA damage stimulus,centrosome,cerebral cortex cell migration,choline,choline transport,ciliary rootlet,CMD1U,CVD,cytoplasmic vesicle,dementia,dendritic shaft,dilated 1U,dorsal/ventral neural tube patterning,draining sinuses,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,epithelial cell proliferation,extracellular matrix disassembly,extracellular matrix organization,familial dilated cardiomyopathy,frontotemporal,Frontotemporal dementia,frontotemporal lobar degeneration,FTD,gamma-secretase complex,glutamatergic,Golgi apparatus,growth cone,hair,hair follicles,heart,heart disease,heart looping,hematopoietic progenitor cell differentiation,Hidradenitis suppurativa,Hydrolase,immune system,inflammation,integral component of membrane,integral component of plasma membrane,intracellular signal transduction,kinetochore,L-Glutamate,L-glutamate transport,L-Glutamine,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane raft,memory,mitochondria,mitochondrial inner membrane,mitochondrial transport,mitochondrion,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of apoptotic signaling pathway,negative regulation of axonogenesis,negative regulation of epidermal growth factor-activated receptor activity,negative regulation of neuron apoptotic process,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,negative regulation of transcription from RNA polymerase II promoter,negative regulation of ubiquitin-protein transferase activity,neurodegenerative disorder,neuromuscular junction,neuron apoptotic process,neuron development,neuron migration,neuronal cell body,nodules,Notch,Notch receptor processing,Notch signaling pathway,nuclear membrane,nuclear outer membrane,oxidative stress,Parkinson,Parkinson's disease,parkinsonian,PD,PDZ domain binding,perinuclear region of cytoplasm,Phosphoprotein,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of MAP kinase activity,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of receptor recycling,post-embryonic development,Presenilin-1,Presenilin-1 CTF subunit,Presenilin-1 CTF12,Presenilin-1 NTF subunit,Progressive non-fluent aphasia,Protease,protein glycosylation,protein processing,Protein S182,protein transport,PS-1,PS1,PS1-CTF12,PSEN1,PSN1,PSNL1,regulation of phosphorylation,regulation of protein binding,regulation of resting membrane potential,regulation of synaptic plasticity,regulation of synaptic transmission,response to oxidative stress,ROS,rough endoplasmic reticulum,scars,Semantic dementia,single organismal cell-cell adhesion,sinus,skeletal system morphogenesis,skin,skin morphogenesis,smooth endoplasmic reticulum,smooth endoplasmic reticulum calcium ion homeostasis,somitogenesis,synaptic vesicle targeting,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63751320",
        "SNP Name": "PSEN1 Tyr252Ser",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "3,Acne inversa familial,ACNINV3,activation of MAPKK activity,AD,AD3,Alzheimer,Alzheimer's disease,amyloid,anagen,aphasia,apical plasma membrane,apoptosis,APP,aspartic-type endopeptidase activity,autophagic vacuole assembly,axon,beta-amyloid formation,beta-amyloid metabolic process,beta-amyloid precursor protein,beta-catenin,beta-catenin binding,blood vessel development,brain morphogenesis,cadherin binding,Cajal-Retzius cell differentiation,calcium channel activity,calcium influx,calcium ion transmembrane transport,canonical Wnt signaling pathway,cardio,Cardiomyopathy,cardiovascular,Cell adhesion,cell cortex,cell fate specification,cell surface,cellular response to DNA damage stimulus,centrosome,cerebral cortex cell migration,choline,choline transport,ciliary rootlet,CMD1U,CVD,cytoplasmic vesicle,dementia,dendritic shaft,dilated 1U,dorsal/ventral neural tube patterning,draining sinuses,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,epithelial cell proliferation,extracellular matrix disassembly,extracellular matrix organization,familial dilated cardiomyopathy,frontotemporal,Frontotemporal dementia,frontotemporal lobar degeneration,FTD,gamma-secretase complex,glutamatergic,Golgi apparatus,growth cone,hair,hair follicles,heart,heart disease,heart looping,hematopoietic progenitor cell differentiation,Hidradenitis suppurativa,Hydrolase,immune system,inflammation,integral component of membrane,integral component of plasma membrane,intracellular signal transduction,kinetochore,L-Glutamate,L-glutamate transport,L-Glutamine,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane raft,memory,mitochondria,mitochondrial inner membrane,mitochondrial transport,mitochondrion,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of apoptotic signaling pathway,negative regulation of axonogenesis,negative regulation of epidermal growth factor-activated receptor activity,negative regulation of neuron apoptotic process,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,negative regulation of transcription from RNA polymerase II promoter,negative regulation of ubiquitin-protein transferase activity,neurodegenerative disorder,neuromuscular junction,neuron apoptotic process,neuron development,neuron migration,neuronal cell body,nodules,Notch,Notch receptor processing,Notch signaling pathway,nuclear membrane,nuclear outer membrane,oxidative stress,Parkinson,Parkinson's disease,parkinsonian,PD,PDZ domain binding,perinuclear region of cytoplasm,Phosphoprotein,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of MAP kinase activity,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of receptor recycling,post-embryonic development,Presenilin-1,Presenilin-1 CTF subunit,Presenilin-1 CTF12,Presenilin-1 NTF subunit,Progressive non-fluent aphasia,Protease,protein glycosylation,protein processing,Protein S182,protein transport,PS-1,PS1,PS1-CTF12,PSEN1,PSN1,PSNL1,regulation of phosphorylation,regulation of protein binding,regulation of resting membrane potential,regulation of synaptic plasticity,regulation of synaptic transmission,response to oxidative stress,ROS,rough endoplasmic reticulum,scars,Semantic dementia,single organismal cell-cell adhesion,sinus,skeletal system morphogenesis,skin,skin morphogenesis,smooth endoplasmic reticulum,smooth endoplasmic reticulum calcium ion homeostasis,somitogenesis,synaptic vesicle targeting,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63751229",
        "SNP Name": "PSEN1 Pro263Ser",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "3,Acne inversa familial,ACNINV3,activation of MAPKK activity,AD,AD3,Alzheimer,Alzheimer's disease,amyloid,anagen,aphasia,apical plasma membrane,apoptosis,APP,aspartic-type endopeptidase activity,autophagic vacuole assembly,axon,beta-amyloid formation,beta-amyloid metabolic process,beta-amyloid precursor protein,beta-catenin,beta-catenin binding,blood vessel development,brain morphogenesis,cadherin binding,Cajal-Retzius cell differentiation,calcium channel activity,calcium influx,calcium ion transmembrane transport,canonical Wnt signaling pathway,cardio,Cardiomyopathy,cardiovascular,Cell adhesion,cell cortex,cell fate specification,cell surface,cellular response to DNA damage stimulus,centrosome,cerebral cortex cell migration,choline,choline transport,ciliary rootlet,CMD1U,CVD,cytoplasmic vesicle,dementia,dendritic shaft,dilated 1U,dorsal/ventral neural tube patterning,draining sinuses,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,epithelial cell proliferation,extracellular matrix disassembly,extracellular matrix organization,familial dilated cardiomyopathy,frontotemporal,Frontotemporal dementia,frontotemporal lobar degeneration,FTD,gamma-secretase complex,glutamatergic,Golgi apparatus,growth cone,hair,hair follicles,heart,heart disease,heart looping,hematopoietic progenitor cell differentiation,Hidradenitis suppurativa,Hydrolase,immune system,inflammation,integral component of membrane,integral component of plasma membrane,intracellular signal transduction,kinetochore,L-Glutamate,L-glutamate transport,L-Glutamine,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane raft,memory,mitochondria,mitochondrial inner membrane,mitochondrial transport,mitochondrion,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of apoptotic signaling pathway,negative regulation of axonogenesis,negative regulation of epidermal growth factor-activated receptor activity,negative regulation of neuron apoptotic process,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,negative regulation of transcription from RNA polymerase II promoter,negative regulation of ubiquitin-protein transferase activity,neurodegenerative disorder,neuromuscular junction,neuron apoptotic process,neuron development,neuron migration,neuronal cell body,nodules,Notch,Notch receptor processing,Notch signaling pathway,nuclear membrane,nuclear outer membrane,oxidative stress,Parkinson,Parkinson's disease,parkinsonian,PD,PDZ domain binding,perinuclear region of cytoplasm,Phosphoprotein,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of MAP kinase activity,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of receptor recycling,post-embryonic development,Presenilin-1,Presenilin-1 CTF subunit,Presenilin-1 CTF12,Presenilin-1 NTF subunit,Progressive non-fluent aphasia,Protease,protein glycosylation,protein processing,Protein S182,protein transport,PS-1,PS1,PS1-CTF12,PSEN1,PSN1,PSNL1,regulation of phosphorylation,regulation of protein binding,regulation of resting membrane potential,regulation of synaptic plasticity,regulation of synaptic transmission,response to oxidative stress,ROS,rough endoplasmic reticulum,scars,Semantic dementia,single organismal cell-cell adhesion,sinus,skeletal system morphogenesis,skin,skin morphogenesis,smooth endoplasmic reticulum,smooth endoplasmic reticulum calcium ion homeostasis,somitogenesis,synaptic vesicle targeting,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63750900",
        "SNP Name": "PSEN1 Arg265His",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "3,Acne inversa familial,ACNINV3,activation of MAPKK activity,AD,AD3,Alzheimer,Alzheimer's disease,amyloid,anagen,aphasia,apical plasma membrane,apoptosis,APP,aspartic-type endopeptidase activity,autophagic vacuole assembly,axon,beta-amyloid formation,beta-amyloid metabolic process,beta-amyloid precursor protein,beta-catenin,beta-catenin binding,blood vessel development,brain morphogenesis,cadherin binding,Cajal-Retzius cell differentiation,calcium channel activity,calcium influx,calcium ion transmembrane transport,canonical Wnt signaling pathway,cardio,Cardiomyopathy,cardiovascular,Cell adhesion,cell cortex,cell fate specification,cell surface,cellular response to DNA damage stimulus,centrosome,cerebral cortex cell migration,choline,choline transport,ciliary rootlet,CMD1U,CVD,cytoplasmic vesicle,dementia,dendritic shaft,dilated 1U,dorsal/ventral neural tube patterning,draining sinuses,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,epithelial cell proliferation,extracellular matrix disassembly,extracellular matrix organization,familial dilated cardiomyopathy,frontotemporal,Frontotemporal dementia,frontotemporal lobar degeneration,FTD,gamma-secretase complex,glutamatergic,Golgi apparatus,growth cone,hair,hair follicles,heart,heart disease,heart looping,hematopoietic progenitor cell differentiation,Hidradenitis suppurativa,Hydrolase,immune system,inflammation,integral component of membrane,integral component of plasma membrane,intracellular signal transduction,kinetochore,L-Glutamate,L-glutamate transport,L-Glutamine,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane raft,memory,mitochondria,mitochondrial inner membrane,mitochondrial transport,mitochondrion,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of apoptotic signaling pathway,negative regulation of axonogenesis,negative regulation of epidermal growth factor-activated receptor activity,negative regulation of neuron apoptotic process,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,negative regulation of transcription from RNA polymerase II promoter,negative regulation of ubiquitin-protein transferase activity,neurodegenerative disorder,neuromuscular junction,neuron apoptotic process,neuron development,neuron migration,neuronal cell body,nodules,Notch,Notch receptor processing,Notch signaling pathway,nuclear membrane,nuclear outer membrane,oxidative stress,Parkinson,Parkinson's disease,parkinsonian,PD,PDZ domain binding,perinuclear region of cytoplasm,Phosphoprotein,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of MAP kinase activity,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of receptor recycling,post-embryonic development,Presenilin-1,Presenilin-1 CTF subunit,Presenilin-1 CTF12,Presenilin-1 NTF subunit,Progressive non-fluent aphasia,Protease,protein glycosylation,protein processing,Protein S182,protein transport,PS-1,PS1,PS1-CTF12,PSEN1,PSN1,PSNL1,regulation of phosphorylation,regulation of protein binding,regulation of resting membrane potential,regulation of synaptic plasticity,regulation of synaptic transmission,response to oxidative stress,ROS,rough endoplasmic reticulum,scars,Semantic dementia,single organismal cell-cell adhesion,sinus,skeletal system morphogenesis,skin,skin morphogenesis,smooth endoplasmic reticulum,smooth endoplasmic reticulum calcium ion homeostasis,somitogenesis,synaptic vesicle targeting,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63750886",
        "SNP Name": "PSEN1 Leu267Val",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "3,Acne inversa familial,ACNINV3,activation of MAPKK activity,AD,AD3,Alzheimer,Alzheimer's disease,amyloid,anagen,aphasia,apical plasma membrane,apoptosis,APP,aspartic-type endopeptidase activity,autophagic vacuole assembly,axon,beta-amyloid formation,beta-amyloid metabolic process,beta-amyloid precursor protein,beta-catenin,beta-catenin binding,blood vessel development,brain morphogenesis,cadherin binding,Cajal-Retzius cell differentiation,calcium channel activity,calcium influx,calcium ion transmembrane transport,canonical Wnt signaling pathway,cardio,Cardiomyopathy,cardiovascular,Cell adhesion,cell cortex,cell fate specification,cell surface,cellular response to DNA damage stimulus,centrosome,cerebral cortex cell migration,choline,choline transport,ciliary rootlet,CMD1U,CVD,cytoplasmic vesicle,dementia,dendritic shaft,dilated 1U,dorsal/ventral neural tube patterning,draining sinuses,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,epithelial cell proliferation,extracellular matrix disassembly,extracellular matrix organization,familial dilated cardiomyopathy,frontotemporal,Frontotemporal dementia,frontotemporal lobar degeneration,FTD,gamma-secretase complex,glutamatergic,Golgi apparatus,growth cone,hair,hair follicles,heart,heart disease,heart looping,hematopoietic progenitor cell differentiation,Hidradenitis suppurativa,Hydrolase,immune system,inflammation,integral component of membrane,integral component of plasma membrane,intracellular signal transduction,kinetochore,L-Glutamate,L-glutamate transport,L-Glutamine,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane raft,memory,mitochondria,mitochondrial inner membrane,mitochondrial transport,mitochondrion,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of apoptotic signaling pathway,negative regulation of axonogenesis,negative regulation of epidermal growth factor-activated receptor activity,negative regulation of neuron apoptotic process,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,negative regulation of transcription from RNA polymerase II promoter,negative regulation of ubiquitin-protein transferase activity,neurodegenerative disorder,neuromuscular junction,neuron apoptotic process,neuron development,neuron migration,neuronal cell body,nodules,Notch,Notch receptor processing,Notch signaling pathway,nuclear membrane,nuclear outer membrane,oxidative stress,Parkinson,Parkinson's disease,parkinsonian,PD,PDZ domain binding,perinuclear region of cytoplasm,Phosphoprotein,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of MAP kinase activity,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of receptor recycling,post-embryonic development,Presenilin-1,Presenilin-1 CTF subunit,Presenilin-1 CTF12,Presenilin-1 NTF subunit,Progressive non-fluent aphasia,Protease,protein glycosylation,protein processing,Protein S182,protein transport,PS-1,PS1,PS1-CTF12,PSEN1,PSN1,PSNL1,regulation of phosphorylation,regulation of protein binding,regulation of resting membrane potential,regulation of synaptic plasticity,regulation of synaptic transmission,response to oxidative stress,ROS,rough endoplasmic reticulum,scars,Semantic dementia,single organismal cell-cell adhesion,sinus,skeletal system morphogenesis,skin,skin morphogenesis,smooth endoplasmic reticulum,smooth endoplasmic reticulum calcium ion homeostasis,somitogenesis,synaptic vesicle targeting,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63751235",
        "SNP Name": "PSEN1 Leu282Val",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "3,Acne inversa familial,ACNINV3,activation of MAPKK activity,AD,AD3,Alzheimer,Alzheimer's disease,amyloid,anagen,aphasia,apical plasma membrane,apoptosis,APP,aspartic-type endopeptidase activity,autophagic vacuole assembly,axon,beta-amyloid formation,beta-amyloid metabolic process,beta-amyloid precursor protein,beta-catenin,beta-catenin binding,blood vessel development,brain morphogenesis,cadherin binding,Cajal-Retzius cell differentiation,calcium channel activity,calcium influx,calcium ion transmembrane transport,canonical Wnt signaling pathway,cardio,Cardiomyopathy,cardiovascular,Cell adhesion,cell cortex,cell fate specification,cell surface,cellular response to DNA damage stimulus,centrosome,cerebral cortex cell migration,choline,choline transport,ciliary rootlet,CMD1U,CVD,cytoplasmic vesicle,dementia,dendritic shaft,dilated 1U,dorsal/ventral neural tube patterning,draining sinuses,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,epithelial cell proliferation,extracellular matrix disassembly,extracellular matrix organization,familial dilated cardiomyopathy,frontotemporal,Frontotemporal dementia,frontotemporal lobar degeneration,FTD,gamma-secretase complex,glutamatergic,Golgi apparatus,growth cone,hair,hair follicles,heart,heart disease,heart looping,hematopoietic progenitor cell differentiation,Hidradenitis suppurativa,Hydrolase,immune system,inflammation,integral component of membrane,integral component of plasma membrane,intracellular signal transduction,kinetochore,L-Glutamate,L-glutamate transport,L-Glutamine,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane raft,memory,mitochondria,mitochondrial inner membrane,mitochondrial transport,mitochondrion,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of apoptotic signaling pathway,negative regulation of axonogenesis,negative regulation of epidermal growth factor-activated receptor activity,negative regulation of neuron apoptotic process,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,negative regulation of transcription from RNA polymerase II promoter,negative regulation of ubiquitin-protein transferase activity,neurodegenerative disorder,neuromuscular junction,neuron apoptotic process,neuron development,neuron migration,neuronal cell body,nodules,Notch,Notch receptor processing,Notch signaling pathway,nuclear membrane,nuclear outer membrane,oxidative stress,Parkinson,Parkinson's disease,parkinsonian,PD,PDZ domain binding,perinuclear region of cytoplasm,Phosphoprotein,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of MAP kinase activity,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of receptor recycling,post-embryonic development,Presenilin-1,Presenilin-1 CTF subunit,Presenilin-1 CTF12,Presenilin-1 NTF subunit,Progressive non-fluent aphasia,Protease,protein glycosylation,protein processing,Protein S182,protein transport,PS-1,PS1,PS1-CTF12,PSEN1,PSN1,PSNL1,regulation of phosphorylation,regulation of protein binding,regulation of resting membrane potential,regulation of synaptic plasticity,regulation of synaptic transmission,response to oxidative stress,ROS,rough endoplasmic reticulum,scars,Semantic dementia,single organismal cell-cell adhesion,sinus,skeletal system morphogenesis,skin,skin morphogenesis,smooth endoplasmic reticulum,smooth endoplasmic reticulum calcium ion homeostasis,somitogenesis,synaptic vesicle targeting,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs17125721",
        "SNP Name": "PSEN1 Glu314Gly",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "3,Acne inversa familial,ACNINV3,activation of MAPKK activity,AD,AD3,Alzheimer,Alzheimer's disease,amyloid,anagen,aphasia,apical plasma membrane,apoptosis,APP,aspartic-type endopeptidase activity,autophagic vacuole assembly,axon,beta-amyloid formation,beta-amyloid metabolic process,beta-amyloid precursor protein,beta-catenin,beta-catenin binding,blood vessel development,brain morphogenesis,cadherin binding,Cajal-Retzius cell differentiation,calcium channel activity,calcium influx,calcium ion transmembrane transport,canonical Wnt signaling pathway,cardio,Cardiomyopathy,cardiovascular,Cell adhesion,cell cortex,cell fate specification,cell surface,cellular response to DNA damage stimulus,centrosome,cerebral cortex cell migration,choline,choline transport,ciliary rootlet,CMD1U,CVD,cytoplasmic vesicle,dementia,dendritic shaft,dilated 1U,dorsal/ventral neural tube patterning,draining sinuses,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,epithelial cell proliferation,extracellular matrix disassembly,extracellular matrix organization,familial dilated cardiomyopathy,frontotemporal,Frontotemporal dementia,frontotemporal lobar degeneration,FTD,gamma-secretase complex,glutamatergic,Golgi apparatus,growth cone,hair,hair follicles,heart,heart disease,heart looping,hematopoietic progenitor cell differentiation,Hidradenitis suppurativa,Hydrolase,Idiopathic Dilated Cardiomyopathy,immune system,inflammation,integral component of membrane,integral component of plasma membrane,intracellular signal transduction,Jarcho-Levin Syndrome,kinetochore,L-Glutamate,L-glutamate transport,L-Glutamine,LDL,low density lipoprotein,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane raft,memory,mental health,mitochondria,mitochondrial inner membrane,mitochondrial transport,mitochondrion,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of apoptotic signaling pathway,negative regulation of axonogenesis,negative regulation of epidermal growth factor-activated receptor activity,negative regulation of neuron apoptotic process,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,negative regulation of transcription from RNA polymerase II promoter,negative regulation of ubiquitin-protein transferase activity,neurodegenerative disease,neurodegenerative disorder,neuromuscular junction,neuron apoptotic process,neuron development,neuron migration,neuronal cell body,neuropsychiatric disorders,nodules,Notch,Notch receptor processing,Notch signaling pathway,nuclear membrane,nuclear outer membrane,oxidative stress,oxidized LDL receptor gene,Parkinson,Parkinson's disease,parkinsonian,PD,PDZ domain binding,perinuclear region of cytoplasm,Phosphoprotein,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of MAP kinase activity,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of receptor recycling,post-embryonic development,Presenilin-1,Presenilin-1 CTF subunit,Presenilin-1 CTF12,Presenilin-1 NTF subunit,Progressive non-fluent aphasia,Protease,protein glycosylation,protein processing,Protein S182,protein transport,PS-1,PS1,PS1-CTF12,PSEN1,PSN1,PSNL1,psychiatric disorder,regulation of phosphorylation,regulation of protein binding,regulation of resting membrane potential,regulation of synaptic plasticity,regulation of synaptic transmission,response to oxidative stress,ROS,rough endoplasmic reticulum,scars,Semantic dementia,single organismal cell-cell adhesion,sinus,skeletal system morphogenesis,skin,skin morphogenesis,smooth endoplasmic reticulum,smooth endoplasmic reticulum calcium ion homeostasis,somitogenesis,Spondylothoracic Dysostosis,Spondylothoracic Dy",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63750218",
        "SNP Name": "PSEN1 Leu388Pro",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "3,Acne inversa familial,ACNINV3,activation of MAPKK activity,AD,AD3,Alzheimer,Alzheimer's disease,amyloid,anagen,aphasia,apical plasma membrane,apoptosis,APP,aspartic-type endopeptidase activity,autophagic vacuole assembly,axon,beta-amyloid formation,beta-amyloid metabolic process,beta-amyloid precursor protein,beta-catenin,beta-catenin binding,blood vessel development,brain morphogenesis,cadherin binding,Cajal-Retzius cell differentiation,calcium channel activity,calcium influx,calcium ion transmembrane transport,canonical Wnt signaling pathway,cardio,Cardiomyopathy,cardiovascular,Cell adhesion,cell cortex,cell fate specification,cell surface,cellular response to DNA damage stimulus,centrosome,cerebral cortex cell migration,choline,choline transport,ciliary rootlet,CMD1U,CVD,cytoplasmic vesicle,dementia,dendritic shaft,dilated 1U,dorsal/ventral neural tube patterning,draining sinuses,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,epithelial cell proliferation,extracellular matrix disassembly,extracellular matrix organization,familial dilated cardiomyopathy,frontotemporal,Frontotemporal dementia,frontotemporal lobar degeneration,FTD,gamma-secretase complex,glutamatergic,Golgi apparatus,growth cone,hair,hair follicles,heart,heart disease,heart looping,hematopoietic progenitor cell differentiation,Hidradenitis suppurativa,Hydrolase,immune system,inflammation,integral component of membrane,integral component of plasma membrane,intracellular signal transduction,kinetochore,L-Glutamate,L-glutamate transport,L-Glutamine,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane raft,memory,mitochondria,mitochondrial inner membrane,mitochondrial transport,mitochondrion,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of apoptotic signaling pathway,negative regulation of axonogenesis,negative regulation of epidermal growth factor-activated receptor activity,negative regulation of neuron apoptotic process,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,negative regulation of transcription from RNA polymerase II promoter,negative regulation of ubiquitin-protein transferase activity,neurodegenerative disorder,neuromuscular junction,neuron apoptotic process,neuron development,neuron migration,neuronal cell body,nodules,Notch,Notch receptor processing,Notch signaling pathway,nuclear membrane,nuclear outer membrane,oxidative stress,Parkinson,Parkinson's disease,parkinsonian,PD,PDZ domain binding,perinuclear region of cytoplasm,Phosphoprotein,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of MAP kinase activity,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of receptor recycling,post-embryonic development,Presenilin-1,Presenilin-1 CTF subunit,Presenilin-1 CTF12,Presenilin-1 NTF subunit,Progressive non-fluent aphasia,Protease,protein glycosylation,protein processing,Protein S182,protein transport,PS-1,PS1,PS1-CTF12,PSEN1,PSN1,PSNL1,regulation of phosphorylation,regulation of protein binding,regulation of resting membrane potential,regulation of synaptic plasticity,regulation of synaptic transmission,response to oxidative stress,ROS,rough endoplasmic reticulum,scars,Semantic dementia,single organismal cell-cell adhesion,sinus,skeletal system morphogenesis,skin,skin morphogenesis,smooth endoplasmic reticulum,smooth endoplasmic reticulum calcium ion homeostasis,somitogenesis,synaptic vesicle targeting,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63751223",
        "SNP Name": "PSEN1 Ala422Pro",
        "Risk Allele": "C",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "3,Acne inversa familial,ACNINV3,activation of MAPKK activity,AD,AD3,Alzheimer,Alzheimer's disease,amyloid,anagen,aphasia,apical plasma membrane,apoptosis,APP,aspartic-type endopeptidase activity,autophagic vacuole assembly,axon,beta-amyloid formation,beta-amyloid metabolic process,beta-amyloid precursor protein,beta-catenin,beta-catenin binding,blood vessel development,brain morphogenesis,cadherin binding,Cajal-Retzius cell differentiation,calcium channel activity,calcium influx,calcium ion transmembrane transport,canonical Wnt signaling pathway,cardio,Cardiomyopathy,cardiovascular,Cell adhesion,cell cortex,cell fate specification,cell surface,cellular response to DNA damage stimulus,centrosome,cerebral cortex cell migration,choline,choline transport,ciliary rootlet,CMD1U,CVD,cytoplasmic vesicle,dementia,dendritic shaft,dilated 1U,dorsal/ventral neural tube patterning,draining sinuses,embryonic limb morphogenesis,endopeptidase activity,endoplasmic reticulum,endoplasmic reticulum calcium ion homeostasis,endoprotease complex,epithelial cell proliferation,extracellular matrix disassembly,extracellular matrix organization,familial dilated cardiomyopathy,frontotemporal,Frontotemporal dementia,frontotemporal lobar degeneration,FTD,gamma-secretase complex,glutamatergic,Golgi apparatus,growth cone,hair,hair follicles,heart,heart disease,heart looping,hematopoietic progenitor cell differentiation,Hidradenitis suppurativa,Hydrolase,immune system,inflammation,integral component of membrane,integral component of plasma membrane,intracellular signal transduction,kinetochore,L-Glutamate,L-glutamate transport,L-Glutamine,lysosomal membrane,membrane,membrane protein ectodomain proteolysis,membrane raft,memory,mitochondria,mitochondrial inner membrane,mitochondrial transport,mitochondrion,myeloid leukocyte differentiation,negative regulation of apoptotic process,negative regulation of apoptotic signaling pathway,negative regulation of axonogenesis,negative regulation of epidermal growth factor-activated receptor activity,negative regulation of neuron apoptotic process,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,negative regulation of transcription from RNA polymerase II promoter,negative regulation of ubiquitin-protein transferase activity,neurodegenerative disease,neurodegenerative disorder,neuromuscular junction,neuron apoptotic process,neuron development,neuron migration,neuronal cell body,nodules,Notch,Notch receptor processing,Notch signaling pathway,nuclear membrane,nuclear outer membrane,oxidative stress,Parkinson,Parkinson's disease,parkinsonian,PD,PDZ domain binding,perinuclear region of cytoplasm,Phosphoprotein,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of coagulation,positive regulation of MAP kinase activity,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of receptor recycling,post-embryonic development,Presenilin-1,Presenilin-1 CTF subunit,Presenilin-1 CTF12,Presenilin-1 NTF subunit,Progressive non-fluent aphasia,Protease,protein glycosylation,protein processing,Protein S182,protein transport,PS-1,PS1,PS1-CTF12,PSEN1,PSN1,PSNL1,regulation of phosphorylation,regulation of protein binding,regulation of resting membrane potential,regulation of synaptic plasticity,regulation of synaptic transmission,response to oxidative stress,ROS,rough endoplasmic reticulum,scars,Semantic dementia,single organismal cell-cell adhesion,sinus,skeletal system morphogenesis,skin,skin morphogenesis,smooth endoplasmic reticulum,smooth endoplasmic reticulum calcium ion homeostasis,somitogenesis,synaptic vesicle targeting,T cell,T cell activation involved in immune response,T cell receptor signaling pathway,T-cell,thymus development,Z disc",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs732765",
        "SNP Name": "DLST A22136G",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs732765",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs732765",
        "SNP Name": "DLST A22136G",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs732765",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs861539",
        "SNP Name": "XRCC3 T241M",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "2-Phenoxyethanol"
    },
    {
        "SNP ID": "rs861539",
        "SNP Name": "XRCC3 T241M",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Alcohol"
    },
    {
        "SNP ID": "rs861539",
        "SNP Name": "XRCC3 T241M",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs6494223",
        "SNP Name": "CHRFAM7A/CHRNA7 C78732T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Benzethonium Chloride"
    },
    {
        "SNP ID": "rs1909884",
        "SNP Name": "CHRFAM7A/CHRNA7 G121573A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Benzethonium Chloride"
    },
    {
        "SNP ID": "rs11636774",
        "SNP Name": "SORD A45317915C",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs8043226",
        "SNP Name": "SORD G45321593A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs1048943",
        "SNP Name": "CYP1A1*2C A4889G",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1048943",
        "Video": "Uf_IW_Ahd6U",
        "Tags": "2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),9-cis-retinoic acid biosynthetic process,acting on diphenols and related substances as donors,Acute Leukemia,advanced colorectal adenoma,Adverse Pregnancy Outcomes,aging,amine metabolic process,antibiotic response,antibiotics,arachidonic acid metabolic process,aromatase activity,Arsenic trioxide,atherosclerosis,basal cell carcinomas,BCCs,Benzphetamine,biliary tract cancers and stones,Bladder cancer,Bleomycin,breast cancer,camera-type eye development,cancer,cancerous,carcinogen,cardiovascular,cell proliferation,cellular lipid metabolic process,cellular response to organic cyclic compound,Cervical Cancer,childhood leukemia,Chlorzoxazone,cigarette smoking,clubfoot,colorectal cancer,colorectal neoplasia,community-acquired pneumonia,coumarin metabolic process,CVD,CYP P450,CYP1A1,Cytochrome P450 1A1,Cytochrome P450 form 6,Cytochrome P450-C,Cytochrome P450-P1,Dacarbazine,Dactinomycin,demethylase activity,detox,dibenzo-p-dioxin catabolic process,digestive tract development,drug metabolic process,drug metabolism,drug response,dysmenorrhea,E2,embryo development ending in birth or egg hatching,Endoplasmic reticulum membrane,environmental,environmental factors,epoxygenase P450 pathway,Esomeprazole,Esophageal Cancer,esophageal squamous cell carcinoma,estrogen,estrogen dominance,estrogen plus progestin hormone therapy,estrogen related cancer,Estrogen Synthesis,Estrone,fat metabolism,fatty acids,flavonoid 3'-monooxygenase activity,flavonoid metabolic process,Fluvastatin,Fluvoxamine,Gallbladder Cancer,Ginseng,GlcNAc,Glycosylation,Granisetron,Head and Neck Cancer,heart,heme binding,Heme group,heme-thiolate monooxygenase,hepatocyte differentiation,hormone therapy,hydrogen peroxide biosynthetic process,Idiopathic Male Infertility,insecticide metabolic process,iron (heme axial ligand),iron ion binding,Ketoconazole,leukemia,lipid metabolism,lipid related cardiovascular disease,liver,lung cancer,Malignant Brain Tumors,maternal process involved in parturition,Menadione,Metal binding,Microsome,Microsome membrane,mitochondrion,Monooxygenase,Myocardial Infarction,N-Acetylglucosamine,N-Acetyltransferase,NADPH,NADPH-dependent electron transport pathway,Non-Hodgkin lymphoma,omega-hydroxylase P450 pathway,oral cancer,ovarian cancer,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Papillary Thyroid Cancer,perimenopausal,Peripheral membrane protein,Pharmacogenomics,Picrotoxin,pneumonia,porphyrin-containing compound metabolic process,positive regulation of G1/S transition of mitotic cell cycle,postmenopausal breast cancer,pregnancy,Primaquine,Quinidine,Quinine,Renal Cell Cancer,response to antibiotic,response to arsenic-containing substance,response to drug,response to food,response to herbicide,response to hyperoxia,response to hypoxia,response to iron(III) ion,response to lipopolysaccharide,response to nematode,response to virus,response to vitamin A,response to wounding,RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O,sex hormones,Sex steroid metabolism,small molecule metabolic process,smoking,steroid hydroxylase activity,steroids,Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),Thiabendazole,uterine leiomyoma,vitamin A,vitamin D,vitamin D 24-hydroxylase activity,vitamin D metabolic process,xenobiotic,xenobiotic metabolic process",
        "Group": "Cellulose Acetate Phthalate"
    },
    {
        "SNP ID": "rs1048943",
        "SNP Name": "CYP1A1*2C A4889G",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1048943",
        "Video": "Uf_IW_Ahd6U",
        "Tags": "2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),9-cis-retinoic acid biosynthetic process,acting on diphenols and related substances as donors,Acute Leukemia,advanced colorectal adenoma,Adverse Pregnancy Outcomes,aging,amine metabolic process,antibiotic response,antibiotics,arachidonic acid metabolic process,aromatase activity,Arsenic trioxide,atherosclerosis,basal cell carcinomas,BCCs,Benzphetamine,biliary tract cancers and stones,Bladder cancer,Bleomycin,breast cancer,camera-type eye development,cancer,cancerous,carcinogen,cardiovascular,cell proliferation,cellular lipid metabolic process,cellular response to organic cyclic compound,Cervical Cancer,childhood leukemia,Chlorzoxazone,cigarette smoking,clubfoot,colorectal cancer,colorectal neoplasia,community-acquired pneumonia,coumarin metabolic process,CVD,CYP P450,CYP1A1,Cytochrome P450 1A1,Cytochrome P450 form 6,Cytochrome P450-C,Cytochrome P450-P1,Dacarbazine,Dactinomycin,demethylase activity,detox,dibenzo-p-dioxin catabolic process,digestive tract development,drug metabolic process,drug metabolism,drug response,dysmenorrhea,E2,embryo development ending in birth or egg hatching,Endoplasmic reticulum membrane,environmental,environmental factors,epoxygenase P450 pathway,Esomeprazole,Esophageal Cancer,esophageal squamous cell carcinoma,estrogen,estrogen dominance,estrogen plus progestin hormone therapy,estrogen related cancer,Estrogen Synthesis,Estrone,fat metabolism,fatty acids,flavonoid 3'-monooxygenase activity,flavonoid metabolic process,Fluvastatin,Fluvoxamine,Gallbladder Cancer,Ginseng,GlcNAc,Glycosylation,Granisetron,Head and Neck Cancer,heart,heme binding,Heme group,heme-thiolate monooxygenase,hepatocyte differentiation,hormone therapy,hydrogen peroxide biosynthetic process,Idiopathic Male Infertility,insecticide metabolic process,iron (heme axial ligand),iron ion binding,Ketoconazole,leukemia,lipid metabolism,lipid related cardiovascular disease,liver,lung cancer,Malignant Brain Tumors,maternal process involved in parturition,Menadione,Metal binding,Microsome,Microsome membrane,mitochondrion,Monooxygenase,Myocardial Infarction,N-Acetylglucosamine,N-Acetyltransferase,NADPH,NADPH-dependent electron transport pathway,Non-Hodgkin lymphoma,omega-hydroxylase P450 pathway,oral cancer,ovarian cancer,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Papillary Thyroid Cancer,perimenopausal,Peripheral membrane protein,Pharmacogenomics,Picrotoxin,pneumonia,porphyrin-containing compound metabolic process,positive regulation of G1/S transition of mitotic cell cycle,postmenopausal breast cancer,pregnancy,Primaquine,Quinidine,Quinine,Renal Cell Cancer,response to antibiotic,response to arsenic-containing substance,response to drug,response to food,response to herbicide,response to hyperoxia,response to hypoxia,response to iron(III) ion,response to lipopolysaccharide,response to nematode,response to virus,response to vitamin A,response to wounding,RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O,sex hormones,Sex steroid metabolism,small molecule metabolic process,smoking,steroid hydroxylase activity,steroids,Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),Thiabendazole,uterine leiomyoma,vitamin A,vitamin D,vitamin D 24-hydroxylase activity,vitamin D metabolic process,xenobiotic,xenobiotic metabolic process",
        "Group": "Nonylphenol Ethoxylate"
    },
    {
        "SNP ID": "rs1048943",
        "SNP Name": "CYP1A1*2C A4889G",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1048943",
        "Video": "Uf_IW_Ahd6U",
        "Tags": "2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),9-cis-retinoic acid biosynthetic process,acting on diphenols and related substances as donors,Acute Leukemia,advanced colorectal adenoma,Adverse Pregnancy Outcomes,aging,amine metabolic process,antibiotic response,antibiotics,arachidonic acid metabolic process,aromatase activity,Arsenic trioxide,atherosclerosis,basal cell carcinomas,BCCs,Benzphetamine,biliary tract cancers and stones,Bladder cancer,Bleomycin,breast cancer,camera-type eye development,cancer,cancerous,carcinogen,cardiovascular,cell proliferation,cellular lipid metabolic process,cellular response to organic cyclic compound,Cervical Cancer,childhood leukemia,Chlorzoxazone,cigarette smoking,clubfoot,colorectal cancer,colorectal neoplasia,community-acquired pneumonia,coumarin metabolic process,CVD,CYP P450,CYP1A1,Cytochrome P450 1A1,Cytochrome P450 form 6,Cytochrome P450-C,Cytochrome P450-P1,Dacarbazine,Dactinomycin,demethylase activity,detox,dibenzo-p-dioxin catabolic process,digestive tract development,drug metabolic process,drug metabolism,drug response,dysmenorrhea,E2,embryo development ending in birth or egg hatching,Endoplasmic reticulum membrane,environmental,environmental factors,epoxygenase P450 pathway,Esomeprazole,Esophageal Cancer,esophageal squamous cell carcinoma,estrogen,estrogen dominance,estrogen plus progestin hormone therapy,estrogen related cancer,Estrogen Synthesis,Estrone,fat metabolism,fatty acids,flavonoid 3'-monooxygenase activity,flavonoid metabolic process,Fluvastatin,Fluvoxamine,Gallbladder Cancer,Ginseng,GlcNAc,Glycosylation,Granisetron,Head and Neck Cancer,heart,heme binding,Heme group,heme-thiolate monooxygenase,hepatocyte differentiation,hormone therapy,hydrogen peroxide biosynthetic process,Idiopathic Male Infertility,insecticide metabolic process,iron (heme axial ligand),iron ion binding,Ketoconazole,leukemia,lipid metabolism,lipid related cardiovascular disease,liver,lung cancer,Malignant Brain Tumors,maternal process involved in parturition,Menadione,Metal binding,Microsome,Microsome membrane,mitochondrion,Monooxygenase,Myocardial Infarction,N-Acetylglucosamine,N-Acetyltransferase,NADPH,NADPH-dependent electron transport pathway,Non-Hodgkin lymphoma,omega-hydroxylase P450 pathway,oral cancer,ovarian cancer,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Papillary Thyroid Cancer,perimenopausal,Peripheral membrane protein,Pharmacogenomics,Picrotoxin,pneumonia,porphyrin-containing compound metabolic process,positive regulation of G1/S transition of mitotic cell cycle,postmenopausal breast cancer,pregnancy,Primaquine,Quinidine,Quinine,Renal Cell Cancer,response to antibiotic,response to arsenic-containing substance,response to drug,response to food,response to herbicide,response to hyperoxia,response to hypoxia,response to iron(III) ion,response to lipopolysaccharide,response to nematode,response to virus,response to vitamin A,response to wounding,RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O,sex hormones,Sex steroid metabolism,small molecule metabolic process,smoking,steroid hydroxylase activity,steroids,Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),Thiabendazole,uterine leiomyoma,vitamin A,vitamin D,vitamin D 24-hydroxylase activity,vitamin D metabolic process,xenobiotic,xenobiotic metabolic process",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1048943",
        "SNP Name": "CYP1A1*2C A4889G",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1048943",
        "Video": "Uf_IW_Ahd6U",
        "Tags": "2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),9-cis-retinoic acid biosynthetic process,acting on diphenols and related substances as donors,Acute Leukemia,advanced colorectal adenoma,Adverse Pregnancy Outcomes,aging,amine metabolic process,antibiotic response,antibiotics,arachidonic acid metabolic process,aromatase activity,Arsenic trioxide,atherosclerosis,basal cell carcinomas,BCCs,Benzphetamine,biliary tract cancers and stones,Bladder cancer,Bleomycin,breast cancer,camera-type eye development,cancer,cancerous,carcinogen,cardiovascular,cell proliferation,cellular lipid metabolic process,cellular response to organic cyclic compound,Cervical Cancer,childhood leukemia,Chlorzoxazone,cigarette smoking,clubfoot,colorectal cancer,colorectal neoplasia,community-acquired pneumonia,coumarin metabolic process,CVD,CYP P450,CYP1A1,Cytochrome P450 1A1,Cytochrome P450 form 6,Cytochrome P450-C,Cytochrome P450-P1,Dacarbazine,Dactinomycin,demethylase activity,detox,dibenzo-p-dioxin catabolic process,digestive tract development,drug metabolic process,drug metabolism,drug response,dysmenorrhea,E2,embryo development ending in birth or egg hatching,Endoplasmic reticulum membrane,environmental,environmental factors,epoxygenase P450 pathway,Esomeprazole,Esophageal Cancer,esophageal squamous cell carcinoma,estrogen,estrogen dominance,estrogen plus progestin hormone therapy,estrogen related cancer,Estrogen Synthesis,Estrone,fat metabolism,fatty acids,flavonoid 3'-monooxygenase activity,flavonoid metabolic process,Fluvastatin,Fluvoxamine,Gallbladder Cancer,Ginseng,GlcNAc,Glycosylation,Granisetron,Head and Neck Cancer,heart,heme binding,Heme group,heme-thiolate monooxygenase,hepatocyte differentiation,hormone therapy,hydrogen peroxide biosynthetic process,Idiopathic Male Infertility,insecticide metabolic process,iron (heme axial ligand),iron ion binding,Ketoconazole,leukemia,lipid metabolism,lipid related cardiovascular disease,liver,lung cancer,Malignant Brain Tumors,maternal process involved in parturition,Menadione,Metal binding,Microsome,Microsome membrane,mitochondrion,Monooxygenase,Myocardial Infarction,N-Acetylglucosamine,N-Acetyltransferase,NADPH,NADPH-dependent electron transport pathway,Non-Hodgkin lymphoma,omega-hydroxylase P450 pathway,oral cancer,ovarian cancer,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Papillary Thyroid Cancer,perimenopausal,Peripheral membrane protein,Pharmacogenomics,Picrotoxin,pneumonia,porphyrin-containing compound metabolic process,positive regulation of G1/S transition of mitotic cell cycle,postmenopausal breast cancer,pregnancy,Primaquine,Quinidine,Quinine,Renal Cell Cancer,response to antibiotic,response to arsenic-containing substance,response to drug,response to food,response to herbicide,response to hyperoxia,response to hypoxia,response to iron(III) ion,response to lipopolysaccharide,response to nematode,response to virus,response to vitamin A,response to wounding,RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O,sex hormones,Sex steroid metabolism,small molecule metabolic process,smoking,steroid hydroxylase activity,steroids,Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),Thiabendazole,uterine leiomyoma,vitamin A,vitamin D,vitamin D 24-hydroxylase activity,vitamin D metabolic process,xenobiotic,xenobiotic metabolic process",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs1799814",
        "SNP Name": "CYP1A1*4 C2453A",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1799814",
        "Video": "Uf_IW_Ahd6U",
        "Tags": "2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),9-cis-retinoic acid biosynthetic process,acting on diphenols and related substances as donors,Advanced Colorectal Adenoma,aging,amine metabolic process,antibiotic response,antibiotics,arachidonic acid metabolic process,aromatase activity,Arsenic trioxide,atherosclerosis,Benzphetamine,Bladder cancer,Bleomycin,breast cancer,camera-type eye development,cancer,Cancer Susceptibility,cancerous,carcinogen,cell proliferation,cellular lipid metabolic process,cellular response to organic cyclic compound,Chlorzoxazone,colorectal cancer,colorectal neoplasia,coumarin metabolic process,CYP P450,CYP1A1,Cytochrome P450 1A1,Cytochrome P450 form 6,Cytochrome P450-C,Cytochrome P450-P1,Dacarbazine,Dactinomycin,demethylase activity,detox,dibenzo-p-dioxin catabolic process,digestive tract development,drug metabolic process,drug metabolism,drug response,E2,embryo development ending in birth or egg hatching,Endoplasmic reticulum membrane,environmental,environmental factors,epoxygenase P450 pathway,Esomeprazole,Esophageal Cancer,estrogen,estrogen dominance,estrogen related cancer,Estrogen Synthesis,Estrone,fat metabolism,fatty acids,flavonoid 3'-monooxygenase activity,flavonoid metabolic process,Fluvastatin,Fluvoxamine,Ginseng,GlcNAc,Glycosylation,Granisetron,heme binding,Heme group,heme-thiolate monooxygenase,hepatocyte differentiation,hydrogen peroxide biosynthetic process,insecticide metabolic process,iron (heme axial ligand),iron ion binding,Ketoconazole,lipid metabolism,liver,lung cancer,maternal process involved in parturition,Meat-Related Exposures,Menadione,Metal binding,Microsome,Microsome membrane,mitochondrion,Monooxygenase,N-Acetylglucosamine,NADPH,NADPH-dependent electron transport pathway,omega-hydroxylase P450 pathway,oral cancer,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,pancreatic cancer,Peripheral membrane protein,Picrotoxin,porphyrin-containing compound metabolic process,positive regulation of G1/S transition of mitotic cell cycle,Primaquine,Prostate Cancer,Quinidine,Quinine,response to antibiotic,response to arsenic-containing substance,response to drug,response to food,response to herbicide,response to hyperoxia,response to hypoxia,response to iron(III) ion,response to lipopolysaccharide,response to nematode,response to virus,response to vitamin A,response to wounding,RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O,sex hormones,small molecule metabolic process,steroid hydroxylase activity,steroids,Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),Thiabendazole,vitamin A,vitamin D,vitamin D 24-hydroxylase activity,vitamin D metabolic process,xenobiotic,xenobiotic metabolic process",
        "Group": "Cellulose Acetate Phthalate"
    },
    {
        "SNP ID": "rs1799814",
        "SNP Name": "CYP1A1*4 C2453A",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1799814",
        "Video": "Uf_IW_Ahd6U",
        "Tags": "2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),9-cis-retinoic acid biosynthetic process,acting on diphenols and related substances as donors,Advanced Colorectal Adenoma,aging,amine metabolic process,antibiotic response,antibiotics,arachidonic acid metabolic process,aromatase activity,Arsenic trioxide,atherosclerosis,Benzphetamine,Bladder cancer,Bleomycin,breast cancer,camera-type eye development,cancer,Cancer Susceptibility,cancerous,carcinogen,cell proliferation,cellular lipid metabolic process,cellular response to organic cyclic compound,Chlorzoxazone,colorectal cancer,colorectal neoplasia,coumarin metabolic process,CYP P450,CYP1A1,Cytochrome P450 1A1,Cytochrome P450 form 6,Cytochrome P450-C,Cytochrome P450-P1,Dacarbazine,Dactinomycin,demethylase activity,detox,dibenzo-p-dioxin catabolic process,digestive tract development,drug metabolic process,drug metabolism,drug response,E2,embryo development ending in birth or egg hatching,Endoplasmic reticulum membrane,environmental,environmental factors,epoxygenase P450 pathway,Esomeprazole,Esophageal Cancer,estrogen,estrogen dominance,estrogen related cancer,Estrogen Synthesis,Estrone,fat metabolism,fatty acids,flavonoid 3'-monooxygenase activity,flavonoid metabolic process,Fluvastatin,Fluvoxamine,Ginseng,GlcNAc,Glycosylation,Granisetron,heme binding,Heme group,heme-thiolate monooxygenase,hepatocyte differentiation,hydrogen peroxide biosynthetic process,insecticide metabolic process,iron (heme axial ligand),iron ion binding,Ketoconazole,lipid metabolism,liver,lung cancer,maternal process involved in parturition,Meat-Related Exposures,Menadione,Metal binding,Microsome,Microsome membrane,mitochondrion,Monooxygenase,N-Acetylglucosamine,NADPH,NADPH-dependent electron transport pathway,omega-hydroxylase P450 pathway,oral cancer,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,pancreatic cancer,Peripheral membrane protein,Picrotoxin,porphyrin-containing compound metabolic process,positive regulation of G1/S transition of mitotic cell cycle,Primaquine,Prostate Cancer,Quinidine,Quinine,response to antibiotic,response to arsenic-containing substance,response to drug,response to food,response to herbicide,response to hyperoxia,response to hypoxia,response to iron(III) ion,response to lipopolysaccharide,response to nematode,response to virus,response to vitamin A,response to wounding,RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O,sex hormones,small molecule metabolic process,steroid hydroxylase activity,steroids,Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),Thiabendazole,vitamin A,vitamin D,vitamin D 24-hydroxylase activity,vitamin D metabolic process,xenobiotic,xenobiotic metabolic process",
        "Group": "Nonylphenol Ethoxylate"
    },
    {
        "SNP ID": "rs1799814",
        "SNP Name": "CYP1A1*4 C2453A",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1799814",
        "Video": "Uf_IW_Ahd6U",
        "Tags": "2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),9-cis-retinoic acid biosynthetic process,acting on diphenols and related substances as donors,Advanced Colorectal Adenoma,aging,amine metabolic process,antibiotic response,antibiotics,arachidonic acid metabolic process,aromatase activity,Arsenic trioxide,atherosclerosis,Benzphetamine,Bladder cancer,Bleomycin,breast cancer,camera-type eye development,cancer,Cancer Susceptibility,cancerous,carcinogen,cell proliferation,cellular lipid metabolic process,cellular response to organic cyclic compound,Chlorzoxazone,colorectal cancer,colorectal neoplasia,coumarin metabolic process,CYP P450,CYP1A1,Cytochrome P450 1A1,Cytochrome P450 form 6,Cytochrome P450-C,Cytochrome P450-P1,Dacarbazine,Dactinomycin,demethylase activity,detox,dibenzo-p-dioxin catabolic process,digestive tract development,drug metabolic process,drug metabolism,drug response,E2,embryo development ending in birth or egg hatching,Endoplasmic reticulum membrane,environmental,environmental factors,epoxygenase P450 pathway,Esomeprazole,Esophageal Cancer,estrogen,estrogen dominance,estrogen related cancer,Estrogen Synthesis,Estrone,fat metabolism,fatty acids,flavonoid 3'-monooxygenase activity,flavonoid metabolic process,Fluvastatin,Fluvoxamine,Ginseng,GlcNAc,Glycosylation,Granisetron,heme binding,Heme group,heme-thiolate monooxygenase,hepatocyte differentiation,hydrogen peroxide biosynthetic process,insecticide metabolic process,iron (heme axial ligand),iron ion binding,Ketoconazole,lipid metabolism,liver,lung cancer,maternal process involved in parturition,Meat-Related Exposures,Menadione,Metal binding,Microsome,Microsome membrane,mitochondrion,Monooxygenase,N-Acetylglucosamine,NADPH,NADPH-dependent electron transport pathway,omega-hydroxylase P450 pathway,oral cancer,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,pancreatic cancer,Peripheral membrane protein,Picrotoxin,porphyrin-containing compound metabolic process,positive regulation of G1/S transition of mitotic cell cycle,Primaquine,Prostate Cancer,Quinidine,Quinine,response to antibiotic,response to arsenic-containing substance,response to drug,response to food,response to herbicide,response to hyperoxia,response to hypoxia,response to iron(III) ion,response to lipopolysaccharide,response to nematode,response to virus,response to vitamin A,response to wounding,RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O,sex hormones,small molecule metabolic process,steroid hydroxylase activity,steroids,Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),Thiabendazole,vitamin A,vitamin D,vitamin D 24-hydroxylase activity,vitamin D metabolic process,xenobiotic,xenobiotic metabolic process",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1799814",
        "SNP Name": "CYP1A1*4 C2453A",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1799814",
        "Video": "Uf_IW_Ahd6U",
        "Tags": "2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD),9-cis-retinoic acid biosynthetic process,acting on diphenols and related substances as donors,Advanced Colorectal Adenoma,aging,amine metabolic process,antibiotic response,antibiotics,arachidonic acid metabolic process,aromatase activity,Arsenic trioxide,atherosclerosis,Benzphetamine,Bladder cancer,Bleomycin,breast cancer,camera-type eye development,cancer,Cancer Susceptibility,cancerous,carcinogen,cell proliferation,cellular lipid metabolic process,cellular response to organic cyclic compound,Chlorzoxazone,colorectal cancer,colorectal neoplasia,coumarin metabolic process,CYP P450,CYP1A1,Cytochrome P450 1A1,Cytochrome P450 form 6,Cytochrome P450-C,Cytochrome P450-P1,Dacarbazine,Dactinomycin,demethylase activity,detox,dibenzo-p-dioxin catabolic process,digestive tract development,drug metabolic process,drug metabolism,drug response,E2,embryo development ending in birth or egg hatching,Endoplasmic reticulum membrane,environmental,environmental factors,epoxygenase P450 pathway,Esomeprazole,Esophageal Cancer,estrogen,estrogen dominance,estrogen related cancer,Estrogen Synthesis,Estrone,fat metabolism,fatty acids,flavonoid 3'-monooxygenase activity,flavonoid metabolic process,Fluvastatin,Fluvoxamine,Ginseng,GlcNAc,Glycosylation,Granisetron,heme binding,Heme group,heme-thiolate monooxygenase,hepatocyte differentiation,hydrogen peroxide biosynthetic process,insecticide metabolic process,iron (heme axial ligand),iron ion binding,Ketoconazole,lipid metabolism,liver,lung cancer,maternal process involved in parturition,Meat-Related Exposures,Menadione,Metal binding,Microsome,Microsome membrane,mitochondrion,Monooxygenase,N-Acetylglucosamine,NADPH,NADPH-dependent electron transport pathway,omega-hydroxylase P450 pathway,oral cancer,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,pancreatic cancer,Peripheral membrane protein,Picrotoxin,porphyrin-containing compound metabolic process,positive regulation of G1/S transition of mitotic cell cycle,Primaquine,Prostate Cancer,Quinidine,Quinine,response to antibiotic,response to arsenic-containing substance,response to drug,response to food,response to herbicide,response to hyperoxia,response to hypoxia,response to iron(III) ion,response to lipopolysaccharide,response to nematode,response to virus,response to vitamin A,response to wounding,RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O,sex hormones,small molecule metabolic process,steroid hydroxylase activity,steroids,Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),Thiabendazole,vitamin A,vitamin D,vitamin D 24-hydroxylase activity,vitamin D metabolic process,xenobiotic,xenobiotic metabolic process",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs2069526",
        "SNP Name": "CYP1A2*1K -739T>G",
        "Risk Allele": "G",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs2069526",
        "Video": "JX91czj1oSg",
        "Tags": "2-hydroxylation,Acenocoumarol,acetaminophen,adverse reaction,aflatoxin B1,Agomelatine,Albendazole,Alitretinoin,alkaloid metabolic process,Almotriptan,Alosetron,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Anagrelide,Anastrozole,antidepressant,antidepressant metabolism,antidepressant response,antidepressant side effect,Antipyrine,Apixaban,Aprepitant,arachidonic acid metabolic process,aromatase activity,aromatic amine,ARTIFICIAL ESTROGEN,Asenapine,Atropine,Axitinib,Azelastine,Azithromycin,Benzyl alcohol,Betaxolol,Bortezomib,Bromazepam,Bromocriptine,Bupivacaine,Buprenorphine,Bupropion,caffeine,caffeine metabolism,caffeine oxidase activity,CANCER,CANCEROUS,Carbamazepine,CARCINOGEN,carcinogenic aromatic amine,Carmustine,Carvedilol,cellular respiration,cellular response to cadmium ion,Chlorpromazine,Chlorzoxazone,Cilostazol,Cimetidine,Cinacalcet,Cinnarizine,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clenbuterol,Clevidipine,Clobetasol propionate,Clomifene,Clomipramine,Clonidine,Clopidogrel,Clotrimazole,clozapine,compounds,Conjugated Estrogens,Cyclobenzaprine,CYP,CYP P450,CYP1A2,CYPIA2,CYTOCHROME,Cytochrome P(3)450,CYTOCHROME P450,Cytochrome P450 1A2,Cytochrome P450 4,Cytochrome P450-P3,Dacarbazine,Dapagliflozin,Dasatinib,Daunorubicin,Delavirdine,demethylase activity,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexfenfluramine,Dexmedetomidine,Diazepam,dibenzo-p-dioxin metabolic process,Diclofenac,Dinoprostone,Diphenhydramine,Domperidone,Dopamine,Doxepin,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Duloxetine,Edetic Acid,Efavirenz,electron carrier activity,electron transport pathway,Eltrombopag,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enoxacin,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,ENZYME,enzyme binding,Epinephrine,epoxygenase P450 pathway,Ergotamine,Erlotinib,Erythromycin,escitalopram,escitalopram adverse reaction,Estradiol,ESTROGEN,Estrone,Estropipate,Ethanol,Etoposide,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Fluphenazine,Flutamide,Fluvastatin,Fluvoxamine,Frovatriptan,Gemfibrozil,Griseofulvin,Guanabenz,Haloperidol,HEME,heme binding,heme-thiolate monooxygenases,Hesperetin,heterocycle metabolic process,heterocyclic amines,Hexobarbital,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydrogen peroxide biosynthetic process,Iloperidone,Imatinib,imidazole,Imipramine,Imiquimod,inhaled insulin,Insulin Aspart,Insulin Detemir,Insulin Glargine,Insulin Glulisine,Insulin Lispro,Insulin Regular,intracellular membrane-bounded organelle,Irbesartan,iron,iron ion binding,Isoniazid,Ketoconazole,Lansoprazole,Leflunomide,Levobupivacaine,Levofloxacin,Lidocaine,LIVER,LIVER ENZYME,Lomefloxacin,Lopinavir,Lorcaserin,Losartan,Lumiracoxib,lung cancer,lung development,Malathion,Maprotiline,Meclizine,Melatonin,Membrane,Menadione,Metal-binding,Methadone,Methimazole,Methotrimeprazine,Methoxsalen,Methoxyflurane,methylation,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,Mirtazapine,Moclobemide,Modafinil,molecular oxygen,monocarboxylic acid metabolic process,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,N-hydroxylation,N3-demethylation,Nabumetone,NADPH,NADPH-dependent,Nafcillin,Naproxen,Nelfinavir,Nevirapine,Niclosamide,Nicotine,Nifedipine,Nilvadipine,Nisoldipine,Nitric Oxide,Nitroprusside,Norepinephrine,Norfloxacin,Nortriptyline,O-deethylation,Ofloxacin,Olanzapine,omega-hydroxylase P450 pathway,Omeprazole,Ondansetron,Oxaliplatin,oxidation,oxidation-reduction process,oxidative deethylation,oxidative demethylation,oxidizes,Oxidoreductase,oxidoreductase activity,Oxtriphylline,oxygen,P450,Palonosetron,Pantoprazole,Pazopanib,Peflox",
        "Group": "Nonylphenol Ethoxylate"
    },
    {
        "SNP ID": "rs2069526",
        "SNP Name": "CYP1A2*1K -739T>G",
        "Risk Allele": "G",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs2069526",
        "Video": "JX91czj1oSg",
        "Tags": "2-hydroxylation,Acenocoumarol,acetaminophen,adverse reaction,aflatoxin B1,Agomelatine,Albendazole,Alitretinoin,alkaloid metabolic process,Almotriptan,Alosetron,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Anagrelide,Anastrozole,antidepressant,antidepressant metabolism,antidepressant response,antidepressant side effect,Antipyrine,Apixaban,Aprepitant,arachidonic acid metabolic process,aromatase activity,aromatic amine,ARTIFICIAL ESTROGEN,Asenapine,Atropine,Axitinib,Azelastine,Azithromycin,Benzyl alcohol,Betaxolol,Bortezomib,Bromazepam,Bromocriptine,Bupivacaine,Buprenorphine,Bupropion,caffeine,caffeine metabolism,caffeine oxidase activity,CANCER,CANCEROUS,Carbamazepine,CARCINOGEN,carcinogenic aromatic amine,Carmustine,Carvedilol,cellular respiration,cellular response to cadmium ion,Chlorpromazine,Chlorzoxazone,Cilostazol,Cimetidine,Cinacalcet,Cinnarizine,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clenbuterol,Clevidipine,Clobetasol propionate,Clomifene,Clomipramine,Clonidine,Clopidogrel,Clotrimazole,clozapine,compounds,Conjugated Estrogens,Cyclobenzaprine,CYP,CYP P450,CYP1A2,CYPIA2,CYTOCHROME,Cytochrome P(3)450,CYTOCHROME P450,Cytochrome P450 1A2,Cytochrome P450 4,Cytochrome P450-P3,Dacarbazine,Dapagliflozin,Dasatinib,Daunorubicin,Delavirdine,demethylase activity,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexfenfluramine,Dexmedetomidine,Diazepam,dibenzo-p-dioxin metabolic process,Diclofenac,Dinoprostone,Diphenhydramine,Domperidone,Dopamine,Doxepin,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Duloxetine,Edetic Acid,Efavirenz,electron carrier activity,electron transport pathway,Eltrombopag,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enoxacin,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,ENZYME,enzyme binding,Epinephrine,epoxygenase P450 pathway,Ergotamine,Erlotinib,Erythromycin,escitalopram,escitalopram adverse reaction,Estradiol,ESTROGEN,Estrone,Estropipate,Ethanol,Etoposide,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Fluphenazine,Flutamide,Fluvastatin,Fluvoxamine,Frovatriptan,Gemfibrozil,Griseofulvin,Guanabenz,Haloperidol,HEME,heme binding,heme-thiolate monooxygenases,Hesperetin,heterocycle metabolic process,heterocyclic amines,Hexobarbital,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydrogen peroxide biosynthetic process,Iloperidone,Imatinib,imidazole,Imipramine,Imiquimod,inhaled insulin,Insulin Aspart,Insulin Detemir,Insulin Glargine,Insulin Glulisine,Insulin Lispro,Insulin Regular,intracellular membrane-bounded organelle,Irbesartan,iron,iron ion binding,Isoniazid,Ketoconazole,Lansoprazole,Leflunomide,Levobupivacaine,Levofloxacin,Lidocaine,LIVER,LIVER ENZYME,Lomefloxacin,Lopinavir,Lorcaserin,Losartan,Lumiracoxib,lung cancer,lung development,Malathion,Maprotiline,Meclizine,Melatonin,Membrane,Menadione,Metal-binding,Methadone,Methimazole,Methotrimeprazine,Methoxsalen,Methoxyflurane,methylation,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,Mirtazapine,Moclobemide,Modafinil,molecular oxygen,monocarboxylic acid metabolic process,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,N-hydroxylation,N3-demethylation,Nabumetone,NADPH,NADPH-dependent,Nafcillin,Naproxen,Nelfinavir,Nevirapine,Niclosamide,Nicotine,Nifedipine,Nilvadipine,Nisoldipine,Nitric Oxide,Nitroprusside,Norepinephrine,Norfloxacin,Nortriptyline,O-deethylation,Ofloxacin,Olanzapine,omega-hydroxylase P450 pathway,Omeprazole,Ondansetron,Oxaliplatin,oxidation,oxidation-reduction process,oxidative deethylation,oxidative demethylation,oxidizes,Oxidoreductase,oxidoreductase activity,Oxtriphylline,oxygen,P450,Palonosetron,Pantoprazole,Pazopanib,Peflox",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs762551",
        "SNP Name": "CYP1A2*1F C164A",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs762551",
        "Video": "JX91czj1oSg",
        "Tags": "2-amino-1-methyl-6-phenylimidazo,2-amino-2,2-amino-3,2-amino-3-methylimidazo,2-amino-6-methyldipyrido,2-hydroxylation,4-dimethylimidazo,8-dimethylimidazo,Acenocoumarol,Acetaminophen,Aciclovir,adverse reaction due to clozapine,aflatoxin B1,Agomelatine,Albendazole,Alitretinoin,alkaloid metabolic process,Almotriptan,Alosetron,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Anagrelide,Anastrozole,Anti-coagulation Therapy,Anti-platelet,antibiotic response,antibiotics,Antipyrine,Apixaban,Aprepitant,arachidonic acid metabolic process,aromatase activity,aromatic amine,Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2,arthritis,ARTIFICIAL ESTROGEN,Asenapine,Atropine,Axitinib,Azelastine,Azithromycin,Benzyl alcohol,Betaxolol,bioactivation of carcinogenic aromatic and heterocyclic amines,birth defect,bladder cancer,Bortezomib,breast cancer,Bromazepam,Bromocriptine,Bupivacaine,Buprenorphine,Bupropion,Caffeine,caffeine and risk of non-fatal myocardial infraction (MI),Caffeine metabolism,caffeine oxidase activity,caffeine pathway,cancer,cancerous,Carbamazepine,carcinogen,carcinogen-metabolizing enzymes,carcinogenic aromatic amine,cardio,cardiovascular,Carmustine,Carvedilol,Catalizes the N-hydroxylation of heterocyclic amines and the O-deethylation of phenacetin,catalyzation,catalyzing 2-hydroxylation,cellular respiration,cellular response to cadmium ion,Chlordiazepoxide,Chlorpromazine,Chlorzoxazone,chronic migraine,cigarette,cigarette smoking,Cilostazol,Cimetidine,Cinacalcet,Cinnarizine,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,cleft lip,cleft palate,Clenbuterol,Clevidipine,Clobetasol propionate,Clomifene,Clomipramine,Clonidine,Clopidogrel,Clotrimazole,Clozapine,coffee intake,colorectal adenoma,Colorectal Cancer,colorectal neoplasia,compounds,Conjugated Estrogens,CVD,Cyclobenzaprine,CYP,CYP P450,CYP1A2,CYPIA2,CYTOCHROME,Cytochrome P(3)450,CYTOCHROME P450,Cytochrome P450 1A2,Cytochrome P450 4,Cytochrome P450-P3,Dacarbazine,Dapagliflozin,Dasatinib,Daunorubicin,defect,deferasirox C,Delavirdine,demethylase activity,Desipramine,Desloratadine,detox,DETOXIFICATION,Dexfenfluramine,Dexmedetomidine,Diazepam,dibenzo-p-dioxin metabolic process,Dibucaine,Diclofenac,Dinoprostone,Diphenhydramine,Domperidone,dopamine,Doxepin,DRUG,drug catabolic process,drug metabolic process,drug metabolism,DRUG POISONING,drug response,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Duloxetine,E2,Edetic Acid,Efavirenz,electron carrier activity,electron transport pathway,Eltrombopag,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enoxacin,ENVIRONMENT,environmental,environmental factors,ENZYME,enzyme binding,Epinephrine,Epithelial Ovarian Cancer,epoxygenase P450 pathway,Ergotamine,Erlotinib,Erythromycin,Esomeprazole,Esophageal Cancer,estradiol,estrogen,estrogen dominance,estrogen related cancer,Estrone,Estropipate,Ethanol,Etoposide,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,fish,flavin,flavoprotein,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Fluphenazine,Flutamide,Fluvastatin,Fluvoxamine,Frovatriptan,gastric cancer,gastric cancer in Helicobacter pylori infection,Gemfibrozil,GlcNAc,Glycosylation,Grepafloxacin,Griseofulvin,Guanabenz,Haloperidol,heart,heart attack,heme,heme binding,Heme group,heme-thiolate monooxygenases,Hesperetin,heterocycle metabolic process,heterocyclic amines,Hexobarbital,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydrogen peroxide biosynthetic process,Iloperidone,Imatinib,imidazole,Imipramine,Imiquimod,Induction by,inhaled insulin,Initiator methionine,Insulin Aspart,Insulin Detemir,Insulin Glargine,Insulin Glulisine,Insulin Lispro,Insulin Regular,intracellular membrane-bounded organelle,Irbesartan,iron,iron ion binding,Isoniazid,Ketoconazole,Lansoprazole,Leflunomide,Levobupivacaine,Levofloxacin,Lidoc",
        "Group": "Nonylphenol Ethoxylate"
    },
    {
        "SNP ID": "rs762551",
        "SNP Name": "CYP1A2*1F C164A",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs762551",
        "Video": "JX91czj1oSg",
        "Tags": "2-amino-1-methyl-6-phenylimidazo,2-amino-2,2-amino-3,2-amino-3-methylimidazo,2-amino-6-methyldipyrido,2-hydroxylation,4-dimethylimidazo,8-dimethylimidazo,Acenocoumarol,Acetaminophen,Aciclovir,adverse reaction due to clozapine,aflatoxin B1,Agomelatine,Albendazole,Alitretinoin,alkaloid metabolic process,Almotriptan,Alosetron,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Anagrelide,Anastrozole,Anti-coagulation Therapy,Anti-platelet,antibiotic response,antibiotics,Antipyrine,Apixaban,Aprepitant,arachidonic acid metabolic process,aromatase activity,aromatic amine,Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2,arthritis,ARTIFICIAL ESTROGEN,Asenapine,Atropine,Axitinib,Azelastine,Azithromycin,Benzyl alcohol,Betaxolol,bioactivation of carcinogenic aromatic and heterocyclic amines,birth defect,bladder cancer,Bortezomib,breast cancer,Bromazepam,Bromocriptine,Bupivacaine,Buprenorphine,Bupropion,Caffeine,caffeine and risk of non-fatal myocardial infraction (MI),Caffeine metabolism,caffeine oxidase activity,caffeine pathway,cancer,cancerous,Carbamazepine,carcinogen,carcinogen-metabolizing enzymes,carcinogenic aromatic amine,cardio,cardiovascular,Carmustine,Carvedilol,Catalizes the N-hydroxylation of heterocyclic amines and the O-deethylation of phenacetin,catalyzation,catalyzing 2-hydroxylation,cellular respiration,cellular response to cadmium ion,Chlordiazepoxide,Chlorpromazine,Chlorzoxazone,chronic migraine,cigarette,cigarette smoking,Cilostazol,Cimetidine,Cinacalcet,Cinnarizine,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,cleft lip,cleft palate,Clenbuterol,Clevidipine,Clobetasol propionate,Clomifene,Clomipramine,Clonidine,Clopidogrel,Clotrimazole,Clozapine,coffee intake,colorectal adenoma,Colorectal Cancer,colorectal neoplasia,compounds,Conjugated Estrogens,CVD,Cyclobenzaprine,CYP,CYP P450,CYP1A2,CYPIA2,CYTOCHROME,Cytochrome P(3)450,CYTOCHROME P450,Cytochrome P450 1A2,Cytochrome P450 4,Cytochrome P450-P3,Dacarbazine,Dapagliflozin,Dasatinib,Daunorubicin,defect,deferasirox C,Delavirdine,demethylase activity,Desipramine,Desloratadine,detox,DETOXIFICATION,Dexfenfluramine,Dexmedetomidine,Diazepam,dibenzo-p-dioxin metabolic process,Dibucaine,Diclofenac,Dinoprostone,Diphenhydramine,Domperidone,dopamine,Doxepin,DRUG,drug catabolic process,drug metabolic process,drug metabolism,DRUG POISONING,drug response,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Duloxetine,E2,Edetic Acid,Efavirenz,electron carrier activity,electron transport pathway,Eltrombopag,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enoxacin,ENVIRONMENT,environmental,environmental factors,ENZYME,enzyme binding,Epinephrine,Epithelial Ovarian Cancer,epoxygenase P450 pathway,Ergotamine,Erlotinib,Erythromycin,Esomeprazole,Esophageal Cancer,estradiol,estrogen,estrogen dominance,estrogen related cancer,Estrone,Estropipate,Ethanol,Etoposide,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,fish,flavin,flavoprotein,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Fluphenazine,Flutamide,Fluvastatin,Fluvoxamine,Frovatriptan,gastric cancer,gastric cancer in Helicobacter pylori infection,Gemfibrozil,GlcNAc,Glycosylation,Grepafloxacin,Griseofulvin,Guanabenz,Haloperidol,heart,heart attack,heme,heme binding,Heme group,heme-thiolate monooxygenases,Hesperetin,heterocycle metabolic process,heterocyclic amines,Hexobarbital,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydrogen peroxide biosynthetic process,Iloperidone,Imatinib,imidazole,Imipramine,Imiquimod,Induction by,inhaled insulin,Initiator methionine,Insulin Aspart,Insulin Detemir,Insulin Glargine,Insulin Glulisine,Insulin Lispro,Insulin Regular,intracellular membrane-bounded organelle,Irbesartan,iron,iron ion binding,Isoniazid,Ketoconazole,Lansoprazole,Leflunomide,Levobupivacaine,Levofloxacin,Lidoc",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs56276455",
        "SNP Name": "CYP1A2*3 D348N",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/14725854",
        "Video": "JX91czj1oSg",
        "Tags": "2-hydroxylation,Acenocoumarol,acetaminophen,aflatoxin B1,Agomelatine,Albendazole,Alitretinoin,alkaloid metabolic process,Almotriptan,Alosetron,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Anagrelide,Anastrozole,Antipyrine,Apixaban,Aprepitant,arachidonic acid metabolic process,aromatase activity,aromatic amine,ARTIFICIAL ESTROGEN,Asenapine,Atropine,Axitinib,Azelastine,Azithromycin,Benzyl alcohol,Betaxolol,Bortezomib,Bromazepam,Bromocriptine,Bupivacaine,Buprenorphine,Bupropion,caffeine,caffeine metabolism,caffeine oxidase activity,CANCER,CANCEROUS,Carbamazepine,CARCINOGEN,carcinogenic aromatic amine,Carmustine,Carvedilol,cellular respiration,cellular response to cadmium ion,Chlorpromazine,Chlorzoxazone,Cilostazol,Cimetidine,Cinacalcet,Cinnarizine,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clenbuterol,Clevidipine,Clobetasol propionate,Clomifene,Clomipramine,Clonidine,Clopidogrel,Clotrimazole,clozapine,compounds,Conjugated Estrogens,Cyclobenzaprine,CYP,CYP P450,CYP1A2,CYPIA2,CYTOCHROME,Cytochrome P(3)450,CYTOCHROME P450,Cytochrome P450 1A2,Cytochrome P450 4,Cytochrome P450-P3,Dacarbazine,Dapagliflozin,Dasatinib,Daunorubicin,Delavirdine,demethylase activity,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexfenfluramine,Dexmedetomidine,Diazepam,dibenzo-p-dioxin metabolic process,Diclofenac,Dinoprostone,Diphenhydramine,Domperidone,Dopamine,Doxepin,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Duloxetine,Edetic Acid,Efavirenz,electron carrier activity,electron transport pathway,Eltrombopag,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enoxacin,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,ENZYME,enzyme binding,Epinephrine,epoxygenase P450 pathway,Ergotamine,Erlotinib,Erythromycin,Estradiol,ESTROGEN,Estrone,Estropipate,Ethanol,Etoposide,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Fluphenazine,Flutamide,Fluvastatin,Fluvoxamine,Frovatriptan,Gemfibrozil,Griseofulvin,Guanabenz,Haloperidol,HEME,heme binding,heme-thiolate monooxygenases,Hesperetin,heterocycle metabolic process,heterocyclic amines,Hexobarbital,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydrogen peroxide biosynthetic process,Iloperidone,Imatinib,imidazole,Imipramine,Imiquimod,inhaled insulin,Insulin Aspart,Insulin Detemir,Insulin Glargine,Insulin Glulisine,Insulin Lispro,Insulin Regular,intracellular membrane-bounded organelle,Irbesartan,iron,iron ion binding,Isoniazid,Ketoconazole,Lansoprazole,Leflunomide,Levobupivacaine,Levofloxacin,Lidocaine,LIVER,LIVER ENZYME,Lomefloxacin,Lopinavir,Lorcaserin,Losartan,Lumiracoxib,lung development,Malathion,Maprotiline,Meclizine,Melatonin,Membrane,Menadione,Metal-binding,Methadone,Methimazole,Methotrimeprazine,Methoxsalen,Methoxyflurane,methylation,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,Mirtazapine,Moclobemide,Modafinil,molecular oxygen,monocarboxylic acid metabolic process,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,N-hydroxylation,N3-demethylation,Nabumetone,NADPH,NADPH-dependent,Nafcillin,Naproxen,Nelfinavir,Nevirapine,Niclosamide,Nicotine,Nifedipine,Nilvadipine,Nisoldipine,Nitric Oxide,Nitroprusside,Norepinephrine,Norfloxacin,Nortriptyline,O-deethylation,Ofloxacin,Olanzapine,omega-hydroxylase P450 pathway,Omeprazole,Ondansetron,Oxaliplatin,oxidation,oxidation-reduction process,oxidative deethylation,oxidative demethylation,oxidizes,Oxidoreductase,oxidoreductase activity,Oxtriphylline,oxygen,P450,Palonosetron,Pantoprazole,Pazopanib,Pefloxacin,Pentamidine,Pentoxifylline,Peripheral membrane protein,Perphenazine,phenacetin,Phenobarbital,Phentermine,Phenylephrine,Phenylpropanolamine,Pimozide,Pipotiaz",
        "Group": "Nonylphenol Ethoxylate"
    },
    {
        "SNP ID": "rs56276455",
        "SNP Name": "CYP1A2*3 D348N",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/14725854",
        "Video": "JX91czj1oSg",
        "Tags": "2-hydroxylation,Acenocoumarol,acetaminophen,aflatoxin B1,Agomelatine,Albendazole,Alitretinoin,alkaloid metabolic process,Almotriptan,Alosetron,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Anagrelide,Anastrozole,Antipyrine,Apixaban,Aprepitant,arachidonic acid metabolic process,aromatase activity,aromatic amine,ARTIFICIAL ESTROGEN,Asenapine,Atropine,Axitinib,Azelastine,Azithromycin,Benzyl alcohol,Betaxolol,Bortezomib,Bromazepam,Bromocriptine,Bupivacaine,Buprenorphine,Bupropion,caffeine,caffeine metabolism,caffeine oxidase activity,CANCER,CANCEROUS,Carbamazepine,CARCINOGEN,carcinogenic aromatic amine,Carmustine,Carvedilol,cellular respiration,cellular response to cadmium ion,Chlorpromazine,Chlorzoxazone,Cilostazol,Cimetidine,Cinacalcet,Cinnarizine,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clenbuterol,Clevidipine,Clobetasol propionate,Clomifene,Clomipramine,Clonidine,Clopidogrel,Clotrimazole,clozapine,compounds,Conjugated Estrogens,Cyclobenzaprine,CYP,CYP P450,CYP1A2,CYPIA2,CYTOCHROME,Cytochrome P(3)450,CYTOCHROME P450,Cytochrome P450 1A2,Cytochrome P450 4,Cytochrome P450-P3,Dacarbazine,Dapagliflozin,Dasatinib,Daunorubicin,Delavirdine,demethylase activity,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexfenfluramine,Dexmedetomidine,Diazepam,dibenzo-p-dioxin metabolic process,Diclofenac,Dinoprostone,Diphenhydramine,Domperidone,Dopamine,Doxepin,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Duloxetine,Edetic Acid,Efavirenz,electron carrier activity,electron transport pathway,Eltrombopag,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enoxacin,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,ENZYME,enzyme binding,Epinephrine,epoxygenase P450 pathway,Ergotamine,Erlotinib,Erythromycin,Estradiol,ESTROGEN,Estrone,Estropipate,Ethanol,Etoposide,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Fluphenazine,Flutamide,Fluvastatin,Fluvoxamine,Frovatriptan,Gemfibrozil,Griseofulvin,Guanabenz,Haloperidol,HEME,heme binding,heme-thiolate monooxygenases,Hesperetin,heterocycle metabolic process,heterocyclic amines,Hexobarbital,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydrogen peroxide biosynthetic process,Iloperidone,Imatinib,imidazole,Imipramine,Imiquimod,inhaled insulin,Insulin Aspart,Insulin Detemir,Insulin Glargine,Insulin Glulisine,Insulin Lispro,Insulin Regular,intracellular membrane-bounded organelle,Irbesartan,iron,iron ion binding,Isoniazid,Ketoconazole,Lansoprazole,Leflunomide,Levobupivacaine,Levofloxacin,Lidocaine,LIVER,LIVER ENZYME,Lomefloxacin,Lopinavir,Lorcaserin,Losartan,Lumiracoxib,lung development,Malathion,Maprotiline,Meclizine,Melatonin,Membrane,Menadione,Metal-binding,Methadone,Methimazole,Methotrimeprazine,Methoxsalen,Methoxyflurane,methylation,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,Mirtazapine,Moclobemide,Modafinil,molecular oxygen,monocarboxylic acid metabolic process,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,N-hydroxylation,N3-demethylation,Nabumetone,NADPH,NADPH-dependent,Nafcillin,Naproxen,Nelfinavir,Nevirapine,Niclosamide,Nicotine,Nifedipine,Nilvadipine,Nisoldipine,Nitric Oxide,Nitroprusside,Norepinephrine,Norfloxacin,Nortriptyline,O-deethylation,Ofloxacin,Olanzapine,omega-hydroxylase P450 pathway,Omeprazole,Ondansetron,Oxaliplatin,oxidation,oxidation-reduction process,oxidative deethylation,oxidative demethylation,oxidizes,Oxidoreductase,oxidoreductase activity,Oxtriphylline,oxygen,P450,Palonosetron,Pantoprazole,Pazopanib,Pefloxacin,Pentamidine,Pentoxifylline,Peripheral membrane protein,Perphenazine,phenacetin,Phenobarbital,Phentermine,Phenylephrine,Phenylpropanolamine,Pimozide,Pipotiaz",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs2470890",
        "SNP Name": "CYP1A2 1545T>C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs2470890",
        "Video": "JX91czj1oSg",
        "Tags": "2-hydroxylation,Acenocoumarol,acetaminophen,aflatoxin B1,Agomelatine,Albendazole,Alitretinoin,alkaloid metabolic process,Almotriptan,Alosetron,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Anagrelide,Anastrozole,antidepressant,antidepressant side effect,Antipyrine,Apixaban,Aprepitant,arachidonic acid metabolic process,aromatase activity,aromatic amine,ARTIFICIAL ESTROGEN,Asenapine,Atropine,Axitinib,Azelastine,Azithromycin,Benzyl alcohol,Betaxolol,Bortezomib,Bromazepam,Bromocriptine,Bupivacaine,Buprenorphine,Bupropion,caffeien and Parkinson's disease,caffeine,caffeine metabolism,caffeine oxidase activity,CANCER,CANCEROUS,Carbamazepine,CARCINOGEN,carcinogenic aromatic amine,Carmustine,Carvedilol,cellular respiration,cellular response to cadmium ion,Chlorpromazine,Chlorzoxazone,Cilostazol,Cimetidine,Cinacalcet,Cinnarizine,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clenbuterol,Clevidipine,Clobetasol propionate,Clomifene,Clomipramine,Clonidine,Clopidogrel,Clotrimazole,clozapine,clozapine metabolism,clozapine response,compounds,Conjugated Estrogens,Cyclobenzaprine,CYP,CYP P450,CYP1A2,CYPIA2,CYTOCHROME,Cytochrome P(3)450,CYTOCHROME P450,Cytochrome P450 1A2,Cytochrome P450 4,Cytochrome P450-P3,Dacarbazine,Dapagliflozin,Dasatinib,Daunorubicin,deferasirox,Delavirdine,demethylase activity,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexfenfluramine,Dexmedetomidine,Diazepam,dibenzo-p-dioxin metabolic process,Diclofenac,Dinoprostone,Diphenhydramine,Domperidone,Dopamine,Doxepin,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Duloxetine,Edetic Acid,Efavirenz,electron carrier activity,electron transport pathway,Eltrombopag,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enoxacin,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,ENZYME,enzyme binding,Epinephrine,epoxygenase P450 pathway,Ergotamine,Erlotinib,Erythromycin,Estradiol,ESTROGEN,Estrone,Estropipate,Ethanol,Etoposide,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Fluphenazine,Flutamide,Fluvastatin,Fluvoxamine,Frovatriptan,Gemfibrozil,Griseofulvin,Guanabenz,Haloperidol,HEME,heme binding,heme-thiolate monooxygenases,Hesperetin,heterocycle metabolic process,heterocyclic amines,Hexobarbital,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydrogen peroxide biosynthetic process,Iloperidone,Imatinib,imidazole,Imipramine,Imiquimod,inhaled insulin,Insulin Aspart,Insulin Detemir,Insulin Glargine,Insulin Glulisine,Insulin Lispro,Insulin Regular,intracellular membrane-bounded organelle,Irbesartan,iron,iron ion binding,Isoniazid,Ketoconazole,Lansoprazole,Leflunomide,Levobupivacaine,Levofloxacin,Lidocaine,LIVER,LIVER ENZYME,Lomefloxacin,Lopinavir,Lorcaserin,Losartan,Lumiracoxib,lung cancer,lung development,Malathion,Maprotiline,Meclizine,Melatonin,Membrane,Menadione,Metal-binding,Methadone,Methimazole,Methotrimeprazine,Methoxsalen,Methoxyflurane,methylation,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,Mirtazapine,Moclobemide,Modafinil,molecular oxygen,monocarboxylic acid metabolic process,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,N-hydroxylation,N3-demethylation,Nabumetone,NADPH,NADPH-dependent,Nafcillin,Naproxen,Nelfinavir,Nevirapine,Niclosamide,Nicotine,Nifedipine,Nilvadipine,Nisoldipine,Nitric Oxide,Nitroprusside,Norepinephrine,Norfloxacin,Nortriptyline,O-deethylation,Ofloxacin,Olanzapine,omega-hydroxylase P450 pathway,Omeprazole,Ondansetron,Oxaliplatin,oxidation,oxidation-reduction process,oxidative deethylation,oxidative demethylation,oxidizes,Oxidoreductase,oxidoreductase activity,Oxtriphylline,oxygen,P450,Palonosetron,Pantoprazole,Parkinson,Parkinson's disease,paroxetine",
        "Group": "Nonylphenol Ethoxylate"
    },
    {
        "SNP ID": "rs2470890",
        "SNP Name": "CYP1A2 1545T>C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs2470890",
        "Video": "JX91czj1oSg",
        "Tags": "2-hydroxylation,Acenocoumarol,acetaminophen,aflatoxin B1,Agomelatine,Albendazole,Alitretinoin,alkaloid metabolic process,Almotriptan,Alosetron,Aminoglutethimide,Aminophenazone,Aminophylline,Amiodarone,Amitriptyline,Amlodipine,Anagrelide,Anastrozole,antidepressant,antidepressant side effect,Antipyrine,Apixaban,Aprepitant,arachidonic acid metabolic process,aromatase activity,aromatic amine,ARTIFICIAL ESTROGEN,Asenapine,Atropine,Axitinib,Azelastine,Azithromycin,Benzyl alcohol,Betaxolol,Bortezomib,Bromazepam,Bromocriptine,Bupivacaine,Buprenorphine,Bupropion,caffeien and Parkinson's disease,caffeine,caffeine metabolism,caffeine oxidase activity,CANCER,CANCEROUS,Carbamazepine,CARCINOGEN,carcinogenic aromatic amine,Carmustine,Carvedilol,cellular respiration,cellular response to cadmium ion,Chlorpromazine,Chlorzoxazone,Cilostazol,Cimetidine,Cinacalcet,Cinnarizine,Ciprofloxacin,Cisapride,Citalopram,Clarithromycin,Clenbuterol,Clevidipine,Clobetasol propionate,Clomifene,Clomipramine,Clonidine,Clopidogrel,Clotrimazole,clozapine,clozapine metabolism,clozapine response,compounds,Conjugated Estrogens,Cyclobenzaprine,CYP,CYP P450,CYP1A2,CYPIA2,CYTOCHROME,Cytochrome P(3)450,CYTOCHROME P450,Cytochrome P450 1A2,Cytochrome P450 4,Cytochrome P450-P3,Dacarbazine,Dapagliflozin,Dasatinib,Daunorubicin,deferasirox,Delavirdine,demethylase activity,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexfenfluramine,Dexmedetomidine,Diazepam,dibenzo-p-dioxin metabolic process,Diclofenac,Dinoprostone,Diphenhydramine,Domperidone,Dopamine,Doxepin,DRUG,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Duloxetine,Edetic Acid,Efavirenz,electron carrier activity,electron transport pathway,Eltrombopag,Endoplasmic reticulum,Endoplasmic reticulum membrane,Enoxacin,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,ENZYME,enzyme binding,Epinephrine,epoxygenase P450 pathway,Ergotamine,Erlotinib,Erythromycin,Estradiol,ESTROGEN,Estrone,Estropipate,Ethanol,Etoposide,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluorouracil,Fluoxetine,Fluphenazine,Flutamide,Fluvastatin,Fluvoxamine,Frovatriptan,Gemfibrozil,Griseofulvin,Guanabenz,Haloperidol,HEME,heme binding,heme-thiolate monooxygenases,Hesperetin,heterocycle metabolic process,heterocyclic amines,Hexobarbital,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydrogen peroxide biosynthetic process,Iloperidone,Imatinib,imidazole,Imipramine,Imiquimod,inhaled insulin,Insulin Aspart,Insulin Detemir,Insulin Glargine,Insulin Glulisine,Insulin Lispro,Insulin Regular,intracellular membrane-bounded organelle,Irbesartan,iron,iron ion binding,Isoniazid,Ketoconazole,Lansoprazole,Leflunomide,Levobupivacaine,Levofloxacin,Lidocaine,LIVER,LIVER ENZYME,Lomefloxacin,Lopinavir,Lorcaserin,Losartan,Lumiracoxib,lung cancer,lung development,Malathion,Maprotiline,Meclizine,Melatonin,Membrane,Menadione,Metal-binding,Methadone,Methimazole,Methotrimeprazine,Methoxsalen,Methoxyflurane,methylation,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,Mirtazapine,Moclobemide,Modafinil,molecular oxygen,monocarboxylic acid metabolic process,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,N-hydroxylation,N3-demethylation,Nabumetone,NADPH,NADPH-dependent,Nafcillin,Naproxen,Nelfinavir,Nevirapine,Niclosamide,Nicotine,Nifedipine,Nilvadipine,Nisoldipine,Nitric Oxide,Nitroprusside,Norepinephrine,Norfloxacin,Nortriptyline,O-deethylation,Ofloxacin,Olanzapine,omega-hydroxylase P450 pathway,Omeprazole,Ondansetron,Oxaliplatin,oxidation,oxidation-reduction process,oxidative deethylation,oxidative demethylation,oxidizes,Oxidoreductase,oxidoreductase activity,Oxtriphylline,oxygen,P450,Palonosetron,Pantoprazole,Parkinson,Parkinson's disease,paroxetine",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs3825932",
        "SNP Name": "CTSH A6975G",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Benzethonium Chloride"
    },
    {
        "SNP ID": "rs2733103",
        "SNP Name": "MTHFS - ST20 MTHFS G56057A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2733103",
        "Video": null,
        "Tags": "10-methenyl-tetrahydrofolate synthetase,10-methenyltetrahydrofolate,5,5-formyltetrahydrofolate cyclo-ligase,5-formyltetrahydrofolate cyclo-ligase activity,5-formyltetrahydrofolate cyclo-ligase family,5-MTHF,Acetylation,Alternative splicing,amino acids,ATP,ATP + 5-formyltetrahydrofolate = ADP + phosphate + 5,ATP binding,ATP-binding,birth defect,cardiovascular,cellular energy,CHDs,Complete proteome,congenital heart defects,CVD,Cytoplasm,defect,energy,folate,Folate-binding,folic acid,folic acid binding,folic acid-containing compound biosynthetic process,formate metabolic process,formyltetrahydrofolate,G39646A,heart,heart disease,homocysteine,L-5-MTHF,Ligase,Magnesium,mitochondria,mitochondrion,Monomer,MTHFS,Nucleotide-binding,phosphate,plasma folate,Polymorphism,purines,Reference proteome,regulate carbon flow through the folate-dependent one-carbon metabolic network that supplies carbon for the biosynthesis of,rs2733103,tetrahydrofolate,tetrahydrofolate metabolic process,tetrahydrofolate metabolism,thymidine,transsulfuration,transsulfuration pathways",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2733103",
        "SNP Name": "MTHFS - ST20 MTHFS G56057A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2733103",
        "Video": null,
        "Tags": "10-methenyl-tetrahydrofolate synthetase,10-methenyltetrahydrofolate,5,5-formyltetrahydrofolate cyclo-ligase,5-formyltetrahydrofolate cyclo-ligase activity,5-formyltetrahydrofolate cyclo-ligase family,5-MTHF,Acetylation,Alternative splicing,amino acids,ATP,ATP + 5-formyltetrahydrofolate = ADP + phosphate + 5,ATP binding,ATP-binding,birth defect,cardiovascular,cellular energy,CHDs,Complete proteome,congenital heart defects,CVD,Cytoplasm,defect,energy,folate,Folate-binding,folic acid,folic acid binding,folic acid-containing compound biosynthetic process,formate metabolic process,formyltetrahydrofolate,G39646A,heart,heart disease,homocysteine,L-5-MTHF,Ligase,Magnesium,mitochondria,mitochondrion,Monomer,MTHFS,Nucleotide-binding,phosphate,plasma folate,Polymorphism,purines,Reference proteome,regulate carbon flow through the folate-dependent one-carbon metabolic network that supplies carbon for the biosynthesis of,rs2733103,tetrahydrofolate,tetrahydrofolate metabolic process,tetrahydrofolate metabolism,thymidine,transsulfuration,transsulfuration pathways",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2733103",
        "SNP Name": "MTHFS - ST20 MTHFS G56057A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2733103",
        "Video": null,
        "Tags": "10-methenyl-tetrahydrofolate synthetase,10-methenyltetrahydrofolate,5,5-formyltetrahydrofolate cyclo-ligase,5-formyltetrahydrofolate cyclo-ligase activity,5-formyltetrahydrofolate cyclo-ligase family,5-MTHF,Acetylation,Alternative splicing,amino acids,ATP,ATP + 5-formyltetrahydrofolate = ADP + phosphate + 5,ATP binding,ATP-binding,birth defect,cardiovascular,cellular energy,CHDs,Complete proteome,congenital heart defects,CVD,Cytoplasm,defect,energy,folate,Folate-binding,folic acid,folic acid binding,folic acid-containing compound biosynthetic process,formate metabolic process,formyltetrahydrofolate,G39646A,heart,heart disease,homocysteine,L-5-MTHF,Ligase,Magnesium,mitochondria,mitochondrion,Monomer,MTHFS,Nucleotide-binding,phosphate,plasma folate,Polymorphism,purines,Reference proteome,regulate carbon flow through the folate-dependent one-carbon metabolic network that supplies carbon for the biosynthesis of,rs2733103,tetrahydrofolate,tetrahydrofolate metabolic process,tetrahydrofolate metabolism,thymidine,transsulfuration,transsulfuration pathways",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs2733103",
        "SNP Name": "MTHFS - ST20 MTHFS G56057A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2733103",
        "Video": null,
        "Tags": "10-methenyl-tetrahydrofolate synthetase,10-methenyltetrahydrofolate,5,5-formyltetrahydrofolate cyclo-ligase,5-formyltetrahydrofolate cyclo-ligase activity,5-formyltetrahydrofolate cyclo-ligase family,5-MTHF,Acetylation,Alternative splicing,amino acids,ATP,ATP + 5-formyltetrahydrofolate = ADP + phosphate + 5,ATP binding,ATP-binding,birth defect,cardiovascular,cellular energy,CHDs,Complete proteome,congenital heart defects,CVD,Cytoplasm,defect,energy,folate,Folate-binding,folic acid,folic acid binding,folic acid-containing compound biosynthetic process,formate metabolic process,formyltetrahydrofolate,G39646A,heart,heart disease,homocysteine,L-5-MTHF,Ligase,Magnesium,mitochondria,mitochondrion,Monomer,MTHFS,Nucleotide-binding,phosphate,plasma folate,Polymorphism,purines,Reference proteome,regulate carbon flow through the folate-dependent one-carbon metabolic network that supplies carbon for the biosynthesis of,rs2733103,tetrahydrofolate,tetrahydrofolate metabolic process,tetrahydrofolate metabolism,thymidine,transsulfuration,transsulfuration pathways",
        "Group": "Trans-Sulfuration Pathway"
    },
    {
        "SNP ID": "rs6495446",
        "SNP Name": "MTHFS - ST20 MTHFS G39646A",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6495446",
        "Video": null,
        "Tags": "10-methenyl-tetrahydrofolate synthetase,10-methenyltetrahydrofolate,5,5-formyltetrahydrofolate cyclo-ligase,5-formyltetrahydrofolate cyclo-ligase activity,5-formyltetrahydrofolate cyclo-ligase family,5-MTHF,Acetylation,Alternative splicing,amino acids,Atherosclerosis Risk,ATP,ATP + 5-formyltetrahydrofolate = ADP + phosphate + 5,ATP binding,ATP-binding,blood pressure,cardiovascular,cellular energy,chronic kidney disease,CKD,Complete proteome,CVD,Cytoplasm,electrolytes,energy,folate,Folate-binding,folic acid,folic acid binding,folic acid-containing compound biosynthetic process,formate metabolic process,formyltetrahydrofolate,G39646A,heart,heart disease,high BP,hypertension,kidney,L-5-MTHF,Ligase,low BP,Magnesium,mitochondria,mitochondrion,Monomer,MTHFS,Nucleotide-binding,phosphate,Polymorphism,purines,Reference proteome,regulate carbon flow through the folate-dependent one-carbon metabolic network that supplies carbon for the biosynthesis of,rs6495446,tetrahydrofolate,tetrahydrofolate metabolic process,tetrahydrofolate metabolism,thymidine",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs6495446",
        "SNP Name": "MTHFS - ST20 MTHFS G39646A",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6495446",
        "Video": null,
        "Tags": "10-methenyl-tetrahydrofolate synthetase,10-methenyltetrahydrofolate,5,5-formyltetrahydrofolate cyclo-ligase,5-formyltetrahydrofolate cyclo-ligase activity,5-formyltetrahydrofolate cyclo-ligase family,5-MTHF,Acetylation,Alternative splicing,amino acids,Atherosclerosis Risk,ATP,ATP + 5-formyltetrahydrofolate = ADP + phosphate + 5,ATP binding,ATP-binding,blood pressure,cardiovascular,cellular energy,chronic kidney disease,CKD,Complete proteome,CVD,Cytoplasm,electrolytes,energy,folate,Folate-binding,folic acid,folic acid binding,folic acid-containing compound biosynthetic process,formate metabolic process,formyltetrahydrofolate,G39646A,heart,heart disease,high BP,hypertension,kidney,L-5-MTHF,Ligase,low BP,Magnesium,mitochondria,mitochondrion,Monomer,MTHFS,Nucleotide-binding,phosphate,Polymorphism,purines,Reference proteome,regulate carbon flow through the folate-dependent one-carbon metabolic network that supplies carbon for the biosynthesis of,rs6495446,tetrahydrofolate,tetrahydrofolate metabolic process,tetrahydrofolate metabolism,thymidine",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs6495446",
        "SNP Name": "MTHFS - ST20 MTHFS G39646A",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6495446",
        "Video": null,
        "Tags": "10-methenyl-tetrahydrofolate synthetase,10-methenyltetrahydrofolate,5,5-formyltetrahydrofolate cyclo-ligase,5-formyltetrahydrofolate cyclo-ligase activity,5-formyltetrahydrofolate cyclo-ligase family,5-MTHF,Acetylation,Alternative splicing,amino acids,Atherosclerosis Risk,ATP,ATP + 5-formyltetrahydrofolate = ADP + phosphate + 5,ATP binding,ATP-binding,blood pressure,cardiovascular,cellular energy,chronic kidney disease,CKD,Complete proteome,CVD,Cytoplasm,electrolytes,energy,folate,Folate-binding,folic acid,folic acid binding,folic acid-containing compound biosynthetic process,formate metabolic process,formyltetrahydrofolate,G39646A,heart,heart disease,high BP,hypertension,kidney,L-5-MTHF,Ligase,low BP,Magnesium,mitochondria,mitochondrion,Monomer,MTHFS,Nucleotide-binding,phosphate,Polymorphism,purines,Reference proteome,regulate carbon flow through the folate-dependent one-carbon metabolic network that supplies carbon for the biosynthesis of,rs6495446,tetrahydrofolate,tetrahydrofolate metabolic process,tetrahydrofolate metabolism,thymidine",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs6495446",
        "SNP Name": "MTHFS - ST20 MTHFS G39646A",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6495446",
        "Video": null,
        "Tags": "10-methenyl-tetrahydrofolate synthetase,10-methenyltetrahydrofolate,5,5-formyltetrahydrofolate cyclo-ligase,5-formyltetrahydrofolate cyclo-ligase activity,5-formyltetrahydrofolate cyclo-ligase family,5-MTHF,Acetylation,Alternative splicing,amino acids,Atherosclerosis Risk,ATP,ATP + 5-formyltetrahydrofolate = ADP + phosphate + 5,ATP binding,ATP-binding,blood pressure,cardiovascular,cellular energy,chronic kidney disease,CKD,Complete proteome,CVD,Cytoplasm,electrolytes,energy,folate,Folate-binding,folic acid,folic acid binding,folic acid-containing compound biosynthetic process,formate metabolic process,formyltetrahydrofolate,G39646A,heart,heart disease,high BP,hypertension,kidney,L-5-MTHF,Ligase,low BP,Magnesium,mitochondria,mitochondrion,Monomer,MTHFS,Nucleotide-binding,phosphate,Polymorphism,purines,Reference proteome,regulate carbon flow through the folate-dependent one-carbon metabolic network that supplies carbon for the biosynthesis of,rs6495446,tetrahydrofolate,tetrahydrofolate metabolic process,tetrahydrofolate metabolism,thymidine",
        "Group": "Trans-Sulfuration Pathway"
    },
    {
        "SNP ID": "rs4932178",
        "SNP Name": "FURIN variant",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs17514846",
        "SNP Name": "FURIN variant",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs2229765",
        "SNP Name": "IGF1R variant",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.snpedia.com/index.php/Rs2229765",
        "Video": null,
        "Tags": null,
        "Group": "Mercury (Thiomersal/Thimerosal)"
    },
    {
        "SNP ID": "rs2229765",
        "SNP Name": "IGF1R variant",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs2229765",
        "Video": null,
        "Tags": null,
        "Group": "IgA"
    },
    {
        "SNP ID": "rs28940578",
        "SNP Name": "MeFV M694I variant",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs28940578",
        "Video": null,
        "Tags": null,
        "Group": "Other Immune Factors"
    },
    {
        "SNP ID": "rs11466023",
        "SNP Name": "MeFV P369S variant",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs11466023",
        "Video": null,
        "Tags": null,
        "Group": "Other Immune Factors"
    },
    {
        "SNP ID": "rs3743930",
        "SNP Name": "MeFV E148Q variant",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs3743930",
        "Video": null,
        "Tags": null,
        "Group": "Other Immune Factors"
    },
    {
        "SNP ID": "rs1800067",
        "SNP Name": "ERCC4 R415Q",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "A-Tocopheryl Hydrogen Succinate"
    },
    {
        "SNP ID": "rs1799801",
        "SNP Name": "ERCC4 S835S",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "A-Tocopheryl Hydrogen Succinate"
    },
    {
        "SNP ID": "rs6497563",
        "SNP Name": "UQCRC2 variant",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs459894",
        "SNP Name": "NDUFAB1 A23601488G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs459894",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs459894",
        "SNP Name": "NDUFAB1 A23601488G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs459894",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs1801275",
        "SNP Name": "IL4R Q576R variant",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs1801275",
        "Video": null,
        "Tags": null,
        "Group": "Other Immune Factors"
    },
    {
        "SNP ID": "rs35979293",
        "SNP Name": "CD19 Pro235Pro",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "FD&C Yellow #6 Aluminum Lake Dye"
    },
    {
        "SNP ID": "rs17221417",
        "SNP Name": "NOD2 13533C>G",
        "Risk Allele": "G",
        "Your Allele": "GC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs17221417",
        "SNP Name": "NOD2 13533C>G",
        "Risk Allele": "G",
        "Your Allele": "GC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "IgA"
    },
    {
        "SNP ID": "rs17221417",
        "SNP Name": "NOD2 13533C>G",
        "Risk Allele": "G",
        "Your Allele": "GC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2066843",
        "SNP Name": "NOD2 19150C>T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs2066843",
        "SNP Name": "NOD2 19150C>T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "IgA"
    },
    {
        "SNP ID": "rs2066843",
        "SNP Name": "NOD2 19150C>T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2066844",
        "SNP Name": "NOD2 Arg675Trp",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs2066844",
        "SNP Name": "NOD2 Arg675Trp",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "IgA"
    },
    {
        "SNP ID": "rs2066844",
        "SNP Name": "NOD2 Arg675Trp",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2066845",
        "SNP Name": "NOD2 Gly881Arg",
        "Risk Allele": "C",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs2066845",
        "SNP Name": "NOD2 Gly881Arg",
        "Risk Allele": "C",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "IgA"
    },
    {
        "SNP ID": "rs2066845",
        "SNP Name": "NOD2 Gly881Arg",
        "Risk Allele": "C",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs5743289",
        "SNP Name": "NOD2 30725C>T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs5743289",
        "SNP Name": "NOD2 30725C>T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "IgA"
    },
    {
        "SNP ID": "rs5743289",
        "SNP Name": "NOD2 30725C>T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs168924",
        "SNP Name": "SLC6A2 A5003G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs168924",
        "Video": null,
        "Tags": "ADHD,altered mentation,Alternative splicing,amine,Amine transporter,antidepressants,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,cell surface,CFS,Chronic Fatigue Syndrome,Complete proteome,depression,Disease mutation,epinephrine,fatigue,Glycoprotein,integral component of plasma membrane,Interacts with PRKCABP,lightheadedness,Membrane,membrane raft,Membrane; Multi-pass membrane protein,mental disorder,monoamine transmembrane transporter activity,monoamine transport,NET,neuron projection,Neurotransmitter transport,neurotransmitters,noradrenaline,norepinephrine,norepinephrine transport,norepinephrine:sodium symporter activity,OI,Orthostatic intolerance,pharmacogenetics,plasma membrane,Plasma norepinephrine concentration is abnormally high,Polymorphism,postural tachycardia,POTS,PRKCABP,protein binding,Reference proteome,response to drug,response to pain,SLC6A2,SLC6A2 subfamily,Smoking during Pregnancy,sodium,sodium-dependent,Sodium-dependent noradrenaline transporter,Solute carrier family 6 member 2,Symport,synaptic transmission,syncope,syndrome,Terminates the action of noradrenaline by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs168924",
        "SNP Name": "SLC6A2 A5003G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs168924",
        "Video": null,
        "Tags": "ADHD,altered mentation,Alternative splicing,amine,Amine transporter,antidepressants,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,cell surface,CFS,Chronic Fatigue Syndrome,Complete proteome,depression,Disease mutation,epinephrine,fatigue,Glycoprotein,integral component of plasma membrane,Interacts with PRKCABP,lightheadedness,Membrane,membrane raft,Membrane; Multi-pass membrane protein,mental disorder,monoamine transmembrane transporter activity,monoamine transport,NET,neuron projection,Neurotransmitter transport,neurotransmitters,noradrenaline,norepinephrine,norepinephrine transport,norepinephrine:sodium symporter activity,OI,Orthostatic intolerance,pharmacogenetics,plasma membrane,Plasma norepinephrine concentration is abnormally high,Polymorphism,postural tachycardia,POTS,PRKCABP,protein binding,Reference proteome,response to drug,response to pain,SLC6A2,SLC6A2 subfamily,Smoking during Pregnancy,sodium,sodium-dependent,Sodium-dependent noradrenaline transporter,Solute carrier family 6 member 2,Symport,synaptic transmission,syncope,syndrome,Terminates the action of noradrenaline by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2242446",
        "SNP Name": "SLC6A2 C5884T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2242446",
        "Video": null,
        "Tags": "ADHD,altered mentation,Alternative splicing,amine,Amine transporter,antidepressants,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,blood pressure,catecholamine,cell surface,CFS,Chronic Fatigue Syndrome,Complete proteome,depression,Disease mutation,epinephrine,Exercise,fatigue,Financial and Psychological Risk Attitudes,Glycoprotein,high BP,hypertension,integral component of plasma membrane,Interacts with PRKCABP,lightheadedness,major depression,Membrane,membrane raft,Membrane; Multi-pass membrane protein,mental disorder,monoamine transmembrane transporter activity,monoamine transport,NET,neuron projection,Neurotransmitter transport,neurotransmitters,nicotine receptor (CHRNA4),noradrenaline,norepinephrine,norepinephrine transport,norepinephrine:sodium symporter activity,OI,orepinephrine transporter,Orthostatic intolerance,pharmacogenetics,plasma membrane,Plasma norepinephrine concentration is abnormally high,Polymorphism,postural tachycardia,POTS,PRKCABP,protein binding,Reference proteome,response to drug,response to pain,SLC6A2,SLC6A2 subfamily,Smoking during Pregnancy,sodium,sodium-dependent,Sodium-dependent noradrenaline transporter,Solute carrier family 6 member 2,Symport,synaptic transmission,syncope,syndrome,Terminates the action of noradrenaline by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2242446",
        "SNP Name": "SLC6A2 C5884T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2242446",
        "Video": null,
        "Tags": "ADHD,altered mentation,Alternative splicing,amine,Amine transporter,antidepressants,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,blood pressure,catecholamine,cell surface,CFS,Chronic Fatigue Syndrome,Complete proteome,depression,Disease mutation,epinephrine,Exercise,fatigue,Financial and Psychological Risk Attitudes,Glycoprotein,high BP,hypertension,integral component of plasma membrane,Interacts with PRKCABP,lightheadedness,major depression,Membrane,membrane raft,Membrane; Multi-pass membrane protein,mental disorder,monoamine transmembrane transporter activity,monoamine transport,NET,neuron projection,Neurotransmitter transport,neurotransmitters,nicotine receptor (CHRNA4),noradrenaline,norepinephrine,norepinephrine transport,norepinephrine:sodium symporter activity,OI,orepinephrine transporter,Orthostatic intolerance,pharmacogenetics,plasma membrane,Plasma norepinephrine concentration is abnormally high,Polymorphism,postural tachycardia,POTS,PRKCABP,protein binding,Reference proteome,response to drug,response to pain,SLC6A2,SLC6A2 subfamily,Smoking during Pregnancy,sodium,sodium-dependent,Sodium-dependent noradrenaline transporter,Solute carrier family 6 member 2,Symport,synaptic transmission,syncope,syndrome,Terminates the action of noradrenaline by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs36020",
        "SNP Name": "SLC6A2 C28547T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs36020",
        "Video": null,
        "Tags": "ADHD,altered mentation,Alternative splicing,amine,Amine transporter,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,cell surface,CFS,Chronic Fatigue Syndrome,Complete proteome,Disease mutation,epinephrine,fatigue,Glycoprotein,integral component of plasma membrane,Interacts with PRKCABP,lightheadedness,Membrane,membrane raft,Membrane; Multi-pass membrane protein,mental disorder,monoamine transmembrane transporter activity,monoamine transport,NET,neuron projection,Neurotransmitter transport,neurotransmitters,noradrenaline,norepinephrine,norepinephrine transport,norepinephrine:sodium symporter activity,OI,Orthostatic intolerance,plasma membrane,Plasma norepinephrine concentration is abnormally high,Polymorphism,postural tachycardia,POTS,PRKCABP,protein binding,Reference proteome,response to drug,response to pain,Sexually dimorphic effects,SLC6A2,SLC6A2 subfamily,sodium,sodium-dependent,Sodium-dependent noradrenaline transporter,Solute carrier family 6 member 2,Symport,synaptic transmission,syncope,syndrome,Terminates the action of noradrenaline by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs36020",
        "SNP Name": "SLC6A2 C28547T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs36020",
        "Video": null,
        "Tags": "ADHD,altered mentation,Alternative splicing,amine,Amine transporter,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,cell surface,CFS,Chronic Fatigue Syndrome,Complete proteome,Disease mutation,epinephrine,fatigue,Glycoprotein,integral component of plasma membrane,Interacts with PRKCABP,lightheadedness,Membrane,membrane raft,Membrane; Multi-pass membrane protein,mental disorder,monoamine transmembrane transporter activity,monoamine transport,NET,neuron projection,Neurotransmitter transport,neurotransmitters,noradrenaline,norepinephrine,norepinephrine transport,norepinephrine:sodium symporter activity,OI,Orthostatic intolerance,plasma membrane,Plasma norepinephrine concentration is abnormally high,Polymorphism,postural tachycardia,POTS,PRKCABP,protein binding,Reference proteome,response to drug,response to pain,Sexually dimorphic effects,SLC6A2,SLC6A2 subfamily,sodium,sodium-dependent,Sodium-dependent noradrenaline transporter,Solute carrier family 6 member 2,Symport,synaptic transmission,syncope,syndrome,Terminates the action of noradrenaline by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs3785152",
        "SNP Name": "SLC6A2 T32009C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3785152",
        "Video": null,
        "Tags": "ADHD,altered mentation,Alternative splicing,amine,Amine transporter,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,cell surface,CFS,Chronic Fatigue Syndrome,Complete proteome,Continuous Performance Task,Disease mutation,dopamine,epinephrine,fatigue,Glycoprotein,integral component of plasma membrane,Interacts with PRKCABP,lightheadedness,Membrane,membrane raft,Membrane; Multi-pass membrane protein,mental disorder,monoamine transmembrane transporter activity,monoamine transport,NET,neuron projection,Neurotransmitter transport,neurotransmitters,noradrenaline,norepinephrine,norepinephrine transport,norepinephrine:sodium symporter activity,OI,Orthostatic intolerance,plasma membrane,Plasma norepinephrine concentration is abnormally high,Polymorphism,postural tachycardia,POTS,PRKCABP,protein binding,Reference proteome,response to drug,response to pain,Sexually dimorphic effects,SLC6A2,SLC6A2 subfamily,Smoking during Pregnancy,sodium,sodium-dependent,Sodium-dependent noradrenaline transporter,Solute carrier family 6 member 2,Symport,synaptic transmission,syncope,syndrome,Terminates the action of noradrenaline by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs3785152",
        "SNP Name": "SLC6A2 T32009C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3785152",
        "Video": null,
        "Tags": "ADHD,altered mentation,Alternative splicing,amine,Amine transporter,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,cell surface,CFS,Chronic Fatigue Syndrome,Complete proteome,Continuous Performance Task,Disease mutation,dopamine,epinephrine,fatigue,Glycoprotein,integral component of plasma membrane,Interacts with PRKCABP,lightheadedness,Membrane,membrane raft,Membrane; Multi-pass membrane protein,mental disorder,monoamine transmembrane transporter activity,monoamine transport,NET,neuron projection,Neurotransmitter transport,neurotransmitters,noradrenaline,norepinephrine,norepinephrine transport,norepinephrine:sodium symporter activity,OI,Orthostatic intolerance,plasma membrane,Plasma norepinephrine concentration is abnormally high,Polymorphism,postural tachycardia,POTS,PRKCABP,protein binding,Reference proteome,response to drug,response to pain,Sexually dimorphic effects,SLC6A2,SLC6A2 subfamily,Smoking during Pregnancy,sodium,sodium-dependent,Sodium-dependent noradrenaline transporter,Solute carrier family 6 member 2,Symport,synaptic transmission,syncope,syndrome,Terminates the action of noradrenaline by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs40147",
        "SNP Name": "SLC6A2 G32299A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs40147",
        "Video": null,
        "Tags": "ADHD,altered mentation,Alternative splicing,amine,Amine transporter,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,cell surface,CFS,Chronic Fatigue Syndrome,Complete proteome,Continuous Performance Task,Disease mutation,dopamine,epinephrine,fatigue,Glycoprotein,integral component of plasma membrane,Interacts with PRKCABP,lightheadedness,Membrane,membrane raft,Membrane; Multi-pass membrane protein,mental disorder,monoamine transmembrane transporter activity,monoamine transport,NET,neuron projection,Neurotransmitter transport,neurotransmitters,noradrenaline,norepinephrine,norepinephrine transport,norepinephrine:sodium symporter activity,OI,Orthostatic intolerance,plasma membrane,Plasma norepinephrine concentration is abnormally high,Polymorphism,postural tachycardia,POTS,PRKCABP,protein binding,Reference proteome,response to drug,response to pain,Sexually dimorphic effects,SLC6A2,SLC6A2 subfamily,sodium,sodium-dependent,Sodium-dependent noradrenaline transporter,Solute carrier family 6 member 2,Symport,synaptic transmission,syncope,syndrome,Terminates the action of noradrenaline by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs40147",
        "SNP Name": "SLC6A2 G32299A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs40147",
        "Video": null,
        "Tags": "ADHD,altered mentation,Alternative splicing,amine,Amine transporter,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,cell surface,CFS,Chronic Fatigue Syndrome,Complete proteome,Continuous Performance Task,Disease mutation,dopamine,epinephrine,fatigue,Glycoprotein,integral component of plasma membrane,Interacts with PRKCABP,lightheadedness,Membrane,membrane raft,Membrane; Multi-pass membrane protein,mental disorder,monoamine transmembrane transporter activity,monoamine transport,NET,neuron projection,Neurotransmitter transport,neurotransmitters,noradrenaline,norepinephrine,norepinephrine transport,norepinephrine:sodium symporter activity,OI,Orthostatic intolerance,plasma membrane,Plasma norepinephrine concentration is abnormally high,Polymorphism,postural tachycardia,POTS,PRKCABP,protein binding,Reference proteome,response to drug,response to pain,Sexually dimorphic effects,SLC6A2,SLC6A2 subfamily,sodium,sodium-dependent,Sodium-dependent noradrenaline transporter,Solute carrier family 6 member 2,Symport,synaptic transmission,syncope,syndrome,Terminates the action of noradrenaline by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs3785157",
        "SNP Name": "SLC6A2 C45295T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3785157",
        "Video": null,
        "Tags": "ADHD,altered mentation,Alternative splicing,amine,Amine transporter,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,cell surface,CFS,Chronic Fatigue Syndrome,Complete proteome,Disease mutation,epinephrine,fatigue,Glycoprotein,integral component of plasma membrane,Interacts with PRKCABP,lightheadedness,Membrane,membrane raft,Membrane; Multi-pass membrane protein,mental disorder,monoamine transmembrane transporter activity,monoamine transport,NET,neuron projection,Neurotransmitter transport,neurotransmitters,noradrenaline,norepinephrine,norepinephrine transport,norepinephrine:sodium symporter activity,OI,Orthostatic intolerance,plasma membrane,Plasma norepinephrine concentration is abnormally high,Polymorphism,postural tachycardia,POTS,PRKCABP,protein binding,Reference proteome,response to drug,response to pain,Sexually dimorphic effects,SLC6A2,SLC6A2 subfamily,Smoking during Pregnancy,sodium,sodium-dependent,Sodium-dependent noradrenaline transporter,Solute carrier family 6 member 2,Symport,synaptic transmission,syncope,syndrome,Terminates the action of noradrenaline by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs3785157",
        "SNP Name": "SLC6A2 C45295T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3785157",
        "Video": null,
        "Tags": "ADHD,altered mentation,Alternative splicing,amine,Amine transporter,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,cell surface,CFS,Chronic Fatigue Syndrome,Complete proteome,Disease mutation,epinephrine,fatigue,Glycoprotein,integral component of plasma membrane,Interacts with PRKCABP,lightheadedness,Membrane,membrane raft,Membrane; Multi-pass membrane protein,mental disorder,monoamine transmembrane transporter activity,monoamine transport,NET,neuron projection,Neurotransmitter transport,neurotransmitters,noradrenaline,norepinephrine,norepinephrine transport,norepinephrine:sodium symporter activity,OI,Orthostatic intolerance,plasma membrane,Plasma norepinephrine concentration is abnormally high,Polymorphism,postural tachycardia,POTS,PRKCABP,protein binding,Reference proteome,response to drug,response to pain,Sexually dimorphic effects,SLC6A2,SLC6A2 subfamily,Smoking during Pregnancy,sodium,sodium-dependent,Sodium-dependent noradrenaline transporter,Solute carrier family 6 member 2,Symport,synaptic transmission,syncope,syndrome,Terminates the action of noradrenaline by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs5568",
        "SNP Name": "SLC6A2 A45583C",
        "Risk Allele": "C",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5568",
        "Video": null,
        "Tags": "ADHD,altered mentation,Alternative splicing,amine,Amine transporter,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,cell surface,CFS,Chronic Fatigue Syndrome,Complete proteome,Continuous Performance Task,Disease mutation,dopamine,epinephrine,fatigue,Glycoprotein,integral component of plasma membrane,Interacts with PRKCABP,lightheadedness,Membrane,membrane raft,Membrane; Multi-pass membrane protein,mental disorder,monoamine transmembrane transporter activity,monoamine transport,NET,neuron projection,Neurotransmitter transport,neurotransmitters,noradrenaline,norepinephrine,norepinephrine transport,norepinephrine:sodium symporter activity,OI,Orthostatic intolerance,plasma membrane,Plasma norepinephrine concentration is abnormally high,Polymorphism,postural tachycardia,POTS,PRKCABP,protein binding,Reference proteome,response to drug,response to pain,Sexually dimorphic effects,SLC6A2,SLC6A2 subfamily,sodium,sodium-dependent,Sodium-dependent noradrenaline transporter,Solute carrier family 6 member 2,Symport,synaptic transmission,syncope,syndrome,Terminates the action of noradrenaline by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs5568",
        "SNP Name": "SLC6A2 A45583C",
        "Risk Allele": "C",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5568",
        "Video": null,
        "Tags": "ADHD,altered mentation,Alternative splicing,amine,Amine transporter,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,cell surface,CFS,Chronic Fatigue Syndrome,Complete proteome,Continuous Performance Task,Disease mutation,dopamine,epinephrine,fatigue,Glycoprotein,integral component of plasma membrane,Interacts with PRKCABP,lightheadedness,Membrane,membrane raft,Membrane; Multi-pass membrane protein,mental disorder,monoamine transmembrane transporter activity,monoamine transport,NET,neuron projection,Neurotransmitter transport,neurotransmitters,noradrenaline,norepinephrine,norepinephrine transport,norepinephrine:sodium symporter activity,OI,Orthostatic intolerance,plasma membrane,Plasma norepinephrine concentration is abnormally high,Polymorphism,postural tachycardia,POTS,PRKCABP,protein binding,Reference proteome,response to drug,response to pain,Sexually dimorphic effects,SLC6A2,SLC6A2 subfamily,sodium,sodium-dependent,Sodium-dependent noradrenaline transporter,Solute carrier family 6 member 2,Symport,synaptic transmission,syncope,syndrome,Terminates the action of noradrenaline by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs36009",
        "SNP Name": "SLC6A2 C48079T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs36009",
        "Video": null,
        "Tags": "ADHD,altered mentation,Alternative splicing,amine,Amine transporter,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,cell surface,CFS,Chronic Fatigue Syndrome,Complete proteome,Continuous Performance Task,Disease mutation,dopamine,epinephrine,fatigue,Glycoprotein,integral component of plasma membrane,Interacts with PRKCABP,lightheadedness,Membrane,membrane raft,Membrane; Multi-pass membrane protein,mental disorder,monoamine transmembrane transporter activity,monoamine transport,NET,neuron projection,Neurotransmitter transport,neurotransmitters,noradrenaline,norepinephrine,norepinephrine transport,norepinephrine:sodium symporter activity,OI,Orthostatic intolerance,plasma membrane,Plasma norepinephrine concentration is abnormally high,Polymorphism,postural tachycardia,POTS,PRKCABP,protein binding,Reference proteome,response to drug,response to pain,SLC6A2,SLC6A2 subfamily,Smoking during Pregnancy,sodium,sodium-dependent,Sodium-dependent noradrenaline transporter,Solute carrier family 6 member 2,Symport,synaptic transmission,syncope,syndrome,Terminates the action of noradrenaline by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs36009",
        "SNP Name": "SLC6A2 C48079T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs36009",
        "Video": null,
        "Tags": "ADHD,altered mentation,Alternative splicing,amine,Amine transporter,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,cell surface,CFS,Chronic Fatigue Syndrome,Complete proteome,Continuous Performance Task,Disease mutation,dopamine,epinephrine,fatigue,Glycoprotein,integral component of plasma membrane,Interacts with PRKCABP,lightheadedness,Membrane,membrane raft,Membrane; Multi-pass membrane protein,mental disorder,monoamine transmembrane transporter activity,monoamine transport,NET,neuron projection,Neurotransmitter transport,neurotransmitters,noradrenaline,norepinephrine,norepinephrine transport,norepinephrine:sodium symporter activity,OI,Orthostatic intolerance,plasma membrane,Plasma norepinephrine concentration is abnormally high,Polymorphism,postural tachycardia,POTS,PRKCABP,protein binding,Reference proteome,response to drug,response to pain,SLC6A2,SLC6A2 subfamily,Smoking during Pregnancy,sodium,sodium-dependent,Sodium-dependent noradrenaline transporter,Solute carrier family 6 member 2,Symport,synaptic transmission,syncope,syndrome,Terminates the action of noradrenaline by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1800887",
        "SNP Name": "SLC6A2 T49048C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1800887",
        "Video": null,
        "Tags": "ADHD,altered mentation,Alternative splicing,amine,Amine transporter,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,cell surface,CFS,Chronic Fatigue Syndrome,Complete proteome,Disease mutation,epinephrine,fatigue,Glycoprotein,integral component of plasma membrane,Interacts with PRKCABP,lightheadedness,Membrane,membrane raft,Membrane; Multi-pass membrane protein,mental disorder,monoamine transmembrane transporter activity,monoamine transport,NET,neuron projection,Neurotransmitter transport,neurotransmitters,noradrenaline,norepinephrine,norepinephrine transport,norepinephrine:sodium symporter activity,OI,Orthostatic intolerance,plasma membrane,Plasma norepinephrine concentration is abnormally high,Polymorphism,postural tachycardia,POTS,PRKCABP,protein binding,Reference proteome,response to drug,response to pain,SLC6A2,SLC6A2 subfamily,Smoking during Pregnancy,sodium,sodium-dependent,Sodium-dependent noradrenaline transporter,Solute carrier family 6 member 2,Symport,synaptic transmission,syncope,syndrome,Terminates the action of noradrenaline by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1800887",
        "SNP Name": "SLC6A2 T49048C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1800887",
        "Video": null,
        "Tags": "ADHD,altered mentation,Alternative splicing,amine,Amine transporter,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,cell surface,CFS,Chronic Fatigue Syndrome,Complete proteome,Disease mutation,epinephrine,fatigue,Glycoprotein,integral component of plasma membrane,Interacts with PRKCABP,lightheadedness,Membrane,membrane raft,Membrane; Multi-pass membrane protein,mental disorder,monoamine transmembrane transporter activity,monoamine transport,NET,neuron projection,Neurotransmitter transport,neurotransmitters,noradrenaline,norepinephrine,norepinephrine transport,norepinephrine:sodium symporter activity,OI,Orthostatic intolerance,plasma membrane,Plasma norepinephrine concentration is abnormally high,Polymorphism,postural tachycardia,POTS,PRKCABP,protein binding,Reference proteome,response to drug,response to pain,SLC6A2,SLC6A2 subfamily,Smoking during Pregnancy,sodium,sodium-dependent,Sodium-dependent noradrenaline transporter,Solute carrier family 6 member 2,Symport,synaptic transmission,syncope,syndrome,Terminates the action of noradrenaline by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2242447",
        "SNP Name": "SLC6A2 C51371T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2242447",
        "Video": null,
        "Tags": "ADHD,altered mentation,Alternative splicing,amine,Amine transporter,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,cell surface,CFS,Chronic Fatigue Syndrome,Complete proteome,Disease mutation,dopamine,dopaminergic,epinephrine,fatigue,Glycoprotein,integral component of plasma membrane,Interacts with PRKCABP,lightheadedness,Membrane,membrane raft,Membrane; Multi-pass membrane protein,mental disorder,monoamine transmembrane transporter activity,monoamine transport,NET,neuron projection,neuropsychological deficits,Neurotransmitter transport,neurotransmitters,noradrenaline,norepinephrine,norepinephrine transport,norepinephrine:sodium symporter activity,obsessive compulsive disorder,OCD,OI,Orthostatic intolerance,plasma membrane,Plasma norepinephrine concentration is abnormally high,Polymorphism,postural tachycardia,POTS,PRKCABP,protein binding,Reference proteome,response to drug,response to pain,reward circuit,reward deficiency syndrome,reward dependence,SLC6A2,SLC6A2 subfamily,Smoking during Pregnancy,sodium,sodium-dependent,Sodium-dependent noradrenaline transporter,Solute carrier family 6 member 2,substance abuse,Symport,synaptic transmission,syncope,syndrome,Terminates the action of noradrenaline by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Tourette syndrome,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2242447",
        "SNP Name": "SLC6A2 C51371T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2242447",
        "Video": null,
        "Tags": "ADHD,altered mentation,Alternative splicing,amine,Amine transporter,Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family,cell surface,CFS,Chronic Fatigue Syndrome,Complete proteome,Disease mutation,dopamine,dopaminergic,epinephrine,fatigue,Glycoprotein,integral component of plasma membrane,Interacts with PRKCABP,lightheadedness,Membrane,membrane raft,Membrane; Multi-pass membrane protein,mental disorder,monoamine transmembrane transporter activity,monoamine transport,NET,neuron projection,neuropsychological deficits,Neurotransmitter transport,neurotransmitters,noradrenaline,norepinephrine,norepinephrine transport,norepinephrine:sodium symporter activity,obsessive compulsive disorder,OCD,OI,Orthostatic intolerance,plasma membrane,Plasma norepinephrine concentration is abnormally high,Polymorphism,postural tachycardia,POTS,PRKCABP,protein binding,Reference proteome,response to drug,response to pain,reward circuit,reward deficiency syndrome,reward dependence,SLC6A2,SLC6A2 subfamily,Smoking during Pregnancy,sodium,sodium-dependent,Sodium-dependent noradrenaline transporter,Solute carrier family 6 member 2,substance abuse,Symport,synaptic transmission,syncope,syndrome,Terminates the action of noradrenaline by its high affinity sodium-dependent reuptake into presynaptic terminals,This protein is the target of psychomotor stimulants such as amphetamines or cocaine,Tourette syndrome,Transmembrane,Transmembrane helix,transmembrane transport,Transport",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1800775",
        "SNP Name": "CETP C4402A",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,aging,ALS,Alzheimer,Alzheimer's disease,amyotrophic lateral sclerosis,Ashkenazi,Ashkenazi jews,Atherosclerosis,Atrial Fibrillation,CAD,cardio,Cardiometabolic,cardiovascular,cardiovascular disease,carotid atherosclerosis,CETP,cholesterol,cholesterol binding,cholesterol homeostasis,cholesterol metabolic process,Cholesterol metabolism,cholesterol transport,cholesterol transporter activity,Cholesterol-ester transfer protein deficiency,cholesteryl ester,Cholesteryl ester transfer protein,choline,Choroidal Vasculopathy,chronic kidney disease,CKD,coronary artery disease,coronary atherosclerosis,coronary heart disease,dementia,Dyslipidemia and dementia,Early Onset of Non-Fatal Myocardial Infarction,extracellular region,extracellular space,extracellular vesicular exosome,fat,fats,HALP1,HDL,HDL Levels,HDL-cholesterol,heart,heart disease,high density lipoprotein,High Density Lipoprotein Cholesterol,high-density lipoprotein particle,high-density lipoprotein particle remodeling,Homocysteine,Hyperalphalipoproteinemia 1,Ischemic Stroke,kidneys,LDL,lipid,lipid binding,lipid homeostasis,Lipid metabolism,lipid transport,lipid transporter activity,lipids,lipoprotein,lipoprotein metabolic process,lipoprotein particles,longevity,low-density lipoprotein particle remodeling,Lymphotoxin-alpha,memory,memory decline,metabolic syndrome,Myocardial Infarction,negative regulation of macrophage derived foam cell differentiation,neurodegenerative disorder,neutral lipids,Non-Fatal Myocardial Infarction,phosphatidylcholine,phosphatidylcholine binding,phosphatidylcholine metabolic process,phospholipid homeostasis,phospholipid transport,phospholipid transporter activity,plasma HDL,Plasma Homocysteine,polypoidal choroidal vasculopathy,PS,receptor-mediated endocytosis,regulation of cholesterol efflux,reverse cholesterol transport,SALS,Serum High-Density Lipoprotein-Cholesterol,Sex-Dependent Cardiovascular,small molecule metabolic process,Smith\u2013Lemli\u2013Opitz syndrome,sporadic amyotrophic lateral sclerosis,Steroid metabolism,Sterol metabolism,stroke,Transport,triglyceride,triglyceride binding,triglyceride homeostasis,triglyceride metabolic process,very low density lipoproteins,very-low-density lipoprotein particle remodeling,vesicle,VLDL",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs1800775",
        "SNP Name": "CETP C4402A",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,aging,ALS,Alzheimer,Alzheimer's disease,amyotrophic lateral sclerosis,Ashkenazi,Ashkenazi jews,Atherosclerosis,Atrial Fibrillation,CAD,cardio,Cardiometabolic,cardiovascular,cardiovascular disease,carotid atherosclerosis,CETP,cholesterol,cholesterol binding,cholesterol homeostasis,cholesterol metabolic process,Cholesterol metabolism,cholesterol transport,cholesterol transporter activity,Cholesterol-ester transfer protein deficiency,cholesteryl ester,Cholesteryl ester transfer protein,choline,Choroidal Vasculopathy,chronic kidney disease,CKD,coronary artery disease,coronary atherosclerosis,coronary heart disease,dementia,Dyslipidemia and dementia,Early Onset of Non-Fatal Myocardial Infarction,extracellular region,extracellular space,extracellular vesicular exosome,fat,fats,HALP1,HDL,HDL Levels,HDL-cholesterol,heart,heart disease,high density lipoprotein,High Density Lipoprotein Cholesterol,high-density lipoprotein particle,high-density lipoprotein particle remodeling,Homocysteine,Hyperalphalipoproteinemia 1,Ischemic Stroke,kidneys,LDL,lipid,lipid binding,lipid homeostasis,Lipid metabolism,lipid transport,lipid transporter activity,lipids,lipoprotein,lipoprotein metabolic process,lipoprotein particles,longevity,low-density lipoprotein particle remodeling,Lymphotoxin-alpha,memory,memory decline,metabolic syndrome,Myocardial Infarction,negative regulation of macrophage derived foam cell differentiation,neurodegenerative disorder,neutral lipids,Non-Fatal Myocardial Infarction,phosphatidylcholine,phosphatidylcholine binding,phosphatidylcholine metabolic process,phospholipid homeostasis,phospholipid transport,phospholipid transporter activity,plasma HDL,Plasma Homocysteine,polypoidal choroidal vasculopathy,PS,receptor-mediated endocytosis,regulation of cholesterol efflux,reverse cholesterol transport,SALS,Serum High-Density Lipoprotein-Cholesterol,Sex-Dependent Cardiovascular,small molecule metabolic process,Smith\u2013Lemli\u2013Opitz syndrome,sporadic amyotrophic lateral sclerosis,Steroid metabolism,Sterol metabolism,stroke,Transport,triglyceride,triglyceride binding,triglyceride homeostasis,triglyceride metabolic process,very low density lipoproteins,very-low-density lipoprotein particle remodeling,vesicle,VLDL",
        "Group": "Clotting Factors"
    },
    {
        "SNP ID": "rs5882",
        "SNP Name": "CETP I405V",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,aging,ALS,Alzheimer,Alzheimer's disease,amyotrophic lateral sclerosis,Ashkenazi,Ashkenazi jews,Atherosclerosis,Atrial Fibrillation,CAD,cardio,Cardiometabolic,cardiovascular,cardiovascular disease,carotid atherosclerosis,CETP,cholesterol,cholesterol binding,cholesterol homeostasis,cholesterol metabolic process,Cholesterol metabolism,cholesterol transport,cholesterol transporter activity,Cholesterol-ester transfer protein deficiency,cholesteryl ester,Cholesteryl ester transfer protein,choline,Choroidal Vasculopathy,chronic kidney disease,CKD,coronary artery disease,coronary atherosclerosis,coronary heart disease,dementia,Dyslipidemia and dementia,Early Onset of Non-Fatal Myocardial Infarction,extracellular region,extracellular space,extracellular vesicular exosome,fat,fats,HALP1,HDL,HDL Levels,HDL-cholesterol,heart,heart disease,high density lipoprotein,High Density Lipoprotein Cholesterol,high-density lipoprotein particle,high-density lipoprotein particle remodeling,Homocysteine,Hyperalphalipoproteinemia 1,Ischemic Stroke,kidneys,LDL,lipid,lipid binding,lipid homeostasis,Lipid metabolism,lipid transport,lipid transporter activity,lipids,lipoprotein,lipoprotein metabolic process,lipoprotein particles,longevity,low-density lipoprotein particle remodeling,Lymphotoxin-alpha,memory,memory decline,metabolic syndrome,Myocardial Infarction,negative regulation of macrophage derived foam cell differentiation,neurodegenerative disorder,neutral lipids,Non-Fatal Myocardial Infarction,phosphatidylcholine,phosphatidylcholine binding,phosphatidylcholine metabolic process,phospholipid homeostasis,phospholipid transport,phospholipid transporter activity,plasma HDL,Plasma Homocysteine,polypoidal choroidal vasculopathy,PS,receptor-mediated endocytosis,regulation of cholesterol efflux,reverse cholesterol transport,SALS,Serum High-Density Lipoprotein-Cholesterol,Sex-Dependent Cardiovascular,small molecule metabolic process,Smith\u2013Lemli\u2013Opitz syndrome,sporadic amyotrophic lateral sclerosis,Steroid metabolism,Sterol metabolism,stroke,Transport,triglyceride,triglyceride binding,triglyceride homeostasis,triglyceride metabolic process,very low density lipoproteins,very-low-density lipoprotein particle remodeling,vesicle,VLDL",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs11640843",
        "SNP Name": "CDH5 C66425176T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Octylphenol Ethoxylate (Triton X-100)"
    },
    {
        "SNP ID": "rs1049970",
        "SNP Name": "CDH5 I517T",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Octylphenol Ethoxylate (Triton X-100)"
    },
    {
        "SNP ID": "rs28934592",
        "SNP Name": "HSD11B2 R208H",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs28934591",
        "SNP Name": "HSD11B2 R213C",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs10517",
        "SNP Name": "NQO1 C494+",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10517",
        "Video": "bvdhopdC5GM",
        "Tags": "acting on NAD(P)H,aging,alcohol response,Alternative splicing,asthma,ATP,bladder cancer,cancer,cancerous,carcinogen,cellular energy,cellular nitrogen compound metabolic process,cholinergic,Complete proteome,cytochrome-b5 reductase activity,Cytoplasm,cytosol,detoxification,detoxification pathways,DIA4,dioxin,DT-diaphorase,DTD,ECHRS,energy,environmental related,FAD,Flavoprotein,glioma,glutamate,Homodimer,hydroquinons,Inhibited by dicoumarol,Menadione reductase,mitochondria,mitochondrion,NAD,NAD(P)H + a quinone = NAD(P)+ + a hydroquinone,NAD(P)H dehydrogenase (quinone) activity,NAD(P)H dehydrogenase (quinone) family,NAD(P)H dehydrogenase [quinone] 1 Azoreductase,NAD(P)H:quinone oxidoreductase 1,NADP,NADPH,Nasopharyngeal Carcinoma,negative regulation of catalytic activity,neuronal cell body,nitric oxide biosynthetic process,NMOR1,NQO1,oxidative stress,Oxidoreductase,Phylloquinone reductase,poly(A) RNA binding,Polymorphism,positive regulation of neuron apoptotic process,QR1,quinone reductase,Quinone reductase 1,Quinone reductase accepts electrons from both NADH and NADPH with equal efficiency,Reference proteome,regulation of cellular amino acid metabolic process,response to estradiol,response to ethanol,response to nutrient,response to oxidative stress,response to toxic substance,ROS,Ser-187 polymorphism may be linked to susceptibility to forms of cancers,serves as a quinone reductase in connection with conjugation reactions of hydroquinons involved in detoxification pathways as well as in biosynthetic processes such as the vitamin K-dependent gamma-carboxylation of glutamate residues in prothrombin synthe,small molecule metabolic process,superoxide dismutase activity,superoxide metabolic process,synaptic transmission,Traffic-Related Air Pollution,vitamin K,vitamin K-dependent gamma-carboxylation,xenobiotic,xenobiotic metabolic process,xenobiotic metabolizing genes",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1800566",
        "SNP Name": "NQO1 C609T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1800566",
        "Video": "bvdhopdC5GM",
        "Tags": "Acetaminophen,Acetaminophen and asthma,acting on NAD(P)H,aging,alcohol response,Alternative splicing,asthma,ATP,Bladder cancer,breast cancer,Breast tumor,cancer,cancerous,carcinogen,cellular energy,cellular nitrogen compound metabolic process,cervical cancer,childhood asthma,cholinergic,Complete proteome,cytochrome-b5 reductase activity,Cytoplasm,cytosol,detoxification,detoxification pathways,DIA4,dioxin,DT-diaphorase,DTD,early age leukaemia modulated by NQO1 are associated with second-hand smoking exposures,ECHRS,energy,environmental factors,FAD,Flavoprotein,Gastrointestinal Cancer,glutamate,Head and Neck Cancer,head cancer,homocysteine,Homodimer,hydroquinons,Inhibited by dicoumarol,leukema,lung cancer,Lymphoma,Menadione reductase,mitochondria,mitochondrion,MS,multiple sclerosis,NAD,NAD(P)H + a quinone = NAD(P)+ + a hydroquinone,NAD(P)H dehydrogenase (quinone) activity,NAD(P)H dehydrogenase (quinone) family,NAD(P)H dehydrogenase [quinone] 1 Azoreductase,NAD(P)H:quinone oxidoreductase 1,NADP,NADPH,Nasopharyngeal Carcinoma,neck cancer,negative regulation of catalytic activity,Neurodegenerative,Neurodegenerative disease,neuronal cell body,nicotine,nitric oxide biosynthetic process,NMOR1,Non-Hodgkin Lymphoma,NQO1,oxidative stress,Oxidoreductase,Ozone exposure and vitamin C intake and genetic susceptibility of asthmatic children,Papillary Thyroid Microcarcinoma,Phylloquinone reductase,pollution,poly(A) RNA binding,Polymorphism,positive regulation of neuron apoptotic process,QR1,quinone reductase,Quinone reductase 1,Quinone reductase accepts electrons from both NADH and NADPH with equal efficiency,Reference proteome,regulation of cellular amino acid metabolic process,response to estradiol,response to ethanol,response to nutrient,response to oxidative stress,response to toxic substance,ROS,Ser-187 polymorphism may be linked to susceptibility to forms of cancers,serves as a quinone reductase in connection with conjugation reactions of hydroquinons involved in detoxification pathways as well as in biosynthetic processes such as the vitamin K-dependent gamma-carboxylation of glutamate residues in prothrombin synthe,small molecule metabolic process,smoking,superoxide dismutase activity,superoxide metabolic process,synaptic transmission,thyroid cancer,tobacco,vitamin K,vitamin K-dependent gamma-carboxylation,xenobiotic,xenobiotic metabolic process,xenobiotic metabolizing genes",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs689453",
        "SNP Name": "NQO1 G13161A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs689453",
        "Video": "bvdhopdC5GM",
        "Tags": "acting on NAD(P)H,aging,alcohol response,Alternative splicing,ATP,Bladder cancer,cancer,cancerous,carcinogen,cellular energy,cellular nitrogen compound metabolic process,cholinergic,Complete proteome,cytochrome-b5 reductase activity,Cytoplasm,cytosol,detoxification,detoxification pathways,DIA4,diabetic nephropathy,dioxin,DT-diaphorase,DTD,energy,FAD,Flavoprotein,glutamate,Homodimer,hydroquinons,Inhibited by dicoumarol,Menadione reductase,mitochondria,mitochondrion,NAD,NAD(P)H + a quinone = NAD(P)+ + a hydroquinone,NAD(P)H dehydrogenase (quinone) activity,NAD(P)H dehydrogenase (quinone) family,NAD(P)H dehydrogenase [quinone] 1 Azoreductase,NAD(P)H:quinone oxidoreductase 1,NADP,NADPH,negative regulation of catalytic activity,neuronal cell body,nitric oxide biosynthetic process,NMOR1,NQO1,oxidative stress,Oxidoreductase,Phylloquinone reductase,poly(A) RNA binding,Polymorphism,positive regulation of neuron apoptotic process,QR1,quinone reductase,Quinone reductase 1,Quinone reductase accepts electrons from both NADH and NADPH with equal efficiency,Reference proteome,regulation of cellular amino acid metabolic process,response to estradiol,response to ethanol,response to nutrient,response to oxidative stress,response to toxic substance,ROS,Ser-187 polymorphism may be linked to susceptibility to forms of cancers,serves as a quinone reductase in connection with conjugation reactions of hydroquinons involved in detoxification pathways as well as in biosynthetic processes such as the vitamin K-dependent gamma-carboxylation of glutamate residues in prothrombin synthe,small molecule metabolic process,superoxide dismutase activity,superoxide metabolic process,synaptic transmission,vitamin K,vitamin K-dependent gamma-carboxylation,xenobiotic,xenobiotic metabolic process,xenobiotic metabolizing genes",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs689452",
        "SNP Name": "NQO1 G13070C",
        "Risk Allele": "C",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs689452",
        "Video": "bvdhopdC5GM",
        "Tags": "acting on NAD(P)H,aging,alcohol response,Alternative splicing,ATP,Bladder cancer,cancer,cancerous,carcinogen,cellular energy,cellular nitrogen compound metabolic process,cholinergic,Complete proteome,cytochrome-b5 reductase activity,Cytoplasm,cytosol,detoxification,detoxification pathways,DIA4,dioxin,DT-diaphorase,DTD,energy,FAD,Flavoprotein,glutamate,Homodimer,hydroquinons,Inhibited by dicoumarol,Menadione reductase,mitochondria,mitochondrion,NAD,NAD(P)H + a quinone = NAD(P)+ + a hydroquinone,NAD(P)H dehydrogenase (quinone) activity,NAD(P)H dehydrogenase (quinone) family,NAD(P)H dehydrogenase [quinone] 1 Azoreductase,NAD(P)H:quinone oxidoreductase 1,NADP,NADPH,Nasopharyngeal Carcinoma,negative regulation of catalytic activity,neuronal cell body,nitric oxide biosynthetic process,NMOR1,NQO1,oxidative stress,Oxidoreductase,Phylloquinone reductase,poly(A) RNA binding,Polymorphism,positive regulation of neuron apoptotic process,QR1,quinone reductase,Quinone reductase 1,Quinone reductase accepts electrons from both NADH and NADPH with equal efficiency,Reference proteome,regulation of cellular amino acid metabolic process,response to estradiol,response to ethanol,response to nutrient,response to oxidative stress,response to toxic substance,ROS,Ser-187 polymorphism may be linked to susceptibility to forms of cancers,serves as a quinone reductase in connection with conjugation reactions of hydroquinons involved in detoxification pathways as well as in biosynthetic processes such as the vitamin K-dependent gamma-carboxylation of glutamate residues in prothrombin synthe,small molecule metabolic process,superoxide dismutase activity,superoxide metabolic process,synaptic transmission,vitamin K,vitamin K-dependent gamma-carboxylation,xenobiotic,xenobiotic metabolic process,xenobiotic metabolizing genes",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1437135",
        "SNP Name": "NQO1 T7706C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1437135",
        "Video": "bvdhopdC5GM",
        "Tags": "acting on NAD(P)H,aging,alcohol response,Alternative splicing,anticoagulant,asthma,ATP,bladder cancer,cancer,cancerous,carcinogen,cellular energy,cellular nitrogen compound metabolic process,cholinergic,Complete proteome,cytochrome-b5 reductase activity,Cytoplasm,cytosol,detoxification,detoxification pathways,DIA4,dioxin,DT-diaphorase,DTD,energy,environmental related,FAD,Flavoprotein,glutamate,Homodimer,hydroquinons,Inhibited by dicoumarol,Menadione reductase,mitochondria,mitochondrion,NAD,NAD(P)H + a quinone = NAD(P)+ + a hydroquinone,NAD(P)H dehydrogenase (quinone) activity,NAD(P)H dehydrogenase (quinone) family,NAD(P)H dehydrogenase [quinone] 1 Azoreductase,NAD(P)H:quinone oxidoreductase 1,NADP,NADPH,negative regulation of catalytic activity,neuronal cell body,nitric oxide biosynthetic process,NMOR1,NQO1,oxidative stress,Oxidoreductase,Phylloquinone reductase,poly(A) RNA binding,Polymorphism,positive regulation of neuron apoptotic process,Protein C Anticoagulant Pathway,QR1,quinone reductase,Quinone reductase 1,Quinone reductase accepts electrons from both NADH and NADPH with equal efficiency,Reference proteome,regulation of cellular amino acid metabolic process,response to estradiol,response to ethanol,response to nutrient,response to oxidative stress,response to toxic substance,ROS,Ser-187 polymorphism may be linked to susceptibility to forms of cancers,serves as a quinone reductase in connection with conjugation reactions of hydroquinons involved in detoxification pathways as well as in biosynthetic processes such as the vitamin K-dependent gamma-carboxylation of glutamate residues in prothrombin synthe,small molecule metabolic process,superoxide dismutase activity,superoxide metabolic process,synaptic transmission,vitamin K,vitamin K-dependent gamma-carboxylation,xenobiotic,xenobiotic metabolic process,xenobiotic metabolizing genes",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs730168",
        "SNP Name": "LDHD C75150275T",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs730168",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs730168",
        "SNP Name": "LDHD C75150275T",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs730168",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs4889294",
        "SNP Name": "BCMO1 36464T>C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs4889294",
        "Video": null,
        "Tags": null,
        "Group": "Eye Health"
    },
    {
        "SNP ID": "rs4889294",
        "SNP Name": "BCMO1 36464T>C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs4889294",
        "Video": null,
        "Tags": null,
        "Group": "Thyroid"
    },
    {
        "SNP ID": "rs7501331",
        "SNP Name": "BCMO1 A379V Ala379Val",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs7501331",
        "Video": null,
        "Tags": null,
        "Group": "Eye Health"
    },
    {
        "SNP ID": "rs7501331",
        "SNP Name": "BCMO1 A379V Ala379Val",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs7501331",
        "Video": null,
        "Tags": null,
        "Group": "Thyroid"
    },
    {
        "SNP ID": "rs4790353",
        "SNP Name": "PAFAH1B1 G2578648T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs224534",
        "SNP Name": "TRPV1 T469I",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs12150220",
        "SNP Name": "NLRP1 7466T>A",
        "Risk Allele": "T",
        "Your Allele": "TA",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs12150220",
        "SNP Name": "NLRP1 7466T>A",
        "Risk Allele": "T",
        "Your Allele": "TA",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "IgA"
    },
    {
        "SNP ID": "rs12150220",
        "SNP Name": "NLRP1 7466T>A",
        "Risk Allele": "T",
        "Your Allele": "TA",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs4792800",
        "SNP Name": "TNFRSF13B variant",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs4792800",
        "Video": null,
        "Tags": null,
        "Group": "IgG"
    },
    {
        "SNP ID": "rs7946",
        "SNP Name": "PEMT G634A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7946",
        "Video": null,
        "Tags": "5-MTHF,Alternative splicing,associated with the severity of hepatic steatosis,ATP,belongs to class VI-like SAM-binding methyltransferase superfamily,birth defect,breast cancer,can predict which humans will develop liver dysfunction when deprived of dietary choline,cancer,cancerous,carcinogen,Catalyzes three sequential methylation reactions of phosphatidylethanolamine (PE) by AdoMet,cell proliferation,cellular energy,choline,choline metabolism,choline metabolism when folate intake is restricted,Complete proteome,defect,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Multi-pass membrane protein Potential,energy,fat,folate,folate metabolism,folic acid,found in endoplasmic reticulum where most PEMT activity is generated and in mitochondria,glycerophospholipid biosynthetic process,high intakes of choline and betaine reduce breast cancer mortality,homocysteine,integral component of membrane,L-5-MTHF,L-homocysteine,L-methionine,leukocyte telomere length,lipid,Lipid biosynthesis,lipid metabolic process,Lipid metabolism,Membrane,metabolic stress,methionine,methylenetetrahydrofolate,Methyltransferase,mitochondria,mitochondrial membrane,mitochondrion,Mitochondrion membrane; Multi-pass membrane protein Potential,neural tube defects,Non-alcoholic Fatty Liver Disease and its Progression,NTDs,obesity,PEAMT,PEMPT,PEMT,PEMT/PEM2 methyltransferase family,PEMT2,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,phosphatidyl-N-methylethanolamine N-methyltransferase activity,phosphatidylcholine,phosphatidylcholine biosynthetic process,phosphatidyle,phosphatidylethanolamine,Phosphatidylethanolamine N-methyltransferase,phosphatidylethanolamine N-methyltransferase activity,Phospholipid biosynthesis,phospholipid metabolic process,Phospholipid metabolism,Phospholipid metabolism; phosphatidylcholine biosynthesis,PNMT,Polymorphism,Reference proteome,S-adenosyl-L-methionine,S-adenosyl-L-methionine + phosphatidyl-N-dimethylethanolamine = S-adenosyl-L-homocysteine + phosphatidylcholine,S-adenosyl-L-methionine + phosphatidyl-N-methylethanolamine = S-adenosyl-L-homocysteine + phosphatidyl-N-dimethylethanolamine,S-adenosyl-L-methionine + phosphatidylethanolamine = S-adenosyl-L-homocysteine + phosphatidyl-N-methylethanolamine,small molecule metabolic process,Spina Bifida,telomere,thanolamine,thereby producing phosphatidylcholine (PC),Transferase,Transmembrane,Transmembrane helix",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs7946",
        "SNP Name": "PEMT G634A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7946",
        "Video": null,
        "Tags": "5-MTHF,Alternative splicing,associated with the severity of hepatic steatosis,ATP,belongs to class VI-like SAM-binding methyltransferase superfamily,birth defect,breast cancer,can predict which humans will develop liver dysfunction when deprived of dietary choline,cancer,cancerous,carcinogen,Catalyzes three sequential methylation reactions of phosphatidylethanolamine (PE) by AdoMet,cell proliferation,cellular energy,choline,choline metabolism,choline metabolism when folate intake is restricted,Complete proteome,defect,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Multi-pass membrane protein Potential,energy,fat,folate,folate metabolism,folic acid,found in endoplasmic reticulum where most PEMT activity is generated and in mitochondria,glycerophospholipid biosynthetic process,high intakes of choline and betaine reduce breast cancer mortality,homocysteine,integral component of membrane,L-5-MTHF,L-homocysteine,L-methionine,leukocyte telomere length,lipid,Lipid biosynthesis,lipid metabolic process,Lipid metabolism,Membrane,metabolic stress,methionine,methylenetetrahydrofolate,Methyltransferase,mitochondria,mitochondrial membrane,mitochondrion,Mitochondrion membrane; Multi-pass membrane protein Potential,neural tube defects,Non-alcoholic Fatty Liver Disease and its Progression,NTDs,obesity,PEAMT,PEMPT,PEMT,PEMT/PEM2 methyltransferase family,PEMT2,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,phosphatidyl-N-methylethanolamine N-methyltransferase activity,phosphatidylcholine,phosphatidylcholine biosynthetic process,phosphatidyle,phosphatidylethanolamine,Phosphatidylethanolamine N-methyltransferase,phosphatidylethanolamine N-methyltransferase activity,Phospholipid biosynthesis,phospholipid metabolic process,Phospholipid metabolism,Phospholipid metabolism; phosphatidylcholine biosynthesis,PNMT,Polymorphism,Reference proteome,S-adenosyl-L-methionine,S-adenosyl-L-methionine + phosphatidyl-N-dimethylethanolamine = S-adenosyl-L-homocysteine + phosphatidylcholine,S-adenosyl-L-methionine + phosphatidyl-N-methylethanolamine = S-adenosyl-L-homocysteine + phosphatidyl-N-dimethylethanolamine,S-adenosyl-L-methionine + phosphatidylethanolamine = S-adenosyl-L-homocysteine + phosphatidyl-N-methylethanolamine,small molecule metabolic process,Spina Bifida,telomere,thanolamine,thereby producing phosphatidylcholine (PC),Transferase,Transmembrane,Transmembrane helix",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs7946",
        "SNP Name": "PEMT G634A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs7946",
        "Video": null,
        "Tags": "5-MTHF,Alternative splicing,associated with the severity of hepatic steatosis,ATP,belongs to class VI-like SAM-binding methyltransferase superfamily,birth defect,breast cancer,can predict which humans will develop liver dysfunction when deprived of dietary choline,cancer,cancerous,carcinogen,Catalyzes three sequential methylation reactions of phosphatidylethanolamine (PE) by AdoMet,cell proliferation,cellular energy,choline,choline metabolism,choline metabolism when folate intake is restricted,Complete proteome,defect,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Multi-pass membrane protein Potential,energy,fat,folate,folate metabolism,folic acid,found in endoplasmic reticulum where most PEMT activity is generated and in mitochondria,glycerophospholipid biosynthetic process,high intakes of choline and betaine reduce breast cancer mortality,homocysteine,integral component of membrane,L-5-MTHF,L-homocysteine,L-methionine,leukocyte telomere length,lipid,Lipid biosynthesis,lipid metabolic process,Lipid metabolism,Membrane,metabolic stress,methionine,methylenetetrahydrofolate,Methyltransferase,mitochondria,mitochondrial membrane,mitochondrion,Mitochondrion membrane; Multi-pass membrane protein Potential,neural tube defects,Non-alcoholic Fatty Liver Disease and its Progression,NTDs,obesity,PEAMT,PEMPT,PEMT,PEMT/PEM2 methyltransferase family,PEMT2,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,phosphatidyl-N-methylethanolamine N-methyltransferase activity,phosphatidylcholine,phosphatidylcholine biosynthetic process,phosphatidyle,phosphatidylethanolamine,Phosphatidylethanolamine N-methyltransferase,phosphatidylethanolamine N-methyltransferase activity,Phospholipid biosynthesis,phospholipid metabolic process,Phospholipid metabolism,Phospholipid metabolism; phosphatidylcholine biosynthesis,PNMT,Polymorphism,Reference proteome,S-adenosyl-L-methionine,S-adenosyl-L-methionine + phosphatidyl-N-dimethylethanolamine = S-adenosyl-L-homocysteine + phosphatidylcholine,S-adenosyl-L-methionine + phosphatidyl-N-methylethanolamine = S-adenosyl-L-homocysteine + phosphatidyl-N-dimethylethanolamine,S-adenosyl-L-methionine + phosphatidylethanolamine = S-adenosyl-L-homocysteine + phosphatidyl-N-methylethanolamine,small molecule metabolic process,Spina Bifida,telomere,thanolamine,thereby producing phosphatidylcholine (PC),Transferase,Transmembrane,Transmembrane helix",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs4244593",
        "SNP Name": "PEMT T17023592G",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4244593",
        "Video": null,
        "Tags": "5-MTHF,Alternative splicing,associated with the severity of hepatic steatosis,ATP,belongs to class VI-like SAM-binding methyltransferase superfamily,Catalyzes three sequential methylation reactions of phosphatidylethanolamine (PE) by AdoMet,cell proliferation,cellular energy,choline metabolism,Complete proteome,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Multi-pass membrane protein Potential,energy,fat,folate,folate metabolism,folic acid,found in endoplasmic reticulum where most PEMT activity is generated and in mitochondria,glycerophospholipid biosynthetic process,homocysteine,integral component of membrane,L-5-MTHF,L-homocysteine,L-methionine,lipid,Lipid biosynthesis,lipid metabolic process,Lipid metabolism,Membrane,mental disorder,methionine,methylenetetrahydrofolate,Methyltransferase,mitochondria,mitochondrial membrane,mitochondrion,Mitochondrion membrane; Multi-pass membrane protein Potential,PEAMT,PEMPT,PEMT,PEMT/PEM2 methyltransferase family,PEMT2,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,phosphatidyl-N-methylethanolamine N-methyltransferase activity,phosphatidylcholine,phosphatidylcholine biosynthetic process,phosphatidyle,phosphatidylethanolamine,Phosphatidylethanolamine N-methyltransferase,phosphatidylethanolamine N-methyltransferase activity,Phospholipid biosynthesis,phospholipid metabolic process,Phospholipid metabolism,Phospholipid metabolism; phosphatidylcholine biosynthesis,PNMT,Polymorphism,Reference proteome,S-adenosyl-L-methionine,S-adenosyl-L-methionine + phosphatidyl-N-dimethylethanolamine = S-adenosyl-L-homocysteine + phosphatidylcholine,S-adenosyl-L-methionine + phosphatidyl-N-methylethanolamine = S-adenosyl-L-homocysteine + phosphatidyl-N-dimethylethanolamine,S-adenosyl-L-methionine + phosphatidylethanolamine = S-adenosyl-L-homocysteine + phosphatidyl-N-methylethanolamine,schizophrenia,small molecule metabolic process,thanolamine,thereby producing phosphatidylcholine (PC),Transferase,Transmembrane,Transmembrane helix",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs4244593",
        "SNP Name": "PEMT T17023592G",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4244593",
        "Video": null,
        "Tags": "5-MTHF,Alternative splicing,associated with the severity of hepatic steatosis,ATP,belongs to class VI-like SAM-binding methyltransferase superfamily,Catalyzes three sequential methylation reactions of phosphatidylethanolamine (PE) by AdoMet,cell proliferation,cellular energy,choline metabolism,Complete proteome,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Multi-pass membrane protein Potential,energy,fat,folate,folate metabolism,folic acid,found in endoplasmic reticulum where most PEMT activity is generated and in mitochondria,glycerophospholipid biosynthetic process,homocysteine,integral component of membrane,L-5-MTHF,L-homocysteine,L-methionine,lipid,Lipid biosynthesis,lipid metabolic process,Lipid metabolism,Membrane,mental disorder,methionine,methylenetetrahydrofolate,Methyltransferase,mitochondria,mitochondrial membrane,mitochondrion,Mitochondrion membrane; Multi-pass membrane protein Potential,PEAMT,PEMPT,PEMT,PEMT/PEM2 methyltransferase family,PEMT2,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,phosphatidyl-N-methylethanolamine N-methyltransferase activity,phosphatidylcholine,phosphatidylcholine biosynthetic process,phosphatidyle,phosphatidylethanolamine,Phosphatidylethanolamine N-methyltransferase,phosphatidylethanolamine N-methyltransferase activity,Phospholipid biosynthesis,phospholipid metabolic process,Phospholipid metabolism,Phospholipid metabolism; phosphatidylcholine biosynthesis,PNMT,Polymorphism,Reference proteome,S-adenosyl-L-methionine,S-adenosyl-L-methionine + phosphatidyl-N-dimethylethanolamine = S-adenosyl-L-homocysteine + phosphatidylcholine,S-adenosyl-L-methionine + phosphatidyl-N-methylethanolamine = S-adenosyl-L-homocysteine + phosphatidyl-N-dimethylethanolamine,S-adenosyl-L-methionine + phosphatidylethanolamine = S-adenosyl-L-homocysteine + phosphatidyl-N-methylethanolamine,schizophrenia,small molecule metabolic process,thanolamine,thereby producing phosphatidylcholine (PC),Transferase,Transmembrane,Transmembrane helix",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs4244593",
        "SNP Name": "PEMT T17023592G",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4244593",
        "Video": null,
        "Tags": "5-MTHF,Alternative splicing,associated with the severity of hepatic steatosis,ATP,belongs to class VI-like SAM-binding methyltransferase superfamily,Catalyzes three sequential methylation reactions of phosphatidylethanolamine (PE) by AdoMet,cell proliferation,cellular energy,choline metabolism,Complete proteome,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Multi-pass membrane protein Potential,energy,fat,folate,folate metabolism,folic acid,found in endoplasmic reticulum where most PEMT activity is generated and in mitochondria,glycerophospholipid biosynthetic process,homocysteine,integral component of membrane,L-5-MTHF,L-homocysteine,L-methionine,lipid,Lipid biosynthesis,lipid metabolic process,Lipid metabolism,Membrane,mental disorder,methionine,methylenetetrahydrofolate,Methyltransferase,mitochondria,mitochondrial membrane,mitochondrion,Mitochondrion membrane; Multi-pass membrane protein Potential,PEAMT,PEMPT,PEMT,PEMT/PEM2 methyltransferase family,PEMT2,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,phosphatidyl-N-methylethanolamine N-methyltransferase activity,phosphatidylcholine,phosphatidylcholine biosynthetic process,phosphatidyle,phosphatidylethanolamine,Phosphatidylethanolamine N-methyltransferase,phosphatidylethanolamine N-methyltransferase activity,Phospholipid biosynthesis,phospholipid metabolic process,Phospholipid metabolism,Phospholipid metabolism; phosphatidylcholine biosynthesis,PNMT,Polymorphism,Reference proteome,S-adenosyl-L-methionine,S-adenosyl-L-methionine + phosphatidyl-N-dimethylethanolamine = S-adenosyl-L-homocysteine + phosphatidylcholine,S-adenosyl-L-methionine + phosphatidyl-N-methylethanolamine = S-adenosyl-L-homocysteine + phosphatidyl-N-dimethylethanolamine,S-adenosyl-L-methionine + phosphatidylethanolamine = S-adenosyl-L-homocysteine + phosphatidyl-N-methylethanolamine,schizophrenia,small molecule metabolic process,thanolamine,thereby producing phosphatidylcholine (PC),Transferase,Transmembrane,Transmembrane helix",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs11868035",
        "SNP Name": "SREBF1 C*835T",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Magnesium Stearate"
    },
    {
        "SNP ID": "rs9902941",
        "SNP Name": "SREBF1/SREBP G11566A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs9902941",
        "SNP Name": "SREBF1/SREBP G11566A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Magnesium Stearate"
    },
    {
        "SNP ID": "rs1889018",
        "SNP Name": "SREBF1/SREBP C10586T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs1889018",
        "SNP Name": "SREBF1/SREBP C10586T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Magnesium Stearate"
    },
    {
        "SNP ID": "rs9909104",
        "SNP Name": "SHMT1 A23836G",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs9909104",
        "Video": null,
        "Tags": "10-methylenetetrahydrofolate + glycine + H2O = tetrahydrofolate + L-serine,5,5-MTHF,Acetylation,Alternative splicing,amino acid binding,amino acids,ATP,birth defect,cancer,cancerous,carcinogen,carnitine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,Childhood Acute Lymphoblastic Leukemia,Complete proteome,Conotruncal Heart Defects,Cytoplasm,cytosol,cytosolic,defect,energy,extracellular vesicular exosome,folate,folic acid,folic acid metabolic process,glycine,glycine biosynthetic process from serine,Glycine hydroxymethyltransferase,glycine hydroxymethyltransferase activity,Homotetramer,In eukaryotes there are two forms of the enzymes: a cytosolic one and a mitochondrial one,Interconversion of serine and glycine,Ischemic Stroke,L-5-MTHF,L-allo-threonine aldolase activity,L-glycine,L-serine,L-serine catabolic process,methylenetetrahydrofolate,methyltransferase activity,mitochondria,mitochondrion,Neural Tube Defects,NTDs,one carbon transfer pathway,One-carbon metabolism,One-carbon metabolism; tetrahydrofolate interconversion,ovarian cancer,Ovarian neoplasms,phosphate,Polymorphism,protein homodimerization activity,protein homotetramerization,protein tetramerization,purine nucleobase biosynthetic process,Pyridoxal phosphate,pyridoxal phosphate binding,Reference proteome,serine,Serine hydroxymethyltransferase,Serine methylase,SHMT,SHMT family,SHMT1,small molecule metabolic process,tetrahydrofolate interconversion,Transferase,vitamin,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs9909104",
        "SNP Name": "SHMT1 A23836G",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs9909104",
        "Video": null,
        "Tags": "10-methylenetetrahydrofolate + glycine + H2O = tetrahydrofolate + L-serine,5,5-MTHF,Acetylation,Alternative splicing,amino acid binding,amino acids,ATP,birth defect,cancer,cancerous,carcinogen,carnitine biosynthetic process,cellular energy,cellular nitrogen compound metabolic process,Childhood Acute Lymphoblastic Leukemia,Complete proteome,Conotruncal Heart Defects,Cytoplasm,cytosol,cytosolic,defect,energy,extracellular vesicular exosome,folate,folic acid,folic acid metabolic process,glycine,glycine biosynthetic process from serine,Glycine hydroxymethyltransferase,glycine hydroxymethyltransferase activity,Homotetramer,In eukaryotes there are two forms of the enzymes: a cytosolic one and a mitochondrial one,Interconversion of serine and glycine,Ischemic Stroke,L-5-MTHF,L-allo-threonine aldolase activity,L-glycine,L-serine,L-serine catabolic process,methylenetetrahydrofolate,methyltransferase activity,mitochondria,mitochondrion,Neural Tube Defects,NTDs,one carbon transfer pathway,One-carbon metabolism,One-carbon metabolism; tetrahydrofolate interconversion,ovarian cancer,Ovarian neoplasms,phosphate,Polymorphism,protein homodimerization activity,protein homotetramerization,protein tetramerization,purine nucleobase biosynthetic process,Pyridoxal phosphate,pyridoxal phosphate binding,Reference proteome,serine,Serine hydroxymethyltransferase,Serine methylase,SHMT,SHMT family,SHMT1,small molecule metabolic process,tetrahydrofolate interconversion,Transferase,vitamin,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs72547564",
        "SNP Name": "ALDH3A2 G641A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/clinvar/RCV000001706/",
        "Video": null,
        "Tags": "aldehyde,aldehyde dehydrogenase,Aldehyde dehydrogenase 10,aldehyde dehydrogenase family,Aldehyde dehydrogenase family 3 member A2,ALDH10,ALDH3A2,aliphatic aldehyde,aliphatic aldehydes,Alternative splicing,autosomal recessive neurocutaneous disorder,carboxylate,central nervous system,CNS,congenital ichthyosis,Disease mutation,EC=1.2.1.3,Endoplasmic reticulum,erythema,FADH,FALDH,fatty acids,FATTY ALCOHOL,Fatty aldehyde dehydrogenase,Fatty aldehyde dehydrogenase deficiency,glistening white spots on retina,H20,hexadecenal,hexadecenoic acid,ichthyosis,long-chain aliphatic aldehydes,low IQ,membrane,mental retardation,Microsomal aldehyde dehydrogenase,NAD,NADH,NADP,neuro,neurologic symptoms,neurological,neurological disorder,niacin,oxidation-reduction,oxidation-reduction process,Oxidoreductase,OXIDOREDUCTASE DEFICIENCY,peripheral nervous system,peripheral nervous system development,phytol metabolic process,retardation,S1P,saturated alphatic aldehyde,scaling,seizure,seizures,sesquiterpenoid metabolic process,severe mental retardation,short stature,sjoegren,Sjoegren Larsson syndrome,sjoegren syndrome,sjoegren's,Sjoegren-Larsson syndrome,sjoegrens,spastic di,spastic di-,speech defect,speech defects,sphingosine 1-phosphate,tetraplegia,Transmembrane,Transmembrane helix,unsaturated aliphatic aldehydes,white spots on retina",
        "Group": "Glutaraldehyde"
    },
    {
        "SNP ID": "rs72547564",
        "SNP Name": "ALDH3A2 G641A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/clinvar/RCV000001706/",
        "Video": null,
        "Tags": "aldehyde,aldehyde dehydrogenase,Aldehyde dehydrogenase 10,aldehyde dehydrogenase family,Aldehyde dehydrogenase family 3 member A2,ALDH10,ALDH3A2,aliphatic aldehyde,aliphatic aldehydes,Alternative splicing,autosomal recessive neurocutaneous disorder,carboxylate,central nervous system,CNS,congenital ichthyosis,Disease mutation,EC=1.2.1.3,Endoplasmic reticulum,erythema,FADH,FALDH,fatty acids,FATTY ALCOHOL,Fatty aldehyde dehydrogenase,Fatty aldehyde dehydrogenase deficiency,glistening white spots on retina,H20,hexadecenal,hexadecenoic acid,ichthyosis,long-chain aliphatic aldehydes,low IQ,membrane,mental retardation,Microsomal aldehyde dehydrogenase,NAD,NADH,NADP,neuro,neurologic symptoms,neurological,neurological disorder,niacin,oxidation-reduction,oxidation-reduction process,Oxidoreductase,OXIDOREDUCTASE DEFICIENCY,peripheral nervous system,peripheral nervous system development,phytol metabolic process,retardation,S1P,saturated alphatic aldehyde,scaling,seizure,seizures,sesquiterpenoid metabolic process,severe mental retardation,short stature,sjoegren,Sjoegren Larsson syndrome,sjoegren syndrome,sjoegren's,Sjoegren-Larsson syndrome,sjoegrens,spastic di,spastic di-,speech defect,speech defects,sphingosine 1-phosphate,tetraplegia,Transmembrane,Transmembrane helix,unsaturated aliphatic aldehydes,white spots on retina",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs72547564",
        "SNP Name": "ALDH3A2 G641A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/clinvar/RCV000001706/",
        "Video": null,
        "Tags": "aldehyde,aldehyde dehydrogenase,Aldehyde dehydrogenase 10,aldehyde dehydrogenase family,Aldehyde dehydrogenase family 3 member A2,ALDH10,ALDH3A2,aliphatic aldehyde,aliphatic aldehydes,Alternative splicing,autosomal recessive neurocutaneous disorder,carboxylate,central nervous system,CNS,congenital ichthyosis,Disease mutation,EC=1.2.1.3,Endoplasmic reticulum,erythema,FADH,FALDH,fatty acids,FATTY ALCOHOL,Fatty aldehyde dehydrogenase,Fatty aldehyde dehydrogenase deficiency,glistening white spots on retina,H20,hexadecenal,hexadecenoic acid,ichthyosis,long-chain aliphatic aldehydes,low IQ,membrane,mental retardation,Microsomal aldehyde dehydrogenase,NAD,NADH,NADP,neuro,neurologic symptoms,neurological,neurological disorder,niacin,oxidation-reduction,oxidation-reduction process,Oxidoreductase,OXIDOREDUCTASE DEFICIENCY,peripheral nervous system,peripheral nervous system development,phytol metabolic process,retardation,S1P,saturated alphatic aldehyde,scaling,seizure,seizures,sesquiterpenoid metabolic process,severe mental retardation,short stature,sjoegren,Sjoegren Larsson syndrome,sjoegren syndrome,sjoegren's,Sjoegren-Larsson syndrome,sjoegrens,spastic di,spastic di-,speech defect,speech defects,sphingosine 1-phosphate,tetraplegia,Transmembrane,Transmembrane helix,unsaturated aliphatic aldehydes,white spots on retina",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs72547564",
        "SNP Name": "ALDH3A2 G641A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/clinvar/RCV000001706/",
        "Video": null,
        "Tags": "aldehyde,aldehyde dehydrogenase,Aldehyde dehydrogenase 10,aldehyde dehydrogenase family,Aldehyde dehydrogenase family 3 member A2,ALDH10,ALDH3A2,aliphatic aldehyde,aliphatic aldehydes,Alternative splicing,autosomal recessive neurocutaneous disorder,carboxylate,central nervous system,CNS,congenital ichthyosis,Disease mutation,EC=1.2.1.3,Endoplasmic reticulum,erythema,FADH,FALDH,fatty acids,FATTY ALCOHOL,Fatty aldehyde dehydrogenase,Fatty aldehyde dehydrogenase deficiency,glistening white spots on retina,H20,hexadecenal,hexadecenoic acid,ichthyosis,long-chain aliphatic aldehydes,low IQ,membrane,mental retardation,Microsomal aldehyde dehydrogenase,NAD,NADH,NADP,neuro,neurologic symptoms,neurological,neurological disorder,niacin,oxidation-reduction,oxidation-reduction process,Oxidoreductase,OXIDOREDUCTASE DEFICIENCY,peripheral nervous system,peripheral nervous system development,phytol metabolic process,retardation,S1P,saturated alphatic aldehyde,scaling,seizure,seizures,sesquiterpenoid metabolic process,severe mental retardation,short stature,sjoegren,Sjoegren Larsson syndrome,sjoegren syndrome,sjoegren's,Sjoegren-Larsson syndrome,sjoegrens,spastic di,spastic di-,speech defect,speech defects,sphingosine 1-phosphate,tetraplegia,Transmembrane,Transmembrane helix,unsaturated aliphatic aldehydes,white spots on retina",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs72547564",
        "SNP Name": "ALDH3A2 G641A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/clinvar/RCV000001706/",
        "Video": null,
        "Tags": "aldehyde,aldehyde dehydrogenase,Aldehyde dehydrogenase 10,aldehyde dehydrogenase family,Aldehyde dehydrogenase family 3 member A2,ALDH10,ALDH3A2,aliphatic aldehyde,aliphatic aldehydes,Alternative splicing,autosomal recessive neurocutaneous disorder,carboxylate,central nervous system,CNS,congenital ichthyosis,Disease mutation,EC=1.2.1.3,Endoplasmic reticulum,erythema,FADH,FALDH,fatty acids,FATTY ALCOHOL,Fatty aldehyde dehydrogenase,Fatty aldehyde dehydrogenase deficiency,glistening white spots on retina,H20,hexadecenal,hexadecenoic acid,ichthyosis,long-chain aliphatic aldehydes,low IQ,membrane,mental retardation,Microsomal aldehyde dehydrogenase,NAD,NADH,NADP,neuro,neurologic symptoms,neurological,neurological disorder,niacin,oxidation-reduction,oxidation-reduction process,Oxidoreductase,OXIDOREDUCTASE DEFICIENCY,peripheral nervous system,peripheral nervous system development,phytol metabolic process,retardation,S1P,saturated alphatic aldehyde,scaling,seizure,seizures,sesquiterpenoid metabolic process,severe mental retardation,short stature,sjoegren,Sjoegren Larsson syndrome,sjoegren syndrome,sjoegren's,Sjoegren-Larsson syndrome,sjoegrens,spastic di,spastic di-,speech defect,speech defects,sphingosine 1-phosphate,tetraplegia,Transmembrane,Transmembrane helix,unsaturated aliphatic aldehydes,white spots on retina",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs72547564",
        "SNP Name": "ALDH3A2 G641A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/clinvar/RCV000001706/",
        "Video": null,
        "Tags": "aldehyde,aldehyde dehydrogenase,Aldehyde dehydrogenase 10,aldehyde dehydrogenase family,Aldehyde dehydrogenase family 3 member A2,ALDH10,ALDH3A2,aliphatic aldehyde,aliphatic aldehydes,Alternative splicing,autosomal recessive neurocutaneous disorder,carboxylate,central nervous system,CNS,congenital ichthyosis,Disease mutation,EC=1.2.1.3,Endoplasmic reticulum,erythema,FADH,FALDH,fatty acids,FATTY ALCOHOL,Fatty aldehyde dehydrogenase,Fatty aldehyde dehydrogenase deficiency,glistening white spots on retina,H20,hexadecenal,hexadecenoic acid,ichthyosis,long-chain aliphatic aldehydes,low IQ,membrane,mental retardation,Microsomal aldehyde dehydrogenase,NAD,NADH,NADP,neuro,neurologic symptoms,neurological,neurological disorder,niacin,oxidation-reduction,oxidation-reduction process,Oxidoreductase,OXIDOREDUCTASE DEFICIENCY,peripheral nervous system,peripheral nervous system development,phytol metabolic process,retardation,S1P,saturated alphatic aldehyde,scaling,seizure,seizures,sesquiterpenoid metabolic process,severe mental retardation,short stature,sjoegren,Sjoegren Larsson syndrome,sjoegren syndrome,sjoegren's,Sjoegren-Larsson syndrome,sjoegrens,spastic di,spastic di-,speech defect,speech defects,sphingosine 1-phosphate,tetraplegia,Transmembrane,Transmembrane helix,unsaturated aliphatic aldehydes,white spots on retina",
        "Group": "Yeast/Alcohol Metabolism"
    },
    {
        "SNP ID": "rs72547575",
        "SNP Name": "ALDH3A2 A1157G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/clinvar/RCV000001711/",
        "Video": null,
        "Tags": "aldehyde,aldehyde dehydrogenase,Aldehyde dehydrogenase 10,aldehyde dehydrogenase family,Aldehyde dehydrogenase family 3 member A2,ALDH10,ALDH3A2,aliphatic aldehyde,aliphatic aldehydes,Alternative splicing,autosomal recessive neurocutaneous disorder,carboxylate,central nervous system,CNS,congenital ichthyosis,Disease mutation,EC=1.2.1.3,Endoplasmic reticulum,erythema,FADH,FALDH,fatty acids,FATTY ALCOHOL,Fatty aldehyde dehydrogenase,Fatty aldehyde dehydrogenase deficiency,glistening white spots on retina,H20,hexadecenal,hexadecenoic acid,ichthyosis,IQ,long-chain aliphatic aldehydes,low IQ,membrane,mental retardation,Microsomal aldehyde dehydrogenase,NAD,NADH,NADP,neuro,neurologic symptoms,neurological,neurological disorder,niacin,oxidation-reduction,oxidation-reduction process,Oxidoreductase,OXIDOREDUCTASE DEFICIENCY,peripheral nervous system,peripheral nervous system development,phytol metabolic process,retardation,S1P,saturated alphatic aldehyde,scaling,seizure,seizures,sesquiterpenoid metabolic process,severe mental retardation,short stature,sjoegren,Sjoegren Larsson syndrome,sjoegren syndrome,sjoegren's,Sjoegren-Larsson syndrome,sjoegrens,spastic di,spastic di-,speech defect,speech defects,sphingosine 1-phosphate,tetraplegia,Transmembrane,Transmembrane helix,unsaturated aliphatic aldehydes,white spots on retina",
        "Group": "Glutaraldehyde"
    },
    {
        "SNP ID": "rs72547575",
        "SNP Name": "ALDH3A2 A1157G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/clinvar/RCV000001711/",
        "Video": null,
        "Tags": "aldehyde,aldehyde dehydrogenase,Aldehyde dehydrogenase 10,aldehyde dehydrogenase family,Aldehyde dehydrogenase family 3 member A2,ALDH10,ALDH3A2,aliphatic aldehyde,aliphatic aldehydes,Alternative splicing,autosomal recessive neurocutaneous disorder,carboxylate,central nervous system,CNS,congenital ichthyosis,Disease mutation,EC=1.2.1.3,Endoplasmic reticulum,erythema,FADH,FALDH,fatty acids,FATTY ALCOHOL,Fatty aldehyde dehydrogenase,Fatty aldehyde dehydrogenase deficiency,glistening white spots on retina,H20,hexadecenal,hexadecenoic acid,ichthyosis,IQ,long-chain aliphatic aldehydes,low IQ,membrane,mental retardation,Microsomal aldehyde dehydrogenase,NAD,NADH,NADP,neuro,neurologic symptoms,neurological,neurological disorder,niacin,oxidation-reduction,oxidation-reduction process,Oxidoreductase,OXIDOREDUCTASE DEFICIENCY,peripheral nervous system,peripheral nervous system development,phytol metabolic process,retardation,S1P,saturated alphatic aldehyde,scaling,seizure,seizures,sesquiterpenoid metabolic process,severe mental retardation,short stature,sjoegren,Sjoegren Larsson syndrome,sjoegren syndrome,sjoegren's,Sjoegren-Larsson syndrome,sjoegrens,spastic di,spastic di-,speech defect,speech defects,sphingosine 1-phosphate,tetraplegia,Transmembrane,Transmembrane helix,unsaturated aliphatic aldehydes,white spots on retina",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs72547575",
        "SNP Name": "ALDH3A2 A1157G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/clinvar/RCV000001711/",
        "Video": null,
        "Tags": "aldehyde,aldehyde dehydrogenase,Aldehyde dehydrogenase 10,aldehyde dehydrogenase family,Aldehyde dehydrogenase family 3 member A2,ALDH10,ALDH3A2,aliphatic aldehyde,aliphatic aldehydes,Alternative splicing,autosomal recessive neurocutaneous disorder,carboxylate,central nervous system,CNS,congenital ichthyosis,Disease mutation,EC=1.2.1.3,Endoplasmic reticulum,erythema,FADH,FALDH,fatty acids,FATTY ALCOHOL,Fatty aldehyde dehydrogenase,Fatty aldehyde dehydrogenase deficiency,glistening white spots on retina,H20,hexadecenal,hexadecenoic acid,ichthyosis,IQ,long-chain aliphatic aldehydes,low IQ,membrane,mental retardation,Microsomal aldehyde dehydrogenase,NAD,NADH,NADP,neuro,neurologic symptoms,neurological,neurological disorder,niacin,oxidation-reduction,oxidation-reduction process,Oxidoreductase,OXIDOREDUCTASE DEFICIENCY,peripheral nervous system,peripheral nervous system development,phytol metabolic process,retardation,S1P,saturated alphatic aldehyde,scaling,seizure,seizures,sesquiterpenoid metabolic process,severe mental retardation,short stature,sjoegren,Sjoegren Larsson syndrome,sjoegren syndrome,sjoegren's,Sjoegren-Larsson syndrome,sjoegrens,spastic di,spastic di-,speech defect,speech defects,sphingosine 1-phosphate,tetraplegia,Transmembrane,Transmembrane helix,unsaturated aliphatic aldehydes,white spots on retina",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs72547575",
        "SNP Name": "ALDH3A2 A1157G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/clinvar/RCV000001711/",
        "Video": null,
        "Tags": "aldehyde,aldehyde dehydrogenase,Aldehyde dehydrogenase 10,aldehyde dehydrogenase family,Aldehyde dehydrogenase family 3 member A2,ALDH10,ALDH3A2,aliphatic aldehyde,aliphatic aldehydes,Alternative splicing,autosomal recessive neurocutaneous disorder,carboxylate,central nervous system,CNS,congenital ichthyosis,Disease mutation,EC=1.2.1.3,Endoplasmic reticulum,erythema,FADH,FALDH,fatty acids,FATTY ALCOHOL,Fatty aldehyde dehydrogenase,Fatty aldehyde dehydrogenase deficiency,glistening white spots on retina,H20,hexadecenal,hexadecenoic acid,ichthyosis,IQ,long-chain aliphatic aldehydes,low IQ,membrane,mental retardation,Microsomal aldehyde dehydrogenase,NAD,NADH,NADP,neuro,neurologic symptoms,neurological,neurological disorder,niacin,oxidation-reduction,oxidation-reduction process,Oxidoreductase,OXIDOREDUCTASE DEFICIENCY,peripheral nervous system,peripheral nervous system development,phytol metabolic process,retardation,S1P,saturated alphatic aldehyde,scaling,seizure,seizures,sesquiterpenoid metabolic process,severe mental retardation,short stature,sjoegren,Sjoegren Larsson syndrome,sjoegren syndrome,sjoegren's,Sjoegren-Larsson syndrome,sjoegrens,spastic di,spastic di-,speech defect,speech defects,sphingosine 1-phosphate,tetraplegia,Transmembrane,Transmembrane helix,unsaturated aliphatic aldehydes,white spots on retina",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs72547575",
        "SNP Name": "ALDH3A2 A1157G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/clinvar/RCV000001711/",
        "Video": null,
        "Tags": "aldehyde,aldehyde dehydrogenase,Aldehyde dehydrogenase 10,aldehyde dehydrogenase family,Aldehyde dehydrogenase family 3 member A2,ALDH10,ALDH3A2,aliphatic aldehyde,aliphatic aldehydes,Alternative splicing,autosomal recessive neurocutaneous disorder,carboxylate,central nervous system,CNS,congenital ichthyosis,Disease mutation,EC=1.2.1.3,Endoplasmic reticulum,erythema,FADH,FALDH,fatty acids,FATTY ALCOHOL,Fatty aldehyde dehydrogenase,Fatty aldehyde dehydrogenase deficiency,glistening white spots on retina,H20,hexadecenal,hexadecenoic acid,ichthyosis,IQ,long-chain aliphatic aldehydes,low IQ,membrane,mental retardation,Microsomal aldehyde dehydrogenase,NAD,NADH,NADP,neuro,neurologic symptoms,neurological,neurological disorder,niacin,oxidation-reduction,oxidation-reduction process,Oxidoreductase,OXIDOREDUCTASE DEFICIENCY,peripheral nervous system,peripheral nervous system development,phytol metabolic process,retardation,S1P,saturated alphatic aldehyde,scaling,seizure,seizures,sesquiterpenoid metabolic process,severe mental retardation,short stature,sjoegren,Sjoegren Larsson syndrome,sjoegren syndrome,sjoegren's,Sjoegren-Larsson syndrome,sjoegrens,spastic di,spastic di-,speech defect,speech defects,sphingosine 1-phosphate,tetraplegia,Transmembrane,Transmembrane helix,unsaturated aliphatic aldehydes,white spots on retina",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs72547575",
        "SNP Name": "ALDH3A2 A1157G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/clinvar/RCV000001711/",
        "Video": null,
        "Tags": "aldehyde,aldehyde dehydrogenase,Aldehyde dehydrogenase 10,aldehyde dehydrogenase family,Aldehyde dehydrogenase family 3 member A2,ALDH10,ALDH3A2,aliphatic aldehyde,aliphatic aldehydes,Alternative splicing,autosomal recessive neurocutaneous disorder,carboxylate,central nervous system,CNS,congenital ichthyosis,Disease mutation,EC=1.2.1.3,Endoplasmic reticulum,erythema,FADH,FALDH,fatty acids,FATTY ALCOHOL,Fatty aldehyde dehydrogenase,Fatty aldehyde dehydrogenase deficiency,glistening white spots on retina,H20,hexadecenal,hexadecenoic acid,ichthyosis,IQ,long-chain aliphatic aldehydes,low IQ,membrane,mental retardation,Microsomal aldehyde dehydrogenase,NAD,NADH,NADP,neuro,neurologic symptoms,neurological,neurological disorder,niacin,oxidation-reduction,oxidation-reduction process,Oxidoreductase,OXIDOREDUCTASE DEFICIENCY,peripheral nervous system,peripheral nervous system development,phytol metabolic process,retardation,S1P,saturated alphatic aldehyde,scaling,seizure,seizures,sesquiterpenoid metabolic process,severe mental retardation,short stature,sjoegren,Sjoegren Larsson syndrome,sjoegren syndrome,sjoegren's,Sjoegren-Larsson syndrome,sjoegrens,spastic di,spastic di-,speech defect,speech defects,sphingosine 1-phosphate,tetraplegia,Transmembrane,Transmembrane helix,unsaturated aliphatic aldehydes,white spots on retina",
        "Group": "Yeast/Alcohol Metabolism"
    },
    {
        "SNP ID": "rs2297518",
        "SNP Name": "NOS2 C1823T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2297518",
        "Video": null,
        "Tags": "2 L-arginine + 3 NADPH + 4 O2 = 2 L-citrulline + 2 nitric oxide + 3 NADP+ + 4 H2O,Alternative splicing,arginine,arginine binding,arginine catabolic process,aspirin,Aspirin inhibits expression and function of this enzyme and effects may be exerted at the level of translational/post-translational modification and directly on the catalytic activity,Associated with Fetal Growth,B-cell lymphoma,benign prostatic hyperplasia,BH4,Biliary Tract Cancers and Stones,Binds 1 FAD,Binds 1 FMN,Binds SLC9A3R1,blood coagulation,blood pressure,Calcium,Calmodulin-binding,cancer,cancerous,carcinogen,cellular response to interferon-gamma,cellular response to lipopolysaccharide,Chron,Chron's disease,clearance of drug-resistant Plasmodium falciparum parasites,Colon cancer,Complete proteome,cortical cytoskeleton,cysteine,cysteine S-nitrosylation,cytoplasm,cytosol,defense response to bacterium,defense response to Gram-negative bacterium,dopamine,drug metabolism,drugs,Essential hypertension,Expressed in the liver and retina and bone cells and airway epithelial cells of the lung,FAD,FAD-binding FR-type domain,ferritin,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,Genetic predisposition to Helicobacter pylori-induced gastric precancerous conditions,Genetic variations in NOS2 are involved in resistance to malaria,glioma,heme,heme binding,Heme group,HEP-NOS,Hepatocyte NOS,high BP,Homodimer,hypertension,IBD,IBS,in macrophages NO mediates tumoricidal and bactericidal actions,Induced by IFNG/IFN-gamma acting synergistically with bacterial lipopolysaccharides (LPS) and TNF or IL1B/interleukin-1 beta,inducible,Inducible NO synthase,Inducible NOS,Induction by endotoxins and cytokines,inflammation,Inflammatory Bowel Disease,inflammatory response,innate immune response in mucosa,iNOS,interaction with host,interleukin,intracellular,invasive pneumococcal disease,Irate Bowel Syndrome,Iron,iron ion binding,L-Arginine,malaria,malaria resistance,Malian Population,mediates tumoricidal and bactericidal actions,Metal-binding,migraine,migraine aura,NADP,NADP binding,NADPH-hemoprotein reductase activity,natural killer cell,negative regulation of blood pressure,negative regulation of gene expression,negative regulation of protein catabolic process,nitric oxide,nitric oxide biosynthetic process,nitric oxide mediated signal transduction,Nitric oxide synthase,Nitric Oxide Synthase and Arginase Influence Exhaled Nitric Oxide Levels in Children,nitric-oxide synthase activity,nitrosylase activity,nitrosylase activity and mediates cysteine S-nitrosylation of cytoplasmic target proteins such COX2,NO,NOS family,NOS type II,NOS2,NOS2A,Not expressed in the platelets,nucleus,oxidate stress pathway,oxidative stress,Oxidoreductase,pain severity in lung cancer patients,Peptidyl-cysteine S-nitrosylase NOS2,peptidyl-cysteine S-nitrosylation,perinuclear region of cytoplasm,peroxisome,phagosome maturation,Phosphoprotein,Polymorphism,positive regulation of guanylate cyclase activity,positive regulation of killing of cells of other organism,positive regulation of leukocyte mediated cytotoxicity,positive regulation of vasodilation,Produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body,prostate cancer,protein homodimerization activity,pulmonary tuberculosis,Radiation-Induced Toxicity Following Treatment for Non-Small Cell Lung Cancer,reactive free radical,receptor binding,Rectal Cancer,Reference proteome,Regulated by calcium/calmodulin,regulation of cell proliferation,regulation of cellular respiration,regulation of insulin secretion,relationship between vegetable and fruit intake and risk of non-Hodgkin lymphoma,response to bacterium,response to hypoxia,rheumatoid arthritis,ROS,serotonin,Severe Malaria,smoking in age-related macular degeneration,superoxide metabolic process,Tetrahydrobiopterin (BH4),tetrahydrobiopterin binding,THB,type 2 diabetes mellitus,UC",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2297518",
        "SNP Name": "NOS2 C1823T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2297518",
        "Video": null,
        "Tags": "2 L-arginine + 3 NADPH + 4 O2 = 2 L-citrulline + 2 nitric oxide + 3 NADP+ + 4 H2O,Alternative splicing,arginine,arginine binding,arginine catabolic process,aspirin,Aspirin inhibits expression and function of this enzyme and effects may be exerted at the level of translational/post-translational modification and directly on the catalytic activity,Associated with Fetal Growth,B-cell lymphoma,benign prostatic hyperplasia,BH4,Biliary Tract Cancers and Stones,Binds 1 FAD,Binds 1 FMN,Binds SLC9A3R1,blood coagulation,blood pressure,Calcium,Calmodulin-binding,cancer,cancerous,carcinogen,cellular response to interferon-gamma,cellular response to lipopolysaccharide,Chron,Chron's disease,clearance of drug-resistant Plasmodium falciparum parasites,Colon cancer,Complete proteome,cortical cytoskeleton,cysteine,cysteine S-nitrosylation,cytoplasm,cytosol,defense response to bacterium,defense response to Gram-negative bacterium,dopamine,drug metabolism,drugs,Essential hypertension,Expressed in the liver and retina and bone cells and airway epithelial cells of the lung,FAD,FAD-binding FR-type domain,ferritin,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,Genetic predisposition to Helicobacter pylori-induced gastric precancerous conditions,Genetic variations in NOS2 are involved in resistance to malaria,glioma,heme,heme binding,Heme group,HEP-NOS,Hepatocyte NOS,high BP,Homodimer,hypertension,IBD,IBS,in macrophages NO mediates tumoricidal and bactericidal actions,Induced by IFNG/IFN-gamma acting synergistically with bacterial lipopolysaccharides (LPS) and TNF or IL1B/interleukin-1 beta,inducible,Inducible NO synthase,Inducible NOS,Induction by endotoxins and cytokines,inflammation,Inflammatory Bowel Disease,inflammatory response,innate immune response in mucosa,iNOS,interaction with host,interleukin,intracellular,invasive pneumococcal disease,Irate Bowel Syndrome,Iron,iron ion binding,L-Arginine,malaria,malaria resistance,Malian Population,mediates tumoricidal and bactericidal actions,Metal-binding,migraine,migraine aura,NADP,NADP binding,NADPH-hemoprotein reductase activity,natural killer cell,negative regulation of blood pressure,negative regulation of gene expression,negative regulation of protein catabolic process,nitric oxide,nitric oxide biosynthetic process,nitric oxide mediated signal transduction,Nitric oxide synthase,Nitric Oxide Synthase and Arginase Influence Exhaled Nitric Oxide Levels in Children,nitric-oxide synthase activity,nitrosylase activity,nitrosylase activity and mediates cysteine S-nitrosylation of cytoplasmic target proteins such COX2,NO,NOS family,NOS type II,NOS2,NOS2A,Not expressed in the platelets,nucleus,oxidate stress pathway,oxidative stress,Oxidoreductase,pain severity in lung cancer patients,Peptidyl-cysteine S-nitrosylase NOS2,peptidyl-cysteine S-nitrosylation,perinuclear region of cytoplasm,peroxisome,phagosome maturation,Phosphoprotein,Polymorphism,positive regulation of guanylate cyclase activity,positive regulation of killing of cells of other organism,positive regulation of leukocyte mediated cytotoxicity,positive regulation of vasodilation,Produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body,prostate cancer,protein homodimerization activity,pulmonary tuberculosis,Radiation-Induced Toxicity Following Treatment for Non-Small Cell Lung Cancer,reactive free radical,receptor binding,Rectal Cancer,Reference proteome,Regulated by calcium/calmodulin,regulation of cell proliferation,regulation of cellular respiration,regulation of insulin secretion,relationship between vegetable and fruit intake and risk of non-Hodgkin lymphoma,response to bacterium,response to hypoxia,rheumatoid arthritis,ROS,serotonin,Severe Malaria,smoking in age-related macular degeneration,superoxide metabolic process,Tetrahydrobiopterin (BH4),tetrahydrobiopterin binding,THB,type 2 diabetes mellitus,UC",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs2297518",
        "SNP Name": "NOS2 C1823T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2297518",
        "Video": null,
        "Tags": "2 L-arginine + 3 NADPH + 4 O2 = 2 L-citrulline + 2 nitric oxide + 3 NADP+ + 4 H2O,Alternative splicing,arginine,arginine binding,arginine catabolic process,aspirin,Aspirin inhibits expression and function of this enzyme and effects may be exerted at the level of translational/post-translational modification and directly on the catalytic activity,Associated with Fetal Growth,B-cell lymphoma,benign prostatic hyperplasia,BH4,Biliary Tract Cancers and Stones,Binds 1 FAD,Binds 1 FMN,Binds SLC9A3R1,blood coagulation,blood pressure,Calcium,Calmodulin-binding,cancer,cancerous,carcinogen,cellular response to interferon-gamma,cellular response to lipopolysaccharide,Chron,Chron's disease,clearance of drug-resistant Plasmodium falciparum parasites,Colon cancer,Complete proteome,cortical cytoskeleton,cysteine,cysteine S-nitrosylation,cytoplasm,cytosol,defense response to bacterium,defense response to Gram-negative bacterium,dopamine,drug metabolism,drugs,Essential hypertension,Expressed in the liver and retina and bone cells and airway epithelial cells of the lung,FAD,FAD-binding FR-type domain,ferritin,flavin adenine dinucleotide binding,flavodoxin-like domain,Flavoprotein,FMN,FMN binding,Genetic predisposition to Helicobacter pylori-induced gastric precancerous conditions,Genetic variations in NOS2 are involved in resistance to malaria,glioma,heme,heme binding,Heme group,HEP-NOS,Hepatocyte NOS,high BP,Homodimer,hypertension,IBD,IBS,in macrophages NO mediates tumoricidal and bactericidal actions,Induced by IFNG/IFN-gamma acting synergistically with bacterial lipopolysaccharides (LPS) and TNF or IL1B/interleukin-1 beta,inducible,Inducible NO synthase,Inducible NOS,Induction by endotoxins and cytokines,inflammation,Inflammatory Bowel Disease,inflammatory response,innate immune response in mucosa,iNOS,interaction with host,interleukin,intracellular,invasive pneumococcal disease,Irate Bowel Syndrome,Iron,iron ion binding,L-Arginine,malaria,malaria resistance,Malian Population,mediates tumoricidal and bactericidal actions,Metal-binding,migraine,migraine aura,NADP,NADP binding,NADPH-hemoprotein reductase activity,natural killer cell,negative regulation of blood pressure,negative regulation of gene expression,negative regulation of protein catabolic process,nitric oxide,nitric oxide biosynthetic process,nitric oxide mediated signal transduction,Nitric oxide synthase,Nitric Oxide Synthase and Arginase Influence Exhaled Nitric Oxide Levels in Children,nitric-oxide synthase activity,nitrosylase activity,nitrosylase activity and mediates cysteine S-nitrosylation of cytoplasmic target proteins such COX2,NO,NOS family,NOS type II,NOS2,NOS2A,Not expressed in the platelets,nucleus,oxidate stress pathway,oxidative stress,Oxidoreductase,pain severity in lung cancer patients,Peptidyl-cysteine S-nitrosylase NOS2,peptidyl-cysteine S-nitrosylation,perinuclear region of cytoplasm,peroxisome,phagosome maturation,Phosphoprotein,Polymorphism,positive regulation of guanylate cyclase activity,positive regulation of killing of cells of other organism,positive regulation of leukocyte mediated cytotoxicity,positive regulation of vasodilation,Produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body,prostate cancer,protein homodimerization activity,pulmonary tuberculosis,Radiation-Induced Toxicity Following Treatment for Non-Small Cell Lung Cancer,reactive free radical,receptor binding,Rectal Cancer,Reference proteome,Regulated by calcium/calmodulin,regulation of cell proliferation,regulation of cellular respiration,regulation of insulin secretion,relationship between vegetable and fruit intake and risk of non-Hodgkin lymphoma,response to bacterium,response to hypoxia,rheumatoid arthritis,ROS,serotonin,Severe Malaria,smoking in age-related macular degeneration,superoxide metabolic process,Tetrahydrobiopterin (BH4),tetrahydrobiopterin binding,THB,type 2 diabetes mellitus,UC",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1042173",
        "SNP Name": "SLC6A4 A28525011C",
        "Risk Allele": "C",
        "Your Allele": "AC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Amphotericin B"
    },
    {
        "SNP ID": "rs2066713",
        "SNP Name": "SLC6A4 G28551665A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Amphotericin B"
    },
    {
        "SNP ID": "rs2953014",
        "SNP Name": "NF1 T29495895G",
        "Risk Allele": "G",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Octylphenol Ethoxylate (Triton X-100)"
    },
    {
        "SNP ID": "rs2285892",
        "SNP Name": "NF1 P678P",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Octylphenol Ethoxylate (Triton X-100)"
    },
    {
        "SNP ID": "rs876493",
        "SNP Name": "PNMT G-184A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs876493",
        "Video": null,
        "Tags": "acute kidney injury,adrenaline,AKI,amino acids,associated with norepinephrine and epinephrine concentrations at rest and exercise,asthma,Belongs to the class I-like SAM-binding methyltransferase superfamily,beta-carboline 2N-methyltransferase activity,biosynthesis,blood pressure,catecholamine,Catecholamine biosynthesis,Catecholamine biosynthesis; (R)-adrenaline biosynthesis; (R)-adrenaline from (R)-noradrenaline,catecholamine biosynthetic process,catecholaminergic pathway,cellular nitrogen compound metabolic process,Complete proteome,Converts noradrenaline to adrenaline,cytosol,epinephrine,epinephrine biosynthetic process,Essential hypertension,high BP,homocysteine,hypertension,kidney,L-homocysteine,methionine,methylates norepinephrine to form epinephrine (adrenaline),methylphenylethanolamine,Methyltransferase,Mortality,NNMT/PNMT/TEMT family,noradrenaline,Noradrenaline N-methyltransferase,norepinephrine,phenol,phenylethanolamine,Phenylethanolamine N-methyltransferase,phenylethanolamine N-methyltransferase activity,PNMT,PNMTase,Polymorphism,Reference proteome,regulates epinephrine production,S-adenosy-lmethionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,S-adenosyl-L-methionine + phenylethanolamine = S-adenosyl-L-homocysteine + N-methylphenylethanolamine,SAMe,small molecule metabolic process,Transferase",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs876493",
        "SNP Name": "PNMT G-184A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs876493",
        "Video": null,
        "Tags": "acute kidney injury,adrenaline,AKI,amino acids,associated with norepinephrine and epinephrine concentrations at rest and exercise,asthma,Belongs to the class I-like SAM-binding methyltransferase superfamily,beta-carboline 2N-methyltransferase activity,biosynthesis,blood pressure,catecholamine,Catecholamine biosynthesis,Catecholamine biosynthesis; (R)-adrenaline biosynthesis; (R)-adrenaline from (R)-noradrenaline,catecholamine biosynthetic process,catecholaminergic pathway,cellular nitrogen compound metabolic process,Complete proteome,Converts noradrenaline to adrenaline,cytosol,epinephrine,epinephrine biosynthetic process,Essential hypertension,high BP,homocysteine,hypertension,kidney,L-homocysteine,methionine,methylates norepinephrine to form epinephrine (adrenaline),methylphenylethanolamine,Methyltransferase,Mortality,NNMT/PNMT/TEMT family,noradrenaline,Noradrenaline N-methyltransferase,norepinephrine,phenol,phenylethanolamine,Phenylethanolamine N-methyltransferase,phenylethanolamine N-methyltransferase activity,PNMT,PNMTase,Polymorphism,Reference proteome,regulates epinephrine production,S-adenosy-lmethionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,S-adenosyl-L-methionine + phenylethanolamine = S-adenosyl-L-homocysteine + N-methylphenylethanolamine,SAMe,small molecule metabolic process,Transferase",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs7216389",
        "SNP Name": "GSDMB variant",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs7216389",
        "Video": null,
        "Tags": null,
        "Group": "Other Immune Factors"
    },
    {
        "SNP ID": "rs1126642",
        "SNP Name": "GFAP Asp295Asn",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Octylphenol Ethoxylate (Triton X-100)"
    },
    {
        "SNP ID": "rs2289681",
        "SNP Name": "GFAP A286A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs5918",
        "SNP Name": "ITGB3 \u00a0P1A2/T196C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "3D-structure,Abciximab,activation of protein kinase activity,acute myocardial infarction,alphav-beta3 integrin-vitronectin complex,Altered Serum Cholesterol,Alternative splicing,Antithymocyte globulin,apolipoprotein A-I-mediated signaling pathway,apolipoprotein D,Arteriovenous Fistula,Arteriovenous Fistula Failure,aspirin,asthma,atherosclerosis,atherosclerotic plaque,atherothrombotic,autism,autism spectrum disorder,Autosomal dominant macrothrombocytopenia,axon guidance,bleeding tendency,blood coagulation,Blood Pressure,breast cancer,cancer,cancerous,carcinogen,cardio,cardiovascular,CD61,cell adhesion,cell adhesion molecule binding,cell growth,Cell junction,Cell membrane,cell migration,Cell projection,cell surface,cell-matrix adhesion,cell-substrate adhesion,cell-substrate junction assembly,cholesterol,coagulation,coagulation pathways,Complete proteome,CVD,cytotactin,Direct protein sequencing,Disulfide bond,Eptifibatide,extracellular matrix binding,extracellular matrix organization,extracellular vesicular exosome,Fetal and neonatal alloimmune thrombocytopenia,fibrinogen,fibronectin,fibronectin binding,filopodium membrane,fistula,focal adhesion,Glanzmann thrombasthenia,Glycoprotein,GP3A,GPIIIa,heart,heart attack,heterotypic cell-cell adhesion,HIV-1 Tat,Host-virus interaction,Hypertension,identical protein binding,Incident Hypertension,inflammation,integral component of plasma membrane,Integrin,Integrin alpha-IIb/beta-3,Integrin alpha-V/beta-3,integrin alphav-beta3 complex,integrin beta chain family,Integrin beta-3,integrin complex,integrin-mediated signaling pathway,Ischemic Stroke,ITB3,ITGB3,L-Tyrosine,lacunar stroke,lamellipodium membrane,laminin,leukocyte migration,lipid,macrothrombocytopenia,matrix metalloproteinase-2,melanosome,Membrane,mesodermal cell differentiation,microvillus membrane,Migraine,mold,Mold Allergen,mortality,myocardial infarction,negative chemotaxis,negative regulation of lipid storage,negative regulation of lipid transport,negative regulation of lipoprotein metabolic process,negative regulation of low-density lipoprotein particle receptor biosynthetic process,negative regulation of macrophage derived foam cell differentiation,neonatal alloimmune thrombocytopenia,non-Hodgkin lymphoma,nucleus,osteomodulin,osteopontin,ovarian cancer,Phosphoprotein,plasma membrane,plasminogen,platelet,platelet activation,Platelet adhesion,platelet aggregation,Platelet aggregation pathway,platelet alpha granule membrane,platelet anisocytosis,platelet degranulation,Platelet membrane glycoprotein IIIa,platelet reactivity,platelet serotonin system,platelet-derived growth factor receptor binding,Polymorphism,positive regulation of endothelial cell migration,positive regulation of endothelial cell proliferation,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of protein phosphorylation,positive regulation of vascular endothelial growth factor receptor signaling pathway,Premature Peripheral Arterial Occlusive Disease,protease binding,protein disulfide isomerase activity,protein folding,prothrombin,Receptor,receptor activity,receptor complex,Recurrent Venous Thromboembolism,Reference proteome,regulation of bone resorption,renal,renal function,Repeat,ruffle membrane,serotonin,Severe Neonatal Alloimmune Thrombocytopenia,Severe Thrombocytopenia,Signal,smooth muscle cell migration,Staphylococcus aureus,stroke,substrate adhesion-dependent cell spreading,thrombasthenia,thrombocytopenia,thrombospondin,Tirofiban,Transmembrane,Transmembrane helix,tube development,tyrosine,vascular endothelial growth factor receptor 2 binding,Venous Thromboembolism,viral entry into host cell,vitronectin,von Willebrand factor,VWFA domain,Whole Blood Serotonin,Willebrand,wound healing",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs5918",
        "SNP Name": "ITGB3 \u00a0P1A2/T196C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "3D-structure,Abciximab,activation of protein kinase activity,acute myocardial infarction,alphav-beta3 integrin-vitronectin complex,Altered Serum Cholesterol,Alternative splicing,Antithymocyte globulin,apolipoprotein A-I-mediated signaling pathway,apolipoprotein D,Arteriovenous Fistula,Arteriovenous Fistula Failure,aspirin,asthma,atherosclerosis,atherosclerotic plaque,atherothrombotic,autism,autism spectrum disorder,Autosomal dominant macrothrombocytopenia,axon guidance,bleeding tendency,blood coagulation,Blood Pressure,breast cancer,cancer,cancerous,carcinogen,cardio,cardiovascular,CD61,cell adhesion,cell adhesion molecule binding,cell growth,Cell junction,Cell membrane,cell migration,Cell projection,cell surface,cell-matrix adhesion,cell-substrate adhesion,cell-substrate junction assembly,cholesterol,coagulation,coagulation pathways,Complete proteome,CVD,cytotactin,Direct protein sequencing,Disulfide bond,Eptifibatide,extracellular matrix binding,extracellular matrix organization,extracellular vesicular exosome,Fetal and neonatal alloimmune thrombocytopenia,fibrinogen,fibronectin,fibronectin binding,filopodium membrane,fistula,focal adhesion,Glanzmann thrombasthenia,Glycoprotein,GP3A,GPIIIa,heart,heart attack,heterotypic cell-cell adhesion,HIV-1 Tat,Host-virus interaction,Hypertension,identical protein binding,Incident Hypertension,inflammation,integral component of plasma membrane,Integrin,Integrin alpha-IIb/beta-3,Integrin alpha-V/beta-3,integrin alphav-beta3 complex,integrin beta chain family,Integrin beta-3,integrin complex,integrin-mediated signaling pathway,Ischemic Stroke,ITB3,ITGB3,L-Tyrosine,lacunar stroke,lamellipodium membrane,laminin,leukocyte migration,lipid,macrothrombocytopenia,matrix metalloproteinase-2,melanosome,Membrane,mesodermal cell differentiation,microvillus membrane,Migraine,mold,Mold Allergen,mortality,myocardial infarction,negative chemotaxis,negative regulation of lipid storage,negative regulation of lipid transport,negative regulation of lipoprotein metabolic process,negative regulation of low-density lipoprotein particle receptor biosynthetic process,negative regulation of macrophage derived foam cell differentiation,neonatal alloimmune thrombocytopenia,non-Hodgkin lymphoma,nucleus,osteomodulin,osteopontin,ovarian cancer,Phosphoprotein,plasma membrane,plasminogen,platelet,platelet activation,Platelet adhesion,platelet aggregation,Platelet aggregation pathway,platelet alpha granule membrane,platelet anisocytosis,platelet degranulation,Platelet membrane glycoprotein IIIa,platelet reactivity,platelet serotonin system,platelet-derived growth factor receptor binding,Polymorphism,positive regulation of endothelial cell migration,positive regulation of endothelial cell proliferation,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of protein phosphorylation,positive regulation of vascular endothelial growth factor receptor signaling pathway,Premature Peripheral Arterial Occlusive Disease,protease binding,protein disulfide isomerase activity,protein folding,prothrombin,Receptor,receptor activity,receptor complex,Recurrent Venous Thromboembolism,Reference proteome,regulation of bone resorption,renal,renal function,Repeat,ruffle membrane,serotonin,Severe Neonatal Alloimmune Thrombocytopenia,Severe Thrombocytopenia,Signal,smooth muscle cell migration,Staphylococcus aureus,stroke,substrate adhesion-dependent cell spreading,thrombasthenia,thrombocytopenia,thrombospondin,Tirofiban,Transmembrane,Transmembrane helix,tube development,tyrosine,vascular endothelial growth factor receptor 2 binding,Venous Thromboembolism,viral entry into host cell,vitronectin,von Willebrand factor,VWFA domain,Whole Blood Serotonin,Willebrand,wound healing",
        "Group": "Clotting Factors"
    },
    {
        "SNP ID": "rs2759",
        "SNP Name": "MPO A15191G",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2759",
        "Video": null,
        "Tags": "84 kDa myeloperoxidase,89 kDa myeloperoxidase,acute kidney injury,aging,Alternative splicing,Alzheimer,Alzheimer's disease,azurophil granule,Binds 1 calcium ion per monomer,Binds 1 heme B (iron-protoporphyrin IX) group covalently per monomer,blood cells,blood sugar,calcium,candida,cardiac surgery,chromatin binding,cirrhosis,Cl- + H2O2 + H+ = HClO + H2O,Cl- + H2O2 = HOCl + 2 H2O,defense response,defense response to fungus,diabetes,diabetes mellitus,Disease mutation,disorder characterized by decreased myeloperoxidase activity in neutrophils and monocytes that results in disseminated candidiasis,Disulfide bond,disulfide-linked,Each monomer consists of a light and a heavy chain,extracellular space,extracellular vesicular exosome,ferritin,fungal,Glycoprotein,heart,heme,heme binding,heparin binding,Homodimer,Hydrogen peroxide,hydrogen peroxide catabolic process,hypochlorous acid biosynthetic process,hypohalous acid,iron,kidney,kidney disease,liver,low-density lipoprotein particle remodeling,Lysosome,metal ion binding,Metal-binding,mitochondrion,mortality,MPO,MPO catalyzes the production of hypohalous acids,mpod,Myeloperoxidase,Myeloperoxidase deficiency,Myeloperoxidase heavy chain,Myeloperoxidase light chain,negative regulation of apoptotic process,negative regulation of growth of symbiont in host,nucleus,Oxidation,oxidation-reduction process,oxidative stress and cognition,Oxidoreductase,Peroxidase,peroxidase activity,peroxidase family,PMN,PMN microbicidal activity,Polymorphism,polymorphonuclear leukocytes,psychiatric,psychology,red blood cell,removal of superoxide radicals,respiratory burst involved in defense response,response to food,response to lipopolysaccharide,response to mechanical stimulus,response to oxidative stress,response to yeast,ROS,secretory granule,Signal,toxin,white blood cell,XPO subfamily",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2071409",
        "SNP Name": "MPO A15067C",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2071409",
        "Video": null,
        "Tags": "84 kDa myeloperoxidase,89 kDa myeloperoxidase,acute kidney injury,aging,Alternative splicing,Alzheimer,Alzheimer's disease,Ambient Air Pollution and Respiratory-related School Absences,azurophil granule,Binds 1 calcium ion per monomer,Binds 1 heme B (iron-protoporphyrin IX) group covalently per monomer,blood cells,calcium,candida,cardiac surgery,chromatin binding,Cl- + H2O2 + H+ = HClO + H2O,Cl- + H2O2 = HOCl + 2 H2O,defense response,defense response to fungus,development of benzene hematotoxicity,Disease mutation,disorder characterized by decreased myeloperoxidase activity in neutrophils and monocytes that results in disseminated candidiasis,Disulfide bond,disulfide-linked,Each monomer consists of a light and a heavy chain,extracellular space,extracellular vesicular exosome,ferritin,fungal,Glycoprotein,heart,heme,heme binding,heparin binding,Homodimer,Hydrogen peroxide,hydrogen peroxide catabolic process,hypochlorous acid biosynthetic process,hypohalous acid,immune system,immunity,iron,kidney,kidney disease,low-density lipoprotein particle remodeling,Lysosome,metal ion binding,Metal-binding,mitochondrion,mortality,MPO,MPO catalyzes the production of hypohalous acids,mpod,Myeloperoxidase,Myeloperoxidase deficiency,Myeloperoxidase heavy chain,Myeloperoxidase light chain,Nasopharyngeal Carcinoma,negative regulation of apoptotic process,negative regulation of growth of symbiont in host,nucleus,Oxidation,oxidation-reduction process,Oxidoreductase,Peroxidase,peroxidase activity,peroxidase family,PMN,PMN microbicidal activity,Polymorphism,Polymorphisms,polymorphonuclear leukocytes,psychiatric,psychology,red blood cell,relationship between vegetable and fruit intake and risk of non-Hodgkin lymphoma,removal of superoxide radicals,respiratory burst involved in defense response,response to food,response to lipopolysaccharide,response to mechanical stimulus,response to oxidative stress,response to yeast,secretory granule,sepsis,Signal,susceptibility to benzene-induced hematotoxicity,toxin,white blood cell,XPO subfamily",
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs2071409",
        "SNP Name": "MPO A15067C",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2071409",
        "Video": null,
        "Tags": "84 kDa myeloperoxidase,89 kDa myeloperoxidase,acute kidney injury,aging,Alternative splicing,Alzheimer,Alzheimer's disease,Ambient Air Pollution and Respiratory-related School Absences,azurophil granule,Binds 1 calcium ion per monomer,Binds 1 heme B (iron-protoporphyrin IX) group covalently per monomer,blood cells,calcium,candida,cardiac surgery,chromatin binding,Cl- + H2O2 + H+ = HClO + H2O,Cl- + H2O2 = HOCl + 2 H2O,defense response,defense response to fungus,development of benzene hematotoxicity,Disease mutation,disorder characterized by decreased myeloperoxidase activity in neutrophils and monocytes that results in disseminated candidiasis,Disulfide bond,disulfide-linked,Each monomer consists of a light and a heavy chain,extracellular space,extracellular vesicular exosome,ferritin,fungal,Glycoprotein,heart,heme,heme binding,heparin binding,Homodimer,Hydrogen peroxide,hydrogen peroxide catabolic process,hypochlorous acid biosynthetic process,hypohalous acid,immune system,immunity,iron,kidney,kidney disease,low-density lipoprotein particle remodeling,Lysosome,metal ion binding,Metal-binding,mitochondrion,mortality,MPO,MPO catalyzes the production of hypohalous acids,mpod,Myeloperoxidase,Myeloperoxidase deficiency,Myeloperoxidase heavy chain,Myeloperoxidase light chain,Nasopharyngeal Carcinoma,negative regulation of apoptotic process,negative regulation of growth of symbiont in host,nucleus,Oxidation,oxidation-reduction process,Oxidoreductase,Peroxidase,peroxidase activity,peroxidase family,PMN,PMN microbicidal activity,Polymorphism,Polymorphisms,polymorphonuclear leukocytes,psychiatric,psychology,red blood cell,relationship between vegetable and fruit intake and risk of non-Hodgkin lymphoma,removal of superoxide radicals,respiratory burst involved in defense response,response to food,response to lipopolysaccharide,response to mechanical stimulus,response to oxidative stress,response to yeast,secretory granule,sepsis,Signal,susceptibility to benzene-induced hematotoxicity,toxin,white blood cell,XPO subfamily",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs28730837",
        "SNP Name": "MPO C7900T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs28730837",
        "Video": null,
        "Tags": "84 kDa myeloperoxidase,89 kDa myeloperoxidase,aging,Alternative splicing,Alzheimer,Alzheimer's disease,artery,Atherosclerosis,azurophil granule,Binds 1 calcium ion per monomer,Binds 1 heme B (iron-protoporphyrin IX) group covalently per monomer,blood cells,blood pressure,calcium,candida,chromatin binding,Cl- + H2O2 + H+ = HClO + H2O,Cl- + H2O2 = HOCl + 2 H2O,defense response,defense response to fungus,Disease mutation,disorder characterized by decreased myeloperoxidase activity in neutrophils and monocytes that results in disseminated candidiasis,Disulfide bond,disulfide-linked,Each monomer consists of a light and a heavy chain,extracellular space,extracellular vesicular exosome,ferritin,fungal,Genetic and Environmental Factors to Systemic Inflammatory Biomarker Concentrations,Glycoprotein,heme,heme binding,heparin binding,high BP,Homodimer,Hydrogen peroxide,hydrogen peroxide catabolic process,hypertension,hypochlorous acid biosynthetic process,hypohalous acid,iron,low-density lipoprotein particle remodeling,Lysosome,metal ion binding,Metal-binding,mitochondrion,MPO,MPO catalyzes the production of hypohalous acids,mpod,Myeloperoxidase,Myeloperoxidase deficiency,Myeloperoxidase heavy chain,Myeloperoxidase light chain,negative regulation of apoptotic process,negative regulation of growth of symbiont in host,nucleus,Oxidation,oxidation-reduction process,Oxidoreductase,Peroxidase,peroxidase activity,peroxidase family,PMN,PMN microbicidal activity,Polymorphism,polymorphonuclear leukocytes,psychiatric,psychology,red blood cell,removal of superoxide radicals,respiratory burst involved in defense response,response to food,response to lipopolysaccharide,response to mechanical stimulus,response to oxidative stress,response to yeast,secretory granule,Signal,toxin,white blood cell,XPO subfamily",
        "Group": "Castor Oil"
    },
    {
        "SNP ID": "rs28730837",
        "SNP Name": "MPO C7900T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs28730837",
        "Video": null,
        "Tags": "84 kDa myeloperoxidase,89 kDa myeloperoxidase,aging,Alternative splicing,Alzheimer,Alzheimer's disease,artery,Atherosclerosis,azurophil granule,Binds 1 calcium ion per monomer,Binds 1 heme B (iron-protoporphyrin IX) group covalently per monomer,blood cells,blood pressure,calcium,candida,chromatin binding,Cl- + H2O2 + H+ = HClO + H2O,Cl- + H2O2 = HOCl + 2 H2O,defense response,defense response to fungus,Disease mutation,disorder characterized by decreased myeloperoxidase activity in neutrophils and monocytes that results in disseminated candidiasis,Disulfide bond,disulfide-linked,Each monomer consists of a light and a heavy chain,extracellular space,extracellular vesicular exosome,ferritin,fungal,Genetic and Environmental Factors to Systemic Inflammatory Biomarker Concentrations,Glycoprotein,heme,heme binding,heparin binding,high BP,Homodimer,Hydrogen peroxide,hydrogen peroxide catabolic process,hypertension,hypochlorous acid biosynthetic process,hypohalous acid,iron,low-density lipoprotein particle remodeling,Lysosome,metal ion binding,Metal-binding,mitochondrion,MPO,MPO catalyzes the production of hypohalous acids,mpod,Myeloperoxidase,Myeloperoxidase deficiency,Myeloperoxidase heavy chain,Myeloperoxidase light chain,negative regulation of apoptotic process,negative regulation of growth of symbiont in host,nucleus,Oxidation,oxidation-reduction process,Oxidoreductase,Peroxidase,peroxidase activity,peroxidase family,PMN,PMN microbicidal activity,Polymorphism,polymorphonuclear leukocytes,psychiatric,psychology,red blood cell,removal of superoxide radicals,respiratory burst involved in defense response,response to food,response to lipopolysaccharide,response to mechanical stimulus,response to oxidative stress,response to yeast,secretory granule,Signal,toxin,white blood cell,XPO subfamily",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs4343",
        "SNP Name": "ACE G2328A",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4343",
        "Video": "Huu5gwcU0m0",
        "Tags": "3D-structure,ACE,ACE inhibitors,ACEH,actin binding,ADAM17,Alternative splicing,Alzheimer's,Angiotensin,angiotensin 1-7,angiotensin 1-9,angiotensin catabolic process,angiotensin catabolic process in blood,Angiotensin Converting Enzyme,Angiotensin I,Angiotensin II,angiotensin maturation,Angiotensin-converting enzyme,Angiotensin-converting enzyme homolog,angiotensin-mediated drinking behavior,anxiety,apelin-13,ApoE,arachidonic acid secretion,Asn-90,asthma,atherosclerosis,atrial fibrillation,avalox,blood pressure,blood vessel remodeling,bradykinin receptor binding,C-terminal dipeptide,captopril,Carboxypeptidase,carboxypeptidase activity,cardiovascular disease,CD_antigen=CD143,Cell membrane,cell proliferation,cellular protein metabolic process,chloride,chloride ion,chloride ions,cipro,CK2,Complete proteome,Coronary Artery Disease,coronary atherosclerosis,coronaviruses,cortisol,cortisol secretion,CVD,cytokine,DCP,depression,Diabetes,Dipeptidyl carboxypeptidase I,Direct protein sequencing,disease,Disulfide bond,drug binding,dynorphin-13,enalaprilat,End-Stage Renal Disease,endopeptidase activity,endosome,Essential Hypertension,extracellular region,extracellular space,extracellular vesicular exosome,failing heart,fluoride,fluoroquinolone,fluoroquinolones,Glycoprotein,glycosidase activity,GPI moiety,GPI-anchored proteins,H2O,HCoV-NL63,heart,heart attack,heart disease,heart failure,heart function,hematopoietic stem cell differentiation,high BP,hormone catabolic process,Host-virus interaction,Hydrolase,hypertension,inactivate bradykinin,inflammation,inflammatory response,integral component of membrane,Intracerebral hemorrhage,Ischemic stroke,ITGB1,kidney development,Kininase II,L-phenylalanine,levequin,linosipril,lisinopril,longevity,low BP,magnesium,mannose,mannose linkage,Membrane,Metal-binding,metallopeptidase activity,Metalloprotease,MI,Mild Cognitive Impairment,mononuclear cell proliferation,MPROT15,myocardial infarction,N-glycosylation,obesity,Pancreatic Lipase,peptidase M2,peptidase M2 family,peptide catabolic process,peptidyl-dipeptidase activity,PH,pH dependence,Pharmacogenetics,phenylalanine,Phosphoprotein,plasma membrane,Polymorphism,positive regulation of reactive oxygen species metabolic process,potassium,PRO1885,Processed angiotensin-converting enzyme 2,Protease,receptor biosynthetic process,receptor-mediated virion attachment to host cell,Reference proteome,regulation of blood pressure,regulation of cell proliferation,regulation of cytokine production,regulation of inflammatory response,regulation of renal output by angiotensin,regulation of smooth muscle cell migration,regulation of systemic arterial blood pressure by renin-angiotensin,regulation of vasoconstriction,renal disease,Renal tubular dysgenesis,SARS,SARS infection,SARS-CoV,Secreted,Signal,sodium,stroke,Transmembrane,Transmembrane helix,UNQ868,UNQ868/PRO1885,vasoconstrictor activity,vasodilator,zinc,zinc ion,zinc ion binding,zinc ions,\u00a0 glycoprotein,\u00a0HCoV-NL63 infection,\u00a0\u00a0ACE-related carboxypeptidase,\u00a0\u00a0ACE2",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1140409",
        "SNP Name": "DDX5 S480A",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Cellulose Acetate Phthalate"
    },
    {
        "SNP ID": "rs11077820",
        "SNP Name": "AANAT C10236T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs11077820",
        "Video": "HNyuNrXtlmo",
        "Tags": "5-hydroxytryptamine,a 2-arylethylamine,AANAT,Acetyl-CoA,acetylation,acetyltransferase family,Acyltransferase,Alternative splicing,an N-acetyl-2-arylethylamine,Aralkylamine N-acetyltransferase,aralkylamine N-acetyltransferase activity,Aromatic compound metabolism,arylamine N-acetyltransferase activity,ASMT,Biological rhythms,bipolar,calcium ion,cAMP,cellular nitrogen compound metabolic process,cellular response to cAMP,circadian rhythm,circadian rhythm sleep disorder,CoA,Complete proteome,copper ion,corticosterone,cytokine,cytoplasm,cytosol,Delayed sleep phase syndrome,depression,difficulty in awakening,DSPS,indolalkylamine biosynthetic process,insomnia,insulin,light stimulus,lithium,melatonin,melatonin biosynthesis,melatonin biosynthetic process,melatonin from serotonin,melatonin production,melatonin serotonin,mutation,N-acetylserotonin,N-acetyltransferase domain,N-terminal protein amino acid acetylation,perinuclear region of cytoplasm,phenylethylamine,Phosphoprotein,pineal gland,pituitary gland,Polymorphism,prostaglandin E,Reference proteome,response to calcium ion,response to cAMP,response to copper ion,response to corticosterone,response to insulin,response to light stimulus,response to zinc ion,retina,serotonin,Serotonin acetylase,serotonin melatonin,Serotonin N-acetyltransferase,sleep disorder,small molecule metabolic process,synthesis of melatonin,Transferase,tryptamine,tyramine,zinc ion,\u00a0 N-acetyltransferase,\u00a0response to prostaglandin E,\u00a0\u00a0Disease mutation,\u00a0\u00a0response to cytokine",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs502396",
        "SNP Name": "TYMS C6633T",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs502396",
        "Video": null,
        "Tags": "10-methylenetetrahydrofolate + dUMP = dihydrofolate + dTMP,5,5-MTHF,Abdominal Aortic Aneurysm,aging,Alternative splicing,ATP,Belongs to the thymidylate synthase family,birth defect,cancer,cancerous,carcinogen,cartilage development,cellular energy,circadian rhythm,cofactor binding,Complete proteome,Contributes to the de novo mitochondrial thymidylate biosynthesis pathway,Cytoplasm,cytosol,defect,deoxyribonucleoside monophosphate biosynthetic process,developmental growth,dihydrofolate,Direct protein sequencing,DNA repair,DNA replication,drug binding,dTMP biosynthetic process,dTTP biosynthetic process,dUMP metabolic process,endometrial cancer,energy,folate,folic acid,folic acid binding,G1/S transition of mitotic cell cycle,heart defect,Homodimer,immortalization of host cell by virus,intestinal epithelial cell maturation,L-5-MTHF,Membrane,methylene-THF,methylenetetrahydrofolate,Methyltransferase,mitochondria,mitochondrial,mitochondrial inner membrane,mitochondrial matrix,mitochondrion,Mitochondrion inner membrane,Mitochondrion matrix,mitotic cell cycle,mRNA binding,neural tube defect,NTDs,nucleobase-containing compound metabolic process,nucleobase-containing small molecule metabolic process,nucleolus,nucleoplasm,nucleotide binding,Nucleotide biosynthesis,Nucleus,organ regeneration,phosphatidylinositol-mediated signaling,Phosphoprotein,polysaccharide metabolic process,Prostate Cancer Risk,Pyrimidine metabolism; dTTP biosynthesis,pyrimidine nucleobase metabolic process,pyrimidine nucleoside biosynthetic process,Reference proteome,regulation of transcription involved in G1/S transition of mitotic cell cycle,response to cytokine,response to drug,response to ethanol,response to folic acid,response to glucocorticoid,response to organophosphorus,response to progesterone,response to toxic substance,response to vitamin A,small molecule metabolic process,spina bifida,spina bifida and conotruncal heart defects,tetrahydrofolate metabolic process,thymidylate biosynthesis,Thymidylate synthase,thymidylate synthase activity,Transferase,TS,Tsase,TYMS,uracil metabolic process,Variation Predicts Cardiovascular Disease Risk",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs16940765",
        "SNP Name": "HRH4 T3537649C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs16940765",
        "Video": "SUB1OPw9Jig",
        "Tags": "Alternative splicing,AXOR35,bone marrow,Both N-alpha-methylhistamine > R--alpha-methylhistamine behave as full agonists,burimamide clozapine,cAMP,cardiovascular disease,Cell membrane,cell membrane integrity,chlorpheniramine,cimetidine,clobenpropit,Clobenpropit behaves as a partial agonist,colon,Complete proteome,CVD,dendritic cells,dimaprit,Disulfide bond,Does not bind diphenhydramine,downregulation,energy,eosinophils,Expressed primarily in the bone marrow and eosinophils,Expression is either up-regulated or down-regulated upon activation of the lymphoid tissues,fatty acids,fetal liver,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor 105,Glycoprotein,GPCR105,GPRv53,H4,H4R,heart,HH4R,histamine,Histamine H4 receptor,histamine receptor activity,HRH4,IL10,IL13,imetit,immepip,immune response,immune system,impromidine,inflammation,inflammatory response,integral component of membrane,interleukin-10,interleukin-13,intestine,kidney,Lipoprotein,liver,loratadine,lung,lymph node,mast cell,mast cell activation syndrome,MCAS,Membrane,mitochondria,mitochondrion,modest affinity for dimaprit,monocytes,mortality,Multi-pass membrane protein,neutrophils,omage-6,omega-3,Palmitate,pancreas,peripheral tissues,Pfi-013,plasma membrane,Plasma Polyunsaturated Fatty Acids,Polymorphism,positive regulation of cytosolic calcium ion concentration,prostate,PUFA,ranitidine,Receptor,Reference proteome,regulation of MAPK cascade,skeletal muscle,small intestine,SP9144,spleen,T cell,T-cells,testicles,testis,The order of inhibitory activity was imetit > clobenpropit > burimamide > thioperamide,thioperamide,Thioperamide shows inverse agonism (enhances cAMP activity) Histamine > N-alpha-methylhistamine > R--alpha-methylhistamine > S+-alpha-methylhistamine,Transducer,Transmembrane,Transmembrane helix,upregulation",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs11662595",
        "SNP Name": "HRH4 A617G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=rs11662595",
        "Video": "SUB1OPw9Jig",
        "Tags": "Alternative splicing,AXOR35,bone marrow,Both N-alpha-methylhistamine > R--alpha-methylhistamine behave as full agonists,breast cancer,burimamide clozapine,cAMP,cancer,cancerous,carcinogen,Cell membrane,chlorpheniramine,cimetidine,clobenpropit,Clobenpropit behaves as a partial agonist,colon,Complete proteome,dendritic cells,dimaprit,Disulfide bond,Does not bind diphenhydramine,downregulation,eosinophils,Expressed primarily in the bone marrow and eosinophils,Expression is either up-regulated or down-regulated upon activation of the lymphoid tissues,fetal liver,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor 105,Glycoprotein,GPCR105,GPRv53,H4,H4R,heart,HH4R,histamine,Histamine H4 receptor,histamine receptor,histamine receptor activity,HRH4,IL10,IL13,imetit,immepip,immune response,immune system,impromidine,inflammatory response,integral component of membrane,interleukin-10,interleukin-13,intestine,kidney,Lipoprotein,liver,loratadine,lung,lymph node,mast cell,mast cell activation syndrome,MCAS,Membrane,modest affinity for dimaprit,monocytes,Multi-pass membrane protein,neutrophils,Palmitate,pancreas,peripheral tissues,Pfi-013,plasma membrane,Polymorphism,positive regulation of cytosolic calcium ion concentration,prostate,ranitidine,Receptor,Reference proteome,regulation of MAPK cascade,skeletal muscle,small intestine,SP9144,spleen,T cell,T-cells,testicles,testis,The order of inhibitory activity was imetit > clobenpropit > burimamide > thioperamide,thioperamide,Thioperamide shows inverse agonism (enhances cAMP activity) Histamine > N-alpha-methylhistamine > R--alpha-methylhistamine > S+-alpha-methylhistamine,Transducer,Transmembrane,Transmembrane helix,upregulation",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1421125",
        "SNP Name": "HRH4 G*385T",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=rs1421125",
        "Video": "SUB1OPw9Jig",
        "Tags": "Alternative splicing,AXOR35,bone marrow,Both N-alpha-methylhistamine > R--alpha-methylhistamine behave as full agonists,breast cancer,burimamide clozapine,cAMP,cancer,cancerous,carcinogen,Cell membrane,chlorpheniramine,cimetidine,clobenpropit,Clobenpropit behaves as a partial agonist,colon,Complete proteome,dendritic cells,dimaprit,Disulfide bond,Does not bind diphenhydramine,downregulation,eosinophils,Expressed primarily in the bone marrow and eosinophils,Expression is either up-regulated or down-regulated upon activation of the lymphoid tissues,fetal liver,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor 105,Glycoprotein,GPCR105,GPRv53,H4,H4R,heart,HH4R,histamine,Histamine H4 receptor,histamine receptor,histamine receptor activity,HRH4,IL10,IL13,imetit,immepip,immune response,immune system,impromidine,inflammatory response,integral component of membrane,interleukin-10,interleukin-13,intestine,kidney,Lipoprotein,liver,loratadine,lung,lymph node,mast cell,mast cell activation syndrome,MCAS,Membrane,modest affinity for dimaprit,monocytes,Multi-pass membrane protein,neutrophils,Palmitate,pancreas,peripheral tissues,Pfi-013,plasma membrane,Polymorphism,positive regulation of cytosolic calcium ion concentration,prostate,ranitidine,Receptor,Reference proteome,regulation of MAPK cascade,skeletal muscle,small intestine,SP9144,spleen,T cell,T-cells,testicles,testis,The order of inhibitory activity was imetit > clobenpropit > burimamide > thioperamide,thioperamide,Thioperamide shows inverse agonism (enhances cAMP activity) Histamine > N-alpha-methylhistamine > R--alpha-methylhistamine > S+-alpha-methylhistamine,Transducer,Transmembrane,Transmembrane helix,upregulation",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs4800573",
        "SNP Name": "HRH4 G*2144A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=%20rs4800573",
        "Video": "SUB1OPw9Jig",
        "Tags": "allergic reaction,Alternative splicing,asthma,AXOR35,bone marrow,Both N-alpha-methylhistamine > R--alpha-methylhistamine behave as full agonists,burimamide clozapine,cAMP,Cell membrane,chlorpheniramine,cimetidine,clobenpropit,Clobenpropit behaves as a partial agonist,colon,Complete proteome,dendritic cells,dimaprit,Disulfide bond,Does not bind diphenhydramine,downregulation,eosinophils,Expressed primarily in the bone marrow and eosinophils,Expression is either up-regulated or down-regulated upon activation of the lymphoid tissues,fetal liver,G-protein coupled receptor,G-protein coupled receptor 1 family,G-protein coupled receptor 105,Glycoprotein,GPCR105,GPRv53,H4,H4R,heart,HH4R,histamine,Histamine H4 receptor,histamine receptor activity,HRH4,IL10,IL13,imetit,immepip,immune response,immune system,impromidine,infection-induced asthma,inflammatory response,integral component of membrane,interleukin-10,interleukin-13,intestine,kidney,Lipoprotein,liver,loratadine,lung,lymph node,mast cell,mast cell activation syndrome,MCAS,Membrane,modest affinity for dimaprit,monocytes,Multi-pass membrane protein,neutrophils,Palmitate,pancreas,peripheral tissues,Pfi-013,plasma membrane,Polymorphism,positive regulation of cytosolic calcium ion concentration,prostate,ranitidine,Receptor,Reference proteome,regulation of MAPK cascade,skeletal muscle,small intestine,SP9144,spleen,T cell,T-cells,testicles,testis,The order of inhibitory activity was imetit > clobenpropit > burimamide > thioperamide,thioperamide,Thioperamide shows inverse agonism (enhances cAMP activity) Histamine > N-alpha-methylhistamine > R--alpha-methylhistamine > S+-alpha-methylhistamine,Transducer,Transmembrane,Transmembrane helix,upregulation",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs723744",
        "SNP Name": "TTR 5747G>T",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs1800458",
        "SNP Name": "TTR Gly26Ser",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,Alzheimer,Alzheimer disease,Alzheimer's disease,AMYL-TTR,Amyloid,Amyloidosis,amyloidotic cardiomyopathy,amyloids,arachnoid,arrhythmia,ataxia,ATTR,autonomic nervous system,autosomal,autosomal dominant,blood pressure,canonical retinoid cycle in rods Non-integrin membrane-ECM interactions,cardio,cardiomyopathy,cardiovascular,carpal,carpal tunnel,carpal tunnel syndrome,Carpal tunnel syndrome 1,central nervous system,choroid,choroid plexus,CNS,constipation,CTS1,CVD,cytoplasm,dementia,ED,erectile dysfunction,extracellular matrix organization,extracellular region,extracellular space,extracellular vesicular exosome,Gamma-carboxyglutamic acid,glaucoma,Glycoprotein,heart,heart disease,heart failure,high BP,hippocampal atrophy,hormone,hormone binding,hydrocephalus,hypertension,hypotension,identical protein binding,impotence,kidneys,L-thyroxine,leptomeningeal amyloidosis,leptomeningeal vessels,Lewy Body,Lewy Body Disorders,low BP,neurodegenerative disease,neurodegenerative disorder,Neuropathologic,neuropathy,oculoleptomeningeal amyloidosis,orthostatic,PALB,peripheral,peripheral nervous system,peripheral neuropathy,phototransduction,pia arachnoid,Prealbumin,protein complex,psychomotor deterioration,RBP4,retina,Retinoid,Retinoid cycle,retinoid metabolic process,Retinoid metabolism,Retinoid transport,retinol metabolic process,Secreted,seizure,senile,senile amyloidosis,sex hormone,stroke-like,syndrome,systemic senile amyloidosis,T3,T4,TBPA,thyroid,Thyroid hormone,Thyroid hormone-binding protein,thyroid hormones,thyroxine,Thyroxine-binding globulin,TPO,transport,Transthyretin,transthyretin amyloid deposition,transthyretin-related,triiodo-L-thyronine,TSH,TTHY,TTR,visible light,vision,visual,visual impairment,vitreous,vitreous amyloid deposition,vitreous humor",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs1800458",
        "SNP Name": "TTR Gly26Ser",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs1800458",
        "SNP Name": "TTR Gly26Ser",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "https://www.snpedia.com/index.php/Rs1800458",
        "Video": null,
        "Tags": null,
        "Group": "Thyroid"
    },
    {
        "SNP ID": "rs76992529",
        "SNP Name": "TTR Val142Ile",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs3764650",
        "SNP Name": "ABCA7 T1046520G",
        "Risk Allele": "G",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "ABCA-SSN,ABCA7,AD,aging,Alzheimer,Alzheimer's disease,apical plasma membrane,APOA1,apolipoprotein,apolipoprotein A-I receptor activity,apolipoprotein A-I-mediated signaling pathway,apolipoprotein-mediated phospholipid efflux,apoptosis,ATP 1,ATP 2,ATP binding,ATP catabolic process,ATP-binding,ATP-binding cassette (ABC) transporter complex,ATP-binding cassette sub-family A member 7,ATPase activity,Autoantigen SS-N,Bioenergetic Dysfunction,brain,Brain Lipid,Cell membrane,cell surface,cholesterol,cholesterol efflux,Cholesterol Metabolism,cytoplasm,dementia,Disulfide bond,Down\u2019s syndrome,endosome,Endosome membrane,Expressed in fetal tissues,Expressed in leukocytes,GlcNAc,Glycoprotein,Glycosylation,Golgi apparatus,Golgi apparatus membrane,high-density lipoprotein particle assembly,immune system,inflammation,integral component of membrane,keratinocytes,Late-Onset Alzheimer's Disease,late-onset Alzheimer\u2019s disease,lipid,Macrophage ABC transporter,macrophages of apoptic cells,Membrane,memory,Multi-pass membrane protein,N-linked,negative regulation of amyloid precursor protein biosynthetic process,negative regulation of ATPase activity,negative regulation of beta-amyloid formation,Neuritic Plaque,neurodegenerative disease,Nucleotide binding,Nucleotide-binding,peptide cross-linking,phagocytic cup,phagocytosis,phospholipid efflux,phospholipid scrambling,phospholipid transporter activity,plasma membrane,positive regulation of ATPase activity,positive regulation of beta-amyloid clearance,positive regulation of cholesterol efflux,positive regulation of engulfment of apoptotic cell,positive regulation of ERK1 and ERK2 cascade,positive regulation of phagocytosis,positive regulation of phospholipid efflux,protein localization to nucleus,regulate cellular ceramide homeostasis during keratinocytes differentiation,ruffle membrane,Strongly expressed in fetal liver,Topological domain,Transmembrane,Transmembrane helix,transmembrane transport,Transport,transporter activity,Up-regulated in keratinocytes during terminal differentiation,Up-regulated in macrophages upon cholesterol uptake and inversely regulated upon cholesterol deloading from the cells (at protein level)",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs1142530",
        "SNP Name": "NDUFS7 variant",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs1142530",
        "Video": null,
        "Tags": null,
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs11666067",
        "SNP Name": "NDUFS7 variant",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.snpedia.com/index.php/Rs11666067",
        "Video": null,
        "Tags": null,
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs17851582",
        "SNP Name": "GAMT C9110T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/m/pubmed/12701824/",
        "Video": "Et5wC2_U37Y",
        "Tags": "Acetylation,AGAT deficiency,Alternative splicing,amidinotransferase (AGAT) deficiency,Amine and polyamine biosynthesis,amino acids,arginine,ASD,autism,autism spectrum disorder,autosomal recessive metabolic disorder,bodybuilding,brain,cardiovascular,cellular nitrogen compound metabolic process,Cerebral creatine deficiency syndrome 2 (CCDS2),class I-like SAM-binding methyltransferase superfamily,cognitive performance,cognitive skills,cognitive speech,creatine,creatine biosynthesis,creatine biosynthetic process,Creatine deficiency syndrome,Creatine deficiency syndromes,creatine metabolic process,creatine transporter (CrT1) defect,CrT1 defect,CVD,cytosol,defect,developmental delay,Disease mutation,disorder,dopamine,epilepsy,epileptic,extrapyramidal dysfunction,Fish odour syndrome,GAMT,glycine,guanidinoacetate methyltransferase deficiency,Guanidinoacetate N-methyltransferase,guanidinoacetate N-methyltransferase activity,guanidinoacetic,guanidinoacetic accumulation,guanidinoacetic acid,heart,histone,homocysteine,intractable seizures,L-arginine,L-homocysteine,liver,male infertility,meiosis,mental retardation,methionine,Methyltransferase,methyltransferase activity,mitosis,Monomer,motor,movement disturbances,muscle,muscle contraction,muscle performance,muscle weakness,nervous system,organ morphogenesis,phosphocreatine,Polymorphism,regulation of multicellular organism growth,RMT2 (arginine N-methyltransferase 2-like),RMT2 methyltransferase family,S-adenosyl-L-methionine,S-adenosyl-L-methionine + guanidinoacetate = S-adenosyl-L-homocysteine + creatine,S-Adenosyl-Methionine,SAM,SAM-e,SAMe,seizure,small molecule metabolic process,social interaction,sperm,spermatogenesis,spermatogonia,tics,Transferase,tremor,Trimethylaminuria,urine,X chromosome,X-linked disorder",
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs17851582",
        "SNP Name": "GAMT C9110T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/m/pubmed/12701824/",
        "Video": "Et5wC2_U37Y",
        "Tags": "Acetylation,AGAT deficiency,Alternative splicing,amidinotransferase (AGAT) deficiency,Amine and polyamine biosynthesis,amino acids,arginine,ASD,autism,autism spectrum disorder,autosomal recessive metabolic disorder,bodybuilding,brain,cardiovascular,cellular nitrogen compound metabolic process,Cerebral creatine deficiency syndrome 2 (CCDS2),class I-like SAM-binding methyltransferase superfamily,cognitive performance,cognitive skills,cognitive speech,creatine,creatine biosynthesis,creatine biosynthetic process,Creatine deficiency syndrome,Creatine deficiency syndromes,creatine metabolic process,creatine transporter (CrT1) defect,CrT1 defect,CVD,cytosol,defect,developmental delay,Disease mutation,disorder,dopamine,epilepsy,epileptic,extrapyramidal dysfunction,Fish odour syndrome,GAMT,glycine,guanidinoacetate methyltransferase deficiency,Guanidinoacetate N-methyltransferase,guanidinoacetate N-methyltransferase activity,guanidinoacetic,guanidinoacetic accumulation,guanidinoacetic acid,heart,histone,homocysteine,intractable seizures,L-arginine,L-homocysteine,liver,male infertility,meiosis,mental retardation,methionine,Methyltransferase,methyltransferase activity,mitosis,Monomer,motor,movement disturbances,muscle,muscle contraction,muscle performance,muscle weakness,nervous system,organ morphogenesis,phosphocreatine,Polymorphism,regulation of multicellular organism growth,RMT2 (arginine N-methyltransferase 2-like),RMT2 methyltransferase family,S-adenosyl-L-methionine,S-adenosyl-L-methionine + guanidinoacetate = S-adenosyl-L-homocysteine + creatine,S-Adenosyl-Methionine,SAM,SAM-e,SAMe,seizure,small molecule metabolic process,social interaction,sperm,spermatogenesis,spermatogonia,tics,Transferase,tremor,Trimethylaminuria,urine,X chromosome,X-linked disorder",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs17851582",
        "SNP Name": "GAMT C9110T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/m/pubmed/12701824/",
        "Video": "Et5wC2_U37Y",
        "Tags": "Acetylation,AGAT deficiency,Alternative splicing,amidinotransferase (AGAT) deficiency,Amine and polyamine biosynthesis,amino acids,arginine,ASD,autism,autism spectrum disorder,autosomal recessive metabolic disorder,bodybuilding,brain,cardiovascular,cellular nitrogen compound metabolic process,Cerebral creatine deficiency syndrome 2 (CCDS2),class I-like SAM-binding methyltransferase superfamily,cognitive performance,cognitive skills,cognitive speech,creatine,creatine biosynthesis,creatine biosynthetic process,Creatine deficiency syndrome,Creatine deficiency syndromes,creatine metabolic process,creatine transporter (CrT1) defect,CrT1 defect,CVD,cytosol,defect,developmental delay,Disease mutation,disorder,dopamine,epilepsy,epileptic,extrapyramidal dysfunction,Fish odour syndrome,GAMT,glycine,guanidinoacetate methyltransferase deficiency,Guanidinoacetate N-methyltransferase,guanidinoacetate N-methyltransferase activity,guanidinoacetic,guanidinoacetic accumulation,guanidinoacetic acid,heart,histone,homocysteine,intractable seizures,L-arginine,L-homocysteine,liver,male infertility,meiosis,mental retardation,methionine,Methyltransferase,methyltransferase activity,mitosis,Monomer,motor,movement disturbances,muscle,muscle contraction,muscle performance,muscle weakness,nervous system,organ morphogenesis,phosphocreatine,Polymorphism,regulation of multicellular organism growth,RMT2 (arginine N-methyltransferase 2-like),RMT2 methyltransferase family,S-adenosyl-L-methionine,S-adenosyl-L-methionine + guanidinoacetate = S-adenosyl-L-homocysteine + creatine,S-Adenosyl-Methionine,SAM,SAM-e,SAMe,seizure,small molecule metabolic process,social interaction,sperm,spermatogenesis,spermatogonia,tics,Transferase,tremor,Trimethylaminuria,urine,X chromosome,X-linked disorder",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs17851582",
        "SNP Name": "GAMT C9110T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/m/pubmed/12701824/",
        "Video": "Et5wC2_U37Y",
        "Tags": "Acetylation,AGAT deficiency,Alternative splicing,amidinotransferase (AGAT) deficiency,Amine and polyamine biosynthesis,amino acids,arginine,ASD,autism,autism spectrum disorder,autosomal recessive metabolic disorder,bodybuilding,brain,cardiovascular,cellular nitrogen compound metabolic process,Cerebral creatine deficiency syndrome 2 (CCDS2),class I-like SAM-binding methyltransferase superfamily,cognitive performance,cognitive skills,cognitive speech,creatine,creatine biosynthesis,creatine biosynthetic process,Creatine deficiency syndrome,Creatine deficiency syndromes,creatine metabolic process,creatine transporter (CrT1) defect,CrT1 defect,CVD,cytosol,defect,developmental delay,Disease mutation,disorder,dopamine,epilepsy,epileptic,extrapyramidal dysfunction,Fish odour syndrome,GAMT,glycine,guanidinoacetate methyltransferase deficiency,Guanidinoacetate N-methyltransferase,guanidinoacetate N-methyltransferase activity,guanidinoacetic,guanidinoacetic accumulation,guanidinoacetic acid,heart,histone,homocysteine,intractable seizures,L-arginine,L-homocysteine,liver,male infertility,meiosis,mental retardation,methionine,Methyltransferase,methyltransferase activity,mitosis,Monomer,motor,movement disturbances,muscle,muscle contraction,muscle performance,muscle weakness,nervous system,organ morphogenesis,phosphocreatine,Polymorphism,regulation of multicellular organism growth,RMT2 (arginine N-methyltransferase 2-like),RMT2 methyltransferase family,S-adenosyl-L-methionine,S-adenosyl-L-methionine + guanidinoacetate = S-adenosyl-L-homocysteine + creatine,S-Adenosyl-Methionine,SAM,SAM-e,SAMe,seizure,small molecule metabolic process,social interaction,sperm,spermatogenesis,spermatogonia,tics,Transferase,tremor,Trimethylaminuria,urine,X chromosome,X-linked disorder",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs17851582",
        "SNP Name": "GAMT C9110T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/m/pubmed/12701824/",
        "Video": "Et5wC2_U37Y",
        "Tags": "Acetylation,AGAT deficiency,Alternative splicing,amidinotransferase (AGAT) deficiency,Amine and polyamine biosynthesis,amino acids,arginine,ASD,autism,autism spectrum disorder,autosomal recessive metabolic disorder,bodybuilding,brain,cardiovascular,cellular nitrogen compound metabolic process,Cerebral creatine deficiency syndrome 2 (CCDS2),class I-like SAM-binding methyltransferase superfamily,cognitive performance,cognitive skills,cognitive speech,creatine,creatine biosynthesis,creatine biosynthetic process,Creatine deficiency syndrome,Creatine deficiency syndromes,creatine metabolic process,creatine transporter (CrT1) defect,CrT1 defect,CVD,cytosol,defect,developmental delay,Disease mutation,disorder,dopamine,epilepsy,epileptic,extrapyramidal dysfunction,Fish odour syndrome,GAMT,glycine,guanidinoacetate methyltransferase deficiency,Guanidinoacetate N-methyltransferase,guanidinoacetate N-methyltransferase activity,guanidinoacetic,guanidinoacetic accumulation,guanidinoacetic acid,heart,histone,homocysteine,intractable seizures,L-arginine,L-homocysteine,liver,male infertility,meiosis,mental retardation,methionine,Methyltransferase,methyltransferase activity,mitosis,Monomer,motor,movement disturbances,muscle,muscle contraction,muscle performance,muscle weakness,nervous system,organ morphogenesis,phosphocreatine,Polymorphism,regulation of multicellular organism growth,RMT2 (arginine N-methyltransferase 2-like),RMT2 methyltransferase family,S-adenosyl-L-methionine,S-adenosyl-L-methionine + guanidinoacetate = S-adenosyl-L-homocysteine + creatine,S-Adenosyl-Methionine,SAM,SAM-e,SAMe,seizure,small molecule metabolic process,social interaction,sperm,spermatogenesis,spermatogonia,tics,Transferase,tremor,Trimethylaminuria,urine,X chromosome,X-linked disorder",
        "Group": "Other Immune Factors"
    },
    {
        "SNP ID": "rs34377097",
        "SNP Name": "TBXA2R R60L",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phenol Red"
    },
    {
        "SNP ID": "rs2230199",
        "SNP Name": "C3 R102G",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs2230199",
        "SNP Name": "C3 R102G",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Bovine Serum Albumin"
    },
    {
        "SNP ID": "rs2230199",
        "SNP Name": "C3 R102G",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Chicken Protein"
    },
    {
        "SNP ID": "rs2230199",
        "SNP Name": "C3 R102G",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Human Serum Albumin"
    },
    {
        "SNP ID": "rs2230199",
        "SNP Name": "C3 R102G",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Ovalbumin"
    },
    {
        "SNP ID": "rs5491",
        "SNP Name": "ICAM1 L56M",
        "Risk Allele": "T",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs5498",
        "SNP Name": "ICAM1 L469G",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Polysorbate 80"
    },
    {
        "SNP ID": "rs892086",
        "SNP Name": "DNM2 G13923A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Acetylation,acetylator,AD,Alzheimer,Alzheimer's disease,amino acids,antigen processing and presentation of exogenous peptide antigen via MHC class II,cell death,cell division,Cell junction,Cell membrane,Charcot,Charcot Marie,Charcot Marie Tooth,Charcot-Marie-Tooth disease,CNM1,congenital muscle disorder,CVD,cytokinesis,cytoplasm,Cytoskeleton,cytosol,dementia,DNA-template,DNA-templated,DNM2,drooping,droopy eyelids,droopy eyes,DYN2,Dynamin-2,endocytic vesicle membrane,endocytosis,enzyme binding,extracellular vesicular exosome,fast acetylator,focal adhesion,G2/M transition of mitotic cell cycle,glutamic acid,Golgi apparatus,Golgi membrane,GTP + H2O = GDP + phosphate,GTP binding,GTP catabolic process,GTP-binding,GTPase activity,heart,heart disease,Hydrolase,intermediate type B,L-Lysine,LCCS5,Lethal congenital contracture syndrome 5,lysine,Membrane,membrane organization,microtubule,microtubule binding,Microtubule-associated force-producing protein,Motor protein,muscle atrophy,muscle wasting,muscle weakness,muscular weakness,Myopathy,nervous system,Neurodegeneration,neurodegenerative disorder,Neuropathy,nitric oxide,nitric oxide metabolic process,NOS,Nucleotide-binding,peripheral nervous system,Phosphoprotein,plasma membrane,positive regulation of apoptotic process,positive regulation of transcription,post-Golgi vesicle-mediated transport,Postsynaptic cell membrane,postsynaptic membrane,Ptosis,receptor internalization,regulation of nitric-oxide synthase activity,regulation of transcription,Schwann cells,signal transduction,slow acetylator,small molecule metabolic process,Synapse,synaptic vesicle transport,transferrin transport",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs28493229",
        "SNP Name": "ITPKC G41224204C",
        "Risk Allele": "C",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Mercury (Thiomersal/Thimerosal)"
    },
    {
        "SNP ID": "rs1801272",
        "SNP Name": "CYP2A6*2 A1799T",
        "Risk Allele": "T",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs1801272",
        "Video": "mqYsF9_PpqA",
        "Tags": "1,2-exo-hydroxy-1,4-cineole,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acetaminophen,acting on paired donors,ADHD,Advanced Colorectal Adenoma,Adverse Pregnancy Outcomes,aflatoxin B1,Amiodarone,Amlodipine,Amobarbital,Amphetamine,and incorporation of one atom of oxygen,antibiotic response,antibiotics,Antipyrine,arachidonic acid,arachidonic acid epoxygenase activity,Arformoterol,ARTIFICIAL ESTROGEN,Azelastine,Azithromycin,breast cancer,Buprenorphine,Bupropion,cancer,cancerous,carcinogen,Chlorzoxazone,Cholesterol,cineole,Cinnarizine,Cisapride,Clofibrate,Clomifene,Clotrimazole,Clozapine,compounds,coumarin,Coumarin 7-hydroxylase,coumarin 7-hydroxylase activity,coumarin catabolic process,coumarin metabolic process,cyclophosphamide,CYP,CYP P450,CYP2A6,CYPIIA6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2A6,Cytochrome P450 IIA3,Cytochrome P450(I),cytoplasmic microtubule,Dapagliflozin,decreased chance of lung cancer (deletion),Desipramine,detox,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Diethylstilbestrol,Dronabinol,DRUG,drug metabolic process,drug metabolism,DRUG POISONING,drug response,DRUG TOXICITY,drugs,DRUX TOXICITY,E2,Eletriptan,endoplasmic,Endoplasmic reticulum,Endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,environmental,environmental factors,enzyme binding,Epithelial Ovarian Cancer,epoxygenase P450 pathway,Estradiol,estrogen,estrogen dominance,Ethinyl Estradiol,exogenous drug catabolic process,Ezogabine,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluorouracil,Flurazepam,Fomepizole,Formoterol,Genetics of Friendship,Genetics of Happiness,Halothane,Heme,heme binding,Heme group,heme-thiolate monooxygenases,Homophily,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hydroxylation,hydroxylation of the anti-cancer drugs,Ifosfamide,ifosphamide,intracellular membrane-bounded organelle,Iron,iron ion binding,Isoniazid,Ketoconazole,Letrozole,Lidocaine,liver,Lorcaserin,low phenacetin O-deethylation activity,Lung Cancer,lungs,Memantine,Membrane,Menadione,Metabolism of Antineoplastic Drugs,Metal-binding,Methimazole,Methoxsalen,Methoxyflurane,Metyrapone,Miconazole,Microsome,Microsome membrane,Monooxygenase,Montelukast,NADP,NADPH,Nevirapine,Nicotine,nicotine C-oxidase,Nicotine Metabolism,Nifedipine,Nilvadipine,Norfloxacin,oxidase,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Pentobarbital,Peripheral membrane protein,pharmacokinetics,phenacetin,phenacetin O-deethylation,Phenobarbital,Pilocarpine,Prednisolone,Progesterone,Propofol,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Renal Cell Cancer,retinoid,Rifampicin,Rosiglitazone,Selegiline,Sevoflurane,sex hormones,SLOW METABOLIZER,small molecule metabolic process,smoking,smoking behavior,smoking behaviors in COPD,smoking behaviours in COPD,Smoking Gene,steroid,steroid hydroxylase activity,steroid metabolic process,Substance Dependence,Sulfaphenazole,Tamoxifen,TESTOSTERONE,Tolbutamide,TOXIC,TOXICITY,Tranylcypromine,Tretinoin,Troleandomycin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,warfarin,with incorporation or reduction of molecular oxygen,XENO,xenobiotic,xenobiotic metabolic process,Xenobiotics,xenoestrogen,Zidovudine",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs8192709",
        "SNP Name": "CYP2B6 R22C",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs8192709",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs8192709",
        "SNP Name": "CYP2B6 R22C",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs8192709",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs35303484",
        "SNP Name": "CYP2B6 A136G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs35303484",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,AIDS,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,antiretroviral therapy,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HIV,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,S-methadone plasma levels,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs35303484",
        "SNP Name": "CYP2B6 A136G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs35303484",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,AIDS,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,antiretroviral therapy,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HIV,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,S-methadone plasma levels,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs12721655",
        "SNP Name": "CYP2B6 K139E",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://dmd.aspetjournals.org/content/40/3/635.short",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs3745274",
        "SNP Name": "CYP2B6 Q172H",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs3745274",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,AIDS,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,anti-tuberculosis drug-induced hepatotoxicity,antibiotics,Antipyrine,antiretroviral therapy,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,breast cancer,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,chemotherapy,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,efavirenz plasma concentration,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HIV,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,methadone S-enantiomer,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,nevirapine toxicity,Nicardipine,Nicotine,nicotine metabolism,Nifedipine,Nilotinib,Nitric Oxide,opioid addiction,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Pharmacogenetics,pharmacokinetics,Phenobarbital,Phenytoin,plasma efavirenz exposure,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,smoking,smoking cessation,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs3745274",
        "SNP Name": "CYP2B6 Q172H",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs3745274",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,AIDS,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,anti-tuberculosis drug-induced hepatotoxicity,antibiotics,Antipyrine,antiretroviral therapy,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,breast cancer,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,chemotherapy,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,efavirenz plasma concentration,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HIV,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,methadone S-enantiomer,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,nevirapine toxicity,Nicardipine,Nicotine,nicotine metabolism,Nifedipine,Nilotinib,Nitric Oxide,opioid addiction,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Pharmacogenetics,pharmacokinetics,Phenobarbital,Phenytoin,plasma efavirenz exposure,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,smoking,smoking cessation,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs36079186",
        "SNP Name": "CYP2B6 T20715C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940150/",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs36079186",
        "SNP Name": "CYP2B6 T20715C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940150/",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs2279345",
        "SNP Name": "CYP2B6 T23499C",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs2279345",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,AIDS,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HIV,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,methadone plasma concentrationefavirenz concentrations,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs2279345",
        "SNP Name": "CYP2B6 T23499C",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs2279345",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,AIDS,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HIV,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,methadone plasma concentrationefavirenz concentrations,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs28399499",
        "SNP Name": "CYP2B6 I328T",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs28399499",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,AIDS,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,efavirenz exposure,efavirenz response,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HIV,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,nevirapine response,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,plasma efavirenz concentrations,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs28399499",
        "SNP Name": "CYP2B6 I328T",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs28399499",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,AIDS,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,efavirenz exposure,efavirenz response,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HIV,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,nevirapine response,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,plasma efavirenz concentrations,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs34097093",
        "SNP Name": "CYP2B6 C1132T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940150/",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs34097093",
        "SNP Name": "CYP2B6 C1132T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940150/",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs8192719",
        "SNP Name": "CYP2B6 C26570T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs8192719",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,AIDS,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HIV,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,plasma efavirenz concentrations,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,S-methadone plasma levels,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs8192719",
        "SNP Name": "CYP2B6 C26570T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs8192719",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,AIDS,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HIV,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,plasma efavirenz concentrations,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,S-methadone plasma levels,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs7260329",
        "SNP Name": "CYP2B6 G29435A",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.nature.com/npp/journal/v37/n3/full/npp2011232a.html",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs7260329",
        "SNP Name": "CYP2B6 G29435A",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.nature.com/npp/journal/v37/n3/full/npp2011232a.html",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs1042389",
        "SNP Name": "CYP2B6 T1421C",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs1042389",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,Hirschsprung Disease urinary phytoestrogens,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,idiopathic male infertility,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,male infertility,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs1042389",
        "SNP Name": "CYP2B6 T1421C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs1042389",
        "Video": null,
        "Tags": "1,4-cineole + NADP+ + H2O,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole 2-exo-monooxygenase,Acids,acting on paired donors,Amitriptyline,Amlodipine,Amprenavir,and incorporation of one atom of oxygen,Antipyrine,arachidonic acid epoxygenase activity,Artemether,ARTIFICIAL ESTROGEN,Atorvastatin,Azelastine,Benzphetamine,Benzyl alcohol,Bifonazole,Brompheniramine,Bupropion,CANCER,CANCEROUS,Carbamazepine,Carbinoxamine,CARCINOGEN,cellular ketone metabolic process,Cholecalciferol,cholesterol,Cinnarizine,Cisapride,Cisplatin,Citalopram,Clobazam,Clofibrate,Clopidogrel,Clotiazepam,Clotrimazole,Colchicine,compounds,Cyclophosphamide,CYP,CYP P450,CYP2B6,CYPIIB6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2B6,Cytochrome P450 IIB1,cytoplasm,Desipramine,DETOX,DETOXIFICATION,Dexamethasone,Dextromethorphan,Diazepam,Diclofenac,Diphenhydramine,Domperidone,Doxorubicin,DRUG,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Efavirenz,Efavirenz toxicity,electron,Endoplasmic reticulum,endoplasmic reticulum membrane,Endoplasmic reticulum membrane; Peripheral membrane protein,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,Epinastine,epoxygenase P450 pathway,Erythromycin,ESTROGEN,Estrone,Ethanol,Ethylmorphine,exogenous drug catabolic process,FAST METABOLIZER,fatty acids,Flunarizine,Flunitrazepam,Fluoxetine,Fluvastatin,Fluvoxamine,Fosphenytoin,Halothane,heme,heme binding,Hirschsprung Disease urinary phytoestrogens,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,idiopathic male infertility,Ifosfamide,Imipramine,intracellular membrane-bounded organelle,Irinotecan,Iron,iron ion binding,Isoflurane,Itraconazole,Ketamine,Ketobemidone,Ketoconazole,Lidocaine,Loperamide,Lopinavir,Lorcaserin,Malathion,male infertility,Memantine,Membrane,Metal-binding,Methadone,Methimazole,Methoxyflurane,Methylphenobarbital,Methyltestosterone,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,microsomes,Midazolam,Modafinil,Monooxygenase,monooxygenase activity,NADP,NADPH,Nelfinavir,Nevirapine,Nicardipine,Nicotine,Nifedipine,Nilotinib,Nitric Oxide,Orphenadrine,Ospemifene,oxidation,oxidation-reduction process,Oxidoreductase,oxidoreductase activity,oxygen binding,P450,Paroxetine,Perhexiline,Peripheral membrane protein,Permethrin,Perphenazine,Pethidine,Phenobarbital,Phenytoin,Prasugrel,Primidone,Promethazine,Propofol,protein,pseudogene,Quinidine,Raloxifene,RAPID METABOLISM,RAPID METABOLIZER,reduced flavin or flavoprotein as one donor,Regorafenib,retinoid,Rifampicin,Rilpivirine,Ritonavir,Ropivacaine,Roxithromycin,Selegiline,Sertraline,Sevoflurane,Simvastatin,SLOW METABOLIZER,small molecule metabolic process,Sorafenib,steroid,steroid hydroxylase activity,steroid metabolic process,Sulfaphenazole,Sulfinpyrazone,synthesis,Tamoxifen,Temazepam,TESTOSTERONE,Thiotepa,Ticlopidine,TOXIC,TOXICITY,Tramadol,transcript,Tretinoin,TUMOR,TUMOR GROWTH,ULTRA RAPID METABOLISM,ULTRA RAPID METABOLIZER,Valproic Acid,Venlafaxine,Verapamil,with incorporation or reduction of molecular oxygen,XENO,XENOBIOTIC,xenobiotic metabolic process,XENOESTROGEN",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs3810174",
        "SNP Name": "BCKDHA C5472T",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3810174",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs3810174",
        "SNP Name": "BCKDHA C5472T",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3810174",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs25487",
        "SNP Name": "XRCC1 G399A",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "2-Phenoxyethanol"
    },
    {
        "SNP ID": "rs25487",
        "SNP Name": "XRCC1 G399A",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Alcohol"
    },
    {
        "SNP ID": "rs25487",
        "SNP Name": "XRCC1 G399A",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs25489",
        "SNP Name": "XRCC1 A280H",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "2-Phenoxyethanol"
    },
    {
        "SNP ID": "rs25489",
        "SNP Name": "XRCC1 A280H",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Alcohol"
    },
    {
        "SNP ID": "rs25489",
        "SNP Name": "XRCC1 A280H",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs1799782",
        "SNP Name": "XRCC1 A194T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "2-Phenoxyethanol"
    },
    {
        "SNP ID": "rs1799782",
        "SNP Name": "XRCC1 A194T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Alcohol"
    },
    {
        "SNP ID": "rs1799782",
        "SNP Name": "XRCC1 A194T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs6859",
        "SNP Name": "PVRL2 A37642G",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "acrosome assembly,AD,adherens junction organization,adhesion of symbiont to host,Alzheimer,Alzheimer's disease,cancer,cancerous,carcinogen,CD112,CD226,cell adhesion,cell adhesion molecule binding,cell junction assembly,Cell membrane,cell part morphogenesis,cell surface,cell-cell junction,cell-cell junction organization,cilium organization,coreceptor activity,coreceptor-mediated virion attachment to host cell,cytoskeleton organization,cytotoxicity,dementia,Disulfide bond,energy,establishment of mitochondrion localization,extracellular vesicular exosome,fertilization,focal adhesion,fusion of virus membrane with host plasma membrane,Glycoprotein,herpes,herpes simplex virus 1,Herpes virus entry mediator B,Herpesvirus entry mediator B,HHV-1,HHV-2,homophilic cell adhesion via plasma membrane adhesion molecules,Host cell receptor for virus entry,Host-virus interaction,HVEB,identical protein binding,immune,immune  systeme,immune response,immunoglobulin,integral component of membrane,killer cell,L-Serine,Late-Onset Alzheimer's Disease,Lymphoid and a non-Lymphoid cell,Membrane,mitochondria,MS,multiple sclerosis,Nectin-2,neurodegenerative disease,neurodegenerative disorder,Phosphoprotein,Phosphoserine,plasma membrane,polio,Poliovirus,Poliovirus receptor-related protein 2,positive regulation of immunoglobulin mediated immune response,positive regulation of mast cell activation,positive regulation of natural killer cell mediated cytotoxicity,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,protein homodimerization activity,PRR2,PRV,pseudorabies virus,PVRL2,Receptor,regulation of immune response,Rid1,sclerosis,serine,signal transduction,sperm mitochondrion organization,spermatid development,spermatid nucleus differentiation,susceptibility to natural killer cell mediated cytotoxicity,susceptibility to T cell mediated cytotoxicity,T cell,TIGIT,tumor,virus,virus receptor activity,zonula adherens",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs157580",
        "SNP Name": "TOMM40 G45395266A",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,Alzheimer,Alzheimer's disease,Amnestic Mild Cognitive,Blood Lipids,C-Reactive Protein,C19orf1,cardio,cardiovascular,cellular energy,cellular protein metabolic process,Channel-forming protein essential for import of protein precursors into mitochondria,cholesterol,chronic kidney disease,CKD,cleft lip,cleft palate,CVD,dementia,Diabetic Nephropathy,endometriosis,energy,extracellular vesicular exosome integral component of membrane,HDL,heart,heart disease,High Sensitivity C-Reactive Protein,integral component of mitochondrial outer membrane mitochondrial outer membrane translocase complex,ion transport,kidneys,late-onset Alzheimer's disease,LDL,longevity,Membrane,mitochondria,mitochondrial,Mitochondrial import receptor subunit TOM40 homolog,mitochondrion,Mitochondrion outer membrane,Multi-pass membrane protein,multiple sclerosis,neurodegenerative disease,neurodegenerative disorder,p38.5,PEREC1,pore complex,porin,porin activity,Protein Haymaker,protein transmembrane transport,protein transmembrane transporter activity,Protein transport,serum lipid levels,TOM40,TOMM40,Translocase of outer membrane 40 kDa subunit homolog,Transmembrane,Transmembrane beta strand,Transport,Triglyceride",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs769449",
        "SNP Name": "APOE G5964A",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,aging,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor clustering,Alzheimer,Alzheimer's disease,amyloid,amyloid plaques,Amyloidosis,antioxidant,antioxidant activity,Apo-E,APOE,APOE 2,APOE 3,APOE 4,APOE E2,APOE E3,APOE E4,APOE4,apolipoprotein A1/A4/E family,Apolipoprotein E,apoptosis,arteries,artery,artery morphogenesis,atherosclerosis,beta-amyloid,beta-amyloid binding,blood microparticle,blood pressure,blood sugar,C reactive protein,C-reactive protein,CAD,cardio,cardiovascular,cardiovascular disease,cardiovascular diseases,catabolism of lipoprotein particles,CD,cell death,cellular calcium ion homeostasis,cellular response to cholesterol,cellular response to growth factor stimulus,cellular response to interleukin-1,cGMP-mediated signaling,cholesterol,cholesterol catabolic process,cholesterol efflux,cholesterol homeostasis,cholesterol metabolic process,Cholesterol metabolism,cholesterol transporter activity,cholinergic,chron,chylomicron,chylomicron remnant,chylomicron remnant clearance,coagulation,cognitive,cognitive function,coronary artery disease,Crohn\u2019s Disease,CVD,cytoplasm,cytoskeleton organization,dementia,dendrite,diabetic,digestive,Disease mutation,early endosome,endocytic vesicle lumen,extracellular matrix,extracellular region,extracellular space,extracellular vesicular exosome,extrinsic component of external side of plasma membrane,fat,fat metabolism,fat transport,fatty acid homeostasis,fatty acids,G-protein coupled receptor signaling pathway,glutamate,Glycation,Glycoprotein,Glycosylation,Golgi apparatus,HDL,heart,heart attack,heart disease,heavy metal poisoning,heavy metal toxicity,heavy metals,heparin binding,Heparin-binding,high-density lipoprotein,high-density lipoprotein particle,high-density lipoprotein particle assembly,high-density lipoprotein particle clearance,high-density lipoprotein particle remodeling,hydroxyapatite binding,hypercholesterolemia,Hyperlipidemia,Hyperlipoproteinemia 3,identical protein binding,IDL,IL-1,inflammation,insulin,interleukin,intermediate-density lipoprotein particle,intracellular transport,kidney disease,late endosome,late-onset Alzheimer disease,LDL,Lewy,Lewy bodies,Lewy body,lipid binding,Lipid metabolism,Lipid transport,lipid transporter activity,lipids,lipoprotein,lipoprotein biosynthetic process,lipoprotein catabolic process,Lipoprotein glomerulopathy,lipoprotein metabolic process,lipoprotein particle binding,liver,long-chain fatty acid transport,longevity,low-density lipoprotein particle,low-density lipoprotein particle receptor binding,low-density lipoprotein particle remodeling,lower extremity deep venous thrombosis,LPG,lysosomal dysfunction,maintenance of location in cell,membrane,mercury,mercury poisoning,mercury toxicity,Metabolic,metal chelating activity,mortality after acute coronary syndrome,N-methyl-D-aspartate receptor clustering,negative regulation of beta-amyloid formation,negative regulation of blood coagulation,negative regulation of blood vessel endothelial cell migration,negative regulation of cholesterol biosynthetic process,negative regulation of cholesterol efflux,negative regulation of dendritic spine development,negative regulation of dendritic spine maintenance,negative regulation of endothelial cell proliferation,negative regulation of inflammatory response,negative regulation of lipid biosynthetic process,negative regulation of lipid transport across blood brain barrier,negative regulation of MAP kinase activity,negative regulation of neuron apoptotic process,negative regulation of neuron death,negative regulation of phospholipid efflux,negative regulation of platelet activation,negative regulation of presynaptic membrane organization,Neurodegeneration,neurodegenerative disorder,neuronal cell body,nitric oxide,nitric oxide mediated signal transduction,nucleus,oligodendrocyte differentiation,omega,omega 3-6-9,omega-3,omega-6,omega-9",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs28931576",
        "SNP Name": "APOE A178G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,aging,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor clustering,Alzheimer,Alzheimer's disease,amyloid,amyloid plaques,Amyloidosis,antioxidant,antioxidant activity,Apo-E,APOE,APOE 2,APOE 3,APOE 4,APOE E2,APOE E3,APOE E4,APOE4,apolipoprotein A1/A4/E family,Apolipoprotein E,apoptosis,arteries,artery,artery morphogenesis,atherosclerosis,beta-amyloid,beta-amyloid binding,blood microparticle,blood pressure,blood sugar,CAD,cardiovascular,cardiovascular disease,cardiovascular diseases,catabolism of lipoprotein particles,cell death,cellular calcium ion homeostasis,cellular response to cholesterol,cellular response to growth factor stimulus,cellular response to interleukin-1,cGMP-mediated signaling,cholesterol,cholesterol catabolic process,cholesterol efflux,cholesterol homeostasis,cholesterol metabolic process,Cholesterol metabolism,cholesterol transporter activity,cholinergic,chylomicron,chylomicron remnant,chylomicron remnant clearance,coagulation,cognitive,cognitive function,coronary artery disease,CVD,cytoplasm,cytoskeleton organization,dementia,dendrite,diabetic,Disease mutation,early endosome,endocytic vesicle lumen,extracellular matrix,extracellular region,extracellular space,extracellular vesicular exosome,extrinsic component of external side of plasma membrane,fat,fat metabolism,fat transport,fatty acid homeostasis,fatty acids,G-protein coupled receptor signaling pathway,glutamate,Glycation,Glycoprotein,Glycosylation,Golgi apparatus,HDL,heart,heart attack,heart disease,heavy metal poisoning,heavy metal toxicity,heavy metals,heparin binding,Heparin-binding,high-density lipoprotein,high-density lipoprotein particle,high-density lipoprotein particle assembly,high-density lipoprotein particle clearance,high-density lipoprotein particle remodeling,hydroxyapatite binding,hypercholesterolemia,Hyperlipidemia,Hyperlipoproteinemia 3,identical protein binding,IDL,IL-1,insulin,interleukin,intermediate-density lipoprotein particle,intracellular transport,kidney disease,late endosome,late-onset Alzheimer disease,LDL,Lewy body,lipid binding,Lipid metabolism,Lipid transport,lipid transporter activity,lipids,lipoprotein,lipoprotein biosynthetic process,lipoprotein catabolic process,Lipoprotein glomerulopathy,lipoprotein metabolic process,lipoprotein particle binding,liver,long-chain fatty acid transport,low-density lipoprotein particle,low-density lipoprotein particle receptor binding,low-density lipoprotein particle remodeling,lower extremity deep venous thrombosis,LPG,maintenance of location in cell,membrane,mercury,mercury poisoning,mercury toxicity,metal chelating activity,N-methyl-D-aspartate receptor clustering,negative regulation of beta-amyloid formation,negative regulation of blood coagulation,negative regulation of blood vessel endothelial cell migration,negative regulation of cholesterol biosynthetic process,negative regulation of cholesterol efflux,negative regulation of dendritic spine development,negative regulation of dendritic spine maintenance,negative regulation of endothelial cell proliferation,negative regulation of inflammatory response,negative regulation of lipid biosynthetic process,negative regulation of lipid transport across blood brain barrier,negative regulation of MAP kinase activity,negative regulation of neuron apoptotic process,negative regulation of neuron death,negative regulation of phospholipid efflux,negative regulation of platelet activation,negative regulation of presynaptic membrane organization,Neurodegeneration,neurodegenerative disorder,neuronal cell body,nitric oxide,nitric oxide mediated signal transduction,nucleus,oligodendrocyte differentiation,omega,omega 3-6-9,omega-3,omega-6,omega-9,Oxidation,oxidative damage,pancreas,peripheral nervous system axon regeneration,phosphatidylcholine-sterol O-acyltransferase activator activity,phospholipid binding,phospholipid efflux,Phosphoprotein",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs769455",
        "SNP Name": "APOE C8002T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,ADHD,aging,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor clustering,Alzheimer,Alzheimer's disease,amyloid,amyloid plaques,Amyloidosis,antioxidant,antioxidant activity,Apo-E,APOE,APOE 2,APOE 3,APOE 4,APOE E2,APOE E3,APOE E4,APOE4,apolipoprotein A1/A4/E family,Apolipoprotein E,apoptosis,arteries,artery,artery morphogenesis,atherosclerosis,beta-amyloid,beta-amyloid binding,blood microparticle,blood pressure,blood sugar,CAD,cardiovascular,cardiovascular disease,cardiovascular diseases,catabolism of lipoprotein particles,cell death,cellular calcium ion homeostasis,cellular response to cholesterol,cellular response to growth factor stimulus,cellular response to interleukin-1,cGMP-mediated signaling,cholesterol,cholesterol catabolic process,cholesterol efflux,cholesterol homeostasis,cholesterol metabolic process,Cholesterol metabolism,cholesterol transporter activity,cholinergic,Choroidal Neovascularization,chylomicron,chylomicron remnant,chylomicron remnant clearance,coagulation,cognitive,cognitive function,coronary artery disease,CVD,cytoplasm,cytoskeleton organization,dementia,dendrite,diabetic,Disease mutation,early endosome,endocytic vesicle lumen,extracellular matrix,extracellular region,extracellular space,extracellular vesicular exosome,extrinsic component of external side of plasma membrane,fat,fat metabolism,fat transport,fatty acid homeostasis,fatty acids,G-protein coupled receptor signaling pathway,glutamate,Glycation,Glycoprotein,Glycosylation,Golgi apparatus,HDL,heart,heart attack,heart disease,heavy metal poisoning,heavy metal toxicity,heavy metals,heparin binding,Heparin-binding,High Myopia,high-density lipoprotein,high-density lipoprotein particle,high-density lipoprotein particle assembly,high-density lipoprotein particle clearance,high-density lipoprotein particle remodeling,hydroxyapatite binding,hypercholesterolemia,Hyperlipidemia,Hyperlipoproteinemia 3,identical protein binding,IDL,IL-1,insulin,intelligence,interleukin,intermediate-density lipoprotein particle,intracellular transport,kidney disease,late endosome,late-onset Alzheimer disease,LDL,Lewy body,lipid binding,Lipid metabolism,Lipid transport,lipid transporter activity,lipids,lipoprotein,lipoprotein biosynthetic process,lipoprotein catabolic process,Lipoprotein glomerulopathy,lipoprotein metabolic process,lipoprotein particle binding,liver,long-chain fatty acid transport,low-density lipoprotein particle,low-density lipoprotein particle receptor binding,low-density lipoprotein particle remodeling,lower extremity deep venous thrombosis,LPG,maintenance of location in cell,membrane,mercury,mercury poisoning,mercury toxicity,metal chelating activity,Myopia,N-methyl-D-aspartate receptor clustering,negative regulation of beta-amyloid formation,negative regulation of blood coagulation,negative regulation of blood vessel endothelial cell migration,negative regulation of cholesterol biosynthetic process,negative regulation of cholesterol efflux,negative regulation of dendritic spine development,negative regulation of dendritic spine maintenance,negative regulation of endothelial cell proliferation,negative regulation of inflammatory response,negative regulation of lipid biosynthetic process,negative regulation of lipid transport across blood brain barrier,negative regulation of MAP kinase activity,negative regulation of neuron apoptotic process,negative regulation of neuron death,negative regulation of phospholipid efflux,negative regulation of platelet activation,negative regulation of presynaptic membrane organization,Neovascularization,Neurodegeneration,neurodegenerative disorder,neuronal cell body,nitric oxide,nitric oxide mediated signal transduction,nucleus,oligodendrocyte differentiation,omega,omega 3-6-9,omega-3,omega-6,omega-9,Oxidation,oxidative damage,pancreas,peripheral nervous system axon regeneration,phosphatidylcholine-sterol O-acy",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs7412",
        "SNP Name": "APOE APOE epsilon 2",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "abdominal aortic aneurysm,AD,age-related macular degeneration,aging,air pollution,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor clustering,Alzheimer,Alzheimer's disease,amyloid,amyloid plaques,Amyloidosis,aneurysm,antioxidant,antioxidant activity,apnea,Apo-E,APOE,APOE 2,APOE 3,APOE 4,APOE E2,APOE E3,APOE E4,APOE4,apolipoprotein A1/A4/E family,Apolipoprotein E,Apolipoproteins,apoptosis,arteries,artery,artery morphogenesis,arthritis,atherosclerosis,atorvastatin,Auditory Oddball Response,beta-amyloid,beta-amyloid binding,blood microparticle,blood pressure,blood sugar,body fat,Body Fatness,bodyfat,BP,C-reactive protein,CAD,cardio,Cardiometabolic,cardiovascular,cardiovascular disease,cardiovascular diseases,catabolism of lipoprotein particles,cell death,cellular calcium ion homeostasis,cellular response to cholesterol,cellular response to growth factor stimulus,cellular response to interleukin-1,Cerebral Hemorrhage,cGMP-mediated signaling,cholesterol,cholesterol catabolic process,cholesterol efflux,cholesterol homeostasis,cholesterol metabolic process,Cholesterol metabolism,cholesterol transporter activity,cholinergic,chronic kidney disease,chylomicron,chylomicron remnant,chylomicron remnant clearance,CKD,coagulation,cognition,cognitive,cognitive function,colorectal cancer,coronary artery disease,Coronary Heart Disease,CVD,cytoplasm,cytoskeleton organization,dementia,dendrite,diabetic,Disease mutation,dopamine,dyslipidemia,early endosome,endocytic vesicle lumen,extracellular matrix,extracellular region,extracellular space,extracellular vesicular exosome,extrinsic component of external side of plasma membrane,fasting blood lipids,fat,fat metabolism,fat transport,fatty acid homeostasis,fatty acids,folate-pathway abnormalities,G-protein coupled receptor signaling pathway,gallbladder cancer,glutamate,Glycation,Glycoprotein,Glycosylation,Golgi apparatus,HDL,heart,heart attack,heart disease,heart rate variability,heavy metal poisoning,heavy metal toxicity,heavy metals,heparin binding,Heparin-binding,high-density lipoprotein,High-Density Lipoprotein Cholesterol,high-density lipoprotein particle,high-density lipoprotein particle assembly,high-density lipoprotein particle clearance,high-density lipoprotein particle remodeling,hydroxyapatite binding,hypercholesterolemia,hypercholesterolemic,Hyperlipidemia,Hyperlipoproteinemia 3,hypertension,hypertriglyceridemia,identical protein binding,IDL,IL-1,inflammation,insulin,intelligence,interleukin,intermediate-density lipoprotein particle,intracellular transport,IQ,Ischemic Stroke,kidney disease,kidneys,late endosome,late-onset Alzheimer disease,LDL,LDL Cholesterol,Lewy body,lipid binding,Lipid metabolism,Lipid transport,lipid transporter activity,lipids,lipoprotein,lipoprotein biosynthetic process,lipoprotein catabolic process,Lipoprotein glomerulopathy,lipoprotein metabolic process,lipoprotein particle binding,liver,long-chain fatty acid transport,longevity,Low-Density Lipoprotein,low-density lipoprotein particle,low-density lipoprotein particle receptor binding,low-density lipoprotein particle remodeling,lower extremity deep venous thrombosis,LPG,macular,macular degeneration,maintenance of location in cell,membrane,memory,mercury,mercury poisoning,mercury toxicity,metabolic syndrome,metal chelating activity,myocardial infarction,N-methyl-D-aspartate receptor clustering,negative regulation of beta-amyloid formation,negative regulation of blood coagulation,negative regulation of blood vessel endothelial cell migration,negative regulation of cholesterol biosynthetic process,negative regulation of cholesterol efflux,negative regulation of dendritic spine development,negative regulation of dendritic spine maintenance,negative regulation of endothelial cell proliferation,negative regulation of inflammatory response,negative regulation of lipid biosynthetic process,negati",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs28931579",
        "SNP Name": "APOE A8455C",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "AD,aging,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor clustering,Alzheimer,Alzheimer's disease,amyloid,amyloid plaques,Amyloidosis,antioxidant,antioxidant activity,Apo-E,APOE,APOE 2,APOE 3,APOE 4,APOE E2,APOE E3,APOE E4,APOE4,apolipoprotein A1/A4/E family,Apolipoprotein E,apoptosis,arteries,artery,artery morphogenesis,atherosclerosis,beta-amyloid,beta-amyloid binding,blood microparticle,blood pressure,blood sugar,CAD,cardiovascular,cardiovascular disease,cardiovascular diseases,catabolism of lipoprotein particles,cell death,cellular calcium ion homeostasis,cellular response to cholesterol,cellular response to growth factor stimulus,cellular response to interleukin-1,cGMP-mediated signaling,cholesterol,cholesterol catabolic process,cholesterol efflux,cholesterol homeostasis,cholesterol metabolic process,Cholesterol metabolism,cholesterol transporter activity,cholinergic,chylomicron,chylomicron remnant,chylomicron remnant clearance,coagulation,cognitive,cognitive function,coronary artery disease,CVD,cytoplasm,cytoskeleton organization,dementia,dendrite,diabetic,Disease mutation,early endosome,endocytic vesicle lumen,extracellular matrix,extracellular region,extracellular space,extracellular vesicular exosome,extrinsic component of external side of plasma membrane,fat,fat metabolism,fat transport,fatty acid homeostasis,fatty acids,G-protein coupled receptor signaling pathway,glutamate,Glycation,Glycoprotein,Glycosylation,Golgi apparatus,HDL,heart,heart attack,heart disease,heavy metal poisoning,heavy metal toxicity,heavy metals,heparin binding,Heparin-binding,high-density lipoprotein,high-density lipoprotein particle,high-density lipoprotein particle assembly,high-density lipoprotein particle clearance,high-density lipoprotein particle remodeling,hydroxyapatite binding,hypercholesterolemia,Hyperlipidemia,Hyperlipoproteinemia 3,identical protein binding,IDL,IL-1,insulin,interleukin,intermediate-density lipoprotein particle,intracellular transport,kidney disease,late endosome,late-onset Alzheimer disease,LDL,Lewy body,lipid binding,Lipid metabolism,Lipid transport,lipid transporter activity,lipids,lipoprotein,lipoprotein biosynthetic process,lipoprotein catabolic process,Lipoprotein glomerulopathy,lipoprotein metabolic process,lipoprotein particle binding,liver,long-chain fatty acid transport,low-density lipoprotein particle,low-density lipoprotein particle receptor binding,low-density lipoprotein particle remodeling,lower extremity deep venous thrombosis,LPG,maintenance of location in cell,membrane,mercury,mercury poisoning,mercury toxicity,metal chelating activity,N-methyl-D-aspartate receptor clustering,negative regulation of beta-amyloid formation,negative regulation of blood coagulation,negative regulation of blood vessel endothelial cell migration,negative regulation of cholesterol biosynthetic process,negative regulation of cholesterol efflux,negative regulation of dendritic spine development,negative regulation of dendritic spine maintenance,negative regulation of endothelial cell proliferation,negative regulation of inflammatory response,negative regulation of lipid biosynthetic process,negative regulation of lipid transport across blood brain barrier,negative regulation of MAP kinase activity,negative regulation of neuron apoptotic process,negative regulation of neuron death,negative regulation of phospholipid efflux,negative regulation of platelet activation,negative regulation of presynaptic membrane organization,Neurodegeneration,neurodegenerative disorder,neuronal cell body,nitric oxide,nitric oxide mediated signal transduction,nucleus,oligodendrocyte differentiation,omega,omega 3-6-9,omega-3,omega-6,omega-9,Oxidation,oxidative damage,pancreas,peripheral nervous system axon regeneration,phosphatidylcholine-sterol O-acyltransferase activator activity,phospholipid binding,phospholipid efflux,Phosphoprotein",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs50871",
        "SNP Name": "ERCC2/XPD G16331T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "2-Phenoxyethanol"
    },
    {
        "SNP ID": "rs50871",
        "SNP Name": "ERCC2/XPD G16331T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Alcohol"
    },
    {
        "SNP ID": "rs50871",
        "SNP Name": "ERCC2/XPD G16331T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sorbitol"
    },
    {
        "SNP ID": "rs3212986",
        "SNP Name": "ERCC1 G540K",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "A-Tocopheryl Hydrogen Succinate"
    },
    {
        "SNP ID": "rs11615",
        "SNP Name": "ERCC1 N118N",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "A-Tocopheryl Hydrogen Succinate"
    },
    {
        "SNP ID": "rs4149452",
        "SNP Name": "SULT2A1 G17136A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://jme.endocrinology-journals.org/content/36/2/301.full.pdf",
        "Video": null,
        "Tags": "3'-phosphoadenosine 5'-phosphosulfate metabolic process,3'-phosphoadenylyl sulfate + glycolithocholate = adenosine 3',3'-phosphoadenylyl sulfate + taurolithocholate = adenosine 3',5'-bisphosphate + glycolithocholate 3-sulfate,5'-bisphosphate + taurolithocholate sulfate,adrenal,adrenal androgen,adrenal glands,amino acids,Belongs to the sulfotransferase 1 family,bile acid,bile acid catabolic process,Bile acid catabolism,Bile acids are conjugated with taurine or glycine in the liver to forming bile salts,Bile salt sulfotransferase,bile-salt sulfotransferase activity,cellular lipid metabolic process,cholesterol,cholesterol oxidation,Complete proteome,cytochrome P450,Cytoplasm,cytosol,Dehydroepiandrosterone sulfotransferase,DHEA,DHEA-ST,digestion,Direct protein sequencing,drug metabolism,estrogen,Estrogens present in maternal circulation is predominantly derived from fetal dehydroepiandosterone sulfate which is hydrolyzed and metabolized to estrogens in placenta,fat,fat metabolism,glycine,Homodimer,HST,Hydroxysteroid Sulfotransferase,Is present in human fetus in higher level in the adrenal than the liver and the kidney,L-Glycine,L-Taurine,lipid,Lipid degradation,Lipid metabolism,liver,may have a role in the inherited adrenal androgen excess in women with polycystic ovary syndrome,P450,PAPS,PCOS,phosphate,polycystic ovary syndrome,Polymorphism,Present in Liver and adrenal and at lower level in the kidney,protein binding,Reference proteome,sex hormone production,small molecule metabolic process,ST2,ST2A1,ST2A3,steroid metabolic process,Steroid metabolism,sulfation,Sulfotransferase,Sulfotransferase 2A1,sulfotransferase activity,Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfonation of steroids and bile acids in the liver and adrenal glands,Sulfotransferases aid in the metabolism of drugs and endogenous compounds by converting these substances into more hydrophilic water-soluble sulfate conjugates that can be easily excreted,SULT2A1,taurine,The N-terminus is blocked,Transferase,xenobiotic metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs4149452",
        "SNP Name": "SULT2A1 G17136A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://jme.endocrinology-journals.org/content/36/2/301.full.pdf",
        "Video": null,
        "Tags": "3'-phosphoadenosine 5'-phosphosulfate metabolic process,3'-phosphoadenylyl sulfate + glycolithocholate = adenosine 3',3'-phosphoadenylyl sulfate + taurolithocholate = adenosine 3',5'-bisphosphate + glycolithocholate 3-sulfate,5'-bisphosphate + taurolithocholate sulfate,adrenal,adrenal androgen,adrenal glands,amino acids,Belongs to the sulfotransferase 1 family,bile acid,bile acid catabolic process,Bile acid catabolism,Bile acids are conjugated with taurine or glycine in the liver to forming bile salts,Bile salt sulfotransferase,bile-salt sulfotransferase activity,cellular lipid metabolic process,cholesterol,cholesterol oxidation,Complete proteome,cytochrome P450,Cytoplasm,cytosol,Dehydroepiandrosterone sulfotransferase,DHEA,DHEA-ST,digestion,Direct protein sequencing,drug metabolism,estrogen,Estrogens present in maternal circulation is predominantly derived from fetal dehydroepiandosterone sulfate which is hydrolyzed and metabolized to estrogens in placenta,fat,fat metabolism,glycine,Homodimer,HST,Hydroxysteroid Sulfotransferase,Is present in human fetus in higher level in the adrenal than the liver and the kidney,L-Glycine,L-Taurine,lipid,Lipid degradation,Lipid metabolism,liver,may have a role in the inherited adrenal androgen excess in women with polycystic ovary syndrome,P450,PAPS,PCOS,phosphate,polycystic ovary syndrome,Polymorphism,Present in Liver and adrenal and at lower level in the kidney,protein binding,Reference proteome,sex hormone production,small molecule metabolic process,ST2,ST2A1,ST2A3,steroid metabolic process,Steroid metabolism,sulfation,Sulfotransferase,Sulfotransferase 2A1,sulfotransferase activity,Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfonation of steroids and bile acids in the liver and adrenal glands,Sulfotransferases aid in the metabolism of drugs and endogenous compounds by converting these substances into more hydrophilic water-soluble sulfate conjugates that can be easily excreted,SULT2A1,taurine,The N-terminus is blocked,Transferase,xenobiotic metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs4149452",
        "SNP Name": "SULT2A1 G17136A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://jme.endocrinology-journals.org/content/36/2/301.full.pdf",
        "Video": null,
        "Tags": "3'-phosphoadenosine 5'-phosphosulfate metabolic process,3'-phosphoadenylyl sulfate + glycolithocholate = adenosine 3',3'-phosphoadenylyl sulfate + taurolithocholate = adenosine 3',5'-bisphosphate + glycolithocholate 3-sulfate,5'-bisphosphate + taurolithocholate sulfate,adrenal,adrenal androgen,adrenal glands,amino acids,Belongs to the sulfotransferase 1 family,bile acid,bile acid catabolic process,Bile acid catabolism,Bile acids are conjugated with taurine or glycine in the liver to forming bile salts,Bile salt sulfotransferase,bile-salt sulfotransferase activity,cellular lipid metabolic process,cholesterol,cholesterol oxidation,Complete proteome,cytochrome P450,Cytoplasm,cytosol,Dehydroepiandrosterone sulfotransferase,DHEA,DHEA-ST,digestion,Direct protein sequencing,drug metabolism,estrogen,Estrogens present in maternal circulation is predominantly derived from fetal dehydroepiandosterone sulfate which is hydrolyzed and metabolized to estrogens in placenta,fat,fat metabolism,glycine,Homodimer,HST,Hydroxysteroid Sulfotransferase,Is present in human fetus in higher level in the adrenal than the liver and the kidney,L-Glycine,L-Taurine,lipid,Lipid degradation,Lipid metabolism,liver,may have a role in the inherited adrenal androgen excess in women with polycystic ovary syndrome,P450,PAPS,PCOS,phosphate,polycystic ovary syndrome,Polymorphism,Present in Liver and adrenal and at lower level in the kidney,protein binding,Reference proteome,sex hormone production,small molecule metabolic process,ST2,ST2A1,ST2A3,steroid metabolic process,Steroid metabolism,sulfation,Sulfotransferase,Sulfotransferase 2A1,sulfotransferase activity,Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfonation of steroids and bile acids in the liver and adrenal glands,Sulfotransferases aid in the metabolism of drugs and endogenous compounds by converting these substances into more hydrophilic water-soluble sulfate conjugates that can be easily excreted,SULT2A1,taurine,The N-terminus is blocked,Transferase,xenobiotic metabolic process",
        "Group": "Trans-Sulfuration Pathway"
    },
    {
        "SNP ID": "rs2910393",
        "SNP Name": "SULT2A1 A13527G",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.funakoshi.co.jp/data/datasheet/RSD/MAB5828.pdf",
        "Video": null,
        "Tags": "3'-phosphoadenosine 5'-phosphosulfate metabolic process,3'-phosphoadenylyl sulfate + glycolithocholate = adenosine 3',3'-phosphoadenylyl sulfate + taurolithocholate = adenosine 3',5'-bisphosphate + glycolithocholate 3-sulfate,5'-bisphosphate + taurolithocholate sulfate,adrenal,adrenal androgen,adrenal glands,amino acids,Belongs to the sulfotransferase 1 family,bile acid,bile acid catabolic process,Bile acid catabolism,Bile acids are conjugated with taurine or glycine in the liver to forming bile salts,Bile salt sulfotransferase,bile-salt sulfotransferase activity,cellular lipid metabolic process,cholesterol,cholesterol oxidation,Complete proteome,cytochrome P450,Cytoplasm,cytosol,Dehydroepiandrosterone sulfotransferase,DHEA,DHEA-ST,digestion,Direct protein sequencing,drug metabolism,estrogen,Estrogens present in maternal circulation is predominantly derived from fetal dehydroepiandosterone sulfate which is hydrolyzed and metabolized to estrogens in placenta,fat,fat metabolism,glycine,Homodimer,HST,Hydroxysteroid Sulfotransferase,Is present in human fetus in higher level in the adrenal than the liver and the kidney,L-Glycine,L-Taurine,lipid,Lipid degradation,Lipid metabolism,liver,may have a role in the inherited adrenal androgen excess in women with polycystic ovary syndrome,P450,PAPS,PCOS,phosphate,polycystic ovary syndrome,Polymorphism,Present in Liver and adrenal and at lower level in the kidney,protein binding,Reference proteome,sex hormone production,small molecule metabolic process,ST2,ST2A1,ST2A3,steroid metabolic process,Steroid metabolism,sulfation,Sulfotransferase,Sulfotransferase 2A1,sulfotransferase activity,Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfonation of steroids and bile acids in the liver and adrenal glands,Sulfotransferases aid in the metabolism of drugs and endogenous compounds by converting these substances into more hydrophilic water-soluble sulfate conjugates that can be easily excreted,SULT2A1,taurine,The N-terminus is blocked,Transferase,xenobiotic metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2910393",
        "SNP Name": "SULT2A1 A13527G",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.funakoshi.co.jp/data/datasheet/RSD/MAB5828.pdf",
        "Video": null,
        "Tags": "3'-phosphoadenosine 5'-phosphosulfate metabolic process,3'-phosphoadenylyl sulfate + glycolithocholate = adenosine 3',3'-phosphoadenylyl sulfate + taurolithocholate = adenosine 3',5'-bisphosphate + glycolithocholate 3-sulfate,5'-bisphosphate + taurolithocholate sulfate,adrenal,adrenal androgen,adrenal glands,amino acids,Belongs to the sulfotransferase 1 family,bile acid,bile acid catabolic process,Bile acid catabolism,Bile acids are conjugated with taurine or glycine in the liver to forming bile salts,Bile salt sulfotransferase,bile-salt sulfotransferase activity,cellular lipid metabolic process,cholesterol,cholesterol oxidation,Complete proteome,cytochrome P450,Cytoplasm,cytosol,Dehydroepiandrosterone sulfotransferase,DHEA,DHEA-ST,digestion,Direct protein sequencing,drug metabolism,estrogen,Estrogens present in maternal circulation is predominantly derived from fetal dehydroepiandosterone sulfate which is hydrolyzed and metabolized to estrogens in placenta,fat,fat metabolism,glycine,Homodimer,HST,Hydroxysteroid Sulfotransferase,Is present in human fetus in higher level in the adrenal than the liver and the kidney,L-Glycine,L-Taurine,lipid,Lipid degradation,Lipid metabolism,liver,may have a role in the inherited adrenal androgen excess in women with polycystic ovary syndrome,P450,PAPS,PCOS,phosphate,polycystic ovary syndrome,Polymorphism,Present in Liver and adrenal and at lower level in the kidney,protein binding,Reference proteome,sex hormone production,small molecule metabolic process,ST2,ST2A1,ST2A3,steroid metabolic process,Steroid metabolism,sulfation,Sulfotransferase,Sulfotransferase 2A1,sulfotransferase activity,Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfonation of steroids and bile acids in the liver and adrenal glands,Sulfotransferases aid in the metabolism of drugs and endogenous compounds by converting these substances into more hydrophilic water-soluble sulfate conjugates that can be easily excreted,SULT2A1,taurine,The N-terminus is blocked,Transferase,xenobiotic metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2910393",
        "SNP Name": "SULT2A1 A13527G",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.funakoshi.co.jp/data/datasheet/RSD/MAB5828.pdf",
        "Video": null,
        "Tags": "3'-phosphoadenosine 5'-phosphosulfate metabolic process,3'-phosphoadenylyl sulfate + glycolithocholate = adenosine 3',3'-phosphoadenylyl sulfate + taurolithocholate = adenosine 3',5'-bisphosphate + glycolithocholate 3-sulfate,5'-bisphosphate + taurolithocholate sulfate,adrenal,adrenal androgen,adrenal glands,amino acids,Belongs to the sulfotransferase 1 family,bile acid,bile acid catabolic process,Bile acid catabolism,Bile acids are conjugated with taurine or glycine in the liver to forming bile salts,Bile salt sulfotransferase,bile-salt sulfotransferase activity,cellular lipid metabolic process,cholesterol,cholesterol oxidation,Complete proteome,cytochrome P450,Cytoplasm,cytosol,Dehydroepiandrosterone sulfotransferase,DHEA,DHEA-ST,digestion,Direct protein sequencing,drug metabolism,estrogen,Estrogens present in maternal circulation is predominantly derived from fetal dehydroepiandosterone sulfate which is hydrolyzed and metabolized to estrogens in placenta,fat,fat metabolism,glycine,Homodimer,HST,Hydroxysteroid Sulfotransferase,Is present in human fetus in higher level in the adrenal than the liver and the kidney,L-Glycine,L-Taurine,lipid,Lipid degradation,Lipid metabolism,liver,may have a role in the inherited adrenal androgen excess in women with polycystic ovary syndrome,P450,PAPS,PCOS,phosphate,polycystic ovary syndrome,Polymorphism,Present in Liver and adrenal and at lower level in the kidney,protein binding,Reference proteome,sex hormone production,small molecule metabolic process,ST2,ST2A1,ST2A3,steroid metabolic process,Steroid metabolism,sulfation,Sulfotransferase,Sulfotransferase 2A1,sulfotransferase activity,Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfonation of steroids and bile acids in the liver and adrenal glands,Sulfotransferases aid in the metabolism of drugs and endogenous compounds by converting these substances into more hydrophilic water-soluble sulfate conjugates that can be easily excreted,SULT2A1,taurine,The N-terminus is blocked,Transferase,xenobiotic metabolic process",
        "Group": "Trans-Sulfuration Pathway"
    },
    {
        "SNP ID": "rs4149449",
        "SNP Name": "SULT2A1 G9696A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.unboundmedicine.com/medline/citation/23874324/SULT2A1_Gene_Copy_Number_Variation_is_Associated_with_Urinary_Excretion_Rate_of_Steroid_Sulfates_",
        "Video": null,
        "Tags": "3'-phosphoadenosine 5'-phosphosulfate metabolic process,3'-phosphoadenylyl sulfate + glycolithocholate = adenosine 3',3'-phosphoadenylyl sulfate + taurolithocholate = adenosine 3',5'-bisphosphate + glycolithocholate 3-sulfate,5'-bisphosphate + taurolithocholate sulfate,adrenal,adrenal androgen,adrenal glands,amino acids,Belongs to the sulfotransferase 1 family,bile acid,bile acid catabolic process,Bile acid catabolism,Bile acids are conjugated with taurine or glycine in the liver to forming bile salts,Bile salt sulfotransferase,bile-salt sulfotransferase activity,cellular lipid metabolic process,cholesterol,cholesterol oxidation,Complete proteome,cytochrome P450,Cytoplasm,cytosol,Dehydroepiandrosterone sulfotransferase,DHEA,DHEA-ST,digestion,Direct protein sequencing,drug metabolism,estrogen,Estrogens present in maternal circulation is predominantly derived from fetal dehydroepiandosterone sulfate which is hydrolyzed and metabolized to estrogens in placenta,fat,fat metabolism,glycine,Homodimer,HST,Hydroxysteroid Sulfotransferase,Is present in human fetus in higher level in the adrenal than the liver and the kidney,L-Glycine,L-Taurine,lipid,Lipid degradation,Lipid metabolism,liver,may have a role in the inherited adrenal androgen excess in women with polycystic ovary syndrome,P450,PAPS,PCOS,phosphate,polycystic ovary syndrome,Polymorphism,Present in Liver and adrenal and at lower level in the kidney,protein binding,Reference proteome,sex hormone production,small molecule metabolic process,ST2,ST2A1,ST2A3,steroid metabolic process,Steroid metabolism,sulfation,Sulfotransferase,Sulfotransferase 2A1,sulfotransferase activity,Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfonation of steroids and bile acids in the liver and adrenal glands,Sulfotransferases aid in the metabolism of drugs and endogenous compounds by converting these substances into more hydrophilic water-soluble sulfate conjugates that can be easily excreted,SULT2A1,taurine,The N-terminus is blocked,Transferase,xenobiotic metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs4149449",
        "SNP Name": "SULT2A1 G9696A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.unboundmedicine.com/medline/citation/23874324/SULT2A1_Gene_Copy_Number_Variation_is_Associated_with_Urinary_Excretion_Rate_of_Steroid_Sulfates_",
        "Video": null,
        "Tags": "3'-phosphoadenosine 5'-phosphosulfate metabolic process,3'-phosphoadenylyl sulfate + glycolithocholate = adenosine 3',3'-phosphoadenylyl sulfate + taurolithocholate = adenosine 3',5'-bisphosphate + glycolithocholate 3-sulfate,5'-bisphosphate + taurolithocholate sulfate,adrenal,adrenal androgen,adrenal glands,amino acids,Belongs to the sulfotransferase 1 family,bile acid,bile acid catabolic process,Bile acid catabolism,Bile acids are conjugated with taurine or glycine in the liver to forming bile salts,Bile salt sulfotransferase,bile-salt sulfotransferase activity,cellular lipid metabolic process,cholesterol,cholesterol oxidation,Complete proteome,cytochrome P450,Cytoplasm,cytosol,Dehydroepiandrosterone sulfotransferase,DHEA,DHEA-ST,digestion,Direct protein sequencing,drug metabolism,estrogen,Estrogens present in maternal circulation is predominantly derived from fetal dehydroepiandosterone sulfate which is hydrolyzed and metabolized to estrogens in placenta,fat,fat metabolism,glycine,Homodimer,HST,Hydroxysteroid Sulfotransferase,Is present in human fetus in higher level in the adrenal than the liver and the kidney,L-Glycine,L-Taurine,lipid,Lipid degradation,Lipid metabolism,liver,may have a role in the inherited adrenal androgen excess in women with polycystic ovary syndrome,P450,PAPS,PCOS,phosphate,polycystic ovary syndrome,Polymorphism,Present in Liver and adrenal and at lower level in the kidney,protein binding,Reference proteome,sex hormone production,small molecule metabolic process,ST2,ST2A1,ST2A3,steroid metabolic process,Steroid metabolism,sulfation,Sulfotransferase,Sulfotransferase 2A1,sulfotransferase activity,Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfonation of steroids and bile acids in the liver and adrenal glands,Sulfotransferases aid in the metabolism of drugs and endogenous compounds by converting these substances into more hydrophilic water-soluble sulfate conjugates that can be easily excreted,SULT2A1,taurine,The N-terminus is blocked,Transferase,xenobiotic metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs4149449",
        "SNP Name": "SULT2A1 G9696A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.unboundmedicine.com/medline/citation/23874324/SULT2A1_Gene_Copy_Number_Variation_is_Associated_with_Urinary_Excretion_Rate_of_Steroid_Sulfates_",
        "Video": null,
        "Tags": "3'-phosphoadenosine 5'-phosphosulfate metabolic process,3'-phosphoadenylyl sulfate + glycolithocholate = adenosine 3',3'-phosphoadenylyl sulfate + taurolithocholate = adenosine 3',5'-bisphosphate + glycolithocholate 3-sulfate,5'-bisphosphate + taurolithocholate sulfate,adrenal,adrenal androgen,adrenal glands,amino acids,Belongs to the sulfotransferase 1 family,bile acid,bile acid catabolic process,Bile acid catabolism,Bile acids are conjugated with taurine or glycine in the liver to forming bile salts,Bile salt sulfotransferase,bile-salt sulfotransferase activity,cellular lipid metabolic process,cholesterol,cholesterol oxidation,Complete proteome,cytochrome P450,Cytoplasm,cytosol,Dehydroepiandrosterone sulfotransferase,DHEA,DHEA-ST,digestion,Direct protein sequencing,drug metabolism,estrogen,Estrogens present in maternal circulation is predominantly derived from fetal dehydroepiandosterone sulfate which is hydrolyzed and metabolized to estrogens in placenta,fat,fat metabolism,glycine,Homodimer,HST,Hydroxysteroid Sulfotransferase,Is present in human fetus in higher level in the adrenal than the liver and the kidney,L-Glycine,L-Taurine,lipid,Lipid degradation,Lipid metabolism,liver,may have a role in the inherited adrenal androgen excess in women with polycystic ovary syndrome,P450,PAPS,PCOS,phosphate,polycystic ovary syndrome,Polymorphism,Present in Liver and adrenal and at lower level in the kidney,protein binding,Reference proteome,sex hormone production,small molecule metabolic process,ST2,ST2A1,ST2A3,steroid metabolic process,Steroid metabolism,sulfation,Sulfotransferase,Sulfotransferase 2A1,sulfotransferase activity,Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfonation of steroids and bile acids in the liver and adrenal glands,Sulfotransferases aid in the metabolism of drugs and endogenous compounds by converting these substances into more hydrophilic water-soluble sulfate conjugates that can be easily excreted,SULT2A1,taurine,The N-terminus is blocked,Transferase,xenobiotic metabolic process",
        "Group": "Trans-Sulfuration Pathway"
    },
    {
        "SNP ID": "rs2547231",
        "SNP Name": "SULT2A1 G9598T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2547231",
        "Video": null,
        "Tags": "3'-phosphoadenosine 5'-phosphosulfate metabolic process,3'-phosphoadenylyl sulfate + glycolithocholate = adenosine 3',3'-phosphoadenylyl sulfate + taurolithocholate = adenosine 3',5'-bisphosphate + glycolithocholate 3-sulfate,5'-bisphosphate + taurolithocholate sulfate,adrenal,adrenal androgen,adrenal glands,aging,aging mechanism,amino acids,Belongs to the sulfotransferase 1 family,bile acid,bile acid catabolic process,Bile acid catabolism,Bile acids are conjugated with taurine or glycine in the liver to forming bile salts,Bile salt sulfotransferase,bile-salt sulfotransferase activity,cellular lipid metabolic process,cholesterol,cholesterol oxidation,Complete proteome,cytochrome P450,Cytoplasm,cytosol,Dehydroepiandrosterone sulfotransferase,DHEA,DHEA-ST,DHEAS,digestion,Direct protein sequencing,drug metabolism,estrogen,Estrogens present in maternal circulation is predominantly derived from fetal dehydroepiandosterone sulfate which is hydrolyzed and metabolized to estrogens in placenta,fat,fat metabolism,glycine,Homodimer,HST,Hydroxysteroid Sulfotransferase,Is present in human fetus in higher level in the adrenal than the liver and the kidney,L-Glycine,L-Taurine,lipid,Lipid degradation,Lipid metabolism,liver,may have a role in the inherited adrenal androgen excess in women with polycystic ovary syndrome,P450,PAPS,PCOS,phosphate,polycystic ovary syndrome,Polymorphism,Present in Liver and adrenal and at lower level in the kidney,protein binding,Reference proteome,sex hormone production,small molecule metabolic process,ST2,ST2A1,ST2A3,steroid metabolic process,Steroid metabolism,sulfation,Sulfotransferase,Sulfotransferase 2A1,sulfotransferase activity,Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfonation of steroids and bile acids in the liver and adrenal glands,Sulfotransferases aid in the metabolism of drugs and endogenous compounds by converting these substances into more hydrophilic water-soluble sulfate conjugates that can be easily excreted,SULT2A1,taurine,The N-terminus is blocked,Transferase,xenobiotic metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2547231",
        "SNP Name": "SULT2A1 G9598T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2547231",
        "Video": null,
        "Tags": "3'-phosphoadenosine 5'-phosphosulfate metabolic process,3'-phosphoadenylyl sulfate + glycolithocholate = adenosine 3',3'-phosphoadenylyl sulfate + taurolithocholate = adenosine 3',5'-bisphosphate + glycolithocholate 3-sulfate,5'-bisphosphate + taurolithocholate sulfate,adrenal,adrenal androgen,adrenal glands,aging,aging mechanism,amino acids,Belongs to the sulfotransferase 1 family,bile acid,bile acid catabolic process,Bile acid catabolism,Bile acids are conjugated with taurine or glycine in the liver to forming bile salts,Bile salt sulfotransferase,bile-salt sulfotransferase activity,cellular lipid metabolic process,cholesterol,cholesterol oxidation,Complete proteome,cytochrome P450,Cytoplasm,cytosol,Dehydroepiandrosterone sulfotransferase,DHEA,DHEA-ST,DHEAS,digestion,Direct protein sequencing,drug metabolism,estrogen,Estrogens present in maternal circulation is predominantly derived from fetal dehydroepiandosterone sulfate which is hydrolyzed and metabolized to estrogens in placenta,fat,fat metabolism,glycine,Homodimer,HST,Hydroxysteroid Sulfotransferase,Is present in human fetus in higher level in the adrenal than the liver and the kidney,L-Glycine,L-Taurine,lipid,Lipid degradation,Lipid metabolism,liver,may have a role in the inherited adrenal androgen excess in women with polycystic ovary syndrome,P450,PAPS,PCOS,phosphate,polycystic ovary syndrome,Polymorphism,Present in Liver and adrenal and at lower level in the kidney,protein binding,Reference proteome,sex hormone production,small molecule metabolic process,ST2,ST2A1,ST2A3,steroid metabolic process,Steroid metabolism,sulfation,Sulfotransferase,Sulfotransferase 2A1,sulfotransferase activity,Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfonation of steroids and bile acids in the liver and adrenal glands,Sulfotransferases aid in the metabolism of drugs and endogenous compounds by converting these substances into more hydrophilic water-soluble sulfate conjugates that can be easily excreted,SULT2A1,taurine,The N-terminus is blocked,Transferase,xenobiotic metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2547231",
        "SNP Name": "SULT2A1 G9598T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2547231",
        "Video": null,
        "Tags": "3'-phosphoadenosine 5'-phosphosulfate metabolic process,3'-phosphoadenylyl sulfate + glycolithocholate = adenosine 3',3'-phosphoadenylyl sulfate + taurolithocholate = adenosine 3',5'-bisphosphate + glycolithocholate 3-sulfate,5'-bisphosphate + taurolithocholate sulfate,adrenal,adrenal androgen,adrenal glands,aging,aging mechanism,amino acids,Belongs to the sulfotransferase 1 family,bile acid,bile acid catabolic process,Bile acid catabolism,Bile acids are conjugated with taurine or glycine in the liver to forming bile salts,Bile salt sulfotransferase,bile-salt sulfotransferase activity,cellular lipid metabolic process,cholesterol,cholesterol oxidation,Complete proteome,cytochrome P450,Cytoplasm,cytosol,Dehydroepiandrosterone sulfotransferase,DHEA,DHEA-ST,DHEAS,digestion,Direct protein sequencing,drug metabolism,estrogen,Estrogens present in maternal circulation is predominantly derived from fetal dehydroepiandosterone sulfate which is hydrolyzed and metabolized to estrogens in placenta,fat,fat metabolism,glycine,Homodimer,HST,Hydroxysteroid Sulfotransferase,Is present in human fetus in higher level in the adrenal than the liver and the kidney,L-Glycine,L-Taurine,lipid,Lipid degradation,Lipid metabolism,liver,may have a role in the inherited adrenal androgen excess in women with polycystic ovary syndrome,P450,PAPS,PCOS,phosphate,polycystic ovary syndrome,Polymorphism,Present in Liver and adrenal and at lower level in the kidney,protein binding,Reference proteome,sex hormone production,small molecule metabolic process,ST2,ST2A1,ST2A3,steroid metabolic process,Steroid metabolism,sulfation,Sulfotransferase,Sulfotransferase 2A1,sulfotransferase activity,Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfonation of steroids and bile acids in the liver and adrenal glands,Sulfotransferases aid in the metabolism of drugs and endogenous compounds by converting these substances into more hydrophilic water-soluble sulfate conjugates that can be easily excreted,SULT2A1,taurine,The N-terminus is blocked,Transferase,xenobiotic metabolic process",
        "Group": "Trans-Sulfuration Pathway"
    },
    {
        "SNP ID": "rs516246",
        "SNP Name": "FUT2 11945C>T",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "IgA"
    },
    {
        "SNP ID": "rs492602",
        "SNP Name": "FUT2 A12190G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs492602",
        "Video": "tZdWO-SQcfc",
        "Tags": "2)FT 2,2)Galbeta-),A12190G,abdominal pain,adenosylcobalamin,adenysol,Alpha(1,B12,B12 transport,bioavailability,Blood group antigen Glycosyltransferase,cancer,cancerous,carb,carbohydrate metabolic process,carcinogen,cardiovascular disease,CD,cell division,cell membrane,Chron,cognitive impairment,cognitive performance,colon,Congenital Heart Disease,Crohn's disease,cyanocobalamin,deficiency,diabetes,diarrhea,dibencozide,dietary deficiency,digestive,DNA synthesis,enzyme,extracellular vesicular exosome,fucosylation,Fucosyltransferase 2,fucosyltransferase activity,FUT1,FUT2,Galactoside 2-alpha-L-fucosyltransferase 2,galactoside 2-alpha-L-fucosyltransferase activity,galactoside 2-L-fucosyltransferase,GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide = GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4),GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2,Glycoprotein,glycosyltransferase 11 family,Golgi apparatus,Golgi cisterna membrane,Golgi stack membrane,Golgi trans cisternae,H and Se enzymes fucosylate acceptor substrates,H antigen,intelligence,IQ,L-fucose catabolic process,l-methylcobalamin,lung,membrane,Membrane Alternative initiation,methylcobalamin,mitochondria,myelin nerve sheath,nervous system,neurodegenerative disorder,neurology,offspring IQ,pernicious anemia,plasma B12,plasma level,plasma vitamin B12 levels,polymorphisms,poor B12 absorption,precursor oligosaccharide FuC-alpha ((1,pregnancy,protein,protein glycosylation,Psoriasis,red blood cell formation,rs492602,SE2,Secretor blood group alpha-2-fucosyltransferase,Secretor factor,Signal-anchor,Single-pass type II membrane protein,Small intestine,soluble A and B antigen synthesis pathway,Transferase,Transmembrane,Transmembrane helix,Type 1 Diabetes,UC,Ulcerative Colitis,vitamin B12,vitamin B12 and transcobalamin in prostate cancer,vitamin deficiency,weight loss",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs492602",
        "SNP Name": "FUT2 A12190G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs492602",
        "Video": "tZdWO-SQcfc",
        "Tags": "2)FT 2,2)Galbeta-),A12190G,abdominal pain,adenosylcobalamin,adenysol,Alpha(1,B12,B12 transport,bioavailability,Blood group antigen Glycosyltransferase,cancer,cancerous,carb,carbohydrate metabolic process,carcinogen,cardiovascular disease,CD,cell division,cell membrane,Chron,cognitive impairment,cognitive performance,colon,Congenital Heart Disease,Crohn's disease,cyanocobalamin,deficiency,diabetes,diarrhea,dibencozide,dietary deficiency,digestive,DNA synthesis,enzyme,extracellular vesicular exosome,fucosylation,Fucosyltransferase 2,fucosyltransferase activity,FUT1,FUT2,Galactoside 2-alpha-L-fucosyltransferase 2,galactoside 2-alpha-L-fucosyltransferase activity,galactoside 2-L-fucosyltransferase,GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide = GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4),GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2,Glycoprotein,glycosyltransferase 11 family,Golgi apparatus,Golgi cisterna membrane,Golgi stack membrane,Golgi trans cisternae,H and Se enzymes fucosylate acceptor substrates,H antigen,intelligence,IQ,L-fucose catabolic process,l-methylcobalamin,lung,membrane,Membrane Alternative initiation,methylcobalamin,mitochondria,myelin nerve sheath,nervous system,neurodegenerative disorder,neurology,offspring IQ,pernicious anemia,plasma B12,plasma level,plasma vitamin B12 levels,polymorphisms,poor B12 absorption,precursor oligosaccharide FuC-alpha ((1,pregnancy,protein,protein glycosylation,Psoriasis,red blood cell formation,rs492602,SE2,Secretor blood group alpha-2-fucosyltransferase,Secretor factor,Signal-anchor,Single-pass type II membrane protein,Small intestine,soluble A and B antigen synthesis pathway,Transferase,Transmembrane,Transmembrane helix,Type 1 Diabetes,UC,Ulcerative Colitis,vitamin B12,vitamin B12 and transcobalamin in prostate cancer,vitamin deficiency,weight loss",
        "Group": "IgA"
    },
    {
        "SNP ID": "rs492602",
        "SNP Name": "FUT2 A12190G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs492602",
        "Video": "tZdWO-SQcfc",
        "Tags": "2)FT 2,2)Galbeta-),A12190G,abdominal pain,adenosylcobalamin,adenysol,Alpha(1,B12,B12 transport,bioavailability,Blood group antigen Glycosyltransferase,cancer,cancerous,carb,carbohydrate metabolic process,carcinogen,cardiovascular disease,CD,cell division,cell membrane,Chron,cognitive impairment,cognitive performance,colon,Congenital Heart Disease,Crohn's disease,cyanocobalamin,deficiency,diabetes,diarrhea,dibencozide,dietary deficiency,digestive,DNA synthesis,enzyme,extracellular vesicular exosome,fucosylation,Fucosyltransferase 2,fucosyltransferase activity,FUT1,FUT2,Galactoside 2-alpha-L-fucosyltransferase 2,galactoside 2-alpha-L-fucosyltransferase activity,galactoside 2-L-fucosyltransferase,GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide = GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4),GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2,Glycoprotein,glycosyltransferase 11 family,Golgi apparatus,Golgi cisterna membrane,Golgi stack membrane,Golgi trans cisternae,H and Se enzymes fucosylate acceptor substrates,H antigen,intelligence,IQ,L-fucose catabolic process,l-methylcobalamin,lung,membrane,Membrane Alternative initiation,methylcobalamin,mitochondria,myelin nerve sheath,nervous system,neurodegenerative disorder,neurology,offspring IQ,pernicious anemia,plasma B12,plasma level,plasma vitamin B12 levels,polymorphisms,poor B12 absorption,precursor oligosaccharide FuC-alpha ((1,pregnancy,protein,protein glycosylation,Psoriasis,red blood cell formation,rs492602,SE2,Secretor blood group alpha-2-fucosyltransferase,Secretor factor,Signal-anchor,Single-pass type II membrane protein,Small intestine,soluble A and B antigen synthesis pathway,Transferase,Transmembrane,Transmembrane helix,Type 1 Diabetes,UC,Ulcerative Colitis,vitamin B12,vitamin B12 and transcobalamin in prostate cancer,vitamin deficiency,weight loss",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs281377",
        "SNP Name": "FUT2 C12376T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs281377",
        "Video": "tZdWO-SQcfc",
        "Tags": "2)FT 2,2)Galbeta-),abdominal pain,adenosylcobalamin,adenysol,Alpha(1,B12,B12 transport,Bifidobacteria,Blood group antigen Glycosyltransferase,cancer,cancerous,carb,carbohydrate metabolic process,carcinogen,cardiovascular disease,cell division,cell membrane,cognitive impairment,cognitive performance,colon,cyanocobalamin,deficiency,diarrhea,dibencozide,dietary deficiency,digestive,DNA synthesis,enzyme,extracellular vesicular exosome,fucosylation,Fucosyltransferase 2,fucosyltransferase activity,FUT1,FUT2,Galactoside 2-alpha-L-fucosyltransferase 2,galactoside 2-alpha-L-fucosyltransferase activity,galactoside 2-L-fucosyltransferase,GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide = GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4),GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2,Glycoprotein,glycosyltransferase 11 family,Golgi apparatus,Golgi cisterna membrane,Golgi stack membrane,Golgi trans cisternae,H and Se enzymes fucosylate acceptor substrates,H antigen,intelligence,IQ,L-fucose catabolic process,l-methylcobalamin,lung,membrane,Membrane Alternative initiation,methylcobalamin,mitochondria,myelin nerve sheath,neurodegenerative disorder,neurology,Pancreatic Cancer,pernicious anemia,phosphatase,phosphatase levels,phosphate,plasma level,polymorphisms,poor B12 absorption,precursor oligosaccharide FuC-alpha ((1,protein,protein glycosylation,red blood cell formation,SE2,Secretor blood group alpha-2-fucosyltransferase,Secretor factor,Signal-anchor,Single-pass type II membrane protein,Small intestine,soluble A and B antigen synthesis pathway,Transferase,Transmembrane,Transmembrane helix,UC,Ulcerative Colitis,vitamin B12,vitamin deficiency,weight loss",
        "Group": "IgA"
    },
    {
        "SNP ID": "rs281377",
        "SNP Name": "FUT2 C12376T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs281377",
        "Video": "tZdWO-SQcfc",
        "Tags": "2)FT 2,2)Galbeta-),abdominal pain,adenosylcobalamin,adenysol,Alpha(1,B12,B12 transport,Bifidobacteria,Blood group antigen Glycosyltransferase,cancer,cancerous,carb,carbohydrate metabolic process,carcinogen,cardiovascular disease,cell division,cell membrane,cognitive impairment,cognitive performance,colon,cyanocobalamin,deficiency,diarrhea,dibencozide,dietary deficiency,digestive,DNA synthesis,enzyme,extracellular vesicular exosome,fucosylation,Fucosyltransferase 2,fucosyltransferase activity,FUT1,FUT2,Galactoside 2-alpha-L-fucosyltransferase 2,galactoside 2-alpha-L-fucosyltransferase activity,galactoside 2-L-fucosyltransferase,GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide = GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4),GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2,Glycoprotein,glycosyltransferase 11 family,Golgi apparatus,Golgi cisterna membrane,Golgi stack membrane,Golgi trans cisternae,H and Se enzymes fucosylate acceptor substrates,H antigen,intelligence,IQ,L-fucose catabolic process,l-methylcobalamin,lung,membrane,Membrane Alternative initiation,methylcobalamin,mitochondria,myelin nerve sheath,neurodegenerative disorder,neurology,Pancreatic Cancer,pernicious anemia,phosphatase,phosphatase levels,phosphate,plasma level,polymorphisms,poor B12 absorption,precursor oligosaccharide FuC-alpha ((1,protein,protein glycosylation,red blood cell formation,SE2,Secretor blood group alpha-2-fucosyltransferase,Secretor factor,Signal-anchor,Single-pass type II membrane protein,Small intestine,soluble A and B antigen synthesis pathway,Transferase,Transmembrane,Transmembrane helix,UC,Ulcerative Colitis,vitamin B12,vitamin deficiency,weight loss",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1047781",
        "SNP Name": "FUT2 A12404T",
        "Risk Allele": "T",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1047781",
        "Video": "tZdWO-SQcfc",
        "Tags": "2)FT 2,2)Galbeta-),abdominal pain,adenosylcobalamin,adenysol,Alpha(1,B12,B12 transport,Bifidobacteria,Blood group antigen Glycosyltransferase,cancer,cancerous,carb,carbohydrate metabolic process,carcinogen,cardiovascular disease,cell division,cell membrane,chron's disease,cognitive impairment,cognitive performance,colon,crohn,cyanocobalamin,deficiency,diabetes,diarrhea,dibencozide,dietary deficiency,digestive,DNA synthesis,enzyme,extracellular vesicular exosome,fucosylation,Fucosyltransferase 2,fucosyltransferase activity,FUT1,FUT2,Galactoside 2-alpha-L-fucosyltransferase 2,galactoside 2-alpha-L-fucosyltransferase activity,galactoside 2-L-fucosyltransferase,GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide = GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4),GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2,Glycoprotein,glycosyltransferase 11 family,Golgi apparatus,Golgi cisterna membrane,Golgi stack membrane,Golgi trans cisternae,H and Se enzymes fucosylate acceptor substrates,H antigen,intelligence,IQ,L-fucose catabolic process,l-methylcobalamin,lung,membrane,Membrane Alternative initiation,methylcobalamin,mitochondria,myelin nerve sheath,neurodegenerative disorder,neurology,pernicious anemia,plasma level,polymorphisms,poor B12 absorption,precursor oligosaccharide FuC-alpha ((1,protein,protein glycosylation,red blood cell formation,Resistance to Infection,SE2,Secretor blood group alpha-2-fucosyltransferase,Secretor factor,Signal-anchor,Single-pass type II membrane protein,Small intestine,soluble A and B antigen synthesis pathway,Sporadic Colorectal Cancer,Transferase,Transmembrane,Transmembrane helix,Type 1 Diabetes Susceptibility,UC,Ulcerative Colitis,vitamin B12,vitamin deficiency,weight loss",
        "Group": "IgA"
    },
    {
        "SNP ID": "rs1047781",
        "SNP Name": "FUT2 A12404T",
        "Risk Allele": "T",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1047781",
        "Video": "tZdWO-SQcfc",
        "Tags": "2)FT 2,2)Galbeta-),abdominal pain,adenosylcobalamin,adenysol,Alpha(1,B12,B12 transport,Bifidobacteria,Blood group antigen Glycosyltransferase,cancer,cancerous,carb,carbohydrate metabolic process,carcinogen,cardiovascular disease,cell division,cell membrane,chron's disease,cognitive impairment,cognitive performance,colon,crohn,cyanocobalamin,deficiency,diabetes,diarrhea,dibencozide,dietary deficiency,digestive,DNA synthesis,enzyme,extracellular vesicular exosome,fucosylation,Fucosyltransferase 2,fucosyltransferase activity,FUT1,FUT2,Galactoside 2-alpha-L-fucosyltransferase 2,galactoside 2-alpha-L-fucosyltransferase activity,galactoside 2-L-fucosyltransferase,GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide = GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4),GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2,Glycoprotein,glycosyltransferase 11 family,Golgi apparatus,Golgi cisterna membrane,Golgi stack membrane,Golgi trans cisternae,H and Se enzymes fucosylate acceptor substrates,H antigen,intelligence,IQ,L-fucose catabolic process,l-methylcobalamin,lung,membrane,Membrane Alternative initiation,methylcobalamin,mitochondria,myelin nerve sheath,neurodegenerative disorder,neurology,pernicious anemia,plasma level,polymorphisms,poor B12 absorption,precursor oligosaccharide FuC-alpha ((1,protein,protein glycosylation,red blood cell formation,Resistance to Infection,SE2,Secretor blood group alpha-2-fucosyltransferase,Secretor factor,Signal-anchor,Single-pass type II membrane protein,Small intestine,soluble A and B antigen synthesis pathway,Sporadic Colorectal Cancer,Transferase,Transmembrane,Transmembrane helix,Type 1 Diabetes Susceptibility,UC,Ulcerative Colitis,vitamin B12,vitamin deficiency,weight loss",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs601338",
        "SNP Name": "FUT2 G12447A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs601338",
        "Video": "tZdWO-SQcfc",
        "Tags": "2)FT 2,2)Galbeta-),abdominal pain,adenosylcobalamin,adenysol,Alpha(1,antibiotic therapy,B. adolescentis,B. catenulatum/pseudocatenulatum,B.bifidum,B12,B12 transport,Bifidobacteria,Blood group antigen Glycosyltransferase,cancer,cancerous,carb,carbohydrate metabolic process,carcinogen,cardiovascular disease,CD,celiac,Celiac Disease,cell division,cell membrane,chron,Chron's disease,cognitive impairment,cognitive performance,colon,Composition of Bifidobacteria,Congenital Heart Disease,Crohn's disease,cyanocobalamin,Cystic Fibrosis,deficiency,diabetes,diarrhea,dibencozide,dietary deficiency,digestive,DNA synthesis,enzyme,extracellular vesicular exosome,Faecal Microbiota Composition,fucosylation,Fucosyltransferase 2,fucosyltransferase activity,FUT1,FUT2,G12447A,Galactoside 2-alpha-L-fucosyltransferase 2,galactoside 2-alpha-L-fucosyltransferase activity,galactoside 2-L-fucosyltransferase,GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide = GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4),GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2,gluten,Glycoprotein,glycosyltransferase 11 family,Golgi apparatus,Golgi cisterna membrane,Golgi stack membrane,Golgi trans cisternae,H and Se enzymes fucosylate acceptor substrates,H antigen,Heterosexual HIV-1 Acquisition,HIV,HIV-1,IBD,IBS,inflammatory bowel disease,intelligence,intestinal layer,intestinal microbiota,intestinal mucus,IQ,Irritable Bowel Syndrome,L-fucose catabolic process,l-methylcobalamin,lactose,lung,membrane,Membrane Alternative initiation,methylcobalamin,microscopic holes,mitochondria,myelin nerve sheath,neurodegenerative disorder,neurology,pancreatic cancer,pernicious anemia,plasma B12,plasma level,plasma vitamin B12 levels,polymorphisms,poor B12 absorption,prebiotics,precursor oligosaccharide FuC-alpha ((1,predicts severe outcomes in premature infants,probiotics,protein,protein glycosylation,red blood cell formation,Resistance to Infection,rs601338,SE2,Secretor blood group alpha-2-fucosyltransferase,Secretor factor,Signal-anchor,Single-pass type II membrane protein,Small intestine,soluble A and B antigen synthesis pathway,Transferase,Transmembrane,Transmembrane helix,Type 1 Diabetes,Type 1 Diabetes Susceptibility,UC,Ulcerative Colitis,Vitamin B-12 Status during Pregnancy and Child\u2019s IQ,vitamin B12,vitamin B12 and transcobalamin in prostate cancer,vitamin deficiency,weight loss",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs601338",
        "SNP Name": "FUT2 G12447A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs601338",
        "Video": "tZdWO-SQcfc",
        "Tags": "2)FT 2,2)Galbeta-),abdominal pain,adenosylcobalamin,adenysol,Alpha(1,antibiotic therapy,B. adolescentis,B. catenulatum/pseudocatenulatum,B.bifidum,B12,B12 transport,Bifidobacteria,Blood group antigen Glycosyltransferase,cancer,cancerous,carb,carbohydrate metabolic process,carcinogen,cardiovascular disease,CD,celiac,Celiac Disease,cell division,cell membrane,chron,Chron's disease,cognitive impairment,cognitive performance,colon,Composition of Bifidobacteria,Congenital Heart Disease,Crohn's disease,cyanocobalamin,Cystic Fibrosis,deficiency,diabetes,diarrhea,dibencozide,dietary deficiency,digestive,DNA synthesis,enzyme,extracellular vesicular exosome,Faecal Microbiota Composition,fucosylation,Fucosyltransferase 2,fucosyltransferase activity,FUT1,FUT2,G12447A,Galactoside 2-alpha-L-fucosyltransferase 2,galactoside 2-alpha-L-fucosyltransferase activity,galactoside 2-L-fucosyltransferase,GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide = GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4),GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2,gluten,Glycoprotein,glycosyltransferase 11 family,Golgi apparatus,Golgi cisterna membrane,Golgi stack membrane,Golgi trans cisternae,H and Se enzymes fucosylate acceptor substrates,H antigen,Heterosexual HIV-1 Acquisition,HIV,HIV-1,IBD,IBS,inflammatory bowel disease,intelligence,intestinal layer,intestinal microbiota,intestinal mucus,IQ,Irritable Bowel Syndrome,L-fucose catabolic process,l-methylcobalamin,lactose,lung,membrane,Membrane Alternative initiation,methylcobalamin,microscopic holes,mitochondria,myelin nerve sheath,neurodegenerative disorder,neurology,pancreatic cancer,pernicious anemia,plasma B12,plasma level,plasma vitamin B12 levels,polymorphisms,poor B12 absorption,prebiotics,precursor oligosaccharide FuC-alpha ((1,predicts severe outcomes in premature infants,probiotics,protein,protein glycosylation,red blood cell formation,Resistance to Infection,rs601338,SE2,Secretor blood group alpha-2-fucosyltransferase,Secretor factor,Signal-anchor,Single-pass type II membrane protein,Small intestine,soluble A and B antigen synthesis pathway,Transferase,Transmembrane,Transmembrane helix,Type 1 Diabetes,Type 1 Diabetes Susceptibility,UC,Ulcerative Colitis,Vitamin B-12 Status during Pregnancy and Child\u2019s IQ,vitamin B12,vitamin B12 and transcobalamin in prostate cancer,vitamin deficiency,weight loss",
        "Group": "IgA"
    },
    {
        "SNP ID": "rs601338",
        "SNP Name": "FUT2 G12447A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs601338",
        "Video": "tZdWO-SQcfc",
        "Tags": "2)FT 2,2)Galbeta-),abdominal pain,adenosylcobalamin,adenysol,Alpha(1,antibiotic therapy,B. adolescentis,B. catenulatum/pseudocatenulatum,B.bifidum,B12,B12 transport,Bifidobacteria,Blood group antigen Glycosyltransferase,cancer,cancerous,carb,carbohydrate metabolic process,carcinogen,cardiovascular disease,CD,celiac,Celiac Disease,cell division,cell membrane,chron,Chron's disease,cognitive impairment,cognitive performance,colon,Composition of Bifidobacteria,Congenital Heart Disease,Crohn's disease,cyanocobalamin,Cystic Fibrosis,deficiency,diabetes,diarrhea,dibencozide,dietary deficiency,digestive,DNA synthesis,enzyme,extracellular vesicular exosome,Faecal Microbiota Composition,fucosylation,Fucosyltransferase 2,fucosyltransferase activity,FUT1,FUT2,G12447A,Galactoside 2-alpha-L-fucosyltransferase 2,galactoside 2-alpha-L-fucosyltransferase activity,galactoside 2-L-fucosyltransferase,GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide = GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4),GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2,gluten,Glycoprotein,glycosyltransferase 11 family,Golgi apparatus,Golgi cisterna membrane,Golgi stack membrane,Golgi trans cisternae,H and Se enzymes fucosylate acceptor substrates,H antigen,Heterosexual HIV-1 Acquisition,HIV,HIV-1,IBD,IBS,inflammatory bowel disease,intelligence,intestinal layer,intestinal microbiota,intestinal mucus,IQ,Irritable Bowel Syndrome,L-fucose catabolic process,l-methylcobalamin,lactose,lung,membrane,Membrane Alternative initiation,methylcobalamin,microscopic holes,mitochondria,myelin nerve sheath,neurodegenerative disorder,neurology,pancreatic cancer,pernicious anemia,plasma B12,plasma level,plasma vitamin B12 levels,polymorphisms,poor B12 absorption,prebiotics,precursor oligosaccharide FuC-alpha ((1,predicts severe outcomes in premature infants,probiotics,protein,protein glycosylation,red blood cell formation,Resistance to Infection,rs601338,SE2,Secretor blood group alpha-2-fucosyltransferase,Secretor factor,Signal-anchor,Single-pass type II membrane protein,Small intestine,soluble A and B antigen synthesis pathway,Transferase,Transmembrane,Transmembrane helix,Type 1 Diabetes,Type 1 Diabetes Susceptibility,UC,Ulcerative Colitis,Vitamin B-12 Status during Pregnancy and Child\u2019s IQ,vitamin B12,vitamin B12 and transcobalamin in prostate cancer,vitamin deficiency,weight loss",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs602662",
        "SNP Name": "FUT2 G12758A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs602662",
        "Video": "tZdWO-SQcfc",
        "Tags": "2)FT 2,2)Galbeta-),abdominal pain,adenosylcobalamin,adenysol,Alpha(1,B12,B12 transport,Blood group antigen Glycosyltransferase,cancer,cancerous,carb,carbohydrate metabolic process,carcinogen,cardiovascular disease,CD,cell division,cell membrane,chron,Chron's,cognitive impairment,cognitive performance,colon,Congenital Heart Disease,Crohn's disease,CVD,cyanocobalamin,deficiency,diabetes,diarrhea,dibencozide,dietary deficiency,digestive,DNA synthesis,enzyme,extracellular vesicular exosome,fucosylation,Fucosyltransferase 2,fucosyltransferase activity,FUT1,FUT2,G12758A,Galactoside 2-alpha-L-fucosyltransferase 2,galactoside 2-alpha-L-fucosyltransferase activity,galactoside 2-L-fucosyltransferase,GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide = GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4),GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2,Glycoprotein,glycosyltransferase 11 family,Golgi apparatus,Golgi cisterna membrane,Golgi stack membrane,Golgi trans cisternae,H and Se enzymes fucosylate acceptor substrates,H antigen,heart,heart disease,IBD,IBS,Inflammatory Bowel Disease,intelligence,IQ,Irritable Bowel Syndrome,L-fucose catabolic process,l-methylcobalamin,lung,membrane,Membrane Alternative initiation,methylcobalamin,mitochondria,MS,multiple sclerosis,myelin nerve sheath,neurodegenerative disease,neurodegenerative disorder,neurology,Pancreatic Cancer,pernicious anemia,plasma B12,plasma level,plasma vitamin B12 levels,polymorphisms,poor B12 absorption,precursor oligosaccharide FuC-alpha ((1,protein,protein glycosylation,red blood cell formation,rs602662,SE2,Secretor blood group alpha-2-fucosyltransferase,Secretor factor,Signal-anchor,Single-pass type II membrane protein,Small intestine,soluble A and B antigen synthesis pathway,Transferase,Transmembrane,Transmembrane helix,Type 1 Diabetes,UC,Ulcerative Colitis,vitamin B12,vitamin deficiency,weight loss",
        "Group": "Cannabinoid Pathway"
    },
    {
        "SNP ID": "rs602662",
        "SNP Name": "FUT2 G12758A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs602662",
        "Video": "tZdWO-SQcfc",
        "Tags": "2)FT 2,2)Galbeta-),abdominal pain,adenosylcobalamin,adenysol,Alpha(1,B12,B12 transport,Blood group antigen Glycosyltransferase,cancer,cancerous,carb,carbohydrate metabolic process,carcinogen,cardiovascular disease,CD,cell division,cell membrane,chron,Chron's,cognitive impairment,cognitive performance,colon,Congenital Heart Disease,Crohn's disease,CVD,cyanocobalamin,deficiency,diabetes,diarrhea,dibencozide,dietary deficiency,digestive,DNA synthesis,enzyme,extracellular vesicular exosome,fucosylation,Fucosyltransferase 2,fucosyltransferase activity,FUT1,FUT2,G12758A,Galactoside 2-alpha-L-fucosyltransferase 2,galactoside 2-alpha-L-fucosyltransferase activity,galactoside 2-L-fucosyltransferase,GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide = GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4),GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2,Glycoprotein,glycosyltransferase 11 family,Golgi apparatus,Golgi cisterna membrane,Golgi stack membrane,Golgi trans cisternae,H and Se enzymes fucosylate acceptor substrates,H antigen,heart,heart disease,IBD,IBS,Inflammatory Bowel Disease,intelligence,IQ,Irritable Bowel Syndrome,L-fucose catabolic process,l-methylcobalamin,lung,membrane,Membrane Alternative initiation,methylcobalamin,mitochondria,MS,multiple sclerosis,myelin nerve sheath,neurodegenerative disease,neurodegenerative disorder,neurology,Pancreatic Cancer,pernicious anemia,plasma B12,plasma level,plasma vitamin B12 levels,polymorphisms,poor B12 absorption,precursor oligosaccharide FuC-alpha ((1,protein,protein glycosylation,red blood cell formation,rs602662,SE2,Secretor blood group alpha-2-fucosyltransferase,Secretor factor,Signal-anchor,Single-pass type II membrane protein,Small intestine,soluble A and B antigen synthesis pathway,Transferase,Transmembrane,Transmembrane helix,Type 1 Diabetes,UC,Ulcerative Colitis,vitamin B12,vitamin deficiency,weight loss",
        "Group": "IgA"
    },
    {
        "SNP ID": "rs602662",
        "SNP Name": "FUT2 G12758A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs602662",
        "Video": "tZdWO-SQcfc",
        "Tags": "2)FT 2,2)Galbeta-),abdominal pain,adenosylcobalamin,adenysol,Alpha(1,B12,B12 transport,Blood group antigen Glycosyltransferase,cancer,cancerous,carb,carbohydrate metabolic process,carcinogen,cardiovascular disease,CD,cell division,cell membrane,chron,Chron's,cognitive impairment,cognitive performance,colon,Congenital Heart Disease,Crohn's disease,CVD,cyanocobalamin,deficiency,diabetes,diarrhea,dibencozide,dietary deficiency,digestive,DNA synthesis,enzyme,extracellular vesicular exosome,fucosylation,Fucosyltransferase 2,fucosyltransferase activity,FUT1,FUT2,G12758A,Galactoside 2-alpha-L-fucosyltransferase 2,galactoside 2-alpha-L-fucosyltransferase activity,galactoside 2-L-fucosyltransferase,GDP-beta-L-fucose + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide = GDP + alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4),GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2,Glycoprotein,glycosyltransferase 11 family,Golgi apparatus,Golgi cisterna membrane,Golgi stack membrane,Golgi trans cisternae,H and Se enzymes fucosylate acceptor substrates,H antigen,heart,heart disease,IBD,IBS,Inflammatory Bowel Disease,intelligence,IQ,Irritable Bowel Syndrome,L-fucose catabolic process,l-methylcobalamin,lung,membrane,Membrane Alternative initiation,methylcobalamin,mitochondria,MS,multiple sclerosis,myelin nerve sheath,neurodegenerative disease,neurodegenerative disorder,neurology,Pancreatic Cancer,pernicious anemia,plasma B12,plasma level,plasma vitamin B12 levels,polymorphisms,poor B12 absorption,precursor oligosaccharide FuC-alpha ((1,protein,protein glycosylation,red blood cell formation,rs602662,SE2,Secretor blood group alpha-2-fucosyltransferase,Secretor factor,Signal-anchor,Single-pass type II membrane protein,Small intestine,soluble A and B antigen synthesis pathway,Transferase,Transmembrane,Transmembrane helix,Type 1 Diabetes,UC,Ulcerative Colitis,vitamin B12,vitamin deficiency,weight loss",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs485186",
        "SNP Name": "FUT2 12979A>G",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "IgA"
    },
    {
        "SNP ID": "rs504963",
        "SNP Name": "FUT2 14638G>A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "IgA"
    },
    {
        "SNP ID": "rs2304206",
        "SNP Name": "IRF3 G50168871A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Purified Capsular Polysaccharide"
    },
    {
        "SNP ID": "rs2304204",
        "SNP Name": "IRF3 T50169020C",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Purified Capsular Polysaccharide"
    },
    {
        "SNP ID": "rs1405655",
        "SNP Name": "NR1H2 T50882619C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs1613662",
        "SNP Name": "GP6 Pro219Ser",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "arterial and venous thrombus formation,Aspirin platelet reactivity,BDPLT11,bleeding,bleeding disorder,blood clot,blood coagulation,C-type lectin convulxin,cell surface,clotting,coagulation,collagen,collagen binding,Collagen receptor,collagen-induced platelet adhesion and activation,collagen-related peptidek,CRP,CVX,deep venous thrombosis,Disulfide bond,drug metabolism,drugs,enzyme linked receptor protein signaling pathway,extracellular vesicular exosome,FcR gamma-chain,fibrin formation,Glycoprotein,Glycoprotein 6,GP6,GPVI,GPVI-mediated activation cascade,Hemostasis,human platelet alloantigen (HPA)-5 system,Immunoglobulin domain,LAT,leukocyte migration,lupus,Megakaryocytes and platelets,nonfatal myocardial infarction,phospholipase C gamma2,platelet,platelet activation,Platelet adhesion,Platelet Adhesion to exposed collagen,Platelet Dysfunction,Platelet glycoprotein VI,platelet procoagulant activity,platelet reactivity,platelet-specific collagen receptor,platelet-type 11,procoagulant,Puumala,Puumala hantavirus infection,Receptor,receptor activity,Recurrent Bleeding,renal function,Repeat,Signal,Src kinase,Systemic Lupus Erythematosus,Tamoxifen,Tamoxifen-Induced Venothromboembolic,tetraspanin-enriched microdomain,thrombin,thrombocytopenia,Thrombosis,thrombus,Transmembrane,Transmembrane helix,transmembrane signaling receptor activity,Type 1 Fibrillar Collagen,Venous Thromboembolism,vit K,vitamin K,vitamin K antagonists",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs1613662",
        "SNP Name": "GP6 Pro219Ser",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "arterial and venous thrombus formation,Aspirin platelet reactivity,BDPLT11,bleeding,bleeding disorder,blood clot,blood coagulation,C-type lectin convulxin,cell surface,clotting,coagulation,collagen,collagen binding,Collagen receptor,collagen-induced platelet adhesion and activation,collagen-related peptidek,CRP,CVX,deep venous thrombosis,Disulfide bond,drug metabolism,drugs,enzyme linked receptor protein signaling pathway,extracellular vesicular exosome,FcR gamma-chain,fibrin formation,Glycoprotein,Glycoprotein 6,GP6,GPVI,GPVI-mediated activation cascade,Hemostasis,human platelet alloantigen (HPA)-5 system,Immunoglobulin domain,LAT,leukocyte migration,lupus,Megakaryocytes and platelets,nonfatal myocardial infarction,phospholipase C gamma2,platelet,platelet activation,Platelet adhesion,Platelet Adhesion to exposed collagen,Platelet Dysfunction,Platelet glycoprotein VI,platelet procoagulant activity,platelet reactivity,platelet-specific collagen receptor,platelet-type 11,procoagulant,Puumala,Puumala hantavirus infection,Receptor,receptor activity,Recurrent Bleeding,renal function,Repeat,Signal,Src kinase,Systemic Lupus Erythematosus,Tamoxifen,Tamoxifen-Induced Venothromboembolic,tetraspanin-enriched microdomain,thrombin,thrombocytopenia,Thrombosis,thrombus,Transmembrane,Transmembrane helix,transmembrane signaling receptor activity,Type 1 Fibrillar Collagen,Venous Thromboembolism,vit K,vitamin K,vitamin K antagonists",
        "Group": "Clotting Factors"
    },
    {
        "SNP ID": "rs6084312",
        "SNP Name": "SLC4A11 T463T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Borate"
    },
    {
        "SNP ID": "rs3827075",
        "SNP Name": "SLC4A11 R161R",
        "Risk Allele": "T",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Borate"
    },
    {
        "SNP ID": "rs11538758",
        "SNP Name": "PRNP V210I",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs1799990",
        "SNP Name": "PRNP M129V",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs16990018",
        "SNP Name": "PRNP N171S",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs28933385",
        "SNP Name": "PRNP E200K",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs3178250",
        "SNP Name": "BMP2 T*465C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": "8ez_0J3AQDs",
        "Tags": null,
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs3178250",
        "SNP Name": "BMP2 T*465C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": "8ez_0J3AQDs",
        "Tags": null,
        "Group": "Gelatin"
    },
    {
        "SNP ID": "rs235756",
        "SNP Name": "BMP2 C282Y",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs235756",
        "Video": "8ez_0J3AQDs",
        "Tags": "activation of MAPK activity,advanced non-small cell lung cancer,atrioventricular valve morphogenesis,BMP receptor binding,BMP signaling pathway,BMP signaling pathway involved in heart induction,BMP-2,BMP-2A,BMP2,BMP2A,bone,bone mineralization,bone mineralization involved in bone maturation,Bone morphogenetic protein 2,Bone morphogenetic protein 2A,bone production,Brain Metastasis,branching involved in ureteric bud morphogenesis,cardiac cell differentiation,cardiac epithelial to mesenchymal transition,cardiac muscle cell differentiation,cardiac muscle tissue morphogenesis,cardiocyte differentiation,cell fate commitment,cell surface,cell-cell signaling,cellular response to BMP stimulus,cellular response to organic cyclic compound,chondrocyte differentiation,Chondrogenesis,Cleavage on pair of basic residues,Cleaved by PCSK5,corticotropin hormone secreting cell differentiation,Cytokine,dentistry,development of bone and cartilage,Developmental protein,Differentiation,Disulfide bond,DNA-templated,embryo development,embryonic heart tube anterior/posterior pattern specification,endocardial cushion morphogenesis,epithelial to mesenchymal transition,extracellular matrix organization,extracellular region,extracellular space,Glycoprotein,growth,Growth factor,Haemochromatosis,heart development,hedgehog pathway,Hemochromatosis,high mannose,Homodimer,hormone,Implantation of BMP-2 in a collagen sponge induces new bone formation,in utero embryonic development,inflammatory response,inner ear development,Interacts with ASPN,Interacts with GREM2,Interacts with SOSTDC1,lung cancer,mesenchymal cell differentiation,mesenchymal cell proliferation involved in ureteric bud development,mesenchyme development,negative regulation of aldosterone biosynthetic process,negative regulation of calcium-independent cell-cell adhesion,negative regulation of canonical Wnt signaling pathway,negative regulation of cardiac muscle cell differentiation,negative regulation of cell cycle,negative regulation of cell proliferation,negative regulation of cortisol biosynthetic process,negative regulation of insulin-like growth factor receptor signaling pathway,negative regulation of steroid biosynthetic process,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,negative regulation of Wnt signaling pathway involved in heart development,Notch signaling pathway,odontogenesis of dentin-containing tooth,organ morphogenesis,osteoblast differentiation,Osteogenesis,oxidation-reduction process,Pancreatic Cancer,pathway-restricted SMAD protein phosphorylation,pericardium development,phosphatase activator activity,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of bone mineralization,positive regulation of cartilage development,positive regulation of cell migration,positive regulation of endothelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of ERK1 and ERK2 cascade,positive regulation of fat cell differentiation,positive regulation of gene expression,positive regulation of MAPK cascade,positive regulation of neuron differentiation,positive regulation of odontogenesis,positive regulation of ossification,positive regulation of osteoblast differentiation,positive regulation of osteoblast proliferation,positive regulation of p38MAPK cascade,positive regulation of pathway-restricted SMAD protein phosphorylation,positive regulation of phosphatase activity,positive regulation of protein phosphorylation,positive regulation of transcription,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,positive regulation of Wnt signaling pathway,positive regulation of Wnt signaling pathway by BMP signaling pathway,protein binding,protein destabilization,protein heterodimerization",
        "Group": "Amino Acids"
    },
    {
        "SNP ID": "rs235756",
        "SNP Name": "BMP2 C282Y",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs235756",
        "Video": "8ez_0J3AQDs",
        "Tags": "activation of MAPK activity,advanced non-small cell lung cancer,atrioventricular valve morphogenesis,BMP receptor binding,BMP signaling pathway,BMP signaling pathway involved in heart induction,BMP-2,BMP-2A,BMP2,BMP2A,bone,bone mineralization,bone mineralization involved in bone maturation,Bone morphogenetic protein 2,Bone morphogenetic protein 2A,bone production,Brain Metastasis,branching involved in ureteric bud morphogenesis,cardiac cell differentiation,cardiac epithelial to mesenchymal transition,cardiac muscle cell differentiation,cardiac muscle tissue morphogenesis,cardiocyte differentiation,cell fate commitment,cell surface,cell-cell signaling,cellular response to BMP stimulus,cellular response to organic cyclic compound,chondrocyte differentiation,Chondrogenesis,Cleavage on pair of basic residues,Cleaved by PCSK5,corticotropin hormone secreting cell differentiation,Cytokine,dentistry,development of bone and cartilage,Developmental protein,Differentiation,Disulfide bond,DNA-templated,embryo development,embryonic heart tube anterior/posterior pattern specification,endocardial cushion morphogenesis,epithelial to mesenchymal transition,extracellular matrix organization,extracellular region,extracellular space,Glycoprotein,growth,Growth factor,Haemochromatosis,heart development,hedgehog pathway,Hemochromatosis,high mannose,Homodimer,hormone,Implantation of BMP-2 in a collagen sponge induces new bone formation,in utero embryonic development,inflammatory response,inner ear development,Interacts with ASPN,Interacts with GREM2,Interacts with SOSTDC1,lung cancer,mesenchymal cell differentiation,mesenchymal cell proliferation involved in ureteric bud development,mesenchyme development,negative regulation of aldosterone biosynthetic process,negative regulation of calcium-independent cell-cell adhesion,negative regulation of canonical Wnt signaling pathway,negative regulation of cardiac muscle cell differentiation,negative regulation of cell cycle,negative regulation of cell proliferation,negative regulation of cortisol biosynthetic process,negative regulation of insulin-like growth factor receptor signaling pathway,negative regulation of steroid biosynthetic process,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,negative regulation of Wnt signaling pathway involved in heart development,Notch signaling pathway,odontogenesis of dentin-containing tooth,organ morphogenesis,osteoblast differentiation,Osteogenesis,oxidation-reduction process,Pancreatic Cancer,pathway-restricted SMAD protein phosphorylation,pericardium development,phosphatase activator activity,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of bone mineralization,positive regulation of cartilage development,positive regulation of cell migration,positive regulation of endothelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of ERK1 and ERK2 cascade,positive regulation of fat cell differentiation,positive regulation of gene expression,positive regulation of MAPK cascade,positive regulation of neuron differentiation,positive regulation of odontogenesis,positive regulation of ossification,positive regulation of osteoblast differentiation,positive regulation of osteoblast proliferation,positive regulation of p38MAPK cascade,positive regulation of pathway-restricted SMAD protein phosphorylation,positive regulation of phosphatase activity,positive regulation of protein phosphorylation,positive regulation of transcription,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,positive regulation of Wnt signaling pathway,positive regulation of Wnt signaling pathway by BMP signaling pathway,protein binding,protein destabilization,protein heterodimerization",
        "Group": "Gelatin"
    },
    {
        "SNP ID": "rs235756",
        "SNP Name": "BMP2 C282Y",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs235756",
        "Video": "8ez_0J3AQDs",
        "Tags": "activation of MAPK activity,advanced non-small cell lung cancer,atrioventricular valve morphogenesis,BMP receptor binding,BMP signaling pathway,BMP signaling pathway involved in heart induction,BMP-2,BMP-2A,BMP2,BMP2A,bone,bone mineralization,bone mineralization involved in bone maturation,Bone morphogenetic protein 2,Bone morphogenetic protein 2A,bone production,Brain Metastasis,branching involved in ureteric bud morphogenesis,cardiac cell differentiation,cardiac epithelial to mesenchymal transition,cardiac muscle cell differentiation,cardiac muscle tissue morphogenesis,cardiocyte differentiation,cell fate commitment,cell surface,cell-cell signaling,cellular response to BMP stimulus,cellular response to organic cyclic compound,chondrocyte differentiation,Chondrogenesis,Cleavage on pair of basic residues,Cleaved by PCSK5,corticotropin hormone secreting cell differentiation,Cytokine,dentistry,development of bone and cartilage,Developmental protein,Differentiation,Disulfide bond,DNA-templated,embryo development,embryonic heart tube anterior/posterior pattern specification,endocardial cushion morphogenesis,epithelial to mesenchymal transition,extracellular matrix organization,extracellular region,extracellular space,Glycoprotein,growth,Growth factor,Haemochromatosis,heart development,hedgehog pathway,Hemochromatosis,high mannose,Homodimer,hormone,Implantation of BMP-2 in a collagen sponge induces new bone formation,in utero embryonic development,inflammatory response,inner ear development,Interacts with ASPN,Interacts with GREM2,Interacts with SOSTDC1,lung cancer,mesenchymal cell differentiation,mesenchymal cell proliferation involved in ureteric bud development,mesenchyme development,negative regulation of aldosterone biosynthetic process,negative regulation of calcium-independent cell-cell adhesion,negative regulation of canonical Wnt signaling pathway,negative regulation of cardiac muscle cell differentiation,negative regulation of cell cycle,negative regulation of cell proliferation,negative regulation of cortisol biosynthetic process,negative regulation of insulin-like growth factor receptor signaling pathway,negative regulation of steroid biosynthetic process,negative regulation of transcription,negative regulation of transcription from RNA polymerase II promoter,negative regulation of Wnt signaling pathway involved in heart development,Notch signaling pathway,odontogenesis of dentin-containing tooth,organ morphogenesis,osteoblast differentiation,Osteogenesis,oxidation-reduction process,Pancreatic Cancer,pathway-restricted SMAD protein phosphorylation,pericardium development,phosphatase activator activity,positive regulation of apoptotic process,positive regulation of astrocyte differentiation,positive regulation of bone mineralization,positive regulation of cartilage development,positive regulation of cell migration,positive regulation of endothelial cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of ERK1 and ERK2 cascade,positive regulation of fat cell differentiation,positive regulation of gene expression,positive regulation of MAPK cascade,positive regulation of neuron differentiation,positive regulation of odontogenesis,positive regulation of ossification,positive regulation of osteoblast differentiation,positive regulation of osteoblast proliferation,positive regulation of p38MAPK cascade,positive regulation of pathway-restricted SMAD protein phosphorylation,positive regulation of phosphatase activity,positive regulation of protein phosphorylation,positive regulation of transcription,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,positive regulation of Wnt signaling pathway,positive regulation of Wnt signaling pathway by BMP signaling pathway,protein binding,protein destabilization,protein heterodimerization",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs235756",
        "SNP Name": "BMP2 C282Y",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs2423322",
        "SNP Name": "HAO1 A7873112G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2423322",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs2423322",
        "SNP Name": "HAO1 A7873112G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2423322",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs16994134",
        "SNP Name": "HAO1 T7894092C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs16994134",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs16994134",
        "SNP Name": "HAO1 T7894092C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs16994134",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs6118004",
        "SNP Name": "HAO1 C7897049T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6118004",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs6118004",
        "SNP Name": "HAO1 C7897049T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6118004",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs2423334",
        "SNP Name": "HAO1 T7905947C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2423334",
        "Video": null,
        "Tags": null,
        "Group": "Glyphosate"
    },
    {
        "SNP ID": "rs2423334",
        "SNP Name": "HAO1 T7905947C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2423334",
        "Video": null,
        "Tags": null,
        "Group": "Glyoxylate Metabolic Process"
    },
    {
        "SNP ID": "rs1042580",
        "SNP Name": "THBD A7681G",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "2-oxoglutarate dependent 3-hydroxylation,3D-structure,activated protein C,AHUS6,anemia,asparagine,aspartate,blood coagulation,calcium ion binding,carbohydrate binding,CD141,cell surface,coagulation,Complete proteome,diarrhea,Direct protein sequencing,Disease mutation,Disulfide bond,EGF-like domain,end-stage renal disease,endothelial cell,enterocolitis,extracellular space,female pregnancy,Fetomodulin,Glycoprotein,hemolytic uremic syndrome,Hemolytic uremic syndrome atypical 6,Hemostasis,Hydroxylation,integral component of plasma membrane,leukocyte migration,microangiopathic hemolytic anemia,mortality,N-glycosylated,negative regulation of blood coagulation,negative regulation of fibrinolysis,negative regulation of platelet activation,plasma membrane,platelet,protein C,Protein C Pathway,protein Ca,receptor activity,Reference proteome,renal failure,Repeat,response to cAMP,response to lipopolysaccharide,response to X-ray,Signal,stoichiometric complex,THBD,THPH12,THRM,thrombin,thrombocytopenia,Thrombomodulin,Thrombophilia,Thrombophilia due to thrombomodulin defect,thrombosis,TM,Transmembrane,Transmembrane helix,transmembrane signaling receptor activity,TRBM,venous thrombosis",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs2273684",
        "SNP Name": "GSS A18836C",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2273684",
        "Video": "sU1SO36EPR0",
        "Tags": "3D-structure,Acetylation,ADP,aging,air pollution,Alternative splicing,ATP,ATP binding,ATP-binding,cancer,cancerous,carcinogen,cellular amino acid metabolic process,Complete proteome,cytosol,defective function of the central nervous system,Direct protein sequencing,Disease mutation,eukaryotic GSH synthase family,extracellular vesicular exosome,gamma-L-glutamyl-L-cysteine,GLUSYNDE,glutathione,glutathione binding,glutathione biosynthesis,glutathione biosynthetic process,glutathione derivative biosynthetic process,Glutathione synthase,glutathione synthase activity,Glutathione synthetase,Glutathione synthetase deficiency,Glutathione synthetase deficiency of erythrocytes,glycine,glycine binding,GSH synthetase,GSH-S,GSS,GSS deficiency,hemolysis,hemolytic anemia,Hereditary hemolytic anemia,Homodimer,L-cysteine,L-glutamate,Ligase,lung cancer,lung function,Magnesium,magnesium ion,magnesium ion binding,mental disorder,Metal-binding,nervous system development,Nucleotide-binding,Oxidative Stress,phosphate,Polymorphism,protein homodimerization activity,Reference proteome,response to amino acid,response to cadmium ion,response to nutrient levels,response to oxidative stress,response to tumor necrosis factor,ROS,schizophrenia,small molecule metabolic process,small-cell lung cancer,Sulfur metabolism,xenobiotic metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2273684",
        "SNP Name": "GSS A18836C",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2273684",
        "Video": "sU1SO36EPR0",
        "Tags": "3D-structure,Acetylation,ADP,aging,air pollution,Alternative splicing,ATP,ATP binding,ATP-binding,cancer,cancerous,carcinogen,cellular amino acid metabolic process,Complete proteome,cytosol,defective function of the central nervous system,Direct protein sequencing,Disease mutation,eukaryotic GSH synthase family,extracellular vesicular exosome,gamma-L-glutamyl-L-cysteine,GLUSYNDE,glutathione,glutathione binding,glutathione biosynthesis,glutathione biosynthetic process,glutathione derivative biosynthetic process,Glutathione synthase,glutathione synthase activity,Glutathione synthetase,Glutathione synthetase deficiency,Glutathione synthetase deficiency of erythrocytes,glycine,glycine binding,GSH synthetase,GSH-S,GSS,GSS deficiency,hemolysis,hemolytic anemia,Hereditary hemolytic anemia,Homodimer,L-cysteine,L-glutamate,Ligase,lung cancer,lung function,Magnesium,magnesium ion,magnesium ion binding,mental disorder,Metal-binding,nervous system development,Nucleotide-binding,Oxidative Stress,phosphate,Polymorphism,protein homodimerization activity,Reference proteome,response to amino acid,response to cadmium ion,response to nutrient levels,response to oxidative stress,response to tumor necrosis factor,ROS,schizophrenia,small molecule metabolic process,small-cell lung cancer,Sulfur metabolism,xenobiotic metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2273684",
        "SNP Name": "GSS A18836C",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2273684",
        "Video": "sU1SO36EPR0",
        "Tags": "3D-structure,Acetylation,ADP,aging,air pollution,Alternative splicing,ATP,ATP binding,ATP-binding,cancer,cancerous,carcinogen,cellular amino acid metabolic process,Complete proteome,cytosol,defective function of the central nervous system,Direct protein sequencing,Disease mutation,eukaryotic GSH synthase family,extracellular vesicular exosome,gamma-L-glutamyl-L-cysteine,GLUSYNDE,glutathione,glutathione binding,glutathione biosynthesis,glutathione biosynthetic process,glutathione derivative biosynthetic process,Glutathione synthase,glutathione synthase activity,Glutathione synthetase,Glutathione synthetase deficiency,Glutathione synthetase deficiency of erythrocytes,glycine,glycine binding,GSH synthetase,GSH-S,GSS,GSS deficiency,hemolysis,hemolytic anemia,Hereditary hemolytic anemia,Homodimer,L-cysteine,L-glutamate,Ligase,lung cancer,lung function,Magnesium,magnesium ion,magnesium ion binding,mental disorder,Metal-binding,nervous system development,Nucleotide-binding,Oxidative Stress,phosphate,Polymorphism,protein homodimerization activity,Reference proteome,response to amino acid,response to cadmium ion,response to nutrient levels,response to oxidative stress,response to tumor necrosis factor,ROS,schizophrenia,small molecule metabolic process,small-cell lung cancer,Sulfur metabolism,xenobiotic metabolic process",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs2273684",
        "SNP Name": "GSS A18836C",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2273684",
        "Video": "sU1SO36EPR0",
        "Tags": "3D-structure,Acetylation,ADP,aging,air pollution,Alternative splicing,ATP,ATP binding,ATP-binding,cancer,cancerous,carcinogen,cellular amino acid metabolic process,Complete proteome,cytosol,defective function of the central nervous system,Direct protein sequencing,Disease mutation,eukaryotic GSH synthase family,extracellular vesicular exosome,gamma-L-glutamyl-L-cysteine,GLUSYNDE,glutathione,glutathione binding,glutathione biosynthesis,glutathione biosynthetic process,glutathione derivative biosynthetic process,Glutathione synthase,glutathione synthase activity,Glutathione synthetase,Glutathione synthetase deficiency,Glutathione synthetase deficiency of erythrocytes,glycine,glycine binding,GSH synthetase,GSH-S,GSS,GSS deficiency,hemolysis,hemolytic anemia,Hereditary hemolytic anemia,Homodimer,L-cysteine,L-glutamate,Ligase,lung cancer,lung function,Magnesium,magnesium ion,magnesium ion binding,mental disorder,Metal-binding,nervous system development,Nucleotide-binding,Oxidative Stress,phosphate,Polymorphism,protein homodimerization activity,Reference proteome,response to amino acid,response to cadmium ion,response to nutrient levels,response to oxidative stress,response to tumor necrosis factor,ROS,schizophrenia,small molecule metabolic process,small-cell lung cancer,Sulfur metabolism,xenobiotic metabolic process",
        "Group": "Trans-Sulfuration Pathway"
    },
    {
        "SNP ID": "rs28936396",
        "SNP Name": "GSS C373T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs28936396",
        "Video": "sU1SO36EPR0",
        "Tags": "3D-structure,Acetylation,ADP,aging,Alternative splicing,ATP,ATP binding,ATP-binding,cellular amino acid metabolic process,Complete proteome,cytosol,defective function of the central nervous system,Direct protein sequencing,Disease mutation,eukaryotic GSH synthase family,extracellular vesicular exosome,gamma-L-glutamyl-L-cysteine,GLUSYNDE,glutathione,glutathione binding,glutathione biosynthesis,glutathione biosynthetic process,glutathione derivative biosynthetic process,Glutathione synthase,glutathione synthase activity,Glutathione synthetase,Glutathione synthetase deficiency,Glutathione synthetase deficiency of erythrocytes,glycine,glycine binding,GSH synthetase,GSH-S,GSS,GSS deficiency,hemolysis,hemolytic anemia,Hereditary hemolytic anemia,Homodimer,L-cysteine,L-glutamate,Ligase,Magnesium,magnesium ion,magnesium ion binding,Metal-binding,nervous system development,Nucleotide-binding,phosphate,Polymorphism,protein homodimerization activity,Reference proteome,response to amino acid,response to cadmium ion,response to nutrient levels,response to oxidative stress,response to tumor necrosis factor,small molecule metabolic process,Sulfur metabolism,xenobiotic metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs28936396",
        "SNP Name": "GSS C373T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs28936396",
        "Video": "sU1SO36EPR0",
        "Tags": "3D-structure,Acetylation,ADP,aging,Alternative splicing,ATP,ATP binding,ATP-binding,cellular amino acid metabolic process,Complete proteome,cytosol,defective function of the central nervous system,Direct protein sequencing,Disease mutation,eukaryotic GSH synthase family,extracellular vesicular exosome,gamma-L-glutamyl-L-cysteine,GLUSYNDE,glutathione,glutathione binding,glutathione biosynthesis,glutathione biosynthetic process,glutathione derivative biosynthetic process,Glutathione synthase,glutathione synthase activity,Glutathione synthetase,Glutathione synthetase deficiency,Glutathione synthetase deficiency of erythrocytes,glycine,glycine binding,GSH synthetase,GSH-S,GSS,GSS deficiency,hemolysis,hemolytic anemia,Hereditary hemolytic anemia,Homodimer,L-cysteine,L-glutamate,Ligase,Magnesium,magnesium ion,magnesium ion binding,Metal-binding,nervous system development,Nucleotide-binding,phosphate,Polymorphism,protein homodimerization activity,Reference proteome,response to amino acid,response to cadmium ion,response to nutrient levels,response to oxidative stress,response to tumor necrosis factor,small molecule metabolic process,Sulfur metabolism,xenobiotic metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs28936396",
        "SNP Name": "GSS C373T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs28936396",
        "Video": "sU1SO36EPR0",
        "Tags": "3D-structure,Acetylation,ADP,aging,Alternative splicing,ATP,ATP binding,ATP-binding,cellular amino acid metabolic process,Complete proteome,cytosol,defective function of the central nervous system,Direct protein sequencing,Disease mutation,eukaryotic GSH synthase family,extracellular vesicular exosome,gamma-L-glutamyl-L-cysteine,GLUSYNDE,glutathione,glutathione binding,glutathione biosynthesis,glutathione biosynthetic process,glutathione derivative biosynthetic process,Glutathione synthase,glutathione synthase activity,Glutathione synthetase,Glutathione synthetase deficiency,Glutathione synthetase deficiency of erythrocytes,glycine,glycine binding,GSH synthetase,GSH-S,GSS,GSS deficiency,hemolysis,hemolytic anemia,Hereditary hemolytic anemia,Homodimer,L-cysteine,L-glutamate,Ligase,Magnesium,magnesium ion,magnesium ion binding,Metal-binding,nervous system development,Nucleotide-binding,phosphate,Polymorphism,protein homodimerization activity,Reference proteome,response to amino acid,response to cadmium ion,response to nutrient levels,response to oxidative stress,response to tumor necrosis factor,small molecule metabolic process,Sulfur metabolism,xenobiotic metabolic process",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs28936396",
        "SNP Name": "GSS C373T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs28936396",
        "Video": "sU1SO36EPR0",
        "Tags": "3D-structure,Acetylation,ADP,aging,Alternative splicing,ATP,ATP binding,ATP-binding,cellular amino acid metabolic process,Complete proteome,cytosol,defective function of the central nervous system,Direct protein sequencing,Disease mutation,eukaryotic GSH synthase family,extracellular vesicular exosome,gamma-L-glutamyl-L-cysteine,GLUSYNDE,glutathione,glutathione binding,glutathione biosynthesis,glutathione biosynthetic process,glutathione derivative biosynthetic process,Glutathione synthase,glutathione synthase activity,Glutathione synthetase,Glutathione synthetase deficiency,Glutathione synthetase deficiency of erythrocytes,glycine,glycine binding,GSH synthetase,GSH-S,GSS,GSS deficiency,hemolysis,hemolytic anemia,Hereditary hemolytic anemia,Homodimer,L-cysteine,L-glutamate,Ligase,Magnesium,magnesium ion,magnesium ion binding,Metal-binding,nervous system development,Nucleotide-binding,phosphate,Polymorphism,protein homodimerization activity,Reference proteome,response to amino acid,response to cadmium ion,response to nutrient levels,response to oxidative stress,response to tumor necrosis factor,small molecule metabolic process,Sulfur metabolism,xenobiotic metabolic process",
        "Group": "Trans-Sulfuration Pathway"
    },
    {
        "SNP ID": "rs6060124",
        "SNP Name": "GSS G11705T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6060124",
        "Video": "sU1SO36EPR0",
        "Tags": "3D-structure,Acetylation,ADP,aging,air pollution,Alternative splicing,ATP,ATP binding,ATP-binding,cellular amino acid metabolic process,Complete proteome,cytosol,defective function of the central nervous system,Direct protein sequencing,Disease mutation,eukaryotic GSH synthase family,extracellular vesicular exosome,gamma-L-glutamyl-L-cysteine,GLUSYNDE,glutathione,glutathione binding,glutathione biosynthesis,glutathione biosynthetic process,glutathione derivative biosynthetic process,Glutathione synthase,glutathione synthase activity,Glutathione synthetase,Glutathione synthetase deficiency,Glutathione synthetase deficiency of erythrocytes,glycine,glycine binding,GSH synthetase,GSH-S,GSS,GSS deficiency,hemolysis,hemolytic anemia,Hereditary hemolytic anemia,Homodimer,L-cysteine,L-glutamate,Ligase,lung,lung function,Magnesium,magnesium ion,magnesium ion binding,Metal-binding,nervous system development,Nucleotide-binding,phosphate,Polymorphism,protein homodimerization activity,Reference proteome,response to amino acid,response to cadmium ion,response to nutrient levels,response to oxidative stress,response to tumor necrosis factor,small molecule metabolic process,Sulfur metabolism,xenobiotic metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs6060124",
        "SNP Name": "GSS G11705T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6060124",
        "Video": "sU1SO36EPR0",
        "Tags": "3D-structure,Acetylation,ADP,aging,air pollution,Alternative splicing,ATP,ATP binding,ATP-binding,cellular amino acid metabolic process,Complete proteome,cytosol,defective function of the central nervous system,Direct protein sequencing,Disease mutation,eukaryotic GSH synthase family,extracellular vesicular exosome,gamma-L-glutamyl-L-cysteine,GLUSYNDE,glutathione,glutathione binding,glutathione biosynthesis,glutathione biosynthetic process,glutathione derivative biosynthetic process,Glutathione synthase,glutathione synthase activity,Glutathione synthetase,Glutathione synthetase deficiency,Glutathione synthetase deficiency of erythrocytes,glycine,glycine binding,GSH synthetase,GSH-S,GSS,GSS deficiency,hemolysis,hemolytic anemia,Hereditary hemolytic anemia,Homodimer,L-cysteine,L-glutamate,Ligase,lung,lung function,Magnesium,magnesium ion,magnesium ion binding,Metal-binding,nervous system development,Nucleotide-binding,phosphate,Polymorphism,protein homodimerization activity,Reference proteome,response to amino acid,response to cadmium ion,response to nutrient levels,response to oxidative stress,response to tumor necrosis factor,small molecule metabolic process,Sulfur metabolism,xenobiotic metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs6060124",
        "SNP Name": "GSS G11705T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6060124",
        "Video": "sU1SO36EPR0",
        "Tags": "3D-structure,Acetylation,ADP,aging,air pollution,Alternative splicing,ATP,ATP binding,ATP-binding,cellular amino acid metabolic process,Complete proteome,cytosol,defective function of the central nervous system,Direct protein sequencing,Disease mutation,eukaryotic GSH synthase family,extracellular vesicular exosome,gamma-L-glutamyl-L-cysteine,GLUSYNDE,glutathione,glutathione binding,glutathione biosynthesis,glutathione biosynthetic process,glutathione derivative biosynthetic process,Glutathione synthase,glutathione synthase activity,Glutathione synthetase,Glutathione synthetase deficiency,Glutathione synthetase deficiency of erythrocytes,glycine,glycine binding,GSH synthetase,GSH-S,GSS,GSS deficiency,hemolysis,hemolytic anemia,Hereditary hemolytic anemia,Homodimer,L-cysteine,L-glutamate,Ligase,lung,lung function,Magnesium,magnesium ion,magnesium ion binding,Metal-binding,nervous system development,Nucleotide-binding,phosphate,Polymorphism,protein homodimerization activity,Reference proteome,response to amino acid,response to cadmium ion,response to nutrient levels,response to oxidative stress,response to tumor necrosis factor,small molecule metabolic process,Sulfur metabolism,xenobiotic metabolic process",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs6060124",
        "SNP Name": "GSS G11705T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6060124",
        "Video": "sU1SO36EPR0",
        "Tags": "3D-structure,Acetylation,ADP,aging,air pollution,Alternative splicing,ATP,ATP binding,ATP-binding,cellular amino acid metabolic process,Complete proteome,cytosol,defective function of the central nervous system,Direct protein sequencing,Disease mutation,eukaryotic GSH synthase family,extracellular vesicular exosome,gamma-L-glutamyl-L-cysteine,GLUSYNDE,glutathione,glutathione binding,glutathione biosynthesis,glutathione biosynthetic process,glutathione derivative biosynthetic process,Glutathione synthase,glutathione synthase activity,Glutathione synthetase,Glutathione synthetase deficiency,Glutathione synthetase deficiency of erythrocytes,glycine,glycine binding,GSH synthetase,GSH-S,GSS,GSS deficiency,hemolysis,hemolytic anemia,Hereditary hemolytic anemia,Homodimer,L-cysteine,L-glutamate,Ligase,lung,lung function,Magnesium,magnesium ion,magnesium ion binding,Metal-binding,nervous system development,Nucleotide-binding,phosphate,Polymorphism,protein homodimerization activity,Reference proteome,response to amino acid,response to cadmium ion,response to nutrient levels,response to oxidative stress,response to tumor necrosis factor,small molecule metabolic process,Sulfur metabolism,xenobiotic metabolic process",
        "Group": "Trans-Sulfuration Pathway"
    },
    {
        "SNP ID": "rs6088659",
        "SNP Name": "GSS A5997G",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6088659",
        "Video": "sU1SO36EPR0",
        "Tags": "3D-structure,Acetylation,ADP,aging,Alternative splicing,ATP,ATP binding,ATP-binding,cancer,cancerous,carcinogen,cellular amino acid metabolic process,Chronic Obstructive Pulmonary Disease,Complete proteome,COPD,cytosol,defective function of the central nervous system,Direct protein sequencing,Disease mutation,eukaryotic GSH synthase family,extracellular vesicular exosome,gamma-L-glutamyl-L-cysteine,GLUSYNDE,glutathione,glutathione binding,glutathione biosynthesis,glutathione biosynthetic process,glutathione derivative biosynthetic process,Glutathione synthase,glutathione synthase activity,Glutathione synthetase,Glutathione synthetase deficiency,Glutathione synthetase deficiency of erythrocytes,glycine,glycine binding,GSH synthetase,GSH-S,GSS,GSS deficiency,hemolysis,hemolytic anemia,Hereditary hemolytic anemia,Homodimer,L-cysteine,L-glutamate,Ligase,lung,Lung Cancer,Magnesium,magnesium ion,magnesium ion binding,Metal-binding,nervous system development,Nucleotide-binding,phosphate,Polymorphism,protein homodimerization activity,Reference proteome,response to amino acid,response to cadmium ion,response to nutrient levels,response to oxidative stress,response to tumor necrosis factor,small molecule metabolic process,Sulfur metabolism,xenobiotic metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs6088659",
        "SNP Name": "GSS A5997G",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6088659",
        "Video": "sU1SO36EPR0",
        "Tags": "3D-structure,Acetylation,ADP,aging,Alternative splicing,ATP,ATP binding,ATP-binding,cancer,cancerous,carcinogen,cellular amino acid metabolic process,Chronic Obstructive Pulmonary Disease,Complete proteome,COPD,cytosol,defective function of the central nervous system,Direct protein sequencing,Disease mutation,eukaryotic GSH synthase family,extracellular vesicular exosome,gamma-L-glutamyl-L-cysteine,GLUSYNDE,glutathione,glutathione binding,glutathione biosynthesis,glutathione biosynthetic process,glutathione derivative biosynthetic process,Glutathione synthase,glutathione synthase activity,Glutathione synthetase,Glutathione synthetase deficiency,Glutathione synthetase deficiency of erythrocytes,glycine,glycine binding,GSH synthetase,GSH-S,GSS,GSS deficiency,hemolysis,hemolytic anemia,Hereditary hemolytic anemia,Homodimer,L-cysteine,L-glutamate,Ligase,lung,Lung Cancer,Magnesium,magnesium ion,magnesium ion binding,Metal-binding,nervous system development,Nucleotide-binding,phosphate,Polymorphism,protein homodimerization activity,Reference proteome,response to amino acid,response to cadmium ion,response to nutrient levels,response to oxidative stress,response to tumor necrosis factor,small molecule metabolic process,Sulfur metabolism,xenobiotic metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs6088659",
        "SNP Name": "GSS A5997G",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6088659",
        "Video": "sU1SO36EPR0",
        "Tags": "3D-structure,Acetylation,ADP,aging,Alternative splicing,ATP,ATP binding,ATP-binding,cancer,cancerous,carcinogen,cellular amino acid metabolic process,Chronic Obstructive Pulmonary Disease,Complete proteome,COPD,cytosol,defective function of the central nervous system,Direct protein sequencing,Disease mutation,eukaryotic GSH synthase family,extracellular vesicular exosome,gamma-L-glutamyl-L-cysteine,GLUSYNDE,glutathione,glutathione binding,glutathione biosynthesis,glutathione biosynthetic process,glutathione derivative biosynthetic process,Glutathione synthase,glutathione synthase activity,Glutathione synthetase,Glutathione synthetase deficiency,Glutathione synthetase deficiency of erythrocytes,glycine,glycine binding,GSH synthetase,GSH-S,GSS,GSS deficiency,hemolysis,hemolytic anemia,Hereditary hemolytic anemia,Homodimer,L-cysteine,L-glutamate,Ligase,lung,Lung Cancer,Magnesium,magnesium ion,magnesium ion binding,Metal-binding,nervous system development,Nucleotide-binding,phosphate,Polymorphism,protein homodimerization activity,Reference proteome,response to amino acid,response to cadmium ion,response to nutrient levels,response to oxidative stress,response to tumor necrosis factor,small molecule metabolic process,Sulfur metabolism,xenobiotic metabolic process",
        "Group": "Mitochondrial Function"
    },
    {
        "SNP ID": "rs6088659",
        "SNP Name": "GSS A5997G",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6088659",
        "Video": "sU1SO36EPR0",
        "Tags": "3D-structure,Acetylation,ADP,aging,Alternative splicing,ATP,ATP binding,ATP-binding,cancer,cancerous,carcinogen,cellular amino acid metabolic process,Chronic Obstructive Pulmonary Disease,Complete proteome,COPD,cytosol,defective function of the central nervous system,Direct protein sequencing,Disease mutation,eukaryotic GSH synthase family,extracellular vesicular exosome,gamma-L-glutamyl-L-cysteine,GLUSYNDE,glutathione,glutathione binding,glutathione biosynthesis,glutathione biosynthetic process,glutathione derivative biosynthetic process,Glutathione synthase,glutathione synthase activity,Glutathione synthetase,Glutathione synthetase deficiency,Glutathione synthetase deficiency of erythrocytes,glycine,glycine binding,GSH synthetase,GSH-S,GSS,GSS deficiency,hemolysis,hemolytic anemia,Hereditary hemolytic anemia,Homodimer,L-cysteine,L-glutamate,Ligase,lung,Lung Cancer,Magnesium,magnesium ion,magnesium ion binding,Metal-binding,nervous system development,Nucleotide-binding,phosphate,Polymorphism,protein homodimerization activity,Reference proteome,response to amino acid,response to cadmium ion,response to nutrient levels,response to oxidative stress,response to tumor necrosis factor,small molecule metabolic process,Sulfur metabolism,xenobiotic metabolic process",
        "Group": "Trans-Sulfuration Pathway"
    },
    {
        "SNP ID": "rs11555566",
        "SNP Name": "ADA A239G",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs11555566",
        "Video": "7MxmWQeEqMA",
        "Tags": "acetylating,acetylation,acetyltransferase,ADA,ADA2,ADA3,ADA3 homolog,ADA3m,adenosine deaminase deficiency,ATAC,ATAC complex,B6,bacteria,CCDC101,chromatin organization,Coiled coil,Complete proteome,CSRP2BP,deoxyadenosine,DNA-templated,DR1,GCN5L2,H3,H4,histone,histone H3 acetylation,histones,HPV,human papiloma virus,immune system,immunodeficiency,intracellular,intracellular estrogen receptor signaling pathway,KAT2A,Lymphocytes,MBIP,mitosis,mitotic spindle,NGG1 family,Nucleus,p53/TP53,p53/TP53-dependent transcriptional activation,PCAF,PCAF complex,positive regulation of gene expression,positive regulation of transcription,Reference proteome,regulation of histone deacetylation,regulation of protein phosphorylation,regulation of protein stability,regulation of transcription from RNA polymerase II promoter,regulation of tubulin deacetylation,SAGA,SAGA complex,SPT3,STAF54,STAGA transcription coactivator-HAT complex,SUPT3H,SUPT7L,TAD1L,TADA2L,TADA2L/ADA2,TADA3,TADA3L,TADA3L/ADA3m TADA2L,TAF10,TAF12,TAF5,TAF5L,TAF6,TAF6L,TAF9,TFTC-HAT complex,Transcription,Transcription regulation,Transcriptional adapter 3,Transcriptional adapter 3-like,TRRAP,virus,WDR5,yeast SAGA complex,YEATS2,ZZ3",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs447833",
        "SNP Name": "ADA G22021A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs447833",
        "Video": "7MxmWQeEqMA",
        "Tags": "acetylating,acetylation,acetyltransferase,ADA,ADA2,ADA3,ADA3 homolog,ADA3m,adenosine deaminase deficiency,ATAC,ATAC complex,B6,bacteria,bifida,CCDC101,chromatin organization,Coiled coil,Complete proteome,CSRP2BP,deoxyadenosine,DNA-templated,DR1,folate,GCN5L2,H3,H4,histone,histone H3 acetylation,histones,HPV,human papiloma virus,immune system,immunodeficiency,intracellular,intracellular estrogen receptor signaling pathway,KAT2A,Lymphocytes,MBIP,mitosis,mitotic spindle,NGG1 family,NTDs,Nucleus,p53/TP53,p53/TP53-dependent transcriptional activation,PCAF,PCAF complex,positive regulation of gene expression,positive regulation of transcription,Reference proteome,regulation of histone deacetylation,regulation of protein phosphorylation,regulation of protein stability,regulation of transcription from RNA polymerase II promoter,regulation of tubulin deacetylation,SAGA,SAGA complex,Spina,SPT3,STAF54,STAGA transcription coactivator-HAT complex,SUPT3H,SUPT7L,TAD1L,TADA2L,TADA2L/ADA2,TADA3,TADA3L,TADA3L/ADA3m TADA2L,TAF10,TAF12,TAF5,TAF5L,TAF6,TAF6L,TAF9,TFTC-HAT complex,Transcription,Transcription regulation,Transcriptional adapter 3,Transcriptional adapter 3-like,TRRAP,virus,WDR5,yeast SAGA complex,YEATS2,ZZ3",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs452159",
        "SNP Name": "ADA C14275A",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs452159",
        "Video": "7MxmWQeEqMA",
        "Tags": "acetylating,acetylation,acetyltransferase,ADA,ADA2,ADA3,ADA3 homolog,ADA3m,adenosine,adenosine deaminase deficiency,ATAC,ATAC complex,B6,bacteria,birth defect,CCDC101,chromatin organization,Coiled coil,Complete proteome,CSRP2BP,defect,deoxyadenosine,Depression,DNA-templated,DR1,folic acid,GCN5L2,H3,H4,histone,histone H3 acetylation,histones,HPV,human papiloma virus,immune system,immunodeficiency,intracellular,intracellular estrogen receptor signaling pathway,KAT2A,Lymphocytes,MBIP,mitosis,mitotic spindle,neural tube defect,NGG1 family,NTDs,Nucleus,p53/TP53,p53/TP53-dependent transcriptional activation,PCAF,PCAF complex,positive regulation of gene expression,positive regulation of transcription,Reference proteome,regulation of histone deacetylation,regulation of protein phosphorylation,regulation of protein stability,regulation of transcription from RNA polymerase II promoter,regulation of tubulin deacetylation,SAGA,SAGA complex,sleep,spina bifida,SPT3,STAF54,STAGA transcription coactivator-HAT complex,SUPT3H,SUPT7L,TAD1L,TADA2L,TADA2L/ADA2,TADA3,TADA3L,TADA3L/ADA3m TADA2L,TAF10,TAF12,TAF5,TAF5L,TAF6,TAF6L,TAF9,TFTC-HAT complex,Transcription,Transcription regulation,Transcriptional adapter 3,Transcriptional adapter 3-like,TRRAP,virus,WDR5,yeast SAGA complex,YEATS2,ZZ3",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs17576",
        "SNP Name": "THBS2 Q279R",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Calcium Chloride"
    },
    {
        "SNP ID": "rs17576",
        "SNP Name": "THBS2 Q279R",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Sodium Taurodeoxycholate"
    },
    {
        "SNP ID": "rs1883832",
        "SNP Name": "CD40 T44746982C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs28931586",
        "SNP Name": "CD40 C83A",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Hydrocortisone"
    },
    {
        "SNP ID": "rs1051295",
        "SNP Name": "KCNB1 T*615C",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs756529",
        "SNP Name": "KCNB1 G18207100A",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs7269297",
        "SNP Name": "MOCS3 Ser429Ala",
        "Risk Allele": "G",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs1801475",
        "SNP Name": "KCNQ2 Asn752Thr",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs2297385",
        "SNP Name": "KCNQ2 62070966G>A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Molybdenum"
    },
    {
        "SNP ID": "rs63749964",
        "SNP Name": "APP Val586Gly",
        "Risk Allele": "C",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "A4,ABPP,acetylcholine,acetylcholine receptor binding,AD,AD1,adult locomotory behavior,AICD-50,AICD-57,AICD-59,AID(50),AID(57),AID(59),alpha-secretase,Alzheimer,Alzheimer disease amyloid protein,Alzheimer's disease,Amyloid,Amyloid beta A4 protein,Amyloid intracellular domain 50,Amyloid intracellular domain 57,Amyloid intracellular domain 59,amyloid-beta peptide,APBB1-KAT5,apical part of cell,APOE,apolipoprotein,apolipoprotein E,apolipoprotein J,apolipoproteins,apolipoproteins E,apolipoproteins J,apopotosis,apoptosis,APP,APPI,ATPase,axon,axon cargo transport,axon midline choice point recognition,axonogenesis,Beta-amyloid peptides,Beta-amyloid protein 40,Beta-amyloid protein 42,Beta-APP40,Beta-APP42,beta-secretase,blood coagulation,blood pressure,BP,brain,C31,C80,C83,C99,cell adhesion,cell surface,cell surface receptor,cell-cell junction,cellular,cellular copper ion homeostasis,cellular energy,central nervous system,cerebral hemorrhage,Cerebral vascular amyloid peptide,chelation,Chelation of metal ions,cholesterol,cholesterol metabolic process,ciliary rootlet,CNS,coagulation,coated pit,collagen,collateral sprouting in absence of injury,copper,copper homeostasis/oxidative stress,CSF,CU,Cu2+,Cu2+ ions,CVAP,cytoplasm,cytosol,dementia,dendrite development,dendritic shaft,dendritic spine,DNA binding,dopamine,early-onset alzheimer's disease,endocytosis,endosome,enzyme binding,ER to Golgi transport vesicle,extracellular matrix organization,extracellular region,extracellular space,extracellular vesicular exosome,fat,FE,forebrain development,Gamma-CTF(50),Gamma-CTF(57),Gamma-CTF(59),Gamma-secretase C-terminal fragment 50,Gamma-secretase C-terminal fragment 57,Gamma-secretase C-terminal fragment 59,Golgi apparatus,GPC1,HDL,HDL plasma,heart,heavy metal poisoning,heavy metal toxicity,heavy metals,hemorrhage,heparin binding,Heparin-binding,Hereditary cerebral hemorrhage,high BP,identical protein binding,inflammation,innate immune response,integral component of membrane,integral component of plasma membrane,intracellular membrane-bounded organelle,ionotropic glutamate receptor signaling pathway,iron,kidney,kinesin I membrane receptor,L-tyrosine,LDL,learning,leucine rich repeat containing receptor signaling pathway,lipid,lipids,lipophilic metal chelators,lipoprotein,lipoproteins,locomotory behavior,low BP,lymphocytes,mating behavior,Membrane,membrane raft,metal binding,Metal-binding,mitochondria,mitochondrial,mitochondrial dysfunction,mRNA polyadenylation,N-APP,negative regulation of endopeptidase activity,negative regulation of neuron differentiation,nerve cells,nervous system,neurite growth,neurodegenerative disorder,neuromuscular junction,neuromuscular process controlling balance,neuron apoptotic process,neuron projection development,neuron remodeling,neuronal adhesion,neuronal apoptosis,nitric oxide,NO,Notch signaling,Notch signaling pathway,nuclear envelope lumen,nucleotide-binding domain,oxidation,oxidative stress,P3(40),P3(42),peptidase activator activity,peptides,perinuclear region of cytoplasm,Phosphorylated,Phosphorylation,Phosphothreonine,Phosphotyrosine,plasma membrane,platelet,platelet activation,platelet alpha granule lumen,platelet degranulation,platelets,PN-II,positive regulation of G2/M transition of mitotic cell cycle,positive regulation of mitotic cell cycle,positive regulation of transcription from RNA polymerase II promoter,PreA4,presenilin 1,Protease inhibitor,Protease nexin-II,protein phosphorylation,PTB domain binding,reactive oxygen species,receptor binding,receptor complex,regulation of epidermal growth factor-activated receptor activity,regulation of multicellular organism growth,regulation of protein binding,regulation of synapse structure and activity,regulation of translation,response to oxidative stress,ROS,S-APP-alpha,sAPP,serine,serine phosphorylation,Serine protease inhibitor,serine-type endopep",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63750399",
        "SNP Name": "APP Ile698Val",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "A4,ABPP,acetylcholine,acetylcholine receptor binding,AD,AD1,adult locomotory behavior,AICD-50,AICD-57,AICD-59,AID(50),AID(57),AID(59),alpha-secretase,Alzheimer,Alzheimer disease amyloid protein,Alzheimer's disease,Amyloid,Amyloid beta A4 protein,Amyloid intracellular domain 50,Amyloid intracellular domain 57,Amyloid intracellular domain 59,amyloid-beta peptide,APBB1-KAT5,apical part of cell,APOE,apolipoprotein,apolipoprotein E,apolipoprotein J,apolipoproteins,apolipoproteins E,apolipoproteins J,apopotosis,apoptosis,APP,APPI,ATPase,axon,axon cargo transport,axon midline choice point recognition,axonogenesis,Beta-amyloid peptides,Beta-amyloid protein 40,Beta-amyloid protein 42,Beta-APP40,Beta-APP42,beta-secretase,blood coagulation,blood pressure,BP,brain,C31,C80,C83,C99,cell adhesion,cell surface,cell surface receptor,cell-cell junction,cellular,cellular copper ion homeostasis,cellular energy,central nervous system,cerebral hemorrhage,Cerebral vascular amyloid peptide,chelation,Chelation of metal ions,cholesterol,cholesterol metabolic process,ciliary rootlet,CNS,coagulation,coated pit,collagen,collateral sprouting in absence of injury,copper,copper homeostasis/oxidative stress,CSF,CU,Cu2+,Cu2+ ions,CVAP,cytoplasm,cytosol,dementia,dendrite development,dendritic shaft,dendritic spine,DNA binding,dopamine,early-onset alzheimer's disease,endocytosis,endosome,enzyme binding,ER to Golgi transport vesicle,extracellular matrix organization,extracellular region,extracellular space,extracellular vesicular exosome,fat,FE,forebrain development,Gamma-CTF(50),Gamma-CTF(57),Gamma-CTF(59),Gamma-secretase C-terminal fragment 50,Gamma-secretase C-terminal fragment 57,Gamma-secretase C-terminal fragment 59,Golgi apparatus,GPC1,HDL,HDL plasma,heart,heavy metal poisoning,heavy metal toxicity,heavy metals,hemorrhage,heparin binding,Heparin-binding,Hereditary cerebral hemorrhage,high BP,identical protein binding,inflammation,innate immune response,integral component of membrane,integral component of plasma membrane,intracellular membrane-bounded organelle,ionotropic glutamate receptor signaling pathway,iron,kidney,kinesin I membrane receptor,L-tyrosine,LDL,learning,leucine rich repeat containing receptor signaling pathway,lipid,lipids,lipophilic metal chelators,lipoprotein,lipoproteins,locomotory behavior,low BP,lymphocytes,mating behavior,Membrane,membrane raft,metal binding,Metal-binding,mitochondria,mitochondrial,mitochondrial dysfunction,mRNA polyadenylation,N-APP,negative regulation of endopeptidase activity,negative regulation of neuron differentiation,nerve cells,nervous system,neurite growth,neurodegenerative disorder,neuromuscular junction,neuromuscular process controlling balance,neuron apoptotic process,neuron projection development,neuron remodeling,neuronal adhesion,neuronal apoptosis,nitric oxide,NO,Notch signaling,Notch signaling pathway,nuclear envelope lumen,nucleotide-binding domain,oxidation,oxidative stress,P3(40),P3(42),peptidase activator activity,peptides,perinuclear region of cytoplasm,Phosphorylated,Phosphorylation,Phosphothreonine,Phosphotyrosine,plasma membrane,platelet,platelet activation,platelet alpha granule lumen,platelet degranulation,platelets,PN-II,positive regulation of G2/M transition of mitotic cell cycle,positive regulation of mitotic cell cycle,positive regulation of transcription from RNA polymerase II promoter,PreA4,presenilin 1,Protease inhibitor,Protease nexin-II,protein phosphorylation,PTB domain binding,reactive oxygen species,receptor binding,receptor complex,regulation of epidermal growth factor-activated receptor activity,regulation of multicellular organism growth,regulation of protein binding,regulation of synapse structure and activity,regulation of translation,response to oxidative stress,ROS,S-APP-alpha,sAPP,serine,serine phosphorylation,Serine protease inhibitor,serine-type endopep",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63750734",
        "SNP Name": "APP Val697Met",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "A4,ABPP,acetylcholine,acetylcholine receptor binding,AD,AD1,adult locomotory behavior,AICD-50,AICD-57,AICD-59,AID(50),AID(57),AID(59),alpha-secretase,Alzheimer,Alzheimer disease amyloid protein,Alzheimer's disease,Amyloid,Amyloid beta A4 protein,Amyloid intracellular domain 50,Amyloid intracellular domain 57,Amyloid intracellular domain 59,amyloid-beta peptide,APBB1-KAT5,apical part of cell,APOE,apolipoprotein,apolipoprotein E,apolipoprotein J,apolipoproteins,apolipoproteins E,apolipoproteins J,apopotosis,apoptosis,APP,APPI,ATPase,axon,axon cargo transport,axon midline choice point recognition,axonogenesis,Beta-amyloid peptides,Beta-amyloid protein 40,Beta-amyloid protein 42,Beta-APP40,Beta-APP42,beta-secretase,blood coagulation,blood pressure,BP,brain,C31,C80,C83,C99,cell adhesion,cell surface,cell surface receptor,cell-cell junction,cellular,cellular copper ion homeostasis,cellular energy,central nervous system,cerebral hemorrhage,Cerebral vascular amyloid peptide,chelation,Chelation of metal ions,cholesterol,cholesterol metabolic process,ciliary rootlet,CNS,coagulation,coated pit,collagen,collateral sprouting in absence of injury,copper,copper homeostasis/oxidative stress,CSF,CU,Cu2+,Cu2+ ions,CVAP,cytoplasm,cytosol,dementia,dendrite development,dendritic shaft,dendritic spine,DNA binding,dopamine,early-onset alzheimer's disease,endocytosis,endosome,enzyme binding,ER to Golgi transport vesicle,extracellular matrix organization,extracellular region,extracellular space,extracellular vesicular exosome,fat,FE,forebrain development,Gamma-CTF(50),Gamma-CTF(57),Gamma-CTF(59),Gamma-secretase C-terminal fragment 50,Gamma-secretase C-terminal fragment 57,Gamma-secretase C-terminal fragment 59,Golgi apparatus,GPC1,HDL,HDL plasma,heart,heavy metal poisoning,heavy metal toxicity,heavy metals,hemorrhage,heparin binding,Heparin-binding,Hereditary cerebral hemorrhage,high BP,identical protein binding,inflammation,innate immune response,integral component of membrane,integral component of plasma membrane,intracellular membrane-bounded organelle,ionotropic glutamate receptor signaling pathway,iron,kidney,kinesin I membrane receptor,L-tyrosine,LDL,learning,leucine rich repeat containing receptor signaling pathway,lipid,lipids,lipophilic metal chelators,lipoprotein,lipoproteins,locomotory behavior,low BP,lymphocytes,mating behavior,Membrane,membrane raft,metal binding,Metal-binding,mitochondria,mitochondrial,mitochondrial dysfunction,mRNA polyadenylation,N-APP,negative regulation of endopeptidase activity,negative regulation of neuron differentiation,nerve cells,nervous system,neurite growth,neurodegenerative disorder,neuromuscular junction,neuromuscular process controlling balance,neuron apoptotic process,neuron projection development,neuron remodeling,neuronal adhesion,neuronal apoptosis,nitric oxide,NO,Notch signaling,Notch signaling pathway,nuclear envelope lumen,nucleotide-binding domain,oxidation,oxidative stress,P3(40),P3(42),peptidase activator activity,peptides,perinuclear region of cytoplasm,Phosphorylated,Phosphorylation,Phosphothreonine,Phosphotyrosine,plasma membrane,platelet,platelet activation,platelet alpha granule lumen,platelet degranulation,platelets,PN-II,positive regulation of G2/M transition of mitotic cell cycle,positive regulation of mitotic cell cycle,positive regulation of transcription from RNA polymerase II promoter,PreA4,presenilin 1,Protease inhibitor,Protease nexin-II,protein phosphorylation,PTB domain binding,reactive oxygen species,receptor binding,receptor complex,regulation of epidermal growth factor-activated receptor activity,regulation of multicellular organism growth,regulation of protein binding,regulation of synapse structure and activity,regulation of translation,response to oxidative stress,ROS,S-APP-alpha,sAPP,serine,serine phosphorylation,Serine protease inhibitor,serine-type endopep",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63750973",
        "SNP Name": "APP Thr696Ile",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "A4,ABPP,acetylcholine,acetylcholine receptor binding,AD,AD1,adult locomotory behavior,AICD-50,AICD-57,AICD-59,AID(50),AID(57),AID(59),alpha-secretase,Alzheimer,Alzheimer disease amyloid protein,Alzheimer's disease,Amyloid,Amyloid beta A4 protein,Amyloid intracellular domain 50,Amyloid intracellular domain 57,Amyloid intracellular domain 59,amyloid-beta peptide,APBB1-KAT5,apical part of cell,APOE,apolipoprotein,apolipoprotein E,apolipoprotein J,apolipoproteins,apolipoproteins E,apolipoproteins J,apopotosis,apoptosis,APP,APPI,ATPase,axon,axon cargo transport,axon midline choice point recognition,axonogenesis,Beta-amyloid peptides,Beta-amyloid protein 40,Beta-amyloid protein 42,Beta-APP40,Beta-APP42,beta-secretase,blood coagulation,blood pressure,BP,brain,C31,C80,C83,C99,cell adhesion,cell surface,cell surface receptor,cell-cell junction,cellular,cellular copper ion homeostasis,cellular energy,central nervous system,cerebral hemorrhage,Cerebral vascular amyloid peptide,chelation,Chelation of metal ions,cholesterol,cholesterol metabolic process,ciliary rootlet,CNS,coagulation,coated pit,collagen,collateral sprouting in absence of injury,copper,copper homeostasis/oxidative stress,CSF,CU,Cu2+,Cu2+ ions,CVAP,cytoplasm,cytosol,dementia,dendrite development,dendritic shaft,dendritic spine,DNA binding,dopamine,early-onset alzheimer's disease,endocytosis,endosome,enzyme binding,ER to Golgi transport vesicle,extracellular matrix organization,extracellular region,extracellular space,extracellular vesicular exosome,fat,FE,forebrain development,Gamma-CTF(50),Gamma-CTF(57),Gamma-CTF(59),Gamma-secretase C-terminal fragment 50,Gamma-secretase C-terminal fragment 57,Gamma-secretase C-terminal fragment 59,Golgi apparatus,GPC1,HDL,HDL plasma,heart,heavy metal poisoning,heavy metal toxicity,heavy metals,hemorrhage,heparin binding,Heparin-binding,Hereditary cerebral hemorrhage,high BP,identical protein binding,inflammation,innate immune response,integral component of membrane,integral component of plasma membrane,intracellular membrane-bounded organelle,ionotropic glutamate receptor signaling pathway,iron,kidney,kinesin I membrane receptor,L-tyrosine,LDL,learning,leucine rich repeat containing receptor signaling pathway,lipid,lipids,lipophilic metal chelators,lipoprotein,lipoproteins,locomotory behavior,low BP,lymphocytes,mating behavior,Membrane,membrane raft,metal binding,Metal-binding,mitochondria,mitochondrial,mitochondrial dysfunction,mRNA polyadenylation,N-APP,negative regulation of endopeptidase activity,negative regulation of neuron differentiation,nerve cells,nervous system,neurite growth,neurodegenerative disorder,neuromuscular junction,neuromuscular process controlling balance,neuron apoptotic process,neuron projection development,neuron remodeling,neuronal adhesion,neuronal apoptosis,nitric oxide,NO,Notch signaling,Notch signaling pathway,nuclear envelope lumen,nucleotide-binding domain,oxidation,oxidative stress,P3(40),P3(42),peptidase activator activity,peptides,perinuclear region of cytoplasm,Phosphorylated,Phosphorylation,Phosphothreonine,Phosphotyrosine,plasma membrane,platelet,platelet activation,platelet alpha granule lumen,platelet degranulation,platelets,PN-II,positive regulation of G2/M transition of mitotic cell cycle,positive regulation of mitotic cell cycle,positive regulation of transcription from RNA polymerase II promoter,PreA4,presenilin 1,Protease inhibitor,Protease nexin-II,protein phosphorylation,PTB domain binding,reactive oxygen species,receptor binding,receptor complex,regulation of epidermal growth factor-activated receptor activity,regulation of multicellular organism growth,regulation of protein binding,regulation of synapse structure and activity,regulation of translation,response to oxidative stress,ROS,S-APP-alpha,sAPP,serine,serine phosphorylation,Serine protease inhibitor,serine-type endopep",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63750066",
        "SNP Name": "APP Ala695Thr",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "A4,ABPP,acetylcholine,acetylcholine receptor binding,AD,AD1,adult locomotory behavior,AICD-50,AICD-57,AICD-59,AID(50),AID(57),AID(59),alpha-secretase,Alzheimer,Alzheimer disease amyloid protein,Alzheimer's disease,Amyloid,Amyloid beta A4 protein,Amyloid intracellular domain 50,Amyloid intracellular domain 57,Amyloid intracellular domain 59,amyloid-beta peptide,APBB1-KAT5,apical part of cell,APOE,apolipoprotein,apolipoprotein E,apolipoprotein J,apolipoproteins,apolipoproteins E,apolipoproteins J,apopotosis,apoptosis,APP,APPI,ATPase,axon,axon cargo transport,axon midline choice point recognition,axonogenesis,Beta-amyloid peptides,Beta-amyloid protein 40,Beta-amyloid protein 42,Beta-APP40,Beta-APP42,beta-secretase,blood coagulation,blood pressure,BP,brain,C31,C80,C83,C99,cell adhesion,cell surface,cell surface receptor,cell-cell junction,cellular,cellular copper ion homeostasis,cellular energy,central nervous system,cerebral hemorrhage,Cerebral vascular amyloid peptide,chelation,Chelation of metal ions,cholesterol,cholesterol metabolic process,ciliary rootlet,CNS,coagulation,coated pit,collagen,collateral sprouting in absence of injury,copper,copper homeostasis/oxidative stress,CSF,CU,Cu2+,Cu2+ ions,CVAP,cytoplasm,cytosol,dementia,dendrite development,dendritic shaft,dendritic spine,DNA binding,dopamine,early-onset alzheimer's disease,endocytosis,endosome,enzyme binding,ER to Golgi transport vesicle,extracellular matrix organization,extracellular region,extracellular space,extracellular vesicular exosome,fat,FE,forebrain development,Gamma-CTF(50),Gamma-CTF(57),Gamma-CTF(59),Gamma-secretase C-terminal fragment 50,Gamma-secretase C-terminal fragment 57,Gamma-secretase C-terminal fragment 59,Golgi apparatus,GPC1,HDL,HDL plasma,heart,heavy metal poisoning,heavy metal toxicity,heavy metals,hemorrhage,heparin binding,Heparin-binding,Hereditary cerebral hemorrhage,high BP,identical protein binding,inflammation,innate immune response,integral component of membrane,integral component of plasma membrane,intracellular membrane-bounded organelle,ionotropic glutamate receptor signaling pathway,iron,kidney,kinesin I membrane receptor,L-tyrosine,LDL,learning,leucine rich repeat containing receptor signaling pathway,lipid,lipids,lipophilic metal chelators,lipoprotein,lipoproteins,locomotory behavior,low BP,lymphocytes,mating behavior,Membrane,membrane raft,metal binding,Metal-binding,mitochondria,mitochondrial,mitochondrial dysfunction,mRNA polyadenylation,N-APP,negative regulation of endopeptidase activity,negative regulation of neuron differentiation,nerve cells,nervous system,neurite growth,neurodegenerative disorder,neuromuscular junction,neuromuscular process controlling balance,neuron apoptotic process,neuron projection development,neuron remodeling,neuronal adhesion,neuronal apoptosis,nitric oxide,NO,Notch signaling,Notch signaling pathway,nuclear envelope lumen,nucleotide-binding domain,oxidation,oxidative stress,P3(40),P3(42),peptidase activator activity,peptides,perinuclear region of cytoplasm,Phosphorylated,Phosphorylation,Phosphothreonine,Phosphotyrosine,plasma membrane,platelet,platelet activation,platelet alpha granule lumen,platelet degranulation,platelets,PN-II,positive regulation of G2/M transition of mitotic cell cycle,positive regulation of mitotic cell cycle,positive regulation of transcription from RNA polymerase II promoter,PreA4,presenilin 1,Protease inhibitor,Protease nexin-II,protein phosphorylation,PTB domain binding,reactive oxygen species,receptor binding,receptor complex,regulation of epidermal growth factor-activated receptor activity,regulation of multicellular organism growth,regulation of protein binding,regulation of synapse structure and activity,regulation of translation,response to oxidative stress,ROS,S-APP-alpha,sAPP,serine,serine phosphorylation,Serine protease inhibitor,serine-type endopep",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs63750363",
        "SNP Name": "APP Glu647Asp",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "A4,ABPP,acetylcholine,acetylcholine receptor binding,AD,AD1,adult locomotory behavior,AICD-50,AICD-57,AICD-59,AID(50),AID(57),AID(59),alpha-secretase,Alzheimer,Alzheimer disease amyloid protein,Alzheimer's disease,Amyloid,Amyloid beta A4 protein,Amyloid intracellular domain 50,Amyloid intracellular domain 57,Amyloid intracellular domain 59,amyloid-beta peptide,APBB1-KAT5,apical part of cell,APOE,apolipoprotein,apolipoprotein E,apolipoprotein J,apolipoproteins,apolipoproteins E,apolipoproteins J,apopotosis,apoptosis,APP,APPI,ATPase,axon,axon cargo transport,axon midline choice point recognition,axonogenesis,Beta-amyloid peptides,Beta-amyloid protein 40,Beta-amyloid protein 42,Beta-APP40,Beta-APP42,beta-secretase,blood coagulation,blood pressure,BP,brain,C31,C80,C83,C99,cell adhesion,cell surface,cell surface receptor,cell-cell junction,cellular,cellular copper ion homeostasis,cellular energy,central nervous system,cerebral hemorrhage,Cerebral vascular amyloid peptide,chelation,Chelation of metal ions,cholesterol,cholesterol metabolic process,ciliary rootlet,CNS,coagulation,coated pit,collagen,collateral sprouting in absence of injury,copper,copper homeostasis/oxidative stress,CSF,CU,Cu2+,Cu2+ ions,CVAP,cytoplasm,cytosol,dementia,dendrite development,dendritic shaft,dendritic spine,DNA binding,dopamine,early-onset alzheimer's disease,endocytosis,endosome,enzyme binding,ER to Golgi transport vesicle,extracellular matrix organization,extracellular region,extracellular space,extracellular vesicular exosome,fat,FE,forebrain development,Gamma-CTF(50),Gamma-CTF(57),Gamma-CTF(59),Gamma-secretase C-terminal fragment 50,Gamma-secretase C-terminal fragment 57,Gamma-secretase C-terminal fragment 59,Golgi apparatus,GPC1,HDL,HDL plasma,heart,heavy metal poisoning,heavy metal toxicity,heavy metals,hemorrhage,heparin binding,Heparin-binding,Hereditary cerebral hemorrhage,high BP,identical protein binding,inflammation,innate immune response,integral component of membrane,integral component of plasma membrane,intracellular membrane-bounded organelle,ionotropic glutamate receptor signaling pathway,iron,kidney,kinesin I membrane receptor,L-tyrosine,LDL,learning,leucine rich repeat containing receptor signaling pathway,lipid,lipids,lipophilic metal chelators,lipoprotein,lipoproteins,locomotory behavior,low BP,lymphocytes,mating behavior,Membrane,membrane raft,metal binding,Metal-binding,mitochondria,mitochondrial,mitochondrial dysfunction,mRNA polyadenylation,N-APP,negative regulation of endopeptidase activity,negative regulation of neuron differentiation,nerve cells,nervous system,neurite growth,neurodegenerative disorder,neuromuscular junction,neuromuscular process controlling balance,neuron apoptotic process,neuron projection development,neuron remodeling,neuronal adhesion,neuronal apoptosis,nitric oxide,NO,Notch signaling,Notch signaling pathway,nuclear envelope lumen,nucleotide-binding domain,oxidation,oxidative stress,P3(40),P3(42),peptidase activator activity,peptides,perinuclear region of cytoplasm,Phosphorylated,Phosphorylation,Phosphothreonine,Phosphotyrosine,plasma membrane,platelet,platelet activation,platelet alpha granule lumen,platelet degranulation,platelets,PN-II,positive regulation of G2/M transition of mitotic cell cycle,positive regulation of mitotic cell cycle,positive regulation of transcription from RNA polymerase II promoter,PreA4,presenilin 1,Protease inhibitor,Protease nexin-II,protein phosphorylation,PTB domain binding,reactive oxygen species,receptor binding,receptor complex,regulation of epidermal growth factor-activated receptor activity,regulation of multicellular organism growth,regulation of protein binding,regulation of synapse structure and activity,regulation of translation,response to oxidative stress,ROS,S-APP-alpha,sAPP,serine,serine phosphorylation,Serine protease inhibitor,serine-type endopep",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs380417",
        "SNP Name": "APP .T27272159C",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "A-Tocopheryl Hydrogen Succinate"
    },
    {
        "SNP ID": "rs2070788",
        "SNP Name": "TMPRSS2 variant",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs12329760",
        "SNP Name": "TMPRSS2 variant",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs2156310",
        "SNP Name": "TFF1 G781047A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2156310",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs706209",
        "SNP Name": "CBS\u00a0 C*351T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs706209",
        "Video": null,
        "Tags": "adenosyl methionine,adenosyl-methionine,AdoMet,Allosteric enzyme,Amino-acid biosynthesis,ammonia,ammonia detoxification,ammonia detoxification issues,anencephaly,antioxidant,B6,Beta-thionase,BHMT,bifida,birth defect,bleeding,blood sugar metabolism,blood vessel,blood vessel stability,brain,broken blood vessels,bruising,cancer,cancerous,carcinogen,CBS,CBS deficiency,chelation agents,chondroitin sulfate,chronic stress,Clear Cell Renal Cell Carcinoma,Congenital Heart Defects,Congenital Heart Defects Among Individuals With Down Syndrome,cortisol response,crucifers,cystathionine,Cystathionine beta-synthase,Cystathionine beta-synthase deficiency,cysteine,Cysteine biosynthesis,Cytoplasm,defect,depressed T-cell mediated immune function,Disease mutation,DMPS,dopamine ynthesis,ectopia lentis,elevated alkaline phosphatase levels,enzyme,folate,G6PDH,garlic,gastratransmitter,glutathione,glycine,H2O,heart,heme,heteroxygous variant,homocysteine,homocystinuria,homozygous variant,hydrogen sulfide,hypoxic injury,increased urinary homocystine,increased urinary methionine,iron,isoleucine,Isopeptide bond,kidney,L-cystathionine,L-cysteine biosynthesis,L-homocysteine,L-serine,light hair,light skin,liver,low cholesterol,lung,lyase,magnesium sulfate,manganese,Marfan syndrome,marfanoid,mental retardation,metal binding,methionine,methylation cycle,methylcysteine snythase,molybdenum,MSM,myelomeningocele,myopia,neural tube defects,neurotransmitter,NTDs,Nucleus,P5P,pancreas,Phosphoprotein,proteome,pyridoxal phosphate,pyridoxal phosphate-dependent enzyme,red blood cell formation,SAH,SAMe,serine,Serine sulfhydrase,skeletal anomalies,spina,Spina Bifida,sulfites,sulfur metabolism,sulphur,sulphur donors,SUOX,taurine,threonine,thromboembolic,thromboembolic events,thymus issues,trans-sulfuration,trans-sulfuration pathway,UAA,upregulation,urine amino acid test,zinc/copper ratio",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs706209",
        "SNP Name": "CBS\u00a0 C*351T",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs706209",
        "Video": null,
        "Tags": "adenosyl methionine,adenosyl-methionine,AdoMet,Allosteric enzyme,Amino-acid biosynthesis,ammonia,ammonia detoxification,ammonia detoxification issues,anencephaly,antioxidant,B6,Beta-thionase,BHMT,bifida,birth defect,bleeding,blood sugar metabolism,blood vessel,blood vessel stability,brain,broken blood vessels,bruising,cancer,cancerous,carcinogen,CBS,CBS deficiency,chelation agents,chondroitin sulfate,chronic stress,Clear Cell Renal Cell Carcinoma,Congenital Heart Defects,Congenital Heart Defects Among Individuals With Down Syndrome,cortisol response,crucifers,cystathionine,Cystathionine beta-synthase,Cystathionine beta-synthase deficiency,cysteine,Cysteine biosynthesis,Cytoplasm,defect,depressed T-cell mediated immune function,Disease mutation,DMPS,dopamine ynthesis,ectopia lentis,elevated alkaline phosphatase levels,enzyme,folate,G6PDH,garlic,gastratransmitter,glutathione,glycine,H2O,heart,heme,heteroxygous variant,homocysteine,homocystinuria,homozygous variant,hydrogen sulfide,hypoxic injury,increased urinary homocystine,increased urinary methionine,iron,isoleucine,Isopeptide bond,kidney,L-cystathionine,L-cysteine biosynthesis,L-homocysteine,L-serine,light hair,light skin,liver,low cholesterol,lung,lyase,magnesium sulfate,manganese,Marfan syndrome,marfanoid,mental retardation,metal binding,methionine,methylation cycle,methylcysteine snythase,molybdenum,MSM,myelomeningocele,myopia,neural tube defects,neurotransmitter,NTDs,Nucleus,P5P,pancreas,Phosphoprotein,proteome,pyridoxal phosphate,pyridoxal phosphate-dependent enzyme,red blood cell formation,SAH,SAMe,serine,Serine sulfhydrase,skeletal anomalies,spina,Spina Bifida,sulfites,sulfur metabolism,sulphur,sulphur donors,SUOX,taurine,threonine,thromboembolic,thromboembolic events,thymus issues,trans-sulfuration,trans-sulfuration pathway,UAA,upregulation,urine amino acid test,zinc/copper ratio",
        "Group": "Trans-Sulfuration Pathway"
    },
    {
        "SNP ID": "rs706208",
        "SNP Name": "CBS\u00a0 T*330C",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs706208",
        "Video": null,
        "Tags": "adenosyl methionine,adenosyl-methionine,AdoMet,Allosteric enzyme,Amino-acid biosynthesis,ammonia,ammonia detoxification,ammonia detoxification issues,anencephaly,antioxidant,B6,Beta-thionase,BHMT,bifida,bleeding,blood sugar metabolism,blood vessel,blood vessel stability,brain,broken blood vessels,bruising,CBS,CBS deficiency,chelation agents,chondroitin sulfate,chronic stress,congenital heart disease,cortisol response,crucifers,cystathionine,Cystathionine beta-synthase,Cystathionine beta-synthase deficiency,cysteine,Cysteine biosynthesis,Cytoplasm,depressed T-cell mediated immune function,diabetes,Diabetic Nephropathy,Disease mutation,DMPS,dopamine ynthesis,ectopia lentis,elevated alkaline phosphatase levels,enzyme,folate,G6PDH,garlic,gastratransmitter,glutathione,glycine,H2O,heart,heme,heteroxygous variant,homocysteine,homocystinuria,homozygous variant,hydrogen sulfide,hypoxic injury,increased urinary homocystine,increased urinary methionine,iron,isoleucine,Isopeptide bond,kidney,L-cystathionine,L-cysteine biosynthesis,L-homocysteine,L-serine,light hair,light skin,liver,low cholesterol,lung,lyase,magnesium sulfate,manganese,Marfan syndrome,marfanoid,mental retardation,metal binding,methionine,methylation cycle,methylcysteine snythase,molybdenum,MSM,myelomeningocele,myopia,neural tube defects,neurotransmitter,NTDs,Nucleus,Obesity,Obesity in Children,P5P,pancreas,Phosphoprotein,proteome,pyridoxal phosphate,pyridoxal phosphate-dependent enzyme,red blood cell formation,SAH,SAMe,serine,Serine sulfhydrase,skeletal anomalies,spina,sulfites,sulfur metabolism,sulphur,sulphur donors,SUOX,taurine,threonine,thromboembolic,thromboembolic events,thymus issues,trans-sulfuration,trans-sulfuration pathway,Type 2 Diabetes,UAA,upregulation,urine amino acid test,zinc/copper ratio",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs706208",
        "SNP Name": "CBS\u00a0 T*330C",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs706208",
        "Video": null,
        "Tags": "adenosyl methionine,adenosyl-methionine,AdoMet,Allosteric enzyme,Amino-acid biosynthesis,ammonia,ammonia detoxification,ammonia detoxification issues,anencephaly,antioxidant,B6,Beta-thionase,BHMT,bifida,bleeding,blood sugar metabolism,blood vessel,blood vessel stability,brain,broken blood vessels,bruising,CBS,CBS deficiency,chelation agents,chondroitin sulfate,chronic stress,congenital heart disease,cortisol response,crucifers,cystathionine,Cystathionine beta-synthase,Cystathionine beta-synthase deficiency,cysteine,Cysteine biosynthesis,Cytoplasm,depressed T-cell mediated immune function,diabetes,Diabetic Nephropathy,Disease mutation,DMPS,dopamine ynthesis,ectopia lentis,elevated alkaline phosphatase levels,enzyme,folate,G6PDH,garlic,gastratransmitter,glutathione,glycine,H2O,heart,heme,heteroxygous variant,homocysteine,homocystinuria,homozygous variant,hydrogen sulfide,hypoxic injury,increased urinary homocystine,increased urinary methionine,iron,isoleucine,Isopeptide bond,kidney,L-cystathionine,L-cysteine biosynthesis,L-homocysteine,L-serine,light hair,light skin,liver,low cholesterol,lung,lyase,magnesium sulfate,manganese,Marfan syndrome,marfanoid,mental retardation,metal binding,methionine,methylation cycle,methylcysteine snythase,molybdenum,MSM,myelomeningocele,myopia,neural tube defects,neurotransmitter,NTDs,Nucleus,Obesity,Obesity in Children,P5P,pancreas,Phosphoprotein,proteome,pyridoxal phosphate,pyridoxal phosphate-dependent enzyme,red blood cell formation,SAH,SAMe,serine,Serine sulfhydrase,skeletal anomalies,spina,sulfites,sulfur metabolism,sulphur,sulphur donors,SUOX,taurine,threonine,thromboembolic,thromboembolic events,thymus issues,trans-sulfuration,trans-sulfuration pathway,Type 2 Diabetes,UAA,upregulation,urine amino acid test,zinc/copper ratio",
        "Group": "Trans-Sulfuration Pathway"
    },
    {
        "SNP ID": "rs12613",
        "SNP Name": "CBS\u00a0 G*299A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs12613",
        "Video": null,
        "Tags": "adenosyl methionine,adenosyl-methionine,AdoMet,Allosteric enzyme,Amino-acid biosynthesis,ammonia,ammonia detoxification,ammonia detoxification issues,anencephaly,antioxidant,B6,Beta-thionase,BHMT,bifida,birth defect,bleeding,blood sugar metabolism,blood vessel,blood vessel stability,brain,broken blood vessels,bruising,CBS,CBS deficiency,chelation agents,chondroitin sulfate,chronic stress,conotruncal heart defects,cortisol response,crucifers,cystathionine,Cystathionine beta-synthase,Cystathionine beta-synthase deficiency,cysteine,Cysteine biosynthesis,Cytoplasm,defect,depressed T-cell mediated immune function,Disease mutation,DMPS,dopamine ynthesis,ectopia lentis,elevated alkaline phosphatase levels,enzyme,folate,G6PDH,garlic,gastratransmitter,glutathione,glycine,H2O,heart,heme,heteroxygous variant,homocysteine,homocystinuria,homozygous variant,hydrogen sulfide,hypoxic injury,increased urinary homocystine,increased urinary methionine,iron,isoleucine,Isopeptide bond,kidney,L-cystathionine,L-cysteine biosynthesis,L-homocysteine,L-serine,light hair,light skin,liver,low cholesterol,lung,lyase,magnesium sulfate,manganese,Marfan syndrome,marfanoid,mental retardation,metal binding,methionine,methylation cycle,methylcysteine snythase,molybdenum,MSM,myelomeningocele,myopia,neural tube defects,neurotransmitter,non-Hodgkin lymphoma,NTDs,Nucleus,P5P,pancreas,Phosphoprotein,proteome,pyridoxal phosphate,pyridoxal phosphate-dependent enzyme,red blood cell formation,SAH,SAMe,serine,Serine sulfhydrase,skeletal anomalies,spina,spina bifida,sulfites,sulfur metabolism,sulphur,sulphur donors,SUOX,taurine,threonine,thromboembolic,thromboembolic events,thymus issues,trans-sulfuration,trans-sulfuration pathway,UAA,upregulation,urine amino acid test,zinc/copper ratio",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs12613",
        "SNP Name": "CBS\u00a0 G*299A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs12613",
        "Video": null,
        "Tags": "adenosyl methionine,adenosyl-methionine,AdoMet,Allosteric enzyme,Amino-acid biosynthesis,ammonia,ammonia detoxification,ammonia detoxification issues,anencephaly,antioxidant,B6,Beta-thionase,BHMT,bifida,birth defect,bleeding,blood sugar metabolism,blood vessel,blood vessel stability,brain,broken blood vessels,bruising,CBS,CBS deficiency,chelation agents,chondroitin sulfate,chronic stress,conotruncal heart defects,cortisol response,crucifers,cystathionine,Cystathionine beta-synthase,Cystathionine beta-synthase deficiency,cysteine,Cysteine biosynthesis,Cytoplasm,defect,depressed T-cell mediated immune function,Disease mutation,DMPS,dopamine ynthesis,ectopia lentis,elevated alkaline phosphatase levels,enzyme,folate,G6PDH,garlic,gastratransmitter,glutathione,glycine,H2O,heart,heme,heteroxygous variant,homocysteine,homocystinuria,homozygous variant,hydrogen sulfide,hypoxic injury,increased urinary homocystine,increased urinary methionine,iron,isoleucine,Isopeptide bond,kidney,L-cystathionine,L-cysteine biosynthesis,L-homocysteine,L-serine,light hair,light skin,liver,low cholesterol,lung,lyase,magnesium sulfate,manganese,Marfan syndrome,marfanoid,mental retardation,metal binding,methionine,methylation cycle,methylcysteine snythase,molybdenum,MSM,myelomeningocele,myopia,neural tube defects,neurotransmitter,non-Hodgkin lymphoma,NTDs,Nucleus,P5P,pancreas,Phosphoprotein,proteome,pyridoxal phosphate,pyridoxal phosphate-dependent enzyme,red blood cell formation,SAH,SAMe,serine,Serine sulfhydrase,skeletal anomalies,spina,spina bifida,sulfites,sulfur metabolism,sulphur,sulphur donors,SUOX,taurine,threonine,thromboembolic,thromboembolic events,thymus issues,trans-sulfuration,trans-sulfuration pathway,UAA,upregulation,urine amino acid test,zinc/copper ratio",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs1801181",
        "SNP Name": "CBS\u00a0 A360A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1801181",
        "Video": null,
        "Tags": "adenosyl methionine,adenosyl-methionine,AdoMet,Allosteric enzyme,Amino-acid biosynthesis,ammonia,ammonia detoxification,ammonia detoxification issues,anencephaly,antioxidant,B6,Beta-thionase,BHMT,bleeding,blood sugar metabolism,blood vessel,blood vessel stability,brain,broken blood vessels,bruising,cancer,cancerous,carcinogen,CBS,CBS deficiency,chelation agents,chondroitin sulfate,chronic stress,Colorectal Adenoma,conotruncal heart defects,cortisol response,crucifers,cystathionine,Cystathionine beta-synthase,Cystathionine beta-synthase deficiency,cysteine,Cysteine biosynthesis,Cytoplasm,depressed T-cell mediated immune function,Diabetic Nephropathy,Disease mutation,DMPS,dopamine synthesis,ectopia lentis,elevated alkaline phosphatase levels,enzyme,folate,Folic Acid,G6PDH,garlic,gastratransmitter,glaucoma,glutathione,glycine,H2O,heart,heme,heteroxygous variant,homocysteine,homocystinuria,homozygous variant,hydrogen sulfide,hypoxic injury,increased urinary homocystine,increased urinary methionine,iron,isoleucine,Isopeptide bond,kidney,L-cystathionine,L-cysteine biosynthesis,L-homocysteine,L-serine,light hair,light skin,liver,low cholesterol,lung,lyase,magnesium sulfate,manganese,Marfan syndrome,marfanoid,mental retardation,metal binding,methionine,methylation cycle,methylcysteine snythase,molybdenum,MSM,myopia,Nephropathy,neural tube defects,neurotransmitter,non-Hodgkin lymphoma,NTDs,Nucleus,P5P,pancreas,Phosphoprotein,Prostate Cancer,proteome,pseudoexfoliation syndrome,pyridoxal phosphate,pyridoxal phosphate-dependent enzyme,red blood cell formation,SAH,SAMe,serine,Serine sulfhydrase,skeletal anomalies,spina bifida,sulfites,sulfur metabolism,sulphur,sulphur donors,SUOX,taurine,threonine,thromboembolic,thromboembolic events,thymus issues,trans-sulfuration,trans-sulfuration pathway,UAA,upregulation,urine amino acid test,zinc/copper ratio",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs1801181",
        "SNP Name": "CBS\u00a0 A360A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1801181",
        "Video": null,
        "Tags": "adenosyl methionine,adenosyl-methionine,AdoMet,Allosteric enzyme,Amino-acid biosynthesis,ammonia,ammonia detoxification,ammonia detoxification issues,anencephaly,antioxidant,B6,Beta-thionase,BHMT,bleeding,blood sugar metabolism,blood vessel,blood vessel stability,brain,broken blood vessels,bruising,cancer,cancerous,carcinogen,CBS,CBS deficiency,chelation agents,chondroitin sulfate,chronic stress,Colorectal Adenoma,conotruncal heart defects,cortisol response,crucifers,cystathionine,Cystathionine beta-synthase,Cystathionine beta-synthase deficiency,cysteine,Cysteine biosynthesis,Cytoplasm,depressed T-cell mediated immune function,Diabetic Nephropathy,Disease mutation,DMPS,dopamine synthesis,ectopia lentis,elevated alkaline phosphatase levels,enzyme,folate,Folic Acid,G6PDH,garlic,gastratransmitter,glaucoma,glutathione,glycine,H2O,heart,heme,heteroxygous variant,homocysteine,homocystinuria,homozygous variant,hydrogen sulfide,hypoxic injury,increased urinary homocystine,increased urinary methionine,iron,isoleucine,Isopeptide bond,kidney,L-cystathionine,L-cysteine biosynthesis,L-homocysteine,L-serine,light hair,light skin,liver,low cholesterol,lung,lyase,magnesium sulfate,manganese,Marfan syndrome,marfanoid,mental retardation,metal binding,methionine,methylation cycle,methylcysteine snythase,molybdenum,MSM,myopia,Nephropathy,neural tube defects,neurotransmitter,non-Hodgkin lymphoma,NTDs,Nucleus,P5P,pancreas,Phosphoprotein,Prostate Cancer,proteome,pseudoexfoliation syndrome,pyridoxal phosphate,pyridoxal phosphate-dependent enzyme,red blood cell formation,SAH,SAMe,serine,Serine sulfhydrase,skeletal anomalies,spina bifida,sulfites,sulfur metabolism,sulphur,sulphur donors,SUOX,taurine,threonine,thromboembolic,thromboembolic events,thymus issues,trans-sulfuration,trans-sulfuration pathway,UAA,upregulation,urine amino acid test,zinc/copper ratio",
        "Group": "Trans-Sulfuration Pathway"
    },
    {
        "SNP ID": "rs4920037",
        "SNP Name": "CBS\u00a0 C19150T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4920037",
        "Video": null,
        "Tags": "adenosyl methionine,adenosyl-methionine,AdoMet,Allosteric enzyme,Amino-acid biosynthesis,ammonia,ammonia detoxification,ammonia detoxification issues,anencephaly,antioxidant,arsenic,B6,Beta-thionase,BHMT,bleeding,blood sugar metabolism,blood vessel,blood vessel stability,brain,broken blood vessels,bruising,cancer,cancerous,carcinogen,Cardioembolic Stroke,CBS,CBS deficiency,chelation agents,childhood acute lymphoblastic leukemia,chondroitin sulfate,chronic stress,cortisol response,crucifers,cystathionine,Cystathionine beta-synthase,Cystathionine beta-synthase deficiency,cysteine,Cysteine biosynthesis,Cytoplasm,depressed T-cell mediated immune function,Disease mutation,DMPS,dopamine synthesis,ectopia lentis,elevated alkaline phosphatase levels,enzyme,G6PDH,garlic,gastratransmitter,glutathione,glycine,H2O,heart,heme,heteroxygous variant,homocysteine,homocystinuria,homozygous variant,hydrogen sulfide,hypoxic injury,increased urinary homocystine,increased urinary methionine,iron,isoleucine,Isopeptide bond,kidney,L-cystathionine,L-cysteine biosynthesis,L-homocysteine,L-serine,leukemia,light hair,light skin,liver,low cholesterol,lung,lung cancer,lyase,magnesium sulfate,manganese,Marfan syndrome,marfanoid,mental retardation,metal binding,methionine,methylation cycle,methylcysteine snythase,molybdenum,MSM,myopia,neural tube defects,neurotransmitter,NTDs,Nucleus,P5P,pancreas,Phosphoprotein,proteome,pyridoxal phosphate,pyridoxal phosphate-dependent enzyme,red blood cell formation,SAH,SAMe,serine,Serine sulfhydrase,skeletal anomalies,stroke,sulfites,sulfur metabolism,sulphur,sulphur donors,SUOX,taurine,threonine,thromboembolic,thromboembolic events,thymus issues,trans-sulfuration,trans-sulfuration pathway,UAA,upregulation,urine amino acid test,zinc/copper ratio",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs4920037",
        "SNP Name": "CBS\u00a0 C19150T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4920037",
        "Video": null,
        "Tags": "adenosyl methionine,adenosyl-methionine,AdoMet,Allosteric enzyme,Amino-acid biosynthesis,ammonia,ammonia detoxification,ammonia detoxification issues,anencephaly,antioxidant,arsenic,B6,Beta-thionase,BHMT,bleeding,blood sugar metabolism,blood vessel,blood vessel stability,brain,broken blood vessels,bruising,cancer,cancerous,carcinogen,Cardioembolic Stroke,CBS,CBS deficiency,chelation agents,childhood acute lymphoblastic leukemia,chondroitin sulfate,chronic stress,cortisol response,crucifers,cystathionine,Cystathionine beta-synthase,Cystathionine beta-synthase deficiency,cysteine,Cysteine biosynthesis,Cytoplasm,depressed T-cell mediated immune function,Disease mutation,DMPS,dopamine synthesis,ectopia lentis,elevated alkaline phosphatase levels,enzyme,G6PDH,garlic,gastratransmitter,glutathione,glycine,H2O,heart,heme,heteroxygous variant,homocysteine,homocystinuria,homozygous variant,hydrogen sulfide,hypoxic injury,increased urinary homocystine,increased urinary methionine,iron,isoleucine,Isopeptide bond,kidney,L-cystathionine,L-cysteine biosynthesis,L-homocysteine,L-serine,leukemia,light hair,light skin,liver,low cholesterol,lung,lung cancer,lyase,magnesium sulfate,manganese,Marfan syndrome,marfanoid,mental retardation,metal binding,methionine,methylation cycle,methylcysteine snythase,molybdenum,MSM,myopia,neural tube defects,neurotransmitter,NTDs,Nucleus,P5P,pancreas,Phosphoprotein,proteome,pyridoxal phosphate,pyridoxal phosphate-dependent enzyme,red blood cell formation,SAH,SAMe,serine,Serine sulfhydrase,skeletal anomalies,stroke,sulfites,sulfur metabolism,sulphur,sulphur donors,SUOX,taurine,threonine,thromboembolic,thromboembolic events,thymus issues,trans-sulfuration,trans-sulfuration pathway,UAA,upregulation,urine amino acid test,zinc/copper ratio",
        "Group": "Trans-Sulfuration Pathway"
    },
    {
        "SNP ID": "rs234706",
        "SNP Name": "CBS\u00a0 C699T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs234706",
        "Video": null,
        "Tags": "adenosyl methionine,adenosyl-methionine,AdoMet,Allosteric enzyme,Amino-acid biosynthesis,ammonia,ammonia detoxification,ammonia detoxification issues,anencephaly,antioxidant,arsenic,B6,Beta-thionase,BHMT,birth defect,bleeding,blood sugar metabolism,blood vessel,blood vessel stability,brain,broken blood vessels,bruising,cancer,cancerous,carcinogen,CBS,CBS deficiency,chelation agents,chondroitin sulfate,chronic stress,cleft lip,cleft palate,Colorectal Adenomas,colorectal cancer,Congenital Heart Defect,Congenital Heart Defects Among Individuals With Down Syndrome,cortisol response,crucifers,cystathionine,Cystathionine beta-synthase,Cystathionine beta-synthase deficiency,cysteine,Cysteine biosynthesis,Cytoplasm,defect,depressed T-cell mediated immune function,Disease mutation,DMPS,dopamine synthesis,ectopia lentis,elevated alkaline phosphatase levels,enzyme,folate,folic acid,G6PDH,garlic,gastratransmitter,glutathione,glycine,H2O,heart,heart defect,heme,heteroxygous variant,homocysteine,homocystinuria,homozygous variant,hydrogen sulfide,hypoxic injury,increased urinary homocystine,increased urinary methionine,iron,isoleucine,Isopeptide bond,kidney,L-cystathionine,L-cysteine biosynthesis,L-homocysteine,L-serine,light hair,light skin,liver,low cholesterol,lung,lyase,magnesium sulfate,manganese,Marfan syndrome,marfanoid,mental retardation,metal binding,methionine,methylation cycle,methylcysteine snythase,molybdenum,MSM,Myelomeningocele,myopia,neural tube defects,neurotransmitter,non-Hodgkin lymphoma,NTDs,Nucleus,Obesity,Obesity in children,Oral Facial Clefts,oxidative stress,P5P,pancreas,Phosphoprotein,Prostate Cancer,proteome,pyridoxal phosphate,pyridoxal phosphate-dependent enzyme,red blood cell formation,ROS,SAH,SAMe,serine,Serine sulfhydrase,skeletal anomalies,sulfites,sulfur metabolism,sulphur,sulphur donors,SUOX,taurine,telomere,Telomere Length,threonine,thromboembolic,thromboembolic events,thymus issues,trans-sulfuration,trans-sulfuration pathway,UAA,upregulation,urine amino acid test,zinc/copper ratio",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs234706",
        "SNP Name": "CBS\u00a0 C699T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs234706",
        "Video": null,
        "Tags": "adenosyl methionine,adenosyl-methionine,AdoMet,Allosteric enzyme,Amino-acid biosynthesis,ammonia,ammonia detoxification,ammonia detoxification issues,anencephaly,antioxidant,arsenic,B6,Beta-thionase,BHMT,birth defect,bleeding,blood sugar metabolism,blood vessel,blood vessel stability,brain,broken blood vessels,bruising,cancer,cancerous,carcinogen,CBS,CBS deficiency,chelation agents,chondroitin sulfate,chronic stress,cleft lip,cleft palate,Colorectal Adenomas,colorectal cancer,Congenital Heart Defect,Congenital Heart Defects Among Individuals With Down Syndrome,cortisol response,crucifers,cystathionine,Cystathionine beta-synthase,Cystathionine beta-synthase deficiency,cysteine,Cysteine biosynthesis,Cytoplasm,defect,depressed T-cell mediated immune function,Disease mutation,DMPS,dopamine synthesis,ectopia lentis,elevated alkaline phosphatase levels,enzyme,folate,folic acid,G6PDH,garlic,gastratransmitter,glutathione,glycine,H2O,heart,heart defect,heme,heteroxygous variant,homocysteine,homocystinuria,homozygous variant,hydrogen sulfide,hypoxic injury,increased urinary homocystine,increased urinary methionine,iron,isoleucine,Isopeptide bond,kidney,L-cystathionine,L-cysteine biosynthesis,L-homocysteine,L-serine,light hair,light skin,liver,low cholesterol,lung,lyase,magnesium sulfate,manganese,Marfan syndrome,marfanoid,mental retardation,metal binding,methionine,methylation cycle,methylcysteine snythase,molybdenum,MSM,Myelomeningocele,myopia,neural tube defects,neurotransmitter,non-Hodgkin lymphoma,NTDs,Nucleus,Obesity,Obesity in children,Oral Facial Clefts,oxidative stress,P5P,pancreas,Phosphoprotein,Prostate Cancer,proteome,pyridoxal phosphate,pyridoxal phosphate-dependent enzyme,red blood cell formation,ROS,SAH,SAMe,serine,Serine sulfhydrase,skeletal anomalies,sulfites,sulfur metabolism,sulphur,sulphur donors,SUOX,taurine,telomere,Telomere Length,threonine,thromboembolic,thromboembolic events,thymus issues,trans-sulfuration,trans-sulfuration pathway,UAA,upregulation,urine amino acid test,zinc/copper ratio",
        "Group": "Trans-Sulfuration Pathway"
    },
    {
        "SNP ID": "rs2851391",
        "SNP Name": "CBS\u00a0 A13637G",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2851391",
        "Video": null,
        "Tags": "A360A,adenosyl-methionine,Ado-Met,Allosteric enzyme,altered sulfur metabolism,Amino-acid biosynthesis,ammonia,ammonia detoxification,ammonia detoxification issues,anencephaly,antioxidant,Beta-thionase,BHMT,birth defect,bleeding,blood sugar metabolism,blood vessel stability,brain,broken blood vessels,bruising,C699T,CBS,CBS deficiency,CBSD,chelation agents,chondroitin sulfate,chronic stress,Congenital Heart Defect,Congenital Heart Defects Among Individuals With Down Syndrome,conotruncal heart defects,cortisol response,crucifers,Cystathionine beta-synthase,Cystathionine beta-synthase deficiency,cysteine,Cysteine biosynthesis,cysteine synthase/cystathionine beta-synthase family,Cytoplasm,cytoprotective effects,defect,depressed T-cell mediated immune function,Disease,Disease mutation,DMPS,dopamine synthesis,ectopia lentis,elevated alkaline phosphatase levels,enzymatic deficiency,enzyme,Folic Acid,G6PDH,garlic,gastratransmitter,glutathione,glycine,H2O,heart,heme,heteroxygous variant,HIP4,homocysteine,homocystinuria,homozygous variant,hydrogen sulfide,hypoxic injury,Iron,isoleucine,Isopeptide bond,kidney,L-cystathionine,L-cysteine,L-cysteine biosynthesis,L-homocysteine,L-serine,light hair,light skin,lipomeningecele,liver,low cholesterol,lung,Lyase,magnesium sulfate,manganese,Marfan syndrome,meningomyleocele,mental retardation,methionine,methylation cycle,methylcysteine snythase,molybdenum,MSM,mutations,myelomeningocele,myopia,neural tube defects,neuromodulator,neurons,neurotransmitter,NTDs,pancreas,Phosphoprotein,proteome,Pyridoxal phosphate,pyridoxal phosphate-dependent enzyme,red blood cell formation,SAH,SAMe,SB,serine,Serine sulfhydrase,skeletal anomalies,Spina Bifida,stroke,sulfites,sulphur,sulphur donors,SUOX,taurine,threonine,thromboembolic events,thymus issues,trans-sulfuration,trans-sulfuration pathway,UAA,upregulation,urinary homocystine,urinary methionine,urine amino acid test,zinc/copper ratio",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2851391",
        "SNP Name": "CBS\u00a0 A13637G",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2851391",
        "Video": null,
        "Tags": "A360A,adenosyl-methionine,Ado-Met,Allosteric enzyme,altered sulfur metabolism,Amino-acid biosynthesis,ammonia,ammonia detoxification,ammonia detoxification issues,anencephaly,antioxidant,Beta-thionase,BHMT,birth defect,bleeding,blood sugar metabolism,blood vessel stability,brain,broken blood vessels,bruising,C699T,CBS,CBS deficiency,CBSD,chelation agents,chondroitin sulfate,chronic stress,Congenital Heart Defect,Congenital Heart Defects Among Individuals With Down Syndrome,conotruncal heart defects,cortisol response,crucifers,Cystathionine beta-synthase,Cystathionine beta-synthase deficiency,cysteine,Cysteine biosynthesis,cysteine synthase/cystathionine beta-synthase family,Cytoplasm,cytoprotective effects,defect,depressed T-cell mediated immune function,Disease,Disease mutation,DMPS,dopamine synthesis,ectopia lentis,elevated alkaline phosphatase levels,enzymatic deficiency,enzyme,Folic Acid,G6PDH,garlic,gastratransmitter,glutathione,glycine,H2O,heart,heme,heteroxygous variant,HIP4,homocysteine,homocystinuria,homozygous variant,hydrogen sulfide,hypoxic injury,Iron,isoleucine,Isopeptide bond,kidney,L-cystathionine,L-cysteine,L-cysteine biosynthesis,L-homocysteine,L-serine,light hair,light skin,lipomeningecele,liver,low cholesterol,lung,Lyase,magnesium sulfate,manganese,Marfan syndrome,meningomyleocele,mental retardation,methionine,methylation cycle,methylcysteine snythase,molybdenum,MSM,mutations,myelomeningocele,myopia,neural tube defects,neuromodulator,neurons,neurotransmitter,NTDs,pancreas,Phosphoprotein,proteome,Pyridoxal phosphate,pyridoxal phosphate-dependent enzyme,red blood cell formation,SAH,SAMe,SB,serine,Serine sulfhydrase,skeletal anomalies,Spina Bifida,stroke,sulfites,sulphur,sulphur donors,SUOX,taurine,threonine,thromboembolic events,thymus issues,trans-sulfuration,trans-sulfuration pathway,UAA,upregulation,urinary homocystine,urinary methionine,urine amino acid test,zinc/copper ratio",
        "Group": "Trans-Sulfuration Pathway"
    },
    {
        "SNP ID": "rs1051298",
        "SNP Name": "SLC19A1 C32560T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1051298",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs1051296",
        "SNP Name": "SLC19A1 T32525G",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1051296",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs3788190",
        "SNP Name": "SLC19A1 C30428T",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs3788190",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs2838956",
        "SNP Name": "SLC19A1 T22362C",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2838956",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs4818789",
        "SNP Name": "SLC19A1 C18559A",
        "Risk Allele": "G",
        "Your Allele": "TG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4818789",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs12659",
        "SNP Name": "SLC19A1 P192P",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs12659",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs914232",
        "SNP Name": "SLC19A1 A14636G",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs914232",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs1051266",
        "SNP Name": "SLC19A1 H27R",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1051266",
        "Video": null,
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs737866",
        "SNP Name": "COMT/TXNRD2 A4251G",
        "Risk Allele": "C",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs737866",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,addiction susceptibility,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,autism,avoid methyl donors,B12,Brain,brain chemicals,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,children,class I-like SAM-binding methyltransferase superfamily,cocaine-induced paranoia,COMT,COMT*1,COMT*2,COMT*H,COMT*L,cyanocobalamin,Cytoplasm,cytosol,depleting methyl groups,depression,dibencozide,dopamine,dopamine catabolic process,dopamine levels,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,guaiacol,heroin,homozygous mutation,hydroxylcobalamin,hyperactivity,impulsivity,integral component of membrane,irritability,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,morphine requirements,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,O-methylation,O-methyltransferase activity,pain,pain sensitivity,paranoia,Parkinson's,Parkinson's Disease,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,ransmembrane helix,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl  L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,sensitivity to pain,serotonin reuptake inhibitor response,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,SSRI,SSRI response,synaptic transmission,Transferase,Transmembrane,trauma,Val-158,VDR/Taq,xenobiotic metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs737865",
        "SNP Name": "COMT/TXNRD2 T4239C",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs737865",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,adenosyl,ADHD,affective disorder,alcoholism,alpha-methyl DOPA,Alternative initiation,Alzheimer,Alzheimer Disease,Alzheimer's Disease,antidepressant response,anxiety,autism,avoid methyl donors,B12,bipolar,bipolar disorder,Brain,brain chemicals,Breast Cancer,cancer,cancerous,carcinogen,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,class I-like SAM-binding methyltransferase superfamily,cocaine,cocaine dependence,cognition,cognitive function,COMT,COMT*1,COMT*2,COMT*H,COMT*L,creative potential,creativity,cyanocobalamin,Cytoplasm,cytosol,Dementia,depleting methyl groups,dibencozide,dopamine,dopamine catabolic process,dopamine levels,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,guaiacol,homozygous mutation,hydroxylcobalamin,hyperactivity,integral component of membrane,irritability,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,mental disorder,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,Neural Tube Defect,neuroactive drugs,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,NTDs,O-methylation,O-methyltransferase activity,Parkinson's,Parkinson's Disease,Pharmacogenomics,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,Psychosis,psychotic disorder,ransmembrane helix,recurrent preeclampsia,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl  L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,sensitivity to pain,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,synaptic transmission,Transferase,Transmembrane,Val-158,VDR/Taq,Working Memory,xenobiotic metabolic process",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs933271",
        "SNP Name": "COMT A2953G",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs933271",
        "Video": "BMnD8_rBLSU",
        "Tags": "acute post-surgical pain,ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,autism,avoid methyl donors,B12,birth defect,Brain,brain chemicals,cancer,cancerous,carcinogen,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,CFS,Chronic Fatigue Syndrome,class I-like SAM-binding methyltransferase superfamily,cocaine,cocaine-induced paranoia,cold sensitivity,COMT,COMT*1,COMT*2,COMT*H,COMT*L,CVD,cyanocobalamin,Cytoplasm,cytosol,defect,depleting methyl groups,dibencozide,dopamine,dopamine catabolic process,dopamine levels,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,guaiacol,heart,heat sensitivity,homozygous mutation,hydroxylcobalamin,hyperactivity,integral component of membrane,irritability,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,Novelty Seeking Personality,O-methylation,O-methyltransferase activity,pain,pain sensitivity,Panic Disorder,paranoia,Parkinson's,Parkinson's Disease,pesticide,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,prostate cancer,ransmembrane helix,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl  L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,selective serotonin reuptake inhibitor response,sensitivity to pain,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,SSRI,SSRi response,synaptic transmission,Transferase,Transmembrane,Val-158,VDR/Taq,xeno,xenobiotic,xenobiotic metabolic process",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs933271",
        "SNP Name": "COMT A2953G",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs933271",
        "Video": "BMnD8_rBLSU",
        "Tags": "acute post-surgical pain,ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,autism,avoid methyl donors,B12,birth defect,Brain,brain chemicals,cancer,cancerous,carcinogen,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,CFS,Chronic Fatigue Syndrome,class I-like SAM-binding methyltransferase superfamily,cocaine,cocaine-induced paranoia,cold sensitivity,COMT,COMT*1,COMT*2,COMT*H,COMT*L,CVD,cyanocobalamin,Cytoplasm,cytosol,defect,depleting methyl groups,dibencozide,dopamine,dopamine catabolic process,dopamine levels,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,guaiacol,heart,heat sensitivity,homozygous mutation,hydroxylcobalamin,hyperactivity,integral component of membrane,irritability,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,Novelty Seeking Personality,O-methylation,O-methyltransferase activity,pain,pain sensitivity,Panic Disorder,paranoia,Parkinson's,Parkinson's Disease,pesticide,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,prostate cancer,ransmembrane helix,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl  L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,selective serotonin reuptake inhibitor response,sensitivity to pain,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,SSRI,SSRi response,synaptic transmission,Transferase,Transmembrane,Val-158,VDR/Taq,xeno,xenobiotic,xenobiotic metabolic process",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1544325",
        "SNP Name": "COMT A7406G",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1544325",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,autism,avoid methyl donors,B12,Brain,brain chemicals,Breast Cancer,cancer,cancerous,carcinogen,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,class I-like SAM-binding methyltransferase superfamily,COMT,COMT*1,COMT*2,COMT*H,COMT*L,cyanocobalamin,Cytoplasm,cytosol,depleting methyl groups,depression,dibencozide,dopamine,dopamine catabolic process,dopamine levels,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,guaiacol,homozygous mutation,hydroxylcobalamin,hyperactivity,integral component of membrane,irritability,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,mental disorder,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,Novelty Seeking Personality,O-methylation,O-methyltransferase activity,Panic Disorder,Parkinson's,Parkinson's Disease,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,ransmembrane helix,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl  L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,Schizophrenia,sensitivity to pain,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,synaptic transmission,Transferase,Transmembrane,Val-158,VDR/Taq,xenobiotic metabolic process",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1544325",
        "SNP Name": "COMT A7406G",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1544325",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,autism,avoid methyl donors,B12,Brain,brain chemicals,Breast Cancer,cancer,cancerous,carcinogen,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,class I-like SAM-binding methyltransferase superfamily,COMT,COMT*1,COMT*2,COMT*H,COMT*L,cyanocobalamin,Cytoplasm,cytosol,depleting methyl groups,depression,dibencozide,dopamine,dopamine catabolic process,dopamine levels,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,guaiacol,homozygous mutation,hydroxylcobalamin,hyperactivity,integral component of membrane,irritability,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,mental disorder,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,Novelty Seeking Personality,O-methylation,O-methyltransferase activity,Panic Disorder,Parkinson's,Parkinson's Disease,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,ransmembrane helix,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl  L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,Schizophrenia,sensitivity to pain,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,synaptic transmission,Transferase,Transmembrane,Val-158,VDR/Taq,xenobiotic metabolic process",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs5993883",
        "SNP Name": "COMT T13376G",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5993883",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,autism,avoid methyl donors,B12,Bipolar,Bipolar Disorder,Brain,brain chemicals,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,class I-like SAM-binding methyltransferase superfamily,cocaine,cocaine-induced paranoia,COMT,COMT*1,COMT*2,COMT*H,COMT*L,creative potential,creativity,cyanocobalamin,Cytoplasm,cytosol,DAO,depleting methyl groups,depression,dibencozide,dopamine,dopamine catabolic process,dopamine levels,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,guaiacol,homozygous mutation,hydroxylcobalamin,hyperactivity,integral component of membrane,irritability,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,Mania,membrane,mental disorder,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,O-methylation,O-methyltransferase activity,Panic Disorder,paranoia,Parkinson's,Parkinson's Disease,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,ransmembrane helix,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl  L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,selective serotonin reuptake inhibitor response,sensitivity to pain,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,SSRI,SSRI response,synaptic transmission,Transferase,Transmembrane,Val-158,VDR/Taq,xenobiotic metabolic process",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs5993883",
        "SNP Name": "COMT T13376G",
        "Risk Allele": "T",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5993883",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,autism,avoid methyl donors,B12,Bipolar,Bipolar Disorder,Brain,brain chemicals,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,class I-like SAM-binding methyltransferase superfamily,cocaine,cocaine-induced paranoia,COMT,COMT*1,COMT*2,COMT*H,COMT*L,creative potential,creativity,cyanocobalamin,Cytoplasm,cytosol,DAO,depleting methyl groups,depression,dibencozide,dopamine,dopamine catabolic process,dopamine levels,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,guaiacol,homozygous mutation,hydroxylcobalamin,hyperactivity,integral component of membrane,irritability,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,Mania,membrane,mental disorder,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,O-methylation,O-methyltransferase activity,Panic Disorder,paranoia,Parkinson's,Parkinson's Disease,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,ransmembrane helix,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl  L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,selective serotonin reuptake inhibitor response,sensitivity to pain,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,SSRI,SSRI response,synaptic transmission,Transferase,Transmembrane,Val-158,VDR/Taq,xenobiotic metabolic process",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs4646312",
        "SNP Name": "COMT T24075C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4646312",
        "Video": "BMnD8_rBLSU",
        "Tags": "acute post-surgical pain,ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,autism,avoid methyl donors,B12,Brain,brain chemicals,cancerous,carcinogen,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,CFS,Chronic Fatigue Syndrome,class I-like SAM-binding methyltransferase superfamily,COMT,COMT*1,COMT*2,COMT*H,COMT*L,creative potential,creativity,cyanocobalamin,Cytoplasm,cytosol,depleting methyl groups,dibencozide,dopamine,dopamine catabolic process,dopamine levels,DRD2,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,gastric cancer,guaiacol,homozygous mutation,hydroxylcobalamin,hyperactivity,integral component of membrane,irritability,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,O-methylation,O-methyltransferase activity,pain,pain sensitivity,Parkinson's,Parkinson's Disease,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,ransmembrane helix,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl  L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,sensitivity to pain,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,synaptic transmission,Transferase,Transmembrane,Val-158,VDR/Taq,xenobiotic metabolic process",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs4646312",
        "SNP Name": "COMT T24075C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4646312",
        "Video": "BMnD8_rBLSU",
        "Tags": "acute post-surgical pain,ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,autism,avoid methyl donors,B12,Brain,brain chemicals,cancerous,carcinogen,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,CFS,Chronic Fatigue Syndrome,class I-like SAM-binding methyltransferase superfamily,COMT,COMT*1,COMT*2,COMT*H,COMT*L,creative potential,creativity,cyanocobalamin,Cytoplasm,cytosol,depleting methyl groups,dibencozide,dopamine,dopamine catabolic process,dopamine levels,DRD2,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,gastric cancer,guaiacol,homozygous mutation,hydroxylcobalamin,hyperactivity,integral component of membrane,irritability,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,O-methylation,O-methyltransferase activity,pain,pain sensitivity,Parkinson's,Parkinson's Disease,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,ransmembrane helix,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl  L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,sensitivity to pain,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,synaptic transmission,Transferase,Transmembrane,Val-158,VDR/Taq,xenobiotic metabolic process",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs165656",
        "SNP Name": "COMT G24601C",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs165656",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,autism,avoid methyl donors,B12,Brain,brain chemicals,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,class I-like SAM-binding methyltransferase superfamily,COMT,COMT*1,COMT*2,COMT*H,COMT*L,cyanocobalamin,Cytoplasm,cytosol,depleting methyl groups,dibencozide,Disc Degeneration,dopamine,dopamine catabolic process,dopamine levels,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,Financial and Psychological Risk Attitudes,guaiacol,homozygous mutation,hydroxylcobalamin,hyperactivity,integral component of membrane,irritability,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,mental disorder,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,O-methylation,O-methyltransferase activity,Parkinson's,Parkinson's Disease,Pharmacogenomics,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,ransmembrane helix,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl  L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,Schizophrenia,sensitivity to pain,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,synaptic transmission,Transferase,Transmembrane,Val-158,VDR/Taq,xenobiotic metabolic process",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs165656",
        "SNP Name": "COMT G24601C",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs165656",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,autism,avoid methyl donors,B12,Brain,brain chemicals,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,class I-like SAM-binding methyltransferase superfamily,COMT,COMT*1,COMT*2,COMT*H,COMT*L,cyanocobalamin,Cytoplasm,cytosol,depleting methyl groups,dibencozide,Disc Degeneration,dopamine,dopamine catabolic process,dopamine levels,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,Financial and Psychological Risk Attitudes,guaiacol,homozygous mutation,hydroxylcobalamin,hyperactivity,integral component of membrane,irritability,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,mental disorder,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,O-methylation,O-methyltransferase activity,Parkinson's,Parkinson's Disease,Pharmacogenomics,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,ransmembrane helix,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl  L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,Schizophrenia,sensitivity to pain,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,synaptic transmission,Transferase,Transmembrane,Val-158,VDR/Taq,xenobiotic metabolic process",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs6269",
        "SNP Name": "COMT A-1324G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6269",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,Analgesia,anxiety,ASD,autism,Autism Spectrum Disorders,avoid methyl donors,B12,Brain,brain chemicals,Breast Cancer,cancer,cancerous,carcinogen,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,childhood,children,Chronic Fatigue Syndrome,Chronic Pain,class I-like SAM-binding methyltransferase superfamily,clinical outcome after lumbar spine surgery,Clinical Pain,Cognitive Function,Cognitive Function of Children,COMT,COMT*1,COMT*2,COMT*H,COMT*L,creative potential,creativity,cyanocobalamin,Cytoplasm,cytosol,depleting methyl groups,depression,dibencozide,dopamine,dopamine catabolic process,dopamine levels,drug metabolism,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,fibromyalgia,Gastrointestinal Sensation,guaiacol,homozygous mutation,hydroxylcobalamin,hyperactivity,increased pain sensitivity,integral component of membrane,irritability,isoproterenol,L-DOPA,learning,liver,low back pain,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,mental disorder,mercury,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,morphine requirements,multicellular organismal reproductive process,N-terminus,Neck Pain,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,Neurobehavioral Effects of Mercury in Children,neurotoxin,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,O-methylation,O-methyltransferase activity,opioid,opioid-induced sedation,pain,Pain modality,pain tolerance,Parenting Influence Attention,Parkinson,Parkinson's,Parkinson's Disease,PCOS,PD,Pharmacogenetics,placenta,plasma membrane,pleasurable feelings,Polycystic Ovary Syndrome,Polymorphism,positive regulation of homocysteine metabolic process,Preeclampsia,recurrent preeclampsia,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,sensitivity to pain,severe fibromyalgia,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,Spontaneous Preterm Birth,stress,synaptic transmission,Temporomandibular Disorder,TMJ,Transferase,Transmembrane,Transmembrane helix,Val-158,VDR/Taq,xenobiotic metabolic process",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs6269",
        "SNP Name": "COMT A-1324G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6269",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,Analgesia,anxiety,ASD,autism,Autism Spectrum Disorders,avoid methyl donors,B12,Brain,brain chemicals,Breast Cancer,cancer,cancerous,carcinogen,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,childhood,children,Chronic Fatigue Syndrome,Chronic Pain,class I-like SAM-binding methyltransferase superfamily,clinical outcome after lumbar spine surgery,Clinical Pain,Cognitive Function,Cognitive Function of Children,COMT,COMT*1,COMT*2,COMT*H,COMT*L,creative potential,creativity,cyanocobalamin,Cytoplasm,cytosol,depleting methyl groups,depression,dibencozide,dopamine,dopamine catabolic process,dopamine levels,drug metabolism,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,fibromyalgia,Gastrointestinal Sensation,guaiacol,homozygous mutation,hydroxylcobalamin,hyperactivity,increased pain sensitivity,integral component of membrane,irritability,isoproterenol,L-DOPA,learning,liver,low back pain,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,mental disorder,mercury,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,morphine requirements,multicellular organismal reproductive process,N-terminus,Neck Pain,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,Neurobehavioral Effects of Mercury in Children,neurotoxin,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,O-methylation,O-methyltransferase activity,opioid,opioid-induced sedation,pain,Pain modality,pain tolerance,Parenting Influence Attention,Parkinson,Parkinson's,Parkinson's Disease,PCOS,PD,Pharmacogenetics,placenta,plasma membrane,pleasurable feelings,Polycystic Ovary Syndrome,Polymorphism,positive regulation of homocysteine metabolic process,Preeclampsia,recurrent preeclampsia,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,sensitivity to pain,severe fibromyalgia,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,Spontaneous Preterm Birth,stress,synaptic transmission,Temporomandibular Disorder,TMJ,Transferase,Transmembrane,Transmembrane helix,Val-158,VDR/Taq,xenobiotic metabolic process",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs4633",
        "SNP Name": "COMT H62H",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4633",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,antipsychotics,autism,avoid methyl donors,B12,biliary tract cancer,biliary tract stones,binge eating,Bladder Cancer,Brain,brain chemicals,Brain Disorders,cancer,cancerous,carcinogen,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,Central Nervous System Depression among Neonates Exposed to Codeine through Breast Milk,CFS,Chronic Fatigue Syndrome,Chronic Pain,class I-like SAM-binding methyltransferase superfamily,clinical outcome after lumbar spine surgery,cognitive therapy,COMT,COMT*1,COMT*2,COMT*H,COMT*L,creative potential,creativity,cyanocobalamin,Cytoplasm,cytosol,Dementia,depleting methyl groups,dibencozide,divergent thinking,dopamine,dopamine catabolic process,dopamine levels,epinephrine,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,fibromyalgia,Financial and Psychological Risk Attitudes,gastric cancer,guaiacol,homozygous mutation,Human Disc Degeneration,hydroxylcobalamin,hyperactivity,IBS,increased pain sensitivity,integral component of membrane,irritability,Irritable Bowel Syndrome,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,Met-158,Metal-binding,methionine,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,morphine requirements in cancer patients,multicellular organismal reproductive process,N-terminus,Neck Pain,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,Neurobehavioral Effects of Mercury in Children,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,Nicotine Receptor,norepinephrine,norepinephrine levels,O-methylation,O-methyltransferase activity,opioid use,opioid-induced sedation,pain,Panic Disorder,Parkinson,Parkinson's,Parkinson's Disease,PCOS,PD,Pharmacogenetics,pharmacogenomics,placenta,plasma membrane,pleasurable feelings,Polycystic Ovary Syndrome,Polymorphism,positive regulation of homocysteine metabolic process,Preeclampsia,recurrent preeclampsia,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,Schizotypal Personality Disorder,sensitivity to pain,serotonin reuptake inhibitor response,shoulder pain,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,Spontaneous Preterm Birth,Sporadic Colon Adenocarcinoma,SSRI,SSRI response,synaptic transmission,Temporomandibular Disorder,Therapygenetics,TMJ,Transferase,Transmembrane,Transmembrane helix,treatment outcome of low back pain,Val-158,VDR/Taq,xenobiotic metabolic process",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs4633",
        "SNP Name": "COMT H62H",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4633",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,antipsychotics,autism,avoid methyl donors,B12,biliary tract cancer,biliary tract stones,binge eating,Bladder Cancer,Brain,brain chemicals,Brain Disorders,cancer,cancerous,carcinogen,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,Central Nervous System Depression among Neonates Exposed to Codeine through Breast Milk,CFS,Chronic Fatigue Syndrome,Chronic Pain,class I-like SAM-binding methyltransferase superfamily,clinical outcome after lumbar spine surgery,cognitive therapy,COMT,COMT*1,COMT*2,COMT*H,COMT*L,creative potential,creativity,cyanocobalamin,Cytoplasm,cytosol,Dementia,depleting methyl groups,dibencozide,divergent thinking,dopamine,dopamine catabolic process,dopamine levels,epinephrine,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,fibromyalgia,Financial and Psychological Risk Attitudes,gastric cancer,guaiacol,homozygous mutation,Human Disc Degeneration,hydroxylcobalamin,hyperactivity,IBS,increased pain sensitivity,integral component of membrane,irritability,Irritable Bowel Syndrome,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,Met-158,Metal-binding,methionine,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,morphine requirements in cancer patients,multicellular organismal reproductive process,N-terminus,Neck Pain,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,Neurobehavioral Effects of Mercury in Children,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,Nicotine Receptor,norepinephrine,norepinephrine levels,O-methylation,O-methyltransferase activity,opioid use,opioid-induced sedation,pain,Panic Disorder,Parkinson,Parkinson's,Parkinson's Disease,PCOS,PD,Pharmacogenetics,pharmacogenomics,placenta,plasma membrane,pleasurable feelings,Polycystic Ovary Syndrome,Polymorphism,positive regulation of homocysteine metabolic process,Preeclampsia,recurrent preeclampsia,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,Schizotypal Personality Disorder,sensitivity to pain,serotonin reuptake inhibitor response,shoulder pain,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,Spontaneous Preterm Birth,Sporadic Colon Adenocarcinoma,SSRI,SSRI response,synaptic transmission,Temporomandibular Disorder,Therapygenetics,TMJ,Transferase,Transmembrane,Transmembrane helix,treatment outcome of low back pain,Val-158,VDR/Taq,xenobiotic metabolic process",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2239393",
        "SNP Name": "COMT A 26166G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2239393",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,autism,avoid methyl donors,B12,Brain,brain chemicals,Breast Cancer,cancer,cancerous,carcinogen,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,class I-like SAM-binding methyltransferase superfamily,cocaine-induced paranoia,COMT,COMT*1,COMT*2,COMT*H,COMT*L,cyanocobalamin,Cytoplasm,cytosol,depleting methyl groups,depression,dibencozide,dopamine,dopamine catabolic process,dopamine levels,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,guaiacol,homozygous mutation,hydroxylcobalamin,hyperactivity,integral component of membrane,irritability,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,mental disorder,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,morphine,morphine requirements in cancer,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,O-methylation,O-methyltransferase activity,opioid,opioid-induced sedation,p450,paranoia,Parkinson's,Parkinson's Disease,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,postoperative pain,ransmembrane helix,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl  L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,sensitivity to pain,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,synaptic transmission,tacrolimus,Transferase,Transmembrane,Val-158,VDR/Taq,xenobiotic metabolic process",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs2239393",
        "SNP Name": "COMT A 26166G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2239393",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,autism,avoid methyl donors,B12,Brain,brain chemicals,Breast Cancer,cancer,cancerous,carcinogen,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,class I-like SAM-binding methyltransferase superfamily,cocaine-induced paranoia,COMT,COMT*1,COMT*2,COMT*H,COMT*L,cyanocobalamin,Cytoplasm,cytosol,depleting methyl groups,depression,dibencozide,dopamine,dopamine catabolic process,dopamine levels,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,guaiacol,homozygous mutation,hydroxylcobalamin,hyperactivity,integral component of membrane,irritability,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,mental disorder,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,morphine,morphine requirements in cancer,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,O-methylation,O-methyltransferase activity,opioid,opioid-induced sedation,p450,paranoia,Parkinson's,Parkinson's Disease,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,postoperative pain,ransmembrane helix,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl  L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,sensitivity to pain,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,synaptic transmission,tacrolimus,Transferase,Transmembrane,Val-158,VDR/Taq,xenobiotic metabolic process",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs4680",
        "SNP Name": "COMT V158M",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4680",
        "Video": "BMnD8_rBLSU",
        "Tags": "Acute Kidney Injury,ADD,adenosyl,ADHD,aggressive behavior,alcohol,alcohol dependence,alcoholism,alpha-methyl DOPA,Alternative initiation,altruism,Alzheimer,Alzheimer's Disease,Analgesia,antidepressant effects,antidepressant resistance,Antidepressants,Antidepressants in Major Depression,antioxidant status,Antipsychotic-Induced Movement Disorder,anxiety,anxiety disorder,Anxiety Spectrum,appetite loss,ASD,autism,Autism Spectrum Disorder,avoid methyl donors,B12,bipolar,bipolar disorder,birth defect,Bladder Cancer,borderline personality,Brain,brain chemicals,Breast Cancer,breast cancer risk,Breast Cancer Survival,cancer,cancerous,Cannabis and Psychosis,carcinogen,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,children\u2019s telomere length,Chronic pain,Cigarette Smoking,cigarette smoking and pancreatic cancer,class I-like SAM-binding methyltransferase superfamily,clinical outcome after lumbar spine surgery,cocaine dependence,cocaine-induced paranoia,Codeine through Breast Milk,Cognition,Cognitive Behavior Therapy,cognitive decline,Cognitive Flexibility,cognitive-behavioral treatment,Complex Neurodevelopmental Disorders,COMT,COMT*1,COMT*2,COMT*H,COMT*L,cortical function,creative potential,creativity,cyanocobalamin,Cytoplasm,cytosol,defect,depleting methyl groups,depression,developmental neurotoxicity,diabetes,dibencozide,dopamine,dopamine catabolic process,dopamine levels,dopamine neurotransmission,drug addiction,Ecstasy,Emotional Processing,Episodic Remembering,erratic behavior,erythrocytes,esophageal squamous cell carcinoma,estrogen,estrogen metabolic process,Estrogen Synthesis,excess methyl groups,Executive Dysfunction,extracellular vesicular exosome,Eye Tracking Dysfunction,fear conditioning,female pregnancy,fibromyalgia,focus and reward responsiveness,GABA Levels,General Intelligence,guaiacol,Heroin Dependence,Highly Sensitive Personality,hippocampus-dependent memory,homozygous mutation,hydroxylcobalamin,hyperactivity,IBS,increased pain sensitivity,integral component of membrane,irritability,Irritable Bowel Syndrome,Ischemic Stroke,isoproterenol,L-DOPA,learning,liver,low back pain,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,Major Depression,major depressive disorder,MDMA,membrane,mental disorder,Met-158,Metabolic Syndrome,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,methylmercury,Methyltransferase,mitochondrion,Morphine metabolism,morphine requirements in cancer patients,Motor Learning,multicellular organismal reproductive process,N-terminus,Neck Pain,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,Neural Tube Defect,neuroactive drugs,Neurobehavioral Effects of Mercury in Children,neurocognitive deficits,neurodegenerative disorder,neuropsychiatric disorders,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,nicotine and cognitive performance,nicotine dependence,non-small cell lung cancer,norepinephrine,norepinephrine levels,Novelty Seeking Personality,NTDs,O-methylation,O-methyltransferase activity,Obesity,Opioid Dependence,opioid management of pain,opioid use,opioids for cancer pain,oppositional defiant disorder,oxytocin,pain,pancreatic cancer,panic disorder,Parkinson,Parkinson's,Parkinson's Disease,PD,personality,Personality Traits,Pharmacogenetics,placenta,plasma membrane,pleasurable feelings,Polycystic Ovary Syndrome,Polymorphism,positive regulation of homocysteine metabolic process,postmenopausal breast cancer,postoperative pain,posttraumatic stress disorder,Preeclampsia,psoriasis vulgaris,psychi",
        "Group": "Mercury (Thiomersal/Thimerosal)"
    },
    {
        "SNP ID": "rs4680",
        "SNP Name": "COMT V158M",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4680",
        "Video": "BMnD8_rBLSU",
        "Tags": "Acute Kidney Injury,ADD,adenosyl,ADHD,aggressive behavior,alcohol,alcohol dependence,alcoholism,alpha-methyl DOPA,Alternative initiation,altruism,Alzheimer,Alzheimer's Disease,Analgesia,antidepressant effects,antidepressant resistance,Antidepressants,Antidepressants in Major Depression,antioxidant status,Antipsychotic-Induced Movement Disorder,anxiety,anxiety disorder,Anxiety Spectrum,appetite loss,ASD,autism,Autism Spectrum Disorder,avoid methyl donors,B12,bipolar,bipolar disorder,birth defect,Bladder Cancer,borderline personality,Brain,brain chemicals,Breast Cancer,breast cancer risk,Breast Cancer Survival,cancer,cancerous,Cannabis and Psychosis,carcinogen,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,children\u2019s telomere length,Chronic pain,Cigarette Smoking,cigarette smoking and pancreatic cancer,class I-like SAM-binding methyltransferase superfamily,clinical outcome after lumbar spine surgery,cocaine dependence,cocaine-induced paranoia,Codeine through Breast Milk,Cognition,Cognitive Behavior Therapy,cognitive decline,Cognitive Flexibility,cognitive-behavioral treatment,Complex Neurodevelopmental Disorders,COMT,COMT*1,COMT*2,COMT*H,COMT*L,cortical function,creative potential,creativity,cyanocobalamin,Cytoplasm,cytosol,defect,depleting methyl groups,depression,developmental neurotoxicity,diabetes,dibencozide,dopamine,dopamine catabolic process,dopamine levels,dopamine neurotransmission,drug addiction,Ecstasy,Emotional Processing,Episodic Remembering,erratic behavior,erythrocytes,esophageal squamous cell carcinoma,estrogen,estrogen metabolic process,Estrogen Synthesis,excess methyl groups,Executive Dysfunction,extracellular vesicular exosome,Eye Tracking Dysfunction,fear conditioning,female pregnancy,fibromyalgia,focus and reward responsiveness,GABA Levels,General Intelligence,guaiacol,Heroin Dependence,Highly Sensitive Personality,hippocampus-dependent memory,homozygous mutation,hydroxylcobalamin,hyperactivity,IBS,increased pain sensitivity,integral component of membrane,irritability,Irritable Bowel Syndrome,Ischemic Stroke,isoproterenol,L-DOPA,learning,liver,low back pain,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,Major Depression,major depressive disorder,MDMA,membrane,mental disorder,Met-158,Metabolic Syndrome,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,methylmercury,Methyltransferase,mitochondrion,Morphine metabolism,morphine requirements in cancer patients,Motor Learning,multicellular organismal reproductive process,N-terminus,Neck Pain,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,Neural Tube Defect,neuroactive drugs,Neurobehavioral Effects of Mercury in Children,neurocognitive deficits,neurodegenerative disorder,neuropsychiatric disorders,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,nicotine and cognitive performance,nicotine dependence,non-small cell lung cancer,norepinephrine,norepinephrine levels,Novelty Seeking Personality,NTDs,O-methylation,O-methyltransferase activity,Obesity,Opioid Dependence,opioid management of pain,opioid use,opioids for cancer pain,oppositional defiant disorder,oxytocin,pain,pancreatic cancer,panic disorder,Parkinson,Parkinson's,Parkinson's Disease,PD,personality,Personality Traits,Pharmacogenetics,placenta,plasma membrane,pleasurable feelings,Polycystic Ovary Syndrome,Polymorphism,positive regulation of homocysteine metabolic process,postmenopausal breast cancer,postoperative pain,posttraumatic stress disorder,Preeclampsia,psoriasis vulgaris,psychi",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs4680",
        "SNP Name": "COMT V158M",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4680",
        "Video": "BMnD8_rBLSU",
        "Tags": "Acute Kidney Injury,ADD,adenosyl,ADHD,aggressive behavior,alcohol,alcohol dependence,alcoholism,alpha-methyl DOPA,Alternative initiation,altruism,Alzheimer,Alzheimer's Disease,Analgesia,antidepressant effects,antidepressant resistance,Antidepressants,Antidepressants in Major Depression,antioxidant status,Antipsychotic-Induced Movement Disorder,anxiety,anxiety disorder,Anxiety Spectrum,appetite loss,ASD,autism,Autism Spectrum Disorder,avoid methyl donors,B12,bipolar,bipolar disorder,birth defect,Bladder Cancer,borderline personality,Brain,brain chemicals,Breast Cancer,breast cancer risk,Breast Cancer Survival,cancer,cancerous,Cannabis and Psychosis,carcinogen,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,children\u2019s telomere length,Chronic pain,Cigarette Smoking,cigarette smoking and pancreatic cancer,class I-like SAM-binding methyltransferase superfamily,clinical outcome after lumbar spine surgery,cocaine dependence,cocaine-induced paranoia,Codeine through Breast Milk,Cognition,Cognitive Behavior Therapy,cognitive decline,Cognitive Flexibility,cognitive-behavioral treatment,Complex Neurodevelopmental Disorders,COMT,COMT*1,COMT*2,COMT*H,COMT*L,cortical function,creative potential,creativity,cyanocobalamin,Cytoplasm,cytosol,defect,depleting methyl groups,depression,developmental neurotoxicity,diabetes,dibencozide,dopamine,dopamine catabolic process,dopamine levels,dopamine neurotransmission,drug addiction,Ecstasy,Emotional Processing,Episodic Remembering,erratic behavior,erythrocytes,esophageal squamous cell carcinoma,estrogen,estrogen metabolic process,Estrogen Synthesis,excess methyl groups,Executive Dysfunction,extracellular vesicular exosome,Eye Tracking Dysfunction,fear conditioning,female pregnancy,fibromyalgia,focus and reward responsiveness,GABA Levels,General Intelligence,guaiacol,Heroin Dependence,Highly Sensitive Personality,hippocampus-dependent memory,homozygous mutation,hydroxylcobalamin,hyperactivity,IBS,increased pain sensitivity,integral component of membrane,irritability,Irritable Bowel Syndrome,Ischemic Stroke,isoproterenol,L-DOPA,learning,liver,low back pain,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,Major Depression,major depressive disorder,MDMA,membrane,mental disorder,Met-158,Metabolic Syndrome,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,methylmercury,Methyltransferase,mitochondrion,Morphine metabolism,morphine requirements in cancer patients,Motor Learning,multicellular organismal reproductive process,N-terminus,Neck Pain,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,Neural Tube Defect,neuroactive drugs,Neurobehavioral Effects of Mercury in Children,neurocognitive deficits,neurodegenerative disorder,neuropsychiatric disorders,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,nicotine and cognitive performance,nicotine dependence,non-small cell lung cancer,norepinephrine,norepinephrine levels,Novelty Seeking Personality,NTDs,O-methylation,O-methyltransferase activity,Obesity,Opioid Dependence,opioid management of pain,opioid use,opioids for cancer pain,oppositional defiant disorder,oxytocin,pain,pancreatic cancer,panic disorder,Parkinson,Parkinson's,Parkinson's Disease,PD,personality,Personality Traits,Pharmacogenetics,placenta,plasma membrane,pleasurable feelings,Polycystic Ovary Syndrome,Polymorphism,positive regulation of homocysteine metabolic process,postmenopausal breast cancer,postoperative pain,posttraumatic stress disorder,Preeclampsia,psoriasis vulgaris,psychi",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs769224",
        "SNP Name": "COMT -61 P199P",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs769224",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,ASD,autism,Autism Spectrum Disorders,avoid methyl donors,B12,Brain,brain chemicals,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,class I-like SAM-binding methyltransferase superfamily,COMT,COMT*1,COMT*2,COMT*H,COMT*L,creative potential,creativity,cyanocobalamin,Cytoplasm,cytosol,depleting methyl groups,dibencozide,dopamine,dopamine catabolic process,dopamine levels,epinephrine,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,guaiacol,homozygous mutation,hydroxylcobalamin,hyperactivity,integral component of membrane,irritability,isoproterenol,Kawasaki syndrome,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,Mercurial Autoimmunity,Mercurial Autoimmunity and Vasodilation,mercury,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,neurotoxin,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,O-methylation,O-methyltransferase activity,Parkinson's,Parkinson's Disease,pharmacogenomics,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,selective serotonin reuptake inhibitor response,sensitivity to pain,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,SSRI response,synaptic transmission,Transferase,Transmembrane,Transmembrane helix,Val-158,VDR/Taq,xenobiotic metabolic process",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs769224",
        "SNP Name": "COMT -61 P199P",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs769224",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,ASD,autism,Autism Spectrum Disorders,avoid methyl donors,B12,Brain,brain chemicals,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,class I-like SAM-binding methyltransferase superfamily,COMT,COMT*1,COMT*2,COMT*H,COMT*L,creative potential,creativity,cyanocobalamin,Cytoplasm,cytosol,depleting methyl groups,dibencozide,dopamine,dopamine catabolic process,dopamine levels,epinephrine,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,guaiacol,homozygous mutation,hydroxylcobalamin,hyperactivity,integral component of membrane,irritability,isoproterenol,Kawasaki syndrome,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,Mercurial Autoimmunity,Mercurial Autoimmunity and Vasodilation,mercury,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,neurotoxin,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,O-methylation,O-methyltransferase activity,Parkinson's,Parkinson's Disease,pharmacogenomics,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,selective serotonin reuptake inhibitor response,sensitivity to pain,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,SSRI response,synaptic transmission,Transferase,Transmembrane,Transmembrane helix,Val-158,VDR/Taq,xenobiotic metabolic process",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs4646316",
        "SNP Name": "COMT C27870T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4646316",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,Anxiety,autism,avoid methyl donors,B12,Brain,brain chemicals,Breast Cancer,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,chemotherapy,children,Cisplatin,Cisplatin-Induced Hearing Loss,class I-like SAM-binding methyltransferase superfamily,cocaine,cocaine-induced paranoia,COMT,COMT*1,COMT*2,COMT*H,COMT*L,cyanocobalamin,Cytoplasm,cytosol,deafness,depleting methyl groups,depression,dibencozide,dopamine,dopamine catabolic process,dopamine levels,drug,drug interaction,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,guaiacol,hearing loss,homozygous mutation,hydroxylcobalamin,hyperactivity,integral component of membrane,irritability,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,mental disorder,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,O-methylation,O-methyltransferase activity,paranoia,Parkinson's,Parkinson's Disease,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,ransmembrane helix,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl  L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,selective serotonin reuptake inhibitor response,sensitivity to pain,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,SSRI,SSRI response,synaptic transmission,Transferase,Transmembrane,Val-158,VDR/Taq,Velco-Cardio-Facial syndrome,xenobiotic metabolic process",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs4646316",
        "SNP Name": "COMT C27870T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4646316",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,Anxiety,autism,avoid methyl donors,B12,Brain,brain chemicals,Breast Cancer,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,chemotherapy,children,Cisplatin,Cisplatin-Induced Hearing Loss,class I-like SAM-binding methyltransferase superfamily,cocaine,cocaine-induced paranoia,COMT,COMT*1,COMT*2,COMT*H,COMT*L,cyanocobalamin,Cytoplasm,cytosol,deafness,depleting methyl groups,depression,dibencozide,dopamine,dopamine catabolic process,dopamine levels,drug,drug interaction,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,guaiacol,hearing loss,homozygous mutation,hydroxylcobalamin,hyperactivity,integral component of membrane,irritability,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,mental disorder,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,O-methylation,O-methyltransferase activity,paranoia,Parkinson's,Parkinson's Disease,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,ransmembrane helix,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl  L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,selective serotonin reuptake inhibitor response,sensitivity to pain,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,SSRI,SSRI response,synaptic transmission,Transferase,Transmembrane,Val-158,VDR/Taq,Velco-Cardio-Facial syndrome,xenobiotic metabolic process",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs174699",
        "SNP Name": "COMT C30196T",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs174699",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,anxiety,autism,avoid methyl donors,B12,Brain,brain chemicals,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,class I-like SAM-binding methyltransferase superfamily,cocaine-induced paranoia,cold sensitivity,COMT,COMT*1,COMT*2,COMT*H,COMT*L,cyanocobalamin,Cytoplasm,cytosol,depleting methyl groups,dibencozide,dopamine,dopamine catabolic process,dopamine levels,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,fMRI,guaiacol,heat sensitivity,homozygous mutation,hydroxylcobalamin,hyperactivity,integral component of membrane,irritability,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,mental disorder,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,morphine requirements in cancer,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,O-methylation,O-methyltransferase activity,pain sensitivity,Parkinson's,Parkinson's Disease,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,post-surgical pain,ransmembrane helix,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl  L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,sensitivity to pain,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,synaptic transmission,Transferase,Transmembrane,Val-158,VDR/Taq,xenobiotic metabolic process",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs174699",
        "SNP Name": "COMT C30196T",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs174699",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,anxiety,autism,avoid methyl donors,B12,Brain,brain chemicals,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,class I-like SAM-binding methyltransferase superfamily,cocaine-induced paranoia,cold sensitivity,COMT,COMT*1,COMT*2,COMT*H,COMT*L,cyanocobalamin,Cytoplasm,cytosol,depleting methyl groups,dibencozide,dopamine,dopamine catabolic process,dopamine levels,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,fMRI,guaiacol,heat sensitivity,homozygous mutation,hydroxylcobalamin,hyperactivity,integral component of membrane,irritability,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,mental disorder,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,morphine requirements in cancer,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,O-methylation,O-methyltransferase activity,pain sensitivity,Parkinson's,Parkinson's Disease,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,post-surgical pain,ransmembrane helix,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl  L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,sensitivity to pain,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,synaptic transmission,Transferase,Transmembrane,Val-158,VDR/Taq,xenobiotic metabolic process",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs9332377",
        "SNP Name": "COMT C31430T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs9332377",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,adenosyl,ADHD,adverse drug reactions,alcoholism,alpha-methyl DOPA,Alternative initiation,androgen,anxiety,autism,avoid methyl donors,B12,Brain,brain chemicals,cancer,cancerous,carcinogen,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,chemotherapy,Cisplatin-Induced Hearing Loss,cisplatin-induced ototoxicity,class I-like SAM-binding methyltransferase superfamily,cocaine-induced paranoia,COMT,COMT*1,COMT*2,COMT*H,COMT*L,cyanocobalamin,Cytoplasm,cytosol,depleting methyl groups,dibencozide,dopamine,dopamine catabolic process,dopamine levels,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,gastric cancer,guaiacol,Hearing Loss,homozygous mutation,hydroxylcobalamin,hyperactivity,integral component of membrane,intelligence,irritability,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,O-methylation,O-methyltransferase activity,Parkinson's,Parkinson's Disease,PD,Pharmacogenomics,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,ransmembrane helix,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl  L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,selective serotonin reuptake inhibitor response,sensitivity to pain,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,SSRI,SSRI response,synaptic transmission,Transferase,Transmembrane,Val-158,VDR/Taq,Velco-Cardio-Facial syndrome,xenobiotic metabolic process",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs9332377",
        "SNP Name": "COMT C31430T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs9332377",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,adenosyl,ADHD,adverse drug reactions,alcoholism,alpha-methyl DOPA,Alternative initiation,androgen,anxiety,autism,avoid methyl donors,B12,Brain,brain chemicals,cancer,cancerous,carcinogen,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,chemotherapy,Cisplatin-Induced Hearing Loss,cisplatin-induced ototoxicity,class I-like SAM-binding methyltransferase superfamily,cocaine-induced paranoia,COMT,COMT*1,COMT*2,COMT*H,COMT*L,cyanocobalamin,Cytoplasm,cytosol,depleting methyl groups,dibencozide,dopamine,dopamine catabolic process,dopamine levels,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,gastric cancer,guaiacol,Hearing Loss,homozygous mutation,hydroxylcobalamin,hyperactivity,integral component of membrane,intelligence,irritability,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,membrane,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,norepinephrine,norepinephrine levels,O-methylation,O-methyltransferase activity,Parkinson's,Parkinson's Disease,PD,Pharmacogenomics,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,ransmembrane helix,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl  L-methionine,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,selective serotonin reuptake inhibitor response,sensitivity to pain,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,SSRI,SSRI response,synaptic transmission,Transferase,Transmembrane,Val-158,VDR/Taq,Velco-Cardio-Facial syndrome,xenobiotic metabolic process",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs165599",
        "SNP Name": "COMT G*522A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs165599",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,Alzheimer,Alzheimer Disease,Analgesia,anxiety,Anxiety spectrum,autism,avoid methyl donors,B12,bipolar,Bipolar Disorder,Brain,brain chemicals,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,class I-like SAM-binding methyltransferase superfamily,cocaine dependence,cocaine-induced paranoia,cognitive function,COMT,COMT*1,COMT*2,COMT*H,COMT*L,Conduct Disorder,cyanocobalamin,Cytoplasm,cytosol,depleting methyl groups,dibencozide,dopamine,dopamine catabolic process,dopamine levels,emotion,Emotional Symptoms,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,fibromyalgia,guaiacol,homozygous mutation,hydroxylcobalamin,hyperactivity,integral component of membrane,irritability,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,major depressive disorder,membrane,mental disorder,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,mood,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,neurodegenerative disorder,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,nicotine dependence,norepinephrine,norepinephrine levels,O-methylation,O-methyltransferase activity,pain,paranoia,Parkinson's,Parkinson's Disease,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,preeclampsia,recurrent preeclampsia,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,selective serotonin reuptake inhibitor response,sensitivity to pain,severe fibromyalgia,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,smoking,SSRI,SSRI response,synaptic transmission,Transferase,Transmembrane,Transmembrane helix,Val-158,VDR/Taq,Working Memory,xenobiotic metabolic process",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs165599",
        "SNP Name": "COMT G*522A",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs165599",
        "Video": "BMnD8_rBLSU",
        "Tags": "ADD,adenosyl,ADHD,alcoholism,alpha-methyl DOPA,Alternative initiation,Alzheimer,Alzheimer Disease,Analgesia,anxiety,Anxiety spectrum,autism,avoid methyl donors,B12,bipolar,Bipolar Disorder,Brain,brain chemicals,catalytic activity,catalyze,catechol,Catechol hormones,Catechol O-methyltransferase,catechol O-methyltransferase activity,catecholamine,Catecholamine metabolism,catecholamine neurotransmitters,catecholo-methyl-transferase,Cation-dependent O-methyltransferase family,Cell membrane,class I-like SAM-binding methyltransferase superfamily,cocaine dependence,cocaine-induced paranoia,cognitive function,COMT,COMT*1,COMT*2,COMT*H,COMT*L,Conduct Disorder,cyanocobalamin,Cytoplasm,cytosol,depleting methyl groups,dibencozide,dopamine,dopamine catabolic process,dopamine levels,emotion,Emotional Symptoms,erratic behavior,erythrocytes,estrogen,estrogen metabolic process,excess methyl groups,extracellular vesicular exosome,female pregnancy,fibromyalgia,guaiacol,homozygous mutation,hydroxylcobalamin,hyperactivity,integral component of membrane,irritability,isoproterenol,L-DOPA,learning,liver,lymphocytes,Magnesium,magnesium ion,magnesium ion binding,major depressive disorder,membrane,mental disorder,Met-158,Metal-binding,methyl group supplementation,methyl-containing supplements,methylating agents,methylation,Methyltransferase,mitochondrion,mood,multicellular organismal reproductive process,N-terminus,negative regulation of dopamine metabolic process,negative regulation of smooth muscle cell proliferation,neuroactive drugs,neurodegenerative disorder,neurotransmitter,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,nicotine dependence,norepinephrine,norepinephrine levels,O-methylation,O-methyltransferase activity,pain,paranoia,Parkinson's,Parkinson's Disease,placenta,plasma membrane,pleasurable feelings,Polymorphism,positive regulation of homocysteine metabolic process,preeclampsia,recurrent preeclampsia,reinforcing positive behaviors,response to drug,response to lipopolysaccharide,response to organic cyclic compound,response to pain,reward seeking behavior,role in attention,S-adenosyl-L-homocysteine,S-adenosyl-L-methionine,schizophrenia,selective serotonin reuptake inhibitor response,sensitivity to pain,severe fibromyalgia,Signal-anchor,Single-pass type II membrane protein,small molecule metabolic process,smoking,SSRI,SSRI response,synaptic transmission,Transferase,Transmembrane,Transmembrane helix,Val-158,VDR/Taq,Working Memory,xenobiotic metabolic process",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1064422",
        "SNP Name": "IGLL1/14.1 P142L",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Acetone"
    },
    {
        "SNP ID": "rs140174",
        "SNP Name": "IGLL1/14.1 T4513C",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Acetone"
    },
    {
        "SNP ID": "rs5760485",
        "SNP Name": "GGT1 T11756C",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5760485",
        "Video": "ErHtdZmn0i8",
        "Tags": "5-L-glutamyl amino acid,A (5-L-glutamyl)-peptide,acceptor amino acid,acyltransferase,amino acid,amino acids,antioxidant,arachidonic acid,autocatalysis,autocatalytic cleavage,cell antioxidant,cell antioxidant defense,cell membrane,cellular amino acid,cysteine,cysteine biosynthetic process,cysteine supply,cysteinyl-glycine,dipeptidases,dipeptide,disulfide bond,extracellular glutathione,gamma-glutamyl compound,gamma-glutamyl compounds,gamma-glutamyl moiety,gamma-glutamyltransferase,gamma-glutamyltransferase 1,gamma-glutamyltransferase family,gamma-glutamyltranspeptidase 1,GGT,GGT 1,GGT1,glutamate,glutathione,glutathione biosynthesis,glutathione conjugates,glutathione hydrolase,glutathione hydrolase 1,glutathione metabolism,glutathionuria,glycan composition,glycine,glycoprotein,glycosylation,GSH,GSH breakdown,GSH level,H2O,heavy chain,heavy chains,Heterodimer,hetrodimer,hexosamines,hexoses,hydrolase,immune system,inflammation,inflammatory response,intestine,kidney,L-cysteinylglycine,L-glutamate,leukotriene,Leukotriene C4,leukotriene D4,leukotriene-c4 hydrolase,Leukotriene\u00a0c4,light chain,light chains,liver,membrane,n-glycans,n-glycosylated,pancreas,peptide,placenta,protease,protein binding,sialic acid,small molecule,spermatogenesis,stomach,sulfur metabolism,transferase,transpeptidation,transpeptidation reaction,xenobiotic,zymogen,zymogen activation,\u00a0lung,\u00a0Sulfur metabolism",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs4820599",
        "SNP Name": "GGT1/FAM211B A15496G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs4820599",
        "Video": "ErHtdZmn0i8",
        "Tags": "5-L-glutamyl amino acid,A (5-L-glutamyl)-peptide,acceptor amino acid,acyltransferase,amino acid,amino acids,antioxidant,arachidonic acid,autocatalysis,autocatalytic cleavage,cancer,cancerous,carcinogen,cell antioxidant,cell antioxidant defense,cell membrane,cellular amino acid,chronic pancreatitis,cysteine,cysteine biosynthetic process,cysteine supply,cysteinyl-glycine,dipeptidases,dipeptide,disulfide bond,extracellular glutathione,fatty liver,gamma-glutamyl compound,gamma-glutamyl compounds,gamma-glutamyl moiety,gamma-glutamyltransferase,gamma-glutamyltransferase 1,gamma-glutamyltransferase family,gamma-glutamyltranspeptidase 1,GGT,GGT 1,GGT1,glutamate,glutathione,glutathione biosynthesis,glutathione conjugates,glutathione hydrolase,glutathione hydrolase 1,glutathione metabolism,glutathionuria,glycan composition,glycine,glycoprotein,glycosylation,GSH,GSH breakdown,GSH level,H2O,heavy chain,heavy chains,Heterodimer,hetrodimer,hexosamines,hexoses,hydrolase,immune system,immunogenetics,inflammation,inflammatory response,intestine,kidney,L-cysteinylglycine,L-glutamate,leukotriene,Leukotriene C4,leukotriene D4,leukotriene-c4 hydrolase,Leukotriene\u00a0c4,light chain,light chains,liver,Liver Enzymes,Liver Enzymes Plasma Levels,membrane,n-glycans,n-glycosylated,Nonalcoholic Fatty Liver Disease,pancreas,pancreatic cancer,Pancreatic Carcinogenesis,pancreatitis,peptide,placenta,primary sclerosing cholangitis,protease,protein binding,sialic acid,small molecule,spermatogenesis,stomach,sulfur metabolism,transferase,transpeptidation,transpeptidation reaction,xenobiotic,zymogen,zymogen activation,\u00a0lung,\u00a0Sulfur metabolism",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs6519519",
        "SNP Name": "GGT1 C17146T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6519519",
        "Video": "ErHtdZmn0i8",
        "Tags": "5-L-glutamyl amino acid,A (5-L-glutamyl)-peptide,acceptor amino acid,acyltransferase,amino acid,amino acids,antioxidant,arachidonic acid,autocatalysis,autocatalytic cleavage,cancer,cancerous,carcinogen,cardiometabolic disease associations,cell antioxidant,cell antioxidant defense,cell membrane,cellular amino acid,cysteine,cysteine biosynthetic process,cysteine supply,cysteinyl-glycine,dipeptidases,dipeptide,disulfide bond,extracellular glutathione,gamma-glutamyl compound,gamma-glutamyl compounds,gamma-glutamyl moiety,gamma-glutamyltransferase,gamma-glutamyltransferase 1,gamma-glutamyltransferase family,gamma-glutamyltranspeptidase 1,GGT,GGT 1,GGT1,glutamate,glutathione,glutathione biosynthesis,glutathione conjugates,glutathione hydrolase,glutathione hydrolase 1,glutathione metabolism,glutathionuria,glycan composition,glycine,glycoprotein,glycosylation,GSH,GSH breakdown,GSH level,H2O,heavy chain,heavy chains,Heterodimer,hetrodimer,hexosamines,hexoses,hydrolase,immune system,inflammation,inflammatory response,intestine,kidney,L-cysteinylglycine,L-glutamate,leukotriene,Leukotriene C4,leukotriene D4,leukotriene-c4 hydrolase,Leukotriene\u00a0c4,light chain,light chains,liver,Liver Enzymes,Liver Enzymes Plasma Levels,membrane,n-glycans,n-glycosylated,pancreas,peptide,placenta,protease,protein binding,Renal Cell Cancer,sialic acid,small molecule,spermatogenesis,stomach,sulfur metabolism,transferase,transpeptidation,transpeptidation reaction,xenobiotic,zymogen,zymogen activation,\u00a0lung,\u00a0Sulfur metabolism",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs5751901",
        "SNP Name": "GGT1 T17549C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5751901",
        "Video": "ErHtdZmn0i8",
        "Tags": "5-L-glutamyl amino acid,A (5-L-glutamyl)-peptide,acceptor amino acid,acyltransferase,amino acid,amino acids,antioxidant,arachidonic acid,autocatalysis,autocatalytic cleavage,cardiometabolic disease,cell antioxidant,cell antioxidant defense,cell membrane,cellular amino acid,chronic pancreatitis,cysteine,cysteine biosynthetic process,cysteine supply,cysteinyl-glycine,dipeptidases,dipeptide,disulfide bond,elemental mercury,extracellular glutathione,gamma-glutamyl compound,gamma-glutamyl compounds,gamma-glutamyl moiety,gamma-glutamyltransferase,gamma-glutamyltransferase 1,gamma-glutamyltransferase family,gamma-glutamyltranspeptidase 1,GGT,GGT 1,GGT1,glutamate,glutathione,glutathione biosynthesis,glutathione conjugates,glutathione hydrolase,glutathione hydrolase 1,glutathione metabolism,glutathionuria,glycan composition,glycine,glycoprotein,glycosylation,GSH,GSH breakdown,GSH level,H2O,heavy chain,heavy chains,heavy metals,Heterodimer,hetrodimer,hexosamines,hexoses,hydrolase,immune system,inflammation,inflammatory response,intestine,kidney,L-cysteinylglycine,L-glutamate,leukotriene,Leukotriene C4,leukotriene D4,leukotriene-c4 hydrolase,Leukotriene\u00a0c4,light chain,light chains,liver,Liver Enzymes,Liver Enzymes Plasma Levels,membrane,mercury,mercury biomarker,mercury levels,methylmercury,n-glycans,n-glycosylated,neurotoxin,pancreas,Pancreatic Carcinogenesis,pancreatitis,peptide,placenta,protease,protein binding,selenoprotein,sialic acid,small molecule,spermatogenesis,stomach,sulfur metabolism,transferase,transpeptidation,transpeptidation reaction,xenobiotic,zymogen,zymogen activation,\u00a0lung,\u00a0Sulfur metabolism",
        "Group": "Mercury (Thiomersal/Thimerosal)"
    },
    {
        "SNP ID": "rs5751901",
        "SNP Name": "GGT1 T17549C",
        "Risk Allele": "T",
        "Your Allele": "TC",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5751901",
        "Video": "ErHtdZmn0i8",
        "Tags": "5-L-glutamyl amino acid,A (5-L-glutamyl)-peptide,acceptor amino acid,acyltransferase,amino acid,amino acids,antioxidant,arachidonic acid,autocatalysis,autocatalytic cleavage,cardiometabolic disease,cell antioxidant,cell antioxidant defense,cell membrane,cellular amino acid,chronic pancreatitis,cysteine,cysteine biosynthetic process,cysteine supply,cysteinyl-glycine,dipeptidases,dipeptide,disulfide bond,elemental mercury,extracellular glutathione,gamma-glutamyl compound,gamma-glutamyl compounds,gamma-glutamyl moiety,gamma-glutamyltransferase,gamma-glutamyltransferase 1,gamma-glutamyltransferase family,gamma-glutamyltranspeptidase 1,GGT,GGT 1,GGT1,glutamate,glutathione,glutathione biosynthesis,glutathione conjugates,glutathione hydrolase,glutathione hydrolase 1,glutathione metabolism,glutathionuria,glycan composition,glycine,glycoprotein,glycosylation,GSH,GSH breakdown,GSH level,H2O,heavy chain,heavy chains,heavy metals,Heterodimer,hetrodimer,hexosamines,hexoses,hydrolase,immune system,inflammation,inflammatory response,intestine,kidney,L-cysteinylglycine,L-glutamate,leukotriene,Leukotriene C4,leukotriene D4,leukotriene-c4 hydrolase,Leukotriene\u00a0c4,light chain,light chains,liver,Liver Enzymes,Liver Enzymes Plasma Levels,membrane,mercury,mercury biomarker,mercury levels,methylmercury,n-glycans,n-glycosylated,neurotoxin,pancreas,Pancreatic Carcinogenesis,pancreatitis,peptide,placenta,protease,protein binding,selenoprotein,sialic acid,small molecule,spermatogenesis,stomach,sulfur metabolism,transferase,transpeptidation,transpeptidation reaction,xenobiotic,zymogen,zymogen activation,\u00a0lung,\u00a0Sulfur metabolism",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs9606756",
        "SNP Name": "TCN2 A8700G",
        "Risk Allele": "G",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs9606756",
        "Video": null,
        "Tags": "Alternative splicing,anemia,associated with poststroke homocysteine modifies recurrent stroke risk,B12 binding,Belongs to the eukaryotic cobalamin transport proteins family,birth defects,cleft lip,cleft palate,cobalamin binding,cobalamin metabolic process,cobalamin transport,Cobalt,cobalt ion transport,Cobalt transport,Complete proteome,cyanocobalamin,defect,Delivers cobalamin to cells,Direct protein sequencing,Disulfide bond,endosome,extracellular region,extracellular space,Folate and Vitamin B12 Related Genes and Risk for Omphalocele,Folate Pathway Genes,gastric,Histone Methylation,homocysteine,homocysteine metabolism,intestine,intestines,Ion transport,L-homocysteine,longevity,lysosomal lumen,metal ion binding,Metal-binding,methylcobalamin,NTDs,Obesity,omphalocele,Oral Facial Clefts,pernicious anemia,Polymorphism Signal,pregnancy,Primary vitamin B12-binding and transport protein,Pro/Arg-259 polymorphism affects TCN2 plasma concentration and may interfere in vitamin B12 cellular availability and homocysteine metabolism,Reference proteome,Results in various forms of anemia,Secreted,small molecule metabolic process,stroke,TC II,TC-2,TC2,TCII,TCN2,Telomere Length,temporomandibular disorder,TMD,TMJ,Transcobalamin II,Transcobalamin II deficiency (TCN2 deficiency),Transcobalamin-2,Transport,transport of cobalamin into cells,Vitamin B-12 Status during Pregnancy and Child\u2019s IQ at Age 8,vitamin B12,vitamin B12 binding,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs1801198",
        "SNP Name": "TCN2 C766G",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1801198",
        "Video": null,
        "Tags": "Abdominal Aortic Aneurysm,Alternative splicing,anemia,aneurysm,B12 binding,Belongs to the eukaryotic cobalamin transport proteins family,birth defects,cancer,cancerous,carcinogen,cardiovascular defect,celiac disease,cholesterol prediction,cleft lip,cleft palate,cobalamin binding,cobalamin metabolic process,cobalamin transport,Cobalt,cobalt ion transport,Cobalt transport,colorectal cancer,Complete proteome,conotruncal heart defects,CVD,cyanocobalamin,defect,Delivers cobalamin to cells,Direct protein sequencing,Disulfide bond,dna methylation,endosome,extracellular region,extracellular space,folate,Folate Metabolic Pathwa,folic acid,gastric,HDL,heart,histone,histone methylation,homocysteine,intelligence,intestine,Ion transport,IQ,L-homocysteine,longevity,lysosomal lumen,metal ion binding,Metal-binding,methylcobalamin,Neural Tube Defects and Folic Acid,NTDs,obesity,Oral Facial Clefts,pernicious anemia,plasma HDL,plasma homocysteine,plasma homocysteine prediction,Polymorphism Signal,pregnancy,prenatal vitamins,Primary vitamin B12-binding and transport protein,Pro/Arg-259 polymorphism affects TCN2 plasma concentration and may interfere in vitamin B12 cellular availability and homocysteine metabolism,prostate cancer,Reference proteome,Results in various forms of anemia,Secreted,small molecule metabolic process,TC II,TC-2,TC2,TCII,TCN2,telomere,telomere length,Transcobalamin II,Transcobalamin II deficiency (TCN2 deficiency),Transcobalamin-2,Transport,transport of cobalamin into cells,Vitamin B-12 Status during Pregnancy and Child\u2019s IQ at Age 8,vitamin B12,vitamin B12 binding,vitamin metabolic process,water-soluble vitamin metabolic process",
        "Group": "Methylation & Methionine/Homocysteine Pathways"
    },
    {
        "SNP ID": "rs2071747",
        "SNP Name": "HMOX1 A7H",
        "Risk Allele": "C",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Acetone"
    },
    {
        "SNP ID": "rs2071748",
        "SNP Name": "HMOX1 5559G>A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs2071749",
        "SNP Name": "HMOX1 11354A>G",
        "Risk Allele": "A",
        "Your Allele": "AG",
        "Result": "+/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs5755720",
        "SNP Name": "HMOX1 14814A>G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs2899292",
        "SNP Name": "LGALS1/GAL1 C54T",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dextrose"
    },
    {
        "SNP ID": "rs1135840",
        "SNP Name": "CYP2D6*2 S486T",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs1135840",
        "Video": "ROMlBdGf908",
        "Tags": "Abiraterone,Acebutolol,Acetaminophen,acting on paired donors,adrenoceptor antagonists,Ajmaline,alkaloid catabolic process,alkaloid metabolic process,Almotriptan,Alogliptin,Alprenolol,Aminophenazone,Amiodarone,Amitriptyline,Amlodipine,Amodiaquine,Amoxapine,Amphetamine,Amprenavir,Amsacrine,and incorporation of one atom of oxygen,antagonist,antiarrhythmics,antidepressant,antidepressant metabolism,Antidepressant toxicity,antipsychotic,antipsychotic agents,antipsychotics toxicity,Antipyrine,Aprindine,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Aripiprazole,aromatase activity,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atenolol,Atomoxetine,Atorvastatin,Azelastine,Benzatropine,benzene,benzene poisoning,Benzyl alcohol,Bepridil,Betaxolol,Bicalutamide,Biperiden,Bisoprolol,Bortezomib,breast cancer,Brompheniramine,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Caffeine,cancer,cancerous,Captopril,Carbinoxamine,carcinogen,Carteolol,Carvedilol,Celecoxib,cellular energy,Cephalexin,Cevimeline,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorpheniramine,Chlorpromazine,Chlorpropamide,Chlorzoxazone,Cholecalciferol,Cholesterol,chronic benzene poisoning,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,Cinnarizine,Cisapride,Citalopram,Clemastine,Clevidipine,Clomipramine,Clonidine,Clotrimazole,Clozapine,clozapine pharmacogenetics,Cocaine,Codeine,Codeine toxicity,COMPOUNDS,coumarin metabolic process,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2D6,CYPIID6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2D6,Cytochrome P450-DB1,Dapagliflozin,Darifenacin,Debrisoquin,Debrisoquine 4-hydroxylase,Delavirdine,Dementia,Depression,Desipramine,Desloratadine,DETOX,detoxification,Dexamethasone,Dexfenfluramine,Dexmedetomidine,Dexmethylphenidate,Dextroamphetamine,Dextromethorphan,Dextropropoxyphene,Dibucaine,Diclofenac,Dihydrocodeine,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Dolasetron,Domperidone,Donepezil,Dopamine,Doxazosin,Doxepin,Doxorubicin,Dronedarone,DRUG,drug binding,drug catabolic process,drug metabolic process,drug metabolism,DRUG POISONING,drug response,DRUG TOXICITY,drugs,DRUX TOXICITY,Duloxetine,Efavirenz,Eletriptan,Encainide,Endocrine-Responsive Breast Cancer,endoplasmic,endoplasmic reticulum,endoplasmic reticulum membrane,energy,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Epinastine,Erlotinib,Escitalopram,Esomeprazole,ESTROGEN,estrogen related cancer,Ethylmorphine,Etoricoxib,exogenous drug catabolic process,extensive,eye,FAST METABOLIZER,Fatty acids,Felodipine,Fenfluramine,Fesoterodine,Fexofenadine,Fingolimod,Flecainide,Flunarizine,Fluoxetine,Fluphenazine,Fluvastatin,Fluvoxamine,Formoterol,Galantamine,Gefitinib,glaucoma,Glutethimide,Granisetron,Halofantrine,Haloperidol,Halothane,heme,heme binding,heterocycle metabolic process,Histamine Phosphate,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,hot flashes,Hydrocodone,Hydromorphone,Hydroxychloroquine,Hydroxyurea,Hydroxyzine,Idarubicin,Iloperidone,Imatinib,Imipramine,Indinavir,Insular Cortex and Hypothalamus Predicts Hot Flashes,intermediate,Ipratropium,Ipratropium bromide,Irbesartan,iron,iron ion binding,isoforms,Isoniazid,isoquinoline alkaloid metabolic process,Itraconazole,Ketoconazole,L-DOPA,Labetalol,Lansoprazole,Lercanidipine,Levobunolol,Levomilnacipran,Lidocaine,Lisuride,Lomustine,Loperamide,Lopinavir,Loratadine,Lorcaserin,Lovastatin,Lumefantrine,Major Depression,major depressive disorders,Maprotiline,Mefloquine,Membrane,Meperidine,Mephenytoin,Mepyramine,Mequitazine,Mesoridazine,Metal-binding,Methadone,Methamphetamine,Methazolamide,Methimazole,Methotrimeprazine,Methoxyflurane,Methylnaltrexone,Methylphenidate,Methyprylon,Metoclopramide,Metoprolol,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,Midazolam,Mido",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs59421388",
        "SNP Name": "CYP2D6 V287M",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373606/",
        "Video": "ROMlBdGf908",
        "Tags": "Abiraterone,Acebutolol,Acetaminophen,acting on paired donors,adrenoceptor antagonists,Ajmaline,alkaloid catabolic process,alkaloid metabolic process,Almotriptan,Alogliptin,Alprenolol,Aminophenazone,Amiodarone,Amitriptyline,Amlodipine,Amodiaquine,Amoxapine,Amphetamine,Amprenavir,Amsacrine,and incorporation of one atom of oxygen,antagonist,antiarrhythmics,antidepressant,antidepressant metabolism,Antidepressant toxicity,antipsychotics toxicity,Antipyrine,Aprindine,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Aripiprazole,aromatase activity,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atomoxetine,Atorvastatin,Azelastine,Benzatropine,Benzyl alcohol,Bepridil,Betaxolol,Bicalutamide,Biperiden,Bisoprolol,Bortezomib,Brompheniramine,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Caffeine,CANCER,CANCEROUS,Captopril,Carbinoxamine,CARCINOGEN,Carteolol,Carvedilol,Celecoxib,Cephalexin,Cevimeline,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Cholesterol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,Cinnarizine,Cisapride,Citalopram,Clemastine,Clevidipine,Clomipramine,Clonidine,Clotrimazole,Clozapine,Cocaine,Codeine,Codeine toxicity,COMPOUNDS,coumarin metabolic process,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2D6,CYPIID6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2D6,Cytochrome P450-DB1,Dapagliflozin,Darifenacin,Debrisoquin,Debrisoquine 4-hydroxylase,Delavirdine,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dexmedetomidine,Dexmethylphenidate,Dextroamphetamine,Dextromethorphan,Dextropropoxyphene,Dihydrocodeine,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Dolasetron,Domperidone,Donepezil,Dopamine,Doxazosin,Doxepin,Doxorubicin,Dronedarone,DRUG,drug binding,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Duloxetine,Efavirenz,Eletriptan,Encainide,endoplasmic,endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Epinastine,Erlotinib,Escitalopram,ESTROGEN,Ethylmorphine,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felodipine,Fesoterodine,Fexofenadine,Fingolimod,Flecainide,Flunarizine,Fluoxetine,Fluphenazine,Fluvastatin,Fluvoxamine,Formoterol,Galantamine,Gefitinib,Glutethimide,Granisetron,Halofantrine,Haloperidol,Halothane,heme,heme binding,heterocycle metabolic process,Histamine Phosphate,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Hydrocodone,Hydromorphone,Hydroxychloroquine,Hydroxyurea,Hydroxyzine,Idarubicin,Iloperidone,Imatinib,Imipramine,Indinavir,Ipratropium bromide,Irbesartan,iron,iron ion binding,isoforms,Isoniazid,isoquinoline alkaloid metabolic process,Itraconazole,Ketoconazole,L-DOPA,Labetalol,Lansoprazole,Lercanidipine,Levomilnacipran,Lidocaine,Lisuride,Lomustine,Loperamide,Lopinavir,Loratadine,Lorcaserin,Lovastatin,Lumefantrine,Maprotiline,Mefloquine,Membrane,Mepyramine,Mequitazine,Mesoridazine,Metal-binding,Methadone,Methamphetamine,Methazolamide,Methimazole,Methotrimeprazine,Methoxyflurane,Methylnaltrexone,Methylphenidate,Methyprylon,Metoclopramide,Metoprolol,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,Midodrine,Mifepristone,Minaprine,Mirabegron,Mirtazapine,mitochondria,mitochondrial,mitochondrion,Moclobemide,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,Morphine,NADPH,Nateglinide,Nebivolol,Nefazodone,negative regulation of binding,negative regulation of cellular organofluorine metabolic process,Nelfinavir,Nevirapine,Niacin,Nicardipine,Nicergoline,Nicotine,Nifedipine,Nilotinib,Nitrofural,Nortriptyline,Olanzapine,Omeprazole,Ondansetron,Oxamniquine,OXIDATION,oxidation-reduction process,oxidative demethylation",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs28371725",
        "SNP Name": "CYP2D6*41 2988G>A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs28371725",
        "Video": "ROMlBdGf908",
        "Tags": "Abiraterone,Acebutolol,Acetaminophen,acting on paired donors,adrenoceptor antagonists,Ajmaline,alkaloid catabolic process,alkaloid metabolic process,Almotriptan,Alogliptin,Alprenolol,Aminophenazone,Amiodarone,Amitriptyline,Amlodipine,Amodiaquine,Amoxapine,Amphetamine,Amprenavir,Amsacrine,and incorporation of one atom of oxygen,antagonist,antiarrhythmics,antidepressant,antidepressant metabolism,Antidepressant toxicity,antipsychotics toxicity,Antipyrine,Aprindine,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Aripiprazole,aromatase activity,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atomoxetine,Atorvastatin,Azelastine,Benzatropine,Benzyl alcohol,Bepridil,Betaxolol,Bicalutamide,Biperiden,Bisoprolol,Bortezomib,Brompheniramine,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Caffeine,CANCER,CANCEROUS,Captopril,Carbinoxamine,CARCINOGEN,Carteolol,Carvedilol,Celecoxib,Cephalexin,Cevimeline,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Cholesterol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,Cinnarizine,Cisapride,Citalopram,Clemastine,Clevidipine,Clomipramine,Clonidine,Clotrimazole,Clozapine,Cocaine,Codeine,Codeine toxicity,COMPOUNDS,coumarin metabolic process,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2D6,CYPIID6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2D6,Cytochrome P450-DB1,Dapagliflozin,Darifenacin,Debrisoquin,Debrisoquine 4-hydroxylase,Delavirdine,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dexmedetomidine,Dexmethylphenidate,Dextroamphetamine,Dextromethorphan,Dextropropoxyphene,Dihydrocodeine,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Dolasetron,Domperidone,Donepezil,Dopamine,Doxazosin,Doxepin,Doxorubicin,Dronedarone,DRUG,drug binding,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Duloxetine,Efavirenz,Eletriptan,Encainide,endoplasmic,endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Epinastine,Erlotinib,Escitalopram,ESTROGEN,Ethylmorphine,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felodipine,Fesoterodine,Fexofenadine,Fingolimod,Flecainide,Flunarizine,Fluoxetine,Fluphenazine,Fluvastatin,Fluvoxamine,Formoterol,Galantamine,Gefitinib,Glutethimide,Granisetron,Halofantrine,Haloperidol,Halothane,heme,heme binding,heterocycle metabolic process,Histamine Phosphate,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Hydrocodone,Hydromorphone,Hydroxychloroquine,Hydroxyurea,Hydroxyzine,Idarubicin,Iloperidone,Imatinib,Imipramine,Indinavir,Ipratropium bromide,Irbesartan,iron,iron ion binding,isoforms,Isoniazid,isoquinoline alkaloid metabolic process,Itraconazole,Ketoconazole,L-DOPA,Labetalol,Lansoprazole,Lercanidipine,Levomilnacipran,Lidocaine,Lisuride,Lomustine,Loperamide,Lopinavir,Loratadine,Lorcaserin,Lovastatin,Lumefantrine,Maprotiline,Mefloquine,Membrane,Mepyramine,Mequitazine,Mesoridazine,Metal-binding,Methadone,Methamphetamine,Methazolamide,Methimazole,Methotrimeprazine,Methoxyflurane,Methylnaltrexone,Methylphenidate,Methyprylon,Metoclopramide,Metoprolol,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,Midodrine,Mifepristone,Minaprine,Mirabegron,Mirtazapine,mitochondria,mitochondrial,mitochondrion,Moclobemide,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,Morphine,NADPH,Nateglinide,Nebivolol,Nefazodone,negative regulation of binding,negative regulation of cellular organofluorine metabolic process,Nelfinavir,Nevirapine,Niacin,Nicardipine,Nicergoline,Nicotine,Nifedipine,Nilotinib,Nitrofural,Nortriptyline,Olanzapine,Omeprazole,Ondansetron,Oxamniquine,OXIDATION,oxidation-reduction process,oxidative demethylation",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs5030867",
        "SNP Name": "CYP2D6*7 2935A>C",
        "Risk Allele": "G",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.sciencedirect.com/science/article/pii/S1574789112000063",
        "Video": "ROMlBdGf908",
        "Tags": "Abiraterone,Acebutolol,Acetaminophen,acting on paired donors,adrenoceptor antagonists,Ajmaline,alkaloid catabolic process,alkaloid metabolic process,Almotriptan,Alogliptin,Alprenolol,Aminophenazone,Amiodarone,Amitriptyline,Amlodipine,Amodiaquine,Amoxapine,Amphetamine,Amprenavir,Amsacrine,and incorporation of one atom of oxygen,antagonist,antiarrhythmics,antidepressant,antidepressant metabolism,Antidepressant toxicity,antipsychotics toxicity,Antipyrine,Aprindine,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Aripiprazole,aromatase activity,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atomoxetine,Atorvastatin,Azelastine,Benzatropine,Benzyl alcohol,Bepridil,Betaxolol,Bicalutamide,Biperiden,Bisoprolol,Bortezomib,Brompheniramine,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Caffeine,CANCER,CANCEROUS,Captopril,Carbinoxamine,CARCINOGEN,Carteolol,Carvedilol,Celecoxib,Cephalexin,Cevimeline,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Cholesterol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,Cinnarizine,Cisapride,Citalopram,Clemastine,Clevidipine,Clomipramine,Clonidine,Clotrimazole,Clozapine,Cocaine,Codeine,Codeine toxicity,COMPOUNDS,coumarin metabolic process,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2D6,CYPIID6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2D6,Cytochrome P450-DB1,Dapagliflozin,Darifenacin,Debrisoquin,Debrisoquine 4-hydroxylase,Delavirdine,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dexmedetomidine,Dexmethylphenidate,Dextroamphetamine,Dextromethorphan,Dextropropoxyphene,Dihydrocodeine,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Dolasetron,Domperidone,Donepezil,Dopamine,Doxazosin,Doxepin,Doxorubicin,Dronedarone,DRUG,drug binding,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Duloxetine,Efavirenz,Eletriptan,Encainide,endoplasmic,endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Epinastine,Erlotinib,Escitalopram,ESTROGEN,Ethylmorphine,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felodipine,Fesoterodine,Fexofenadine,Fingolimod,Flecainide,Flunarizine,Fluoxetine,Fluphenazine,Fluvastatin,Fluvoxamine,Formoterol,Galantamine,Gefitinib,Glutethimide,Granisetron,Halofantrine,Haloperidol,Halothane,heme,heme binding,heterocycle metabolic process,Histamine Phosphate,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Hydrocodone,Hydromorphone,Hydroxychloroquine,Hydroxyurea,Hydroxyzine,Idarubicin,Iloperidone,Imatinib,Imipramine,Indinavir,Ipratropium bromide,Irbesartan,iron,iron ion binding,isoforms,Isoniazid,isoquinoline alkaloid metabolic process,Itraconazole,Ketoconazole,L-DOPA,Labetalol,Lansoprazole,Lercanidipine,Levomilnacipran,Lidocaine,Lisuride,Lomustine,Loperamide,Lopinavir,Loratadine,Lorcaserin,Lovastatin,Lumefantrine,Maprotiline,Mefloquine,Membrane,Mepyramine,Mequitazine,Mesoridazine,Metal-binding,Methadone,Methamphetamine,Methazolamide,Methimazole,Methotrimeprazine,Methoxyflurane,Methylnaltrexone,Methylphenidate,Methyprylon,Metoclopramide,Metoprolol,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,Midodrine,Mifepristone,Minaprine,Mirabegron,Mirtazapine,mitochondria,mitochondrial,mitochondrion,Moclobemide,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,Morphine,NADPH,Nateglinide,Nebivolol,Nefazodone,negative regulation of binding,negative regulation of cellular organofluorine metabolic process,Nelfinavir,Nevirapine,Niacin,Nicardipine,Nicergoline,Nicotine,Nifedipine,Nilotinib,Nitrofural,Nortriptyline,Olanzapine,Omeprazole,Ondansetron,Oxamniquine,OXIDATION,oxidation-reduction process,oxidative demethylation",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs5030865",
        "SNP Name": "CYP2D6*14 1758G>A",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.biomedcentral.com/1471-2407/12/568",
        "Video": "ROMlBdGf908",
        "Tags": "Abiraterone,Acebutolol,Acetaminophen,acting on paired donors,adrenoceptor antagonists,Ajmaline,alkaloid catabolic process,alkaloid metabolic process,Almotriptan,Alogliptin,Alprenolol,Aminophenazone,Amiodarone,Amitriptyline,Amlodipine,Amodiaquine,Amoxapine,Amphetamine,Amprenavir,Amsacrine,and incorporation of one atom of oxygen,antagonist,antiarrhythmics,antidepressant,antidepressant metabolism,Antidepressant toxicity,antipsychotics toxicity,Antipyrine,Aprindine,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Aripiprazole,aromatase activity,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atomoxetine,Atorvastatin,Azelastine,Benzatropine,Benzyl alcohol,Bepridil,Betaxolol,Bicalutamide,Biperiden,Bisoprolol,Bortezomib,Brompheniramine,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Caffeine,CANCER,CANCEROUS,Captopril,Carbinoxamine,CARCINOGEN,Carteolol,Carvedilol,Celecoxib,Cephalexin,Cevimeline,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Cholesterol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,Cinnarizine,Cisapride,Citalopram,Clemastine,Clevidipine,Clomipramine,Clonidine,Clotrimazole,Clozapine,Cocaine,Codeine,Codeine toxicity,COMPOUNDS,coumarin metabolic process,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2D6,CYPIID6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2D6,Cytochrome P450-DB1,Dapagliflozin,Darifenacin,Debrisoquin,debrisoquine,Debrisoquine 4-hydroxylase,debrisoquine metabolism,Delavirdine,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dexmedetomidine,Dexmethylphenidate,Dextroamphetamine,Dextromethorphan,Dextropropoxyphene,Dihydrocodeine,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Dolasetron,Domperidone,Donepezil,Dopamine,Doxazosin,Doxepin,Doxorubicin,Dronedarone,DRUG,drug binding,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Duloxetine,Efavirenz,Eletriptan,Encainide,endoplasmic,endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Epinastine,Erlotinib,Escitalopram,ESTROGEN,Ethylmorphine,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felodipine,Fesoterodine,Fexofenadine,Fingolimod,Flecainide,Flunarizine,Fluoxetine,Fluphenazine,Fluvastatin,Fluvoxamine,Formoterol,Galantamine,Gefitinib,Glutethimide,Granisetron,Halofantrine,Haloperidol,Halothane,heme,heme binding,heterocycle metabolic process,Histamine Phosphate,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Hydrocodone,Hydromorphone,Hydroxychloroquine,Hydroxyurea,Hydroxyzine,Idarubicin,Iloperidone,Imatinib,Imipramine,Indinavir,Ipratropium bromide,Irbesartan,iron,iron ion binding,isoforms,Isoniazid,isoquinoline alkaloid metabolic process,Itraconazole,Ketoconazole,L-DOPA,Labetalol,Lansoprazole,Lercanidipine,Levomilnacipran,Lidocaine,Lisuride,Lomustine,Loperamide,Lopinavir,Loratadine,Lorcaserin,Lovastatin,Lumefantrine,Maprotiline,Mefloquine,Membrane,Mepyramine,Mequitazine,Mesoridazine,Metal-binding,Methadone,Methamphetamine,Methazolamide,Methimazole,Methotrimeprazine,Methoxyflurane,Methylnaltrexone,Methylphenidate,Methyprylon,Metoclopramide,Metoprolol,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,Midodrine,Mifepristone,Minaprine,Mirabegron,Mirtazapine,mitochondria,mitochondrial,mitochondrion,Moclobemide,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,Morphine,NADPH,Nateglinide,Nebivolol,Nefazodone,negative regulation of binding,negative regulation of cellular organofluorine metabolic process,Nelfinavir,Nevirapine,Niacin,Nicardipine,Nicergoline,Nicotine,Nifedipine,Nilotinib,Nitrofural,Nortriptyline,Olanzapine,Omeprazole,Ondansetron,Oxamniquine,OXIDATION,oxidation-red",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs61736512",
        "SNP Name": "CYP2D6 G1659A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373606/",
        "Video": "ROMlBdGf908",
        "Tags": "Abiraterone,Acebutolol,Acetaminophen,acting on paired donors,adrenoceptor antagonists,Ajmaline,alkaloid catabolic process,alkaloid metabolic process,Almotriptan,Alogliptin,Alprenolol,Aminophenazone,Amiodarone,Amitriptyline,Amlodipine,Amodiaquine,Amoxapine,Amphetamine,Amprenavir,Amsacrine,and incorporation of one atom of oxygen,antagonist,antiarrhythmics,antidepressant,antidepressant metabolism,Antidepressant toxicity,antipsychotics toxicity,Antipyrine,Aprindine,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Aripiprazole,aromatase activity,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atomoxetine,Atorvastatin,Azelastine,Benzatropine,Benzyl alcohol,Bepridil,Betaxolol,Bicalutamide,Biperiden,Bisoprolol,Bortezomib,Brompheniramine,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Caffeine,CANCER,CANCEROUS,Captopril,Carbinoxamine,CARCINOGEN,Carteolol,Carvedilol,Celecoxib,Cephalexin,Cevimeline,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Cholesterol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,Cinnarizine,Cisapride,Citalopram,Clemastine,Clevidipine,Clomipramine,Clonidine,Clotrimazole,Clozapine,Cocaine,Codeine,Codeine toxicity,COMPOUNDS,coumarin metabolic process,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2D6,CYPIID6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2D6,Cytochrome P450-DB1,Dapagliflozin,Darifenacin,Debrisoquin,Debrisoquine 4-hydroxylase,Delavirdine,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dexmedetomidine,Dexmethylphenidate,Dextroamphetamine,Dextromethorphan,Dextropropoxyphene,Dihydrocodeine,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Dolasetron,Domperidone,Donepezil,Dopamine,Doxazosin,Doxepin,Doxorubicin,Dronedarone,DRUG,drug binding,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Duloxetine,Efavirenz,Eletriptan,Encainide,endoplasmic,endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Epinastine,Erlotinib,Escitalopram,ESTROGEN,Ethylmorphine,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felodipine,Fesoterodine,Fexofenadine,Fingolimod,Flecainide,Flunarizine,Fluoxetine,Fluphenazine,Fluvastatin,Fluvoxamine,Formoterol,Galantamine,Gefitinib,Glutethimide,Granisetron,Halofantrine,Haloperidol,Halothane,heme,heme binding,heterocycle metabolic process,Histamine Phosphate,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Hydrocodone,Hydromorphone,Hydroxychloroquine,Hydroxyurea,Hydroxyzine,Idarubicin,Iloperidone,Imatinib,Imipramine,Indinavir,Ipratropium bromide,Irbesartan,iron,iron ion binding,isoforms,Isoniazid,isoquinoline alkaloid metabolic process,Itraconazole,Ketoconazole,L-DOPA,Labetalol,Lansoprazole,Lercanidipine,Levomilnacipran,Lidocaine,Lisuride,Lomustine,Loperamide,Lopinavir,Loratadine,Lorcaserin,Lovastatin,Lumefantrine,Maprotiline,Mefloquine,Membrane,Mepyramine,Mequitazine,Mesoridazine,Metal-binding,Methadone,Methamphetamine,Methazolamide,Methimazole,Methotrimeprazine,Methoxyflurane,Methylnaltrexone,Methylphenidate,Methyprylon,Metoclopramide,Metoprolol,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,Midodrine,Mifepristone,Minaprine,Mirabegron,Mirtazapine,mitochondria,mitochondrial,mitochondrion,Moclobemide,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,Morphine,NADPH,Nateglinide,Nebivolol,Nefazodone,negative regulation of binding,negative regulation of cellular organofluorine metabolic process,Nelfinavir,Nevirapine,Niacin,Nicardipine,Nicergoline,Nicotine,Nifedipine,Nilotinib,Nitrofural,Nortriptyline,Olanzapine,Omeprazole,Ondansetron,Oxamniquine,OXIDATION,oxidation-reduction process,oxidative demethylation",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs28371706",
        "SNP Name": "CYP2D6*17 T107I",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs28371706",
        "Video": "ROMlBdGf908",
        "Tags": "Abiraterone,Acebutolol,Acetaminophen,acting on paired donors,adrenoceptor antagonists,Ajmaline,alkaloid catabolic process,alkaloid metabolic process,Almotriptan,Alogliptin,Alprenolol,Aminophenazone,Amiodarone,Amitriptyline,Amlodipine,Amodiaquine,Amoxapine,Amphetamine,Amprenavir,Amsacrine,and incorporation of one atom of oxygen,antagonist,antiarrhythmics,antidepressant,antidepressant metabolism,Antidepressant toxicity,antipsychotics toxicity,Antipyrine,Aprindine,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Aripiprazole,aromatase activity,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atomoxetine,Atorvastatin,Azelastine,Benzatropine,Benzyl alcohol,Bepridil,Betaxolol,Bicalutamide,Biperiden,Bisoprolol,Bortezomib,Brompheniramine,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Caffeine,CANCER,CANCEROUS,Captopril,Carbinoxamine,CARCINOGEN,Carteolol,Carvedilol,Celecoxib,Cephalexin,Cevimeline,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Cholesterol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,Cinnarizine,Cisapride,Citalopram,Clemastine,Clevidipine,Clomipramine,Clonidine,Clotrimazole,Clozapine,Cocaine,Codeine,Codeine toxicity,COMPOUNDS,coumarin metabolic process,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2D6,CYPIID6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2D6,Cytochrome P450-DB1,Dapagliflozin,Darifenacin,Debrisoquin,Debrisoquine 4-hydroxylase,Delavirdine,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dexmedetomidine,Dexmethylphenidate,Dextroamphetamine,Dextromethorphan,Dextropropoxyphene,Dihydrocodeine,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Dolasetron,Domperidone,Donepezil,Dopamine,Doxazosin,Doxepin,Doxorubicin,Dronedarone,DRUG,drug binding,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Duloxetine,Efavirenz,Eletriptan,Encainide,endoplasmic,endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Epinastine,Erlotinib,Escitalopram,ESTROGEN,Ethylmorphine,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felodipine,Fesoterodine,Fexofenadine,Fingolimod,Flecainide,Flunarizine,Fluoxetine,Fluphenazine,Fluvastatin,Fluvoxamine,Formoterol,Galantamine,Gefitinib,Glutethimide,Granisetron,Halofantrine,Haloperidol,Halothane,heme,heme binding,heterocycle metabolic process,Histamine Phosphate,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Hydrocodone,Hydromorphone,Hydroxychloroquine,Hydroxyurea,Hydroxyzine,Idarubicin,Iloperidone,Imatinib,Imipramine,Indinavir,Ipratropium bromide,Irbesartan,iron,iron ion binding,isoforms,Isoniazid,isoquinoline alkaloid metabolic process,Itraconazole,Ketoconazole,L-DOPA,Labetalol,Lansoprazole,Lercanidipine,Levomilnacipran,Lidocaine,Lisuride,Lomustine,Loperamide,Lopinavir,Loratadine,Lorcaserin,Lovastatin,Lumefantrine,Maprotiline,Mefloquine,Membrane,Mepyramine,Mequitazine,Mesoridazine,Metal-binding,Methadone,Methamphetamine,Methazolamide,Methimazole,Methotrimeprazine,Methoxyflurane,Methylnaltrexone,Methylphenidate,Methyprylon,Metoclopramide,Metoprolol,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,Midodrine,Mifepristone,Minaprine,Mirabegron,Mirtazapine,mitochondria,mitochondrial,mitochondrion,Moclobemide,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,Morphine,NADPH,Nateglinide,Nebivolol,Nefazodone,negative regulation of binding,negative regulation of cellular organofluorine metabolic process,Nelfinavir,Nevirapine,Niacin,Nicardipine,Nicergoline,Nicotine,Nifedipine,Nilotinib,Nitrofural,Nortriptyline,Olanzapine,Omeprazole,Ondansetron,Oxamniquine,OXIDATION,oxidation-reduction process,oxidative demethylation",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs5030862",
        "SNP Name": "CYP2D6*12 124G>A",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2011.03905.x/full",
        "Video": "ROMlBdGf908",
        "Tags": "Abiraterone,Acebutolol,Acetaminophen,acting on paired donors,adrenoceptor antagonists,Ajmaline,alkaloid catabolic process,alkaloid metabolic process,Almotriptan,Alogliptin,Alprenolol,Aminophenazone,Amiodarone,Amitriptyline,Amlodipine,Amodiaquine,Amoxapine,Amphetamine,Amprenavir,Amsacrine,and incorporation of one atom of oxygen,antagonist,antiarrhythmics,antidepressant,antidepressant metabolism,Antidepressant toxicity,antipsychotics toxicity,Antipyrine,Aprindine,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Aripiprazole,aromatase activity,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atomoxetine,Atorvastatin,Azelastine,Benzatropine,Benzyl alcohol,Bepridil,Betaxolol,Bicalutamide,Biperiden,Bisoprolol,Bortezomib,Brompheniramine,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Caffeine,CANCER,CANCEROUS,Captopril,Carbinoxamine,CARCINOGEN,Carteolol,Carvedilol,Celecoxib,Cephalexin,Cevimeline,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Cholesterol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,Cinnarizine,Cisapride,Citalopram,Clemastine,Clevidipine,Clomipramine,Clonidine,Clotrimazole,Clozapine,Cocaine,Codeine,Codeine toxicity,COMPOUNDS,coumarin metabolic process,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2D6,CYPIID6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2D6,Cytochrome P450-DB1,Dapagliflozin,Darifenacin,Debrisoquin,Debrisoquine 4-hydroxylase,Delavirdine,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dexmedetomidine,Dexmethylphenidate,Dextroamphetamine,Dextromethorphan,Dextropropoxyphene,Dihydrocodeine,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Dolasetron,Domperidone,Donepezil,Dopamine,Doxazosin,Doxepin,Doxorubicin,Dronedarone,DRUG,drug binding,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Duloxetine,Efavirenz,Eletriptan,Encainide,endoplasmic,endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Epinastine,Erlotinib,Escitalopram,ESTROGEN,Ethylmorphine,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felodipine,Fesoterodine,Fexofenadine,Fingolimod,Flecainide,Flunarizine,Fluoxetine,Fluphenazine,Fluvastatin,Fluvoxamine,Formoterol,Galantamine,Gefitinib,Glutethimide,Granisetron,Halofantrine,Haloperidol,Halothane,heme,heme binding,heterocycle metabolic process,Histamine Phosphate,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Hydrocodone,Hydromorphone,Hydroxychloroquine,Hydroxyurea,Hydroxyzine,Idarubicin,Iloperidone,Imatinib,Imipramine,Indinavir,Ipratropium bromide,Irbesartan,iron,iron ion binding,isoforms,Isoniazid,isoquinoline alkaloid metabolic process,Itraconazole,Ketoconazole,L-DOPA,Labetalol,Lansoprazole,Lercanidipine,Levomilnacipran,Lidocaine,Lisuride,Lomustine,Loperamide,Lopinavir,Loratadine,Lorcaserin,Lovastatin,Lumefantrine,Maprotiline,Mefloquine,Membrane,Mepyramine,Mequitazine,Mesoridazine,Metal-binding,Methadone,Methamphetamine,Methazolamide,Methimazole,Methotrimeprazine,Methoxyflurane,Methylnaltrexone,Methylphenidate,Methyprylon,Metoclopramide,Metoprolol,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,Midodrine,Mifepristone,Minaprine,Mirabegron,Mirtazapine,mitochondria,mitochondrial,mitochondrion,Moclobemide,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,Morphine,NADPH,Nateglinide,Nebivolol,Nefazodone,negative regulation of binding,negative regulation of cellular organofluorine metabolic process,Nelfinavir,Nevirapine,Niacin,Nicardipine,Nicergoline,Nicotine,Nifedipine,Nilotinib,Nitrofural,Nortriptyline,Olanzapine,Omeprazole,Ondansetron,Oxamniquine,OXIDATION,oxidation-reduction process,oxidative demethylation",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs1080985",
        "SNP Name": "CYP2D6 G3502C",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Rs1080985",
        "Video": "ROMlBdGf908",
        "Tags": "Abiraterone,Acebutolol,Acetaminophen,acting on paired donors,AD,adrenoceptor antagonists,Ajmaline,alkaloid catabolic process,alkaloid metabolic process,Almotriptan,Alogliptin,Alprenolol,Alzheimer,Alzheimer's disease,Aminophenazone,Amiodarone,Amitriptyline,Amlodipine,Amodiaquine,Amoxapine,Amphetamine,Amprenavir,Amsacrine,and incorporation of one atom of oxygen,antagonist,antiarrhythmics,antidepressant,antidepressant metabolism,Antidepressant toxicity,antipsychotics toxicity,Antipyrine,Aprindine,arachidonic acid epoxygenase activity,arachidonic acid metabolic process,Arformoterol,Aripiprazole,aromatase activity,Artemether,ARTIFICIAL ESTROGEN,Asenapine,Astemizole,Atomoxetine,Atorvastatin,Azelastine,Benzatropine,Benzyl alcohol,Bepridil,Betaxolol,Bicalutamide,Biperiden,Bisoprolol,Bortezomib,Brompheniramine,Bupivacaine,Buprenorphine,Bupropion,Buspirone,Caffeine,CANCER,CANCEROUS,Captopril,Carbinoxamine,CARCINOGEN,Carteolol,Carvedilol,Celecoxib,Cephalexin,Cevimeline,Chlordiazepoxide,Chloroquine,Chlorphenamine,Chlorpromazine,Chlorzoxazone,Cholecalciferol,Cholesterol,Ciclesonide,Cilostazol,Cimetidine,Cinacalcet,Cinnarizine,Cisapride,Citalopram,Clemastine,Clevidipine,Clomipramine,Clonidine,Clotrimazole,Clozapine,Cocaine,Codeine,Codeine toxicity,COMPOUNDS,coumarin metabolic process,Cyclobenzaprine,Cyclophosphamide,Cyclosporine,CYP,CYP P450,CYP2D6,CYPIID6,CYTOCHROME,CYTOCHROME P450,Cytochrome P450 2D6,Cytochrome P450-DB1,Dapagliflozin,Darifenacin,Debrisoquin,debrisoquine,Debrisoquine 4-hydroxylase,debrisoquine ultrarapid hydroxylation,Delavirdine,Desipramine,Desloratadine,DETOX,DETOXIFICATION,Dexamethasone,Dexfenfluramine,Dexmedetomidine,Dexmethylphenidate,Dextroamphetamine,Dextromethorphan,Dextropropoxyphene,Dihydrocodeine,Diltiazem,Dimethyl sulfoxide,Diphenhydramine,Dolasetron,Domperidone,Donepezil,Donepezil response,Dopamine,Doxazosin,Doxepin,Doxorubicin,Dronedarone,DRUG,drug binding,drug catabolic process,drug metabolic process,DRUG METABOLISM,DRUG POISONING,DRUG TOXICITY,DRUGS,DRUX TOXICITY,Duloxetine,Efavirenz,Eletriptan,Encainide,endoplasmic,endoplasmic reticulum,Endoplasmic reticulum membrane,ENVIRONMENT,ENVIRONMENTAL,ENVIRONMENTAL FACTORS,Enzalutamide,enzyme,Epinastine,Erlotinib,Escitalopram,ESTROGEN,Ethylmorphine,Etoricoxib,exogenous drug catabolic process,FAST METABOLIZER,FATTY ACIDS,Felodipine,Fesoterodine,Fexofenadine,Fingolimod,Flecainide,Flunarizine,Fluoxetine,Fluphenazine,Fluvastatin,Fluvoxamine,Formoterol,Galantamine,Gefitinib,Glutethimide,Granisetron,Halofantrine,Haloperidol,Halothane,heme,heme binding,heterocycle metabolic process,Histamine Phosphate,HORMONAL BALANCE,Hormonal carcinogenesis,HORMONAL IMBALANCE,HORMONE,Hydrocodone,Hydromorphone,Hydroxychloroquine,Hydroxyurea,Hydroxyzine,Idarubicin,Iloperidone,Imatinib,Imipramine,Indinavir,Ipratropium bromide,Irbesartan,iron,iron ion binding,isoforms,Isoniazid,isoquinoline alkaloid metabolic process,Itraconazole,Ketoconazole,L-DOPA,Labetalol,Lansoprazole,Lercanidipine,Levomilnacipran,Lidocaine,Lisuride,Lomustine,Loperamide,Lopinavir,Loratadine,Lorcaserin,Lovastatin,Lumefantrine,Maprotiline,Mefloquine,Membrane,Mepyramine,Mequitazine,Mesoridazine,mesoridazine plasma concentration,Metal-binding,Methadone,Methamphetamine,Methazolamide,Methimazole,Methotrimeprazine,Methoxyflurane,Methylnaltrexone,Methylphenidate,Methyprylon,Metoclopramide,Metoprolol,Mexiletine,Mianserin,Miconazole,Microsome,Microsome membrane,Midodrine,Mifepristone,Minaprine,Mirabegron,Mirtazapine,mitochondria,mitochondrial,mitochondrion,Moclobemide,Monooxygenase,monooxygenase activity,monoterpenoid metabolic process,Morphine,NADPH,Nateglinide,Nebivolol,Nefazodone,negative regulation of binding,negative regulation of cellular organofluorine metabolic process,Nelfinavir,Nevirapine,Niacin,Nicardipine,Nicergoline,Nicotine,Nifedipine,Nilotin",
        "Group": "Liver Detox - Phase I"
    },
    {
        "SNP ID": "rs7062536",
        "SNP Name": "PRPS2 G12839152A",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=rs7062536",
        "Video": null,
        "Tags": "2,3-bisphosphoglyceride,5-phospho-alpha-D-ribose 1-diphosphate,5-phospho-alpha-D-ribose 1-diphosphate     biosynthesis,5-phospho-alpha-D-ribose 1-diphosphate biosynthesis,5-phospho-alpha-D-ribose 1-diphosphate from D-ribose 5-phosphate (route I),5-Phosphoribose 1-diphosphate,ADP,ADP binding,AMP,AMP binding,AMP biosynthetic process,ATP,ATP binding,ATP-binding,Binding of phosphoribosylpyrophosphate,Carbohydrate binding,Complete proteome,D-ribose 5-phosphate,D-ribose 5-phosphate (route I),Direct protein sequencing,extracellular esosome,G12839152A,GDP,GDP binding,identical protein binding,inorganic phosphate,Kinase,kinase activity,magnesium,magnesium ion binding,Metabolic intermediate biosynthesis,Metal binding,Nucleiotide binding,nucleobase-containing compound metabolic process,Nucleotide biosynethesis,nucleotide synthesis,organ regeneration,pentose-phosphate pathway,phosphoribosyl 1-pyrophosphate,phosphoribosyl pyrophosphate,phosphoribosyl pyrophosphate synthetase 2,protein homodimerization activity,PRPS1,PRPS1L1,PRPS2,purines,pyrimidines,Reference proteopme,ribose phosphate diphosophokinase complex,ribose phosphate diphosphokinase activity,Ribose-phosphate pyrophosphokinase 1,Ribose-phosphate pyrophosphokinase 2,Ribose-phosphate pyrophosphokinase 3,rs7062536,Transferase",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs2048683",
        "SNP Name": "ACE2 variant",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "Covid Report",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Covid"
    },
    {
        "SNP ID": "rs1800278",
        "SNP Name": "DMD N2912D",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Hydroxyphosphate Sulfate"
    },
    {
        "SNP ID": "rs1800278",
        "SNP Name": "DMD N2912D",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Phosphate"
    },
    {
        "SNP ID": "rs1800278",
        "SNP Name": "DMD N2912D",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dipotassium Phosphate"
    },
    {
        "SNP ID": "rs1800278",
        "SNP Name": "DMD N2912D",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Disodium Phosphate"
    },
    {
        "SNP ID": "rs1800278",
        "SNP Name": "DMD N2912D",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Monopotassium Phosphate"
    },
    {
        "SNP ID": "rs1800278",
        "SNP Name": "DMD N2912D",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Monosodium Phosphate"
    },
    {
        "SNP ID": "rs1800278",
        "SNP Name": "DMD N2912D",
        "Risk Allele": "T",
        "Your Allele": "TT",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phosphate-Buffered Saline"
    },
    {
        "SNP ID": "rs921896",
        "SNP Name": "DMD T32213962C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Hydroxyphosphate Sulfate"
    },
    {
        "SNP ID": "rs921896",
        "SNP Name": "DMD T32213962C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Aluminum Phosphate"
    },
    {
        "SNP ID": "rs921896",
        "SNP Name": "DMD T32213962C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Dipotassium Phosphate"
    },
    {
        "SNP ID": "rs921896",
        "SNP Name": "DMD T32213962C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Disodium Phosphate"
    },
    {
        "SNP ID": "rs921896",
        "SNP Name": "DMD T32213962C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Monopotassium Phosphate"
    },
    {
        "SNP ID": "rs921896",
        "SNP Name": "DMD T32213962C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Monosodium Phosphate"
    },
    {
        "SNP ID": "rs921896",
        "SNP Name": "DMD T32213962C",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Phosphate-Buffered Saline"
    },
    {
        "SNP ID": "rs5953210",
        "SNP Name": "MAOA G3638A",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=rs5953210",
        "Video": null,
        "Tags": "5-ht,5-htp,5-hydroxytryptamine,5ht,5htp,Acetylation,aggression,Alternative splicing,Amine oxidase [flavin-containing] A,amines,biogenic,blood vessels,Brunner syndrome (BRUNS),BRUNS,Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues,Catecholamine metabolism,catecholamines,cellular biogenic amine metabolic process,central nervous system,Cytoplasmic side,dopamine,dopamine catabolic process,duodenum,energy,epinephrine,FAD,female agression,female anger,flavin,flavin monoamine oxidase family,Flavoprotein,Heart,heterodimer,homodimer,impulsive aggression,integral component of membrane,kidney,liver,MAO-A,MAOA,MAOA preferentially oxidizes biogenic amines such as 5-hydroxytryptamine (5-HT),Membrane,mental disorder,Mental retardation,mitochondria,mitochondrial outer membrane,mitochondrion,Mitochondrion outer membrane,Mitochondrion outer membrane; Single-pass type IV membrane protein,monoamine,Monoamine oxidase A deficiency,Monoamine oxidase type A,Monomer,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,neurotransmitter secretion,neurotransmitters,non-dysmorphic mild mental retardation,norepinephrine,norepinephrine and epinephrine,oxidative stress,Oxidoreductase,peripheral tissue,Polymorphism,primary amine oxidase activity,psychology,RCH2NHR' + H2O + O2 = RCHO + R'NH2 + H2O2,riboflavin,ribose,serotonin,small molecule metabolic process,synaptic transmission,Transmembrane,Transmembrane helix,warrior gene,X-chromosome,X-linked,xenobiotic metabolic process,xenobiotics",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs5953210",
        "SNP Name": "MAOA G3638A",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pubmed/?term=rs5953210",
        "Video": null,
        "Tags": "5-ht,5-htp,5-hydroxytryptamine,5ht,5htp,Acetylation,aggression,Alternative splicing,Amine oxidase [flavin-containing] A,amines,biogenic,blood vessels,Brunner syndrome (BRUNS),BRUNS,Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues,Catecholamine metabolism,catecholamines,cellular biogenic amine metabolic process,central nervous system,Cytoplasmic side,dopamine,dopamine catabolic process,duodenum,energy,epinephrine,FAD,female agression,female anger,flavin,flavin monoamine oxidase family,Flavoprotein,Heart,heterodimer,homodimer,impulsive aggression,integral component of membrane,kidney,liver,MAO-A,MAOA,MAOA preferentially oxidizes biogenic amines such as 5-hydroxytryptamine (5-HT),Membrane,mental disorder,Mental retardation,mitochondria,mitochondrial outer membrane,mitochondrion,Mitochondrion outer membrane,Mitochondrion outer membrane; Single-pass type IV membrane protein,monoamine,Monoamine oxidase A deficiency,Monoamine oxidase type A,Monomer,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,neurotransmitter secretion,neurotransmitters,non-dysmorphic mild mental retardation,norepinephrine,norepinephrine and epinephrine,oxidative stress,Oxidoreductase,peripheral tissue,Polymorphism,primary amine oxidase activity,psychology,RCH2NHR' + H2O + O2 = RCHO + R'NH2 + H2O2,riboflavin,ribose,serotonin,small molecule metabolic process,synaptic transmission,Transmembrane,Transmembrane helix,warrior gene,X-chromosome,X-linked,xenobiotic metabolic process,xenobiotics",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs5906957",
        "SNP Name": "MAOA A36902G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5906957",
        "Video": null,
        "Tags": "5-ht,5-htp,5-hydroxytryptamine,5ht,5htp,Acetylation,aggression,Alternative splicing,Amine oxidase [flavin-containing] A,amines,anger,anger management,anger regulation,biogenic,blood vessels,Brunner syndrome (BRUNS),BRUNS,Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues,Catecholamine metabolism,catecholamines,cellular biogenic amine metabolic process,central nervous system,Cytoplasmic side,dopamine,dopamine catabolic process,duodenum,energy,epinephrine,FAD,flavin,flavin monoamine oxidase family,Flavoprotein,Heart,heterodimer,homodimer,impulsive aggression,integral component of membrane,kidney,liver,male behavior,male mental retardation,MAO-A,MAOA,MAOA preferentially oxidizes biogenic amines such as 5-hydroxytryptamine (5-HT),Membrane,mental disorder,Mental retardation,mitochondria,mitochondrial outer membrane,mitochondrion,Mitochondrion outer membrane,Mitochondrion outer membrane; Single-pass type IV membrane protein,monoamine,Monoamine oxidase A deficiency,Monoamine oxidase type A,Monomer,Negative emotionality,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,neurotransmitter secretion,neurotransmitters,non-dysmorphic mild mental retardation,norepinephrine,norepinephrine and epinephrine,oxidative stress,Oxidoreductase,parkinson,parkinson's,Parkinson's disease,PD,peripheral tissue,personality traits,Polymorphism,primary amine oxidase activity,psychology,RCH2NHR' + H2O + O2 = RCHO + R'NH2 + H2O2,riboflavin,ribose,serotonin,small molecule metabolic process,stress tolerance,synaptic transmission,Transmembrane,Transmembrane helix,warrior gene,X-chromosome,X-linked,xenobiotic metabolic process,xenobiotics",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs5906957",
        "SNP Name": "MAOA A36902G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5906957",
        "Video": null,
        "Tags": "5-ht,5-htp,5-hydroxytryptamine,5ht,5htp,Acetylation,aggression,Alternative splicing,Amine oxidase [flavin-containing] A,amines,anger,anger management,anger regulation,biogenic,blood vessels,Brunner syndrome (BRUNS),BRUNS,Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues,Catecholamine metabolism,catecholamines,cellular biogenic amine metabolic process,central nervous system,Cytoplasmic side,dopamine,dopamine catabolic process,duodenum,energy,epinephrine,FAD,flavin,flavin monoamine oxidase family,Flavoprotein,Heart,heterodimer,homodimer,impulsive aggression,integral component of membrane,kidney,liver,male behavior,male mental retardation,MAO-A,MAOA,MAOA preferentially oxidizes biogenic amines such as 5-hydroxytryptamine (5-HT),Membrane,mental disorder,Mental retardation,mitochondria,mitochondrial outer membrane,mitochondrion,Mitochondrion outer membrane,Mitochondrion outer membrane; Single-pass type IV membrane protein,monoamine,Monoamine oxidase A deficiency,Monoamine oxidase type A,Monomer,Negative emotionality,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,neurotransmitter secretion,neurotransmitters,non-dysmorphic mild mental retardation,norepinephrine,norepinephrine and epinephrine,oxidative stress,Oxidoreductase,parkinson,parkinson's,Parkinson's disease,PD,peripheral tissue,personality traits,Polymorphism,primary amine oxidase activity,psychology,RCH2NHR' + H2O + O2 = RCHO + R'NH2 + H2O2,riboflavin,ribose,serotonin,small molecule metabolic process,stress tolerance,synaptic transmission,Transmembrane,Transmembrane helix,warrior gene,X-chromosome,X-linked,xenobiotic metabolic process,xenobiotics",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs909525",
        "SNP Name": "MAOA C42794T",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs909525",
        "Video": null,
        "Tags": "5-ht,5-htp,5-hydroxytryptamine,5ht,5htp,Acetylation,acute post-surgical pain,aggression,Alternative splicing,Amine oxidase [flavin-containing] A,amines,biogenic,blood vessels,Brunner syndrome (BRUNS),BRUNS,Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues,Catecholamine metabolism,catecholamines,cellular biogenic amine metabolic process,central nervous system,Cytoplasmic side,depression,dopamine,dopamine catabolic process,duodenum,energy,epinephrine,FAD,flavin,flavin monoamine oxidase family,Flavoprotein,Heart,heterodimer,homodimer,impulsive aggression,integral component of membrane,kidney,liver,male behavior,male mental retardation,MAO-A,MAOA,MAOA preferentially oxidizes biogenic amines such as 5-hydroxytryptamine (5-HT),Membrane,mental disorder,Mental retardation,mitochondria,mitochondrial outer membrane,mitochondrion,Mitochondrion outer membrane,Mitochondrion outer membrane; Single-pass type IV membrane protein,monoamine,Monoamine oxidase A deficiency,Monoamine oxidase type A,Monomer,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,neurotransmitter secretion,neurotransmitters,non-dysmorphic mild mental retardation,norepinephrine,norepinephrine and epinephrine,oxidative stress,Oxidoreductase,parkinson,parkinson's,Parkinson's disease,PD,peripheral tissue,Polymorphism,primary amine oxidase activity,psychology,RCH2NHR' + H2O + O2 = RCHO + R'NH2 + H2O2,riboflavin,ribose,serotonin,small molecule metabolic process,suicidal,suicidal behavior,suicide,synaptic transmission,Transmembrane,Transmembrane helix,warrior gene,X-chromosome,X-linked,xenobiotic metabolic process,xenobiotics",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs909525",
        "SNP Name": "MAOA C42794T",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs909525",
        "Video": null,
        "Tags": "5-ht,5-htp,5-hydroxytryptamine,5ht,5htp,Acetylation,acute post-surgical pain,aggression,Alternative splicing,Amine oxidase [flavin-containing] A,amines,biogenic,blood vessels,Brunner syndrome (BRUNS),BRUNS,Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues,Catecholamine metabolism,catecholamines,cellular biogenic amine metabolic process,central nervous system,Cytoplasmic side,depression,dopamine,dopamine catabolic process,duodenum,energy,epinephrine,FAD,flavin,flavin monoamine oxidase family,Flavoprotein,Heart,heterodimer,homodimer,impulsive aggression,integral component of membrane,kidney,liver,male behavior,male mental retardation,MAO-A,MAOA,MAOA preferentially oxidizes biogenic amines such as 5-hydroxytryptamine (5-HT),Membrane,mental disorder,Mental retardation,mitochondria,mitochondrial outer membrane,mitochondrion,Mitochondrion outer membrane,Mitochondrion outer membrane; Single-pass type IV membrane protein,monoamine,Monoamine oxidase A deficiency,Monoamine oxidase type A,Monomer,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,neurotransmitter secretion,neurotransmitters,non-dysmorphic mild mental retardation,norepinephrine,norepinephrine and epinephrine,oxidative stress,Oxidoreductase,parkinson,parkinson's,Parkinson's disease,PD,peripheral tissue,Polymorphism,primary amine oxidase activity,psychology,RCH2NHR' + H2O + O2 = RCHO + R'NH2 + H2O2,riboflavin,ribose,serotonin,small molecule metabolic process,suicidal,suicidal behavior,suicide,synaptic transmission,Transmembrane,Transmembrane helix,warrior gene,X-chromosome,X-linked,xenobiotic metabolic process,xenobiotics",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs6323",
        "SNP Name": "MAOA R297R/G492T/T941G",
        "Risk Allele": "G",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6323",
        "Video": null,
        "Tags": "5-ht,5-htp,5-hydroxytryptamine,5ht,5htp,Acetylation,ADHD,aggression,Alternative splicing,Amine oxidase [flavin-containing] A,amines,associated with norepinephrine and epinephrine concentrations at rest and exercise,biogenic,bipolar,bipolar affective disorder,blood vessels,Brunner syndrome (BRUNS),BRUNS,Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues,Catecholamine metabolism,catecholamines,cellular biogenic amine metabolic process,central nervous system,Cytoplasmic side,dopamine,dopamine catabolic process,duodenum,energy,epinephrine,FAD,flavin,flavin monoamine oxidase family,Flavoprotein,Heart,heterodimer,homodimer,impulsive aggression,integral component of membrane,kidney,liver,male behavior,male mental retardation,MAO-A,MAOA,MAOA preferentially oxidizes biogenic amines such as 5-hydroxytryptamine (5-HT),Membrane,mental disorder,Mental retardation,mitochondria,mitochondrial outer membrane,mitochondrion,Mitochondrion outer membrane,Mitochondrion outer membrane; Single-pass type IV membrane protein,monoamine,Monoamine oxidase A deficiency,Monoamine oxidase type A,Monomer,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,neurotransmitter secretion,neurotransmitters,non-dysmorphic mild mental retardation,norepinephrine,norepinephrine and epinephrine,oxidative stress,Oxidoreductase,parkinson,parkinson's,Parkinson's disease,peripheral tissue,Pharmacogenetics,Pharmacogenetics of Antidepressants,Polymorphism,primary amine oxidase activity,psychology,RCH2NHR' + H2O + O2 = RCHO + R'NH2 + H2O2,riboflavin,ribose,schizophrenia,serotonin,small molecule metabolic process,synaptic transmission,Transmembrane,Transmembrane helix,warrior gene,X-chromosome,X-linked,xenobiotic metabolic process,xenobiotics",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs6323",
        "SNP Name": "MAOA R297R/G492T/T941G",
        "Risk Allele": "G",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6323",
        "Video": null,
        "Tags": "5-ht,5-htp,5-hydroxytryptamine,5ht,5htp,Acetylation,ADHD,aggression,Alternative splicing,Amine oxidase [flavin-containing] A,amines,associated with norepinephrine and epinephrine concentrations at rest and exercise,biogenic,bipolar,bipolar affective disorder,blood vessels,Brunner syndrome (BRUNS),BRUNS,Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues,Catecholamine metabolism,catecholamines,cellular biogenic amine metabolic process,central nervous system,Cytoplasmic side,dopamine,dopamine catabolic process,duodenum,energy,epinephrine,FAD,flavin,flavin monoamine oxidase family,Flavoprotein,Heart,heterodimer,homodimer,impulsive aggression,integral component of membrane,kidney,liver,male behavior,male mental retardation,MAO-A,MAOA,MAOA preferentially oxidizes biogenic amines such as 5-hydroxytryptamine (5-HT),Membrane,mental disorder,Mental retardation,mitochondria,mitochondrial outer membrane,mitochondrion,Mitochondrion outer membrane,Mitochondrion outer membrane; Single-pass type IV membrane protein,monoamine,Monoamine oxidase A deficiency,Monoamine oxidase type A,Monomer,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,neurotransmitter secretion,neurotransmitters,non-dysmorphic mild mental retardation,norepinephrine,norepinephrine and epinephrine,oxidative stress,Oxidoreductase,parkinson,parkinson's,Parkinson's disease,peripheral tissue,Pharmacogenetics,Pharmacogenetics of Antidepressants,Polymorphism,primary amine oxidase activity,psychology,RCH2NHR' + H2O + O2 = RCHO + R'NH2 + H2O2,riboflavin,ribose,schizophrenia,serotonin,small molecule metabolic process,synaptic transmission,Transmembrane,Transmembrane helix,warrior gene,X-chromosome,X-linked,xenobiotic metabolic process,xenobiotics",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs2235186",
        "SNP Name": "MAOA A85020G",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2235186",
        "Video": null,
        "Tags": "5-ht,5-htp,5-hydroxytryptamine,5ht,5htp,Acetylation,aggression,Alternative splicing,Amine oxidase [flavin-containing] A,amines,anger,anger management,anger regulation,biogenic,blood vessels,Brunner syndrome (BRUNS),BRUNS,Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues,Catecholamine metabolism,catecholamines,cellular biogenic amine metabolic process,central nervous system,cigarette smoking behaviors,Cytoplasmic side,dopamine,dopamine catabolic process,duodenum,energy,epinephrine,FAD,flavin,flavin monoamine oxidase family,Flavoprotein,Heart,heterodimer,homodimer,impulsive aggression,integral component of membrane,kidney,liver,male behavior,male mental retardation,MAO-A,MAOA,MAOA preferentially oxidizes biogenic amines such as 5-hydroxytryptamine (5-HT),Membrane,mental disorder,Mental retardation,mitochondria,mitochondrial outer membrane,mitochondrion,Mitochondrion outer membrane,Mitochondrion outer membrane; Single-pass type IV membrane protein,monoamine,Monoamine oxidase A deficiency,Monoamine oxidase type A,Monomer,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,neurotransmitter secretion,neurotransmitters,non-dysmorphic mild mental retardation,norepinephrine,norepinephrine and epinephrine,oxidative stress,Oxidoreductase,peripheral tissue,Polymorphism,primary amine oxidase activity,psychology,RCH2NHR' + H2O + O2 = RCHO + R'NH2 + H2O2,riboflavin,ribose,serotonin,small molecule metabolic process,stress tolerance,synaptic transmission,Transmembrane,Transmembrane helix,warrior gene,X-chromosome,X-linked,xenobiotic metabolic process,xenobiotics",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs2235186",
        "SNP Name": "MAOA A85020G",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2235186",
        "Video": null,
        "Tags": "5-ht,5-htp,5-hydroxytryptamine,5ht,5htp,Acetylation,aggression,Alternative splicing,Amine oxidase [flavin-containing] A,amines,anger,anger management,anger regulation,biogenic,blood vessels,Brunner syndrome (BRUNS),BRUNS,Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues,Catecholamine metabolism,catecholamines,cellular biogenic amine metabolic process,central nervous system,cigarette smoking behaviors,Cytoplasmic side,dopamine,dopamine catabolic process,duodenum,energy,epinephrine,FAD,flavin,flavin monoamine oxidase family,Flavoprotein,Heart,heterodimer,homodimer,impulsive aggression,integral component of membrane,kidney,liver,male behavior,male mental retardation,MAO-A,MAOA,MAOA preferentially oxidizes biogenic amines such as 5-hydroxytryptamine (5-HT),Membrane,mental disorder,Mental retardation,mitochondria,mitochondrial outer membrane,mitochondrion,Mitochondrion outer membrane,Mitochondrion outer membrane; Single-pass type IV membrane protein,monoamine,Monoamine oxidase A deficiency,Monoamine oxidase type A,Monomer,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,neurotransmitter secretion,neurotransmitters,non-dysmorphic mild mental retardation,norepinephrine,norepinephrine and epinephrine,oxidative stress,Oxidoreductase,peripheral tissue,Polymorphism,primary amine oxidase activity,psychology,RCH2NHR' + H2O + O2 = RCHO + R'NH2 + H2O2,riboflavin,ribose,serotonin,small molecule metabolic process,stress tolerance,synaptic transmission,Transmembrane,Transmembrane helix,warrior gene,X-chromosome,X-linked,xenobiotic metabolic process,xenobiotics",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1137070",
        "SNP Name": "MAOA T1011C/1460C",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1137070",
        "Video": null,
        "Tags": "5-ht,5-htp,5-hydroxytryptamine,5ht,5htp,Acetylation,ADHD,aggression,aggressive behavior,Alternative splicing,Amine oxidase [flavin-containing] A,amines,attention-deficit/hyperactivity disorder,biogenic,blood vessels,Brunner syndrome (BRUNS),BRUNS,Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues,Catecholamine metabolism,catecholamines,cellular biogenic amine metabolic process,central nervous system,Cytoplasmic side,dopamine,dopamine catabolic process,duodenum,energy,epinephrine,FAD,Familial Non-Lynch Syndrome Colorectal Cancer,flavin,flavin monoamine oxidase family,Flavoprotein,Heart,heterodimer,homodimer,impulsive aggression,integral component of membrane,kidney,liver,male behavior,male mental retardation,MAO-A,MAOA,MAOA preferentially oxidizes biogenic amines such as 5-hydroxytryptamine (5-HT),Membrane,mental disorder,Mental retardation,mitochondria,mitochondrial outer membrane,mitochondrion,Mitochondrion outer membrane,Mitochondrion outer membrane; Single-pass type IV membrane protein,monoamine,Monoamine oxidase A deficiency,Monoamine oxidase type A,Monomer,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,neurotransmitter secretion,neurotransmitters,non-dysmorphic mild mental retardation,norepinephrine,norepinephrine and epinephrine,oxidative stress,Oxidoreductase,parkinson,Parkinson\u2019s,Parkinson\u2019s Disease,peripheral tissue,pharmacogenetics,Polymorphism,primary amine oxidase activity,psychology,RCH2NHR' + H2O + O2 = RCHO + R'NH2 + H2O2,riboflavin,ribose,Schizophrenia,serotonin,small molecule metabolic process,synaptic transmission,Transmembrane,Transmembrane helix,warrior gene,Working memory brain activity and capacity,X-chromosome,X-linked,xenobiotic metabolic process,xenobiotics",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1137070",
        "SNP Name": "MAOA T1011C/1460C",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1137070",
        "Video": null,
        "Tags": "5-ht,5-htp,5-hydroxytryptamine,5ht,5htp,Acetylation,ADHD,aggression,aggressive behavior,Alternative splicing,Amine oxidase [flavin-containing] A,amines,attention-deficit/hyperactivity disorder,biogenic,blood vessels,Brunner syndrome (BRUNS),BRUNS,Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues,Catecholamine metabolism,catecholamines,cellular biogenic amine metabolic process,central nervous system,Cytoplasmic side,dopamine,dopamine catabolic process,duodenum,energy,epinephrine,FAD,Familial Non-Lynch Syndrome Colorectal Cancer,flavin,flavin monoamine oxidase family,Flavoprotein,Heart,heterodimer,homodimer,impulsive aggression,integral component of membrane,kidney,liver,male behavior,male mental retardation,MAO-A,MAOA,MAOA preferentially oxidizes biogenic amines such as 5-hydroxytryptamine (5-HT),Membrane,mental disorder,Mental retardation,mitochondria,mitochondrial outer membrane,mitochondrion,Mitochondrion outer membrane,Mitochondrion outer membrane; Single-pass type IV membrane protein,monoamine,Monoamine oxidase A deficiency,Monoamine oxidase type A,Monomer,neurotransmitter biosynthetic process,neurotransmitter catabolic process,Neurotransmitter degradation,neurotransmitter secretion,neurotransmitters,non-dysmorphic mild mental retardation,norepinephrine,norepinephrine and epinephrine,oxidative stress,Oxidoreductase,parkinson,Parkinson\u2019s,Parkinson\u2019s Disease,peripheral tissue,pharmacogenetics,Polymorphism,primary amine oxidase activity,psychology,RCH2NHR' + H2O + O2 = RCHO + R'NH2 + H2O2,riboflavin,ribose,Schizophrenia,serotonin,small molecule metabolic process,synaptic transmission,Transmembrane,Transmembrane helix,warrior gene,Working memory brain activity and capacity,X-chromosome,X-linked,xenobiotic metabolic process,xenobiotics",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1799836",
        "SNP Name": "MAOB A118723G",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1799836",
        "Video": null,
        "Tags": "Acetylation,alcohol,alcohol metabolism,Amine oxidase [flavin-containing] B,amines,benzylamine,central nervous system,CFS,Chronic Fatigue Syndrome,Cytoplasmic side,dopamine,dopaminergic neurotransmitters,drug metabolism,drug reaction,drugs,electron carrier activity,energy,ethanol,FAD,flavin,flavin adenine dinucleotide binding,flavin monoamine oxidase family,Flavoprotein,heterodimer,homodimer,integral component of membrane,MAOB,MAOB preferentially degrades benzylamine and phenylethylamine,Membrane,mitochondria,mitochondrial envelope,mitochondrial inner membrane,mitochondrial outer membrane,mitochondrion,Mitochondrion outer membrane,Monoamine oxidase type B,monomer,Negative and Positive Symptoms in Schizophrenia,negative regulation of serotonin secretion,neuroactive amines,Neurotransmitter-Related Genes and miRNAs in Egyptian Autistic Patients,Oxidoreductase,Pain Catastrophizing,Parkinson,parkinson's,Parkinson's disease,PD,peripheral tissues,phenol,phenylethylamine,positive regulation of dopamine metabolic process,primary amine oxidase activity,RCH2NHR' + H2O + O2 = RCHO + R'NH2 + H2O2,response to aluminum ion,response to corticosterone,response to drug,response to ethanol,response to lipopolysaccharide,response to selenium ion,response to toxic substance,schizophrenia,selenium,serotonin,Single-pass type IV,small molecule metabolic process,substantia nigra development,toxicology,toxins,Transmembrane,Transmembrane helix,vasoactive amines,xenobiotic metabolic process,xenobiotics",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs1799836",
        "SNP Name": "MAOB A118723G",
        "Risk Allele": "C",
        "Your Allele": "CC",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1799836",
        "Video": null,
        "Tags": "Acetylation,alcohol,alcohol metabolism,Amine oxidase [flavin-containing] B,amines,benzylamine,central nervous system,CFS,Chronic Fatigue Syndrome,Cytoplasmic side,dopamine,dopaminergic neurotransmitters,drug metabolism,drug reaction,drugs,electron carrier activity,energy,ethanol,FAD,flavin,flavin adenine dinucleotide binding,flavin monoamine oxidase family,Flavoprotein,heterodimer,homodimer,integral component of membrane,MAOB,MAOB preferentially degrades benzylamine and phenylethylamine,Membrane,mitochondria,mitochondrial envelope,mitochondrial inner membrane,mitochondrial outer membrane,mitochondrion,Mitochondrion outer membrane,Monoamine oxidase type B,monomer,Negative and Positive Symptoms in Schizophrenia,negative regulation of serotonin secretion,neuroactive amines,Neurotransmitter-Related Genes and miRNAs in Egyptian Autistic Patients,Oxidoreductase,Pain Catastrophizing,Parkinson,parkinson's,Parkinson's disease,PD,peripheral tissues,phenol,phenylethylamine,positive regulation of dopamine metabolic process,primary amine oxidase activity,RCH2NHR' + H2O + O2 = RCHO + R'NH2 + H2O2,response to aluminum ion,response to corticosterone,response to drug,response to ethanol,response to lipopolysaccharide,response to selenium ion,response to toxic substance,schizophrenia,selenium,serotonin,Single-pass type IV,small molecule metabolic process,substantia nigra development,toxicology,toxins,Transmembrane,Transmembrane helix,vasoactive amines,xenobiotic metabolic process,xenobiotics",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs10521432",
        "SNP Name": "MAOB C112982T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10521432",
        "Video": null,
        "Tags": "Acetylation,alcohol,alcohol metabolism,Amine oxidase [flavin-containing] B,amines,benzylamine,central nervous system,Cytoplasmic side,depression,dopamine,dopaminergic neurotransmitters,drug metabolism,drug reaction,drugs,electron carrier activity,energy,ethanol,FAD,flavin,flavin adenine dinucleotide binding,flavin monoamine oxidase family,Flavoprotein,heterodimer,homodimer,integral component of membrane,Major Depression,MAOB,MAOB preferentially degrades benzylamine and phenylethylamine,Membrane,mitochondria,mitochondrial envelope,mitochondrial inner membrane,mitochondrial outer membrane,mitochondrion,Mitochondrion outer membrane,Monoamine oxidase type B,monomer,negative emotionality,negative regulation of serotonin secretion,negativity,neuroactive amines,Oxidoreductase,Pain Catastrophizing,parkinson,parkinson's,Parkinson's disease,PD,peripheral tissues,personality,pessimism,pessimistic,phenol,phenylethylamine,positive regulation of dopamine metabolic process,primary amine oxidase activity,RCH2NHR' + H2O + O2 = RCHO + R'NH2 + H2O2,response to aluminum ion,response to corticosterone,response to drug,response to ethanol,response to lipopolysaccharide,response to selenium ion,response to toxic substance,selenium,serotonin,Single-pass type IV,small molecule metabolic process,substantia nigra development,toxicology,toxins,Transmembrane,Transmembrane helix,vasoactive amines,xenobiotic metabolic process,xenobiotics",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs10521432",
        "SNP Name": "MAOB C112982T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs10521432",
        "Video": null,
        "Tags": "Acetylation,alcohol,alcohol metabolism,Amine oxidase [flavin-containing] B,amines,benzylamine,central nervous system,Cytoplasmic side,depression,dopamine,dopaminergic neurotransmitters,drug metabolism,drug reaction,drugs,electron carrier activity,energy,ethanol,FAD,flavin,flavin adenine dinucleotide binding,flavin monoamine oxidase family,Flavoprotein,heterodimer,homodimer,integral component of membrane,Major Depression,MAOB,MAOB preferentially degrades benzylamine and phenylethylamine,Membrane,mitochondria,mitochondrial envelope,mitochondrial inner membrane,mitochondrial outer membrane,mitochondrion,Mitochondrion outer membrane,Monoamine oxidase type B,monomer,negative emotionality,negative regulation of serotonin secretion,negativity,neuroactive amines,Oxidoreductase,Pain Catastrophizing,parkinson,parkinson's,Parkinson's disease,PD,peripheral tissues,personality,pessimism,pessimistic,phenol,phenylethylamine,positive regulation of dopamine metabolic process,primary amine oxidase activity,RCH2NHR' + H2O + O2 = RCHO + R'NH2 + H2O2,response to aluminum ion,response to corticosterone,response to drug,response to ethanol,response to lipopolysaccharide,response to selenium ion,response to toxic substance,selenium,serotonin,Single-pass type IV,small molecule metabolic process,substantia nigra development,toxicology,toxins,Transmembrane,Transmembrane helix,vasoactive amines,xenobiotic metabolic process,xenobiotics",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs6651806",
        "SNP Name": "MAOB T57758G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6651806",
        "Video": null,
        "Tags": "Acetylation,alcohol,alcohol metabolism,Amine oxidase [flavin-containing] B,amines,benzylamine,central nervous system,Cytoplasmic side,depression,dopamine,dopaminergic neurotransmitters,drug metabolism,drug reaction,drugs,electron carrier activity,energy,ethanol,FAD,flavin,flavin adenine dinucleotide binding,flavin monoamine oxidase family,Flavoprotein,heterodimer,homodimer,integral component of membrane,Major Depression,MAOB,MAOB preferentially degrades benzylamine and phenylethylamine,Membrane,mitochondria,mitochondrial envelope,mitochondrial inner membrane,mitochondrial outer membrane,mitochondrion,Mitochondrion outer membrane,Monoamine oxidase type B,monomer,negative emotionality,negative regulation of serotonin secretion,negativity,neuroactive amines,Oxidoreductase,Pain Catastrophizing,peripheral tissues,personality,personality traits,pessimism,pessimistic,phenol,phenylethylamine,positive regulation of dopamine metabolic process,primary amine oxidase activity,RCH2NHR' + H2O + O2 = RCHO + R'NH2 + H2O2,response to aluminum ion,response to corticosterone,response to drug,response to ethanol,response to lipopolysaccharide,response to selenium ion,response to toxic substance,selenium,serotonin,Single-pass type IV,small molecule metabolic process,substantia nigra development,toxicology,toxins,Transmembrane,Transmembrane helix,vasoactive amines,xenobiotic metabolic process,xenobiotics",
        "Group": "COMT Activity"
    },
    {
        "SNP ID": "rs6651806",
        "SNP Name": "MAOB T57758G",
        "Risk Allele": "A",
        "Your Allele": "AA",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs6651806",
        "Video": null,
        "Tags": "Acetylation,alcohol,alcohol metabolism,Amine oxidase [flavin-containing] B,amines,benzylamine,central nervous system,Cytoplasmic side,depression,dopamine,dopaminergic neurotransmitters,drug metabolism,drug reaction,drugs,electron carrier activity,energy,ethanol,FAD,flavin,flavin adenine dinucleotide binding,flavin monoamine oxidase family,Flavoprotein,heterodimer,homodimer,integral component of membrane,Major Depression,MAOB,MAOB preferentially degrades benzylamine and phenylethylamine,Membrane,mitochondria,mitochondrial envelope,mitochondrial inner membrane,mitochondrial outer membrane,mitochondrion,Mitochondrion outer membrane,Monoamine oxidase type B,monomer,negative emotionality,negative regulation of serotonin secretion,negativity,neuroactive amines,Oxidoreductase,Pain Catastrophizing,peripheral tissues,personality,personality traits,pessimism,pessimistic,phenol,phenylethylamine,positive regulation of dopamine metabolic process,primary amine oxidase activity,RCH2NHR' + H2O + O2 = RCHO + R'NH2 + H2O2,response to aluminum ion,response to corticosterone,response to drug,response to ethanol,response to lipopolysaccharide,response to selenium ion,response to toxic substance,selenium,serotonin,Single-pass type IV,small molecule metabolic process,substantia nigra development,toxicology,toxins,Transmembrane,Transmembrane helix,vasoactive amines,xenobiotic metabolic process,xenobiotics",
        "Group": "Neurotransmitter Pathway: Serotonin & Dopamine"
    },
    {
        "SNP ID": "rs1028348",
        "SNP Name": "HEPH 6731C>T",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs17216603",
        "SNP Name": "HEPH Ala598Thr",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs1264216",
        "SNP Name": "HEPH 57825T>G",
        "Risk Allele": "G",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": null,
        "Group": "Iron Uptake & Transport"
    },
    {
        "SNP ID": "rs6048",
        "SNP Name": "F9 G580A A25386G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Alternative splicing,blood coagulation,Ca2+ ions,calcium,calcium ion binding,cellular protein metabolic process,Christmas factor,Cleavage on pair of basic residues,coagulation,Coagulation factor IX,Coagulation factor IXa heavy chain,Coagulation factor IXa light chain,converting factor X,deep vein thrombosis,Disease mutation,Disulfide bond,due to factor IX defect,EGF-like domain,EGF-like domains,endoplasmic reticulum lumen,extracellular region,extracellular vesicular exosome,extrinsic pathway,F9,FA9,Factor IX,factor IX deficiency,factor VIIIa,Gamma-carboxyglutamic acid,Gamma-carboxylation,Gla (gamma-carboxy-glutamate) domain,Glycoprotein,golgi lumen,HEMB,Hemophilia,hemophilia A,Hemophilia B,Hemostasis,Hydrolase,Hydroxylation,intrinsic pathway,lupus,Mild hemophilia B,Moderately severe hemophilia B,peptidase S1 domain,peptidase S1 family,peptidyl-glutamic acid carboxylation,phospholipids,Phosphoprotein,plasma membrane,Plasma thromboplastin component,Polymorphism,post-translational protein modification,Protease,PTC,Repeat,Serine protease,serine-type endopeptidase activity,Severe hemophilia B,Signal,Sulfation,Symptomatic form of hemophilia B in female carriers,Systemic Lupus Erythematosus,THPH8,Thrombophilia,vit K,vitamin K,vitamin K-dependent plasma,X-linked,Xylosylation,Zymogen",
        "Group": "Alzheimers/Cardio/Lipid"
    },
    {
        "SNP ID": "rs6048",
        "SNP Name": "F9 G580A A25386G",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": null,
        "Video": null,
        "Tags": "Alternative splicing,blood coagulation,Ca2+ ions,calcium,calcium ion binding,cellular protein metabolic process,Christmas factor,Cleavage on pair of basic residues,coagulation,Coagulation factor IX,Coagulation factor IXa heavy chain,Coagulation factor IXa light chain,converting factor X,deep vein thrombosis,Disease mutation,Disulfide bond,due to factor IX defect,EGF-like domain,EGF-like domains,endoplasmic reticulum lumen,extracellular region,extracellular vesicular exosome,extrinsic pathway,F9,FA9,Factor IX,factor IX deficiency,factor VIIIa,Gamma-carboxyglutamic acid,Gamma-carboxylation,Gla (gamma-carboxy-glutamate) domain,Glycoprotein,golgi lumen,HEMB,Hemophilia,hemophilia A,Hemophilia B,Hemostasis,Hydrolase,Hydroxylation,intrinsic pathway,lupus,Mild hemophilia B,Moderately severe hemophilia B,peptidase S1 domain,peptidase S1 family,peptidyl-glutamic acid carboxylation,phospholipids,Phosphoprotein,plasma membrane,Plasma thromboplastin component,Polymorphism,post-translational protein modification,Protease,PTC,Repeat,Serine protease,serine-type endopeptidase activity,Severe hemophilia B,Signal,Sulfation,Symptomatic form of hemophilia B in female carriers,Systemic Lupus Erythematosus,THPH8,Thrombophilia,vit K,vitamin K,vitamin K-dependent plasma,X-linked,Xylosylation,Zymogen",
        "Group": "Clotting Factors"
    },
    {
        "SNP ID": "rs766420",
        "SNP Name": "TKTL1 C35378G",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs766420",
        "Video": null,
        "Tags": "adult heart,adulta placenta,aldose acceptor,alternative slicing,brain,C153554404G,Ca92+),Calcium,canonical sequence,carboxyl oxygen,catalytic activity,Co2+,cofactor,cofactor binding sites,covalent intermediate,Cytoplasm,d-glyceraldehyde 3-phosphate,D-ribose 5-phosphate,D-xylulose 5-phosphate,divalent metal cations,epithelial tumors,fetal heart,glucose catabolic process,Homodimer,ion,Isoform 1,Isoform 2,Isoform 3,Isoform 4,isoforms,ketose,ketose donor,kidney,liver,lung,Magnesium,metal ion binding,Metal-binding,Mg(2+),Nucleotide binding,Nucleus,pancreas,pentose-phosphate pathway,Polymorphism,protein,rs766420,Sedoheptulose 7-phosphate,skeletak muscle,substrate,subunit,thiamine diphosphate,thiamine metabolic process,thiamine pyrophosphate,thiamine pyropphosphate,TK 2,TKTL1,Transferase,Transketolase 2,transketolase activity,transketolase family,Transketolase-like protein 1,Transketolase-related protein,two-carbon ketol group",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs766420",
        "SNP Name": "TKTL1 C35378G",
        "Risk Allele": "G",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs766420",
        "Video": null,
        "Tags": "adult heart,adulta placenta,aldose acceptor,alternative slicing,brain,C153554404G,Ca92+),Calcium,canonical sequence,carboxyl oxygen,catalytic activity,Co2+,cofactor,cofactor binding sites,covalent intermediate,Cytoplasm,d-glyceraldehyde 3-phosphate,D-ribose 5-phosphate,D-xylulose 5-phosphate,divalent metal cations,epithelial tumors,fetal heart,glucose catabolic process,Homodimer,ion,Isoform 1,Isoform 2,Isoform 3,Isoform 4,isoforms,ketose,ketose donor,kidney,liver,lung,Magnesium,metal ion binding,Metal-binding,Mg(2+),Nucleotide binding,Nucleus,pancreas,pentose-phosphate pathway,Polymorphism,protein,rs766420,Sedoheptulose 7-phosphate,skeletak muscle,substrate,subunit,thiamine diphosphate,thiamine metabolic process,thiamine pyrophosphate,thiamine pyropphosphate,TK 2,TKTL1,Transferase,Transketolase 2,transketolase activity,transketolase family,Transketolase-like protein 1,Transketolase-related protein,two-carbon ketol group",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs766419",
        "SNP Name": "TKTL1 A35635G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs766419",
        "Video": null,
        "Tags": "A153554661G,adult heart,adulta placenta,aldose acceptor,alternative slicing,brain,Ca92+),Calcium,canonical sequence,carboxyl oxygen,catalytic activity,Co2+,cofactor,cofactor binding sites,covalent intermediate,Cytoplasm,d-glyceraldehyde 3-phosphate,D-ribose 5-phosphate,D-xylulose 5-phosphate,divalent metal cations,epithelial tumors,fetal heart,glucose catabolic process,Homodimer,ion,Isoform 1,Isoform 2,Isoform 3,Isoform 4,isoforms,ketose,ketose donor,kidney,liver,lung,Magnesium,metal ion binding,Metal-binding,Mg(2+),Nucleotide binding,Nucleus,pancreas,pentose-phosphate pathway,Polymorphism,protein,rs766419,Sedoheptulose 7-phosphate,skeletak muscle,substrate,subunit,thiamine diphosphate,thiamine metabolic process,thiamine pyrophosphate,thiamine pyropphosphate,TK 2,TKTL1,Transferase,Transketolase 2,transketolase activity,transketolase family,Transketolase-like protein 1,Transketolase-related protein,two-carbon ketol group",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs766419",
        "SNP Name": "TKTL1 A35635G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs766419",
        "Video": null,
        "Tags": "A153554661G,adult heart,adulta placenta,aldose acceptor,alternative slicing,brain,Ca92+),Calcium,canonical sequence,carboxyl oxygen,catalytic activity,Co2+,cofactor,cofactor binding sites,covalent intermediate,Cytoplasm,d-glyceraldehyde 3-phosphate,D-ribose 5-phosphate,D-xylulose 5-phosphate,divalent metal cations,epithelial tumors,fetal heart,glucose catabolic process,Homodimer,ion,Isoform 1,Isoform 2,Isoform 3,Isoform 4,isoforms,ketose,ketose donor,kidney,liver,lung,Magnesium,metal ion binding,Metal-binding,Mg(2+),Nucleotide binding,Nucleus,pancreas,pentose-phosphate pathway,Polymorphism,protein,rs766419,Sedoheptulose 7-phosphate,skeletak muscle,substrate,subunit,thiamine diphosphate,thiamine metabolic process,thiamine pyrophosphate,thiamine pyropphosphate,TK 2,TKTL1,Transferase,Transketolase 2,transketolase activity,transketolase family,Transketolase-like protein 1,Transketolase-related protein,two-carbon ketol group",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs2872817",
        "SNP Name": "TKTL1 A39392G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2872817",
        "Video": null,
        "Tags": "A153558418G,adult heart,adulta placenta,aldose acceptor,alternative slicing,brain,Ca92+),Calcium,canonical sequence,carboxyl oxygen,catalytic activity,Co2+,cofactor,cofactor binding sites,covalent intermediate,Cytoplasm,d-glyceraldehyde 3-phosphate,D-ribose 5-phosphate,D-xylulose 5-phosphate,divalent metal cations,epithelial tumors,fetal heart,glucose catabolic process,Homodimer,ion,Isoform 1,Isoform 2,Isoform 3,Isoform 4,isoforms,ketose,ketose donor,kidney,liver,lung,Magnesium,metal ion binding,Metal-binding,Mg(2+),Nucleotide binding,Nucleus,pancreas,pentose-phosphate pathway,Polymorphism,protein,rs2872817,Sedoheptulose 7-phosphate,skeletak muscle,substrate,subunit,thiamine diphosphate,thiamine metabolic process,thiamine pyrophosphate,thiamine pyropphosphate,TK 2,TKTL1,Transferase,Transketolase 2,transketolase activity,transketolase family,Transketolase-like protein 1,Transketolase-related protein,two-carbon ketol group",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs2872817",
        "SNP Name": "TKTL1 A39392G",
        "Risk Allele": "G",
        "Your Allele": "AA",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2872817",
        "Video": null,
        "Tags": "A153558418G,adult heart,adulta placenta,aldose acceptor,alternative slicing,brain,Ca92+),Calcium,canonical sequence,carboxyl oxygen,catalytic activity,Co2+,cofactor,cofactor binding sites,covalent intermediate,Cytoplasm,d-glyceraldehyde 3-phosphate,D-ribose 5-phosphate,D-xylulose 5-phosphate,divalent metal cations,epithelial tumors,fetal heart,glucose catabolic process,Homodimer,ion,Isoform 1,Isoform 2,Isoform 3,Isoform 4,isoforms,ketose,ketose donor,kidney,liver,lung,Magnesium,metal ion binding,Metal-binding,Mg(2+),Nucleotide binding,Nucleus,pancreas,pentose-phosphate pathway,Polymorphism,protein,rs2872817,Sedoheptulose 7-phosphate,skeletak muscle,substrate,subunit,thiamine diphosphate,thiamine metabolic process,thiamine pyrophosphate,thiamine pyropphosphate,TK 2,TKTL1,Transferase,Transketolase 2,transketolase activity,transketolase family,Transketolase-like protein 1,Transketolase-related protein,two-carbon ketol group",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs72554664",
        "SNP Name": "G6PD R493H",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs72554664",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,R493H,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs72554664,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum"
    },
    {
        "SNP ID": "rs72554664",
        "SNP Name": "G6PD R493H",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs72554664",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,R493H,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs72554664,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Hydroxide"
    },
    {
        "SNP ID": "rs72554664",
        "SNP Name": "G6PD R493H",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs72554664",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,R493H,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs72554664,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Hydroxyphosphate Sulfate"
    },
    {
        "SNP ID": "rs72554664",
        "SNP Name": "G6PD R493H",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs72554664",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,R493H,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs72554664,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Phosphate"
    },
    {
        "SNP ID": "rs72554664",
        "SNP Name": "G6PD R493H",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs72554664",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,R493H,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs72554664,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Potassium Sulfate"
    },
    {
        "SNP ID": "rs72554664",
        "SNP Name": "G6PD R493H",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs72554664",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,R493H,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs72554664,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Salts"
    },
    {
        "SNP ID": "rs72554664",
        "SNP Name": "G6PD R493H",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs72554664",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,R493H,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs72554664,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Sulfate"
    },
    {
        "SNP ID": "rs72554664",
        "SNP Name": "G6PD R493H",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs72554664",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,R493H,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs72554664,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Ascorbic Acid"
    },
    {
        "SNP ID": "rs72554664",
        "SNP Name": "G6PD R493H",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs72554664",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,R493H,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs72554664,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "MRC-5 Cellular Proteins/Components"
    },
    {
        "SNP ID": "rs72554664",
        "SNP Name": "G6PD R493H",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs72554664",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,R493H,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs72554664,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Sodium Pyruvate"
    },
    {
        "SNP ID": "rs72554664",
        "SNP Name": "G6PD R493H",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs72554664",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,R493H,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs72554664,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs72554664",
        "SNP Name": "G6PD R493H",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs72554664",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,R493H,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs72554664,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs72554664",
        "SNP Name": "G6PD R493H",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs72554664",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,R493H,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs72554664,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs2230037",
        "SNP Name": "G6PD T438T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2230037",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,C1311T,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs2230037,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum"
    },
    {
        "SNP ID": "rs2230037",
        "SNP Name": "G6PD T438T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2230037",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,C1311T,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs2230037,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Hydroxide"
    },
    {
        "SNP ID": "rs2230037",
        "SNP Name": "G6PD T438T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2230037",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,C1311T,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs2230037,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Hydroxyphosphate Sulfate"
    },
    {
        "SNP ID": "rs2230037",
        "SNP Name": "G6PD T438T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2230037",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,C1311T,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs2230037,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Phosphate"
    },
    {
        "SNP ID": "rs2230037",
        "SNP Name": "G6PD T438T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2230037",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,C1311T,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs2230037,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Potassium Sulfate"
    },
    {
        "SNP ID": "rs2230037",
        "SNP Name": "G6PD T438T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2230037",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,C1311T,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs2230037,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Salts"
    },
    {
        "SNP ID": "rs2230037",
        "SNP Name": "G6PD T438T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2230037",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,C1311T,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs2230037,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Sulfate"
    },
    {
        "SNP ID": "rs2230037",
        "SNP Name": "G6PD T438T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2230037",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,C1311T,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs2230037,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Ascorbic Acid"
    },
    {
        "SNP ID": "rs2230037",
        "SNP Name": "G6PD T438T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2230037",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,C1311T,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs2230037,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "MRC-5 Cellular Proteins/Components"
    },
    {
        "SNP ID": "rs2230037",
        "SNP Name": "G6PD T438T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2230037",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,C1311T,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs2230037,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Polacrilin Potassium"
    },
    {
        "SNP ID": "rs2230037",
        "SNP Name": "G6PD T438T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2230037",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,C1311T,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs2230037,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Sodium Pyruvate"
    },
    {
        "SNP ID": "rs2230037",
        "SNP Name": "G6PD T438T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2230037",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,C1311T,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs2230037,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs2230037",
        "SNP Name": "G6PD T438T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2230037",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,C1311T,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs2230037,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs2230037",
        "SNP Name": "G6PD T438T",
        "Risk Allele": "G",
        "Your Allele": "GG",
        "Result": "+/+",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2230037",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,C1311T,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs2230037,severe NSHA,severe phenotype,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs5986990",
        "SNP Name": "G6PD G153761628A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5986990",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,acute seizures,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G153761628A,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Malaria Susceptibility,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs5030868,seizure,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs5986990",
        "SNP Name": "G6PD G153761628A",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5986990",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,acute seizures,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G153761628A,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Malaria Susceptibility,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs5030868,seizure,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs5030868",
        "SNP Name": "G6PD S219F",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5030868",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,Favism,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,G6PD-Mediterran,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,Glucose-6-phosphate dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell,Red Blood Cell Disorders,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs5030868,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum"
    },
    {
        "SNP ID": "rs5030868",
        "SNP Name": "G6PD S219F",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5030868",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,Favism,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,G6PD-Mediterran,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,Glucose-6-phosphate dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell,Red Blood Cell Disorders,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs5030868,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Hydroxide"
    },
    {
        "SNP ID": "rs5030868",
        "SNP Name": "G6PD S219F",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5030868",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,Favism,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,G6PD-Mediterran,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,Glucose-6-phosphate dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell,Red Blood Cell Disorders,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs5030868,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Hydroxyphosphate Sulfate"
    },
    {
        "SNP ID": "rs5030868",
        "SNP Name": "G6PD S219F",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5030868",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,Favism,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,G6PD-Mediterran,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,Glucose-6-phosphate dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell,Red Blood Cell Disorders,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs5030868,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Phosphate"
    },
    {
        "SNP ID": "rs5030868",
        "SNP Name": "G6PD S219F",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5030868",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,Favism,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,G6PD-Mediterran,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,Glucose-6-phosphate dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell,Red Blood Cell Disorders,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs5030868,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Potassium Sulfate"
    },
    {
        "SNP ID": "rs5030868",
        "SNP Name": "G6PD S219F",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5030868",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,Favism,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,G6PD-Mediterran,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,Glucose-6-phosphate dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell,Red Blood Cell Disorders,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs5030868,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Salts"
    },
    {
        "SNP ID": "rs5030868",
        "SNP Name": "G6PD S219F",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5030868",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,Favism,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,G6PD-Mediterran,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,Glucose-6-phosphate dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell,Red Blood Cell Disorders,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs5030868,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Sulfate"
    },
    {
        "SNP ID": "rs5030868",
        "SNP Name": "G6PD S219F",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5030868",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,Favism,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,G6PD-Mediterran,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,Glucose-6-phosphate dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell,Red Blood Cell Disorders,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs5030868,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Ascorbic Acid"
    },
    {
        "SNP ID": "rs5030868",
        "SNP Name": "G6PD S219F",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5030868",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,Favism,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,G6PD-Mediterran,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,Glucose-6-phosphate dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell,Red Blood Cell Disorders,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs5030868,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "MRC-5 Cellular Proteins/Components"
    },
    {
        "SNP ID": "rs5030868",
        "SNP Name": "G6PD S219F",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5030868",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,Favism,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,G6PD-Mediterran,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,Glucose-6-phosphate dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell,Red Blood Cell Disorders,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs5030868,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Sodium Pyruvate"
    },
    {
        "SNP ID": "rs5030868",
        "SNP Name": "G6PD S219F",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5030868",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,Favism,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,G6PD-Mediterran,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,Glucose-6-phosphate dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell,Red Blood Cell Disorders,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs5030868,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs5030868",
        "SNP Name": "G6PD S219F",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5030868",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,Favism,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,G6PD-Mediterran,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,Glucose-6-phosphate dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell,Red Blood Cell Disorders,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs5030868,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs5030868",
        "SNP Name": "G6PD S219F",
        "Risk Allele": "A",
        "Your Allele": "GG",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs5030868",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,fatigue,fatty acid,Favism,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,G6PD-Mediterran,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,Glucose-6-phosphate dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Mediterranean,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,protein homodimerization activity,Red Blood Cell,Red Blood Cell Disorders,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs5030868,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs1050829",
        "SNP Name": "G6PD N156D",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050829",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,acute seizures,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(+),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Malaria Susceptibility,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050829,seizure,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum"
    },
    {
        "SNP ID": "rs1050829",
        "SNP Name": "G6PD N156D",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050829",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,acute seizures,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(+),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Malaria Susceptibility,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050829,seizure,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Hydroxide"
    },
    {
        "SNP ID": "rs1050829",
        "SNP Name": "G6PD N156D",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050829",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,acute seizures,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(+),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Malaria Susceptibility,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050829,seizure,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Hydroxyphosphate Sulfate"
    },
    {
        "SNP ID": "rs1050829",
        "SNP Name": "G6PD N156D",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050829",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,acute seizures,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(+),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Malaria Susceptibility,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050829,seizure,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Phosphate"
    },
    {
        "SNP ID": "rs1050829",
        "SNP Name": "G6PD N156D",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050829",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,acute seizures,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(+),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Malaria Susceptibility,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050829,seizure,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Potassium Sulfate"
    },
    {
        "SNP ID": "rs1050829",
        "SNP Name": "G6PD N156D",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050829",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,acute seizures,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(+),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Malaria Susceptibility,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050829,seizure,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Salts"
    },
    {
        "SNP ID": "rs1050829",
        "SNP Name": "G6PD N156D",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050829",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,acute seizures,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(+),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Malaria Susceptibility,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050829,seizure,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Sulfate"
    },
    {
        "SNP ID": "rs1050829",
        "SNP Name": "G6PD N156D",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050829",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,acute seizures,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(+),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Malaria Susceptibility,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050829,seizure,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Ascorbic Acid"
    },
    {
        "SNP ID": "rs1050829",
        "SNP Name": "G6PD N156D",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050829",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,acute seizures,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(+),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Malaria Susceptibility,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050829,seizure,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "MRC-5 Cellular Proteins/Components"
    },
    {
        "SNP ID": "rs1050829",
        "SNP Name": "G6PD N156D",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050829",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,acute seizures,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(+),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Malaria Susceptibility,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050829,seizure,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Sodium Pyruvate"
    },
    {
        "SNP ID": "rs1050829",
        "SNP Name": "G6PD N156D",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050829",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,acute seizures,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(+),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Malaria Susceptibility,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050829,seizure,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1050829",
        "SNP Name": "G6PD N156D",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050829",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,acute seizures,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(+),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Malaria Susceptibility,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050829,seizure,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs1050829",
        "SNP Name": "G6PD N156D",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050829",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,acute seizures,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(+),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Malaria Susceptibility,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050829,seizure,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs1050828",
        "SNP Name": "G6PD V98M",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050828",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(-),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hematological,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050828,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum"
    },
    {
        "SNP ID": "rs1050828",
        "SNP Name": "G6PD V98M",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050828",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(-),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hematological,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050828,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Hydroxide"
    },
    {
        "SNP ID": "rs1050828",
        "SNP Name": "G6PD V98M",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050828",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(-),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hematological,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050828,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Hydroxyphosphate Sulfate"
    },
    {
        "SNP ID": "rs1050828",
        "SNP Name": "G6PD V98M",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050828",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(-),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hematological,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050828,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Phosphate"
    },
    {
        "SNP ID": "rs1050828",
        "SNP Name": "G6PD V98M",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050828",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(-),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hematological,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050828,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Potassium Sulfate"
    },
    {
        "SNP ID": "rs1050828",
        "SNP Name": "G6PD V98M",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050828",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(-),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hematological,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050828,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Salts"
    },
    {
        "SNP ID": "rs1050828",
        "SNP Name": "G6PD V98M",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050828",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(-),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hematological,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050828,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Aluminum Sulfate"
    },
    {
        "SNP ID": "rs1050828",
        "SNP Name": "G6PD V98M",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050828",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(-),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hematological,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050828,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Ascorbic Acid"
    },
    {
        "SNP ID": "rs1050828",
        "SNP Name": "G6PD V98M",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050828",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(-),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hematological,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050828,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "MRC-5 Cellular Proteins/Components"
    },
    {
        "SNP ID": "rs1050828",
        "SNP Name": "G6PD V98M",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Excipient Report v1.1",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050828",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(-),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hematological,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050828,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Sodium Pyruvate"
    },
    {
        "SNP ID": "rs1050828",
        "SNP Name": "G6PD V98M",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050828",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(-),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hematological,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050828,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Liver Detox - Phase II"
    },
    {
        "SNP ID": "rs1050828",
        "SNP Name": "G6PD V98M",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050828",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(-),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hematological,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050828,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs1050828",
        "SNP Name": "G6PD V98M",
        "Risk Allele": "T",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs1050828",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,alcohol,alcohol metabolism,Alternative splicing,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-A(-),G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hematological,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs1050828,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,variant B",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs762515",
        "SNP Name": "G6PD A16260G",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs762515",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,acute seizures,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Malaria Susceptibility,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs762515,seizure,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,T153764528C,variant B",
        "Group": "Pentose Phosphate Pathway"
    },
    {
        "SNP ID": "rs762515",
        "SNP Name": "G6PD A16260G",
        "Risk Allele": "C",
        "Your Allele": "TT",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs762515",
        "Video": "a1ZGOo35t24",
        "Tags": "3D-structure,5-lactone,6-phospho-D-glucono-1,Acetylation,acute hemolytic anemia,acute seizures,alcohol,alcohol metabolism,Alternative splicing,amino acids,Anaemia,Anemia,antiphospholipid,antiphospholipid antibody syndrome,antiphospholipid syndrome,asymptomatic,avalox,back pain,C-terminal domain,Carbohydrate degradation,carbohydrate metabolic process,Carbohydrate metabolism,cellular response to oxidative stress,cholesterol biosynthetic process,cipro,Class-I variants,Complete proteome,cosubstrate (bound to the N-terminal domain),cytokine production,cytoplasm,cytoplasmic side of plasma membrane,cytosol,D-glucose 6-phosphate,D-glucose 6-phosphate (oxidative stage),D-ribulose 5-phosphate,dimer,dimers,Direct protein sequencing,Disease mutation,dissimilation of carbohydrates besides glycolysis,drug-resistant Plasmodium falciparum parasites,drugs,endemic,erythrocyte maturation,exogenous agent,extracellular vesicular exosome,falciparum malaria,fatigue,fatty acid,floxie,fluoroquinolone,fluoroquinolone toxicity,fluoroquinolones,food,G6PD,G6PD deficiency,G6PD-deficiency alleles,glucose 6-phosphate metabolic process,glucose binding,Glucose metabolism,Glucose-6-phosphate 1-dehydrogenase,glucose-6-phosphate dehydrogenase activity,glucose-6-phosphate dehydrogenase family,glutathione metabolic process,granulocytes,hemolytic anemia,Hereditary hemolytic anemia,Homotetramer,Hughes syndrome,increased unconjugated bilirubin,infection,Isoform Long,jaundice,lactate dehydrogenase,levequin,lipid metabolic process,low frequencies,lymphoblasts,malaria,Malaria Susceptibility,mutations,NADP,NADP binding,NADP metabolic process,NADPH,NADPH regeneration,negative regulation of protein glutathionylation,non-spherocytic hemolytic,NSHA,nucleic acid synthesis,nucleus,oxidation-reduction process,oxidative branch,oxidative pentose-phosphate pathway,Oxidoreductase,parasite,pentose biosynthetic process,pentose phosphate pathway,pentose phosphates,pentose-phosphate pathway,pentose-phosphate shunt,Phosphoprotein,polymorphism,Pro-inflammatory Molecules,protein homodimerization activity,Red Blood Cell Disorder,reduced glutathione,Reference proteome,regulation of neuron apoptotic process,response to ethanol,response to food,response to organic cyclic compound,reticulocytosis,ribose phosphate biosynthetic process,risk of acute hemolytic attacks,rs762515,seizure,Severe Malaria,severe NSHA,severe phenotype,sickle cell anaemia,silent cerebral infarcts,small molecule metabolic process,sperm,sporadic cases of G6PD deficiency,structural element,substantia nigra development,T153764528C,variant B",
        "Group": "Thiamin/Thiamine Degradation"
    },
    {
        "SNP ID": "rs2472394",
        "SNP Name": "G6PD G9437T",
        "Risk Allele": "A",
        "Your Allele": "CC",
        "Result": "-/-",
        "Report Name": "MTHFRSupport Variant Report v2.5",
        "Info": "http://www.ncbi.nlm.nih.gov/pmc/?term=rs2472394",
        "Video": "a1ZGOo35t24",
        "Tags": null,
        "Group": "Thiamin/Thiamine Degradation"
    }
]